<SEC-DOCUMENT>0001493152-24-044881.txt : 20241112
<SEC-HEADER>0001493152-24-044881.hdr.sgml : 20241112
<ACCEPTANCE-DATETIME>20241112173128
ACCESSION NUMBER:		0001493152-24-044881
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		103
FILED AS OF DATE:		20241112
DATE AS OF CHANGE:		20241112

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NextTrip, Inc.
		CENTRAL INDEX KEY:			0000788611
		STANDARD INDUSTRIAL CLASSIFICATION:	TRANSPORTATION SERVICES [4700]
		ORGANIZATION NAME:           	01 Energy & Transportation
		IRS NUMBER:				820404220
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0228

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-278562
		FILM NUMBER:		241450094

	BUSINESS ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507
		BUSINESS PHONE:		(954) 526-9688

	MAIL ADDRESS:	
		STREET 1:		3900 PASEO DEL SOL
		CITY:			SANTE FE
		STATE:			NM
		ZIP:			87507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGMA ADDITIVE SOLUTIONS, INC.
		DATE OF NAME CHANGE:	20220812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SIGMA LABS, INC.
		DATE OF NAME CHANGE:	20101014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FRAMEWAVES INC
		DATE OF NAME CHANGE:	20010130
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>forms-1a.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:NTRP="http://nexttrip.com/20240831">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_NTRP_nexttrip.com_20240831 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20240301_20240831 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DAmendmentFlag_true -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0000788611 -->
<!-- Field: Set; Name: xdx; ID: xdx_070_XDX_Z%2D%2D\2024 OPERATIONS\EDGAR\11 NOVEMBER\NextTrip Inc\11%2D08%2D2024\Form S%2D1A\Draft\Production\form10%2Dk.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_sqft_0_utr%2D%2Dsqft -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000003" name="dei:AmendmentFlag">true</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000004" name="dei:EntityCentralIndexKey">0000788611</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl0012" name="dei:DocumentType">S-1/A</ix:nonNumeric>
  <ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2023-02-28" id="xdx2ixbrl0043" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-02-28" id="xdx2ixbrl0064" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2024-02-29" id="xdx2ixbrl0066" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2024-02-29" id="xdx2ixbrl0087" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2024-02-29" id="xdx2ixbrl0096" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2024-02-29" id="xdx2ixbrl0105" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2024-02-29" id="xdx2ixbrl0108" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-02-29" id="xdx2ixbrl0114" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2023-02-28" id="xdx2ixbrl0115" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2023-02-28" id="xdx2ixbrl0121" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0191" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0206" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0224" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0227" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0230" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0244" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0245" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0257" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0274" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0276" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0299" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0305" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0312" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0315" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember" id="xdx2ixbrl0320" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0321" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0331" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0335" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl0341" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0346" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0348" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodShareOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0353" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0358" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0363" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0374" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0389" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0390" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0392" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0395" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0396" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="xdx2ixbrl0401" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="xdx2ixbrl0402" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0403" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:DepreciationOfRightOfUseAsset" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0447" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0451" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0454" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0457" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:GainLossOnDispositionOfIntangibleAssets" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0475" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncreaseDecreaseInRightOfUseLeaseLiability" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0477" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0490" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:OriginationOfNotesReceivableFromRelatedParties" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ProceedsFromAcquireBusinessesGross" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0508" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0511" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0529" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0532" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0558" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0559" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForServices" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0568" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ConversionOfConvertibleNotes" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0571" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0574" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0577" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-03-012023-02-28_us-gaap_WarrantMember" id="xdx2ixbrl0622" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-03-012023-02-28_us-gaap_StockOptionMember" id="xdx2ixbrl0625" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember21725578" id="xdx2ixbrl0628" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0631" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0717" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:PrepaidCostOfSales" contextRef="AsOf2023-02-28" id="xdx2ixbrl0746" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" contextRef="AsOf2024-02-29" id="xdx2ixbrl0818" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:DeferredTaxAssetDepreciation" contextRef="AsOf2023-02-28" id="xdx2ixbrl0909" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:DeferredTaxAssetsPayrollAccruals" contextRef="AsOf2023-02-28" id="xdx2ixbrl0912" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2024-02-29" id="xdx2ixbrl0920" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2023-02-28" id="xdx2ixbrl0921" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0936" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0939" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0945" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0948" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0951" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl0956" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl0957" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28" id="xdx2ixbrl1185" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" id="xdx2ixbrl1187" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1195" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1199" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1201" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1207" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29" id="xdx2ixbrl1215" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-02-29" id="xdx2ixbrl1223" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2024-02-29" id="xdx2ixbrl1231" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-02-29" id="xdx2ixbrl1239" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-12-292023-12-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1251" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-12-292023-12-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1253" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1271" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1273" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl1275" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1283" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1285" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1287" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1289" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1291" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1293" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1295" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1303" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1311" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1319" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl1327" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-02-28" id="xdx2ixbrl1349" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" id="xdx2ixbrl1351" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1365" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1367" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1369" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl1371" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl1387" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2022-03-012023-02-28" id="xdx2ixbrl1393" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_NonrelatedPartyMember" id="xdx2ixbrl1524" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-08-31" id="xdx2ixbrl1535" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-02-29" id="xdx2ixbrl1536" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1594" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1596" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1619" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1621" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-06-012024-08-31" id="xdx2ixbrl1663" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1664" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl1665" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1666" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1674" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1676" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1684" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1686" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1713" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl1715" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1721" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1723" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1770" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1771" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1772" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1776" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1777" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-06-012024-08-31" id="xdx2ixbrl1780" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1783" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1785" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1790" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1793" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1798" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1799" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1801" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1814" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1820" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1824" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1825" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1826" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1830" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1836" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1853" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1854" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1855" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1859" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1860" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl1863" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1866" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1868" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1875" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1876" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl1877" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1883" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1886" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1891" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1892" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl1894" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl1907" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl1913" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl1917" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember" id="xdx2ixbrl1923" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1927" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31_us-gaap_CommonStockMember" id="xdx2ixbrl1928" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl1929" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1933" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1939" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1943" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember" id="xdx2ixbrl1949" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:DepreciationOfRightOfUseAsset" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl1971" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1975" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IncreaseDecreaseInPromissoryNoteReceivable" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl1986" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl1996" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2002" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2019" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2023" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2026" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2050" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2053" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2061" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeTaxesPaidNet" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2062" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012023-08-31_us-gaap_WarrantMember" id="xdx2ixbrl2119" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember21742390" id="xdx2ixbrl2122" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012023-08-31_us-gaap_PreferredStockMember21742421" id="xdx2ixbrl2125" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2128" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl2138" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2140" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-06-012023-08-31" id="xdx2ixbrl2148" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-03-012023-08-31" id="xdx2ixbrl2150" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" contextRef="AsOf2024-08-31" id="xdx2ixbrl2261" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28" id="xdx2ixbrl2437" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" id="xdx2ixbrl2439" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-02-28" id="xdx2ixbrl2441" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2449" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2451" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2453" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2455" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2459" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2461" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2467" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29" id="xdx2ixbrl2475" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2477" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2479" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2481" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2485" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2487" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2493" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-08-31" id="xdx2ixbrl2501" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-08-31" id="xdx2ixbrl2509" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2024-08-31" id="xdx2ixbrl2517" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-08-31" id="xdx2ixbrl2525" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl2535" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl2537" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember" id="xdx2ixbrl2539" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2547" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2549" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2551" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2553" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2555" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2557" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2559" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="xdx2ixbrl2567" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2569" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2571" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2573" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2575" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2577" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2579" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2585" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2593" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2601" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2609" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="xdx2ixbrl2617" unitRef="USD" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2023-02-28" id="xdx2ixbrl2627" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2023-02-28" id="xdx2ixbrl2629" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2643" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2645" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2647" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" contextRef="From2023-03-012024-02-29" id="xdx2ixbrl2649" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2657" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2659" unitRef="USDPShares" xs:nil="true"/>
  <ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2661" unitRef="Shares" xs:nil="true"/>
  <ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl2663" unitRef="USDPShares" xs:nil="true"/>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ntrp-20240831.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-03-01to2024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_NonrelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:MembershipUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:PreferredUnitsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-25</xbrli:startDate>
        <xbrli:endDate>2023-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-25_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_NextInnovationLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-02-292024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-29</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_NextInnovationLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ClosingSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember21725562">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_PreferredStockMember21725578">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-09-01_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-09-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-06</xbrli:startDate>
        <xbrli:endDate>2023-10-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-01-25_custom_PrincipalExecutiveOfficesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-01-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_custom_PrincipalExecutiveOfficesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_custom_PrincipalExecutiveOfficesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_custom_PrincipalExecutiveOfficesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_ComputerEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_SoftwareLicenseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_SoftwareDevelopmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SoftwareLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SoftwareLicensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_TrademarksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-10-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-122023-10-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-12</xbrli:startDate>
        <xbrli:endDate>2023-10-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-13</xbrli:startDate>
        <xbrli:endDate>2023-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-06-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-27</xbrli:startDate>
        <xbrli:endDate>2023-02-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-08-10</xbrli:startDate>
        <xbrli:endDate>2023-11-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-11-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-19</xbrli:startDate>
        <xbrli:endDate>2022-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-28</xbrli:startDate>
        <xbrli:endDate>2023-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_custom_NextPlayTechnologiesIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-182024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-18</xbrli:startDate>
        <xbrli:endDate>2024-03-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-14_custom_InvestorsDirectorsOfficersAndEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_InvestorsDirectorsOfficersAndEmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-21_custom_DonaldMonacoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_DonaldMonacoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-312024-08-31_custom_DonaldMonacoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-31</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-212023-09-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-21</xbrli:startDate>
        <xbrli:endDate>2023-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-222023-09-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-22</xbrli:startDate>
        <xbrli:endDate>2023-09-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-10-01</xbrli:startDate>
        <xbrli:endDate>2023-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2024-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:SharePurchaseAndExchangeAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SeriesFConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-01-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-282023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-28</xbrli:startDate>
        <xbrli:endDate>2023-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_StockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_TwoThousandThirteenPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-12-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-12-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-292023-12-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-29</xbrli:startDate>
        <xbrli:endDate>2023-12-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_WarrantMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_WarrantMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_WarrantMember21736515">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-07">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_custom_DooyaMediaGroupIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DooyaMediaGroupIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_custom_SeriesEConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_custom_SeriesGConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-15</xbrli:startDate>
        <xbrli:endDate>2024-08-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-31</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2023-02-28_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2023-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_custom_StockAppreciationRightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-02-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-03-012023-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-07_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-08_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-10_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-11_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:MessrsMonacoAndKerbyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-03-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-152024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:MessrsMonacoAndKerbyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-15</xbrli:startDate>
        <xbrli:endDate>2024-03-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-04-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-04-252024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-04-25</xbrli:startDate>
        <xbrli:endDate>2024-04-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-14_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-08-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-10-11_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-10-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-11_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-132024-09-13_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-13</xbrli:startDate>
        <xbrli:endDate>2024-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-13</xbrli:startDate>
        <xbrli:endDate>2024-09-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-18_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-09-19_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-09-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-19</xbrli:startDate>
        <xbrli:endDate>2024-09-19</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-10-01</xbrli:startDate>
        <xbrli:endDate>2024-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember21742375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember21742390">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-08-31_us-gaap_PreferredStockMember21742406">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-08-31_us-gaap_PreferredStockMember21742421">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-05-242024-05-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-05-24</xbrli:startDate>
        <xbrli:endDate>2024-05-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-05-24">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-05-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-07-112024-07-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-07-11</xbrli:startDate>
        <xbrli:endDate>2024-07-11</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2024-07-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000788611</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2024-07-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000139" toRefs="Footnote000169"/>
  <ix:relationship fromRefs="Fact000140" toRefs="Footnote000169"/>
  <ix:relationship fromRefs="Fact000158" toRefs="Footnote000169"/>
  <ix:relationship fromRefs="Fact000159" toRefs="Footnote000169"/>
  <ix:relationship fromRefs="Fact000262" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000264" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000266" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000268" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000270" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000272" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="xdx2ixbrl0274" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="xdx2ixbrl0276" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000278" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000280" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000282" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000284" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000286" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000288" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000290" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="Fact000292" toRefs="Footnote000293"/>
  <ix:relationship fromRefs="xdx2ixbrl0299" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000300" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000301" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000302" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000303" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="xdx2ixbrl0305" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000307" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="xdx2ixbrl0325" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000326" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000327" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000328" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000329" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="xdx2ixbrl0331" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000333" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="xdx2ixbrl0341" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000343" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000407" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000408" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000409" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000410" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000411" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000413" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000415" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000423" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact000425" toRefs="Footnote000426"/>
  <ix:relationship fromRefs="Fact001693" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001695" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001697" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001699" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001701" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001703" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001705" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001707" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001709" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001711" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="xdx2ixbrl1713" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="xdx2ixbrl1715" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001717" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001719" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="xdx2ixbrl1721" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="xdx2ixbrl1723" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001725" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001727" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001729" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001731" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001733" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001735" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001737" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001739" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001741" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001743" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001745" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001747" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001749" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001751" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001753" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="Fact001755" toRefs="Footnote001756"/>
  <ix:relationship fromRefs="xdx2ixbrl1814" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001815" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001816" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001817" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001818" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="xdx2ixbrl1820" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001822" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="xdx2ixbrl1830" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001831" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001832" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001833" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001834" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="xdx2ixbrl1836" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="Fact001838" toRefs="Footnote001839"/>
  <ix:relationship fromRefs="xdx2ixbrl1907" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001908" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001909" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001910" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001911" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="xdx2ixbrl1913" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001915" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="xdx2ixbrl1923" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001925" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="xdx2ixbrl1933" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001934" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001935" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001936" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001937" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="xdx2ixbrl1939" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001941" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="xdx2ixbrl1949" toRefs="Footnote001952"/>
  <ix:relationship fromRefs="Fact001951" toRefs="Footnote001952"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
filed with the Securities and Exchange Commission on November 12, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 112.75pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registration
No. 333-278562</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90E_edei--AmendmentDescription_c20240301__20240831_zm5o1rnFGNj1" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000011" name="dei:AmendmentDescription">Amendment
No. 2</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>to</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90C_edei--DocumentType_dxL_c20240301__20240831_zkZPuIOASjVb" title="::XDX::S-1%2FA"><span style="-sec-ix-hidden: xdx2ixbrl0012">S-1</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>REGISTRATION
STATEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>UNDER</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>THE
SECURITIES ACT OF 1933</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_904_edei--EntityRegistrantName_c20240301__20240831_zQEqG5gaWXPb"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000013" name="dei:EntityRegistrantName">NEXTTRIP,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_c20240301__20240831_z0IpwcRNRgVh"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:stateprovnameen" id="Fact000014" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span>
    </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4724</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20240301__20240831_zZgoVRZsSRcb"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000015" name="dei:EntityTaxIdentificationNumber">27-1865814</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or Other Jurisdiction of </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Primary
    Standard Industrial </b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification
    Code Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20240301__20240831_zUmYmVl5xy8e"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000016" name="dei:EntityAddressAddressLine1">3900
Paseo del Sol</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressCityOrTown_c20240301__20240831_z7NAvNZdZe7h"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000017" name="dei:EntityAddressCityOrTown">Santa
Fe</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20240301__20240831_zpQCftdwxTFe"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New Mexico</ix:nonNumeric></span> <span id="xdx_903_edei--EntityAddressPostalZipCode_c20240301__20240831_zFbQyhYCVhbi"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000019" name="dei:EntityAddressPostalZipCode">87507</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90A_edei--CityAreaCode_c20240301__20240831_zjmaqBFSBWn7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000020" name="dei:CityAreaCode">(954)</ix:nonNumeric>
</b></span><b><span id="xdx_902_edei--LocalPhoneNumber_c20240301__20240831_zEMU1JA9nCDl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000021" name="dei:LocalPhoneNumber">526-9688</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address,
including zip code, and telephone number, including area code, of registrant&#8217;s principal executive offices)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--ContactPersonnelName_c20240301__20240831__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z3V7DdOxO4p8"><ix:nonNumeric contextRef="From2024-03-012024-08-31_dei_BusinessContactMember" id="Fact000022" name="dei:ContactPersonnelName">William
Kerby</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Chief
Executive Officer</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20240301__20240831__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zcvFcrizIwL"><ix:nonNumeric contextRef="From2024-03-012024-08-31_dei_BusinessContactMember" id="Fact000023" name="dei:EntityAddressAddressLine1">3900
Paseo del Sol</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressCityOrTown_c20240301__20240831__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z3yR2KW2hL2f"><ix:nonNumeric contextRef="From2024-03-012024-08-31_dei_BusinessContactMember" id="Fact000024" name="dei:EntityAddressCityOrTown">Santa
Fe</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressStateOrProvince_c20240301__20240831__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zAo071HHIdC5"><ix:nonNumeric contextRef="From2024-03-012024-08-31_dei_BusinessContactMember" format="ixt-sec:stateprovnameen" id="Fact000025" name="dei:EntityAddressStateOrProvince">New Mexico</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20240301__20240831__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zqit1veFpCp"><ix:nonNumeric contextRef="From2024-03-012024-08-31_dei_BusinessContactMember" id="Fact000026" name="dei:EntityAddressPostalZipCode">87507</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90C_edei--CityAreaCode_c20240301__20240831_zZpIOFAClRx5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000027" name="dei:CityAreaCode">(954)</ix:nonNumeric>
</b></span><b><span id="xdx_909_edei--LocalPhoneNumber_c20240301__20240831_zx89gcUSGGJ9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" id="Fact000028" name="dei:LocalPhoneNumber">526-9688</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name,
address, including zip code, and telephone number, including area code, of agent for service)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Copies
to:</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Christopher
                                            L. Tinen, Esq. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Snell
&amp; Wilmer LLP </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12230
El Camino Real</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Suite
300 | </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>San
Diego, CA 92130</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(858)
910-4809</b></span></p>

</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ross
    D. Carmel, Esq.</b></span></p>
                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Benjamin E. Sklar,</b><b> Esq.</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sichenzia
    Ross Ference Carmel LLP</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1185
    Avenue of the Americas, 31st Floor</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
    York, NY 10036</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(212)
930-9700</b></span></p></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Approximate
date of commencement of proposed sale to the public:</b> As soon as practicable after the effective date of this registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the
</span>Securities Act of 1933 check the following box. &#9746;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following
box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.
&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the </span>Securities
Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;
&#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer &#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer &#9744;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--EntityFilerCategory_c20240301__20240831_zYqqvhXiU2lc"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:entityfilercategoryen" id="Fact000029" name="dei:EntityFilerCategory">Non-accelerated
    filer</ix:nonNumeric></span> &#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company <span id="xdx_909_edei--EntitySmallBusiness_c20240301__20240831_z64Xqg0GQaR1"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt:booleantrue" id="Fact000030" name="dei:EntitySmallBusiness">&#9746;</ix:nonNumeric></span></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20240301__20240831_z5Uj53s8jn11"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt:booleanfalse" id="Fact000031" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until this registration statement shall become effective on such date
as the Commission, acting pursuant to said Section 8(a), may determine.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>The
information contained in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration
statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities
and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>PRELIMINARY
    PROSPECTUS</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>DATED
    NOVEMBER 12, 2024</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><img src="forms-1a_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Funded
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
of Common Stock Underlying the Common Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><b>of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip,
Inc.</b></span></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is a firm commitment public offering of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock,
par value $0.001 per share, and warrants to purchase shares of our common stock (the &#8220;Common Warrants&#8221;), to be sold
together with each share of common stock, at an assumed combined public offering price of $
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share and Common Warrant (based upon the last reported sale price
of our common stock on the Nasdaq Capital Market on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024). Each Common Warrant will have an exercise price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share (100% of
the combined public offering price per share of common stock and Common Warrant), will become exercisable commencing on the date of
issuance, and will expire five years from the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are also offering to those purchasers, if any, whose purchase of common stock in this offering would otherwise result in such purchaser,
together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser,
9.99%) of our outstanding shares of common stock immediately following the consummation of this offering, the opportunity to purchase,
if any such purchaser so chooses, pre-funded warrants (the &#8220;Pre-Funded Warrants&#8221;) in lieu of shares common stock that would
otherwise result in such purchaser&#8217;s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of our
outstanding shares of common stock. The purchase price of each Pre-Funded Warrant will be equal to the combined public offering price
per share of common stock and Common Warrant sold in this offering minus $0.001, the exercise price per share of common stock of each
Pre-Funded Warrant. The Pre-Funded Warrants are immediately exercisable and may be exercised at any time until all of the Pre-Funded
Warrants are exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each Pre-Funded Warrant we sell, the number of shares of common stock we are offering will be decreased on a one-for-one basis. Because
we will issue a Common Warrant for each share of common stock and each Pre-Funded Warrant sold in this offering, the number of Common
Warrants sold in this offering will not change as a result of a change in the mix of shares of common stock and Pre-Funded Warrants sold.
The shares of common stock (or Pre-Funded Warrants) and the accompanying Common Warrants can only be purchased together in this offering,
but the securities will be immediately separable upon issuance and will be issued separately. The shares of common stock issuable from
time to time upon exercise of the Common Warrants and the Pre-Funded Warrants are also being offered by this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual combined public offering price per share of common stock (or Pre-Funded Warrant) and Common Warrant will be determined between
us and the underwriter at the time of pricing, and may be at a discount to the current market price of our common stock. Therefore, the
assumed combined public offering price used throughout this prospectus may not be indicative of the final offering price.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on The Nasdaq Capital Market tier of The Nasdaq Stock Market, LLC under the symbol &#8220;NTRP&#8221;. The last
reported sale price of our common stock on the Nasdaq Capital Market on September 26, 2024 was $2.79 per share. There is
currently no established trading market for the offered Common Warrants or the Pre-Funded Warrants. We do not intend to list the Common
Warrants or Pre-Funded Warrants on the Nasdaq Capital Market or any other national securities exchange or nationally recognized trading
system. Without an active trading market, the liquidity of the Common Warrants and the Pre-Funded Warrants will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>We
are a &#8220;smaller reporting company&#8221; as defined under the federal securities laws and, as such, are eligible for reduced public
company reporting requirements.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investing
in our securities involves a high degree of risk. Before making an investment decision, please read &#8220;Risk Factors&#8221;
on page 11 of this prospectus.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Per
    S<b>hare of Common Stock and Accompanying Common Warrant</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Per
    Pre-Funded Warrant and Accompanying Common Warrant</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 57%">Public offering price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"/><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 11%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting discounts and commissions<sup>(1)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds to NextTrip, Inc. before expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"/><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    underwriting discount does not include a non-accountable expense allowance of 1.0% of the gross proceeds of the shares sold in the
    offering. The registration statement, of which this prospectus is a part, also registers for sale those shares of common stock
    issuable upon exercise of warrants to purchase shares of our common stock to be issued to the underwriter, or its designated
    affiliates, in connection with this offering (the &#8220;Underwriter&#8217;s Warrants&#8221;). We have agreed to issue the warrants
    to the underwriter as a portion of the underwriting compensation payable to the underwriters in connection
    with this offering. See the section titled &#8220;Underwriting&#8221; for a description of the compensation payable to the
    underwriter.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the underwriter an option for a period of 30 days after the closing date of the offering to purchase up to an additional&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
shares of our common stock, Pre-Funded Warrants and/or Common Warrants at the combined public offering price,
less the underwriting discounts and commissions, solely to cover over-allotments, if any.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined
if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter expects to deliver the securities to purchasers on or about&#160;&#160;&#160;&#160;&#160;&#160;&#160; , 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sole
Bookrunner</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 16pt"><b>The
Benchmark Company, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>TABLE
OF CONTENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ABOUT THIS PROSPECTUS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS SUMMARY</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE OFFERING</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY FINANCIAL DATA</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#s_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET FOR OUR COMMON STOCK</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIVIDEND POLICY</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAPITALIZATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DILUTION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_015">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_014">BUSINESS</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">46</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#Z_017"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE AND DIRECTOR COMPENSATION</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_018">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_019">PRINCIPAL STOCKHOLDERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_020">DESCRIPTION OF CAPITAL STOCK</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><a href="#MS_001">DESCRIPTION OF SECURITIES WE ARE OFFERING</a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">77</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_021">SHARES ELIGIBLE FOR FUTURE SALE</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">79</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_022">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_023">UNDERWRITING</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: -30pt; text-align: center">8<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_024">LEGAL MATTERS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_025">EXPERTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Z_026">WHERE YOU CAN FIND MORE INFORMATION</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#fin_toc">INDEX TO FINANCIAL STATEMENTS</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_001"></span>ABOUT
THIS PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement that we filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;).
We have not, and the underwriter has not, authorized anyone to provide you with information that is different from that contained
in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. When you make a decision
about whether to invest in our securities, you should not rely upon any information other than the information in this prospectus or
in any free writing prospectus that we may authorize to be delivered or made available to you. Neither the delivery of this prospectus
nor the sale of our securities means that the information contained in this prospectus or any free writing prospectus is correct after
the date of this prospectus or such free writing prospectus. This prospectus is not an offer to sell or the solicitation of an offer
to buy our securities in any circumstances under which the offer or solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
investors outside the United States: We have not taken any action that would permit this offering or possession or distribution of this
prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United
States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering
of the securities covered hereby and the distribution of this prospectus outside the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including
our general expectations and market position, market opportunity and market share, is based on information from our own
management&#8217;s estimates and research, as well as from industry and general publications and research, surveys and studies
conducted by third parties. Management&#8217;s estimates are derived from publicly available information, our knowledge of our
industry and assumptions based on such information and knowledge, which we believe to be reasonable. Our management&#8217;s
estimates have not been verified by any independent source, and we have not independently verified any third-party information. In
addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of
uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors.&#8221; These and other factors
could cause our future performance to differ materially from our assumptions and estimates. See &#8220;Risk Factors&#8221; and
&#8220;Cautionary Statement on Forward-Looking Statements.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
further note that the representations, warranties and covenants made by us in any agreement that is filed as an exhibit to the registration
statement of which this prospectus is a part were made solely for the benefit of the parties to such agreement, including, in some cases,
for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or
covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such
representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip,
Inc., the NextTrip logo and other trademarks or service marks of NextTrip appearing in this prospectus are the property of NextTrip,
Inc. This prospectus also includes trademarks, tradenames and service marks that are the property of other organizations. Solely for
convenience, trademarks and tradenames referred to in this prospectus appear without the &#174; and &#8482; symbols, but those references
are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or that the
applicable owner will not assert its rights, to these trademarks and tradenames.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; text-align: center; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_002"></span>PROSPECTUS
SUMMARY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you
should consider in making your investment decision in our securities. Before investing in our securities, you should carefully read this
entire prospectus, including our financial statements and the related notes included in this prospectus and the information set forth
under the headings &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations.&#8221; As used in this prospectus, unless the context otherwise requires, references to &#8220;we,&#8221; &#8220;us,&#8221;
&#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;NextTrip&#8221; refer to NextTrip, Inc. and its subsidiaries.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
is an innovative technology company that is building next generation solutions to power the travel industry. NextTrip, through its subsidiaries,
provides travel technology solutions with sales originating in the United States, leisure travel, business travel, groups travel, media
and tech. We connect people to new places and discoveries by utilizing digital media engagement, seasoned planning expertise,
and unique inventory to curate custom vacations and business travel across the globe. Our proprietary booking engine, branded
as NXT2.0, provides travel distributors access to a sizeable inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
vision is to drive the evolution of the travel industry by merging advanced digital solutions with personalized travel services. Our
core technology &#8211; a fully integrated travel booking platform &#8211; focuses on untapped and underserved sectors of the travel
industry, intending to capture new markets. We expect that our future growth will be accelerated by interactive technology, immersive
media and unparalleled travel industry expertise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Presently,
NextTrip generates revenue through two core methods: travel bookings and advertising revenue. Each division can independently drive revenue
through their respective channels, but we have created exponential value by bringing the divisions together to create an engaging consumer-focused
ecosystem. We have created opportunities to seamlessly move customers from one portion of the ecosystem to the next, with the ultimate
goal of influencing a travel purchase decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six months ended August 31, 2024, we recognized revenue of $343,291 and recorded a net loss applicable to common stockholders of
$3,534,743. For the fiscal year ended February 29, 2024, we recognized revenue of $458,752 and recorded a net loss applicable to common
stockholders of $7,339,276.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will need to raise a minimum of $5.5 million in net proceeds to sustain our operations for the next twelve months. If
we fail to raise the minimum amount needed, we will likely need to raise capital from other sources.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
History</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Historical
Monaker Group Business</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
travel business was the principal business of NextPlay (then, Monaker Group, Inc. (&#8220;Monaker&#8221;)) until June 30, 2020, when
Monaker entered into a share exchange transaction with HotPlay Enterprise Limited (&#8220;HotPlay&#8221;), resulting in HotPlay becoming
a wholly owned subsidiary of Monaker and HotPlay&#8217;s business becoming the principal business of Monaker. Prior to this share exchange,
the primary focus of Monaker had been its travel business, which included the sale of vacation rentals, and in particular, alternative
lodging rentals (&#8220;ALRs&#8221;), to consumers through its proprietary booking engine. To support its travel offerings, Monaker
introduced travelmagazine.com, featuring travel and lifestyle content to appeal to travelers researching destinations and planning
future vacations. In January 2023, NextPlay spun the NextTrip business out to its founders to separate it from NextPlay&#8217;s primary
business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>COVID-era Transition and Technology Development</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
spread of the COVID-19 virus globally beginning in January 2020 severely impacted our business. Beginning in March 2020, many
U.S. states and foreign countries began issuing &#8220;stay-at-home&#8221; orders and closed their borders to interstate and international
travel. Such restrictions on travel, together with other measures implemented by governments around the world, severely restricted the
level of economic activity around the world and had an unprecedented effect on the global travel industry. The public&#8217;s ability
to travel was severely curtailed through border closures, mandated travel restrictions and limited operations of hotels, airlines, and
additional voluntary or mandated closures of travel-related businesses from December 2019 through the beginning of 2022 (and beyond in
some jurisdictions). Measures implemented during the COVID-19 pandemic led to unprecedented levels of temporary and permanent business
closures, cancellations and limited new travel bookings, having a severe negative impact on our business, financial condition
and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the significant decrease in demand for the travel related services provided by us during the peak of the COVID-19
pandemic, we shifted our focus to developing and enhancing our program offerings. For example, we began to
develop our online media platform - TravelMagazine.com - allowing consumers to research future travel options as well as
enhancing the functionality of our booking engines, including developing a booking engine platform that allows customers
to book packaged vacations and wellness programs along with the development of a platform to arrange and manage
business travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0"><i>Acquisition of Bookit.com Asset</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
NextTrip&#8217;s separation from NextPlay, our team focused on the continued technological development of our booking platform. As part
of this development, we acquired a travel platform, Bookit.com, in June 2022 to help power our proprietary NXT2.0 booking technology.
Pursuant to the terms of Asset Purchase Agreement (the &#8220;APA&#8221;), in exchange for a cash payment of $600,000, we acquired
the Bookit.com booking engine, customer lists, all content associated to hotel and destination product in the booking engine, including
pictures, hotel descriptions, restaurant descriptions, room descriptions, amenity descriptions, and destination information, and source
code related thereto (the &#8220;Purchased Assets&#8221;). The Purchased Assets included: (i) all permits and licenses related to the
purchased assets; (ii) all contracts and agreements oof Bookit.com (the &#8220;Assumed Contracts&#8221;); and (iii) any goodwill related
to the Purchased Assets. Further to the APA, we agreed to assume any obligation or liability of Bookit.com, and any related claims, whether
asserted prior to or following the Purchased Assets, with the exception of: (i) all tax obligations and liabilities of any nature arising
in connection with or related to Bookit.com and/or the Purchased Assets prior to the Closing Date, and (ii) any post-Closing payment
or performance obligations arising under the Assumed Contracts.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Previously, this technology powered the Bookit.com
business, a well-established online leisure travel agent generating over $400 million in annual sales as recently as 2019 (pre-pandemic).
As part of the acquisition of the assets of Bookit.com, we were not only able to acquire a proven technology platform that could be integrated
with our core travel sectors, but we were also able to secure the Bookit.com database with millions of past travelers and opt-in consumers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
2022 and the acquisition of the Bookit.com business, we have been focused on the holistic development and integration of the NXT2.0 technology
platform, which serves as a base for current and future technology projects as well as proprietary system enhancements. This integration
includes re-engaging with and re-negotiating more than 250 contracts with hotel, airline, and cruise suppliers, and securing unique product
inventory of more than 3 million lodging, air and tour product suppliers at exceptional rates to over 2,100 destinations in 200+ countries
worldwide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
this strategic offering, we will focus on key areas of opportunity in the travel sector and drive enhanced booking conversion rates.
Our proprietary technology, when combined with media, product offerings and customer service, provides a unique lane to serve mid- to
luxury travelers.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><b><i>Our Integrated
Travel Booking Platform</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
direct-to-consumer travel platform, NXT2.0, powers several websites, including our main leisure site, <span style="text-decoration: underline">nexttrip.com</span> , our widgets
for groups travel and travel agents as well as providing travel booking solutions for our media hubs, <span style="text-decoration: underline">travelmagazine.com and Compass.TV</span>.
We serve both leisure and business travelers by offering them access to travel blogs, videos and concierge assistance to aid in planning
travel, coupled with our proprietary booking platform for flights, hotels, tours, and other travel products. Our content includes destination
guides, maps, and travel tips, designed to help travelers plan memorable trips.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Travel Products and Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
offerings span leisure and business travel, alternative lodging, wellness travel, and media solutions, engaging customers throughout
their travel journey with both individual and packaged options. Highlights include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Leisure</b> &#8211; A robust booking engine providing customized vacation packages, flights, hotels, tours, wellness vacations, and
    group travel options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Business</b> &#8211; Corporate travel management for small to mid-sized businesses, featuring booking, expense reporting, concierge
    services, and 24/7 support.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Solutions</b> &#8211; A suite for product management and white-label solutions, including property management, vacation rentals,
    and a portal to support travel agents.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
    Media</b> &#8211; Travel Magazine and Compass.TV offering travelers inspiration and information through articles, videos, and immersive
    digital experiences. This will include customizable travel channels for users to explore and share with friends and family.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Traveler
Features</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketplace at <span style="text-decoration: underline">nexttrip.com</span> offers tools for browsing and comparing flights, hotels, tours and activities. Additionally, we allow
travelers to defer payments on select vacation packages with our proprietary FlexPay program. FlexPay allows travelers to purchase travel
with a small deposit and make subsequent payments between purchase and the week before travel. Registered NextTrip travelers can manage
bookings, receive updates on special offers, and subscribe to newsletters with travel tips and destination highlights. Security is a
priority, with rigorous content screening and Payment Card Industry compliance to safeguard customer information.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Platform
Evolution</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
COVID-19, we&#8217;ve focused on enhancing our booking engine and supplier partnerships. After acquiring Bookit.com&#8217;s technology
in 2022, we launched our platform in May 2023 with limited listings. Since then, we have scaled to over a million hotel properties globally,
now offering a complete leisure travel experience. We will continue to expand our platform to include specialty travel products and services
like cruises and travel rewards programs in 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Technology
and Infrastructure</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our websites are hosted
using cloud services distributed globally across multiple regions. Our systems architecture has been designed to manage increases in
traffic through additional computing power without making software changes. Our cloud services provide our online marketplace with scalable
and redundant Internet connectivity and redundant power and cooling to its hosting environments. We use security methods to ensure the
integrity of our networks and protection of confidential data collected and stored on our servers. We have developed and use internal
policies and procedures to protect the personal information of our travelers using our websites that we collect and use as part of our
normal operations. Access to NextTrip&#8217;s networks, and the servers and databases, on which confidential data is stored, is protected
by industry standard firewall and encryption technology. Physical access to our servers and related equipment is secured by limiting
access to the data center to operations personnel only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Competition</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
U.S. travel market is highly competitive and rapidly evolving. The markets are dominated by a few key distributors, which has caused
suppliers to look for viable alternatives that would diversify their business mix.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition, which is strong and increasing, includes
online and offline travel companies that target leisure and corporate travelers, including travel agencies, tour operators, travel supplier
direct websites and their call centers, consolidators and wholesalers of travel products and services, large online portals and search
websites, certain travel metasearch websites, mobile travel applications, social media websites, as well as traditional consumer eCommerce
and group buying websites. These companies include Expedia, Booking.com, TripAdvisor, Sabre Corp., TravelZoo and AirBnb. In some cases,
competitors are offering more favorable terms and improved interfaces to suppliers and travelers, which make competition increasingly
difficult. We also face competition for customer traffic on internet search engines and metasearch websites, which impacts our
customer acquisition and marketing costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Seasonality</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">experience seasonal fluctuations in the demand for
our travel products and services. For example, traditional leisure travel bookings are generally the highest in the first three
quarters as travelers plan and book their spring, summer and winter holiday travel. The number of bookings typically decreases in the
fourth quarter. Because revenue for most of our travel products is recognized when the travel takes place rather than when it
is booked, revenue typically lags bookings by several weeks to several months. As a result, although travel bookings through our
platforms tend to be highest from the period from January to June, moderate from July through September and low from October through
December, the majority of revenue is recognized in the summer months (June, July, and August), and during the winter holidays (November
and December).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Intellectual
Property</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property includes the content of our websites, registered domain names, registered and unregistered trademarks, business
plan, business strategies and trade secrets, proprietary and acquired software platforms and related assets, licensed software platforms,
and customer and third-party supplier lists. We believe that our intellectual property is an essential asset of our business and that
our registered domain names and our technology infrastructure will give us a competitive advantage in the online market and arrangements
with attractions and tour operators. We rely on a combination of trademark, copyright and trade secret laws in the United States, as
well as contractual provisions, to protect our proprietary technology and our brands. We also rely on copyright laws to protect the appearance
and design of our sites and applications. We have registered numerous Internet domain names related to our business in order to protect
our proprietary interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
key proprietary software platforms and systems include our booking engine, NXT2.0 which we enhanced through our acquisition and subsequent
integration of the Bookit.com assets, the group travel booking platform, which allows for efficient and streamlined travel planning and
booking for travel groups of five or more, FlexPay technology, which allows travelers to book a trip for as little as $1.00 down and
pay over time with no interest, TravelMagazine, which offers tools to create personalized travel using video, blogs, reviews, tourism
boards and AI planner and our recently launched FAST TV channel, Compass.TV, which aims to inspire audiences by highlighting the world&#8217;s
best travel experiences and offering viewers a rich source of inspiration for planning their next journey.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Regulation</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
ability to provide our services and any future services is affected by legal regulations of governments and regulatory authorities around
the world, many of which are evolving and subject to revised interpretations. Violations of any laws or regulations could result in fines,
penalties, and criminal sanctions against us, our officers or employees, and prohibitions on how or where we conduct our business, which
could damage our reputation, brands, global expansion efforts, ability to attract and retain employees and business partners, business,
and operating results. Even if we comply with these laws and regulations, doing business in certain jurisdictions or violations of these
laws and regulations by the parties with which we conduct business runs the risk of harming our reputation and our brands. Regulations
that impact our business or our industry include in the areas of data protection and privacy, payment processing and travel-related regulations
on &#8220;overtourism&#8221; and climate-related issues.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Developments</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-binding
Letter of Intent to Acquire Luxury Travel Company Five Star Alliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2024, we announced that we had signed a non-binding Letter of Intent (LOI) to acquire&#160;Five Star Alliance, an online
luxury travel agency founded in 2004 and renowned for its curated collection of five-star luxury hotels and resorts worldwide. Five Star
Alliance specializes in helping travelers discover and book the world&#8217;s top luxury hotels, offering personalized recommendations, competitive
rates, and is known for world-class customer service. With a proprietary search engine that secures the best rates for thousands of 5-star
hotels globally, the company also handles group travel bookings and high-end cruises.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Acquisition
of NextTrip</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, Sigma Additive Solutions, Inc. (&#8220;Sigma&#8221;) entered into a Share Exchange Agreement with NextTrip Holdings,
Inc. (&#8220;NextTrip&#8221;), NextTrip Group, LLC (&#8220;NextTrip Parent&#8221;) and William Kerby (the &#8220;NextTrip Representative&#8221;),
pursuant to which the Company acquired NextTrip (the &#8220;Acquisition&#8221;) in exchange for shares of our common stock, which
we refer to as the Exchange Shares. The Acquisition was consummated on December 29, 2023. As a result, NextTrip became a wholly
owned subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of the Acquisition, the shareholders of NextTrip, which we refer to collectively as the NextTrip Sellers, were issued a number
of Exchange Shares equal to 19.99% or our issued and outstanding shares of common stock immediately prior to the closing. Under the Share
Exchange Agreement, the NextTrip Sellers will be entitled to receive additional shares of our common stock, referred to as the Contingent
Shares, subject to NextTrip&#8217;s achievement of future business milestones specified in the Share Exchange Agreement as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Earned</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s leisure travel booking platform by either (i) achieving $1,000,000 in cumulative sales under its historical &#8220;phase
    1&#8221; business, or (ii) commencement of its marketing program under its enhanced &#8220;phase 2&#8221; business.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date six months after the closing date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s group travel booking platform and signing of at least five (5) entities to use the groups travel booking platform.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date nine months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s travel agent platform and signing up of at least 100 travel agents to the platform (which calculation includes
    individual agents of an agency that signs up on behalf of multiple agents).</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 12 months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    launch of FlexPay technology in the NXT2.0 system.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 15 months after the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,650,000
    Contingent Shares, less the Exchange Shares issued at the closing of the Acquisition</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
independent of the aforementioned milestones, for each month during the fifteen (15) month period following the closing date that in
which $1,000,000 or more in gross travel bookings are generated by the combined company, to the extent not previously issued, the Contingent
Shares will be issuable up to the maximum Contingent Shares issuable under the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the shares of our common stock issued at the closing, will not exceed 6,000,000 shares of our common
stock, or approximately 90.2% of our issued and outstanding shares of common stock immediately prior to the closing. Assuming all the
business milestones are achieved, historical Sigma shareholders will retain 9.8% of the Company&#8217;s outstanding shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Share Exchange Agreement provided that William Kerby, the Chief Executive Officer and co-founder of NextTrip, was appointed as Chief
Executive Officer of the Company and Donald P. Monaco was appointed as a director of the Company as of the closing of the Acquisition.
The NextTrip Representative (Mr. Kerby) will be entitled to designate a replacement for one additional director of the Company upon achievement
of each of the milestones under the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Asset
Sale to Divergent</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2023, the Company entered into an Asset Purchase Agreement with Divergent Technologies, Inc., or Divergent, pursuant to which
the Company agreed to sell to Divergent, and Divergent agreed to purchase from us, certain legacy Sigma assets of the Company consisting
primarily of patents, software code and other intellectual property for a purchase price of $1,626,242, including a $37,000 earnest-money
deposit previously paid to us by Divergent. In the interim, between the signing date and closing date of the Asset Purchase Agreement,
we granted Divergent a non-exclusive, non-transferable, non-sublicensable (except to Divergent customers and affiliates), limited, irrevocable
(except in connection with the termination of the Asset Purchase Agreement in certain circumstances as described below), worldwide, royalty-free
license to the &#8220;Licensed IP&#8221; (as defined) for testing, evaluation, and commercialization purposes. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Asset Purchase Agreement closed on January 12, 2024. As a result, the NextTrip business became the primary business of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Name
Change and Increase in Authorized Shares </i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the NextTrip Acquisition and the asset sale of the legacy Sigma assets to Divergent, the Company sought and obtained stockholder
approval to change the name of the Company to NextTrip, Inc. and to increase the authorized shares from 1,200,000 shares of common stock
to 250,000,000 shares of common stock. The name change and increase in authorized shares were approved by the Company&#8217;s
stockholders at a Special Meeting of Stockholders held on March 8, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, the Company filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation (the &#8220;Charter
Amendment&#8221;), as amended to date (the &#8220;Current Articles&#8221;), with the Secretary of State of the State of Nevada, pursuant
to which effective as of 12:01 a.m. Pacific time on March 13, 2024, (i) the Company&#8217;s corporate name was changed from Sigma Additive
Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;, and (ii) the number of shares of Company common stock authorized for issuance
under the Current Articles will be increased from 1,200,000 shares to 250,000,000 shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the name change, effective as of the open of the market on March 13, 2024, the Company&#8217;s common stock began trading
on the Nasdaq Capital Market under the new ticker symbol &#8220;NTRP&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promethean
TV License Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company and NextTrip Holdings, Inc., a wholly owned subsidiary of the Company, entered
into a Perpetual License Agreement (the &#8220;License Agreement&#8221;) with Promethean TV, Inc. (&#8220;Promethean&#8221;), pursuant
to which Promethean (i) sold NextTrip the code for the Licensed Software (as defined in the License Agreement) and (ii) granted NextTrip
an irrevocable, worldwide, perpetual right and non-exclusive license to forever retain and use the code and each executable copy of the
Licensed Software for the commercial exploitation by NextTrip in the travel solutions industry, subject to certain limitations set forth
in the License Agreement (the &#8220;Perpetual License&#8221;). Promethean is the owner and developer of the Ignite TV interactive video
platform used for driving engagement and commerce.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term of the License Agreement commenced on the Effective Date and shall continue in perpetuity unless and until terminated by either
party pursuant to the terms of the License Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for the Perpetual License and the other rights granted pursuant to the License Agreement, the Company issued Promethean
100,000 restricted shares of its Series G Convertible Preferred Stock (&#8220;Series G Preferred&#8221;), and NextTrip waived all past
debts to NextTrip previously incurred by Promethean. For a period of six months from the Effective Date, the Company has the right to
repurchase up to fifty percent of the Series G Preferred issued to Promethean, or the shares of Company common stock underlying the Series
G Preferred if converted during such period, for $1.00 as consideration for any breaches of representations and warranties or indemnities
of Promethean pursuant to certain provisions of the License Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nasdaq
Compliance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 18, 2024, the Company received
a notification letter (the &#8220;Notice&#8221;) from the Nasdaq Listing Qualifications Staff (the &#8220;Staff&#8221;) of The Nasdaq
Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that its amount of stockholders&#8217; equity has fallen below the $2,500,000
required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1). The Notice also noted that the Company does not meet
the alternatives of market value of listed securities or net income from continuing operations, and therefore, the Company no longer
complies with Nasdaq&#8217;s Listing Rules.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under Nasdaq Listing Rules, the Company has
until November 4, 2024 to provide Nasdaq with a specific plan to achieve and sustain compliance. If Nasdaq accepts the Company&#8217;s
plan to regain compliance, Nasdaq may grant an extension of up to 180 calendar days from the date of the Notice to evidence compliance.
If Nasdaq does not accept the Company&#8217;s plan to regain compliance, the Company will have the opportunity to appeal the decision
to a Nasdaq Hearings Panel. A hearing request will stay the suspension and delisting of the Company&#8217;s securities pending the Nasdaq
Hearings Panel&#8217;s decision. The Company has, as of November 4, 2024, submitted said compliance plan to Nasdaq as required and is
awaiting a response from Nasdaq.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Notice has no immediate effect on the listing
of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#8217;s listing remains fully effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Reverse
Stock Split</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, Sigma effected a reverse stock split (the &#8220;Reverse Split&#8221;) of the issued and outstanding shares of our
common stock and the number of shares of common stock that we are authorized to issue. The Reverse Split combined each 20 shares of the
issued and outstanding common stock into one share of common stock. No fractional shares were issued in connection with the Reverse Split,
and any fractional shares resulting from the Reverse Split were rounded up to the nearest whole share. All stock options, warrants, shares
issuable upon conversion of the Company&#8217;s preferred stock and stock awards of the Company outstanding immediately prior to the
Reverse Split were adjusted in accordance with their terms. All share and earnings per share information presented in this prospectus
have been adjusted for the Reverse Split.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Securities
Purchase Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with Alumni Capital
LP (&#8220;Alumni Capital&#8221;) for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (&#8220;Warrants&#8221;)
to Alumni Capital for total consideration of $250,000. After deducting commissions, net proceeds to the Company were $230,000.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $300,000 with an original issue discount of $50,000 and guaranteed interest on the principal
amount of ten percent (10%) per annum which shall be due and payable on December 19, 2024. In the event of a failure to re-pay the Alumni
Note on or before December 19, 2024, the interest rate will increase to the lesser of twenty-two percent (22%) per annum or the maximum
amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible into common stock of the
Company only upon an event of default.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company also entered into a Common Stock Securities Purchase Agreement (the &#8220;Common Stock SPA&#8221;) with
Alumni Capital. Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Alumni Capital to purchase
up to $10 million shares of common stock (the &#8220;Commitment Amount&#8221;) at the Purchase Price (defined below) during the period
beginning on the execution date of the Common Stock SPA and ending on the earlier of (i) the date on which Alumni Capital has purchased
$10 million shares of common stock pursuant to the Common Stock SPA or (ii) December 31, 2025. Pursuant to the Common Stock SPA, the
&#8220;Purchase Price&#8221; means the lowest traded price of Company common stock during the five (5) business days prior a closing
date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration statement and no Purchase
Notice will be in an amount greater than $500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were incorporated as Messidor Limited in Nevada on December 23, 1985, and changed our name to Framewaves Inc. in 2001. On September 27,
2010, we changed our name to Sigma Labs, Inc. On May 17, 2022, we began doing business as Sigma Additive Solutions, and on August 9,
2022, changed our name to Sigma Additive Solutions, Inc. On March 13, 2024, we changed our name to NextTrip, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, and our telephone number is (954) 526-9688.
Our website address is www.nexttrip.com. Unless expressly noted, none of the information on our corporate website is part of this
prospectus or any prospectus supplement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
Factor Summary</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Below
is a summary of the principal factors that make an investment in our securities speculative or risky. This summary does not address all
of the risks that we face. Additional discussion of the risks summarized in this risk factor summary, and other risks that we face, can
be found below and should be carefully considered, together with other information included in this prospectus.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face risks and uncertainties related to our business, many of which are beyond our control. In particular, risks associated with our
business include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Uncertainty and illiquidity in credit and capital markets can impair our ability to obtain credit and financing on acceptable terms and
can adversely affect the financial strength of our business partners;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company will need to raise a minimum of $5.5 million in net proceeds to support its operations, which funding may not be available
on favorable terms, if at all;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company&#8217;s operations have been negatively affected by, and have experienced material declines as a result of, COVID-19 and
the governmental responses thereto, additional future government shutdowns or travel restrictions may have a material adverse impact
on our business and financial condition;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company&#8217;s operations are subject to uncertainties and risks outside of its control, including third party delays in submissions
of listings and failures to maintain such rental listings, integrations of such listings and the renewal
of such listings;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company is subject to extensive government regulations and rules, the failure to comply which may have a material adverse effect
on the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&#9679; There is no assurance
that we will continue to satisfy the listing requirements of The Nasdaq Capital Market;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The success of the Company is subject to the development of new products and services over time;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company is subject to competition with competitors who have significantly more resources, more brand recognition and a longer operating
history than the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company is subject to risks associated with failures to maintain intellectual property and claims by third parties relating to an
allegation that the Company violated such third parties&#8217; intellectual property rights;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company relies on third party service providers and the failure of such third parties to provide the services contracted for, on
the terms contracted, or otherwise, could have a material adverse effect on the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company relies on the internet and internet infrastructure for its operations and in order to generate revenues;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The Company&#8217;s ability to raise funding, and dilution caused by such fundings, anti-dilution rights included in outstanding warrants;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Our business depends substantially on suppliers renewing their listings;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
The market in which we participate is highly competitive, and we may be unable to compete successfully with our current or future competitors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
If we are unable to adapt to changes in technology, our business could be harmed;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
We have incurred significant losses to date and require additional capital which may not be available on commercially acceptable terms,
if at all; </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
There is no public market for the Pre-Funded Warrants or the Common Warrants being offered in this offering;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#9679; We may
not receive any additional funds upon the exercise of the Common Stock Warrants or the Pre-Funded Warrants; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
Those discussed under the caption &#8220;Risk Factors&#8221; of this Registration Statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: center; text-indent: -6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: center; text-indent: -6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 6pt; text-align: center; text-indent: -6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.1in; padding-left: 0.1in">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_003"></span>THE
OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    stock outstanding before this </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,429,412
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>offering</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    stock offered by us</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    Warrants offered by us</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Warrants to purchase up to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock. Each Common Warrant
    will have an exercise price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share, will be exercisable
    commencing on the date of issuance and will expire five (5) years from the date of issuance. The shares of common stock and Common
    Warrants will be sold together, with each share of common stock to be sold together in a fixed combination with a Common Warrant
    to purchase a share of common stock. This offering also relates to the shares of common stock issuable upon exercise of Common Warrants
    sold in this offering. To better understand the terms of the Common Warrants, you should carefully read the section of the prospectus
    entitled &#8220;Description of Securities We Are Offering&#8211;Common Warrants.&#8221; You should also read the form of Common Warrant,
    which is filed as an exhibit to the registration statement of which this prospectus forms a part.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Funded
    Warrants offered by us</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            are also offering to those purchasers, if any, whose purchase of common stock in this offering
                                            would otherwise result in such purchaser, together with its affiliates and certain related
                                            parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%)
                                            of our outstanding shares of common stock immediately following the consummation of this
                                            offering, the opportunity to purchase, if any such purchaser so chooses, Pre-Funded Warrants
                                            in lieu of shares common stock that would otherwise result in such purchaser&#8217;s beneficial
                                            ownership exceeding</span></p>
                                                                              <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.99%
(or, at the election of the purchaser, 9.99%) of our outstanding shares of common stock. This offering also relates to the shares of
common stock issuable upon exercise of any Pre-Funded Warrant sold in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
each Pre-Funded Warrant that we sell, the number of shares of common stock that we are offering will be decreased on a one-for-one basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price of each Pre-Funded
Warrant will be equal to the combined public offering price per share of common stock and Common Warrant sold in this offering minus
$0.001, the exercise price per share of common stock of each Pre-Funded Warrant. The Pre-Funded Warrants are immediately exercisable
and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full. To better understand the terms of the Pre-Funded
Warrants, you should carefully read the section of the prospectus entitled &#8220;Description of Securities We Are Offering&#8211;Pre-Funded
Warrants.&#8221; You should also read the form of Pre-Funded Warrant, which is filed as an exhibit to the registration statement of which
this prospectus forms a part.</span></p>
</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    to purchase additional shares</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have granted the underwriter an option, exercisable for 30 days after closing of this offering, to purchase up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional
    shares of Common Stock, Pre-Funded Warrants and/or Common Warrants from us at the combined public offering price per share less the
    underwriting discounts and commissions, solely to cover over-allotments, if any.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"/>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
    stock to be outstanding immediately after this offering</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares
    (or&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares if the underwriter exercises its over-allotment option in full),
    assuming no sales of Pre-Funded Warrants, which, if sold, would reduce the number of shares of common stock that we are offering
    on a one-for-one basis, and no exercise of Common Warrants sold in this offering or Underwriter&#8217;s Warrants issued in connection
    with this offering.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
    of proceeds </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            estimate that our net proceeds from the sale of the shares of common stock (or Pre-Funded
                                            Warrants in lieu thereof) and accompanying Common Warrants we are offering under this prospectus
                                            will be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;million (or approximately
                                            $&#160;&#160;&#160;&#160;&#160;&#160;&#160;million if the underwriter exercises its option
                                            to purchase additional shares in full), assuming a public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;per
                                            share, after deducting the estimated underwriting discounts and commissions and estimated
                                            offering expenses payable by us.</span></p>
                                                                              <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                                              <p style="text-align: justify; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
                                            currently intend to use the net proceeds we receive from this offering for general corporate
                                            purposes, including operating expenses, capital expenditures and working capital. See the
                                            section titled &#8220;Use of Proceeds&#8221; for additional information.</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriter&#8217;s
    Warrants</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    have agreed to issue to the underwriter warrants to purchase up to a total of shares of our common stock (or shares assuming the
    over-allotment option is exercised in full), representing seven percent (7%) of the aggregate number of shares of our common stock
    and Pre-Funded Warrants (if any) sold in this offering. The warrants will be exercisable, at a price per share equal to 100% of the
    combined public offering price per share of common stock and Common Warrant, at any time and from time to time, in whole or in part,
    from 180 days after the commencement of sales in this offering to the fifth anniversary thereof. The registration statement of which
    this prospectus is a part also registers for sale the number of shares of common stock issuable upon exercise of the Underwriter&#8217;s
    Warrants. Please see &#8220;Underwriting &#8211; Underwriter&#8217;s Warrants&#8221; for a description of these warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
    factors </b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
    should read the &#8220;Risk Factors&#8221; section of this prospectus beginning on page 11 and the other information in this prospectus
    for a discussion of factors to consider carefully before deciding to invest in our securities.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
    symbol and trading</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is listed on the Nasdaq Capital Market under the ticker symbol &#8220;NTRP&#8221;. We do not intend to apply for a listing
    of the Pre-Funded Warrants or the Common Warrants on any national securities exchange or other nationally recognized trading system.
    Without an active trading market, the liquidity of the Pre-Funded Warrants and Common Warrants will be limited.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-align: justify; text-indent: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of our common stock to be outstanding after this offering, as set forth above, is based on 1,429,412 shares of
our common stock outstanding as of October 29, 2024. The number of shares of our common stock to be outstanding after this offering,
as set forth above, excludes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,877
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock subject to outstanding
    options having a weighted-average exercise price of $58.19 per share; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">580,837
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock subject to outstanding warrants having a weighted-average exercise price
                                            of $7.67 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,259
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock issuable upon conversion of our Series E Convertible Preferred Stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,000
                                            shares of our common stock issuable upon conversion of our Series H Convertible Preferred
                                            Stock;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">126,204
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock issuable upon conversion of our Series I Convertible Preferred Stock;</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                       <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                                                        shares of our common stock issuable upon exercise of the Common Warrants being offered hereunder; and</td></tr>
                                                                       <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
                                                                       <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
<td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
                                                                        shares of common stock (or shares assuming the over-allotment option is exercised in full), issuable upon exercise of
                                                                        Underwriter&#8217;s Warrants to be issued to the underwriter or its designees as compensation in connection with this offering at
                                                                        an exercise price equal to 100% of the combined public offering price of the shares of common stock (or Pre-Funded Warrants in lieu
                                                                        thereof) and Common Warrants being offered hereunder.</td></tr>
                                                                       </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated, all information in this prospectus assumes no exercise by the underwriter of its option to purchase additional
shares from us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, this prospectus reflects and assumes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sale and issuance by us of all &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock (or Pre-Funded
    Warrants in lieu thereof) and accompanying Common Warrants being offered hereunder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise of the Common Warrants being offered hereunder;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise of the Underwriter&#8217;s Warrants to
    be issued upon consummation of this offering;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of outstanding options or warrants; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise by the underwriters of their option to purchase up to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;additional
    shares of our Common Stock, Pre-Funded Warrants and/or Common Warrants from us to cover over-allotments, if any.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 159.7pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any outstanding options, warrants, and convertible securities are exercised or converted, there may be further dilution
to new investors. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if
we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through
the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; padding-right: 0.1in; padding-left: 0.1in; margin-bottom: 0pt">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="Z_004"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUMMARY
FINANCIAL DATA</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables summarize our historical financial data for the periods ended on and as of the dates indicated. We have derived the
statements of operations data for the years ended February 29, 2024 and February 28, 2023 from our audited financial
statements and related notes included elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have derived the unaudited financial data as of and for the six months ended August 31, 2024 and 2023 from our unaudited
condensed financial statements included elsewhere in this prospectus, which have been prepared in accordance with generally accepted
accounting principles in the United States of America on the same basis as the annual audited financial statements and, in the opinion
of management, the unaudited data reflects all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation
of the financial information in those statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
historical results are not necessarily indicative of results that may be expected in the future, and results for the period ended August
31, 2024 are not necessarily indicative of the results to be expected for the full year ending February 28, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read the following summary financial data together with our financial statements and the related notes appearing elsewhere in
this prospectus, as well as with the information in the section of this prospectus entitled &#8220;Management&#8217;s Discussion and
Analysis of Financial Condition and Results of Operations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">(in thousands, except per share data)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>February 29 and 28,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six
                                            </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Months
                                            Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
                                            </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31,</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(unaudited)</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">(unaudited)</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">459</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">383</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">343</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">47</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Cost of revenue</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">398</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">355</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">41</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Operating expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 20pt">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,788</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,566</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,845</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,364</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 20pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">484</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">707</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">208</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">91</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 20pt">Depreciation and amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">1,469</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">707</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">383</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">668</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total operating expenses</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,741</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,980</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,436</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,123</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Other income (expense)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(977</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(82</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(99</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(139</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gain (loss) from discontinued operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(675</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Preferred dividends</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(21</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,339</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,034</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,534</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(2,256</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss per share &#8211; basic and diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(32.12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(70.32</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(1.07</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(27.06</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Basic and diluted weighted average number of common shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">228</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">72</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,277</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">83</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of August 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Actual</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Adjusted (1)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(unaudited)</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">(unaudited)</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Balance Sheet Data:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">102</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,358</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">4,889</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Liabilities</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">5,023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accumulated Deficit</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(27,686</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total Stockholders&#8217; Equity (Deficit)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(134</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 26pt; text-align: justify; text-indent: -20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    adjusted balance sheet data gives effect to our sale of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock in this offering at a public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per
    share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. As adjusted balance
    sheet data is illustrative only and will change based on the actual public offering price and other terms of this offering determined
    at pricing. Each $0.10 increase (decrease) in the combined public offering price per share of common stock and Common Warrant
    would increase (decrease) the amount of cash and cash equivalents, working capital, total assets, and total stockholders&#8217;
    equity by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;million, assuming no sale of Pre-Funded Warrants, that the number of shares of common stock
    offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting underwriting discounts and
    commissions, estimated offering expenses payable by us. We may also increase or decrease the number of shares of common stock and
    Common Warrants to be issued in this offering. Each increase (decrease) of 500,000 shares of common stock and Common
    Warrants offered by us would increase (decrease) the as adjusted amount of cash and cash equivalents, working capital, total
    assets and total stockholders&#8217; deficit by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming no sale of Pre-Funded Warrants, that
    the combined public offering price per share of common stock remains the same, and after deducting underwriting discounts
    and commissions, and estimated offering expenses payable by us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="s_002"></span>RISK
FACTORS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 194.9pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investing
in our securities involves a high degree of risk. You should carefully consider the risks described below, as well as the other information
in this prospectus, including our financial statements and the related notes and the section entitled &#8220;Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our securities. The occurrence
of any of the events or developments described below could harm our business, financial condition, operating results, and/or growth prospects.
The risks described below are not the only ones facing us. Our business is also subject to the risks that affect many other companies,
such as competition, labor relations, general economic conditions, inflation, supply chain constraints, geopolitical changes, and international
operations. We operate in a rapidly changing environment that involves a number of risks, some of which are beyond our control. Additional
risks not currently known to us or that we currently believe are immaterial also may impair our business operations and our liquidity.
The risks described below could cause our actual results to differ materially from those contained in the forward-looking statements
we have made in this prospectus, the information incorporated herein by reference, and those forward-looking statements we may make from
time to time. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider
the following to be a complete discussion of all potential risks or uncertainties.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Business </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>revenue is derived from the global
travel industry, and a prolonged or substantial decrease in global travel, particularly air travel, could adversely affect our
operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">revenue is derived from the global travel industry
and would be significantly impacted by declines in, or disruptions to, travel activity, particularly air travel. Global factors over
which we have no control, but which could impact our clients&#8217; willingness to travel and, depending on the scope and
duration, cause a significant decline in travel volumes include, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
widespread health concerns, epidemics or pandemics, such as the COVID-19 pandemic, the Zika virus, H1N1 influenza, the Ebola virus, avian
flu, SARS or any other serious contagious diseases;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
global security concerns caused by terrorist attacks, the threat of terrorist attacks, or the precautions taken in anticipation of such
attacks, including elevated threat warnings or selective cancellation or redirection of travel;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
cyber-terrorism, political unrest, the outbreak of hostilities or escalation or worsening of existing hostilities or war, such as Russia&#8217;s
invasion of Ukraine and the military conflict in Israel, resulting sanctions imposed by the U.S. and other countries and retaliatory
actions taken by sanctioned countries in response to such sanctions;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
natural disasters or severe weather conditions, such as hurricanes, flooding and earthquakes;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
climate change-related impact to travel destinations, such as extreme weather, natural disasters and disruptions, and actions taken by
governments, businesses and supplier partners to combat climate change;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
the occurrence of travel-related accidents or the grounding of aircraft due to safety concerns;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
the impact of macroeconomic conditions and labor shortages on the cost and availability of airline travel; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
adverse changes in visa and immigration policies or the imposition of travel restrictions or more restrictive security procedures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
decrease in demand for consumer or business travel could materially and adversely affect our business, financial condition and
results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>need additional capital, which may
not be available on commercially acceptable terms, if at all, which raises questions about our ability to continue as a going
concern.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 31, 2024, we had $4.9 million in total assets, $5.0 million in total liabilities, negative working capital
of $3.7 million and a total accumulated deficit of $27.7 million. We had a net loss of $7.3 million for the fiscal year
ended February 29, 2024 and $3.5 million for the six months ended August 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">We are subject
to all the substantial risks inherent in the development of a new business enterprise within an extremely competitive industry. Due to
the absence of a long-standing operating history and the emerging nature of the markets in which it competes, we anticipate operating
losses until we can successfully implement our business strategy, which includes all associated revenue streams. Our
revenue model is new and evolving, and we cannot be certain that it will be successful. The potential profitability of this
business model is unproven. We may never achieve profitable operations or generate significant revenues. Our future operating
results depend on many factors, including demand for our products, the level of competition, and the ability of our officers
to manage our business and growth. Additional development expenses may delay or negatively impact our ability to generate
profits. Accordingly, we cannot assure you that our business model will be successful or that we can sustain revenue growth,
achieve, or sustain profitability, or continue as a going concern.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that, in the aggregate, it could require several millions of dollars to support and expand the marketing and development
of its products, repay debt obligations, provide capital expenditures for additional equipment and development costs, payment obligations,
office space and systems for managing the business, and cover other operating costs until its planned revenue streams from all products
are fully implemented and begin to offset its operating costs. At a minimum, we estimate that we will need to raise $5.5 million in
net proceeds to sustain our operations for the next twelve months. If we fail to raise the minimum amount needed, we will likely need
to raise capital from other sources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event the Company is unable to raise adequate funding in the future for its operations and to pay its outstanding debt obligations,
the Company may be forced to scale back its business plan and/or liquidate some or all of its assets or may be forced to seek
bankruptcy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> outstanding indebtedness, which
could adversely affect our business and financial condition.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risks
relating to its indebtedness include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing
    our vulnerability to general adverse economic and industry conditions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">requiring
    us to dedicate a portion of our cash flow from operations to principal and interest payments on our indebtedness,
    thereby reducing the availability of cash flow to fund working capital, capital expenditures, acquisitions and investments and other
    general corporate purposes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">making
    it more difficult for us to optimally capitalize and manage the cash flow for our businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
    our flexibility in planning for, or reacting to, changes in our businesses and the markets in which we operate;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">possibly
    placing us at a competitive disadvantage compared to our competitors that have less debt; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">limiting
    our ability to borrow additional funds or to borrow funds at rates or on other terms that we find acceptable.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
distributors are unable to drive customers to our websites and/or we are unable to drive visitors to our websites,
from search engines or otherwise, this could negatively impact transactions on the websites of our distributors as well as our
own websites and consequently cause our travel revenue to decrease.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
visitors find the distributors and NextTrip&#8217;s websites by searching for vacation  information through Internet search engines.
A critical factor in attracting visitors to NextTrip&#8217;s websites, and those of our distributors, is how prominently our
distributors and NextTrip are displayed in response to search queries. Accordingly, we utilize search engine marketing, or
SEM, as a means to provide a significant portion of our visitor acquisition. SEM includes both paid visitor acquisition (on a
cost-per-click basis) and unpaid visitor acquisition, which is often referred to as organic search.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">plan to employ search engine optimization, or SEO,
to acquire visitors. SEO involves developing NextTrip&#8217;s websites in order to rank highly in relevant search queries. In addition
to SEM and SEO, we may also utilize other forms of marketing to drive visitors to our websites, including branded search,
display advertising and email marketing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
various search engine providers, such as Google and Bing, employ proprietary algorithms and other methods for determining which websites
are displayed for a given search query and how highly websites rank. Search engine providers may change these methods in a way that may
negatively affect the number of visitors to our distributors&#8217; websites as well as our own websites and may do so
without public announcement or detailed explanation. Therefore, the success of our SEO and SEM strategy depends, in part, on our
ability to anticipate and respond to such changes in a timely and effective manner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, websites must comply with search engine guidelines and policies. These guidelines and policies are complex and may change at
any time. If we or our distributors fail to follow such guidelines and policies properly, the search engine may cause our
content to rank lower in search results or could remove the content altogether. If we or our distributors fail to understand
and comply with these guidelines and policies and ensure their websites&#8217; compliance, our SEO and SEM strategy may not be
successful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Unfavorable
changes in, or interpretations of, government regulations or taxation of the evolving product offerings, Internet and e-commerce industries
could harm our travel division operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">We have contracted
for products in markets throughout the world, in jurisdictions which have various regulatory and taxation requirements that can affect
our travel division operations or regulate the activity of travel suppliers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Compliance with laws and regulations of different
jurisdictions imposing different standards and requirements is very burdensome because each region has different regulations with respect
to licensing and other requirements. Our online marketplaces are accessible by travelers in many states and foreign jurisdictions. Compliance
requirements that vary significantly from jurisdiction to jurisdiction impose added costs and increased liabilities for compliance deficiencies.
In addition, laws or regulations that may harm our business could be adopted, or interpreted in a manner that affects our activities,
including but not limited to the regulation of personal and consumer information and real estate licensing requirements. Violations or
new interpretations of these laws or regulations may result in penalties, negatively impact our operations and damage our reputation
and business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In addition, many of the fundamental statutes
and regulations that impose taxes or other obligations on travel and lodging companies were established before the growth of the Internet
and e-commerce, which creates a risk of these laws being used, in ways not originally intended, that could burden travel suppliers or
otherwise harm our business. These and other similar new and newly interpreted regulations could increase costs for, or otherwise discourage,
suppliers from partnering with NextTrip, which could harm its business and operating results.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Furthermore, as we expand or change the products and services that we offer or the methods by which we offer
them, we may become subject to additional legal regulations, tax requirements or other risks. Regulators may seek to impose regulations
and requirements on us even if we utilize third parties to offer the products or services. These regulations and requirements may apply
to payment processing, insurance products or the various other products and services we may now or in the future offer or facilitate
through our marketplace. Whether we comply with or challenge these additional regulations, our costs may increase, and our business may
otherwise be harmed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we are not able to maintain and enhance our NextTrip brand and the brands associated with each of our websites,
our reputation and business may suffer.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">It is important
for NextTrip to maintain and enhance its brand identity in order to attract and retain travel suppliers and customers. The successful
promotion of our brands will depend largely on our marketing and public relations efforts. We expect that the promotion of our brands
will require us to make substantial investments, and, as its market becomes more competitive, these branding initiatives may become increasingly
difficult and expensive. In addition, we may not be able to successfully build our NextTrip brand identity without losing value associated
with, or decreasing the effectiveness of, our other brand identities. If we do not successfully maintain and enhance our brands, we could
lose traveler traffic, which could, in turn, cause suppliers to discontinue their distribution with us. In addition, our brand promotion
activities may not be successful or may not yield revenue sufficient to offset their cost, which could adversely affect our reputation
and business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
long-term success depends, in part, on our ability to expand our supplier and traveler bases outside of the United States and,
as a result, our business is susceptible to risks associated with international operations.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> limited operating and e-commerce experience
in many foreign jurisdictions and are making significant investments to build our international operations. We plan
to continue our efforts to expand globally, including potentially acquiring international businesses and conducting business in
jurisdictions where we do not currently operate. Managing a global organization is difficult, time-consuming and expensive and
any international expansion efforts that we undertake may not be profitable in the near or long term or otherwise be successful.
In addition, conducting international operations subjects the Company to risks that include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cost and resources required to localize its services, which requires the translation of our websites and their adaptation
    for local practices and legal and regulatory requirements;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adjusting
    the products and services we provide in foreign jurisdictions, as needed, to better address the needs of
    distributors and travelers, and the threats of local competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">being
                                            subject to foreign laws and regulations, including those laws governing Internet activities,
                                            email messaging, collection and use of personal information, ownership of intellectual property,
                                            taxation and other activities important to our online business practices, which may
                                            be less developed, less predictable, more restrictive, and less familiar, and which may adversely
                                            affect financial results in certain regions;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">competition
    with companies that understand the local market better than we do or who have pre-existing relationships with suppliers, distributors
    and travelers in those markets;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
    uncertainty regarding our liability for the transactions and content on our websites, including online bookings, property listings
    and other content provided by suppliers, including uncertainty resulting from unique local laws or a lack
    of clear precedent of applicable law;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">lack
    of familiarity with and the burden of complying with a wide variety of other foreign laws, legal standards and foreign regulatory
    requirements, including invoicing, data collection and storage, financial reporting and tax compliance requirements, which are subject
    to unexpected changes;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">laws
    and business practices that favor local competitors or prohibit or limit foreign ownership of certain businesses;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
    associated with joint venture relationships and minority investments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adapting
    to variations in foreign payment forms;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in managing and staffing international operations and establishing or maintaining operational efficiencies;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in establishing and maintaining adequate internal controls and security over our data and systems;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency
    exchange restrictions and fluctuations in currency exchange rates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potentially
                                                                              adverse tax consequences, which may be difficult to predict, including the complexities of foreign value added tax systems and
                                                                              restrictions on the repatriation of earnings;</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political,
    social and economic instability abroad, war, terrorist attacks and security concerns in general;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential failure of financial institutions internationally;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    or varied protection for intellectual property rights in some countries; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher
    telecommunications and Internet service provider costs.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
in international markets also requires significant management attention and financial resources. We cannot guarantee that our
international expansion efforts in any or multiple territories will be successful. The investment and additional resources required
to establish operations and manage growth in other countries may not produce desired levels of revenue or profitability and could instead
result in increased costs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
market in which we participate is highly competitive, and we may be unable to compete successfully with our current
or future competitors.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The market to provide listing, search and marketing
services for the travel industry is very competitive and dominated by key players, such as Expedia and Booking.com. In addition, the
barriers to entry are low and new competitors may enter. All of the services that we plan to provide to travelers are provided separately
or in combination by current or potential competitors. Our competitors may adopt aspects of our business model, which could reduce our
ability to differentiate our services. Additionally, current or new competitors may introduce new business models or services that we
may need to adopt or otherwise adapt to in order to compete, which could reduce our ability to differentiate our business or services
from those of our competitors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In addition, most of our current or potential competitors are larger and have more resources than we do. Many
of our current and potential competitors enjoy substantial competitive advantages, such as greater name recognition in their markets,
longer operating histories and larger marketing budgets, as well as substantially greater financial, technical and other resources. In
addition, our current or potential competitors may have access to larger traveler bases. As a result, our competitors may be able to
respond more quickly and effectively than we can to new or changing opportunities, technologies, standards or distribution or traveler
requirements. For all of these reasons, the Company may not be able to compete successfully against its current and future competitors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><b><i>If we are unable to introduce new or upgraded
products, services or features that distributors, travelers or agents recognize as valuable, we may fail to: (i) drive additional travelers
to our websites, (ii) retain existing distributors, and/or (iii) attract new distributors. Our efforts to develop new and upgraded services
and products could require us to incur significant costs.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In order to attract travelers to our distributors, as well as our own online marketplace while retaining, and
attracting new suppliers, we will need to continue to invest in the development of new products, services and features that both add
value for travelers and suppliers and differentiate us from our competitors. The success of new products, services and features depends
on several factors, including the timely completion, introduction and market acceptance of the product, service or feature. If travelers,
or suppliers do not recognize the value of our new services or features, they may choose not to utilize our products or make their inventory
available through our channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Attempting to develop and deliver these new or
upgraded products, services or features involves inherent hazards and difficulties, and is costly. Efforts to enhance and improve the
ease of use, responsiveness, functionality and features of our existing websites have inherent risks, and we may not be able to manage
these product developments and enhancements successfully. We may not succeed in developing new or upgraded products, services or features
or new or upgraded products, services or features may not work as intended or provide value. In addition, some new or upgraded products,
services or features may be difficult for us to market and may also involve unfavorable pricing. Even if we succeed, we cannot guarantee
that our suppliers will respond favorably.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In addition to developing our own improvements, we may choose to license or otherwise integrate applications,
content and data from third parties. The introduction of these improvements imposes costs on the Company and creates a risk that it may
be unable to continue to access these technologies and content on commercially reasonable terms, or at all. In the event we fail to develop
new or upgraded products, services or features, the demand for our services and ultimately our results of operations may be adversely
affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
are</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> exposed to fluctuations in currency
exchange rates.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
we plan to conduct a significant portion of our business outside the United States, but report our results in U.S.
dollars, we face exposure to adverse movements in currency exchange rates, which may cause our revenue and operating results
to differ materially from expectations. In addition, fluctuation in our mix of U.S. and foreign currency denominated transactions
may contribute to this effect as exchange rates vary. Moreover, as a result of these exchange rate fluctuations, revenue, cost of revenue,
operating expenses and other operating results may differ materially from expectations when translated from the local currency into U.S.
dollars upon consolidation. For example, if the U.S. dollar strengthens relative to foreign currencies our non-U.S. revenue would
be adversely affected when translated into U.S. dollars. Conversely, a decline in the U.S. dollar relative to foreign currencies would
increase our non-U.S. revenue when translated into U.S. dollars. We may enter into hedging arrangements in order to manage
foreign currency exposure, but such activity may not completely eliminate fluctuations in our operating results, and there
are costs associated with such hedging activities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to protect confidential information against security breaches, or if distributors or travelers are reluctant to use our online marketplace because
of privacy or security concerns, we might face additional costs, and activity on our websites could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
collect and use personally identifiable information of distributors and travelers in
the operation of our business. Our systems may be vulnerable to computer viruses or physical or electronic break-ins that our security
measures may not detect. Anyone that is able to circumvent our security measures could misappropriate confidential or proprietary information,
cause an interruption in our operations, damage our computers or those of our users, or otherwise damage our reputation and business.
We may need to expend significant resources to protect against security breaches or to address problems caused by breaches. Security
breaches of our systems, or the systems of third parties we rely upon, such as credit card processors, could damage our reputation and
expose us to litigation and possible liability under various laws and regulations. Concern among distributors and travelers regarding our use of personal information collected on our websites could keep them from using, or continuing to use, our
online marketplace.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are risks of security breaches both on our systems and on third party systems which store our information as we increase the types of
technology that we use to operate our marketplace, such as mobile applications. New and evolving technology systems and platforms may
involve security risks that are difficult to predict and adequately guard against. In addition, third parties that process credit card
transactions between NextTrip and travelers maintain personal information collected from them. Such information could be stolen
or misappropriated, and we could be subject to liability as a result. Our distributors and travelers may be harmed by such breaches,
and we may in turn be subject to costly litigation or regulatory compliance costs, and harm to our reputation and brand. Moreover, distributors and travelers may cease using our marketplace altogether.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
laws of some states and countries require businesses that maintain personal information about their residents in electronic databases
to implement reasonable measures to keep that information secure. Our practice is to encrypt all sensitive information, but we
do not know whether our current practice will be challenged under these laws. In addition, under certain of these laws, if
there is a breach of our computer systems and we know or suspect that unencrypted personal data has been stolen, we
are required to inform any user whose data was stolen, which could harm our reputation and business. Complying with the applicable
notice requirements in the event of a security breach could result in significant costs. We may also be subject to contractual
claims, investigation and penalties by regulatory authorities, and claims by persons whose information was disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compounding
these legal risks, many states and countries have enacted different and often contradictory requirements for protecting personal information
collected and maintained electronically. Compliance with these numerous and contradictory requirements is particularly difficult for
us because we collect personal information from users in multiple jurisdictions. While we intend to comply fully
with these laws, failure to comply could result in legal liability, cause the Company to suffer adverse publicity and lose business,
traffic and revenue. If we were required to pay any significant amount of money in satisfaction of claims under these or similar
laws, or if we were forced to cease our business operations for any length of time as a result of our inability
to comply fully, our business, operating results and financial condition could be adversely affected.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cyber-attacks
and system vulnerabilities could lead to sustained service outages, data loss, reduced revenue, increased costs, liability claims, or
harm to our competitive position.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">We may experience
targeted and organized malware, phishing, and account takeover attacks and other forms of attack such as ransomware, SQL injection
(where a third party attempts to insert malicious code into its software through data entry fields in its websites in order to gain control
of the system) and attempts to use our websites as a platform to launch a denial-of-service attack on another party. Our
existing security measures may not be successful in preventing attacks on our systems. Our existing IT business continuity and
disaster recovery practices are less effective against certain types of attacks such as ransomware, which could result in our
services being unavailable for an extended period of time, nullify our data, expose our payment card and personal data,
or expose the Company to an extortion attempt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reductions
in the availability and response time of our online services could cause loss of substantial business volumes during the occurrence
of a cyber-attack on our systems and measures we may take to divert suspect traffic in the event of such an attack could
result in the diversion of bona fide customers. These issues are more difficult to manage during any expansion of the number of places
where we operate and the variety of services we offer, and as the tools and techniques used in such attacks become more
advanced. We use sophisticated technology to identify cybersecurity threats; however, a cyberattack may go undetected for a period
of time resulting in harm to our computer systems and the loss of data. This could result in financial penalties being imposed
by the regulators and reputational harm. Our insurance policies have coverage limits and may not be adequate to reimburse us
for all losses caused by security breaches. Successful attacks could result in significant interruptions in our operations,
severe damage to our information technology infrastructure, negative publicity, damage our reputation, and prevent consumers
from using our services during the attack, any of which could cause consumers to use the services of our competitors, which
would have a negative effect on the value of our brands, market share, business, and results of operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
our systems cannot cope with the level of demand required to service our consumers and accommodations, we could
experience unanticipated disruptions in service, slower response times, decreased customer service and customer satisfaction, and delays
in the introduction of new services.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an online business, we are dependent on the Internet and maintaining connectivity between itself and consumers, sources of Internet
traffic, such as Google, and our travel service providers and restaurants. As consumers increasingly turn to mobile and other
smart devices, we also depend on consumers&#8217; access to the Internet through mobile carriers and their systems. Disruptions
in internet access, especially if widespread or prolonged, could materially adversely affect our business and results of operations.
While we maintain redundant systems and hosting services, it is possible that we could experience an interruption in our
business, and we do not carry business interruption insurance sufficient to compensate us for all losses that may occur.
We have computer hardware for operating our services located in hosting facilities around the world. We do not have
a comprehensive disaster recovery plan in every geographic region in which we conduct business, and these systems and operations
are vulnerable to damage or interruption from human error, misconduct, or catastrophic events. In the event of any disruption of service
at such facilities or the failure by such facilities to provide our required data communications capacity, we may not be
able to switch to back-up systems immediately and it could result in lengthy interruptions or delays in our services. We have
taken and continue to take steps to increase the reliability and redundancy of our systems. These steps are expensive, may
reduce our margins, and may not be successful in reducing the frequency or duration of unscheduled downtime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Loss
or material modification of our credit card acceptance privileges could have a material adverse effect on our business
and operating results.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of our credit card acceptance privileges could significantly limit the availability and desirability of our products
and services. Moreover, if we fail to fully perform our contractual obligations, we could be obligated to reimburse
credit card companies for refunded payments that have been contested by the cardholders. In addition, even when we are in compliance
with these obligations, we bear other expenses including those related to the acceptance of fraudulent credit cards. As a result
of all of these risks, credit card companies may require us to set aside additional cash reserves, may increase the transaction
fees they charge us, or may even refuse to renew our acceptance privileges.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, credit card networks, such as Visa, MasterCard and American Express, have adopted rules and regulations that apply to all merchants
who process and accept credit cards and include the Payment Card Industry Data Security Standards, or the PCI DSS. Under these rules,
we are required to adopt and implement internal controls over the use, storage and security of card data. We assess our
compliance with the PCI DSS rules on a periodic basis and makes necessary improvements to our internal controls. Failure to
comply may subject us to fines, penalties, damages and civil liability and could prevent us from processing or accepting
credit cards. However, we cannot guarantee that compliance with these rules will prevent illegal or improper use of our
payment systems or the theft, loss or misuse of the credit card data.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loss of, or the significant modification of, the terms under which we obtain credit card acceptance privileges could have a material
adverse effect on our business, revenue and operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>currently rely on a small number
of third-party service providers to host and deliver a significant portion of our services, and any interruptions or delays in
services from these third parties could impair the delivery of our services and harm our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> on third-party service providers for numerous
products and services, including payment processing services, data center services, web hosting services, insurance products for customers
and travelers and some customer service functions. We rely on these companies to provide uninterrupted services and to provide
their services in accordance with all applicable laws, rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">use a combination of third-party data centers to
host our websites and core services. We do not control the operation of any of the third-party data center facilities we
use. These facilities may be subject to break-ins, computer viruses, denial-of-service attacks, sabotage, acts of vandalism and other
misconduct. They are also vulnerable to damage or interruption from power loss, telecommunications failures, fires, floods, earthquakes,
hurricanes, tornadoes and similar events. We currently do not have a comprehensive disaster recovery plan in place nor do our
systems provide complete redundancy of data storage or processing. As a result, the occurrence of any of these events, a decision
by our third-party service providers to close their data center facilities without adequate notice or other unanticipated problems
could result in loss of data as well as a significant interruption in our services and harm to our reputation and brand.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our third party service providers experience difficulties and are not able to provide services in a reliable and secure manner,
if they do not operate in compliance with applicable laws, rules and regulations and, with respect to payment and card processing companies,
if they are unable to effectively combat the use of fraudulent payments on our websites, our results of operations and
financial positions could be materially and adversely affected. In addition, if such third-party service providers were to cease operations
or face other business disruption either temporarily or permanently, or otherwise face serious performance problems, we could
suffer increased costs and delays until we find or develop an equivalent replacement, any of which could have an adverse impact
on our business and financial performance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we do not adequately protect our intellectual property, our ability to compete could be impaired.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
intellectual property includes the content of our websites, registered domain names, as well as registered and unregistered trademarks.
we believe that our intellectual property is an essential asset of our business and that our domain names and our technology infrastructure
currently give us a competitive advantage in the online market for travel. If we do not adequately protect our
intellectual property, our brand, reputation and perceived content value could be harmed, resulting in an impaired ability to compete
effectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
protect our intellectual property, we rely on a combination of copyright, trademark, patent and trade secret laws, contractual
provisions and our user policy and restrictions on disclosure. Upon discovery of potential infringement of our intellectual
property, we promptly take action we deem appropriate to protect our rights. We also enter into confidentiality
agreements with our employees and consultants and seek to control access to and distribution of our proprietary information
in a commercially prudent manner. The efforts hawse have taken to protect our intellectual property may not be sufficient
or effective, and, despite these precautions, it may be possible for other parties to copy or otherwise obtain and use the content of
our websites without authorization. We may be unable to prevent competitors from acquiring domain names or trademarks that
are similar to, infringe upon or diminish the value of our domain names, service marks and our other proprietary rights.
Even if we do detect violations and decide to enforce our intellectual property rights, litigation may be necessary to
enforce our rights, and any enforcement efforts we undertake could be time-consuming, expensive, distracting and result
in unfavorable outcomes. A failure to protect our intellectual property in a cost-effective and meaningful manner could have a
material adverse effect on our ability to compete.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
trademark, copyright and trade secret protection may not be available in every country in which our offerings are available over
the Internet. In addition, the legal standards relating to the validity, enforceability and scope of protection of intellectual property
rights are uncertain and still evolving.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
</i></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>may be subject to claims that we
violated intellectual property rights of others, which are extremely costly to defend and could require us to pay significant
damages and limit our ability to operate.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in the Internet and technology industries, and other patent and trademark holders seeking to profit from royalties in connection with
grants of licenses, own large numbers of patents, copyrights, trademarks and trade secrets and frequently enter into litigation based
on allegations of infringement or other violations of intellectual property rights. There may be intellectual property rights held by
others, including issued or pending patents and trademarks, that cover significant aspects of our technologies, content, branding
or business methods. Any intellectual property claims against us, regardless of merit, could be time-consuming and expensive to
settle or litigate and could divert management&#8217;s attention and other resources. These claims also could subject us to significant
liability for damages and could result in the Company having to stop using technology, content, branding or business methods found
to be in violation of another party&#8217;s rights. We might be required or may opt to seek a license for rights to intellectual
property held by others, which may not be available on commercially reasonable terms, or at all. If we cannot license or develop
technology, content, branding or business methods for any allegedly infringing aspect of our business, we may be unable
to compete effectively. Even if a license is available, we could be required to pay significant royalties, which could increase
our operating expenses. We may also be required to develop alternative non-infringing technology, content, branding or
business methods, which could require significant effort and expense and be inferior. Any of these results could harm our operating
results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the businesses and/or assets that we have acquired or invested in do not perform as expected or we are unable to effectively integrate
acquired businesses, our operating results and prospects could be harmed.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
future mergers and acquisitions, if any, will involve numerous risks, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
                                                                                          in integrating and managing the combined operations, technologies, technology platforms and products of the acquired companies and
                                                                                          realizing the anticipated economic, operational and other benefits in a timely manner, which could result in substantial costs and
                                                                                          delays or other operational, technical or financial problems;</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">legal
                                                                                          or regulatory challenges or post-acquisition litigation, which could result in significant costs or require changes to the
                                                                                          businesses or unwinding of the transaction;</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">failure
    of the acquired company or assets to achieve anticipated revenue, earnings or cash flow;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">diversion
    of management&#8217;s attention or other resources from our existing business;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    inability to maintain key distributors and business relationships, and the reputations of acquired businesses;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">uncertainty
                                                                              resulting from entering markets in which we have limited or no prior experience or in which competitors have stronger market
                                                                              positions;</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    dependence on unfamiliar affiliates and partners of acquired businesses;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unanticipated
    costs associated with pursuing acquisitions;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">liabilities
                                                                                          of acquired businesses, which may not be disclosed to us or which may exceed our estimates, including liabilities relating to
                                                                                          non-compliance with applicable laws and regulations, such as data protection and privacy controls;</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in assigning or transferring to us or our subsidiaries intellectual property licensed to companies we acquired;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    loss of key employees of the acquired companies;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in complying with antitrust and other government regulations;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">challenges
                                                                                          in integrating and auditing the financial statements of acquired companies that have not historically prepared financial statements
                                                                                          in accordance with U.S. generally accepted accounting principles; and</span></p></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
                                                                                          accounting charges to the extent intangibles recorded in connection with an acquisition, such as goodwill, trademarks, customer
                                                                                          relationships or intellectual property, are later determined to be impaired and written down in value.</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Moreover,
we rely heavily on the representations and warranties provided to us by the sellers of acquired companies and assets, including as they
relate to creation, ownership and rights in intellectual property, existence of open-source software and compliance with laws and contractual
requirements. If any of these representations and warranties are inaccurate or breached, such inaccuracy or breach could result in costly
litigation and assessment of liability for which there may not be adequate recourse against such sellers, in part due to contractual
time limitations and limitations of liability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><b>Failure
to obtain adequate insurance coverage could put us at risk for uninsured losses.</b></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Some or all of our customers
may require insurance as a requirement to conduct business with us. <span style="text-transform: uppercase">A</span>lthough we currently
have product liability insurance, we may be unable to obtain or maintain adequate liability insurance on acceptable terms, if at all,
and there is a risk that our insurance will not provide adequate coverage against our potential losses. Additionally, there are certain
types of losses that may not be insurable at a cost that we can afford, and insurance may not be available at any cost with respect to
certain losses. Claims or losses in excess of any insurance coverage we may obtain, or the lack of insurance coverage, could put us at
risk of uninsured loss, which would have a material adverse effect on our business and financial condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We are dependent on key personnel, and the
loss of any of these individuals could harm our business.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">We depend on key industry
and other personnel. The loss of any of these individuals could harm our business and significantly delay or prevent the achievement
of our business objectives. In addition, our delivery of services will be labor-intensive: when we are awarded a contract, we may need
to quickly hire project leaders and project management personnel. The additional staff may also create a concurrent demand for increased
administrative personnel. The success of our business will require that we attract, develop, motivate and retain:</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="width: 24px; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">experienced and innovative executive officers;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">senior managers who have successfully managed or designed programs
    in the public sector; and</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">information technology professionals who have designed or implemented
    complex information technology projects.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Innovative, experienced and
technically proficient individuals are in great demand and are likely to remain a limited resource. We may be unable to continue to attract
and retain desirable executive officers, senior managers, and technology professionals. Our inability to hire sufficient personnel on
a timely basis or the loss of significant numbers of executive officers and senior managers could adversely affect our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our bylaws contain provisions for indemnifying
our officers and directors.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Our bylaws contain provisions
with respect to the indemnification of our officers and directors against all costs, charges and expenses actually and reasonably incurred
by an officer or director paid to settle an action or satisfy a judgment in a civil, criminal or administrative action or proceeding
to which he or she is made a party by reason of being or having been one of our directors or officers. To the extent that our directors&#8217;
and officers&#8217; insurance policy does not provide reimbursement for such costs, charges, expenses and other amounts, we may incur
substantial expenses in satisfying our indemnification obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Our operating costs could be significantly
higher than we expect, and this could reduce our future profitability.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">In addition to general economic
conditions, market fluctuations and international risks, significant increases in operating, development and implementation costs could
adversely affect us due to numerous factors, many of which are beyond our control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to Our Securities</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
price of our securities is subject to volatility related or unrelated to our operations, which could result in substantial losses for
our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 1, 2023 and October 29, 2024, the closing price of our common stock has ranged from a low of $1.72 to a high of $12.40 and
could be subject to wide fluctuations in the future in response to various factors, some of which are beyond our control. These factors
include those discussed previously in this &#8220;Risk Factors&#8221; section and others, such as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">delays
    or failures in the commercialization of our current or future products and services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">quarterly
    variations in our results of operations or those of our competitors;</span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our earnings estimates or recommendations by securities analysts or adverse publicity about us or our products or services;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of new products and services, significant contracts, commercial relationships, acquisitions or capital commitments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">adverse
    developments with respect to our intellectual property rights;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
    of litigation involving us or our competitors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    major changes in our Board of Directors or management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">market
    conditions in our industry; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions in the United States and abroad.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock market, in general, may experience broad market fluctuations, which may adversely affect the market price or liquidity
of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could be subject to securities class action litigation.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
sudden decline in the market price of our securities could trigger securities class action lawsuits against us. If any of our stockholders
were to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the time and attention of our management
would be diverted from our business and operations. We also could be subject to damages claims if we are found to be at fault in connection
with a decline in our market price of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Historically,
there has been a limited trading market in our common stock, and you may therefore have difficulty selling your securities at a price
that you determine is satisfactory.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market. Historically, there has been a limited trading market for our common stock. There
is no assurance that our common stock will actively trade in the public market at or above a price that you consider acceptable. If an
active market for our common stock is not maintained, it may be difficult for you to sell your shares of common stock when you wish to
sell them or at a price that you consider satisfactory. An inactive trading market may also impair our ability to raise capital to continue
to fund operations by selling securities and may impair our ability to acquire other companies or technologies by using our securities
as consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no assurance that we will satisfy the continued listing requirements of The Nasdaq Capital Market.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
On August 17, 2023, the Company received a letter from Nasdaq notifying the Company that it no longer complied with Nasdaq Listing Rule 5550(b)(1), which requires companies
listed on the Nasdaq Capital Market to maintain minimum stockholders&#8217; equity of $2,500,000 (the &#8220;Minimum Stockholder Equity
Requirement&#8221;), and did not meet the alternatives of market value of listed securities or net income from continuing operations.
On October 2, 2023, the Company submitted its plan to regain compliance to Nasdaq and requested an extension to February 13, 2024 to regain
compliance with the Minimum Stockholder Equity Requirement. On October 23, 2023, Nasdaq granted the requested extension and provided the
Company until February 13, 2024 to demonstrate compliance. Nasdaq further informed the Company that if the Company fails to show compliance
upon filing its next periodic report with the SEC and Nasdaq, the Company may be subject to delisting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
submitting its plan to Nasdaq, the Company has completed the following transactions, which the Company believes has resulted in the Company
regaining compliance with the Minimum Stockholder Equity Requirement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 38.7pt; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    December 29, 2023, the Company acquired 100% of the outstanding equity interests of NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;)
    pursuant to a share exchange agreement by and among the Company, NextTrip and certain other parties (the &#8220;Acquisition&#8221;).
    As consideration for the Acquisition, at closing the Company issued 156,007&#160;restricted shares of its common stock, constituting
    19.99% of its issued and outstanding shares of common stock immediately prior to execution of the share exchange agreement, and agreed
    to issue up to an aggregate of 5,843,993&#160;shares as further consideration upon NextTrip&#8217;s achievement of certain milestones
    set forth in the exchange agreement.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
    January 16, 2024, the Company completed the sale of certain assets, consisting primarily of patents, software code and other intellectual
    property, to Divergent Technologies, Inc. for a purchase price of $1,626,242, resulting in net proceeds to the Company of $1,533,563.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    October 2023, the Company sold an aggregate of 128,887 shares of its common stock under its existing at-the-market agreement, resulting
    in net proceeds to the Company of approximately $772,468.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
unaudited condensed combined pro-forma balance sheet of the Company as of September 30, 2023, which presents the combination of the financial
information of the Company and NextTrip adjusted to give effect to completion of the Acquisition and the Asset Sale, is filed as Exhibit
99.3 of a Current Report on Form 8-K filed by the Company with the SEC on January 10, 2024, and reflects total stockholders&#8217;
equity of approximately $5.4 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 12, 2024, the Company filed a Current Report on Form 8-K with the SEC disclosing that the Company believes it had regained compliance
with the Minimum Stockholder Equity Requirement based upon the specific transactions and events referenced above. Nasdaq will continue
to monitor the Company&#8217;s ongoing compliance with Minimum Stockholder Equity Requirement and, if at the time of its next periodic
report the Company does not show compliance, the Company may be subject to delisting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On June 17, 2024, the Company received a notification letter (the &#8220;Initial
Notice&#8221;) from Nasdaq advising the Company that it was not in compliance with Nasdaq&#8217;s continued listing requirements under
Nasdaq Listing Rule 5250(c)(1) (the &#8220;Rule&#8221;) as a result of its failure to timely file its Annual Report on Form 10-K for the
fiscal year ended February 29, 2024 (the &#8220;Form 10-K&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On July 17, 2024, the Company
received an additional notification letter (the &#8220;Additional Notice,&#8221; and together with the Initial Notice, the &#8220;Notices&#8221;)
from Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for the quarter ended May 31, 2024 (the
&#8220;Form 10-Q&#8221;), and because the Company remains delinquent in filing the Form 10-K, the Company remains noncompliant with the
Rule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Neither of the Notices have
an immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#8217;s
listing remains fully effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The Notices require the Company
to either file the delinquent Form 10-K and Form 10-Q with the Commission or submit a plan to regain compliance with the Rule by August
16, 2024. If Nasdaq accepts the Company&#8217;s plan, then Nasdaq may grant an exception of up to 180 calendar days from the Form 10-K&#8217;s
due date, or until December 10, 2024, to regain compliance. If Nasdaq does not accept the Company&#8217;s plan, then the Company will
have the opportunity to appeal that decision to a Nasdaq Hearings Panel under Nasdaq Listing Rule 5815.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On August 16, 2024, the
Company submitted a plan to Nasdaq regain compliance with the Rule, including the steps the Company will take to promptly file the
Form 10-K and Form 10-Q and regain compliance. The Company requested an extension until September 30, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company filed its Annual
Report on Form 10-K for the fiscal year ended February 29, 2024 on September 4, 2024, its Quarterly Report on Form 10-Q for the quarter
ended May 31, 2024 on September 16, 2024, and its Quarterly Report on Form 10-Q for the quarter ended August 31, 2024 on October 15,
2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On September 18, 2024, the Company received a notification letter (the
&#8220;Notice&#8221;) from Nasdaq notifying the Company that its amount of stockholders&#8217; equity has fallen below the $2,500,000
required minimum for continued listing set forth in Nasdaq Listing Rule 5550(b)(1). The Notice also noted that the Company does not meet
the alternatives of market value of listed securities or net income from continuing operations, and therefore, the Company no longer complies
with Nasdaq&#8217;s Listing Rules.</p>

<p style="font: 10pt/9pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Under Nasdaq Listing Rules,
the Company has until November 4, 2024 to provide Nasdaq with a specific plan to achieve and sustain compliance.</p>

<p style="font: 10pt/9.15pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">The Notice has no immediate
effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#8217;s listing remains
fully effective.</p>

<p style="font: 10pt/8.1pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On November 4, 2024, the Company
submitted its plan to Nasdaq to achieve and sustain compliance with Nasdaq Listing Rule 5550(b)(1) and is awaiting their response. There
can be no assurance that the Company will regain compliance with Nasdaq Listing Rule 5550(b)(1) or that the Company will be able meet
the continued listing requirements during any compliance period that may be granted by Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">On September 18, 2024, the
Company also received a letter from the Staff of Nasdaq indicating that the Staff has determined that the Company has regained compliance
with the periodic filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) because the Company filed its Annual Report on Form
10-K for the fiscal year ended February 29, 2024 and the Quarterly Report on Form 10-Q for the quarter ended May 31, 2024.</p>

<p style="font: 10pt/8.8pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Accordingly, the Company has
regained full compliance with the periodic filing requirement deficiency, which the Company disclosed in those Current Reports on Form
8-K filed with the Securities and Exchange Commission on June 21, 2024 and July 19, 2024, and Nasdaq has informed the Company in writing
that the matter is now closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we fail to satisfy a Nasdaq requirement for continued listing, Nasdaq could provide notice that our common stock will become subject
to delisting. In such event, Nasdaq rules would permit us to appeal the decision to reject our proposed compliance plan or any delisting
determination to a Nasdaq Hearings Panel. If our securities are de-listed from The Nasdaq Capital Market, our stockholders could incur
material adverse consequences such as reduced liquidity for their securities and reduced market prices for their securities. Following
such de-listing, we could encounter increased difficulty in issuing additional securities at an attractive price, or at all, in order
to fund our operations. See also &#8220;<i>Nasdaq Compliance</i>&#8221; on page 6.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
may experience additional dilution as a result of future equity offerings.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to raise additional capital, we may sell additional shares of our common stock or other securities convertible into or exchangeable
for our common stock. The price per share at which we sell additional shares of our common stock, or securities convertible or exchangeable
into common stock, in future transactions may be lower than the price per share that you paid for our securities in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
have broad discretion in the use of the net proceeds of our securities offerings and may not use them effectively.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use our cash for the development of our products and services, and to pursue a possible strategic investment or other transaction.
Our management has broad discretion in the use of cash and will have the right to use our cash in ways that differ substantially from
our current plans. Management may spend our cash in ways that do not improve our results of operations or enhance the value of our securities.
The failure by management to apply funds effectively could result in financial losses that could have a material and adverse effect on
our business and cause the market price of our securities to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
outstanding warrants may result in further dilution to our stockholders.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain of our outstanding warrants to purchase a total of up to approximately 580,837 shares of our common stock
contain so-called full-ratchet anti-dilution adjustments in the event we sell or issue shares of common stock or common stock equivalents
at an effective price less than the exercise price of such warrants, subject to certain exceptions. Of these warrants, warrants with an
aggregate exercise price of $956,015 also provide for a ratable increase in the number of shares purchasable upon exercise of the warrants
in the event the exercise price per share of the warrants is reduced. The anti-dilution adjustments of our outstanding warrants would
be triggered by future issuances of shares of our common stock at a price per share below the then-exercise price of such warrants, which
adjustments would have a further dilutive effect on our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
do not intend to pay dividends on our common stock, and your ability to achieve a return on your investment will depend on appreciation
in the market price of our securities.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently intend to invest our future earnings, if any, to fund our growth and not to pay any cash dividends on our common stock. Since
we do not intend to pay dividends, your ability to receive a return on your investment will depend on any future appreciation in the
market price of our securities. There is no assurance that our securities will appreciate in price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
securities or industry analysts do not publish research or reports about us, or if they issue adverse or misleading opinions regarding
us or our securities, the market price of our securities and their trading volume could decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we do not obtain and maintain research coverage by securities and industry analysts, the market price for our securities may be adversely
affected. The market price of our securities also may decline if any analyst who covers us issues an adverse or erroneous opinion regarding
us, our business model, our intellectual property or our performance. If one or more analysts cease coverage of us or fail to regularly
publish reports on us, we could lose visibility in the financial markets, which could cause the market price of our securities and their
trading volume to decline and possibly adversely affect our ability to engage in future financings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of a substantial number of shares of our common stock in the public market could cause our stock price to fall.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, we had 1,429,492 outstanding shares of common stock. Future sales of a large number of our shares
or shares issuable upon exercise of our outstanding warrants and stock options, or the perception that a large number of shares may be
sold, could have a material adverse effect on the trading price of our common stock. In addition, there are 5,843,993 contingent shares
issuable upon the achievement of certain business milestones in connection with the NextTrip acquisition as described elsewhere in this
Registration Statement. Such shares, if and when issued, will become immediately saleable and the sale of a substantial number of contingent
shares in the public market could have a material adverse effect on the trading price of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will incur significant costs to ensure compliance with U.S. and Nasdaq reporting and corporate governance requirements.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incur significant costs associated with compliance with our SEC public company reporting requirements and with applicable U.S. and Nasdaq
corporate governance requirements, including requirements under the Sarbanes-Oxley Act of 2002. These rules and regulations may also
make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to accept
reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be
difficult for us to attract and retain qualified individuals to serve on our Board of Directors or as executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to maintain effective internal control over financial reporting, the market price of our securities may be adversely affected.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public reporting company, we are required to establish and maintain effective internal control over financial reporting. Failure to
establish such internal control, or any failure of such internal control once established, could adversely impact our public disclosures
regarding our business, financial condition or results of operations. Any failure of our internal control over financial reporting could
also prevent us from maintaining accurate accounting records and discovering accounting errors and financial frauds.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rules
adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002 require annual assessment of our internal control over financial
reporting. The standards that must be met for management to assess the internal control over financial reporting as effective are complex,
and require significant documentation, testing and possible remediation to meet the detailed standards. We may encounter problems or
delays in completing activities necessary to make an assessment of our internal control over financial reporting. If we cannot assess
our internal control over financial reporting as effective, investor confidence and share value may be negatively impacted. In addition,
management&#8217;s assessment of internal control over financial reporting may identify weaknesses and conditions that need to be addressed
in our internal control over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses
and conditions that need to be addressed in our internal control over financial reporting (including those weaknesses identified in our
periodic reports), or disclosure of management&#8217;s assessment of our internal control over financial reporting may have an adverse
impact on the price of our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Provisions
in our articles of incorporation and bylaws could discourage a takeover that stockholders may consider favorable and may lead to entrenchment
of management.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation and bylaws contain provisions that could delay or prevent changes in control or changes in our management without
the consent of our Board of Directors. These provisions include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    classified Board of Directors with three-year staggered terms, which may delay the ability of stockholders to change the membership
    of a majority of our Board of Directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exclusive right of our Board of Directors to elect a director to fill a vacancy created by the expansion of the Board of Directors
    or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our Board of
    Directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability of our Board of Directors to alter our bylaws without obtaining stockholder approval;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt, amend
    or repeal our bylaws or repeal the provisions of our articles of incorporation and bylaws regarding the election and removal of directors;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting
    of our stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    requirement that a special meeting of stockholders may be called only by the chairman of the Board of Directors, the chief executive
    officer, the president (in the absence of a chief executive officer) or the Board of Directors, which may delay the ability of our
    stockholders to force consideration of a proposal or to take action, including the removal of directors; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">advance
    notice procedures that stockholders must comply with in order to nominate candidates to our Board of Directors or to propose matters
    to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquirer from conducting a solicitation
    of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
provisions could inhibit or prevent possible transactions that some stockholders may consider attractive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
could issue one or more additional series of shares of preferred stock with the effect of diluting existing stockholders and impairing
their voting and other rights.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors is authorized to issue up to 10,000,000 shares of preferred stock and may determine the terms of future preferred
stock offerings without further action by our stockholders. If we issue preferred stock, it could affect your rights or reduce the value
of our outstanding common stock. In particular, specific rights granted to future holders of preferred stock may include voting rights,
preferences as to dividends and liquidation, conversion, and redemption rights, sinking fund provisions, and restrictions on our ability
to merge with or sell our assets to a third party. As of September 26, 2024, 63,494 shares of our preferred stock are outstanding,
consisting of 316 shares of Series E Preferred Stock, 33,000 shares of Series H Preferred Stock and 30,178 shares of Series I Preferred
Stock. Please see the section of this prospectus entitled &#8220;Description of our Capital Stock&#8221; for additional information regarding
the series of our preferred stock of which there are currently shares issued and outstanding. As a result, there is a possible negative
effect on the market price of our common shares resulting from the public sale or perceived sale of common shares issuable upon conversion
or exercise of these securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks
Related to this Offering</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Resales
of our shares of our common stock in the public market by investors in this offering may cause the market price of our shares of our
common stock to fall.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering shares &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of common stock offered under this prospectus, as well
as an aggregate of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock issuable upon exercise
of Common Warrants being offered under this prospectus and Underwriter&#8217;s Warrants to be issued upon consummation of this offering. Sales of a substantial number of shares of our common stock in the public
market, or the perception that such sales might occur, could adversely affect the market price of our shares of common stock. The
issuance of new shares of common stock in this offering or in the future could result in sales of shares of our common stock by our
current stockholders concerned about the potential ownership dilution of their holdings. Furthermore, in the future, we may issue
additional shares of common stock or other equity or debt securities exercisable or convertible into shares of common stock. Any
such issuance could result in substantial dilution to our existing stockholders and could cause our stock price to
decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>You
will experience immediate and substantial dilution in the net tangible book value per share of the shares of common stock you purchase
in this offering.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
the price per share being offered is substantially higher than the net tangible book value per share of our common stock, you will suffer
substantial dilution in the net tangible book value of the shares of common stock you purchase in this offering. Assuming a combined
public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and Common Warrant, which is the last reported sales price of our shares of common stock on the
Nasdaq on &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024, if you purchase shares of common stock in this offering, you will experience an immediate decrease of approximately
$ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share in the net tangible book value of the shares of common stock as of November 30, 2023. In addition, if previously issued options
or warrants to acquire shares of our common stock are exercised at prices below the offering price, you will experience further dilution.
See the section of this prospectus entitled &#8220;Dilution&#8221; for a more detailed discussion of the dilution you may incur in connection
with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no public market for the Pre-Funded Warrants or Common Warrants being offered in this offering</i></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no established
public trading market for the Pre-Funded Warrants or Common Warrants being offered in this offering, and we do not expect a market
to develop. In addition, we do not intend to apply to list the Pre-Funded Warrants or Common Warrants on any securities exchange or
nationally recognized trading system, including the Nasdaq Capital Market. Without an active market, the liquidity of the Pre-Funded
Warrants and Common Warrants will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders
of the Pre-Funded Warrants or the Common Warrants will have no rights as holders of Common Stock until such warrants are exercised.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
you acquire shares of common stock upon exercise of your Pre-Funded Warrants or the Common Warrants, you will have no rights with respect
to the shares of common stock issuable upon exercise of your Pre-Funded Warrants or Common Warrants. Upon exercise of your Pre-Funded
Warrants or the Common Warrants, you will be entitled to exercise the rights of a holder of shares only as to matters for which the record
date occurs after the exercise date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Pre-Funded Warrants and Common Warrants are speculative in nature.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants and Common Warrants offered hereby do not confer any rights of ownership of our shares of common stock on their holders,
such as voting rights or the right to receive dividends, but rather merely represent the right to acquire shares of common stock at a
fixed price. Specifically, commencing on the date of issuance, holders of the Pre-Funded Warrants may acquire shares of common stock
issuable upon exercise of such warrants at an exercise price of $0.001 per share of common stock and holders of Common Warrants may
acquire shares of common stock issuable upon exercise of such warrants at an exercise price of $ &#160;&#160;&#160;&#160;&#160;per share of common stock. Moreover,
following this offering, the market value of the Pre-Funded Warrants and Common Warrants is uncertain, and there can be no assurance
that the market value of the Pre-Funded Warrants or Common Warrants will equal or exceed the combined public offering price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will not receive any meaningful amount of additional funds upon the exercise of the Pre-Funded Warrants.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Pre-Funded Warrant will be exercisable until it is fully exercised and by means of payment of the nominal cash purchase price upon exercise.
Accordingly, we will not receive any meaningful additional funds upon the exercise of the Pre-Funded Warrants. The net proceeds to the Company from the purchase of Pre-Funded Warrants will be immediately available to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Holders
of the Pre-Funded Warrants and Common Warrants purchased in this offering will have no rights as common stockholders until such holders
exercise such warrants and acquire shares of our common stock.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-indent: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
holders of the Pre-Funded Warrants and Common Warrants acquire shares of our common stock upon exercise thereof, holders of such Pre-Funded
Warrants and Common Warrants will have no rights with respect to the shares of our common stock underlying such Pre-Funded Warrants and
Common Warrants. Upon exercise of the Pre-Funded Warrants and Common Warrants, such holders will be entitled to exercise the rights of
a common stockholder only as to matters for which the record date occurs after the exercise date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
will have broad discretion in how we use the net proceeds of this offering. We may not use these proceeds effectively, which could affect
our results of operations and cause our stock price to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we currently intend to use the net proceeds from this offering in the manner described in the section entitled &#8220;Use of Proceeds&#8221;
in this prospectus, we will have considerable discretion in the application of the net proceeds of this offering. We may use the net
proceeds for purposes that do not yield a significant return or any return at all for our stockholders. In addition, pending their use,
we may invest the net proceeds from this offering in a manner that does not produce income or that loses value. If we do not invest or
apply the net proceeds from this offering in ways that enhance stockholder value, we may fail to achieve expected financial results,
which could cause our stock price to decline.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we raise additional capital through the sale of shares of our common stock, convertible securities or debt in the future, your ownership
in us could be diluted and restrictions could be imposed on our business.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to this offering, we may issue shares of our common stock or securities convertible into our common stock to raise additional
capital in the future. To the extent we issue such securities, our stockholders may experience substantial dilution and the trading price
of our common stock could decline. If we obtain funds through a credit facility or through the issuance of debt or preferred securities,
such debt or preferred securities could have rights senior to your rights as a common stockholder, which could impair the value of our
common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sales
of a substantial number of shares of our common stock in the public market could cause our stock price to decline.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a substantial number of shares of our common stock in the public market following this offering could cause the market price of our
common stock to decline. A substantial majority of the outstanding shares of our common stock are, and the shares of common stock
and Common Warrants offered hereby will be, freely tradable without restriction or further registration under the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), unless these shares are owned or purchased by &#8220;affiliates&#8221;
as that term is defined in Rule 144 under the Securities Act. We, along with our directors and executive officers, have agreed that for
a period of 90 days after the date of this prospectus, subject to specified exceptions, we or they will not offer, sell, contract to
sell, pledge or otherwise dispose of, directly or indirectly, any shares of our common stock or securities convertible into or exchangeable
or exercisable for any shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the price of our common stock fluctuates significantly, your investment could lose value.</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock could be highly volatile and could be subject to wide fluctuations in response to various factors,
some of which are beyond our control. In particular, the trading prices for biopharmaceutical companies have been highly volatile as
a result of supply chain disruptions and the COVID-19 pandemic. These factors include those in this &#8220;Risk Factors&#8221; section
and elsewhere in this prospectus or the documents incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the stock markets in general, and the markets for biopharmaceutical stocks in particular, have experienced extreme volatility
that may have been unrelated to the operating performance of the issuer. These broad market fluctuations may adversely affect the trading
price or liquidity of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>We might not be able to maintain the listing
of our securities on The Nasdaq Capital Market.</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">We have listed our common stock
on The Nasdaq Capital Market. We might not be able to maintain the listing standards of that exchange, as evidenced by recent deficiencies,
which standards include requirements that we maintain our shareholders&#8217; equity, total value of shares held by unaffiliated
shareholders, market capitalization above certain specified levels and minimum bid requirement of $1.00 per common share. We do not expect
to become profitable for some time and, as our shareholders&#8217; equity has fallen below the $2.5 million level required
by Nasdaq, we may not be able to raise it to remedy such deficiency. If we do not maintain compliance with the minimum bid requirement
or our shareholders&#8217; equity does not get back above $2.5 million, it will cause us to fail to conform to the Nasdaq listing requirements,
which in turn could cause our common stock to cease to trade on the Nasdaq exchange, and be required to move to the Over the Counter
Bulletin Board or the &#8220;pink sheets&#8221; exchange maintained by OTC Markets Group, Inc. The OTC Bulletin Board and the &#8220;pink
sheets&#8221; are generally considered to be markets that are less efficient, and to provide less liquidity in the shares, than the Nasdaq
market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="Z_005"></span><b>CAUTIONARY
STATEMENT ON FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 66.45pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may contain certain &#8220;forward-looking&#8221; statements as such term is defined by the SEC in its rules, regulations
and releases, which represent our expectations or beliefs, including but not limited to, statements concerning our operations, economic
performance, financial condition, growth and acquisition strategies, investments, and future operational plans. For this purpose, any
statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting
the generality of the foregoing, words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221;
&#8220;intent,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict&#8221; or
&#8220;continue&#8221; or the negative or other variations thereof or comparable terminology are intended to identify forward-looking
statements. These statements, by their nature, involve substantial risks and uncertainties, certain of which are beyond our control,
and actual results may differ materially depending on a variety of important factors, including uncertainty related to acquisitions,
governmental regulation, managing and maintaining growth, the operations of the Company and its subsidiaries, volatility of stock price,
commercial viability of our product candidates and any other factors discussed in this and other registrant filings with the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
risks and uncertainties and other factors include, but are not limited to those set forth under &#8220;Risk Factors&#8221; of this prospectus.
Given these risks and uncertainties, readers are cautioned not to place undue reliance on our forward- looking statements. All subsequent
written and oral forward-looking statements attributable to us or to persons acting on our behalf are expressly qualified in their entirety
by these cautionary statements. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise
any forward-looking statements or the risk factors described in this prospectus or in the documents we incorporate by reference, whether
as a result of new information, future events, changed circumstances or any other reason after the date of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus contains forward-looking statements, including statements regarding, among other things:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    anticipated needs for working capital;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to secure additional financing;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we
    have incurred significant losses since our inception and anticipate that we will continue to incur losses in the future;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory
    or legal developments in the United States and other countries;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    level of expenses related to our product development and operations; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    efforts to expand our products and our business.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 30pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual
events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including,
without limitation, the risks outlined under &#8220;Risk Factors&#8221; and matters described in prospectus generally. In light of these
risks and uncertainties, there can be no assurance that the forward-looking statements contained in this prospectus will in fact occur.
We caution you not to place undue reliance on these forward-looking statements. In addition to the information expressly required to
be included in this prospectus, we will provide such further material information, if any, as may be necessary to make the required statements,
in light of the circumstances under which they are made, not misleading.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="Z_006"></span><b>USE
OF PROCEEDS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 184.9pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will receive net proceeds from the sale of the shares of common stock (or Pre-Funded Warrants in lieu thereof) and
Common Warrants that we are offering of approximately $&#160;&#160;&#160;&#160;&#160;&#160;million (or approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;million
if the underwriter exercises its option to purchase additional shares in full) based on the combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;per
share of common stock and Common Warrant, after deducting the estimated underwriting discounts and commissions and estimated offering
expenses payable by us, and excluding the proceeds, if any, from the subsequent exercise of the Pre-Funded Warrants and Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
$0.10 increase (decrease) in the assumed combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per
share of common stock and Common Warrant, would increase (decrease) the net proceeds to us from this offering by approximately
$&#160;&#160;&#160;&#160;&#160;million, assuming the number of securities offered by us, as set forth on the cover page of this
prospectus, remains the same, and after deducting estimated underwriting discounts and commissions, assuming no sale of Pre-Funded
Warrants. Similarly, each increase (decrease) of 500,000 shares in the number of shares of common stock and Common Warrants
offered by us would increase (decrease) the net proceeds to us from this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;million,
based on the public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;per share and Common Warrant, and after deducting estimated
underwriting discounts and commissions, and assuming no sale of Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>We
currently intend to use the net proceeds we receive from this offering for general corporate purposes, including operating expenses,
capital expenditures and working capital. We cannot specify with certainty all of the particular uses for the net proceeds to us from
this offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>Notwithstanding
the foregoing, w<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e currently estimate that we will use the net proceeds from this offering, together with
our existing cash and cash equivalents, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Proceeds:</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; font-weight: bold; text-align: left">Gross Proceeds</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 16%; font-weight: bold; text-align: right">10,000,000</td><td style="width: 1%; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Underwriting Discounts and Commissions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(800,000</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Estimated Fees and Expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(550,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Proceeds</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Use of Proceeds:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic">Compass.TV:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AI generated video creation platform</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Marketing/viewership acceleration</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">500,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">NextTrip Travel:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">NXT 2.0 (technology enhancements to groups, widget, and travel agent platforms)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expanded Staffing (customer support)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expanded marketing programs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Upgrading Technology Infrastructure - NXT 3.0</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Travel Magazine Marketing:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Marketing for expanded user base</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">400,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">My Bucket List</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic">Other:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Acquisitions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,700,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">General working capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,042,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Repayment of short term promissory note</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">308,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Use of Proceeds</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">8,650,000</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">On September 19, 2024,
the Company entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with an investor for the sale of
a short-term promissory note (&#8220;Note&#8221;) and warrants (&#8220;Warrants&#8221;) to Investor for total consideration of $250,000.
The Note has a principal amount of $300,000 with an original issue discount of $50,000 and guaranteed interest on the principal
amount of ten percent (10%) per annum which shall be due and payable on December 19, 2024 (the &#8220;Maturity Date&#8221;). In the event
of a failure to re-pay the Note on or before the Maturity Date, the interest rate will increase to the lesser of twenty-two percent (22%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. In addition, while any portion
of the Note is outstanding, if the Company receives net cash proceeds in excess of $1,000,000 but less than $2,000,000, the Investor
is entitled to receive up to 50% of the outstanding amounts under the Note and, for such net cash proceeds in excess of $2,000,000, Investor
is entitled to repayment in full. As such the above Use of Proceeds assumes a full repayment of the Note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">On November 1, 2024,
the Company sold a short-term promissory note (&#8220;Note&#8221;) to an investor for a total consideration of $250,000. The Note has
a principal amount of $287,500 with an original issue discount of $37,500. There is no additional stated interest. The Note is due and
payable in full on May 1, 2025 (&#8220;Maturity Date&#8221;), and may be prepaid by the Company at any time prior to the Maturity Date
without penalty. In the event of default by the Company, the note shall become immediately due and payable. In connection with the Note,
the Company issued a warrant to the investor for up to 100,000 shares of the Company&#8217;s common stock. The warrant has an exercise
price of $3.25 and expires on November 1, 2027.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As outlined in the table above, we
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">may also use a portion of the net proceeds to acquire
complementary businesses, products, services, or technologies. However, we do not have agreements or commitments to enter into any acquisitions
at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
expected use of net proceeds from this offering and our existing cash and cash equivalents represents our intentions based upon our current
plans and business conditions, which could change in the future as our plans and business conditions evolve. As a result, we cannot predict
with any certainty our use of the net proceeds from this offering or the amounts that we will actually spend on each area of use set
forth above. Our management will retain broad discretion over the allocation of the net proceeds from this offering. Accordingly, we
will have discretion in the application of the net proceeds, and investors will be relying on our judgment regarding the application
of the proceeds of this offering. See &#8220;Risk Factors&#8212;Risks Related to our Securities and this Offering.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate that we will need to raise a minimum of $5.5 million in net proceeds to sustain our operations for the next twelve months. If
we fail to raise the minimum amount needed, we will likely need to raise capital from other sources.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pending
our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of capital preservation investments,
including short-term, investment-grade, interest-bearing instruments and U.S. government securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="Z_007"></span><b>MARKET
FOR OUR COMMON STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 140.15pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock, par value $0.001 per share, is listed on the Nasdaq Capital Market under the ticker symbol &#8220;NTRP&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is currently no established trading market for the offered Pre-Funded Warrants or Common Warrants. We do not intend to list the Pre-Funded
Warrants or Common Warrants on the Nasdaq Capital Market or any other national securities exchange or nationally recognized trading system.
Without an active trading market, the liquidity of the Pre- Funded Warrants and Common Warrants will be limited.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, there were approximately 600 holders of record of our common stock. A substantially greater number of holders
of our common stock are &#8220;street name&#8221; or beneficial holders, whose shares are held by banks, brokers, and other financial
institutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="Z_008"></span><b>DIVIDEND
POLICY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid cash dividends on our capital stock. We currently intend to retain our future earnings, if any, for use in
our business and therefore do not anticipate paying cash dividends on our common stock in the foreseeable future. Payment of future dividends,
if any, will be at the discretion of our board of directors after taking into account various factors, including our financial condition,
operating results, and current and anticipated cash needs. Investors should not purchase our common stock with the expectation of receiving
cash dividends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="Z_012"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CAPITALIZATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 189.15pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth our capitalization as of August 31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an actual basis; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    an adjusted basis, after giving effect to our sale of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common
    stock and Common Warrants to purchase an aggregate of shares of our common stock in this offering at a combined public
    offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of common stock and accompanying Common
    Warrant, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. The as
    adjusted figures assume no sale of Pre-Funded Warrants, and excludes the proceeds, if any, from the exercise of any Common Warrants
    and Underwriter&#8217;s Warrants to be issued in this offering.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 47pt; text-align: justify; text-indent: -15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
as adjusted information below is illustrative only, and our capitalization following the completion of this offering will be adjusted
based on the actual public offering price and other terms of this offering determined at pricing. You should consider this table in conjunction
with &#8220;Use of Proceeds&#8221; above as well as our &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and
Results of Operations of the Company,&#8221; and our audited and unaudited financial statements and the notes to those financial statements
included elsewhere in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As of August
    31, 2024</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Actual</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">As Adjusted (1)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(unaudited)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands, except share</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and per share amounts)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left; padding-bottom: 1.5pt">Cash and Cash Equivalents</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">102</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">5,023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stockholders&#8217; Equity (Deficit):</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Preferred Stock; par value $0.001, 10,000,000 authorized,
    63,494 issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Common Stock: par value $0.001, 250,000,000 authorized, 1,388,641
    issued and outstanding</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Additional Paid-in Capital</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,550</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accumulated Deficit</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(27,685</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Stockholders&#8217; Equity (Deficit)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(134</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    as adjusted information is illustrative only and will depend on the actual public offering price and other terms of this offering
    determined at pricing.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
    $0.10 increase (decrease) in the combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    per share of common stock and Common Warrant would increase (decrease) cash and cash equivalents, working capital, total assets,
    and total stockholders&#8217; (deficit) equity by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160; million, assuming that
    the number of shares of common stock and Common Warrants offered by us, as set forth on the cover page of this prospectus,
    remains the same, after deducting underwriting discounts and commissions and estimated offering expenses payable by us and assuming
    no sale of Pre-Funded Warrants. Similarly, an increase (decrease) of 500,000 shares of common stock and Common Warrants
    offered by us would increase (decrease) the as adjusted amounts of each of our cash, cash equivalents, and short-term investments,
    additional paid-in capital, total stockholders&#8217; equity (deficit) and total capitalization by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
    million, and after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, assuming
    no sale of Pre-Funded Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: -20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: -20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above discussion and table are based on 1,388,641 shares outstanding as of August 31, 2024. The discussion and table do
not include, as of that date:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,877
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock subject to outstanding
    options having a weighted-average exercise price of $58,19 per share; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">484,063
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock subject to outstanding warrants having a weighted-average exercise price
                                            of $8.58 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,238
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock issuable upon conversion of our Series E, H, and I Convertible Preferred
                                            Stock; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">728
                                            shares of our common stock issuable upon exercise of Unit Purchase Options to acquire up
                                            to 560 units, at an exercise price of $350.00 per unit, consisting of 560 shares of common
                                            stock, and warrants to purchase up to 168 shares of common stock at an exercise price of
                                            $322.00.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated, all information in this prospectus assumes no exercise by the underwriter of its option to purchase additional
shares from us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, this prospectus reflects and assumes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sale and issuance by us of all&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock (or Pre-Funded Warrants in lieu thereof) and accompanying Common Warrants being
    offered hereunder;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise of the Common Warrants being offered hereunder;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise of Underwriter&#8217;s Warrants to be
    issued upon consummation of this offering;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of outstanding options or warrants; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise by the underwriters of their option to purchase up to additional shares of our Common Stock, Pre-Funded Warrants and/or
    Common Warrants from us to cover over-allotments, if any.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any outstanding options, warrants, and convertible securities are exercised or converted, there may be further dilution
to new investors. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if
we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through
the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="Z_013"></span><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>DILUTION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you invest in our securities in this offering, your ownership interest will be immediately diluted to the extent of the difference
between the combined public offering price per share of our common stock and Common Warrant in this offering and
the as adjusted net tangible book value per share of our common stock immediately after this offering. Dilution results from
the fact that the per share offering price of our common stock is substantially in excess of the net tangible book value per
share attributable to our existing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 31, 2024, we had a historical net tangible book value of $(2,445,030), or $(1.76) per share of common stock, based on 1,388,641
shares of our common stock outstanding. Our historical net tangible book value per share represents the amount of our total tangible
assets, less total liabilities, divided by the total number of shares of our common stock outstanding as of August 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our pro-forma net tangible book value as of
August 31, 2024 was $(2,445,030), or $(0.34) per share of common stock. Pro-forma net tangible book value per share represents the
amount of our total tangible assets, less total liabilities, divided by the aggregate number of shares of our common stock
outstanding as of August 31, 2024 plus the total contingent shares to be issued of 5,843,993 shares, on a pro forma basis. As of
August 31, 2024, three of the four business milestones had been achieved as further described in our August 31, 2024 Form 10-Q in
Note 2 to the financial statements under &#8220;Loss Per Share&#8221;. As a result, 4,393,993 of the contingent shares were
eligible to be issued. The remaining 1,450,000 contingent shares will be eligible for issue upon the launch of the Company&#8217;s
Travel Agent platform, currently scheduled for the first quarter of calendar year 2025. As such, the total contingent shares of
5,843,993 shares are included in the calculation of pro-forma net tangible book value.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
giving further effect to the sale and issuance by us of the shares of our common stock (and assuming no sale of Pre-Funded Warrants)
and Common Warrants in this offering at the combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share and
accompanying Common Warrant, and after deducting the estimated underwriting discounts and commissions and estimated offering expenses
payable by us, our pro-forma as adjusted net tangible book value as of August 31, 2024, would be approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;million,
or approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;per share of common stock. This represents an immediate increase in pro-forma
as adjusted net tangible book value to our existing stockholders of approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;per
share and an immediate dilution to new investors participating in this offering of approximately $ &#160;&#160;&#160;&#160;&#160;&#160;&#160;per
share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilution
per share to new investors is determined by subtracting pro-forma as adjusted net tangible book value per share after this offering
from the combined public offering price per share and Common Warrant paid by new investors. The following table illustrates this dilution
on a per share basis (without giving effect to any exercise by the underwriter of its option to purchase additional shares):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 68%">Public offering price per share</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">Pro-forma net tangible book value per share as of August 31, 2024</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Increase in pro-forma net tangible book value per share
    attributable to new investors in this offering</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Pro-forma as adjusted net tangible
    book value per share after this offering</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Dilution per share to new investors in this offering</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
$0.10 increase (decrease) in the combined public offering price of $&#160;&#160;&#160;&#160;&#160;per share of common stock and Common
Warrant, would increase (decrease) our pro-forma as adjusted net tangible book value per share by approximately $&#160;&#160;&#160;&#160;&#160;and
the dilution in pro-forma as adjusted net tangible book value per share to new investors in this offering, assuming no sale of
Pre-Funded Warrants by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;, assuming (i) that the number of shares outstanding
immediately prior to this offering remains&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares, and (ii) the deduction of estimated
underwriting discounts and commissions. Similarly, each increase (decrease) of 500,000 shares in the number of shares of common stock
and Common Warrants offered by us would increase (decrease) our pro-forma as adjusted net tangible book value per share by approximately
$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, assuming no sale of Pre-Funded Warrants and decrease the dilution in pro-forma
as adjusted net tangible book value per share to new investors in this offering by approximately $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;,
after deducting estimated underwriting discounts and commissions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriter exercises its option to purchase additional shares of our common stock in full, the pro-forma as adjusted net
tangible book value per share after this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, the increase in pro-forma
net tangible book value per share attributable to new investors in this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
and the dilution per share to new investors in this offering would be $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, in each case
assuming a combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, as of August 31, 2024, on the as adjusted basis described above, the differences between the existing
stockholders and the new investors purchasing shares in this offering with respect to the number of shares of common stock and common
warrants purchased from us, the total consideration paid, which includes net proceeds received from the issuance of common stock and
Common Warrants and assumes no sale of Pre-Funded Warrants, cash received from the exercise of stock options, and the value of any capital
stock issued for services, and the average price per share of our common stock paid by existing stockholders. The calculation with respect
to shares of common stock and Common Warrants purchased by new investors in this offering reflects the issuance of shares of our common
stock and Common Warrants in this offering at a combined public offering price of $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;per
share and Common Warrant, before deducting underwriting discounts and commissions and estimated offering expenses payable by us, and
assuming no sale of Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif">(amounts in thousands, except share and per</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares
    and Common Warrants purchased</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total consideration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Average<br/> price per</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">share amounts, and percentages)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percent</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Existing stockholders<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">New investors</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    presentation in this table regarding ownership by existing stockholders does not give effect to any purchases that existing stockholders
    may otherwise purchase in this offering.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the underwriter exercises its option to purchase additional shares of our common stock in full, the number of shares of our common stock
held by new investors will increase to&#160;&#160;&#160;&#160;&#160;&#160;% of the total number of shares of our common stock outstanding after this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares of common stock to be outstanding after this offering is based on an aggregate of ________________ shares outstanding
as of August 31, 2024 which includes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares to be sold by us in the
offering, but excludes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,877
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of our common stock subject to outstanding
    options having a weighted-average exercise price of $58.19 per share; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">484,063
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock subject to outstanding warrants having a weighted-average exercise price
                                            of $8.58 per share;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,238
                                            </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
                                            of our common stock issuable upon conversion of our Series E, H, and I Convertible Preferred
                                            Stock; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">728
                                            shares of our common stock issuable upon exercise of Unit Purchase Options to acquire up
                                            to 560 units, at an exercise price of $350.00 per unit, consisting of 560 shares of common
                                            stock, and warrants to purchase up to 168 shares of common stock at an exercise price of
                                            $322.00;</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, this prospectus reflects and assumes the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0pt 0">the sale and issuance by us
                                            of all&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of common stock (or Pre-Funded
                                            Warrants in lieu thereof) and accompanying Common Warrants being offered hereunder;</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin: 0pt 0">no exercise of the Common Warrants
                                            being offered hereunder;</p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise of Underwriter&#8217;s Warrants to be
    issued upon consummation of this offering;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    exercise of outstanding options or warrants; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">no exercise by the underwriters of their option to purchase
    up to additional shares of our Common Stock, Pre-Funded Warrants and/or Common Warrants from us to cover over-allotments, if any.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: -15pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any outstanding options, warrants, and convertible securities are exercised or converted, there may be further dilution
to new investors. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if
we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through
the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_015"></span>MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>You
should read the following discussion and analysis of our financial condition and results of operations together with &#8220;Summary Financial
Data&#8221; and the financial statements and related notes included elsewhere in this prospectus. This discussion contains forward-looking
statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those
anticipated in these forward- looking statements as a result of various factors, including those set forth under the section of this
prospectus entitled &#8220;Risk Factors&#8221; or in other parts of this prospectus. Our historical results are not necessarily indicative
of the results that may be expected for any period in the future.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip is an innovative technology
company that is building next generation solutions to power the travel industry. NextTrip through its subsidiaries, provides travel technology
solutions with sales originating in the United States, with a primary emphasis on accommodations, hotels, flights, wellness, and all-inclusive
travel packages. Its proprietary booking engine, branded as NXT2.0, provides travel distributors access to a sizeable inventory. NextTrip&#8217;s
NXT2.0 booking technology was built upon a platform acquired in June 2022, which previously powered the Bookit.com business, a well-established
online leisure travel agent generating over $400 million in annual sales as recently as 2019 (pre-pandemic).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Since 2022, NextTrip has been focused
on the holistic integration of the NXT2.0 technology platform, which will serve as a base for current and future technology projects
as well as proprietary system enhancements. Through this strategic offering, NextTrip will focus on key areas of opportunity in the travel
sector and drive enhanced booking conversion rates. NextTrip&#8217;s proprietary technology, when combined with media, product offerings
and customer service, provides a unique lane to serve mid- to luxury travelers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The spread of the COVID-19 virus globally
beginning in January 2020, severely impacted NextTrip&#8217;s business. Beginning in March 2020, many U.S. states and foreign countries
began issuing &#8220;stay-at-home&#8221; orders and closed their borders to interstate and international travel. Such restrictions on
travel, together with other measures implemented by governments around the world, severely restricted the level of economic activity
around the world and had an unprecedented effect on the global travel industry. The public&#8217;s ability to travel was severely curtailed
through border closures, mandated travel restrictions and limited operations of hotels, airlines, and additional voluntary or mandated
closures of travel-related businesses from December 2019 through the beginning of 2022 (and beyond in some jurisdictions). Measures implemented
during the COVID-19 pandemic led to unprecedented levels of temporary and permanent business closures, cancellations and limited new
travel bookings, having a severe negatively impacted on NextTrip&#8217;s business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Due to the significant decrease in
demand for the travel related services provided by NextTrip during the peak of the COVID-19 pandemic, NextTrip shifted its focus to developing
and enhancing its program offerings. For example, it enhanced the functionality of its booking engines, including developing a booking
engine platform that allows customers to book packaged vacations and cruises along with a platform to arrange and manage business travel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Prior to the reverse acquisition of
Sigma, NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) was a wholly owned subsidiary of NextTrip Group, LLC (&#8220;Group&#8221;), which
in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc. (&#8220;NextPlay&#8221;). All of the business operations of Group
were conducted through its subsidiaries. On January 25, 2023, NextPlay and Group entered into an Amended and Restated Separation Agreement
(&#8220;Separation Agreement&#8221;), Amended and Restated Operating Agreement (&#8220;Operating Agreement&#8221;), and Exchange Agreement
(&#8220;Exchange Agreement&#8221;), together the Agreements (&#8220;Agreements&#8221;), whereby NextPlay transferred their interest in
the travel business to Group. Pursuant to the Exchange Agreement, NextPlay exchanged 1,000,000 Membership Units of Group for 400,000
Preferred Units of Group, with a value of $10 per unit. Prior to the exchange for Preferred Units, Group had a payable due to NextPlay
of $17,295,873, representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to
provide ongoing support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s
ongoing support obligations except for a $1.5 million advance remaining under a promissory note and as such NextTrip recorded the payable
as contributed capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip completed the reverse acquisition
of Sigma on December 29, 2023. Sigma traded on Nasdaq as SASI which has had a name change to NextTrip, Inc. and now trades as NTRP on
Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As per the acquisition with Sigma as
noted above, the 400,000 Preferred units held by NextPlay will be exchanged for 500,000 common shares in NextTrip, Inc.
13,001 Closing Shares were issued to NextPlay on December 29, 2023, and 486,999 Contingent Shares will be issued to NextPlay when
and if the business milestones are achieved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip has accounted for the reverse
merger as NextTrip being the accounting acquirer and will report the financial results as such on a going forward basis. The capital
section reflected in the financial statements are that of NextTrip, Inc. and the operating results are that of the accounting acquirer&#8217;s
financials. All assets, liabilities and results of operations assumed in the transaction are the basis of the financial information discussed
in this Management&#8217;s Discussion and Analysis of Financial Conditions and Results of Operations, as well as the financial statements
of NextTrip included elsewhere in this Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Policies and Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The preparation of financial statements
in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions
that affect the reported assets, liabilities, sales and expenses in the accompanying financial statements. Critical accounting policies
are those that require the most subjective and complex judgments, often employing the use of estimates about the effect of matters that
are inherently uncertain. By their nature, changes in these assumptions and estimates could significantly affect our financial position
or results of operations. Significant accounting estimates that may materially change in the near future are revenue recognition, impairment
of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts.
Such critical accounting policies, including the assumptions and judgments underlying them, are disclosed in Note 1 to the Financial
Statements included in this prospectus. However, we do not believe that there are any alternative methods of accounting for our operations
that would have a material effect on our financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The critical accounting policies and
estimates addressed below reflect our most significant judgements and estimates used in the preparation of our financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation and Principles of Consolidation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip&#8217;s financial statements
and related disclosures are prepared pursuant to the rules and regulations of the SEC for annual financial statements, as applicable.
The Financial Statements have been prepared using the accrual basis of accounting in accordance with GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The financial statements of NextTrip
have been prepared on a consolidated basis with those of its wholly owned subsidiaries. All intercompany transactions and balances have
been eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
of Estimates</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The preparation of consolidated financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, and the
reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These differences
could have a material effect on NextTrip&#8217;s future results of operations and financial position. Significant items subject to estimates
and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Information about key assumptions
and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts of NextTrip&#8217;s
assets and liabilities within the next financial year are referenced in the notes to the financial statements as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of NextTrip&#8217;s ability to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long-lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Receivables</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Trade accounts receivable are recorded
at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#8217;s best estimate of the amount
of probable credit losses in its existing accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Company considers trade accounts
receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts become uncollectible, they
will be charged to operations when that determination is made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Trade accounts receivable balances
as of February 29, 2024 and February 28, 2023, were $34,082 and $0, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Receivables from NextPlay under the
promissory note as described in <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 &#8211; Business
Description and Going Concern</b></span> were $2,567,665 and $1,933,908 respectively. Management has determined that, since NextPlay
is in default under the terms of the promissory note, collectability of the entire related party receivable as of February 29, 2024 is
uncertain, and has therefore established an allowance for doubtful accounts of $1,567,665. As of February 28, 2023, no allowance for
doubtful accounts was established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible
Assets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip measures separately acquired
intangible assets at cost less accumulated amortization and impairment losses. NextTrip recognizes internally developed intangible assets
when it has determined that the completion of such is technically feasible, and it has sufficient resources to complete the development.
Subsequent expenditures are capitalized when they increase the future economic benefits of the associated asset. All other expenditures
are recorded in profit or loss as incurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip assesses whether the life
of intangible assets is finite or indefinite. NextTrip reviews the amortization method and period of use of its intangible assets at
least annually. Changes in the expected useful life or period of consumption of future economic benefits associated with the asset are
accounted for prospectively by changing the amortization method or period as a change in accounting estimates in profit or loss. NextTrip
has assessed the useful life of its trademarks as indefinite.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The estimated useful lives for NextTrip&#8217;s
finite life intangible assets are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.5
    - 4 years</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Software
Development Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip capitalizes internal software
development costs subsequent to establishing technological feasibility of a software application in accordance with guidelines established
by &#8220;ASC 985-20-25&#8221; Accounting for the Costs of Software to Be Sold, Leased, or Otherwise Marketed, requiring certain software
development costs to be capitalized upon the establishment of technological feasibility. The establishment of technological feasibility
and the ongoing assessment of the recoverability of these costs require considerable judgment by management with respect to certain external
factors such as anticipated future revenue, estimated economic life, and changes in software and hardware technologies. Amortization
of the capitalized software development costs begins when the product is available for general release to customers. Capitalized costs
are amortized based on the straight-line method over the remaining estimated economic life of the product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment
of Intangible Assets</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In accordance with ASC 350-30-65 &#8220;Goodwill
and Other Intangible Assets&#8221;, NextTrip assesses the impairment of identifiable intangible assets whenever events or changes in
circumstances indicate that the carrying value may not be recoverable. Factors it considers important, which could trigger an impairment
review include the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">1. Significant underperformance
compared to historical or projected future operating results;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">2. Significant changes in the
manner or use of the acquired assets or the strategy for the overall business; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">3. Significant negative industry
or economic trends.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 27pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">When NextTrip determines that the
carrying value of an intangible asset may not be recoverable based upon the existence of one or more of the above indicators of impairment
and the carrying value of the asset cannot be recovered from projected undiscounted cash flows, NextTrip records an impairment charge.
NextTrip measures any impairment based on a projected discounted cash flow method using a discount rate determined by management to be
commensurate with the risk inherent to the current business model. Significant management judgment is required in determining whether
an indicator of impairment exists and in projecting cash flows. Intangible assets that have finite useful lives are amortized over their
useful lives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leases</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip adopted ASU 2016-02 (Topic
ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating leases arrangements greater
than twelve months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We determine if an arrangement is
a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, operating lease liabilities
- current, and operating lease liabilities - noncurrent on the balance sheets. Finance leases are included in property and equipment,
other current liabilities, and other long-term liabilities in our balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">ROU assets represent our right to
use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease.
Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the
lease term. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rate based on the estimated
rate of interest for collateralized borrowing over a similar term of the lease payments at commencement date. The operating lease ROU
asset also includes any lease payments made and excludes lease incentives. Our lease terms may include options to extend or terminate
the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line
basis over the lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip recognizes revenue in accordance
with ASC 606 which involves identifying the contracts with customers, identifying performance obligations in the contracts, determining
transactions price, allocating transaction price to the performance obligation, and recognizing revenue when the performance obligation
is satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip recognizes revenue when the
customer has purchased the product, the occurrence of the earlier of date of travel or the date of cancellation has expired, as satisfaction
of the performance obligation, the sales price is fixed or determinable and collectability is reasonably assured. Revenue for customer
travel packages purchased directly from NextTrip are recorded gross (the amount paid to NextTrip by the customer is shown as revenue
and the cost of providing the respective travel package is recorded to cost of revenues).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip generates revenues from sales
directly to customers as well as through other distribution channels of tours and activities at destinations throughout the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip controls the specified travel
product before it is transferred to the customer and is therefore a principal, including but not limited to, the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
    is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
    has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
    has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Payments for tours or activities received
in advance of services being rendered are recorded as deferred revenue and recognized as revenue at the earlier of the date of travel
or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">From time to time, payments are made
to suppliers in advance of customer bookings as required by hotels. These payments are recognized as costs of goods at the earlier of
the date of travel or the last date of cancellation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock-Based
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We measure the compensation costs
of stock-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over
the period during which employees are required to provide services. Stock-based compensation arrangements may include stock options,
grants of shares of common stock with and without restrictions, performance-based awards, share appreciation rights and employee share
purchase plans. Stock-based compensation is measured on the date of grant at its fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt">&#160;</p>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Equity instruments issued to non-employees
are recorded on the basis of the grant date fair value of the instruments. In general, the measurement date is either (a) when a performance
commitment, as defined, is reached or (b) the earlier of the date that (i) the non-employee performance requirement is complete or (ii)
the instruments are vested. The measured value related to the instruments is recognized over a period based on the facts and circumstances
of each particular grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The grant date fair value of stock-based
compensation and other equity instruments is calculated using the Black Scholes valuation model, and requires estimates of several inputs
to the model, including risk-free interest rates, dividends, and expected volatility of our stock price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Three
Months Ended August 31, 2024 and August 31, 2023</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended August 31, 2024, we recognized revenue of $154,498, as compared to $27,663 in the same period in 2023, an increase
of $126,835, or 459%. The increase was primarily due to the implementation of the BookIt asset as well as the integration of Expedia
into our booking engine, NXT 2.0. Expedia significantly increased our product offering from 12-15 hotel chains to over 250,000 properties
worldwide, including hotels, resorts, and alternative accommodations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cost of revenue for the three months ended August 31, 2024 was $155,455, as compared to $23,734 for the same period in 2023, an increase
of $131,721, or 555%. The increase was primarily attributable to a rise in sales from the launch of NXT 2.0 in the second quarter of
2024 as compared to the second quarter of 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total operating expenses for the three months ended August 31, 2024 were $1,468,335, as compared to $1,090,930 for the same period in
2023, an increase of $377,405, or 35%. The increase was primarily attributable to the relaunch of the NXT 2.0 booking engine in March
of 2024, as well as the integration of Sigma Additive Solutions, and the transition to public company status.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary
and benefits costs were $628,759 for the three months ended August 31, 2024, as compared to $360,947 for the same period in 2023, an
increase of $267,812, or 74%. The increase was comprised of an increase in salaries and benefits of $234,255 due to the conversion of
booking engine contractors to employees and the addition of new accounting staff, an increase in taxes and benefits of $30,672, and an
increase in stock appreciation rights of $2,885.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation was $13,841 for the three months ended August 31, 2024, as compared to $0 for the same period in 2023, an increase of $13,841.
This increase was a result of the assumption of employee stock options in connection with the reverse acquisition of Sigma Additive Solutions
in December 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred general and administrative costs of $21,677 during the three months ended August 31, 2024, as compared to $128,955 in the same
period in 2023, a decrease of $107,278, or 83%. The decrease was primarily the result of a decrease in rent expense in 2023 of $34,587,
a decrease in broker fees of $36,746, a decrease in administrative services fees of $27,784, a decrease in travel expense of $3,469 and
a decrease in telephone expense of $5,150.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred marketing costs of $51,347 during the three months ended August 31, 2024, as compared to $49,758 during the same period in 2023.
The increase of $1,589, or 3%, was primarily due to an increase of $25,475 in third party contractor expenses associated with the relaunch
of the NXT 2.0 booking engine in March of 2024. Partially offsetting the increase was a decrease in marketing and advertising expenses
of $9,656, and expenses associated with Travel Magazine of $14,230 as resources were shifted towards NXT 2.0.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred technology costs of $141,022 during the three months ended August 31, 2024, as compared to $83,786 during the same period in
2023. The increase of $57,236, or 68%, was primarily attributable to an increase in dues and subscription services for external travel
services used in connection with our booking engine, and cloud database and software expenses to host the booking engine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
service fees incurred during the three months ended August 31, 2024 were $372,027, as compared to $125,934 incurred during the same period
in 2023, an increase of $246,093, or 195%. This increase was a result of: (a) an increase in investor relations expenses of $88,458;
(b) an increase in accounting fees of $85,448 for audit and related financial services; (c) an increase in consultants contracted for
services of $82,602 for management and administrative services related to the company&#8217;s media initiatives, special projects including
establishing travel related partnerships, and maintenance and bug fixes with the booking engine. Partially offsetting the increases was
a decrease in legal expenses of $10,415.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
costs for the three months ended August 31, 2024 were $80,452, as compared to $0 for the same period in 2023, an increase of $80,452.
The increase resulted primarily from directors&#8217; compensation, and shareholder services expenses including transfer agent fees,
and filing services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense for the three months ended August 31, 2024 was $95,414, as compared to $331,549 for the same period in 2023,
a decrease of $236,135, or 71%. The decrease was primarily due to no new equipment purchases and an increase in fully amortized intangible
assets as compared to the same period in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
operating expenses were $63,796 for the three months ended August 31, 2024, as compared to $ 10,001 for the same period in 2023. The
$53,795 increase was primarily due to an increase in insurance expense of $35,921, and an increase in bank and merchant processing fees
of $17,873.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the three months ended August 31, 2024, we realized net other expense of $64,227, as compared to net other expense of $73,762 in the
same period in 2023. The decrease in net other income of $9,535 was primarily due to a decrease in interest expense associated with convertible
loans as a result of their conversion in December 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
dividends for the three months ended August 31, 2024 were $10,688, as compared to $0 for the same period in 2023. The increase was due
to dividends associated with outstanding shares of Series E convertible preferred stock assumed in the reverse acquisition of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the three months ended August 31, 2024, the net loss from continuing operations totaled $1,533,519 as compared to a net loss from continuing
operations of $1,160,763 for the same period in 2023. The operating loss component increased by $382,291 in 2024, partially offset by
a decrease in the other loss component of $9,535.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net loss from discontinued operations of $1,131 for the three months ended August 31, 2024 was attributable to the termination of an
annual contract of $4,131 from a legacy Sigma subscription. Partially offsetting the loss was a gain of $3,000 from the final payment
due from a legacy Sigma customer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net loss applicable to common stockholders for the three months ended August 31, 2024, was $1,545,338, as compared to $1,160,763 for
the same period in 2023, an increase of $384,575, or 33%. The increase was primarily attributable to an increase in operating loss from
continued operations of 382,291, an increase in preferred dividends of $10,688, and a loss from discontinued operations of $1,131, partially
offset by a decrease in other expense of $9,535.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Six
Months Ended August 31, 2024 and August 31, 2023</span></i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended August 31, 2024, we recognized revenue of $343,291, as compared to $47,225 in the same period in 2023, an increase
of $296,066, or 627%. The increase was primarily due to the implementation of the BookIt asset as well as the integration of Expedia
into our booking engine, NXT 2.0. Expedia significantly increased our product offering from 12-15 hotel chains to over 250,000 properties
worldwide, including hotels, resorts, and alternative accommodations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
cost of revenue for the six months ended August 31, 2024 was $329,036, as compared to $41,452 for the same period in 2023, an increase
of $287,584, or 694%. The increase was primarily attributable to the increase in sales from the launch of NXT 2.0 in the second quarter
of 2024 as compared to the second quarter of 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
total operating expenses for the six months ended August 31, 2024 were $3,435,948, as compared to $2,122,756 for the same period in 2023,
an increase of $1,313,192, or 62%. The increase was primarily attributable to the relaunch of the NXT 2.0 booking engine in March of
2024, as well as the integration of Sigma, and the transition to public company status.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary
and benefits costs were $1,255,511 for the six months ended August 31, 2024, as compared to $768,555 for the same period in 2023, an
increase of $486,956, or 63%. The increase was comprised of an increase in salaries and benefits of $446,629 due to the conversion of
contractors to employees and new accounting staff, and an increase in taxes and benefits of $59,824. Partially offsetting the increase
was a decrease in SAR expense of $19,497 due to the revaluation in March
of 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation was $30,235 for the six months ended August 31, 2024, as compared to $0 for the same period in 2023, an increase of $30,235.
This increase was a result of the assumption of employee stock options in connection with the reverse acquisition of Sigma in December
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred general and administrative costs of $49,231 during the six months ended August 31, 2024, as compared to $198,058 in the same
period in 2023, a decrease of $148,827, or 75%. The decrease was primarily the result of a decrease in rent expense of $68,027, broker
fees of $36,746, administrative fees of $34,860, telephone expenses of $8,772 and travel expenses of $4,859. Partially offsetting the
decrease was an increase in licenses and filing fees of $4,437.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred marketing costs of $207,536 during the six months ended August 31, 2024, as compared to $90,539 during the same period in 2023.
The increase of $116,997, or 129%, was primarily due to the relaunch of our NXT 2.0 booking engine in March of 2024 and ongoing maintenance
with Travel Magazine. Marketing and advertising expenses increased by $40,870, third party contracted marketing services increased by
$74,590, and Travel Magazine costs increased by $1,537.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred technology costs of $325,691 during the six months ended August 31, 2024, as compared to $119,680 during the same period in
2023. The increase of $206,011, or 172%, was primarily attributable to an increase in dues and subscription services of $157,621 for
external travel services used in connection with our booking engine, and an increase cloud database and software expenses of $48,790
to host the booking engine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional
service fees incurred in the six months ended August 31, 2024 were $895,900, as compared to $260,304 incurred during the same period
in 2023, an increase of $635,596, or 244%. This increase was a result of: (a) an increase in investor relations expenses of $209,946;
(b) an increase in legal expense of $163,495 due to the reverse acquisition and associated transactions; (c) an increase in accounting
fees of $110,510 for audit and related financial services; and (d) an increase in consultants contracted for services of $151,645 for
management and administrative services related to the company&#8217;s media initiatives, special projects including establishing travel
related partnerships,</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Organizational
costs for the six months ended August 31, 2024, were $109,189, as compared to $0 for the same period in 2023, an increase of $109,189.
The increase resulted primarily from directors compensation, and shareholder services expenses including transfer agent fees, and filing
services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and amortization expense for the six months ended August 31, 2024 was $383,000, as compared to $667,889 for the same period in 2023,
a decrease of $284,889, or 43%. The decrease was primarily due to no new equipment purchases and an increase in fully amortized intangible
assets as compared to the same period in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
operating expenses were $179,655 for the six months ended August 31, 2024, as compared to $17,731 for the same period in 2023. The $161,924
increase was primarily due to the additional cost for insurance of $124,079, an increase in merchant processing fees of $33,765, and
an increase in filing and other fees of $4,080.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the six months ended August 31, 2024, we realized net other expense of $99,452, as compared to net other expense of $139,151 in the same
period in 2023. The decrease in net other income of $39,699 was primarily due to a decrease in interest expense associated with convertible
loans due to their conversion in December 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
dividends for the six months ended August 31, 2024 were $21,376, as compared to $0 for the same period in 2023. The increase was due
to dividends associated with outstanding shares of Series E Preferred Stock assumed in the reverse acquisition of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the six months ended August 31, 2024, the net loss from continuing operations totaled $3,521,145, as compared to a net loss from continuing
operations of $2,256,134 for the same period in 2023. The operating loss component increased by $1,304,710 in 2024, partially offset
by a decrease in the other loss component of $39,699.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net gain from discontinued operations of $7,778 for the six months ended August 31, 2024 consisted primarily of revenue of $14,731 from
legacy Sigma customers, and a gain of $6,011 from the settlement of a trade accounts payable at a discount, partially offset by expenses
of $12,964 consisting of legal expenses, termination of a subscription contract, and Sigma&#8217;s legacy investor relations website.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
net loss applicable to common stockholders for the six months ended August 31, 2024 was $3,534,743, as compared to $2,256,134 for the
same period in 2023, an increase of $1,278,609, or 57%. The increase was primarily attributable to an increase in operating loss from
continued operations of $1,304,710 and an increase in preferred dividends of $21,376, partially offset by a gain from discontinued operations
of $7,778, and a decrease in other expense of $39,699.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Year
Ended February 29, 2024 and February 28, 2023</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">During the year ended February 29,
2024, NextTrip recognized revenue of $458,752 as compared to $382,832 in the same period in 2023, an increase of $75,920, or 19.8%. The
increase was a result of the continued implementation of the company&#8217;s booking engine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cost
of Revenue</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Cost of revenue for the year ended
February 29, 2024, was $397,532 as compared to $354,921 for the same period in 2023, an increase of $42,611, or 12%. The increase was
attributable to the increase in revenue in the year ended February 29, 2024, as compared to the same period in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating
Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Operating expenses totaled $5,740,577
for the year ended February 29, 2024, versus $4,979,766 for the year ended February 28, 2023. The increase of $760,811, or 15.3% was
due to an increase in professional service fees of $806,076, an increase in depreciation and amortization of $761,524, an increase in
other operating expenses of $91,838, stock based compensation of $116,512, and organization costs of $25,000. Partially offsetting these
increases were a decrease in salaries and benefits of $519,809, a decrease in general and administrative expenses of $57,455, a decrease
in sales and marketing expenses of $222,887, and a decrease in technology expenses of $239,988.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salaries
and Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Salaries &amp; Stock based compensation
expenses were $1,604,487 for the year ended February 29, 2024, as compared to $2,124,296 for the same period in 2023. The decrease of
$519,809 or 24.5% was the result of a reduction in the number of employees which was offset by the increase in professional contracted
staff.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Based Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Stock based compensation totaled $116,512
for the year ended February 29, 2024, versus $0 for the year ended February 28, 2023. The increase was attributable to expense associated
with the assumption of Sigma&#8217;s outstanding stock options upon completion of the reverse merger transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
on Promissory Note Receivable</b></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The loss of $1,567,665 on the promissory
note receivable for the year ended February 29, 2024 is attributable to the establishment of a reserve taken on the total outstanding
balance due from NextPlay of $2,567,665. Management has determined that, since NextPlay is in default under the terms of its promissory
note, collectability of the entire related party receivable as of February 29, 2024 is uncertain. As of February 28, 2023, no allowance
for doubtful accounts was established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
and Administrative Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">General and administrative expense
for the year ended February 29, 2024 was $152,106, versus $209,561, a decrease of $57,455. The decrease was primarily attributable to
a reduction in rent expense of $28,000 and a decrease in medical insurance premiums due to fewer employees in fiscal 2024 as compared
to fiscal 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sales
and Marketing Expense</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Sales and marketing expenses were
$484,250 for the year ended February 29, 2024, as compared to $707,137 for the same period in 2023. The decrease of $222,887 or 31.5%
was primarily related to reduced marketing costs during the booking engine enhancement upgrade.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Professional
Service Fees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Professional Service Fees were $1,421,508
for the year ended February 29, 2024, as compared to $615,432 for the same period in 2023. The increase of $806,076 or 131% was the result
of an increase in the number of professional contracted staff and an increase in legal costs associated with various public company filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Technology</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Technology expenses for the year ended
February 29, 2024 were $311,430, as compared to $551,418 for the year ended February 28, 2023. The decrease of $239,988, or 43.5% was
primarily attributable to a decrease in website maintenance and bug fixes of $137,258, a decrease in software licensing expenses of $41,215
due to renegotiation of licensing agreements and adoption of more cost-effective solutions, a decrease of $13,420 in cloud database and
networking expenses related to optimization of our cloud infrastructure, and a decrease in software hosting expenses of $83,109 due to
consolidation of services. Partially offsetting these decreases was an increase in dues and subscriptions of $7,888 in new services to
support the Company&#8217;s operations, and an increase of $29,341 in expenses associated with maintenance and support of the Company&#8217;s
technology infrastructure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Organization
Costs</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Organization costs were $25,000 for
the year ended February 29, 2024, as compared to $0 for 2023. The increase is attributable to compensation expense for our directors
subsequent to the reverse acquisition of Sigma on December 29, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Depreciation
and Amortization</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Depreciation and amortization expense
for the year ended February 29, 2024, was $1,468,762 as compared to $707,238 for the same period in 2023, an increase of $761,524 or
107.6%. The increase was primarily the result of amortization of software additions during the year as well as amortizing certain software
purchases, in particular the BookIt.com asset, over a shorter period due to its estimated useful life.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Other expenses totaled $156,522 for
the year ended February 29, 2024, as compared to $64,684 for the year ended February 28, 2023. The increase of $91,838, or 142.0% was
primarily due to an increase in D&amp;O insurance premiums.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Income (Expense)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Other expense was $977,480 for the
year ended February 29, 2024, as compared to other expense of $81,641 for the same period in 2023. The increase of $895,839 was primarily
due to the loss on the promissory note receivable of $1,567,665, partially offset by other income in the amount of $486,633 of which
$479,460 was due to the reversal of accrued expenses. Such reversal was offset by the allocation of expenses to the appropriate expense
accounts. Additionally, the gain on the extinguishment of liability in the amount of $166,889 resulted from the exchange of a consulting
expense for the issuance of common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The net loss of $14,718 on the disposal
of assets was due to a reduction in goodwill of $52,310, partially offset by a gain of $37,592 on the sale of assets to Divergent, and
the decrease in interest expense of $23,251 was due to the conversion of convertible notes to common shares on December 29, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss From Continuing Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In the year ended February 29, 2024,
the net loss from continuing operations totaled $6,656,837 as compared to a net loss from continuing operations of $5,033,496 for the
year ended February 28, 2023. The operating loss component increased by $727,502 in 2024, and the other loss component increased by $895,839.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss From Discontinued Operations</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The net loss from discontinued operations
of $675,314 for the year ended February 29, 2024 consisted primarily of expenses incurred attributable to the legacy business operations
of Sigma, and were comprised of $528,930 in retention bonuses paid to former Sigma employees, salaries and benefits of $28,475, severance
of $62,500 and organization and other expenses of $60,415. Partially offsetting these expenses was $5,006 in revenue related to a maintenance
contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Net
Loss Applicable to Common Shareholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The net loss applicable to common
shareholders totaled $7,339.276 for the year ended February 29, 2024, as compared to $5,033,496 for the year ended February 28, 2023.
Preferred dividends were $7,125 in 2024 and $0 in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity
and Capital Resources</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Our major sources of funding have
been proceeds from private offerings of our securities, advances from related parties, and issuance of convertible and non-convertible
debt. We will need to raise additional amounts to fund our operations, maintain compliance with the Nasdaq continued listing requirements
and implement our business plan. We currently have no arrangement to obtain any additional financing, and there is no assurance as to
the amount and availability of any required future financing or the terms thereof. Any such financing, if in the form of equity, may
be highly dilutive to our existing stockholders and may otherwise include onerous terms. If in the form of debt, such financing may include
covenants and repayment obligations which may be difficult to meet and that could adversely affect our business and operations. To the
extent that funds are not available to us, we may be required to delay, limit, or terminate our business and operations and/or lose our
Nasdaq listing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We estimate that we will need to raise
a minimum of $5.5 million in net proceeds to continue operation for the next twelve months. We have based this estimate on assumptions
that may prove to be wrong, and we could exhaust our capital resources sooner than we expect, or extend such resources longer than we
expect. Because of the numerous risks and uncertainties associated with the research, development, and commercialization of our products,
we are unable to estimate the exact amount of our working capital requirements. Our future capital requirements will depend on many factors,
including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    cost of developing and maintaining our proprietary software and NXT2.0 booking engine;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    effect of competing technological and market developments;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    revenue from the sales of our existing and future products; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    cost of operating as a public company.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The effects of a U.S. or global recession,
while difficult to predict, could result in some customers delaying or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Due to uncertainties regarding our
ability to meet our current and future operating and capital expenses, there is substantial doubt about our ability to continue as a
going concern for 12 months from the date of the filing of this Report, and the report of our registered independent public accounting
firm on our financial statements as of and for the year ended February 29, 2024 contains a going concern
qualification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of August 31, 2024, we had $102,006
in cash and a working capital deficit of $3,664,705, as compared with $323,805 in cash and a working capital deficit of $262,005 as of
February 29, 2024. Additionally, at August 31, 2024, the amount due under our notes payable to related parties totaled $2,718,594.
As of February 29, 2024, NextTrip had $323,805 in cash and a working capital deficit of $245,005 as compared to $282,475 in cash,
and a working capital deficit of $2,310,654 as of February 28, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On March 15, 2024, the Company&#8217;s
Board of Directors approved the Company to enter into an unsecured promissory note for a line of credit with Messrs. Monaco and Kerby,
the Company&#8217;s Chairman of the Board of Directors and Chief Executive Officer, respectively, for the aggregate principal amount
of $500,000. Under the terms of the note, advances under the line of credit may be made at the Company&#8217;s request until May 31,
2024. The note bears an annual interest rate of 7.5% and matures on February 28, 2025, and may be prepaid by the Company at any time
prior to maturity without penalty. As of September 13, 2024, the full principal amount of the note had been advanced to the Company and
remains outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On April 25, 2024, the Company&#8217;s
Board of Directors approved the Company to enter into a series of unsecured promissory notes with certain related parties, including
investors, directors, officers and employees, who shall individually provide funds for the aggregate principal amount of $1,000,000.
The notes bear an annual interest rate of 7.5% and shall mature one year from the date of each note&#8217;s execution and may be prepaid
by the Company at any time prior to maturity without penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the board
of directors, the directors unanimously approved an increase in the principal amount of the related party line of credit to $2,000,000
on the same terms and conditions as previously approved. As of September 13, 2024, the total principal amount advanced under the line
of credit was $1,441,414.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2024, the Company&#8217;s board of directors approved the conversion of up to 100% of the outstanding principal balance
of the promissory notes held by Messrs. Kerby and Monaco into shares of a series of non-redeemable convertible preferred stock preferred
stock yet to be designated. Messrs. Kerby and Monaco have agreed to initially convert $1,500,000, or 56.3% of their total outstanding
principal balance of $2,666,790 into the new series of convertible preferred stock, and, at their discretion, may convert up to the remaining
principal balance, or any portion thereof, into additional shares of such convertible preferred stock at a future date. The conversion
remains subject to completion of final documentation for the transaction, including the filing of the certificate of designation for
the new series of convertible preferred stock with the Nevada Secretary of State.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024 the Company entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with Alumni Capital
LP (&#8220;Alumni Capital&#8221;) for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (&#8220;Warrants&#8221;)
to Alumni Capital for total consideration of $250,000. After deducting commissions, net proceeds to the Company were $230,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $300,000 with an original issue discount of $50,000 and guaranteed interest on the principal
amount of ten percent (10%) per annum which shall be due and payable on December 19, 2024. In the event of a failure to re-pay the Alumni
Note on or before December 19, 2024, the interest rate will increase to the lesser of twenty-two percent (22%) per annum or the maximum
amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible into common stock of the
Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company also entered into a Common Stock Securities Purchase Agreement (the &#8220;Common Stock SPA&#8221;) with
Alumni Capital. Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Alumni Capital to purchase
up to $10 million shares of common stock (the &#8220;Commitment Amount&#8221;) at the Purchase Price (defined below) during the period
beginning on the execution date of the Common Stock SPA and ending on the earlier of (i) the date on which Alumni Capital has purchased
$10 million shares of common stock pursuant to the Common Stock SPA or (ii) December 31, 2025. Pursuant to the Common Stock SPA, the
&#8220;Purchase Price&#8221; means the lowest traded price of Company common stock during the five (5) business days prior a closing
date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration statement and no Purchase
Notice will be in an amount greater than $500,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of 66,225 shares of Series I
Convertible Preferred Stock at $3.02 per share, for total consideration of $200,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, the aggregate outstanding principal balance of related party advances as of was $2,724,865.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 1, 2024, the Company sold a short-term promissory note (&#8220;Note&#8221;) to an investor for a total consideration of $250,000.
The Note has a principal amount of $287,500 with an original issue discount of $37,500. There is no additional stated interest. The Note
is due and payable in full on May 1, 2025 (&#8220;Maturity Date&#8221;), and may be prepaid by the Company at any time prior to the Maturity
Date without penalty. In the event of default by the Company, the note shall become immediately due and payable. In connection with the
Note, the Company issued a warrant to the investor for up to 100,000 shares of the Company&#8217;s common stock. The warrant has an exercise
price of $3.25 and expires on November 1, 2027.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Used in Operating Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Six
</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">months ended August 31, 2024
and 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
cash used in operating activities from continuing operations for the six months ended August 31, 2024 totaled $1,960,326, as compared
to $1,393,118 during the same period in 2023, an increase of $567,208, or 41%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended August 31, 2024, the net cash used in operating activities was the result of a net loss of $3,521,145 before preferred
dividends, partially offset by changes in working capital of $1,147,584, and non-cash expenses of $413,235 related to depreciation and
amortization of $383,000 and stock-based compensation of $30,235. Changes in working capital were driven by a decrease in accounts receivable
of $22,881, a decrease in prepaid expenses of $96,051, and an increase in accounts payable and accrued expenses of $1,033,506, partially
offset by an increase in security deposits of $3,000 and a decrease in deferred revenue of $1,854.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the six months ended August 31, 2023, the net cash used in operating activities was the result of a net loss of $2,256,134, partially
offset by changes inworking capital of $120,279, and non-cash expenses of $742,737 related to depreciation and amortization. Changes
in working capital were driven by an increase in accounts payable and accrued expenses of $110,959 and an increase in deferred revenue
of $57,156, partially offset by an increase in accounts receivable of $5,000, an increase of $34,114 in prepaid expenses, and a decrease
in notes receivable of $8,722.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Year
ended February 29, 2024 and February 28, 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Net cash used in operating activities
from continuing operations during the year ended February 29, 2024, was $5,056,095 as compared to $3,792,600 during the same period in
2023, an increase of $1,263,495 or 33.3%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">During the year ended February 29,
2024, the net cash used in operating activities from continuing operations was the result of a net loss of $6,656,837, partially offset
by changes in working capital of $1,400,025 and non-cash expenses of $3,000,767. The non-cash expenses were primarily comprised of depreciation
and amortization of $1,468,762 and the loss of $1,567,665 on the related party receivable. Changes in working capital were driven by
an increase in accounts receivable of $662,939, an increase in prepaid expenses of $281,506, an increase in security deposits of $27,167,
and a decrease in accounts payable and accrued expenses of $531,367, partially offset by an increase in deferred revenue of $102,954.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Net cash used in operating activities
from discontinued operations during the year ended February 29, 2024, was $675,314 as compared to $0 during the same period in 2023,
and was related to wind down expenses associated with the legacy Sigma business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As a result, total net cash used in
operating activities increased by $1,938,809 during the year ended February 29, 2024, to $5,731,409 as compared to $3,792,600 during
the same period in 2023, an increase of 51.1%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">During the year ended February 28,
2023, the net cash used in operating activities was the result of a net loss of $5,033,496, partially offset by changes in working capital
of $521,490 and non-cash expenses of $719,406, primarily related to depreciation and amortization. Changes in working capital were driven
by a decrease in accounts receivable of $5,503, a decrease in prepaid expenses of $48,796, an increase in accounts payable and accrued
expenses of $533,193, a decrease in deferred revenue of $46,855 and an increase in right of use asset in the amount of $18,697.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><b style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided (Used) in Investing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Six
</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">months ended August 31, 2024
and 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Net cash used in investing activities
during the six months ended August 31, 2024 was $389,568, which compares to $345,807 of cash used in investing activities during the
same period of 2023, an increase of $43,761, or 13%. The increase resulted from an increase in capitalized software development costs
during the period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Year Ended February 29, 2024 and 2023</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Net cash provided by investing activities
during the year ended February 29, 2024, was $980,936, which compares to net cash used by investing activities of $4,290,930 during the
same period of 2023, an increase of $5,271,865. The primary causes for the increase resulted from the reverse acquisition of Sigma, which
provided cash of $417,122, and the subsequent sale of Sigma&#8217;s legacy assets to a third party, which generated an additional $1,589,241
in cash. Further contributing to the increase were decreases in capitalized software development costs of $1,337,919 and a decrease in
the related party promissory note of $1,933,908. These increases were partially offset by an increase in the purchases of equipment of
$6,325.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Net
Cash Provided by Financing Activities</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Six
</span></b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">months ended August 31, 2024
and 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Net cash provided by financing activities
for the six months ended August 31, 2024 was $2,120,317, as compared to $1,562,352 for the same period in 2023. The increase of $557,965,
or 36%, was due to an increase in advances from related parties of $1,597,817, the issuance of promissory notes for $140,000 to investors,
and the issuance of preferred shares to investors for $90,000, partially offset by a decrease in the issuance of convertible notes of
$1,269,852.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Year
ended February 29, 2024 and February 28, 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">NextTrip raised $4,791,804 in net
proceeds during the year ended February 29, 2024, consisting of $735,037 from the issuance of convertible notes, $1,905,970 from the
issuance of common shares, $1,603,500 from the issuance of preferred shares, and $547,277 from related party advances. For the year ended
February 28, 2023, the Company raised $8,134,955 in net proceeds consisting of advances to the company by related parties of $4,901,452
and proceeds from the issuance of convertible notes of $3,233,503.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Inflation, changing prices and rising
interest rates have had no material effect on NextTrip&#8217;s continuing operations over our two most recent fiscal years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">We have no off-balance sheet arrangements
as defined in Item 303(a) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="Z_014"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Business
Overview</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip,
Inc. (&#8220;NextTrip,&#8221; &#8220;we,&#8221; or &#8220;our&#8221;) is a technology-driven travel company building next-generation
solutions to power the travel industry. With a suite of brands, including NextTrip Vacations, Travel Magazine, and Compass.TV, we aim
to inspire and empower travel while curating personalized experiences for both leisure and business travelers. Our proprietary NXT2.0
booking engine offers extensive inventory, supporting both travelers and distributors with a platform for efficient trip planning and
booking.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
mission is to lead the travel industry forward by combining the digital innovation offered in Compass.TV and Travel Magazine with tailored
travel services and booking capabilities of NextTrip. This fully integrated platform not only services traditional vacationers travel
needs, but also provides users with a solution for more complex travel needs such as conferences, conventions and destination weddings
through our groups widget, an under-served and emerging markets. Our growth will leverage interactive technology, immersive media, and
our travel expertise to deliver impactful and personalized travel solutions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Strategy
and Ecosystem</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip&#8217;s
strategy focuses on integrating its Media and Travel divisions, offering users a comprehensive ecosystem designed to guide and support
them throughout the travel experience. Presently, NextTrip generates revenue through two core methods: travel bookings and advertising
revenue. Each division can independently drive revenue through their respective channels, but we have created exponential value by bringing
the divisions together to create an engaging consumer-focused ecosystem. Today, we have created opportunities to seamlessly move customers
from one portion of the ecosystem to the next, with the ultimate goal of influencing a travel purchase decision. As we move into the
future, NextTrip will add additional revenue streams including more diversified exclusive product from around the world, niche travel
segments, technology licensing and enhanced media advertising opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our current state, NextTrip travel offers travel product worldwide, but with a targeted initial focus on Mexico and the Caribbean. We
will strategically expand this as the business scales. Compass.TV offers travel content across a variety of destinations and travel interests
with the intent of capturing a broad audience. The audience capture and traffic directly impacts the advertising opportunity on the channel,
so we anticipate this broad approach to continue as the business scales.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
user benefits available today include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access
                                            to relevant travel videos and articles for trip planning.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personalized
                                            profiles for saving destinations and activities.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Social
                                            sharing of travel ideas and communication with others.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concierge
                                            support for travel planning.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
                                            to book travel online or via our call center.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Proprietary
                                            payment solutions like FlexPay</td></tr>
                                                                                                              <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Exclusive
                                            rates and promotions from targeted suppliers, creating strategic pricing and competitive
                                            advantage.</td></tr>
                                                                                                              <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Technology
                                            for booking groups travel, applicable to both corporate and leisure travel.</td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuous
                                            customer support from booking through post-travel.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 76.5pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key
user benefits under development for 2025 include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Introduction
                                            of a NextTrip Rewards programs for repeat bookings.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Introduction
                                            of Travel Magazine &#8220;My Bucket List&#8221; personalized planner.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Group
                                            chat and sharing platform.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
                                            travel assist to compliment concierge services.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhanced
                                            groups and travel agent widgets.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI
                                            video creation for customized travel solutions.</span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanded
                                            travel product offerings including cruise and wellness vacations.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Key
Pillars of the NextTrip Ecosystem</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip Vacations</b>:
                                                                                                                                                                                                                                            Our core platform, powered by NXT2.0, delivers seamless booking and customizable travel options across airlines, hotels, ground
                                                                                                                                                                                                                                            activities, and more. NextTrip provides travelers with curated packages and detailed trip planning information through an intuitive
                                                                                                                                                                                                                                            booking system.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Travel
                                            Magazine</b>: Our media hub that inspires global travelers with engaging stories, practical
                                            tips, and diverse travel perspectives. Coming soon is &#8220;My Bucket List,&#8221; a platform
                                            where travelers can create and share personalized travel lists, supported by booking features
                                            and local insights.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compass.TV</b>:
                                            Launched in fall 2024, Compass.TV is a Free Ad-supported Streaming TV (FAST) channel offering
                                            over 1,200 hours of travel content and has engaged influencer with millions of followers.
                                            In 2025 these followers will begin to receive access to travel promotions and specially designed
                                            vacation products that benefit the influencer through shared advertising and travel overrides.
                                            Additionally, the company plans to launch the Compass.TV Apps with Apple, Android, Fire Stick
                                            as well as expansion onto major platforms like Roku and YouTube. Using AI, Compass.TV will
                                            personalize content, convert blogs into videos, and enable users to create their own custom
                                            travel channels.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PrometheanTV</b>:
                                            Our influencer-led video platform will drive ad revenue and content-to-commerce integration.
                                            The company purchased a perpetual license from Promethean TV, Inc. and is integrating this
                                            platform into Compass.TV and Travel Magazine&#8217;s video content with interactive overlays
                                            that allow users to book travel directly from their screens.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_002.jpg" alt="A screenshot of a website&#10;&#10;Description automatically generated" style="height: 351px; width: 625px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Comprehensive
Travel Solutions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
integrating our booking platform across all media and travel offerings, NextTrip supports users from initial planning through post-travel.
Our ecosystem spans leisure, wellness, and business travel, alternative lodging, and tech and media solutions. NextTrip has negotiated
over 250 direct relationships ensuring top-tier rates and options in premier destinations in Mexico and the Caribbean. In 2025 we will
expand our relationships into the United States and Europe. Unlike traditional pre-packaged offerings, NextTrip approach is to offer
flexibility for users to create personalized experiences, fostering a thriving ecosystem that promotes travel transactions and targeted
ad revenue while enhancing customer engagement and satisfaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organizational
History</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Early
Travel Business with Monaker Group</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
began as the primary business of NextPlay Technologies, Inc. (formerly Monaker Group, Inc.) until June 2020, when Monaker acquired HotPlay
Enterprise Limited, shifting its focus to digital entertainment. Prior to this, Monaker&#8217;s core business was travel, primarily offering
vacation rentals and Alternative Lodging Rentals (ALRs) through its booking platform. To support its travel services, Monaker also launched
TravelMagazine.com, providing travel content for destination research. In January 2023, NextPlay spun off the NextTrip business, returning
it to its founders to focus exclusively on travel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Impact
of COVID and Technology Shift</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
COVID-19 pandemic severely impacted travel, leading to widespread travel restrictions, border closures, and a steep decline in bookings.
With travel operations halted, we concentrated on technology development, enhancing our booking engines, and expanding our online media
platform, TravelMagazine.com, to help travelers research future trips. We also developed new features, including a platform for packaged
vacations, wellness programs, and business travel management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition
of Bookit.com Asset</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After
separating from NextPlay, NextTrip acquired the technology assets of Bookit.com in June 2022 to strengthen our NXT2.0 booking platform.
Before the pandemic, Bookit.com was a popular online travel platform, generating over $400 million in sales, but ceased to operate during
the pandemic. Through this acquisition, we not only gained a proven booking technology but also a database of millions of opt-in users,
key staff and relationships with hotel groups anxious to reopen this distribution channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
acquiring Bookit.com&#8217;s assets, we&#8217;ve focused on fully integrating and enhancing the NXT2.0 platform, which now supports both
current and upcoming projects. This integration includes renewing over 250 supplier contracts, securing inventory from over 3 million
providers, and offering competitive rates across 2,100 destinations worldwide.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
strategy positions us to capitalize on key opportunities within the travel industry, combining proprietary technology with media, service
offerings, and exceptional customer support to cater to mid- to luxury-level travelers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Recent
Developments</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-binding
Letter of Intent to Acquire Luxury Travel Company Five Star Alliance</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 5, 2024, we announced that we had signed a non-binding Letter of Intent (LOI) to acquire&#160;Five Star Alliance, an online
luxury travel agency founded in 2004 and renowned for its curated collection of five-star luxury hotels and resorts worldwide. Five Star
Alliance specializes in helping travelers discover and book the world&#8217;s top luxury hotels, offering personalized recommendations, competitive
rates, and is known for world-class customer service. With a proprietary search engine that secures the best rates for thousands of 5-star
hotels globally, the company also handles group travel bookings and high-end cruises.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition
by Sigma Additive Solutions, Inc.; Name Change</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2023, Sigma Additive Solutions, Inc. (&#8220;Sigma&#8221;) acquired 100% of the outstanding equity interests in NextTrip, which
resulted in NextTrip becoming a wholly-owned subsidiary of a public company and the principal business of the Company moving forward.
To align the new business with NextTrip&#8217;s travel-focused business model, the Company recently changed its name to &#8220;NextTrip,
Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Acquisition
of Promethean FAST TV Exclusive License</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip
entered into a perpetual license agreement with Promethean TV, Inc. for the Ignite TV interactive video platform, which will power our
Free Ad-supported Streaming TV (FAST) channel, Compass.TV, allowing for targeted advertising via video overlays, allowing the viewer
to purchase travel from their screen. This integrated technology is intended to boost engagement with customers, driving ad-supported
revenue and travel transactions. The integration of Promethean is targeted to be completed in late November.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_003.jpg" alt="A close-up of a website&#10;&#10;Description automatically generated" style="height: 351px; width: 625px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
Fully Integrated Travel Booking Platform</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our main leisure site, NextTrip.com, and media platform, TravelMagazine.com, are powered
by our NXT2.0 booking engine. We offer booking for airlines, hotels, rental cars, tours, and event tickets, with content on destinations,
maps, and travel tips. TravelMagazine.com also inspires travelers with articles, videos, and podcasts, supported by advertising and direct
booking options.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_004.jpg" alt="A white background with blue text&#10;&#10;Description automatically generated" style="height: 324px; width: 577px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Travel
Products and Services</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
the launch of Compass.TV and Travel Magazine, we have created the foundation for building a NextTrip travel ecosystem that will become
a source of both advertising and travel booking revenues. Initial traffic for our ecosystem will be driven by our multimillion-person
email list and through partnerships with travel influencers that boast millions of followers. As users engage, they will be able to research
travel from thousands of hours of video content and articles helping them to build their trip, share with others and then book through
NextTrip&#8217;s booking engine. Our offerings currently cover leisure, wellness, business, and alternative lodging, supported by concierge
services and competitive rates worldwide. Our main offerings include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
                                            Travel</b>: A booking engine for custom travel packages, wellness trips, and business/group
                                            travel. We are also developing a travel agent portal to enhance brand loyalty.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
                                            Solutions</b>: Technology for product management, inventory, and white-label services, offering
                                            NextTrip products under other brands.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NextTrip
                                            Media</b>: Travel Magazine and Compass.TV offer immersive content and destination information
                                            for travelers in the planning stage. This FAST channel allows users to explore and customize
                                            vacation options before booking.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Products
and Services for Travelers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Search
                                            and Compare</b>: NextTrip.com lets travelers easily search and filter travel options like
                                            flights, accommodations, activities, and transportation by criteria like location, dates,
                                            amenities, price, and more.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Traveler
                                            Login</b>: Travelers can create accounts to track bookings and access exclusive rates and
                                            discounts.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Travel
                                            Blog</b>: TravelMagazine.com features travel guides, videos, images, and articles to inspire
                                            travelers.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Security</b>:
                                            We use technology and human review to ensure listing accuracy and prevent fraud. Our platform
                                            is PCI-compliant for secure credit card transactions.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Communication</b>:
                                            Account holders receive regular updates on destinations, special offers, new listings, and
                                            newsletters with travel tips and new locations to explore.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the COVID-19 pandemic, we&#8217;ve focused on building our booking engine and expanding our inventory. We integrated Bookit.com&#8217;s
technology in 2022, fully launching our site in May 2024 with over one million hotel listings globally.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Key
Revenue Drivers</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
current revenue comes from commissions on travel products like hotels, flights, and vacation packages booked on our website and/or through
our call center. We have also started to leverage Bookit.com&#8217;s database to boost sales. In 2025, we anticipated increases in revenues
from travel product commissions, affiliate sales, ads, and sponsored content as the Compass.TV and Travel Magazine ecosystem grow. Additionally,
our tech solutions will be available for licensing with a SaaS model in development.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_005.jpg" alt="A website with text and images&#10;&#10;Description automatically generated with medium confidence" style="height: 324px; width: 577px"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Future
Growth through R&amp;D</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
capture underserved markets, we are expanding our booking platforms and investing in new technology.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compass.TV</b>:
Launched with the support of the Dooya Media Group, Compass.TV is an owned and operated FAST (Free Ad-Supported Television) travel discovery
platform that seamlessly translates content into commerce opportunities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compass
TV is a vital component in the NextTrip ecosystem. It aims to inspire audiences by highlighting the world&#8217;s best travel experiences
and offering viewers a rich source of inspiration for planning their next journey. When coupled with NextTrip&#8217;s unique website,
tools and exclusive resort deals, the platform provides the perfect showcase to drive travel bookings and deliver commissions at a fraction
of the marketing costs incurred by competitors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Compass.TV
currently includes close to 1,200 hours of curated travel material, featuring a variety of documentaries, shows, and influencer-driven
experiences.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
focusing on categorization by destination, Compass.TV is positioning itself as a premier discovery tool for prospective travelers. Our
unique Content Creator Program incentivizes travel influencers to distribute their content on the platform and promote it to their millions
of followers. Influencers are, in return, able to benefit from a revenue-sharing model designed to provide better and broader earnings
than existing platforms like YouTube, including commissions on bookings and a portion of sponsorships.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
broadcasting on FAST networks, Compass.TV enhances partner brand visibility and drives high CPM advertising revenue. Crucially, Compass.TV
leads the way in FAST 2.0 innovation, setting a new standard for travel discovery and engagement. The platform features content-to-commerce
funnels, combining targeted advertising with high-conversion affiliate commerce for travel. By integrating an exclusive license for the
Promethean.tv interactive overlays, the platform aims to increase Click Though Rates by up to 10 times the industry average. This innovative
approach offers viewers direct access to travel offers related to the content they are engaging with, driving strong results for commerce
partners and advertisers alike.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initially
we will use our NextTrip customer list and engage with influencers boasting millions of followers to build out our ecosystem. Compass.TV
is designed to offer <i>curated </i>&amp; <i>personalized </i>content to viewers, learning from their preferences and plans to ensure
they see the most relevant and enticing videos. We will enhance our offerings with future development that uses AI to customize travel
content and allow users to create personalized travel channels with integrated booking. Strategic partnerships will enhance content,
distribution, and tech capabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Travel
Magazine</b>: Relaunched in mid-2024, this platform offers targeted ads through Promethean&#8217;s tech and is expanding with My Bucket
List, a private platform for its users that offers tools to create personalized travel using video, blogs, reviews, tourism boards and
AI planner. It will also allow for chat amongst fellow travelers and be linked to NextTrip booking and concierge services, ensuring a
well thought out vacation solution. Plans are to launch the platform in the spring of 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_006.jpg" alt="A screenshot of a phone&#10;&#10;Description automatically generated"/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Technology
and Infrastructure</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our websites are
hosted using cloud services distributed globally across multiple regions. Our systems architecture has been designed to manage increases
in traffic through additional computing power without making software changes. Our cloud services provide our online marketplace with
scalable and redundant Internet connectivity and redundant power and cooling to our hosting environments. We use security methods to
ensure the integrity of our networks and protection of confidential data collected and stored on our servers, and we have developed and
use internal policies and procedures to protect the personal information of travel suppliers and customers using our websites that we
collect and use as part of our normal operations. Access to our networks, and the servers and databases, on which confidential data is
stored, is protected by industry standard firewall and encryption technology. Physical access to our servers and related equipment is
secured by limiting access to the data center to operations personnel only.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Competition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The U.S. travel
market is highly competitive and rapidly evolving. The markets are dominated by a few key distributors, which has caused suppliers to
look for viable alternatives that would diversify their business mix.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our competition,
which is strong and increasing, includes online and offline travel companies that target leisure and corporate travelers, including travel
agencies, tour operators, travel supplier direct websites and their call centers, consolidators and wholesalers of travel products and
services, large online portals and search websites, certain travel metasearch websites, mobile travel applications, social media websites,
as well as traditional consumer eCommerce and group buying websites. These companies include Expedia, Booking.com, TripAdvisor, Sabre
Corp., and TravelZoo. In some cases, competitors are offering more favorable terms and improved interfaces to suppliers and travelers,
which make competition increasingly difficult. We also face competition for customer traffic on internet search engines and metasearch
websites, which impacts our customer acquisition and marketing costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Seasonality</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">We experience seasonal
fluctuations in the demand for our travel products and services. For example, traditional leisure travel bookings are generally the highest
in the first three quarters as travelers plan and book their spring, summer and winter holiday travel. The number of bookings typically
decreases in the fourth quarter. Because revenue for most of our travel products is recognized when the travel takes place rather than
when it is booked, revenue typically lags bookings by several weeks to several months. As a result, although travel bookings through
NextTrip&#8217;s platforms tend to be highest from the period from January to June, moderate from July through September and low from
October through December, the majority of revenue is recognized in the summer months (June, July, and August), and during the winter
holidays (November and December).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Intellectual Property</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our intellectual
property includes the content of our websites, registered domain names, registered and unregistered trademarks, business plan, business
strategies and trade secrets, proprietary and acquired software platforms and related assets, licensed software platforms, and customer
and third-party supplier lists. We believe that our intellectual property is an essential asset of our business and that our registered
domain names and our technology infrastructure will give us a competitive advantage in the online market and arrangements with attractions
and tour operators. We rely on a combination of trademark, copyright and trade secret laws in the United States, as well as contractual
provisions, to protect our proprietary technology and our brands. We also rely on copyright laws to protect the appearance and design
of our sites and applications. We have registered numerous Internet domain names related to our business in order to protect our proprietary
interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our key proprietary
software platforms and systems include our booking engine, NXT2.0 which we enhanced through our acquisition and subsequent integration
of the Bookit.com assets, the group travel booking platform, which allows for efficient and streamlined travel planning and booking for
travel groups of five or more, FlexPay technology, which allows travelers to book a trip for as little as $1.00 down and pay over time
with no interest, TravelMagazine, which offers tools to create personalized travel using video, blogs, reviews, tourism boards and AI
planner and our recently launched FAST TV channel, Compass.TV, which aims to inspire audiences by highlighting the world&#8217;s best
travel experiences and offering viewers a rich source of inspiration for planning their next journey.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Regulation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our ability to provide
our services and any future services is affected by legal regulations of governments and regulatory authorities around the world, many
of which are evolving and subject to revised interpretations. Violations of any laws or regulations could result in fines, penalties,
and criminal sanctions against us, our officers or employees, and prohibitions on how or where we conduct our business, which could damage
our reputation, brands, global expansion efforts, ability to attract and retain employees and business partners, business, and operating
results. Even if we comply with these laws and regulations, doing business in certain jurisdictions or violations of these laws and regulations
by the parties with which we conduct business runs the risk of harming our reputation and our brands. Regulations that impact our business
or our industry include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in">&#9679; <i>Data Protection and Privacy</i>: We have policies and a
global governance framework to comply with privacy laws that apply to our business, meet evolving stakeholder expectations, and support
business innovation and growth. In the European Union, the General Data Protection Regulation (the &#8220;GDPR&#8221;) imposes significant
compliance obligations and costs. In the United States, the California Consumer Privacy Act (the &#8220;CCPA&#8221;) and the California
Privacy Rights Act (&#8220;CPRA&#8221;) impose privacy requirements and rights for consumers in California that will result in additional
compliance complexity, risks, and costs. Other U.S. states and jurisdictions globally have adopted or may adopt similar data protection
regulations. Some data protection and privacy laws afford consumers a private right of action against companies like ours for certain
statutory violations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in">&#9679; <i>Regulation of the Travel Industry</i>: Our business is
impacted by travel-related regulations such as local regulation of the use of alternative accommodations. Local jurisdictions around
the world have instituted a variety of measures to address the issues of &#8220;overtourism&#8221; and the impact of tourism on the climate.
As our business evolves, we expect to become subject to existing and new regulations. For example, some parts of our business are already
subject to certain requirements of the US Department of Transportation (DOT), and as our offerings continue to diversify and expand,
we may become subject to additional requirements of regulatory agencies across the world.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="margin: 0pt; text-align: justify; text-indent: 0.5in">&#9679; <i>Payments</i>: As we expand our payments services to consumers
and business partners, we are subject to additional regulations, such as financial services regulations and license requirements, which
has resulted in increased compliance costs and complexities, including those associated with the implementation of new or advanced internal
controls. We are also subject to payment card association rules and obligations under our contracts with payment card processors, including
the Payment Card Industry Data Security Standard, compliance with which is complex and costly.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Facilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our principal executive
offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. The lease has a 6-month term which ends on December 31, 2024.
The landlord can terminate the lease upon 30 days written notice and NextTrip can terminate the lease upon 45 days written notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Human Capital Resources</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">As of August 31,
2024, we had 14 full-time employees and 13 independent contractors, We use independent contractors and temporary personnel to supplement
our workforce, particularly in the software development and technology tasks. Our employees are not represented by a labor union, and
we consider our employee relations to be very good. Competition for qualified personnel in its industry has historically been intense,
particularly for software engineers, developers, and other technical staff. Our human capital resources objectives include, as applicable,
identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. We strive to provide competitive
compensation and benefits to our employees. Our benefit programs include bonuses, stock-based compensation awards, a 401(k) plan with
employer matching, healthcare and insurance benefits, flexible paid time off and other employee assistance programs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The principal purposes
of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting
of stock-based compensation awards and cash-based performance bonus awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">All employees are
responsible for upholding the NextTrip Code of Ethics and Business Conduct, which is important in delivering on our strategy. We maintain
a compliance hotline for the confidential reporting of any suspected policy violations or unethical business conduct on the part of our
businesses, employees, officers, directors, suppliers, or customers.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Legal
Proceedings</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not currently a party to any material legal proceedings. We may, however, in the ordinary course of business face various claims
brought by third parties, and we may, from time to time, make claims or take legal actions to assert our rights, including intellectual
property rights as well as claims relating to employment matters. Any of these claims could subject us to costly litigation. If this
were to happen, the payment of any such awards could have a material adverse effect on our business, financial condition and results
of operations. Additionally, any such claims, whether or not successful, could damage our reputation and business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Sigma was initially
incorporated as Messidor Limited in Nevada on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010,
the name was changed to Sigma Labs, Inc. On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August
9, 2022, changed its name to Sigma Additive Solutions, Inc. On March 13, 2024, we changed our name to NextTrip, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal executive offices are located at 3900 Paseo del Sol, Santa Fe, New Mexico 87507, and our current telephone number at that address
is (954) 526-9688. Our website address is www.nexttrip.com. The Company&#8217;s annual reports, quarterly reports, current reports
on Form 8-K and amendments to such reports filed or furnished pursuant to section 13(a) or 15(d) of the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;), and other information related to the Company, are available, free of charge, on that website
as soon as we electronically file those documents with, or otherwise furnish them to, the SEC. The Company&#8217;s website and the information
contained therein, or connected thereto, are not and are not intended to be incorporated into this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_016"></span>MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 7pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names, ages, and positions of our executive officers and directors:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Lyndsey North</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">42</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">President</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    Orzechowski</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer, Treasurer and Corporate Secretary</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Monaco</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair
    of the Board</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis
    Duitch</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent
    Summers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
    Brunsberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore
    Battinelli</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive
Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>William
Kerby</i></b> has served as our Chief Executive Officer since December 29, 2023. Mr. Kerby has over two decades of experience in the
travel and media industries, and approximately a decade of experience in the financial industry. He acted as the architect of the NextTrip
model, overseeing the development and operations of the Travel, Real Estate and Television Media divisions of the company. From January
25, 2023 to December 29, 2023, Mr. Kerby was the Chief Executive Officer of NextTrip Group, LLC. Mr. Kerby served as the Co-Chief Executive
Officer of NextPlay Technologies, Inc. (formerly Monaker Group, Inc.) from September 16, 2021 to January 25, 2023. From July 2008 to
September 16, 2021, Mr. Kerby was the Chief Executive Officer of Monaker Group, Inc. During that time, Mr. Kerby also served as Chief
Executive Officer of NextPlay Media from 2009 through 2020 as well as being the CEO of the Company&#8217;s real estate holding Verus
International, Inc., formerly Realbiz Media Group, Inc., from October 2012 until August 2015 and on the board of directors until April
of 2016. From April 2002 to July 2008, Mr. Kerby served as the Chief Executive Officer of various media and travel entities that ultimately
became part of Extraordinary Vacations Group. Operations included Cruise &amp; Vacation Shoppes, Maupintour Extraordinary Vacations,
Attach&#233; Travel and the Travel Magazine - a TV series of 160 travel shows. From February 1999 to April 2002, Mr. Kerby founded
and managed Travelbyus, a publicly- traded company on the TSX and Nasdaq Small Cap Market. The launch included an intellectually patented
travel model that utilized technology-based marketing to promote its travel services and products. Mr. Kerby negotiated the acquisition
and financing of 21 companies encompassing multiple tour operators, 2,100 travel agencies, media that included print, television, outdoor
billboard and wireless applications and leading-edge technology in order to build and complete the Travelbyus model. The company had
over 500 employees, gross revenues exceeding $3 billion and a market cap of over $900 million. From June 1989 to January 1999, Mr. Kerby
founded and grew Leisure Canada &#8211; a company that included the Master Franchise for Thrifty Car Rental British Columbia, TravelPlus
(a nationwide Travel Agency), Bluebird Holidays (an international tour company with operations in the U.S., Canada, Great Britain, France,
South Africa and the South Pacific) and Canadian Traveler (a travel magazine). Leisure Canada was acquired in May 1998 by Wilton Properties,
a Canadian company developing hotel and resort properties in Cuba. From October 1980 through June 1989, Mr. Kerby worked in the financial
industry as an investment advisor. Mr. Kerby graduated from York University with a Specialized Honors Economics degree.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><b><i>Lyndsey North
</i></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">has served as our President since July 2023. With more
than 15 years of experience in leisure tour and travel technology, Ms. North is responsible for all aspects of the NextTrip leisure,
business and technology products including development of the World1 Metaverse. Prior to joining NextTrip, Ms. North led the Supplier
Strategy &amp; Investment division at Apple Leisure Group (ALG). Here she lead global partnership marketing and strategic relationships
across the ALG Vacations and VAX VacationAccess brands including Apple Vacations, Funjet Vacations, United Vacations, Southwest Vacations,
CheapCaribbean.com, and Travel Impressions. Ms. North joined the team at The Mark Travel Corporation (TMTC) in 2003, and served in a
variety of marketing and engagement capacities. Prior to the merger with ALG, Ms. North was appointed to lead the Supplier Strategy &amp;
Investment efforts for all TMTC and Trisept Solutions brands in 2014. During her tenure with the company Ms. North was involved in the
development of many new business relationships and was part of the leadership team for both TMTC and Trisept Solutions. Ms. North holds
a Bachelor&#8217;s degree in Marketing from Marquette University.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Frank
D. Orzechowski </i></b>has served as our Chief Financial Officer, Treasurer, principal accounting officer, principal financial
officer, and Corporate Secretary since July 1, 2019. Prior to joining the Company, Mr. Orzechowski served as the Chief Financial Officer
of StormHarbour Partners LP, an independent global markets and financial advisory firm since September 2013. From May 2013 to August
2013, Mr. Orzechowski served as a contract Chief Financial Officer for Etouches Inc., a cloud-based event management software company,
to assist with financial matters in connection with that company&#8217;s planned equity financing. Prior to that, he served as President
and Owner/Operator of Four-O Technologies Inc. from August 2009 to December 2012, where he successfully launched and guided operations
for two Cartridge World franchise units in Connecticut. From February 2006 to July 2009, Mr. Orzechowski served as President and Chief
Financial Officer of Nikko Americas Holding Company Inc., where he was responsible for managing all of the support and infrastructure
for that company&#8217;s U.S. business, as well as investment manager selection and due diligence functions for its World Series Platform.
Mr. Orzechowski began his career at Coopers &amp; Lybrand in 1982, received his CPA certification in 1984 and received his Bachelor of
Science in Business Administration with a major in Accounting from Georgetown University in 1982.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Donald
P. Monaco </i></b>has been the Chairman of the Board of Directors since December 29, 2023. Mr. Monaco has approximately three decades
of experience as an international information technology and business management consultant. Mr. Monaco is the founder and owner of Monaco
Air Duluth, LLC, a full service, fixed-base operator aviation services business at Duluth International Airport in Duluth, Minnesota,
serving airline, military, and general aviation customers since November 2005. Since January 2009, he has been appointed and reappointed
by Minnesota Governors to serve as a Commissioner of the Metropolitan Airports Commission in Minneapolis-St. Paul, Minnesota, and currently
serves as Chairman of the Operations, Finance and Administration Committee. Mr. Monaco is also the President and Chairman of the Monaco
Air Foundation, Treasurer of Honor Flight Northland, Treasurer of the Duluth Aviation Institute, and a member of the Duluth Chamber of
Commerce Military Affairs Committee. Mr. Monaco previously worked as an international information technology and business management
consultant with Accenture in Chicago, Illinois for 28 years, and as a partner and senior executive for 18 of such years. From August
2011 to January 2023, Mr. Monaco served as a member of the board of directors of NextPlay (known as Monaker prior to June 2020), where
he served as chairman of the board of directors from August 2018 to June 2021 and as co-chairman of the board from June 2021 to December
2021. He previously served as a director at Republic Bank in Duluth, Minnesota from May 2015 until October 2019. He also served on the
Verus International, Inc., formerly RealBiz Media Group, Inc., board of directors from October 2012 until April 2016, serving as chairman
of the board from August 2015 to April 2016. Mr. Monaco holds Bachelor&#8217;s and Master&#8217;s degrees in Computer Science Engineering
from Northwestern University. Our Board of Directors believes that Mr. Monaco is qualified to serve as a member of our Board on the basis of his
deep understanding of information technology, early-stage business growth strategies, and business acquisitions, as well as his background
and extensive company management and leadership experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dennis
Duitch</i></b> was appointed to our Board of Directors on August 8, 2017. Mr. Duitch has served as Managing Director of Duitch Consulting
Group, a private consulting company, since 2003. Prior to that time, he practiced public accounting, business management, mediation and
consultancy nationally, with expertise in strategic and operations management, finance, accounting, strategic planning and business operations
for a wide spectrum of companies, including technology, manufacturing and distribution, marketing, real estate, entertainment, and professional
practices. He has served in executive officer roles and as a director of public and private companies, not-for-profit organizations,
including as Vice-Chairman for Accountants Global Network, and as a top-level advisor for public companies, closely held businesses,
families and high-wealth individuals for over thirty years. Mr. Duitch began his career with the international CPA firm Grant Thornton
in its Chicago, San Francisco and Beverly Hills offices before founding Duitch &amp; Franklin LLP, which evolved to become one of Southern
California&#8217;s largest independent CPA/Business Management/Consultancy practices, and which was acquired by a public company in 1998.
He subsequently served as President for a consumer products company with direct responsibility for marketing, retail, and fulfillment
operations, until forming Duitch Consulting Group in 2003 to serve clients in advisory, C-level, and board of director roles. Mr. Duitch
is a Certified Family Business and Estate Advisor, and mediator for matters including partner/stockholder agreements and disputes, business
and marital property dissolution, and dysfunctional executive teams and boards of directors. He has lectured extensively in management,
financial and accounting areas for the California CPA Foundation, business and professional groups, has instructed at several colleges
and universities, and has authored technical articles in management and taxation for regional and national publications. Mr. Duitch earned
a B.B.A degree in Accounting from the University of Iowa and a Master of Business Administration in Finance from Northwestern University.
Our Board of Directors believes that Mr. Duitch is qualified to serve as a member of the board because of his extensive public accounting
experience, which will assist the Board and the Audit Committee in addressing the numerous accounting-related issues, regulations and
SEC reporting requirements to which we are subject, as well as his expertise in business management, finance and strategic planning.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Kent
Summers</i></b> was appointed to our Board of Directors on January 18, 2018. Mr. Summers was also appointed to serve as a member of the
Company&#8217;s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Mr. Summers currently divides
his time among a number of independent activities which focus on early-stage technology company formation and development strategies,
and sales planning and execution needs for emerging- and mid-market technology companies located primarily in the Boston metropolitan
area, including: management consultant to private and family-owned businesses; volunteer Mentor and Instructor with the Massachusetts
Institute of Technology Venture Mentoring Services program; regular lectures on enterprise, business-to-business sales to company founders
and students enrolled at the Massachusetts Institute of Technology Sloan School of Management, the Harvard MBA Program, the Wharton School
at the University of Pennsylvania, and a number of domestic and international entrepreneurship support organizations; and consultant
to Fellows enrolled in the Harvard Advanced Leadership Initiative. Mr. Summers has served in those roles at various times from 2003 to
the present. From 2009 to the present, Mr. Summers has served as the non-executive Chairman of CADNexus, Inc., and from 2017 to the present,
as a director and Chairman of the Compensation Committee with iQ3 Connect, Inc. Mr. Summers also currently serves as Chairman, Board
of Managers, Massachusetts Materials Technologies LLC. From 2005 to 2017, Mr. Summers served as Managing Partner at Practical Computer
Applications, Inc., a Boston-based database consulting and engineering services firm, where he was responsible for sales planning and
execution activities. Prior to Practical Computer Applications, from 2001 to 2005, Mr. Summers provided independent merger &amp; acquisition
advisory services to support the sale of privately-owned companies. Over a prior 14-year period, Mr. Summers served in leadership roles
at several software and internet start-ups, including: Chairman and CEO of Collego Corporation (acquired by MRO Software), founder and
CEO of MyHelpDesk, Inc. (acquired by Support.com), founder of PCMovingVan.com (acquired by a PE firm), and Vice President of Marketing
at Electronic Book Technologies, Inc. (acquired by INSO Corporation, formerly listed on Nasdaq). Prior to the software industry, Mr.
Summers served as Technology Analyst at Electronic Joint Venture Partners LLC and Associate Program Trader on the Options Trading Desk
at Bear Stearns &amp; Co. In 1986, Mr. Summers received a BA in English from the University of Houston. Our Board of Directors believes
that Mr. Summers is qualified to serve as a member of our Board on the basis of his deep understanding of early-stage business growth
strategies, enterprise sales, business acquisitions, as well as his background and extensive company management and leadership experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jacob
Brunsberg</i></b> was appointed to our Board of Directors on April 1, 2022. He was appointed Senior Vice President of Product Management
and Strategic Relationships on September 20, 2021, on February 16, 2022, he was named President and Chief Operating Officer, and on April
1, 2022, he was named President and Chief Executive Officer, of the Company. He resigned from his executive roles with the Company on
December 29, 2023. Prior to joining the Company, Mr. Brunsberg was a P&amp;L leader for General Electric&#8217;s Binder Jet Technology
unit, with management responsibility for strategy, development, commercialization, and overall business performance. Mr. Brunsberg holds
a Bachelor of Science degree in Material Science and Engineering from the University of Wisconsin-Madison. Our Board of Directors believes that Mr. Brunsberg is qualified to serve as a member of the board because of his
experience in leading early-stage growth companies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Salvatore
Battinelli</i></b> was appointed to our Board of Directors on August 16, 2017. Mr. Battinelli is currently the President and Chief
Executive Officer of Bello e Preciso Co., a manufacturer and wholesaler of Italian-made fashion watches and has served in those
roles since early 2017. Prior to joining Bello e Preciso Co., from 2011 to 2013, Mr. Battinelli served as Vice President of
Development and Long-Term Strategy of North American Management Corporation, a wealth management firm based in Boston, Massachusetts
with over $2 billion in assets under management. From 1987 to 2011, Mr. Battinelli served as Executive Vice President and acting
Chief Executive Officer and Chief Operating Officer of Faneuil Hall Associates, Inc., a concierge boutique family office devoted to
five interrelated ultra-high net-worth families. Mr. Battinelli&#8217;s primary responsibilities while at Faneuil Hall Associates
included providing planning and investment advice, the management of approximately 30 asset portfolios and more than 65 individual
business entities; and assisting the families in their various business ventures worldwide while working closely with law,
accounting and banking functions. During his tenure at Faneuil Hall Associates, Mr. Battinelli served as an executive officer or
director for certain of the family-owned entities and successfully managed several portfolio company IPOs, as well as serving as CEO
and COO for Designhouse International, a Scandinavian furniture company operating out of Atlanta, Georgia, which was previously
listed on NASDAQ in 1983. From 1970 to 1974, Mr. Battinelli served as Audit Manager for Deloitte &amp; Touche (formally Touche
Ross), where he specialized in management information systems. From 2002 to 2011, Mr. Battinelli also served as the Chairman of the
Board of Directors of HealthLink Europe, BV, a logistics and services company that serves the healthcare industry. Mr. Battinelli is
a Certified Public Accountant and received a BS in accounting and an MBA with an emphasis in international economics and accounting,
both from Babson College. Our Board of Directors believes that Mr. Battinelli is qualified to serve as a member of the board on the
basis of his deep understanding of business acquisitions and sales, as well as his background and extensive company management and
integration experience.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate
Governance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Independence</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board currently consists of five members. As a result of his previous service as our Chief Executive Officer, Mr. Brunsberg is not considered
an independent director. Our Board of Directors has determined that our other directors, Salvatore Battinelli, Dennis Duitch and Kent
Summers, constituting a majority of our directors, are &#8220;independent&#8221; as that term is defined under Rule 5605(a)(2) of the
Nasdaq marketplace rules. Pursuant to Nasdaq rules, our board must consist of a majority of independent directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nasdaq independence definition includes a series of objective tests, including that the director is not, and has not been for at least
three years, one of our employees and that neither the director nor any of his family members has engaged in various types of business
dealings with us. In addition, as required by Nasdaq rules, our Board of Directors has made a subjective determination as to Messrs.
Battinelli, Duitch and Summers, our independent directors, that no relationships exist, which, in the opinion of our Board of Directors,
would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In making these determinations,
our Board of Directors reviewed and discussed information provided by the directors and us with regard to each director&#8217;s business
and personal activities and relationships as they may relate to us and our management. There are no family relationships among any of
our directors or executive officers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classified
Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with our amended and restated bylaws, our Board of Directors is divided into three classes with staggered, three-year terms.
At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of
election and qualification until the third annual meeting following election. Our directors are classified as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Class I director is Donald P. Monaco, with a term expiring at our 2024 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Class II directors are Salvatore Battinelli and Jacob Brunsberg, with terms expiring at our 2025 annual meeting of stockholders;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Class III directors are Dennis Duitch and Kent Summers, with terms expiring at our 2026 annual meeting of stockholders.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws provide that the authorized number of directors may be changed by resolution of the Board of Directors. Any
additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as
nearly as possible, each class will consist of one-third of the directors. The division of our Board of Directors into three classes
with staggered three-year terms may delay or prevent a change of our management or a change in control of our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Leadership
Structure of the Board</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
director or our Board of Directors as a whole may be removed with or without cause at any meeting of stockholders by the affirmative
vote of the holders of at least two-thirds of our outstanding voting stock entitled to vote in the election of directors. Our amended
and restated bylaws provide our Board of Directors with flexibility in its discretion to combine or separate the positions of Chairman
of the Board and Chief Executive Officer. Our Board of Directors believes it is important to select the Company&#8217;s Chairman and
Chief Executive Officer in the manner it considers in the best interests of the Company at any given time. Our Board of Directors believes
that the Chairman and Chief Executive Officer positions may be filled by one individual or by two different individuals, as determined
by our Board of Directors based on circumstances then in existence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Chairman of the Board presides at all meetings of our Board of Directors and exercises and performs such other powers and duties as may
be assigned to him from time to time by the Board or prescribed by our amended and restated bylaws. The Chairman of the Board is appointed
by our Board of Directors on an annual basis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has no established policy on whether it should be led by a Chairman who is also the Chief Executive Officer, and in
the past has combined the roles of Chairman and Chief Executive Officer. Our Board currently is committed to the separation of the offices
of Chairman and Chief Executive Officer. However, our Board of Directors continually evaluates our leadership structure and could, in
the future, decide to combine the Chairman and Chief Executive Officer positions if it believes that doing so would serve the best interests
of our Company and our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board
Meetings and Committees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
our fiscal year ended February 29, 2024, the Board of Directors held 25 meetings, and each director attended at least 75%
of the aggregate of (i) the total number of meetings of our Board of Directors held during the period he was a director and (ii) the
total number of meetings held by all committees of our Board of Directors on which he served during the periods that he served.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we do not have a formal policy regarding attendance by members of our Board of Directors at annual meetings of stockholders, we encourage,
but do not require, our directors to attend. Each of our then current directors attended our 2023 Annual Meeting of Stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has established three standing committees&#8211;audit, compensation, and nominating and corporate governance,
each of which operates under a written charter that has been approved by our Board of Directors. Each committee charter has been posted
on the Investors section of our website at www.nexttrip.com. The reference to our website address does not constitute incorporation by
reference of the information contained at or available through our website, and you should not consider it to be a part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Audit Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing,
    approving the compensation of, and assessing the independence of our registered public accounting firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    the work of our registered public accounting firm, including through the receipt and consideration of reports from such firm;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing with management and the registered public accounting firm our annual and quarterly financial statements and related
    disclosures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring
    our internal control over financial reporting, disclosure controls and procedures;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing
    procedures for the receipt, retention and treatment of accounting related complaints and concerns;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">meeting
    independently with our registered public accounting firm and management;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving or ratifying any related person transactions; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preparing
    the Audit Committee report required by SEC rules.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Audit Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Duitch serves as the chairperson of the committee.
Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is an independent director under the applicable
Nasdaq rules and under SEC Rule 10A-3. All members of our Audit Committee meet the requirements for financial literacy under the applicable
rules and regulations of the SEC and Nasdaq. Our Board of Directors has determined that each member of our Audit Committee is an &#8220;audit
committee financial expert&#8221; as defined by applicable SEC rules and has the requisite financial sophistication as defined under
the applicable Nasdaq rules and regulations. The Audit Committee met four times during 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation
Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Compensation Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">annually
    reviewing and approving corporate goals and objectives applicable to CEO compensation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining
    our CEO&#8217;s compensation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and approving, or making recommendations to our Board of Directors with respect to the compensation of our other executive officers;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    an evaluation of our senior executives;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    and administering our equity incentive plans;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and making recommendations to our Board of Directors with respect to director compensation; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing
    and discussing annually with management our &#8220;Compensation Discussion and Analysis&#8221; when it is required by SEC rules to
    be included in our Proxy Statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Compensation Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Battinelli serves as the chairperson of the
committee. Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is independent under the applicable
Nasdaq rules and regulations and is a &#8220;non-employee director&#8221; as defined in Rule 16b-3 promulgated under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominating
and Corporate Governance Committee</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nominating and Corporate Governance Committee&#8217;s responsibilities include:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying
    individuals qualified to become board members;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recommending
    to our board the persons to be nominated for election as directors and to each of the board&#8217;s committees; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">overseeing
    an annual evaluation of the board.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
members of our Nominating and Corporate Governance Committee are Messrs. Duitch, Battinelli and Summers, and Mr. Duitch serves as the
chairperson of the committee. Our Board of Directors has determined that each of Messrs. Duitch, Battinelli and Summers is independent
under the applicable Nasdaq rules and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Code
of Ethics and Business Conduct</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a code of ethics that applies to all employees, including the Company&#8217;s principal executive officer, principal financial
officer, and principal accounting officer, as well as to the members of the Board of Directors. The code is available on our website
at www.nexttrip.com. The Company intends to disclose any changes in, or waivers from, this code by posting such information on
the same website or by filing a Current Report on Form 8-K, in each case to the extent such disclosure is required by the rules of the
SEC or Nasdaq. The reference to our website address does not constitute incorporation by reference of the information contained at or
available through our website, and you should not consider it to be a part of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Considerations
in Evaluating Director Nominees</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee uses a variety of methods for identifying and evaluating director nominees. In its evaluation
of director candidates, our Nominating and Corporate Governance Committee will consider the current size and composition of our Board
of Directors and the needs of our Board of Directors and the respective committees of our Board of Directors. Some of the qualifications
that our Nominating and Corporate Governance Committee considers include, without limitation, issues of character, integrity, judgment,
diversity of experience, independence, area of expertise, corporate experience, length of service, potential conflicts of interest and
other commitments. Nominees must also have the ability to offer advice and guidance to our Chief Executive Officer based on past experience
in positions with a high degree of responsibility and be leaders in the companies or institutions with which they are affiliated. Director
candidates must have sufficient time available in the judgment of our Nominating and Corporate Governance Committee to perform all board
of director and committee responsibilities. Members of our Board of Directors are expected to prepare for, attend, and participate in
all board of directors and applicable committee meetings. Other than the foregoing, there are no stated minimum criteria for director
nominees, although our Nominating and Corporate Governance Committee may also consider such other factors as it may deem, from time to
time, are in our and our stockholders&#8217; best interests.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
our Board of Directors does not maintain a specific policy with respect to board diversity, our Board of Directors believes that our
Board of Directors should be a diverse body, and our Nominating and Corporate Governance Committee considers a broad range of backgrounds
and experiences. In making determinations regarding nominations of directors, our Nominating and Corporate Governance Committee may take
into account the benefits of diverse viewpoints. Our Nominating and Corporate Governance Committee also will consider these and other
factors as it oversees the annual Board of Director and committee evaluations. After completing its review and evaluation of director
candidates, our Nominating and Corporate Governance Committee recommends to our full Board of Directors the director nominees for selection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently does not meet the diversity objectives of Rule 5605(f)(2)(C). Our Nominating and Corporate Governance Committee is
committed to ensuring that our Board&#8217;s composition appropriately reflects the current and anticipated needs of our Board of Directors
and the Company and believes that our current directors are well-suited to serve as directors based on the expertise and experience.
Our Nominating and Corporate Governance Committee, however, has and will continue to consider diverse candidates for membership on our
Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stockholder
Recommendations for Nominations to the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Nominating and Corporate Governance Committee will consider candidates for director recommended by stockholders so long as such recommending
stockholder was a stockholder of record both at the time of giving notice and at the time of the annual meeting, and such recommendations
comply with our amended and restated articles of incorporation and amended and restated bylaws and applicable laws, rules and regulations,
including those promulgated by the SEC. The Nominating and Corporate Governance Committee will evaluate such recommendations in accordance
with its charter, our amended and restated bylaws, our policies and procedures for director candidates, as well as the regular director
nominee criteria described above. This process is designed to ensure that our Board of Directors includes members with suitable backgrounds,
skills and experience, including appropriate financial and other expertise relevant to our business. Eligible stockholders wishing to
recommend a candidate for nomination should contact the Secretary in writing. Our Nominating and Corporate Governance Committee has the
discretion to decide which individuals to recommend for nomination as directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
nomination should be sent in writing to our Corporate Secretary at NextTrip, Inc., 3900 Paseo del Sol, Santa Fe, New Mexico 87507.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Role
of Board in Risk Oversight Process</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
assessment and oversight are an integral part of our governance and management processes. Our Board of Directors encourages management
to promote a culture that incorporates risk management into our corporate strategy and day-to-day business operations. Management discusses
strategic and operational risks at regular management meetings and conducts specific strategic planning and review sessions during the
year that include a focused discussion and analysis of the risks we face. Throughout the year, senior management reviews these risks
with the Board of Directors at regular board meetings as part of management presentations that focus on particular business functions,
operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. Our Board of Directors does
not have a standing risk management committee, but rather administers this oversight function directly through the Board of Directors
as a whole, as well as through standing committees of the Board of Directors that will address risks inherent in their respective areas
of oversight. In particular, our Audit Committee is responsible for overseeing our major financial risk exposures and the steps our management
has taken to monitor and control these exposures. The Audit Committee also monitors compliance with legal and regulatory requirements
and considers and approves or disapproves of any related-person transactions. Our Nominating and Governance Committee monitors the effectiveness
of our corporate governance guidelines that we may adopt or amend from time to time. Our Compensation Committee assesses and monitors
whether any of our compensation policies and programs has the potential to encourage excessive risk-taking by our management.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 122.55pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 122.55pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 122.55pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 122.55pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_017"></span>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unless
otherwise indicated, share and per share information in this section gives retroactive effect to the 1-for-20 reverse stock split effected
on September 22, 2023.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Processes
and Procedures for Compensation Decisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Compensation Committee is responsible for the executive compensation programs for our executive officers and reports to our Board of
Directors on its discussions, decisions and other actions. Typically, our Chief Executive Officer makes recommendations to our Compensation
Committee and is involved in the determination of compensation for the respective executive officers that report to him. Our Chief Executive
Officer does not determine his own compensation. Our Chief Executive Officer makes recommendations to our Compensation Committee regarding
short- and long-term compensation for all executive officers based on our results, an individual executive officer&#8217;s contribution
toward these results and performance toward individual goal achievement. Our Compensation Committee then reviews the recommendations
and other data and makes decisions (or makes recommendations to the Board) as to total compensation for each executive officer as well
as each individual compensation component.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth compensation for services rendered in all capacities to the Company: (i) for each person who served as the
Company&#8217;s Chief Executive Officer at any time during the past fiscal year and (ii) for our two most highly compensated executive
officers, other than our Chief Executive Officer, who were employed with the Company on February 29, 2024 (the foregoing executives
are herein collectively referred to as the &#8220;named executive officers&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Summary
Compensation Table</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    and Principal Position</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            <sup>(1)</sup></b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            <sup>(1)</sup></b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
                                            Awards</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
                                            Awards</b></span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            <sup>(2)</sup></b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other Compensation</b></span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)
                                            <sup>(1)</sup></b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></p>
                                                                                <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($)</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bill
    Kerby &#8211; Chief Executive Officer</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">441,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">417,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
    Brunsberg &#8211; Former President and Chief Executive Officer and Current Director</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">214,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,011</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(7)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">481,344</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">477,861</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">727,861</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    Orzechowski - Chief Financial Officer</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">109,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(8)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">309,073</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">260,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(4)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">460,976</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lyndsey
    North, President</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Actual
    amounts paid or accrued.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    option awards and stock appreciation rights awards. Stock appreciation rights awards are only payable in cash. As such, no shares
    of common stock were reserved in connection with the awards since no shares will be issued pursuant to exercise. The Fair Value of
    option and SARs awards are calculated in accordance with FASB ASC Topic 718. The amount recognized for all awards is calculated using
    the Black Scholes pricing model. No options or SARs were awarded during the twelve months ended February 29, 2024.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">On July 1, 2022, we granted Mr. Brunsberg: (i) an option to purchase
    up to 2,490 shares of common stock, with an exercise price of $50.00, and a grant date fair value of $46,367; (ii) an option to purchase
    up to 760 shares of common stock, with an exercise price of $50.00, and a grant date fair value of $14,152; (iii) 9,747 SARs, with
    an exercise price of $50.00 and a grant date fair value of $181,503; and (iv) 9,098 SARs in connection with his employment retention
    agreement. The SARs have an exercise price of $26.00 and had a grant date fair value of $187,530. On January 26, 2023, we granted
    Mr. Brunsberg an option to purchase up to 5,457 shares of common stock, with an exercise price of $11.60 and a grant date fair value
    of $48,295. In connection with Mr. Brunsberg&#8217;s resignation from the Company, on February 29, 2024, the Compensation Committee
    of the Board of Directors approved (i) the accelerated vesting of all unvested options and SARs as of his resignation of December
    29, 2023; and (ii) such options and SARs be and remain outstanding and exercisable for the full duration of the options. Notwithstanding
    the forgoing, as of February 29, 2024, all of Mr. Brunsberg&#8217;s vested options to purchase shares of our common stock were subject
    to an exercisability waiver until such time as we received shareholder approval to increase our authorized common shares from 1,200,000
    to 250,000,000 shares. Such approval was obtained at a special meeting of stockholders on March 8, 2024.</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">On July 1, 2022, we granted Mr. Orzechowski: (i) an option to purchase
    up to 797 shares of our common stock under our 2013 Equity Incentive Plan in connection with his employment arrangement. The option
    has an exercise price of $50.00 and vests as follows: 25% on the date of the grant, and the remaining 75% in equal monthly installments
    over the subsequent thirty-six months. As of February 29,2024, 521 shares were vested. The option had a grant date fair value of
    $14,841; (ii)&#160;&#160;an option to purchase up to 2,609 shares of our common stock with an exercise price of $50.00 and vests as
    follows: 25% on the date of the grant, and the remaining 75% in equal monthly installments over the subsequent thirty-six months.
    As of February 29, 2024, 1,691 shares were fully vested. The option had a grant date fair value of $48,583; (iii) 3,474
    SARs with an exercise price of $50.00 and vests as follows: 25% on the date of the grant, and the remaining 75% in equal monthly
    installments over the subsequent thirty-six months. As of February 29, 2024, 2,249 SARs were fully vested and exercisable. The SARs
    had a grant date fair value of $64,691; and (iv)&#160;&#160;4,852 SARs in connection with his employment retention agreement. The
    SARs have an exercise price of $26.00 and will vest and become exercisable on March 15, 2025 if Mr. Orzechowski remains an employee
    of the Company on that date. The SARs had a grant date fair value of $100,017. On January 26, 2023, we granted Mr. Orzechowski an
    option to purchase up to 3,711 shares of common stock. The option has an exercise price of $11.60 and vests as follows: 50% on the
    date of the grant, and the remaining 50% in equal monthly installments over the subsequent 23 months. As of February 29, 2024, 2,909
    shares were fully vested. The option had a grant date fair value of $32,843. As of February 29, 2024, all of Mr. Orzechowski&#8217;s
    vested options to purchase shares of our common stock were subject to an exercisability waiver until such time as we received shareholder
    approval to increase our authorized common shares from 1,200,000 to 250,000,000 shares. Such approval was obtained at a special meeting
    of stockholders on March 8, 2024.</span></td></tr>

<tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">(5)</td>
  <td style="text-align: justify">In fiscal year 2024, we paid Mr. Kerby $24,000 in connection with various personal financial guarantees,
  and a personal car allowance of $18,000 pursuant to the terms of his employment agreement.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">(6)</td>
  <td style="text-align: justify">In fiscal year 2023, we paid Mr. Kerby $10,000 in connection with various personal financial guarantees,
  and a personal car allowance of $7,500 pursuant to the terms of his employment agreement.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">(7)</td>
  <td style="text-align: justify">In fiscal year 2024, we paid Mr. Brunsberg a retention bonus of $204,511 and severance of $62,500
  in connection with his resignation from the Company pursuant to the terms of his Retention and Separation Agreement. In addition, Mr.
  Brunsberg is entitled to receive an award of 31,250 shares of Restricted Stock or Restricted Stock Units, or a stock option to Purchase
  up to 31,250 shares of the Company&#8217;s common stock as determined by the 2023 Equity Incentive Plan Administrator. Such award has
  not been granted as of February 29, 2024.</td></tr>

<tr style="vertical-align: top">
  <td style="text-align: justify">&#160;</td>
  <td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
  <td style="text-align: justify; width: 0.25in">(8)</td>
  <td style="text-align: justify">In fiscal year 2024, we paid Mr. Orzechowski a retention bonus of $109,073 pursuant to the terms
  of his Retention Bonus and Separation Agreement.</td></tr>
</table>


<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Named
Executive Officer Employment Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>William Kerby</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In connection with
this appointment as Chief Executive Officer of Company on December 29, 2023, the Company and Mr. Kerby entered into an employment letter
agreement, dated as of December 29, 2023. Under the employment agreement, Mr. Kerby will be entitled to receive an annual base salary
of $400,000, which is subject to increase (but not decrease) in the discretion of the Compensation Committee of our Board of Directors
based on an annual or special case assessments of his performance and other factors. At the discretion of our Board of Directors, Mr.
Kerby will also be eligible to earn a discretionary, annual fiscal end-of-year incentive bonus in an amount of up to 100% of his base
annual salary. The exact amount of the incentive bonus will be dependent on the achievement of Company milestones and profitability,
and such other milestones as the Board deems appropriate. Mr. Kerby will have the option of receiving some or all of his base annual
salary and any incentive bonus in cash or in shares of our common stock valued for this purpose as set forth in his employment agreement
and will be eligible to receive equity compensation at the discretion and in an amount to be determined by our Board of Directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">During his employment,
Mr. Kerby will be entitled to an automobile allowance of $1,500 per month and to receive all benefits under any and all deferred compensation
plans, retirement plans, life, disability, health, accident and other insurance programs, and similar employee benefit plans and programs,
sick leave and vacation time that the Company elects, in its sole discretion, to provide from time to time to its executive officers,
and to earn four weeks of paid time off in accordance with the Company&#8217;s PTO policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Mr. Kerby has entered
into various personal guarantees with the Airline Reporting Commission, sellers of travel, merchant providers, financial institutions,
associations and service providers for the benefit of NextTrip, in consideration of which the Company agrees in his employment agreement
to pay him a $2,000 per month guarantee fee for so long as the employment agreement and the guarantees remain in place. In the event
Mr. Kerby resigns for &#8220;Good Reason&#8221; (as defined in the employment agreement), or his employment is terminated by the Company
for any reason, the Company will immediately eliminate any and all guarantees failing which, for each month the guarantees remain in
place, the monthly guarantee fee will rise to $10,000 per month after 30 days in the event the Company is unable to assume the guarantees
during such 30-day period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The term of Mr.
Kerby&#8217;s employment under his employment agreement will continue from month-to-month until terminated by either party with 30 days&#8217;
prior written notice, unless sooner terminated in accordance with the terms thereof. Should the Company notice the termination of Mr.
Kerby&#8217;s employment agreement (other than as a result of death, &#8220;Disability&#8221; or &#8220;Cause,&#8221; as defined therein),
he will be entitled to payment of an amount equal to 12 months of his base annual salary in a lump sum payment upon termination and the
continuation of his health care coverage, at the Company&#8217;s expense, for up to 12 months following the termination (collectively,
the &#8220;Kerby Severance Payments&#8221;). In addition, in the event that Mr. Kerby&#8217;s agreement is terminated by the Company
for any reason within 12 months from the date of closing of the Acquisition, Mr. Kerby will be entitled to receive the Kerby Severance
Payments and the Contingent Shares will automatically accelerate and be issuable in full if not yet earned or issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Jacob
Brunsberg</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 7, 2021, we entered into an &#8220;at-will&#8221; employment letter agreement with Jacob Brunsberg, effective as of
September 20, 2021 (the &#8220;Brunsberg Effective Date&#8221;), pursuant to which Mr. Brunsberg agreed to serve as Senior Vice-President,
Product Management and Strategic Relationships on an &#8220;at-will&#8221; basis. As of February 16, 2022, Mr. Brunsberg was appointed
President and Chief Operating Officer, and as of April 1, 2022, Mr. Brunsberg was appointed President, Chief Executive Officer, and Principal
Executive Officer of the Company. Additionally, Mr. Brunsberg was appointed to serve as a member of our Board of Directors, effective
as of April 1, 2022, with a term expiring at the 2025 annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the employment letter agreement. Mr. Brunsberg is entitled to (i) an annual base salary of $200,000, which was increased to $250,000
effective February 16, 2022, and (ii) all benefits that we elect in our sole discretion to provide from time to time to our other executive
officers, and received a grant of a five-year stock option to purchase up to 5,000 shares of common stock of the Company, which has
an exercise price equal to the closing price of the Company&#8217;s common stock on the Brunsberg Effective Date, and vested and
became exercisable in full on the Brunsberg Effective Date. The option is on such other terms and provisions as are contained
in the Company&#8217;s standard form nonqualified stock option agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
during the term of his employment, Mr. Brunsberg is eligible to receive one or more bonuses relating to each fiscal year in recognition
of his achievement of individual and Company goals established by the Board of Directors from time to time. However, the decision to
provide any such bonuses and the amount and terms of any such bonuses is in the sole discretion of the Board of Directors. On January
24, 2022, Mr. Brunsberg was awarded a performance bonus of $19,876 for 2021. On December 29, 2023, Mr. Brunsberg resigned as President
and Chief Executive Officer but remains a member of our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Lyndsey North</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0; text-align: justify">On June 17, 2022, we entered into an &#8220;at will&#8221; employment agreement, with Lyndsey North under which
she was engaged to serve as Vice President of Marketing of the Company. As of September 28, 2022, Ms. North was appointed President of
the Company. Under the terms of Ms. North&#8217;s employment agreement, she was entitled to receive an annual base salary of $155,000,
which was increased to $200,000 effective September 28, 2022. Pursuant to the employment agreement, Ms. North was granted 4,000 Stock
Appreciation Rights (&#8220;SARs&#8221;) at an exercise price of $7.00, which will vest over a period of three years, with one-third
of the award vesting each year on her employment anniversary date. At the discretion of the Board of Directors, and subject to the achievement
of certain performance goals, Ms. North is also eligible for a performance bonus consisting of a cash award of up to 30% of base salary,
which was increased to 50% of base salary, and a SAR award of up to 25% of base salary. Ms. North is eligible to participate in the Company&#8217;s
group benefit plans, including medical, dental, and vision plans, as well as a 401K plan.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Frank
D. Orzechowski</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 1, 2019, we entered into an &#8220;at-will&#8221; employment agreement, with Frank Orzechowski under which he was engaged
to serve as our Chief Financial Officer, Treasurer, Principal Accounting Officer and Corporate Secretary of the Company. Under Mr. Orzechowski&#8217;s
employment agreement, he was entitled to receive an annual base salary of $135,000, which was increased to $155,000 effective March 1,
2020, which was increased to $180,000 on January 1, 2021, and which was increased to $200,000 on October 1, 2021. Pursuant to the employment
agreement, Mr. Orzechowski was granted (i) a stock option to purchase up to 13 shares of common stock of the Company, at an exercise
price equal to $280.00 per share, which was the closing market price of the Company&#8217;s common stock on July 1, 2019 (the &#8220;Orzechowski
Effective Date&#8221;), and (ii) to purchase up to 300 shares of common stock of the Company, with an exercise price of $280.00,
and will vest and become exercisable as follows: 20 shares vested and became exercisable on the one-year anniversary of the Orzechowski
Effective Date, 45 shares vested and became exercisable on the second-year anniversary of the Orzechowski Effective Date,
71 shares will vest and become exercisable on the third-year anniversary of the Orzechowski Effective Date, and 164 shares will
vest and become exercisable on the fourth-year anniversary of the Orzechowski Effective Date, provided, in each case, that Mr.
Orzechowski remains an employee of the Company through such vesting dates. Further, Mr. Orzechowski is eligible to participate in the
Company&#8217;s 2013 Equity Incentive Plan, and is eligible to receive medical and dental benefits, life insurance, short and long-term
disability coverage, and to participate in the Company&#8217;s Section 125 cafeteria plan, vision plan and 401K plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Equity Awards at 2024 Fiscal Year-End</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth outstanding stock
options granted under our 2013 Equity Incentive Plan and SARs under our 2020 Stock Appreciation Rights Plan that are held
by our named executive officers as of February 29, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Option
    Awards<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Name</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number
                                            of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>options
                                            (#)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>exercisable</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number
                                            of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>unexercised</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>options
                                            (#)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>unexercisable</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>exercise
                                            price ($)</b></p></td><td style="padding-bottom: 1.5pt; font-size: 10pt">&#160;</td><td style="font-size: 10pt; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>expiration
                                            date</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 38%; font-size: 10pt"><span style="font-size: 10pt">Jacob Brunsberg<sup>(2)</sup></span></td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 12%; font-size: 10pt; text-align: right">-</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 12%; font-size: 10pt; text-align: right">5,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">$</td><td style="width: 12%; font-size: 10pt; text-align: right">63.60</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 12%; font-size: 10pt; text-align: right">9/20/2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,500</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2/16/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,500</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">2/16/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right"><span style="font-size: 10pt">760</span></td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,490</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,747</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">9,098</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">26.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5,457</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.60</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">1/25/2028</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt"><span style="font-size: 10pt">Frank Orzechowski<sup>(3)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">13</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">280.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2024</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">300</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">280.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2024</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,750</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">6/14/2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">902</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">52.60</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">6/22/2025</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,429</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">68.40</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">8/11/2026</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,620</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">809</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">68.40</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">8/11/2026</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">797</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,609</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,249</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,225</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">50.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,852</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">26.00</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">7/1/2027</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">-</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,711</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">$</td><td style="font-size: 10pt; text-align: right">11.60</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">1/25/2028</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(1) On June 23, 2020, we adopted the 2020 Stock
Appreciation Rights Plan. The Plan provides for incentive awards in the form of SARs payable in cash. No shares of common stock were
reserved in connection with the adoption of the Plan since no shares will be issued pursuant to the Plan. Awards issued under the Plan
are included in the table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(2) On September 20, 2021, in conjunction with
the hiring of Jacob Brunsberg, the Company&#8217;s current President and Chief Executive Officer, the Company granted to Mr. Brunsberg
an option to purchase 5,000 shares of our common stock with an exercise price of $63.60, which was fully vested on the date of the grant.
On February 16, 2022, the Company granted an option to Mr. Brunsberg to purchase up to 3,500 shares of common stock with an exercise
price of $50.00, which as of February 29, 2024, was fully vested. Also on February 16, 2022, the Company granted 1,500 SARs to Mr. Brunsberg,
with an exercise price of $50.00, which as of February 29, 2024, was fully vested and exercisable. On July 1, 2022, we granted Mr. Brunsberg: (i)
an option to purchase up to 760 shares of our common stock with an exercise price of $50.00, which as of February 29, 2024, was fully
vested; (ii) an option to purchase up to 2,490 shares of our common stock with an exercise
price of $50.00, which as of February 29, 2024, was fully vested; (iii) 9,747 SARs with
an exercise price of $50.00, which as of February 29, 2024, was fully vested and exercisable; and (iv) 9,098 SARs in connection with his employment retention agreement. The SARs have an exercise price of $26.00 and as of February 29, 2024,
were fully vested and exercisable. On January 26, 2023, we granted Mr. Brunsberg an option to purchase up to 5,457 shares of common
stock with an exercise price of $11.60, which as of February 29, 2024 was fully vested. As of February 29, 2024, all of Mr. Brunsberg&#8217;s
vested options to purchase shares of our common stock were subject to an exercisability waiver until such time as we received shareholder
approval to increase our authorized common shares from 1,200,000 to 250,000,000 shares. Such approval was obtained at a special meeting
of stockholders on March 8, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">(4) On July 1, 2019, in conjunction with the hiring
of Frank Orzechowski, our Chief Financial Officer, the Company granted to Mr. Orzechowski (i) an option to purchase 13 shares of our common
stock with an exercise price of $280.00, which fully vested on July 1, 2019; and (ii) an option to purchase up to 300 shares of our common
stock, with an exercise price of $280.00, which as of February 29, 2024was fully vested. On May 28, 2020, we granted Mr. Orzechowski
an option to purchase 1,750 shares of our common stock under our 2013 Equity Incentive Plan in connection with his employment arrangement.
The option has an exercise price of $50.00, which as of February 29, 2024 was fully vested. On June 23, 2020, pursuant to our 2020
Stock Appreciation Rights Plan, we granted Mr. Orzechowski 902 SARs. The SARs have an exercise price of $52.60 which as of February 29,
2024 were fully vested and exercisable. On August 11, 2021, we granted Mr. Orzechowski an option to purchase 2,429 shares of our common
stock under our 2013 Equity Incentive Plan in connection with his employment arrangement. The option has an exercise price of $68.40
and as of February 29, 2024, 2,129 shares were fully vested, and the remaining 300 shares will vest in equal monthly installments over
the next eight months. On August 11, 2021, pursuant to our 2020 Stock Appreciation Rights Plan, we granted Mr. Orzechowski 2,429 SARs.
The SARs have an exercise price of $68.40 and will vest and become exercisable in three equal installments on each of the first, second,
and third anniversaries of the grant date. As of February 29, 2024, 1,620 SARs were fully vested and exercisable.  On July 1, 2022,
we granted Mr. Orzechowski: (i) an option to purchase up to 797 shares of our common stock with an exercise price of $50.00. As of February
29, 2024, 521 were fully vested, and the remaining 276 shares will vest in equal monthly installments over the next sixteen months; (ii) an option to purchase up to 2,609 shares of our common stock with an exercise price
of $50.00. As of February 29, 2024, 1,691 shares were fully vested and the remaining 918 shares will vest in equal monthly installments
over the next sixteen months; (iii) 3,474 SARs with an exercise price of $50.00. As
of February 29, 2024, 2,249 SARs were fully vested and exercisable, and the remaining 1,225 SARs will vest in equal monthly installments
over the next sixteen months; and (iv) 4,852 SARs in connection with his employment retention
agreement. The SARs have an exercise price of $26.00 and will vest and become exercisable on March 15, 2025 if Mr. Orzechowski remains
an employee of the Company on that date. On January 26, 2023, we granted Mr. Orzechowski an option to purchase up to 3,711 shares
of our common stock, with an exercise price of $11.60. As of February 29, 2024, 2,909 shares were fully vested, and the remaining 802
shares will vest in equal monthly installments over the next ten months. As of February 29, 2024, all of Mr. Orzechowski&#8217;s vested
options to purchase shares of our common stock were subject to an exercisability waiver until such time as we received shareholder approval
to increase our authorized common shares from 1,200,000 to 250,000,000 shares. Such approval was obtained at a special meeting of stockholders
on March 8, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Awards</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
offer stock options, stock appreciation rights, and stock awards to certain of our employees, including our executive officers, as the
long-term incentive component of our compensation program. We generally grant equity awards to new hires upon their commencing employment
with us. Our stock options allow employees to purchase shares of our common stock at a price per share equal to the fair market value
of our common stock on the date of grant and may or may not be intended to qualify as &#8220;incentive stock options&#8221; for U.S.
federal income tax purposes. Our stock appreciation rights allow employees to receive a cash payment for the difference between the market
price of our common stock on the date of exercise and the strike price. We sometimes also offer stock options, stock appreciation rights
and stock awards to our consultants in lieu of cash. Our stock options allow consultants to purchase shares of our common stock at a
price per share equal to the fair market value of our common stock on the date of grant and are not intended to qualify as &#8220;incentive
stock options&#8221; for U.S. federal income tax purposes. Our stock appreciation rights allow consultants to receive a cash payment
for the difference between the market price of our common stock on the date of exercise and the strike price. Stock options, stock appreciation
rights, and stock awards granted to our executive officers may be subject to accelerated vesting in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Retirement
Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain two qualified 401(k) plans, in which all eligible employees may participate. We make safe harbor contributions
to both plans: one plan matches 100% of each participant&#8217;s contribution up to 3% of salary, and 50% of the next 2% of salary contributed,
and the other plan makes a 3% non-elective contribution for all eligible participants. Safe harbor contributions are 100% vested. We may
also elect, on an annual basis, to make a discretionary contribution to the plan, but have not done so to date. Our elective matches and
elective contributions vest to participant accounts as follows: 20% after two years of service, and 20% per year thereafter until the
participant reaches 6 years of service, at which time, employer contributions vest 100%. As a tax-qualified retirement plan, contributions
to the 401(k) plans and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plans.</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>No
Tax Gross-Ups</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not make gross-up payments to cover our executive officers&#8217; personal income taxes that may pertain to any of the compensation
paid or provided by our Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>2023 Equity Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">On November 19,
2023, our Board of Directors adopted the Sigma Additive Solutions, Inc. 2023 Equity Incentive Plan, which we refer to as the &#8220;2023
Plan.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our Board of Directors
believes that the grant of options and other stock awards is an important incentive for the Company&#8217;s employees, officers and directors.
Previously, we issued options and stock awards pursuant to our 2013 Equity Incentive Plan, which plan expired according to the terms
thereof in March 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">A summary of the
2023 Plan is set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Purpose</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Our Board of Directors
adopted the 2023 Plan to (1) encourage selected employees, officers, directors, consultants and advisers to improve our operations and
increase our profitability, (2) encourage selected employees, officers, directors, consultants and advisers to accept or continue employment
or association with us, and (3) increase the interest of selected employees, officers, directors, consultants and advisers in our welfare
through participation in the growth in value of our common stock. All of our current employees, directors and consultants are eligible
to participate in the 2023 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Administration</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The 2023 Plan is
to be administered by the Board of Directors or by a committee to which administration of the 2023 Plan, or of part of thereof, is delegated
by the Board of Directors. The 2023 Plan is currently administered by our Compensation Committee, which we refer to below as the &#8220;Administrator.&#8221;
The Administrator is responsible for selecting the officers, employees, directors, consultants and advisers who will receive Options,
Stock Appreciation Rights and Stock Awards. Subject to the requirements imposed by the 2023 Plan, the Administrator is also responsible
for determining the terms and conditions of each Option and Stock Appreciation Right award, including the number of shares subject to
the Option, the exercise price, expiration date and vesting period of the Option and whether the option is an Incentive Option or a Non-Qualified
Option. Subject to the requirements imposed by the 2023 Plan, the Administrator is also responsible for determining the terms and conditions
of each Stock Award, including the number of shares granted, the purchase price (if any), and the vesting, transfer and other restrictions
imposed on the stock. The Administrator has the power, authority and discretion to make all other determinations deemed necessary or
advisable for the administration of the 2023 Plan or of any award under the 2023 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The 2023 Plan is
not subject to the Employee Retirement Income Security Act of 1974 and is not a qualified pension, profit sharing or bonus plan under
Section 401(a) of the Internal Revenue Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock Subject to the 2023 Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The aggregate number
of shares of common stock set aside and reserved for issuance under the 2023 Plan is 7,000,000 shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">If awards granted
under the 2023 Plan expire or otherwise terminate or are cancelled without being exercised in full, the shares of common stock not acquired
pursuant to such awards will again become available for issuance under the 2023 Plan. If shares of common stock issued pursuant to awards
under the 2023 Plan are forfeited to or repurchased by us, the forfeited or repurchased stock will again become available for issuance
under the 2023 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">If shares of common
stock subject to an award are not delivered to a participant because such shares are withheld for payment of taxes incurred in connection
with the exercise of an Option, or the issuance of shares under a Stock Award, or the award is exercised through a reduction of shares
subject to the award (&#8220;net exercised&#8221;), then the number of shares that are not delivered will not again be available for
issuance under the 2023 Plan. In addition, if the exercise price of any award is satisfied by the tender of shares of common stock to
us (whether by actual delivery or attestation), the shares tendered will not again be available for issuance under the 2023 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Eligibility</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">All directors, employees,
consultants and advisors of the Company and its subsidiaries are eligible to receive awards under the 2023 Plan. Incentive Options may
only be granted under the 2023 Plan to a person who is a full-time officer or employee of the Company or a subsidiary. The Administrator
will determine from time-to-time which directors, employees, consultants and advisers will be granted awards under the 2023 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Terms of Awards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Maximum Grant</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The maximum number
of shares of Common Stock subject to a Stock Award granted during a single Fiscal Year to any Non-Employee Director (together with any
cash fees paid to such Non-Employee Director during the Fiscal Year) is not permitted to exceed a total value of $500,000. The value
of the Stock Award is based on the fair value for financial reporting purposes on the grant date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Written Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Each award under
the 2023 Plan will be evidenced by an agreement in a form approved by the Administrator.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Exercise Price; Base Value</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The exercise price
for a Non-Qualified Option or an Incentive Option may not be less than 100% of the fair market value of the Common Stock on the date
of the grant of the Non-Qualified Option or Incentive Option. With respect to an Option holder who owns stock possessing more than 10%
of the total voting power of all classes of our stock, the exercise price for an Incentive Option may not be less than 110% of the fair
market value of the Common Stock on the date of the grant of the Incentive Option. The base value of a Stock Appreciation Right shall
also be no less than 100% of the Common Stock on the date of the grant of the Stock Appreciation Right. The 2023 Plan does not specify
a minimum exercise price for Stock Awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Vesting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Each Option, Stock
Appreciation Right or Stock Award will become exercisable or non-forfeitable (that is, &#8220;vest&#8221;) under conditions specified
by the Administrator at the time of grant. Vesting typically is based upon continued service as a director or employee but may be based
upon any performance criteria and other contingencies that are determined by the Administrator. Shares subject to Stock Awards may be
subject to specified restrictions concerning transferability, repurchase by the Company and forfeiture of the shares issued, together
with such other restrictions as may be determined by the Administrator.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Expiration Date</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Each Option or Stock
Appreciation Right must be exercised by a date specified in the award agreement, which may not be more than ten years after the grant
date. Except as otherwise provided in the relevant agreement, an Option or Stock Appreciation Right ceases to be exercisable ninety days
after the termination of the holder&#8217;s employment with us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Transfers of Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Unless otherwise
determined by the Administrator, Options are not transferable except by will or the laws of descent and distribution.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Purchase Price Payment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Unless otherwise
determined by the Administrator, the purchase price of Common Stock acquired under the 2023 Plan is payable by cash or check at the time
of an Option exercise or acquisition of a Stock Award. The Company does not charge participants any fees or commissions in connection
with their acquisition of Common Stock under the 2023 Plan. The Administrator also has the discretion to accept the following types of
payment from participants: shares of Common Stock, cash or a combination thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Withholding Taxes</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">At the time of his
or her exercise of an Option or Stock Appreciation Right, an employee is responsible for paying all applicable federal and state withholding
taxes. A holder of Stock Awards is responsible for paying all applicable federal and state withholding taxes once the shares covered
by the award cease to be forfeitable or at any other time required by applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Securities Law Compliance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Shares of Common
Stock will not be issued pursuant to the exercise of an Option or the receipt of a Stock Award unless the Administrator determines that
the exercise of the Option or receipt of the Stock Award and the issuance and delivery of such shares will comply with all relevant provisions
of law, including, without limitation, the Securities Act, applicable state and foreign securities laws and the requirements of any stock
exchange on which our Common Stock is traded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Effects of Change of Control</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Except as otherwise
provided in an Award Agreement, in the event of a Change in Control, all outstanding Options and Stock Appreciation Rights shall become
immediately exercisable with respect to 100% of the shares subject to such Options or Stock Appreciation Rights, and/or the Restricted
Period shall expire immediately with respect to 100% of the outstanding shares of Restricted Stock or Restricted Stock Units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">With respect to
Performance Share Awards and Cash Awards, in the event of a Change in Control, all Performance Goals or other vesting criteria will be
deemed achieved at 100% of target levels and all other terms and conditions will be deemed met.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">In general, a &#8220;Change
of Control&#8221; means:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify">&#160;</td>
    <td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">A sale of all or substantially all of our assets;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our liquidation or dissolution;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">A purchase or other acquisition of 51% or more of our Common Stock</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Our merger or consolidation with or into another corporation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Other Adjustment Provisions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">If the stock of
the Company is changed by reason of a stock split, reverse stock split, stock dividend, recapitalization, combination or reclassification,
appropriate adjustments shall be made by the Administrator, in its discretion, in (1) the number and class of shares of stock subject
to the 2023 Plan and each Option and grant of Stock Awards outstanding under the 2023 Plan, and (2) the purchase price of each outstanding
Option and (if applicable) Stock Award. For example, if an Option is for 1,000 shares for $20.00 per share and there is a 2-for-1 stock
split, the Option would be adjusted to be exercisable for 2,000 shares at $10.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Amendment or Termination of the Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">The Board of Directors
may at any time amend, discontinue or terminate the 2023 Plan. With specified exceptions, no amendment, suspension or termination of
the Plan may adversely affect outstanding Options or Stock Appreciation Rights or the terms that are applicable to outstanding Stock
Awards. No amendment, suspension or termination of the Plan requires stockholder approval unless such approval is required under applicable
law or under the rules of any stock exchange on which our Common Stock is traded. Unless terminated earlier by the Board of Directors,
the 2023 Plan will terminate on the tenth anniversary of the date of the 2023 Plan&#8217;s adoption by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Federal Income Tax Consequences</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>The following
discussion is a summary of the federal income tax provisions relating to the grant and exercise of awards under the 2023 Plan and the
subsequent sale of Common Stock acquired under the 2023 Plan. The tax effect of awards may vary depending upon the circumstances, and
the income tax laws and regulations change frequently. This summary is not intended to be exhaustive and does not constitute legal or
tax advice.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>General</i>.
A recipient of an award of Options or Stock Appreciation Rights under the 2023 Plan will realize no taxable income at the time of grant
if the exercise price is not less than the fair market value of our Common Stock on the date of the grant. The recipient generally will
realize no taxable income at the time of a grant of a Stock Award so long as the Stock Award is not vested (that is, remains subject
to forfeiture and is not transferable) and an election under Section 83(b) of the Internal Revenue Code is not made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>Non-Qualified
Options. </i>The holder of a Non-Qualified Option will recognize ordinary income at the time of the Non-Qualified Option exercise in
an amount equal to the excess of the fair market value of the shares on the date of exercise over the exercise price. This taxable income
will be subject to payroll tax withholding if the holder is an employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">When a holder disposes
of shares acquired upon the exercise of a Non-Qualified Option, any amount received in excess of the fair market value of the shares
on the date of exercise will be treated as long-term or short-term capital gain, depending upon the holding period of the shares, and
if the amount received is less than the fair market value of the shares on the date of exercise, the loss will be treated as long-term
or short-term capital loss, depending upon on the holding period of the shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>Incentive Options.
</i>The holder of an Incentive Option will not recognize taxable income upon exercise of the Incentive Option. In order to retain this
tax benefit, the holder must make no disposition of the shares so received for at least one year from the date of exercise and for at
least two years from the date of grant of the Incentive Option. The holder&#8217;s compliance with the holding period requirement and
other applicable tax provisions will result in the realization of long-term capital gain or loss when he or she disposes of the shares,
measured by the difference between the exercise price and the amount received for the shares at the time of disposition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">If a holder disposes
of shares acquired by exercise of an Incentive Option before the expiration of the required holding period, the gain, if any, arising
from such disqualifying disposition will be taxable as ordinary income in the year of disposition to the extent of the lesser of (1)
the excess of the fair market value of the shares over the exercise price on the date the Incentive Option was exercised or (2) the excess
of the amount realized over the exercise price upon such disposition. Any amount realized in excess of the fair market value on the date
of exercise is treated as long-term or short-term capital gain, depending upon the holding period of the shares. If the amount realized
upon such disposition is less than the exercise price, the loss will be treated as long-term or short-term capital loss, depending upon
the holding period of the shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">For purposes of
the alternative minimum tax, the holder will recognize as an addition to his or her tax base, upon the exercise of an Incentive Option,
an amount equal to the excess of the fair market value of the shares at the time of exercise over the exercise price. If the holder makes
a disqualifying disposition in the year of exercise, the holder will recognize taxable income for purposes of the regular income tax
and the holder&#8217;s alternative minimum tax base will not be additionally increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>Stock Appreciation
Rights. </i>The holder of a Stock Appreciation Right will recognize ordinary income at the time that it is exercised in an amount equal
to the excess of the fair market value of the number of shares of Common Stock as to which it is exercised on the date of exercise over
their value at the date of grant. This taxable income will be subject to payroll tax withholding if the holder is an employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>Stock Awards.
</i>The recipient of a Stock Award will recognize ordinary income when the stock vests in an amount equal to the excess of the fair market
value of the shares at the time of vesting over the purchase price for the shares, if any, subject to payroll tax withholding if the
holder is an employee. When the recipient sells a Stock Award that has vested, any amount received in excess of the fair market value
of the shares on the date of vesting will be treated as long-term or short-term capital gain, depending upon the holding period of the
shares (after vesting has occurred), and if the amount received is less than the fair market value on the date of vesting, the loss will
be treated as long-term or short-term capital loss, depending on the holding period of the shares. Dividends paid on Stock Awards that
have not vested and that have not been the subject of an election under Section 83(b) of the Internal Revenue Code are treated as compensation
income, subject to payroll tax withholding with respect to an employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in">Section 83(b) of
the Internal Revenue Code permits the recipient to elect, not more than thirty days after the date of receipt of a Stock Award, to include
as ordinary income the difference between the fair market value of the Stock Award on the date of grant and its purchase price (rather
than being taxed as the shares vest). If such an election is made, the holding period for long-term capital gain or loss treatment will
commence on the day following the receipt of the Stock Award, dividends on the Stock Award will be treated as such and not as compensation,
and the tax basis of the shares will be their fair market value at the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>



<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deduction
for the Company. </i>The Company will be entitled to a deduction for federal income tax purposes at the same time and in the same amount
as the recipient of an award is considered to have realized ordinary income as a result of the award, assuming that the limitation under
Section 162(m) of the Internal Revenue Code is not applicable. Assuming that the holder of shares received on exercise of an Incentive
Option disposes of the shares after compliance with the holding period requirement described above, the Company will not be entitled
to a federal income tax deduction since the holder will not have realized any ordinary income in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Tax Cuts and Jobs Act of 2017 (&#8220;TCJA&#8221;), Section 162(m) of the Internal Revenue Code generally disallowed a tax deduction
to publicly held companies for compensation paid to certain executive officers in excess of $1 million per officer in any year that did
not qualify as performance-based. Under the TCJA, the performance-based exception has been repealed and the $1 million deduction limit
now applies to anyone serving as the chief executive officer or the chief financial officer at any time during the taxable year and the
top three other highest compensated executive officers serving at any fiscal year-end.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Subject to the 2023 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 31, 2024, there were no shares previously issued or subject to outstanding awards under the 2023 Plan. All 7,000,000
shares are available for future issuance under the 2023 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
Plan Benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than with respect to certain future awards that may be made to our directors as described in &#8220;<i>Director Compensation</i>&#8221;
and the award to Mr. Brunsberg described in Note 7 to the Summary Compensation Table<i>, </i>the amount and timing of awards under the
2023 Plan to executive officers, other employees and directors are not determinable at this time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2013
Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Plan
Purpose</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors adopted the 2013 Plan, which terminated on March 15, 2023, to (1) encourage selected employees, officers, directors,
consultants and advisers to improve our operations and increase our profitability, (2) encourage selected employees, officers, directors,
consultants and advisers to accept or continue employment or association with us, and (3) increase the interest of selected employees,
officers, directors, consultants and advisers in our welfare through participation in the growth in value of our common stock. All of
our current employees, officers, directors and consultants were eligible to participate in the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan is administered by the Board or by a committee to which administration of the Plan, or of part of thereof, is delegated by
the Board. The 2013 Plan is currently administered by our Compensation Committee, which we refer to below as the &#8220;Administrator.&#8221;
The Administrator is responsible for selecting the officers, employees, directors, consultants and advisers who will receive Options,
Stock Appreciation Rights and Stock Awards. Subject to the requirements imposed by the 2013 Plan, the Administrator is also responsible
for determining the terms and conditions of each Option and Stock Appreciation Right award, including the number of shares subject to
the Option, the exercise price, expiration date and vesting period of the Option and whether the option is an Incentive Option or a Non-Qualified
Option. Subject to the requirements imposed by the 2013 Plan, the Administrator is also responsible for determining the terms and conditions
of each Stock Award, including the number of shares granted, the purchase price (if any), and the vesting, transfer and other restrictions
imposed on the stock. The Administrator has the power, authority and discretion to make all other determinations deemed necessary or
advisable for the administration of the 2013 Plan or of any award under the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2013 Plan is not subject to the Employee Retirement Income Security Act of 1974 and is not a qualified pension, profit sharing or bonus
plan under Section 401(a) of the Internal Revenue Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Subject to the 2013 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 31, 2024, there were 78,877 shares previously issued or subject to outstanding awards under the 2013 Plan. The
plan expired on March 15, 2023 and therefore there are no shares available for future issuance under the 2013 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vesting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option, Stock Appreciation Right or Stock Award will become exercisable or non-forfeitable (that is, &#8220;vest&#8221;) under conditions
specified by the Administrator at the time of grant. Vesting typically is based upon continued service as a director or employee but
may be based upon any performance criteria and other contingencies that are determined by the Administrator. Shares subject to Stock
Awards may be subject to specified restrictions concerning transferability, repurchase by the Company and forfeiture of the shares issued,
together with such other restrictions as may be determined by the Administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration
Date</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or Stock Appreciation Right must be exercised by a date specified in the award agreement, which may not be more than ten years
after the grant date. Except as otherwise provided in the relevant agreement, an Option or Stock Appreciation Right ceases to be exercisable
ninety days after the termination of the holder&#8217;s service with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfers
of Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, Options are not transferable except by will or the laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Purchase
Price Payment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise determined by the Administrator, the purchase price of common stock acquired under the 2013 Plan is payable by cash or check
at the time of an Option exercise or acquisition of a Stock Award. The Company does not charge participants any fees or commissions in
connection with their acquisition of common stock under the 2013 Plan. The Administrator also has discretion to accept the following
types of payment from participants:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    secured or unsecured promissory note, provided that this method of payment is not available to a participant who is a director or
    an executive officer;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
    of our Common Stock already owned by the Option or Stock Award holder as long as the surrendered shares have a fair market value
    that is equal to the acquired stock and have been owned by the participant for at least six months;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    surrender of shares of Common Stock then issuable upon exercise of an Option; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    &#8220;cashless&#8221; option exercise in accordance with applicable regulations of the SEC and the Federal Reserve Board.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Withholding
Taxes</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the time of his or her exercise of an Option or Stock Appreciation Right, an employee is responsible for paying all applicable federal
and state withholding taxes. A holder of Stock Awards is responsible for paying all applicable federal and state withholding taxes once
the shares covered by the award cease to be forfeitable or at any other time required by applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Law Compliance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of common stock will not be issued pursuant to the exercise of an Option or the receipt of a Stock Award unless the Administrator determines
that the exercise of the Option or receipt of the Stock Award and the issuance and delivery of such shares will comply with all relevant
provisions of law, including, without limitation, the Securities Act, applicable state and
foreign securities laws and the requirements of any stock exchange on which our common stock is traded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effects
of Certain Corporate Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise determined by the Administrator, in the event of a &#8220;corporate transaction,&#8221; all previously unexercised Options
and Stock Appreciation Rights will terminate immediately prior to the consummation of the corporate transaction and all unvested Restricted
Stock awards will be forfeited immediately prior to the consummation of the corporate transaction. The Administrator, in its discretion,
may permit exercise of any Options or Stock Appreciation Rights prior to their termination, even if those awards would not otherwise
have been exercisable, or provide that outstanding awards will be assumed or an equivalent Option or Stock Appreciation Right substituted
by a successor corporation. The Administrator, in its discretion, may remove any restrictions as to any Restricted Stock awards or provide
that all outstanding Restricted Stock awards will participate in the corporate transaction with an equivalent stock substituted by the
successor corporation subject to the restrictions. In general, a &#8220;corporate transaction&#8221; means:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    liquidation or dissolution;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    merger or consolidation with or into another corporation as a result of which we are not the surviving corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    sale of all or substantially all of our assets; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    purchase or other acquisition of more than 50% of our outstanding stock by one person, or by more than one person acting in concert.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Adjustment Provisions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the stock of the Company is changed by reason of a stock split, reverse stock split, stock dividend, recapitalization, combination or
reclassification, appropriate adjustments shall be made by the Administrator, in its discretion, in (1) the number and class of shares
of stock subject to the 2013 Plan and each Option and grant of Stock Awards outstanding under the 2013 Plan, and (2) the purchase price
of each outstanding Option and (if applicable) Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
of the Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2013 Plan terminated automatically on March 15, 2023, which was the tenth anniversary of the date of the 2013
Plan&#8217;s adoption by our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020
Stock Appreciation Rights Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2020, our Board of Directors adopted the Sigma Labs, Inc. 2020 Stock Appreciation Rights Plan (the &#8220;Plan&#8221;). The
purposes of the Plan are to: (i) enable the Company to attract and retain the types of employees, consultants, and directors (collectively,
&#8220;Service Providers&#8221;) who will contribute to the Company&#8217;s long-range success; (ii) provide incentives that align the
interests of Service Providers with those of the stockholders of the Company; and (iii) promote the success of the Company&#8217;s business.
The Plan only provides for incentive awards that are only made in the form of stock appreciation rights payable in cash (&#8220;SARs&#8221;).
No shares of common stock were reserved in connection with the adoption of the Plan since no shares will be issued pursuant to the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Administration</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan will be administered by the Compensation Committee of the Board or, in the Board&#8217;s sole discretion, by the Board. The Compensation
Committee will have the authority to, among other things, (i) construe and interpret the Plan and apply its provisions; (ii) promulgate,
amend, and rescind rules and regulations relating to the administration of the Plan; (iii) delegate its authority to one or more persons
who is an officer of the Company within the meaning of Section 16 of the Exchange Act, and the rules and regulations promulgated thereunder
with respect to SARs that do not involve &#8220;insiders&#8221; within the meaning of Section 16 of the Exchange Act; (iv) determine
when SARs are to be granted under the Plan and the applicable grant date; (v) prescribe the terms and conditions of each SAR, including,
without limitation, the exercise price and medium of payment and vesting provisions, and to specify the provisions of the SAR Agreement
relating to such grant; (vi) amend any outstanding SARs, subject, in certain cases, to the participant&#8217;s consent; and (vii) make
all other determinations which may be necessary or advisable for the administration of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Eligible
Participants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted only to persons who are Service Providers, and those persons whom the Committee determines are reasonably expected to
become Service Providers following the grant date. The Committee may from time to time designate those Service Providers, if any, to
be granted SARs under the Plan, the number of SARs which will be granted to each such person, and any other terms or conditions relating
to SARs as it may deem appropriate to the extent consistent with the provisions of the Plan. A participant who has been granted a SAR
may, if otherwise eligible, be granted additional incentive awards at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Grant</i>.
The Committee may grant SARs to any Service Provider. An SAR is the right to receive an amount equal to the Spread with respect to a
share of the Company&#8217;s common stock upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference between the exercise
price per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the
SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>General
Provisions</i>. The terms and conditions of each SAR will be evidenced by a SAR agreement. The exercise price per share will not be less
than 100% of the fair market value of a Share on the date of grant of the SAR. The term of the SAR will be determined by the Committee
but may not be greater than ten years from the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise</i>.
SARs are exercisable subject to such terms and conditions as the Committee may specify in the SAR agreement for the SAR. A SAR may be
exercised by the delivery of a signed written notice of exercise to the Company, which must be received and accepted by the Company as
of a date set by the Company in advance of the effective date of the proposed exercise. The notice must set forth the number of SARs
being exercised, together with any additional documents the Company may require.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Settlement</i>.
Upon exercise of a SAR, the Grantee will receive an amount equal to the Spread. The Spread, less applicable withholdings, will be payable
only in cash. In no event may any SAR be settled in any manner other than by delivery of a cash payment from the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Form
of SAR Agreement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
participant to whom a SAR is granted will be required to enter into a SAR agreement with the Company, in such a form as is provided by
the Committee. The SAR agreement will contain specific terms as determined by the Committee, in its discretion, with respect to the participant&#8217;s
particular SAR. Such terms need not be uniform among all participants or any similarly situated participants. The SAR agreement may include,
without limitation, vesting, forfeiture and other provisions particular to the particular participant&#8217;s SAR, as well as, for example,
provisions to the effect that the participant must abide by all the terms and conditions of the Plan and such other terms and conditions
as may be imposed by the Committee. A SAR will include such terms and conditions as are determined by the Committee, in its discretion,
to be appropriate with respect to any participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may specify in a SAR agreement that the participant&#8217;s rights, payments, and benefits with respect to a SAR will be subject
to forfeiture upon the occurrence of certain specified events, in addition to any otherwise applicable vesting or performance conditions
of the incentive award. Such events may include, but are not limited to, termination with cause or other conduct by the participant that
is detrimental to the business or reputation of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
of Employment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, if the participant&#8217;s employment is terminated for any reason
other than due to cause, death or disability, any non-vested portion of any outstanding SAR at the time of such termination will automatically
expire and terminate and no further vesting will occur after the termination date. In such event, except as otherwise expressly provided
in the SAR agreement, the participant will be entitled to exercise such participant&#8217;s rights only with respect to the portion of
the SAR that was vested as of the termination date for a period that will end on the earlier of (i) the expiration date set forth in
the SAR agreement or (ii) ninety days after the date of termination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Termination
for Cause</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, in the event of the termination of a participant&#8217;s employment
for cause, all vested and non-vested SARs granted to such participant will immediately expire and will not be exercisable to any extent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Disability
or Death</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise expressly provided in the participant&#8217;s SAR agreement, upon termination of employment as a result of the participant&#8217;s
disability or death, (i) any non-vested portion of any outstanding SAR will immediately terminate upon termination and no further vesting
will occur, and (ii) any vested SAR will expire on the earlier of either (A) the expiration date set forth in the SAR agreement or (B)
12 months following the participant&#8217;s termination of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Continuation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the conditions and limitations of the Plan and applicable law, in the event that a participant ceases to be an employee, outside director
or consultant, as applicable, for whatever reason, the Committee and participant may mutually agree with respect to any outstanding SAR
then held by the participant (i) for an acceleration or other adjustment in any vesting schedule applicable to the SAR award; (ii) for
a continuation of the exercise period following termination for a longer period than is otherwise provided under such SAR; or (iii) to
any other change in the terms and conditions of the SAR. In the event of any such change to an outstanding SAR, a written amendment to
the participant&#8217;s SAR agreement will be required. No amendment to a participant&#8217;s SAR will be made to the extent compensation
payable pursuant thereto as a result of such amendment would be considered deferred compensation that is not excepted from taxation or
penalties under Code Section 409A, unless otherwise determined by the Committee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
granted under the Plan are not transferable other than to a designated beneficiary upon the Participant&#8217;s death or by will or the
laws of descent and distribution.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Change
in Control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise provided in a SAR Agreement, notwithstanding any contrary provision in the Plan, in the event of a Change in Control (as defined
in the Plan), all outstanding SARs will become 100% vested and immediately exercisable. The closing of the Acquisition will not result
in an immediate Change in Control under the Plan. Depending on the achievement of future milestones under the Exchange Agreement and
other changes in the outstanding shares of our common stock, the issuance of the Contingent Shares might constitute a Change in Control
at that time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amendment</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board at any time, and from time to time, may amend or terminate the Plan. The Committee at any time, and from time to time, may amend
the terms of any one or more SAR agreements, except that the Committee may not affect any amendment which would otherwise constitute
an impairment of the rights under any SAR unless the participant consents in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of August 31, 2024, there were 40,223 SARs outstanding under the 2020 Plan, giving effect the 1-for-20 reverse stock split effected
on September 22, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that a combination of cash and equity compensation is appropriate to attract and retain the individuals we desire to serve on
our Board of Directors. Our cash compensation policies are designed to encourage frequent and active interaction between directors and
our executives both during and between formal meetings as well as compensate our directors for their time and effort. Further, we believe
it is important to align the long-term interests of our non-employee directors (i.e., directors who are not employed by us as officers
or employees) with those of the Company and its stockholders, and that awarding equity compensation to, and thereby increasing ownership
of our common stock by, our non-employee directors is an appropriate means to achieve this alignment. Directors who are also employees
of our company do not receive compensation for their service on our Board of Directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our director compensation program for fiscal year 2024, each non-employee director received annual compensation of $25,000,
and an option to purchase 655 shares of our common stock, which is fully vested. All cash fees are paid quarterly. Also, each
non-employee director may be reimbursed for his reasonable expenses incurred in the performance of his duties as a director as our Board
of Directors determines from time to time. Our Compensation Committee intends to evaluate our director compensation program and determine
whether any changes should be recommended to the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information concerning the compensation paid to non-employee directors in fiscal year 2024
for their services as directors of the Company. The compensation of Mr. Brunsberg, who serves as a director and our former President
and Chief Executive Officer, is described in the Summary Compensation Table of Executive Officers. Our non-employee directors do not
receive fringe or other benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fees Earned or<br/>
 Paid in Cash ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    <br/> Awards ($)<sup>(6)(7)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total ($)</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark K. Ruport<sup>(1)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">25,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">5,797</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right">30,797</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco <sup>(2)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,797</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch<sup>(4)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,797</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent Summers<sup>(5)</sup></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,797</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,797</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fees shown were
    paid to Mr. Ruport for services as director. On January 26, 2023, the Company granted Mr. Ruport an option to purchase up to 655
    shares of the Company&#8217;s common stock in connection with his service as a director. The exercise price of the option is equal
    to $11.60 per share, is fully vested, and had a grant date fair value of $5,797. Mr. Ruport resigned as chairman on December 29,
    2023, pursuant to the Share Exchange agreement between NextTrip and Sigma Additive Solutions, Inc. </span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Monaco was appointed
    chairman as of December 29, 2023 pursuant to the Share Exchange agreement between NextTrip and Sigma Additive Solutions, Inc., and
    did not receive any compensation for his services in fiscal year 2024.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fees shown were
    paid to Mr. Battinelli for services as a director. On January 26, 2023, the Company granted Mr. Battinelli an option to purchase
    up to 655 shares of the Company&#8217;s common stock in connection with his service as a director. The exercise price of the option
    is equal to $11.60 per share, is fully vested, and had a grant date fair value of $5,797.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fees shown were
    paid to Mr. Duitch for services as a director. On January 26, 2023, the Company granted Mr. Duitch an option to purchase up to 555
    shares of the Company&#8217;s common stock in connection with his service as a director. The exercise price of the option is equal
    to $11.60 per share, is fully vested, and had a grant date fair value of $5,797.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fees shown were
    paid to Mr. Summers for services as a director. On January 26, 2023, the Company granted Mr. Summers an option to purchase up to
    655 shares of the Company&#8217;s common stock in connection with his service as a director. The exercise price of the option is
    equal to $11.60 per share, is fully vested, and had a grant date fair value of $5,797.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These columns represent
    the aggregate grant date fair value of stock awards and stock options computed in accordance with FASB ASC Topic 718. These amounts
    do not correspond to the actual value that will be recognized by the named directors from these awards.</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">(7)</td>
    <td style="text-align: justify">As of February 29, 2024, all <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding
    vested Option Awards granted to directors were subject to an exercisability waiver until such time as we received shareholder approval
    to increase our authorized common shares from 1,200,000 to 250,000,000 shares. Such approval was obtained at a special meeting of
    stockholders on March 8, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_018"></span>CERTAIN
RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as described below in this section, since the beginning of our last fiscal year, there has not been, nor is there currently proposed,
any transaction or series of similar transactions to which we were a party other than equity and other compensation, termination, change
in control and other arrangements, which are described under &#8220;<i>Executive Compensation</i>&#8221; and &#8220;<i>Director Compensation</i>&#8221;
above:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    which the amount involved exceeds the lesser of $120,000 or 1% of the average of our total assets at year-end for the last two completed
    fiscal years; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    which any director, executive officer, or other stockholder of more than 5% of our common stock or any member of their immediate
    family had or will have a direct or indirect material interest.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Related
Party Loans to Company</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 29, 2024, NextTrip Holdings, Inc., a wholly owned subsidiary of the Company, issued an unsecured promissory note, in the principal
amount of $391,776.54 (the &#8220;Promissory Note&#8221;), to William Kerby, to memorialize the terms and conditions of certain working
capital advances made by Mr. Kerby to NextTrip. The Promissory Note accrues interest at a rate equal to 7.5% simple interest per annum,
and will automatically mature and become due and payable in full on February 28, 2025, subject to certain limited exceptions. The Promissory
Note, or any portion thereof, may be prepaid by NextTrip Holdings, Inc. without any penalty. Mr. Kerby serves as Chief Executive
Officer of both the Company and NextTrip. The Promissory Note was approved by the Company&#8217;s Board of Directors, including all independent
members thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white">On March 18, 2024, the Company&#8217;s wholly-owned
subsidiary, NextTrip, entered into an unsecured promissory note for a line of credit with Donald Monaco and William Kerby, the Company&#8217;s
Chairman of the board of directors and Chief Executive Officer, respectively, for the aggregate principal amount of $500,000 with an
initial advance of $125,000, provided that the aggregate principal amount of the note does not exceed $500,000 at any time. Under the
terms of the note, advances under the line of credit may be made at the Company&#8217;s request until August 31, 2024. The note bears
an annual interest rate of 7.5% and matures on February 28, 2025, and may be prepaid by the Company at any time prior to maturity without
penalty. As of September 26, 2024, the full principal amount of the note had been advanced to the Company. The Promissory Note was approved
by the Company&#8217;s Board of Directors, including the independent members thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white">On
April 23, 2024, the Company&#8217;s board of directors approved the Company&#8217;s wholly-owned subsidiary, NextTrip, to enter into
a series of unsecured promissory notes with certain related parties, including investors, directors, officers and employees, who may
individually provide funds for the aggregate principal amount of $1,000,000. The notes bear an annual interest rate of 7.5% and shall
mature one year from the date of each note&#8217;s execution, and may be prepaid by the Company at any time prior to maturity without
penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the board of directors, the directors unanimously approved
an increase in the principal amount of the related party line of credit to $2,000,000 on the same terms and conditions as previously
approved. As of October 29, 2024, the total principal amount advanced under the line of credit was $1,451,833.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white">On May 21, 2024, NextTrip issued an unsecured promissory note, in the principal amount of $455,000 (the &#8220;Promissory
Note&#8221;), to Mr. Monaco to memorialize the terms and conditions of certain working capital advances made by Mr. Monaco to NextTrip.
As of September 26, 2024, the outstanding principal balance of the Line of Credit Promissory Note was $405,000. The Promissory Note accrues
interest at a rate equal to 7.5% simple interest per annum, and will automatically mature and become due and payable in full on February
28, 2025, subject to certain limited exceptions. The Promissory Note, or any portion thereof, may be prepaid by NextTrip without any
penalty. The Promissory Note was approved by the Company&#8217;s Board of Directors, including the independent members thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnification agreements with each of our directors and executive officers. These agreements, among other things,
require us to indemnify each director and executive officer to the fullest extent permitted by Nevada law, including indemnification
of expenses such as attorneys&#8217; fees, judgments, fines and settlement amounts incurred by the director or executive officer in any
action or proceeding, including any action or proceeding by or in the right of us, arising out of the person&#8217;s services as a director
or executive officer, including in connection with the Acquisition and related matters.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Policies
and Procedures for Related Person Transactions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Audit Committee is responsible for reviewing and approving, as appropriate, all transactions with related persons (other than compensation-related
matters, which should be reviewed by our Compensation Committee), in accordance with its Charter and the Nasdaq marketplace rules. In
reviewing and approving any such transactions, our Audit Committee is tasked to consider all relevant facts and circumstances, including,
but not limited to, whether the transaction is on terms comparable to those that could be obtained in an arm&#8217;s length transaction
and the extent of the related person&#8217;s interest in the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_019"></span>PRINCIPAL
STOCKHOLDERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables set forth certain information regarding beneficial ownership of our common stock, Series H Preferred and Series I Preferred
as of October 29, 2024 (a) by each person known by us to own beneficially 5% or more of the outstanding shares of each class of
the outstanding securities, (b) by our named executive officers and each of our directors (and director nominees) and (c) by all executive
officers and directors of the Company as a group.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
number of shares beneficially owned by each stockholder is determined in accordance with SEC rules. Under these rules, beneficial ownership
includes any shares as to which a person has sole or shared voting power or investment power. At the close of business on October
29, 2024, there were 1,429,492 shares of Company common stock outstanding, 33,000 shares of Series H Preferred outstanding,
and 126,204 shares of Series I Preferred outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the foregoing, as of October 29, 2024 there were 316 shares of the Company&#8217;s Series E Preferred Stock (&#8220;Series
E Preferred&#8221;) outstanding, which, including accrued dividends thereon, were convertible into an aggregate of 3,293 shares
of Company common stock. The Series E Preferred do not have any voting rights and therefore are not included in a separate table below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, shares of
common stock subject to stock options, warrants, convertible preferred stock or other rights held by such person that are currently convertible
or exercisable or will become convertible or exercisable within 60 days of October 29, 2024 are considered outstanding, although
these shares are not considered outstanding for purposes of computing the percentage ownership of any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe, based on information provided to us, that each of the stockholders listed below has sole voting and investment power with respect
to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of Shares<br/>
 Beneficially Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Named Executive Officers and Directors:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William Kerby<sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">50,011</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">3.5</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank Orzechowski<sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">11,093</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald P. Monaco<sup>(4)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">41,745</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob Brunsberg<sup>(5)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">17,302</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.2</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore Battinelli<sup>(6)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,067</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis Duitch<sup>(7)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,767</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent J. Summers<sup>(8)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,730</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All executive officers and directors as a group (7 persons)<sup>(9)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">137,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif">5% Stockholders:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promethean TV, Inc. <sup>(10)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">David Jiang</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">134,043</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9.4</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Less
than 1%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 1,429,492 shares outstanding at October 29, 2024.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,386 shares held by Travel and Media Tech, LLC (&#8220;TMT&#8221;). Mr. Kerby is a 50% member of TMT, and is deemed to beneficially
    own the shares held by TMT. Mr. Kerby disclaims beneficial ownership of all securities held by TMT in excess of his pecuniary interest,
    if any.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    11,045 shares issuable upon the exercise of stock options.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 1,733 shares held by Monaco Investment Partners, LP (&#8220;MIP&#8221;); (ii) 28,626 shares held by the Donald P. Monaco Insurance
    Trust (the &#8220;Trust&#8221;); and (iii) 11,386 shares held by TMT. Mr. Monaco is the managing general partner of MI Partners,
    is the trustee of the Trust and is a 50% member of TMT, and as such is deemed to beneficially own the securities held by the MI Partners,
    Trust and TMT, respectively. Mr. Monaco disclaims beneficial ownership of all securities held by MIP, the Trust and TMT in excess
    of his pecuniary interest, if any.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    17,207 shares issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 5,105 shares issuable upon the exercise of stock options, (ii) 173 shares issuable upon the conversion of shares of the
    Company&#8217;s Series E Preferred Stock, and (iii) 122 shares issuable upon exercise of Class A Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    5,105 shares issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    5,105 shares issuable upon the exercise of stock options.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    (i) 43,567 shares issuable upon the exercise of stock options, (ii) 173 shares issuable upon the conversion of the
    shares of the Company&#8217;s Series E Preferred Stock, and (iii) 122 shares issuable upon exercise of Class A Warrants.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Ian Sharpe is the control party of Promethean TV, Inc., and as such is deemed to beneficially own the securities held by Promethean
    TV, Inc. Mr. Sharpe disclaims beneficial ownership of all securities held by Promethean TV, Inc. in excess of his pecuniary interest,
    if any.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
H Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series H Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of Shares<br/>
 Beneficially Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Procopio
    Cory Hargreaves &amp; Savitch LLP <br/>c/o NextTrip, Inc.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">33,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">100.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 33,000 shares of Series H Preferred outstanding at October 29, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Series
I Preferred</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of the Company&#8217;s officers or directors beneficially own any shares of the outstanding shares of Series I Preferred, and therefore
have been excluded from the following table.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Beneficial Owner<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares<br/>
 Beneficially Owned</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage of Shares<br/>
 Beneficially Owned<sup>(1)</sup></b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">5% Beneficial Owners:</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: justify">David Jiang <br/><i>c/o NextTrip, Inc.</i></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">96,403</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">100</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on 96,403 shares of Series I Preferred outstanding at October 29, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_020"></span>DESCRIPTION
OF CAPITAL STOCK</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><i>The following summary
of certain material provisions of our common stock and preferred stock does not purport to be complete. You should refer to our articles
of incorporation and bylaws, which are included as exhibits to the registration statement on Form S-1 of which this prospectus is a part
for additional information about our common stock and preferred stock.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently authorized to issue 250,000,000 shares of common stock, $0.001 par value per share, of which 1,429,492 shares were
outstanding as of October 29, 2024. We are currently authorized to issue 10,000,000 shares of preferred stock, $0.001 par value
per share, of which 159,520 shares are outstanding, including 316 shares of our Series E Convertible Preferred Stock, 33,000 shares
of our Series H Convertible Preferred Stock and 126,204 shares of our Series I Convertible Preferred Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and per share data included in this &#8220;Description
of Capital Stock&#8221; has, where applicable, been retrospectively adjusted to reflect the 1-for-20 reverse stock split of our common
stock, which was effected on September 22, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have one class of common stock. Holders of our common stock are entitled to one vote per share on all matters to be voted upon by stockholders
and do not have cumulative voting rights in the election of directors. Holders of shares of common stock are entitled to receive on a
pro rata basis such dividends, if any, as may be declared from time to time by our board of directors in its discretion from funds legally
available for that use, subject to any preferential dividend rights of outstanding preferred stock. They are also entitled to share on
a pro rata basis in any distribution to our common stockholders upon our liquidation, dissolution or winding up, subject to the prior
rights of any outstanding preferred stock. Common stockholders do not have preemptive rights to subscribe to any additional stock issuances
by us, and they do not have the right to require the redemption of their shares or the conversion of their shares into any other class
of our stock. The rights, preferences and privileges of holders of common stock are subject to, and may be adversely affected by, the
rights of the holders of any series of preferred stock that we may designate and issue in the future.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our articles of incorporation, our board of directors has the authority, without further action by stockholders, to designate one or
more series of preferred stock and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights
granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption,
liquidation preference and sinking fund terms, any or all of which may be preferential to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will not issue any shares of preferred stock as part of this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, we had 159,520 shares of preferred stock outstanding, including 316 shares of our Series E Convertible
Preferred Stock, 33,000 shares of our Series H Convertible Preferred Stock and 126,204 shares of our Series I Convertible Preferred
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $1,500
per share (the &#8220;Stated Value&#8221;). Dividends at the initial rate of 9% per annum will accrue and, on a monthly basis, shall
be payable in kind by the increase of the Stated Value of the Series E Preferred Stock by said amount. The holders of the Series E Preferred
Shares have the right at any time to convert all or a portion of the Preferred Shares (including, without limitation, accrued and unpaid
dividends and make-whole dividends through the third anniversary of the closing date) into shares of the Company&#8217;s Common Stock
at an initial conversion rate determined by dividing the Conversion Amount by the Conversion Price ($0.13 above the consolidated closing
bid price for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the
Stated Value of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E
Preferred Shares being converted plus the &#8220;Make Whole Amount&#8221; (the amount of any dividends that, but for the conversion,
would have accrued at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate
is also subject to adjustment for stock splits, dividends recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating 150,000 shares of the Company&#8217;s preferred
stock as Series H Preferred Stock, par value $0.001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: -1in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking. </i>The
Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: -1in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends. </i>Holders
of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any, on shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; text-indent: -1in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Series I Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating 331,124 shares of the Company&#8217;s preferred
stock as Series I Convertible Preferred Stock, par value $0.001 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking. </i>The
Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends. </i>Holders
of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any, on shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, we had outstanding options under our 2013 Equity Incentive Plan to purchase an aggregate of 76,377
shares of our common stock at a weighted-average exercise price of $57.76 per share, and outstanding inducement options to
purchase an aggregate of 2,500 shares of our common stock at an exercise price of $225.00 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 27, 2023, our stockholders approved our 2023 Equity Incentive Plan which has reserved for issuance 7,000,000 shares of common
stock for equity awards of which 0 shares have been issued or granted thereunder to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 29, 2024, we had outstanding warrants to purchase an aggregate of 580,837 shares of our common stock at a weighted-average
exercise price of $7.67 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Certain of our outstanding warrants contain so-called full-ratchet anti-dilution adjustments
in the event we sell or issue shares of common stock or common stock equivalents at an effective price less than the exercise price of
such warrants, subject to certain exceptions. Of these warrants, warrants with an aggregate exercise price of $956,015 also provide for
a ratable increase in the number of shares purchasable upon exercise of the warrants in the event the exercise price per share of the
warrants is reduced. The anti-dilution adjustments of our outstanding warrants would be triggered by future issuances of shares of our
common stock at a price per share below the then-exercise price of such warrants, which adjustments would have a further dilutive effect
on our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Anti-Takeover
Effects of Our Articles of Incorporation and Bylaws</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of our articles of incorporation and bylaws contain provisions that could have the effect of delaying or discouraging another
party from acquiring control of us. These provisions, which are summarized below, are designed to discourage certain types of takeover
proposals that are considered coercive or inadequate. These provisions are also intended to encourage anyone seeking to acquire control
of us to first negotiate with our board of directors. We believe that protecting our ability to negotiate with any unsolicited and potentially
unfriendly acquirer outweigh the disadvantages of discouraging such proposals, including those that may be priced at a premium above
the market price of our common stock, because, among other reasons, we may be able to improve the terms of any such proposals by negotiation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
articles of incorporation and bylaws include the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; a
classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of
a majority of our board of directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; no
cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or
the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the terms of those shares,
including preferences and voting rights, without stockholder approval, which could adversely affect the rights of our common stockholders
or be used to deter a possible acquisition of our company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
ability of our board of directors to alter our bylaws without obtaining stockholder approval;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt, amend or
repeal our bylaws or repeal the provisions of our articles of incorporation and bylaws regarding the election and removal of directors;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; a
prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of
our stockholders;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; the
requirement that a special meeting of stockholders may be called only by the chairman of the board of directors, the chief executive
officer, the president or the board of directors, which may delay the ability of our stockholders to force consideration of a proposal
or to take action, including the removal of directors; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; advance
notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters
to be acted upon at a stockholders&#8217; meeting, which may discourage or deter a potential acquirer from conducting a solicitation
of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
Capital Market Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is listed on The Nasdaq Capital Market under the symbol &#8220;NTRP&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transfer
Agent and Registrar</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar of our common stock is Issuer Direct Corporation. The address of our transfer agent and registrar is 1981
Murray Holladay Road, Suite 100 Salt Lake City, Utah 84117, and its telephone number is (801) 272-9294.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="MS_001"></span>DESCRIPTION
OF SECURITIES WE ARE OFFERING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are offering &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock and/or Pre-Funded
Warrants to purchase shares of our common stock. Our shares of Common Stock and/or Pre-Funded Warrants are being offered together with
Common Warrants to purchase &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shares of our common stock. We are also registering
the shares of common stock issuable from time to time upon exercise of the Pre-Funded Warrants and Common Warrants offered hereby.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
securities are being issued pursuant to an underwriting agreement between us and the underwriter. You should review the underwriting
agreement filed as an exhibit to the registration statement of which this prospectus is a part, for a complete description of the terms
and conditions applicable to this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material terms and provisions of our common stock and each other class of our securities which qualifies or limits our common stock are
described under the caption &#8220;Description of Capital Stock&#8221; in this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Funded
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following summary of certain terms and provisions of the Pre-Funded Warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the Pre-Funded Warrants, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
Pre-Funded Warrant for a complete description of the terms and conditions of the Pre-Funded Warrants.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Pre-Funded Warrant offered hereby will have an initial exercise price equal to $0.001 per share of common stock. The Pre-Funded Warrants
will be exercisable immediately, and may be exercised at any time until the Pre-Funded Warrants are exercised in full. The exercise price
and number of shares of common stock issuable upon exercise is subject to appropriate proportional adjustment in the event of share dividends,
share splits, reorganizations or similar events affecting shares of our common stock and the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants will be exercisable, at the option of each holder, in whole or in part by delivering to us a duly executed exercise
notice and within the earlier of (i) two trading days and (ii) the number of trading days comprising the standard settlement period with
respect to the shares of common stock as in effect on the date of delivery of the notice of exercise thereafter, payment in full for
the number of shares of common stock purchased upon such exercise (except in the case of a cashless exercise as discussed below). A holder
may not exercise any portion of the Pre-Funded Warrant to the extent that the holder, together with its affiliates and any other persons
acting as group together with any such persons, would own more than 4.99% (or, at the election of the purchaser, 9.99%) of the number
of shares of our common stock outstanding immediately after exercise (the &#8220;Beneficial Ownership Limitation&#8221;); provided that
a holder with Beneficial Ownership Limitation of 4.99%, upon notice to use and effective 61 days after the date such notice is delivered
to us may increase the Beneficial Ownership Limitation so long as it in no event exceeds 9.99% of the number of ordinary shares outstanding
immediately after exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Pre-Funded Warrants may also be exercised, in whole or in part, at any time by means of &#8220;cashless exercise&#8221; in which the
holder shall be entitled to receive upon such exercise (either in whole or in part) the net number of shares of common stock determined
according to a formula set forth in the Pre-Funded Warrants, which generally provides for a number of shares of common stock equal to
(A)(1) the volume weighted average price on (x) the trading day preceding the notice of exercise, if the notice of exercise is executed
and delivered on d ay that is not a trading day or prior to the opening of &#8220;regular trading hours&#8221; on a trading day or (y)
the trading day of the notice of exercise, if the notice of exercise is executed and delivered after the close of &#8220;regular trading
hours&#8221; on such trading day, or (2) the bid price on the day of the notice of exercise, if the notice of exercise is executed during
&#8220;regular trading hours&#8221; on a trading day and is delivered within two hours thereafter, less (B) the exercise price, multiplied
by (C) the number of shares of common stock the Pre-Funded Warrant was exercisable into, with such product then divided by the number
determined under clause (A) in this sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued upon the exercise of the Pre-Funded Warrants. Rather, we will, at our election, either
pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price or round
up to the next whole shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Pre-Funded Warrant may be transferred at the option of the holder upon surrender of the Pre-Funded Warrant to us
together with the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the Pre-Funded Warrants on any securities exchange or nationally recognized trading system. We do
not intend to list the Pre-Funded Warrants on any securities exchange or nationally recognized trading system. The shares of common stock
issuable upon exercise of the Pre-Funded Warrants are currently listed on The Nasdaq Capital Market under the symbol &#8220;NTRP&#8221;.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Shareholder</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Pre-Funded Warrants or by virtue of such holder&#8217;s ownership of the underlying shares of common stock,
the holders of the Pre-Funded Warrants do not have the rights or privileges of holders of shares of our common stock, including any voting
rights, until they exercise their Pre-Funded Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the Pre-Funded Warrants and generally including any reorganization, recapitalization
or reclassification of our shares of common stock, the sale, transfer or other disposition of all or substantially all of our properties
or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares of our
common stock, the holders of the Pre-Funded Warrants will be entitled to receive upon exercise of the Pre-Funded Warrants the kind and
amount of securities, cash or other property that the holders would have received had they exercised the Pre-Funded Warrants immediately
prior to such fundamental transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The
following summary of certain terms and provisions of the Common Warrants that are being offered hereby is not complete and is subject
to, and qualified in its entirety by, the provisions of the Common Warrants, the form of which is filed as an exhibit to the registration
statement of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of
Common Warrant for a complete description of the terms and conditions of the Common Warrants.</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Duration
and Exercise Price</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Common Warrant offered hereby will have an initial exercise price equal to $&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
per share. The Common Warrants will be immediately exercisable and will expire on the fifth anniversary of the initial
exercise</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">date.
The exercise price and number of shares of common stock issuable upon exercise is subject to appropriate proportional adjustment in the
event of share dividends, share splits, reorganizations or similar events affecting our shares of common stock and the exercise price.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercisability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Warrants will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice and, within the earlier of (i) two trading days and (ii) the number of trading days comprising the standard settlement period
with respect to the shares of common stock as in effect on the date of delivery of the notice of exercise thereafter, payment in full
for the number of shares of common stock purchased upon such exercise (except in the case of a cashless exercise as discussed below).
A holder may not exercise any portion of the Common Warrant to the extent that the holder, together with its affiliates and any other
persons acting as a group together with any such persons, would own more than 4.99% (or, at the election of the purchaser, 9.99%) of
the number of ordinary shares outstanding immediately after exercise; provided that a holder with a Beneficial Ownership Limitation of
4.99%, upon notice to us and effective 61 days after the date such notice is delivered to us, may increase the Beneficial Ownership Limitation
so long as it in no event exceeds 9.99% of the number of ordinary shares outstanding immediately after exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cashless
Exercise</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
at the time a holder exercises its Common Warrants, a registration statement registering the issuance of the shares of common stock underlying
the Common Warrants under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), is not then effective or available
for the issuance of such shares, then in lieu of making the cash payment otherwise contemplated to be made to us upon such exercise in
payment of the aggregate exercise price, the holder may elect instead to receive upon such exercise (either in whole or in part) the
net number of shares of common stock determined according to a formula set forth in the Common Warrants, which generally provides for
a number of shares of common stock equal to (A) (1) the volume weighted average price on (x) the trading day preceding the notice of
exercise, if the notice of exercise is executed and delivered on a day that is not a trading day or prior to the opening of &#8220;regular
trading hours&#8221; on a trading day or (y) the trading day of the notice of exercise, if the notice of exercise is executed and delivered
after the close of &#8220;regular trading hours&#8221; on such trading day, or (2) the bid price on the day of the notice of exercise,
if the notice of exercise is executed during &#8220;regular trading hours&#8221; on a trading day and is delivered within two hours thereafter,
less (B) the exercise price, multiplied by (C) the number of shares of common stock the Common Warrant was exercisable into, with such
product then divided by the number determined under clause (A) in this sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fractional
Shares</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
fractional shares of common stock will be issued upon the exercise of the Common Warrants. Rather, we will, at our election, either pay
a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price or round up
to the next whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to applicable laws, a Common Warrant may be transferred at the option of the holder upon surrender of the Common Warrant to us together
with the appropriate instruments of transfer and funds sufficient to pay any transfer taxes payable upon such transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Trading
Market</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no trading market available for the Common Warrants on any securities exchange or nationally recognized trading system. We do not
intend to list the Common Warrants on any securities exchange or nationally recognized trading system. The shares of Common Stock issuable
upon exercise of the Common Warrants are currently listed on The Nasdaq Capital Market under the symbol &#8220;NTRP.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Rights
as a Shareholder</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise provided in the Common Warrants or by virtue of such holder&#8217;s ownership of the underlying shares of common stock,
the holders of the Common Warrants do not have the rights or privileges of holders of shares of our common Stock, including any voting
rights, until they exercise their Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fundamental
Transaction</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a fundamental transaction, as described in the Common Warrants and generally including any reorganization, recapitalization
or reclassification of shares of our common stock, the sale, transfer or other disposition of all or substantially all of our properties
or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares of our
common stock, the holders of the Common Warrants will be entitled to receive upon exercise of the Common Warrants the kind and amount
of securities, cash or other property that the holders would have received had they exercised the Common Warrants immediately prior to
such fundamental transaction. Additionally, in the event of a fundamental transaction, we or any successor entity will, at the option
of the holder of a Common Warrant exercisable at any time concurrently with or within 30 days after the consummation of the fundamental
transaction (or, if later, the date of the public announcement thereof), purchase the Common Warrant from the holder by paying to the
holder an amount of consideration equal to the value of the remaining unexercised portion of such Common Warrant on the date of consummation
of the fundamental transaction based on the Black-Scholes option pricing model, determined pursuant to a formula set forth in the Common
Warrants. The consideration paid to the holder will be the same type or form of consideration that was offered and paid to the holders
of ordinary shares in connection with the fundamental transaction; provided that if no such consideration was offered or paid, the holders
of ordinary shares will be deemed to have received ordinary shares of the successor entity in such fundamental transaction for purposes
of this provision of the Common Warrants.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in; background-color: white"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b><span id="Z_021"></span>SHARES
ELIGIBLE FOR FUTURE SALE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in; background-color: white"><span style="font: small-caps 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to this offering, there has been a limited public market for our common stock, and a liquid trading market for our common stock may not
develop or be sustained after this offering. Future sales of our common stock, including shares issued upon the exercise of outstanding
options or warrants or settlement of restricted stock units, in the public market after the completion of this offering, or the perception
that those sales may occur, could adversely affect the prevailing market price for our common stock from time to time or impair our ability
to raise equity capital in the future. As described below, only a limited number of shares of our common stock will be available for
sale in the public market for a period of several months after the completion of this offering due to contractual and legal restrictions
on resale described below. Future sales of our common stock in the public market either before (to the extent permitted) or after restrictions
lapse, or the perception that those sales may occur, could adversely affect the prevailing market price of our common stock at such time
and our ability to raise equity capital at a time and price we deem appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the closing of this offering, a total of &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock will
be outstanding, assuming the underwriter does not exercise its option to purchase additional shares. Of these outstanding shares,
&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; shares of our common stock sold in this offering (excluding any exercise
of the underwriter&#8217;s over-allotment option and assuming no exercise of Pre-Funded Warrants or Common Warrants) will be freely
tradable in the public market without restriction or further registration under the Securities Act, unless these shares are held by &#8220;affiliates,&#8221;
as that term is defined in Rule 144 under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining outstanding shares of our common stock will be deemed &#8220;restricted securities&#8221; as that term is defined under Rule
144. Restricted securities may be sold in the public market only if their offer and sale is registered under the Securities Act or if
the offer and sale of those securities qualify for an exemption from registration, including exemptions provided by Rules 144 and 701
under the Securities Act, which are summarized below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
includes up to 5,843,993 shares of our common stock issuable as Contingent Shares in the Acquisition with NextTrip which are eligible
to be issued on or after June 29, 2024, which Contingent Shares are &#8220;restricted securities&#8221; as that term is defined under
Rule 144 which are expected to be eligible to be sold in the public market Rule 144 following issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Standstill
and Lock-up Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed that, without the prior written consent of the underwriter, we will not, for a period of six (6) months after the
closing of this offering, subject to certain exceptions, (a) offer, sell, issue, or otherwise transfer or dispose of, directly or indirectly,
any of our equity securities or any securities convertible into or exercisable or exchangeable for our equity securities; (b) file or
caused to be filed any registration statement with the SEC relating to the offering of any of our equity securities or any securities
convertible into or exercisable or exchangeable for our equity securities; or (c) enter into any swap or other agreement that transfers,
in whole or in part, any of the economic consequences of ownership of the Common Stock or any such other securities, whether any such
transaction described in clause (a) or (c) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise,
or enter into any agreement or announce the intention to effect any of the actions described above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors, executive officers, employees and principal stockholders (holding 5% or more of the common stock of the Company) have
agreed that, without the prior written consent of the underwriter, we and they will not, subject to certain exceptions, during the period
ending six (6) months after the date of this prospectus, offer, issue, sell, contract to sell, encumber, grant any option for
the sale of or otherwise dispose any shares of our common stock or any securities convertible into or exercisable or exchangeable for
shares of our common stock. For additional information, see &#8220;<i>Underwriting</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the lock-up periods set forth in the agreements described above, substantially all of the shares of our common stock will be eligible
for sale in the public market in compliance with Rule 144 or another exemption under the Securities Act or pursuant to the registration
statement of which this prospectus forms a part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
S</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulation
S under the Securities Act provides that shares owned by any person may be sold without registration in the U.S., provided that the sale
is effected in an offshore transaction and no directed selling efforts are made in the U.S. (as these terms are defined in Regulation
S), subject to certain other conditions. In general, this means that our shares of common stock may be sold in some other manner outside
the United States without requiring registration in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity
Incentive Plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to file with the SEC a registration statement under the Securities Act covering the shares of common stock that are outstanding
or reserved for issuance under the 2013 Plan and 2023 Plan. Once such registration statement become effective, shares registered thereunder
will be available for sale in the open market following its effective date, subject to Rule 144 volume limitations and the lock-up agreements
described above, if applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_022"></span>MATERIAL
U.S. FEDERAL INCOME TAX CONSEQUENCES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is a summary of the material U.S. federal income tax consequences of the purchase, ownership and disposition of
the shares of Common Stock, Pre-Funded Warrants and Common Warrants acquired pursuant to this Offering but does not purport to be a complete
analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable
state, local or foreign tax laws are not discussed. This discussion is based on the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS,
in effect as of the date of this offering. These authorities may change or be subject to differing interpretations. Any such change or
differing interpretation may be applied retroactively in a manner that could adversely affect a U.S. holder of our Common Stock, Pre-Funded
Warrants and Common Warrants. We have not sought and will not seek any rulings from the Internal Revenue Service (the &#8220;IRS&#8221;)
regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position regarding the tax
consequences of the purchase, ownership and disposition of our Common Stock, Pre-Funded Warrants and Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
assume in this discussion that each holder holds shares of our Common Stock, Pre-Funded Warrants and Common Warrants as &#8220;capital
assets&#8221; within the meaning of Section&#160;1221 of the Code (generally, property held for investment). This discussion does not
address all U.S. federal income tax consequences that may be relevant to a particular holder&#8217;s individual circumstances, including
the impact of the alternative minimum tax or the unearned income Medicare contribution tax. In addition, it does not address consequences
relevant to holders subject to particular rules, including, without limitation:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
    expatriates and certain former citizens or long-term residents of the United States;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    holding our Common Stock, Common Warrants or Pre-Funded Warrants as part of a hedge, straddle or other risk reduction strategy or
    as part of a conversion transaction or other integrated investment;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">banks,
    insurance companies, and other financial institutions;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulated
    investment companies or real estate investment trusts;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">brokers,
    dealers or traders in securities or currencies;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">controlled
    foreign corporations, &#8220;passive foreign investment companies,&#8221; and corporations that accumulate earnings to avoid U.S.
    federal income tax;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">partnerships
    or other entities or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-exempt
    organizations or governmental organizations;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    deemed to sell our Common Stock, Common Warrants or Pre-Funded Warrants under the constructive sale provisions of the Code;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    for whom our Common Stock, Common Warrants or Pre-Funded Warrants constitutes &#8220;qualified small business stock&#8221; within
    the meaning of Section 1202 of the Code or as &#8220;Section 1244 stock&#8221; for purposes of Section 1244 of the Code;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    subject to special tax accounting rules as a result of any item of gross income with respect to our Common Stock or Common Warrants
    being taken into account in an &#8220;applicable financial statement&#8221; (as defined in the Code);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">persons
    who hold or receive our Common Stock, Common Warrants or Pre-Funded Warrants pursuant to the exercise of any employee stock option
    or otherwise as compensation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tax-qualified
    retirement plans; and</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;qualified
    foreign pension funds&#8221; as defined in Section 897(l)(2) of the Code and entities all of the interest of which are held by qualified
    foreign pension funds.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) holds our Common Stock, Pre-Funded Warrants
or Common Warrants, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the
partnership and certain determinations made at the partner level. Accordingly, partnerships holding our Common Stock, Pre-Funded Warrants
or Common Warrants, and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences
to them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS
DISCUSSION IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED AS LEGAL OR TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX ADVISORS WITH
RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE
PURCHASE, OWNERSHIP AND DISPOSITION OF OUR COMMON STOCK, PRE-FUNDED WARRANTS, AND COMMON WARRANTS ARISING UNDER THE U.S. FEDERAL ESTATE
OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of this discussion, a &#8220;U.S. holder&#8221; is any beneficial owner of our Common Stock, Pre-Funded Warrants, or Common
Warrants that, for U.S. federal income tax purposes, is:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the
    laws of the United States, any state thereof, or the District of Columbia;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income tax regardless of its source; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust that (1) is subject to the primary supervision of a U.S. court and the control of one or more United States persons (within
    the meaning of Section 7701(a)(30) of the Code), or (2) has made a valid election under applicable Treasury Regulations to be treated
    as a United States person for U.S. federal income tax purposes.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
term &#8220;non-U.S. holder&#8221; means any beneficial owner of our Common Stock, Pre-Funded Warrants or Common Warrants that is not
a U.S. holder and is not a partnership or other entity properly classified as a partnership for U.S. federal income tax purposes. For
the purposes of this discussion, U.S. holders and non-U.S. holders are referred to collectively as &#8220;holders.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General
Treatment of Pre-Funded Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
it is not entirely free from doubt, a Pre-Funded Warrant should be treated as a share of our Common Stock for U.S. federal income tax
purposes and a holder of Pre-Funded Warrants should generally be taxed in the same manner as a holder of Common Stock as described below.
Each holder should consult his, her or its own tax advisor regarding the risks associated with the acquisition of a Unit pursuant to
this offering (including potential alternative characterizations). The balance of this discussion generally assumes that the characterization
described above is respected for U.S. federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Allocation
of Purchase Price Between Share of Common Stock and Accompanying Warrant to Purchase Our Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
U.S. federal income tax purposes, each Unit and Pre-Funded Unit should be treated as an &#8220;investment unit&#8221; consisting of one
share of Common Stock or one Pre-Funded Warrant, as applicable, and a Warrant to acquire one share of our Common Stock. The purchase
price for each investment unit will be allocated between these two components in proportion to their relative fair market values at the
time the unit is purchased by the holder. This allocation of the purchase price for each investment unit will establish the holder&#8217;s
initial tax basis for U.S. federal income tax purposes in the share of Common Stock or Pre-Funded Warrant, as applicable, and the Warrant
included in each investment unit. The separation of the Common Stock or Pre-Funded Warrant, as applicable, and the Warrant included in
each investment unit should not be a taxable event for U.S. federal income tax purposes. Each holder should consult his, her or its own
tax advisor regarding the allocation of the purchase price for an investment unit.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
or Expiration of Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a U.S. holder will not recognize gain or loss for U.S. federal income tax purposes upon exercise of a Warrant, except to the
extent the U.S. holder receives a cash payment for any fractional share of Common Stock that would otherwise have been issuable upon
exercise of the Warrant, which will be&#160;treated as a sale subject to the rules described under &#8220;Disposition of Our Common
Stock, Pre-Funded Warrants or Common Warrants&#8221; below. The U.S. holder will take a tax basis in the shares acquired on the exercise
of a Warrant equal to the exercise price of the Warrant, increased by the U.S. holder&#8217;s adjusted tax basis in the Warrant exercised
(as determined pursuant to the rules discussed above) and decreased by the adjusted tax basis allocable to any fractional share that
would otherwise have been issuable upon exercise of the Warrant. The U.S. holder&#8217;s holding period in the shares of our Common Stock
acquired on exercise of the Warrant will begin on the date of exercise of the Warrant, and will not include any period for which the
U.S. holder held the Warrant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
certain limited circumstances, a U.S. holder may be permitted to undertake a cashless exercise of Common Warrants into our common stock.
The U.S. federal income tax treatment of a cashless exercise of Common Warrants into our Common Stock is unclear, and the tax consequences
of a cashless exercise could differ from the consequences upon the exercise of a Warrant described in the preceding paragraph. U.S. holders
should consult their own tax advisors regarding the U.S. federal income tax consequences of a cashless exercise of Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lapse or expiration of a Warrant will be treated as if the U.S. holder sold or exchanged the Warrant and recognized a capital loss equal
to the U.S. holder&#8217;s tax basis in the Warrant. The deductibility of capital losses is subject to limitations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
Adjustments to Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Section 305 of the Code, an adjustment to the number of shares of Common Stock issued on the exercise of the Common Warrants, or an adjustment
to the exercise price of the Common Warrants, may be treated as a constructive distribution to a U.S. holder of the Common Warrants if,
and to the extent that, such adjustment has the effect of increasing such U.S. holder&#8217;s proportionate interest in our &#8220;earnings
and profits&#8221; or assets, depending on the circumstances of such adjustment (for example, if such adjustment is to compensate for
a distribution of cash or other property to our shareholders). An adjustment made pursuant to a <i>bona fide</i>&#160;reasonable adjustment
formula that has the effect of preventing dilution should generally not be considered to result in a constructive distribution. Any such
constructive distribution would be taxable whether or not there is an actual distribution of cash or other property to the holders of
Common Warrants. In certain circumstances, if we were to make a distribution in cash or other property with respect to our Common Stock
after the issuance of the Common Warrants, then we may make a corresponding distribution to a Warrant holder. The taxation of a distribution
received with respect to a Warrant is unclear. It is possible such a distribution would be treated as a distribution (or constructive
distribution), although other treatments are possible. For more information regarding the tax considerations related to distributions,
see the discussion below in &#8220;<i>Distributions</i>.&#8221; U.S. holders should consult their tax advisors regarding the proper treatment
of any adjustments to the Common Warrants and any distributions with respect to the Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not anticipate declaring or paying dividends to holders of our Common Stock in the foreseeable future. However, if we do make distributions
on our Common Stock or Pre-Funded Warrants to a U.S. holder, such distributions of cash or property generally will constitute dividends
for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S.
federal income tax principles. Distributions in excess of our current and accumulated earnings and profits will constitute a return of
capital that is applied against and reduces, but not below zero, a U.S. holder&#8217;s adjusted tax basis in our Common Stock or Pre-Funded
Warrant, as applicable. Any remaining excess will be treated as gain realized on the sale or exchange of our Common Stock or Pre-Funded
Warrant as described below under the subsection titled &#8220;<i>Disposition of Our Common Stock, Pre-Funded Warrants or Common Warrants.</i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disposition
of Our Common Stock, Pre-Funded Warrants or Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
a sale or other taxable disposition of our Common Stock, Pre-Funded Warrants or Common Warrants, a U.S. holder generally will recognize
capital gain or loss in an amount equal to the difference between the amount realized and the U.S. holder&#8217;s adjusted tax basis
in the Common Stock, Pre-Funded Warrants or Common Warrants. Capital gain or loss will constitute long-term capital gain or loss if the
U.S. holder&#8217;s holding period for the Common Stock, Pre-Funded Warrants or Common Warrants exceeds one year. The deductibility of
capital losses is subject to certain limitations. U.S. holders who recognize losses with respect to a disposition of our Common Stock,
Pre-Funded Warrants or Common Warrants should consult their own tax advisors regarding the tax treatment of such losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Reporting</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
reporting requirements generally will apply to payments of dividends (including constructive dividends) on the Common Stock, Pre-Funded
Warrants and Common Warrants and to the proceeds of a sale or other disposition of Common Stock, Pre-Funded Warrants and Common Warrants
paid by us to a U.S. holder unless such U.S. holder is an exempt recipient, such as a corporation. Backup withholding will apply to those
payments if the U.S. holder fails to provide the holder&#8217;s taxpayer identification number, or certification of exempt status, or
if the holder otherwise fails to comply with applicable requirements to establish an exemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Backup
withholding is not an additional tax. Rather, any amounts withheld under the backup withholding rules will be allowed as a refund or
a credit against the U.S. holder&#8217;s U.S. federal income tax liability provided the required information is timely furnished to the
IRS. U.S. holders should consult their own tax advisors regarding their qualification for exemption from information reporting and backup
withholding and the procedure for obtaining such exemption.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-U.S.
Holders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Exercise
and Expiration of Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, a non-U.S. holder will not recognize gain or loss for U.S. federal income tax purposes upon the exercise of Common Warrants
into shares of Common Stock, except to the extent the non-U.S. holder receives a cash payment for any fractional share of Common Stock
that would otherwise have been issuable upon exercise of the Warrant, which will be treated as a sale subject to the rules described
under &#8220;<i>Disposition of Our Common Stock, Pre-Funded Warrants or Common Warrants</i>&#8221; below. The U.S. federal income tax
treatment of a cashless exercise of Common Warrants into our Common Stock is unclear. A non-U.S. holder should consult his, her, or its
own tax advisor regarding the U.S. federal income tax consequences of a cashless exercise of Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expiration of a Warrant will be treated as if the non-U.S. holder sold or exchanged the Warrant and recognized a capital loss equal to
the non-U.S. holder&#8217;s tax basis in the Warrant. However, a non-U.S. holder will not be able to utilize a loss recognized upon expiration
of a Warrant against the non-U.S. holder&#8217;s U.S. federal income tax liability unless the loss is effectively connected with the
non-U.S. holder&#8217;s conduct of a trade or business within the United States (and, if an income tax treaty applies, is attributable
to a permanent establishment or fixed base in the United States) or is treated as a U.S.-source loss and the non-U.S. holder is present
183 days or more in the taxable year of disposition and certain other conditions are met.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Certain
Adjustments to Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described under &#8220;<i>U.S. Holders - Certain Adjustments to Common Warrants</i>,&#8221; an adjustment to the Common Warrants could
result in a constructive distribution to a non-U.S. holder, which would be treated as described under &#8220;<i>Distributions</i>&#8221;
below. Any resulting withholding tax attributable to deemed dividends would be collected from other amounts payable or distributable
to the non-U.S. holder. Non-U.S. holders should consult their tax advisors regarding the proper treatment of any adjustments to and distributions
on the Common Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Distributions</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed above, we do not anticipate declaring or paying dividends in the foreseeable future. However, if we do make distributions on
our Common Stock or Pre-Funded Warrants, such distributions of cash or property generally will constitute dividends for U.S. federal
income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income
tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and first be
applied against and reduce a non-U.S. holder&#8217;s adjusted tax basis in its Common Stock or Pre-Funded Warrants, but not below zero.
Any excess will be treated as capital gain and will be treated as described below in the section relating to the sale or disposition
of our Common Stock, Pre-Funded Warrants or Common Warrants. Because we may not know the extent to which a distribution is a dividend
for U.S. federal income tax purposes at the time it is made, for purposes of the withholding rules discussed below we or the applicable
withholding agent may treat the entire distribution as a dividend.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the discussion below on backup withholding and the Foreign Account Tax Compliance Act and the rules and regulations promulgated thereunder
(collectively, &#8220;FACTA&#8221;), dividends paid to a non-U.S. holder of our Common Stock or Pre-Funded Warrants that are not effectively
connected with the non-U.S. holder&#8217;s conduct of a trade or business within the United&#160;States will be subject to U.S. federal
withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income tax treaty).
In order to receive a reduced treaty rate, you must provide us with an IRS Form W-8BEN, IRS Form W-8BEN-E or other appropriate version
of IRS Form W-8 certifying qualification for the reduced rate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
dividends paid to a non-U.S. holder are effectively connected with the non-U.S. holder&#8217;s conduct of a trade or business within
the United&#160;States (and, if required by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment
in the United&#160;States to which such dividends are attributable), then, although exempt from U.S. federal withholding tax (provided
the non-U.S. holder provides appropriate certification, as described below), the non-U.S. holder will be subject to U.S. federal income
tax on such dividends on a net income basis at the regular graduated rates. In order to obtain this exemption, you must provide us with
an IRS Form W-8ECI or other applicable IRS Form W-8 properly certifying such exemption. In addition, a non-U.S. holder that is a corporation
may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on its effectively
connected earnings and profits for the taxable year that are attributable to such dividends, as adjusted for certain items. Non-U.S.
holders should consult their tax advisors regarding their entitlement to benefits under any applicable income tax treaty and regarding
any applicable treaties that may provide for different rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold our Common Stock, Pre-Funded Warrants or Common Warrants through a financial institution or other agent acting on your behalf,
you will be required to provide appropriate documentation to the agent, which then will be required to provide certification to us or
our paying agent, either directly or through other intermediaries. You may be eligible to obtain a refund of any excess amounts withheld
by timely filing an appropriate claim for refund with the IRS.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Disposition
of Our Common Stock, Pre-Funded Warrants or Common Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, subject to the discussions below on backup withholding, information reporting and foreign accounts, a non-U.S. holder will not
be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our Common Stock, Pre-Funded
Warrants or Common Warrants unless:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    gain is effectively connected with the non-U.S. holder&#8217;s conduct of a trade or business within the United States (and, if required
    by an applicable income tax treaty, the non-U.S. holder maintains a permanent establishment or fixed base in the United States to
    which such gain is attributable);</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    non-U.S. holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the
    disposition and certain other requirements are met; or</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    Common Stock constitutes U.S. real property interests, or USRPIs, by reason of our status as a U.S. real property holding corporation,
    or USRPHC, for U.S. federal income tax purposes at any time within the shorter of the five-year period preceding the non-U.S. holder&#8217;s
    disposition of, or their holding period for, our Common Stock or Common Warrants.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gain
described in the first bullet point above will generally be subject to U.S. federal income tax on a net income basis at the regular rates.
A non-U.S. holder that is a corporation also may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by
an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
non-U.S. holder described in the second bullet point above will be subject to U.S. federal income tax at a rate of 30% (or such lower
rate specified by an applicable income tax treaty) on any gain derived from the disposition, which may be offset by certain U.S. source
capital losses of the non-U.S. holder (even though the individual non-U.S. holder is not considered a resident of the United&#160;States)
provided the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the third bullet point above, we believe we are not currently and do not anticipate becoming a USRPHC. However, because the
determination of whether we are a USRPHC depends on the fair market value of our USRPIs relative to the fair market value of our non-U.S.
real property interests and our other business assets, there can be no assurance we will not become a USRPHC in the future. Even if we
are determined to be or were to become a USRPHC, gain arising from the sale or other taxable disposition by a non-U.S. holder of our
Common Stock, Pre-Funded Warrants or Common Warrants will not be subject to U.S. federal income tax if our Common Stock is &#8220;regularly
traded,&#8221; as defined by applicable Treasury Regulations, on an established securities market, and such non-U.S. holder owned, actually
and constructively, 5% or less of our Common Stock throughout the shorter of the five-year period ending on the date of the sale or other
taxable disposition or the non-U.S. holder&#8217;s holding period. Special rules may apply to the determination of the 5% threshold in
the case of a holder of a Pre-Funded Warrant or Warrant. Non-U.S. holders are urged to consult their own tax advisors regarding the effect
of holding our Pre-Funded Warrants or Common Warrants on the calculation of such 5% threshold. If we are a USRPHC and either our Common
Stock is not regularly traded on an established securities market or a non-U.S. holder holds, or is treated as holding, more than 5%
of our outstanding common stock, directly or indirectly, during the applicable testing period, such non-U.S. holder&#8217;s gain on the
disposition of shares of our Common Stock, Pre-Funded Warrants or Common Warrants generally will be taxed in the same manner as gain
that is effectively connected with the conduct of a U.S. trade or business, except that the branch profits tax generally will not apply.
If we are a USRPHC and our Common Stock is not regularly traded on an established securities market, a non-U.S. holder&#8217;s proceeds
received on the disposition of shares will also generally be subject to withholding at a rate of 15%. No assurance can be provided that
our Common Stock will be regularly traded on an established securities market for purposes of the rules described above. Prospective
investors are encouraged to consult their tax advisors regarding the possible consequences to them if we are, or were to become, a USRPHC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
holders should consult their tax advisors regarding potentially applicable income tax treaties that may provide for different rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
Reporting and Backup Withholding</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
we must report annually to the IRS the amount of distributions (including constructive distributions) on our Common Stock, Pre-Funded
Warrants or Common Warrants paid to each non-U.S. holder, their name and address, and the amount of tax withheld, if any. Copies of information
returns that are filed with the IRS may also be made available under the provisions of an applicable treaty or agreement to the tax authorities
of the country in which the non-U.S. holder resides or is established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
of dividends (including constructive dividends) or of proceeds on the disposition of our Common Stock, Pre-Funded Warrants or Common
Warrants made to a non-U.S. holder may be subject to information reporting and backup withholding at a current rate of 24% unless the
non-U.S. holder establishes an exemption, for example, by properly certifying their non-U.S.&#160;status on an IRS Form&#160;W-8BEN,
IRS Form&#160;W-8BEN-E or another appropriate version of IRS Form&#160;W-8. Notwithstanding the foregoing, backup withholding and information
reporting may apply if either we or our paying agent has actual knowledge, or reason to know, that a holder is a U.S. person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
current U.S. federal income tax law, U.S. information reporting and backup withholding requirements generally will apply to the proceeds
of a disposition of our Common Stock, Pre-Funded Warrants or Common Warrants effected by or through a U.S. office of any broker, U.S.
or foreign, except that information reporting and such requirements may be avoided if the holder provides a properly executed and appropriate
IRS&#160;Form&#160;W-8 or otherwise meets documentary evidence requirements for establishing non-&#160;U.S. holder status or otherwise
establishes an exemption. Generally, U.S. information reporting and backup withholding requirements will not apply to a payment of disposition
proceeds to a non-U.S. holder where the transaction is effected outside the U.S. through a non-U.S. office of a non-U.S. broker. Information
reporting and backup withholding requirements may, however, apply to a payment of disposition proceeds if the broker has actual knowledge,
or reason to know, that the holder is, in fact, a U.S. person. For information reporting purposes, certain brokers with substantial U.S.
ownership or operations will generally be treated in a manner similar to U.S. brokers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-U.S.
holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Foreign
Account Tax Compliance Act</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FATCA
generally imposes withholding tax at a rate of 30% on dividends (including constructive dividends) on our Common Stock, Pre-Funded Warrants
or Common Warrants, and certain other withholding payments, if paid to a non-U.S. entity unless (i) if the non-U.S. entity is a &#8220;foreign
financial institution,&#8221; the non-U.S. entity undertakes certain due diligence, reporting, withholding, and certification obligations,
(ii) if the non-U.S. entity is not a &#8220;foreign financial institution,&#8221; the non-U.S. entity identifies certain of its U.S.
investors, if any, or (iii) the non-U.S. entity is otherwise exempt under FATCA. While withholding under FATCA may apply to payments
of gross proceeds from a sale or other disposition of our Common Stock, Pre-Funded Warrants or Common Warrants, under proposed U.S. Treasury
Regulations withholding on payments of gross proceeds is not required. Although such regulations are not final, applicable withholding
agents may rely on the proposed regulations until final regulations are issued.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><b><i>The preceding discussion
of material U.S. federal tax considerations is for general information purposes only. It is not tax advice. Prospective
investors should consult their tax advisors regarding the particular U.S. federal, state, local and non-U.S. income and other
tax consequences of acquiring, holding and disposing of our Common Stock, Pre-Funded Warrants or Common Warrants, including
the consequences of any proposed changes in applicable laws.</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_023"></span>UNDERWRITING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to enter into an underwriting agreement with The Benchmark Company, LLC, or the underwriter, with respect to the securities
subject to this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain conditions, we have agreed to sell to the underwriter such securities listed next to its name in the below table at the public
offering price less the underwriting discounts and commissions set forth on the cover page of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Underwriter</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Per Share of Common Stock and Accompanying Common Warrant</b></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><b>Per Pre-Funded Warrant Accompanying Common Warrant</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 56%; text-align: left; padding-bottom: 1.5pt">The Benchmark Company,
    LLC</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 12%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 12%">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriting agreement provides that the obligation of the underwriter to purchase the shares of common stock and Common Warrants
offered by this prospectus is subject to certain conditions. The underwriter is obligated to purchase all of the shares of common
stock and Warrants offered hereby other than those covered by the over-allotment option described below. The underwriter is offering
the securities, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal matters by their
counsel, and other conditions contained in the underwriting agreement. The underwriter reserves the right to withdraw, cancel or modify
offers to the public and to reject orders in whole or in part.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Over-Allotment
Option</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have granted the underwriter an option to buy up to an additional &#160;&#160;&#160;&#160;&#160; shares of common stock, Pre-Funded
Warrants and/or Common Warrants from us at the combined public offering price less the underwriting discounts and commissions,
to cover over-allotments, if any. The underwriter may exercise this option at any time, in whole at any time or in part from time to
time, during the 30-day period after the date of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discounts,
Commissions and Expenses</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriter proposes to offer the shares of common stock purchased pursuant to the underwriting agreement to the public at the public
offering price set forth on the cover page of this prospectus and to certain dealers at that price less a concession not in excess of
$&#160;&#160;&#160;&#160;&#160;&#160; per share. After this offering, the public offering price and concession may be changed by the underwriter. No such change shall change
the amount of proceeds to be received by us as set forth on the cover page of this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the common stock to be purchased by the underwriter, the underwriter will be deemed to have received compensation
in the form of underwriting commissions and discounts. The underwriting commissions and discounts will be 7.0% of the gross proceeds
of this offering, or $&#160;&#160;&#160;&#160;&#160; per share of common stock, based on the public offering price per share set forth
on the cover page of this prospectus. We have also agreed to pay a non-accountable expense allowance to the underwriter equal to 1.0%
of the gross proceeds received by the Company in this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">We will be responsible for and
will pay all expenses relating to the offering, including without limitation, all reasonable out-of-pocket expenses incurred by the
underwriter in connection with the offering up to a maximum amount of $150,000, including the fees and disbursements of counsel to
the underwriter of up to $125,000 on a non-accountable basis. Additionally, we will be responsible for the costs of background
checks on members of our senior management in an amount not to exceed $7,500. We estimate that the total expenses of the offering,
including registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding underwriting
discounts and commissions and the 1.0% non-accountable expense allowance, will be approximately $&#160;&#160;&#160;&#160;&#160;
million, all of which are payable by us.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the underwriting discounts and commissions and proceeds, before expenses, to us assuming both no exercise
and full exercise by the underwriter of the over-allotment option:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Per Share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total Without<br/> Over-Allotment<br/> Option</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total With<br/> Over-Allotment<br/> Option</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 46%">Public offering price</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Underwriting discounts and commissions and non-accountable
    expense allowance (8.0%)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds to us, before fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify">We estimate the total expenses payable
by us for this offering to be approximately $&#160;&#160;&#160;&#160;&#160; million, which amount includes (i) the underwriting discount
and non-accountable expense allowance of approximately $&#160;&#160;&#160;&#160;&#160;, (ii) legal expenses incurred by the underwriter
in connection with the offering of $&#160;&#160;&#160;&#160;&#160; and (iii) other estimated Company expenses of approximately $&#160;&#160;&#160;&#160;&#160;,
which includes legal, accounting, printing costs and various fees associated with the registration of our securities.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Indemnification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also agreed to indemnify the underwriter against certain liabilities, including civil liabilities under the Securities Act and to
contribute to payments that the underwriter may be required to make in respect of those liabilities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lock-Up
Agreements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed that, for a period of six (6) months after the closing of this offering, without the prior written consent
of the underwriter, and subject to certain exceptions, neither we nor any of our subsidiaries shall issue, enter into any agreement to
issue or announce the issuance or proposed issuance of any shares of our common stock or common stock equivalents or file any registration
statement or amendment or supplement thereto, other than (i) the adoption of an equity incentive plan and the grant of awards pursuant
to any equity incentive plan, and the filing of a registration statement on Form S-8 relating to such a plan, (ii) the issuance of equity
securities in connection with an acquisition or a strategic relationship, which may include the sale of equity securities, and (iii)
the issuance of equity securities upon the exercise or conversion of options, warrants or other convertible securities outstanding prior
to this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, each of our directors, officers and 5% or more stockholders has agreed to enter into a lock-up agreement with the underwriter.
Under the lock-up agreements, without the prior written consent of the underwriter, the foregoing persons may not offer, sell, contract
to sell, lend, hypothecate, pledge or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be
expected to, result in the disposition, whether by actual disposition or effective economic disposition due to cash settlement or otherwise,
by such person or any affiliate or any person in privity with such person), directly or indirectly, or establish or increase a put equivalent
position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act, for a period of six
(6) months from the date of this prospectus. These restrictions on future dispositions by our directors and executive officers are
subject to certain exceptions for transfers of beneficially owned shares, including, but not limited to, transfers (i) as a bona fide
gift or gifts, (ii) to any immediate family member or to any trust for the direct or indirect benefit of such person or the immediate
family of the transferor; (iii) to any corporation, partnership, limited liability company, or other business entity, all of the equity
holders of which consist of the transferor and/or the immediate family of the transferor; (iv) if the undersigned is a corporation, partnership,
limited liability company, trust or other business entity, (a) to another corporation, partnership, limited liability company, trust
or other business entity that is an affiliate of the transferor or (b) in the form of a distribution to limited partners, limited liability
company members or stockholders of the transferor; (v) if the undersigned is a trust, to the beneficiary of such trust, (vi) by will,
other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family
of the transferor, and (vii) by operation of law, such as pursuant to qualified domestic order or in connection with a divorce settlement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Determination
of Offering Price and Warrant Exercise Price</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
actual offering price of the securities we are offering, and the exercise price of the Common Warrants being sold together with the shares
of common stock (or Pre-Funded Warrants in lieu thereof) that we are offering, were negotiated between us and the underwriter based on
the trading of our shares of common stock prior to the offering, among other things. Other factors considered in determining the combined
public offering price of the securities we are offering, as well as the exercise price of the Common Warrants that we are offering, include
our history and prospects, the stage of development of our business, our business plans for the future and the extent to which they have
been implemented, an assessment of our management, the general conditions of the securities markets at the time of the offering and such
other factors as were deemed relevant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underwriter&#8217;s
Warrant</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have agreed to issue to the underwriter, or its designated affiliates, warrants to purchase up to shares of common stock (representing
7% of the aggregate number of shares of common stock and Pre-Funded Warrants (if any) sold in this offering, including the number of
shares of common stock issuable upon exercise of the over-allotment option). The Underwriters&#8217; Warrants will be non-exercisable
for six (6) months after the commencement of sales under the registration statement of which this prospectus forms a part and will expire
five (5) years after the commencement of sales. The Underwriter&#8217;s Warrants will be exercisable at a price equal to 100% of the
initial combined public offering price in connection with this offering. The Underwriter&#8217;s Warrants shall not be redeemable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter&#8217;s Warrants and the shares issuable upon exercise thereof are deemed to be underwriting compensation by FINRA, and,
therefore, will be subject to a lock-up period in accordance with FINRA Rule 5110(e)(1). The Underwriter&#8217;s Warrants and the
shares of common stock issuable upon exercise of the Underwriter&#8217;s Warrants may not be sold, transferred, assigned, pledged,
or hypothecated, or be the subject of any hedging, short sale, derivative, put, or call transaction that would result in the
effective economic disposition of the securities by any person for a period of 180 days following the commencement of sales under
the registration statement of which this prospectus forms a part, except that they may be assigned, in whole or in part, to any
officer or partner of the underwriter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Underwriter&#8217;s Warrants may be exercised as to all or a lesser number of shares of common stock for a period of four and one half
years, commencing six (6) months after the commencement of sales under the registration statement of which this prospectus forms a part,
and will provide for cashless exercise in the event an effective registration statement for the shares of common stock issuable upon
exercise of the Underwriter&#8217;s Warrants is not available. The Underwriter&#8217;s Warrants shall further provide for anti-dilution
protection (adjustment in the number and price of such warrants and the shares issuable upon exercise of such warrants) resulting from
corporate events (which would include dividends, reorganizations, mergers, etc.) when the public stockholders have been proportionally
affected and otherwise in compliance with FINRA Rule 5110(f)(2)(G)(vi). However, the warrant exercise price or underlying shares will
not be adjusted for issuances of shares of common stock at a price below the warrant exercise price. The Underwriter&#8217;s Warrants
also provide for a one-time demand registration right and unlimited &#8220;piggyback&#8221; registration rights with respect to the registration
of the shares issuable upon exercise of the Underwriter&#8217;s Warrants. In accordance with FINRA Rule 5110(g)(8)(C) and (D), each of
the demand registration right and the &#8220;piggyback&#8221; registration rights will have a duration of five (5) years from the commencement
of sales of the public offering. The shares issuable upon exercise of the Underwriter&#8217;s Warrants are being registered under this
registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Electronic
Distribution</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus may be made available in electronic format on websites or through other online services maintained by the underwriter or by
its affiliates. In those cases, prospective investors may view offering terms online and prospective investors may be allowed to place
orders online. Other than this prospectus in electronic format, the information on the underwriter&#8217;s website or our website and
any information contained in any other websites maintained by the underwriter or by us is not part of this prospectus or the registration
statement of which this prospectus forms a part, has not been approved and/or endorsed by us or the underwriter in its capacity as the
underwriter, and should not be relied upon by investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Passive
Market Making</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with this offering, the underwriter and selling group members may also engage in passive market making transactions in our
common stock. Passive market making consists of displaying bids limited by the prices of independent market makers and effecting purchases
limited by those prices in response to order flow. Rule 103 of Regulation M promulgated by the SEC limits the amount of net purchases
that each passive market maker may make and the displayed size of each bid. Passive market making may stabilize the market price of the
shares of common stock at a level above that which might otherwise prevail in the open market and, if commenced, may be discontinued
at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nasdaq
Capital Market Listing</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock trades on The Nasdaq Capital Market under the symbol &#8220;NTRP&#8221;. On September 26, 2024, the closing
price of our common stock was $2.79 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
Stabilization, Short Positions and Penalty Bids</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the offering, the underwriter may engage in stabilizing transactions, over-allotment transactions, syndicate covering
transactions and penalty bids in accordance with Regulation M under the Exchange Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Stabilizing
transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Over-allotment
involves sales by the underwriter of shares in excess of the number of shares the underwriter is obligated to purchase, which creates
a syndicate short position. The short position may be either a covered short position or a naked short position. In a covered short position,
the number of shares over-allotted by the underwriter is not greater than the number of shares that they may purchase pursuant to the
over-allotment option. In a naked short position, the number of shares involved is greater than the number of shares that the underwriter
may purchase pursuant to the over-allotment option. The underwriter may close out any covered short position by either exercising the
over-allotment option and/or purchasing shares in the open market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Syndicate
covering transactions involve purchases of the common stock in the open market after the distribution has been completed in order to
cover syndicate short positions. In determining the source of shares to close out the short position, the underwriter will consider,
among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase
shares through the over-allotment option. A naked short position occurs if the underwriter sell more shares than could be covered by
the over-allotment option. This position can only be closed out by buying shares in the open market. A naked short position is more likely
to be created if the underwriter is concerned that there could be downward pressure on the price of the shares in the open market after
pricing that could adversely affect investors who purchase in the offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; Penalty
bids permit the underwriter to reclaim a selling concession from a syndicate member when the common stock originally sold by the syndicate
member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price
of our common stock or preventing or retarding a decline in the market price of the common stock. As a result, the price of our common
stock may be higher than the price that might otherwise exist in the open market. These transactions may be discontinued at any time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the underwriter make any representation or prediction as to the direction or magnitude of any effect that the transactions described
above may have on the price of our shares of common stock. In addition, neither we nor the underwriter make any representation that the
underwriter will engage in these transactions or that any transaction, if commenced, will not be discontinued without notice.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Offer
Restrictions Outside the United States</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than in the United States, no action has been taken by us or the underwriter that would permit a public offering of the securities offered
by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be
offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with
the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result
in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are
advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus.
This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in
any jurisdiction in which such an offer or a solicitation is unlawful.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Australia</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is not a disclosure document under Chapter 6D of the Australian Corporations Act, has not been lodged with the Australian
Securities and Investments Commission and does not purport to include the information required of a disclosure document under Chapter
6D of the Australian Corporations Act. Accordingly, (i) the offer of the securities under this prospectus is only made to persons to
whom it is lawful to offer the securities without disclosure under Chapter 6D of the Australian Corporations Act under one or more exemptions
set out in section 708 of the Australian Corporations Act, (ii) this prospectus is made available in Australia only to those persons
as set forth in clause (i) above, and (iii) the offeree must be sent a notice stating in substance that by accepting this offer, the
offeree represents that the offeree is such a person as set forth in clause (i) above, and, unless permitted under the Australian Corporations
Act, agrees not to sell or offer for sale within Australia any of the securities sold to the offeree within 12 months after its transfer
to the offeree under this prospectus.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Canada</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may be sold in Canada only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors,
as defined in National Instrument 45-106 Prospectus Exemptions or subsection 73.3(1) of the Securities Act (Ontario), and are permitted
clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale
of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements
of applicable securities laws. Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies
for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies
for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s
province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s
province or territory for particulars of these rights or consult with a legal advisor. Pursuant to section 3A.3 of National Instrument
33-105 Underwriting Conflicts (NI 33-105), the underwriter is not required to comply with the disclosure requirements of NI33-105 regarding
underwriter conflicts of interest in connection with this offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Cayman
Islands</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
invitation, whether directly or indirectly, may be made to the public in the Cayman Islands to subscribe for our securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>European
Economic Area&#8201;&#8212;&#8201;Belgium, Germany, Luxembourg and Netherlands</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document has been prepared on the basis that all offers of securities will be made pursuant to an exemption under
the Directive 2003/71/EC, the Prospectus Directive, as implemented in Member States of the European Economic Area (each, a Relevant Member
State), from the requirement to produce a prospectus for offers of securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
offer to the public of securities has not been made, and may not be made, in a Relevant Member State except pursuant to one of the following
exemptions under the Prospectus Directive as implemented in that Relevant Member State:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; to
legal entities that are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate
purpose is solely to invest in securities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; to
any legal entity that has two or more of (i) an average of at least 250 employees during its last fiscal year; (ii) a total balance sheet
of more than &#8364;43,000,000 (as shown on its last annual unconsolidated or consolidated financial statements) and (iii) an annual net
turnover of more than &#8364;50,000,000 (as shown on its last annual unconsolidated or consolidated financial statements);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; to
fewer than 100 natural or legal persons (other than qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive)
subject to obtaining the prior consent of us or any underwriter for any such offer; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; in
any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of securities shall result
in a requirement for the publication by us of a prospectus pursuant to Article 3 of the Prospectus Directive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>France</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offering of financial securities (offre au public de titres financiers)
in France within the meaning of Article L.411-1 of the French Monetary and Financial Code (Code Mon&#233;taire et Financier) and Articles
211-1 et seq. of the General Regulation of the French Autorit&#233; des march&#233;s financiers (&#8220;AMF&#8221;). The securities
have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document and any other offering material relating to the securities have not been, and will not be, submitted to the AMF for approval
in France and, accordingly, may not be distributed or caused to distributed, directly or indirectly, to the public in France.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Such
offers, sales and distributions have been and shall only be made in France to (i) qualified investors (investisseurs qualifi&#233;s)
acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&#176; and D.411-1 to D.411-3, D.744-1, D.754-1
;and D.764-1 of the French Monetary and Financial Code and any implementing regulation and/or (ii) a restricted number of non-qualified
investors (cercle restreint d&#8217;investisseurs) acting for their own account, as defined in and in accordance with Articles L.411-2-II-2&#176;
and D.411-4, D.744-1, D.754-1; and D.764-1 of the French Monetary and Financial Code and any implementing regulation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Article 211-3 of the General Regulation of the AMF, investors in France are informed that the securities cannot be distributed (directly
or indirectly) to the public by the investors otherwise than in accordance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 to L.621-8-3
of the French Monetary and Financial Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ireland</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this document does not constitute a prospectus under any Irish laws or regulations and this document has not been filed
with or approved by any Irish regulatory authority as the information has not been prepared in the context of a public offering of securities
in Ireland within the meaning of the Irish Prospectus (Directive 2003/71/EC) Regulations 2005, or the Prospectus Regulations. The securities
have not been offered or sold, and will not be offered, sold or delivered directly or indirectly in Ireland by way of a public offering,
except to (i) qualified investors as defined in Regulation 2(l) of the Prospectus Regulations and (ii) fewer than 100 natural or legal
persons who are not qualified investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Israel</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities offered by this prospectus have not been approved or disapproved by the Israeli Securities Authority (the ISA), or ISA, nor
have such securities been registered for sale in Israel. The shares may not be offered or sold, directly or indirectly, to the public
in Israel, absent the publication of a prospectus. The ISA has not issued permits, approvals or licenses in connection with the offering
or publishing the prospectus; nor has it authenticated the details included herein, confirmed their reliability or completeness, or rendered
an opinion as to the quality of the securities being offered. Any resale in Israel, directly or indirectly, to the public of the securities
offered by this prospectus is subject to restrictions on transferability and must be effected only in compliance with the Israeli securities
laws and regulations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Italy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering of the securities in the Republic of Italy has not been authorized by the Italian Securities and Exchange Commission (Commissione
Nazionale per le Societ&#224; e la Borsa, &#8220;CONSOB&#8221; pursuant to the Italian securities legislation and, accordingly, no
offering material relating to the securities may be distributed in Italy and such securities may not be offered or sold in Italy in a
public offer within the meaning of Article 1.1(t) of Legislative Decree No. 58 of 24 February 1998 (&#8220;Decree No. 58&#8221;), other
than:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; to
Italian qualified investors, as defined in Article 100 of Decree no.58 by reference to Article 34-ter of CONSOB Regulation no. 11971
of 14 May 1999 (&#8220;Regulation no. 1197l&#8221;) as amended (&#8220;Qualified Investors&#8221;); and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; in
other circumstances that are exempt from the rules on public offer pursuant to Article 100 of Decree No. 58 and Article 34-ter of Regulation
No. 11971 as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
offer, sale or delivery of the securities or distribution of any offer document relating to the securities in Italy (excluding placements
where a Qualified Investor solicits an offer from the issuer) under the paragraphs above must be:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; made
by investment firms, banks or financial intermediaries permitted to conduct such activities in Italy in accordance with Legislative Decree
No. 385 of 1 September 1993 (as amended), Decree No. 58, CONSOB Regulation No. 16190 of 29 October 2007 and any other applicable laws;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679; in
compliance with all relevant Italian securities, tax and exchange controls and any other applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
subsequent distribution of the securities in Italy must be made in compliance with the public offer and prospectus requirement rules
provided under Decree No. 58 and the Regulation No. 11971 as amended, unless an exception from those rules applies. Failure to comply
with such rules may result in the sale of such securities being declared null and void and in the liability of the entity transferring
the securities for any damages suffered by the investors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Japan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities have not been and will not be registered under Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan
(Law No. 25 of 1948), as amended (the &#8220;FIEL&#8221;) pursuant to an exemption from the registration requirements applicable to a
private placement of securities to Qualified Institutional Investors (as defined in and in accordance with Article 2, paragraph 3 of
the FIEL and the regulations promulgated thereunder). Accordingly, the securities may not be offered or sold, directly or indirectly,
in Japan or to, or for the benefit of, any resident of Japan other than Qualified Institutional Investors. Any Qualified Institutional
Investor who acquires securities may not resell them to any person in Japan that is not a Qualified Institutional Investor, and acquisition
by any such person of securities is conditional upon the execution of an agreement to that effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Portugal</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is not being distributed in the context of a public offer of financial securities (oferta p&#250;blica de valores mobili&#225;rios)
in Portugal, within the meaning of Article 109 of the Portuguese Securities Code (C&#243;digo dos Valores Mobili&#225;rios). The
securities have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in Portugal. This document
and any other offering material relating to the securities have not been, and will not be, submitted to the Portuguese Securities Market
Commission (Comiss&#259;o do Mercado de Valores Mobili&#225;rios) for approval in Portugal and, accordingly, may not be distributed
or caused to distributed, directly or indirectly, to the public in Portugal, other than under circumstances that are deemed not to qualify
as a public offer under the Portuguese Securities Code. Such offers, sales and distributions of securities in Portugal are limited to
persons who are &#8220;qualified investors&#8221; &#160;(as defined in the Portuguese Securities Code). Only
such investors may receive this document and they may not distribute it or the information contained in it to any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sweden</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document has not been, and will not be, registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority).
Accordingly, this document may not be made available, nor may the securities be offered for sale in Sweden, other than under circumstances
that are deemed not to require a prospectus under the Swedish Financial Instruments Trading Act (1991:980) (Sw. lag (1991:980) om handel
med finansiella instrument). Any offering of securities in Sweden is limited to persons who are &#8220;qualified investors&#8221; &#160;(as
defined in the Financial Instruments Trading Act). Only such investors may receive this document and they may not distribute it or the
information contained in it to any other person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Switzerland</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#8220;SIX&#8221;) or on any
other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards
for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses
under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland.
Neither this document nor any other offering material relating to the securities may be publicly distributed or otherwise made publicly
available in Switzerland.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor any other offering material relating to the securities have been or will be filed with or approved by any Swiss regulatory
authority. In particular, this document will not be filed with, and the offer of securities will not be supervised by, the Swiss Financial
Market Supervisory Authority (FINMA).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
document is personal to the recipient only and not for general circulation in Switzerland.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
Arab Emirates</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
this document nor the securities have been approved, disapproved or passed on in any way by the Central Bank of the United Arab Emirates
or any other governmental authority in the United Arab Emirates, nor have we received authorization or licensing from the Central Bank
of the United Arab Emirates or any other governmental authority in the United Arab Emirates to market or sell the securities within the
United Arab Emirates. This document does not constitute and may not be used for the purpose of an offer or invitation. No services relating
to the securities, including the receipt of applications and/or the allotment or redemption of such shares, may be rendered within the
United Arab Emirates by us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
offer or invitation to subscribe for securities is valid or permitted in the Dubai International Financial Centre.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>United
Kingdom</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
the information in this document nor any other document relating to the offer has been delivered for approval to the Financial Conduct
Authority in the United Kingdom and no prospectus (within the meaning of section 85 of the Financial Services and Markets Act 2000, as
amended (&#8220;FSMA&#8221;) has been published or is intended to be published in respect of the securities. This document is issued
on a confidential basis to &#8220;qualified investors&#8221; &#160;(within the meaning of section 86(7) of FSMA)
in the United Kingdom, and the securities may not be offered or sold in the United Kingdom by means of this document, any accompanying
letter or any other document, except in circumstances which do not require the publication of a prospectus pursuant to section 86(1)
FSMA. This document should not be distributed, published or reproduced, in whole or in part, nor may its contents be disclosed by recipients
to any other person in the United Kingdom.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
invitation or inducement to engage in investment activity (within the meaning of section 21 of FSMA) received in connection with the
issue or sale of the securities has only been communicated or caused to be communicated and will only be communicated or caused to be
communicated in the United Kingdom in circumstances in which section 21(1) of FSMA does not apply to us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the United Kingdom, this document is being distributed only to, and is directed at, persons (i) who have professional experience in matters
relating to investments falling within Article 19(5) (investment professionals) of the Financial Services and Markets Act 2000 (Financial
Promotions) Order 2005 (&#8220;FPO&#8221;), (ii) who fall within the categories of persons referred to in Article 49(2)(a) to (d) (high
net worth companies, unincorporated associations, etc.) of the FPO or (iii) to whom it may otherwise be lawfully communicated (together
&#8220;relevant persons&#8221;). The investments to which this document relates are available only to, and any invitation, offer or agreement
to purchase will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document
or any of its contents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_024"></span>LEGAL
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
validity of the securities offered hereby will be passed upon for us by Snell &amp; Wilmer LLP, San Diego, California. Certain
legal matters relating to this offering will be passed upon for the underwriter by Sichenzia Ross Ference Carmel LLP, New York, New York.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_025"></span>EXPERTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynie
and Company,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> NextTrip&#8217;s independent registered
public accounting firm, has audited our financial statements at February 29, 2024 and February 28, 2023, and for the years
then ended, as set forth in their report. We have included our financial statements in this prospectus and elsewhere in the registration
statement in reliance on Haynie and Company&#8217;s report, given on their authority as experts in accounting and auditing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Z_026"></span>WHERE
YOU CAN FIND MORE INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the securities offered hereby.
This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration
statement or the exhibits filed therewith. For further information about us and the securities offered hereby, reference is made
to the registration statement and the exhibits filed therewith. Statements contained in this prospectus regarding the contents of any
contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and in each instance
we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. The SEC also maintains
a website that contains reports, proxy and information statements and other information regarding registrants that file electronically
with the SEC. The address of the website is www.sec.gov.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the periodic reporting requirements of the Exchange Act, and we file periodic reports, proxy statements and other
information with the SEC. These periodic reports, proxy statements and other information are available on the website of the SEC
referred to above. We also maintain a website at www.nexttrip.com. You may access these materials at our corporate website free of
charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained
on our corporate website is not a part of this prospectus and the inclusion of our corporate website address in this prospectus is
an inactive textual reference only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="fin_toc"></span>INDEX
TO FINANCIAL STATEMENTS NEXTTRIP</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Audited
Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the Years Ended February 29, 2024 and February 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_001">Report of Independent Registered Public Accounting
    Firm</a> (PCAOB ID #457)</span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-2</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_002">Consolidated Balance Sheets as of February
    29, 2024 and February 28, 2023</a></span></td>
    <td style="vertical-align: bottom; width: 48px; text-align: center"><span style="font-size: 10pt">F-4</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_003">Consolidated Statements of Operations for
    the years ended February 29, 2024 and February 28, 2023</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-5</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_004">Consolidated Statements of Stockholders&#8217;
    Equity for the years ended February 29, 2024 and February 28, 2023</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-6</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_005">Consolidated Statements of Cash Flows for
    the years ended February 29, 2024 and February 28, 2023</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-7</span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top"><span style="font-size: 10pt"><a href="#na_006">Notes to Consolidated Financial Statements</a></span></td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">F-8</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unaudited Interim Condensed Consolidated Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the Three and Six Months Ended August 31, 2024 and 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Condensed Consolidated Balance Sheets as of August 31, 2024 (unaudited) and February 29, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 48px; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-33</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Condensed Consolidated Statements of Operations for the three and six months ended August 31, 2024 and 2023 (unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-34</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Condensed Consolidated Statements of Stockholders&#8217; Equity for the three and six months ended August 31, 2024
    and 2023 (unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-35</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Condensed Consolidated Statements of Cash Flow for the six months ended August 31, 2024 and 2023 (unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-36</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Interim Condensed Consolidated Financial Statements (unaudited)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-37</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.25pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 96; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="aud_001.jpg" alt="" style="width: 700px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="na_001"></span>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders
of NextTrip, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Opinion
on the Financial Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of NextTrip, Inc. (the Company) as of February 29, 2024 and February
28, 2023, and the related consolidated statements of operations, stockholders&#8217; equity, and cash flows for each of the years in
the two-year period ended February 29, 2024, and the related notes (collectively referred to as the financial statements). In our
opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of February 29,
2024 and February 28, 2023, and the results of its operations and its cash flows for each of the years in the two-year period ended
February 29, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Substantial Doubt about the Company&#8217;s Ability to Continue as a Going Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in
Note 1 to the financial statements, the Company has suffered recurring losses from operations and has a negative working capital
that raise substantial doubt about its ability to continue as a going concern. Management&#8217;s plans in regard to these matters
are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this
uncertainty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
for Opinion</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s
financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board
(United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities
laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company
is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits,
we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion
on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding
the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant
estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits
provide a reasonable basis for our opinion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Audit Matters</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated
or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial
statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters
does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit
matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Reverse
Acquisition with Sigma Additive Solutions, Inc. (Sigma)</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i></i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Description
of the Matter</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in Note 1 of the financial statements, Sigma entered into a share exchange agreement with NextTrip, Inc. whereby the NextTrip,
Inc. would exchange all outstanding shares of NextTrip Inc. in exchange for 156,007 of restricted sigma shares, with a right to receive
up to an additional 5,843,993 restricted shares. Sigma was considered the legal acquirer and NextTrip Inc. was treated as the accounting
acquirer. As such the Company accounted for the transaction as a reverse merger.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
transaction is complex in nature, required management judgment, and required a thorough understanding of the transaction and related
accounting guidance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">How
We Addressed the Matter</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
obtained an understanding of the transaction through discussions with management, review of the underlying agreements, and review of
management&#8217;s memo in connection with ASC 805 Accounting for Business Combinations. We then tested management&#8217;s assumptions
used in their analysis, the valuation of the shares issued, and the calculation of goodwill.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    <span>Haynie &amp; Company</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Haynie &amp; <span style="letter-spacing: -0.1pt">Company</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>Salt
    Lake City, Utah</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 4, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">PCAOB <span style="letter-spacing: -0.2pt">#457</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have served as the Company&#8217;s auditor since <span style="letter-spacing: -0.1pt">2024.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="aud_002.jpg" alt=""/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="na_002"></span>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
of February 29, 2024 and February 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_305_111_zWNUdp7Mv8i5" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20240229_zc8YYwU1l44k" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230228_zwTiCOcFOWWd" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_pp0p0_maACzuJM_zNQ83fc3Ro62" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; width: 60%; text-align: left">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-02-29" id="Fact000036" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2023-02-28" id="Fact000037" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">282,475</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--PromissoryNoteReceivableNet_i01I_pp0p0_maACzuJM_zHbpbXPxYld1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: justify">Promissory note receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2024-02-29" id="Fact000039" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2023-02-28" id="Fact000040" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,933,908</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_i01I_pp0p0_maACzuJM_zyFy3W1PFTqf" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: justify">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-02-29" id="Fact000042" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,082</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0043">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_pp0p0_maACzuJM_zSOKNygZzGf9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000045" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">340,921</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-02-28" id="Fact000046" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,613</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AssetsCurrent_i01TI_pp0p0_mtACzuJM_maAz2rq_zJNu1tCIBKyd" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000048" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,698,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2023-02-28" id="Fact000049" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,224,996</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsNoncurrentAbstract_i01B_pp0p0_zp8mFSkIcu02" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PropertyPlantAndEquipmentNet_i02I_pp0p0_maANzOLA_zIXPeIeCzqR8" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-02-29" id="Fact000054" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,642</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-02-28" id="Fact000055" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">16,226</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_pp0p0_maANzOLA_zrAMjK6excpb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact000057" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-02-28" id="Fact000058" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,607,670</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--SecurityDeposit_i02I_pp0p0_maANzOLA_zEBwBjTPGuh4" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Security deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-02-29" id="Fact000060" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,167</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2023-02-28" id="Fact000061" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">15,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--Goodwill_i02I_pp0p0_maANzOLA_zqrzpx4N0H7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Goodwill</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-02-29" id="Fact000063" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0064">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingLeaseRightOfUseAsset_i02I_pp0p0_maANzOLA_z8hCy1luFJJ3" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Right of Use Asset</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0066">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2023-02-28" id="Fact000067" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,020,443</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--AssetsNoncurrent_i02TI_pp0p0_mtANzOLA_maAz2rq_zq9psy33y8Tc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-Current Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-02-29" id="Fact000069" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,390,034</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2023-02-28" id="Fact000070" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,659,339</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--Assets_i01TI_pp0p0_mtAz2rq_z9nncGmL1qB9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-02-29" id="Fact000072" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2023-02-28" id="Fact000073" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,884,335</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--LiabilitiesAbstract_iB_zmEfnFCO8GTg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AccountsPayableCurrent_i02I_pp0p0_maLCzkfU_zish3S5dxgj7" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-02-29" id="Fact000081" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">531,847</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2023-02-28" id="Fact000082" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">519,136</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AccruedLiabilitiesCurrent_i02I_pp0p0_maLCzkfU_zsm63X6Mk8g5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact000084" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">460,768</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2023-02-28" id="Fact000085" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">329,922</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ConvertibleDebtCurrent_i02I_pp0p0_maLCzkfU_zpb7phZaOalk" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0087">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ConvertibleDebtCurrent" contextRef="AsOf2023-02-28" id="Fact000088" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,233,503</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--DeferredRevenueCurrent_i02I_pp0p0_maLCzkfU_zwhIcMJV0QTd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-02-29" id="Fact000090" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,921</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-02-28" id="Fact000091" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">22,750</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NotesPayableCurrent_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maLCzkfU_zO8hyqQSkJic" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Notes payable - related parties</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">828,277</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-02-28_us-gaap_RelatedPartyMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">281,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_i02I_pp0p0_maLCzkfU_z5pxZrOe9016" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Operating Lease Liability &#8211; Short Term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0096">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2023-02-28" id="Fact000097" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">149,339</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_mtLCzkfU_maLzlYG_zEisGCu9Vpvb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact000099" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2023-02-28" id="Fact000100" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,535,650</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--LiabilitiesNoncurrentAbstract_i01B_zsz7hcEtZaY1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Non- Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityNoncurrent_i02I_maLNzPN7_zm5gsMWzr7Ub" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Operating Lease Liability &#8211; Long Term</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0105">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2023-02-28" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">864,575</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesNoncurrent_i02TI_pp0p0_mtLNzPN7_maLzlYG_z4gavdMRAU93" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Non-Current Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0108">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2023-02-28" id="Fact000109" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">864,575</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--Liabilities_i01TI_pp0p0_mtLzlYG_maLASEzwBb_zfhB6vc6l9L3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-02-29" id="Fact000111" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2023-02-28" id="Fact000112" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,400,225</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0_maLASEzwBb_zHV3n694GSt7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0114">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0115">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--StockholdersEquityAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Stockholder&#8217;s Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PreferredStockValue_i02I_pp0p0_maSEzbFv_zAEBL0BXXaw7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred Stock, $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_zfdV4KF7Bk2k" title="Preferred stock, par value"><span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230228_zet1c69ovnLb" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact000123" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-02-28" id="Fact000125" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_zXvKO1cGolgb" title="Preferred stock, shares authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230228_ztne9h3igMx2" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact000127" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-02-28" id="Fact000129" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_908_eus-gaap--PreferredStockSharesIssued_iI_pid_c20240229_zk3u9HZzqIlb" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20240229_zWCATakdYT5g" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact000131" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact000133" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_pid_c20230228_zt9iOUrR2qn5" title="Preferred stock, shares issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20230228_zl0YslXmaGyd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-02-28" id="Fact000135" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-02-28" id="Fact000137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-02-29" id="Fact000120" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">474</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0121">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--CommonStockValue_i02I_pp0p0_maSEzbFv_z47CyciHdcvi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common Stock, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20240229_zXuG7i5WDC8h" title="Common stock, par shares"><span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20230228_zL8oU1driIZh" title="Common stock, par shares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact000142" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-02-28" id="Fact000144" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span>,
    <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20240229_zQ7NeDRiygjj" title="Common stock, shares authorized"><span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20230228_zbs9crb4dmkb" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact000146" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2023-02-28" id="Fact000148" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized, <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_c20240229_z3kKLMREsq8g" title="Common stock, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20240229_zkeK9mdzIfM" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact000150" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact000152" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></ix:nonFraction></span>
    </span>and <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20230228_zoKEbV63mHI8" title="Common stock, shares issued"><span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20230228_zzDyQkthqsB1" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-02-28" id="Fact000154" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-02-28" id="Fact000156" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></ix:nonFraction></span></span> shares issued and
    outstanding, respectively <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_F49_zoK8EWsDygke">(*)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-02-29" id="Fact000139" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">936</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2023-02-28" id="Fact000140" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AdditionalPaidInCapital_i02I_pp0p0_maSEzbFv_zegOYJLjCC0l" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Additional Paid in Capital <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_F49_zaKAbKQNCpq">(*)</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-02-29" id="Fact000158" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2023-02-28" id="Fact000159" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_maSEzbFv_zdTwN1aZkbD6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-02-29" id="Fact000161" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-02-28" id="Fact000162" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_i02TI_pp0p0_maLASEzwBb_mtSEzbFv_zM46z6ZfmZG" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Stockholders&#8217; Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000164" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact000165" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">484,110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_mtLASEzwBb_zfqsXkJjxGIj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000167" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2023-02-28" id="Fact000168" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,884,335</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0D_zbhMAtMptO4l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F13_zLDNSLqVWZJf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000169" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z6Ekva3JH2xg" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zZ1iSAPMmFo3" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000173" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="na_003"></span>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 29, 2024 AND FEBRUARY 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_113_zZAFRlcOA9L5" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20230301__20240229_zhG4LeWOaIok" style="border-bottom: Black 1pt solid; text-align: center">February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20220301__20230228_zTksySNs4zkj" style="border-bottom: Black 1pt solid; text-align: center">February 28, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maGPzG2Q_zmRqF7xL5W04" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-03-012024-02-29" id="Fact000175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">458,752</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2022-03-012023-02-28" id="Fact000176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">382,832</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CostOfRevenue_di_msGPzG2Q_zM28PwZErC1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-03-012024-02-29" id="Fact000178" format="ixt:numdotdecimal" decimals="0" unitRef="USD">397,532</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2022-03-012023-02-28" id="Fact000179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">354,921</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--GrossProfit_iT_pp0p0_mtGPzG2Q_maOILzn5Y_zk5UEcAO2Xw4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-03-012024-02-29" id="Fact000181" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">61,220</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2022-03-012023-02-28" id="Fact000182" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,911</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--OperatingExpensesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--LaborAndRelatedExpense_i01_pp0p0_maOEz5RN_zMFU8SKdjEma" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-03-012024-02-29" id="Fact000187" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,604,487</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2022-03-012023-02-28" id="Fact000188" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,124,296</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--ShareBasedCompensation_i01_pp0p0_maOEz5RN_zxcaEn8WcAZk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012024-02-29" id="Fact000190" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0191">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_maOEz5RN_zJvYAfCoo6vd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-03-012024-02-29" id="Fact000193" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">152,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2022-03-012023-02-28" id="Fact000194" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">209,561</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--SellingAndMarketingExpense_i01_pp0p0_maOEz5RN_zgEusLzXFfn5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-012024-02-29" id="Fact000196" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">484,250</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-03-012023-02-28" id="Fact000197" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,137</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProfessionalFees_i01_pp0p0_maOEz5RN_zXG1mFqZgRt5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Professional Service Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-03-012024-02-29" id="Fact000199" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,421,508</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2022-03-012023-02-28" id="Fact000200" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">615,432</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--Technology_i01_pp0p0_maOEz5RN_zqV1ifOo9By2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2023-03-012024-02-29" id="Fact000202" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">311,430</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2022-03-012023-02-28" id="Fact000203" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">551,418</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--OrganizationCosts_i01_pp0p0_maOEz5RN_zCl5l4bCXwYd" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Organization Costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2023-03-012024-02-29" id="Fact000205" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0206">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DepreciationAndAmortization_i01_pp0p0_maOEz5RN_zm4JrdLsj0wa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-03-012024-02-29" id="Fact000208" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,468,762</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2022-03-012023-02-28" id="Fact000209" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,238</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--OtherExpenses_i01_pp0p0_maOEz5RN_z9u2JHbpfmV5" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-03-012024-02-29" id="Fact000211" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">156,522</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2022-03-012023-02-28" id="Fact000212" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">64,684</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--OperatingExpenses_i01T_pp0p0_mtOEz5RN_msOILzn5Y_zWUWTNWItyw5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Operating Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-03-012024-02-29" id="Fact000214" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,740,577</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2022-03-012023-02-28" id="Fact000215" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,979,766</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--OperatingIncomeLoss_iT_pp0p0_mtOILzn5Y_maILFCOzjWI_z2wT3mvLuoa7" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000217" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,679,357</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2022-03-012023-02-28" id="Fact000218" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">4,951,855</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--NonoperatingIncomeExpenseAbstract_iB" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other Income/(Expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GainLossOnDispositionOfAssets1_i01_pp0p0_maNIEzWbr_zYoBuNAvQxk2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on disposal of assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-03-012024-02-29" id="Fact000223" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,718</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0224">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i01_pp0p0_maNIEzWbr_zGIlRuvJyBQi" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Gain on extinguishment of liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-03-012024-02-29" id="Fact000226" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0227">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--LossOnRelatedPartyReceivable_i01N_pp0p0_di_msNIEzWbr_zCXtaxooyCLa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left">Loss on promissory note receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(<ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29" id="Fact000229" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,567,665</ix:nonFraction></p></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0230">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--InterestIncomeExpenseNonoperatingNet_i01_pp0p0_maNIEzWbr_zt8kdhpqnkGl" style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 10pt; text-align: left">Interest income (expense), net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2023-03-012024-02-29" id="Fact000232" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">48,620</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2022-03-012023-02-28" id="Fact000233" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">71,871</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--OtherNonoperatingIncomeExpense_i01_pp0p0_maNIEzWbr_z9TG7wo1KF4d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other Income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2023-03-012024-02-29" id="Fact000235" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">486,633</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-03-012023-02-28" id="Fact000236" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">9,770</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_mtNIEzWbr_maILFCOzjWI_zPVKtSfQngf5" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total other income (expense)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-03-012024-02-29" id="Fact000238" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">977,480</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2022-03-012023-02-28" id="Fact000239" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">81,641</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtILFCOzjWI_maILFCOzEdU_zEla7V8h5EWd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss from continuing operations before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000241" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-03-012023-02-28" id="Fact000242" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_msILFCOzEdU_zGF9VB0AF14c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0244">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0245">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iT_mtILFCOzEdU_maNILzv1N_zQvOuAaWq7Oc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000247" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-03-012023-02-28" id="Fact000248" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_maNILzv1N_zKVdeQ2D2K25" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net loss from discontinued operations, net of taxes</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-03-012024-02-29" id="Fact000250" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0251">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_iT_pp0p0_maNILATz4JB_mtNILzv1N_zzTiwS0xDFI4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000253" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28" id="Fact000254" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_pp0p0_di_msNILATz4JB_zLtAu1yGxCCi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Preferred Dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012024-02-29" id="Fact000256" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">7,125</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0257">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pp0p0_mtNILATz4JB_zQ1msUw2Dq2b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Loss Applicable to Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012024-02-29" id="Fact000259" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">7,339,276</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-03-012023-02-28" id="Fact000260" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Basic and diluted loss per common share from continuing operations<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span>*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_900_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230301__20240229_fKCop_zJ7hl0lz6y9i" title="Basic loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90C_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230301__20240229_fKg_____zHeeCca9v2dd" title="Diluted loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-03-012024-02-29" id="Fact000262" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-03-012024-02-29" id="Fact000264" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">29.16</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20220301__20230228_fKg_____z42fa4hmG2yk" title="Basic loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_909_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20220301__20230228_fKg_____zcuYimnin2Rd" title="Diluted loss per common share from continuing operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2022-03-012023-02-28" id="Fact000266" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2022-03-012023-02-28" id="Fact000268" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">70.32</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Basic and diluted loss per common share from discontinued
    operations <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span>*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230301__20240229_fKg_____zZVHCOzdqtfg" title="Basic loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90E_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230301__20240229_fKg_____zW7DjKIA0fMe" title="Diluted loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2023-03-012024-02-29" id="Fact000270" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2023-03-012024-02-29" id="Fact000272" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">2.96</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20220301__20230228_fKg_____zhLRXikMZnTl" title="Basic  loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90E_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20220301__20230228_fKg_____zAhKOfDYBMG1" title="Diluted loss per common share from discontinued operations" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span style="-sec-ix-hidden: xdx2ixbrl0274"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Basic and diluted loss per common share <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span>*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_eus-gaap--EarningsPerShareBasic_pid_c20230301__20240229_fKg_____zi9hNITvamVb" title="Loss per common share basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_907_eus-gaap--EarningsPerShareDiluted_pid_c20230301__20240229_fKg_____zmwgJSLrHJh4" title="Loss per common share diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-03-012024-02-29" id="Fact000278" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-03-012024-02-29" id="Fact000280" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">32.12</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--EarningsPerShareBasic_pid_c20220301__20230228_fKg_____zNLZ7wUUu2wd" title="Loss per common share basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20220301__20230228_fKg_____zlEct43W4iIe" title="Loss per common share diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-03-012023-02-28" id="Fact000282" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-03-012023-02-28" id="Fact000284" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">70.32</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span>*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230301__20240229_fKg_____zKKTNOBMyhrd" title="Weighted average number of shares outstanding basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230301__20240229_fKg_____zH17V1zKIGN" title="Weighted nverage number of shares outstanding diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-03-012024-02-29" id="Fact000286" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-03-012024-02-29" id="Fact000288" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228,274</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20220301__20230228_fKg_____zU3bSVo2eAc1" title="Weighted average number of shares outstanding basic" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20220301__20230228_fKg_____zFCGXZIIUjwd" title="Weighted Average Number of Shares Outstanding diluted" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-03-012023-02-28" id="Fact000290" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-03-012023-02-28" id="Fact000292" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,581</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zwdjUpujRNG7" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F16_zO9RcrePAo57" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000293" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zF2Iyi2frhtk" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000295" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zej8vkWWnJQ4" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000297" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 100; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="na_004"></span>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 29, 2024 AND FEBRUARY 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_303_114_z7yDue4FD07j" summary="xdx: Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_z7Fek5pCAvJi" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z9GOVbR1UIVh" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z9M703zcXMa4" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zcmBQWNwXoB4" style="border-bottom: Black 1pt solid; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_zbDIpknJGNp7" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Preferred</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Common</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Additional Paid in</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1.5pt; text-align: center">Accumulated</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Deficit</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_434_c20220301__20230228_eus-gaap--StockholdersEquity_iS_zSBurVdoucg6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 30%">Balance, February 28, 2022 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_F41_zJjeiB7o4mw">*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_z45gg9fKf0h9" title="Beginning balance, shares" style="width: 6%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl0299">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iS_pid_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_z568yraXSV25" title="Beginning balance, shares" style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2022-02-28_us-gaap_CommonStockMember" id="Fact000307" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">70,370</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_CommonStockMember" id="Fact000300" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000301" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28_us-gaap_RetainedEarningsMember" id="Fact000302" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,778,367</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-02-28" id="Fact000303" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">11,778,267</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueNewIssues_z1wGyOaCEHPe" style="vertical-align: bottom; background-color: White">
    <td>Issuance of Common Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zuqXRI9Z9Rq7" title="Issuance of Common Shares, Shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220301__20230228__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zW8BHD6flmoh" title="Issuance of Common Shares, Shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember" id="Fact000317" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,001</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember" id="Fact000310" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000311" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,860</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0312">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2022-03-012023-02-28" id="Fact000313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,873</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zpXhfWD9Vldh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0320">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0321">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember" id="Fact000322" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-03-012023-02-28" id="Fact000323" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_43D_c20230301__20240229_eus-gaap--StockholdersEquity_iS_zPwRjKViGyC9" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Balance, February 28, 2023 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_F4B_zwAM1AShHzSc">*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zCyeSsg8lFQh" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0331">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zrzogU0cb3Gk" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000333" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000326" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000327" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" id="Fact000328" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact000329" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230301__20240229_eus-gaap--StockholdersEquity_iS_zowT3U2CSkw9" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Beginning balance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_z6QeTu9YPNl1" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0335">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zGtXZqRZpGLd" title="Beginning balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000343" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact000336" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact000337" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" id="Fact000338" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact000339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,110</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--StockIssuedDuringPeriodValueOfPreferredShares_zWxya05VngQ8" style="vertical-align: bottom; background-color: White">
    <td>Issuance of Preferred Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_ecustom--StockIssuedDuringPeriodShareOfPreferredShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zIdyoq1xavs3" title="Issuance of Preferred Shares, Shares" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodShareOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000351" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">472,680</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">473</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_ecustom--StockIssuedDuringPeriodShareOfPreferredShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zS7Mro22Ey3d" title="Issuance of Preferred Shares, Shares" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0346">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000347" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueOfPreferredShares" contextRef="From2023-03-012024-02-29" id="Fact000349" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zE5OWitexIK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Conversion of Convertible Notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z692obb4NTb2" title="Conversion of Convertible Notes, Shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000361" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000356" format="ixt:numdotdecimal" decimals="0" unitRef="USD">53</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000357" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,507</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0358">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2023-03-012024-02-29" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,560</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--StockIssuedDuringPeriodValuePurchasesOfCommonShares_zS2k1Ef0jNL" style="vertical-align: bottom; background-color: White">
    <td>Purchases of Common Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesPurchasesOfCommonShares_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8gYNZ1AZjrf" title="Purchases of Common Shares, Sharers" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000369" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000364" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000365" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,954</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares" contextRef="From2023-03-012024-02-29" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,970</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zFOw3r4bTpZh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of Common Shares for Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4l1VUcLAuye" title="Issuance of Common Shares for Services, Shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000377" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000372" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000373" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2023-03-012024-02-29" id="Fact000375" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--StockIssuedDuringPeriodValueReverseAcquisition_zrtPKl8aUfX7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Reverse Acquisition of Sigma Additive Solutions, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_ecustom--StockIssuedDuringPeriodSharesReverseAcquisition_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zJV1DPnu7Wkb" title="Reverse Acquisition of Sigma Additive Solutions, Inc., Shares" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000385" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember" id="Fact000379" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_ecustom--StockIssuedDuringPeriodSharesReverseAcquisition_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zN8iZng5bOIk" title="Reverse Acquisition of Sigma Additive Solutions, Inc., Shares" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">780,423</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember" id="Fact000380" format="ixt:numdotdecimal" decimals="0" unitRef="USD">780</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000381" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,367,637</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact000383" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_zcwyKKRcWhXj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock Compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000391" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" contextRef="From2023-03-012024-02-29" id="Fact000393" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,512</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DividendsPreferredStock_iN_di_zyUu3SiPgChk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred Stock Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0396">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000397" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,125</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="Fact000398" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zJDJTSz2h9Nl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Net Loss</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember" id="Fact000404" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012024-02-29" id="Fact000405" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,332,151</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_438_c20230301__20240229_eus-gaap--StockholdersEquity_iE_zR8zB07PY0Xf" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Balance, February 29, 2024 <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_F46_zeaNEIBurNT2">*</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zvaF8aEWneqd" title="Ending balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000413" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000407" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--SharesOutstanding_iE_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zpzQ5Wb8A2Mc" title="Ending balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000415" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000408" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000409" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember" id="Fact000410" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_430_c20230301__20240229_eus-gaap--StockholdersEquity_iE_zm6ySm9XK9A8" style="display: none; vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Ending balance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zfLu9fConuHd" title="Ending balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000423" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact000417" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iE_pid_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zqLs9mF6gRRl" title="Ending balance, shares" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000425" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact000418" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember" id="Fact000420" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact000421" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0B_z6qI6TLBnAUf" style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1B_zyOHomwkxSZ2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000426" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zwrW1FaxviGd" title="Number of shares acquired"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000428" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zekArRvcggKb" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact000430" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</ix:footnote></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 101; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="na_005"></span>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONSOLIDATED
STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR
THE YEARS ENDED FEBRUARY 29, 2024 AND FEBRUARY 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_114_zaQmZNphYZJ3" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20230301__20240229_zH3J6knmEEBb" style="border-bottom: Black 1pt solid; text-align: center">February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20220301__20230228_z3meaLiV0Xi1" style="border-bottom: Black 1pt solid; text-align: center">February 28, 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Operating Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01_pp0p0_maNCPBUz4r1_zszrVekn1WFd" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left">Net Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact000435" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-03-012023-02-28" id="Fact000436" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zttN4JRtnqik" style="display: none; vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Noncash Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--DepreciationDepletionAndAmortization_i02_pp0p0_maNCPBUz4r1_zvwOYkqoKmcc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation and amortization &#8211; property and equipment and intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-03-012024-02-29" id="Fact000444" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,468,762</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-03-012023-02-28" id="Fact000445" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">707,238</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DepreciationOfRightOfUseAsset_i02_pp0p0_maNCPBUz4r1_zEy8SSGEicNi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Depreciation of right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0447">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:DepreciationOfRightOfUseAsset" contextRef="From2022-03-012023-02-28" id="Fact000448" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">12,168</ix:nonFraction></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--LossOnRelatedPartyReceivable_i02_pp0p0_maNCPBUz4r1_zepTL31BZ9Ll" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on promissory note receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29" id="Fact000450" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,567,665</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_i02_pp0p0_maNCPBUz4r1_zi6AKhLYDgw6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012024-02-29" id="Fact000453" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,512</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0454">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--GainsLossesOnExtinguishmentOfDebt_i02N_pp0p0_di_msNCPBUz4r1_zw27CeqY6yxa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Gain on extinguishment of liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GainsLossesOnExtinguishmentOfDebt" contextRef="From2023-03-012024-02-29" id="Fact000456" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">166,890</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GainLossOnDispositionOfIntangibleAssets_i02N_pp0p0_di_msNCPBUz4r1_zX4RzPOv3dB5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss on sale of intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfIntangibleAssets" contextRef="From2023-03-012024-02-29" id="Fact000459" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">14,718</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_z4ZRoHuNSjIi" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_pp0p0_di_msNCPBUz4r1_zR4J0yNEucqa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-03-012024-02-29" id="Fact000465" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">662,939</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-03-012023-02-28" id="Fact000466" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">5,053</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_pp0p0_di_msNCPBUz4r1_zWfV16iuv352" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-03-012024-02-29" id="Fact000468" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">281,506</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-03-012023-02-28" id="Fact000469" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">48,796</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IncreaseDecreaseInPromissoryNoteReceivable_i02N_pp0p0_di_msNCPBUz4r1_zTbQaKU29oE4" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Promissory note receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncreaseDecreaseInSecurityDeposits_i02_maNCPBUz4r1_zEGLnb71YX8a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Security deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2023-03-012024-02-29" id="Fact000474" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,167</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0475">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_ecustom--IncreaseDecreaseInRightOfUseLeaseLiability_i02_maNCPBUz4r1_zbYJSnNOLZI7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Right of use lease liability</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="NTRP:IncreaseDecreaseInRightOfUseLeaseLiability" contextRef="From2022-03-012023-02-28" id="Fact000478" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">18,697</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_maNCPBUz4r1_zLPRhfuAfT5k" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-03-012024-02-29" id="Fact000480" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">531,367</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2022-03-012023-02-28" id="Fact000481" format="ixt:numdotdecimal" decimals="0" unitRef="USD">533,193</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_maNCPBUz4r1_zQb5RzUYeL05" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-03-012024-02-29" id="Fact000483" format="ixt:numdotdecimal" decimals="0" unitRef="USD">102,954</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2022-03-012023-02-28" id="Fact000484" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">46,855</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_i01T_mtNCPBUz4r1_maNCPBUzbPp_zCutN54a8iZ5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net cash used in operating activities from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-03-012024-02-29" id="Fact000486" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,056,095</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2022-03-012023-02-28" id="Fact000487" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,792,600</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_i01_maNCPBUzbPp_zyBKGjFqHWk2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities from discontinued operations</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2023-03-012024-02-29" id="Fact000489" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0490">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUzbPp_maCCERCzlyi_zJYuTqWPYSOa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-03-012024-02-29" id="Fact000492" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,731,409</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-03-012023-02-28" id="Fact000493" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,792,600</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_z3x6F5IyCNCd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Investing activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msNCPBUzcro_zbOiwKLXR09b" style="vertical-align: bottom; background-color: White">
    <td>Purchase of equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-03-012024-02-29" id="Fact000498" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,253</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-03-012023-02-28" id="Fact000499" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,928</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsForSoftware_i01N_di_msNCPBUzcro_z3Sj0q914Pu" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Capitalized software development costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2023-03-012024-02-29" id="Fact000501" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,016,175</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2022-03-012023-02-28" id="Fact000502" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,354,094</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--OriginationOfNotesReceivableFromRelatedParties_i01N_di_msNCPBUzcro_zxUyamUR6Sz7" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Promissory note &#8211; related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0504">-</span></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(<ix:nonFraction name="us-gaap:OriginationOfNotesReceivableFromRelatedParties" contextRef="From2022-03-012023-02-28" id="Fact000505" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,933,908</ix:nonFraction></p></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_ecustom--ProceedsFromAcquireBusinessesGross_i01N_di_msNCPBUzcro_zNEFPS3i8w3i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Reverse acquisition of Sigma Additive Solutions, Inc.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:ProceedsFromAcquireBusinessesGross" contextRef="From2023-03-012024-02-29" id="Fact000507" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">417,122</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0508">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProceedsFromSaleOfProductiveAssets_i01_maNCPBUzcro_zj8FjcZRjthe" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Sale of Sigma Additive Solutions, Inc. assets</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleOfProductiveAssets" contextRef="From2023-03-012024-02-29" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,589,241</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_maCCERCzlyi_mtNCPBUzcro_zoaTkMSEEX6b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided (used) in investing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-03-012024-02-29" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">980,935</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-03-012023-02-28" id="Fact000514" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,290,930</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_z9NBKmZoJY4j" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzlEa_zvdGkVQb2fdb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from notes payable - related party</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0519">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2022-03-012023-02-28" id="Fact000520" format="ixt:numdotdecimal" decimals="0" unitRef="USD">281,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--ProceedsFromConvertibleDebt_i01_maNCPBUzlEa_zdE6t5jUMn5d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-03-012024-02-29" id="Fact000522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">735,057</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-03-012023-02-28" id="Fact000523" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,233,503</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_i01_maNCPBUzlEa_zHKUzsQgbIDj" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible preferred shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_maNCPBUzlEa_zTapUdSCsrU9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuances of common shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-03-012024-02-29" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,905,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0529">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_i01_maNCPBUzlEa_zmvZDveKThV1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuances of preferred shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" contextRef="From2023-03-012024-02-29" id="Fact000531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,603,500</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0532">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--ProceedsFromRelatedPartyDebt_i01_maNCPBUzlEa_zg44q7QvK4Ze" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt; text-align: left">Advances from related party, net</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-03-012024-02-29" id="Fact000534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">547,277</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2022-03-012023-02-28" id="Fact000535" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,620,452</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzlEa_maCCERCzlyi_ziRp5t8EiQz9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-03-012024-02-29" id="Fact000537" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,791,804</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-03-012023-02-28" id="Fact000538" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,134,955</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_mtCCERCzlyi_ztMr1Llc81bh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Increase in cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-03-012024-02-29" id="Fact000540" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">41,330</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2022-03-012023-02-28" id="Fact000541" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,425</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zWIykh9Bap3c" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; padding-bottom: 1.5pt">Cash - beginning of the period</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-02-28" id="Fact000543" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">282,475</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2022-02-28" id="Fact000544" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">231,050</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zV0Gyoqbrhdg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Cash - end of the period</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-02-29" id="Fact000546" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-02-28" id="Fact000547" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">282,475</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zybHAQSU9WD4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental cash flow information</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--DisclosureOfCashPaidAbstract_i01B_zMU4LUQ75mA3" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Disclosure of Cash Paid for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_i01_zM02MWMPTRql" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Cash paid for interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-03-012024-02-29" id="Fact000555" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,381</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2022-03-012023-02-28" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,769</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxesPaidNet_i01_zEwsEs2NA2xi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Cash paid for taxes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0558">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_z8y8FPn3xRBa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Cash Financing Transactions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IssuanceOfPreferredSharesForServices_i01_z0ygm7QojHDl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of preferred shares for services</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForServices" contextRef="From2023-03-012024-02-29" id="Fact000564" format="ixt:numdotdecimal" decimals="0" unitRef="USD">569,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0565">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_ecustom--IssuanceOfPreferredSharesForPerpetualSoftwareLicense_i01_zZEkBoqXNVJi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of preferred shares for perpetual software license</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense" contextRef="From2023-03-012024-02-29" id="Fact000567" format="ixt:numdotdecimal" decimals="0" unitRef="USD">362,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0568">-</span></td><td style="text-align: left"/></tr>
  <tr id="xdx_40D_ecustom--ConversionOfConvertibleNotes_i01_zpI2QNlN6Loi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Conversion of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:ConversionOfConvertibleNotes" contextRef="From2023-03-012024-02-29" id="Fact000570" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,968,507</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--PreferredStockDividends_i01_z2g9rHnAB7Yb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Preferred stock dividends</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2023-03-012024-02-29" id="Fact000573" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuanceOfCommonSharesForServices_i01_zHfZnA25WQOj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of common shares for services</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2023-03-012024-02-29" id="Fact000576" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,106</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to financial statements</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 102; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p id="xdx_04B_c20230301__20240229_zPMStjUOlVv6" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="na_006"></span>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FEBRUARY
29, 2024 AND FEBRUARY 28, 2023</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000579" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zqXYvRElwtUa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_825_zkGPBstIeW96">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#8217;s corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507 The consolidated financial statements include the
accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc., incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Prior
to the Share Exchange Agreement as described below, NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) was a wholly owned subsidiary
of NextTrip Group, LLC (&#8220;Group&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#8220;NextPlay&#8221;). All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023,
NextPlay and Group entered into an Amended and Restated Separation Agreement (&#8220;Separation Agreement&#8221;), Amended and
Restated Operating Agreement (&#8220;Operating Agreement&#8221;), and Exchange Agreement (&#8220;Exchange Agreement&#8221;),
together the Agreements (&#8220;Agreements&#8221;), whereby NextPlay transferred their interest in the travel business to Group.
Pursuant to the Exchange Agreement, NextPlay exchanged <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zC1bjJuh2PSg" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember" id="Fact000581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction></span>
Membership Units of Group for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztVenDw12gh4" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact000583" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,000</ix:nonFraction></span>
Preferred Units of Group, with a value of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_z5RjezcFwEtl" title="Share price per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember" id="Fact000585" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10</ix:nonFraction></span>
per unit. Prior to the exchange for Preferred Units, Group had a payable due to NextPlay of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zqx3olpfVV8f" title="Number of common stock issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact000587" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,873</ix:nonFraction></span>,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s
ongoing support obligations except for a $<span id="xdx_907_eus-gaap--NotesPayable_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zK8euId603zb" title="Notes payable"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember" id="Fact000589" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction></span> million advance remaining under a promissory note and as such NextTrip recorded the
payable as contributed capital. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and all-inclusive travel packages. Our proprietary booking engine, branded
as NextTrip 2.0, provides travel distributors access to a sizeable inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240229__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zh7s8zm6l2d4" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-02-29_custom_NextInnovationLLCMember" id="Fact000591" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor
operations occurred in 2023 or 2024 and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#8220;Exchange Agreement&#8221;) with NextTrip, Group,
and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zjZzxRkOfoe" title="Number of restricted shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember" id="Fact000593" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span> restricted shares of Sigma
common stock (the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an additional <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z73AcNf6WlV9" title="Number of additional restricted shares"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember" id="Fact000595" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span> restricted
shares of Sigma common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#8220;Contingent Shares,&#8221;
and together with the Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares are issuable to the members of Group,
on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing conditions (the &#8220;Acquisition&#8221;).
Upon the closing of the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 103; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zM7Xcb3ip1Ok" title="Shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember" id="Fact000597" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> shares of Sigma common stock, or approximately <span id="xdx_90F_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20240229__20240229_z5PfBXCLVr8c" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2024-02-292024-02-29" id="Fact000599" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90.2</ix:nonFraction></span>% of
the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a change
of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the legacy
shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma is
treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information presented
is that of NextTrip.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value under ASC 805 as described in <b>NOTE 8 &#8211;
Goodwill</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, and February 28, 2023, the Company had an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zdrVeNWcMHQ3" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-02-29" id="Fact000601" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230228_z3cV7l4trhdk" title="Accumulated deficit"><ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2023-02-28" id="Fact000603" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></span> respectively, and
working capital deficit of $<span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zRjT0YloBUtk" title="Working capital deficit"><ix:nonFraction name="NTRP:WorkingCapitalDeficit" contextRef="AsOf2024-02-29" id="Fact000605" format="ixt:numdotdecimal" decimals="0" unitRef="USD">262,005</ix:nonFraction></span> and $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_c20230228_zT4KhWTtX9Sg" title="Working capital deficit"><ix:nonFraction name="NTRP:WorkingCapitalDeficit" contextRef="AsOf2023-02-28" id="Fact000607" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,310,654</ix:nonFraction></span>, respectively, and has incurred losses since incorporation. The Company will need
to raise additional funds through equity or debt financings to support the on-going operations, increase market penetration of our products,
expand the marketing and development of our travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset our operating costs. In the event the Company is unable to raise adequate funding in the future
for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business plan and/or liquidate
some or all of its assets or may be forced to seek bankruptcy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In light of the foregoing, there is substantial doubt about our ability
to continue as a going concern for 12 months from the date of the filing of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 104; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Issues Surrounding the COVID-19 Pandemic</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse
public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duration and severity of the COVID-19 pandemic impeded global economic activity for an extended period of time, even as restrictions
have been lifted in many jurisdictions (including the United States) and vaccines are being made available, leading to decreased per
capita income and disposable income, increased and sustained unemployment or a decline in consumer confidence, all of which significantly
reduced discretionary spending by individuals and businesses on travel and may create a recession in the United States or globally. In
turn, that could have a negative impact on demand for our services. We also cannot predict the long-term effects of the COVID-19 pandemic
on our partners and their business and operations or the ways that the pandemic may fundamentally alter the travel industry. The aforementioned
circumstances could result in a material adverse impact on our business, financial condition, results of operations and cash flows, potentially
for a prolonged period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we currently cannot predict the full impact of the COVID-19 pandemic on our fiscal 2025 financial results relating to our operations,
we anticipate an increase in year-over-year revenue as compared to fiscal year 2023. However, the ultimate extent of the COVID-19 pandemic
and its impact on global travel and overall economic activity is constantly changing and impossible to predict currently. However, the
Company is seeing the return to normal operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000609" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zGEHqlcFYsC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_826_zn2PsYiDS8Uf">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000611" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zjJ4SkBSWIy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span>Basis
of Presentation and Principles of Consolidation</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zvT3CGhXthXf" style="display: none">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000613" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYNgtlgrPaga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zvop3Yli0cV7">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 105; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000615" name="us-gaap:UseOfEstimates"><p id="xdx_844_eus-gaap--UseOfEstimates_zi8D4EThlaLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zECwVSN5l3dj">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">The assessment of the allowance on the related party promissory note receivable;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of purchase price allocation;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of fair value of equity instruments;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000617" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znm0W8vScE4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zfCWQ5E57r05">Loss
Per Share</span> &#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 29, 2024 and
February 28, 2023, the Company had the following common shares underlying these instruments:</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000619" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_z8WLjXA0cLk5" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February 29 and 28,</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember" id="Fact000621" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_StockOptionMember" id="Fact000624" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred Stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember21725562" id="Fact000627" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">475,835</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2023-03-012024-02-29" id="Fact000630" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,047,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AB_zFkqvzqgz067" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000633" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHcszlqY6qkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zrX1zFbuQVKb">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in US dollars. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_znz41uPYYRw1" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230228_zWUTqJt7Z4j" title="Cash equivalents"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2024-02-29" id="Fact000635" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="AsOf2023-02-28" id="Fact000637" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> cash equivalents
as of February 29, 2024, or February 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000639" name="NTRP:PrepaidsPolicyTextBlock"><p id="xdx_84E_ecustom--PrepaidsPolicyTextBlock_zP8hsNZqfpp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNq5e7bygDi">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000641" name="us-gaap:TradeAndOtherAccountsReceivablePolicy"><p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zcNsj0Pmudd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpROZHUqB1aj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#8217;s
best estimate of the amount of probable credit losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 106; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 29, 2024 and February 28, 2023, were $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_z7adHWduDhh4" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-02-29" id="Fact000643" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,092</ix:nonFraction></span>, and $<span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_c20230228_zj00rlxIMbt7" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-02-28" id="Fact000645" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000647" name="NTRP:PromissoryNoteReceivablePolicyTextBlock"><p id="xdx_847_ecustom--PromissoryNoteReceivablePolicyTextBlock_zSMvO0PieUsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span id="xdx_864_zokZsbbIL4dd">Promissory Note Receivable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBvEy3SmY4Dj" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact000649" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,567,665</ix:nonFraction></span>
and $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zbPdvDoogrB8" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember" id="Fact000651" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,933,908</ix:nonFraction></span> respectively. Management has determined that, since NextPlay is in default under the terms of the promissory note, collectability
of the entire related party receivable as of February 29, 2024 is uncertain, and has therefore established an allowance for doubtful
accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_ziXkWVEdo8g8" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact000653" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction></span>. As of February 28, 2023, <span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z7sMx8ABAG27" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember" id="Fact000655" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> allowance for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000657" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWWo5BaTFOzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zpFrPVg4yYSa">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000659" name="NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zmJtEukZpK03">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember" format="ixt-sec:duryear" id="Fact000661" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">5</ix:nonNumeric></span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember" format="ixt-sec:duryear" id="Fact000663" name="us-gaap:PropertyPlantAndEquipmentUsefulLife">3</ix:nonNumeric></span>
    years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zniJYxbMVy04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000665" name="us-gaap:IntangibleAssetsFiniteLivedPolicy"><p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1ThpQpoPZ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zZw8ET0O8Acd">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000667" name="NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000669" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">1</ix:nonNumeric></span>
    - <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_custom_SoftwareMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000671" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">3</ix:nonNumeric></span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MinimumMember" format="ixt-sec:duryear" id="Fact000673" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">0.5</ix:nonNumeric></span>
    - <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life"><ix:nonNumeric contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MaximumMember" format="ixt-sec:duryear" id="Fact000675" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife">4</ix:nonNumeric></span> years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_z9Q4puhFe4G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000677" name="us-gaap:InternalUseSoftwarePolicy"><p id="xdx_849_eus-gaap--InternalUseSoftwarePolicy_zwvkT5vMbYIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zl75EYJYMjS">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;<span style="text-decoration: underline">ASC 985-20-25</span>&#8221; Accounting for the Costs of Software to Be Sold, Leased,
or Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 107; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000679" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"><p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zvFWfDgI5X13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zZXLjEm7sf2a">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;<span style="text-decoration: underline">Goodwill and Other Intangible Assets</span>&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000681" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zwKwrmEoAexe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDAn9CatPkj2">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000683" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zazYsWsiYD9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zi4sOZJnCCHi">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 108; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000685" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztnZGNMpNbla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zgQEEVdQUtyc">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000687" name="us-gaap:MarketRiskBenefitPolicyTextBlock"><p id="xdx_84C_eus-gaap--MarketRiskBenefitPolicyTextBlock_ztZNTINE94t6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zDSoyoXIgVT3">Concentration
of Credit Risk</span> -</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000689" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy"><p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zDu3emIxc3X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zPNXd2HD4tXl">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000691" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoUehf2CANRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zwZ4eZtFf9M">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC Topic No. 606. In
May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <i>Revenue from Contracts
with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition
guidance under prior U.S. GAAP and replaced it with a principles-based approach for determining revenue recognition. The core principle
of the standard is the recognition of revenue upon the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. In general, we determine revenue
recognition by: (1) identifying the contract, or contracts, with our customer; (2) identifying the performance obligations in the contract;
(3) determining the transaction price; (4) allocating the transaction price to performance obligations in the contract; and (5) recognizing
revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 109; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000693" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock"><p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_z1eTiudxu4T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zOLzEHL5GHJ7">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and administration expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_zv5DkjtVHw6b" title="Sales and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-012024-02-29" id="Fact000695" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,250</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20220301__20230228_zj2522yghbJ6" title="Sales and marketing expense"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2022-03-012023-02-28" id="Fact000697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">707,137</ix:nonFraction></span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000699" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zhxOkI2P3rRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zQm8MXm4rQE8">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no tax positions at February 29, 2024 and 2023 for which the ultimate deductibility is highly uncertain but for which there
is uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During
the years ended February 29, 2024 and February 28, 2023, the Company recognized no interest and penalties. All tax years starting with
2019 are open for examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 110; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000701" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNkTwcecrh59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zU9TY6EvEIne">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The FASB issued this ASU to address issues identified as a result of the complexity
associated with GAAP for certain financial instruments with characteristics of liabilities and equity. Complexity associated with the
accounting is a significant contributing factor to numerous financial statement restatements and results in complexity for users attempting
to understand the results of applying the current guidance. In addressing the complexity, the FASB focused on amending the guidance on
convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#8217;s own equity. For convertible
instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock.
Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared
with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features
that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for
a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums
are recorded as paid-in capital. The FASB concluded that eliminating certain accounting models simplifies the accounting for convertible
instruments, reduces complexity for preparers and practitioners, and improves the decision usefulness and relevance of the information
provided to financial statement users. In addition to eliminating certain accounting models, the FASB also decided to enhance information
transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance on
the basis of feedback from financial statement users. The FASB decided to amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. The FASB observed that the application
of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically
similar contracts as equity. The FASB also decided to improve and amend the related EPS guidance. The amendments in this ASU are effective
for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified
that an entity should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the
guidance through either a modified retrospective method of transition or a fully retrospective method of transition. The Company adopted
ASU 2020-06 on March 1, 2022 on a prospective basis. The adoption of this standard did not have an impact on the Company&#8217;s consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50),
Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU
2021-04 requires accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants)
that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The
recognition of the modification depends on the nature of the transaction in which the equity-classified written call option is modified.
If there is more than one element in a transaction (for example, if the modification involves both a debt modification and an equity
issuance), then the guidance requires allocating the effect of the option modification to each element. ASU 2021-04 is effective for
the Company beginning in the first quarter of 2022. ASU 2021-04 should be applied prospectively to modifications or exchanges occurring
on or after the effective date of the amendments. The Company adopted ASU 2021-04 on March 1, 2022 on a prospective basis. The adoption
of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, ASC Subtopic 326 &#8220;Credit Losses&#8221;: Troubled Debt Restructurings and Vintage Disclosures.
Since the issuance of Accounting Standards Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments, the Board has provided resources to monitor and assist stakeholders with the implementation of
Topic 326. Post-Implementation Review (PIR) activities have included forming a Credit Losses Transition Resource Group, conducting outreach
with stakeholders of all types, developing educational materials and staff question-and-answer guidance, conducting educational workshops,
and performing an archival review of financial reports. ASU No. 2022-02 is effective for annual and interim periods beginning after December
15, 2022. The adoption of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 111; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

</ix:nonNumeric><p id="xdx_85C_zunsJwzW3tH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000703" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"><p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zHCFg0lCGF38" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_825_ze8xQaKCsNPl">Discontinued Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended February 29, 2024, the Company completed the sale of certain assets of Sigma Additive Solutions, Inc., which has
been classified as discontinued operations in accordance with ASC 205-20, &#8220;Presentation of Financial Statements &#8211; Discontinued
Operations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2023, the Company entered into a definitive asset purchase agreement (&#8220;APA&#8221;) with Divergent Technologies, Inc.,
(&#8220;Divergent&#8221;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from us, certain
assets consisting primarily of patents, software code and other intellectual property for a purchase price of $<span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zxJcJxQr6Uff" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000705" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span>, including a
$<span id="xdx_90E_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zrFjlhjEZsGh" title="Earnest money deposit"><ix:nonFraction name="NTRP:EarnestMoneyDeposit" contextRef="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000707" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,000</ix:nonFraction></span> earnest-money deposit previously paid to us by Divergent. The closing under the Asset Purchase Agreement occurred subsequent
to the closing of the reverse acquisition with NextTrip on January 12, 2024. The parties&#8217; respective obligations to close were
subject to the accuracy of the parties&#8217; respective representations and warranties and performance of their respective covenants
and satisfaction or waiver of other customary conditions specified in the Asset Purchase Agreement. In the interim, between the signing
date and closing date or termination of the Asset Purchase Agreement, Sigma granted Divergent a non-exclusive, nontransferable, non-sublicensable
(except to Divergent customers and affiliates), limited, irrevocable (except in connection with the termination of the Asset Purchase
Agreement), worldwide, royalty-free license to the &#8220;Licensed IP&#8221; (as defined) for testing, evaluation, and commercialization
purposes. A gain of $<span id="xdx_90E_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zk1mrDjw3uUd" title="Asset disposition"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember" id="Fact000709" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,515</ix:nonFraction></span> was recognized in the asset disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 29, 2024, the Company recorded a loss of $<span id="xdx_904_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iN_di_c20230301__20240229_zeTfq5WMGYyf" title="Loss of discontinued operations"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-03-012024-02-29" id="Fact000711" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></span> from discontinued operations as follows:</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000713" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zspOW6uJbF67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zFJHwNhQ5ew8" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zLmFzUI83NA" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zQJi1B0w3Wbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" contextRef="From2023-03-012024-02-29" id="Fact000715" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,006</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zLmAEEUy63K5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zDE4WqxhGyXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross Profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" contextRef="From2023-03-012024-02-29" id="Fact000719" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,006</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_maDGIDOzcGq_zvoNuuDeMlIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" contextRef="From2023-03-012024-02-29" id="Fact000721" format="ixt:numdotdecimal" decimals="0" unitRef="USD">28,475</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_maDGIDOzcGq_zAzoLiABURl6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retention bonuses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" contextRef="From2023-03-012024-02-29" id="Fact000723" format="ixt:numdotdecimal" decimals="0" unitRef="USD">528,930</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationSeverance_maDGIDOzcGq_zsLZdk5FYSb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Severance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationSeverance" contextRef="From2023-03-012024-02-29" id="Fact000725" format="ixt:numdotdecimal" decimals="0" unitRef="USD">62,500</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_maDGIDOzcGq_zR0TkxyWbB7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Organization costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" contextRef="From2023-03-012024-02-29" id="Fact000727" format="ixt:numdotdecimal" decimals="0" unitRef="USD">63,600</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zf4wrCCLOaoh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome" contextRef="From2023-03-012024-02-29" id="Fact000729" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,185</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zcs3dGLy8rPi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense" contextRef="From2023-03-012024-02-29" id="Fact000731" format="ixt:numdotdecimal" decimals="0" unitRef="USD">680,320</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zgDaX1rFDR5g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from Discontinued Operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2023-03-012024-02-29" id="Fact000733" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A7_zIBFAHsMzmJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000735" name="NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock"><p id="xdx_801_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zYfB9V0sTqj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_823_zK7Bo5ikQCZf">Prepaid and Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000737" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zVCnlkJWw6vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 29, 2024 and as of February 28, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B5_zcDtWDvTfd0f" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_zqPJ57abXlch" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230228_znNv015iUfVc" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zBvMxNj4q7s9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid marketing expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidAdvertising" contextRef="AsOf2024-02-29" id="Fact000739" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PrepaidAdvertising" contextRef="AsOf2023-02-28" id="Fact000740" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zGnmmlyN62Xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="AsOf2024-02-29" id="Fact000742" format="ixt:numdotdecimal" decimals="0" unitRef="USD">298,274</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="AsOf2023-02-28" id="Fact000743" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,513</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_zD3GV9zMebki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:PrepaidCostOfSales" contextRef="AsOf2024-02-29" id="Fact000745" format="ixt:numdotdecimal" decimals="0" unitRef="USD">42,547</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_zgwEybw2ARma" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-02-29" id="Fact000748" format="ixt:numdotdecimal" decimals="0" unitRef="USD">340,921</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2023-02-28" id="Fact000749" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,613</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zY0TS1rL3iIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000751" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zOSHswfS6Zd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_82B_zYja0lqoGDzk">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that the arrangement was an operating lease at inception and included it in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023.
The office facility was occupied by NextTrip employees through March 16, 2023, when the landlord informed the NextTrip that would not
recognize NextTrip as the tenant. The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately
unsuccessful, and as a result derecognized the lease in the financial statements as of February 29, 2024. No restatement was made for
fiscal year 2023 as the Company had use of the offices at that time and was in negotiations to assume the lease from NextPlay Technologies,
Inc. No payments have been made on the lease and no expense has been recognized for the year ended February 29, 2024. Rent expense for the year ended February 28, 2023 was $<span id="xdx_90C_eus-gaap--OperatingLeasesRentExpenseNet_c20220301__20230228_zd83MwsvpiSl" title="Rent expense"><ix:nonFraction name="us-gaap:OperatingLeasesRentExpenseNet" contextRef="From2022-03-012023-02-28" id="Fact000753" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,554</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 112; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000755" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zljuX8EqEuQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_82B_zfpt5DQVS2Z5">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000757" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIh2ZEQDqJ0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zrxnKfDl0uy2" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_znd8yztfslTk" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zhsm8QhKGPEj" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRQ2QskFsU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Furniture and Fixtures</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember" id="Fact000759" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,018</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember" id="Fact000760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,018</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zB0mQgDjUIpl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember" id="Fact000762" format="ixt:numdotdecimal" decimals="0" unitRef="USD">82,492</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28_us-gaap_ComputerEquipmentMember" id="Fact000763" format="ixt:numdotdecimal" decimals="0" unitRef="USD">73,238</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zGz2ohFpxjeh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2024-02-29" id="Fact000765" format="ixt:numdotdecimal" decimals="0" unitRef="USD">99,510</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentGross" contextRef="AsOf2023-02-28" id="Fact000766" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,256</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zoHK50A27lB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2024-02-29" id="Fact000768" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,868</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" contextRef="AsOf2023-02-28" id="Fact000769" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,030</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zVBz1Kt5yYd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-02-29" id="Fact000771" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,642</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2023-02-28" id="Fact000772" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,226</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AF_z44mTML7o006" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_zyR0XnAW9mE6" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2023-03-012024-02-29" id="Fact000774" format="ixt:numdotdecimal" decimals="0" unitRef="USD">18,838</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--Depreciation_c20220301__20230228_zBFlSoyJdpK2" title="Depreciation expense"><ix:nonFraction name="us-gaap:Depreciation" contextRef="From2022-03-012023-02-28" id="Fact000776" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,386</ix:nonFraction></span>, respectively, and is recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company acquired property and equipment of $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_z6fY6DCfUJF2" title="Property and equipment"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2023-03-012024-02-29" id="Fact000778" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,253</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220301__20230228_zjwLTWO2FKJ1" title="Property and equipment"><ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-03-012023-02-28" id="Fact000780" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,928</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000782" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVYFFpNKFXPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_828_zYoY3M4ha6U6">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000784" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zO1HTTvrUDY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zgo5YWMjDBfl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zrDVWbd38xfh" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zmKckj41Tnt5" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zxBbl1Pim1Y" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember" id="Fact000786" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,602,028</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-02-28_us-gaap_SoftwareDevelopmentMember" id="Fact000787" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,908,353</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zD40Mz2DEGui" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_custom_SoftwareLicenseMember" id="Fact000789" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,576</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-02-28_custom_SoftwareLicenseMember" id="Fact000790" format="ixt:numdotdecimal" decimals="0" unitRef="USD">467,576</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zMJpTXH2eG1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_TrademarksMember" id="Fact000792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-02-28_us-gaap_TrademarksMember" id="Fact000793" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zAy0at1JXwz3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29" id="Fact000795" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,397,887</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2023-02-28" id="Fact000796" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,382,212</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zayVjVpyCGAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-02-29" id="Fact000798" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,224,467</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2023-02-28" id="Fact000799" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,774,542</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zQUKwIYoULx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact000801" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2023-02-28" id="Fact000802" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,607,670</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_zy9n6F23RI0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zknujk8DHPWh" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-012024-02-29" id="Fact000804" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,449,925</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20220301__20230228_zo2bRN8czsGi" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-03-012023-02-28" id="Fact000806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">676,853</ix:nonFraction></span>, respectively, and recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000808" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zU58TvfWVn3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The estimated aggregate amortization
expense for each of the succeeding years ending February 28 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zsOopBpmQzkj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20240229_zrlf0dRvuEok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zsH7hkik1xyc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025 (Remaining)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zAXCR42xSU57" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-02-29" id="Fact000812" format="ixt:numdotdecimal" decimals="0" unitRef="USD">660,578</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zxzDuRyyVaTi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-02-29" id="Fact000814" format="ixt:numdotdecimal" decimals="0" unitRef="USD">172,152</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zdfBL5UrbNAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-02-29" id="Fact000816" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,498</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zTfOo78Any02" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_zZD48rJHnVX" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-02-29" id="Fact000820" format="ixt:numdotdecimal" decimals="0" unitRef="USD">845,228</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

</ix:nonNumeric><p id="xdx_8A6_z1aPnAnQzyhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000822" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zvcHrVcdP8Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_823_zRfNrhMYhBJc">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 1, the legal acquisition of NextTrip by Sigma Additive Solutions, Inc. was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 113; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zc5R8nYrAQ5b" title="Consideration transferred"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000824" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></span> million consideration for the acquisition and summarizes the estimated fair
values of the Sigma (the accounting acquiree) assets acquired and liabilities assumed for NextTrip (the accounting acquirer). The estimated
consideration of approximately $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z7yjAcdaE3ah" title="Consideration transferred"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000826" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></span> million is based on Sigma&#8217;s closing share price of $<span id="xdx_90A_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zU7DMtPv8M15" title="Share price"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000828" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.0229</ix:nonFraction></span> as reported on Nasdaq on December
29, 2023 multiplied by the <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_znCS7ZvRdSLb" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-10-12" id="Fact000830" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">780,423</ix:nonFraction></span> shares outstanding as of that date and the fair value of Series E Preferred Stock into <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zQv8pKIWaOL" title="Shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember" id="Fact000832" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,069</ix:nonFraction></span> common
shares.</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000834" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zU0HpIBWcCgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z0FBKE9xRo36" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_493_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zelEWS0SL4vi" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zRblBXCjObF3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">417,121</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_zTUEQnFulc8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts Receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000838" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,900</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zswCb8QG6JF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">257,873</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zzOi4JPFnZhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000842" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,802</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_zvXyQ7boHzP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000844" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,357</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_zXsuhXCfxOgf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,277,919</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zxzxBl7aRk0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000848" format="ixt:numdotdecimal" decimals="0" unitRef="USD">837,450</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zsfUNLIaEDFj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000850" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,001</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zw77aao7ReK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">14,218</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_zgrJKj8JaD1a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total identifiable net assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000854" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,148,303</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z26jriaUM0Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000856" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,220,115</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zmwtgIElz11i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000858" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zd0P6YPMG0Zj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000859" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,368,418</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zbckVppMMHZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#8220;IPO&#8221;) transaction. In the reverse acquisition, $<span id="xdx_906_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzEb0MmaLE96" title="Goodwill"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember" id="Fact000861" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,310</ix:nonFraction></span> of goodwill was allocated
to the Sigma Reporting Unit and $<span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGsUMETXeva7" title="Goodwill"><ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember" id="Fact000863" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction></span> of goodwill was allocated to the NextTrip Reporting Unit under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined Company consists of two reporting units, Sigma and NextTrip. As the accounting acquirer in the reverse acquisition, NextTrip
is considered to be an existing reporting unit and Sigma is considered to be a new reporting unit in that it is not in the same business
as NextTrip. Accordingly, the reverse acquisition creates a new reporting unit which holds the Sigma business constituting an asset held
for sale as a result of the agreement for the sale of certain Sigma assets to Divergent 3D (&#8220;Divergent&#8221;) for a sales price
of $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zpSrraxdgqi7" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember" id="Fact000865" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span>. As such, the fair value of the Sigma Reporting Unit is determined to be $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zFpRVgsbDeg1" title="Purchase price"><ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember" id="Fact000867" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,626,242</ix:nonFraction></span> with the difference of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwsfPzk1AYQ" title="Purchase consideration"><ix:nonFraction name="us-gaap:BusinessCombinationConsiderationTransferred1" contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember" id="Fact000869" format="ixt:numdotdecimal" decimals="0" unitRef="USD">742,176</ix:nonFraction></span> from
the purchase consideration being allocated to the NextTrip Reporting Unit. The assets being sold to Divergent and the liabilities being
relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the net fair value of those
assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned to the NextTrip Reporting
Unit is determined by the difference between the purchase consideration assigned to the NextTrip Reporting Unit and the net acquired
Sigma assets and liabilities assumed that are assigned to the NextTrip Reporting Unit. A gain of $<span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zDq8bEsFkXnl" title="Gain on disposition transaction"><ix:nonFraction name="us-gaap:GainLossOnDispositionOfAssets" contextRef="From2023-10-122023-10-12" id="Fact000871" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,592</ix:nonFraction></span> was recognized in the disposition
transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000873" name="us-gaap:ScheduleOfGoodwillTextBlock"><p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zg3u7Jy9ySTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a reconciliation of goodwill as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zvUpXkpYVqPb" style="display: none">Schedule
of Reconciliation of Goodwill</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zKO6pqSRKh5k" style="border-bottom: Black 1pt solid; text-align: center">February 29,<br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_zJrrrh79dZXd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Reverse acquisition of Sigma Additive Solutions, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:GoodwillAcquiredDuringPeriod" contextRef="From2023-03-012024-02-29" id="Fact000875" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,220,115</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GoodwillPeriodIncreaseDecrease_zk91tNEAKvO" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Reduction from sale of assets to Divergent Technologies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:GoodwillPeriodIncreaseDecrease" contextRef="From2023-03-012024-02-29" id="Fact000877" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">52,310</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--Goodwill_iE_zJxyuoFGa3Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-02-29" id="Fact000879" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zGdVHBz6bLO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000881" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zzAtnE9ulwBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_828_zFgUTuazIHNa">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, the Company had accounts payable of $<span id="xdx_900_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_zJ7LxLORrNQ2" title="Accounts payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrentAndNoncurrent" contextRef="AsOf2024-02-29" id="Fact000883" format="ixt:numdotdecimal" decimals="0" unitRef="USD">531,847</ix:nonFraction></span> and accrued expenses of $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_zIqHsMwACo9" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2024-02-29" id="Fact000885" format="ixt:numdotdecimal" decimals="0" unitRef="USD">460,768</ix:nonFraction></span>, compared to $<span id="xdx_90B_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20230228_zUWaYRq1bFv2" title="Accounts payable"><ix:nonFraction name="us-gaap:AccountsPayableCurrentAndNoncurrent" contextRef="AsOf2023-02-28" id="Fact000887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">519,136</ix:nonFraction></span> of accounts
payable and $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20230228_z7omMexVLLii" title="Accrued expenses"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" contextRef="AsOf2023-02-28" id="Fact000889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329,922</ix:nonFraction></span> of accrued expenses for the year ended February 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000891" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zt0ELRovIo6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_82D_zf2xYgcTWgsg">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting
methods and any available operating loss or tax credit carryforwards. Income tax returns open for examination by the Internal Revenue
Service consist of tax years ended December 31, 2020 through 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 114; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had available at February 29, 2024 unused operating loss carryforwards of approximately $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_c20240229_z38HRGr7T7pa" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2024-02-29" id="Fact000893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,934,000</ix:nonFraction></span> which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zHgrSdoo5Ltj" title="Operating loss carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2017-12-31" id="Fact000895" format="ixt:numdotdecimal" decimals="0" unitRef="USD">9,820,000</ix:nonFraction></span> expire in various years through 2038, and the remainder
of the losses, which total $<span id="xdx_902_ecustom--OperatingLossCarryforwardsRemainder_iI_c20240229_zdEMioKoGRW1" title="Operating loss carryforwards remainder"><ix:nonFraction name="NTRP:OperatingLossCarryforwardsRemainder" contextRef="AsOf2024-02-29" id="Fact000897" format="ixt:numdotdecimal" decimals="0" unitRef="USD">34,114,000</ix:nonFraction></span> can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal
income tax reported purposes are subject to annual limitations. Due to the change in ownership as a result of the reverse acquisition,
the Company&#8217;s net operating loss carryforwards may be limited as to use in future years, and any such limitation will be determined
on a year-to-year basis. The
amount of and ultimate realization of the benefits from the operating loss carryforwards for income tax purposes is dependent, in part,
upon the tax laws in effect, the future earnings of the Company and other future events, the effects of which cannot be determined. Because
of the uncertainty surrounding the realization of the loss carryforwards, the Company has established a valuation allowance equal to
the tax effect of the loss carryforwards and other temporary differences of approximately $<span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zSvOYYN7sno5" title="Valuation allowance loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-02-29" id="Fact000899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250,300</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20230228_z8PrZn3RIhDg" title="Valuation allowance loss carryforwards"><ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-02-28" id="Fact000901" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,575,900</ix:nonFraction></span> at February 29, 2024, and February
28, 2023, respectively, and, therefore, no deferred tax asset has been recognized for the loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000903" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNd78jYTjuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zYyFUyW4r6ha" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_z1Oo3OS6nCDe" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230228_zzbE3PTwvBtj" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Deferred tax assets:</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z5v0R8PH3ck4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NOL carryover</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2024-02-29" id="Fact000905" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">9,226,100</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" contextRef="AsOf2023-02-28" id="Fact000906" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,636,900</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zxWcOEgFZtBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="NTRP:DeferredTaxAssetDepreciation" contextRef="AsOf2024-02-29" id="Fact000908" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">173,900</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zDYqZkOxmHUi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="NTRP:DeferredTaxAssetsPayrollAccruals" contextRef="AsOf2024-02-29" id="Fact000911" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">77,800</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0912">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_zv220t6LFyH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2024-02-29" id="Fact000914" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,772,500</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(<ix:nonFraction name="NTRP:DeferredTaxLiabilitiesDepreciation" contextRef="AsOf2023-02-28" id="Fact000915" format="ixt:numdotdecimal" decimals="0" unitRef="USD">61,000</ix:nonFraction><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"></span></p>

</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_z2ASyRQwcpvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2024-02-29" id="Fact000917" format="ixt:numdotdecimal" decimals="0" unitRef="USD">11,250,300</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(<ix:nonFraction name="us-gaap:DeferredTaxAssetsValuationAllowance" contextRef="AsOf2023-02-28" id="Fact000918" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,575,900</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zXzFF6MQgqz6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_ziO8XR5YC6Ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (<span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230301__20240229_zgHGBAptIrAl" title="Federal statutory tax rate"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220301__20230228_znQlYJRtgStc" title="Federal statutory tax rate"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2023-03-012024-02-29" id="Fact000923" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" contextRef="From2022-03-012023-02-28" id="Fact000925" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">21</ix:nonFraction></ix:nonFraction></span></span>%) to the Company&#8217;s effective
tax rate for the years ended February 29, 2024, and February 28, 2023 is as follows:</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000927" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zi0ZQcldxAfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zijvloCzLQ2e" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_z2YYUz1hkBFc" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220301__20230228_z1yWU06gOZti" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zGDEjhraeT47" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Book Loss</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="NTRP:EffectiveIncomeTaxRateReconciliationBookLoss" contextRef="From2023-03-012024-02-29" id="Fact000929" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,541,200</ix:nonFraction></span></td><td style="text-align: left; width: 1%">)</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="NTRP:EffectiveIncomeTaxRateReconciliationBookLoss" contextRef="From2022-03-012023-02-28" id="Fact000930" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,837,400</ix:nonFraction></span></td><td style="text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zofUGS1KiVQ3" style="vertical-align: bottom; background-color: White">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2023-03-012024-02-29" id="Fact000932" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,100</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation" contextRef="From2022-03-012023-02-28" id="Fact000933" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,700</ix:nonFraction></span></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_z8XrZKhH0CU4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Meals &amp; Entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" contextRef="From2023-03-012024-02-29" id="Fact000935" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_zuvAhcfnaMjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends" contextRef="From2023-03-012024-02-29" id="Fact000938" format="ixt:numdotdecimal" decimals="0" unitRef="USD">422,842</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zU40Yk60iqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2023-03-012024-02-29" id="Fact000941" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,468</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(<ix:nonFraction name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" contextRef="From2022-03-012023-02-28" id="Fact000942" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">48,548</ix:nonFraction></p></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zB1uWN5sMOtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on asset disposal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" contextRef="From2023-03-012024-02-29" id="Fact000944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,274</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0945">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zYultU3MZX65" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" contextRef="From2023-03-012024-02-29" id="Fact000947" format="ixt:numdotdecimal" decimals="0" unitRef="USD">51,857</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0948">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zOREvUGNB4Nl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><ix:nonFraction name="NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" contextRef="From2023-03-012024-02-29" id="Fact000950" format="ixt:numdotdecimal" decimals="0" unitRef="USD">114,928</ix:nonFraction></p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_zvyOGfbriJjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2023-03-012024-02-29" id="Fact000953" format="ixt:numdotdecimal" decimals="0" unitRef="USD">589,431</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" contextRef="From2022-03-012023-02-28" id="Fact000954" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,906,648</ix:nonFraction></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zUNGfoM9NiCk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zy03wzJH66j5" style="margin-top: 0; margin-bottom: 0">&#160;</p>
<!-- Field: Split-Segment; Name: 002 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000959" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_zfGjwMdpqgB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 - <span>Convertible Notes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_82F_zcjiXNu7zabi" style="display: none">&#160;Notes
Payable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 13, 2023 and June 9, 2023, the Company issued $<span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zT1NzGmoiSh" title="Convertible note issued"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000961" format="ixt:numdotdecimal" decimals="0" unitRef="USD">650,000</ix:nonFraction></span> in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQ50vlyxTB0l" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000963" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z4xCXSg7KHhg" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000965" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction> </span>per common share, subject
to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zefV4QXnqyzb" title="Convertible note issued"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000967" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,012,000</ix:nonFraction></span>
in convertible notes upon the receipt of proceeds from several investors. The notes had an interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zlrkSrT4Jgid" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000969" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8</ix:nonFraction></span>%
per annum and were convertible into shares and warrants in a new public company upon the completion of a merger with a Special
Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zbKUUzCrPMte" title="Conversion price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember" id="Fact000971" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span>
per common share, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, in connection with, and contingent upon the acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc.
(the &#8220;Sigma Transaction&#8221;), each investor in a convertible note entered into a Debt Assignment and Conversion Agreement (the
Agreement&#8221;) with NextTrip Group, LLC (&#8220;Group&#8221;) and NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) whereby the notes
and the debt represented thereon were assigned from NextTrip to Group and converted into common units of Group with the equivalent value
on the terms and conditions as set forth in the Agreements. In exchange for entering into the Agreements, each investor received the
right to receive a number of Restricted Sigma Shares, including both Closing Shares and Contingent Shares, to be distributed by the Company
to the investor following the consummation of the Sigma Transaction. The shares are issuable at a price of $<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zGR8q3TDMzO4" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember" id="Fact000973" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span>, and include both principal
and accrued interest thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sigma Transaction was closed on December 29, 2023, and as a result, the Company issued to investors <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqsUNYHhWPY8" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember" id="Fact000975" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></span> Closing Shares, and the right
to receive <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_z6AGxmAKrwXc" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember" id="Fact000977" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,978,598</ix:nonFraction></span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company recorded interest expense of $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230301__20240229_zEF6skVkqLwc" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2023-03-012024-02-29" id="Fact000979" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,213</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--InterestExpenseDebt_c20220301__20230228_zE38lbOK5SE6" title="Interest expense"><ix:nonFraction name="us-gaap:InterestExpenseDebt" contextRef="From2022-03-012023-02-28" id="Fact000981" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,347</ix:nonFraction></span> respectively,
related to the notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 115; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact000983" name="NTRP:SharePurchaseAgreementsDisclosureTextBlock"><p id="xdx_802_ecustom--SharePurchaseAgreementsDisclosureTextBlock_z6OzrSGhEMVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_825_zi3AvZo6IKBf">Share Purchase Agreements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August 10, 2023 and November 6, 2023, NextTrip entered into Share Purchase Agreements with several investors to purchase convertible
shares in NextTrip in exchange for total proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zkDGNfyAmjyd" title="Proceeds from convertible shares"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact000985" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,755,970</ix:nonFraction></span>. Pursuant to the Agreements, the shares were initially convertible into
the common shares of a public company at $<span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zlD2u3RIj5gj" title="Conversion share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember" id="Fact000987" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.15</ix:nonFraction></span> per share. The Agreements further provided that contingent upon the consummation of the
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc., the investors would receive the same number of Sigma
shares in lieu of NextTrip common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, concurrent with the consummation of the acquisition, each investor entered into an Exchange Agreement with Group and
Holdings, whereby such investors exchanged their rights to NextTrip shares for rights to common units of Group of the same value, and
Group distributed to investors, that number of Closing Shares as set forth in the Exchange Agreements. Additionally, upon NextTrip&#8217;s
achievement of each of the milestones as set forth in the Share Exchange Agreement, if ever, Group will further distribute the number
of Contingent Shares in accordance with the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third party consultant in which the Company received
a $<span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zLjiRDF7K6lf" title="Proceeds from downpayment for contract"><ix:nonFraction name="NTRP:ProceedsFromDownpaymentForContract" contextRef="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact000989" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,000</ix:nonFraction></span> down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty
in which the down payment became a noninterest bearing share issuance obligation in which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_za85LrKPJc26" title="Conversion share price"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact000991" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.00</ix:nonFraction></span> per common share, subject to adjustments. On December
29, 2023, upon the consummation of the reverse acquisition transaction with Sigma, the counterparty received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zIDIl91RLXd4" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember" id="Fact000993" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,996</ix:nonFraction></span> Closing Shares and
the right to receive an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_z7tjzC67CDi3" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember" id="Fact000995" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">74,786</ix:nonFraction></span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of Closing Shares issued to investors, inclusive of the third party consultant, on December 29, 2023 was <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zOJnM37Cav2c" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember" id="Fact000997" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></span>, and the
Contingent Shares issuable, if ever, totaled <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z9duZrUSNJ57" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember" id="Fact000999" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">579,954</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant which provided for the
full settlement of $<span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zoHnFPGGnQe3" title="Consulting fees"><ix:nonFraction name="NTRP:ConsultingFees" contextRef="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember" id="Fact001001" format="ixt:numdotdecimal" decimals="0" unitRef="USD">180,000</ix:nonFraction></span> in consulting fees by issuing common shares of Sigma contingent upon the closing of the reverse acquisition.
The reverse acquisition closed on December 29, 2023, pursuant to which Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zJ6aPH88sQ" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember" id="Fact001003" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></span> Closing Shares to the consultant, and the
right to receive <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z6P1MdBd0Rsb" title="Conversion of convertible notes, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember" id="Fact001005" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">162,466</ix:nonFraction></span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001007" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4fwFlGmzgAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_821_zEjXjSrIwhXd">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC, (&#8220;TMT&#8221;), pursuant
to which it purchased the right, title and interest in the &#8220;Bookit&#8221; or &#8220;NextTrip 2.0&#8221; booking engine, including
customer lists, all current content associated with hotel and destination product in the booking engine (pictures, hotel descriptions,
restaurant descriptions, room descriptions, amenity descriptions, and destination information.) and source code related thereto. TMT
is a related entity owned by Don Monaco, the Company&#8217;s Chairman and William Kerby, the Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
due to related parties in 2024 and 2023 was $<span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact001009" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">828,277</ix:nonFraction></span> and $<span id="xdx_904_eus-gaap--NotesPayableCurrent_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2023-02-28_us-gaap_RelatedPartyMember" id="Fact001011" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">281,000</ix:nonFraction></span>, respectively. The amounts due in both years are to William Kerby and
Donald Monaco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a loss of $<span id="xdx_906_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zDkGbGIz5Ivb" title="Loss on related party receivable"><ix:nonFraction name="NTRP:LossOnRelatedPartyReceivable" contextRef="From2023-03-012024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact001013" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction></span> on the NextPlay related party receivable for the year ended February 29, 2024. The total amount
receivable from NextPlay was $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zIJzArv2G1Nk" title="Accounts receivable"><ix:nonFraction name="us-gaap:AccountsReceivableNet" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact001015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,567,665</ix:nonFraction></span> at February 29, 2024. NextPlay is in default under the terms of its promissory note and as a
result the Company established an allowance for doubtful accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zpPYCuk8ayNg" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact001017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction></span> as collectability of the note is uncertain. As of February
28, 2023, <span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zsDbYr6wwLf8" title="Allowance for doubtful accounts"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivable" contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember" id="Fact001019" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> allowance for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001021" name="NTRP:DeferredRevenueTextBlock"><p id="xdx_805_ecustom--DeferredRevenueTextBlock_zYu3Z8tfW1rk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 - <span id="xdx_821_z5cIFTK9nBcc">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue as of the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_z7ib0lWAXqcb" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-02-29" id="Fact001023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">139,921</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--DeferredRevenueCurrent_iI_c20230228_zq2jYnylNuZg" title="Deferred revenue"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2023-02-28" id="Fact001025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,750</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 29, 2024, and February 28, 2023 was driven by cash payments from customers in advance of satisfying our performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001027" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXbavLPv1cZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_820_z9nVLyQGXowd">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#8217;s evaluation of the possible liability or outcome of such litigation
or claims.</span></p>
<!-- Field: Split-Segment; Name: 003 -->
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 116; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001029" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNEbszpW6zla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 &#8211; <span id="xdx_82D_zIYDn08hz347">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20240229_zdPXuaENxOBl" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact001031" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span> shares of common stock authorized. For the years ended February 29, 2024 and February 28, 2023, the Company had
<span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20240229_z6O4gG20NB5j" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_z59S9wWhV7I4" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact001033" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001035" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20230228_z077MhmHx3G" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20230228_zVG6L6TorTP9" title="Common stock, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2023-02-28" id="Fact001037" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2023-02-28" id="Fact001039" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></ix:nonFraction></span></span> shares of common stock, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_z6kfYgJVyEmk" title="Common stock, par value"><span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230228_zMaRPRRhT8vf" title="Common stock, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001041" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2023-02-28" id="Fact001043" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and have one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, we effected a <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_zBMYljCigaF5" title="Reverse stock split"><ix:nonNumeric contextRef="From2023-09-212023-09-22" id="Fact001045" name="us-gaap:StockholdersEquityReverseStockSplit">1-for-20 reverse stock split</ix:nonNumeric></span> of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zYuppuwALY54" title="Reverse stock split issued common shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits" contextRef="From2023-09-222023-09-22" id="Fact001047" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,197</ix:nonFraction></span> common
shares to round-up fractional shares to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effects of the reverse stock split have been retroactively reflected in all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Fiscal
Year Ended February 29, 2024</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September and October 2023, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWGZGVr39j98" title="Share issued and sold during period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001049" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">72,721</ix:nonFraction></span> and <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2ghHiETfBcl" title="Share issued and sold during period, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001051" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">128,887</ix:nonFraction></span> shares of common stock, respectively, through our ATM Agreement, resulting
in net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn3OsLTVbAh6" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">364,555</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zURPciHU4IIj" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember" id="Fact001055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">772,468</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company acquired <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwi7QEBlGU85" title="Equity interest acquired"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember" id="Fact001057" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the outstanding equity interests of NextTrip Holdings, Inc. pursuant to a share exchange
agreement by and among the Company, NextTrip and certain other parties (the &#8220;Acquisition&#8221;). As consideration for the Acquisition,
at closing the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zfLu2SyhkAEk" title="Restricted shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001059" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span> restricted shares of its common stock, constituting <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGnERLiFWTkg" title="Percentage of issued and outstanding common shares"><ix:nonFraction name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" contextRef="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember" id="Fact001061" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">19.99</ix:nonFraction></span>% of its issued and outstanding shares
of common stock immediately prior to execution of the share exchange agreement, and agreed to issue up to an aggregate of <span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zdX4wd4V60I2" title="Shares issuable for consideration"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001063" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span> shares
as further consideration upon NextTrip&#8217;s achievement of certain milestones set forth in the exchange agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zQykeyPefPC8" title="Restricted shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001065" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction></span> restricted shares issued at closing, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zXYNTfVXNad9" title="Shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember" id="Fact001067" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">52,818</ix:nonFraction></span> shares were issued pursuant to the Debt Assignment and Conversion agreements,
<span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zDAMv4JKQOpf" title="Purchase of shares issued"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember" id="Fact001069" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,481</ix:nonFraction></span> shares were issued pursuant to the Share Purchase and Exchange Agreements, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zJeY2RmCbsNa" title="Shares issued during period services"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember" id="Fact001071" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,337</ix:nonFraction></span> shares were issued to a third-party consultant.
Pursuant to ASC 805-40-45-1,the remaining <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z3rNaVTKm6jl" title="Shares issued in acquisitions"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember" id="Fact001073" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></span> Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#8217;s
legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal
parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended February 29, 2024 and February 28, 2023, the Company did not issue any shares of common stock to employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 117; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our articles of incorporation, our board of directors has the authority, without further action by stockholders, to designate one or
more series of preferred stock and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights
granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption,
liquidation preference and sinking fund terms, any or all of which may be preferential to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_z5brbXuhefm3" title="Preferred stock, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230228_ztskdZjb6CMd" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact001075" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2023-02-28" id="Fact001077" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_zMIhTuxIBrI" title="Preferred stock, par value"><span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230228_z7ls9C5dadnf" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001079" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2023-02-28" id="Fact001081" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value. <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zUu8VGlmUkI1" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zVWi8hP0ocs1" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact001083" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001085" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20230228_zPRS5vZzceB1" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20230228_zNGYECD7rzai" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2023-02-28" id="Fact001087" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2023-02-28" id="Fact001089" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></ix:nonFraction></span></span> shares of preferred stock were
issued and outstanding at February 29, 2024 and February 28, 2023. respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zZDArrmFJj8k" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,500</ix:nonFraction></span>
per share (the &#8220;Stated Value&#8221;). Dividends at the initial rate of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zke1y58qXVIe" title="Dividends percentage"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001093" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span>% per annum will accrue and, on a monthly basis, shall
be payable in kind by the increase of the Stated Value of the Series E Preferred Stock by said amount. The holders of the Series E Preferred
Shares have the right at any time to convert all or a portion of the Preferred Shares (including, without limitation, accrued and unpaid
dividends and make-whole dividends through the third anniversary of the closing date) into shares of the Company&#8217;s Common Stock
at an initial conversion rate determined by dividing the Conversion Amount by the Conversion Price ($<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zV53xYW3Df13" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001095" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction></span> above the consolidated closing
bid price for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the
Stated Value of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E
Preferred Shares being converted plus the &#8220;Make Whole Amount&#8221; (the amount of any dividends that, but for the conversion,
would have accrued at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate
is also subject to adjustment for stock splits, dividends recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z48xCbsCYbg2" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zqcyJYBE0U5e" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001097" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001099" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></ix:nonFraction></span></span> shares of the issued Series E Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, including the make-whole dividends, would have resulted in the issuance of <span id="xdx_909_eus-gaap--CommonStockDividendsShares_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zHqKlJquvT74" title="Issuance of common stock dividends, shares"><ix:nonFraction name="us-gaap:CommonStockDividendsShares" contextRef="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember" id="Fact001101" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,155</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;)
with the Secretary of State of the State of Nevada, designating <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z8PQtH1UBGKe" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact001103" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span> shares of the Company&#8217;s preferred stock as Series F Convertible
Preferred Stock, par value $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z6sLeL4FDyG" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact001105" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share (the &#8220;Series F Preferred&#8221;). The Series F Preferred was designated by the Company
in connection with its recent acquisition of NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;), and, in the event that the Company does
not have sufficient shares of common stock available to fulfill its obligations pursuant to the share exchange agreement governing the
terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares of
Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ranking</i></b><i>.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 118; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b><i>.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting</i></b>.
Except as provided by the Company&#8217;s amended and restated articles of incorporation, as amended (&#8220;Articles&#8221;) or as otherwise
required by the Nevada Revised Statutes, holders of Series F Preferred are entitled to vote with the holders of outstanding shares of
Company common stock, voting together as a single class, with respect to all matters presented to the Company&#8217;s stockholders for
their action or consideration. In any such vote, each holder is entitled to a number of votes equal to the number of shares of Common
Stock into which the Series F Preferred held by such holder is convertible. The Company may not, without the consent of holders of a
majority of the outstanding shares of Series F Preferred, (i) alter or change adversely the powers, preferences or rights given to the
Series F Preferred or alter or amend the Certificate of Designation, (ii) amend its Articles or other charter documents in any manner
that adversely effects any rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion</i></b>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Conversion
Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#8220;Liquidation&#8221;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zHCMb7Uyrswj" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29_custom_SeriesFConvertiblePreferredStockMember" id="Fact001107" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span> shares of the Series F Convertible Preferred Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvwrZFxYRrfe" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact001109" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> shares of the Company&#8217;s preferred
stock as Series G Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zlrEX0qVjs1c" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact001111" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 119; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_904_eus-gaap--PreferredStockRedemptionTerms_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z92mrP7ixfGl" title="Preferred stock redemption right, description"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_SeriesGConvertiblePreferredStockMember" id="Fact001113" name="us-gaap:PreferredStockRedemptionTerms">The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, all <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvKCVyQ8I033" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztuD2BzyPIbd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember" id="Fact001115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember" id="Fact001117" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></ix:nonFraction></span></span> shares of the issued Series G Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zxhWrseSBlxb" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember" id="Fact001119" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zUokPnKpbPlc" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact001121" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span> shares of the Company&#8217;s preferred
stock as Series H Preferred Stock, par value $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zHDSE5AH5XCf" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact001123" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z12MNeQBJqAc" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkbIykyl0Sah" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember" id="Fact001125" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember" id="Fact001127" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></ix:nonFraction></span></span> shares of the issued Series H Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_90C_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zBeba8KNeNg2" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember" id="Fact001129" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Series I Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1bmw1gvIbI8" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact001131" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">331,124</ix:nonFraction></span> shares of the Company&#8217;s preferred
stock as Series I Convertible Preferred Stock, par value $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zYpQFKtIHEd6" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact001133" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 120; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUt5kE0H2lHd" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zE1gCqn985zd" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember" id="Fact001135" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember" id="Fact001137" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,680</ix:nonFraction></ix:nonFraction></span></span> shares of the issued Series I Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_900_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zMWKmZWfJUZa" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember" id="Fact001139" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,680</ix:nonFraction></span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, we had outstanding options under our 2013 Equity Incentive Plan to purchase an aggregate of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zRP7PwC4bESj" title="Common stock shares option outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember" id="Fact001141" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></span> shares of our
common stock at a weighted-average exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zkpdcyPeZOq7" title="Weighted average exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember" id="Fact001143" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.50</ix:nonFraction></span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, our stockholders approved our 2023 Equity Incentive Plan which has reserved for issuance <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zzIzNj75aTj6" title="Common stock shares reserved for issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001145" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></span> shares of common
stock for equity awards of which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20231228__20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPNmSrpCeLfl" title="Common stock shares equity award issued or granted"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" contextRef="From2023-12-282023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001147" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">0</ix:nonFraction></span> shares have been issued or granted thereunder to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan. <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zpOTycNoRt7e" title="Common stock shares reserved for issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-02-29_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact001149" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction></span> shares of common stock have been reserved for issuance under the Plan., and as of February
29, 2024, all such shares are available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2024, the Company did not grant any options. In fiscal year 2024, <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230301__20240229_zvlmM07Srh2h" title="Share based compensation arrangement by award options vested"><ix:nonFraction name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" contextRef="From2023-03-012024-02-29" id="Fact001151" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,914</ix:nonFraction></span> options vested and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229_zK0Yhq1ApaXd" title="Alloacted share based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-03-012024-02-29" id="Fact001153" format="ixt:numdotdecimal" decimals="0" unitRef="USD">116,512</ix:nonFraction></span> of compensation cost
was recognized during the year. As of February 29, 2024, there were options to purchase <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zP10NLomDqaa" title="Share based compensation arrangement by award options vested outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_us-gaap_StockOptionMember" id="Fact001155" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></span>, shares issued and outstanding, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenPlanMember_zNmPle8JY4wc" title="Share based compensation arrangement by award options vested outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_custom_TwoThousandThirteenPlanMember" id="Fact001157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">82,800</ix:nonFraction></span>
of which have been issued under an Equity Incentive Plan. At February 29, 2024, there are vested options exercisable for <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229_z8NyHWp8vA93" title="Stock issued during Stock options exercised"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-02-29" id="Fact001159" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,849</ix:nonFraction></span> shares
of common stock. <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20230301__20240229_zbhvWNXct6Ul" title="Share based compensation arrangement by award options grants"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-03-012024-02-29" id="Fact001161" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">No</ix:nonFraction></span> options to purchase shares of common stock were exercised during the fiscal year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 121; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#8217;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed options to purchase up to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__srt--RangeAxis__srt--MaximumMember_zGr1Oeir1278" title="Options to purchase of common stock"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-03-012024-02-29_srt_MaximumMember" id="Fact001163" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">86,402</ix:nonFraction></span> shares of common
stock. Between December 29, 2023 and February 29, 2024, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zGEUxmzAgXj7" title="Options to forfeited or expired"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-12-292024-02-29" id="Fact001165" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,342</ix:nonFraction></span> options were forfeited or expired and no options were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
employee share-based compensation expense for the year ended February 29, 2024, was $<span id="xdx_901_eus-gaap--ShareBasedCompensation_pp0p0_c20230301__20240229_zV4g3sIm8nFe" title="Allocation share based compensation expense"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2023-03-012024-02-29" id="Fact001167" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">116,512</ix:nonFraction></span> all of which is related to stock options.
There was no capitalized share-based compensation cost as of February 29, 2024,and there were no recognized tax benefits during the fiscal
year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
estimate the value of an award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as expected
life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate compensation. These inputs
are subjective and generally require significant analysis and judgment to develop. While estimates of expected life, volatility and forfeiture
rate are derived primarily from the Company&#8217;s historical data, the risk-free rate is based on the yield available on U.S. Treasury
constant maturity rates with similar terms to the expected term of the stock option awards. The fair value of outstanding share-based
awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the outstanding options assumed
at February 29, 2024:</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001169" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zCSFN88TgWY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z4z3kIBvCuj8" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229_zlqBKDyoFgY8" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-03-012024-02-29" id="Fact001171" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230301__20240229_z24o0jAfRhXi" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-03-012024-02-29" id="Fact001173" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.19</ix:nonFraction></span>-<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230301__20240229_zXow7RiQAIG9" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-03-012024-02-29" id="Fact001175" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.05</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229_zCWw7cqUHXWa" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-03-012024-02-29" id="Fact001177" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.2</ix:nonFraction></span>
&#8211; <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229_zgJO7kFpKlt" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-03-012024-02-29" id="Fact001179" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">122.8</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229_zKwZJiTg4pi" title="Expected life"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001181" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A9_z6zJScHF9FIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001183" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zvt35IMaoIba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zv8wFumeSark" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zL5oyH2qQuw" title="Number of Options Outstanding, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z8EFvLeepenc" title="Weighted Average Exercise Price Outstanding, Balance" style="padding-bottom: 2.5pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zaB5PLhfK0Ph" title="Number of Options, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact001189" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">86,642</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zz1jKHvhOtGl" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact001191" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">61.43</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zWl06Az60yuj" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001193" name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">2.68</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_zvEB5RHJsxR" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20230301__20240229_zJfFwargF1u5" title="Number of Options, Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-03-012024-02-29" id="Fact001197" format="ixt:zerodash" decimals="INF" unitRef="Shares">-</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zY9C4qfMfa8f" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zsYzXXft9K14" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zZ2EpPMLJcUk" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-03-012024-02-29" id="Fact001203" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,342</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zD2IrqUFHol7" title="Weighted Average Exercise Price, Forfeited or cancelled" style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact001205" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">120.87</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zzjupgviHw64" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229_z7B8b01yMc1l" title="Number of Options Outstanding, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact001209" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zCHV3vEAkOWb" title="Weighted Average Exercise Price Outstanding, Balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001211" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_zZ6ysKBr6t61" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001213" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.52</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229_zgYMEo2TQSI4" title="Aggregate Intrinsic Value Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229_zl7BChXnnYmf" title="Number of Options, Expected to Vest in the Future Ending Balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact001217" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,451</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_z5BTVBA85kH3" title="Weighted Average Exercise Price, Expected to Vest" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001219" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">33.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zSt28PDX2av4" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001221" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.54</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_zQoDu2MU2Eak" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Options exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229_zRnyakrA8o0k" title="Number of Options, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-02-29" id="Fact001225" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">81,849</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zjOzwRU1Mwb3" title="Weighted Average Exercise Price, Exercisable" style="padding-bottom: 1.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001227" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">61.64</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zbWURQG1Spfk" title="Weighted Average Remaining Contractual Life Years, Exercisable"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001229" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">2.48</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229_zztpefCeawxe" title="Aggregate Intrinsic Value, Outstanding, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20220301__20240229_zXolw9eI5SH5" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2024-02-29" id="Fact001233" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230301__20240229_zWzXYpZ4o3sg" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001235" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.50</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zrVYE3TZ1ugd" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001237" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.52</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_ztzN5ewEdRwe" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1239">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_z6NsUfUTtzbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 122; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zub2aAN1mcEk" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-03-012024-02-29" id="Fact001241" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.99</ix:nonFraction></span> closing price of our Common Stock on February 29, 2024.
All of the outstanding option grants have an exercise price above $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zEtxbW0EJI42" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-03-012024-02-29" id="Fact001243" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.99</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, there was $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240229_zKF4Hz2QOcBi" title="Unrecognized stock-based compensation expense, stock option"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-02-29" id="Fact001245" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52,615</ix:nonFraction></span> of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of <span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230301__20240229_ziIqWCowrmg6" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001247" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">0.97</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan are to: (i) enable the Company to attract and retain the types of employees, consultants,
and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the Company&#8217;s long-range success; (ii) provide
incentives that align the interests of Service Providers with those of the shareholders of the Company; and (iii) promote the success
of the Company&#8217;s business. The Plan provides for incentive awards that are only made in the form of stock appreciation rights payable
in cash (&#8220;SARs&#8221;). No shares of common stock were reserved in connection with the adoption of the Plan since no shares will
be issued pursuant to the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#8217;s
common stock (&#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a Share on the date of grant of the SAR. The administrator
of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including, without limitation,
the exercise price and medium of payment and vesting provisions, and to specify the provisions of the SAR Agreement relating to such
grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zK4731N3g1H2" title="Reverse acquisition shares outstanding"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2023-12-29_custom_StockAppreciationRightsMember" id="Fact001249" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></span>
outstanding SARs. Between December 29, 2023 and February 29, 2024, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zg9YZD4oXUT2" title="Shares forfeited or expired::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1251">none </span></span>
were forfeited or expired and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zM310cGJGHnj" title="Shares issued or exercised::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1253">no</span></span>
SARs were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 123; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#8217;s are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation&#8221;,
and any changes in fair value are reflected in income as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" escape="true" id="Fact001255" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ztgRBeF7azpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zxxYOHHfTTl" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zeMJPz4xb8c9" title="Dividend yield"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001257" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zVQRqsNLQFdk" title="Risk-free interest rate, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001259" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.22</ix:nonFraction></span>-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z68qM2z7c3Ig" title="Risk-free interest rate, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001261" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.79</ix:nonFraction></span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zUj9ZmcPkHD8" title="Expected volatility, minimum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001263" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">108.7</ix:nonFraction></span>-<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zz7P4VAvaol8" title="Expected volatility, maximum"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001265" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">122.8</ix:nonFraction></span>.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zBoe9PbkKj6g" title="Expected life"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" format="ixt-sec:duryear" id="Fact001267" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">5</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A2_zbY86XLr6Pk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" escape="true" id="Fact001269" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlXLys9C9ZSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zadJEwVq53t9" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">SARs</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zIMrjeHePj35" title="Number of Options, Outstanding, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BWnETrCiK9" title="Weighted Average Exercise Price, Outstanding Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3uHP9IIpJ87" title="Aggregate Intrinsic Value, Outstanding Balance" style="border-bottom: Black 2.5pt double; text-align: right">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1275">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zTMm3uDNFvv7" title="Number of Options, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="Fact001277" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ziXzJa6obGb5" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="Fact001279" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYJdEJuxiedl" title="Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001281" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2">2.99</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5b1ZtwhFD19" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition" style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsBzFm61Ph3b" title="Number of Options, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1285">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zZ0UbNEnJHid" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3Bd1iutlFWd" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1289">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zylDxWQAfTI8" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zU4OglGs21U6" title="Weighted Average Exercise Price, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1293">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zinJJy9TCc43" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1295">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9wmQesIStRd" title="Number of Options, Outstanding, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001297" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zyDj4FH9HK81" title="Weighted Average Exercise Price, Outstanding Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001299" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVcT60xoQFz2" title="Weighted Average Remaining Contractual Life, Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001301" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.99</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BSIEor05T7" title="Aggregate Intrinsic Value, Outstanding Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1303">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zLTUmsNO1Yt1" title="Number of Options, Expected to vest in the future, Balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001305" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,886</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zzRQbOq9DgRh" title="Weighted Average Exercise Price, Expected to Vest" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001307" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">35.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeCcVa7Qq63a" title="Weighted Average Remaining Contractual Life, Expected to Vest"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001309" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.23</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmrqn5p3GF3" title="Aggregate Intrinsic Value, Options expected to vest in the future" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">SARs exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zG4hQA0mO2t1" title="Number of Options, Exercisable" style="margin-top: 0; margin-bottom: 0"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001313" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,504</ix:nonFraction></p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqob0xu8E512" title="Weighted Average Exercise Price, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001315" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">46.72</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlhYOyZZ3Ts1" title="Weighted Average Remaining Contractual Life, Exercisable"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001317" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">2.93</ix:nonNumeric></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znL79OeYO0Ah" title="Aggregate Intrinsic Value, Options exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1319">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHitT1NzTBG" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001321" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr7jfmrcrhlf" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact001323" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zXmPLCf4Myf2" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact001325" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.99</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9EPt7KsGdW1" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1327">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AC_z8EcsBDOKQd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z6Nd0rKWCYO1" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001329" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.99</ix:nonFraction></span> closing price of our common stock on February 29, 2024.
All the SARs have an exercise price above $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zMkAecVhRf16" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001331" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.99</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended February 29, 2024, $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zj9Eq7Xktc02" title="Share based compensation expense"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001333" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,107</ix:nonFraction></span> of share-based compensation
expense was recognized, and at
February 29, 2024, there was $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zbrXhhMaIAOi" title="Unrecognized share based compensation cost"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" contextRef="AsOf2024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" id="Fact001335" format="ixt:numdotdecimal" decimals="0" unitRef="USD">79,978</ix:nonFraction></span> of unrecognized share-based compensation expense related to unvested SARs with a weighted average
remaining recognition period of <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9SZl3WOrm2" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember" format="ixt-sec:duryear" id="Fact001337" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod">1.08</ix:nonNumeric></span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 124; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, the Company had outstanding warrants to purchase a total of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1TolQeLPCJa" title="Purchase of outstanding warrants"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="AsOf2024-02-29_us-gaap_WarrantMember" id="Fact001339" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></span> shares of common stock. The warrants have exercise
prices that range from $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z9IQaBG5q4Uf" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-02-29_us-gaap_WarrantMember_srt_MinimumMember" id="Fact001341" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></span> to $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zmqGGQl9ICW3" title="Warrants exercise price"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-02-29_us-gaap_WarrantMember_srt_MaximumMember" id="Fact001343" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">350.00</ix:nonFraction></span>, which if not exercised, will <span id="xdx_90E_ecustom--DescriptionForWarrantExpiration_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztfAS2ujet98" title="Warrant description"><ix:nonNumeric contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember21736515" id="Fact001345" name="NTRP:DescriptionForWarrantExpiration">expire between March 15, 2024 and January 25, 2028</ix:nonNumeric></span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001347" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAn9vYBnJnsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zUiVstpbRCj6" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zR5hqo54MQY2" title="Warrants Outstanding, Beginning Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_zrZt9l6sCFPa" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zimhzZ6B6gu4" title="Warrants, Assumed pursuant to reverse acquisition" style="width: 14%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact001353" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">217,593</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zItCnLIOnlZk" title="Weighted Average Exercise Price Outstanding, Assumed pursuant to reverse acquisition" style="width: 14%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact001355" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">21.01</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zZRTn3tQrpq3" title="Weighted Average Remaining Contractual Life Years, Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001357" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">1.86</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zhNYRpssB0ll" title="Warrants, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2023-03-012024-02-29" id="Fact001359" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">268,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z1odbqFbJVnf" title="Weighted Average Exercise Price Outstanding, Granted" style="text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact001361" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zJqwOa61FR59" title="Weighted Average Remaining Contractual Life Years, Granted"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001363" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm">2.17</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zC2dnuNAPTd1" title="Warrants,Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zi59YJj7Maqj" title="Weighted Average Exercise Price Outstanding,Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zVRAagQpbom3" title="Warrants, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1369">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zFBndNbq2Spk" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230301__20240229_zx79BkwEf9Lh" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact001373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zcqN1mm6SkP1" title="Weighted Average Exercise Price Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact001375" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zQae4W9B7KIe" title="Weighted Average Remaining Contractual Life Years, Ending Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact001377" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm">1.96</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<!-- Field: Split-Segment; Name: 004 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 125; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001379" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zQks9xozp2hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_827_zxwb1l59OIdg">Loss Per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001381" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zushP6iSTtB3" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012024-02-29" id="Fact001383" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,656,837</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2022-03-012023-02-28" id="Fact001384" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2023-03-012024-02-29" id="Fact001386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,125</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-03-012024-02-29" id="Fact001389" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,663,962</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-03-012023-02-28" id="Fact001390" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2023-03-012024-02-29" id="Fact001392" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">675,314</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012024-02-29" id="Fact001395" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">7,339,276</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2022-03-012023-02-28" id="Fact001396" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,033,496</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-03-012024-02-29" id="Fact001398" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">228,274</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-03-012023-02-28" id="Fact001399" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">71,581</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AD_zlQzZ3pJf9ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented as the Company&#8217;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 29, 2024, the Company had outstanding
warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXqYqquStvY1" title="Class of warrant or right, outstanding"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="AsOf2024-02-29_us-gaap_WarrantMember" id="Fact001401" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></span> shares of common stock, and stock options exercisable for <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbXxvXGt6d9b" title="Share-based compensation arrangement by share-based payment award, options, exercisable, number"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember" id="Fact001403" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></span> shares of common stock, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8tPW1RFQfZk" title="Conversion of stock, shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember" id="Fact001405" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></span> shares of Series
E Preferred Stock, which could be converted into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zzNjMDxQbtok" title="Common stock issued conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember" id="Fact001407" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,155</ix:nonFraction></span> shares of common stock, <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zwtAF3a119s6" title="Conversion of stock, shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember" id="Fact001409" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> shares of Series G Preferred Stock, convertible
into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zBD7Nr10xJCf" title="Common stock issued conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember" id="Fact001411" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction></span> shares of common stock, <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z2OH8cgJ4ROh" title="Conversion of stock, shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember" id="Fact001413" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span> shares of Series H Preferred Stock, convertible into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z7Tpm96ol8J2" title="Common stock issued conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember" id="Fact001415" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span> shares of common stock, and
<span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zmttEAvTtFjd" title="Conversion of stock, shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember" id="Fact001417" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,680</ix:nonFraction></span> shares of Series I Preferred Stock, convertible into <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zsgYdnPTDTyh" title="Common stock issued conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember" id="Fact001419" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">222,680</ix:nonFraction></span> shares of common stock, resulting in a potential total additional
<span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeOcBMTpquwk" title="Common stock, shares, outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember" id="Fact001421" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,047,300</ix:nonFraction></span> shares of common stock outstanding in the future. At February 28, 2023, the Company had <span id="xdx_90D_eus-gaap--DilutiveSecurities_do_c20220301__20230228_zSbJoHq6qtRk" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:DilutiveSecurities" contextRef="From2022-03-012023-02-28" id="Fact001423" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span> outstanding potentially dilutive
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001425" name="us-gaap:ConcentrationRiskDisclosureTextBlock"><p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_zQRr4cPefesf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 &#8211; <span id="xdx_826_z647dKS4EwH9">Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues
</b>&#8211; During the years ended February 29, 2024 and February 28, 2023, the Company did not have any significant customers who accounted
for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFyLlnfyYKah" title="Concentration of risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zkS3zcxl0UZ3" title="Concentration of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001427" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001429" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% each of the Company&#8217;s revenue in at least one of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts
Receivable</b> &#8211; The Company had no significant customers who accounted for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFSyWAwvlpGl" title="Concentration of risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVmX3RPcPRrf" title="Concentration of risk percentage"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001431" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure"><ix:nonFraction name="us-gaap:ConcentrationRiskPercentage1" contextRef="From2022-03-012023-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember" id="Fact001433" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></ix:nonFraction></span></span>% each of the Company&#8217;s accounts
receivable balance at February 29, 2024 and February 28, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001435" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock"><p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_z29jvcWYNCma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 - <span id="xdx_821_z8ASVaHXhRxl">Defined Contribution Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The
Company has adopted two qualified 401(K) plans (&#8220;the Plans&#8221;), in which all employees over the age of 21 may participate.
Depending on the Plan, <span id="xdx_904_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230301__20240229_zoL9Bx6vk6pd" title="Contribution plan description"><ix:nonNumeric contextRef="From2023-03-012024-02-29" id="Fact001437" name="us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">the
Company makes either a Safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</ix:nonNumeric></span>. The matching
contributions were $<span id="xdx_90C_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240229_z41hV0F4dkse" title="Cost of contribution"><ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="From2023-03-012024-02-29" id="Fact001439" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,112</ix:nonFraction></span>
in 2024 and $<span id="xdx_905_eus-gaap--DefinedContributionPlanCostRecognized_c20220301__20230228_zXQAogfHZkMg" title="Cost of contribution"><ix:nonFraction name="us-gaap:DefinedContributionPlanCostRecognized" contextRef="From2022-03-012023-02-28" id="Fact001441" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,997</ix:nonFraction></span>
in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 126; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2023-03-012024-02-29" escape="true" id="Fact001443" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zFiz1sHsZGB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_82F_z1BjGDx7xlv4">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 8, 2024, the Company held a Special Meeting of Stockholders in a virtual format. The following proposals, constituting all of the
proposals, were voted on by stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 1: </b>The Company&#8217;s stockholders approved an amendment to the Current Articles of Incorporation to change the Company&#8217;s
    corporate name to &#8220;NextTrip, Inc.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 2:</b> The Company&#8217;s stockholders approved an amendment to the Current Articles to increase the number of shares of Company
    common stock authorized for issuance thereunder from <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20240307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB77jDUYEfY" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-07_us-gaap_SubsequentEventMember" id="Fact001445" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span> shares to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240308__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7SuTkZwWo79" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-08_us-gaap_SubsequentEventMember" id="Fact001447" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span> shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 3:</b> The Company&#8217;s stockholders approved the adjournment of the Special Meeting by the chairman thereof to a later date
    to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are
    not sufficient votes to approve either of the foregoing proposals.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Proposal No. 3 was approved by the Company&#8217;s stockholders, the chairman of the Special Meeting did not elect to adjourn the meeting,
as both of the other two proposals were also approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma Additive Solutions, Inc. (the &#8220;Company&#8221;) filed a Certificate of Amendment to its Amended and Restated
Articles of Incorporation (the &#8220;Charter Amendment&#8221;), as amended to date (the &#8220;Current Articles&#8221;), with the Secretary
of State of the State of Nevada, pursuant to which (i) the Company&#8217;s corporate name was changed from Sigma Additive Solutions,
Inc. to &#8220;NextTrip, Inc.&#8221; (the &#8220;Name Change&#8221;), and (ii) the number of shares of Company common stock authorized
for issuance under the Current Articles was increased from <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20240310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztIWndeDhoC7" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-10_us-gaap_SubsequentEventMember" id="Fact001449" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span> shares to <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20240311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTQ7uGmpz7Ul" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-11_us-gaap_SubsequentEventMember" id="Fact001451" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span> shares (the &#8220;Increase in Authorized).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Name Change, effective as of the open of the market on March 13, 2024, the Company&#8217;s common stock began trading
on the Nasdaq Capital Market under the new ticker symbol &#8220;NTRP&#8221; (the &#8220;Ticker Symbol Change&#8221;). The CUSIP of the
Company&#8217;s common stock remained unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2024, the Company&#8217;s Board of Directors approved the Company to enter into an unsecured promissory note for a line of
credit with Messrs. Monaco and Kerby, the Company&#8217;s Chairman of the Board of Directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zNQOLXIgAsfk" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember" id="Fact001453" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction></span>. Under the terms of the note, advances under the line of credit may be made at the Company&#8217;s
request until May 31, 2024. The note bears an annual interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zxrmgW74qKR3" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember" id="Fact001455" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% and matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20240315__20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zVbVfuKyUiB" title="Maturity date"><ix:nonNumeric contextRef="From2024-03-152024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember" format="ixt:datemonthdayyearen" id="Fact001457" name="us-gaap:DebtInstrumentMaturityDate">February 28, 2025</ix:nonNumeric></span>, and may be prepaid by the
Company at any time prior to maturity without penalty. As of April 19, 2024, the full principal amount of the note had been advanced
to the Company and remains outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 25, 2024, the Company&#8217;s Board of Directors approved the Company to enter into a series of unsecured promissory notes
with certain related parties, including investors, directors, officers and employees, who shall individually provide funds for the
aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zg81RIUL8qU3" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember" id="Fact001459" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>.
The notes bear an annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlLOyoRZ9K5" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember" id="Fact001461" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>%
and shall mature <span id="xdx_909_eus-gaap--DebtInstrumentTerm_dc_c20240425__20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzuwFbgvkCFe" title="Debt instrument, term"><ix:nonNumeric contextRef="From2024-04-252024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember" format="ixt-sec:durwordsen" id="Fact001463" name="us-gaap:DebtInstrumentTerm">one
year</ix:nonNumeric></span> from the date of each note&#8217;s execution, and may be prepaid by the Company at any time prior to maturity without
penalty. On August 14, 2024, the Board of Directors approved an increase in the aggregate principal amount of the unsecured
promissory notes to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3iq9JV8rSrh" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-08-14_us-gaap_SubsequentEventMember" id="Fact001465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction></span>.
As of August 31, 2024, $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20240831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxYGxDcGos9g" title="Outstanding payment"><ix:nonFraction name="us-gaap:NotesPayable" contextRef="AsOf2024-08-31_us-gaap_SubsequentEventMember" id="Fact001467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,416,553</ix:nonFraction></span>
had been advanced to the Company and remains outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company received a notification letter (the &#8220;Initial Notice&#8221;) from the Listing Qualifications Department
of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) advising the Company that it was not in compliance with Nasdaq&#8217;s continued
listing requirements under Nasdaq Listing Rule 5250(c)(1) (the &#8220;Rule&#8221;) as a result of its failure to timely file its Annual
Report on Form 10-K for the fiscal year ended February 29, 2024 (the &#8220;Form 10-K&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2024, the Company received an additional notification letter (the &#8220;Additional Notice,&#8221; and together with the Initial
Notice, the &#8220;Notices&#8221;) from Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for
the quarter ended May 31, 2024 (the &#8220;Form 10-Q&#8221;), and because the Company remains delinquent in filing the Form 10-K, the
Company remains noncompliant with the Rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
of the Notices have an immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore,
the Company&#8217;s listing remains fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notices require the Company to either file the delinquent Form 10-K and Form 10-Q with the Commission or submit a plan to regain compliance
with the Rule by August 16, 2024. If Nasdaq accepts the Company&#8217;s plan, then Nasdaq may grant an exception of up to 180 calendar
days from the Form 10-K&#8217;s due date, or until December 10, 2024, to regain compliance. If Nasdaq does not accept the Company&#8217;s
plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel under Nasdaq Listing Rule 5815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 16, 2024, the Company submitted a plan to Nasdaq regain compliance with the Rule, including the steps the Company will take to
promptly file the Form 10-Q and regain compliance. The Company has requested an extension until September 30, 2024. There can be no assurance
that the Company will regain compliance with the Rule, secure an exception until September 30, 2024 to regain compliance, or maintain
compliance with other Nasdaq listing requirements.</span></p>

</ix:nonNumeric><p id="xdx_811_zYGKSeik3yN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 127; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED BALANCE SHEETS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_111_z4uLfmOGmZxa" summary="xdx: Statement - Condensed Consolidated Balance Sheets" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240831_zH2Kq8nRIJE7" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">August
                                            31, 2024</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">(unaudited)</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_495_20240229_zaHF36qjzAma" style="border-bottom: Black 1pt solid; text-align: center">February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--AssetsAbstract_iB_zQiHuSJW312c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">ASSETS</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i01I_pp0p0_zSmDxL3ifoO3" style="vertical-align: bottom; background-color: White">
    <td style="width: 60%; text-align: left; padding-left: 10pt">Cash and cash equivalents</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-08-31" id="Fact001472" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,006</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsAtCarryingValue" contextRef="AsOf2024-02-29" id="Fact001473" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--PromissoryNoteReceivableNet_i01I_pp0p0_zpFfk2DfFFBk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Promissory note receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2024-08-31" id="Fact001475" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:PromissoryNoteReceivableNet" contextRef="AsOf2024-02-29" id="Fact001476" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,000,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--AccountsReceivableNetCurrent_i01I_pp0p0_zg4iJpnEN2B" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-left: 10pt">Accounts receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-08-31" id="Fact001478" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">11,201</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsReceivableNetCurrent" contextRef="AsOf2024-02-29" id="Fact001479" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,082</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_pp0p0_zMFlblIdHtN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Prepaid expenses and other current assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-08-31" id="Fact001481" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">244,870</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2024-02-29" id="Fact001482" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">340,921</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AssetsCurrent_i01TI_pp0p0_zcJHHPCPbzod" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Current Assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-08-31" id="Fact001484" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,358,077</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-02-29" id="Fact001485" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,698,808</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--AssetsNoncurrentAbstract_i01B_pp0p0_zK29dRsXRDPb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Non-Current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--PropertyPlantAndEquipmentNet_i02I_pp0p0_zaC646pbiLX3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-08-31" id="Fact001490" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,703</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2024-02-29" id="Fact001491" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">6,642</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i02I_pp0p0_zsPrYAlpJXr1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Intangible assets, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-08-31" id="Fact001493" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,310,927</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact001494" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--SecurityDeposit_i02I_pp0p0_zyGo7ZcR0S59" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Security deposit</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-08-31" id="Fact001496" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">45,167</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SecurityDeposit" contextRef="AsOf2024-02-29" id="Fact001497" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">42,167</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--Goodwill_i02I_pp0p0_zERDIXUTHRjc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; padding-left: 10pt">Goodwill</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-08-31" id="Fact001499" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2024-02-29" id="Fact001500" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,167,805</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--AssetsNoncurrent_i02TI_pp0p0_z7SRtKRlwJVg" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Non-Current Assets</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-08-31" id="Fact001502" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,530,602</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsNoncurrent" contextRef="AsOf2024-02-29" id="Fact001503" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,390,034</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--Assets_i01TI_pp0p0_zrFbGHMH2tC7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt"><b>Total Assets</b></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-08-31" id="Fact001505" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,888,679</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-02-29" id="Fact001506" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LiabilitiesAbstract_iB_zcoCVx9JceTf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">LIABILITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i01B_zwYc6pkr2aXe" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Current Liabilities</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccountsPayableCurrent_i02I_pp0p0_zRYzG04kgXw" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-08-31" id="Fact001514" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,145,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2024-02-29" id="Fact001515" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">531,847</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_i02I_pp0p0_zd4mFZe7CESc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-08-31" id="Fact001517" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">880,585</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact001518" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">460,768</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--DeferredRevenueCurrent_i02I_pp0p0_zWv8PLv8qx4d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-08-31" id="Fact001520" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">138,067</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2024-02-29" id="Fact001521" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">139,921</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--NotesPayableCurrent_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--NonrelatedPartyMember_zDhSY0RFK87g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-08-31_us-gaap_NonrelatedPartyMember" id="Fact001523" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">140,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1524">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--NotesPayableCurrent_i02I_pp0p0_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z27ZAUh0O6ci" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Notes payable - related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-08-31_us-gaap_RelatedPartyMember" id="Fact001526" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,718,594</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact001527" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">828,277</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesCurrent_i02TI_pp0p0_z5ihG3k4Nd14" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Current Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-08-31" id="Fact001529" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,022,782</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-02-29" id="Fact001530" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--Liabilities_i01TI_pp0p0_z3y3L3K65Quk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Liabilities</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-08-31" id="Fact001532" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,022,782</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-02-29" id="Fact001533" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,960,813</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--CommitmentsAndContingencies_i01I_pp0p0_zkGljZhFmRtg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Commitments and Contingencies</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1536">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockholdersEquityAbstract_i01B_zUkwbGlvVTH8" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Stockholder&#8217;s Equity</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockValue_i02I_pp0p0_zRnAkQpAIRA4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Preferred Stock, $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_c20240229_pdd"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001543" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
    </span>par value, <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_c20240229_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact001544" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></span> shares
    authorized; <span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831_zSH1YgdUTk63"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-08-31" id="Fact001545" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,295</ix:nonFraction></span> and <span id="xdx_904_eus-gaap--PreferredStockSharesOutstanding_c20240229_pdd"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001546" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction>
    </span>shares issued and outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-08-31" id="Fact001541" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">94</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2024-02-29" id="Fact001542" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">474</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--CommonStockValue_i02I_pp0p0_zywnuU3xwDS3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Common Stock, $<span id="xdx_90A_eus-gaap--CommonStockParOrStatedValuePerShare_c20240229_pdd"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact001550" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
    </span>par value, <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20240831_zE30rnx6DMsf"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-08-31" id="Fact001551" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span>
    and <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_c20240229_pdd"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact001552" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span> shares authorized, respectively;
    <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20240831_zjHUSba2rXHl"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-08-31" id="Fact001553" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,388,641</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_zH4rKIUsZW3h"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact001554" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction>
    </span>shares issued and outstanding, respectively</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-08-31" id="Fact001548" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,389</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-02-29" id="Fact001549" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">936</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdditionalPaidInCapital_i02I_pp0p0_zzI2rYTcKC4i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Additional Paid in Capital</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-08-31" id="Fact001556" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,550,296</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2024-02-29" id="Fact001557" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_pp0p0_zv6T1JCOQFeg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Accumulated deficit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-08-31" id="Fact001559" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">27,685,882</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-02-29" id="Fact001560" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--StockholdersEquity_i02TI_pp0p0_znHUq6IMFWE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Stockholders&#8217; Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31" id="Fact001562" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">134,103</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact001563" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_pp0p0_z9TTULj193b3" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Liabilities and Stockholders&#8217; Equity</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-08-31" id="Fact001565" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">4,888,679</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-02-29" id="Fact001566" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,088,842</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to condensed financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 128; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30C_113_zaVkKiRM2Rd6" summary="xdx: Statement - Condensed Consolidated Statements of Operations" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_496_20240601__20240831_z4uqNgHJV3w1">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_492_20230601__20230831_zNA25HBlKlyi">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_491_20240301__20240831_zFcdnRooZ8j8">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_49E_20230301__20230831_zN8tAyvIz3E9">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three
                                            Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">August
                                            31,</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six
                                            Months Ended</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">August
                                            31,</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zy10pvOf0Q8l" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-06-012024-08-31" id="Fact001568" format="ixt:numdotdecimal" decimals="0" unitRef="USD">154,498</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-06-012023-08-31" id="Fact001569" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,663</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2024-03-01to2024-08-31" id="Fact001570" format="ixt:numdotdecimal" decimals="0" unitRef="USD">343,291</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" contextRef="From2023-03-012023-08-31" id="Fact001571" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,225</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--CostOfRevenue_z04wViBBjEhc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Cost of revenue (exclusive of depreciation and amortization, shown separately
    below)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2024-06-012024-08-31" id="Fact001573" format="ixt:numdotdecimal" decimals="0" unitRef="USD">155,455</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-06-012023-08-31" id="Fact001574" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23,734</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2024-03-01to2024-08-31" id="Fact001575" format="ixt:numdotdecimal" decimals="0" unitRef="USD">329,036</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CostOfRevenue" contextRef="From2023-03-012023-08-31" id="Fact001576" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,452</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--GrossProfit_iT_pp0p0_zDshqAVYYrhc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Gross profit (loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-06-012024-08-31" id="Fact001578" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">957</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-06-012023-08-31" id="Fact001579" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,929</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2024-03-01to2024-08-31" id="Fact001580" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">14,255</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GrossProfit" contextRef="From2023-03-012023-08-31" id="Fact001581" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,773</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingExpensesAbstract_iB_zcuiCVexUvW9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Operating Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--LaborAndRelatedExpense_i01_pp0p0_zPW30zSRD4Dd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-06-012024-08-31" id="Fact001588" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">628,759</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-06-012023-08-31" id="Fact001589" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">360,947</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2024-03-01to2024-08-31" id="Fact001590" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,255,511</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LaborAndRelatedExpense" contextRef="From2023-03-012023-08-31" id="Fact001591" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">768,555</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--ShareBasedCompensation_i01_pp0p0_zxZvHhSpcS2e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Stock based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-06-012024-08-31" id="Fact001593" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">13,841</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1594">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-03-01to2024-08-31" id="Fact001595" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1596">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--GeneralAndAdministrativeExpense_i01_pp0p0_zPvfRq2bus1b" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">General and administrative</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-06-012024-08-31" id="Fact001598" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,677</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-06-012023-08-31" id="Fact001599" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">128,955</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2024-03-01to2024-08-31" id="Fact001600" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,231</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2023-03-012023-08-31" id="Fact001601" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">198,058</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--SellingAndMarketingExpense_i01_pp0p0_zbFwZbKU7FOg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Sales and marketing</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-06-012024-08-31" id="Fact001603" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">51,347</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-06-012023-08-31" id="Fact001604" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">49,758</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2024-03-01to2024-08-31" id="Fact001605" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">207,536</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:SellingAndMarketingExpense" contextRef="From2023-03-012023-08-31" id="Fact001606" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">90,539</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--ProfessionalFees_i01_pp0p0_zQLliSgolbHc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Professional service fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-06-012024-08-31" id="Fact001608" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">372,027</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-06-012023-08-31" id="Fact001609" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">125,934</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2024-03-01to2024-08-31" id="Fact001610" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">895,900</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProfessionalFees" contextRef="From2023-03-012023-08-31" id="Fact001611" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">260,304</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_ecustom--Technology_i01_pp0p0_zy58S0EWT3K9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 10pt">Technology</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2024-06-012024-08-31" id="Fact001613" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">141,022</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2023-06-012023-08-31" id="Fact001614" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">83,786</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2024-03-01to2024-08-31" id="Fact001615" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">325,691</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:Technology" contextRef="From2023-03-012023-08-31" id="Fact001616" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">119,680</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--OrganizationCosts_i01_pp0p0_zviXLWAtNfie" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Organization costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2024-06-012024-08-31" id="Fact001618" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">80,452</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1619">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:OrganizationCosts" contextRef="From2024-03-01to2024-08-31" id="Fact001620" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">109,189</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1621">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--DepreciationAndAmortization_i01_pp0p0_zX1SkF8HftQk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-06-012024-08-31" id="Fact001623" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">95,414</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-06-012023-08-31" id="Fact001624" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">331,549</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2024-03-01to2024-08-31" id="Fact001625" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">383,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationAndAmortization" contextRef="From2023-03-012023-08-31" id="Fact001626" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">667,889</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--OtherExpenses_i01_pp0p0_zYxhTBRbXlS9" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Other expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-06-012024-08-31" id="Fact001628" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">63,796</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-06-012023-08-31" id="Fact001629" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,001</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2024-03-01to2024-08-31" id="Fact001630" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">179,655</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherExpenses" contextRef="From2023-03-012023-08-31" id="Fact001631" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">17,731</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingExpenses_i01T_pp0p0_zYjm9YG58Ebb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Operating Expenses</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-06-012024-08-31" id="Fact001633" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,468,335</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-06-012023-08-31" id="Fact001634" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">1,090,930</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-03-01to2024-08-31" id="Fact001635" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">3,435,948</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2023-03-012023-08-31" id="Fact001636" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,122,756</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingIncomeLoss_iT_pp0p0_zbDulS8WgKG6" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Operating loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-06-012024-08-31" id="Fact001638" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,469,292</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-06-012023-08-31" id="Fact001639" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,087,001</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-03-01to2024-08-31" id="Fact001640" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,421,693</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2023-03-012023-08-31" id="Fact001641" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,116,983</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_zj7KjomBPSbb" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Other Income (Expenses)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--InterestIncomeExpenseNonoperatingNet_i01_pp0p0_zx7K4paeyY7g" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Interest income (expense), net</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2024-06-012024-08-31" id="Fact001648" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">64,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2023-06-012023-08-31" id="Fact001649" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">73,762</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2024-03-01to2024-08-31" id="Fact001650" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">99,452</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:InterestIncomeExpenseNonoperatingNet" contextRef="From2023-03-012023-08-31" id="Fact001651" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">139,151</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--NonoperatingIncomeExpense_i01T_pp0p0_zGwLIEHOpWhk" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total Other Income (Expense)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-06-012024-08-31" id="Fact001653" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">64,227</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-06-012023-08-31" id="Fact001654" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">73,762</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-03-01to2024-08-31" id="Fact001655" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">99,452</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2023-03-012023-08-31" id="Fact001656" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">139,151</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_z8t1QiDyBmn6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net loss from continuing operations before taxes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-06-012024-08-31" id="Fact001658" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,533,519</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-06-012023-08-31" id="Fact001659" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2024-03-01to2024-08-31" id="Fact001660" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,521,145</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2023-03-012023-08-31" id="Fact001661" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--IncomeTaxExpenseBenefit_zA6BK9Gk6M62" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Provision for income taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1663">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1664">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1665">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_iT_mtILFCOzEdU_maNILzv1N_z35tfkJekxsk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net loss from continuing operations</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-06-012024-08-31" id="Fact001668" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,533,519</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-06-012023-08-31" id="Fact001669" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2024-08-31" id="Fact001670" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,521,145</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012023-08-31" id="Fact001671" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_maNILzv1N_zZ3fxiU6zbs2" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Net gain (loss) from discontinued operations, net of taxes</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-06-012024-08-31" id="Fact001673" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,131</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" contextRef="From2024-03-01to2024-08-31" id="Fact001675" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,778</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1676">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--NetIncomeLoss_iT_pp0p0_maNILATz4JB_mtNILzv1N_zXsDsdM7QDQ8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31" id="Fact001678" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,534,650</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31" id="Fact001679" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-01to2024-08-31" id="Fact001680" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,513,367</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31" id="Fact001681" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_pp0p0_di_msNILATz4JB_z9JBBl1W3EJj" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Preferred dividends</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-06-012024-08-31" id="Fact001683" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">10,688</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1684">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-03-01to2024-08-31" id="Fact001685" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">21,376</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1686">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_pp0p0_mtNILATz4JB_zP6Ynfij5vO1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net Loss Applicable to Common Stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-06-012024-08-31" id="Fact001688" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,545,338</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-06-012023-08-31" id="Fact001689" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-03-01to2024-08-31" id="Fact001690" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,534,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012023-08-31" id="Fact001691" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Basic and diluted loss per common share from continuing operations (*)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90D_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20240601__20240831_fKg_____z13XLqkqLGE7" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Basic loss per common share from continuing operations"><span id="xdx_90E_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20240601__20240831_fKg_____z56wY8T8xV36" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from continuing operations">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-06-012024-08-31" id="Fact001693" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2024-06-012024-08-31" id="Fact001695" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.29</ix:nonFraction></ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_90B_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230601__20230831_fKg_____ztYw7ebqwUO2" title="Basic loss per common share from continuing operations"><span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230601__20230831_fKg_____zm5JB9LUYol7" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from continuing operations">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-06-012023-08-31" id="Fact001697" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-06-012023-08-31" id="Fact001699" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">13.92</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20240301__20240831_fKg_____zTeQwGwd1eFe" title="Basic loss per common share from continuing operations"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20240301__20240831_fKg_____zirrTIvSuzA9" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from continuing operations">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2024-03-01to2024-08-31" id="Fact001701" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2024-03-01to2024-08-31" id="Fact001703" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_907_eus-gaap--IncomeLossFromContinuingOperationsPerBasicShare_pid_c20230301__20230831_fKg_____zi33VNOXVuC8" title="Basic loss per common share from continuing operations"><span id="xdx_90F_eus-gaap--IncomeLossFromContinuingOperationsPerDilutedShare_pid_c20230301__20230831_fKg_____zJQiFLdjp7Ah" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from continuing operations">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" contextRef="From2023-03-012023-08-31" id="Fact001705" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" contextRef="From2023-03-012023-08-31" id="Fact001707" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">27.06</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Basic and diluted loss per common share from discontinued operations (*)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_909_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20240601__20240831_fKg_____zud1diXyz5N7" title="Basic loss per common share from discontinued operations"><span id="xdx_902_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20240601__20240831_fKg_____zS8kryfmevuj" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from discontinued operations">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2024-06-012024-08-31" id="Fact001709" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2024-06-012024-08-31" id="Fact001711" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_909_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230601__20230831_fKg_____zh9aNVpPYqTi" title="Basic loss per common share from discontinued operations"><span id="xdx_908_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230601__20230831_fKg_____zkMZsuCyj01a" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from discontinued operations"><span style="-sec-ix-hidden: xdx2ixbrl1713"><span style="-sec-ix-hidden: xdx2ixbrl1715">-</span></span></span></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_907_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20240301__20240831_fKg_____z2bLV7A50co8" title="Basic loss per common share from discontinued operations"><span id="xdx_901_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20240301__20240831_fKg_____zfRLTnsKBD83" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from discontinued operations">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" contextRef="From2024-03-01to2024-08-31" id="Fact001717" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" contextRef="From2024-03-01to2024-08-31" id="Fact001719" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.00</ix:nonFraction></ix:nonFraction></span></span></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_90E_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_pid_c20230301__20230831_fKg_____z9XjeLSBj2n5" title="Basic loss per common share from discontinued operations"><span id="xdx_90B_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_pid_c20230301__20230831_fKg_____zZ28D3L4iIGh" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Diluted loss per common share from discontinued operations"><span style="-sec-ix-hidden: xdx2ixbrl1721"><span style="-sec-ix-hidden: xdx2ixbrl1723">-</span></span></span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted loss per common share (*)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_907_eus-gaap--EarningsPerShareBasic_pid_c20240601__20240831_fKg_____zHG4d6F8emG8" title="Loss per common share basic"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240601__20240831_fKg_____zFyYj2fSyRS9" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Loss per common share diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-06-012024-08-31" id="Fact001725" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-06-012024-08-31" id="Fact001727" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.29</ix:nonFraction></ix:nonFraction></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20230601__20230831_fKg_____zXfXVGC7YPE1" title="Loss per common share basic"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20230601__20230831_fKg_____zb6eTd4lzRo5" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Loss per common share diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-06-012023-08-31" id="Fact001729" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-06-012023-08-31" id="Fact001731" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">13.92</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_904_eus-gaap--EarningsPerShareBasic_pid_c20240301__20240831_fKg_____zLv9tvgScA6d" title="Loss per common share basic"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20240301__20240831_fKg_____zo8SDXmescvg" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Loss per common share diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-03-01to2024-08-31" id="Fact001733" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-03-01to2024-08-31" id="Fact001735" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">1.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20230301__20230831_fKg_____z29B1H7VpuIf" title="Loss per common share basic"><span id="xdx_90E_eus-gaap--EarningsPerShareDiluted_pid_c20230301__20230831_fKg_____zn2sjE3BeMi9" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Loss per common share diluted">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2023-03-012023-08-31" id="Fact001737" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2023-03-012023-08-31" id="Fact001739" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">27.06</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">Basic and diluted weighted average number of common shares (*)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240601__20240831_fKg_____zQydtYlvMjz3" title="Weighted average number of shares outstanding basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240601__20240831_fKg_____zivgbZaiT2E1" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Weighted nverage number of shares outstanding diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-06-012024-08-31" id="Fact001741" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-06-012024-08-31" id="Fact001743" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,275,511</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230601__20230831_fKg_____zHvO7Uxm9Pa8" title="Weighted average number of shares outstanding basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230601__20230831_fKg_____zkPUe5NNiGdi" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Weighted nverage number of shares outstanding diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-06-012023-08-31" id="Fact001745" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-06-012023-08-31" id="Fact001747" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240301__20240831_fKg_____zC11JDuARtEa" title="Weighted average number of shares outstanding basic"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240301__20240831_fKg_____zASbacFRmJ8g" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Weighted nverage number of shares outstanding diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-03-01to2024-08-31" id="Fact001749" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-03-01to2024-08-31" id="Fact001751" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,277,338</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20230301__20230831_fKg_____zIDcsS1sC7Mi" title="Weighted average number of shares outstanding basic"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20230301__20230831_fKg_____zTUeWxzbpMOe" class="xdx_phnt_U3RhdGVtZW50IC0gQ29uZGVuc2VkIENvbnNvbGlkYXRlZCBTdGF0ZW1lbnRzIG9mIE9wZXJhdGlvbnMA" title="Weighted nverage number of shares outstanding diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2023-03-012023-08-31" id="Fact001753" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2023-03-012023-08-31" id="Fact001755" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F0C_zUxAcXxOzEMg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zyNKiKMGsyp3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001756" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </ix:footnote></span><span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zYyl46AvLOY9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact001757" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Sigma Additive Solutions, Inc.
    common stock in exchange for <span id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zbEJx2b6KQFk"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember" id="Fact001758" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    of the issued and outstanding capital stock of NextTrip at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to condensed financial statements.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 129; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC. (FORMERLY SIGMAADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">For
the Three Months and Six Months Ended August 31, 2024, and August 31, 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">For
the Three Months Ended August 31, 2024, and August 31, 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_300_114_z2gXj5m9SoXg" summary="xdx: Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zE0dZIGxj28c" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zQnS3VHZMQUd" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zJBLCtQ27Esj" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B3_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zsbWmOugOpqc" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_4B7_zKyUWjcgwgPf" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Preferred</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Paid-in</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Capital</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Deficit</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_432_c20240601__20240831_eus-gaap--StockholdersEquity_iS_zqmfFpmQQ4mh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Balances, May 31, 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--SharesOutstanding_iS_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zuGtWgfdru08" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember" id="Fact001766" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">63,494</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember" id="Fact001760" format="ixt:numdotdecimal" decimals="0" unitRef="USD">64</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iS_pid_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zVAM7xDQ9AI8" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-05-31_us-gaap_CommonStockMember" id="Fact001768" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,345,932</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_CommonStockMember" id="Fact001761" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,346</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001762" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,304,840</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31_us-gaap_RetainedEarningsMember" id="Fact001763" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,140,544</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-05-31" id="Fact001764" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,165,706</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_z1joj5veZxDd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1770">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1771">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1772">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember" id="Fact001773" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,534,650</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-06-012024-08-31" id="Fact001774" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,534,650</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DividendsPreferredStock_iN_di_zZnxl0ZTR4K2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Preferred Stock Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1776">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1777">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001778" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,688</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember" id="Fact001779" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,688</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1780">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_ecustom--StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_zq8lzFkthj06" style="vertical-align: bottom; background-color: White">
    <td>Issuance of Convertible Preferred Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_ecustom--StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zIsQ7pepmaVe" title="Issuance of Convertible Preferred Shares, shares" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="Fact001788" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,801</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember" id="Fact001782" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1783">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001784" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1785">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-06-012024-08-31" id="Fact001786" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zNTqFA7ORtt8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common Shares Issued for Third party Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1790">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zt82gqKomy79" title="Issuance of Common Shares for Third Party Services, Shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact001796" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,709</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact001791" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001792" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1793">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-06-012024-08-31" id="Fact001794" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_zTzuVkXlOZTh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Stock Options Issued to Employees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1798">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1799">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001800" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,841</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-06-012024-08-31" id="Fact001802" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,841</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_438_c20240601__20240831_eus-gaap--StockholdersEquity_iE_zJBSI4MPrNRe" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Balances, August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z94w8BCn50y5" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact001810" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,295</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact001804" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_pid_c20240601__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zK0JFyfPep3i" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: center"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact001812" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,388,641</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact001805" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001806" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,550,296</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember" id="Fact001807" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,685,882</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31" id="Fact001808" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,103</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Preferred</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Paid-in</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Capital</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Deficit</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_43D_c20230601__20230831_eus-gaap--StockholdersEquity_iS_zQT3d55kEtCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F40_zgT2VcQw0263" style="width: 37%">Balances, May 31, 2023(*)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iS_c20230601__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zWPO5wDcSn12" title="Balance, shares" style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1820">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20230601__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zCpMFHCiWQVi" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-05-31_us-gaap_CommonStockMember" id="Fact001822" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_CommonStockMember" id="Fact001815" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001816" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31_us-gaap_RetainedEarningsMember" id="Fact001817" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">17,907,234</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-05-31" id="Fact001818" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">611,261</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zJnioFIjDCij" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1824">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1826">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31_us-gaap_RetainedEarningsMember" id="Fact001827" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-06-012023-08-31" id="Fact001828" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_432_c20230601__20230831_eus-gaap--StockholdersEquity_iE_zVNrtZYGhxOh" style="vertical-align: bottom; background-color: White">
    <td id="xdx_F4C_z7U7KTeZ5KLf" style="padding-bottom: 2.5pt">Balances, August 31, 2023(*)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iE_c20230601__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zNK7HdJ3Cqpi" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1836">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1830">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iE_pid_c20230601__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_z4XmaO6ILgI1" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001838" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001831" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001832" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember" id="Fact001833" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,067,997</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31" id="Fact001834" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,772,024</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-bottom: 6pt"><span id="xdx_F07_zbfJq391ZfW8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zLelXMCTBAv8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001839" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </ix:footnote></span><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z2ulqv9rMGc5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact001840" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Sigma Additive Solutions, Inc.
    common stock in exchange for <span id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zDOpuldAhq2b"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember" id="Fact001841" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    of the issued and outstanding capital stock of NextTrip at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 130; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">For
the Six Months Ended August 31, 2024, and August 31, 2023</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: center">Additional</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Preferred</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares</b></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Paid-in</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Capital</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accumulated</b></span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deficit</b></span></p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_438_c20240301__20240831_eus-gaap--StockholdersEquity_iS_zXAYDb5a1Bm9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 37%">Balances, February 29, 2024</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_eus-gaap--SharesOutstanding_iS_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zHgefmRRI7Ze" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact001849" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember" id="Fact001843" format="ixt:numdotdecimal" decimals="0" unitRef="USD">474</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBhAxVt8JnAh" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact001851" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">936,430</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_CommonStockMember" id="Fact001844" format="ixt:numdotdecimal" decimals="0" unitRef="USD">936</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember" id="Fact001845" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,277,758</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember" id="Fact001846" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">24,151,139</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-02-29" id="Fact001847" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,128,029</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLoss_zJ2Ot8axh2t4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net Loss</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1853">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1854">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1855">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="Fact001856" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,513,367</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-03-01to2024-08-31" id="Fact001857" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,513,367</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--DividendsPreferredStock_iN_di_zV1TxTkmM371" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Preferred Stock Dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1859">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1860">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001861" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">21,376</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:DividendsPreferredStock" contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember" id="Fact001862" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,376</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1863">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_z6c3fPBYY2j9" style="vertical-align: bottom; background-color: White">
    <td>Issuance of Convertible Preferred Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqWZapelXvUc" title="Issuance of Convertible Preferred Shares, shares" style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact001871" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">29,801</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="Fact001865" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1866">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001867" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,970</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1868">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" contextRef="From2024-03-01to2024-08-31" id="Fact001869" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_zq1xxUtTaSV" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Common Shares Issued for Conversion of Preferred Stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zS6AX88Jdknd" title="Common Shares Issued for Conversion of Preferred Stock" style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="Fact001879" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="Shares">409,502</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember" id="Fact001873" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">410</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zH5g7kcGWVRa" title="Common Shares Issued for Conversion of Preferred Stock, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact001881" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">409,502</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact001874" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1875">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1876">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1877">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_zcICw7OkjEqk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Issuance of Common Shares for Third Party Services</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1883">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbnCHTl4Ukd8" title="Issuance of Common Shares for Third Party Services, Shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact001889" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,709</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact001884" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001885" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130,957</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1886">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" contextRef="From2024-03-01to2024-08-31" id="Fact001887" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--StockIssuedDuringPeriodValueEmployeeBenefitPlan_zSNLg4N2Egnc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Stock Options Issued to Employees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1891">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1892">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001893" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,235</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1894">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan" contextRef="From2024-03-01to2024-08-31" id="Fact001895" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,235</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43E_c20240301__20240831_eus-gaap--StockholdersEquity_iE_z4DlyVtNmMn7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balances, August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zhhtp2niGXhh" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact001903" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,295</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember" id="Fact001897" format="ixt:numdotdecimal" decimals="0" unitRef="USD">94</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iE_pid_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsVuKcqqcoj7" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact001905" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,388,641</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_CommonStockMember" id="Fact001898" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,389</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">27,550,296</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember" id="Fact001900" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">27,685,882</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-08-31" id="Fact001901" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,103</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Preferred Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Common Stock</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Additional</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Preferred</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Shares</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Outstanding</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Common</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Stock</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Paid-in</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Capital</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Accumulated</p>
                                                                                <p style="margin-top: 0; margin-bottom: 0">Deficit</p></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_435_c20230301__20230831_eus-gaap--StockholdersEquity_iS_zFVFManT0nK7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F48_zFi0wWMsJ8rf" style="width: 37%">Balances, February 28, 2023(*)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zZUfOe0ghaRe" title="Balance, shares" style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1913">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1907">-</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharesOutstanding_iS_pid_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_z7wgXEYOecM1" title="Balance, shares" style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact001915" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact001908" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact001909" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" id="Fact001910" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 5%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact001911" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,110</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_43A_c20230301__20230831_eus-gaap--StockholdersEquity_iS_zQarefZ918rg" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td id="xdx_F41_zQMzy2tHYsjf">Balances</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zRhKGQ5AEIo" title="Balance, shares" style="text-align: right">&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1923">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1917">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_pid_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_znPBC0n94jY9" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact001925" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_CommonStockMember" id="Fact001918" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember" id="Fact001919" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember" id="Fact001920" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,811,863</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-02-28" id="Fact001921" format="ixt:numdotdecimal" decimals="0" unitRef="USD">484,110</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40A_eus-gaap--NetIncomeLoss_z1a108xWh8Ui" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Net Loss</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1927">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1928">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1929">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31_us-gaap_RetainedEarningsMember" id="Fact001930" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-03-012023-08-31" id="Fact001931" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_43B_c20230301__20230831_eus-gaap--StockholdersEquity_iE_zhtzofTdssZ8" style="vertical-align: bottom; background-color: White">
    <td id="xdx_F4E_z6okPWpAI6V6" style="padding-bottom: 2.5pt">Balances, August 31, 2023(*)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--SharesOutstanding_iE_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_zqptND3rJiDa" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1939">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1933">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--SharesOutstanding_iE_pid_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zZRr9p5BQMxi" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001941" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001934" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001935" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember" id="Fact001936" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,067,997</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31" id="Fact001937" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,772,024</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_431_c20230301__20230831_eus-gaap--StockholdersEquity_iE_zFxpktfVk0Ql" style="display: none; vertical-align: bottom; background-color: White">
    <td id="xdx_F4C_zihQkEp86Wt9" style="padding-bottom: 2.5pt">Balances</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_fKCop_ze4IVeKsQ514" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1949">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1943">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharesOutstanding_iE_pid_c20230301__20230831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_fKCop_zEt8tw9hYKR3" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001951" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_CommonStockMember" id="Fact001944" format="ixt:numdotdecimal" decimals="0" unitRef="USD">83</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact001945" format="ixt:numdotdecimal" decimals="0" unitRef="USD">17,295,890</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember" id="Fact001946" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">19,067,997</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-08-31" id="Fact001947" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,772,024</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; padding-bottom: 6pt"><span id="xdx_F04_zk5WbTsNYbBk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_zJ8mSCeOkkJa" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001952" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </ix:footnote></span><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zTYfrQfuVsag" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember" id="Fact001953" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Sigma Additive Solutions, Inc.
    common stock in exchange for <span id="xdx_90B_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zN4K5nzeCdH3"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember" id="Fact001954" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
    of the issued and outstanding capital stock of NextTrip at the time of the reverse acquisition. The Company has reflected this transaction
    retroactively in these financial statements.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to condensed financial statements.</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 131; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC. (FORMERLY SIGMA ADDITIVE SOLUTIONS, INC.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Unaudited)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30D_112_z8PIeR9cU1ya" summary="xdx: Statement - Condensed Consolidated Statements of Cash Flows" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20240301__20240831_zRB1e3mt0DWi" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49F_20230301__20230831_z72JS4krqgn1" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">August 31, 2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">August 31, 2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zik1hW8FasMk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">OPERATING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_i01_pp0p0_zWsCoR91R4Nc" style="vertical-align: bottom; background-color: White">
    <td style="width: 64%; font-weight: bold; text-align: left">Net Loss &#8211; Continuing Operations</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2024-08-31" id="Fact001959" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">3,521,145</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 2%; font-weight: bold">&#160;</td>
    <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 14%; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012023-08-31" id="Fact001960" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_400_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zqWqDMxTVQUf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zjim8YmpPRQc" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Noncash Expenses:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--DepreciationDepletionAndAmortization_i02_pp0p0_zC10Wi6qYgM4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Depreciation and amortization &#8211; property and equipment and intangibles</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2024-03-01to2024-08-31" id="Fact001968" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">383,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2023-03-012023-08-31" id="Fact001969" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">667,889</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--DepreciationOfRightOfUseAsset_i02_pp0p0_zMTPhOaFWBN4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Depreciation of right of use asset</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1971">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:DepreciationOfRightOfUseAsset" contextRef="From2023-03-012023-08-31" id="Fact001972" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">74,848</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--ShareBasedCompensation_i02_pp0p0_zM2IFimLMzv4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Stock-based compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="From2024-03-01to2024-08-31" id="Fact001974" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">30,235</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1975">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i01B_zhxvz8Dnqo84" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Change in Assets and Liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInAccountsReceivable_i02N_pp0p0_di_z9BultbECKx6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Accounts receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2024-03-01to2024-08-31" id="Fact001980" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">22,881</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2023-03-012023-08-31" id="Fact001981" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">5,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInPrepaidExpense_i02N_pp0p0_di_z5oMBmHapm4e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Prepaid expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-03-01to2024-08-31" id="Fact001983" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">96,051</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2023-03-012023-08-31" id="Fact001984" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">34,114</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40D_ecustom--IncreaseDecreaseInPromissoryNoteReceivable_i02N_pp0p0_di_zK3zZrqaNrq8" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Promissory note receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1986">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="NTRP:IncreaseDecreaseInPromissoryNoteReceivable" contextRef="From2023-03-012023-08-31" id="Fact001987" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">8,722</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_i02_zGriSI21HcP9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 10pt">Accounts payable and accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2024-03-01to2024-08-31" id="Fact001989" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,033,506</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="From2023-03-012023-08-31" id="Fact001990" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,959</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDeferredRevenue_i02_ziJlJFmBiWoa" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 10pt">Deferred revenue</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2024-03-01to2024-08-31" id="Fact001992" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,854</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDeferredRevenue" contextRef="From2023-03-012023-08-31" id="Fact001993" format="ixt:numdotdecimal" decimals="0" unitRef="USD">57,156</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInSecurityDeposits_i02_zPm6jIK5o9z1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Security deposit</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInSecurityDeposits" contextRef="From2024-03-01to2024-08-31" id="Fact001995" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_i01T_ziVU0vyt7I8f" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2024-03-01to2024-08-31" id="Fact001998" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,960,326</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" contextRef="From2023-03-012023-08-31" id="Fact001999" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,393,118</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_i01_z3ANbMOv4Oqf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">NET CASH PROVIDED IN OPERATING ACTIVITIES FROM DISCONTINUED
    OPERATIONS</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" contextRef="From2024-03-01to2024-08-31" id="Fact002001" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,778</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_zSEFnIPJIIzh" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">NET CASH USED IN OPERATING ACTIVITIES</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-03-01to2024-08-31" id="Fact002004" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,952,548</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2023-03-012023-08-31" id="Fact002005" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,393,118</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zeHuPAQlZ2V1" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">INVESTING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsForSoftware_i01N_di_zBdPoF96AWAe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Capitalized software development costs</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2024-03-01to2024-08-31" id="Fact002010" format="ixt:numdotdecimal" decimals="0" unitRef="USD">389,568</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForSoftware" contextRef="From2023-03-012023-08-31" id="Fact002011" format="ixt:numdotdecimal" decimals="0" unitRef="USD">345,807</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_zQj6W1YwwN49" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">NET CASH USED IN INVESTING ACTIVITIES</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-03-01to2024-08-31" id="Fact002013" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">389,568</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2023-03-012023-08-31" id="Fact002014" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">345,807</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zPmYo9QlCC46" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">FINANCING ACTIVITIES</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromConvertibleDebt_i01_z6EKUxhjrd1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Proceeds from issuance of convertible notes</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2019">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2023-03-012023-08-31" id="Fact002020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,269,852</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_eus-gaap--ProceedsFromIssuanceOfConvertiblePreferredStock_i01_zVQU7vUK8sob" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Proceeds from issuance of convertible preferred shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" contextRef="From2024-03-01to2024-08-31" id="Fact002022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2023">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--ProceedsFromNotesPayable_i01_zgpLmBUiYMV5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Notes payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2024-03-01to2024-08-31" id="Fact002025" format="ixt:numdotdecimal" decimals="0" unitRef="USD">140,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2026">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--ProceedsFromRelatedPartyDebt_i01_ziRSQhCgnH5l" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Advances from related parties</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-03-01to2024-08-31" id="Fact002028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,890,317</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2023-03-012023-08-31" id="Fact002029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">292,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_zYVtgFIEOoNj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">NET CASH PROVIDED BY FINANCING ACTIVITIES</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-03-01to2024-08-31" id="Fact002031" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,120,317</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2023-03-012023-08-31" id="Fact002032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,562,352</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_pp0p0_zl2UftpCBRjg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">NET CHANGE IN CASH FOR PERIOD</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-03-01to2024-08-31" id="Fact002034" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">221,799</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2023-03-012023-08-31" id="Fact002035" format="ixt:numdotdecimal" decimals="0" scale="0" sign="-" unitRef="USD">176,573</ix:nonFraction></td><td style="font-weight: bold; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_pp0p0_zU61n3gQPgkk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 1pt">CASH AT BEGINNING OF PERIOD</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-02-29" id="Fact002037" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">323,805</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-02-28" id="Fact002038" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">282,475</ix:nonFraction></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_pp0p0_zeKagRvvnOXf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 2.5pt">CASH AT END OF PERIOD</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-08-31" id="Fact002040" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">102,006</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-08-31" id="Fact002041" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">105,902</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zUSrE4Z47aj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Supplemental Disclosures:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zbHzu442H1pl" style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left">Noncash Investing and Financing Activities Disclosure:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--IssuanceOfCommonSharesForServices_i01_zgMjoT1wA4La" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Issuance of common shares for services</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="NTRP:IssuanceOfCommonSharesForServices" contextRef="From2024-03-01to2024-08-31" id="Fact002049" format="ixt:numdotdecimal" decimals="0" unitRef="USD">131,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--PreferredStockDividends_i01_z4tGho0GnSg1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred stock dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="NTRP:PreferredStockDividends" contextRef="From2024-03-01to2024-08-31" id="Fact002052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,736</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2053">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DisclosureOfCashPaidAbstract_i01B_zwJLhbbndzV2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Disclosure of Cash Paid for:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--InterestPaidNet_i01_zOdBJRzkvsok" style="vertical-align: bottom; background-color: White">
    <td>Interest</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2024-03-01to2024-08-31" id="Fact002058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,620</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InterestPaidNet" contextRef="From2023-03-012023-08-31" id="Fact002059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">410</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeTaxesPaidNet_i01_zxy5wyHmzC08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Income Taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2061">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2062">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
accompanying notes to condensed financial statements.</span></p>
<!-- Field: Split-Segment; Name: 001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 132; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p id="xdx_046_c20240301__20240831_zPDPv4Zh27h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED CONDENSED FINANCIAL STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>August
31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002064" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zyGhn9QLvXGg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_820_zbjEvc9jZZRi">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended, with the Secretary
of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other things, Sigma&#8217;s
corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe, NM 87507 The consolidated financial statements include the
accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc. incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Exchange Agreement as described below, NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) was a wholly owned subsidiary of NextTrip
Group, LLC (&#8220;Group&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc. (&#8220;NextPlay&#8221;).
All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023, NextPlay and Group entered into
an Amended and Restated Separation Agreement (&#8220;Separation Agreement&#8221;), Amended and Restated Operating Agreement (&#8220;Operating
Agreement&#8221;), and Exchange Agreement (&#8220;Exchange Agreement&#8221;, and together, the &#8220;Agreements&#8221;), whereby NextPlay
transferred their interest in the travel business to Group. Pursuant to the Exchange Agreement, NextPlay exchanged <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zru9sXqXfHDd" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember" id="Fact002066" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Units of Group for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_z7nlvlVz3ujb" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact002068" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Units of Group, with a value
of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zP70YTOmZl9k" title="Share price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember" id="Fact002070" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. Prior to the exchange for Preferred
Units, Group had a payable due to NextPlay of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zbgKB0pjyuB2" title="Number of common stock issued, value"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember" id="Fact002072" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">17,295,873</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s ongoing
support obligations except for a $<span id="xdx_90A_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zPFIR2iYhn0a" title="Contributed capital"><ix:nonFraction name="us-gaap:Capital" contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember" id="Fact002074" format="ixt:numdotdecimal" decimals="-5" scale="6" unitRef="USD">1.5</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million advance remaining under a promissory
note and as such NextTrip recorded the payable as contributed capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240831__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_z0Ep2sDSfEGb" title="Ownership percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2024-08-31_custom_NextInnovationLLCMember" id="Fact002076" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor operations occurred
in 2023 or 2024 for this entity, and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#8220;Exchange Agreement&#8221;) with NextTrip, Group,
and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_zI93RNZrJNVh" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember" id="Fact002078" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,007</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted shares of Sigma common stock
(the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an additional <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zB9TW4QL8e87" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember" id="Fact002080" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted shares of Sigma common stock
upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#8220;Contingent Shares,&#8221; and together with the
Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares are issuable to the members of Group, on a pro rata basis,
under the terms of the Exchange Agreement, subject to certain closing conditions (the &#8220;Acquisition&#8221;). Upon the closing of
the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zNyAfJDKGSqd" title="Restricted shares issuable in reverse acquisition"><ix:nonFraction name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember" id="Fact002082" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Sigma common stock, or approximately
<span id="xdx_901_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zik42pZ7S4N1" title="Percentage for issued and outstanding capital stock"><ix:nonFraction name="NTRP:PercentageForIssuedAndOutstandingCapitalStock" contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember" id="Fact002084" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90.2</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a
change of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the
legacy shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma
is treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information
presented is that of NextTrip.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of August 31, 2024, three of the
four business milestones had been achieved as further described in Note 2 under &#8220;Loss Per Share&#8221; below. As a result, <span id="xdx_902_ecustom--ContingentSharesIssuable_iI_c20240831_zxPZe6MGvHmc" title="Contingent shares issuable"><ix:nonFraction name="NTRP:ContingentSharesIssuable" contextRef="AsOf2024-08-31" id="Fact002086" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></span>
of the contingent shares were eligible to be issued. The remaining <span id="xdx_90A_ecustom--LaunchOfTravelAgentPlatformShares_iI_c20240831_zervhS9n3lo1" title="Contigent shares"><ix:nonFraction name="NTRP:LaunchOfTravelAgentPlatformShares" contextRef="AsOf2024-08-31" id="Fact002088" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></span> contingent shares will be eligible for issue upon the launch
of the Company&#8217;s Travel Agent platform, currently scheduled for the first quarter of calendar year 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Despite having achieved three of the
four business milestones, the Company cannot issue the contingent shares until Nasdaq approves the Company&#8217;s initial listing application,
which is pending with Nasdaq. 2024. The Company has been advised by Nasdaq that issuing the contingent shares prior to
approval of the application will result in the immediate delisting of the Company, as such issuance will trigger a change in control.
The Company does anticipate such issuances will occur shortly after the closing of this offering and the Company intends to issue said
securities as soon as Nasdaq has cleared its application.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 133; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value pursuant to ASC 805.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern </b>&#8211; The Company has sustained losses and had negative cash flows from operating activities since its inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently does not have sufficient cash and working capital to fund its operations and will require additional funding in the
public or private markets in the near-term to be able to continue operations. The Company currently has no understanding or agreement
to obtain such funding, and there is no assurance that we will be successful in obtaining additional funding. If we fail to obtain sufficient
funding when needed, we will be forced to delay, scale back or eliminate all or a portion of our commercialization efforts and operations.
As a result, there is substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002090" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zkLlHzbaT2m4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_825_zqSGuePCW51">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002092" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zifpSOSo4639" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_z4YEibwEO6hc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The accompanying financial
statements have been prepared by the Company in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) in the
United States of America. The financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations
and cash flows at August 31, 2024 and 2023 and for the periods then ended have been made. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The Company suggests these
condensed financial statements be read in conjunction with the February 29, 2024 audited financial statements and notes thereto included
in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 4, 2024. The results
of operations for the period ended August 31, 2024 are not necessarily indicative of the operating results for the full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002094" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z64NtA2m0Nik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_860_z0TZFiK14hfe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 134; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002096" name="NTRP:PromissoryNoteReceivablePolicyTextBlock"><p id="xdx_841_ecustom--PromissoryNoteReceivablePolicyTextBlock_zmmDpMNdPObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_864_za2gVtlZF6M2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Promissory Note (the Note&#8221;) between NextTrip and NextPlay, the Note was due and payable in full on the earlier
of September 1, 2023 or the date the Company completed a financing of $<span id="xdx_909_eus-gaap--ConvertibleDebt_iI_pn6n6_c20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zZVrhW5ebi19" title="Convertible debt"><ix:nonFraction name="us-gaap:ConvertibleDebt" contextRef="AsOf2023-09-01_custom_NextPlayTechnologiesIncMember" id="Fact002098" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction></span> million or more. No payments have been made by NextPlay, and
as such NextPlay is in default under the terms of the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into a non-binding Memorandum of Understanding (&#8220;MOU&#8221;) with NextPlay, whereby NextTrip has agreed to
forgive the entire amount due under the Note in exchange for NextTrip&#8217;s cancellation of the <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zixIQTEoeaWg" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember" id="Fact002100" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">400,000</ix:nonFraction></span>
Preferred Units of Group issued to them as described in Note 1. The Preferred Units are convertible into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z8YGuYT6nNYa" title="Number of convertible shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember" id="Fact002102" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000</ix:nonFraction></span>
NextTrip common shares, and NextTrip has a commitment from a third party to purchase such shares at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z39topvmdgid" title="Shares issue per shares"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact002104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.00</ix:nonFraction></span>
per share. As a result, the since Company can realize a minimum of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zVMsH85qhCcc" title="Value of stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember" id="Fact002106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span>
from the sale of the common shares, a valuation allowance of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zgz5fuOcbhR4" title="Valuation allowance"><ix:nonFraction name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember" id="Fact002108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,567,665</ix:nonFraction> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
established as of February 29, 2024. The Company is in the process of negotiating a second offer to purchase the shares, and
therefore has not closed the transaction with NextPlay. The Company expects to close one of the transaction options before year-end.
During the three and six months ended August 31, 2024, and 2023, there was <span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_do_c20230301__20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zLiVFPSz3Dkg" title="Provision for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bad
debt expense recorded related to the allowance account, and the allowance is unchanged as of August 31, 2024. As of August 31, 2023, <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBkpsovmPgMi" title="Allowance for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allowance
for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002114" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zJwYcYLwKita" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_zECKc0O4ONZ" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
Per Share</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; The computation of loss
per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings
Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options and preferred stock were excluded due to the anti-dilutive
effect they would have on the computation. At August 31, 2024 and 2023 the Company had the following common shares underlying these instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002116" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z0TGwOunwYed" style="display: none">Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">August 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012024-08-31_us-gaap_WarrantMember" id="Fact002118" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78,877</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember21742375" id="Fact002121" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">484,063</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember21742406" id="Fact002124" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">96,238</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" contextRef="From2024-03-01to2024-08-31" id="Fact002127" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">659,178</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2128">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A0_zl1be1T4GVai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002130" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B3_zJOeyE98NgVj" style="display: none">Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-06-012024-08-31" id="Fact002132" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,533,519</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-06-012023-08-31" id="Fact002133" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2024-03-01to2024-08-31" id="Fact002134" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,521,145</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" contextRef="From2023-03-012023-08-31" id="Fact002135" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-06-012024-08-31" id="Fact002137" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,688</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:PreferredStockDividendsIncomeStatementImpact" contextRef="From2024-03-01to2024-08-31" id="Fact002139" format="ixt:numdotdecimal" decimals="0" unitRef="USD">21,376</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-06-012024-08-31" id="Fact002142" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,544,207</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-06-012023-08-31" id="Fact002143" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2024-03-01to2024-08-31" id="Fact002144" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,542,521</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2023-03-012023-08-31" id="Fact002145" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2024-06-012024-08-31" id="Fact002147" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,131</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" contextRef="From2024-03-01to2024-08-31" id="Fact002149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,778</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-06-012024-08-31" id="Fact002152" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,545,338</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-06-012023-08-31" id="Fact002153" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,160,763</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2024-03-01to2024-08-31" id="Fact002154" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,534,743</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="From2023-03-012023-08-31" id="Fact002155" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,256,134</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-06-012024-08-31" id="Fact002157" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,275,511</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2023-06-012023-08-31" id="Fact002158" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-03-01to2024-08-31" id="Fact002159" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,277,339</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2023-03-012023-08-31" id="Fact002160" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">83,371</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zkRT0GjwF6Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2024, the Company determined that three of the four business milestones per the Share Exchange Agreement had been achieved.
As a result, <span id="xdx_900_ecustom--ContingentSharesIssuable_iI_c20240610_zO4JexHWcrO6" title="Contingent shares issuable"><ix:nonFraction name="NTRP:ContingentSharesIssuable" contextRef="AsOf2024-06-10" id="Fact002162" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></span> of the total contingent shares of <span id="xdx_90C_ecustom--ContingentShares_iI_c20240610_zv21vZEWMQOd" title="Contingent shares"><ix:nonFraction name="NTRP:ContingentShares" contextRef="AsOf2024-06-10" id="Fact002164" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></span> became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable contingent shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002166" name="NTRP:ScheduleOfIssuableContingentSharesTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zLOFrzikgY4j" style="display: none">Schedule
of Issuable Contingent Shares</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Business Milestones</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center">Contingent Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><p style="margin: 0"><i>Achieved</i></p>


</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Launch of leisure travel booking platform</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><ix:nonFraction name="NTRP:LaunchOfLeisureTravelBookingPlatform" contextRef="AsOf2024-06-30" id="Fact002168" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Launch of group travel booking platform</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="NTRP:LaunchOfGroupTravelBookingPlatform" contextRef="AsOf2024-06-30" id="Fact002170" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of FlexPay technology</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:LaunchOfFlexpayTechnology" contextRef="AsOf2024-06-30" id="Fact002172" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,493,993</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:ContingentSharesIssuable" contextRef="AsOf2024-06-30" id="Fact002174" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,393,993</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><i>Not Achieved</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of travel agent platform</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:LaunchOfTravelAgentPlatformShares" contextRef="AsOf2024-06-30" id="Fact002176" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:ContingentlyIssuableShares" contextRef="AsOf2024-06-30" id="Fact002178" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,450,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total contingent shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="NTRP:ContingentShares" contextRef="AsOf2024-06-30" id="Fact002180" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AA_zoSl7kqh3My3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002182" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"><p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zm2k2w8JtlN5" style="display: none">Schedule
of Weighted Average Common Stock Shares Outstanding</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/>
    Number of Common Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-08-31" id="Fact002186" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,388,641</ix:nonFraction></span> common shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="NTRP:CommonStockShareOutstanding" contextRef="From2024-06-012024-08-31" id="Fact002184" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,359,126</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><ix:nonFraction name="NTRP:CommonStockShareOutstanding" contextRef="From2024-03-01to2024-08-31" id="Fact002185" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,319,146</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">4,393,993 issuable contingent shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:WeightedAverageIssuableContingentShares" contextRef="From2024-06-012024-08-31" id="Fact002188" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,916,385</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:WeightedAverageIssuableContingentShares" contextRef="From2024-03-01to2024-08-31" id="Fact002189" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,958,193</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-06-012024-08-31" id="Fact002191" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,275,511</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-03-01to2024-08-31" id="Fact002192" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,277,339</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



</ix:nonNumeric><p id="xdx_8AE_z3vBGbGZscu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuable contingent shares are of the Company&#8217;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 135; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented, as the Company&#8217;s outstanding warrants, stock options and preferred stock common equivalent shares
for the periods presented would have had an anti-dilutive effect. At August 31, 2024, the Company had outstanding warrants to purchase
<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMHCtVQDgIE8" title="Warrants outstanding to purchase common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-08-31_us-gaap_WarrantMember" id="Fact002194" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">484,063</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, stock options
exercisable for <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2MimFj4uJUa" title="Shares issuable upon exercisable of options"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002196" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78,877</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8TCka5mm3qk" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember" id="Fact002198" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series E Preferred Stock, which
could be converted into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zG35NXFRFZc9" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember" id="Fact002200" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,259</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zlIxo7WVjlSj" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember" id="Fact002202" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series H Preferred Stock, convertible
into <span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpsaAcHrHdS2"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember" id="Fact002203" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, and <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxcqulyETKN4" title="Number of shares converted"><ix:nonFraction name="us-gaap:ConversionOfStockSharesConverted1" contextRef="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember" id="Fact002205" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,979</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Preferred Stock, convertible
into <span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zFenO045MKba" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:ConversionOfStockSharesIssued1" contextRef="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember" id="Fact002207" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,979</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, resulting in a
potential total additional <span id="xdx_90E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbk2XzXNnf" title="Potentially dilutive securities"><ix:nonFraction name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember" id="Fact002209" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">659,178</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock outstanding in
the future. At August 31, 2023, the Company had <span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_do_c20230831__20230831_zA5fYSj15E4c" title="Potentially dilutive securities">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding potentially dilutive securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002213" name="us-gaap:UseOfEstimates"><p id="xdx_84A_eus-gaap--UseOfEstimates_zgBfHCAwKx2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zKlvO8tRqgS8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
Estimates</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities,
the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates
that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents
granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002215" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock"><p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ze7a5NslSCBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_z1OgHMDoOhzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; </span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive
revenue recognition standard that superseded nearly all existing revenue recognition guidance under prior U.S. GAAP and replaced it with
a principles-based approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon
the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to
be entitled in exchange for those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or
contracts, with our customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4)
allocating the transaction price to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance
obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

</ix:nonNumeric><p id="xdx_857_zw8ENaStwBEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002217" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zWtrNzMvGv53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_82A_zHPDyYR016y">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002219" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zr9WT6ZcWyUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of August 31, 2024, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B9_zZLh7VI8bnnl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20240831_zypz4PBWeJH9" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">August
                                            31,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240229_zmq5bCFnM775" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">February
                                            29,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zK34HO26Stbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-08-31_us-gaap_SoftwareDevelopmentMember" id="Fact002221" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,122,596</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember" id="Fact002222" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,602,028</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zgjptkxM7z95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-08-31_custom_SoftwareLicensesMember" id="Fact002224" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,576</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember" id="Fact002225" format="ixt:numdotdecimal" decimals="0" unitRef="USD">789,576</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zbrHfUCcbYyl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Trademark</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-08-31_us-gaap_TrademarksMember" id="Fact002227" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29_us-gaap_TrademarksMember" id="Fact002228" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zzEbWzPCm2Jd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-08-31" id="Fact002230" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,918,455</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2024-02-29" id="Fact002231" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,397,887</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zqtA7BLv8aWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-08-31" id="Fact002233" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,607,528</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2024-02-29" id="Fact002234" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,224,467</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_z0bG6nDEVe07" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-08-31" id="Fact002236" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,310,927</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2024-02-29" id="Fact002237" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,173,420</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AA_zvSE4RGIiv67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the six months ended August 31, 2024, and 2023 was $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20240831_zdUKXMaczsY5" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2024-03-01to2024-08-31" id="Fact002239" format="ixt:numdotdecimal" decimals="0" unitRef="USD">383,061</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20230831_zjYgpdH9JiTi" title="Amortization"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2023-03-012023-08-31" id="Fact002241" format="ixt:numdotdecimal" decimals="0" unitRef="USD">657,389</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three and six months ended August 31, 2024, and 2023, the Company recorded <span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240601__20240831_z3B9tBdTvhAk" title="Impairment losses"><span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240301__20240831_z5UokqdZHCk7" title="Impairment losses"><span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230601__20230831_z0b4lIrlvFGd" title="Impairment losses"><span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230301__20230831_zCgPEc9tisM5" title="Impairment losses"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2024-06-012024-08-31" id="Fact002243" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2024-03-01to2024-08-31" id="Fact002245" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-06-012023-08-31" id="Fact002247" format="ixt-sec:numwordsen" decimals="0" unitRef="USD"><ix:nonFraction name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" contextRef="From2023-03-012023-08-31" id="Fact002249" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment losses associated with the
carrying value exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002251" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdOVf9nbV8e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BB_zu3DsFSttSQ7" style="display: none">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240831_zwls6gO7da3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zrxfoGgoe2Cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 80%">2025 (Remaining)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" contextRef="AsOf2024-08-31" id="Fact002253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,232</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zyyape05oA41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" contextRef="AsOf2024-08-31" id="Fact002255" format="ixt:numdotdecimal" decimals="0" unitRef="USD">313,329</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zZeSfWHXjPrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" contextRef="AsOf2024-08-31" id="Fact002257" format="ixt:numdotdecimal" decimals="0" unitRef="USD">270,728</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zJ4mMxdyOqnj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" contextRef="AsOf2024-08-31" id="Fact002259" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,957</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zjQa3ZhpKh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_z0Or0MvqVMNg" style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsNet" contextRef="AsOf2024-08-31" id="Fact002263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">787,246</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




</ix:nonNumeric><p id="xdx_8AE_zaWZBzr2vEkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 136; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002265" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zkC1RJtuioTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8211; <span id="xdx_827_zHoRWkQFrokf">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc. on December 29, 2023 was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#8220;IPO&#8221;) transaction. In the reverse acquisition, $<span id="xdx_90F_eus-gaap--Goodwill_iI_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zPbF6N17fze4" title="Goodwill"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember" id="Fact002267" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,167,805</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of goodwill was allocated to the NextTrip
Reporting Unit under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002269" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zWyRxbHZVW7k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_827_zRWFXEx8pIc4">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2024, the Company&#8217;s wholly-owned subsidiary, NextTrip, entered into an unsecured promissory note for a line of credit
with Donald Monaco and William Kerby, the Company&#8217;s Chairman of the board of directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zXX8wLxbxl62" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember" id="Fact002271" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with an initial advance of $<span id="xdx_909_eus-gaap--LineOfCredit_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zv32yQuWcHp8" title="Line of credit"><ix:nonFraction name="us-gaap:LineOfCredit" contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember" id="Fact002273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">125,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
provided that the aggregate principal amount of the note does not exceed $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zR7gIUwNaJbl" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember" id="Fact002275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at any time. Under the terms of the note,
advances under the line of credit may be made at the Company&#8217;s request until August 31, 2024. The note bears an annual interest
rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_ziVau7vlg1id" title="Annual interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember" id="Fact002277" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20240318__20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zj8ZxDonO9fk" title="Maturity date"><ix:nonNumeric contextRef="From2024-03-182024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember" format="ixt:datemonthdayyearen" id="Fact002279" name="us-gaap:DebtInstrumentMaturityDate">February
28, 2025</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and may be prepaid by the Company
at any time prior to maturity without penalty. As of August 31, 2024, the full principal amount of the note had been advanced to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2024, the Company&#8217;s board of directors approved the Company&#8217;s wholly-owned subsidiary, NextTrip, to enter into
a series of unsecured promissory notes with certain related parties, including investors, directors, officers and employees, who may
individually provide funds for the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zjmfVSNMXgx1" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember" id="Fact002281" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,000,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The notes bear an annual interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z4ITJ3vrEPsj" title="Annual interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember" id="Fact002283" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and shall mature one year from the date of each note&#8217;s execution, and may be prepaid by the Company at any time prior to maturity
without penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the board of directors, the directors unanimously
approved an increase in the principal amount of the related party line of credit to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z1mX5NVwsI86" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-08-14_custom_InvestorsDirectorsOfficersAndEmployeesMember" id="Fact002285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on the same terms and conditions as previously
approved. As of August 31, 2024, $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zOaCBTT4pDah" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-08-31_custom_InvestorsDirectorsOfficersAndEmployeesMember" id="Fact002287" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,411,414</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">had been advanced to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 21, 2024, NextTrip issued an unsecured promissory note, in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240521__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zacbQbXqGnLg" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-05-21_custom_DonaldMonacoMember" id="Fact002289" format="ixt:numdotdecimal" decimals="0" unitRef="USD">455,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Promissory Note&#8221;), to
Mr. Monaco to memorialize the terms and conditions of certain working capital advances made by Mr. Monaco to NextTrip. As of August 31,
2024, the outstanding principal balance of the Line of Credit Promissory Note was $<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zdCcsK6KsJkj" title="Outstanding principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-08-31_custom_DonaldMonacoMember" id="Fact002291" format="ixt:numdotdecimal" decimals="0" unitRef="USD">405,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Promissory Note accrues interest at a rate equal to <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zIIP6DFhX3Fd" title="Annual interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-08-31_custom_DonaldMonacoMember" id="Fact002293" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
simple interest per annum, and will automatically mature and become due and payable in full on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240831__20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_z3oonYHhvxIc" title="Maturity date"><ix:nonNumeric contextRef="From2024-08-312024-08-31_custom_DonaldMonacoMember" format="ixt:datemonthdayyearen" id="Fact002295" name="us-gaap:DebtInstrumentMaturityDate">February
28, 2025</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, subject to certain limited exceptions.
The Promissory Note, or any portion thereof, may be prepaid by NextTrip without any penalty. Mr. Monaco serves as Chairman of the Company&#8217;s
board of directors. The Promissory Note was approved by the Company&#8217;s Board of Directors, including the independent members thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total amounts due to related parties at August 31, 2024 and February 29, 2024 totaled $<span id="xdx_90A_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zjAVdZSeYa25" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-08-31_us-gaap_RelatedPartyMember" id="Fact002297" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">2,718,594</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_901_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNtwJ8WhjzWf" title="Notes payable - related parties"><ix:nonFraction name="us-gaap:NotesPayableCurrent" contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember" id="Fact002299" format="ixt:numdotdecimal" decimals="0" scale="0" unitRef="USD">828,277</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002301" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zRJTs7tgKSB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_824_zDmSo9251hJ1">Notes Payable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2024, the Company issued an unsecured promissory note for $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_z6wxI60LEQqb" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-05-242024-05-24" id="Fact002303" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to an investor upon receipt of proceeds.
The note bears an annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zUdxOsuTlXRa" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-05-24" id="Fact002305" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and will mature and be due and payable on the earlier date of the completion of a public financing or October 31, 2024, unless extended
by the written consent of the investor. The note can be prepaid at any time by the Company without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2024, the Company issued an unsecured promissory note for $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240711__20240711_zPvJWSx5YaWj" title="Proceeds from convertible debt"><ix:nonFraction name="us-gaap:ProceedsFromConvertibleDebt" contextRef="From2024-07-112024-07-11" id="Fact002307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">40,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to an investor upon receipt of proceeds.
The note bears an annual interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240711_zkSneW3Fkvpa" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-07-11" id="Fact002309" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and will mature and be due and payable on June 25, 2025, unless extended by the written consent of the investor. The note can be prepaid
at any time by the Company without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 137; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002311" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zCvjX1dqR5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_825_ze0gMf9lqdr7">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that the arrangement was an operating lease at inception and included it in operating lease ROU assets, operating lease liabilities
- current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023. The office facility was occupied
by NextTrip employees through March 16, 2023, when the landlord informed NextTrip that it would not recognize NextTrip as the tenant.
The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately unsuccessful, and as a result derecognized
the lease in the financial statements as of February 29, 2024. No restatement was made for fiscal year 2023 as the Company had use of
the offices at that time and was in negotiations to assume the lease from NextPlay Technologies, Inc. No payments have been made on the
lease and no expense has been recognized for the three and six months ended August 31, 2024. Rent expense for the three and six months
ended August 31, 2023 totaled $<span id="xdx_903_eus-gaap--PaymentsForRent_c20230601__20230831_zUDs8rrFXPq5" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-06-012023-08-31" id="Fact002313" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,822</ix:nonFraction></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20230301__20230831_z3hIkLZPzzS7" title="Rent expense"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-03-012023-08-31" id="Fact002315" format="ixt:numdotdecimal" decimals="0" unitRef="USD">74,847</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases approximately <span id="xdx_90B_eus-gaap--AreaOfLand_iI_usqft_c20230125__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zUtMjC0NwaG" title="Area of land"><ix:nonFraction name="us-gaap:AreaOfLand" contextRef="AsOf2023-01-25_custom_PrincipalExecutiveOfficesMember" id="Fact002317" format="ixt:numdotdecimal" decimals="INF" unitRef="sqft">350</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">square feet of space for its principal
executive offices at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. The lease has a 6-month term which ends on December 31, 2024. The
landlord can terminate the lease upon 30 days written notice and NextTrip can terminate the lease upon 45 days written notice. Therefore,
the Company has elected the short-term lease recognition exemption, whereby leases are not recorded on the Company&#8217;s balance sheet
and lease payments are recognized as lease expense on a straight-line basis over the lease term. Rent expense related to this lease for
the three and six months ended August 31, 2024 was $<span id="xdx_901_eus-gaap--PaymentsForRent_c20240601__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z3nkNDFemIRb" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2024-06-012024-08-31_custom_PrincipalExecutiveOfficesMember" id="Fact002319" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,650</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--PaymentsForRent_c20240301__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z2QdZaWDAlth" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2024-03-012024-08-31_custom_PrincipalExecutiveOfficesMember" id="Fact002321" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,300</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, and $<span id="xdx_90A_eus-gaap--PaymentsForRent_c20230301__20230831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zlWbTPJ1qB89" title="Payments for rent"><ix:nonFraction name="us-gaap:PaymentsForRent" contextRef="From2023-03-012023-08-31_custom_PrincipalExecutiveOfficesMember" id="Fact002323" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the same periods in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002325" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFEnqmQabPwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_829_zeJLhLyM0iX4">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 8, 2024, at a special meeting of stockholders, the Company received approval to increase its authorized shares of common stock
from <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20240307_zgqrNH3Cp466" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-07" id="Fact002327" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,200,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
<span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20240308_z63XGH047bEf" title="Common stock, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-03-08" id="Fact002329" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">250,000,000</ix:nonFraction></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&#8220;Increase in Authorized&#8221;). On March 11, 2024, the Company filed a Certificate of Amendment to its amended and restated articles
of incorporation, as amended, with the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific
time on March 13, 2024, the Increase in Authorized was implemented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2024, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zz25wajg3Ekd" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact002331" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zJdBKNDp3Hs8" title="Number of shares converted"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact002333" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series G Convertible Preferred
Stock, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8moQY9qjU9b" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002335" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zOs2ScDReDxj" title="Number of shares converted"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002337" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">117,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series H Convertible Preferred
Stock, and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zceM3EoWEXFi" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember" id="Fact002339" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">192,502</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1XcgGetfQDd" title="Number of shares converted"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" contextRef="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember" id="Fact002341" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">192,502</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the second quarter of 2024, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240601__20240831__dei--LegalEntityAxis__custom--DooyaMediaGroupIncMember_zhssIOx2XrNe" title="Number of common stock issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-06-012024-08-31_custom_DooyaMediaGroupIncMember" id="Fact002343" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">42,709</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to a service provider
as partial compensation for development work related to Compass.TV, the Company&#8217;s Free-Ad Supported TV (&#8220;FAST&#8221;) channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our amended and restated articles of incorporation, as amended (&#8220;Articles&#8221;), our board of directors has the authority, without
further action by stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion rights,
voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be preferential
to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20240831_zPBlx5We5Fej" title="Preferred stock, shares authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240229_ziS720W8L6j8" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-08-31" id="Fact002345" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-29" id="Fact002347" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229_zrisDs6fEKnb" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831_zIfYuIEv3nH1" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-29" id="Fact002349" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-08-31" id="Fact002351" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value. An aggregate of <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240831_z8do2g5cDy15" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831_zagDP9qu0ctg" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-08-31" id="Fact002353" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-08-31" id="Fact002355" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,295</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zwC5kZM3tOlg" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zfgTOPahMzei" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-02-29" id="Fact002357" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-02-29" id="Fact002359" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">472,996</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock were issued
and outstanding at August 31, 2024 and February 29, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<ix:exclude><!-- Field: Page; Sequence: 138; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z6m2ooZr9fyd" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002361" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">1,500</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Stated Value&#8221;).
Dividends at the initial rate of <span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zLBREMrmDomk" title="Dividends percentage"><ix:nonFraction name="us-gaap:PreferredStockDividendRatePercentage" contextRef="From2024-03-012024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002363" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">9</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E Preferred
Stock by said amount. The holders of the Series E Preferred Shares have the right at any time to convert all or a portion of the Series
E Preferred Shares (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third anniversary
of the closing date) into shares of the Company&#8217;s common stock at an initial conversion rate determined by dividing the Conversion
Amount by the Conversion Price ($<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z8pHYNUmYRD" title="Conversion price per share"><ix:nonFraction name="us-gaap:DebtInstrumentConvertibleConversionPrice1" contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002365" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.13</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">above the consolidated closing bid price
for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the Stated Value
of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E Preferred Shares
being converted, plus the &#8220;Make Whole Amount&#8221; (the amount of any dividends that, but for the conversion, would have accrued
at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate is also subject
to adjustment for stock splits, dividends recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zYqkC5iZJpmj" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zkdeVtVujlla" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002367" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002369" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">316</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series E Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, including the make-whole dividends, would have resulted in
the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zbHuFHIiOY82" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember" id="Fact002371" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,259</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Series F Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIyUDMksYNGc" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact002373" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,843,993</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series F Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zXoQxcel26V8" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember" id="Fact002375" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series F Preferred&#8221;).
The Series F Preferred was designated by the Company in connection with its acquisition of NextTrip, and, in the event that the Company
does not have sufficient shares of common stock available to fulfill its obligations pursuant to the Share Exchange Agreement governing
the terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series F Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series F Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series F Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series F Preferred or alter or amend the Series F Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series F Preferred, or
(iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Conversion
Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#8220;Liquidation&#8221;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIzKEFxJBZqc" title="Preferred stock, shares outstanding">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Series F Convertible Preferred
Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 139; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztJZ504a3rX8" title="Preferred stock shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact002379" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">100,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series G Preferred Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zQMolak1TwU7" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember" id="Fact002381" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series G Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_907_eus-gaap--PreferredStockRedemptionTerms_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z4pMlhkdfhPk" title="Preferred stock redemption right, description"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_SeriesGConvertiblePreferredStockMember" id="Fact002383" name="us-gaap:PreferredStockRedemptionTerms">The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with the
terms of the Perpetual License Agreement</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zEasTqb1MJ32" title="Preferred stock, shares outstanding">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series G Convertible
Preferred Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zn2EFnmpBy5d" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact002387" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series H Preferred Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z2CWif6IqCle" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember" id="Fact002389" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series H Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>

<ix:exclude><!-- Field: Page; Sequence: 140; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zr03MBanu6Fc" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkILavaIEv64" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002391" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002393" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series H Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zepCDi8ghZGf" title="Common stock issuable upon conversion"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember" id="Fact002395" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">33,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Series I Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zD5NoIQJCbW2" title="Preferred stock, shares authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact002397" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">331,124</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series I Convertible Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z3od5aJr6LId" title="Preferred stock, par value"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember" id="Fact002399" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.001</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series I Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or
(iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zM5pgFf0Dq11" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002401" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,967</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock, at $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKRUoIlMdNOl" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002403" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, resulting in gross proceeds
to the Company of $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNwLkU9HEH1e" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002405" format="ixt:numdotdecimal" decimals="0" unitRef="USD">15,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmeMEMVFPMC2" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002407" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">24,834</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock at $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzjQy2g38kog" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002409" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, resulting in gross proceeds
to the Company of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsaGNggDVIR3" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002411" format="ixt:numdotdecimal" decimals="0" unitRef="USD">75,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zrfLvlukg2Pi" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUwy5QtNMEl3" title="Preferred stock, shares outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember" id="Fact002413" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember" id="Fact002415" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,979</ix:nonFraction></ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series I Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of <span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zVSTCfiEE8ye" title="Converted issuance of shares of common stock"><ix:nonFraction name="us-gaap:PreferredStockConvertibleSharesIssuable" contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember" id="Fact002417" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">59,979</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;). <span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zMxq9VXF2Q2h" title="Common stock reserved for issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-08-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember" id="Fact002419" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">7,000,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock have been reserved
for issuance under the 2023 Plan., and as of August 31, 2024, all of such shares are available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s 2013 Equity Incentive Plan expired on March 15, 2023. As such, no new grants may be made under the 2013 Plan. At August
31, 2024, there were <span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831_zkYBbGAlwL12" title="Common stock reserved for future issuance"><ix:nonFraction name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" contextRef="AsOf2024-08-31" id="Fact002421" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78,877</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock reserved for issuance
upon exercise of outstanding stock options issued under the 2013 Plan prior to its expiration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfG1Bd8tLNck" title="Number of options issued"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8luLPE8lOAb" title="Number of options issued"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002425" format="ixt-sec:numwordsen" decimals="INF" unitRef="Shares">no</ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuances of stock options for the six
months ended August 31, 2024 or August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 141; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company&#8217;s
common stock on the grant date, but not less than 100% of the fair market value. Stock options are typically granted throughout the year
and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified.
The Company recognizes compensation expense for the fair value of the stock options over the vesting period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
stock-based compensation expense included in the statements of operations for the three and six months ended August 31, 2024 was $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20240601__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhcw6XOUVbDg" title="Stock based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-06-012024-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002427" format="ixt:numdotdecimal" decimals="0" unitRef="USD">13,841</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC7UvZyFNVH8" title="Stock based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">30,235</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, all of which was related to stock options. There was <span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2mL3f0Bd4D2" title="Stock based compensation"><span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z1VdIpbt1Z0j" title="Stock based compensation"><ix:nonFraction name="us-gaap:AllocatedShareBasedCompensationExpense" contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002433" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">no</ix:nonFraction></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock-based compensation included in the
statements of operations for the three or six months ended August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002435" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKW0TltPBr2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B7_z6wRZwGPvSPb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Options outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zVPwjygNRui8" title="Number of Options Outstanding, Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z5MlF0ULIE13" title="Weighted Average Exercise Price Outstanding, Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229_zM1eCMBvpwz9" title="Aggregate Intrinsic Value Outstanding" style="text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zZJryDheMkse" title="Number of Options, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact002443" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">86,642</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_ztL0xiqu3Gbf" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact002445" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">61.43</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zX8uathfpHMf" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact002447" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">2.68</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229_zV3sY59loAyc" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229_zxuUZk3vXkMe" title="Number of Options, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zFVFTvBvicCk" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2453">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_ztxqk2Xultm3" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20230301__20240229_zjf9t1o51tZ2" title="Number of Options, Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2023-03-012024-02-29" id="Fact002457" format="ixt:zerodash" decimals="INF" sign="-" unitRef="Shares">-</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z4EScFQQHEN4" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2459">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zB9EZyzFHrqc" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zUdaSndO13k7" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2023-03-012024-02-29" id="Fact002463" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,342</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z6ZP9fv9yAl4" title="Weighted Average Exercise Price, Forfeited or cancelled" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact002465" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">120.87</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zMgxWTWmT7A8" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2467">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831_zqt32FAa0PV9" title="Number of Options Outstanding, Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact002469" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">85,300</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_zVx7QiD91kd2" title="Weighted Average Exercise Price Outstanding, Balance" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact002471" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">60.50</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z11gLOvNG9i3" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact002473" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.52</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831_zKQSIjEOOO85" title="Aggregate Intrinsic Value Outstanding" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831_z38Jy9bS1vq9" title="Number of Options, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zojvWxzLM2ej" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831_zhmGe9BizPr1" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20240301__20240831_z2bSGtIGzKig" title="Number of Options, Exercised" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-03-01to2024-08-31" id="Fact002483" format="ixt:zerodash" decimals="INF" sign="-" unitRef="Shares">-</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zXHfDQm7zppg" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_z5FHicFbArmd" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831_zrMMLLE2sR6b" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-03-01to2024-08-31" id="Fact002489" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,423</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zUXxvWqBEVHd" title="Weighted Average Exercise Price, Forfeited or cancelled" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-01to2024-08-31" id="Fact002491" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">87.06</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_zl6TTOjgnMic" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831_z806xjANvI75" title="Number of Options Outstanding, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-08-31" id="Fact002495" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78,877</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zrfE4T31Odd" title="Weighted Average Exercise Price Outstanding, Balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-08-31" id="Fact002497" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58.19</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831_zo18FHV6SF37" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:duryear" id="Fact002499" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.03</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831_zcNuu8x7ZMs2" title="Aggregate Intrinsic Value Outstanding" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831_zd2OsdGTetib" title="Number of Options, Expected to Vest in the Future Ending Balance" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2024-08-31" id="Fact002503" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,432</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_z54MtrYKDiF4" title="Weighted Average Exercise Price, Expected to Vest" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-08-31" id="Fact002505" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">32.25</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zfmcGnKHb1Dc" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:duryear" id="Fact002507" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">3.10</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zE35RunqK301" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831_zNfwjMbeqLA2" title="Number of Options, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-08-31" id="Fact002511" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">77,445</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zfGivz01ummg" title="Weighted Average Exercise Price, Exercisable" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-08-31" id="Fact002513" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58.67</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zJnYi6P8Uar" title="Weighted Average Remaining Contractual Life Years, Exercisable"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:duryear" id="Fact002515" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">2.01</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831_zavGZEQo7pL5" title="Aggregate Intrinsic Value, Outstanding, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831_zgTgTrY381M6" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2024-08-31" id="Fact002519" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">78,877</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20240831_z7zw842XH15c" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-08-31" id="Fact002521" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">58.19</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zd3tHOuZQX3c" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:duryear" id="Fact002523" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.03</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zzsR3sAGtJf4" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A3_zxqGBSRwDyK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no option
had an exercise price below the $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831_z7RdAZlvv9Pj" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-01to2024-08-31" id="Fact002527" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.59</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">closing price of our common stock as reported
on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, there was $<span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCB5psPYGnac" title="Unrecognized stock-based compensation expense"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember" id="Fact002529" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,139</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unrecognized stock-based compensation
expense related to unvested stock options with a weighted average remaining recognition period of <span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_za50Cy9in4Ce" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember" format="ixt-sec:duryear" id="Fact002531" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">0.74</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan (the &#8220;SAR Plan&#8221;) are to: (i) enable the Company to attract and retain
the types of employees, consultants, and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the Company&#8217;s
long-range success; (ii) provide incentives that align the interests of Service Providers with those of the stockholders of the Company;
and (iii) promote the success of the Company&#8217;s business. The SAR Plan provides for incentive awards only in the form of stock appreciation
rights payable in cash (&#8220;SARs&#8221;) and no shares of common stock are reserved or will be issued pursuant to the SAR Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#8217;s
common stock (&#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a share of common stock on the date of grant of the SAR.
The administrator of the SAR Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including,
without limitation, the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 142; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not grant any SAR&#8217;s during the six months ended August 31, 2024 or August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the vesting period for each
SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation,&#8221; and
any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002533" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zBcVO56mokq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B9_zMraIxzNLg1h" style="display: none">Schedule
of Stock Appreciation Rights Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">SARs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
                                            Life (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>SARs outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYkx0ZHYPWya" title="Options outstanding, Beginning balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zS7uyrbPFhi6" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4qR70CF3XKh" title="Aggregate Intrinsic Value, Outstanding Balance" style="text-align: right">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2539">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVjpZaEK5g25" title="Options, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="Fact002541" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zX3ZSvxN0Vqc" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" id="Fact002543" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFG7sAYamPr6" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002545" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">2.99</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zvG4Xlkhks45" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zEMmUaNNo3Mb" title="Number of Options, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7HkD0YU49Ok" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zu6LQ7opMcU" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zofD6jbSpdW7" title="Number of Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2555">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ2nUc70M7K8" title="Weighted Average Exercise Price, Forfeited or cancelled" style="padding-bottom: 1pt; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPeBdtZFr9ql" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zymMamZSGrmk" title="Options Outstanding, Beginning Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact002561" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,390</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFjnfz7Fg6G5" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember" id="Fact002563" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.77</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeAAGWZvi1b2" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"><ix:nonNumeric contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002565" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.99</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYromUSLtAK8" title="Aggregate Intrinsic Value, Beginning Balance" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRfhBr9C40X4" title="Options, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqeYMkayp6kb" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2571">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zxkk6a0l7HL" title="Aggregate Intrinsic Value, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2573">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPegzyktlkd7" title="Options, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMWjsximVtgk" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2577">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuXAJ4YstJha" title="Aggregate Intrinsic Value, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2579">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMsoQXUNk7c" title="Options, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="Fact002581" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">167</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znSNcasf1Sif" title="Weighted Average Exercise Price, Forfeited or cancelled" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="Fact002583" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">37.40</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zdAtLr9NkBjb" title="Aggregate Intrinsic Value, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3gqjAiT4wn" title="Options Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002587" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,223</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zrEBS45lc8Z6" title="Weighted Average Exercise Price Outstanding, Ending Balance" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002589" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.80</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zCN3wrZTwhAl" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002591" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">2.49</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zmsTvyPH9nf5" title="Aggregate Intrinsic Value, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2593">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMotYWXHOC8" title="Options, Expected to vest" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002595" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,645</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zV1S0hNdgNUf" title="Weighted Average Exercise Price, Expected to Vest" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002597" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">29.37</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z1OFBeCyAIQ7" title="Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002599" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">2.84</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuHLuAKzFJvk" title="Aggregate Intrinsic Value, Expected to vest" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2601">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z44NDFqKYff9" title="Options, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002603" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">34,578</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlD6VVfHUeFg" title="Weighted Average Exercise Price, Exercisable" style="padding-bottom: 1pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002605" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">47.31</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zhMjmnXKBe8d" title="Weighted Average Remaining Contractual Life (Yrs.), Exercisable"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002607" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">2.43</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwrrLyJVoobh" title="Aggregate Intrinsic Value, Exercisable" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and SARs expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ75WZfpdr1b" title="Number of Options, Vested, Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002611" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">40,223</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGDyBIu3c62g" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest" style="padding-bottom: 2.5pt; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002613" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">44.80</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSvdfpAOI1s9" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002615" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">2.49</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z48Q5wRTqJj2" title="Aggregate Intrinsic Value, Vested, Exercisable and Options Expected to Vest" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A8_zq2NCPWaM1xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no SAR
had an exercise price below the $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaaEsbHvLtS1" title="Options exercise price"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" id="Fact002619" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">2.59</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">closing price of our common stock as reported
on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, there was $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJikAlhk7eF" title="Weighted average remaining recognition period"><ix:nonFraction name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember" id="Fact002621" format="ixt:numdotdecimal" decimals="0" unitRef="USD">943</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unrecognized stock-based compensation
expense related to unvested SARs with a weighted average remaining recognition period of <span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaRwDjEpAXB1" title="Weighted average remaining recognition period"><ix:nonNumeric contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember" format="ixt-sec:duryear" id="Fact002623" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">0.64</ix:nonNumeric>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002625" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsMJkrYQxTV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_zkQxt8HKhodd" style="display: none">Schedule
of Warranty Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Warrants outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zzdUFYwYF1ye" title="Warrants Outstanding, Beginning Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2627">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z0I419FYMyw9" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2629">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_z9wrCuPcqxZg" title="Warrants, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" contextRef="From2023-03-012024-02-29" id="Fact002631" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">217,593</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zjLCAK5GQZT" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition" style="width: 12%; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact002633" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">21.01</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_z0uKOTHVIUK4" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact002635" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">1.86</ix:nonNumeric></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zc6yCmU31tXd" title="Warrants, Granted" style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" contextRef="From2023-03-012024-02-29" id="Fact002637" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">268,572</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zPc4aM2bHHid" title="Weighted Average Exercise Price Outstanding, Granted" style="text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" contextRef="From2023-03-012024-02-29" id="Fact002639" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_ziCGPYjosccd" title="Weighted Average Remaining Contractual Life (Yrs.), Granted"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact002641" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm">2.17</ix:nonNumeric></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zOAcIfbmOxG5" title="Warrants,Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2643">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zacem4gPZU6i" title="Weighted Average Exercise Price Outstanding,Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2645">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zvH05pJxGWC7" title="Warrants, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2647">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zoqzvZ20UDE6" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2649">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20240831_znYtPvJuDObh" title="Warrants Outstanding, Beginning Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-02-29" id="Fact002651" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">486,165</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_z4nT0Ip458oh" title="Weighted Average Exercise Price Outstanding, Beginning Balance" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-02-29" id="Fact002653" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.94</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zYZsstFAZGT" title="Weighted Average Remaining Contractual Life Years"><ix:nonNumeric contextRef="From2023-03-012024-02-29" format="ixt-sec:duryear" id="Fact002655" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm">1.96</ix:nonNumeric></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20240831_zw31jFWOnvZf" title="Warrants, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zbFVB8r8IXP5" title="Weighted Average Exercise Price, Granted" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2659">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20240831_zfFZ1vKAMVMj" title="Warrants, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zlnZRkH0jAAj" title="Weighted Average Exercise Price, Exercised" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20240831_zRm1dGQc7Kb" title="Warrants, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" contextRef="From2024-03-01to2024-08-31" id="Fact002665" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,102</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20240831_zmIPPL4nLMp1" title="Weighted Average Exercise Price, Forfeited or cancelled" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" contextRef="From2024-03-01to2024-08-31" id="Fact002667" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">322.00</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20240831_z5Q7qWwJNiv2" title="Warrants Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" contextRef="AsOf2024-08-31" id="Fact002669" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">484,063</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zivlj0TsIhH9" title="Weighted Average Exercise Price Outstanding, Ending Balance" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" contextRef="AsOf2024-08-31" id="Fact002671" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">8.58</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20240831_z5XvcGsAF1P3" title="Weighted Average Remaining Contractual Life (Yrs.) Outstanding"><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" format="ixt-sec:duryear" id="Fact002673" name="NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm">1.46</ix:nonNumeric></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A1_zEgpYg2Y9qCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<ix:exclude><!-- Field: Page; Sequence: 143; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2024-03-01to2024-08-31" escape="true" id="Fact002675" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zvgvmMIU2Om8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_828_zKDN5G3RXJY9">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Related Party Advances</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
September 1, 2024 and October 11, 2024, additional net related party advances totaled $<span id="xdx_902_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_c20240901__20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z70f9cDxZk99" title="Related party advances"><ix:nonFraction name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" contextRef="From2024-09-012024-10-11_us-gaap_SubsequentEventMember" id="Fact002677" format="ixt:numdotdecimal" decimals="0" unitRef="USD">84,060</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and the aggregate outstanding principal balance of related party advances was $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zydsjIyvL4Dd" title="Related party advances"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-10-11_us-gaap_SubsequentEventMember" id="Fact002679" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,802,654</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2024, the Company&#8217;s board of directors approved the conversion of up to <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpH7f8ZZJUDh" title="Conversion percentage"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentRate" contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember" id="Fact002681" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the outstanding principal balance of the promissory notes held by Messrs. Kerby and Monaco into shares of a series of non-redeemable
convertible preferred stock preferred stock yet to be designated. Messrs. Kerby and Monaco have agreed to initially convert $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zrVjpegsVuJ7" title="Converted amount"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentAmount1" contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember" id="Fact002683" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,500,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_z05GQporSMui" title="Conversion percentage"><ix:nonFraction name="us-gaap:DebtConversionConvertedInstrumentRate" contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember" id="Fact002685" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">56.3</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of their total outstanding principal balance of $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zCZLS7gHqMQ3" title="Outstanding principal  amount"><ix:nonFraction name="us-gaap:DebtInstrumentCarryingAmount" contextRef="AsOf2024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember" id="Fact002687" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,666,790</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into the new series of convertible preferred
stock, and, at their discretion, may convert up to the remaining principal balance, or any portion thereof, into additional shares of
such convertible preferred stock at a future date. The conversion remains subject to completion of final documentation for the transaction,
including the filing of the certificate of designation for the new series of convertible preferred stock with the Nevada Secretary of
State.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Nasdaq Listing Requirement Deficiency Notice </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2024, the Company received a notification letter (the &#8220;Notice&#8221;) from the Nasdaq Listing Qualifications Staff
(the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that its amount of stockholders&#8217;
equity has fallen below the $<span id="xdx_900_ecustom--MinimumRequiredStockholdersEquity_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh6ZX76RWGKe" title="Stockholders equity minimum required"><ix:nonFraction name="NTRP:MinimumRequiredStockholdersEquity" contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember" id="Fact002689" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,500,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required minimum for continued listing
set forth in Nasdaq Listing Rule 5550(b)(1). The Notice also noted that the Company does not meet the alternatives of market value of
listed securities or net income from continuing operations, and therefore, the Company no longer complies with Nasdaq&#8217;s Listing
Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rules, the Company has until November 4, 2024 to provide Nasdaq with a specific plan to achieve and sustain compliance.
If Nasdaq accepts the Company&#8217;s plan to regain compliance, Nasdaq may grant an extension of up to 180 calendar days from the date
of the Notice to evidence compliance. If Nasdaq does not accept the Company&#8217;s plan to regain compliance, the Company will have
the opportunity to appeal the decision to a Nasdaq Hearings Panel. A hearing request will stay the suspension and delisting of the Company&#8217;s
securities pending the Nasdaq Hearings Panel&#8217;s decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice has no immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#8217;s
listing remains fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is evaluating various courses of action to achieve compliance with Nasdaq Listing Rule 5550(b)(1). There can be no assurance
that the Company will regain compliance with Nasdaq Listing Rule 5550(b)(1) or that the Company will be able meet the continued listing
requirements during any compliance period that may be granted by Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2024, the Company also received a letter from the Staff of Nasdaq indicating that the Staff has determined that the Company
has regained compliance with the periodic filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) because the Company filed its
Annual Report on Form 10-K for the fiscal year ended February 29, 2024 and the Quarterly Report on Form 10-Q for the quarter ended May
31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company has regained full compliance with the periodic filing requirement deficiency, which the Company disclosed in those Current
Reports on Form 8-K filed with the Securities and Exchange Commission on June 21, 2024 and July 19, 2024, and Nasdaq has informed the
Company in writing that the matter is now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>September 2024 Alumni Capital Transactions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024 the Company entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with Alumni Capital
LP (Alumni Capital&#8221;) for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (the &#8220;Warrants&#8221;)
to Alumni Capital for total consideration of $<span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKZiBTGYZnf3" title="Total consideration"><ix:nonFraction name="us-gaap:NotesAndLoansPayableCurrent" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002691" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
After deducting commissions, net proceeds to the Company were $<span id="xdx_909_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5ZZ2BU1OIRd" title="Net proceeds"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002693" format="ixt:numdotdecimal" decimals="0" unitRef="USD">230,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zknXAbXIYace" title="Principal amount"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002695" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with an original issue discount of $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5P9Q1Y6laT6" title="Original issue discount"><ix:nonFraction name="us-gaap:DebtInstrumentUnamortizedDiscount" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">50,000</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and guaranteed interest on the principal
amount of ten percent (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOn32w44HPPa" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002699" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
per annum which shall be due and payable on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNPwmNUxeaW8" title="Maturity date"><ix:nonNumeric contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" format="ixt:datemonthdayyearen" id="Fact002701" name="us-gaap:DebtInstrumentMaturityDate">December
19, 2024</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In the event of a failure to
re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase to the lesser of twenty-two percent (<span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zSWDZaP1ycbf" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateStatedPercentage" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember" id="Fact002703" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">22</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
such an event of default, Alumni shall have the right to convert all or any part of the outstanding and unpaid principal, interest, penalties,
and all other amounts under the Alumni Note into fully paid and non-assessable shares of the <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkdkhRbxlD4" title="Debt instrument description"><ix:nonNumeric contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember" id="Fact002705" name="us-gaap:DebtInstrumentDescription">Company&#8217;s
common stock at a conversion price of eighty percent (80%) of the lowest traded price of the common stock during the twenty (20) business
days prior to Alumni&#8217;s delivery of a notice of conversion (the &#8220;Conversion Price&#8217;), subject to adjustment in the event
the Company is no longer DWAC eligible, is subject to a DTC &#8220;chill&#8221; and/or the Company ceases to be a reporting issuer. Notwithstanding
the foregoing, conversions will be subject to limitation whereby such conversion would result in beneficial ownership by Alumni and its
affiliates of more than 9.99% of the outstanding shares of Company&#8217;s common stock (the &#8220;Beneficial Ownership Limitation&#8221;)
or would exceed 19.99% of the Company&#8217;s outstanding common stock</ix:nonNumeric></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
of September 19, 2024 (the &#8220;Exchange Cap&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued Warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJe9Oftka641" title="Warrants to purchase of common stock"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember" id="Fact002707" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">96,774</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of common
stock at a price per share of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCKyZnJ6fITe" title="Exercise price per share"><ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember" id="Fact002709" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.10</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Warrants are exercisable on or prior to the five
(<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztAeVUu8jls6" title="Warrants exercise term"><ix:nonNumeric contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember" format="ixt-sec:duryear" id="Fact002711" name="us-gaap:WarrantsAndRightsOutstandingTerm">5</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">)
year anniversary of the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company also entered into a Common Stock Securities Purchase Agreement (the &#8220;Common Stock SPA&#8221;) with
Alumni Capital. Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Alumni Capital to purchase
up to $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zVmxjK8NY4p6" title="Number of purchase of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember" id="Fact002713" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock (the &#8220;Commitment
Amount&#8221;) at the Purchase Price (defined below) during the period beginning on the execution date of the Common Stock SPA and ending
on the earlier of (i) the date on which Alumni Capital has purchased $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxwKLMfSVCL1" title="Number of purchase of shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002715" format="ixt:numdotdecimal" decimals="-6" scale="6" unitRef="USD">10</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock pursuant
to the Common Stock SPA or (ii) December 31, 2025. <span id="xdx_90B_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GRZ4Rowijb" title="Sale of stock description" style="background-color: white"><ix:nonNumeric contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002717" name="us-gaap:SaleOfStockDescriptionOfTransaction">Pursuant
to the Common Stock SPA, the &#8220;Purchase Price&#8221; means the lowest traded price of Company common stock during the five (5) business
days prior a closing date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration
statement and no Purchase Notice will be in an amount greater than $500,000.</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
consideration for Alumni Capital&#8217;s execution and delivery of, and performance under, the Common Stock SPA, the Company (i) issued
and delivered <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zz2mdgfPrNMg" title="Number of shares issued"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember" id="Fact002719" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">32,786</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of Company
common stock to Alumni Capital on September 19, 2024, and (ii) within one (1) business day from the date off effectiveness of the S-1
Registration Statement registering shares issuable pursuant to the Common Stock SPA, the Company shall cause its transfer agent to issue
and deliver as DWAC or DRS shares to Alumni Capital that number of shares of common stock equal to two percent (2.00%) of the Commitment
Amount divided by the VWAP for the Company&#8217;s common stock for the business day prior to the notice of effectiveness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>October
2024 Preferred Stock Sale</i></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zH6sqARaCE8g" title="Sale of stock, shares"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002721" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">66,225</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock at $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ze5wQJnyIt7b" title="Sale of stock, shares price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002723" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">3.02</ix:nonFraction>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, for total consideration of
$<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6HTDv7wnkwk" title="Sale of stock proceeds"><ix:nonFraction name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember" id="Fact002725" format="ixt:numdotdecimal" decimals="0" unitRef="USD">200,000</ix:nonFraction></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>




</ix:nonNumeric><p id="xdx_815_zcZw69ajMQa3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<!-- Field: Page; Sequence: 144; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares
of Common Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-Funded
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Shares of Common Stock Underlying the Common
Warrants and Pre-Funded Warrants</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="forms-1a_001.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>NextTrip,
Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRELIMINARY
PROSPECTUS&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sole
Bookrunner</i></b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>The
Benchmark Company, LLC</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
and including &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024 (the
25th day after the date of this offering), all dealers effecting transactions in these securities, whether or not participating in this
offering, may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting
as an underwriter and with respect to an unsold allotment or subscription.&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; margin-top: 0pt; font-size: 1pt; margin-bottom: 0pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PART
II</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INFORMATION
NOT REQUIRED IN PROSPECTUS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the costs and expenses payable by us in connection with the issuance and distribution of the securities being
registered hereunder. All of the amounts shown are estimates, except for the Securities and Exchange Commission (&#8220;SEC&#8221;)
registration fee and FINRA filing fee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Amount to <br/>
be Paid</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left">SEC Registration Fee</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">3,644.55</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">FINRA filing fee</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,070.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Legal fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accounting fees and expenses</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transfer agent and registrar fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Printer service fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,200</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">Miscellaneous expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">270,415.30</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
14. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Nevada Revised Statutes provide us with the power to indemnify any of our directors and officers. The director or officer must have conducted
himself/herself in good faith and reasonably believe that his/her conduct was in, or not opposed to, our best interests. In a criminal
action, the director or officer must not have had reasonable cause to believe his/her conduct was unlawful. Under applicable sections
of the Nevada Revised Statutes, advances for expenses may be made by agreement if the director or officer affirms in writing that he/she
believes he/she has met the standards and will personally repay the expenses if it is determined the officer or director did not meet
the standards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
bylaws include an indemnification provision under which we must indemnify any of our directors or officers, or any of our former directors
or officers, to the full extent permitted by law. We have also entered into indemnification agreements with each of our directors and
officers under which we must indemnify them to the full extent permitted by law. At present, there is no pending litigation or proceeding
involving any of our directors or officers for which indemnification is sought, nor are we aware of any threatened litigation that is
likely to result in claims for indemnification. We also maintain insurance policies that indemnify our directors and officers against
various liabilities, including liabilities arising under the Securities Act, which may be incurred by any director or officer in his
or her capacity as such.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted for our directors, officers and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been informed that in the opinion of the SEC such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event a claim for indemnification against such
liabilities (other than payment by us for expenses incurred or paid by a director, officer or controlling person of ours in successful
defense of any action, suit, or proceeding) is asserted by a director, officer or controlling person in connection with the securities
being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction, the question of whether such indemnification by it is against public policy in the Securities Act and will
be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have entered into indemnification agreements with each of our directors and intend to enter into such agreements with certain of our
executive officers. These agreements provide that we will indemnify each of our directors, certain of our executive officers and, at
times, their affiliates to the fullest extent permitted by Nevada law. We will advance expenses, including attorneys&#8217; fees (but
excluding judgments, fines and settlement amounts), to each indemnified director, executive officer or affiliate in connection with any
proceeding in which indemnification is available and we will indemnify our directors and officers for any action or proceeding arising
out of that person&#8217;s services as a director or officer brought on behalf of the Company and/or in furtherance of our rights. Additionally,
each of our directors may have certain rights to indemnification, advancement of expenses and/or insurance provided by their affiliates,
which indemnification relates to and might apply to the same proceedings arising out of such director&#8217;s services as a director
referenced herein. Nonetheless, we have agreed in the indemnification agreements that the Company&#8217;s obligations to those same directors
are primary and any obligation of the affiliates of those directors to advance expenses or to provide indemnification for the expenses
or liabilities incurred by those directors are secondary.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 146; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
15. RECENT SALES OF UNREGISTERED SECURITIES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">share and per share data included in this Item 15
has been retrospectively adjusted to reflect the 1-for-20 reverse stock split of our common stock, which was effected on September 22,
2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions
during the fiscal year ended December 31, 2021</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
issued in connection with January 2021 H.C. Wainwright underwritten offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 8, 2021, the Company entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with H.C. Wainwright &amp;
Co. (the &#8220;Underwriter&#8221;), which provided for the issuance and sale by the Company in an underwritten public offering (the
&#8220;Offering&#8221;) and the purchase by the Underwriter of 1,488,507 shares of the Company&#8217;s common stock, $0.001 par value
per share. The offering closed on January 12, 2021.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Underwriting Agreement, we also issued to the Underwriter or its designee warrants to purchase a number of shares equal to 8%
of the aggregate number of shares of common stock sold in the Offering, including shares issued upon exercise of the option to purchase
additional shares (the &#8220;Underwriter Warrants&#8221;). The Underwriter Warrants have a term of five years from the commencement
of sales in the Offering and an exercise price of $3.75 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Also
on January 8, 2021, the Company obtained a waiver (&#8220;Waiver&#8221;) from certain investors (&#8220;Investors&#8221;) with respect
to certain anti-dilution adjustment provisions of a January 2020 warrant and an April 2020 warrant issued to the Investors. As consideration
for the Waiver, the Company issued an additional warrant (&#8220;Warrant&#8221;) to the Investors to purchase an aggregate of 100,000
shares of common stock, each exercisable after six months for a five-year period with an exercise price equal to 115% of the closing
price of the Company&#8217;s stock on the date of the waiver.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Warrants
issued in connection with March 2021 H.C. Wainwright registered direct offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 25, 2021, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with certain purchasers
named therein (the &#8220;Purchasers&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering
2,190,000 shares (the &#8220;Shares&#8221;) of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;)
at a purchase price of $4.445 per share, (the &#8220;Registered Offering&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
a concurrent private placement (the &#8220;Private Placement&#8221; and together with the Registered Offering, the &#8220;Offerings&#8221;)
under the Purchase Agreement, the Company issued to the Purchasers warrants to purchase an aggregate of 2,190,000 shares of Common Stock
at an exercise price of $4.32 per share. Each Warrant will be exercisable commencing on the date the Company obtains Stockholder Approval
and will expire two years after the initial exercise date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a letter agreement, dated January 4, 2021, as amended on March 22, 2021 (the &#8220;Engagement Letter&#8221;), the Company engaged
H.C. Wainwright &amp; Co., LLC (the &#8220;Placement Agent&#8221;) as placement agent in connection with the Offerings. Pursuant to the
Engagement Letter, the Company also issued to designees of the Placement Agent warrants to purchase up to 175,200 shares of Common Stock
(the &#8220;Placement Agent Warrants&#8221;) constituting 8% of the aggregate number of shares of Common Stock sold in the Registered
Offering, The Placement Agent Warrants have substantially the same terms as the Warrants, except that the Placement Agent Warrants have
an exercise price equal to 125% of the offering price per share (or $5.55625 per share).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Additional
2021 Transactions</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2021, the Company issued 1,500 shares of common stock valued at $4.99 per share to an investor relations firm as partial compensation
for services previously rendered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal 2021, we purchased 5,204 shares of our common stock at a price of $3.47 per share, the average of the Company&#8217;s opening
and closing stock price on the date of purchase, upon the exercise of our right of first refusal in connection with an employee&#8217;s
exercise of an option to purchase such shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 147; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions
during the fiscal year ended December 31, 2022</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Transactions
from January 1, 2023 to present</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>January
2023 Warrant Offering</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2023, the Company agreed to issue to a holder of 132 shares of the Company&#8217;s outstanding Series D Preferred Stock (the
&#8220;Preferred Shares&#8221;) a five-year warrant to purchase up to 225,000 shares of common stock of the Company at an initial exercise
price of $0.58 per share, the closing price of the common stock as reported on the Nasdaq Capital Market on such date, which exercise
price is subject to adjustment in the event of a stock split, reverse stock split and similar events. The warrant was issued in consideration
of the holder&#8217;s agreement to convert, in full, the Series D Shares in accordance with their terms into 270,828 shares of common
stock, which equates to a conversion price of $0.58 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>NextTrip
Acquisition - Stock Consideration</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 13, 2023, the Company entered into a Share Exchange Agreement (as amended, the &#8220;Exchange Agreement&#8221;) with NextTrip
Holdings, Inc. (&#8220;NextTrip&#8221;), NextTrip Group, LLC (&#8220;NextTrip Parent&#8221;), and William Kerby, as the NextTrip Representative,
pursuant to which, amongst other things, we agreed to acquire NextTrip in exchange for shares of our common stock, subject to approval
of our shareholders (the &#8220;Acquisition&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, we completed the Acquisition, pursuant to the terms of the Exchange Agreement, NextTrip became a wholly-owned subsidiary
of the Company and the ongoing business of the Company became the business of NextTrip. In connection with closing of the Acquisition,
we issued to the NextTrip Parent&#8217;s members (the &#8220;NextTrip Sellers&#8221;) an aggregate of 156,007 restricted shares our common
stock (the &#8220;Closing Shares&#8221;), constituting 19.99% of our issued and outstanding shares of common stock immediately prior
to closing of the Acquisition. Under the Exchange Agreement, the NextTrip Sellers will be entitled to receive additional shares of our
common stock (the &#8220;Contingent Shares,&#8221; and together with the Closing Shares, the &#8220;Exchange Shares&#8221;) upon NextTrip&#8217;s
achievement of future milestones, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 54%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Milestone</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
    Earned</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contingent
    Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s leisure travel booking platform by either (i) achieving $1,000,000 in cumulative sales under its historical &#8220;phase
    1&#8221; business, or (ii) commencement of its marketing program under its enhanced &#8220;phase 2&#8221; business.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date six months after the closing date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s group travel booking platform and signing of at least five (5) entities to use the groups travel booking platform.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date nine months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Launch
    of NextTrip&#8217;s travel agent platform and signing up of at least 100 travel agents to the platform (which calculation includes
    individual agents of an agency that signs up on behalf of multiple agents).</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 12 months from the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,450,000
    Contingent Shares</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commercial
    launch of PayDelay technology in the NXT2.0 system.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of a date 15 months after the closing date (or earlier date six months after the closing date)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,650,000
    Contingent Shares, less the Exchange Shares issued at the closing of the Acquisition</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternatively,
independent of achievement of the foregoing milestones, for each month during the 15-month period following the closing date in which
$1,000,000 or more in gross travel bookings are generated by NextTrip, Inc., to the extent not previously issued, the Contingent Shares
will be issuable in the order indicated above up to the maximum Exchange Shares issuable under the Exchange Agreement. In no event, however,
will the Contingent Shares, together with the Closing Shares, exceed 6,000,000 shares of our common stock, subject to adjustment in the
event of future stock splits, reverse stock splits and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Page; Sequence: 148; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Preferred Stock Issuance</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024 (the &#8220;Effective Date&#8221;), the Company and NextTrip Holdings, Inc., a wholly owned subsidiary of the Company
(&#8220;NextTrip&#8221;), entered into a Perpetual License Agreement (the &#8220;License Agreement&#8221;) with Promethean TV, Inc. (&#8220;Promethean&#8221;),
pursuant to which Promethean (i) sold NextTrip the code for the Licensed Software (as defined in the License Agreement) and (ii) granted
NextTrip an irrevocable, worldwide, perpetual right and non-exclusive license to forever retain and use the code and each executable
copy of the Licensed Software for the commercial exploitation by NextTrip in the travel solutions industry, subject to certain limitations
set forth in the License Agreement (the &#8220;Perpetual License&#8221;). The term of the License Agreement commenced on the Effective
Date and shall continue in perpetuity unless and until terminated by either party pursuant to the terms of the License Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
consideration for the Perpetual License and the other rights granted pursuant to the License Agreement, the Company issued Promethean
100,000 restricted shares of its Series G Convertible Preferred Stock (&#8220;Series G Preferred&#8221;), and NextTrip waived all past
debts to NextTrip previously incurred by Promethean. For a period of six months from the Effective Date, the Company has the right to
repurchase up to fifty percent of the Series G Preferred issued to Promethean, or the shares of Company common stock underlying the Series
G Preferred if converted during such period, for $1.00 as consideration for any breaches of representations and warranties or indemnities
of Promethean pursuant to certain provisions of the License Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Preferred Stock Issuances</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company also issued an aggregate of 150,000 shares of Series H Convertible Preferred Stock (the &#8220;Series H
Preferred&#8221;) to two parties in exchange for resolution of certain services, payables and/or other liabilities of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Preferred Stock Issuances</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 15, 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited
investors (the &#8220;Purchasers&#8221;), pursuant to which the Company issued and sold an aggregate of $672,500 of the Company&#8217;s
securities, consisting of (i) 222,680 restricted shares of newly designated Series I Convertible Preferred Stock of the Company (the
&#8220;Series I Preferred&#8221;), and (ii) unregistered warrants (the &#8220;Warrants&#8221;) to purchase up to 111,340 shares of Company
common stock (the &#8220;Offering&#8221;). Each share of Series I Preferred was sold together with one-half of a Warrant at a combined
price of $3.02. The Offering was priced at the &#8220;Minimum Price&#8221; under Nasdaq Rule 5635(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants shall be exercisable on such date that the Company amends its Articles of Incorporation, as amended (the &#8220;Charter&#8221;),
to increase the number of shares of common stock authorized for issuance thereunder by an amount sufficient to issue the shares of common
stock issuable upon conversion of the Series I Preferred and Warrants. The Warrants will expire three years following the issuance date
and have an exercise price of $3.02 per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Umergence
LLC (&#8220;Umergence&#8221;) served as the placement agent for the Company, on a reasonable best-efforts basis, in connection with the
Offering. As compensation for its services as placement agent, the Company paid Umergence an aggregate cash fee equal to 5.0% of the
gross proceeds of the Offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August of 2024, the Company entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;) with certain accredited
investors (the &#8220;Purchasers&#8221;), pursuant to which the Company issued and sold an aggregate of 29,801 of restricted shares of
Series I Preferred, at a price of $3.02 per share, resulting in gross proceeds to the Company of $90,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><i>Common Stock Issuances for Services</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">In July and August 2024,
the Company issued a total of 42,709 shares of common stock valued at $3.02 per share, to Dooya Media Group, Inc. as partial compensation
for services provided in connection with the launch of the Compass.TV FAST channel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">On October 25, 2024,
the Company issued 8,065 shares of common stock valued at $3.10 per share to FSA Travel LLC in connection with executing a non-binding
Letter of Intent to acquire a majority ownership interest in the company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><i>Common Stock Purchase Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">On September 19, 2024,
the Company entered into a Common Stock Securities Purchase Agreement (the &#8220;Common Stock SPA&#8221;) with Alumni Capital LP (the
&#8220;Investor&#8221;). Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Investor to purchase
up to $10 million of Common Stock (the &#8220;Commitment Amount&#8221;) at the Purchase Price (defined below) during the period beginning
on the execution date of the Common Stock SPA and ending on the earlier of (i) the date on which Investor has purchased $10 million in
Common Stock pursuant to the Common Stock SPA or (ii) December 31, 2025.</p>

<p style="font: 9pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">In consideration for
the Investor&#8217;s execution and delivery of, and performance under, the Common Stock SPA, the Company issued to the Investor 32,786
common shares, which was equal to one percent (1.00%) of the Commitment Amount divided by the VWAP for the Common Stock for the business
day prior to September 19, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><i>Securities Purchase Agreement &#8211; Note
and Warrants</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">On the September 19,
2024, the Company also entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with Investor for the
sale of a short-term promissory note (&#8220;Note&#8221;) and warrants (&#8220;Warrants&#8221;) to Investor for total consideration of
$250,000. In conjunction with the issuance of the Note to the Investor, the Company also issued Warrants to purchase 96,774 shares of
common stock at a price per share of $3.10, which represents 100% warrant coverage on the principal amount of the Note. The Warrants
are exercisable on or prior to the five (5) year anniversary of the Effective Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Applicable
Exemptions</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as otherwise indicated above, no underwriters were used in the foregoing transactions, and no discounts or commissions were paid for
the transactions described in this item. All sales of securities described in this item were exempt from the registration requirements
of the Securities Act in reliance on Section 4(a)(2) of the Securities Act, Rule 701 promulgated under the Securities Act or Regulation
D promulgated under the Securities Act, relating to transactions by an issuer not involving a public offering. All of the foregoing securities
are deemed restricted securities for purposes of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 149; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a) Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registrant has filed the exhibits listed on the accompanying Exhibit Index of this registration statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Financial Statement Schedules.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
financial statement schedules are omitted because the information called for is not required or is shown either in the financial statements
or in the notes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM
17. UNDERTAKINGS.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The undersigned registrant hereby undertakes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.)
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i.)
To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii.)
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range
may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration
Fee&#8221; table in the effective registration statement; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii.)
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or
any material change to such information in the registration statement;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2.)
That, for the purpose of determining any liability under the Securities Act of 1933, each such post- effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3.)
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4.)
That, for the purpose of determining liability under the Securities Act of 1933, as amended, to any purchaser in the initial distribution
of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant
to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities
are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer or sell such securities to such purchaser:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule
424;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by
the undersigned registrant;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 150; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5.)
That, for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus
filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant
pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of
the time it was declared effective; and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 25pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6.)
That, for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form
of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insofar
as indemnification for liabilities arising under the Securities Act of 1933, as amended, may be permitted to directors, officers
and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in
the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act
of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment
by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to
a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act of 1933, as amended, and will be governed by the final adjudication of such issue.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 151; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBIT
INDEX</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; width: 0.1in; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Underwriting Agreement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&#8224;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223037109/ex2-1.htm" style="-sec-extract: exhibit">Share Exchange Agreement dated as of October 12, 2023 among Sigma Additive Solutions, Inc., NextTrip Holdings, Inc., NextTrip Group, LLC and the NextTrip Representative (filed as Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K dated October 13, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222007671/ex3-1.htm" style="-sec-extract: exhibit">Amended and Restated Articles of Incorporation of the Company, as amended (previously filed by the Company as Exhibit 3.1 to the Company&#8217;s Form 10-K filed on March 24, 2022 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222022379/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment to Amended and Restated Articles of Incorporation, as amended (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed August 12, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221006709/ex3-12.htm" style="-sec-extract: exhibit">Amended and Restated Bylaws of the Company, as amended. (filed by the Company as Exhibit 3.12 to the Company&#8217;s Form 10-K, filed on March 24, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222035735/ex3-1.htm" style="-sec-extract: exhibit">Amendment No. 3 to Amended and Restated By-Laws of Sigma Additive Solutions, Inc. (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed December 16, 2022, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223033449/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Change (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K dated September 22, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224001847/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series F Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K dated January 9, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series G Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K dated January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex3-2.htm" style="-sec-extract: exhibit">Certificate of Designation of Series H Convertible Preferred Stock (filed as Exhibit 3.2 to the Company&#8217;s Current Report on Form 8-K dated January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Designation of Series I Convertible Preferred Stock (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K dated February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224009634/ex3-1.htm" style="-sec-extract: exhibit">Certificate of Amendment, effective as of March 13, 2024 (filed as Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K dated March 12, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315218004882/ex4-1.htm" style="-sec-extract: exhibit">Form
    of Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed April 6, 2018, and
    incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315218004882/ex4-2.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrants (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed April 6, 2018, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315218009205/ex4-1.htm" style="-sec-extract: exhibit">Form
    of Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed June 26, 2018, and
    incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219003281/ex4-1.htm" style="-sec-extract: exhibit">Form of Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed March 14, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219003281/ex4-2.htm" style="-sec-extract: exhibit">Form of Unit Purchase Option (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed March 14, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219006587/ex4-1.htm" style="-sec-extract: exhibit">Form
    of Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed May 8, 2019, and
    incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219006587/ex4-2.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed May 8, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001399/ex10-4.htm" style="-sec-extract: exhibit">Form of Institutional Common Warrant (filed as Exhibit 10.4 to the Company&#8217;s Current Report on Form 8-K, filed January 30, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001399/ex10-8.htm" style="-sec-extract: exhibit">Form of Class A Warrant(filed as Exhibit 10.8 to the Company&#8217;s Current Report on Form 8-K, filed January 30, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220005763/ex10-3.htm" style="-sec-extract: exhibit">Form of Common Stock Purchase Warrants (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221000848/ex4-1.htm" style="-sec-extract: exhibit">Form of Underwriter Common Stock Purchase Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed January 12, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221000848/ex4-2.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed January 12, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant to Purchase Common Stock (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex4-2.htm" style="-sec-extract: exhibit">Form of Placement Agent Warrant (filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 152; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223009743/ex4-15.htm" style="-sec-extract: exhibit">Warrant to Purchase Common Stock issued January 26, 2023 (filed as Exhibit 4.15 to the Company&#8217;s Annual Report on Form 10-K filed on March 30, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222007671/ex4-15.htm" style="-sec-extract: exhibit">Description of Securities (filed as Exhibit 4.15 to the Company&#8217;s Annual Report on Form 10-K filed on March 24, 2022 and incorporated herein by reference).</a></span></p>


<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex4-1.htm" style="-sec-extract: exhibit">Form of Warrant (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K dated February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.18</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex4-1.htm" style="-sec-extract: exhibit"><span>Warrant by and between the Company and Alumni Capital LP, dated September 19, 2024 (filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K dated September 25, 2024 and incorporated herein by reference)<span style="font-size: 10pt">.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.19*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Form of Pre-Funded Warrant (current offering).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.20*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Form of Common Stock Purchase Warrant (current offering).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.21*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Form of Warrant Agency Agreement (current offering).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">4.22*</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Form of Underwriter&#8217;s Warrant (current offering).</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion
    of Snell &amp; Wilmer LLP.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219004380/ex10-4.htm" style="-sec-extract: exhibit">Form of Nonqualified Stock Option Agreement (previously filed by the Company as Exhibit 10.4 to the Company&#8217;s Form 10-K, filed on April 1, 2019, and incorporated herein by reference) #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000114420414044763/v384543_ex4-3.htm" style="-sec-extract: exhibit">Form of Incentive Stock Option Agreement (filed as Exhibit 4.3 to the Company&#8217;s Form S-8 Registration Statement, filed on July 24, 2014, and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219004380/ex10-6.htm" style="-sec-extract: exhibit">Form of Restricted Stock Agreement (previously filed by the Company as Exhibit 10.6 to the Company&#8217;s Form 10-K, filed on April 1, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000107878216003155/s1_ex10z12.htm" style="-sec-extract: exhibit">Form of Indemnification Agreement for directors and officers of Sigma Labs, Inc. (filed as Exhibit 10.12 to the Company&#8217;s Registration Statement on Form S-1, filed on July 28, 2016, and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315218004882/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of April 6, 2018, between Sigma Labs, Inc. and the Purchasers thereunder (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on April 6, 2018 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219006587/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of May 7, 2019, between the Company and the Purchaser (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed May 8, 2019, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315219012517/ex10-2.htm" style="-sec-extract: exhibit">Employment letter agreement, effective as of July 1, 2019, between the Company and Frank D. Orzechowski. (filed as Exhibit 10.2 to the Company&#8217;s Quarterly Report on Form 10-Q filed August 14, 2019, and incorporated herein by reference) #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement (Institutional Investors) (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-3.htm" style="-sec-extract: exhibit">Registration Rights Agreement (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001134/ex10-6.htm" style="-sec-extract: exhibit">Securities Purchase Agreement (Other Investors) (filed as Exhibit 10.6 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220001399/ex10-9.htm" style="-sec-extract: exhibit">Private Placement Agreement (filed as Exhibit 10.9 to the Company&#8217;s Current Report on Form 8-K, filed January 27, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220005763/ex10-1.htm" style="-sec-extract: exhibit">Securities Purchase Agreement, dated as of April 2, 2020, between the Company and Purchasers (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed April 3, 2020, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-1.htm" style="-sec-extract: exhibit">Sigma Labs, Inc. 2020 Stock Appreciation Rights Plan (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-2.htm" style="-sec-extract: exhibit">Form of Stock Appreciation Rights Agreement (Employees; 2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315220012176/ex10-3.htm" style="-sec-extract: exhibit">Form of Stock Appreciation Rights Agreement (Non-employee Directors; 2020 Stock Appreciation Rights Plan) (filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K filed June 29, 2020 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221000848/ex10-1.htm" style="-sec-extract: exhibit">Form of Waiver (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed January 12, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221007229/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed March 30, 2021, and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221014443/ex10-1.htm" style="-sec-extract: exhibit">2021 and 2022 Corporate Goals &#8211; Cash and Equity Incentive Plan, dated June 10, 2021 (filed as an exhibit to the Company&#8217;s Current Report on Form 8-K filed June 15, 2021, and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/788611/000149315222018927/form8-k.htm" style="-sec-extract: exhibit">2022 Corporate Goals &#8211; Cash and Equity Incentive Plan, dated July 1, 2023 (filed as an exhibit to the Company&#8217;s Current Report on Form 8-K filed July 8, 2022, and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315222028882/ex99-1.htm" style="-sec-extract: exhibit">Sigma Additive Solutions, Inc. 2013 Equity Incentive Plan, as Amended (filed as Exhibit 99.1 to the Company&#8217;s Form S-8 Registration Statement, filed on October 19, 2022 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315221017084/ex10-2.htm" style="-sec-extract: exhibit">Sigma Labs, Inc. 2021 Employee Stock Purchase Plan (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed July 16, 2021 and incorporated herein by reference). #</a></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 153; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223009743/ex10-30.htm" style="-sec-extract: exhibit">Retention Bonus and Change in Control Agreement, dated as of January 26, 2023, entered into by Sigma Additive Solutions, Inc. and Jacob Brunsberg (filed as Exhibit 10.30 to the Company&#8217;s Annual Report on Form 10-K filed on March 30, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223009743/ex10-31.htm" style="-sec-extract: exhibit">Retention Bonus and Change in Control Agreement, dated as of January 26, 2023, entered into by Sigma Additive Solutions, Inc. and Frank Orzechowski (filed as Exhibit 10.31 to the Company&#8217;s Annual Report on Form 10-K filed on March 30, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223028476/ex1-1.htm" style="-sec-extract: exhibit">At-The-Market Sales Issuance Agreement dated August 14, 2023 between Sigma Additive Solutions, Inc. and Lake Street Capital Markets, LLC (filed as Exhibit 1.1 to the Company&#8217;s Current Report on Form 8-K filed on August 14, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223037110/ex10-1.htm" style="-sec-extract: exhibit">Asset Purchase Agreement dated as of October 6, 2023 between Sigma Additive Solutions, Inc. and Divergent Technologies, Inc. (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated October 13, 2023 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223042671/ex10-1.htm" style="-sec-extract: exhibit">Separation Agreement between Sigma Additive Solutions and Jacob Brunsberg, dated November 22, 2023 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated November 24, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223042671/ex10-2.htm" style="-sec-extract: exhibit">Separation Agreement between Sigma Additive Solutions and Frank Orzechowski, dated November 22, 2023 (filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K dated November 24, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315223043301/formdef14a.htm#mj_017" style="-sec-extract: exhibit">2023 Equity Incentive Plan (filed as Annex D to the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed on December 1, 2023 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224000196/ex10-1.htm" style="-sec-extract: exhibit">Employment letter agreement dated December 29, 2023 between Sigma Additive Solutions, Inc. and William Kerby (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 3, 2024 and incorporated herein by reference). #</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224004337/ex10-1.htm" style="-sec-extract: exhibit">Perpetual License Agreement, by and among the Company, NextTrip Holdings, Inc. and Promethean TV, Inc., dated as of January 26, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 30, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224007564/ex10-1.htm" style="-sec-extract: exhibit">Form of Securities Purchase Agreement, dated as of February 15, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224008511/ex10-1.htm" style="-sec-extract: exhibit">Unsecured Promissory Note by and between NextTrip Holdings, Inc. and William Kerby, dated as of February 29, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 1, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224011008/ex10-1.htm" style="-sec-extract: exhibit">Unsecured Line of Credit Promissory Note by and between NextTrip Holdings, Inc. and William Kerby and Donald Monaco, dated as of March 18, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on March 22, 2024 and incorporated herein by reference).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.33</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex10-1.htm" style="-sec-extract: exhibit"><span>Securities Purchase Agreement by and between the Company and Alumni Capital LP, dated September 19, 2024 (filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K dated September 25, 2024 and incorporated herein by reference)<span style="font-size: 10pt">.</span></span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.34</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex10-2.htm" style="-sec-extract: exhibit">Promissory Note by and between the Company and Alumni Capital LP, dated September 19, 2024(filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K dated September 25, 2024 and incorporated herein by reference).</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">10.35</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/788611/000149315224038111/ex10-3.htm" style="-sec-extract: exhibit">Securities Purchase Agreement by and between the Company and Alumni Capital LP, dated September 19, 2024 <span style="font-size: 10pt">(filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K dated September 25, 2024 and incorporated herein by reference).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1**</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex23-1.htm">Consent
    of Haynie &amp; Company.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Snell &amp; Wilmer LLP (included in Exhibit 5.1).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#poa">Power
    of Attorney (included on signature page to the initial Registration Statement).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Instance Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
    XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">107**</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex107.htm">Filing Fee Table.</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
Indicates a management contract or compensatory plan or arrangement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
To be filed by amendment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**
Filed herewith.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 15pt; text-align: justify; text-indent: -10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8224;
Portions of the exhibit, marked by brackets, have been omitted because the omitted information (i) is not material and (ii) would likely
cause competitive harm if publicly disclosed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 154; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="poa"></span>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement on Form S-1 to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of Santa Fe, State of New Mexico, on November 12, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NEXTTRIP,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    William Kerby </i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief
    Executive Officer</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 262.45pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 28%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAME</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 48%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TITLE</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DATE</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    William Kerby</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    Kerby</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
    Executive Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Frank Orzechowski</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frank
    Orzechowski</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
    Financial and Accounting Officer)</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chair
    of the Board of Directors</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    P. Monaco</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salvatore
    Battinelli</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
    Brunsberg</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dennis
    Duitch</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>*</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Director</i></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November
    12,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2024</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kent
    Summers</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 5%">*By:</td>
  <td style="border-bottom: Black 1pt solid; width: 45%"><i>/s/ William Kerby</i></td>
  <td style="width: 50%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>Attorney-in-Fact</td>
  <td>&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 155; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex23-1_001.jpg" ALT="" STYLE="height: 189px; width: 850px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consent to the inclusion in this Amendment No. 2 to the Registration
statement filed on Form S-1 of NextTrip, Inc. of our report dated September 4, 2024, relating to our audits of the February 29, 2024 and
February 28, 2023 financial statements of NextTrip, Inc., appearing in the Preliminary Prospectus, which is part of this Registration
Statement.</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also consent to the reference to our firm under the caption &ldquo;Experts&rdquo;
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><IMG SRC="ex23-1_002.jpg" ALT="" style="width:200px"></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Haynie
&amp; Company</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salt
Lake City, Utah</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 12, 2024</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="aud_002.jpg" ALT="" STYLE="height: 26px; width: 850px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Symbol; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>3
<FILENAME>ex107.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
107</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation
of Filing Fee Tables</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
S-1 (Form Type)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NextTrip,
Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
Name of Registrant as Specified in its Charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 83.2pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Table
1: Newly Registered Securities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Security Type</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Security Class Title</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee
                                            Calculation</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Rule</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registered</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Proposed</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
                                            Per</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unit</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Aggregate</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Offering
                                            Price<SUP>(1)</SUP></B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fee Rate</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
                                            of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Registration</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fee</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 11%; text-align: center">Equity</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 11%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                            Stock, par value $0.001 per share<SUP>(2)(6)</SUP></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 11%; text-align: center">457(o)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">11,500,000.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right"> 0.00015310 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 8%; text-align: right"> 1,760.65 </TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-Funded Warrants<SUP>(3)(6)(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock underlying
    Pre-Funded Warrants<SUP>(2)(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(o)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Warrants<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                    Stock</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying
                                            Common</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants<SUP>(2)(4)(5)</SUP></FONT></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(o)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">11,500,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 1,760.65 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriter Warrants<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
                                    Stock</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underlying
                                            Underwriter</FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants<SUP>(9)(10)</SUP></FONT></P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">457(g)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">805,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 123.25 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="5" STYLE="font-weight: bold; text-align: left">Total Offering Amounts</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,805,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 0.00015310 </TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 3,644.55 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="5" STYLE="font-weight: bold; text-align: left">Total Fees Previously Paid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"> 3,513.62 </TD><TD STYLE="text-align: left"> <SUP>(11)</SUP> </TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="5" STYLE="font-weight: bold; text-align: left">Total Fee Offsets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD COLSPAN="5" STYLE="font-weight: bold; text-align: left">Net Fee Due</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right"> 130.93 </TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of computing the registration fee in accordance with Rule 457(o) under the Securities Act of 1933, as amended,
    on the basis of the maximum aggregate offering price of all securities to be registered, including the underwriters option to purchase
    over-allotments, if any.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
    </FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act, the shares registered hereby also include an indeterminate number of additional shares of common
    stock as may from time to time become issuable by reason of stock splits, distributions, recapitalizations or other similar transactions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required pursuant to Rule 457(g) under the Securities Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares of common stock issuable upon exercise of the common stock warrants.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act and based on
    an assumed per-share exercise price for the common stock warrants of 100% of the combined public offering price of the common stock
    and common stock warrants; the proposed maximum aggregate offering price of the common stock and pre-funded warrants, which includes
    securities issuable pursuant to the underwriter&rsquo;s option to purchase over-allotments, is $11,500,000.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering
    price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants
    to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued
    in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including
    the common stock issuable upon exercise of the pre-funded warrants), if any, is $11,500,000.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant may issue pre-funded warrants to purchase common shares in the offering. The purchase price of each pre-funded warrant
    will equal the price per share at which shares of common stock are being sold to the public in this offering, minus $0.001, which
    constitutes the pre-funded portion of the exercise price, and the remaining unpaid exercise price of the pre-funded warrant will
    equal $0.001 per share (subject to adjustment as provided for therein).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
    shares of common stock issuable upon exercise of the pre-funded warrants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(9)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Represents shares of common stock issuable upon exercise
    of the underwriter warrants.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">(10)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Estimated solely for the purpose of calculating the
    registration fee pursuant to Rule 457(g) under the Securities Act. The underwriter warrants are exercisable at a per share exercise
    price equal to 100% of the combined public offering price. As estimated solely for the purpose of calculating the registration fee
    pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the underwriter warrants is $805,000
    (which is 7% of $11,500,000).</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</FONT> </TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    registration fee of $3,513.62 has previously been paid in connection with the initial filing of the Registration Statement, filed
    with the Securities and Exchange Commission on April 8, 2024.</FONT> </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>forms-1a_001.jpg
<TEXT>
begin 644 forms-1a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !0 0L# 2(  A$! Q$!_\0
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MOFJU5UI<[5CT8Q459#)O]6_^Z?Y5^8?[#O\ R?7\0/K>_P#H9K]/)O\ 5O\
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M_!)5E'Q2\7@L 38)@9Y/S5[K_P %+OV>]9^*G@K1_%/ART;4M1T M]HM(_\
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MH8[==L<:QI_=48%/I:* &21K(K*ZJZG^%AD&F06\5L-L421+U*QJ /TJ:DI
M?._[?_\ R:KXT_ZXI_Z$*XW_ ()A@-^S': C(^VS<'ZUZ]^U7\,=9^,'P-\1
M^$]!\G^U+^-5B^T/M3((/)[5SO[%/P7\1? ?X,V_A?Q/]F&I1W,DI^R2>8F"
M>.:[XSC]5Y+ZW,K/GN>K:E\,O">K7?VJ\\-Z9=7&<^9);*3_ "K<TW2[+2;<
=06-I#9Q#I'!&$'Z5<VCTHP.E<5WU9J+1112 _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>forms-1a_002.jpg
<TEXT>
begin 644 forms-1a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %? G$# 2(  A$! Q$!_\0
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MDV3O8SZLC1MJ8C#>"O&U7,J^"Q%/),+@\+#AVO5SJKQ'DD,FQ>&XHJQCD_\
M8V9UL31P>;XO,*5/&5,%@L/.E5KU,*Z4I4G5I2J:8OQYX"HY50Q^&J9]C,;B
MY\3X>ED5'A?/JF>8/%<)49RSO^W,JH86MCLEP66UIX*GC\=B85:6'IXM5HPK
M*C7C2_H+^)?[1GP&^#GA.P\=_%#XO?#_ ,$^#=5UR#PUIGB36_$VFPZ3J&O7
M$<LR:59W<4\R7%XEO!/<W$<6[[):PS75T8;>-Y%]BMKFVO;:WO+.X@N[.[@B
MNK2[M9H[BVNK:XC66"YMYXF>*>">)TEAFC9HY8V5T9E8$_Q3^'O&7@;X>_\
M!&;X-ZMXV^"?P_\ CA9S?MF^.-,LM&\=ZEXTT6UTBX;PMJE_)JFFZCX$\1>&
MM966ZCTL:;>V,]_+IM]IUW<17-J\B6\L/Z]_'C_@I'^TA\'OVL?AG^Q[^SU^
MSC\./BB?%?P5\!ZYX*\,IJ6K^&]7@UG6O".LWT%BFJS:O%X>TSP;X4M]#CO+
MS[7:PS#0;&[@.IVT\D5U#]#GG@;F.'K2R_A[$5,PQF$SCQ PN,Q^<X[(<DR>
MIE7 \\C6(QU&53$5,1@ZU.GG'M,;#,:L,,X0Y\)7<:=6_P WD'T@LJQ-%9CQ
M)AZ>78'%Y+X<8S Y=DF7\0Y]G=/-O$".?_5,!7A2PU/#XVC5J9+[/!2RVE/%
M1G4<,9AU*=.W[QT5^)_[(_\ P4[^*_BCXR?'W]GC]MGX.^'_ ()_$[X%_#KQ
M'\6=4N_!EQ?76D/X2\(6.GZSXAM;JROM9UY+BY'A_6-.\0>']:T;7;S2]<TQ
MKC,5I+%%)=?,/AS_ (*\_MZ?$?P3\4?VE?AA^Q-X3U[]E#P(_B>U&OW.NZDO
MBS1QI-D]Q!K6K7 \06S^);7P_P#:-/O_ !K;>%_"!L=.LOMUFNN6TMK+J$7S
M5/P6X\J8W'8/ZOD5*&!IY%4CF6)XGR3#9-F+XGIRJY!1R?-JU>&#S3$9K2A5
MJ82AAG&I.-*:ER2=*-;ZBKX\>'=/ 9?CEB>(*\\?4XAIRRO"\)Y]BL]RQ<)U
M%1XCK9WDU##SQN4X;)ZLZ5+&8C%*5.$JU/E<XJM.A_2=2X/H?R-?!G_!.+]J
MGQG^V7^S%X>^.7C[P[X7\+>(]6\7>,O#\^D>#UU1=#CM?#6L'3K2>$:S?:C?
M>?<1#?<;[IHR_,:(ORU_*M<:Q^SMKW[4_P"W/:_M:_M1?M#_  <L=!^,/Q-_
MX5+;_"_4_$^M#6M5_P"%@^.(M2TV[TV*QUFTAM=,AM]#73;)[GP[:3+<SP_V
ME!'%NA[.$?!_,>(<YXVR/,\?7RO'\#+"PS+#91DN+XMQ6*Q.(S:.45*&!PN5
MXK!5<3'#U9QKU*U)N'U>-:KRQC1FWQ<:^-V5\,Y)P!G^5Y=A\WR_Q">,GE6*
MSC/<'P=A,)A<-DLLZIU\?B\VPF.I8:6)HPEAZ5"K%3^LRHTN:4ZT$O[FZ*_E
MB_9I_;?_ &O/V4_^"5=]^T/XKDTGXN?:?V@M'\$?!IOBWKVJ>);X?#C5-)F@
MU<ZC?Z/KJ:_%;V'B;2[V/P]8:WJ?VZRMGO$\@:2='%?6.E_\%=/CAX9_9T^+
MW[4/QQ_99N?AO\/X-*^$6E?LT:;J#ZUI-S\:/&OCZT\22:WJ,NMZF9HH/!VG
M0:&/%$!T[2&N+?PR\<2:EK=Y>VMU1F7@=QGA<7F%++)Y+GF$PG%.(X0PF,PF
M;X'"ULUSG#U\LH3PN"RS'5:6.J5:<LTIRQ,(?6%@Z6"S6OB*M/#8"=:J95](
M#@7&8++:V:PSS(,;C.$<-QKC<#C,FQ^+HY/D>)H9I7AB\?FN7T:V7TZ-195.
M&%J5'AY8VKC\HP^%HU<5F$*%+][**_F1^*/_  5V_P""DGP'^#?A/XM?&/\
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MK3H-%O\ 6/#/B9GT/3=#\,Z%X-T_[$]S%+J=VUW)+ J6H,O]'=%>9AO%;B?
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M.6;NTFTM6TFTDW9-M+1-M)-V5VEOH%UIKOMYZ7T[Z:Z7TUV-ZJ\^T*!@ L<
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M'6H2#$2XR5./, [= ' Z$@ !NY SU'(!/10"#R#D>HIDC;58\]#C'KP!^I%
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M5:C"JHPQ&'G.E.=-SE1K1C)NG7HUJ;<E&%2M_K5G6-'&3_:^E8'_ %$K(?\
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M>-]S)\A97C9P/9^?X?\ !/\ 9H_MK13TUG23_P!Q.Q_^/T?VSHW_ $&-)_\
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M1?V4/C9XV^.-G\<OC38? [3I9_VI/A9\>;GP)X5USQ+X[LM"\.?#G]DWXG?
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MINM>(];2Z>VTWPSX7T^+Q!K>LVMC?1;/6;C]K[X(V?P \5_M*WNL>(;+X;^
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MYHI/EDFGRN235FRHSA-7C*,EI\,E*UU=7LW:Z::NE=:V-$."H'?!!'H1Q_\
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MUT/Q+=W5^8B;PGS(=.\17");3SJZO!J<MO=JRS*[-^L7[,W@2S^ W@*^\&>
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MIEO)=&U<WEQ;A;*WDE9HHUU/'7[.GP<U;Q5-KGAKPM)<Z1I&DW=O=^%M>==
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M[D(V2A3BW4;5E&BU5^!IE*>#2>FE[MN-5J\K?%)W;E*24-;MU$X?%=&=K7[
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MQ\ OV@/"NF_"GP=<_L?V6D>.[$Z!H^AW$GQ/_P"%Y7GQ'\.^#OC7XF\ >/\
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MIC\6&T;X8+^U#KEQ^T+K'[(%M_P3O\.6>AZ9>2Z;\5I/BZ/@18_&+3M;OHO
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M]3_X)JVGP]N?$7P6_:7MC\68/VG]*_:4^-GC7P#X>^+_ (F^&GQ<T/Q+K7Q
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M&K&.[U&6-);H17>I79A#J%AC<1HN 2?4MPQN_P _TK%U(,65_P"''Y'..O\
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M^P*4,1T/\J /D23]A']FZ;[3YNA?$B87OE?;1-^T#^T#)]L,  M_M@?XFO\
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M#7*:!HFF:.MPR]&G&G6UN)B.QDW8P,5N*VT#@X]SG\L_KS3G(*D CD8X/K0
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M( Z=><?7'YT 4AIB,00Y"]>@/]>?Q]/>M"&!(%VH/Q(YYJ:B@ HHHH ****
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M^)']AIJ-WH%\IL/!DL,O@_PZ8HKG0_"NEM"&C /ZEP'Y^1B1D-QR.G7"]_\
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M'X0:OLT9)O&OP/\ C-H7BS]E?1_#&L^-OBCX!\0Z+J4<NJ@'[=45_-9\1?\
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M"M!^*/AWXGZG\=/"NE^*?#7P[T?X/^*+/PGXE\.?!'1!\5]0^'NK:-\!E_:
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M8V6IZ;!/9>"O#ZV?AKX::,MN4CL?!UA,&ANVME4(M_XAN_M6MZ@55!YM^+<
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M_"GBKQCK-]JGB/6_'T9L;Z!9M%T>*UN]!D19B6CGU/3IBL$4W<Q6S':V\*"
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MA%^SK^ROXX_;!_:;U6UT%-=\5>)/#DK^,?#/PH^%_@0W6HZ?IVC:CK=U\/\
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M-CK'B26'5=-TEM<\$^+9_B;<:OX=^(GA*/6?!&L1^'/$US'K=Y(R-+]!0?\
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M'A?Q!:Z5XO\ #GBJ[C^)6D7$.AZSHVFZE96<27U[:)9ZGIL]QJ_$[]L3X(^
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MTCP[X>^'6K>(+CPU;ZM<:U^F% "Y'H/U_P :<-O.0!Z=?\33** )/W?^=U*
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MP_J^LZ#J?B7PEJ;W@@\3>'TU?P[K.GV,VF[M3UBZT^ZCT;2;][2[6WVUU_\
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M?S@_\$,I;2[_ ."9WP1O;.(6\5QXJ^,C^5YBS1Q,/B;X@$JQN, Q&0,R@A6
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M\:/BO^RS\3-"^*'[+?A[]I72O'OP(75?"FB_##5_$'C[P/X!T?X;^)9O$GQ
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MING6^JZ+I$5GINHP:?90WEM-':P*@!^)C?\ !3W]H3X.S^*-=^/?AGX;ZO\
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MB+!2'V@*S [ERQ-5[;X@^$K+S;*W^'^JVGVB8-#>-X\U)RDI*\>;_9&TPOC
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M !Q^,7@NWAT_1=:\:64O@3P;XF\426DN@^"O%OB;P;X?\4^,O"NL:KI-O>(
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M_O?B' VI_&"R\ ?$.R^-RW'P8TKXI^(-*^$'A;7_ -HS1/$NA_&+Q?X1\'V
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M78;[3=:\"7>B^+_!/@'Q)9>.([_4/B3+JOP^\"RZCXSOHO"FC0V@!X3\9?\
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M*I^T%\;Y#!<*S0R9^*7B[Y9%1T)'S9X;&0"01Q7^U%=VLK:EIEPB,R)=VRR
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MG\Z2@ HHI ,9X(R22#_/GI].GIZT +111@CJ,4 %%%% !1110 4444 %%%%
M!36. ??C]#3J:02RCZ-]><<4 *!@ >E#' )]N/KVI:1LY48ZL.OH,M^1QC\>
MN:  #  ]/\_SI:** "BBB@ HHHH A?[Q_#^0IM2NN>?0<_2HJ *]%%% #>1G
M^Z!P/H!WI Y)QCC^53F/@\D\'H/_ -=1["!P"..N/U- #X_]9'_OK_Z$*_Q0
MOCY%-/\ M(_M"V]NR++-^T-\<T3S)!%$2/BIXP;$C$% N ?OC;GWQ7^V#$H#
M(<Y.5Y[=1TK_ !-OVA_^3B?VBO\ LX3XY_\ JUO%U9U.GS.BAO+T7YL^MO\
M@E)J::!_P45_9DO[I8E_L_QEXE\R6WE\L*1X"\6Q$QRK(D6"6(#@*,$$>E?Z
M%7A+XD'6[2*6TDU".[D+0K87/B&S6.-8?,B@F6?[1L1+M(X9]@$DL1N DB@Q
MR[?\S']FO5;G0OCG\.]5L9Y;:ZL]4OF@F@D:&2)I-$U2!F21"&0[96!((RI(
M/!K][O 'Q1U+4WU&V\4>/_%WAV"WTDZAILMJ]WJ#:G<K(L0L8;6[UO20ZS0^
M=)')9R7$K20LBQ,/F3[;A?*L5B\!B,7A\:L.J>,=&4'A9XF_[FE)SY(5(N2]
M^*DDFTDY-I:K[W*<_P 'E?#6-PN)H5YRGCJV(C4H5^2?+]4H0E3C15.<JTOW
M=TH/F:;CI>Z_KI_X71X,M+W5;&_^*'AJTGT:\^QWT-YXC@LM0@O#*Q-G-I\\
MZS!5CDMHX+F(2_:W+",F564<_J7[3WPHTHF.[^*.AOFZ:$&VU\RE4*EHY94D
M:!PQ*D26\*SNF0P:1=Y3^4#X7ZUXFU;QC)X1T+QC9:AJ5WXCOI]#\2^+&B\/
M:?:W&I1SWNF0ZQ>ZC=SV.CI97/\ HWFW%[-';RKO5WXKQ&Y\6ZH]Y=23B]6]
M,NIVFJ$7-TL$4MO?/;2+%+;W[%VG,#3PSHBCR'C>%WAD#U]G1P$7-T*F*FZ]
M.CAZU2-'"6JJE74E3G6I5IP='VDZ511C>4X2C.$XQE#W_P"?^-JE#'NO*.+C
M2Y_:M4\5B51FUSI<U"5/#U8U80C-0ES55)3C\,H-3?\ 7U??MC?!2RCN;:X^
M)9N'D5WB)O$5)&D<*MM"S7,1=UW((@RY9'&69@X3\U_V+;;P'\:/^"VW[<5_
MJ^C6/CO1Y?V)O@;+I=OJ(C6[L[NS\4^'X7N].O8S+<V-_:1"1+>\L;RVN@'Y
MD$;$#^=[4?VEM+\->)'\-74/CZ];2HK&UO!I'A#QOXMM;2;64EN=-MKF2SM+
M^%KZ\C,DMG'*?M$B)MBB944U^A__  0X^*?AW5O^"@'[37CBWM]7UJWUS]DO
MPA;>'KVTB;2-1TK4[3Q_I6GO>7>E:K9HYDLI;:]M9])OK;#2C;<;D#5X>;T\
M/A'AYX/-ZL,72S&E&5ZZI5<)S0Q*E.^'G&M1C3NXM*;FE4G#WW-4Y?GG!N43
MP&?8O%XK"R>7XC),;%8FI"53!UHO$Y;))3J4(TZKG%*K%*+4E3YXV:3/[ ]3
MU[XB_"FYM[+P9>^*?$_@J'3WCN/#WC6Z9->TJ:Q!FN(;;5Y$,FK68M9(=K7Z
M/=VJQ":>]N8IA(OP!^WOX/F_:2L_AYKOAK1?'6D>)M"$^F:OH=_IEU-I=_'J
M5HM]:3V4MO=36]S?1QPR-&L4!GGTUOM"?N4)/T3?_%/Q:+UFTS3?B1JT]Q97
ML$FHM_PA*^6+NU2R>.VLYO#]]*TDMG;VUO<2)-%YL<> %DRU1?%'2OVFM4^
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MIV;B"[O+Y)#^<?CSX'ZEJGB+PIJ^I0)#K&M+%#X6TC7[V+PTM]J6MVUOXEM
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M)EO8?#G_  DVN^%[;Q#K/CSQ#X?CU'6-2T3P4U_J-R-)T-K4 _.'X?:[K_B
M?LN_#[X[?M$_%[X1?LN_&OXF_MO?$3X?6.J_M):_X(^+/AGP3X-T+X;ZC^S%
M\!OC!\>-&\9#QY#XFL/!'B'XL?'$_#C5_B/-XH\.6FB^'O"'C2[U@_#+5=/K
MP35OVB?B-XU_9W\0_$#XM_M7_%;X??$#X._\$G_ _P"T9^REJ.B_%F]^%LWQ
MT^-%QXX_:,TC2_BSXC\-:+=:!I?QV\0^,K+X<?L[:'?^ ==T;Q#X;NH/BQ=6
M%OX7AN_B;9/)^XWAJ/\ 8:UGX2?"OP-XB^%_[.?PL\'?'F[TSQUX&_9V^*/A
M?X%>&;GQ+XPNA8K#<6OPRMKO5/"WB3QW8RMIUK->^&&\17<=P+*&WU*4B"O:
M_BS;?LT:1<_#/6?CM;_ C2KSP]XHM+/X.:K\78?A[8W.A^-)DMTL;3X97WC-
M(I=,\3R1V=JMI;^%98-59+6W6%"(8@H!\;>/?VA/VY-&_:U_9I^&WAC]FO1=
M8^#WCCX8_$+7/'NOR_%?1/#_ /:>LZ78_ >>[UC4-.O_ (<:WJ?@F]^'.H>+
MO&VG:-X.'B<R_$=)+B[-U:1Z#MAR?VG?$O[2B_MV_#+PC^S[\5_!?P_$7[!W
M[3_Q&UO2OBAX5\6?$3P-J^L^$/C)^SA9^%KQO ?AOX@_#R(:L)=:O]'O?%MQ
MJMUJ6A^&-5UFQT6R>[U9IK?[&^%?[6'P$^,7B[QE\//!WQ&\.CXC>"/B%\2_
MAMK/PYUO6='T;Q_=:U\)==F\/>,]5T;P9=:E_P )%J_A2SU&"0VGB6VTYM.N
M[;;=+(D3JQZ:W^)O[/&N^*?%4]K\0_@IK/C?X;P-X'\<SP>+O FI>*O 5KXG
MUS3[0^#_ !9+'J$VK>%K;Q#XDL-*M3X>UAK&'5]=L]/@-I<:A;VRH ?BTW_!
M5_XW^+OA-X\_:"\/77[.WPOT?X,?LZ_LE?'"?]GSX@V/B/7OB5^TOJ'[1GPH
M\,_%35]!^%7BVU\=>%3X8TR]O/$$_P &O@AJ6G^ OB5<^+OB]H6LVGB"TAMX
M1H2?0\/_  4C\5C5O!_A*]E^#]EX^\1?\%8?%W["UWX&N;N\M_%EM\(-(N?'
M>HZ+XEC\-R>*#JZ?$"]\&:!X>\32ZF]M-X;N=*U1M9L]$&E7EC,OZ"ZAX _9
M8GU[P9XAU7P3^SU-XG^"FIV7@'X>:YJ/AOX:R:]\(]9BTNUUG3O!7@S4KFR.
MH> =4CT6:RU:R\-Z)-I-VFERVU_!9"U>.4L\)^%_V4_BUX@_X:'\"^&_V=_B
M?XI%W#9_\+T\):/\-?&FOK?^$HC:V]J?B=HUOJ6HB[\,P2-;PPG6Q/HT4C1(
M+9&*D _&+4/^"DW[97A/X(_LW_&[XC^+/V0_#FA?%WX&6_[2?C:7P_X*\5^(
M8_AWX8UGQ'\/]#\.>&_%/@E_CI;_ !E;X7II6N:Y=>,/VA?AI\/OBM/X;\9W
MFE:-=_"BUT'2X;[Q=]T_M8_M6?%7P#\>=4^"_@#XG?LX? /3?!G[*FN?M0W_
M ,0_VD]&UOQ!HOQ%O-/\7ZWX6C^'WA^#3OB%\,;?P_X9\&PZ"NN_%SQG!JGB
M?7]#L/&W@)-+\,PK>W%W<_09UC]A7XGZ)X5UA-0_9)^(_AKX+O%J?@G5H[OX
M->+]!^$DFFZEIVD6^I>&+_S=0T_P UAK,&DZ7!>:7+I/V;58M-L$D2\6TBK6
M\<ZY^QC\9_AW8_%;XEZQ^R[\6/A-\/?$4E_IGQ*\>:C\)O'GPZ\#>+K2[M=,
MEO+'QEX@FU;PUX9\1VM_+9Z=)/;ZE9:G%=R6UJS+,\2$ ^"_^">OQ3^)W[1?
M[7?[3GQT\>ZY=Z5H>L?LO_L#:IX*^"=^GBA)/@M;_&OX/7OQ@\3^&D%SXKC\
M-3Z@?%%]J/\ ;^MS_#G2?%NN&'1;>ZU:PTW0(=&E^>?'7_!4?]I?0O%GB#QM
M9>)OV1?"_P .]+_X*<^$/^"?%O\ LW^-],\8O^T:WAN[^,>@?##6?BB?$5E\
M2K#3F\;>(=(U&X^*/A3P6?AS_P (]%\+;_2];EU_4KBW:75OU8TW]K#]FJ#X
M5?M2?M/^'2+OP;\ +WQ]I_QL\:^&/"EM=ZQXH_X45X,M_%.JW>AWFE;[CXB:
M9IWA?58T\(7L%[<V]VEQ+9:4T2,RMY[\1_$7_!.BZB\3_M::_P""_P!G/XL>
M+?"'B/X2> /&7Q*\)^"_AG\4/BOX9\2>,/'_ (.\%?#?0O$NLZ/!JGB;1]3T
M7Q7KOAN6V@U/4+>]\-6UDVHVJPIIF4 /RQUW_@M%^T3X6\1ZOX/U;X4_".ZU
MKP;HOC_]E/QI<V4/B^*PMO\ @JE>>-O&6E_ #X-V"R^(GN)/A=\2/A_X+B\>
M7UFL<_B=;3QMX873_$*1>:9>K\*?\%1?VK;[Q!^S]XN\2Z]^R'H_AGXX_P#!
M2&Z_81U?]F2;1_&<'[1?PZT?PMXU\?\ @+Q%XON=>;XGM:WGCF\NO 4GC&]\
M+ZA\-K#1?#O@[Q'HDUOJFLM'#>Z[^TEOIO[)_B3XB^*OAS9V?[/6O?%JR\7:
M%\9_&W@.TC^'6I?$6R\>:'::19^&_BQXG\+P>=XEM/%NE6$>A6FC^.M3L8M8
MM+)=)M[35$@6T0<!I/AK_@G_ ./_ (J^(_BSH.C?L@^-/C9HMW+=^+?B/HMM
M\'?$'Q-TC4OAJUF]Q?>(?%6GBZ\3:=J?@+?IZW-_J-[#>^&(GLHII[*$PI0!
M^1?P(_X*2_MR?&F+]E#3/$OC3]B;X'W/[3_PG_: _:3LOB'XU\"_$0_#[2O
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M%=$TO3/V@O\ A!KSX>+J6F6AL?"4,<GQ$+:%+KB6\,L6D2ASJ4H-P+5FWRY
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M>003'<""4<\D%1DJ?4$=.X/KGC3=P7/N?RXX_.@">+AU'.0RYZ8&2#UZY_\
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MGQYE_9^T7XN^$]?^"7QA\33^$-$U(_%_0/ NC6_Q1\%^*)/!OC_1=/\ '_@
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M5N9J+_E- $7SN?W@&4C[QD@_O)1_"0,%$/S9PS !1E(B$W2D_P"K'R^OF/\
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MUMX?$^JZ?I\]UIEQ+XXBMKZXT]+\Y1T%NUU \)<KEJ_G@_X+A_LU?!/]D/\
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M?\.>*;&X5O"?C"?6O!O@KP]XW\?^'M/\)Z]J^N>%;#2;:&^N.?\ B=_P4_\
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MBU,F#YC_ &D/^"H/A/X17WQ(N_AEX;O_ (PV7P;^"?QP^)WB;PEHWA^ZBO\
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M<5752C4H2I5HX=0<:C@VW*E"%3F3@K>_;=/30_U.3_P6 _X(US/)]L_X*2?
MVZMW0 6LG@C31%YL5O-!8S2?\6V9ISIAF::PCD)B@DW+L:-R@Z[PK_P6<_X(
MF^'[/4$U+]N_]GOQ->:G?B[N]5O_  Y=6-Q*L,%M#:V;II/@6S@EMK);=7MU
MECD:)G)# ! O^4Q4K']S&OJTC_@=J _0E&_+-<4\PQ52+A*K/E;3:BU#5-M:
MTU![N[UUTO>RM[4,IP5.2G&E'F2:3DO:6YE9V51S6VB=KI72LFT_]4KXR_\
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MAR/E\Q>)5QQAE/$A '!?#8XW8% '^CQ_P;V(I_X)-?L\E"2#XL^.)^88.?\
MA;'B3@@9&0>"0<$\C K^G?X?QJ_@CPKOW9CTZ*10&*C<)9\;@#AEP3E3D'ZB
MOYB_^#>D ?\ !)K]GG:VX?\ "6_'(@E2IY^+/B7@@DX(Z'DBOZ</ US':^ ?
M#ES,2(X]*C+;02?]?*HP/J1_/(%?89I_R(\H_P .'_\ 4.7_  3X#*/^2BSO
M_'B?_4V)A_'/X80?&[X-?%/X/76L3>'K3XH^ _$W@.[UVUM8[VYT>T\4:5<:
M1=:C:V<LD45Q=6MO=22V\4TBQ-.J>;F/<IA^!7P-^''[.'PH\'?!GX3:$- \
M#>"=-^PZ9;/,;F_OKF:62[U37-9O7"R:AKFN:C-<ZIJUZRH)[VYE,,4$ B@C
M]6@E2XBBFC),<R*Z$C!VMTR.Q'0CU%3[".<9_P#K>H]_05Y*SC-%D\L@CCL1
M')9YG'.:F6QGRX6KFD,%_9U/'5J<4O;5Z."<\/0=64XT(5:SHPIU*U6I/WGE
M&6/-XY]+!8>6<PRUY/3S&4.;$TLLEC/[0J8*E.3?LJ-7&\N(KJG&$J\Z=%59
MSIT:5./SU\0_V<_#7Q'_ &@/V;_VB-2UO6K#Q-^S58_&K3/#6B6@LGT'Q#8?
M'#PSX>\->)%UU)H'O5N-+B\,:;=:/-97,,:R27D5W!<I-$T'YH?$K_@DU/I'
MP>\8>$/!/QJ^*?Q,^'_P=^#/[5NG_L8?LM^(XO!.C>#_ (:_$+XZ_";XE>!=
M.M;SQWINE:1XN\<VGAG3OB'XA\%?#%O'VM7B^!O#7B"XMYKS4+FW@U2']M ^
M.H_+C'M4@(/<<]L\UYIZ)^8G[(G[!7B7X7ZW\'OB_P#'GX\_%#X\^./A?^S)
MI/P ^&'@GXC:3X T[1/@WX5\1V'@:]^).G3/X)T#1U^(/C/Q'J'@;PKHNN^.
MO%)O=3OM'\)Z5;+^_DU.^U/ZL^.G[,W@SXZ6_P $H-0O[[PBOP*_:%^'G[1O
MAJ+PQ::9;VFJ^*_AY!KMI9Z/K=J]J5DT;5+3Q#?1WK6;6M^LT5G-%<[(7AF^
MD** /S5\5_\ !-+P+K%MX[U7PE\7/B1\//B=K7[:6K?MW?#?XI:);>%M2UGX
M4_&?7?A[H_PPUS2+30M<T>]\-^,OAQKO@W3]3T+7/"7BG3KHW^G^(;UHM1L]
M6L=&U?3O%-;_ ."-G@'QG\"OC5\(OB#^T?\ '#Q=XN^./[21_:E\1_&XGPMH
M/Q TOXAZWX.@^&OQ#T30X=#TBRT/3_A_X_\ A9<>)_A=J'A6SL+:/2_ ?BS4
M]#TNZ@6TTR>U_96B@#\=/B5_P1:_9M\;_M _\+R\/:A:>!;37O%/P:\9?$7P
M1#\)O@]XM?Q-KGP+TCPYX=\(IX4^(GBWP=JGQ%^%NA:[X<\'^%="^(/AOP7X
MAL]'\66.@VI%OI=S?^(+C6ON7]EK]E#X?_LI? _PK\!?#-U>>-?"O@O6/&.I
M^'M3\;6.CWVO6\'C#Q7J?BVYL[B:UL;6R=K.]U6:VBN+2RLA-;6]L9(1+&7/
MU'(&*_(P0AE))7=E0<LH&5P6' ;/RGG!Z4U1N.3SCG\?\.M 'Y]_"/\ X)U_
M#7X/_%_5_C#H7CGQMJ.IZUJ'[85Y<:-J:Z-]ABA_;,^*_A+XQ^.8+>:UL()T
M?PKXH\)P67A29BP30KR6UU**]O(DOCYGX-_X)0?"GP3\,[[X8Z9\3_B%/IE[
MX"_8<\!#4[N#0&OX+3]@OXFS_$SX8:B%CL([=[KQ5>2II?C:-HA%/;QO<:.-
M+EEV+^JM% 'Y#7G_  2)\#ZYXJT/3O%W[0/Q:\5_LU^#_'7[3WCCP3^RWJ&E
M^";3P;H,O[7O@[XM>$/C'H-WXYTO1++XB>(-$MXOC7X\O/AU%JFNO=^!DU5M
M/AN]3MH;,VG"?"?_ ((@?!#X8OI-V_Q,U;4]5\)>,OV:?$7@G4/#7PA^!WPH
M:QT?]F'XEVWQ/\,:;XQB^&?@;PZ/B)XH\<:O8Z;8_$CX@^(7.OZ]9:5IILH]
M)E@G:Y_;2B@#\TO'?_!-[2=5^,GB[]H_X4_'?X@?!G]H#7?C%X@^+6@?$32_
M#?@GQG;>&;7QQ\#?A;\!_B'\-[KPAXOTB^T#Q-X%\5Z!\'? ?BF.#5(DUK0_
M&^@Z=K&FZLEK!+IUS\__ !:_X(D?!CXO^*="\;>*?B_XU\0^--5^'WPP^'7Q
MU^(/Q%^'GP8^*_Q.^--C\*=5U#4M%\46GQ \=>!-4USX0^.=:L=7U/PCXGUW
MX8MHMKJ/@QM*T:UTG3KK0=)U.U_:VB@#\J/B'_P2J\#>+O@-XF^ GASXQ^,O
M"?AKQ+\>/CM\<[RWU7P1\+?B5X4OKKX_>(->\2>(/"VO_#WX@^$];\+:I;^"
M=3\03W_PJ\565OH_C3P%JVFZ1J6FZ[(4U6VU?Z \7?L6Z5XK_9F^$O[-,WQ<
M^(+:3\)-&\*Z##XG\5:5\/\ XLO\2-*\+>&;GPK#IGQC\'_&/PCX^\%_$K3[
MRRN(M6=M?T=]7L_%FDZ'XIL-7MM4TXO<?:]% 'XO?$?_ ()V2_L]^&/AOXS_
M &6E_:%^(7Q(^&_CCX.W5EXAT3XI?"0?&OPOX0^&G[-TW[-6H:CX:M_CAX;@
M^$WQAN/&/@JPT6#XB?#_ .)VO>$;/67N)_%'@GQ5X7\3>%/">ER^C?L'?L,^
M*/A;!X3^,OQNU;QQ;?&73OB_^VM\3]-\->(O%OA#QAK-EH7[7WQ \(^([G3/
MBKXC\'Z+8^%-?\?:/H_P\\-3W1^'8TWP+X>U'5-5\.>'O[:T+2M*U*3]6Z*
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M1M:MO \/Q!US2_#%W\4?'^O?#CPAXJ\6ZSX;\&ZWXD>>WLKVST+PC8^'/9/
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M9XO^&%UXP\":7JMKKTGBS2/B5\)M<L+#7/#\'C?1-<\8:#)^O596L:I)ID,
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MX'%8>GEN4U,QPM7#RJ5L1*5.A4HUXS<71]C]:C*4''WJ=:W+/57C+W#^R?\
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MMCKGGZ/VC.<<_CVI:^;/M@II4$Y.:=10 @&,\D^GM2T4@926 ()7 8 \@D9
M/ID<T +110>AQU[4 -.#A3]?Y_\ U_\ .,JHP/U/UH /<Y/MTQ].!^E+0 44
M44 %%%% !4$LK(P50#_>)[>G<>]3TTJK=0#CUH %.Y0>F13J  !@< 44 %%%
M% !1110 445#<)))#(D,ODRLI"2XSL;L<<\=CWP>.: )J*CA61(HTED\V14
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M<-'+=N9KLZ>5N+N"YNS;S32,A+_(/BW]KC]K6?QCK?B[2/V:?C]*IT.V\/\
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M_F_M@?1OB'G_ )!OBW_OSJ8Y[D_IR:XW5?"/Q$NKUI1H/BFX#A!&ZV=^Q4@
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M""G5Q*J*G&56$')J*\W:/-*W-8Z&LZZO1$<+\QQZX';TY[_UXJXYR<=A_/\
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M/QQ6U8VIC5G<8+X&/48]O?\ PJX N<ENG;!Y^N14F]?7]#_A0 *B)G8H7/7
MQ3J;O7U_0_X4;U]?T/\ A0 ZJ\C3B:,1J#$0-[8S@Y;J>H& #4V]?7]#_A1O
M7U_0_P"% "KNVC>06Q\Q4$#/L#DXI:;O7U_0_P"%&]?7]#_A0 ZBF[U]?T/^
M%&]?7]#_ (4 .HIN]?7]#_A1O7U_0_X4 .HIN]?7]#_A1O7U_0_X4 .HIN]?
M7]#_ (4;U]?T/^% #J*;O7U_0_X4;U]?T/\ A0 ZBF[U]?T/^%&]?7]#_A0
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F7)]AC-2@ =!304'0_P Z7>OK^A_PH AHJ/S8_P"]^C?X44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>forms-1a_003.jpg
<TEXT>
begin 644 forms-1a_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %? G$# 2(  A$! Q$!_\0
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MEB2<# % !))'#&\LK*D<:EW=B JJHRS$D@  =:S%CEU%A).ABL5(,5JXP]R
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MGD<K&B]V8 <D5!96SQJ\T^#=7#^=,0<A"5VI"I_YYP)^[7LQWRGYI#C^6/\
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M/,,=A8_I91117Y4?L 52FL()6,J[X+CM<6[&.4D'(WXRDRY_AF21<?PU=HH
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MD+2-_M,>G2OQ2^(/[?M_X-_;$^#GQ1TGXE:/XM_88^*!\4_LT:Q/IK26VG^
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MP)\1/A!HUA=Z3:Z1\0);+2O#'B-+74O =MXDMKB+P+H/SOXITSX/?%?]D?\
MX);?#CQ3^R'XC_;5^*GQHO\ ]N;4O@E!KO[0GQ'^%/C+4=4U#X_PZ]K>@ZUJ
M/A6\U2S\4>+/&\$ESX@UKQ/XQUR.*SO=+NQ<7%F+HV\/]B/[('[!_@#]CG]C
MR#]B/P5X]\<>*OA[IVF?%716\=>)8=!A\3S?\+;U;5;K4X;F+P]I=AH4M]HI
M\1W"Z<_]GHN^*S:\AD9;D'Y?^$'_  1)^"_P:O?^">.L:5\;/C#K5U_P3LUS
MXN7WPWA\0Q>!53XAR?&'Q'>:SJL'CT:=H, ']C+=/:Z&WATZ5*T<%N]Z)YPV
M'[2-V]M6[I-.7NR2;ML[VO;S?<?M8W;V:DVFDTY^[))RLU9MN*:5EJW:[=OQ
MH_8:^$7Q@_X):>./VI?^"A7Q8_9@UG]@_P#8^^''[*H\-ZS^S)K?QTN/BYJW
MQZ^.MSXBTS_A7B:!?:KK6M7-I?+J,-MX;LM9U*.*&QNM;DCT2UN[/4/$D]K[
MU^QO^UEJ_P"RQ_P4R\.^)_&NI>-;+]D3_@MUX/\ "G[2OPEN_B79^(F\0_#?
MX_>)M'TB&#P=XGUG4K&#2=-M]*GN[/X1:;'9QZ99ZEX9U+X(W\*W-I#-?/\
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MD8!<"J>GEW!=8@9[BY:>2QE&=UU-);2R7ENP(4"TLI%2/)RK @;AG=*?):#
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M(3C&1@@?)4VDI;ZDT<S%C' 9[F"*;F=UN;F1A+*< ?9=T9^RQ'[^Q;B1<"$
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M! ))9!@[UGIT%K#:1Y:5K(2K!*Q(8";(88& 1LP@R#A5&*_.7_@JK^W]<_\
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M7[D;!M1@K%V)Z_+OP7_;U_9N_:%\3Z=X*^%7BOQ/<>)/$_A:Y\?_  Y3QO\
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M[93R[_P9\2I85==N%:1(%V[0/FB<*2"6,R^%^G^0'^?_ /&/]D2\?7[Z^TZ
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MG5^V?_P4#^)W_!;_ /9M\"?&_P"$WP/_ &1_CG_P52\1V/[1-AX^^!^O:_\
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M?"^D?%2XTJXUC1/%6E>*+#0&\#1>)/#WC;2?$&LZ1/\ VI9@%J\_X)Z?M"^
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M=H7WSD' .!ZG_2\^ EE#IOP+^"VG6ZA8+#X3?#FR@4# 6&U\'Z-!$H'8!(U
M'M6E/J-)*]OGK<]9HHHK097HHHH L4444 %%%% !0>A[T4A. 2>@!/Y<T ?G
M;_P4+^ 7C7]I'X0?!OP#X*A\7>;!^V9^S!\0O$WB#P%XCLO"?C'P-X*\ _&/
M1_%&N^/_  [K][/$++5/!5II4&NVJV\.I7%T]D+/^R-6MYY["XHZ=_P3;\(:
MHWQ#\3?&'X[_ !M^.GQ@^)WB?]FG5?$/QC\;'X9Z)XATOP;^R?\ &C2OCO\
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M!/#GPHL=<\5^)?AWX3O?A;X?\(^)+7QSI'B;P7X/^'/PX\*_#K4_B7%XKLM
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M3\?/VE/B'\3OAYX*^#NF?%'Q;K'@/P'XL^$7@7P)\0M.^+?A&#X06WPA\"^
MO#'AGQCH/Q6T;PO\4=7\=:EH.M>(?%/C+P?X0DU^6\T3P_9Z,8M0_P""9O@'
MQ]9?%:_^/_QT^/O[0/Q?^*VB?#'X=Z9\=/$.I_#[X??$'X1^&_@A\0;?XO\
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M?WA4_)+<7LVXP9P&+GRVDA)+'JK%3P%E6."ZD!B!M[ZSB><H$VQI<:E;GYI
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MQ7'F082M"C4Q-:I.4822I46U!3;TG)SAJK-RBDWV;/L?]D3]C;X<_&G]IWX
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M.?";_LFG@3KU_P"16TJKBDF[.[LC2GU^7ZGI=%%%6:%>BBB@"Q1110 4444
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M+R96B"D0L68DY&<[#A3E@ .5=DQ01_=NRPM6#LDT6D6*B,VIV':3.T9QGJI
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M\2W,6AW]I86JV47Q3^ULW[.K:_HT7P%L/ $$EKX@\?W>K:]\.O$&K>(]'O\
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M^I_M4?LX_$OQ_J'['7BWX":A\/--\0?LF?'VT^)MKX5^*%WXMM?"WBKP7??
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M3M**:U2OG4RO%5.52P[?+)2B^:,91DKVE"<9<T)*^DHM/?=/7^=;_@K_ /\
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M6JTZ\(Q=_=]^O9JS[:;+0_'3P]X;\)_#[PU=Z#\/K.7P\U[EKC5@IO-5DD/
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M2>$==\:_!7QUJO@'2-&\">*O&'PTUK2=1U;PYH/AZYL4T;Q7HMIXG'!>/?\
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MUNP\+:YJ%EH5SZA^S9^PMH/[/FJ_"W6M1^+WQ ^,]]\)?V5W_9#\+Q_$+1?
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M\,ZS$?!.B>&;/X5VWPA\&7WAJ^^"B_"6#PCJ/P[U[P!X2US3]5N=;BU;5=5
M.0^(_P#P4?UGX':M\2OB=\6/AE\?M*3PG^R5^R=\7+_]CZVT+X*:GXH\+>)/
MVB_VG?'WP+T*UMO'.G^)H;G5OBS>7EOH6G^,?!E[XKE^''AZUTBR_P"$=U^\
MUJ]URY;T/5/^"G-E\/;/XV>'?CC^S1\7_AI\=/A/J/[/=AX6^!FD:Y\-OB-K
M?QP;]K/Q[X@^%G[/%O\ "_Q?X<\50^#'U3Q9\1?"GB;PIXML/%>J>&K?X?3Z
M%J&NZQJ-UX1^Q^(KRSXM_P""8OASXDZ!JUC\5/V@_C)\1/%OB#X,?LO_  3\
M1_$;7+?P+;^+/$NC_LH_M(ZS^TAX'\5Z\=-\+VFDWGC;Q/K.K)X9\>:K!IMG
M8ZSIUJVJV.E:3K5Y<W1B_;H_8NLOB+I7Q]^.OA7P_P#%?XE?%OQ-\/\ ]EW2
MO"7@7X7^/? OPS\<>%_$G[*'QS\9?&GX>_$[X->,/'.A:GX7MOBWX8UKXAZW
MKFE:%X_D;P#XWD\-Z5X%\02:1HOB76]1(!R/BS_@J[#\(O\ AHC0_P!H+]D_
MXT_"/X@_LW? SX3?'7Q1X:/B;X5^,?#GBKPW\:OBOKWP@\&S^#OB'HOB^+PY
M_P (YI'B70KFZ^)/C;Q>/"6@_#?1;/7M:\1-'H^@7&H7'W%^RS\?]5_:.^&T
M_CK6?A9KGPJO;3Q!>:$MC=^+O GQ(\'^+;&*PTS5M-\<?"OXH_#77=?\'_$7
MX?:W8ZO!!9>(+&?3;^SUW3_$'AS6M$TO5M#NX#^2O[,7[)W[2?QQ^-W[5OQN
M^*WQ0_;)^&5M\3_V:_V>_@'X.^,?Q:TGX'_"GX]-XU^%GQ4^)WQ7U?6?AY\'
M?AQHNN_#KP)\(-$3Q5X8\+:QX<\<Z%JZ?&36+_XEG7=-U3P;J=E<:A]_? G]
MA%?V>O@K\6_AM\.OCSX_\->/OC9\5H_C'XR^+WA/P7\'O"3:3XM:/P+I.IVW
MP\^$6D^ !\&? N@:]X3\ Z?H6OV.G^"KF^UG4];\5>.-3U2[\;:Y-KL0!]]3
M)%)#+'.B20/%(DT<J+)')$RE9$DC8%71T)5T8%64E2"#7&+N6V@"E(_^);';
M6[(FVP*ZA=K## +=8PD(CMHDC2-%5(U8A455S79S*SQ2HA"N\;JK'H&92%)R
M#P"0>A^AKEC"UO.D4A1&270+=Y H>.X*"4LB0A2(AY@^5]J@'!&"30!&S!7<
MB'*B>]O#9N?OQZ;#':VC6KE?E'G*C 9.2Q^^!@M6(D+ 6DECC%KIZRY(N;0E
M/MUZ90%'F*PC@1B3@9(!4\-'M'V9HV0Y^P3L;<L"R^9J^))%N/NKP 63/( !
M7BK$K9FFD#Y,=SKA^T !# Z6:(B%2/\ 2-JG&[#8"@9P* (S(S 7#$"65/M4
M=Q&I-O<M<-+9Z9;3Q8V*%CEC<@KC(+.N1NJ2-6$I1% E,QS:S?/;3O'<6US?
M:C&[$1JR%RD( .UEQ&3R 1JJS1C"Q*]UHT:C:K)=)'8O+&!$!^X_><AOEPR=
MB*K*!]G$6-^+"$M;LP+6XO-287<HN", 8&'4GCRQN!P30!)&JRK''&KM"RV4
M9A8 7EG&][<74LSOY0#1.8%R@)&T?,%(!+XV$[VS,0PN[NYUJ;:.&M;/"6A
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MVG&<''3.*,'T/Y&J609=_P ^:KMK_$G;_P!(#VC6[7S1_;?_ ,1LG[1V\/\
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MSJ9^&WACX:0Z!XIFL];\%:AIX\(QI+X>T+6_#&J:7J7BNYU[7+2_TY5M??\
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MWNIZCK-S96=W+%"UXFG-J8L)+M8DANIK:2XMQY$D=?65%??YOXE<59[P5EW
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MO^"5W[0WP*\;_!CXH>%I_B7\1/\ @HA%X7^$?[0$FH'XEWG@WXF_'CXUZO\
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M4?'S>,OB#I@\.:=\%OC5<Z3?_#K3Y=#\>/X8\::&WBVQU/6?OJ^^&?[:S_\
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MS0-6T+Q+IFM:?HUG+<:?_P (QK&G>(+B9?L^F7232<^#_M,_L<?''XK?%O\
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MEN/#&A)XG^(W@*YCN-2>WTS4)Y8]4B+MHAE@^<OC!_P3I^-'Q+^&'[*'PO\
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M6BC(*D9Y^7_'!/\ GWKJ1IS1#[JGM@#IZ8(&,<>O4],U86Q0XW'GV_3D^_\
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MU33_ !=!J?[07CC4/&<+:EH^E6B^$?"OP\^']Y97ND^%X9Y?V?HH _!S2?\
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M/X8\6:=+"HN8+O0M2NP]LPEE2([E7P4:2,YP6!Y&<EE&>#D$9&.>G6O[7/\
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MJP:B3(K 12[56958+UV(3\P0^802#&;B)'_>. NGZ7+]@MPT:@>9 ]O.&RN
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M2ISX/A^ZLUB\QZWO_LN%^9]QP1)2K9C:^E'#;_\ 7VJ>O4445^#'Z$5Z***
M+%%%% !1110 4444 %%%% !1110!1O[=IHUDB(%S;MYMN2< L 0T3GJ(YT)B
M?G RK_>12)[:=+B&.6/(5A]UAAE9?E=&7)P\;AHW'9U(YX)GK*<BPN_,&1:7
MK@2CC$%XY")(23A8[L[8Y.@%PL3$_OI" #5HH'-% !1110 4444 5[JVCNH6
MBDW '#(R-L=)%YCDC?!*21L R,.A'(*D@U[2YD+O:71474*Y)4$+<Q%L+<Q>
MS$A9HQDP2_*24:-FT*JW5J+E4(8Q3PL9+:=?O0R[2N2.-\; E)8F^26,E6&=
MK* 8NI) ER$&XI,89)[2 %'>>2\@$=\[X*%8VC"29(;;Z###/)?&7$;7$85F
M1#LL-,N!9W,BSM@O!)#<K*-^#MW9WLY&*LSSS/=>7.L=I<0I:I(R;VDN=\D[
MO:P.#N-K<K&6CD9!LE#12L'7;54J/L\2+$WEM;LMOI\9)N+R+^ST+V][)'M=
M)8F;,1>,MC&Q!D&@"1=PD9X9-K>?(CW\N1';SFYLDFL(57S$,5P%;R3L!'&W
M8,FFQE B;!)!;3!5BW\WE]N.H--8S&-B53)+0LT809ZNV*E8;YU78EW,&;RX
M%*BVCMDU& 9D8&)FO+3:,@[BVWYF<G!CC8L5D$RW$CK!Y^H2J LD834 K6*2
MK&PNH"-I",9&_A"C)( TKF)8Q")-T,B6VFH1ND0:?;$PW\B&.031@YC9@79>
M?E!&.ILHIXHG6X=79IY73:,".%VS%%T',:X4GGIU/6L?2XIFECFB4I;C8TL\
MN[S-05["!8YPK!]C*X"R*C@?+\Q9L@]'0 4444 0SV\-Q&8IHUDC)R58<9'1
M@>H8=592&4X*D$ U1\N]LLF%C>VR](IG'VQ%SDK%.Y"7  SMCN"DG'_'PQXK
M4HH K6]Y!<EEC8K*@'F02*8YX\_WXGPX'HV"C=49AS5FJUQ:6]SM\Z,,R<QR
M F.6,^L<T966,_[K#/?/%51'J%L!Y4D=Y$,'R[@B*Y '4+<(OE2$]?WL2DG.
MZ;G- &G16>NI6X*I<"6TD8D!;I/*4GDX6;+6\G SB.9B1R0.16@"#C!!R,C'
M<>H]J "BBB@ HHHH **** "L74+!Y8M1E1W=YX[>2&(E0L<UG^\3:6)4+(ZJ
M9,A<@8R<YK:H(S_7IR/0Y[4 <:Y>Y%T80Q^V65MK%J44DK=VQ59\?QH\X$<2
M!6;"[B!V-AK>2>ZN+9#]GDNEL]8MF8;C#<1-'%=#Y=K#:NR-589+.QY ..G2
M-(U"(JHJC"JJA5 [ !0  .P  'I2[%WB3:"X4H&P-P4D$J#C(!(!(S@D#T%
M JJHPJA1DG"@ 9)))P,#))R?<G/-?FM_P5/TZUU']GGPNMXBO;VWQ>\*73@@
M$@IHOBF-2@.<N#)D  D#)Q@&OTKK\RO^"K$+77[//A*T%O/=I-\8O"GGV]K,
M8+EX%T/Q66,3A9&4A_+7<(Y-I894@X/O\+77$>3-2<6L=3:DFHN+4,0[IMI+
MUNNO<^)\2+?ZA\5\T/:+^QZUZ=K\_P#M& M&UI7N^73E>VS/F[_@G%H<MI\;
M-4U2V^73)OAAJ5MY48*QI.-9T/8RJ>,.B,RX.2."H4<?AW^VU\6O@WI/_!3:
MU^(?Q&L/V=_A_P#')/VQ/C%^RQ^RMXZ^($_[:/C/X@>(/$&K?#GX.>!]?O=?
MN?A#K<'@3PCX<T)OCGIUG\-;">Q,?@/5-3\0>*-',%Y>WLI_>W_@G!--;^-M
M5M;O;"D7@6;'G3$F.6._TR$1[I2-K,@!DR26920<8QS/Q8_X(Y:)\2/CCXZ^
M->F_M/WF@W'BGXYZG^T3X4\-^*?V:_V5/C*/A/\ $_6=&\":3JNM?#;Q5\5O
MAQXG\6Z";M_AQX4U1E@U15BU/3(+J(1R11[=^-)2J9_B&[OEHX>":3=U&-3J
MHM-ZZZM]=;L\KPJA0H\'X50M!5,9C:KIRE&+IRG.ES1Y>9-13B[>ZEOHC^9K
MQ!=>'_ 1^'?[4?[4%E\-OA?^R=XH\%?!+P_KR^(;'6?B1\5/%/QEM_'OQD?]
MIOQ=\&/CS\25U#4 ?BA\./@L_P ,_P!H"Q^)4TNH_&KPOXOT3X8:--)XVO\
MPGCT?]N?0O\ @G_8?%?]BSPS\>/BEJOC?]DK]I[]F3Q#/\%?@9^S&?C0WP?T
M'Q=KW[2GP/U63PIX T;X:W5C\6-)\.^)O#J6]Y\-_AWXZD@\%_#[XL:79VUE
M!::9=ZA91_N3%_P0,^#GV==#U7]I;QCXL\%^*_@CX&^ 'QL\,>-/A/\ L_\
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M,$H1VC;I,$?>A)2<A^#U]_:I<1!FP7MB]Q"&91&95BD11+N!4Q$.=X.!CDD
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M&H^'OV[?!,-O*^@?$WQ;\-D@AC\WP9\%?$4>O:?#:*)8[O6?#/\ 8\3WKW[
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M8P1?$+XN0);3ZA^RW\:A;3RQ^1;6OA#Q[<7<]NP99I"Y\!VT,?EL$()D))<
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MZ^OZ'_"C>OK^A_PH =13=Z^OZ'_"C>OK^A_PH =13=Z^OZ'_  HWKZ_H?\*
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30_X4 0T5'YL?][]&_P ** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>forms-1a_004.jpg
<TEXT>
begin 644 forms-1a_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %$ D # 2(  A$! Q$!_\0
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MS323US2;O4T 245%^M.^]0 ^BF44 /HIE% #FS29/K2'I3* ),GUHR?6HZ*
M),GUHR?6HZ* )%S3JB6GB@!U%-;H/K0N: '4444 %%%-;M0 ZBFKUIU !111
MF@ HI,CUI<T %%%)N% "T4W<:-QH =132Q -)YGTH ?13-V[WI5]: '44W(7
MFF[CU&: )*;G/M3*2@!]%,HH ?13** 'TO6HZ* )#D<49/K323Q2<GB@!^3Z
MU7>QMY+Z*]:"-KN*-HDF*C>J,064'T)5?R%244 /VCGA?FZ\=:.13** #\:7
M;[TS=]*1G]!S0!)M]Z7;[U#N)ZFEWMZT 2;?>C9[U'YC#WIWF\T .V^]*RG_
M .M3?,_"G>8OK0 M%,:3TYHWX/M0 XKGO1M]Z:6(I=_XT &WWHV^]!^;D<T;
M?:@ VFE7COFD(4=:4** %I-O&!Q2T9'<T %&T4W<?6ES\H)H 7MBDV^]-7M3
MZ $V^](%V]^.]./(Q3,8H ?13.1TI^X=C0 4444 %)M'TH.<^U-X.30 NWWH
MV^])Q1Q0 I'&<YI=OO3?I0HW 8Z4 .V^]*HVB@<44 (%.3D_2GK[TVB@!W%-
MHHH *.E%% !SZTOKZ4E%  PSWI-HI:*  #%. '7O3:3CI0 O)')HI"WI2;C0
M ZD9=W>A<]Z3<>>: '8&,4W;[TA?&<FF^:: '[?>D9AMX.:CR:-Q]ORH =UH
MIN3ZT9/K0 ZBFC/>G4 &,]/YTE.7/>FY% #EQ^-.J,<K3]P]: %V^]+M'K3>
M/:DR/\B@!QI.M-R:,GUH ?13-Q]:-WO0 [-+4>124 (V%.:3</\ (I/,..>G
MTINX4 /W#UHW#U_2D'WOTYI_R=ES0 @/O^E*!TYR*,K_ ':7<O3;0 W:/\B@
M  \']*=E?[M&X?W: $[YS3J;\O\ =IVY?[M "[3Z4E'F#^[1Y@_N_K0 H8KT
MH#$$9.1WI-X_N_K1O']W]: !L,:/H<4;Q_=_6C>/[OZT +N([TAY.>E&\?W?
MUHWC^[^M !@XSG/XT!=W?BC<O]V@R!OX<T 2;0.@Q2U'YH_N_K09 ?X?UH <
M9 /<TTMNSQ2;E_NT>8O]W]: '*H;(H"A6X%-\P?W?UI?.']V@"2BH_.']W]:
M/.']W]: '/T//%,# <#-+YP_N_K2>8/[OZT )MSUYI?04;Q_=_6CS!_=H >J
M;>*< !T&*C\X?W:3S!_=/YT 2T5%Y@_NG\Z7S1_=_6@"3\?TIK-^%-\X>E(9
M >JT /)!.,\TY:C\X#G;1YP_NT 24?C^E1^:/[M'FC^[^M $F1Z_I0/K^E1^
M8.FVE\X>E #_ ,?THJ/SA_=_6CS1_=_6@"2F[@.:9Y@_N_K1Y@_NT .W+Z?I
M1U]A3?,']W]:0OG^']: 'M*J]\U&9-QZX_"CY?[GZT?+_=_6@!N[WS^%&[_.
M*=\O]W]:/E_N_K0 W=_G%*.:7Y?[OZT97^[0 E*JCK2[E_NTN\?W?UH /K2\
M#I_*DWK_ '?UHWC^[^M #MPJ/;UIV]?[M&]?[OZT ''&!BD*@]J7>/[M&\?W
M?UH 3:/2EHWC^[^M&\?W?UH *3;GN:7>O]W]:-R_W: &GN#28 Z']*=N5OX2
M/>F^HX_.@ VC_(I-P_R*-P]>:0L/QH 8SAC14>[VI=Q/K0 ]G^Z,?Q5+GV-0
MM@!,GG<*R?&WB"^\,>&+[4=,T.[\2:C$N+?3++:'F<\ $L0%7/4]AV-5&+DU
M%=2924(N3V1N4#FO@K7OVDOV@/!?C'0[+Q9:6?AZ'5KU!%:RZ?$<Q&55958,
M3P&QD\U]?_&WXJ6/P0^&&O\ C34+26_@TN$,EG P5[B5F"1Q@G@99@,]AD\U
MZN.RRM@%3=1Q:G>W*[['EX',J./<U333AOS*VYVU%>#:/\9OB?X-L]<U3XJ?
M#NQTOP_8Z--K(U3PUJ/VH0^6N]K65)-I\W;T9?E)':K?BS]KGP?X-TZ*]O;#
M5WBD\'Q^-1Y,*$BR>1(PARW^MS(..F,\UYGLY7LCT^9;GMU%> 7'[:7A"--*
M^S>&?&5_<W]I<:F;&WT9OM-MI\3E#>RQL05B8CY>[#D"L70?VV+#Q)\1O"FF
MVGA;4HO!VN>&7\1OKEPJJUG$K/NDD4,0(D$9#-R0Q  /6G[*?8.>)],T5\ZZ
M/^W?\--0TW5[^^CUK0K6RTHZY;-J%HH;4K(.(Q) JLQ)+$#8VUN0<8YJ_P#!
MS]I+4OBU\<->\)/X:O/#>D:?X?MM46WUNS>VU))I)-I#C<4,94@@KZ]>,4>R
MFKMK8.>/<][HKXW^%G[<^O\ C;XA:1HM]H?AVXL[^_U*TGLM'O9FU/38;42'
M[3/&Z[/+81\;6S\PKO=-_;H\#ZQX-TO7[+0?%$S:O=K8Z5I[Z>L4^HR^67D\
MEG<(R1@?-)NVY(&2:;HS707M(]SZ+HKY_'[;?@"^L?#UQH>G^(_$UQJUM<7L
MEAI&FF:YT^WMW,<\EPF1MV."N 220<9K-U3]N/PI-X1TK4?#^@^(M8U'5O#\
M_B**UM].,_\ 9]JADC2:["M\J&1,84DXYI>SGV'SQ[GTE17R'X9_;6\3:L=*
ML)_!7FWM[\/W\6MJ5FC&SBN LC#<"^1; H$+9W;R!TYKO_V?/VL-/^+\GAC0
MM7T;4M!\5ZQH:ZQ"\]BT-C?@8$QM69BQ5&/\6,CD9INC.*NT)5(O8]]HKPV3
M]L+P3'XWDT!;#7Y;!=6;P^/$B6!_LM]4&?\ 0UF)SOR-F<;=W&:X?X9_M2>,
M/$'[./Q2^*FL:+#'/HE_>_V3I,ML8(A!#M41M('+2,&W!VXPVY0,#-+V<[7L
M/G6Q]545\B^#_P!O2*ST_P 177C?2M.N[/2;33+QM4\$W+7UN/MKA%MY X!6
M9"<LH)X#8''/;:U^VYX*T+8\_A_Q>8;>RAU'6'71V!T*WF=EA>]4D-&6V[M@
M!8*<D4W1FG:PE4B^I]"45\M_&K]M^P\)V.O6_@?1KS7KW2=1LM-FUNXL7?1E
MGF>,M"9D8'?Y<@8'[N2!FO0;K]J;PK:Z/K&H/8:JT6E^+8/!LRK$FYKR62-%
M=?F_U>95R>O!XI>RG:]A\\;VN>QT5XE9_M8>'=9\3:KI.C^&?%FL6]G->V4.
MM6>DM)I]Y>VJL9;:.4'ALJ5#.%0MP&K8_9D^-5Y\?OA'I?C"_P##T_ARXNBR
MF&3F&;!_UD#$Y:/MD@'(88XJ7"25VA\RO8]5HHHJ"@HHHH **** "BBB@ HH
MHH **I:UJ3Z/I%Y>Q6-UJ<EO$TBV=FH::8CHB D#)]R!7PU\5/VE/VA/ =S)
MJFJZ%!X/T:\N&CL;>[L8IMN 2$W[B6; R2<=Z];+\LK9E-PHN*?FTK^G5GDY
MAF5'+8J=92:\E>WKT1]Y45S]KJ&L:EX!MK[35LYM?N=-CG@6\+);-<-&"-^P
M%@FX\X&<5\[^#?VMO%-CX/\ '?C3XAZ#HEEX4\)ZE+H=R/#LL\UY)>1S)&65
M9 %,7SDYR&XZ5YWLY7:['I^T32EW/JBBOGK6_P!MSP=HL;-_PC'C*\>WTIM:
MU*"#1F$NE6NYQ$]TC$&,R;,@=0I!.!G%V\_;*\$Z=H?B/4KJQUB#^QM(TO6A
M:F%#-?07X'V<6X#?.VY@C#C#&E[.?8.>/<]XHKPJX_;(\"6?Q!7PK<V^K0A=
M2BT.?63;H;&WU*105M68-N+98*7"E QQNKB_!_[<MC#\/](U'Q;HUQ?>*-0N
M=48:3X9@#>596=PT37#^;(   O3=EB"%!QBG[*?8.>/<^J:*\1\-?M>>"/&G
MQ"T3PCH%GKFLW6L6-KJ5M?V=@SVB6TZ.PDE?/[H+LVG<!\Q &37"^*OVJOB!
MX?\ $GQ3O;'P3HNM>"/AWJ26>J-'?R0ZE)"88Y6EC4J8V*AR=I(SBA4I-VL'
M/'<^J*3/M7SMXH_;H\!>')=5DBTCQ/K.D:6;6*[UK3M-W64-Q<*CQP-(6&'V
M2*3Q@9QG.*I6/[:EEINM?%6+Q5X4U;1]*\&ZE'IUM=00>;)?RR%$BM]F?]?(
MSAD4<%""2#Q1[*?8.>/<^EMWL:-WL:^6?'W[;T.F^%=;N]"\,:OIFM>'M8T.
MPUC3?$NGLDL<5_,RL(XXWW/(J(Q&."2N,YKJ)OVT_!=IH^JR7FB^)[#Q%8:G
M;Z/_ ,(E<:;MU6>XG4M;B./=M*NJLV[=@!6STH]E/L'/'N>_;O8TN:^>YOVW
M/!D.@ZA?MH/B:.\M=?3PRND7%G'!=2WQ@$YCQ)(JH N[EV )'&<C,_B[]M3P
M/X/M=)EN-)\27,UYI7]N75G'IWEW&F6(<HTMRDC*00P/R+N8@9 (YH]G/L'/
M'N>^T52T/6K'Q+HNGZOIEPMYINH6\=W:W"9VRQ.H9&'U!!J[6184444 %&**
M* "BBB@ HHHH **** "BBB@ HHHH *8N/G]<T^H_XG^M "EO:D+ #&*:S'L*
M7D]: &,JKU'-.C&U@< 4;<L2>:/J: ', -I']ZI*C;^'ZBI* /-/B!\"]'^)
MGQ(\+^)]=;[3:>'X7\C3<866<NK*\A[JNW.WN<9X&#U/Q&^'^B?%;P3K'A/Q
M';-=Z-JL!@N(T<HX&<AE8?=92 0>Q%=%7+_$S5M3T7P?=7>E-)#.LL*RW,,'
MGR6T#2*)9ECP=Y5"3C!]<'&*WE6J5%",I:1T7EU,(4:=)RG%:RU?F>:^&_V5
M+6SAUF+Q7\0O&7CZ+4-'FT*.'6K]5BM;652K[8XE57EP?]:X9ACK7)-^PCI=
M]H^HZ?JWQ$\4:U]J\,?\(E#->):[K2R$R2QB,+&!E?+"\YSDDUT=S\6M9\/Z
MI]@L-;M;SP_/<S)9^(=>L9ILK';"1XQY13S0'.WS#@<[1DBF)\?O%DDDS1Z#
M9SWD11#X:CMKG[<-UDL[2&7.T!'.PKLR>G#$"FI5-TQVAU1K_$;]F.R\>>)-
M)U^Q\8>(/!^KVNC'P_=W.B21 ZA8$[O*D#HP4[LD,N",^PQC:+^QGX;T.'P3
M%!XAUHQ>'="N/#5S"3$(]8TZ8NSP7 V?+\SD[HRIX%7!\5O'&MP7]IHXTF[,
M5O=RQZU;:9<B*8I:K(J11M)_K%D?:268'&,9R M]\=M;TG16C2VM-6UD+;-
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MXP64LJ]<$5OV?Q \;:3>:W:PVUO=VVD7$C327\%Q++=HLT46V)MX"94NPX8
M]B,T^1AS'N/UHYS[5\_:?\8/$WA<ZEJ6KC[7H-F(Y)+&6VE:]6%[BXA,L<A;
M]X=XA79MSAAC P:]TT=[]]'L6U9(8=4:!&NH[4DQ)*5&]4SR5!R!GTJ7%H%*
MY<Y]JAW-O?TW5/S^%0%L.^?[U24*W&?6DW&FL6[<#THR><B@!^[VI&.<4E%
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M$0"3]W&^.@,F ",;1@T>Z+4U+'XI^%M1L1=VVLQ26WFQ0;]CC$DBED0@C(.
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M\D$D?F+N0E74'#+R*YZ[^"?AJ?PW<:.L,[VTABD$=Q.[H7BM_(C#X()79]X
M@GKD4?"SP'J_A&?6[[7-0^W7^I&!.+N2ZV)$A4'S'1#DY)VA<#U8Y-+W;:!J
M>@=N*@/^L?\ WJEJ%V^=Q_M5!0M-Y-!.5 IK'M0 ]F[9YH7O3"<\=J4?+TH
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MY<8\P@C!;'&X\UF:+\-_#NAZIJ.IQ:7:S:E?7$MP]Y/;QM,@D55:-7VY$>%
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MQ[O'_">U>:?\*EU_6GM[;5XII2FL0WE_J+:W(RW\:3.X:*(?ZDK&RK\I0]0
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M/.&_YZ,ORENI%>4:U\)O%UQI+/97%Y#YNHRRMI:ZR^Y+?R%2U02%MJB)]S$
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ME;J;'9^0?H* (V;!]32A=WL.YIJRDR8.<?2GG+8QP<T 7*<H[FD S]*7V%
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MP]FOO WAGQJ-,TG4]&N?#FLZHJ6VG/<73R1WL;!65SL95(4;@%&"#@B[\/\
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M0!<F^[^--JE>7UW#;L_V56VX_P"6G_UJJ+K5RP'^B)_W\_\ K4 ;%(>U9/\
M;%T./LB?]_/_ *U(VL77'^AH>?\ GI_]:@#8HK(.L77_ #Z)_P!_/_K4?VQ=
M?\^B?]_#_A0!K+W^M+6,NM77/^AKU_YZ?_6I?[9NO^?-/^_G_P!:@#77O]:6
ML5-:NCD?8TSG_GI_]:G?VU=?\^:?]_/_ *U &LW:C[N16,VMW1_Y<T_[^?\
MUJ1M<N_^?-/^_G_UJ -FBL)O$%VO_+DG_?T_X4G_  D-V<_Z"G_?W_ZU &\O
MWOQJ:N=M=:N[J94%DB^I\T_X5I_;+K_GV3_OY_\ 6H O56:0"63@_>J+[5=O
MP((T/]XMG'X4J6^U<%B6ZD^IH 'D'H1^%1LRMG(/XT_RU7KDTUUW8VMM/O0!
M9^POW=1]*<+ <9?]*N8QVS]* N[L?QH JFS0?Q$53U*QEEC1;<^N[<<<5L>4
MOI2>7VP* .0D1K>39*-KBA9AV(/XUU;V<4F-T,;?4"HFTFU;K;1_E0!SHD#?
MQ?K2[O\ :_6MUM%LN]NH^A--_L&R;_ED1_P(T 838<@G/'O3_,ZG/ZUL_P#"
M.VG8.#_O4T^&[;/WI/\ OJ@#!D8.P(&34@@E.,-'^+BMK_A'+;/+28_WJ</#
M]HI  8_4T 9"VTL.'EV&->3L<9J[_;T8X\N0X_NUH)HT$? 3C\ZD73XUR0JC
M_@- &/)<-J3J%C:,J"0Q/'TJ.QEGF#K&F_:><GFMW[(NTC<W(QC.*J6>DM92
M2,DH)<#EEH HI>%K@PA"9>ZT^1KCRR!#(#V^4U8_L1TN6GCN=LIZG9ZU(UA>
M_P#/YG\* ,5[B=6"-O#'^''-13"2/!DW ,<#<,5JSZ3=29W.LI(ZYP137T>\
MF^_(GI\QS0!/9Q_9;<G<&S\W!JE-J4KW*KC8%.>#U!JRNES1*%,R@#WIK::-
MK#S1S_=% %OS#Z@4GGG<0!^M9CM/#QM9\<;E!YH%U*.L;C_@)H T_/(ZJ?SH
M%QZ!OSK,^V,IY##\*/[0'K^E &I]I/\ =:F_:._-9G]HC^\*:=07INH N2R$
MC&"3]:IP_-=?\"J-KS*_+R:;#<"'D [J -8KNZG)^N:55QT%41?-W_E3OMIX
MS0!.;Q(9&1P0:='.)N5.<'%4KAEG0D@AATJK:M)YCKO"GT- &V6.TYYXH)^3
M\*R%OG,HCP2>GM5M6FQC;G\: +A<KUX%1-.BY^=?SJ!_/E4J$)S[U3N(I+?[
MZ$9Z=Z +4\R[>&&?K5:S4&Z [%A@U$T4JPB5E^7MC!J]I,4;+O+[G7^'IB@#
M3D7:K]S@_P JS(KP;%&"HQ6FTBCJ:S;NS5 TB'C.2M "K,LC$ Y/6GK@YK+C
ME=IBL:YQUJQ]MVG!^4^E %P]C[TO5O2JGVG=@\X[<4OVH+U/Z4 6U^Z/I2-(
MHZD566[&W&[ [5#(^^0MF@"XTB[2=PQ]:K7$B[1S58N%Y(H;:PR>E "JP\X'
MT&<UT\<@\M!CL/Y5S]G8F9@S#;'[GDUM>8 ,9H ;JC?Z#+@9XS^M8T<AVC=T
M]:VF9)%96.588K*FMC!P!E!WH :9 .1DTOF"15(]:KO)M&2>*9'<#\,YH M\
M^OTH+'/7%1>?[_I1YF[G- $BD?-SWI0W;-1;O>D\S'7F@"2,_*>,\FE))Z<5
M&&(I-YYH =G'4YI-PQ4&X=^M(6'TH >_S-U%-^[CGFF_+GI0=J^U %C2&Q>
M'OG%;^1ZUB:7&R/YI& .%K6\P=Z 'EJ3<*C+<=>::6[DT .=O;FHZ-_X"DW#
MCF@#<%%%% !12[?>C!H 2BEVGUIU #=OXT;:6EYS0 PPANI/YT>2/4_G3Z*
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L10 [[+%Q\@IK6D7]RBB@!39Q==M M8R#\M%% #/(3/W>^*7[.GI110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>forms-1a_005.jpg
<TEXT>
begin 644 forms-1a_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %$ D # 2(  A$! Q$!_\0
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MM]*%^Z/K35S\OY4I^Z?8T ._B--'W/\ /K2_Q#Z4G\!'I0 I^\*%[TFX?*:
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M<'4[HE;;_@ 'S2_AA>/O5#<*?&^IW%GEET"S?R[@*<?;9AUCS_SS7HW]X\=
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MVIO\)]FH 5ONM['-#?>8=R*7^)AZBD!SL/8B@!>N!ZBD4YVGMC%)G 'L<4=
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M9,"%QCIUV/"OPM\9:YJNM6>I:3/H&CZSK$&J:G+=RVH C@D$J6]O#;$J9'D
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M2VYE 7)&3GC-8]ZUWXKT/0H_$/PP\+ZE>Z990VL=X_B^&*XB"J 0'10R\@G
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M[_[)]12>N>?[P]1ZT /W'[V.1P?\:3;_  @^ZF@,>.[ ?]]"@]@.G53_ $H
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M#87NK[4H+"UCFU((H$JS-B0["4=1"21C'S<'(K,TW]HWQ1&)K[48K.ZN;/\
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M "[DW"V O%$B%-J*5)0G=P1G&*[_ .$OB70OB#X5O8['P])I]AI.I3:?Y-_
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MJ?JE'L'URMW/N!O^"F'F,A;X;[BO3.L?_::AO/\ @J!]EB7/PWWG/"_VS_\
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MO<Z3!K,<-DIF$,,Q;RE8YP'949@JY; Z<''E8F+FTXSY=3NHOD5I+F/?-/\
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M/<?A_P#LE^'M2\/> _$FI7>JRV^J6^EZG=1W4,4>FW*W%WY#V,,ROYAN,?O
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M9VVJ'=@JY/89(YKKQF(A747""BTM;;7./"8>=!R4YN2;TOO8^E_B3^S?X/\
M"]KXEU71FDO=)LO#-S<6LRZDEP$U.VNH89&9HV(VND@<1GIN/'%.L_V>_#OB
MCP;X*N[""^T674$C-Y>7ESNN;R4V\DIBM8#^ZE\PIMC*N"I.'6O"5\(ZY'I<
M=]_9-XEC(C3"18R$90"Q8CL, MDCD D9 J2+P3KLMN)O[*NX[6-T_?,I5(]^
MTA_IAT)8#@,"<9%?.\LK?&>]S1O\![S<?LRZ(/#UU9VMU>OKK7DLMIYRHMX
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M#;>,G&45I/4OFBWK ?X5^'&EZU'/'>:A>PW4NMOH=G]GB0Q[Q$[K+)DYVY0
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MH&!/."PP,CFEU+X8^+M+OKZTFT&XDELHHYK@VQ65422(2KRIY.P[BHR0 3C
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M99H9'3?=>6L8GVC R%#?*<C+GVQB0^ _$NH065Q:Z!J$\=Y((+<QP$M)(20
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MEM\9[FPUVXUBTT#3;?4[R03WT_G3O]IF\V*4OM+X0%H1\J@#YV]L><CY>O\
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MMI3%S5+_ !FIX5_:<N;CQ'JJ^)K6SM- UV\GN]2-O;S7.WS-/%B8@@E5O**
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M/OQ+$TB_-QE6W'(&=SQ%J?PATAG_ +.MM(N[MC;1*EK-(+=(FNR'="A;:X@
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M4M$UZ]CNA8W<LL+(T+ PONC8,,8.5)((;!Y&:DD^.6N#Q5+KL=K8P7_DRQ(
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MO)!^YM>S)?'_ (!NOASJ%G9WUW:WKW4/G*]D7,> VT[690)!D<.A93V-<NP
M.,5T'B+XC>(O%UK';:SJCW\$8"I&T,2!<,6R-J#!+,2QZL3\Q-8<81H6/S>8
MOW1V]ZZZ?.HKGW.>?+?W-B'"\D@]>.:0G=U'ZTG5LFEJ[!;03Y=I^7\S5F/6
M+^#2Y]-BO[N/39W$DMDD[B"1AT9HP=I(]2*KMC8:C/WJ3BF6KHZ6;5YO[+@G
M:YG%TTBGSQ(WF$@8)W9STX^E:&AM)/IJY0LC(8_E..AP#7/+;O/I@D/RQ0@=
M>I)(SBNE\/S+;Z;'"K;FP6VGJ,FN*JE&.G<P(9-/FX4(VW_>J)M*EVGY6/\
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M+$9?;N91O?",2HW'C%0W'Q"\0W%U'/+K4YEC<R1E%C18V,1A)554*O[LE,
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M9Y_/^SC"C*A@AW?>.P9-;WA7X^^.--UJQ\0:WJ>L^)=-TJ-M."->FW,/GQD
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MJ%4_+MP5!(JWKWQVT/5[J8VL>L:3(\9V:U:VT)OHA]H$IM@&E(,)4;/OC'9
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M,DBO)C+APO#D<<[A\I\P\R3_ )Y_K2%YNNQ?SIK#Q6PG5EN>S+\:M%62*?\
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$B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>forms-1a_006.jpg
<TEXT>
begin 644 forms-1a_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %? G$# 2(  A$! Q$!_\0
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M(/0@TF0.I _&H02#G]/;_P"O2YW,-V,?EZ^] $N1ZC\Q1D>H_,4;5/8?A_\
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M7MY<06EG:0375U=W,T<%M;6UO&TL]Q<3RLD4,$,2M)--(ZQQQJSNRJ"1X_\
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M:YT'4GET'5[S1-0$^F7>9X%6_L+A8F8D2Q!95^5A7F7PF_:P/Q3_ &F/CO\
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M48'7/I@DC'\NM %C>OK^AI2<#/\ DU!10!8R/6C(]:KU^(G_  <7?M$?%O\
M9>_X(_\ [5_Q3^!_B[4_ /Q%DM_ACX"TWQGH5S/8>(?#VD?$SXK^"_ OBF\\
M/:G;2176D:W+X9UW5K+3M9LY8K_29[I=1TZ>VO[:VN(@#]JYO$.@6\LD%QKF
MCP3Q.T<L,VIV44L4BG#))&\ZNCJ00RL P(P0#4+>)/#1_P"9AT,'_L+6'/\
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MO!6KVVFP6M[>WMVO'_M?>(?%/PD_X)JWGACX??M_W7[52>#/VLO 6@:-\2/
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MQEX@\+:S97=A>Z'_ ,)5J%]-JFE::8+V9X[319=.@2[$-^T;WD$,Z>94\7^
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M0?B#9_M$_P#!;[0K7Q_XZ@T7P'^S?K$G@?28_&/B1=.\'36EAH$5M<>%K/\
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M-\KE2KXS,55K8:%&EQ3E.)JT,.J/W 8P#T!)_']#].N*,@=3BFB0#JO/Y_U
M_2C*GN/Q_P#KU_)Y_8P[(Z9Y]**&C7C!SZX X^O7\*9Y>3P3^7_ZJ 'U_/)_
MP=.Z==ZM_P $3/VHK&QC$US)XM_9V9(S(D8(B_:"^&\K_-(RJ,(C'!(SC YK
M^AH0GN?Y?_7K\"/^#G1?+_X(S?M,GCCQ1\ .G7_DO/P['/3/6@#_ #%/V%OV
MM_VN/^">7Q;N/BW^SW=^&WEUO1Y?#OCOX<_$"QT[QG\)?B=X?)>XL=*^(/@:
MZU&ULM>30M5,.O>'+]+BSU;0-:M8[O2]0MDFOH;OY]^-7B7]H#]HOXJ>-OC9
M\:O$VJ_$/XH_$/6[CQ!XN\6Z]JUA-?ZCJ$X6******2&STS2],LX;?2]$T/2
M[:ST;0='L['1]'L;'3+*TM8>T\[W/Y#C_/MFG"1F(5=SL>BHA9CZX4 DXZ\"
M@#Y[;X?^,BOEM: IV1M2M"I^8M]W[01]YF;IC<Q.<GD/P_\ &;8!M VW(4'4
MK0[<EF(&;GC+,['&,EF)Y)S]$[+G_GA<?^ \O_QNDV7)/_'O<CG_ )]Y<?\
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M5?#FD^)+V&/3+N+6H]*.AW-S'.UI;F]$UY)%:K*X\6\4> /VNOVOO@A^QO\
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MM-YPED#N)(T* MW(\!: ?X]2_P# N,'@X((-KD$'@@TO_"!:#_>U+_P+B_\
MD6@#R;S^V>?]XD?Y_&D\WU*G\?\ Z]>M?\(#H/7?J7_@9'_+[+BC_A M!_OZ
ME_X%Q?\ R+0!Y-YQ[$8'N3CTZ&E\_P!__'LUZQ_P@6@_WM2_\"XO_D6C_A M
M!_O:E_X%Q?\ R+0!Y-YQX^;_ ,>_SCZ4"8\ $?@W\A_^NO6?^$"T'^]J7_@7
M%_\ (M'_  @6@_WM2_\  N+_ .1: /)O/(ZG\B<CZ]?Z4>=GG(X]2<_KC^5>
MKOX T1U*1S:C%(PVI(;B&0(QZ,4-LH< ]5)&1D9!.1XM(YCDEC+%O*EEBW
M;C%(T9;!Z9*DXYQGJ: -(S=\C/8YSQ_.E\XYZ_0;N?\ /X5E><??\A1YQ]_R
M% &H9O<?BV?\*3S2.A4?C_\ 7K,\X^_Y"CSC[_D* /M__@G-*6_X*"_L0KN'
M/[5'P3[G_H>=)]\?A7^ME\-"!\0M*)_Y^-1_]([NO\CS_@G%*3_P4(_8>&3S
M^U5\$AT'?QSI-?ZW_P -@P^(&EG=G%QJ/&!S_H=WQ7U&3_\ (HSC_!4_]0ZA
M\CGG_(ZR3_KY2_\ 4VF?86]?7]#_ (4H8'.#T^M5QN// ]L'_$4X$CIWQV[_
M *U\N?7#-Z^OZ'_"BH_F_N_^.C_"B@"_D%\ALC(]/7\^.GI4I=0,DC\Q_C51
M2!GIT/X]./\ (S322>OY=J +#2 @X(QV]3C\?7^E5P">0"<>@)_D#5:YD:*%
MY%_@!8C.,X!_KS_]84GVA]D>TXRBL?JZAB>W)SD_Y  +1##/RMQ_LM_A2<_W
M6_[Y;_"JOGR_WJ//E_O4 6N?[K?]\M_A29/]Q_\ ODUAZWXCTGPSHNL>)?$N
MM:7X=\.>'=+O]<\0>(-<O[;2M%T/1=*MI+W4]7U?4[V6&ST[3=/LX9KJ]O;J
M:*WMK>)Y975%)K\MOV&?^"T/[%'_  4%^-7Q@^ WP,\::G;>.OAKJU^?!L'C
M*SAT&'X\^!-*@MTU7XD?"..>?[7JVB:=J?VV&[T;48+'Q/#H<>G^*6TH:-J+
M2V8!^LH:13E5<'U&X''X"@-(N=JN,\'&X9'H<"JXGD) W 9(&3T&>Y]A7X,_
MM6?\%P/&7[)GQID^$/C+_@F3^VIKMGXA^,ES\$/@M\1M*B\"V/A#]H/Q@9)!
MH<7PH.IZG%?:RWBBWBDO-$M)(H[FXMU8GYE8  _>T-* 0%8 ]0 P!^H[T%IF
MQE68]!D,>/09KXW^$/[5_BOQ]^R=XF_:>^)?[-GQD_9QU?PEX9^*GBK6/@/\
M88M'TSXH6^F?#&WUN]CEG%C/<:5;1^,+#1OMN@3R2M&MK>VTUS@;U'XW>#?^
M#D30+WX2^#?VFOB=_P $W_VX_A?^R#XOFTM?^&I$T7P;XW^&&BV.J:VWAP:W
MJ$VB:I:W<NC6>MQ7.FW5Q:"6X>^MI+"RM;J^>WMI@#^EK=.!MVOM/\.'P3UZ
M=.O-(//7.U9!GJ0K D>AP.E8N@>(=-\4Z-HGB+P[J5OJ^@^)=)TO7=!U6T9F
MM-4T;6K*#4=*U&V9U1S;WUC=6]U"71&\J52RJV0/RE_8Q_X+&_L_?MM?MC?M
M/?L=?#O0/$&B>(?V>I]>?PQX]UC5M(N?"_QWT?P5XL?P/X_USX>VUJL=]%9^
M%/$CV<,R73W,E]IU['J=OMMXI]@!^CWQR^"O@C]HKX3^-/@M\3].O]1\$>.]
M+73-6BTZ\DTS5;.2WNK?4=-U;1M11':PU;1]4L[/4M/N#%-"+FU1+FWN;9YK
M>3\P_AA_P1I\"^%/B)\+/%WQ4_:2^/W[0G@_X&ZA!JGPD^%/Q)U.WE\'>%;S
M3KRWO-%C>)+B[$VF:9-9V<K:5I=IH=GJ$EC9P7<;:7"VFO\ 17[0O_!0KPC^
MS3^V5^Q_^R3\1?AQXQATW]LX^+="^''QTM=1T,> -'^)/A>)Y8OAMX@TN>:/
M75UG7OM&AQ:3>6BR6TL_B"RC$;"VO6BGU+_@H'X3'_!1KP]_P3@\*_#OQ=XS
M\?CX$7WQ_P#BG\2=)U'2(/!7P:\,&YN++PUI'BNRN2=9O==\5W9TB/3H-/18
MX8O$&FW,K-$)RGU>2<<<6<-Y=C<IR/.\7EV7YA*O/$8>C#"3Y:N)PD\OQ-?!
MU\1@<3BLNQ.)P%2>"Q&)RS%9?B*^%DZ-6K.%G'X_/^ .#N*,SP&<9_D&#S/,
MLMC0AAL36GC(<U+"XV&987#XRAAL?A<+F>&PN84X8[#87-,+F.'H8J*K4J4)
MN2E^@C)*Q^<R-R3C!QD]2!R!WZ 4%6XW!SC@%@2?SQP/T%?CE^VE_P %;-5_
M92_:P\*_L=?#O]BG]HC]KOXM^*O@I#\=;?3?@5>^$GN[3P=_PDNK>%]0>?2-
M;GBOW&DWVFVSWMY'_HRKJUC&A,I9:^O_ -BO]J/XI?M5>!O%/BWXH_L@_'C]
MC36/#WC%/#&F^!_C_%HD7B/Q7ICZ-IVICQ;HB:%--!_8BW5]/H[>>PG^WZ?<
MC:$"D_*'V!]H'S&QD.V!QD,0!Z D8_ 4$2-C<'..F0QQ],U^?_[!O[?WA#]O
M72/VB=6\&_#_ ,6?#Y?V=/VD?B!^S=KT'BK4M&U)O$>N> 'MUNO$VC2:,["W
MT?41<*UM:WRI>P[2)0>M?>?GR_WJ +K"1L;@[8Z;@QQ],YQ01(0%(<J.@(;
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M1OAE)OUN^7CC3&/_ )-0#O\ X5Y-YI_VL?7^G_UZ]-^%+[M>U <\:4QY.?\
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MPY^*'Q8T;QMX2T/Q9H'PL\(V'ABS^+TUWJ.J0:-KOA&[TKQAXH\+^&M,\8>
M]8&K:=XUTW5?%%DFEWOAS7+6*>ZN[>&"?YW\"_\ !43X/>.OV/\ XD?MO3_"
MKX]^$?@Y\.?'O_"OFA\6>'?!O_"1>/+N+Q[X>^&%YXF^&SZ#XYUSPQXN\#VG
MC;Q VB+XJLO$:Z7J<NA:]/HLNI6UK;2W8!^!'_!9G3+;1_\ @LC\)?B%XX\8
M?MZ_!CX6VW[!D?AF?XT_L%?#_P <>)OB7;^+;WXG^+9[+P3/K/A?PYKEM:Z!
MJMC]HOO$-F^+D/::(SI%%<).O[C_ /!'CX@_#GQC^S5KFB?#CXH_MQ_&33_!
M'Q9U^RU7X@_M_P#A'Q9X4^-&H:AXAL='\0QZ7I;^+M)T6\U?P1HEG=0VFCW-
MI9FTM+EK^S\Z2:.4+Z[\?_\ @I?^S1^S)\>_$'[-GQ4U'QCH_P 2](_9?\:_
MM6Z'#9Z19OH'C[PAX!M_&%_X@\ ^#=8N-6M(;OXM2:/X$\1ZYHWA+4HM,AUO
M2M/NIK#59I;*]A@P/VBO^"FWP=_9WU7]GC0=:^'_ ,5O'FO_ +2_PL\1_&#X
M?:9X:U+X.^%XK#PCX7M?!-UJD7B37_C%\5_AIX7L=<8>/M BLM'L-;U&\OY%
MOS:QR164DE '\[W_  3'_P""C'P__P""<VH_\%!OAM\?OV;_ -N'6=;^(7_!
M0']H;XL>%]0^$W[*WC_QWX=OO!U[K1T>RNQK)72+=I;J?1[NY@^SBXM9["6S
MNX;J2.X^7^Q3P;XHL?&_@_PGXUTNTU;3],\8^&- \5Z=8:_I\ND:[8V'B/2;
M36;.SUO29RT^EZQ:VU['!J>G3,TMC>QSVLC%XB3J^'M9NM>T'0]=FL-6T*36
M]&TO5Y-#UB6T.L:+)J=C;WKZ3JITR^U+3#J6FM.;._.G:CJ%@;J"4V=[=VWE
MW$FH5!)))8DDDDY))Y))ZDGN30!#0!GI5@ #@4A!.<G@]@!_7/\ 2@"''KQ^
M')^G3/YT?+ZG\A_C4NQ?<_4_X8H"KV X]\_G0!%Q[G\A_C2@J/X<_4__ %L5
M-@#H ** & *W;'T_SBD9,<C)]L9_E4E% %?!'48HJ<@'K490CIS_ #_^O0 T
MC!QU_P _X\4E%% !1110 4444 %%%% !1110 4444 %%%% !1110!7A7_3;O
MYC]R#H>/]6OM7X!?\'1F5_X(I?M1DD\>+OV=\9Y_YK[\/1ZG/7T':OWU5V6_
MNP&('EV__HM:_G^_X.CW(_X(F_M2DG/_ !5_[.G7 Z_'WX?]_KB@#_*8\[/?
M'X?_ *Z]7^#\F[Q#J*DC']D-@G  )O+9<DG  R0<GIR3BO$O-'^SCZ_U_P#K
M5[!\%I-WB34U '&B.>H/_+Y;#T[<GWH ^NK?5O)CTF*;3/#]_%I,-]%Y5ZZ&
M*^^W,6\R\^SR6\[R09_=O]H+[E5E:, +4L6M6L!N';PWX/<2PP1MY[7+QP&W
MFGE:Y@7^T%\B:9)A;SD.8G@@A)B$JM(W+5Z3\&Y;"W^+7PWN=4M+2_T^S\7Z
M3?75E?VT-Y8W*6,K7B17EG<I);W=OYT$;2VUQ')!,JF.:-XV9&3:BG*3M&*<
MI-[)13;;O9)))ZMI+=Z)GHY/EM7.<XRG)J$X4J^;YKEN54:M2,YTZ57,\PP6
M7TJDX4[U)PIU,;"I.-/WY1A*,/>E$YC_ (2/26>8MH?@@K.\?EQ+=3HEOMCB
MB"VY35%EWRF,/(SROYDDCLJ*7.;$NL6DDUO*/#/A*$0&8R0P27<<%RLJH/+G
M234IFVQ%-T30M%*N^3]Z2P9?WHU;Q9\']-_9A_9M^+^C^//!_BSXK?%[Q7X4
MT+QOX'L[WX!^//"<&C>+H_'.F>*=#\6> 9O ^B>._ _B2T.EZ3&FDVL?B?3K
M%-5FEN=?LIAH]S/_ #UJJIN1?NH[HHR3A58JJY)).%  ))..I/6IC-N3A*#A
M)1C.TFF^63E%.R2:UBUU5TU?0^RXYX!7!M#+<71SW#9YALQS#/<K52CEN/RN
MI0Q>05,)#%<U''5\0ZN'KK&4YX7$4YQ52,9MTU'DG4Z/4M1MKRR6VAT'PSID
MD<RW!O=-ENQ>NJHRM;8N=1NHO(DR&*+&&#HFQE!8'QWX6LLG[6WPSA89#_$G
MPNI&.H-O#U!]<<@C.<<5Z#7 _!JRN]5_;3^$6D6$*7%]J7Q8\&V5I;R7<%@D
MUQ=1V\42/>7)$%LI=AF64[%QR"3@]^78BC@\QR_%XB2AA\)C\%BJ\WJH4,-B
M\-B*TVK-M1I4*DFDFVHM+5H_'.+<-7QG"?%.#PU-U<3C.&>(\)AJ4?BJ8C%9
M#G.'P]./]Z=>O1A';62U6Z_J"\%:?8RHB/!&^TA6WHN&( Y3(&5PP^88&1CC
M!%?1FA>&-.G5&33E=5*@R)#(R0EE9MTC)&ZPIMCD=F. L<<DC82-V'RYIA\0
M>&?$$^FZM83V+:=-):W%J]S!= 2H_E-(D]NJP72%U./*):$?NY LJ2(OU)!J
M/BK4?AYXDT;PCK>H^$M=UN"./2]=M[J]T]+*:.*9)F<V:LUW*\4QABCO4NK*
M&*2X?[,+B59D_JKQ#X\S_+/##-.*/#'A+#<?<32AE:R7),12Q=6C5H9GCJ6"
MQ6<U\)EMLQQV&R#"8G^V\5EF!J0Q>8X3+\7@\/.GB*V':_P X>\.^'\X\:.'
MN"/%WC^?A3PCB\RQF$XDXKGB,-3CD];!8:IBJ.75<1C:BP> JYM7P\LHIYEB
M:-7#Y=B,QP6-JTJN'HXA/J[:P\/?:396U]H=Y<QQ"66WTO5])U.XCB=0V^6/
M3;RXFB0;AN\Y4*E@' )Q4MYX)TV]1)(=D#@ *4!X&<\[3GDXR2QP,8XP*_+[
M3OV!_P!I_P"'/B9?%OAFVU"+4X+>7Q':>(M/GGN;B51!+>Q2SK9"6^B:^5=B
M37=NENY:);ETC((^TO@?\4_'FH^'-8M/B_IRZ7XP\.:DEI/(FGS:8VK:5=VX
MDT_4IK*:.&&*[\V&\M+TVBM;/);K,"#*P//X7^(62<68O"Y/Q#3X0Q6?/ UI
MU<UX6PV:9=E]3,,'[99A@8X'-*F95L'.E+!8Z#A3S[%U,-B,!B<'C\-A,6H4
MY?I'TF_HF9GX2<%OQ/\ "OQ"XJXGX#EFF587%91Q+7R?&9MAL#GDZ=')LXPN
M:</8BGE><8"M6Q6 I5E7R+*\3&EF>"QV$K8S!3KNC[-%X<U+2UE33=7N[,.,
M.+*YN+02@@C,HAE57."02P/!/X<K=:9?:A+=Q:UXGT"TCTZ(RV\OCQ/$.KVU
MQB(F.+3?L.FZTS,K-M4.EN8Y0&W!2Q/<1>)]/OTGDMIDD6UC26YE7Y4MH97C
MC66:5P$CC#S1K)*Q$<+-^]9 #CY9_:3^)6K^&] MM-^'-[:7^N^(I;_2V\;O
M8ZG)X+\#R6+HFJ:E<:BMBQ\4WUK9RI>:5;>&+;5X+F=B99$2TE5OV#.LLX4K
MX/$.4<+.I"%K4:-#&8A2E3O"FX0]E4A.K&4%!U\3AH2C/F<W!2J1_E/PPQ_B
M35XAP&'PLL>L/4K04I8S'XS*,LI0C44ZN)E6FJ]*<,+&E5K5J> R[,,5:GR4
ML,Z]2C2G\=_&#]JY/@9XR_X1_2M'6YU>XE%Q<FR3Q'X;MWMQ,?(N)HO$86'[
M%<Q&46]RFG(C*22B@9;[4_9R^,&M?$/P1I'C2SM='N;/5 XNK:?3[&\N[>^W
MD75A>7=NEG*Y@#QL&ELXAY4D<L9>&56;\U/@5^REIWQ,^(?B#QUX[N->\8?#
M:TORF@:MXICN=-U3XG:LCAK_ %Z>VD=-0@\*?;3=2V\,TBRZE%)!!)(Z)<U^
MI.E>'X/ _BY-7T>!+/P[XITVST74M'L+,PV$'B324CBT+4[>.UB\FTDOM$2?
M1KHR"&&1=,TL/)YJQJWYKPIX;92L;5SW,L#1H8"MB9TZ-%U9QQ*C.K*G0QDJ
ML*L8RH1J1A2ARU)NK2J>VH1C1IN=;^N_&;Q=I8')\OX%X1SK'8[C3 Y72QN;
MYO"E3>6U\11PD,3B.'X87$4ZU6CF#PLZ^(JQK8>F\#B<&\LQ\Y8[$3P^ ]MG
M\2V<\;M>Z-:02P.6E:TT:'R#E5 (N(=SS,$)C8[&2,H5)#1G'">(-=TZ"\TZ
MP33M1_XFKW"1W=CHQN([41HK/+?7V)(]-)5@+::4@.V5'S"O*_BQ^TG\)_@K
M?:%I'Q#\0-X:N_$4<UQ8--H^L76GP6<-TEI<:AJFI:9I]W8Z791W4\<4EQ>S
M0A7DWR*J[F'HEMK6E:]I]IJFF7UAJ>GWEM%=V5[83P7MG<VMQ&LD4]M=V[R1
M30RH4DCEA<HZX.3S7Z_A,@X7J5L5@,+6P=3%8?V"QN%C6I5:^'<[5*4<33CB
M%B%ST;>S]MS:24_>347_ "CC,X\2:&!R;B//<!Q'A<DSF&/60YOB,-BL%EF:
M3H<^&Q-3*\9+*YY=4EA\;!RQ4,!4BY.G*A)4XJ=5<#XDTC28@T4%E<72RB3S
M+F=FF8'&X!WFG\YF=F)RA(+@[@JGGY:\6>#[=Y[B:-)F+ELL[)&(^P6.)#Y:
MC'.2&8$  ]*^P-0NX+K[0L;HSP.89E#*625%4E77DKD,K+G&Y2".!D>&^)0&
M\T$=W!R!\WTYQ_$,<<\=,8'?6X5R:4?X;<5%QA&,THI)6M%1]V/76U[W7-;;
MZG@[B?.:==.I7K2JR<)59593E.HY.$E.3G&^L'!KWE#EY96:=SX0\;>%D<>5
M<6Z7 CD#[KAGDS@\ ID1[5P-J[,8'()(%?S_ .I2XU350. -5U,< 8XOIQ^&
M,8P!7](OB])54+=&!Y]B"1H%=(2X(#&)9&>14/ 57=CCJQ-?S3ZM-G6-9R5.
M-:U8=>W]H7/3T_'-?RKX]Y1@<KGPV\'1]E*O/-55?VI*E# N',[7;C[26[DU
M=^\S_7+Z&V98G,,)QI]8J^U]E3R!Q:E)P;G5S7FE!2:5I<D6FH0;CRWBME.)
MO?\ ,=?RH\[CK^&!G_#]?UK)\T?[/YT>;[K^?_UZ_G<_MLUO.]_?.!^7^1^-
M'G>^/PZ?S_K63YONOY__ %Z7S1[?G0!]U_\ !->7_C8E^PL,]?VL/@:.GKX\
MTCT K_7T^&L@_P"%@:6.0?M&H@GO_P >=V,^O/T_.O\ 'X_X)IR9_P""BW["
M8^7G]K/X%]^>?'VCCUK_ & /AZ0GQ"THC_GXU$<'_ITNSS_ASVKZ?)_^13F_
M;DJ_^H<SY#//^1WD?^.G_P"IU,^PTF9<C<2,\'GC]?IV-/$Y'4L1G_\ 7CD?
MK5!9AQGKGG/3^56 4/4?B"<?S_EFOF#Z\7[0/]O]/_BJ*@_=_P"=U% $[8(#
MJ<,#@''7V/J,=.:\H^+7BKQ!I.G>&_"G@JYM;+Q_\3/$D?@[PKJ5Y;PWUOX<
MB73=0UWQ5XTFTZ>2./4/^$1\*Z3JFIZ?83DVFH^(6T+2KTK:ZA*1[(UD<Y##
MZ#_]0KPOX@H-)^,W[/FLWRJ-,NKSXG>"X[MV@2&U\0^)?"=GKFBJYD965[ZS
M\%:[I]LT>6DN[J"T +W4:MZ644Z=3'0=2G"LJ-#&XJ%"I%3IUZV#P.*Q="C4
M@VE4ISK4(2J4G=5:="I2:<:LU+R<[J5*>75%3JSH.OB,OP=3$4I.%3#T,=F.
M#P>(KTZD=:52%#$3A3K*SHU,13K1:G2IRCT6F:'\-_V>_AYXFUQY)-(\.^'=
M)U?QI\0?&NK&^U[Q1KQTFPGU+Q!XR\8ZO#!=Z]XHUQ[6"XN;B=H[JX$21Z?I
M5I!906=C"?#CXD?"']IGX4Z;XZ\!:MHGQ0^$OCRTU2TL[V[T>YDT/Q%96.H7
MFB:M:W>C>(].M9IK>/4+"\LKBWO]/5)&@<A'C*NWK<D0:.12%8-&ZE64%6#*
M5VL&RI4YP0001P1BOB+_ ()U?!7XB?L]?LB?#/X3?%;2++0O'7AO4_B-<ZOI
M>GZOI^NVEM#XA^)?BWQ'I+1ZGI<LUE.9]'U6QN)$AD)MY)6MY0)8G ]&$,%B
MLCS7.,5F&(_UDH9[DU/"TY8RFI8O 8S"9K5QN*C0]G'%^VR_%X#+HQQ-#$TL
M/AZ6*HT%AZ3CAI4O,G/'X/B')\BPF5X7_57$\.Y[5QE6&!JN&#S' XW)J. P
M<Z_M)X+V.9X+,LSE+"XC#5L1B:N#Q&(>)K*>*C5]'\%VM[\*_'__  IN6]O=
M2\"ZYX<U'Q=\(+G5+N;4-3\.6OAZ\TVP\8_#&YU*[FFO=1TGP^FM:%KG@:YO
MI);^WT*^UCP]-/-9^&--ED]UKQSXC*-3^.G[/^EV9C>^T&#XK^-]5VN?-MO#
M<?@Y?!(\U4R4CO\ Q'XRT06XFVQW#Z?<-%ODM"%]-\3>(-#\&^&_$/B_Q-J$
M>E>&_"FAZMXE\0:I/DP:=HFAV%QJ>J7TH0%VCM;&UGF94!=PFU 7*@\F90GB
MJF65U!SQN9X.E4KTZ<+U,1C)8[%8&G65.$4Y5\P5'#U9*$$Z^)E4JQ@ZF)G[
M3LRJ=/!T\WPTJBIY?E&/K4\/5JU+4\-@5E^$S&K0=6I-J.'RR5;$T8.I4:P^
M$C3HRFJ6$I^SFU?2-(\0Z1JOA_Q!I.FZ]H&O:;?:+KNA:U8VVJ:-K>C:I;26
M6IZ3JVF7L4UGJ.FZC9S36E[974,MO<V\LD,L;HY!_,K]B+_@CG^P_P#\$_OC
M%\7_ (Y? 'P'J4'CGXI:I??V%=>+-2B\0P?!7P5J:0S:C\-/@^9[2.Z\.^%;
M[4EN+J[NKVYU/Q'<Z>UCX>GUE]$TNULZ^I3^VG^S7#\%_A;^T%=?$2'3OA3\
M9?%'A[P7X"\1ZEI&K6,M_P")_$NJW^B66E:GI5Q:)J6ARV.HZ7J<.NR:M;6T
M6A1V%W<:F]O!"[C>N_VN/V5[..&6\_:2^!UM'<:OJ.@0F7XG>$4\W7-(2&35
M-'5#JGF?VEIZ7%LUW9LHG@-S;(R![B%7J7#?$47)/(,\;ABL9@I<F49G5Y<9
ME]=X;'863H8#$J.(P>(BZ.)HR<9T:J<)*ZDXI<5<,.W_ !DG#\>;"X+'1]IG
M>4T>;!YE06)R_%Q^L9CA>;#XW#M5\-6CSTZU)J<9)./-]#%P!A>WY?\ U_\
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MW\4VFHZ9\/;#3-1U_3+/4-&DN-.;Q1-!K.GKHGAF6[AU;6YYFAL+>1X)_+]
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M^S7=VNOZ*4O66]TF6UT[4I[:]B8PW::9J8M6F;3;Y;?"/[3'[.83P](/CO\
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MIK..YF\A+E7<1#YCM_CXM[->6>KVMS;M"9I5F"&1S#EI )DCR(2JD1JVXJH
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MA\')?$7Q#^(-II'PJ^!^D? /4M-T&W\-Z1J'CWP9H?A?6?"]FFL>)X=*?6[
M7,>O:CJ&H:;#->Z:+[R9M'AT:=]0N+_D[+_@F!X/T^WTW6K7X[?$9/BG9:[/
M<7'Q+?P-\'KF*\\'W'PLT7X*/X+_ .%:7G@>Y^&D*I\.O#VE6,?BD^')O$3Z
MY%<:U=7%R+E[$6_"OP,_:[U74+*?X@?&'XU:9:VOQ'\*>$YXM"^*WAJRBU+X
M#:?X8\2Z9X@UR]BTBT#)XZUK4X?"6HZKXGT\6/C4:D+F\T";2([K6EN8/#^E
M?M\V?A>Q\$ZY8^,-1\4OJ&N:\_Q3C\??#,Z-9^'K?]F/QGX&\-^$=2MEU.WU
MFY\7S_'6Q\'^-=0?3_#DWAV:^UE?%4VL0P6FK:3;<U/CKC.A0IX6AQ;+ZO0Y
MXQHNE@735.M7Q^)KPE[;+Y^WHUJV8XJ>(HSE.%93HTY4I4\)AZ='JK>&O 5?
M$5,76X1H/$UO9N6(5;,8U>>AA\OPN'J0=+,X>QK4*&682&&KTXTZM&4*U6%5
M5<9BJE:CXG_X)8_#/7==\0ZCIGQE^(7AR?X@:[JNI>,M,CT#X;ZL/$^DK\6[
M#XV:!X?T[^VO#LU]X=7PMXIM)!/J_A&72=1UG2+K[-J9BCMH&'HU_P#\$[?A
MMJ?@'P;\/M1\<>*;[3?!/P^_:V\ :;>7FB^%[NZN(/VN-1O=1\2:Y)#<6,EK
M;ZOX'DOI(_"K6L:1W"*!JPG+N3X]\6/V:_VK/$G@WQSX$TSQ5\0?%NF3>!_%
MW_"'^)O$'Q1T"#XBP>*O%'P1\-VNKZ-I/CI'TS7/#]GJ?Q6T6]AL4MI]-TK3
M_P"UKZ))K'P9+;6UC[5\%T^/VL>)_P!H/PQ>^+O'8\,?"+1?$/@CX5:AK>MZ
M#JGC#7O''Q6\/:'\5((/%^LZDFMZ#JOB_P#9\MM6T/X:Z+J]W=^(?#5TVHWU
MUJMSJKQ7;*JW'7&52CAG+BRM56 G"K0M3PD:E*2HT\%2J*I#!1JSE'#N.&C&
MK*;IT(.$9.$;!1\-. :57%\G"6%I_P!H4YT<2O:X^5.M">)GCZU-TYYA.E"-
M3%\V+G*E&'M,1/VDESRN>??$W_@E=\'/B2UW)+X]\6^&[RYU7PW>1II&@^#)
M-/@T;2_@=X6^ 7B/23X?O-,DTRZ'BWPOX5L=4FU.YMY)]&UV:9;5+G2YGT^6
MA<?\$I/A@]_JUMI?Q;^(6D^!9%^(P\*>!(O#_@&XA\''XJ^(/ 'BKQF(?%G]
MA6_B[Q)%<ZS\/=/?2;?Q-JFHP:%8WES9:9' B+(W,^&?@;^V7J'A_2?&&MZO
M\5-#^*?P^^&/Q,TGP5>W_P 6/"\FM^,/%MSX_P#A7XC\)6?Q!M8]:\5:7+X?
MU>'P_P",1-X3U7Q?XM\.VFGW-PCZU9V^I^'M&\-Z&I_##]N[7?'L5F?%'QH\
M.Z5J.M>/;/XG^+M(^+GPZLO FIZ/J?Q_^$VH> =1^!GA8W.H^)?!<>C?L^V'
MQ!TB]74='TB\M-4FO;2\MO$7B>\LO$EST4^/^.*5*&&I\:5O88>,E3A..#JQ
MIN\)<]+VF#JMS4*48TZT92K05:MAXR4,3B'+"KX6^'=:M4Q-3@O!NOB&G5JP
MGCJ<ZJY:D7"HZ6/I+V<G6<JE%QC1J2I8>O*'M,+AG#I=!_X)TZ-\-/#WQRNO
MAO\ $SQ#XVU7Q7^S'\;OV;OACX-\56'@;2- \):)\0=>UCQGIFBZCXL\,:#I
M_B#7KO2?%^H7.GW7B'Q7<ZIJRZ;=2"\/VFSS)Y_HG_!(_P #:]X+TI/BI\5_
M'NI>/KWP3H/A[Q!>Z)IGP_TO2]('A_X7:'X!\):-I-AHGA?3-$U.W^']WI;Z
ME%K.IZ7=WWCH[;7Q4US8;8A[1<?!K]IZW\7>(=8\.>*?&?AW2M \0:MXC\!^
M'_#_ (U\+Z7X9\6ZKK'[47B;Q%J5SX]T01!?$K:O\"KG2K>_'B&9&F:]NP9$
M\:11:C8^/?LN_&GXL:C^T[:^$]=UGXN?$^&3P-\0M"^+PA\:^#_&'PO\-_%D
M?%_38-(\8Z7X;TS[+K'P<\)Z;X,T#Q3IVC>%/&%EX4UZ[M)8-,LO!^HZM;ZG
MXDU:Z?B'QS"GBZ^&XF:Q,YX7%XG&TL/@H8Z:P6"E@\/AY5UA%2A05.I4JU(Q
MHQGB<;.=3$U,1-V6=7PJ\/*L\+2Q/#%.>$H4<7A<-E]7%8Z>7TWC\?#'8G$Q
MP[QKJ2Q#J4J5"E*=>=/"X&G"CA*.'@FWVEW_ ,$P?!SZ9XFGUCX[>/Y/$/C(
M_M$R>.O%L_@[X5Z9!KND?M*^!O"'A3QY:?V%9^&;+P]X<BTK4/ VB^*/#FIZ
M%!IUQI]Q]NL+J6ZL[J>20\0?\$K/A1XB?X@VT_Q1^(<'AWQGX;^)^FZ%X=M]
M)\#I!X*\1_&K0O"WA_XG^+K368="@\0>)QKUAX1TXZ1X7\4:IJ/ASPQ)=WK:
M7:L%L!9QZK^SO^T9<:S^U!9Z=K7Q170O%<G[5'BSP)I&J?%3P[K?P]\?>+?B
M=H/@#3_@YI(\/ZW>:G>:)X:\,0GQ_;7GA76;/P]X7L]<6WN[VWU>P.FW![/]
MGB/]HW5_CA>^(M5OOB@?AQH_Q0_:-\.^,+_Q?XW\&:G\+=4\$:#XLU?PY\+/
M"_PT\ Z8L/BSP[XL\,^(--C>]UN^TNSMW\,6&KP7GB3Q1!KWANVT7%>('&\%
M4K4>+:JE3C1J6A0R^E9P]A5P\:<8X#E@Z#PT:%!0C:A24\+2C"AB,13-O^(7
M>'LN2E4X1PLXR=6-ZF)S.JW[18BGB)3E/,G*?UCZS.OB'.3=>O[/%U7/$8?#
MU8]JO["GP@N/'+_$*UU"V2*?XWR_&RST:T\+^"&\.VMS+^SQ)^SE#X*T[R].
M*#PK:Z.P\3VEM"3(GB6*-$46ZA*]N_9X^"D_[/OP_P! ^&<'Q%\1^/O"?@_P
MUX&\)>"K'Q%H_AO3&\+Z+X+\):9X;EMK:XT#3[*XU(^(KZPF\1:C+J\M[+:7
MU]-9:=)!ID-O;1_G+!\"OVU3H/PU\*W5AXQ75?#>K?!+6O#=SH_Q$^&>D? W
MP;%X0^(5UXJ\=CXJ> [6:'5?&?B$ZS!I7B/3Y/#&F:BNIZ"NF:5I&JZ#=Z3X
MBT_7Z_AOX<_\%&H/"XC\=:U\9=;T]K:_CN_#?@?XF?#/PI\2_P#A:Y\ +9Z?
MXWT_QOK_ (^\4:?-\$9/';7DUYX/?5-%B@N3H^O6?PW_ .$3BU+PO)X^/SC.
MLSP:P&/XAAC<)&5'DH8KV%5P>&4:5"I0J2IRJTZBI05.52%:A4J0]I2JSJ4Y
MRE7]_+^&^'LIQSS'+<AC@,:U74Z^$=>BJD<5*5;$4ZU*G6C0JTY5INK&E5H5
MJ=*I[.K1ITJD(>R^J='_ &"O!NC^*]+\9K\5/BGJVLOXRTGQ[XTC\17^FZQH
MGC7Q'H7Q]T_]HO2+E-"N;9=-\(IIOCB/7K.S7PY%$T.B>)KZV4B:TL9H?1[W
M]ERR@\,>"=,\'?$#7/"?BSX;_&SXF_'#P1XP'A[P]K\.FZ[\6]<^(U]XPT/4
M/"FHPQZ+JFC2Z-\4O$^AZ;<*UEK&G2IIVM0:@+V*ZCO/'/V<_"W[9.A^+O&P
M^+6I^)K]=1^"WARWT7Q+XX\8^%]<\%:;\6[;PCX-L4M-)\(^$]2OYM3TV#Q%
M!XMU/7O$0T?P'J+EKFQU1/'QU30M>T?ROX<_"+]L_P 0^)O#VD^/O%'[17@K
MP!=V'P<C^)VI:K\<_A_>^(-2\::3I7Q[?XTZQ\/=0\&7=]K'ASP#XA\2:G\'
MI-'T^S_L2ZFTJSM8]#\/^%+33=6LJ\:7MG*?/F%"2HQA)2]V49IPJ-QC%*//
M:+E3Y&GS<R@U"/*SWU[-1CRX6HG-R36L7%J4-7)M\MVE+F35K.2<G='I_AS_
M ()Z:!X/T#PIX=T3XT^-+>Q\+VO@Z.%]0\+^!)YM4U?P]\/_ (L_";5]1N$@
MT^PL[<>*?AU\8/$.DOI&FVMK9:-KNGZ5XBT1+;R[G2I];Q5^P/X/\2"WT:U^
M)WBC1/ .HV/[/UI\0_!MAX>\(7<GC.\_9K;2(/ UQ8^)KJP?6? ,=]H^DPZ5
MXAT_PNT&T[=2\/SZ!?W.KRZOX4_PC_;.\4>,O@!/\4;?XA^)[CP9\5?V;?&6
MKZWI7Q,^'&F_"C1_ _@3PTD?Q,C\;>";>[LM;\3_ !8N?B"NJ>(I-8T#2]1L
M=9TS5?#RZ+JFEZ?H6L^'+GL/'7PN_:VTGQ;X]NOAQ%XYM=-\3_$?XG^+_A[)
MX(^(W@GP[H>C>/-=USP8_A/QM\;=,\0W?VSQ5\)SX:T[4K:Z\':-#K%] ]IK
MMI>^$+O5?$'A?6=#T<J_/'_A2H.;4YN7[OD4G5Y;\UDW*W[V,G&,HVDXQO&/
MM)2I\K_V2HHIQCRWGS64+[=%]AJ[3NE)V;Y?2=2_8=_MOP'H7@/5_CAXKN;;
MPIH>K?#_ ,-:C;?#_P"'.F7%C\)=3^$'BGX+'P7J"Z?I%O+K>KQ>&?%,VH+X
MOO[TRV^M6%LVDZ)I6EW.I:9>Q>._^"?W@#QMKWC+Q7!X]\8:3XAU'QMX-^(/
M@<Q165SHWPJ\2Z%:ZHWBA=%TS3Y]&U"[T?XJZYKFI^+_ !MIEQK=A/-XDELM
M2TB_L386PKQ^"R_:U\7>+O&=M9^+_B=XN^$WP>^/>M?"?4K#X:^-_#OA#XD_
M%/P.UGXB^(?_  EFG^)/$]QX<L[?5?AMXJ\7_"[X1^)+:'7M,O==\/?#7Q]+
M9ZC?2:O<Z/J/C'A7]FK]LFVT7P-\0/BCXR^(W@KXB:5;^(-5\??$#2?B_P"&
MYYM"UP_LN^%?"VD?$3XCZ9H.IV/AOXBZ!X2\>^"CIWBK3--TR[EU&QN);[1?
M#L^E7]S-;U%5XW<LSH4Y7NHQC%MNI:K9P48OWKQ<THMQ=5P]YSJ4VG[-Z+"5
M)+JY2=K1]RZDVUI9\K<M5!2]U1C)??TW[&'P[;X?^ ?AS:ZUJ]EH?P_^ WQP
M^ MB8],T&5M1TGX]Z;X7L/%_B6[M9+/[';ZK;3^&FO['3[2*/2I'U:]M+R&>
MV2$#F/'/[!7PZ^(&I?%"?6_&7BR'1?C!X#L_ACXV\/Z?8>'[:&?P2- ^#?AC
M6=/TC4OL;7NB:GK6B_!K2;:/7K+&IZ!+K-_>Z%+9WVGZ+<V,'@+2_P!H7XN?
M"']G+QOXF\1>-O FN?$KXOZ=\;/B]X;\,>*[+2+KP!\)-;\!>,=4\+?""QU"
MXL$O[KPWI^L+\,K+Q38:;#'KVI:A=>(KQ;BQMYKI[;YJ\*_"[_@IE=:-K\/B
M#XE>(M(\3:Q=Z1X-U^^&O^$!H,5UX_;QKX5^(OQM^%\<_BSQ8]EI?PHTO5_!
MOQ$^'W@Z;1_!%I?7_AI=%M/ L>KOK#:IE#VZE-O,J-*<*DHR4Y._.J[YI1ER
M24OWD)5%**?PPDM)TV7+V34?]DJ3C**:LNGLU9-737N.,;/O)/6,D?8?C_\
M9(A\?:/X3TN?XK>(])N++X,W/[//Q$U2U\(>"+J3XD_"/5)-+FUK2DT^]TV;
M2_ 7B6^ETI##XD\*6D<%FMY<,FAR36/A^71.GU7]FG39?AUJW@O1O'FN^']6
M/QXU_P#:,\+^-7T[1M3N/"?CO5_B7J/Q-M[631M01-,UWPUI]WJ=YH%Q9ZE)
M!>7^BSR2MJ5IJHAU"'XNU_P-_P %"=1TR+4-3O?BC+XQU:V\,3>%K+X:_%OX
M:>'?!_PZU_1?B19Z-XUD^)EOK%W#+XP\/^-?A-X?T/Q7H5KHX\2'3==UWQ]H
ML6G>&_$.J:7K%OSWQK^ G[:OBCX0ZSX'FU?XP_$6Z\=_"KXO6)TO0_C'X!\.
M+H7QC\7>--4_L>+XDWNMW>DVNL_!>+X8/I&B>%O#OAO^UQH=[!XB75]-F\0Z
M_I?B32G&G-NE&69851]HGIRR46I2;D[\L91C[6HDIN$6G.$4X6YDYQ2G)82L
MWR-:\R;NDE'JTY<D&^52:?+)M2O;W^Y_X)Y^%-8MK#2O$GQ<\<:GI-UX'^(W
M@OX@-8:!X1\,:[\1H_B-J7Q3U:\N=<UW0;"UC&FZ+??%SQ!>:+H-YIFJVNCW
M.FZ6^@W>AVU[XKM?$GH7P,_8V\$?"?Q'??$";Q3)\1]?\5>$?%OA?Q-?:CH6
MC1Z)XHT?QC_PK>W65X#<ZW=RPVWAWX9Z#HK17&LZC9ZK:7=YYBPZ?#I6FV'D
MEC\+_P!J+Q+\)_VY_ASXZE^(%[<_$7P!\2?#_P %-;UWXC^%[:_O]=\3Z1\1
M[#2=,\)0>%]6O;#P-HNGV6H>!],LO$L=WX)L[Z 1+J'@'0]?T7Q'XD\2<K_P
MJ?\ ;,T"Z\2>$O 6K?$/1-/TGP3X\\)>#]<7XB>!'^%\/PT@^"/_  C?P2\,
M^"_"EW-<:_HOQW\+_%&+1=4\1>.]9TBRT2>/2?$>H7^NZUX?U_0/#6FIRK5(
MU*<LQHI7BFO=C"<)0IU')2@E+W9U.245=ITTDDHI4A*G%PFL)4;LVGJY1E&4
MXI-2NM8PYD]GSO75N?4_M5?LE>+?$-E%I/[,?A3PCX%L_&?P@^(_P*\9VVCI
MX \.>%M-\.>/-5TO6(+^\\(ZUX0U&TBL8M4BO]3UO7_!;-XNG\FUTW_A'-7F
METG7?"O2>!/^">GPT\">/],\;VGC+Q+J4/A3QU-XY\"Z+J.GVEZ?#=QK/Q$D
M^*?BS2)M7U*ZU&ZU'3]<\8M;SV4MO;:/<:586%@LXU?6;:/6DF_:P\"_M+2^
M%?#_ (>^ FL_&'7K/1_@M\5O#^DW7@?XG^#O"'Q&D^/LN@Z/:?!OQS\2/%OC
MN[TFS\2^"+-H_$R:_:P-?0IXDU#2M6U?PEK>GPPG2G?%7P=^UKJ?C?X'3> M
M:\91Z>GPD?PW\0[NW\:>&] \#Z%\0[WPYK5IJ7C3Q%$FIR:_XDU>VU.;2'M=
M/7PAXLTN^^SP77A[6? VJV>H7^MD*M=T*=...HTXS593YF_:-0C)Q]M*4IRO
M*+E3ALTIN%ZG-HY0I*I.3PU23BZ=K)<B<FK^S2459-*4MT^52M"QSM__ ,$V
MOAE?^(8=7'CSQ4NGW=H8_$FC3:7IMQ;ZO?Z3XG^(_BSP1J6F@W$6FZ!)X2U/
MXE:@##'H^H-J4>CZ1-:7.AWTVKWFH=_JO[%.BW6M^'Y=+^)_B30O"%I<_L\Z
MKXL\&6_A'P/?+XNUS]FB?1!X!O[;Q'?:5)K/@ZSO].T*TT[Q!I7A]@F4^V:!
M<Z'+=ZRNL?,WBG6OVP-0\5_"W3/&WAC]H#PIHGBS5/#?AN^\!_#KXM_"G3OB
M#XMF\#?LY?$V^^).L:+XHL?$@T'1]/O_ (I#PIK%NU]XL\*ZSXDMM)MM5@%K
M!+=^&[OG9OAC_P %1K^75+/6?B-KUMK=]X.T_3V\2^#?$?@VQ\-Q:/<> O"V
MGSZ1IR:AXI2PL/B_IOCX>(]=O_&EI\+(;*^DMYKBV\1S^%=4L?"5IKRXJ2BZ
MF9X:/N/EYY1DK.7(^5QC)2E&SO)*\;0Y92E?V<7HJZCA*S]Y7Y5).]N97NTX
MI]GI+WKI)KG]4/\ P2[^%6MQ#2?$_P 4?&7BKPV?#.B>%/$&EBPT*PU&ZO?
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M/%.FI$MOJ<_V"[MD$4@GCD$4PC^5)8)$1U8.H#,APR,2.1@T =:7 / S^/\
M^NO&_CW\:M'^ 7PRU/XDZUHFK>(H[?7O!GA/2M#T6.=[O5/$OQ \7:-X(\,6
ML\]O9:C+IVEG7-=LGU?5$T_4'L-.2XG@T^_N1!93^@?\)3X>_P"@M;?E-_\
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MZK:#\)Q_[3J5/$>A."RZC;;1U8B=5Y]V0 _AFN8V-_S&]A]&4?RI-Q],_P#
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M"0_]C'HW_I!95]@&Y!!'V2R&01D1W (R,9&;HC(ZC((SU!'%?'^J\?M!P?\
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MZZ.VG]G8W_GQ+_P*'_R9^_O_  BNDCYRD4DG.)+B,NHYZK$"%.?]K/3I3O\
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MDL,,-K'Y2+08'_$PTT\#GS;GGW_X]>].S[?BO\P*U%6OL@_Y_P#3?^_MS_\
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MGP[SSQQ]:_V(_AQYW_"P-+"F.7_2-1/.#_RZ7? /KCL.E?3Y/_R*<W_P5/\
MU$F?(9Y_R.\D_P =/_U-IGUCYEK)T4QGGMWX/\/H:<(R1F*4$'G'3Z'@YR/>
MD9H_^6ML4_VEX .>H.,Y[]?0<TW9 W,<VWMANIY^H[^A/K7S!]>08N/?\V_Q
MHI/L[_\ /5?S-% %]KFR&1'9%NH!EGDY'N% Z_4]_:F_;P!B.SM(^^?*,A_
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MZF+2Q@T.:SNXM8ENIHDTR6UN8[UH'@E"X0^E5FE.G4HP\/N!(TJM>.)J4O\
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MF\<?LVDGGJ?C[X$)Z\#IC )%?T$7LI_M.ZA4_*D=L<CNS0KG(('(Z9K^?/\
MX.D$)_X(B?M5.> /&W[-A4G^)A\?O 08#Z!P?SH _P F6OHS]F6XFL_'[WMN
MEI)<65I97T$>H6J7UA)-9ZWI=S$E_82@Q7UB[Q*MW92@Q7=N9+>0;)&KYS'X
M^^/2OH?]FW/_  F]X<D :5&>-K':NJ:>Q&&RO*@J001SRI'!<5>45T<HI^CE
M%/;79O;7MJ!^S/ARY_:(UK1/ 'B;1/V</A+XGT7XL>(?&US\-M0?]G_P%=Q^
M*M6\":=8W?Q"AT6,ZK:RC3]+TVRBN->6Z6*SDSJ30SFZFO,^3^(OV;_VD-4U
MG6-<U+X _$[2)=5UFYN;FVTGX87>A^';"]U6\FD33](LH&73=+TR.=FM-,L;
M:3[+:PI#:1.<1AM'2/"6I^)/!_PBDD\??#+1?#/B2^^(\&@:/XO^)'BK0M)^
M%EWI%C/JNNOKUM]LO(O#7_"PH+)%\.S:982?\)E<K):RA)(&21NI_#*_T^S>
M2/XC?LX:VL$MK#;Z?H/[1$NIWUTDLWE0S:?IS:C!,8;8 7$@D2VFM;<&9H$*
M,J^OF"R:=:D\JG7H8=8/!QKPS"I+$U99A##QCF%6C4PV&P\(8.MB5.K@Z%2G
M*O0H2C1K5JTH>TERX2.-C3J+'5,+5JO$XETI82C6H4XX25:3P=.I"O5K2EB:
M>'<88FK"<:5:JG4I4Z49<B\3\9> /%OPZU:#0?B!X9\5>"M<NM+L=;M]'\3Z
M#)I&I3:/J8D;3M32SNYXY_L=\L4IMIF11((WP/E-<GLM?^?BY_\  6'_ .2J
M].\=:?:^$]0LK;4+KX9>-9KVVN)EO_!7Q!U/QO:VL5I=-:I!?7\5\ILY9QBZ
MLK23YC:.)"D3F2).)_MO1_\ H5M&_P# W6/_ )85P<E'KB:'_@K%_P#R)U?U
MM_P2"VT>6[AAN(FG6VN+M+&.YEBMEC%U(SI&K1)>-=&,O&Z/*D#(F"6/W0WQ
M?JIS^T% ?7Q%HQ_.PLJ^]]/NK&XL[2:WLM&LGFU-+2"S@O=;DN[:>4R11ZG%
M#<74VFN\+KY@CE1Y'!1BA5RR_G9XYUC_ (1_XQWNM^1]J_LO5=)O#;ES'YRP
MZ?8L\8D 8HS+D*^U@K8)5AP7B*5.G"C*#4G.-Y37,E)J,6K1GK%/F;2=I):2
M6J _5/X._"CPK\0K74KCQ%XY\,^#GLX_-MI/$]SK%M9WK+=QVS6%FVBZ;J4I
MU!(Y1?2+=K!"UH"87:1"K>CS_L]>"HM2:PB\?_#NZAWR+%JD?BG6X["5%MK>
MZ21C-HR3PB07(M]KQ';>0W-ON80F0_F%;?M*:/9[C::7XEM#)@R"VO;6(.1P
M-WESH'P"0"RY /&*M_\ #45I_P ^WB[_ ,&</_R37)9=E]R_R _3V3]G+P+%
M ]Q_PL_X7S!$#>1;^*/%$EV[-.T"QQ0/X:B#.VPS-NEC2*W:.261=X4>7R?#
MSPW'(\;6<^Y#AC'J4LT9. <I+%(T<@P0-R,PR",Y! ^$O^&HK3_GV\7?^#.'
M_P"2J/\ AJ*T_P"?;Q=_X,X?_DJF!]U?\*_\-?\ /G=?^!MS_P#%4?\ "O\
MPU_SYW7_ (&W/_Q5?"O_  U%:?\ /MXN_P#!G#_\E4?\-16G_/MXN_\ !G#_
M /)5 'W5_P *_P##7_/G=?\ @;<__%4?\*_\-?\ /G=?^!MS_P#%5\*_\-16
MG_/MXN_\&</_ ,E4?\-16G_/MXN_\&</_P E4 ?=7_"O_#7_ #YW7_@;<_\
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MTG[+7P^2YU8SC2;9V^)J7.K&T=H[L:7 UN)M2-I(CQW8LDG-LZ.D_ELK /\
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MF!*\EL88*Q4YPP5B"0"0J_#GP*ZLR>$-'=4 +LMBS*@/0N5)" X."Q (!(.
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M&EPEX6TXSG3J34.#\1'FG2452DVN).9\BC&,5S\JC&,'"4(J"%F=9;4L,O\
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MO/\ =/57O9OVFU[.WDNBL?RI7W[!'_!5/4;OPM>7?P<^&[R^#?$-EXDT(?\
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MKUR.>V,GIQUJ&&**WC6*)5"HH" >W!]ATX]N_.:<23U^E #RYSQC'TI ['@
M$^@!_P :: 3T^OX#J:=PHX/S<Y/U' 4=P>A/IGH.: '[MHSD;@>G/'L1W/OT
M'UIF\\].>?\ /-,R3U.:D51U;Z@>N/7T'Y$YXP.: ' \!G P3P!P6QWSG@#C
MGOT]Z:9"2<8_+'X=>W2FLVX^W8>@^G0?0?\ UZ55 &YN1V'KCN<=%'?UZ"@"
M0,57<< D?*/Z\GOZ>ASZ9CWMZ#]?\:1B2>N?_K]<>W8>@IRC:-Y'^[['^\1Q
MP.GN>QH Y_4+D0WM[;1#]Y,EI)<N<YVK"HCB'MSN?&.<#GFOY\?^#HD$_P#!
M$']JR1UP&\;?LVI"><,Z?'_P 7'X(^?;Z\5^_P#?(SZY>(@+/)'9JHZDNT**
M!^)Q^I/%?@1_P=-M''_P1(_:AL8B"EGXU_9N5V'1[A_CWX%,[@Y.1N 0=1A1
MSF@#_)AKZ"_9SS_PF=_AE5AI*!'?!12=4T\ L"Z*5!QE3)&",CS(\[U^?ACG
M/IQ]:^A_V;;3^T/'%QIXN;*T-_I]K8?;-4N5L]+LS>ZSIEK]JU.]<%+/3+4R
MB>_NW!2UM$FG8$1D4T[-.U[-.UVMFGNM5MNMMP/VI;7?B!?Z?!9+\?OAO=V,
M&B6P6TO9GL)[:PTZRNI3I,D=_P##7[0]Q9>;<67V2*\O?[2GDB,%QJ*-!./%
M/&FM^*/ NNMXFL_'/A?Q)JFM">RO+GPXT%_:JT#I]H$ZW>B:7"TEPT-O,DL>
MEW%G>Q(EQ#-!<12B62;]G?5[6YMH)OC'^R@+6YNOLUOJ4'QVT"\LU.;C;<7,
M5GY^H:=9L+9F6XO;&!%6:UR UQ$I\,\0:?)X>U[5]!N9O#.KW.BW]QILNJ^&
M]3C\0>']0>!L-=:'KME<M9ZMILWWK>]M6,,P!(P5('4\3&TE&$(\T7&\:5*&
M^W,X0O)+=Q=XR:U5K6#K=;^+OC?Q!JFAZQJ-]:O?^'61]*N(-/T^RDA>*X-Y
M&SG3[2S2:2.])O%FG2:9K@DR2/ 6MVWO$_[0?Q3\8:->:#X@\0C4=-O[^UU6
MZ@FT[1HS+JEG]H^S:@\]EI=E=M<PF[N'.;D0W#R;KV*Y"1JGCWVD?\^MI_WQ
M-_\ 'Z/M(_Y];3_OB;_X_6'M:FGOKW?A]R/N]?=_=KEUU]VVK;W; J@   =
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M&OF']K;X\^,OV;OA=9?$SPI\//#WQ%MQXW\#^#-:TC6_'%YX'FLF^(?BO1?
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M4_94L+.MC<TQ,\PP>#JT*&&>!I1P%.K'ZO1Q53%\-X__ ."G?A+P5X^_:O\
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MMIO%D?A[Q)H_B;5_ E[J6CZP^CW<>H:QX<:PNS=/'C67AS]CJ+4;:ZT;P_\
M!RZC-G\5EO?%?A^3PY>>&?#L-GXX\._&3XJ6OBGQ-IVI-I?AV>Z^(+Z#X^U:
M'4YH9)-9M$OI3;V\ 1YA'"J,54PN+E-0BY.,G&+E=W>L'[LK-1<6M^5*4XMR
M<G6;?+6H*+DTKI-VLK?:6JO=IKS=HM6I^+OVKFTGX:Z-X\\.?#+Q9J.O-^TA
MX+_9R\5_##6'T&T\9Z'XGU_QQI_A#6[?3[O3_$%WX-U6]LK?4['6]$U%?%0\
M+W^FWD-W>:M:1I<I#9\-_MD?"WQ'9>,+B32O&V@7OPZ\1?#CP?\ $+1]<TO2
MEO\ P=XK^(_Q8\5?!BWT/4I=+UK4]-O&\+^,_!VLOXBU/1K[4=)DT)K#5?#]
M[K2WBP(_7-7_ &-?B!)%\*=;USX.^(;;XD^)K3XL66G1^)M*_L;Q?\0[+Q-H
M=CI_B+1?$FG:U;V]Y\2+/Q,GAV;3[71-3'B.TO%TF^M;>*0VTC<]X)\&?L%>
M,[_X?WW@:+X'ZUK'A3Q)K'A;P'!I_BNW&L3^,OA7X[U77]6LQHMQKL=_XV\3
M^"?B-_;GB<:AKUCX@U:P\0ZEJGB.TO"^MW%[>/DPRIMSPN,@U*4E*,9V4)-.
M*DY1LXWA5@I-1E&W-*4N240YJO,N6O0:LERMQUDK\S23NFU*$FDVGLDN92.=
M\3_MT:+X;C^"VL7?PC^)VE>&/CAXRTWPK\/9_$&FZ%%K?Q.7QEX#\5^*_AFW
MPRL]'\3:IISZQXNU3P_8V%]H/C[4/!^H>%M'U:+7/$4.F6P\Q*&H_P#!0?P#
M=^(H_"OP[^&_C_XB:Q+\4M%^&MHUA=^"])TS5P?B]IGP7\;:WIM]J/B93IX\
M'^+=31;+2_&%OX6NO&MC%+JGAAKO28+R_M/H"W_90_9IM-/OM*C^#'@F33K^
M]-^]I=VE[J$5E.MEJ6GVJ:(+^^N3X<LM*M-9U:/0=,\/MI>F^'I-0NKK0K33
MKMQ.NE<_LW_ F[O_ !+J5Q\,?#\MYXNU*SUG7)3/K*I)K%EXFM/&D>K:5;QZ
MJMMX9U2X\8V%EXLU+4/"\.C7>K^)+:/6=5FO+[=,Q[3+=/\ 9\0VE+_EY92O
M-N+DE+FO&#2=I)2E%VY5*/*<F+_Y^TU>WV;M6CK9M6UDKK1V3UNTW+RKXC_M
M7Q_#'XE>-_"6L>$[S5?#_@;0M2U^9?"NG:GK_C;Q);6/@;PAXJEBTC3UN++2
M;*2RO/%<4-[)J$ALTT:"?5;BZTZ+3[V>F>!?VO\ 3_'.I?%^6U^%7C:U\'?"
M?X(> _C8?$UMK/@7Q#=>*+3Q?'\2)=0\(Z1I'AWQ/J<,^NZ1%\-M4?3KVPU7
M4=!\1!V%KJELQT\:C[WXF^#?PK\97VKZGXG\!Z!K.JZ]93Z=JVJSP7$.JW5I
M<Z?IFERJNHV=S;7EK,+#1='MX+RRFMKRT_LNQFM+B">VCE#?!'P6^$_PTNEO
MO G@+0/"][_PBEIX'GN=+2Z6:]\+6.L:SXBM=*U9KBZG_MHQZ]XD\1:PVI:O
M]NU>34-?UJ>6_D;5+T3Y^TP7LK.A4]KRQ7-SV@Y+V;G*RE=.5JB3:DDII\ON
MQ17+B.?^)%0O)VY;RL^;E6JM97BWJK\MKZMGS/>_MU_#;5[Q]+^&^FZUXJU2
MP\>7'AF^2\TV*VTW5-"L+OPI80>(?#^HQZS"@TGQUJ7C'3](^'GB34471M0O
MM'\52:C;PVVAR&6C\"OVW;OXMZSX8T_Q5\$/'/P\T_QQ%\&[?P_KKZEX3\2:
M/HOB7XO_  4MOC%IGA3Q;=Z9XD?4?M<EFNH6VFZQH.A7^BQ6DF@+XBN=$UC5
MI=-LOHWPW^SQ\"?!RZ8GA;X2>!- 31M \!^%M*33=#@MUL?#GPOU36M;^'>B
MP $C^SO!VK^(]=U'1+9]Z6]UJMY(XE#J%TO"/P,^#_@73]+TSP?\.O#7A_3]
M$U;0]=TBWLK>Y<:?K/A?19O#?AJ_M)+NZN9HY?#_ (=N)=!T=1(;?3-&*:=:
M0Q6L,$4=2J8#DG&&'K<STA.=1<RNGJ^1J.DE%I.+5G*-[)-I0Q7-%RJT[?:C
M&'NO5:>\F]KJ]T[I2M>Z7JJKGD\#G'N0/Y#N>W3J12,Q8Y]. ,8P/3Z#H/SZ
MDT,V3[ <#' ]AWQZ^IY/:A5W<GA1U/\ 0>__ .L\5PG2*B[CD]!^I]![D9/L
M 3BAV)..F !@'@#'0=.*<S!>!VX"]0.1R>AR1W_I347<>X4#+'&<#_$G@#K[
M&@#"F"VNI7]ZVTSR16T=BIQ\I%N%FN3UYCR(XL]78D9QD?SS?\'1>YO^")/[
M5)&2!XV_9L9B>3C_ (7YX%&2?]Y@,]R:_H)U)RVM7H)^40VFU>RCR5X'YDGU
M))K\ O\ @Z-C-O\ \$/?VHW/#WOC;]G %#U%O'\?_ 312?\ ;21'Q_LC.>H
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M .RQIUK\:[/X?>!+GQ#;Z!'>_L/>-? 6I7^DZK:6WB71Y=<_:<U.34W6QCU
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MF7_RD3_8<_[.L^!'_JR?#M?[!?PW8K\0-+92587&H$,#@C_1+KH1R*^HR?\
MY%&;_P""K_ZB3/D,\_Y'>2?XZ?\ ZFTSZ[F62%FBE0HX."#T/NI[Y[=?SJO6
MD+X2H([M!+C@28&\8'&3C)/J0<G)SUJ(P6\G,,I7D#;)G()]R<G/./YU\N?7
MF515O[&_]]/SHH Z9K?5+E-UW,MG #_RU81 +W"PQD#/H&(],#-)%!IZG;%%
M-J<JD?,V8K=6 /).54@8[[L^YZV)8[&U)>^N9+R<#.R1MRAL\[8A\HR>#NXQ
MG(JA/K9 V6L21+T4D D#MM ^5>.#U//3G% %RZ^V2VLZ96&(QN/(M0D$8RO
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M) ;WX9Z.-;\8RZ;XIL+2P\07&LZ9974FD7WAN_\ $FOW-U0\2_\ !/G0-2\
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M6:LTTTG=-,#[P/QV\%LP9O%NL,P#@,T>NE@KXWKN*%MKX7>N<.54MDC-0/\
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MJ:_(S4OAY_P4$\$^!UT+Q'XKN?&Y\/>&[/XA^+?C-X;^*5TVK37'A/\ 8O\
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M#C2;CX?:'K6D6+Z+>^%M1L/"FG:WJ/[&NQD8GNQ/   R2>B@ #KP , <#B@
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MA?#;PKX;^&7Q"2U76/VF]-\7:;\9O!KPZJW@][+0VF\1>"-!\9-XWG^M;O\
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M _Q#N;2_\1'7]*_;+CNO 6BZOJOB76?!=G<:C+X2.GW[Z=IOB:/]?<GU--+
M9Y&?3WH _"_3?BQ_P5'O]:O?#GAG3/B!9:(-&\.V.@>)?B#\!HIM8;X?WOAS
MX5V6E_$W4+6X^&_A?0HOCI_PE^I^-KGQWX"UCQK<VUEI%EK\%Q\,?#D&CZ'X
MJU+ZC^$Y_:U@_:]\"VWQ6\5?&+5O@]H?AW]K7X=1ZJO@/PIIG@+Q_>:/X_\
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M#3-2GL[>74-.@U)8%U*#3[V2-KFRAU%;2T74(K:6)+U;6V6Y6001!)W)X!]
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MR1I<P/L<O'/:WEJZ75A?VLUQ97ULZSVT\D3([?DMJO\ R%-2_P"O^\_]*)*
M*%%%% !12\8SGG/3V]?\_P!:2@#[A_X)F?\ *1']AW_LZOX$_P#JR/#M?[ ?
MPY_Y'_3/^OC4/_22[K_'\_X)F?\ *1']AW_LZOX$_P#JR/#M?[ ?PY_Y'_3/
M^OC4/_22[KZC)_\ D49O_@J_^H<SY#//^1WDG^.G_P"IM,^M**G@MI;@X08
MZL>@_P ?PZ=^E;"6MK:1^9,P+@@Y?!.><!% /IP>H[GH:^7/KSFMC_W6_P"^
M3_A16U_:-K_=D_[Y:B@##/))]:XCQ_X/N_&6B6T&BZJOA_Q?X=UK3?%W@3Q)
M);M=PZ%XOT3SQI]QJ%G&\4M]H.J65WJ/AWQ1IT4L4NH>&M:U:U@EBNI+>:+T
M 6KD?,0I[C!R/SV\58C5(-QXR.Y().1@\<>OI]*VP]>KA:]+$T)*%6C-5*<G
M&,XW7,G&<)IPJ4YPG4IU:<TX5:56K2FG"I)&&)PU'&8>MA<1%SHUZ<J=2*E*
M$K/E:E"I!J=*K3G"E5HU:<HU*-:C1JTY*=*+.+\,?'[PI-+#X9^)S6GP?^)$
M:&.[\)^,M4MM/TS6)H\+)J/P]\77WV'0O'OAZZ;=/8W>D7 U>VMB(?$.B:%J
M<5SI\'2^)?CS\(_"T4"7?CK0]8UB]_=Z/X4\(W<?C+QIX@N3D):Z!X2\,MJF
MO:K,\FV-I+:Q:UMRZR7EQ;0!I5K^(K33]<TFZTW5]-T[5]+D1GDTW5["TU2P
MED4$+))97\-Q;.RC@,\1(R<$<UM>&O"GA3PK;*/"WA;PSX8%U;0?:?\ A'/#
M^D:%]H#1(S+/_95G:><I;YMDFY<X..!7H.MDLY.M/!9A2FWS2PF&QF%^I.6K
M<:>(Q&'JYA0H-[4W'%5J4&X4\14Y:=0\Q4,_IQ5"&8996@ERQQV*P.,^OJ&B
MC.KAL+B:.68C$*.]12P=&K-*I4PU-2J4C@O FA>*M;\3ZU\6_B'IIT'Q%K.D
M)X7\&>!VN[>^E^'?@%;R/5)[+6+NQFN--N_'/B_5H+/5O&4NEW%UI>FPZ5X<
M\,:?>ZDNA76L:MTGB[X<^"_'FH>#-2\8:#:Z]<?#_7=4\2^%X-0W3Z=:ZOK/
MA+Q!X&U&>_TN3=8:Q!-X:\4ZW9+9ZI;W5K#/<PZA%$E[9VL\7=N<#K[=.O\
MA42C) _/Z5Q8O%3QE9UIPITHQA3HT:%%2C1P^'HQY*.'HJ4I3Y*<7*\JDYU:
MM2I6KUISK5ZDCOP.#IX'#JC"=2M.52K7Q&(KN,J^*Q5>:J8C$UG",(<]6:BE
M"G"%&C2I4,/0A"AAZ42M<Z5I6H)&FHZ5I6H)'>6VI1I?Z98WD<>H6<?DV=^B
M7-O*JWUI!B"UNP!<6\ $,,B1 ()!I^G1R7$\>FZ:D]W$(KJ=+"S2:ZA2V2S2
M&YE6$27$*V<45FL,S/&+2**V"B"-(UN<=/R%1N>@_P ^U<QUF=9Z7I-C:6^G
MV>DZ39Z=:VG]GVNGVFF6-M8VNG[@YL+:S@MTMH+%G =[.*);9W =XBP#"[):
M6<HD$ME93+,7:436EM*)GEMS9RO,)(F$LDMFS64CR;GDLV:T=FMV,9*<O4?G
M^73_ #[X[T 06.FZ=ID,5OING:=IL$-K:V,,.G6%I80Q65BCQV-G'%:0PHEI
M91R2)9VRJ(+59)1!'&)'#7:3N!['],?XTA8 X.: '4PN.W/Z5&22<FDH =O;
MU_0?X4G)/J33@F1DG'^%2  =!0 B1CJ_ ^O7V]?R]/RD8YX &T?KU_S^)S3:
M* #I4+'))'3M0S$].!_/ZT@!)P!DT .C7>P';J?I4S')Z<#@?K^/_P"OZTN-
MB[1U(RQ_IQ_G%-H 0G S_7'ZU"3DD^_UI6.3[#./\YIT:;CD_=')_P /\_K0
M!(HV)G!W/Q]%_'C^O-1L>#@#'?L<_H?3M4C-G+'\,<\>U5_I0 5.@VI[L<]N
M@Z>_7_/K&B[V _$_3O4QP3QT P/H* *[=3]34R+A">[< ]\#].N/K4)Y8_4_
MSJPW&0/X1@?@/\>M $#G+'VX_P _C4J_*@'=OF/T'3MTYZ<]B/6H@-S >IY_
M$\U*Y SQQT [8 P/PP* (>_'//%/<;0J?\"8>Y_ =!1&!DL1PHS[$] /UIK$
MD_,!G.<]_7\N: $))ZTJJ6Z#ZGH!]3TIR)GYCPH_-CZ#^I[>GI*3V   Z <?
MB?7_ ": &J% [L><XX7IQSP3CM@CD]B.%R3WP#U P/S(Y[^M'H .I]N]'RC&
MY@3WV] 1R1D\>Q]\\]* "@9(R.!QRW ]\=R<>F1FFF0 G:O/<DYY]1G(_2D_
M>/Z_7IV]3CZ_C[T .!4$A<DGJW<]21[#VQGIFFE2S  =N3P/Q8\ #BE$:C&X
MYXZ+_5N@_K3RW& -H]B23GKDGG_ZV* $(4  $[5Y)QC<PZGZ<<#&<4Q1@-(>
MO.T<\MW.,'(7G/OWX-.QN&2<+P2>_P!![G/X>X-#DX.!@ $ =@/\<?KZ\4 1
MJ"[@?GCT&2?_ -=2!MYP#R20HYX X'8]!CKG\>E(!L3/\3=NZIGK_P "/'TH
MC& 7]]J_4]3U]./\: .9U&9GU6Y@S^Y@BMS&.VYXE9WQZDXY],#CI7\]O_!T
M9S_P1(_:H/KXX_9L_P#5]^!Z_H(OVQK%\/6&T_(P+^M?S\?\'1*,_P#P1&_:
MK91E8O&W[-;.?13\?? L8^IWNH([ Y- '^3A0,9YSCVZTO7Z]\G_ #_6DH *
M*** "BBB@ KJO!&H6>D^+_#FI:A-Y%E9ZK:3W4VUW$4*R#?(RH"Y5 =S;%9M
MH) )&*Y6B@#]//"G[0VG^"X[B+P_\0=,L$N<B0VNL7MC,49D=XFFT^XM9G@>
M1$E,$Q>(2J)54.,UVO\ PV+K/G"X_P"%KJ;A4\M;@^+O$)F6/R(+4()6U4R!
M1;6UM;!=V!;V\$./*B1%_(ZB@#];A^V'JZQ/;CXK*+>0PM);CQ=XA\B1K:9K
MBV,D(U7RW-O<.\\&Y3Y4SO*FV1F8X%Q^TKI-W/+<W?BKPK=7,[!YKBYO+F:>
M9@JH&EEEN&=VVJJY9B0H Z 5^6%% 'ZD?\-&Z#_T,?@[C_IO+_\ 'N?PH_X:
M-T$_\S'X._&>8?SFK\MZ* /U)_X:-T'_ *&/P=_W_E_GYV/U_I1_PT;H/_0Q
M^#O^_P#+_(S9_2ORVHH _4C_ (:.T'_H8_!__?\ F_\ CU'_  T=H(_YF/P?
M_P!_YO\ X]7Y;T4 ?J3_ ,-&Z#_T,?@[G_IO-_\ 'L?UJS8_M-Z;I=]8ZIIW
MBSPI9:CIMY:ZAI][;W,J7%G?64Z7-G=P,96VS6UQ%'-$Q4A9$5L'&*_*VB@#
M],O&'Q^T?QG?OK7B?Q]IFJ7GFR7MQ,^H7-[>7,[ >9++).US=7,QC4101AMD
M2 0PQHF /S7OIDN+V\GCSY<]U<31Y&#LDF=UR.QVL,CL>*JT4 %%*.#R,^V?
M\*2@ HHHH ^X?^"9@)_X*)?L.@<D_M6? @ >I/Q(\.U_L)?#&SW?$#2VF'R^
M?J)V9Y/^B7>,G/ [GU''K7^/C_P3'(7_ (*+?L-,3@#]JWX#DGT ^)'AW-?[
M!OP]NGD^(&F)"& -QJ(R,[V_T2['&.@Q^/N*^HR?_D49O_@J_P#J),^0SS_D
M=Y)_CI_^IM,^P)KR.V7RX%1G'8?=4'UQU/&0.?6LB22:=B<L[<_1>>@!^4#M
MQ^M78[(8WS9)Y.T=/Q)ZGMZ#Z5'++%%\J#<<\*O3L .,X_(D8QTKY<^O,G[/
M-_<_\>7_ .*HJ;[1-_SP_P#'Q_A10!8-SGI@?F3_ "%,)).3R35:G;F'&<?E
M0 R\_P"/6X_ZY/\ RKM("/L]MS_R[6__ *)CKA[Q_P#1+C.<^4_ICH<5V<9_
M<6P_Z=;?_P!$I_@* )7/./3^N*>@P/<_I3%7)SV'ZGTJ6@ J%CDGVXJ1S@>Y
MZ5#0 5(@Y)]L?G_^JHZG P/YT ,9L,,=OZ__ %L5'3GP3QZ#_/Y8IM !4B+W
M/X?XTU021[8/ZU(6 .#F@!U(6 ."?T-1%B?IGCI3: )?,'8'^7^-,+D\=!2
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M?:E<@>3#%:"WC."TTZP+C"GLAP<X/3(!&:_!O_@Y.G>;_@CQ^TU(YW/)XQ^
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M;7^5'_"J/#/_ #\:M_X$6_\ \C5Z910!YG_PJCPS_P ]]6^OVBWS_P"DV/\
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M,_YYR:IOX-TGIY2DD9)VKGKSGCOWH ]2-_8DY-_8_P#@9;?_ !VD^W6'_/\
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M@'RKP/@GX''Z#PM5BR_9O^"AC?/[.7P@/SXY^"7@8]A_U*U'^K3_ .AA0_\
M!;_^7A_K6O\ H68G_P &Q_\ F8_R8_[1T_\ Y_K/_P "8/\ XNC^T=/_ .?Z
MS_\  F#_ .+K_6.E_9P^"JR./^&=/A#C<2/^+)^!\8)SQ_Q2W2K-I^SA\%,/
MG]G/X09XZ_!+P,Q_7PO1_JT_^AA0_P#!;_\ F@/]:U_T+,3_ .#8_P#S,?Y-
M']HZ?_S_ %G_ .!,'_Q=']HZ?_S_ %G_ .!4'_Q=?ZR-Q^SC\%?-./V<_A .
MG ^"?@8?7IX6]?7G%);_ +.OP5BE1S^SG\(& .&#?!+P,1@\'@^%L4?ZM/\
MZ&%#_P %O_YH#_6M?]"S$_\ @V/_ ,S'^3=_:6G'I?V1_P"WJ#_XY2_VCI__
M #_6?_@3!_\ %U_K9W/[-7P1FM\K^SC\'E)'!7X(^!01UP<CPKGKVS[9KF6_
M9N^#"$@_LY_"+@G_ )HGX'[$C/\ R*WM1_JT_P#H84/_  6__F@/]:U_T+,3
M_P"#8_\ S,?YMG_!+3P%XL^*_P#P4,_9%T+X?Z->>)KW0?CCX#\=>(FTN%[R
MV\.^#?!6LV_B'Q-XFUVX@#PZ7H^F:;83-)>WCPPR7,EM91-)=74$,G^H_P#"
M\";X@:+CD/<7K >WV.Z;!_J/PKS7P3\*?"/@Y;Y_ WPL\)^"9M0C2WU.7P;\
M/=$\*SZC#$WF10W\V@Z+I\MY!$^)(X+AY(D?#HH?YJ]R^%?A76(_'%AJ,MA=
MVNGV"W<DMQ<V\T"&66UE@CMHO.1/,E=I-Y"!MD:L6*_+N]"G@J6697F$)XFG
M5E6I5I.2<81NZ+I4X1BZDY.4F_-N322239YE3'U<WSC+*D,)5HQH5:,5%J=2
M7*JZK5*DY*E"$8Q4?)**;E*[2/JR]/E6K%1@[<?F0.A[#..Q]ZY;]:[/5+=C
M9NP&<*#CV!!/0]?K_C7&5\0?H)7HHHH V-RC.?3CV/:F[U^OX?XXJAO!ZL3^
M=)O7U_G_ (4 72Y[<#]?ZBFDDG)JIO7U_0_X4X2X[Y^H/_ZZ +%1N>WIUJ,R
M@\9_(&F[U]?T/^% #@,G ZG@?C5Y0(U&.W.>,D_U/_ZJAAV ;LY)[X/ P.*)
M)4SMS^AYST[?6@!68DECD\_D/\!4#')_3_/XT/(.@/J#P>>![>],# G /7Z_
MX4 2QH9&QT'&3Z9Z5>9EB0*H&<<#],GN>G'4\#-,0QQ1@Y.>_7D_X?6JCS#<
M3D<\]#QR?;&/Z\T #GMW)R?R[_I4=-WKZ_H?\* RD@9Z^Q_PH LP+G+'MP/K
MU/Y<8ILK;FXS@ #Z]\X_&I6=8D&#GC'<>HR>/:J>]?7^?^% #J4#) ]3BF;U
M]?T/^%2HZJ"W!.#U!Z?Y% $ZA8EY(R>1_GL.<'GW]:8T@SZGVZ?Y^F:@:4,>
MP^@/^']*;O7U_0_X4 2ER?;\3_CS0B%SU^I//_ZZ;'B0G#8 ZG!]^G'L:F>5
M$&Q<#\&]\CH>3ZDT 3 B,83&>F?RR3UY] <\_G4+.,G))/?O4!E!SSP>V/ZX
MIN]?7]#_ (4 /+$]3_*K<,"@>9-@*,%5;H<8)+#![=!QSUIL")@2,<CJHP<<
M=SQV[#VS44UP'( (V#G&#R>>3P"?ITH L33^8<9 0= /ES[G!_(=NW2JK-NP
M!GGCZY(Q^HJ,NI[_ $&#Q[=*MVH3!G<@H,[>"3D Y.,=L<4 3J!:Q9Z2N 2#
MU4>F/0'\R<?2@S%L^F<T^:<2,26[D8P> ,$ <=L_B<T6RK+( 2-J\L,'GKQC
M'?'//3- %R$?9X#*>))1A.G _+KZCMQW.*HLP;'7OU]ZFN+@,^ ?E7(7@^N,
MXP,9Q^6!VI+1%EF!)R$^8]?48'OD@?\ ZLT 6I!Y-G'"2 \A\R0^@P,#/3 S
M@=^/QJC%&99$C'\3 9]!W/X"GW-PLDC^@.U3S]U>G&!UZ_C5FQVQQS7)/**4
MCX/WB.21CZ#\Z &7T@:;RU^Y"!&H]UX)_/CC@XJN%"@EL'^0^G^?84FY&.[.
M223DYY.?Z58M@LLZ(>1]YLY^ZI&1^/3^E %J1A;V:H,B6X(:3GD1\?*",=?_
M (K'&:R3R>!U/ ^IJY<3K-,S _*IVIP>B@CN,\DGK^E%E&DMP2Q^2/+L.><'
M@=/7G\* +,V+2UCM^DD_SS>N,X"Y] 0!U]>.:J0J9YDC4\,>3WVCEL=>W3(Z
MTRZN1-,[;OE. HP?N@<=JMVC+;V\MT2,MF-#@Y'.TGIW)],\>AH 6^F5I!&N
M!% /+0#ID##'ZYXR><"GV2)L:[E'[N/E%/&Y@>"!SGG@#N>>W.6K>:RINY=@
M 2.Y/7I[]^*T;V9(Q';*<+$H)&",L0=O0 <C))]2?J0"&>=YW,CG'4*I/"KG
M('IGU]\]JLV]H'7SKA_*A'//!<?4]!]!D@@BH+%%GD+/_JX\,1SR>R],X[GU
MZ4MW=B=BH.(4X5<$9(X+$<\\<>G:@"X]]% "MI$HP,;V!Y/3@=3GL20<GIU%
M5B]]<')<HI/J% 'L!SCT_G4"!43SG(.2-@P<@YP,';WQU/3IBD:Y9OXR!@C
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M<\KJ".>O'0]_PK?LF58 <\L7/0\8P?3N,=N,=Z N^[^]_P"9GWTDGVECO;(
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@!D]^..WT '?V7:_\\E_[Z:BL#^W+C_GHG_?MJ* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>aud_001.jpg
<TEXT>
begin 644 aud_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #X!&(# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!U1KE(;XSR64C"*?\[?BQ_P6,_X+B_MR?LG_ !3^'GP-_P""==C\)/V7]?\
M@SXG\+^)?'FB_"OQG?:-X<^"W_"#/8^);*P\=_$>2U\(W-K%X/@OTBNUT?3K
MAHU4V22[%2'\_?\ @YO^!GQ;^ G_  6,^(?Q]\?>#[OQ3\,/C'??"/Q_\.-6
MUZU:+PIXMT_P7X&\'^&/$7@6:1&:%(;7Q!X>OH+@3+M5+R$QEPS;/UF_:,_X
M.8O'_P#P4(_9H\5?L9_\$^OV(OBE!\9/BQ\)];\)>.]4O'L/$/AKX?\ @BY\
M.O:>.[CPSH?AU9;A-+M?#MGK<MKKNIO!#HL"CRXIKF8NH,^3?^#+:13^WW^U
M T:1Q-)^Q]JDD$DD,S12;OC1\-)UMI'E"A'$J"Y86G[C-I*83EG:OC#_ (+G
M_!GQ'_P2[_X+?:I\;/AI9W>B:#XD^(/@S]LGX2RV.+6"XN[[6YM3\:>'[)B6
M+6B>-=$\8:/=L#N2*:$$_.P/T]_P9Q>./#/@G_@I#\7?"GBC4H-'U;XH_LJ^
M+- \!PZK/<68\3Z]I7Q#^'7BR;P[!#=Q>7=W=QX5\/\ B/7+>XB"+)%X;G0*
M[(D,O[E_\'A_[&Z_%;]B_P"%7[7?A[2%OO%G[+_CE/#WC.ZBB\N^U#X2?%.?
M3M"U&"612!)%8^-K?PG=VH *QG4+DJ,MP&L?A7S_ #/R6_X.Z_VU-#_:%\1?
ML$? SX9:U'K?A>[^#5C^TO+;6)6[M9[[XO62:?X',A!&V>T\*Z5J\L@&6*:T
MH/$9(_LV_P""8?[(47[#7_!,+X'?LZW.FQZ;XL\,?!6\UWXC(L#0RO\ $;QO
MI-[XR\803EB3(^D:MKDN@*^%!325P"22?\V#_@AW\ _&W_!1_P#X*K?LF>%_
MBE>WOC7P?\!M,\)^*O%=UJ$)FLM-^&/[.^D6FH^$?";'DHNH:S;Z3X;))Z:L
M"Q^7-?ZW'C#!\&>+XT8,/^$;U_R]B!$"C2[Z,018.&:'RBK# (P"5&X"@H_R
M?_\ @V/^&?A#XH?\%FO@=8^,]%L->L/".C?&?X@:58ZI#Y]A!XF\,Z#X@_X1
M_5'0Y4W.GZC?126BLK*TKG(XY_M+_P"#L/1=(U/_ ((]?$C6KW3=-OM0\,_%
M[X.ZCX=NKC3A->6>IWWB<:2DNFR!2T0FT[4#%(R-MD2)$E#LBB/^/S_@U8AG
MB_X+0_"\RP7,*O\ #;X^F-I_NR8T'6-QB_W<KO\ JOU/]D7_  =;QR2?\$9O
MC"D4<DTC?$WX(!8H^KG_ (3>SX/MWH,9?$_D?G?_ ,&5:QI^R+^V<D98K'^T
M!X2B3S'S*$@^':P?/'_RS'G1S%/49_NU_-A^Q:H?_@YK\!@MY?\ QLO^*'[T
M?>1C\0_B*L*CV>Y:#..ZCMFOZ4_^#+16B_9'_;.6<20,G[07AOS().B@^!).
MF?8$GZ#/2OYKOV+K>>/_ (.9O 5V()4MC_P4P^*(6=(A(C%_B)\1(Q;2$G"B
M]WBV!/&)"2<+P&D?A7S_ #/0O^#L+QAXD\4?\%A_&^AZI->:AI?@[X1_!C0?
M"&B!9Q(NFZQX:?6[N*W^Q@WKP:QKNM7]E=6]MB2?SHL'?&C#]1_@U_P6\_X+
M1_"3X)?#_P"!W@;_ ((MZ<?AEX'\!>&? FD:-%\#/VB!HNI>'(-%TRS6ROXU
M;^R9!XGLM2E%Q/;J8+R352SJ0[[_ $#_ (.X_P#@EI\9/B!XZ^'_ /P41^ 7
M@?5_'FBZ-X"T_P"'?Q_L/">GW^H^)/#4GA.YN]3\%?$N?3K$%9O"MUHTZ>%_
M$.JL3_8UQX>T @*NH$'YJ_9P_P"#Q7XI?![]EK0OA1\3/V6[7XI?&_P+X$T_
MP=X:^*MG\2Y/"VB:Y'H6D0:-H/B#QSX8U+PSKLC:XJ>7>:Q/97-K'K,;6.Z(
MRPO(P9S^)_+\D?G3_P $MOV8_P!O/X9_\%??V7_VAI?V)OC_ /![PGJ_[3T>
MM:Y8)\(O'^@>#O!'@[Q]K>KZ3XGT-M3U!!]F\):3I&NZ]IMNURQ!BL6&-RN!
M_JY%3YD4A,3*VT3LP5F:$V]Y,4>=EW&R$S0^5N0%664/N5]H_AN_X(&?M:?\
M%NO^"D'[55O\8OCG\8O&&E_L,^!=0U[Q%XK2\^&GA/PSX.\=ZC=07%IX6^%'
M@K4%\-:'K.J6>CWU]#J5WJ&CR7;VZ:=;0:@8GNK5)O[DEERR"3;O.3+*=D8@
M$4<\,LL2RYE1!,H"M)D%;LE&<>80&D?A7]=3_/(_X.=O^"NG[1?CG]J35O\
M@E_^S1XFUSP?X"\-S>%/"_Q;?PM<MI/B7XL?$7QI/I4EMX"U75MQGB\&:,+^
MP%KI-JR+KFL:K975PKQZ/;PU^0__  44_P"" _[8'_!,7]G+X(_M;>,=6T'X
MAZ=K;6+?&RR\*:5?:DOP(\:WUYIVN^%](UZYUS$'B+PYJCW*Z;?>-;!8X[+Q
ME:S:3+'Y.H6,C_8?_!SC^PQ\?_V4/^"D6M?M[^$?#>NWWPA^-'B+P?\ %#PY
M\2K.RO=6T7P-\7_!\>EI>^'/$4UKI]];Z5:R'1M.N[&PO'@BUR*>Y9/.CTV7
MR_>_C+_P=Y^)OCE^QWXC_9[\9?L.^ _%/Q+^(O@";X=>,_$/BSQTVO?##5TU
M?1UTJ\\06W@G1_"]OJ\NN737B:G;:)_:$$.CW5F@21_-"6P1+XOZ['RQ^VQ_
MP<G?'?\ :._8*_9#^#GPG\6_$S]GW]J'X;>(-5_X:,\?_"/7W\&^'_%VA>&/
M#=EH'@V]\,MHKG4=.C\4/J"ZOJVB6P5=)U?3[V3Y8-1ACC_OZ_X([^$_CIX1
M_P"";?[*4'[2OBSQ=XU^-WB+X<)X[\>Z[XXU2]UGQ&+_ ,?ZYK/C*PTJ^U'4
MRVI3MI&CZWIUG_I1)5E8(2,FO\CB'X&?M/?LE/\ LS_M<>//V<-5T_P%XQ\9
M6?CWX-GXI^ KF]^'7Q;?X?ZSINIR:->>'M1U&YOM2\*WRI:V4>E7EKI\>N:?
M;R10+,D+R1_Z[7_!+O\ X*+?!?\ X*8_LP^'/CY\)WCT36EBT_2?BG\,;R[C
MF\2_"[QRMDOV[P[K<*D/)82RP7,WA/6C'''KWAF/3[N,;HY$C"X_"OG^9^CU
M%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% $,_W!_O#^1JG)_JW_ -V+
M_P!%+5R?[@_WA_(U3D_U;_[L7_HI:;_@U/G^43"?Q1_Z_P!+_P!-,^$_^";?
M_)O.N?\ 9?/VC_\ U>'CNOOZO@'_ ()M_P#)O.N?]E\_:/\ _5X>.Z^_JX\#
M_NM+_M__ -.5#[OQ'_Y+[C'_ +*',/\ W3"JER,M&V0/+621F,DWR(NPLX@C
M!CG=3MV>9S&22@.Y@;=5+LA54DQY_>"-7;RV,GE.S-%/@F&1+9;G# #(8Y=%
M!)ZSXL_+/_@I%_P53_9V_P"">WA.RM_%]Y%\1/C=XBU#1;#PC\"/#6M64?C&
M^MM8U73;)?%OB=[9FD\$^&-,BN8[D^)]1B6&/S8H;5)9)W:#Z"_:6^+_ .UI
MX!T'X>:K^RS^REHO[3.H>+#/)XSTS6OC[X9^"4/@"WF@T^ZL]5CU+Q+X9\01
M>)87)OK9;#34L"6M_.F-P+U"GYR?\%V_@Q\+O#O[!W[4/QHT3X>>&K#XK>/=
M=^ 5AXP^(=OH4 \:ZSI?ACXD>"?#^C6]SXA"FXCL],TJ$P6J,_E+;W#YC#$,
MWZY?$WXL^&_@-^SIXS^-/BEE_P"$9^$OP?UWXB:O;P3+)]LTGP=X2N]9N+.*
M=U'GSZ@MJME$5$@%]<V996#YD /R]^ ?_!2G]K7XC_MMQ_L5?%C]@W1/A#K>
ME_#R?XI_%+QCX3_:J\+?&:S^$G@VX\ZV\--X@LM$^&%GI,>H^+M4LC9Z1X7U
M'7="OY[(:W>Z.U__ &->K;8WB3_@K9\:=7M_C/\ %K]GC]@/Q_\ '/\ 9$_9
MV\:?$3P5\2?COI_Q:^'_ (2\1ZW<_"#4M2T[XGZM\'/A=K/FZ[X_T?PA'8ZC
M)%-;7T=OJ9TW5[*T-L+-ED[_ /X([?"S7_!G[(VJ_M:_&5IM3_:%_;<UC7OV
MLOC-XD:WA.JG0_$L5[?_  J\+V4MRR6::/X-^&YT/3/"L=VR6K:<JM(X,0:/
M\AO@)^S+^V5^U)^PU^T[\<_V6?VJ](_9._94_:8\3?M'_$/PA^QA#X%T?XB:
M7<>%+O7O%4'CBSUGX^^()%\7_#BZ^*5Y9^)+W7++PM')X:T7^W+==,*(LFX
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MUX/TKPKI&@R?$;Q3X>^&WA/XA_#WQ;X*U6RG^*?Q"\":YXWM/%?A>V\;6>J
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M<C,S5M)TG6[.XTW6]/L-5TZXXFL=3MK:[LIR#E!+!<HZ.0?N_+W.>HK)\/\
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MJ?FW/B?QDWB[6+/5]1\17OC/5)IY_&$.MZ7=:=X@DM[)88+.VME2'HOV;O\
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MB#5=6O6FMKS2[98OL$<T\GF6G]?/_!XDFIM_P2S\'FU%\=,7]JOX7'5_LO\
MJ-A\.>/OLWVL#MN\[RNW^LSQ7RC_ ,&4#Z$W[,7[:(B_LW_A*U^./P]_M$PY
M^T'2#\/9QH_FY[;AJ8&WC?YH/((KZL_F(_1/X\_\&M/_  2?^(_P?UCP!\,O
MA+K?P4^(D>BW5IX5^+'AWQKXPU'Q#I^M"&\L=,U+Q):^(]7U*TUNTNIHUMKU
MKBT@@O8RK66] <?RR_\ !%[]E3_@J[_P31_X*G^ ;BY_91_:5B^".N_$VY^
M?QR\167PL\477PWUWX;WNLG0K+QG=76G9T673O#E_'HGC2R\1(S#0U-V[DG4
M 6_T\8MOS;=^-Q^]TSD[MOMGKVS[YI)@2K'<B!4D;S&&3$VW D7/'R@MNSC@
M]<9! /C?]M#]NS]FG_@G_P#!;4_CG^U%\0[+P%X,@)M-.L+>.XU+Q1XGUJ2T
M@N%\.>$-'L(VOM<UF629"LQ:RLH&O(6O[RU21)1_*#XQ_P"#USX#V7B^ZM/
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M^(7C&*]URWU+QA?65H-9E\/^%M+U01:=<:>=1N89)[8/ZS^QE_P=<_\ !/\
M_:/^'_Q9\1?&RR\3?LL>*OA%X,O_ !QJ7A3QAJ.D>*=.\?Z)::C;6#:?\,M9
MLI=(N=4\7W=S>6=E;>%M:M- G$VHV+6;ZA&EZ;+Q?_@W[_X(_?\ !/SXN?\
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M98[V>206.K?M>V-I;22B4Z9;1^#K:9K -G(#W<]UJF, ?\3/@DY  .[^ _\
MP=N?\$\?C,_Q(OO%OP^^./P3T'X6?#?4OB)<ZYXZA\$7MUXJO[36M,\.:;X/
M\&:#X<\:ZEK6N^(/$<_B"5=&M;FP@M8W@+W QM,'R!H__!ZG^SS)X]32]?\
MV)?C#I_PUGU>XLYO$%A\1O!.J^-;31DGD/\ :5SX)FT[2]%DU<1&2>^\+6_B
MS^T84V1F\N9=@/\ *W_P;X_L5?"+]O/_ (*6?"KX)_'FP;6_A+I/@KQS\3?&
M'A@7 M8?%=OX+T8_V7X?U.;ACH=]KFJ:8-5MXV1[F)(X@P&0?ZDO^#H__@EW
M^PY\!O\ @GMHGQ_^ O[/?P_^"/Q*\$?&+P/X.LM8^'&B1^';?5O#GB^VUJTO
M= \0Z?" NLP136+2Z),5V6[WFJ2*N+C<P!^['[2'_!;[]F'X&?L!_#K_ (*0
M>"O#?Q%_:)_9X^(WB31/#!NOA=!X>L_$/A#4M;M=5NIK?Q?H_C#6K6'1+W2+
MO3#X?UG3GO[H6M]/FW>*&2*6\['_ ()._P#!8?\ 9_\ ^"M_A+XK^(_@SX)\
M?_#N^^$7B+0]$\1>%/B7_P (V=9N].\0VES<Z/XCTX>&-2U33GTV2[L+K3D9
MI5</8%E>8D^5_,M_P;R?LXG]N3_@@O\ \%%OV4-9EDNK;QI\2O&T'PXBFG5K
M;PU\1IOAAX2\5>"M0L;/<%LC9^--+\.3S$;C<*B!<[!7YO\ _!IS^T'K'[,_
M_!4OQ7^S3XU:;0+;X_\ @CQA\,]5T>=BD%K\5_A?>:AJVE:-)'N92]G)HWC*
MUC\MSY?VHGG.7 /[1_\ @K3_ ,%R?V<?^"2?B;X,>"OC#\.?B?\ %'Q1\8M#
M\1>)+/2OA@OA$-H>@Z+J>E:-#>ZP_BW6=(M0=;UB_N/[+6#S"5T/4VG>(",3
M?H/^PE^U9I'[;_[+7PK_ &JO#G@'QM\,_"_QETF]\2^&/"7Q"_L<^*(O#\.L
MZGI&D:W=G0-1U'2!;>)[#3K?Q#9I:2*$AU'#F1OWA_S@/^"[/B7Q%_P4K_X+
MYM^S+\/I[G5K/1_&7PH_9)\+6UC/Y@L=162T3QW>6^ %2WM_$NMZJ;HMM7RU
MBR2P /\ IW_!OX8^'?@O\+/A_P#"3PC:1V/A;X:^#?#7@?0;>'"Q'3O#FD6N
MGQW C_Y9RW$D<KS@LQ:3+\9P #TRBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH AG^X/]X?R-4Y/]6_\ NQ?^BEJY/]P?[P_D:IR?ZM_]V+_T4M-_P:GS_*)A
M/XH_]?Z7_IIGPG_P3;_Y-YUS_LOG[1__ *O#QW7W]7P#_P $V_\ DWG7/^R^
M?M'_ /J\/'=??U<>!_W6E_V__P"G*A]WXC_\E]QC_P!E#F'_ +IA5.\\S:GE
MD*Q\U5D^8"*18FFCDD*R(SV^^$)- %;S?,3.U4.;E03,P,84X)9RQW*"D8C<
M&4H2-Z)*T08=%W!C@ UUGQ9_/%J/P^_;8_96_:\_;'_:A_8=^&_[/_[=GPI_
M:5^(OA_4?BO\/IOBQ8^ OCU\+OB)\._#%IX6U#P/I7C/5M.U+PGJ.@SK<;;?
MP?K=W83>'3)%/:Y^UW(C]#_9*_:#^#?Q7_:&_:_\=Z1^S/\ $#]C+_@IA;_L
M^Z9-\4_A5^T->OX<\#>-_"GAJ?6SX*^)MIXI\,W.O>$_&?@;2_%%]!HFN_%'
M0--M=7N=,LXX+:&[AM+J.+L/%?[$'[:_[-_[0_QP^.?_  3B^,7[/VB^%OVF
M?%4'Q&^,'[._[4'A7Q[/\-K7XI6^DPZ)?^/? .O?#,IXBTO5/%(6Q3Q):I$L
M.IO8Z-&I9;(.^/X2_P""8_QU^,%[^UO\8/VV?CQX+\1_M#?M.?LR^)OV2/#L
M'P \-ZWX=^#_ ,!?A%X@L[^2YT_PG;^,YW\3^(=0O?$5V+[Q _B#,LT%G:1P
MI'+=SRQ@'XT_'G_@HI\4_@S\*?$/QO\ "?\ P6,OOV@_VL?!&IVFN^*_@#\#
M?@'8_$/]AMX_^$E&C:QX#M/']C\'-"GMOA]HFFWPLAXVU;Q=;:['K>)M0G=A
M&EM^C'@ZUU[XW_\ !2;_ (*.-H_C/Q%\(O$GQ'_X)D?LJ:Q:^./!=OI\^K>
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MVG^,;BVB\6ZH-7>>V6^O$.DK"C7IF] ^/W_*<[_@GG_V:!^V1_Z=/ =>P?\
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M]ES_ (+-_LS^ =,_9Y^"'[3?[&GQ4^"?@^QM_#/PW^+'[2?P[^,5Q^TCX/\
M >FVT%IHD.KZ1X 8?#'Q[XK\*QPVUOINH:UM.IVFF68G1M\JM7\4?\$@/%>D
M_LE>!_@QX(^+MAX[^.6J?MP_"#]MC]H;XY?%W[=8R_%+Q[X2\<Z/XK\;7NG:
M9X>T_4;W1GDT;3WTSP;H?F)I^FQPSF]G87"[0#Y[3]G;XK>+/^"_7[0O]B_M
M=?&SP<9_V)/ GCK3H]$L/ "P6/AGQ+X^\:^'])^%>R\\-&Y7P_X*U&6_\5Z4
M79]:6^O+1]6F=1ITK6/"'_!1;X_Z5_P2<^)VF^*O%5UK7_!1#P%\=[_]@&/4
M-NEQ:]KW[1/B[XAVG@KPA\0;&W%CI]F+"/PAKD?Q$TQX8'$FG>&HR[[B<_H#
MX^_9+_::T#_@IMH'[;WP.\9_!&;X=>+_ (&>%OV?/V@/ WQ;B\>1^)['P3X.
M\6ZSXYM?$?PME\(VL7AU/$-Q+JD=I<2^)O.@MQ_9ZR1>0)(V_.WP'^S3X%^.
M/_!>[X@?$CX4>/M$\<?L_?!WP%X-_:A^*_AGPY>V6M>"I/VS/%GA#Q;\%? N
MIWMSIK-H6K>*+7X>+=^+]1$#-?Z)>Z/HPOR7OHL@']'7PMT'Q!X6^'O@KPUX
MM\27OC+Q7H'A30-(\2^+]2^RB_\ $^N:?IT-KJFOW*VH"*^M7\5QJP0C*_;B
MIPP=%_)C_@L__P @;_@GI_VDN_99_P#3]J=?9W[.'QD^./Q%_: _;)\ ?$31
M_AJOPW^"OQ%\">&/@_XH^'J>-);W5M)\0>"AXD\0^'OB'J'B,?V!<?$'PG>7
M>FMK-KX0;R+&TU[3/[313<V#2)^W[^R)9?MI_L^WGPI@\:ZA\,O'?A[QAX.^
M+'P@^)FF:=;:S<> /BU\,]9A\2^!O$EUHERRC6]*M]9MK>WU+28V\R[@N1L!
M>-!0 W_@I)_RCQ_;D_[-&_:)_P#50>+:YS_@GM_RC0_9#_[-#^$O_JL=+KX;
M^*G[*O\ P6$_:G^'FN?LR_M"_M#?L3>"/@'XXL6\*?%+X@? KP'\7[WX[_$7
MX?3216OB+0#H7CO'PN\)7?C72DU"PUJ\T:6231EU%/LN\NBG]C/"GP\T7X<_
M"OP]\)?!,1TSPMX"\!Z/\//"-K=W,TLEKX?\->%[3PQX>CO)S:37%TL-I#:V
M]W>0A#MM5D@3(>*@#\N?^" O_*,3X.?]CY\?_P#U>WQ"KWS_ (*YR?"EO^"=
M'[5^F_&GQ;XD\#_#[7OA/K&@:KXC\':8=9\5VVH:O?:98>%[+PWHQ>VC\0ZQ
MJWBZ?0-+C\-/J-@-9L;O4(S,(X)7CW_^"9'[*?CS]BO]DCP7^SW\1_$/A3Q/
MXH\*>(_B+JMUJG@B75IO#,D/C+X@^)O&-FEI)XAL;#7S>1V>N6\>H"_C:#S4
M1K%O*9Z]._;?_99\+_MG?LT_$O\ 9X\5:U>>%X/'.EV3:)XNTZ!9]0\*>+O#
M^N:3XF\(:];Q.ZQWB6'B31M,DN=*<-_:D&^W38X$B '\U7Q<\;_MCZY\)O\
M@F-X7_X*!_LM^'/V3OV6/A)^T'^R[XBU?]H+X;>)?#7C[Q18>,O $&EV/P>T
MCQ3\/--U&#6/V?O!_P 1[JY;2?'&O0:MK3^#KR_M],E:T^WJMQ?_ ."BW[1?
MP8_X*+:-^VUI_B;XZ?#OPQ^RI^Q-\,OC?H?PU^'-U\1?">A>(OVJ?VQ/#_PK
M\36]IX^FT:\UV/4KWX?_  ,UN-8?!UK?Y_X2'QY%HM]#($C\JOT'\8_L*_\
M!2O]K+0OAO\ L_?MO_'K]DV;]E[P#XX\!>,O%U_^S]X"^*</QF^/%O\ #748
MM5\.>&_'D/CQV\%^#(-7UFP@N_$]SX <:E;B#<K;&A"_4_[37_!+/]DCXS_
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MWH>C^)?%T<_]GZ??:U-K&JV$DAU7Q-#<:W=!8_M 7*B3R[]ES]DKQ_\ !?\
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MU.>2TTP?$KP1>1:WX;M]4ND201Z;JZQ7WAZ]C=-DD&LLS,JQ-G_-I_X(N_\
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ME:^(-:N]9UF%->\5:YXHU?[=K-P!+<S2ZYKVJR+L7**P0EO,5C^9_P ,O^"
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MNJ>)])^,"ZM>)>>*KCQ=>:UJ&L:?J^NR\&]75M+O+=K"]QMGM+-;7)%AA/\
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M2<D[R^[_ ((?\2 >,G_0YX.^_B[_ .@X_P!$S>ON/J/\,T;U]?T/^%?YV?\
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M /P4W_Z+M8_^&Z^'/_S/4_\ B).2=Y?=_P $7_$@'C)_T.>#OOXN_P#H./\
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M3D_U;_[L7_HI:;_@U/G^43"?Q1_Z_P!+_P!-,^$_^";?_)O.N?\ 9?/VC_\
MU>'CNOOZO@'_ ()M_P#)O.N?]E\_:/\ _5X>.Z^_JX\#_NM+_M__ -.5#[OQ
M'_Y+[C'_ +*',/\ W3(I0" 2I;&?7V]/7_\ 555)=S[5B*\XW9)_+.>>>@Y]
MQBK$LBHT:DX9]VWG'3;G_P!"'<?C5&YG,*F1R L(+,!&7=TW*I2-49-KES&%
MD(;9S\OS9'<Y>SI.3C?335K>7+HEOKIZZ,^)]Q5(1EAN>I7?+1FDFY35DK]K
M/3T5RPY&X[$#LOWCS\I/ [XP<'D^E"X9@9$*,",$<CKW'?GZ$<&OQ^^-/_!:
M/]COX(_M):9^S)K6J>*=8\4R^*]*\%>,/%7A[3--NO!7@#6]42(VX\5:_J&K
M6+,]E)<6EKK,6G17LNF-=VZW"*\L(/ZWV+K-:"XBG2XAN!!/#-&X>-UDC#))
M$%GG1(983%+&L;[2K[\EI&-<N&QF$Q=:M0A*/UG#N"J1NW)<R37O)J+LK7C9
MJVSNCW,YX6XDX?I9)6XAR#$8'!\18>KC,LQU6')'$4J524%4@G[UHN,8OF4)
M+1\EFF;$0023%00Q*[L],C=C'ZG\?K4]0Q8RWKMCS^(;'Z>YJ:M^9RU>^J[_
M  MQ7RLE;R/$7-JI2YVI2CS=U&3C%?**2?H%%%% PHHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH AE'*L!EE#E0>F>.3]/3]>*SI0Z>20J/(\N'WD85 I?>N03O5DPIY +
M#OC%V[">4[,VS;&^7 RX0E-P0Y&TL0OKG'8X(_,G_@I'_P %&/A?^P%\)U\0
M:HT'BOXN>)(9].^%?PZBO,2ZQJQ$?_$Y\0NJLVD^%M#>XM9M6U.9@B?:K.V3
M>]Y&ZX8FO2PF&KXO$Z4:$92O;I&#E:[<59R5N5-RUYDG8]?ASAG/N,^(<JX:
MX6RRIG_$698FEA\!DE*+E.K2JS4:V*:C%\L</%SJSG*T(1IMRDEI+C_^"H?_
M  4N^&O[ _PT0 Z3XN^.'C;3M0MOAMX"FF:=;66X1+23QAXR6*59+3PAI4I@
M^T+Q+?7 2ULQ&P:Y@_SW?BU\6_B#\=/B'XI^*WQ0\1:IXH\:>--5N=:U/4]6
ME626..X<I;:=9P* --TFP2)HM*TD#_0K P=YB3M?'GXZ?$O]I'XJ>+?C'\6_
M$-QXD\;>,]2FU&_NI6Q9:=;;VCL]#T&R_P"83X=TJ-&BTO2SS'ON+TDF_P U
MX_7X#Q3Q37XCKN&%;6649J-!=_9KDJ2:O;F]HJFRLKM*UY.7^WWT?/H[Y)X&
M<-SIPA#/>->)L-2J\1YE&*M2KMQJ5<KHN4>>-+*W;+Y)M.I4PCJ5+OV<:111
M17RKLWIM9+YI)/\ &Y_2GN6BJ='ZO&,(0]E_)*$(PG_X%*+E\PHHHI""BBB@
M HHHH *#]QOP_DU%!^XWX?R:@#^KW_@UK_Y&[]LW_L6/@?\ ^G/XGU_8O%]S
M_@4G_HQJ_CH_X-:_^1N_;-_[%CX'_P#IS^)]?V+Q?<_X%)_Z,:OZ%X'_ .26
MRO\ [G?_ %/Q!_AI],G_ )2'X^_[M7_UD<C/YJO^#G+_ )-(^"G_ &74?^H5
MXBK^()NK?]=)/_0J_M]_X.<O^32/@I_V74?^H5XBK^()NK?]=)/_ $*ORWC_
M /Y'V+_Q87_U$H'^B?T&_P#E'O)O^RSXY_\ 4_A$;1117QLM_DOR1_6\?ACZ
M/_TNJ%%%,?@;C)L1?O+_ '\]/RP?^^J0Q=N]@"=J!7=I/[NW;C\R3^5?<'[!
MG["'Q?\ V]_BY:?#KX?Z:=-\*V/V6_\ B/\ $"^LUF\.>$O"[W+9N]8D)47]
MW=M:3IH7A=F5=;U" W\C(F@,PJ?L,_L+_&+]N[XP67PP^'.G?V?X=ABM[_X@
M^/K^S$WAOP1X8ENEW7>L29'V^[U!K69="\+Y"ZW?VC7[%5T!F'^BA^R7^R?\
M)?V-O@WHOP;^#NB16&FZ9!'=:]KE^T=SXB\9>)98(EU+Q1XKU3'F:GJ=Z40A
MYB?*M4M;>-%@AB1?M^$.$:V?8BGB\8^7+</.].^G,U.THI_]?.:[Z>NA_(WT
MG?I,Y7X/99+AWA^O2S7Q)S+!U*.6Y742GD_"^'Q5*<_]:<\A=<^80A4MEM)M
M<].-*<K4HN4[_P"R#^RC\'OV./A#I7P>^#6B#3M%T\QW>N:U>%;CQ'XR\1RP
MA=0\4>*-2QYVI:O?A8QYTQ)AM$M[6)8X(8XU^IJJ6@8+\S(Y\N/+IQN/SYX[
M*. O '!QFK=?NU.A1PT(T,/%0HTER0BG=)1T>MEKS)MZ)W>NI_BYF&:YEG>/
MQF;YQF%?-<TS'$UL5CLQQ,G*KC,35J2G4K)MO]U)RM02M%4(THQC&*C%%%%%
M6<84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!#/]P?[P_D:IR?ZM_\ =B_]%+5R?[@_WA_(
MU3D_U;_[L7_HI:;_ (-3Y_E$PG\4?^O]+_TTSX3_ .";?_)O.N?]E\_:/_\
M5X>.Z^_J^ ?^";?_ ";SKG_9?/VC_P#U>'CNOOZN/ _[K2_[?_\ 3E0^[\1_
M^2^XQ_[*',/_ '3(9&PR#&2VX9] -N3S_G\<57R%8B)=W]YSP/SZ <_X58E(
MRJ]"P?!^@&1Z\Y_QK)ODV0*[-L2#=,[[8V*!2 \JA^?,2(N$P=OS,'##BNQ.
M#C4]JER0UUN[KE<F[)INSM%*ZNV?"S;BIU84GBZZJ4Z-##II-2JN"4;M:7<N
M9M]'ZC[R:&V"/+Y,<;B0RR23QPI&L*B9ICYF0PC$9<X^[W()%?G]J7_!5/\
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MFXZ#_<D_G'5:7_5S_P#7%?\ T):N/\.I\_\ TE'/6^*O_P!BZI_Z<F?Q<_\
M!S]_R7K]F7_LEOC/_P!2NQK^7^OZ@/\ @Y^_Y+U^S+_V2WQG_P"I78U_+_7\
MY\9?\E)F?^+#?^H>'/\ >7Z)?_*//AK_ -BW-/\ UH<Y"BBBOF#^BPH/W&_#
M^3444 ?U??\ !K5_R-W[9O\ V*_P1_\ 3C\4/Z5_8>3\BGN)'_1F/\R:_B^_
MX-A/&^AZ-\8/VI?!-U>00^(?%?@/X;^(=$M9#B2[T_P9K7BZUUQXN0<6S^+M
M):7T60'! K^T)4!5FQM!"@ =-BLVPJ.@R",\=  .G/\ 0? BMPUELGWQGRMC
MJU_S3]#_  Z^F72J4OI%<959IJG7H\,RCH[-+A3**;:?6TJ<EIUT/YK_ /@Y
MO '[)7P4EZH?CE\W3J?!'B+'!]><=?S%?RB_L1_L0_&7]N7XP6/PN^&>FF+1
M4D6^\>^.+Z$_\(UX#\*O=J)]3\17:@N8[IX&CTO1T!?6=2MH$16:U K^UK_@
MM-^RE\0?VU_ W[-WP!^&T(AO=7^,&I>(/%/B6^MR?#_@WP5H?A.]CUSQ!K=V
M.2MO+J%A#IFD<'6=4EM5!'V/-?=?[&_['_PB_8J^#^G?"#X5Z)';6MJUGJ'B
M?Q7JJF;Q+X\\3S1,NH^*/$>H*!Y]W/<ATL=/C/DZ;8B& 1LQ>:;R,TX3Q/$'
M$U>OBG;+L+/"N&JYI*.&H.48Q;O*\D[NUK/J]#]4\._I+Y/X)_1DR?(^'J]#
M-O$?.N)?$&EE>4XB,IY-PUAL70P=&7%/$JY5&I*BYR?#5+G4O[3INK)*E3<I
M:W[&'['OP?\ V)OA#8?!_P"$6F!((/LM]XM\3WL<;^)/&OB=X"+S7_$5\F6E
MN9BS?8[ NT>EV;1PQ#$K._US5:V18PRJ2QSN8DY^8L^?PR#]>ON;-??T*5"A
M1IT<,DJ%.*A3MM:.CZ+>2D_\S^&<WS;-,]S3,,YSK,,3FN:YGC*^,Q^8XR;J
M8K&8FO/GJ5Z\VVY3DW;HE&,(Q48Q211116IYP4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $
M,_W!_O#^1JG)_JW_ -V+_P!%+5R?[@_WA_(U3D_U;_[L7_HI:;_@U/G^43"?
MQ1_Z_P!+_P!-,^$_^";?_)O.N?\ 9?/VC_\ U>'CNOOZO@'_ ()M_P#)O.N?
M]E\_:/\ _5X>.Z^_JX\#_NM+_M__ -.5#[OQ'_Y+[C'_ +*',/\ W3*]Q]W_
M +9S?^BS6;<?\>ES_P!<9?\ T7#6E<?=_P"V<W_HLUFW'_'I<_\ 7&7_ -%P
MUW_\NJG_ %ZG_P"DS/A/^7D/^PFI_P"H5$_S3/V?6V_\%(/AR0P$G_#5>GM$
M'_U2R0_$6*X:>3OF*"&<+CO(:^CO@!^S_P"!/BUX"_:;\>>+?VH_B'\'=<^%
M?QCL-&\'?#S04N)--UW1]=\9&6XO2ELP<JRW\UY&=KX,!/"[C7SA^S^57_@I
M#\.&=MB+^U5:-O1\3Q-_PGC!)HH_^6@C)(<=MZ_WJ_1+]B+X[>$/AE\!_P!M
M[P?XA_:7\%?!_6?$GQ]\(7&E^ -?\&6&L:OXF:R\=Z9=3ZC;B](810PN+R]:
M!3E1 9&554-^$8"A2GB:\L0DZ3Q.,W=EIB*RONM;K375I*SO8_V=\3,=G.74
M\/B,B<EC/]4/#M7A!SDT^,<K7*TLFXC?(TTIR_LQ*$'*;E%)U7C?M!?L9_!K
MX4_#_P#:@\5^#_V]_B;XTU;X'Z)\-[[P7H]U:ZD]IXVF\76NE0ZO'J4D4LJ_
MZ%<W5O8P-$[@!I2V",#](_\ @V#U+4)OAQ^U5ID\MU';6_C3X?7D5E)=7L@M
M=1N-%\2PZI<Q)=JWE?;CI]HT@B'S>2A;(C6O-/VS?VN/ACXT^#7_  4#TC2O
MV\OAE\1KGQ[X&^$5IX>\.:/\/=#L9/B')9"U@FL=+U*(Y@NM,NV.GW;VXR#)
M!M*A<-Z1_P &PEE<+\/?VJ[N:UFM[;_A-OAW8QM.+\".\L?#>M_;;03W3+!,
MMK]JM]JVK!4^T 2Y#Q5]7ED,/3X@RR.&LJ"IUN3E:EKS3OU=_?NEW5G9WO+^
M=N/<XXGSOZ,_'\^+Y592I\4<%O"NK2=&7_(GP?V7P;P9O&SG;DY*CG3YFX.1
M_4V-BLS% RK$_G 123%HECD+H8H;=)+J1URL=H/,,FYIA&SP(C_S'^%OV:OA
MA_P4%_;[_P""C'B?]I+XL?$;X!>-/@'\0-%_9O\  W@;X'?%F+]G_P 7ZQ\'
M].\*VOB;3_BY\0?$WAEE\4?$W3?&5MJ-]<^%Y/%"R>'M)@TC7])NK;[-=N(O
MZ=H0"TR@;OW17 &,JQ8&-9A._ELYVA>4W;=PSM#)\4_M'?\ !.;]BO\ :M\9
M:9\1?CY^SWX*\?\ CG3+.WTU?%LZZUHGBJ]T.%/(&@ZQJWAFZL]0US141D0Z
M==326T:,Z#9%+()?TNI\<O7]$?YWTVW!-^:7HFTO^8G%]$O^8B?I#X(_S#Z7
MXO7PU^Q!^S7J-S=:#JG[.O\ P3B_X+B?"7PEI?Q>T;2],\-:/X_^ ?@+Q_+H
M$7Q&\5PZ2?[.U75],\6Z]I5OXH\8Q@:?XGGEMKFS_>6UWG]@/^"H_C+PO\4_
MVAO^"/OP;^'?BG1/$WCN\_X*!?#_ /: %AX;O])U/48/A/\ "?X;_$RY\4>*
M+<:?-*;72)Y=?TTB>=A%<BUF$!8VUPU?K)8_LW? +2O@FW[-6F_![X=P? 8^
M&Y/"<GPD@\*V#> FT*9P)--O- 8+IM_&SCS[XR!M1N9L7#%II ]>)_LV_P#!
M.C]BO]DGQ3J_CG]GO]G[P1\-/&6JV-WX?C\2Z8-9U#6M/T&Z:*X;PWHM]K]S
M>W'AS0=Z9BT33I$L;<;5A^0&.H+/C;_@OG%#'_P3H\6/'$D8N/C[^S1-.8DV
MF:0?&WP5;^=(0 &D:."-&)Y"QH,="?NK]J#Q1^VIX8T'P-)^QU\*O@9\5-4O
M9[V+QEI_QK^(_B;X<6NGZ;%IMHVDOX=OO#?AKQ&UY=W4K:C]M%XMHMJMK9^0
M9A<SF#U[XV? SX4?M&^!I_AI\9_!NF>._ ]YKOAKQ/<:%JLMTFEMJ_A?5[/6
M?#]T);5XA/=6&MZ593HCD%=Y* \!O7[&"*WA2.!/+BBC2!4\V>41B%G4PH9@
M#Y4+$QQL H* +M540  _G3_:1TKXS:A^TU^Q+\4=0^,_[/\ ^R)_P58U#X:?
M&/POHOPR\3Z'\3/B;^R=\<?A#;ZK::IK7PYUWXD0Z9X%OM.\5V<UOH>LZ;%I
MFLW6MWTD=T=,T'4K>Q8VG#_L=?#SXW^)O^"YWQ)^)_Q;^-_@[XY^,?AC^PB?
M#7QGUWX1^'[KPY\%?A;XP^(/Q5TK4? _P5\'0W^H:]K-QK&F^#M+U#Q5JEUK
M^L#6YE-N^H:+HS2QM?\ [Q?M*_LI?LZ?M;^$-.\"_M(?"7PI\5_#&DZ@=:T6
MU\1V#/=^'M9C$+)K/A_6[1K75O#NI1B"/%_IFJ:=(?+C\UIC'$(Y/V?OV7_@
M#^ROX-7P#^SQ\,/#'PK\)7&I3:SJMAX;LYXI_$.IWD,L<NI^(-:G>[U7Q#JD
M\UQ [:CJNI:A,=DHA:/,P< _++X!6#_M;?\ !93]K'X\>(474_ ?_!/OP/X7
M_9+^"]C(NZQLOBE\1=.7QS\;O%L3[2!K$6CW^G>$+@-C,,4(!5D0GZI_;G_;
MYT?]F#5O _P(^%W@UOCI^V#\<X-1B^"OP/L]872+26VLW6WO?B-\5O%9&SP=
M\+O#<UNW]NW\RR2ZI'9/I=NRRS//;?8'PJ^ GPK^"M_\3-4^&7A#3/"FH_&/
MXD:G\7?BE<V#7,TGB_Q]K>D:;HNL^(+W[4\LBS7=IH^FQAH-JN+/[N"0?F/]
MH#_@F!^P[^U3\4I?C-\?/@/H_CWXH'P_I7A ^++CQ3X\TZ[&@Z--J$^E6*C2
M/$NB6Q%I_:-R!LBF8&0D!&9_, / ?V;/V6OCM^S9\)_V@?C=H_B7X6?M)_\
M!2C]HO4="\9_$WQ-XQUJ[\*_"8ZW9W.F0>'OAAH)T;[5K7AOX6?#KP[J%Q;>
M'XM/MI[G4-1OHKZ:$_;$C/QK_P %#OC1^W[;_L,^./"G[7GP<_9?^$'A3XT_
M'#]G;]G[7?''@;QAJ?QO\*^ _A1\5_&"Z!\0_B%X_P!'^(_A?P]IFAZOX9N$
M\-VOA/6M2NM5TRS\2:UH%Q.;>YMT>X_7O]FC]@#]DG]C[Q)XH\7?L\_":/X?
MZYXRT6V\,^*=23Q1XK\1_;M(TVXDU*UAV>)_$.OBP6"Z#%OL LFG,Z"Z%P(8
M/)^G/'/@;P=\3?"FL^ OB#X4T'QEX+\4V%WI?BGPKXETNUUO0]7MKR%!)8:G
MIM]8W=K-;RQS%FF=H);:6.)[=C(=\0!_,7\6/V8/A#_P3I_:1_X)K?%W]FWX
MQ_$;X^?$7QY\<?"7[.$?PP^.OQ6G_:&U/5_A%\0M N[7Q=X^^%\6HL=;^'5[
MX1TFP37M7D\'+!X"M([B*.\M8HK;3E?UKX=>'/BIX _:6_;^T7_@G;^VS^SK
MX"^'=[\>-=\<?M7?"+]J7X7_ ! B\2_L]_&;Q)I&E3^-_B=\+M;US5-+TCQA
MX(\7Z1%I^KRWNK,_@.TO-*C2UF$5S=,_ZP?L_?\ !-/]AG]EWQNWQ(^!7[-W
M@?P'X]AL+K3;'Q8HU?7M5T'1[R0M>:%X5NO%.K:G+X=TJ:14Q::9%864J10?
M+(EM"L3OC]_P39_8<_:>^)%C\5OCC^S?\/?'OQ!^Q6>GWOBS4[2^M;O7M)TV
M16T_1/%<>EW$.F>+-.M)7D^S:?XA2YAB$]PMD,3W0(!_+I^SM^S[^W7X\_8(
MU?P)^S=\(_$_[4_[//[1'_!1G]I/XH_''5I?B]\-OV??&OQ\_9V\/^,=+L=!
MBEUSX@^([[1+'2OVB]5T_6=4\9)X9\.Z[I4GA^TELH5M!?C[5]A_L<_%C]K=
M?^"U'Q2T[7/^">T'P;AU3]D?]F?X<^./ &E_M/\ PHU^P^ GP?T'Q;XSMO"?
MCR"YT;2-+L?&L?V9;K0+/X3^'K.&YLM)T'2=9>=FOX"?ZC_#'ACP]X,\/Z+X
M0\*Z)I/ACPOX?L+70M!\/Z'9Q:?IFDZ58PO#::;IEK;A;6QL8H88DAL+=42T
MACQDAU">?:5\!?A/HGQL\6_M&:=X/T^U^,/CSP1X?^'?B_QT@5=0U/PAX5N-
M0O\ 1-(N225$>D7-S<B(@(5^UR EOG6@#\M/^"[$4,7[%7@0PP6\*3?MK?L9
MRY@2W0R'_A>WAF/=)]G&R1BL8<2[B3YABP#$<_MC!_'_ +\O_I1/7C'QP^ W
MPI_:,\'6?P]^,?A&T\9^%+#Q?X6\<6^EWDMW$MKXM\%ZO9^(O#&L0&U=7+Z9
MJ4$#@OF)=V"#RP]EM]@,NPY#/YBC?,_RR%BQ(E^5&,XG&R/"J@3(7A0 6:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M<=!
M_N2?SCJM+_JY_P#KBO\ Z$M6;CH/]R3^<=5I?]7/_P!<5_\ 0EJX_P .I\__
M $E'/6^*O_V+JG_IR9_%S_P<_?\ )>OV9?\ LEOC/_U*[&OY?Z_J _X.?O\
MDO7[,O\ V2WQG_ZE=C7\O]?SGQE_R4F9_P"+#?\ J'AS_>7Z)?\ RCSX:_\
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M_P!7/_UQ7_T):LW'0?[DG\XZK2_ZN?\ ZXK_ .A+5Q_AU/G_ .DHYZWQ5_\
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MVQ)2H=B ,F,%EY&1D#/5<XXS^4ECX_\ B[XB_:8LO%WPX\.>$M8\3>+?V5?
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M3_4WA+GBI=[_ (-HMT444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AG^X/]X?
MR-4Y/]6_^[%_Z*6KD_W!_O#^1JG)_JW_ -V+_P!%+3?\&I\_RB83^*/_ %_I
M?^FF?"?_  3;_P"3>=<_[+Y^T?\ ^KP\=U]_5\ _\$V_^3>=<_[+Y^T?_P"K
MP\=U]_5QX'_=:7_;_P#Z<J'W?B/_ ,E]QC_V4.8?^Z92NP"T(;RRGSDB0XS(
M-GEXQSUW9[<C=Q61=11S%TO" OD1B>3C8,3K)AG)PH"8<GOY1S]VM>[*[HES
M%YIWF(2#.2NS=M_AXR,[N*X#XB6]W>^#/&-EIS3#4K_PKXBL[0VSNLJZ@VA7
M@M'@$'^D/<K=&);=864,[G)8F-3Z,G*.&J.-^94I\MEJG>Z<>NZU:O>22Z'Q
M$,/2Q-9X6M*M&GCO88%RQ;MEL5F>89;@&[W5HQY^:K=I)*JVTKM?RW_'3XG?
MM+?'WQ5\4?\ @H?=_!KX4_&#]C;]GJ3QI%\ O!OQ.^(6L6/AG3[KX?:P_ACQ
M)\;X_ 5AI6HZ/X[\4W>J6=]H?A.TUSR#HS07'V"0OJ=PP\7L?AG^VY\(;']A
MN;Q'^SU\#=4\=?%_]J>X^*K>)=7^)\<FK_%/XI_$#X;^-_$ECHWQ#T:V\+?9
MO"'AOP_X2UEM,M+.%Y!HZ:;)F)'+[]/3?A'^UYK/_!'CQ1XOT/\ :_TE?@=X
M4\#^*M+\3_LZQ_LZ> X-6T&3P+\0FL-?TC4?'=WJ=CXGDNM,UW1I-3U)95:6
MYV1]%92_TA^T+\&OVY3X@_X)X:AKO[=_A3QJ_CGXY>&+7X1:A8_LS> =,MOA
MWXBU7X5Z_J>C^+[ED\2-<>.9;70GCLFTW6';S8PE["L;V]XH_/:N'=2=2HU.
M3:C--^S:YI5(Q;=XR?):"C!)Z-)2M%N+_P!!\OQF!RR=+AU8CPLAA\JX@X_X
M1KT)4^+OK.)R_@OPSSK%93A8O >SPCQV7YY/$9_F]:C9ULKQ"<JE:JHSI_+B
M_L^?M<7_ ,0?BO\ L;V?[,?P9T'XA13)^UI\ _$&B?&*6R\1?LQ'Q5XKFMG'
MP@^)\&A6#>(M-TOQCIVG>)KSP7)''!%::I+:S^09DC;^BO\ X)T?M!^/?CK\
M%M8T'XTV%GI'[1'P \9ZY\#OCII=CL73I_&_A+R9K;Q#;#<&6R\3:%J6E:[
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M:@$UMXXUCX<:CJ?@K]C>>4,<(DFCZS=>+M/X.X>$9N#M H _9#Q;_P %L_\
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M:N+Q^8XAN53%XBI-N=9-MVHRVP\5[L</&E&*48I'R+#^Q?\ !"VUR'5/[/\
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M:PT#P->6*B!M$NHX7+2^>/*_OYNK=9B@&]T*R+)'YI6-U<+E)(6#).IP1A@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>aud_002.jpg
<TEXT>
begin 644 aud_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  S!J,# 2(  A$! Q$!_\0
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M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_[]BC^SK+_GT@_[]BK5%',^X>QI
M?RK[E_D5?[.LO^?2#_OV*/[.LO\ GT@_[]BK5%',^X>QI?RK[E_D5?[.LO\
MGT@_[]BC^SK+_GT@_P"_8JU11S/N'L:7\J^Y?Y%7^SK+_GT@_P"_8H_LZR_Y
M](/^_8JU11S/N'L:7\J^Y?Y%4Z;9?\^D/_? HJS11S/N+V-/^5?<O\A:***1
ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 )1110(6BBB@84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%% @H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
9B@ HHHH **** "BBB@ HHHH 2BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $3!-8# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\M'N)(U=]JLVU26V@G&!7>?$-OG2OIV^\_TE:_AH_:\_X.[?BY^S+^U[\?\
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MZWTWQOJND_LM?L7VWB3P%I][=6VF^-?C7\1+S0M<\1VT,Y2#44\$^$-'O(M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKYU^#?QZ?XL_$W]I?X=M
MX6701^SS\3O#WPZ35QK)U(^+1KOPU\(?$(ZNUB=,L1HAM3XJ.D_81=ZKYPL?
MMOVN/[1]EASG5IPG2IRE:=>4X4E9OFE"G*M)72LK4XRE>32=K*[T.["Y;C<9
MA<SQN&H^TPV3X?"XK,:GM*</J]#&9A1RO#3Y)RC.K[3'5Z5'EHQG*'-[2:C2
MC*:^BJ***T.$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;_L6O&/_ *LWQK7ZEU_2.2?\B;*?^Q;@?_46B?X ^+__ "=GQ/\ ^SA\:?\
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M_P#"M;;Q;'9:[=IX7@\1^*GU"Y\4Z]K?GS::FL^'(X4L# L(O)!<>8SQ[/\
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MX?L<_P#)R_\ P4J_[.9^'W_K-OPBKS\7_O>5?]A.*_\ 5=7/N.&?^26\2O\
ML0<,_P#K>Y2?H?1117H'PX445Q'Q,L/'NJ_#GQ[IGPKU[1/"OQ-U'P;XFL?A
MYXG\2Z7)K?A[PYXWN]&O;?PMKNNZ-$R2:OI&D:W)8W^HZ8CJU_:6\MJ&'FY
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M6EZ5!>:A+''(\=LZHQ',_L[_ +7G[,/[6NB:KX@_9K^.OPU^,^F:#<I::\?
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MW">&U-P;?4)+N)[J=3]S_$K]IG6/^";W[&W[#7[.G[.6L3?MY_'WX[ZAX;^
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M[C\8ZO>ZYJWP/^(OAK4];^&6BZGJ,K7-Y_P@7B3PY-)X@\+:"]T\DMMX8O=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *_/#]CG_DY?_@I5_P!G,_#[_P!9M^$5?H?7
MYX?L<_\ )R__  4J_P"SF?A]_P"LV_"*O/Q?^]Y5_P!A.*_]5U<^XX9_Y);Q
M*_[$'#/_ *WN4GZ'T445Z!\.%%%% 'XH>./ _C:X_P""_P!\#OB'!X.\5S^
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M'M,,\ U'6]06WTRQ,\(NKJ(RQ[OW'HHH **** "BBB@ HHHH **** "BBB@
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M>'D_:&^(]IK-WJ_AE[SX>^'(-,U;Q%!J]W8V.HZW>ZU#IUM.JC3DU+6==O\
M[):6D][=PQ2_PS_MM_\ !XC^UK\1?B%JWA']@#X6^#/A#\-(=3?3/"WC'XA^
M%_\ A9/Q@\9)YT45OJ;^'I[E_!OAE=29'^R>'HM(\2ZC;QW*B;6YKG;' %N2
M2U^[J?Z/U%?Y?7PD_P"#M7_@K;\#_'EC_P -%^%_A=\8O#;36]SJ_@7QO\*3
M\(?$DNE/O24Z!K_A*WT2?3+F8!FM;_5= \1V,4\0+Z?<1^;$_P#?U_P30_X*
M4_L_?\%1OV<-*_:"^!-W=:;<6EZOAOXF_#+7I[9_&'PK\<Q6L5U<^&]?6VVP
MWME=6\J:AX<\16<:Z=XATJ1;B%;6^M]3TS3@2DGL?H717\"'_!1#_@Z _;P_
M9$_X*3?M ?LJ^%_"W[.)^#'PB^.-GX%M]=\2^!/&.I>+(?!@_L.?4]0U&^T_
MQY96EUJ-K97][*LMOI$:'RHP+61@0_QQ^VI_P=I?\%&O'WQ&\2>)OV-/"?AS
MX"_LQ:3K]_HW@;Q!XC^%%KX]\3^+]/M;B6UM=8\9>)_%5MJ?A73-3U0*M['X
M<\.6=F-'61-.N=0UF>"2]F YX^?:Q_I;45_GP?LD_P#!Y1\1/#W[.7QGL/VP
M/@]H'Q&_:5\+:#I]Q^S]KOP]T^7P?X0^*.NZCJ$>FWFD_%33H+B[M_"8\.0W
M">)'U;PM#%;^(=,LKW0[?2]'U;[)J%Y^<6J?\'7'_!:3PSX[L_%WB34/A1I'
MAG5;LZSIGPTU[X 6.D>$K[1)'!2PT_5KE[3QQ=Z8J%434H?%DUZS,':^8L!0
M+GCIOK^'J?ZGE%?D#_P1?_X*R^"/^"M_[+U[\7;#PK!\./BW\.?$,/@;XV_#
M2VU";5=.T#Q)<6"ZEH^O>&M1N8H;R[\(^+M.$]WHWVY#?:?>6.KZ+=3WTFE?
MVE>_S2_\%./^#F_]NW]BW_@I3\>OV4?!/A;]G>;X-?"GXF^&/#=IK?BGP)XN
MU7Q=%X8U'0_#.KZQ=7U[IWCO3K*[O;9-4U![=X=)C&Q(4,,C*2X4VDD^C/[V
M**_S4/VU/^#M[_@H%\2_BMXTN_V&/#7A7X,?LY^$M9O=/\,ZYK?PQL_B-XX\
M3:-:SSPV?B7QWJGB.#5/#GAF;681%J$'A[2-.M3HT,D5E=:OK$T<MW+]Y_\
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M,^"/B+PWI,-[\</#4:2S6?CWXY_VE%96_BS5]2M4OO L["STJQM;SP_)%X4
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MEC8_A=^R?XT_X*C_ +,/[*V@?L*>%?V.?AU\8+#X;^&_$?PX^#G[>VC?M!^
M=._9@N_A0+K5E\/?%#QSX=B^W>/S>^"M"GF76?"F@6-UJ.OW^C16<<]G->7-
MXGO7_!M?HFMZ+_P2>^$1UB=KN'5?B=\?]4T*_P#+DA@U+16^+_BNP35+*&0!
MX['4M2L-2OK3Y0LL,ZSIN2568 _>BBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ I&955F9@JJ"S,Q 55 R68G   !)). .32U_(#_ ,%M_P#@LT-2;Q9^
MQK^R3XJFCL8)M0\-_'7XP>'[SRQJ+Q&2RU7X9^!=2MSYAT^.436?C/Q+93(M
M^R2^'=*EDT\ZK<7OD9UG.#R/!3QF+E=ZPP]"+7M<36LW&E33^4JE1KDI4[SD
M[\D9_J'A)X2\5>,?%V%X5X8P_+%<F)SO.L13J2RSA_*?:JG6S''U().4F^:C
M@,#3FL5F6-=/"X>,8K%8G!\-_P %L_\ @LN?B/-XD_9!_9-\5RQ_#^UEO-#^
M-'Q7T&[,8\>7,,GD7G@3P=J-NPD_X0RVDCE@\1ZW:RA/%TA?3+)V\,Q7$WB+
M^5[KUH))))Y).2?4FBOYZS?-\9G6-J8W&3O*7NTJ46_98>BFW"C1BV[16\I/
MWZD^:I-N32A_NIX7>%_"OA'PE@N$>%,)[/#T$J^8YE7C2>9Y[FDZ<(8G-<TK
MTX1]K7JN+A0H1?U;+\)&C@<%3IT*4YXDHHHKRS]$"BBB@ HHHH _TC?^"*O_
M "C%_96_[%KQC_ZLWQK7ZEU^6G_!%7_E&+^RM_V+7C'_ -6;XUK]2Z_IS)/^
M1-E/_8MP/_J+1/\ G<\7_P#D[/B?_P!G#XT_]:7-S^,+_@]6T?4[G]BG]DC7
M(+.>72-*_:=U33]2OD0M!9WFL_"[Q/+I<,[ 81KQ-)U$P[L!C;2*.< ^._\
M!DCXHT"3X2_M[>"TN(AXHM/B)\%/$]Q:[0)Y-!O_  WXYTJSG#;<O%!J&G7L
M9!8B-[A2 #(Q/]%O_!<7]@?5/^"C7_!.7XU_ 3P;:V]U\6]'32_BM\%8[B2.
M%+KXE?#^2>_L-"$\N(K=_%^A7.O^#H;F5XX+6XU^&ZGD2&!R/\RK_@D7_P %
M,/BE_P $;?VTM0^)&K^!==USPCJ%IJGPC_:/^"]^9/#OB2]T.SUB*2Z6RAU2
M)$TCQ]X%\0Z:M[I<>J00I(\>J^'[Z6RM=7NKJ#U#\W>DTWLU:Y_LCURNK^.O
M!'A^\.G:]XQ\*Z)J"Q1S-8:OXATC3;Q89=WE3&UO+R&<12[6\N0IL?:VTG!Q
M_-KXC_X.WO\ @D+I/POE\=:)XN^-GBCQDVGW$UI\'+3X/:]IGC5M32T,UMIN
MH:UJT]M\/;*&:Z*6DNI6WC'4H(,O/'%=*B)+_ /\>OB]^U)_P7/_ ."F][XE
M\+^$[F?XL_M,>/- \'?#SX>Z'=7EUHOP\\!Z/:VVA^'["]U%(XQ'H/@GPI9/
MK?C+Q1<V]I!+)#KOB"XAM1<&! ;DEMJ^R9_<5_P>%?';7/"G_!,;X8^!O ^O
M0MX<^/O[17A30_%5[I%Z+BUU[PEX1\->)_&D6F+>64[6USI]QXGTKP[?S)NF
MCFDTN$8PCU^?'_!F)^QM\(O%6@_M/?MH^-?"VA>+/B5X1\<>'O@M\+[S7--M
M-2D\ 68\.1^+/&>MZ&MY!,ECKGB,:SX>TM=7M?+O[33-+O[&":*WU6^2?],_
M^"]/_!+'5=9_X(6_#+X#? +2=3\7Z]_P3\TGX8^-]'TO3X;B[UOQCX2^'/@G
M4_!GQ/U*UL8DN+B]UBXTG6M3\?W-K&6FF_LN_@MDEGE@A;^9+_@VA_X+6?!?
M_@F3XM^-/P1_:JGU_1?@#\=+[PWXLTKQ_H.B:AXE_P"%<?$7PW:WFD7,^N^'
M](CN-:NO#?BK0[JUM[^]T:QU+4-,U'0=+)TV>SO+RXL@EZ33>BMIZG]D_P#P
M<C_L9_"+]IC_ ():?M(^.O$OA#P\WQ3_ &=?!<WQF^%GC\Z?:0>)/#UYX0O+
M2\\1Z+#K4=I+J+Z'XH\+?VQI6HZ*TO\ 9]U>2:9?RQI=Z9975O\ R;?\&9GQ
MH\4^%?\ @H+\;O@E;7<[^"OBY^SAK'B36-+,T@M4\3_#3Q=X9G\.ZT( XB:Z
MM]+\3>)M+$A1F\C57&<(N/T:_P""^_\ P<?_ +%_QK_8D^(G[(?[#_CO5?C-
MXV_:#L-/\+>.O'UGX6\5>$_"/P^^'D>K:?J_B&UBNO%NE:#J&N^)O%-M8+X=
MALM,T^XTVPTK4=6O+_4(KN&SL;GP#_@S#_8K\:W7Q7_:#_;T\3:%J&F?#S1/
M <OP!^%^JWEM);VGBSQ;XAUO1/$GCR]T:66,"]L_"6D^']'TB]N;=OL_]H>)
M6M!(]Q87D,(#LYQMKWM\S^>C_@NO:1W_ /P6?_;NL92RQ7O[1D]G*R8WK'<Z
M7X<@=EW!EW!7)7<I7(&01D5_JL?%O]ESX&6'_!/3XC_LO67PY\)P_!G2OV7?
M%GP_TWP>- TL:5:Z1IGPWO[&PO([**VCMTUBVG@AU>/58ECOUUN,:JERM^!<
M#_*Q_P""Y/\ RFL_;B_[.77_ -(?#%?ZZ'QE_P"3>/BM_P!D8\<_^H/JE 0W
MEZ_JS_(__P"#?/X.?#OXX?\ !8/]CKP#\4/#6F>,/!EOXT\7>+KGPUK=K%J&
MCZIJGP^\ ^+/&/AE-6L+E7MM1L;7Q#H>EWUQ87<4UG>BU%O=P36\DL3?W&?\
M'=7PH^'_ (B_X)-7_C_4_"VBR>,?A1\</A)<^!?$2Z;9IJ^@P>*-6N?"?B#3
M+#4%B6ZMM*U?2]24W^G0R+:75SIVESS0O+86SQ?QA_\ !LU_RFR_9%_Z^_C)
M_P"J:^(-?W _\'9O_*&GXK?]ED^ O_J>6U"_K[F)?!+^NQ^0_P#P9",W]A?\
M%'$W-L&L?LOL$W':&:Q^.H9@N<!F"J&8#)"J"2%&/YQ?^"_&AS>)_P#@M_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-U<Q:I:RQZ=:I:?8;?1VTC^R-*DM/U_HH _G<^.O_!$/]I+]J_2/!TO[5/\
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MI\76&F6_B#Q!!9Q6]O':Q:MJ%W';QP0I$J+$@7T2@ K\DOC]_P $O?%'B/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_/#]CG_DY?_@I5_P!G
M,_#[_P!9M^$5?H?7YX?L<_\ )R__  4J_P"SF?A]_P"LV_"*O/Q?^]Y5_P!A
M.*_]5U<^XX9_Y);Q*_[$'#/_ *WN4GZ'T445Z!\.%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME%'^OG$__0=2_P#"+"?_ " ?\27_ $=O^B-S+_Q,.)__ )K/[,_^(I'X2?\
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M[/(SNV]%K\E/^(I'X2?]&E_$'_PYWA[_ .9.J/\ P=*_\DW_ &0/^QS^+_\
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ME%'^OG$__0=2_P#"+"?_ " ?\27_ $=O^B-S+_Q,.)__ )K/[,_^(I'X2?\
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M_P 0];\<S^,;34[/P9:1VJSW.B>&;SPC-9Q^*/MLVG^)9IYKG1X6TF"SU/5
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MM\%O"MYXN\=^+KSR+*RMPT=CIMC#M?4=?U_42C6^C>'M&MB;O5M6NRL%K H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-/\ '=OK(\/S>'I-2L? EUH<EQ'K!%BUU!JDNGB3+_:_)!D'YH_LZ_'+4O\
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M:&[FLVL;CYI\0?L3_P#!37]M[QC\$- _X*,?$/\ 8]\&_LY_ OXM^#OC7?\
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MT?\ #,'[2?\ T;]\:_\ PUOC?_Y1T?5<5_T"XG_PFQ'_ ,SA_;^0?]#[(?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQTK3'M]-6XFUW^CZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7YX?L<_\G+_ /!2K_LY
MGX??^LV_"*OT/K\\/V.?^3E_^"E7_9S/P^_]9M^$5>?B_P#>\J_["<5_ZKJY
M]QPS_P DMXE?]B#AG_UO<I/T/HHHKT#X<*_G _X.:/\ DS;X-_\ 9P^E?^H!
MXYK^C^OYP/\ @YH_Y,V^#?\ V</I7_J >.:\#BC_ )$&9_\ 7B/_ *?PY^T_
M1U_Y/CX9_P#934O_ %6YV?S _L[RRP?L+?\ !0*>"62">'4_V2I89HG:.6*6
M/XG>*'CDCD0AT=' 9'4AE8 @@@5^C?PN_P"">'QC^)7A3]DCQ1+_ ,%-%\.R
M?M2:#J^NW6EWOBSQ-<7?PW.F^ -0\<_V?J1;XEV9UF^9[)="NTDCT(V=_,S@
M7)B$$OYP_L^?\F)?\%!N_P#Q,/V3>/7_ (N9XIK^E/\ 9D^%?C"_^%O_  2B
MN8?V0?V0M>@UOP+XJN+35=?\4B#5?&\/_"A]?O(M6\>1#X#ZO]CU.XMA_;DD
M27?C4C7ML3SVQ']IP?F>3X:GBI0A4IU*D8X3#M1ISQL;.IF[HR;^IU*<GS4Z
MDH+VETN;W+5'%K_0/Q8XIS+A1YUBLKQ^!R^MB^.<_HU:N,P/"&,]I3P/@_DV
M;4(4_P#6W!8RE3]CC<+0Q4OJ7LYS]FHXOGPCE%_BK^U%^R!\6_@;^RQXF^.]
MY^WW+\5;>W^-_CKX$7GPOTCQ;XCGNM;TWPUXV\;^!9O$LD\OCO44N-+URW\(
M_P!LMI$FC3P)I6MVJ/J-TBF2?]P?^#9#6=5O/V4_CQHUUJ%U<:7H_P =8Y]*
ML)IGDMM/DU3P/X>;4#9QL2L"W;V=O).D>U'EC,I7S'D9_AS_ (*+_#_Q/H7_
M  39\9ZUJ?[-?[-GPZLXOVY/C#ITGC;X>:^M]XYL[B'XW_&>UD\-V5DGPD\,
MJWABPN;6?0["?_A*[=GT/2-)E_X1S3PXT_3_ +1_X-A_^39?VBO^RX:9_P"H
M+H]>SDU&.&XIR^G3C4IQGE]6<HSGBI.3G1Q7,_\ :ZDZG+)TH:1?L[PO&/,I
ML_+O%7/,7Q+]&/B_,LQQ&!QV)P_B1EF!IXC"8/AG"QA0P689.L/2MPQ@\+@9
M5*$<QQ<55JQECO9XF4*U3V3HP/Z:*_FY_:H^$.I?\%&/^"P%S^SD/B/XS_96
MT_\ 89_9T\+?%&S^.?P O8O!7[4WQ U3XTWSVDOA3PW\4IX;Z/P_\)=$M)]V
MK:5_8>M"Y\4+.2(CJ3267](U?GG^U_\ \$U_@I^UYXZ\(?&6X\=?'']GG]H;
MP)H$_A#PU^T+^S+\1[CX7?%2+P9=:B-5N/!NL:C_ &=K6B^)/#1OVGN[;3]=
MT2^?3[FZN)M/GMC-*'_4C_.0_&'X2_![Q+^QG^V7_P %!?\ @GKH_B_7/VEM
M8_:S_P""?GQ&_:BT']H[XG2_\))^U1:^(=-M];^$>G?#'XO_ !#@EA7QGX>-
MQJ']I>"9TTGPZ-)DN8[:'3Y#J,LZ_I?_ ,$7?&_A$_\ !'?]D3Q0M_8+H'@_
MX#:I8^*)GFABM],OO >K^*-+\8P:DQ94M9;#4=(U,7XN"CQE7DFQDD_0_P"Q
MS_P3N^"?[&FN>/\ X@^'?$_Q<^-/QT^+%OI5C\3/VA_VA_'UU\3?C%XPTK1
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MX@Z=KDOA?2M?&J^&]<DT^"_&ABWMM>M[72;;3+2*W>PFO]5_H\K\H?C_ /\
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MTUW/$1"/K2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[X/\*:1XMU3Q-<R/')<3W%]HL?A\7VB:=IUI#/?:MJFN0Z;IVE6<$MQ?W,"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1C*"E["OBEE.6X&6)E1E*52G&M.4%5Y:LHU*E.E*D4445[)^5!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\;_\ P=*?\E%_9"_[
M$GXK_P#I^\%U_9!7\;__  =*?\E%_9"_[$GXK_\ I^\%U\AQW_R3&/\ ^OF#
M_P#4NF?U-]##_E(C@O\ [ .+?_68QQ_*/1117\_'^X04444 %>K?!+X)?$[]
MHGXG>$_@_P#!_P *:EXR\>^,M2BT[1]'TZ+<%!^>ZU'4;IMMMIFCZ7;++?:M
MJU]+!8Z=8P3W=W/%#$S"M\'?@[\2/C[\2/"GPE^$OA74_&?CWQIJD.E:%H6E
MP^9++-*2TUU=3,5M[#3-/MUEO=4U.]E@L=-L(+B]O9X;:"61?[YOV'OV)_@'
M_P $B/@#!XM\:!?&?[0'Q CTG1O&WB[1M-_M7Q!K_B&_7[9:_##X964HAN(?
M#>GW$+LTA-I<>([JR76=8\LIH^D:9]1PQPQBN(L6HI3HX"C*/UK$J.O?V%"Z
MY9XB<?6-&#=6KIR0G_._TAOI"</>!G#?M)_5\UXUS?#UEPUPXZR2?*I4GG6<
M^RG[;"Y'@ZS2;2IXC-<5!9=@'S/&8O!>M?\ !,+_ ()A?#'_ ()Y_#$<:=XR
M^/WC/3;7_A:'Q/\ LQ.#\ER?!O@PW,:W.F>#M,N0I+%(+[Q)>P)J^KI&(M+T
MS2/U+KY=\ ?M0:7XI\?:7\,O&/PX^(?PH\7^(],GU?PG:>-])A@LO$EK:6\M
MS?06%_:7$\:ZA900227-K*BI'M6)YUN9;>"?ZBK^@,)@,/EF&HX+"T8T*%&"
MC3A&S376<IIOVDYR3E4J2E*4YMN3V4?\0.*N+\_X\X@S3BKB?-,1G&=YOB95
M\;C,0VFGM2PN'H:4\'@L)1<,/@L%AZ=+#X7#4Z=*E#^)4KE%&<?S]3^74UX=
M8?M ^"-?^'B?$_P9I_C#Q]X6F\177ANT/@SPQ?ZOJM]/9:C/IEWJ5II3_9;Q
M]&@N;>4O?.D8,*B5(G5X]_2HM[)O5+RN[V5[I:V=M>C/G'*,=VEHW;K96N[)
M-NUU>R>Z/<:*^<M8_:+TZR^,&I_![1? ?C?Q9JOAK1+/7O%^L:%96DVF^'K3
M4-/_ +3LHI(IKN.[O;JXMGMO*@@B#3S74=O:_:)EE1/9_!WB>+QEX;TOQ+#H
MOB+P]'JD<TBZ-XMTF70O$-EY%U/:LFHZ5,\DEJ\C0&:$&1Q+;20SHQ2533<)
M12;5DTFM5LTVM+MJZ3:NEI\KD9QDVHN[3:>CWBTFKV2=FTG9O73O;IJ**\=M
M?C)I%U\<-1^!B:3J2ZWIO@6+QW+K)>U_LM[&;4;73DLE02?:_M1ENM^3%Y02
M&3<RDQATDW>RO9.3\DK7?XH;DHVN[<S45YMW:7X/[CV*BOGKXW_'^V^#.L_#
MKPY'X'\3>.M>^)EYK]AX?TOPRUB+EKKP_#I,]Q$Z7L\19IX=5$D/EAE5;6?S
M60F(/7^$7[1VC_%#QEXH^&^J>#/&'PX^(7A33[;6KSPOXRL[:WN+W0[HVB+J
MNFSVMQ,ES;Q37UI%-O2$9N(FMVN$$S0U[.?+S\ONV;O=;)V;M?FLGHWRVOU)
M]K#GY.;WKI6M+=KF2O;ENXZI<UVNA]&T45XS\)OC1HWQ:U/XEZ9I6D:EI<OP
MR\<:EX&U.34'M734+[399HI+RR%M+(5M91#YD8FV2A9$#JKAU64FTVEI&UWV
MN[+[WH4Y).,6[.5^5=^57?W+7H>S45XEK_QOT;P_\8+3X.S:#KM]K-Y\.-3^
M),5]IL4%U#+I^EW>HVDNE6UDLHO;K59Y-.86T,<829[BWC1V8R>7Z-X.\41>
M,_#>F>)8=%\1^'HM42=UT?Q;I$NA>(;+R+J>T*:CI4SR26KR- 9H 7<36TD$
MZ,4E4TW&22;5DTFGIL[VZWUY7TZ=.J4HMM)W:;36NC5KK:VG,NO7KTZ>BBOF
MS]HS]IWP7^S;9>%;GQ3INK:W=^+-0O[:QTO0_LK7\5CI5M'/J>JRQW,T0-I:
M-<V<#;"6:6Z0\1QS/&1C*;48IN3V2^_\D$I1A%RDU&*W;V6MO/J^Q])T53T^
M_L]5L+'5-/N([NPU*TMK^QNHCNBN;.\A2XMIXV[QS0R)(A[JP-7*DH**** "
MBBB@ HKB?B+\0_"GPJ\':SX\\;:BVE^&]"B@>^NX[6YO9?,N[J"QLK>"ULXI
MIYKB\O;FWM8$5-OFS(9'CC#R+U]M<)=6UO=1AUCN8(KB-9!MD"31K(H=<G:X
M5@&&3ALC)ZT[.U[.S;2?2ZLVO5)J_JA75[75TDVNMG=)V[-IV]&3T45B>)?$
M>C>$/#^L^*?$-ZNG:%X?TV[U;5KYXYIEM;"QA>>YF\FWCEN)2D:,5BABDED;
M"1HSD K?1:MZ(;:2;;LDKMOHEN_D;=%<_P"$_$VE^-/#'A_Q=HC3OH_B;1].
MUW2GNH'M;F33]5M(KVS>:VD_>02/;S1NT3X="=K $$5T%&VCW6@)W2:U35T_
M)ZH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGANZ">-_AS?3Z;X:TC0_%$U]\'OA)=P7MOH<&LZ7/XQ\7QQZ;XON+JWEE6,
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M^%/A)X)U.Z\.Z98)-8V6O^+S<:_XGU".\UU]%2_N)[NZFMK9  ?T8UXG\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!'2O$7Q&NO&6E^'I/VLOVK/%W]HIXGUI]>NK:&XU+X4>!M2\2W%R\.ERWO\
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MG^H'_@F5_P $JOA+_P $[?".H:C!J$7Q'^._C"QAM/&_Q2NM.%E%;:>KI/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MPM^RKX,\7>&OV@O^"@.N^(?#6MZ)HOCG]H3P1KO@S5=4T^XL[#Q3HME\ OA?
MH=WJNA7,R+'J5A;:SINH:7-=6Q>)+ZRN;8MYD+J/NFBL*M!5:N&JN33PU2K4
MBDDU-U:$\.U)O5)1FY+EU<DD]#V,OSBKEV6\09;3H4JM/B#!9?@J]6<JD9X:
M&79UAL[IU*,8>Y.=6MA8T)JK[L:4Y2A^\40HHHK<\<**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
5** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %I!YL# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HIF\>A_3_ !I] !13=Z^OZ'_"
MG4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ )P"?09J/S/;]?_ *U//((]0:CV'U'Z_P"% "^9
M[?K3@X)QS_G\:9L;VH (89!__7QVH EHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHIK-M.,9XSU_^M0 ZBBLC7+\:9IT]VQVB)2Q).,
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M!:5J$I+-)%$22<GYHU/7_/\ 6@#UVBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1C@$_YZT +148<
MD@<<D>O^-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWICVD8.=^.F/T[=@>E?KW^SE^QM(UI:^(;/3Q*S10R@I&2>F>,+S_P#6'TH
M[3X8_L^^*O$^BV]ZTUP\K1H_5R<[0?Z\G/M6KKOA#XD_#&<W%F;X+;G<"HE_
M@).<@>W;.*_4[X!^!=8TNXM=)N--<1@I'S$0,81>01Q_GVK]5/#G["FE?%S1
M=\VGPF6> 'F(9!9>/X<]3T/O0!_-9\+O^"D/Q.^$.I6MK=7U_"D$L:G=)*
MI^HZ8_SS7[V?LG?\%D[O7AIFGZQKK*7DA1A+<GV!ZM_GZ5\S_M.?\$8KZ&WO
MM4TG3""BRRH8X3U )&,)_0$ ?G^#WQ3_ &??BM^SQK<TEA#J$*6=P[+L68#]
MVV1T'MGB@#_39_9O_:]\%?$G2+3[3KEJTMQ%&0QGC)#,/=L]<],\?3-?<UIJ
M%CJ$2365W;W44BAD:&57#*1G. <C@]" :_RA_@3_ ,%1_B9\'-=L-)U74K^W
MC@FCB8232(,(RJ<DL.V?IR?I_8E_P3B_X*B:9\6H=&LM8UM9))%@1A+< G+
M#'S.?\\?0 _IL,0R2/J.3G]/>FUDZ!XDTGQ'IUIJ.FWD,\5U$DBA)%+ LH)7
M&><$\$9R,=#D#<* DGGF@!$Z'Z_T%/I  !@4M !1110 4444 %%%% !1110
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MD'T]/<5)31@G<.X_#_/%.H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/''A;196G$K-:6XR6R3\BCW_ ,]<]: /L6BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *BWGT'Z_XU+5>@!^\^W^?QI5+$Y)
MX[]*:JD_3N:D++&A9F"JH)+'H!ZF@!W3K7SG\=_C3H7PX\/7TMQ?0Q310R.Q
M,BJ054G R>0,<^I]A6Q\5_C;X5^'NDWDEWJ-NMPD+GYI%7;\N< $@D].>/\
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M#?\ !8C2;35;N/3?$2;1*X7R[H8(SQC#]3QT^E ']GMO\3?!=RX2'68&8G
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0O\
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M/V;?V?\ 1OA+X9L+6"QA@>*"-541JIRJ@>@X'K7U8W"G''3I]13@      ,
M#@ #H .P%! /!H @!)(!)(R.]3;1QQTYH"J.@I: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB6X0*"H;G&5Z$=R1ZCM7\XW_  4"_P""H^DRZ=J]EX=UR+S?+G1%@N%Z\J
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M -;O7^H];_\ !-;X*P6Z0#3[#Y4"G%FN,@ ''R]#[CGVK\J_V]/^"1'@?7=
MU:\T+1+67S(9WADAMDYRK$'A<Y[$'!SG(]0#^0G]AC_@IWXJ\%>*M+TSQ!K5
MU%LN88V6:=QT8#!#-_D^]?WS_P#!/[]L#3?C-H>CHFI1W$D\$.1YP<DLHZC)
M.#W_ )GM_F2?MM?LK>)OV;/B/=7FG65S:0V=\[@QQN@ CDXY QT_E7[/?\$9
MO^"@[^"O$&B:'KVKM%Y4L$+)/.5Y#!3D,P/U_/VH _TO< \X!]#P>*A/4_4_
MSKYT^!G[0GA;XL>&](O+&\@FN9[:$,8I5;<2BX)&3D]N, \=\Y^DB >H!^M
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MM?H_;V\5K!%;PJ%CB0(B@8P /Z]: &6=LEG;16R8VQ($&!@8 JS110 4444
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M%2*, #:H4848'  [5L*JHH50%50%4#H !@ ?04QV[#\?\* )**1>@^@_E2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_"[4+:&TGL8FA=0-K1J?DQZ'KQ_G@U^(G@7Q!XMUGP_#8Z.ET6>!441[^#C
M'']/;VK9TS]F7XZ^.-8AN+2TU=XY) P*I<'AF!XP/?\ EZ8H _N(_8T_;^\.
M:Y-IUC:7T!5FB0!9%(P=H &#P.<_TK^D3X3_ !+L?&FA6DZ.I9H8V5E(/# '
M!&>G.01[CFOX'/V"OV3?C%X6U#2+C4[/4T"R0,QD28=&&>H'H<_X]/[0?V4/
M#^NZ)X?TZ#45E5E@A4B0-V0#G/?_ #Z4 ?H0"",CD&L;7-"T_P 0V,EAJ,*R
MP2!@00&QN&#P>#D5JQ?ZM/\ =%24 ?R._P#!8G_@GAI7BW3=?UO3](CD?RKF
M97BMU/5=P.57ICOU([5_ -X^7Q5^RQ\8'6T^U6,5MJK !=\8 2<#'&!Q_+]?
M]EKX_P#PGT[XF>$=2L[JVCGD>UE3#H&.#'M'8DCC'X\]:_SF/^"S/[#D>A>,
M=9U>PTO84NKB0-'#CD2,V<A?\]R* /U5_P""*/[>&H>-!H&DZIJKR;3:Q[9)
MB>@53P6].*_ML\+^([3Q!I=C=V\BN9K6"0E6!RS1J3TSR2?IUY]/\H'_ ()@
M?$'4/@_\0=.L)II+80WL2;68KC:^.<X_SQZU_I#?L._&%?B#X6T0-<^<S6L
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M:OZ<O!O@S2O!NDVNFZ=!'&((E0LBA0, # P!T QG_P"M0!T&DV,>EZ;9:?&
MD=I D*J,  +U _$FM#(]1^8IC]OQ_I4= $^0>A!_&EJ- 03D$<>GN*DH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG@CC^==&OW1^/\S0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%-+@''/^?QH =130P)P,TZ@
MHK(UO6;+0K":^O9HXHXU)&]@NX@9XR<D#'.*\#_X:%\/R:G_ &?#=VK-YFP
M,A.<XQ^?<T ?2=%8VA:M'K-C'>1,&1PI!7&/F!/;]:UF?:P'J,_S_+I^- #Z
M* 0>110 QR, =\Y_#FA5QR>O8>G_ -?_ #UH926'I@9_,U2U34K;2;&XOKJ5
M(HH(V<ER "0"0/TH AUK6+/0]/GU"]E2**%&;YV"@D#..2.,#FOQY_;2_P""
MD/A3X0Z!JUE#JUI!+%#,N$F16+*C8SALD]< D_05X=_P4;_X*-Z-\(M&US3[
M;688I8H9T54G52"J,   >,=/QSZ8_@>_; _;K\=_M"^.;_1-"U"]N8[J[DA
MAED<$.Y7@*3SS_7TH ^E/^"B_P#P56\3>.-0UR#PYJ]U("URJ>1.Y'+/CE6_
MSQ7X'Z%^UG\7AXM@U2;7[N5)[U6^SI--N16<$X.\[\=3\JX&3GCG]@?V?/\
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M*,?I4U 'E^A?"3PAX?:-K"QBC,9!&V%%Y&/3Z?\ UJ],BBC@C6.,!410 !V
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M **** "BBB@ HHHH **** "BF;SD@+G'O_\ 6IXZ#M0!&JXY(^G^/^?\*>2
M"20 !DDG  ]23P!56]OK33[>2ZO)X[>")2S/*ZH,*,X&2,GV&?RK\UOVGOVT
M]$^&MAJ$5IJD(:%)<!)E_A# =&_7B@#Z?^-/[07A[X76-S-/J%K&\$3L2TB
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M]G'4_A'X6T&2^MGMW2VMB0Z%>B#U _&OWCH B*L2>.Y[C_&I%!  /^>:6B@
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MO!MKX)\+V>DVT2Q+''&I55"X"+@#   Z_I7HS D$#_/-*  ,   = . /PHH
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MKD'H:_SU?^"R_P"W%JWCGQ+K.B:%JDDRRSW$(2&8L/F;;T5CZX_^O0!^:?\
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M 1PPP,-[_C[]*_SY_P!I#X_ZO\9_B=',US+=QW^J!2/,9PPDE/0Y(/7^O;D
M]H_8J^ 'CKXU?%73=4%M>7,4FI&8MMD<$27"$9.#U]OUK_3E_P""37P'U/X5
M>#-%^WV\D++8P@^8A7D(H[CW.*_G&_X(*?LO:/XB.A:IJ.E1N[BUDW/"&.24
M8X)7\>G0^E?WB>"/!.E>#=(M+#3[:.$PP)&=BA0, <#'T _.@#MJ*** $  Z
M?Y^M+7#>,_'FA>#M.N+K4+^WADCC9@K2)E<#.6R>OH/7K7Y"_M'_ /!3OPW\
M+5U"*/7+=/(64#%R@ VAAP W3C- 'ZL_%+XJZ%\.=)GO+Z^MXIHHWD9'D0%
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M /K@'TG^W'_P4VL/#FD:IHNFZL@D6*>)5BF P0'7@*V>QX]3GZ?RK_$?XO\
MQ!_:(\936MA)?7%O>7;<(TCJ0[GTR#U_Q[US1G^)'[2WBQC&+ZX@N[L@8,C
MK)(>,<COFOWR_8'_ .";EW%)INLZ[H[.1Y,SM+!GN#R67W_^MZ 'G_[!G_!.
MV^\2C3=;\1Z.\H9H97:> G.XC.=RG/'7K7]6?P(_9F\!_#/P[8I'HEI]K$*
M#R$7;A<9.%R>>@!'3))&!7?_  ;^$GA[X<^%[*QM-.MTG\E%8^4HVA ,8&.I
M/4GT]Z]K^ZN% &,  #@#T ']* (;:UM[.)8+6%((EZ(@PH[58I!GN,<_I2T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1/\ >^@_^O\
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MFB<# )S[YZ<8SDBO\]__ (+L?%6R75-?%I>(Y5KG:%DSG&_ X/\ G\Z_:O\
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M5/KC'Z=/7-?WM_LE&[;P':M=[O,-G!G=G.<1^OT]: /K$< #T I:0YQQUI:
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M!)V((,X'0.1WZ5^8?_!3'_@JGK_Q*O-8T"RUJ62*5;M%VW#$?>VCHV._I_\
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MSP">H&3BN7_;[_;HT/X0>'M7T'1M8@1H;:XA6..=1@@.H&%?(X[=^,>_S_\
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M1^_9SLO"/P\TJ\O;!4EALH&):, C"IZ@'OT'?OVK]]XXHX(UCB0(B+A54
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MMY4#;(&SDCMN/Z&OX)/CU_P4CU7Q'\2)=-T_69'1KZ1 $G)'^L*]F-?T-_\
M!)WXI:WXYGT>:\GEE6;[.WS$M][;Z]?\\9H _I^!R ?4 _F* .2?7'Z"@#
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M#WPMTKX7>&;?1K&U@@D6*-',2J"%1<;<KQR>3] ..:].O=3T_3HVEOKR"V1
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M6_3Z=2:];B_X*5^$C&&_X2"V[?\ +TA[GL7X]\]?K0!^\OG1?\]8_P#OM?\
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M/GJ> ,GH?T[T 8=[XFCTV;;<,$"GDL<#C(QSQ]>GOTK9T_Q-HNHJ/)O[<2<
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MTZ4=.E% #22"H]3_ (4.BR*R.H9'5D=3R&5@0RD=P02#[4I&2#GH<_R_PI:
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M\"6ME! L)^S0H0%"X 5#@<#T&?UKZE;H?H?Y5R7@O35TW1+6()Y?[I!C '0
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M;9<YX'7;UKZNM_\ @FSX:$2(- MB5 '_ !ZI_P#$8'3!^F:_98 * J@  8
M   Z  < #T%,EFA@4O-+'$@ZM(ZHO'NQ _6@#^?;]HG_ ()G>&#\.]<NW\/V
MR^3;288VR <Q29YV^PSSCVK^"3]OK]FC3?AW\1M4CTZVBMVBU"XP(T"D%)6
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M)XVX(YR,?Q0_\%*O^"L.L:EKFLZ%X<UV216::W007#-G!*# 5L]OI0!]??\
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M_@BM?:?=6EW>Z.S;&1R7@)Z9/=?I^G7M_4]\)OV=_#/@.TAB;2K93"J@+Y*
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M]\-OA_I_@;2(+*VMXXI(XUC&U0I   /3ITP,]J]+H /I2 8&,Y]Z , #TI:
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MNFI=V&F^5!&LK?(A("+P2O( (R1TR!UQP .'PN\+Z)X1O-/:SME2#3[C+"-
MH*6[X&<#/(]/TK^%[_@M9HN@+JOB&W@:&-?-NUPNT#&YR.!UQ]*_K?\ VK_V
MW?A]\.?"FKVUAK5JTRVETDDGGQAG8Q.G WX"C)P#SG.3GA?\Z#_@K)^VM%X[
M\3Z['I^HB;?=7041REL[F8#H3_\ 7]* /R:T?P?H>D^(I=1D>+='<R2 Y7)R
M^[/;&<>U?IG^SI^W>?@=?V5O9ZH;>.V9 -LNW 0\=&';_#I7XG:5JOC'Q7?0
MKIT5S+]ID ^0.WWL^GUZ^_I7N]E^R[\5?$5H-0AL=2R\>]2L4QSP#GH3W_\
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M*T"VUI)G"1X4)$>3C/I7\L'_  6H^,6D^%9]:L+=H(EC-PF%VK]TL!P,=O\
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MY,I*(2'N&!SCG.6XX]N>G:O/_B?_ ,$7[GP^MS=V6D/&R;V79"1TR>P_E_\
M7K\Q?B]^Q/\ $+P$]U#IUI?H(BRCRXY!PN?0?Y[@4 ?T0^#O^"NL5S=1)<>(
M< D YN>!Z_Q<?E[]*^R?#G_!4+0;NR1WU^$L44Y-R"<\9ZMU]>/YU_"1?_#+
MXS:#=M)%#JJA'.,+/V^N/3\:[30M4^-]F@@_XFX"@#!$_101P/H/Z4 ?W6:9
M_P %,] FNE5]>AVEL<W QC(]6]QW^M>Z:/\ \%&O!\ENC2Z];9(!.;E/3O\
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M-=Z!9WDMZ(TEME(<R#@;?7^?K7^A;^S5K5WK7@FTGNRQD^RPD[LYR0@[\]*
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MBYM2L+<$S7<,8'4LXQ_6N6U;XC>#=&B>6^URSC"!B5$@W?*,G[VT#\37X/\
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M+MXI(H83N>)$.X*A_B7)/'Z?C0!I_LE?L<Z3X=^&UGIUSID2,ME"F'A5>2B
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MP4&^+_Q4U V$5]J<L=S+LPKS'(8D'N>,'_(Q7TO\!_V5_'7[0S0W6L6U[/\
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ML04;9@GW%R.C=L=OTKQ#Q5_P< >,-3U-['1?$5VXP8X_*N)-K,"PVJ0V">Q
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MU_H*B)).34J?=^O_ .K^E #J*** "BBB@ HHHH **** "BBB@ HHHH ****
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M4<MYWFC/4?Q=O7\_8 'IW[57_!4[QAXSNM2TP:Y=.)I)H\"=R"&)'][T./\
M.#^7'A_P9XW_ &D/%JR;+R]6\N\Y(=\B1LGKGU_QKA_%7PYN=5\<1V;>8YDN
M@I!)/63G//X]O>OZW/\ @C9^P!IGC630K^]TI)BYMG)>$-G(4\Y!_G_.@#@_
MV /^"1U[XI.BW>L:"S!C [&6WZ[E3^\OO7]47PI_X(Y^"[?P_:1WFBV4>Z!%
M)FBB0?='=@,_AV(]<U^KWP(_9=\+?"O1]-2"QM8IX88OD6)0PPHZX7 /''?!
M[#K]<(BQHJ(H5$ 5548"@#  'M0!_+'^UQ_P1M\):3X3O]9TK1+1_*AF?S((
MHF&X1EL;DSR,<C.>>?6OYT]%\#R_LY?%J&,VYMH+/41P5VKB.3'; ' /]:_T
MBOB?HL?B#P5K.F21"47$# *5W8)5ER!]&Q^/K7\97_!2G]FR\\-7^L>*+:Q>
M()+/<!U0C #,<Y _'(^N.@H _?'_ ()V?M<^$O$WP^TOPYJ%[ DI@M]C"1=Z
MR!0G()&00>02"3@@C&*_7JSO;74+>.YLYDG@D4,KH>"",C(ZC_.,U_FY_L<?
MMBZM\/?B+8^&I=2EA6.^A@V&5E&!*%QC.?\ (K^]_P#8[^(__"QOA=I^JM-Y
MSM;6LA);<?FC /.3W(- 'UO7S3^TM\3(_ASX.N;]IA"4MI9BQ8KT#=#]%_(G
MTKZ5) !)Z $GZ#FOQ/\ ^"M_Q>MO!_PUU..&Z$;1Z7*#AP"#Y1)Z'W/ZT ?R
M=?\ !7C]N74?&%[J_AZQU61MY>W"I,QX'R8P&K\/_P!D/]D_5?CO\4;+6=3M
M9;N*YO<LTBEQMEF1OXL]0?\ (KR?]I[XUP>-/B[J-O=7IDC74W#!I-P ,F<8
MSTZ^OTXK]H_^"<_Q9^'7@*VTV^NY[))XA'(2[1@[@%())(_S[T ?U3_L%_LA
M?"[]GWP%INN:U8Z=:S6ME!,S31Q(050-R2!W'_UZ\'_X*1?\%//!GPG\*ZOX
M=\*:Q:PS06]Q BVTRJ<HC(!\I'H,8&?3@U^>?[5W_!3X:-X'N=%\(ZIM;[(8
M46VFP<["HQL;WX!%?RZ_$'Q)\8OVH_'\UO(VJ7=K?7;K@&=U*RN1C)R#P?\
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M/P/H_A.W2&QMX5,:[594 P   1P.0.GIVKM: /C?X<_LC^$_ B6Z06=F! %
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M^7XBNMCA6 !4 48XQP,?Y_SZ@%INGXC^8I:0<@9]!2T %%%% !1110 4444
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M%4#.!UP,#/%?R9?\%UOA;JGC'PWX@EL[-WS#<LI2,GC:Y[ XZ_EZ4 ?Q ?\
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MU$^P17/.1N (VMWQ^'%?R\?M3_\ !3+XG>/-8OM.T75]1FBG=T0132G(9F4
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M.BCC].O7BNU^$/\ P1M5GMX+G2#MW $-#GH/0@?Y_.O[5]<^''A_7)&EGM8
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M]L>_].U?WX_L2?L:VGAWX0Q+?::GVAM-&?,B&<F$<'(R>3S]/QKY _X)J?\
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ML@!5@P(/0[ACGV_GZ&OA;XW?L7^'_BG#<+<V=M.9E?<&5&)+;NQ'.<U]^T4
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MXZ#T]N.?I_=%_P $F?VC=,O/A[HVAWE]&Q>U@C96D&2=BCOWYX..O%?S:?\
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M R =\#IC&1^'K7T/32P'^ H5MQ/H,8_6@!U%%)D>H_.@!:*,@]#FB@ HHHH
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M*$E$50"B*K;2 .,@C/<5VS-M(&*<2!U('UJ ]3]3_.@"8$'I2TQ.A^O^%/H
M**** "D) Y-+1@'J,T 1,P/ _&I:3 ]!^0I: "J&IZ=:ZK9S6-W&LD$PPRL
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M=+2 G*;2/W8YZ9S[=Z_1N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHI"0.IH 7(Z9Y]**80=X..,=?SI)9%AC
MDE<A4C1G8DX "@DY/X4 4=6U2UT>REOKMU2*)2268*#@9/)]!UK\[/VC_P!O
M[P'\(]"U-/[0LX;V.*=-YF3> %(XW-@9[X&<<9 S7FW[=_[8VE_"WPMJ]O'J
M$4,D%O. %D52"$(Z ^H]SZ5_ +^W3^WOXX^)OC35-$T'4;V:.>YFA5899&!W
MN5& K$>_Z>E 'Z;_ +>__!063XW7VKZ+HVHFY%R\L*K%+O!#EU' )SU''?%?
MDS\)_P!@;Q#\??&,&M7FDW%RES=I-N:%F!#R G)*GKNZUZW^P;^R5\1?CCX@
ML=6UBQO[B&XFCF9I8Y'!5G#'.X$'@]:_N/\ V%?V"_#/@K0M.O-8TF&)H((G
M<O N\E0I  8<DGCK[D\4 ?EU^Q-_P1]\,66E:9_:_A^ .8H-WFVJCLA.=R9S
MU_4G%?MG\/O^"9'P@\+B">[TO3?,15S&EK&[9 [G9M'H?FSP<BOT<T3POH/A
MFW$6EV4-K'%'@O@ JB+R20   !DG'0=:^%OVOOVU/#?P)\*ZG+!J%O#>0QSJ
MTOG(' 5.@.?E[YQU'RF@#Y*_;(^'GP0^#?AC4%6'28)8+:48VP(RE488XZ$<
M#^5?Q$_MM3>&/BSXJO\ 1?#<<,_FW4D2+ %;),FT8V@\\_TKW;_@HC_P5(\4
M?%K7=4T#0M6N9Q/// JPS.V0SE> K$8Y_P :\T_X)\?LW>-_C?X[TO6]>L;N
MYMKF]BE9IHW92'E5^=P/8_ATH ]-_P""<W_!+6]\1>*=*\17^AL]N]U;S%GM
MR05:16ZE3QC].E?WP?LO_LI>#_A9X&T:%M-@BNUMX2JK"@8!% R3@$9(X'/3
MM@9I_LC_ ++OA'X8_#S16ETR%;Y[:W8 1(K+L1<L25)Z]!Z@GC'/W/'''!&D
M48"1QJ%1>@ '04 -@@BMH8X(4"11J%11T ']?>IJ86.[ Z9&3UXXI] 'P=^U
M_P#&B#P)X5U=#<K"4M+E -P7HC#U'N3R/I7^=-_P4U^)X^)?Q.OK>.?[1YFH
M2K@-NSF0CMGCDY'U^E?U[?\ !7/XFW?AK3M;M8KAD_=W*X#XR-K =_?_ /77
M\/.K:=?_ !0^+9,F^<2:B2<Y8#,V.G..W]: /W^_X(:?!OSM8T:\DM/OS0.2
MR9^\RGT_S^=?W@>'=*ATG2-/M(T"F&T@0X&!D1KD<>G2OYG/^".GP<'A6ST*
MX>U"$+;,24P>B,>2!USS^G7%?T_@   < # 'H!0 4444 %<]XI2&31+Q)PI1
MHR"&Z=ZZ&N)^($CQ^&[UH\AO+?!'7(7('Z?I0!_,+_P5@\,Z+<^'-;>&*'SC
M#<X("[@2'P>!GH1T^M?R:_L^>&]8M_CI;?91*(O[8  7<.// [?Y/K7]1_\
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M?0_D:E7[H_'^9IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!@^A_(U/
M10!$H.X<'OV]C4A.!FEHH :&!X!Y-.HHH **** &.<#'KFH\$] 3^%3T4 ,0
M$ Y&.?\ "GT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %(>5./0TM-7[H_'^9H 7A5R2 %')[  <GZ5\8_M3?M$Z+\*?"NH327T,#P
MV\S,6E522JGKR#VX !_4U[-\:OB98?#KPQ>7]S<QP.MO(Y+.%( 7(Z^W/O\
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M4S!]#^1J>B@!B @'(QS_ (4^BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9V8/ERQ)))^7.!@8S@YR#7VU_P $[_A"OC_QEI3269G#W\3$F/=D"8 <XZ8
M_+UK\^_ 7@74_'>K1V-E#-,990K&-6)9G//(!)Y/)'?-?V+_ /!&[]A?4!/X
M>U&\TF1?GMG+/"W!#(<DE: /ZL/^"6_P%M_!WAK09_L8AV06S F,+T5?;_)]
MZ_?$    8    Z #@#\*^8_V>?A?#X"\-:9;+ (FBMX01MQT09_7V'Y5].T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^"4Q\(S:3J&NZ%\R&%W,UOSP5).67G/>@#YD_P"">7_!,S4]5_LS7/$NC22
MM!,S3P%LY8$YW+UP>_M7]?\ \ _V=/!/PN\+V,$&B6?VSR(P28%78%4#.  2
M21QS@8YSGCO?A)\)?#?PY\,V6G6&F6T<PAC#MY* J%'"@8QGN3Z8QCG/L)PJ
M\   8  P/8 #''T[4 ,BABMXQ%#&L4:_=1!M4?A4AS@XZ]O\FHBS-QTSQ_\
MKJ:@"(*V03Z@\GK_ #J6BD)QCW.* %KY\^/7C5?#7A+5OWFQEMIN<@?P$>WI
MV_&OH.OSL_;:U.XL_"^M")BO^C3 8/\ TS;M^G\L4 ?PI_\ !8;XHIKWC;4K
M<S!]UU,I^;/\3CCD\5VO_!%SPS!JOC729S$#NNH3DK_MC)Z=R1_^JOS^_P""
MF^K7=[\2KY9'8@W\P(R?^>AK]:?^"$NBQ7/B/1)' ),T'U W#T/MW/O0!_>O
M\*M%BTCPAI"*@4M9PGIC^'&?T';/->EUDZ%;K:Z-I<"C CL;;'_ HE;^M:U
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M*** "BBB@ HHHH *\4^,?Q.A^'&C7&HRRB(10/)N) Z*3G/M^7Y5[77YG_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "$ C!J-E"XQGG/7\*EI" >HH @J5.A^O\
M04NQ?3]3_C2@ =* %HHHH **** "BBB@ HHHH *0@'K2T4 -"@'('2D<D8P?
M7^E/I"H;&<\4 *#D9]:\*^+'P4T#XD6LJ75C;222JP?=&G)*X)Y&.?YU[F%
M.1FG4 ?D!XH_X)F^%-;NYK@:3:9D8MQ%$?4]<<]>^35;PG_P3*\,:!J$5Y_9
M5H/+D5_]5'V[]/Y#W[5^Q%% 'C7PJ^$6A_#C3XX+2QMHYHXU5&6./*8&"1@'
M!&..A!Y&"*]EHHH ",^H^G6D P,?SI:* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>14
<FILENAME>ntrp-20240831.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaWMGbP9z5Z8+ekhvWBwbekqHy0sJe282iQka7Lm0VQF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:NTRP="http://nexttrip.com/20240831" elementFormDefault="qualified" targetNamespace="http://nexttrip.com/20240831">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://nexttrip.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BalanceSheets" id="BalanceSheets">
          <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
          <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfOperations" id="StatementsOfOperations">
          <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" id="StatementsOfOperationsParenthetical">
          <link:definition>00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" id="StatementsOfStockholdersEquityDeficit">
          <link:definition>00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" id="StatementsOfStockholdersEquityDeficitParenthetical">
          <link:definition>00000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
          <link:definition>00000008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" id="BusinessDescriptionAndGoingConcern">
          <link:definition>00000009 - Disclosure - Business Description and Going Concern</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
          <link:definition>00000010 - Disclosure - Summary of Significant Accounting Policies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperations" id="DiscontinuedOperations">
          <link:definition>00000011 - Disclosure - Discontinued Operations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" id="PrepaidAndOtherCurrentAssets">
          <link:definition>00000012 - Disclosure - Prepaid and Other Current Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/Leases" id="Leases">
          <link:definition>00000013 - Disclosure - Leases</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
          <link:definition>00000014 - Disclosure - Property and Equipment</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssets" id="IntangibleAssets">
          <link:definition>00000015 - Disclosure - Intangible Assets</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/Goodwill" id="Goodwill">
          <link:definition>00000016 - Disclosure - Goodwill</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
          <link:definition>00000017 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxes" id="IncomeTaxes">
          <link:definition>00000018 - Disclosure - Income Taxes</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/NotesPayable" id="NotesPayable">
          <link:definition>00000019 - Disclosure - Notes Payable</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SharePurchaseAgreements" id="SharePurchaseAgreements">
          <link:definition>00000020 - Disclosure - Share Purchase Agreements</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
          <link:definition>00000021 - Disclosure - Related Party Transactions</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DeferredRevenue" id="DeferredRevenue">
          <link:definition>00000022 - Disclosure - Deferred Revenue</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
          <link:definition>00000023 - Disclosure - Commitments and Contingencies</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquity" id="StockholdersEquity">
          <link:definition>00000024 - Disclosure - Stockholders&#8217; Equity</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShare" id="LossPerShare">
          <link:definition>00000025 - Disclosure - Loss Per Share</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/Concentrations" id="Concentrations">
          <link:definition>00000026 - Disclosure - Concentrations</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DefinedContributionPlans" id="DefinedContributionPlans">
          <link:definition>00000027 - Disclosure - Defined Contribution Plans</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SubsequentEvents" id="SubsequentEvents">
          <link:definition>00000028 - Disclosure - Subsequent Events</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
          <link:definition>00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
          <link:definition>00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" id="DiscontinuedOperationsTables">
          <link:definition>00000031 - Disclosure - Discontinued Operations (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" id="PrepaidAndOtherCurrentAssetsTables">
          <link:definition>00000032 - Disclosure - Prepaid and Other Current Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
          <link:definition>00000033 - Disclosure - Property and Equipment (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssetsTables" id="IntangibleAssetsTables">
          <link:definition>00000034 - Disclosure - Intangible Assets (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/GoodwillTables" id="GoodwillTables">
          <link:definition>00000035 - Disclosure - Goodwill (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
          <link:definition>00000036 - Disclosure - Income Taxes (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
          <link:definition>00000037 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShareTables" id="LossPerShareTables">
          <link:definition>00000038 - Disclosure - Loss Per Share (Tables)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" id="BusinessDescriptionAndGoingConcernDetailsNarrative">
          <link:definition>00000039 - Disclosure - Business Description and Going Concern (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" id="ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails">
          <link:definition>00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" id="ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails">
          <link:definition>00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" id="ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails">
          <link:definition>00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
          <link:definition>00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" id="ScheduleOfDiscontinuedOperationsDetails">
          <link:definition>00000044 - Disclosure - Schedule of Discontinued Operations (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" id="DiscontinuedOperationsDetailsNarrative">
          <link:definition>00000045 - Disclosure - Discontinued Operations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" id="ScheduleOfPrepaidAndOtherCurrentAssetsDetails">
          <link:definition>00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
          <link:definition>00000047 - Disclosure - Leases (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" id="ScheduleOfPropertyAndEquipmentDetails">
          <link:definition>00000048 - Disclosure - Schedule of Property and Equipment (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
          <link:definition>00000049 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
          <link:definition>00000050 - Disclosure - Schedule of Intangible Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" id="ScheduleOfEstimatedAggregateAmortizationExpenseDetails">
          <link:definition>00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" id="IntangibleAssetsDetailsNarrative">
          <link:definition>00000052 - Disclosure - Intangible Assets (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" id="ScheduleOfFairValueOfAssetsAcquiredDetails">
          <link:definition>00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" id="ScheduleOfReconciliationOfGoodwillDetails">
          <link:definition>00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" id="GoodwillDetailsNarrative">
          <link:definition>00000055 - Disclosure - Goodwill (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" id="AccountsPayableAndAccruedLiabilitiesDetailsNarrative">
          <link:definition>00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" id="ScheduleOfDeferredTaxAssetsDetails">
          <link:definition>00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" id="ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails">
          <link:definition>00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
          <link:definition>00000059 - Disclosure - Income Taxes (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
          <link:definition>00000060 - Disclosure - Notes Payable (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" id="SharePurchaseAgreementsDetailsNarrative">
          <link:definition>00000061 - Disclosure - Share Purchase Agreements (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
          <link:definition>00000062 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" id="DeferredRevenueDetailsNarrative">
          <link:definition>00000063 - Disclosure - Deferred Revenue (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" id="ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails">
          <link:definition>00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" id="ScheduleOfStockOptionActivityDetails">
          <link:definition>00000065 - Disclosure - Schedule of Stock Option Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" id="ScheduleOfWarrantyActivityDetails">
          <link:definition>00000066 - Disclosure - Schedule of Warranty Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" id="StockholdersEquityDetailsNarrative">
          <link:definition>00000067 - Disclosure - Stockholders&#8217; Equity (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" id="ScheduleOfEarningsPerShareBasicAndDilutedDetails">
          <link:definition>00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" id="LossPerShareDetailsNarrative">
          <link:definition>00000069 - Disclosure - Loss Per Share (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" id="ConcentrationsDetailsNarrative">
          <link:definition>00000070 - Disclosure - Concentrations (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" id="DefinedContributionPlansDetailsNarrative">
          <link:definition>00000071 - Disclosure - Defined Contribution Plans (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" id="ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails">
          <link:definition>00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" id="ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails">
          <link:definition>00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" id="ScheduleOfIssuableContingentSharesDetails">
          <link:definition>00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" id="ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails">
          <link:definition>00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
          <link:definition>00000076 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:roleType roleURI="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" id="ScheduleOfStockAppreciationRightsActivityDetails">
          <link:definition>00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20240831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20240831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20240831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="ntrp-20240831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="NTRP_NextTripGroupLLCMember" name="NextTripGroupLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextPlayTechnologiesIncMember" name="NextPlayTechnologiesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareExchangeAgreementMember" name="ShareExchangeAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MembershipUnitsMember" name="MembershipUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PreferredUnitsMember" name="PreferredUnitsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextInnovationLLCMember" name="NextInnovationLLCMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ContingentSharesMember" name="ContingentSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ClosingSharesMember" name="ClosingSharesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesIPreferredStockMember" name="SeriesIPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareMember" name="SoftwareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareLicensesMember" name="SoftwareLicensesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DivergentTechnologiesIncMember" name="DivergentTechnologiesIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrincipalExecutiveOfficesMember" name="PrincipalExecutiveOfficesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareLicenseMember" name="SoftwareLicenseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SigmaAdditiveSolutionsIncMember" name="SigmaAdditiveSolutionsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_NextTripHoldingsIncMember" name="NextTripHoldingsIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SpecialPurposeAcquisitionCorporationMember" name="SpecialPurposeAcquisitionCorporationMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeveralInvestorsMember" name="SeveralInvestorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConvertibleNotesMember" name="ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DebtAssignmentAndConversionAgreementsMember" name="DebtAssignmentAndConversionAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAgreementsMember" name="SharePurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SoftwareAsAServiceAgreementMember" name="SoftwareAsAServiceAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ThirdPartyMember" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ThirdPartyConsultantMember" name="ThirdPartyConsultantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConsultingModificationAgreementMember" name="ConsultingModificationAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" name="BoardOfDirectorsAndChiefExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_InvestorsDirectorsOfficersAndEmployeesMember" name="InvestorsDirectorsOfficersAndEmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DonaldMonacoMember" name="DonaldMonacoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_AtTheMarketIssuanceSalesAgreementMember" name="AtTheMarketIssuanceSalesAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAndExchangeAgreementsMember" name="SharePurchaseAndExchangeAgreementsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesEConvertiblePreferredStockMember" name="SeriesEConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesFConvertiblePreferredStockMember" name="SeriesFConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesGConvertiblePreferredStockMember" name="SeriesGConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesHConvertiblePreferredStockMember" name="SeriesHConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SeriesIConvertiblePreferredStockMember" name="SeriesIConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandThirteenEquityIncentivePlanMember" name="TwoThousandThirteenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" name="TwoThousandTwentyThreeEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandThirteenPlanMember" name="TwoThousandThirteenPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockAppreciationRightsMember" name="StockAppreciationRightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" name="TwoThousandAndTwentyStockAppreciationRightsPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DooyaMediaGroupIncMember" name="DooyaMediaGroupIncMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_CustomerMember" name="CustomerMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_UnsecuredPromissoryNoteMember" name="UnsecuredPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MessrsMonacoAndKerbyMember" name="MessrsMonacoAndKerbyMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MessrsKerbyAndMonacoMember" name="MessrsKerbyAndMonacoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PromissoryNoteReceivableNet" name="PromissoryNoteReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PercentageForIssuedAndOutstandingCapitalStock" name="PercentageForIssuedAndOutstandingCapitalStock" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_Technology" name="Technology" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_OrganizationCosts" name="OrganizationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LossOnRelatedPartyReceivable" name="LossOnRelatedPartyReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" name="StockIssuedDuringPeriodValueOfPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" name="StockIssuedDuringPeriodShareOfPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" name="StockIssuedDuringPeriodValuePurchasesOfCommonShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" name="StockIssuedDuringPeriodSharesPurchasesOfCommonShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" name="StockIssuedDuringPeriodValueReverseAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" name="StockIssuedDuringPeriodSharesReverseAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" name="StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" name="StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DepreciationOfRightOfUseAsset" name="DepreciationOfRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncreaseDecreaseInPromissoryNoteReceivable" name="IncreaseDecreaseInPromissoryNoteReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" name="IncreaseDecreaseInRightOfUseLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ProceedsFromAcquireBusinessesGross" name="ProceedsFromAcquireBusinessesGross" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureOfCashPaidAbstract" name="DisclosureOfCashPaidAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfPreferredSharesForServices" name="IssuanceOfPreferredSharesForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" name="IssuanceOfPreferredSharesForPerpetualSoftwareLicense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConversionOfConvertibleNotes" name="ConversionOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PreferredStockDividends" name="PreferredStockDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuanceOfCommonSharesForServices" name="IssuanceOfCommonSharesForServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" name="DisclosurePrepaidAndOtherCurrentAssetsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureLeasesAbstract" name="DisclosureLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureSharePurchaseAgreementsAbstract" name="DisclosureSharePurchaseAgreementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharePurchaseAgreementsDisclosureTextBlock" name="SharePurchaseAgreementsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisclosureDeferredRevenueAbstract" name="DisclosureDeferredRevenueAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredRevenueTextBlock" name="DeferredRevenueTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidsPolicyTextBlock" name="PrepaidsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PromissoryNoteReceivablePolicyTextBlock" name="PromissoryNoteReceivablePolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" name="ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" name="ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" name="ScheduleOfIssuableContingentSharesTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" name="StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_WorkingCapitalDeficit" name="WorkingCapitalDeficit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ContingentSharesIssuable" name="ContingentSharesIssuable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LaunchOfTravelAgentPlatformShares" name="LaunchOfTravelAgentPlatformShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ContingentShares" name="ContingentShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" name="DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" name="DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" name="DisposalGroupIncludingDiscontinuedOperationSeverance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" name="DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" name="DisposalGroupIncludingDiscontinuedOperationsOtherIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_EarnestMoneyDeposit" name="EarnestMoneyDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PrepaidCostOfSales" name="PrepaidCostOfSales" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxAssetDepreciation" name="DeferredTaxAssetDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxAssetsPayrollAccruals" name="DeferredTaxAssetsPayrollAccruals" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DeferredTaxLiabilitiesDepreciation" name="DeferredTaxLiabilitiesDepreciation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" name="EffectiveIncomeTaxRateReconciliationBookLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" name="IncomeTaxReconciliationNondeductibleExpensePreferredDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" name="IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" name="IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" name="IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_OperatingLossCarryforwardsRemainder" name="OperatingLossCarryforwardsRemainder" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ProceedsFromDownpaymentForContract" name="ProceedsFromDownpaymentForContract" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_DescriptionForWarrantExpiration" name="DescriptionForWarrantExpiration" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LaunchOfLeisureTravelBookingPlatform" name="LaunchOfLeisureTravelBookingPlatform" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LaunchOfGroupTravelBookingPlatform" name="LaunchOfGroupTravelBookingPlatform" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_LaunchOfFlexpayTechnology" name="LaunchOfFlexpayTechnology" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_ContingentlyIssuableShares" name="ContingentlyIssuableShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_CommonStockShareOutstanding" name="CommonStockShareOutstanding" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_WeightedAverageIssuableContingentShares" name="WeightedAverageIssuableContingentShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_MinimumRequiredStockholdersEquity" name="MinimumRequiredStockholdersEquity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_IssuableContingentShares" name="IssuableContingentShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="NTRP_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>15
<FILENAME>ntrp-20240831_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20240831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20240831.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20240831.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20240831.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20240831.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20240831.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Leases" xlink:href="ntrp-20240831.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20240831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20240831.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20240831.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20240831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20240831.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20240831.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20240831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20240831.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20240831.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20240831.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20240831.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20240831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20240831.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20240831.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20240831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20240831.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20240831.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:href="ntrp-20240831.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20240831.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20240831.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20240831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20240831.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20240831.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20240831.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20240831.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20240831.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockAppreciationRightsActivityDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_NTRPPromissoryNoteReceivableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_Technology" xlink:label="loc_NTRPTechnology" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_NTRPTechnology" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_OrganizationCosts" xlink:label="loc_NTRPOrganizationCosts" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_NTRPOrganizationCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaapInterestIncomeExpenseNonoperatingNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNonoperatingNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DepreciationOfRightOfUseAsset" xlink:label="loc_NTRPDepreciationOfRightOfUseAsset" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPDepreciationOfRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfIntangibleAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainLossOnDispositionOfIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:label="loc_NTRPIncreaseDecreaseInPromissoryNoteReceivable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPIncreaseDecreaseInPromissoryNoteReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" xlink:label="loc_NTRPIncreaseDecreaseInRightOfUseLeaseLiability" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_NTRPIncreaseDecreaseInRightOfUseLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="loc_us-gaapPaymentsForSoftware" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForSoftware" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OriginationOfNotesReceivableFromRelatedParties" xlink:label="loc_us-gaapOriginationOfNotesReceivableFromRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapOriginationOfNotesReceivableFromRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="loc_NTRPProceedsFromAcquireBusinessesGross" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_NTRPProceedsFromAcquireBusinessesGross" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="00000009 - Disclosure - Business Description and Going Concern" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="00000011 - Disclosure - Discontinued Operations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepaid and Other Current Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Leases" xlink:title="00000013 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="00000014 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="00000015 - Disclosure - Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="00000016 - Disclosure - Goodwill" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="00000019 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="00000020 - Disclosure - Share Purchase Agreements" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="00000022 - Disclosure - Deferred Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="00000024 - Disclosure - Stockholders&#8217; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="00000025 - Disclosure - Loss Per Share" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="00000026 - Disclosure - Concentrations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="00000027 - Disclosure - Defined Contribution Plans" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="00000031 - Disclosure - Discontinued Operations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="00000032 - Disclosure - Prepaid and Other Current Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="00000033 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="00000034 - Disclosure - Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="00000035 - Disclosure - Goodwill (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="00000037 - Disclosure - Stockholders&#8217; Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="00000038 - Disclosure - Loss Per Share (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Business Description and Going Concern (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000044 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationRetentionBonuses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSeverance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationOrganizationCosts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000045 - Disclosure - Discontinued Operations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidCostOfSales" xlink:label="loc_NTRPPrepaidCostOfSales" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:to="loc_NTRPPrepaidCostOfSales" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:title="00000047 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000048 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000049 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000050 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:label="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000052 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:title="00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="00000055 - Disclosure - Goodwill (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="loc_NTRPDeferredTaxAssetDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxAssetDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="loc_NTRPDeferredTaxAssetsPayrollAccruals" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxAssetsPayrollAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_NTRPDeferredTaxLiabilitiesDepreciation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_NTRPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeTaxExpenseBenefit" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000059 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="00000060 - Disclosure - Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="00000061 - Disclosure - Share Purchase Agreements (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000062 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="00000063 - Disclosure - Deferred Revenue (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000065 - Disclosure - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="00000066 - Disclosure - Schedule of Warranty Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Stockholders&#8217; Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="00000069 - Disclosure - Loss Per Share (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="00000070 - Disclosure - Concentrations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="00000071 - Disclosure - Defined Contribution Plans (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:title="00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:title="00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:title="00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:title="00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000076 - Disclosure - Subsequent Events (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:title="00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>16
<FILENAME>ntrp-20240831_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20240831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20240831.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20240831.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20240831.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20240831.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20240831.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Leases" xlink:href="ntrp-20240831.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20240831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20240831.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20240831.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20240831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20240831.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20240831.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20240831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20240831.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20240831.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20240831.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20240831.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20240831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20240831.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20240831.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20240831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20240831.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20240831.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:href="ntrp-20240831.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20240831.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20240831.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20240831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20240831.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20240831.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20240831.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20240831.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20240831.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockAppreciationRightsActivityDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_30" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_30" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_30" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_30" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_30" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_30" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_30" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_30" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_30" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_30" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_30" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_30" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_30" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_30" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_30" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_30" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_30" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_30" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_30" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_30" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_30" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_30" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_30" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_30" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_30" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_30" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_30" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_30" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_30" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_30" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_30" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_30" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_30" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_30" xlink:type="arc" order="58" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_NTRPPromissoryNoteReceivableNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAccountsReceivableNetCurrent_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsCurrent_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapSecurityDeposit_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapGoodwill_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsNoncurrentAbstract_90" xlink:to="loc_us-gaapAssetsNoncurrent_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAssetsAbstract_90" xlink:to="loc_us-gaapAssets_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccountsPayableCurrent_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapConvertibleDebtCurrent_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapDeferredRevenueCurrent_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapNotesPayableCurrent_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesCurrent_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract_90" xlink:to="loc_us-gaapLiabilitiesNoncurrent_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapLiabilities_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapCommitmentsAndContingencies_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapStockholdersEquityAbstract_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapPreferredStockValue_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapCommonStockValue_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapAdditionalPaidInCapital_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStockholdersEquityAbstract_90" xlink:to="loc_us-gaapStockholdersEquity_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLiabilitiesAbstract_90" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity_90" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_50" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan_60" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Condensed Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="00000009 - Disclosure - Business Description and Going Concern" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="00000011 - Disclosure - Discontinued Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepaid and Other Current Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Leases" xlink:title="00000013 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="00000014 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="00000015 - Disclosure - Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="00000016 - Disclosure - Goodwill" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="00000019 - Disclosure - Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="00000020 - Disclosure - Share Purchase Agreements" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="00000022 - Disclosure - Deferred Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="00000024 - Disclosure - Stockholders&#8217; Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="00000025 - Disclosure - Loss Per Share" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="00000026 - Disclosure - Concentrations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="00000027 - Disclosure - Defined Contribution Plans" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="00000031 - Disclosure - Discontinued Operations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="00000032 - Disclosure - Prepaid and Other Current Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="00000033 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="00000034 - Disclosure - Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="00000035 - Disclosure - Goodwill (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="00000037 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="00000038 - Disclosure - Loss Per Share (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Business Description and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MembershipUnitsMember" xlink:label="loc_NTRPMembershipUnitsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPMembershipUnitsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PreferredUnitsMember" xlink:label="loc_NTRPPreferredUnitsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPPreferredUnitsMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextInnovationLLCMember" xlink:label="loc_NTRPNextInnovationLLCMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextInnovationLLCMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ClosingSharesMember" xlink:label="loc_NTRPClosingSharesMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPClosingSharesMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_WorkingCapitalDeficit" xlink:label="loc_NTRPWorkingCapitalDeficit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPWorkingCapitalDeficit_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCapital_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_160" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="loc_NTRPContingentSharesIssuable_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPContingentSharesIssuable_160" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfTravelAgentPlatformShares" xlink:label="loc_NTRPLaunchOfTravelAgentPlatformShares_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPLaunchOfTravelAgentPlatformShares_160" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareMember" xlink:label="loc_NTRPSoftwareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="loc_NTRPContingentSharesIssuable_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPContingentSharesIssuable_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentShares" xlink:label="loc_NTRPContingentShares_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPContingentShares_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_190" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_190" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_190" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_190" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment_190" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000044 - Disclosure - Schedule of Discontinued Operations (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000045 - Disclosure - Discontinued Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EarnestMoneyDeposit" xlink:label="loc_NTRPEarnestMoneyDeposit_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPEarnestMoneyDeposit_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:title="00000047 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrincipalExecutiveOfficesMember" xlink:label="loc_NTRPPrincipalExecutiveOfficesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPPrincipalExecutiveOfficesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand_80" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000048 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000049 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000050 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicenseMember" xlink:label="loc_NTRPSoftwareLicenseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicenseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_140" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000052 - Disclosure - Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:title="00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="00000055 - Disclosure - Goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_90" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000059 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="00000060 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="loc_NTRPSpecialPurposeAcquisitionCorporationMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPSpecialPurposeAcquisitionCorporationMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPSeveralInvestorsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConvertibleNotesMember" xlink:label="loc_NTRPConvertibleNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPConvertibleNotesMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_140" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSharePrice_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_140" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="00000061 - Disclosure - Share Purchase Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="loc_NTRPSharePurchaseAgreementsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSharePurchaseAgreementsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="loc_NTRPSoftwareAsAServiceAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSoftwareAsAServiceAgreementMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="loc_NTRPConsultingModificationAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPConsultingModificationAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPSeveralInvestorsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyMember" xlink:label="loc_NTRPThirdPartyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyConsultantMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="loc_NTRPProceedsFromDownpaymentForContract_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPProceedsFromDownpaymentForContract_120" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_120" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_120" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingFees" xlink:label="loc_NTRPConsultingFees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPConsultingFees_120" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000062 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:label="loc_NTRPBoardOfDirectorsAndChiefExecutiveOfficerMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPBoardOfDirectorsAndChiefExecutiveOfficerMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_InvestorsDirectorsOfficersAndEmployeesMember" xlink:label="loc_NTRPInvestorsDirectorsOfficersAndEmployeesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPInvestorsDirectorsOfficersAndEmployeesMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DonaldMonacoMember" xlink:label="loc_NTRPDonaldMonacoMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPDonaldMonacoMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableCurrent_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableNet_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLineOfCredit_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_150" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="00000063 - Disclosure - Deferred Revenue (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000065 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_90" xlink:type="arc" order="34" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="00000066 - Disclosure - Schedule of Warranty Activity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="loc_NTRPAtTheMarketIssuanceSalesAgreementMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_NTRPAtTheMarketIssuanceSalesAgreementMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="loc_NTRPSharePurchaseAndExchangeAgreementsMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPSharePurchaseAndExchangeAgreementsMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_NTRPThirdPartyConsultantMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesEConvertiblePreferredStockMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesEConvertiblePreferredStockMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesFConvertiblePreferredStockMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesFConvertiblePreferredStockMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesGConvertiblePreferredStockMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesGConvertiblePreferredStockMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesHConvertiblePreferredStockMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesHConvertiblePreferredStockMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenPlanMember" xlink:label="loc_NTRPTwoThousandThirteenPlanMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenPlanMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_590" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_590" xlink:type="arc" order="591" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_370" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_370" xlink:type="arc" order="372" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DooyaMediaGroupIncMember" xlink:label="loc_NTRPDooyaMediaGroupIncMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDooyaMediaGroupIncMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember_530" xlink:type="arc" order="532" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_680" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_680" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_680" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_680" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_680" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits_680" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_680" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock_680" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired_680" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_680" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction_680" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_680" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions_680" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_680" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_680" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_680" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_680" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_680" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_680" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage_680" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_680" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsShares" xlink:label="loc_us-gaapCommonStockDividendsShares_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockDividendsShares_680" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="loc_us-gaapPreferredStockRedemptionTerms_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockRedemptionTerms_680" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable_680" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_680" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_680" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_680" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_680" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_680" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_680" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_680" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_680" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_680" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_680" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation_680" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_680" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_680" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_680" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_680" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_680" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_680" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_680" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="loc_NTRPDescriptionForWarrantExpiration_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_NTRPDescriptionForWarrantExpiration_680" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_680" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_680" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_680" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_680" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_680" xlink:type="arc" order="46" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="00000069 - Disclosure - Loss Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="loc_us-gaapSeriesGPreferredStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesGPreferredStockMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapDilutiveSecurities_80" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="00000070 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_CustomerMember" xlink:label="loc_NTRPCustomerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NTRPCustomerMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="00000071 - Disclosure - Defined Contribution Plans (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:title="00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:title="00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:title="00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:title="00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000076 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_UnsecuredPromissoryNoteMember" xlink:label="loc_NTRPUnsecuredPromissoryNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPUnsecuredPromissoryNoteMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsMonacoAndKerbyMember" xlink:label="loc_NTRPMessrsMonacoAndKerbyMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPMessrsMonacoAndKerbyMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="loc_NTRPMessrsKerbyAndMonacoMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPMessrsKerbyAndMonacoMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_250" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_250" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_250" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_250" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_250" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNotesPayable_250" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties_250" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate_250" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_250" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount_250" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MinimumRequiredStockholdersEquity" xlink:label="loc_NTRPMinimumRequiredStockholdersEquity_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_NTRPMinimumRequiredStockholdersEquity_250" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent_250" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_250" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_250" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_250" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_250" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_250" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_250" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_250" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction_250" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_250" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_250" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_250" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction_250" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:title="00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_60" xlink:type="arc" order="31" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>17
<FILENAME>ntrp-20240831_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related and Nonrelated Parties [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyMember_lbl" xml:lang="en-US">Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xml:lang="en-US">Nonrelated Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="NTRP_NextTripGroupLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripGroupLLCMember" xlink:to="NTRP_NextTripGroupLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextTripGroupLLCMember_lbl" xml:lang="en-US">NextTrip Holdings, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Retained Earnings [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="NTRP_NextPlayTechnologiesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextPlayTechnologiesIncMember" xlink:to="NTRP_NextPlayTechnologiesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextPlayTechnologiesIncMember_lbl" xml:lang="en-US">NextPlay Technologies Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="NTRP_ShareExchangeAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareExchangeAgreementMember" xlink:to="NTRP_ShareExchangeAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareExchangeAgreementMember_lbl" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MembershipUnitsMember" xlink:label="NTRP_MembershipUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipUnitsMember" xlink:to="NTRP_MembershipUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MembershipUnitsMember_lbl" xml:lang="en-US">Membership Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PreferredUnitsMember" xlink:label="NTRP_PreferredUnitsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredUnitsMember" xlink:to="NTRP_PreferredUnitsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PreferredUnitsMember_lbl" xml:lang="en-US">Preferred Units [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xml:lang="en-US">Investment, Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextInnovationLLCMember" xlink:label="NTRP_NextInnovationLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextInnovationLLCMember" xlink:to="NTRP_NextInnovationLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextInnovationLLCMember_lbl" xml:lang="en-US">Next Innovation LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="NTRP_ContingentSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesMember" xlink:to="NTRP_ContingentSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ContingentSharesMember_lbl" xml:lang="en-US">Contingent Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ClosingSharesMember" xlink:label="NTRP_ClosingSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ClosingSharesMember" xlink:to="NTRP_ClosingSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ClosingSharesMember_lbl" xml:lang="en-US">Closing Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="us-gaap_StockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionMember" xlink:to="us-gaap_StockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionMember_lbl" xml:lang="en-US">Equity Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="us-gaap_SeriesEPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesEPreferredStockMember" xlink:to="us-gaap_SeriesEPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesEPreferredStockMember_lbl" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="us-gaap_SeriesHPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesHPreferredStockMember" xlink:to="us-gaap_SeriesHPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesHPreferredStockMember_lbl" xml:lang="en-US">Series H Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="NTRP_SeriesIPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPreferredStockMember" xlink:to="NTRP_SeriesIPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesIPreferredStockMember_lbl" xml:lang="en-US">Series I Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xml:lang="en-US">Computer Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareMember" xlink:label="NTRP_SoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareMember" xlink:to="NTRP_SoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareMember_lbl" xml:lang="en-US">Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicensesMember" xlink:label="NTRP_SoftwareLicensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicensesMember" xlink:to="NTRP_SoftwareLicensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareLicensesMember_lbl" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="NTRP_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AssetPurchaseAgreementMember" xlink:to="NTRP_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="NTRP_DivergentTechnologiesIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DivergentTechnologiesIncMember" xlink:to="NTRP_DivergentTechnologiesIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DivergentTechnologiesIncMember_lbl" xml:lang="en-US">Divergent Technologies, Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title and Position [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrincipalExecutiveOfficesMember" xlink:label="NTRP_PrincipalExecutiveOfficesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrincipalExecutiveOfficesMember" xlink:to="NTRP_PrincipalExecutiveOfficesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrincipalExecutiveOfficesMember_lbl" xml:lang="en-US">Principal Executive Offices [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xml:lang="en-US">Software Development [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicenseMember" xlink:label="NTRP_SoftwareLicenseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicenseMember" xlink:to="NTRP_SoftwareLicenseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SoftwareLicenseMember_lbl" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TrademarksMember_lbl" xml:lang="en-US">Trademarks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SigmaAdditiveSolutionsIncMember" xlink:to="NTRP_SigmaAdditiveSolutionsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember_lbl" xml:lang="en-US">Sigma Additive Solutions Inc. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="NTRP_NextTripHoldingsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripHoldingsIncMember" xlink:to="NTRP_NextTripHoldingsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_NextTripHoldingsIncMember_lbl" xml:lang="en-US">Next Trip Holdings Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:to="NTRP_SpecialPurposeAcquisitionCorporationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember_lbl" xml:lang="en-US">Special Purpose Acquisition Corporation [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeveralInvestorsMember" xlink:label="NTRP_SeveralInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeveralInvestorsMember" xlink:to="NTRP_SeveralInvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeveralInvestorsMember_lbl" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConvertibleNotesMember" xlink:label="NTRP_ConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleNotesMember" xlink:to="NTRP_ConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConvertibleNotesMember_lbl" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:to="NTRP_DebtAssignmentAndConversionAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember_lbl" xml:lang="en-US">Debt Assignment and Conversion Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="NTRP_SharePurchaseAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsMember" xlink:to="NTRP_SharePurchaseAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAgreementsMember_lbl" xml:lang="en-US">Share Purchase Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="NTRP_SoftwareAsAServiceAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareAsAServiceAgreementMember" xlink:to="NTRP_SoftwareAsAServiceAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareAsAServiceAgreementMember_lbl" xml:lang="en-US">Software as a Service Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyMember" xlink:label="NTRP_ThirdPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyMember" xlink:to="NTRP_ThirdPartyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ThirdPartyMember_lbl" xml:lang="en-US">Third Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="NTRP_ThirdPartyConsultantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyConsultantMember" xlink:to="NTRP_ThirdPartyConsultantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ThirdPartyConsultantMember_lbl" xml:lang="en-US">Third Party Consultant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="NTRP_ConsultingModificationAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingModificationAgreementMember" xlink:to="NTRP_ConsultingModificationAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConsultingModificationAgreementMember_lbl" xml:lang="en-US">Consulting Modification Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:label="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:to="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Board Of Directors And Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_InvestorsDirectorsOfficersAndEmployeesMember" xlink:label="NTRP_InvestorsDirectorsOfficersAndEmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_InvestorsDirectorsOfficersAndEmployeesMember" xlink:to="NTRP_InvestorsDirectorsOfficersAndEmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_InvestorsDirectorsOfficersAndEmployeesMember_lbl" xml:lang="en-US">Investors Directors Officers And Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DonaldMonacoMember" xlink:label="NTRP_DonaldMonacoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DonaldMonacoMember" xlink:to="NTRP_DonaldMonacoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DonaldMonacoMember_lbl" xml:lang="en-US">Donald Monaco [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:to="NTRP_AtTheMarketIssuanceSalesAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember_lbl" xml:lang="en-US">At-The-Market Issuance Sales Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueArrangementTypeAxis" xlink:to="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueArrangementTypeAxis_lbl" xml:lang="en-US">Deferred Revenue Arrangement Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:to="NTRP_SharePurchaseAndExchangeAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember_lbl" xml:lang="en-US">Share Purchase And Exchange Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesEConvertiblePreferredStockMember" xlink:to="NTRP_SeriesEConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesFConvertiblePreferredStockMember" xlink:to="NTRP_SeriesFConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series F Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesGConvertiblePreferredStockMember" xlink:to="NTRP_SeriesGConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesHConvertiblePreferredStockMember" xlink:to="NTRP_SeriesHConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIConvertiblePreferredStockMember" xlink:to="NTRP_SeriesIConvertiblePreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember_lbl" xml:lang="en-US">Series I Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandThirteenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember_lbl" xml:lang="en-US">2013 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_lbl" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenPlanMember" xlink:label="NTRP_TwoThousandThirteenPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenPlanMember" xlink:to="NTRP_TwoThousandThirteenPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandThirteenPlanMember_lbl" xml:lang="en-US">2013 Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="NTRP_StockAppreciationRightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockAppreciationRightsMember" xlink:to="NTRP_StockAppreciationRightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockAppreciationRightsMember_lbl" xml:lang="en-US">Stock Appreciation Rights [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:to="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_lbl" xml:lang="en-US">2020 Stock Appreciation Rights Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DooyaMediaGroupIncMember" xlink:label="NTRP_DooyaMediaGroupIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DooyaMediaGroupIncMember" xlink:to="NTRP_DooyaMediaGroupIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DooyaMediaGroupIncMember_lbl" xml:lang="en-US">Dooya Media Group Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="NTRP_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SecuritiesPurchaseAgreementMember" xlink:to="NTRP_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="us-gaap_SeriesGPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesGPreferredStockMember" xlink:to="us-gaap_SeriesGPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SeriesGPreferredStockMember_lbl" xml:lang="en-US">Series G Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_CustomerMember" xlink:label="NTRP_CustomerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CustomerMember" xlink:to="NTRP_CustomerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_CustomerMember_lbl" xml:lang="en-US">Customer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_UnsecuredPromissoryNoteMember" xlink:label="NTRP_UnsecuredPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_UnsecuredPromissoryNoteMember" xlink:to="NTRP_UnsecuredPromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_UnsecuredPromissoryNoteMember_lbl" xml:lang="en-US">Unsecured Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsMonacoAndKerbyMember" xlink:label="NTRP_MessrsMonacoAndKerbyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MessrsMonacoAndKerbyMember" xlink:to="NTRP_MessrsMonacoAndKerbyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MessrsMonacoAndKerbyMember_lbl" xml:lang="en-US">Messrs Monaco and Kerby [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="NTRP_MessrsKerbyAndMonacoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MessrsKerbyAndMonacoMember" xlink:to="NTRP_MessrsKerbyAndMonacoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MessrsKerbyAndMonacoMember_lbl" xml:lang="en-US">Messrs Kerby And Monaco [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_lbl" xml:lang="en-US">Defined Benefit Plan [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedBenefitPlanDisclosureLineItems_lbl" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="NTRP_PromissoryNoteReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivableNet" xlink:to="NTRP_PromissoryNoteReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PromissoryNoteReceivableNet_lbl" xml:lang="en-US">Promissory note receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Non-Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="us-gaap_SecurityDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SecurityDeposit" xlink:to="us-gaap_SecurityDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SecurityDeposit_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of Use Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Non-Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="us-gaap_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAbstract" xlink:to="us-gaap_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAbstract_lbl" xml:lang="en-US">LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="us-gaap_ConvertibleDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtCurrent" xlink:to="us-gaap_ConvertibleDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtCurrent_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Notes payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Operating Lease Liability &#8211; Short Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Non- Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating Lease Liability &#8211; Long Term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Non-Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholder&#8217;s Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred Stock, $0.001 par value, 10,000,000 shares authorized; 93,295 and 472,996 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, $0.001 par value, 250,000,000 and 1,200,000 shares authorized, respectively; 1,388,641 and 936,430 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_lbl" xml:lang="en-US">Restructuring Cost [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="us-gaap_RestructuringCostAndReserveLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCostAndReserveLineItems" xlink:to="us-gaap_RestructuringCostAndReserveLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCostAndReserveLineItems_lbl" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xml:lang="en-US">Number of shares acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:to="NTRP_PercentageForIssuedAndOutstandingCapitalStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock_lbl" xml:lang="en-US">Percentage for issued and outstanding capital stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="us-gaap_LaborAndRelatedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LaborAndRelatedExpense" xlink:to="us-gaap_LaborAndRelatedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LaborAndRelatedExpense_lbl" xml:lang="en-US">Salaries and benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="us-gaap_ProfessionalFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfessionalFees" xlink:to="us-gaap_ProfessionalFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfessionalFees_lbl" xml:lang="en-US">Professional service fees</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_Technology" xlink:label="NTRP_Technology" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_Technology" xlink:to="NTRP_Technology_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_Technology_lbl" xml:lang="en-US">Technology</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_OrganizationCosts" xlink:label="NTRP_OrganizationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OrganizationCosts" xlink:to="NTRP_OrganizationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_OrganizationCosts_lbl" xml:lang="en-US">Organization costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="us-gaap_OtherExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenses" xlink:to="us-gaap_OtherExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherExpenses_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other Income (Expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Gain on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="NTRP_LossOnRelatedPartyReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_LossOnRelatedPartyReceivable_lbl" xml:lang="en-US">Loss on promissory note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNonoperatingNet_lbl" xml:lang="en-US">Interest income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total Other Income (Expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net loss from continuing operations before taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_lbl" xml:lang="en-US">Net gain (loss) from discontinued operations, net of taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_lbl" xml:lang="en-US">Preferred dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US">Net Loss Applicable to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_lbl" xml:lang="en-US">Basic loss per common share from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_lbl" xml:lang="en-US">Diluted loss per common share from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_lbl" xml:lang="en-US">Basic loss per common share from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_lbl" xml:lang="en-US">Diluted loss per common share from discontinued operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Loss per common share basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Loss per common share diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average number of shares outstanding basic</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted nverage number of shares outstanding diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Issuance of Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Issuance of Common Shares, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_lbl" xml:lang="en-US">Issuance of Preferred Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_lbl" xml:lang="en-US">Issuance of Preferred Shares, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common Shares Issued for Conversion of Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common Shares Issued for Conversion of Preferred Stock, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_lbl" xml:lang="en-US">Purchases of Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_lbl" xml:lang="en-US">Purchases of Common Shares, Sharers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Issuance of Common Shares for Third Party Services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Issuance of Common Shares for Third Party Services, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_lbl" xml:lang="en-US">Reverse Acquisition of Sigma Additive Solutions, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_lbl" xml:lang="en-US">Reverse Acquisition of Sigma Additive Solutions, Inc., Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xml:lang="en-US">Stock Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="us-gaap_DividendsPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DividendsPreferredStock_lbl" xml:lang="en-US">Preferred Stock Dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_lbl" xml:lang="en-US">Issuance of Convertible Preferred Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_lbl" xml:lang="en-US">Issuance of Convertible Preferred Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Stock Options Issued to Employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Net Loss &#8211; Continuing Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Noncash Expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization &#8211; property and equipment and intangibles</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DepreciationOfRightOfUseAsset" xlink:label="NTRP_DepreciationOfRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DepreciationOfRightOfUseAsset" xlink:to="NTRP_DepreciationOfRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DepreciationOfRightOfUseAsset_lbl" xml:lang="en-US">Depreciation of right of use asset</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LossOnRelatedPartyReceivable_2_lbl" xml:lang="en-US">Loss on promissory note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Stock-based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Gain on extinguishment of liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_lbl" xml:lang="en-US">Loss on sale of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Change in Assets and Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:label="NTRP_IncreaseDecreaseInPromissoryNoteReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:to="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_lbl" xml:lang="en-US">Promissory note receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_lbl" xml:lang="en-US">Security deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" xlink:label="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" xlink:to="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability_lbl" xml:lang="en-US">Right of use lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations_lbl" xml:lang="en-US">NET CASH PROVIDED IN OPERATING ACTIVITIES FROM DISCONTINUED OPERATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">NET CASH USED IN OPERATING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="us-gaap_PaymentsForSoftware" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForSoftware_lbl" xml:lang="en-US">Capitalized software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OriginationOfNotesReceivableFromRelatedParties" xlink:label="us-gaap_OriginationOfNotesReceivableFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OriginationOfNotesReceivableFromRelatedParties" xlink:to="us-gaap_OriginationOfNotesReceivableFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OriginationOfNotesReceivableFromRelatedParties_lbl" xml:lang="en-US">Promissory note &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_lbl" xml:lang="en-US">Reverse acquisition of Sigma Additive Solutions, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleOfProductiveAssets_lbl" xml:lang="en-US">Sale of Sigma Additive Solutions, Inc. assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="us-gaap_ProceedsFromConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromConvertibleDebt_lbl" xml:lang="en-US">Proceeds from issuance of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_lbl" xml:lang="en-US">Proceeds from issuance of convertible preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuances of common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:to="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_lbl" xml:lang="en-US">Proceeds from issuances of preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Advances from related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">NET CASH PROVIDED BY FINANCING ACTIVITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">NET CHANGE IN CASH FOR PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">CASH AT BEGINNING OF PERIOD</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">CASH AT END OF PERIOD</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosures:</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureOfCashPaidAbstract" xlink:label="NTRP_DisclosureOfCashPaidAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureOfCashPaidAbstract" xlink:to="NTRP_DisclosureOfCashPaidAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureOfCashPaidAbstract_lbl" xml:lang="en-US">Disclosure of Cash Paid for:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Noncash Investing and Financing Activities Disclosure:</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfPreferredSharesForServices" xlink:label="NTRP_IssuanceOfPreferredSharesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForServices" xlink:to="NTRP_IssuanceOfPreferredSharesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfPreferredSharesForServices_lbl" xml:lang="en-US">Issuance of preferred shares for services</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:to="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_lbl" xml:lang="en-US">Issuance of preferred shares for perpetual software license</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConversionOfConvertibleNotes" xlink:label="NTRP_ConversionOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConversionOfConvertibleNotes" xlink:to="NTRP_ConversionOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConversionOfConvertibleNotes_lbl" xml:lang="en-US">Conversion of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PreferredStockDividends" xlink:label="NTRP_PreferredStockDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredStockDividends" xlink:to="NTRP_PreferredStockDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PreferredStockDividends_lbl" xml:lang="en-US">Preferred stock dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfCommonSharesForServices" xlink:label="NTRP_IssuanceOfCommonSharesForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForServices" xlink:to="NTRP_IssuanceOfCommonSharesForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IssuanceOfCommonSharesForServices_lbl" xml:lang="en-US">Issuance of common shares for services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:to="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubstantialDoubtAboutGoingConcernTextBlock_lbl" xml:lang="en-US">Business Description and Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_lbl" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_lbl" xml:lang="en-US">Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_lbl" xml:lang="en-US">Prepaid And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:to="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xml:lang="en-US">Prepaid and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureLeasesAbstract" xlink:label="NTRP_DisclosureLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureLeasesAbstract" xlink:to="NTRP_DisclosureLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureLeasesAbstract_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="us-gaap_GoodwillDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillDisclosureTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="NTRP_DisclosureSharePurchaseAgreementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:to="NTRP_DisclosureSharePurchaseAgreementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureSharePurchaseAgreementsAbstract_lbl" xml:lang="en-US">Share Purchase Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_lbl" xml:lang="en-US">Share Purchase Agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="NTRP_DisclosureDeferredRevenueAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosureDeferredRevenueAbstract" xlink:to="NTRP_DisclosureDeferredRevenueAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisclosureDeferredRevenueAbstract_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredRevenueTextBlock" xlink:label="NTRP_DeferredRevenueTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DeferredRevenueTextBlock_lbl" xml:lang="en-US">Deferred Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_lbl" xml:lang="en-US">Defined Contribution Plans</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Functional and presentation currency</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Accounting Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidsPolicyTextBlock" xlink:label="NTRP_PrepaidsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidsPolicyTextBlock" xlink:to="NTRP_PrepaidsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidsPolicyTextBlock_lbl" xml:lang="en-US">Prepaids</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:to="NTRP_PromissoryNoteReceivablePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock_lbl" xml:lang="en-US">Promissory Note Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsFiniteLivedPolicy_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="us-gaap_InternalUseSoftwarePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalUseSoftwarePolicy" xlink:to="us-gaap_InternalUseSoftwarePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InternalUseSoftwarePolicy_lbl" xml:lang="en-US">Software Development Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_lbl" xml:lang="en-US">Impairment of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassification</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:label="us-gaap_MarketRiskBenefitPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:to="us-gaap_MarketRiskBenefitPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketRiskBenefitPolicyTextBlock_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_lbl" xml:lang="en-US">Sales and Marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently adopted accounting pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US">Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Useful Lives for Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Useful Lives for Finite Life Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" xlink:label="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" xlink:to="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Issuable Contingent Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xml:lang="en-US">Schedule of Weighted Average Common Stock Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_lbl" xml:lang="en-US">Schedule of Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_lbl" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimated Aggregate Amortization Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Fair Value of Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Reconciliation of Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warranty Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Appreciation Rights Activity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of common stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Share price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of common stock issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:label="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:to="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of additional restricted shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_WorkingCapitalDeficit" xlink:label="NTRP_WorkingCapitalDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WorkingCapitalDeficit" xlink:to="NTRP_WorkingCapitalDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_WorkingCapitalDeficit_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="us-gaap_Capital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Capital" xlink:to="us-gaap_Capital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Capital_lbl" xml:lang="en-US">Contributed capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Restricted shares issuable in reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="NTRP_ContingentSharesIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesIssuable" xlink:to="NTRP_ContingentSharesIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ContingentSharesIssuable_lbl" xml:lang="en-US">Contingent shares issuable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfTravelAgentPlatformShares" xlink:label="NTRP_LaunchOfTravelAgentPlatformShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfTravelAgentPlatformShares" xlink:to="NTRP_LaunchOfTravelAgentPlatformShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LaunchOfTravelAgentPlatformShares_lbl" xml:lang="en-US">Contigent shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US">Total Underlying Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SellingAndMarketingExpense_2_lbl" xml:lang="en-US">Sales and marketing expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="us-gaap_ConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebt" xlink:to="us-gaap_ConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebt_lbl" xml:lang="en-US">Convertible debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_lbl" xml:lang="en-US">Number of convertible shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Shares issue per shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Value of stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Provision for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentShares" xlink:label="NTRP_ContingentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentShares" xlink:to="NTRP_ContingentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ContingentShares_lbl" xml:lang="en-US">Contingent shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrants outstanding to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Shares issuable upon exercisable of options</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Number of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Common stock issuable upon conversion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_lbl" xml:lang="en-US">Salaries and benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_lbl" xml:lang="en-US">Retention bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance_lbl" xml:lang="en-US">Severance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_lbl" xml:lang="en-US">Organization costs</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_lbl" xml:lang="en-US">Total Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2_lbl" xml:lang="en-US">Loss from Discontinued Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EarnestMoneyDeposit" xlink:label="NTRP_EarnestMoneyDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EarnestMoneyDeposit" xlink:to="NTRP_EarnestMoneyDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_EarnestMoneyDeposit_lbl" xml:lang="en-US">Earnest money deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_2_lbl" xml:lang="en-US">Asset disposition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_3_lbl" xml:lang="en-US">Loss of discontinued operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract_2_lbl" xml:lang="en-US">Schedule Of Prepaid And Other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="us-gaap_PrepaidAdvertising" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidAdvertising" xlink:to="us-gaap_PrepaidAdvertising_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidAdvertising_lbl" xml:lang="en-US">Prepaid marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidCostOfSales" xlink:label="NTRP_PrepaidCostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidCostOfSales" xlink:to="NTRP_PrepaidCostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_PrepaidCostOfSales_lbl" xml:lang="en-US">Prepaid cost of sales</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRent_lbl" xml:lang="en-US">Payments for rent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and Equipment, net of depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Intangible assets, net of amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xml:lang="en-US">2025 (Remaining)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2028</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:to="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xml:lang="en-US">Impairment losses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total identifiable net assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US">Total Fair Value of Net Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAcquiredDuringPeriod_lbl" xml:lang="en-US">Reverse acquisition of Sigma Additive Solutions, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xml:lang="en-US">Reduction from sale of assets to Divergent Technologies</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_Goodwill_2_lbl" xml:lang="en-US">Balance, February 29, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Purchase consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="us-gaap_BusinessAcquisitionSharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionSharePrice" xlink:to="us-gaap_BusinessAcquisitionSharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionSharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Gain on disposition transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">NOL carryover</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="NTRP_DeferredTaxAssetDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetDepreciation" xlink:to="NTRP_DeferredTaxAssetDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxAssetDepreciation_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetsPayrollAccruals" xlink:to="NTRP_DeferredTaxAssetsPayrollAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals_lbl" xml:lang="en-US">Payroll accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax asset (liability)</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:to="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_lbl" xml:lang="en-US">Book Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_lbl" xml:lang="en-US">Meals &amp; Entertainment</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_lbl" xml:lang="en-US">Preferred dividends</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xml:lang="en-US">Stock compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_lbl" xml:lang="en-US">Loss on asset disposal</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_lbl" xml:lang="en-US">Accrued payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_lbl" xml:lang="en-US">Related party accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Change in valuation allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_OperatingLossCarryforwardsRemainder" xlink:label="NTRP_OperatingLossCarryforwardsRemainder" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OperatingLossCarryforwardsRemainder" xlink:to="NTRP_OperatingLossCarryforwardsRemainder_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_OperatingLossCarryforwardsRemainder_lbl" xml:lang="en-US">Operating loss carryforwards remainder</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Valuation allowance loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal statutory tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="us-gaap_ScheduleOfShortTermDebtTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShortTermDebtTable" xlink:to="us-gaap_ScheduleOfShortTermDebtTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShortTermDebtTable_lbl" xml:lang="en-US">Short-Term Debt [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="us-gaap_ShortTermDebtLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtLineItems" xlink:to="us-gaap_ShortTermDebtLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtLineItems_lbl" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_2_lbl" xml:lang="en-US">Proceeds from convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Share price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2_lbl" xml:lang="en-US">Conversion of convertible notes, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromConvertibleDebt" xlink:to="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromConvertibleDebt_3_lbl" xml:lang="en-US">Proceeds from convertible shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_2_lbl" xml:lang="en-US">Conversion share price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="NTRP_ProceedsFromDownpaymentForContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromDownpaymentForContract" xlink:to="NTRP_ProceedsFromDownpaymentForContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ProceedsFromDownpaymentForContract_lbl" xml:lang="en-US">Proceeds from downpayment for contract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Conversion share price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingFees" xlink:label="NTRP_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingFees" xlink:to="NTRP_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xml:lang="en-US">Related Party Transaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_LossOnRelatedPartyReceivable_3_lbl" xml:lang="en-US">Loss on related party receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LineOfCredit_lbl" xml:lang="en-US">Line of credit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Annual interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xml:lang="en-US">Outstanding principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected life</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options Outstanding, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_lbl" xml:lang="en-US">Number of Options, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_lbl" xml:lang="en-US">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Forfeited or cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options Outstanding, Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Outstanding Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Expected to Vest in the Future Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding, Expected of Vest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Options, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding, Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_lbl" xml:lang="en-US">Number of Options, Vested, Exercisable and Options Expected to Vest, Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_lbl" xml:lang="en-US">Warrants, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Warrants, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Warrants, Forfeited or cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited or cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Years, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.) Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_2_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Reverse stock split</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:to="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits_lbl" xml:lang="en-US">Reverse stock split issued common shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Sale of stock, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_2_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_2_lbl" xml:lang="en-US">Equity interest acquired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_2_lbl" xml:lang="en-US">Restricted shares issued in acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_lbl" xml:lang="en-US">Percentage of issued and outstanding common shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_2_lbl" xml:lang="en-US">Shares issuable for consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_2_lbl" xml:lang="en-US">Shares issued in acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Purchase of shares issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Shares issued during period services</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="us-gaap_PreferredStockDividendRatePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendRatePercentage" xlink:to="us-gaap_PreferredStockDividendRatePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendRatePercentage_lbl" xml:lang="en-US">Dividends percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_3_lbl" xml:lang="en-US">Conversion price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsShares" xlink:label="us-gaap_CommonStockDividendsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockDividendsShares" xlink:to="us-gaap_CommonStockDividendsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockDividendsShares_lbl" xml:lang="en-US">Issuance of common stock dividends, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="us-gaap_PreferredStockRedemptionTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockRedemptionTerms" xlink:to="us-gaap_PreferredStockRedemptionTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockRedemptionTerms_lbl" xml:lang="en-US">Preferred stock redemption right, description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockConvertibleSharesIssuable" xlink:to="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockConvertibleSharesIssuable_lbl" xml:lang="en-US">Converted issuance of shares of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Reverse acquisition shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Weighted average exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock reserved for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xml:lang="en-US">Common stock shares equity award issued or granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Share based compensation arrangement by award options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock based compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xml:lang="en-US">Stock issued during Stock options exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3_lbl" xml:lang="en-US">Shares issued or exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of options issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_lbl" xml:lang="en-US">Shares forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_3_lbl" xml:lang="en-US">Allocation share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Options exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xml:lang="en-US">Weighted average remaining recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xml:lang="en-US">Weighted average remaining recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized share based compensation cost</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_lbl" xml:lang="en-US">Weighted average remaining recognition period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Purchase of outstanding warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="NTRP_DescriptionForWarrantExpiration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DescriptionForWarrantExpiration" xlink:to="NTRP_DescriptionForWarrantExpiration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DescriptionForWarrantExpiration_lbl" xml:lang="en-US">Warrant description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3_lbl" xml:lang="en-US">Number of shares converted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock, shares price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockConsiderationReceivedOnTransaction_lbl" xml:lang="en-US">Sale of stock proceeds</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Loss from continuing operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Loss from continuing operations applicable to common stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_lbl" xml:lang="en-US">Loss from discontinued operations applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_2_lbl" xml:lang="en-US">Net loss applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Class of warrant or right, outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_4_lbl" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, exercisable, number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesConverted1_2_lbl" xml:lang="en-US">Conversion of stock, shares converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockSharesIssued1_2_lbl" xml:lang="en-US">Common stock issued conversion</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_3_lbl" xml:lang="en-US">Common stock, shares, outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecurities" xlink:label="us-gaap_DilutiveSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DilutiveSecurities_lbl" xml:lang="en-US">Potentially dilutive securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="us-gaap_ConcentrationRiskTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTable" xlink:to="us-gaap_ConcentrationRiskTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskTable_lbl" xml:lang="en-US">Concentration Risk [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="us-gaap_ConcentrationRiskLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskLineItems" xlink:to="us-gaap_ConcentrationRiskLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskLineItems_lbl" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration of risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:to="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_lbl" xml:lang="en-US">Contribution plan description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="us-gaap_DefinedContributionPlanCostRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanCostRecognized" xlink:to="us-gaap_DefinedContributionPlanCostRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DefinedContributionPlanCostRecognized_lbl" xml:lang="en-US">Cost of contribution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperations_2_lbl" xml:lang="en-US">Loss from continuing operations applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:to="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_2_lbl" xml:lang="en-US">Gain (loss) from discontinued operations applicable to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xml:lang="en-US">Weighted average number of common shares outstanding used in loss per share during the period (denominator)</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfLeisureTravelBookingPlatform" xlink:label="NTRP_LaunchOfLeisureTravelBookingPlatform" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfLeisureTravelBookingPlatform" xlink:to="NTRP_LaunchOfLeisureTravelBookingPlatform_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LaunchOfLeisureTravelBookingPlatform_lbl" xml:lang="en-US">Launch of leisure travel booking platform</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfGroupTravelBookingPlatform" xlink:label="NTRP_LaunchOfGroupTravelBookingPlatform" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfGroupTravelBookingPlatform" xlink:to="NTRP_LaunchOfGroupTravelBookingPlatform_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LaunchOfGroupTravelBookingPlatform_lbl" xml:lang="en-US">Launch of group travel booking platform</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfFlexpayTechnology" xlink:label="NTRP_LaunchOfFlexpayTechnology" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfFlexpayTechnology" xlink:to="NTRP_LaunchOfFlexpayTechnology_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_LaunchOfFlexpayTechnology_lbl" xml:lang="en-US">Launch of FlexPay technology</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesIssuable" xlink:to="NTRP_ContingentSharesIssuable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ContingentSharesIssuable_2_lbl" xml:lang="en-US">Total contingent shares issuable on June 10, 2024</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfTravelAgentPlatformShares" xlink:to="NTRP_LaunchOfTravelAgentPlatformShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_LaunchOfTravelAgentPlatformShares_2_lbl" xml:lang="en-US">Launch of travel agent platform</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentlyIssuableShares" xlink:label="NTRP_ContingentlyIssuableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentlyIssuableShares" xlink:to="NTRP_ContingentlyIssuableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ContingentlyIssuableShares_lbl" xml:lang="en-US">Total contingent shares potentially issuable in future periods</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentShares" xlink:to="NTRP_ContingentShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ContingentShares_2_lbl" xml:lang="en-US">Total contingent shares</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_CommonStockShareOutstanding" xlink:label="NTRP_CommonStockShareOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CommonStockShareOutstanding" xlink:to="NTRP_CommonStockShareOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_CommonStockShareOutstanding_lbl" xml:lang="en-US">1,388,641 common shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_WeightedAverageIssuableContingentShares" xlink:label="NTRP_WeightedAverageIssuableContingentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WeightedAverageIssuableContingentShares" xlink:to="NTRP_WeightedAverageIssuableContingentShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_WeightedAverageIssuableContingentShares_lbl" xml:lang="en-US">4,393,993 issuable contingent shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_lbl" xml:lang="en-US">Weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt instrument, term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Outstanding payment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="us-gaap_PaymentsToFundLongtermLoansToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToFundLongtermLoansToRelatedParties_lbl" xml:lang="en-US">Related party advances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentRate" xlink:to="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentRate_lbl" xml:lang="en-US">Conversion percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Converted amount</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MinimumRequiredStockholdersEquity" xlink:label="NTRP_MinimumRequiredStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MinimumRequiredStockholdersEquity" xlink:to="NTRP_MinimumRequiredStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_MinimumRequiredStockholdersEquity_lbl" xml:lang="en-US">Stockholders equity minimum required</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="us-gaap_NotesAndLoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayableCurrent" xlink:to="us-gaap_NotesAndLoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesAndLoansPayableCurrent_lbl" xml:lang="en-US">Total consideration</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Net proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Original issue discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt instrument description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Warrants to purchase of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants exercise term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_3_lbl" xml:lang="en-US">Number of purchase of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xml:lang="en-US">Sale of stock description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_2_lbl" xml:lang="en-US">Options, Assumed pursuant to reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_4_lbl" xml:lang="en-US">Options, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_lbl" xml:lang="en-US">Options, Forfeited or cancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Options, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life (Yrs.), Exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LossOnRelatedPartyReceivable" xlink:to="NTRP_LossOnRelatedPartyReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LossOnRelatedPartyReceivable_doc" xml:lang="en-US">Loss on related party receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_Technology" xlink:to="NTRP_Technology_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_Technology_doc" xml:lang="en-US">Technology.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OrganizationCosts" xlink:to="NTRP_OrganizationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_OrganizationCosts_doc" xml:lang="en-US">Organization costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:to="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock_doc" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidCostOfSales" xlink:to="NTRP_PrepaidCostOfSales_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidCostOfSales_doc" xml:lang="en-US">Prepaid cost of sales.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:to="NTRP_AtTheMarketIssuanceSalesAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AtTheMarketIssuanceSalesAgreementMember_doc" xml:lang="en-US">At-The-Market Issuance Sales Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConversionOfConvertibleNotes" xlink:to="NTRP_ConversionOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConversionOfConvertibleNotes_doc" xml:lang="en-US">Conversion of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredStockDividends" xlink:to="NTRP_PreferredStockDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PreferredStockDividends_doc" xml:lang="en-US">Preferred stock dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfCommonSharesForServices" xlink:to="NTRP_IssuanceOfCommonSharesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfCommonSharesForServices_doc" xml:lang="en-US">Issuance of common shares for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SigmaAdditiveSolutionsIncMember" xlink:to="NTRP_SigmaAdditiveSolutionsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SigmaAdditiveSolutionsIncMember_doc" xml:lang="en-US">Sigma Additive Solutions Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueOfPreferredShares_doc" xml:lang="en-US">Stock issued during period value of preferred shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, granted, weighted average remaining contractual term .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodShareOfPreferredShares_doc" xml:lang="en-US">Stock issued during period share of preferred shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_doc" xml:lang="en-US">Share-based compensation arrangement by share based payment award options granted in period intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:to="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember_doc" xml:lang="en-US">2020 Stock Appreciation Rights Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_OperatingLossCarryforwardsRemainder" xlink:to="NTRP_OperatingLossCarryforwardsRemainder_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_OperatingLossCarryforwardsRemainder_doc" xml:lang="en-US">Operating loss carryforwards remainder.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetDepreciation" xlink:to="NTRP_DeferredTaxAssetDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxAssetDepreciation_doc" xml:lang="en-US">Deferred tax asset depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockAppreciationRightsMember" xlink:to="NTRP_StockAppreciationRightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockAppreciationRightsMember_doc" xml:lang="en-US">Stock Appreciation Rights [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:to="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_EffectiveIncomeTaxRateReconciliationBookLoss_doc" xml:lang="en-US">Effective income tax rate reconciliation book loss.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares_doc" xml:lang="en-US">Stock issued during period value purchases of common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares_doc" xml:lang="en-US">Stock issued during period shares purchases of common shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options grant in period weighted average remaining contractual term2.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueReverseAcquisition_doc" xml:lang="en-US">Stock issued during period value reverse acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:to="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesReverseAcquisition_doc" xml:lang="en-US">Stock issued during period shares reverse acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_doc" xml:lang="en-US">Weighted average remaining recognition period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants outstanding.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants grants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average exercise price, warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_doc" xml:lang="en-US">Weighted average exercise price, warrants forfeited or cancelled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average remaining contractual life (years), warrants outstanding, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CustomerMember" xlink:to="NTRP_CustomerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_CustomerMember_doc" xml:lang="en-US">Customer [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_doc" xml:lang="en-US">Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DescriptionForWarrantExpiration" xlink:to="NTRP_DescriptionForWarrantExpiration_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DescriptionForWarrantExpiration_doc" xml:lang="en-US">Description for warrant expiration.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_doc" xml:lang="en-US">Salaries and benefits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_doc" xml:lang="en-US">Retention bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_doc" xml:lang="en-US">Proceeds from acquire businesses gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award non option equity instruments assumed pursuant to reverse acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Share based compensation arrangements by share based payment award non options assumed pursuant to reverse acquisition in period weighted average exercise price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextInnovationLLCMember" xlink:to="NTRP_NextInnovationLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextInnovationLLCMember_doc" xml:lang="en-US">Next Innovation LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIPreferredStockMember" xlink:to="NTRP_SeriesIPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesIPreferredStockMember_doc" xml:lang="en-US">Series I Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_AssetPurchaseAgreementMember" xlink:to="NTRP_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:to="NTRP_DebtAssignmentAndConversionAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DebtAssignmentAndConversionAgreementsMember_doc" xml:lang="en-US">Debt Assignment and Conversion Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:to="NTRP_SharePurchaseAndExchangeAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAndExchangeAgreementsMember_doc" xml:lang="en-US">Share Purchase And Exchange Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyConsultantMember" xlink:to="NTRP_ThirdPartyConsultantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ThirdPartyConsultantMember_doc" xml:lang="en-US">Third Party Consultant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_UnsecuredPromissoryNoteMember" xlink:to="NTRP_UnsecuredPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_UnsecuredPromissoryNoteMember_doc" xml:lang="en-US">Unsecured Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MessrsMonacoAndKerbyMember" xlink:to="NTRP_MessrsMonacoAndKerbyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MessrsMonacoAndKerbyMember_doc" xml:lang="en-US">Messrs Monaco and Kerby [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PrepaidsPolicyTextBlock" xlink:to="NTRP_PrepaidsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PrepaidsPolicyTextBlock_doc" xml:lang="en-US">Prepaids [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:to="NTRP_SpecialPurposeAcquisitionCorporationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SpecialPurposeAcquisitionCorporationMember_doc" xml:lang="en-US">Special Purpose Acquisition Corporation [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeveralInvestorsMember" xlink:to="NTRP_SeveralInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeveralInvestorsMember_doc" xml:lang="en-US">Several Investors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConvertibleNotesMember" xlink:to="NTRP_ConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConvertibleNotesMember_doc" xml:lang="en-US">Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripHoldingsIncMember" xlink:to="NTRP_NextTripHoldingsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextTripHoldingsIncMember_doc" xml:lang="en-US">Next Trip Holdings Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_doc" xml:lang="en-US">Share Purchase Agreements Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsMember" xlink:to="NTRP_SharePurchaseAgreementsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharePurchaseAgreementsMember_doc" xml:lang="en-US">Share Purchase Agreements [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareMember" xlink:to="NTRP_SoftwareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareMember_doc" xml:lang="en-US">Software [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicensesMember" xlink:to="NTRP_SoftwareLicensesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareLicensesMember_doc" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingModificationAgreementMember" xlink:to="NTRP_ConsultingModificationAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConsultingModificationAgreementMember_doc" xml:lang="en-US">Consulting Modification Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandThirteenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandThirteenEquityIncentivePlanMember_doc" xml:lang="en-US">2013 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:to="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember_doc" xml:lang="en-US">2023 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance_doc" xml:lang="en-US">Severance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_doc" xml:lang="en-US">Organization costs.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_TwoThousandThirteenPlanMember" xlink:to="NTRP_TwoThousandThirteenPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_TwoThousandThirteenPlanMember_doc" xml:lang="en-US">2013 Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_doc" xml:lang="en-US">Share based compensation arrangements by share based payment award options exercises in period weighted average forfeited or cancelled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextTripGroupLLCMember" xlink:to="NTRP_NextTripGroupLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextTripGroupLLCMember_doc" xml:lang="en-US">NextTrip Holdings, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:to="NTRP_PercentageForIssuedAndOutstandingCapitalStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PercentageForIssuedAndOutstandingCapitalStock_doc" xml:lang="en-US">Percentage for issued and outstanding, capital stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_doc" xml:lang="en-US">Schedule of Estimated Useful Lives for Property and Equipment [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareExchangeAgreementMember" xlink:to="NTRP_ShareExchangeAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareExchangeAgreementMember_doc" xml:lang="en-US">Share Exchange Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MembershipUnitsMember" xlink:to="NTRP_MembershipUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MembershipUnitsMember_doc" xml:lang="en-US">Membership Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PreferredUnitsMember" xlink:to="NTRP_PreferredUnitsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PreferredUnitsMember_doc" xml:lang="en-US">Preferred Units [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_NextPlayTechnologiesIncMember" xlink:to="NTRP_NextPlayTechnologiesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_NextPlayTechnologiesIncMember_doc" xml:lang="en-US">NextPlay Technologies Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:to="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_doc" xml:lang="en-US">Number of additional restricted shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesMember" xlink:to="NTRP_ContingentSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ContingentSharesMember_doc" xml:lang="en-US">Contingent Shares [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WorkingCapitalDeficit" xlink:to="NTRP_WorkingCapitalDeficit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_WorkingCapitalDeficit_doc" xml:lang="en-US">Working capital deficit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_EarnestMoneyDeposit" xlink:to="NTRP_EarnestMoneyDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_EarnestMoneyDeposit_doc" xml:lang="en-US">Earnest-money deposit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DivergentTechnologiesIncMember" xlink:to="NTRP_DivergentTechnologiesIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DivergentTechnologiesIncMember_doc" xml:lang="en-US">Divergent Technologies, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromDownpaymentForContract" xlink:to="NTRP_ProceedsFromDownpaymentForContract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ProceedsFromDownpaymentForContract_doc" xml:lang="en-US">Proceeds from down-payment for contract.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareAsAServiceAgreementMember" xlink:to="NTRP_SoftwareAsAServiceAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareAsAServiceAgreementMember_doc" xml:lang="en-US">Software as a Service Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ThirdPartyMember" xlink:to="NTRP_ThirdPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ThirdPartyMember_doc" xml:lang="en-US">Third Party [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ConsultingFees" xlink:to="NTRP_ConsultingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ConsultingFees_doc" xml:lang="en-US">Consulting fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:to="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_doc" xml:lang="en-US">Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredRevenueTextBlock_doc" xml:lang="en-US">Deferred Revenue [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicenseMember" xlink:to="NTRP_SoftwareLicenseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SoftwareLicenseMember_doc" xml:lang="en-US">Software Licenses [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesEConvertiblePreferredStockMember" xlink:to="NTRP_SeriesEConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesEConvertiblePreferredStockMember_doc" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesFConvertiblePreferredStockMember" xlink:to="NTRP_SeriesFConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesFConvertiblePreferredStockMember_doc" xml:lang="en-US">Series F Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesGConvertiblePreferredStockMember" xlink:to="NTRP_SeriesGConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesGConvertiblePreferredStockMember_doc" xml:lang="en-US">Series G Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesHConvertiblePreferredStockMember" xlink:to="NTRP_SeriesHConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesHConvertiblePreferredStockMember_doc" xml:lang="en-US">Series H Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SeriesIConvertiblePreferredStockMember" xlink:to="NTRP_SeriesIConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SeriesIConvertiblePreferredStockMember_doc" xml:lang="en-US">Series I Convertible Preferred Stock [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:to="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_doc" xml:lang="en-US">Finite lived intangible assets amortization expense after year three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DepreciationOfRightOfUseAsset" xlink:to="NTRP_DepreciationOfRightOfUseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DepreciationOfRightOfUseAsset_doc" xml:lang="en-US">Depreciation of right of use asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" xlink:to="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncreaseDecreaseInRightOfUseLeaseLiability_doc" xml:lang="en-US">Increase decrease in right of use lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForServices" xlink:to="NTRP_IssuanceOfPreferredSharesForServices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfPreferredSharesForServices_doc" xml:lang="en-US">Issuance of preferred shares for services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:to="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense_doc" xml:lang="en-US">Issuance of preferred shares for perpetual software license.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxAssetsPayrollAccruals" xlink:to="NTRP_DeferredTaxAssetsPayrollAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxAssetsPayrollAccruals_doc" xml:lang="en-US">Deferred tax assets payroll accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_doc" xml:lang="en-US">Deferred tax liabilities depreciation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense preferred dividends.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense loss on asset disposal.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense accrued payroll.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_doc" xml:lang="en-US">Income tax reconciliation nondeductible expense related party accruals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome_doc" xml:lang="en-US">Disposal group including discontinued operations other income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivableNet" xlink:to="NTRP_PromissoryNoteReceivableNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PromissoryNoteReceivableNet_doc" xml:lang="en-US">Promissory note receivable net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:to="NTRP_PromissoryNoteReceivablePolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PromissoryNoteReceivablePolicyTextBlock_doc" xml:lang="en-US">Promissory Note Receivable [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_doc" xml:lang="en-US">Sharebased compensation arrangement by share based payment award options weighted average exercise price assumed pursuant to reverse acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award non options equity instruments assumed pursuant to reverse acquisition weighted average remaining contractual term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares_doc" xml:lang="en-US">Stock issued during period value issuance of convertible preferred shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:to="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares_doc" xml:lang="en-US">Stock issued during period shares issuance of convertible preferred shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:to="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_doc" xml:lang="en-US">Increase decrease in promissory note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_doc" xml:lang="en-US">Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition intrinsic value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award non options equity instruments granted in period weighted average remaining contractual term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_MinimumRequiredStockholdersEquity" xlink:to="NTRP_MinimumRequiredStockholdersEquity_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_MinimumRequiredStockholdersEquity_doc" xml:lang="en-US">Minimum required stockholders equity</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuableContingentShares" xlink:label="NTRP_IssuableContingentShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IssuableContingentShares" xlink:to="NTRP_IssuableContingentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_IssuableContingentShares_doc" xml:lang="en-US">Issuable contingent shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_CommonStockShareOutstanding" xlink:to="NTRP_CommonStockShareOutstanding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_CommonStockShareOutstanding_doc" xml:lang="en-US">Common stock share outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfLeisureTravelBookingPlatform" xlink:to="NTRP_LaunchOfLeisureTravelBookingPlatform_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LaunchOfLeisureTravelBookingPlatform_doc" xml:lang="en-US">Launch of leisure travel booking platform</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfGroupTravelBookingPlatform" xlink:to="NTRP_LaunchOfGroupTravelBookingPlatform_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LaunchOfGroupTravelBookingPlatform_doc" xml:lang="en-US">Launch of group travel booking platform</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfFlexpayTechnology" xlink:to="NTRP_LaunchOfFlexpayTechnology_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LaunchOfFlexpayTechnology_doc" xml:lang="en-US">Launch of flexpay technology</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_WeightedAverageIssuableContingentShares" xlink:to="NTRP_WeightedAverageIssuableContingentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_WeightedAverageIssuableContingentShares_doc" xml:lang="en-US">Weighted average issuable contingent shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_LaunchOfTravelAgentPlatformShares" xlink:to="NTRP_LaunchOfTravelAgentPlatformShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_LaunchOfTravelAgentPlatformShares_doc" xml:lang="en-US">Launch of travel agent platform shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentlyIssuableShares" xlink:to="NTRP_ContingentlyIssuableShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ContingentlyIssuableShares_doc" xml:lang="en-US">Contingently issuable shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentShares" xlink:to="NTRP_ContingentShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ContingentShares_doc" xml:lang="en-US">Contingent shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ContingentSharesIssuable" xlink:to="NTRP_ContingentSharesIssuable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ContingentSharesIssuable_doc" xml:lang="en-US">Contingent shares issuable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" xlink:to="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_ScheduleOfIssuableContingentSharesTableTextBlock_doc" xml:lang="en-US">Schedule of Issuable Contingent Shares [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteMember" xlink:label="NTRP_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_PromissoryNoteMember" xlink:to="NTRP_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="NTRP_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SoftwareLicenseMember" xlink:to="NTRP_SoftwareLicenseMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SoftwareLicenseMember_3_lbl" xml:lang="en-US">Software Licenses [Member] [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Equity, Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:to="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockDividendsIncomeStatementImpact_2_lbl" xml:lang="en-US">Preferred Stock Dividends, Income Statement Impact</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPreferredStock" xlink:to="us-gaap_DividendsPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DividendsPreferredStock_2_lbl" xml:lang="en-US">Dividends, Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="us-gaap_GainLossOnDispositionOfIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfIntangibleAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:to="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncreaseDecreaseInPromissoryNoteReceivable_3_lbl" xml:lang="en-US">Increase decrease in promissory note receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:to="us-gaap_IncreaseDecreaseInSecurityDeposits_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInSecurityDeposits_2_lbl" xml:lang="en-US">Increase (Decrease) in Security Deposits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredRevenue_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForSoftware" xlink:to="us-gaap_PaymentsForSoftware_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForSoftware_2_lbl" xml:lang="en-US">Payments for Software</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OriginationOfNotesReceivableFromRelatedParties" xlink:to="us-gaap_OriginationOfNotesReceivableFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OriginationOfNotesReceivableFromRelatedParties_2_lbl" xml:lang="en-US">Origination of Notes Receivable from Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ProceedsFromAcquireBusinessesGross" xlink:to="NTRP_ProceedsFromAcquireBusinessesGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ProceedsFromAcquireBusinessesGross_3_lbl" xml:lang="en-US">ProceedsFromAcquireBusinessesGross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_2_lbl" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillDisclosureTextBlock" xlink:to="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillDisclosureTextBlock_2_lbl" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_2_lbl" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:to="NTRP_SharePurchaseAgreementsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharePurchaseAgreementsDisclosureTextBlock_3_lbl" xml:lang="en-US">Share Purchase Agreements Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredRevenueTextBlock" xlink:to="NTRP_DeferredRevenueTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredRevenueTextBlock_3_lbl" xml:lang="en-US">Deferred Revenue [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_2_lbl" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_2_lbl" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_2_lbl" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_2_lbl" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2_lbl" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Gross Profit (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:to="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_3_lbl" xml:lang="en-US">DisposalGroupIncludingDiscontinuedOperationOrganizationCosts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:to="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense_2_lbl" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:to="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_3_lbl" xml:lang="en-US">BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_DeferredTaxLiabilitiesDepreciation" xlink:to="NTRP_DeferredTaxLiabilitiesDepreciation_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_DeferredTaxLiabilitiesDepreciation_3_lbl" xml:lang="en-US">Deferred tax liabilities depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:to="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_3_lbl" xml:lang="en-US">IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_4_lbl" xml:lang="en-US">Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:to="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2_lbl" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:to="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_3_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DilutiveSecurities" xlink:to="us-gaap_DilutiveSecurities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DilutiveSecurities_2_lbl" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>18
<FILENAME>ntrp-20240831_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.24b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://nexttrip.com/role/Cover" xlink:href="ntrp-20240831.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheets" xlink:href="ntrp-20240831.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:href="ntrp-20240831.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperations" xlink:href="ntrp-20240831.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:href="ntrp-20240831.xsd#StatementsOfStockholdersEquityDeficitParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StatementsOfCashFlows" xlink:href="ntrp-20240831.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcern" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperations" xlink:href="ntrp-20240831.xsd#DiscontinuedOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Leases" xlink:href="ntrp-20240831.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipment" xlink:href="ntrp-20240831.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssets" xlink:href="ntrp-20240831.xsd#IntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Goodwill" xlink:href="ntrp-20240831.xsd#Goodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxes" xlink:href="ntrp-20240831.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayable" xlink:href="ntrp-20240831.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreements" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreements" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactions" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenue" xlink:href="ntrp-20240831.xsd#DeferredRevenue" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:href="ntrp-20240831.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquity" xlink:href="ntrp-20240831.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShare" xlink:href="ntrp-20240831.xsd#LossPerShare" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/Concentrations" xlink:href="ntrp-20240831.xsd#Concentrations" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlans" xlink:href="ntrp-20240831.xsd#DefinedContributionPlans" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEvents" xlink:href="ntrp-20240831.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:href="ntrp-20240831.xsd#PrepaidAndOtherCurrentAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsTables" xlink:href="ntrp-20240831.xsd#IntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillTables" xlink:href="ntrp-20240831.xsd#GoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesTables" xlink:href="ntrp-20240831.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityTables" xlink:href="ntrp-20240831.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareTables" xlink:href="ntrp-20240831.xsd#LossPerShareTables" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:href="ntrp-20240831.xsd#BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="ntrp-20240831.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:href="ntrp-20240831.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="ntrp-20240831.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:href="ntrp-20240831.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfGoodwillDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:href="ntrp-20240831.xsd#GoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:href="ntrp-20240831.xsd#AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfDeferredTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:href="ntrp-20240831.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:href="ntrp-20240831.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SharePurchaseAgreementsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="ntrp-20240831.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:href="ntrp-20240831.xsd#DeferredRevenueDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWarrantyActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:href="ntrp-20240831.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:href="ntrp-20240831.xsd#LossPerShareDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:href="ntrp-20240831.xsd#ConcentrationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:href="ntrp-20240831.xsd#DefinedContributionPlansDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfIssuableContingentSharesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:href="ntrp-20240831.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:href="ntrp-20240831.xsd#ScheduleOfStockAppreciationRightsActivityDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:label="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:label="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="loc_us-gaapNonrelatedPartyMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapNonrelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivableNet" xlink:label="loc_NTRPPromissoryNoteReceivableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_NTRPPromissoryNoteReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAbstract" xlink:label="loc_us-gaapLiabilitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefinedBenefitPlanDisclosureLineItems" xlink:to="loc_us-gaapLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LaborAndRelatedExpense" xlink:label="loc_us-gaapLaborAndRelatedExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapLaborAndRelatedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_Technology" xlink:label="loc_NTRPTechnology" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_NTRPTechnology" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_OrganizationCosts" xlink:label="loc_NTRPOrganizationCosts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_NTRPOrganizationCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:label="loc_us-gaapInterestIncomeExpenseNonoperatingNet" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNonoperatingNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfOperationsParenthetical" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueOfPreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodShareOfPreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodShareOfPreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValuePurchasesOfCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesPurchasesOfCommonShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesReverseAcquisition" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPreferredStock" xlink:label="loc_us-gaapDividendsPreferredStock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDividendsPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical" xlink:title="00000007 - Statement - Condensed Consolidated Statements of Stockholders&apos; Equity (Deficit) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StatementsOfCashFlows" xlink:title="00000008 - Statement - Condensed Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DepreciationOfRightOfUseAsset" xlink:label="loc_NTRPDepreciationOfRightOfUseAsset" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NTRPDepreciationOfRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfIntangibleAssets" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInPromissoryNoteReceivable" xlink:label="loc_NTRPIncreaseDecreaseInPromissoryNoteReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_NTRPIncreaseDecreaseInPromissoryNoteReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSecurityDeposits" xlink:label="loc_us-gaapIncreaseDecreaseInSecurityDeposits" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInSecurityDeposits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncreaseDecreaseInRightOfUseLeaseLiability" xlink:label="loc_NTRPIncreaseDecreaseInRightOfUseLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_NTRPIncreaseDecreaseInRightOfUseLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredRevenue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForSoftware" xlink:label="loc_us-gaapPaymentsForSoftware" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForSoftware" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OriginationOfNotesReceivableFromRelatedParties" xlink:label="loc_us-gaapOriginationOfNotesReceivableFromRelatedParties" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapOriginationOfNotesReceivableFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromAcquireBusinessesGross" xlink:label="loc_NTRPProceedsFromAcquireBusinessesGross" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_NTRPProceedsFromAcquireBusinessesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_us-gaapProceedsFromSaleOfProductiveAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleOfProductiveAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureOfCashPaidAbstract" xlink:label="loc_NTRPDisclosureOfCashPaidAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_NTRPDisclosureOfCashPaidAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfPreferredSharesForServices" xlink:label="loc_NTRPIssuanceOfPreferredSharesForServices" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_NTRPIssuanceOfPreferredSharesForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:label="loc_NTRPIssuanceOfPreferredSharesForPerpetualSoftwareLicense" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_NTRPIssuanceOfPreferredSharesForPerpetualSoftwareLicense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConversionOfConvertibleNotes" xlink:label="loc_NTRPConversionOfConvertibleNotes" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_NTRPConversionOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PreferredStockDividends" xlink:label="loc_NTRPPreferredStockDividends" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_NTRPPreferredStockDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IssuanceOfCommonSharesForServices" xlink:label="loc_NTRPIssuanceOfCommonSharesForServices" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_NTRPIssuanceOfCommonSharesForServices" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcern" xlink:title="00000009 - Disclosure - Business Description and Going Concern">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubstantialDoubtAboutGoingConcernTextBlock" xlink:label="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapSubstantialDoubtAboutGoingConcernTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000010 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperations" xlink:title="00000011 - Disclosure - Discontinued Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:label="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssets" xlink:title="00000012 - Disclosure - Prepaid and Other Current Assets">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="loc_NTRPPrepaidExpensesAndOtherCurrentAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Leases" xlink:title="00000013 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureLeasesAbstract" xlink:label="loc_NTRPDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipment" xlink:title="00000014 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssets" xlink:title="00000015 - Disclosure - Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Goodwill" xlink:title="00000016 - Disclosure - Goodwill">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayable" xlink:title="00000019 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreements" xlink:title="00000020 - Disclosure - Share Purchase Agreements">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAgreementsDisclosureTextBlock" xlink:label="loc_NTRPSharePurchaseAgreementsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" xlink:to="loc_NTRPSharePurchaseAgreementsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactions" xlink:title="00000021 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenue" xlink:title="00000022 - Disclosure - Deferred Revenue">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="loc_NTRPDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredRevenueTextBlock" xlink:label="loc_NTRPDeferredRevenueTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureDeferredRevenueAbstract" xlink:to="loc_NTRPDeferredRevenueTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/CommitmentsAndContingencies" xlink:title="00000023 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquity" xlink:title="00000024 - Disclosure - Stockholders&#8217; Equity">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShare" xlink:title="00000025 - Disclosure - Loss Per Share">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaapEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapEarningsPerShareTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/Concentrations" xlink:title="00000026 - Disclosure - Concentrations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlans" xlink:title="00000027 - Disclosure - Defined Contribution Plans">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:label="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapCompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEvents" xlink:title="00000028 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidsPolicyTextBlock" xlink:label="loc_NTRPPrepaidsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPPrepaidsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PromissoryNoteReceivablePolicyTextBlock" xlink:label="loc_NTRPPromissoryNoteReceivablePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPPromissoryNoteReceivablePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:label="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIntangibleAssetsFiniteLivedPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InternalUseSoftwarePolicy" xlink:label="loc_us-gaapInternalUseSoftwarePolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInternalUseSoftwarePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="loc_us-gaapLesseeLeasesPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapLesseeLeasesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketRiskBenefitPolicyTextBlock" xlink:label="loc_us-gaapMarketRiskBenefitPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapMarketRiskBenefitPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:label="loc_NTRPScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:label="loc_NTRPScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ScheduleOfIssuableContingentSharesTableTextBlock" xlink:label="loc_NTRPScheduleOfIssuableContingentSharesTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_NTRPScheduleOfIssuableContingentSharesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsTables" xlink:title="00000031 - Disclosure - Discontinued Operations (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables" xlink:title="00000032 - Disclosure - Prepaid and Other Current Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:label="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapDeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentTables" xlink:title="00000033 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsTables" xlink:title="00000034 - Disclosure - Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillTables" xlink:title="00000035 - Disclosure - Goodwill (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="loc_us-gaapScheduleOfGoodwillTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfGoodwillTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesTables" xlink:title="00000036 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityTables" xlink:title="00000037 - Disclosure - Stockholders&#8217; Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareTables" xlink:title="00000038 - Disclosure - Loss Per Share (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative" xlink:title="00000039 - Disclosure - Business Description and Going Concern (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripGroupLLCMember" xlink:label="loc_NTRPNextTripGroupLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripGroupLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareExchangeAgreementMember" xlink:label="loc_NTRPShareExchangeAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPShareExchangeAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MembershipUnitsMember" xlink:label="loc_NTRPMembershipUnitsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPMembershipUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PreferredUnitsMember" xlink:label="loc_NTRPPreferredUnitsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPPreferredUnitsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srtEquityMethodInvesteeNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="loc_srtEquityMethodInvesteeNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextInnovationLLCMember" xlink:label="loc_NTRPNextInnovationLLCMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtEquityMethodInvesteeNameDomain" xlink:to="loc_NTRPNextInnovationLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ClosingSharesMember" xlink:label="loc_NTRPClosingSharesMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPClosingSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPContingentSharesMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:label="loc_NTRPStockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPStockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PercentageForIssuedAndOutstandingCapitalStock" xlink:label="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPPercentageForIssuedAndOutstandingCapitalStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_WorkingCapitalDeficit" xlink:label="loc_NTRPWorkingCapitalDeficit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPWorkingCapitalDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Capital" xlink:label="loc_us-gaapCapital" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="loc_NTRPContingentSharesIssuable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPContingentSharesIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfTravelAgentPlatformShares" xlink:label="loc_NTRPLaunchOfTravelAgentPlatformShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPLaunchOfTravelAgentPlatformShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails" xlink:title="00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails" xlink:title="00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentUsefulLife" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails" xlink:title="00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareMember" xlink:label="loc_NTRPSoftwareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebt" xlink:label="loc_us-gaapConvertibleDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="loc_NTRPContingentSharesIssuable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPContingentSharesIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentShares" xlink:label="loc_NTRPContingentShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPContingentShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000044 - Disclosure - Schedule of Discontinued Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationGrossProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationRetentionBonuses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationRetentionBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSeverance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationSeverance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationOrganizationCosts" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationOrganizationCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:label="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_NTRPDisposalGroupIncludingDiscontinuedOperationsOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:label="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapDisposalGroupIncludingDiscontinuedOperationOperatingExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000045 - Disclosure - Discontinued Operations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AssetPurchaseAgreementMember" xlink:label="loc_NTRPAssetPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EarnestMoneyDeposit" xlink:label="loc_NTRPEarnestMoneyDeposit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_NTRPEarnestMoneyDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:label="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="loc_us-gaapOtherPrepaidExpenseCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapOtherPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrepaidCostOfSales" xlink:label="loc_NTRPPrepaidCostOfSales" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_NTRPPrepaidCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosurePrepaidAndOtherCurrentAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LeasesDetailsNarrative" xlink:title="00000047 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureLeasesAbstract" xlink:label="loc_NTRPDisclosureLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_PrincipalExecutiveOfficesMember" xlink:label="loc_NTRPPrincipalExecutiveOfficesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPPrincipalExecutiveOfficesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRent" xlink:label="loc_us-gaapPaymentsForRent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000048 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember" xlink:label="loc_us-gaapComputerEquipmentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapComputerEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000049 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000050 - Disclosure - Schedule of Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="loc_us-gaapSoftwareDevelopmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareDevelopmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicenseMember" xlink:label="loc_NTRPSoftwareLicenseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicenseMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="loc_us-gaapTrademarksMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapTrademarksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareLicensesMember" xlink:label="loc_NTRPSoftwareLicensesMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_NTRPSoftwareLicensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:label="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_NTRPFiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000052 - Disclosure - Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails" xlink:title="00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaapRestructuringCostAndReserveLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapRestructuringCostAndReserveLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRestructuringAndRelatedCostsTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:label="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_NTRPBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRestructuringCostAndReserveLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails" xlink:title="00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod" xlink:label="loc_us-gaapGoodwillAcquiredDuringPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAcquiredDuringPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/GoodwillDetailsNarrative" xlink:title="00000055 - Disclosure - Goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SigmaAdditiveSolutionsIncMember" xlink:label="loc_NTRPSigmaAdditiveSolutionsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPSigmaAdditiveSolutionsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DivergentTechnologiesIncMember" xlink:label="loc_NTRPDivergentTechnologiesIncMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDivergentTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaapBusinessAcquisitionSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="loc_us-gaapGoodwillPeriodIncreaseDecrease" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative" xlink:title="00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails" xlink:title="00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetDepreciation" xlink:label="loc_NTRPDeferredTaxAssetDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxAssetDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxAssetsPayrollAccruals" xlink:label="loc_NTRPDeferredTaxAssetsPayrollAccruals" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxAssetsPayrollAccruals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DeferredTaxLiabilitiesDepreciation" xlink:label="loc_NTRPDeferredTaxLiabilitiesDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPDeferredTaxLiabilitiesDepreciation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails" xlink:title="00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_EffectiveIncomeTaxRateReconciliationBookLoss" xlink:label="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPEffectiveIncomeTaxRateReconciliationBookLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpensePreferredDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseAccruedPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:label="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPIncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000059 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_OperatingLossCarryforwardsRemainder" xlink:label="loc_NTRPOperatingLossCarryforwardsRemainder" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_NTRPOperatingLossCarryforwardsRemainder" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/NotesPayableDetailsNarrative" xlink:title="00000060 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable" xlink:label="loc_us-gaapScheduleOfShortTermDebtTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShortTermDebtTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems" xlink:label="loc_us-gaapShortTermDebtLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapShortTermDebtLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SpecialPurposeAcquisitionCorporationMember" xlink:label="loc_NTRPSpecialPurposeAcquisitionCorporationMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPSpecialPurposeAcquisitionCorporationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPSeveralInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConvertibleNotesMember" xlink:label="loc_NTRPConvertibleNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShortTermDebtTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative" xlink:title="00000061 - Disclosure - Share Purchase Agreements (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureSharePurchaseAgreementsAbstract" xlink:label="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureSharePurchaseAgreementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAgreementsMember" xlink:label="loc_NTRPSharePurchaseAgreementsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSharePurchaseAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SoftwareAsAServiceAgreementMember" xlink:label="loc_NTRPSoftwareAsAServiceAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSoftwareAsAServiceAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingModificationAgreementMember" xlink:label="loc_NTRPConsultingModificationAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPConsultingModificationAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeveralInvestorsMember" xlink:label="loc_NTRPSeveralInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPSeveralInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyMember" xlink:label="loc_NTRPThirdPartyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPThirdPartyConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesMember" xlink:label="loc_NTRPContingentSharesMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_NTRPContingentSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ProceedsFromDownpaymentForContract" xlink:label="loc_NTRPProceedsFromDownpaymentForContract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPProceedsFromDownpaymentForContract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ConsultingFees" xlink:label="loc_NTRPConsultingFees" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_NTRPConsultingFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000062 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="loc_us-gaapRelatedPartyTransactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextPlayTechnologiesIncMember" xlink:label="loc_NTRPNextPlayTechnologiesIncMember_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextPlayTechnologiesIncMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:label="loc_NTRPBoardOfDirectorsAndChiefExecutiveOfficerMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPBoardOfDirectorsAndChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_InvestorsDirectorsOfficersAndEmployeesMember" xlink:label="loc_NTRPInvestorsDirectorsOfficersAndEmployeesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPInvestorsDirectorsOfficersAndEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DonaldMonacoMember" xlink:label="loc_NTRPDonaldMonacoMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPDonaldMonacoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LossOnRelatedPartyReceivable" xlink:label="loc_NTRPLossOnRelatedPartyReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_NTRPLossOnRelatedPartyReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="loc_us-gaapLineOfCredit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapLineOfCredit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DeferredRevenueDetailsNarrative" xlink:title="00000063 - Disclosure - Deferred Revenue (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DisclosureDeferredRevenueAbstract" xlink:label="loc_NTRPDisclosureDeferredRevenueAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_NTRPDisclosureDeferredRevenueAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails" xlink:title="00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails" xlink:title="00000065 - Disclosure - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_2" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails" xlink:title="00000066 - Disclosure - Schedule of Warranty Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:label="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/StockholdersEquityDetailsNarrative" xlink:title="00000067 - Disclosure - Stockholders&#8217; Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="loc_us-gaapSubsidiarySaleOfStockLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="loc_us-gaapSubsidiarySaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapSubsidiarySaleOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="loc_us-gaapSaleOfStockNameOfTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockAxis" xlink:to="loc_us-gaapSaleOfStockNameOfTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_AtTheMarketIssuanceSalesAgreementMember" xlink:label="loc_NTRPAtTheMarketIssuanceSalesAgreementMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSaleOfStockNameOfTransactionDomain" xlink:to="loc_NTRPAtTheMarketIssuanceSalesAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_NextTripHoldingsIncMember" xlink:label="loc_NTRPNextTripHoldingsIncMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_NTRPNextTripHoldingsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeAxis" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredRevenueArrangementTypeDomain" xlink:label="loc_us-gaapDeferredRevenueArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeAxis" xlink:to="loc_us-gaapDeferredRevenueArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DebtAssignmentAndConversionAgreementsMember" xlink:label="loc_NTRPDebtAssignmentAndConversionAgreementsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPDebtAssignmentAndConversionAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharePurchaseAndExchangeAgreementsMember" xlink:label="loc_NTRPSharePurchaseAndExchangeAgreementsMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDeferredRevenueArrangementTypeDomain" xlink:to="loc_NTRPSharePurchaseAndExchangeAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="loc_us-gaapRelatedPartyTransactionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapRelatedPartyTransactionAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="loc_us-gaapRelatedPartyTransactionDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionAxis" xlink:to="loc_us-gaapRelatedPartyTransactionDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ThirdPartyConsultantMember" xlink:label="loc_NTRPThirdPartyConsultantMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionDomain" xlink:to="loc_NTRPThirdPartyConsultantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesEConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesEConvertiblePreferredStockMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesEConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesFConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesFConvertiblePreferredStockMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesFConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesGConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesGConvertiblePreferredStockMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesGConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesHConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesHConvertiblePreferredStockMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesHConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapPlanNameAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember" xlink:label="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandTwentyThreeEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandThirteenPlanMember" xlink:label="loc_NTRPTwoThousandThirteenPlanMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandThirteenPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:label="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_NTRPTwoThousandAndTwentyStockAppreciationRightsPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapAwardTypeAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionMember" xlink:label="loc_us-gaapStockOptionMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_srtRangeAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_deiLegalEntityAxis" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DooyaMediaGroupIncMember" xlink:label="loc_NTRPDooyaMediaGroupIncMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_NTRPDooyaMediaGroupIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="110" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesReverseStockSplits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:label="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePercentage" xlink:label="loc_us-gaapPreferredStockDividendRatePercentage" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockDividendRatePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsShares" xlink:label="loc_us-gaapCommonStockDividendsShares" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockDividendsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockRedemptionTerms" xlink:label="loc_us-gaapPreferredStockRedemptionTerms" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockRedemptionTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockConvertibleSharesIssuable" xlink:label="loc_us-gaapPreferredStockConvertibleSharesIssuable" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapPreferredStockConvertibleSharesIssuable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_DescriptionForWarrantExpiration" xlink:label="loc_NTRPDescriptionForWarrantExpiration" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_NTRPDescriptionForWarrantExpiration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsidiarySaleOfStockLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/LossPerShareDetailsNarrative" xlink:title="00000069 - Disclosure - Loss Per Share (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaapEarningsPerShareAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="loc_us-gaapEarningsPerShareBasicLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapEarningsPerShareBasicLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember" xlink:label="loc_us-gaapSeriesEPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesEPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesGPreferredStockMember" xlink:label="loc_us-gaapSeriesGPreferredStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesGPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesHPreferredStockMember" xlink:label="loc_us-gaapSeriesHPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapSeriesHPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIPreferredStockMember" xlink:label="loc_NTRPSeriesIPreferredStockMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DilutiveSecurities" xlink:label="loc_us-gaapDilutiveSecurities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicLineItems" xlink:to="loc_us-gaapDilutiveSecurities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ConcentrationsDetailsNarrative" xlink:title="00000070 - Disclosure - Concentrations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable" xlink:label="loc_us-gaapConcentrationRiskTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems" xlink:label="loc_us-gaapConcentrationRiskLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTable" xlink:to="loc_srtMajorCustomersAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_CustomerMember" xlink:label="loc_NTRPCustomerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_NTRPCustomerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative" xlink:title="00000071 - Disclosure - Defined Contribution Plans (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="loc_us-gaapCompensationAndRetirementDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:label="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDescriptionOfDefinedContributionPensionAndOtherPostretirementPlans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized" xlink:label="loc_us-gaapDefinedContributionPlanCostRecognized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCompensationAndRetirementDisclosureAbstract" xlink:to="loc_us-gaapDefinedContributionPlanCostRecognized" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails" xlink:title="00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaapAntidilutiveSecuritiesNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="loc_us-gaapAntidilutiveSecuritiesNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaapEmployeeStockOptionMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapEmployeeStockOptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesNameDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="loc_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails" xlink:title="00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails" xlink:title="00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfLeisureTravelBookingPlatform" xlink:label="loc_NTRPLaunchOfLeisureTravelBookingPlatform" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPLaunchOfLeisureTravelBookingPlatform" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfGroupTravelBookingPlatform" xlink:label="loc_NTRPLaunchOfGroupTravelBookingPlatform" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPLaunchOfGroupTravelBookingPlatform" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfFlexpayTechnology" xlink:label="loc_NTRPLaunchOfFlexpayTechnology" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPLaunchOfFlexpayTechnology" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentSharesIssuable" xlink:label="loc_NTRPContingentSharesIssuable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPContingentSharesIssuable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_LaunchOfTravelAgentPlatformShares" xlink:label="loc_NTRPLaunchOfTravelAgentPlatformShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPLaunchOfTravelAgentPlatformShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentlyIssuableShares" xlink:label="loc_NTRPContingentlyIssuableShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPContingentlyIssuableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ContingentShares" xlink:label="loc_NTRPContingentShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPContingentShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails" xlink:title="00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_CommonStockShareOutstanding" xlink:label="loc_NTRPCommonStockShareOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPCommonStockShareOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_WeightedAverageIssuableContingentShares" xlink:label="loc_NTRPWeightedAverageIssuableContingentShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_NTRPWeightedAverageIssuableContingentShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000076 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_UnsecuredPromissoryNoteMember" xlink:label="loc_NTRPUnsecuredPromissoryNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_NTRPUnsecuredPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsMonacoAndKerbyMember" xlink:label="loc_NTRPMessrsMonacoAndKerbyMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_NTRPMessrsMonacoAndKerbyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="loc_us-gaapRelatedPartyMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_us-gaapRelatedPartyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MessrsKerbyAndMonacoMember" xlink:label="loc_NTRPMessrsKerbyAndMonacoMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_NTRPMessrsKerbyAndMonacoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SecuritiesPurchaseAgreementMember" xlink:label="loc_NTRPSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_NTRPSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_srtRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SeriesIConvertiblePreferredStockMember" xlink:label="loc_NTRPSeriesIConvertiblePreferredStockMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_NTRPSeriesIConvertiblePreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentRate" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="loc_us-gaapDebtInstrumentCarryingAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentCarryingAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_MinimumRequiredStockholdersEquity" xlink:label="loc_NTRPMinimumRequiredStockholdersEquity" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_NTRPMinimumRequiredStockholdersEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayableCurrent" xlink:label="loc_us-gaapNotesAndLoansPayableCurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapNotesAndLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="loc_us-gaapSaleOfStockDescriptionOfTransaction" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockDescriptionOfTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:label="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails" xlink:title="00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_StockAppreciationRightsMember" xlink:label="loc_NTRPStockAppreciationRightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_NTRPStockAppreciationRightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:label="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="ntrp-20240831.xsd#NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:label="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_NTRPShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532720528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Aug. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">Amendment
No. 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEXTTRIP,
INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000788611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1865814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3900
Paseo del Sol<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa
Fe<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">87507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(954)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-9688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3900
Paseo del Sol<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Santa
Fe<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">87507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">William
Kerby<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532671504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th" colspan="2"><div>Feb. 29, 2024</div></th>
<th class="th" colspan="2"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 102,006<span></span>
</td>
<td class="nump">$ 323,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 282,475<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PromissoryNoteReceivableNet', window );">Promissory note receivable, net</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,933,908<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">11,201<span></span>
</td>
<td class="nump">34,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">244,870<span></span>
</td>
<td class="nump">340,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">1,358,077<span></span>
</td>
<td class="nump">1,698,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,224,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">6,703<span></span>
</td>
<td class="nump">6,642<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,310,927<span></span>
</td>
<td class="nump">2,173,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,607,670<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecurityDeposit', window );">Security deposit</a></td>
<td class="nump">45,167<span></span>
</td>
<td class="nump">42,167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,167,805<span></span>
</td>
<td class="nump">1,167,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of Use Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,020,443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Non-Current Assets</a></td>
<td class="nump">3,530,602<span></span>
</td>
<td class="nump">3,390,034<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,659,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">4,888,679<span></span>
</td>
<td class="nump">5,088,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,884,335<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,145,536<span></span>
</td>
<td class="nump">531,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">519,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">880,585<span></span>
</td>
<td class="nump">460,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">329,922<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtCurrent', window );">Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,233,503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">138,067<span></span>
</td>
<td class="nump">139,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,750<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating Lease Liability &#8211; Short Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">149,339<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">5,022,782<span></span>
</td>
<td class="nump">1,960,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,535,650<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non- Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating Lease Liability &#8211; Long Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">864,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Non-Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">864,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">5,022,782<span></span>
</td>
<td class="nump">1,960,813<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,400,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholder&#8217;s Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, $0.001 par value, 10,000,000 shares authorized; 93,295 and 472,996 shares issued and outstanding, respectively</a></td>
<td class="nump">94<span></span>
</td>
<td class="nump">474<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, $0.001 par value, 250,000,000 and 1,200,000 shares authorized, respectively; 1,388,641 and 936,430 shares issued and outstanding, respectively</a></td>
<td class="nump">1,389<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid in Capital</a></td>
<td class="nump">27,550,296<span></span>
</td>
<td class="nump">27,277,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">17,295,890<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(27,685,882)<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,811,863)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders&#8217; Equity</a></td>
<td class="num">(134,103)<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">484,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity</a></td>
<td class="nump">4,888,679<span></span>
</td>
<td class="nump">5,088,842<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,884,335<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - related parties</a></td>
<td class="nump">2,718,594<span></span>
</td>
<td class="nump">828,277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 281,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - related parties</a></td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z6Ekva3JH2xg" title="Number of shares acquired">83,371</span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zZ1iSAPMmFo3" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zwrW1FaxviGd" title="Number of shares acquired">83,371</span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zekArRvcggKb" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PromissoryNoteReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory note receivable net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PromissoryNoteReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecurityDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecurityDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526600272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 08, 2024</div></th>
<th class="th"><div>Mar. 07, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">472,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532139728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Aug. 31, 2024</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2023</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2024</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2023</div></th>
<th class="th" colspan="2"><div>Feb. 29, 2024</div></th>
<th class="th" colspan="2"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 154,498<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 27,663<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 343,291<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 47,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 458,752<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 382,832<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue (exclusive of depreciation and amortization, shown separately below)</a></td>
<td class="nump">155,455<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,734<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">329,036<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">41,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">397,532<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">354,921<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit (loss)</a></td>
<td class="num">(957)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,929<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,255<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,773<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">61,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,911<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LaborAndRelatedExpense', window );">Salaries and benefits</a></td>
<td class="nump">628,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">360,947<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,255,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">768,555<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,604,487<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,124,296<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">13,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">116,512<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">21,677<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">128,955<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,231<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">198,058<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">152,106<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">209,561<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">51,347<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,758<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">207,536<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">90,539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">484,250<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">707,137<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Professional service fees</a></td>
<td class="nump">372,027<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">125,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">895,900<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">260,304<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,421,508<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">615,432<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_Technology', window );">Technology</a></td>
<td class="nump">141,022<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">83,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">325,691<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">119,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">311,430<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">551,418<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_OrganizationCosts', window );">Organization costs</a></td>
<td class="nump">80,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">109,189<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">95,414<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">331,549<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">383,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">667,889<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,468,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">707,238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherExpenses', window );">Other expenses</a></td>
<td class="nump">63,796<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">179,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,731<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">156,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">1,468,335<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,090,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,435,948<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,122,756<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,740,577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,979,766<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(1,469,292)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,087,001)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,421,693)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,116,983)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,679,357)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,951,855)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other Income (Expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(14,718)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">166,890<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,567,665)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="num">(64,227)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(73,762)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(99,452)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(139,151)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(48,620)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(71,871)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income (expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">486,633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(9,770)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total Other Income (Expense)</a></td>
<td class="num">(64,227)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(73,762)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(99,452)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(139,151)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(977,480)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(81,641)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss from continuing operations before taxes</a></td>
<td class="num">(1,533,519)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,521,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,656,837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net loss from continuing operations</a></td>
<td class="num">(1,533,519)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,521,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,656,837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Net gain (loss) from discontinued operations, net of taxes</a></td>
<td class="num">(1,131)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(675,314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(1,534,650)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,513,367)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,332,151)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="num">(10,688)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,376)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,125)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss Applicable to Common Stockholders</a></td>
<td class="num">$ (1,545,338)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,534,743)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,339,276)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic loss per common share from continuing operations</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (13.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (27.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (29.16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">$ (70.32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted loss per common share from continuing operations</a></td>
<td class="num">(0.29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1.07)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(27.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(29.16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(70.32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic loss per common share from discontinued operations</a></td>
<td class="nump">(0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">(0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2.96)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted loss per common share from discontinued operations</a></td>
<td class="nump">(0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">(0.00)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2.96)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per common share basic</a></td>
<td class="num">(0.29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1.07)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(27.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(32.12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(70.32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per common share diluted</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (13.92)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (1.07)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (27.06)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (32.12)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">$ (70.32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding basic</a></td>
<td class="nump">5,275,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,277,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">228,274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">71,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted nverage number of shares outstanding diluted</a></td>
<td class="nump">5,275,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,277,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">228,274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">71,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zF2Iyi2frhtk" title="Number of shares acquired">83,371</span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zej8vkWWnJQ4" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_OrganizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_OrganizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_Technology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Technology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_Technology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 17: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479836/810-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income (expense) classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LaborAndRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LaborAndRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525331360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294528664048">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Retained Earnings [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 28, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
<td class="num">$ (11,778,367)<span></span>
</td>
<td class="num">$ (11,778,267)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 28, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">70,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Common Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">17,295,860<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,295,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Common Shares, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">13,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(5,033,496)<span></span>
</td>
<td class="num">(5,033,496)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">17,295,890<span></span>
</td>
<td class="num">(16,811,863)<span></span>
</td>
<td class="nump">484,110<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="num">(2,256,134)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">17,295,890<span></span>
</td>
<td class="num">(19,067,997)<span></span>
</td>
<td class="num">(1,772,024)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">17,295,890<span></span>
</td>
<td class="num">(16,811,863)<span></span>
</td>
<td class="nump">484,110<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 28, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,332,151)<span></span>
</td>
<td class="num">(7,332,151)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueOfPreferredShares', window );">Issuance of Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">473<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,603,027<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,603,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodShareOfPreferredShares', window );">Issuance of Preferred Shares, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">472,680<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common Shares Issued for Conversion of Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">3,968,507<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,968,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common Shares Issued for Conversion of Preferred Stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares', window );">Purchases of Common Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">1,905,954<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,905,970<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares', window );">Purchases of Common Shares, Sharers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common Shares for Third Party Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">13,106<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of Common Shares for Third Party Services, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueReverseAcquisition', window );">Reverse Acquisition of Sigma Additive Solutions, Inc.</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
<td class="nump">2,367,637<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,368,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesReverseAcquisition', window );">Reverse Acquisition of Sigma Additive Solutions, Inc., Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">316<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock Compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">116,512<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">116,512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred Stock Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,125<span></span>
</td>
<td class="num">(7,125)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 936<span></span>
</td>
<td class="nump">27,277,758<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">17,295,890<span></span>
</td>
<td class="num">(17,907,234)<span></span>
</td>
<td class="num">(611,261)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at May. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="num">(1,160,763)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">17,295,890<span></span>
</td>
<td class="num">(19,067,997)<span></span>
</td>
<td class="num">(1,772,024)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 936<span></span>
</td>
<td class="nump">27,277,758<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 1,346<span></span>
</td>
<td class="nump">27,304,840<span></span>
</td>
<td class="num">(26,140,544)<span></span>
</td>
<td class="nump">1,165,706<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at May. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,494<span></span>
</td>
<td class="nump">1,345,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 474<span></span>
</td>
<td class="nump">$ 936<span></span>
</td>
<td class="nump">27,277,758<span></span>
</td>
<td class="num">(24,151,139)<span></span>
</td>
<td class="nump">3,128,029<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Feb. 29, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,513,367)<span></span>
</td>
<td class="num">(3,513,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common Shares Issued for Conversion of Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (410)<span></span>
</td>
<td class="nump">$ 410<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common Shares Issued for Conversion of Preferred Stock, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(409,502)<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common Shares for Third Party Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">130,957<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">131,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of Common Shares for Third Party Services, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred Stock Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">21,376<span></span>
</td>
<td class="num">(21,376)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares', window );">Issuance of Convertible Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares', window );">Issuance of Convertible Preferred Shares, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Stock Options Issued to Employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">30,235<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">30,235<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 1,389<span></span>
</td>
<td class="nump">27,550,296<span></span>
</td>
<td class="num">(27,685,882)<span></span>
</td>
<td class="num">$ (134,103)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93,295<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at May. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 1,346<span></span>
</td>
<td class="nump">27,304,840<span></span>
</td>
<td class="num">(26,140,544)<span></span>
</td>
<td class="nump">$ 1,165,706<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at May. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">63,494<span></span>
</td>
<td class="nump">1,345,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,534,650)<span></span>
</td>
<td class="num">(1,534,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of Common Shares for Third Party Services</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">130,957<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">131,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of Common Shares for Third Party Services, Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPreferredStock', window );">Preferred Stock Dividends</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,688<span></span>
</td>
<td class="num">(10,688)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares', window );">Issuance of Convertible Preferred Shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 30<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">89,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">90,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares', window );">Issuance of Convertible Preferred Shares, shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Stock Options Issued to Employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,841<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,841<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balances at Aug. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">$ 1,389<span></span>
</td>
<td class="nump">$ 27,550,296<span></span>
</td>
<td class="num">$ (27,685,882)<span></span>
</td>
<td class="num">$ (134,103)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Aug. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">93,295<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zwrW1FaxviGd" title="Number of shares acquired">83,371</span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zekArRvcggKb" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodShareOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period share of preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodShareOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares issuance of convertible preferred shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares purchases of common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value issuance of convertible preferred shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value of preferred shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value purchases of common shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodValueReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodValueReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294639239712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Number of shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Business Acquisition, Percentage of Voting Interests Acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526765408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net Loss &#8211; Continuing Operations</a></td>
<td class="num">$ (3,521,145)<span></span>
</td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="num">$ (6,656,837)<span></span>
</td>
<td class="num">$ (5,033,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Noncash Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization &#8211; property and equipment and intangibles</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">667,889<span></span>
</td>
<td class="nump">1,468,762<span></span>
</td>
<td class="nump">707,238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DepreciationOfRightOfUseAsset', window );">Depreciation of right of use asset</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">74,848<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on promissory note receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,567,665<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">30,235<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">116,512<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166,890)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Loss on sale of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">22,881<span></span>
</td>
<td class="num">(5,000)<span></span>
</td>
<td class="num">(662,939)<span></span>
</td>
<td class="nump">5,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses</a></td>
<td class="nump">96,051<span></span>
</td>
<td class="num">(34,114)<span></span>
</td>
<td class="num">(281,506)<span></span>
</td>
<td class="nump">48,796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncreaseDecreaseInPromissoryNoteReceivable', window );">Promissory note receivable</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(8,722)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInSecurityDeposits', window );">Security deposit</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(27,167)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncreaseDecreaseInRightOfUseLeaseLiability', window );">Right of use lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,697)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,033,506<span></span>
</td>
<td class="nump">110,959<span></span>
</td>
<td class="num">(531,367)<span></span>
</td>
<td class="nump">533,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(1,854)<span></span>
</td>
<td class="nump">57,156<span></span>
</td>
<td class="nump">102,954<span></span>
</td>
<td class="num">(46,855)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations', window );">NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS</a></td>
<td class="num">(1,960,326)<span></span>
</td>
<td class="num">(1,393,118)<span></span>
</td>
<td class="num">(5,056,095)<span></span>
</td>
<td class="num">(3,792,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations', window );">NET CASH PROVIDED IN OPERATING ACTIVITIES FROM DISCONTINUED OPERATIONS</a></td>
<td class="nump">7,778<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(675,314)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH USED IN OPERATING ACTIVITIES</a></td>
<td class="num">(1,952,548)<span></span>
</td>
<td class="num">(1,393,118)<span></span>
</td>
<td class="num">(5,731,409)<span></span>
</td>
<td class="num">(3,792,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,253)<span></span>
</td>
<td class="num">(2,928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Capitalized software development costs</a></td>
<td class="num">(389,568)<span></span>
</td>
<td class="num">(345,807)<span></span>
</td>
<td class="num">(1,016,175)<span></span>
</td>
<td class="num">(2,354,094)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OriginationOfNotesReceivableFromRelatedParties', window );">Promissory note &#8211; related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,933,908)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ProceedsFromAcquireBusinessesGross', window );">Reverse acquisition of Sigma Additive Solutions, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">417,122<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Sale of Sigma Additive Solutions, Inc. assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,589,241<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(389,568)<span></span>
</td>
<td class="num">(345,807)<span></span>
</td>
<td class="nump">980,935<span></span>
</td>
<td class="num">(4,290,930)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Notes payable</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">281,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,269,852<span></span>
</td>
<td class="nump">735,057<span></span>
</td>
<td class="nump">3,233,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred shares</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuances of common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,905,970<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock', window );">Proceeds from issuances of preferred shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,603,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Advances from related parties</a></td>
<td class="nump">1,890,317<span></span>
</td>
<td class="nump">292,500<span></span>
</td>
<td class="nump">547,277<span></span>
</td>
<td class="nump">4,620,452<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH PROVIDED BY FINANCING ACTIVITIES</a></td>
<td class="nump">2,120,317<span></span>
</td>
<td class="nump">1,562,352<span></span>
</td>
<td class="nump">4,791,804<span></span>
</td>
<td class="nump">8,134,955<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET CHANGE IN CASH FOR PERIOD</a></td>
<td class="num">(221,799)<span></span>
</td>
<td class="num">(176,573)<span></span>
</td>
<td class="nump">41,330<span></span>
</td>
<td class="nump">51,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AT BEGINNING OF PERIOD</a></td>
<td class="nump">323,805<span></span>
</td>
<td class="nump">282,475<span></span>
</td>
<td class="nump">282,475<span></span>
</td>
<td class="nump">231,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">CASH AT END OF PERIOD</a></td>
<td class="nump">102,006<span></span>
</td>
<td class="nump">105,902<span></span>
</td>
<td class="nump">323,805<span></span>
</td>
<td class="nump">282,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureOfCashPaidAbstract', window );"><strong>Disclosure of Cash Paid for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">8,620<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="nump">4,381<span></span>
</td>
<td class="nump">1,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income Taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Noncash Investing and Financing Activities Disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfPreferredSharesForServices', window );">Issuance of preferred shares for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense', window );">Issuance of preferred shares for perpetual software license</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConversionOfConvertibleNotes', window );">Conversion of convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,968,507<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PreferredStockDividends', window );">Preferred stock dividends</a></td>
<td class="nump">21,736<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,125<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IssuanceOfCommonSharesForServices', window );">Issuance of common shares for services</a></td>
<td class="nump">$ 131,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 13,106<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConversionOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConversionOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DepreciationOfRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation of right of use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DepreciationOfRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureOfCashPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureOfCashPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncreaseDecreaseInPromissoryNoteReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in promissory note receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncreaseDecreaseInPromissoryNoteReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncreaseDecreaseInRightOfUseLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in right of use lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncreaseDecreaseInRightOfUseLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfCommonSharesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common shares for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfCommonSharesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of preferred shares for perpetual software license.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IssuanceOfPreferredSharesForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of preferred shares for services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IssuanceOfPreferredSharesForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferred stock dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ProceedsFromAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from acquire businesses gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ProceedsFromAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInSecurityDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in security deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInSecurityDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OriginationOfNotesReceivableFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OriginationOfNotesReceivableFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526833776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Description and Going Concern<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock', window );">Business Description and Going Concern</a></td>
<td class="text"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zyGhn9QLvXGg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_820_zbjEvc9jZZRi">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended, with the Secretary
of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other things, Sigma&#8217;s
corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe, NM 87507 The consolidated financial statements include the
accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc. incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to the Exchange Agreement as described below, NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) was a wholly owned subsidiary of NextTrip
Group, LLC (&#8220;Group&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc. (&#8220;NextPlay&#8221;).
All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023, NextPlay and Group entered into
an Amended and Restated Separation Agreement (&#8220;Separation Agreement&#8221;), Amended and Restated Operating Agreement (&#8220;Operating
Agreement&#8221;), and Exchange Agreement (&#8220;Exchange Agreement&#8221;, and together, the &#8220;Agreements&#8221;), whereby NextPlay
transferred their interest in the travel business to Group. Pursuant to the Exchange Agreement, NextPlay exchanged <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zru9sXqXfHDd" title="Number of common stock issued">1,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Units of Group for <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_z7nlvlVz3ujb" title="Number of common stock issued">400,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred Units of Group, with a value
of $<span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zP70YTOmZl9k" title="Share price per share">10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per unit. Prior to the exchange for Preferred
Units, Group had a payable due to NextPlay of $<span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zbgKB0pjyuB2" title="Number of common stock issued, value">17,295,873</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s ongoing
support obligations except for a $<span id="xdx_90A_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zPFIR2iYhn0a" title="Contributed capital">1.5
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million advance remaining under a promissory
note and as such NextTrip recorded the payable as contributed capital.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240831__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_z0Ep2sDSfEGb" title="Ownership percentage">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor operations occurred
in 2023 or 2024 for this entity, and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#8220;Exchange Agreement&#8221;) with NextTrip, Group,
and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_zI93RNZrJNVh" title="Restricted shares issuable in reverse acquisition">156,007
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted shares of Sigma common stock
(the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an additional <span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zB9TW4QL8e87" title="Restricted shares issuable in reverse acquisition">5,843,993
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted shares of Sigma common stock
upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#8220;Contingent Shares,&#8221; and together with the
Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares are issuable to the members of Group, on a pro rata basis,
under the terms of the Exchange Agreement, subject to certain closing conditions (the &#8220;Acquisition&#8221;). Upon the closing of
the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zNyAfJDKGSqd" title="Restricted shares issuable in reverse acquisition">6,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Sigma common stock, or approximately
<span id="xdx_901_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zik42pZ7S4N1" title="Percentage for issued and outstanding capital stock">90.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a
change of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the
legacy shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma
is treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information
presented is that of NextTrip.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of August 31, 2024, three of the
four business milestones had been achieved as further described in Note 2 under &#8220;Loss Per Share&#8221; below. As a result, <span id="xdx_902_ecustom--ContingentSharesIssuable_iI_c20240831_zxPZe6MGvHmc" title="Contingent shares issuable">4,393,993</span>
of the contingent shares were eligible to be issued. The remaining <span id="xdx_90A_ecustom--LaunchOfTravelAgentPlatformShares_iI_c20240831_zervhS9n3lo1" title="Contigent shares">1,450,000</span> contingent shares will be eligible for issue upon the launch
of the Company&#8217;s Travel Agent platform, currently scheduled for the first quarter of calendar year 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Despite having achieved three of the
four business milestones, the Company cannot issue the contingent shares until Nasdaq approves the Company&#8217;s initial listing application,
which is pending with Nasdaq. 2024. The Company has been advised by Nasdaq that issuing the contingent shares prior to
approval of the application will result in the immediate delisting of the Company, as such issuance will trigger a change in control.
The Company does anticipate such issuances will occur shortly after the closing of this offering and the Company intends to issue said
securities as soon as Nasdaq has cleared its application.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value pursuant to ASC 805.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern </b>&#8211; The Company has sustained losses and had negative cash flows from operating activities since its inception.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently does not have sufficient cash and working capital to fund its operations and will require additional funding in the
public or private markets in the near-term to be able to continue operations. The Company currently has no understanding or agreement
to obtain such funding, and there is no assurance that we will be successful in obtaining additional funding. If we fail to obtain sufficient
funding when needed, we will be forced to delay, scale back or eliminate all or a portion of our commercialization efforts and operations.
As a result, there is substantial doubt about our ability to continue as a going concern.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zqXYvRElwtUa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_825_zkGPBstIeW96">Business Description and Going Concern</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sigma
Additive Solutions, Inc. (&#8220;Sigma&#8221;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#8217;s corporate name was changed from Sigma Additive Solutions, Inc. to &#8220;NextTrip, Inc.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507 The consolidated financial statements include the
accounts of the Company&#8217;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc., incorporated on June 24, 2002.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Prior
to the Share Exchange Agreement as described below, NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) was a wholly owned subsidiary
of NextTrip Group, LLC (&#8220;Group&#8221;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#8220;NextPlay&#8221;). All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023,
NextPlay and Group entered into an Amended and Restated Separation Agreement (&#8220;Separation Agreement&#8221;), Amended and
Restated Operating Agreement (&#8220;Operating Agreement&#8221;), and Exchange Agreement (&#8220;Exchange Agreement&#8221;),
together the Agreements (&#8220;Agreements&#8221;), whereby NextPlay transferred their interest in the travel business to Group.
Pursuant to the Exchange Agreement, NextPlay exchanged <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zC1bjJuh2PSg" title="Number of common stock issued">1,000,000</span>
Membership Units of Group for <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztVenDw12gh4" title="Number of common stock issued">400,000</span>
Preferred Units of Group, with a value of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_z5RjezcFwEtl" title="Share price per shares">10</span>
per unit. Prior to the exchange for Preferred Units, Group had a payable due to NextPlay of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zqx3olpfVV8f" title="Number of common stock issued, value">17,295,873</span>,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#8217;s
ongoing support obligations except for a $<span id="xdx_907_eus-gaap--NotesPayable_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zK8euId603zb" title="Notes payable">1.5</span> million advance remaining under a promissory note and as such NextTrip recorded the
payable as contributed capital. </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and all-inclusive travel packages. Our proprietary booking engine, branded
as NextTrip 2.0, provides travel distributors access to a sizeable inventory.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owns <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240229__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zh7s8zm6l2d4" title="Ownership percentage">50</span>% of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor
operations occurred in 2023 or 2024 and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse
Acquisition</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#8220;Exchange Agreement&#8221;) with NextTrip, Group,
and William Kerby (the &#8220;NextTrip Representative&#8221;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zjZzxRkOfoe" title="Number of restricted shares">156,007</span> restricted shares of Sigma
common stock (the &#8220;Closing Shares&#8221;), issuable at closing, and the right to receive up to an additional <span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z73AcNf6WlV9" title="Number of additional restricted shares">5,843,993</span> restricted
shares of Sigma common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#8220;Contingent Shares,&#8221;
and together with the Closing Shares, the &#8220;Restricted Shares&#8221;), which Restricted Shares are issuable to the members of Group,
on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing conditions (the &#8220;Acquisition&#8221;).
Upon the closing of the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contingent Shares, together with the Closing Shares, will not exceed <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zM7Xcb3ip1Ok" title="Shares issued">6,000,000</span> shares of Sigma common stock, or approximately <span id="xdx_90F_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20240229__20240229_z5PfBXCLVr8c" title="Percentage for issued and outstanding capital stock">90.2</span>% of
the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a change
of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the legacy
shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma is
treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information presented
is that of NextTrip.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>1,</i> the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with <i>one</i> adjustment, which
is to retroactively adjust the accounting acquirer&#8217;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
ASC <i>805</i>-<i>40</i>-<i>45</i>-<i>2,</i> the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    retained earnings and other equity balances of the legal subsidiary before the business combination;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value under ASC 805 as described in <b>NOTE 8 &#8211;
Goodwill</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Going
Concern</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, and February 28, 2023, the Company had an accumulated deficit of $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zdrVeNWcMHQ3" title="Accumulated deficit">24,151,139</span> and $<span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230228_z3cV7l4trhdk" title="Accumulated deficit">16,811,863</span> respectively, and
working capital deficit of $<span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zRjT0YloBUtk" title="Working capital deficit">262,005</span> and $<span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_c20230228_zT4KhWTtX9Sg" title="Working capital deficit">2,310,654</span>, respectively, and has incurred losses since incorporation. The Company will need
to raise additional funds through equity or debt financings to support the on-going operations, increase market penetration of our products,
expand the marketing and development of our travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset our operating costs. In the event the Company is unable to raise adequate funding in the future
for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business plan and/or liquidate
some or all of its assets or may be forced to seek bankruptcy protection.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">In light of the foregoing, there is substantial doubt about our ability
to continue as a going concern for 12 months from the date of the filing of this prospectus.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Issues Surrounding the COVID-19 Pandemic</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse
public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
duration and severity of the COVID-19 pandemic impeded global economic activity for an extended period of time, even as restrictions
have been lifted in many jurisdictions (including the United States) and vaccines are being made available, leading to decreased per
capita income and disposable income, increased and sustained unemployment or a decline in consumer confidence, all of which significantly
reduced discretionary spending by individuals and businesses on travel and may create a recession in the United States or globally. In
turn, that could have a negative impact on demand for our services. We also cannot predict the long-term effects of the COVID-19 pandemic
on our partners and their business and operations or the ways that the pandemic may fundamentally alter the travel industry. The aforementioned
circumstances could result in a material adverse impact on our business, financial condition, results of operations and cash flows, potentially
for a prolonged period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we currently cannot predict the full impact of the COVID-19 pandemic on our fiscal 2025 financial results relating to our operations,
we anticipate an increase in year-over-year revenue as compared to fiscal year 2023. However, the ultimate extent of the COVID-19 pandemic
and its impact on global travel and overall economic activity is constantly changing and impossible to predict currently. However, the
Company is seeing the return to normal operations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubstantialDoubtAboutGoingConcernTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubstantialDoubtAboutGoingConcernTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294630010784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zkLlHzbaT2m4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_825_zqSGuePCW51">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zifpSOSo4639" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_z4YEibwEO6hc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The accompanying financial
statements have been prepared by the Company in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) in the
United States of America. The financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations
and cash flows at August 31, 2024 and 2023 and for the periods then ended have been made. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The Company suggests these
condensed financial statements be read in conjunction with the February 29, 2024 audited financial statements and notes thereto included
in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 4, 2024. The results
of operations for the period ended August 31, 2024 are not necessarily indicative of the operating results for the full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z64NtA2m0Nik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_860_z0TZFiK14hfe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_841_ecustom--PromissoryNoteReceivablePolicyTextBlock_zmmDpMNdPObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_864_za2gVtlZF6M2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Promissory Note (the Note&#8221;) between NextTrip and NextPlay, the Note was due and payable in full on the earlier
of September 1, 2023 or the date the Company completed a financing of $<span id="xdx_909_eus-gaap--ConvertibleDebt_iI_pn6n6_c20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zZVrhW5ebi19" title="Convertible debt">10</span> million or more. No payments have been made by NextPlay, and
as such NextPlay is in default under the terms of the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into a non-binding Memorandum of Understanding (&#8220;MOU&#8221;) with NextPlay, whereby NextTrip has agreed to
forgive the entire amount due under the Note in exchange for NextTrip&#8217;s cancellation of the <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zixIQTEoeaWg" title="Number of shares issued">400,000</span>
Preferred Units of Group issued to them as described in Note 1. The Preferred Units are convertible into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z8YGuYT6nNYa" title="Number of convertible shares issued">500,000</span>
NextTrip common shares, and NextTrip has a commitment from a third party to purchase such shares at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z39topvmdgid" title="Shares issue per shares">2.00</span>
per share. As a result, the since Company can realize a minimum of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zVMsH85qhCcc" title="Value of stock issued">1,000,000</span>
from the sale of the common shares, a valuation allowance of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zgz5fuOcbhR4" title="Valuation allowance">1,567,665 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
established as of February 29, 2024. The Company is in the process of negotiating a second offer to purchase the shares, and
therefore has not closed the transaction with NextPlay. The Company expects to close one of the transaction options before year-end.
During the three and six months ended August 31, 2024, and 2023, there was <span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_do_c20230301__20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zLiVFPSz3Dkg" title="Provision for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bad
debt expense recorded related to the allowance account, and the allowance is unchanged as of August 31, 2024. As of August 31, 2023, <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBkpsovmPgMi" title="Allowance for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allowance
for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zJwYcYLwKita" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_zECKc0O4ONZ" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
Per Share</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; The computation of loss
per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings
Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options and preferred stock were excluded due to the anti-dilutive
effect they would have on the computation. At August 31, 2024 and 2023 the Company had the following common shares underlying these instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z0TGwOunwYed" style="display: none">Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">August 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">78,877</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">484,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">96,238</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">659,178</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2128">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zl1be1T4GVai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B3_zJOeyE98NgVj" style="display: none">Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,533,519</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,160,763</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,521,145</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(2,256,134</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,688</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,376</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,544,207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,160,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,542,521</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,256,134</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,131</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,545,338</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,160,763</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,534,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,256,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zkRT0GjwF6Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2024, the Company determined that three of the four business milestones per the Share Exchange Agreement had been achieved.
As a result, <span id="xdx_900_ecustom--ContingentSharesIssuable_iI_c20240610_zO4JexHWcrO6" title="Contingent shares issuable">4,393,993</span> of the total contingent shares of <span id="xdx_90C_ecustom--ContingentShares_iI_c20240610_zv21vZEWMQOd" title="Contingent shares">5,843,993</span> became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable contingent shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zLOFrzikgY4j" style="display: none">Schedule
of Issuable Contingent Shares</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Business Milestones</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center">Contingent Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><p style="margin: 0"><i>Achieved</i></p>


</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Launch of leisure travel booking platform</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,450,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Launch of group travel booking platform</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of FlexPay technology</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,493,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,393,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><i>Not Achieved</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of travel agent platform</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total contingent shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,843,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AA_zoSl7kqh3My3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zm2k2w8JtlN5" style="display: none">Schedule
of Weighted Average Common Stock Shares Outstanding</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/>
    Number of Common Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj">1,388,641</span> common shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,359,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,319,146</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">4,393,993 issuable contingent shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,916,385</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,958,193</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AE_z3vBGbGZscu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuable contingent shares are of the Company&#8217;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented, as the Company&#8217;s outstanding warrants, stock options and preferred stock common equivalent shares
for the periods presented would have had an anti-dilutive effect. At August 31, 2024, the Company had outstanding warrants to purchase
<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMHCtVQDgIE8" title="Warrants outstanding to purchase common stock">484,063
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, stock options
exercisable for <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2MimFj4uJUa" title="Shares issuable upon exercisable of options">78,877
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8TCka5mm3qk" title="Number of shares converted">316
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series E Preferred Stock, which
could be converted into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zG35NXFRFZc9" title="Common stock issuable upon conversion">3,259
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zlIxo7WVjlSj" title="Number of shares converted">33,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series H Preferred Stock, convertible
into <span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpsaAcHrHdS2">33,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, and <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxcqulyETKN4" title="Number of shares converted">59,979
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Preferred Stock, convertible
into <span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zFenO045MKba" title="Common stock issuable upon conversion">59,979
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, resulting in a
potential total additional <span id="xdx_90E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbk2XzXNnf" title="Potentially dilutive securities">659,178
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock outstanding in
the future. At August 31, 2023, the Company had <span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_do_c20230831__20230831_zA5fYSj15E4c" title="Potentially dilutive securities">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding potentially dilutive securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--UseOfEstimates_zgBfHCAwKx2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zKlvO8tRqgS8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
Estimates</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities,
the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates
that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents
granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ze7a5NslSCBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_z1OgHMDoOhzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; </span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive
revenue recognition standard that superseded nearly all existing revenue recognition guidance under prior U.S. GAAP and replaced it with
a principles-based approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon
the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to
be entitled in exchange for those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or
contracts, with our customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4)
allocating the transaction price to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance
obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p id="xdx_857_zw8ENaStwBEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zGEHqlcFYsC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 &#8211; <span id="xdx_826_zn2PsYiDS8Uf">Summary of Significant Accounting Policies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zjJ4SkBSWIy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span>Basis
of Presentation and Principles of Consolidation</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zvT3CGhXthXf" style="display: none">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYNgtlgrPaga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zvop3Yli0cV7">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_844_eus-gaap--UseOfEstimates_zi8D4EThlaLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zECwVSN5l3dj">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">The assessment of the allowance on the related party promissory note receivable;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of purchase price allocation;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of fair value of equity instruments;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znm0W8vScE4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zfCWQ5E57r05">Loss
Per Share</span> &#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 29, 2024 and
February 28, 2023, the Company had the following common shares underlying these instruments:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_z8WLjXA0cLk5" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February 29 and 28,</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">486,165</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred Stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475,835</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,047,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zFkqvzqgz067" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHcszlqY6qkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zrX1zFbuQVKb">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in US dollars. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_znz41uPYYRw1" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230228_zWUTqJt7Z4j" title="Cash equivalents">no</span></span> cash equivalents
as of February 29, 2024, or February 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84E_ecustom--PrepaidsPolicyTextBlock_zP8hsNZqfpp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNq5e7bygDi">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zcNsj0Pmudd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpROZHUqB1aj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#8217;s
best estimate of the amount of probable credit losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 29, 2024 and February 28, 2023, were $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_z7adHWduDhh4" title="Accounts receivable">34,092</span>, and $<span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_c20230228_zj00rlxIMbt7" title="Accounts receivable">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_ecustom--PromissoryNoteReceivablePolicyTextBlock_zSMvO0PieUsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span id="xdx_864_zokZsbbIL4dd">Promissory Note Receivable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBvEy3SmY4Dj" title="Accounts receivable">2,567,665</span>
and $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zbPdvDoogrB8" title="Accounts receivable">1,933,908</span> respectively. Management has determined that, since NextPlay is in default under the terms of the promissory note, collectability
of the entire related party receivable as of February 29, 2024 is uncertain, and has therefore established an allowance for doubtful
accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_ziXkWVEdo8g8" title="Allowance for doubtful accounts">1,567,665</span>. As of February 28, 2023, <span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z7sMx8ABAG27" title="Allowance for doubtful accounts">no</span> allowance for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWWo5BaTFOzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zpFrPVg4yYSa">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zmJtEukZpK03">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A5_zniJYxbMVy04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1ThpQpoPZ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zZw8ET0O8Acd">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life">1</span>
    - <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life">0.5</span>
    - <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<p id="xdx_8A0_z9Q4puhFe4G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--InternalUseSoftwarePolicy_zwvkT5vMbYIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zl75EYJYMjS">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;<span style="text-decoration: underline">ASC 985-20-25</span>&#8221; Accounting for the Costs of Software to Be Sold, Leased,
or Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zvFWfDgI5X13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zZXLjEm7sf2a">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;<span style="text-decoration: underline">Goodwill and Other Intangible Assets</span>&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zwKwrmEoAexe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDAn9CatPkj2">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zazYsWsiYD9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zi4sOZJnCCHi">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztnZGNMpNbla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zgQEEVdQUtyc">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--MarketRiskBenefitPolicyTextBlock_ztZNTINE94t6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zDSoyoXIgVT3">Concentration
of Credit Risk</span> -</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zDu3emIxc3X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zPNXd2HD4tXl">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoUehf2CANRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zwZ4eZtFf9M">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC Topic No. 606. In
May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <i>Revenue from Contracts
with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition
guidance under prior U.S. GAAP and replaced it with a principles-based approach for determining revenue recognition. The core principle
of the standard is the recognition of revenue upon the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. In general, we determine revenue
recognition by: (1) identifying the contract, or contracts, with our customer; (2) identifying the performance obligations in the contract;
(3) determining the transaction price; (4) allocating the transaction price to performance obligations in the contract; and (5) recognizing
revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_z1eTiudxu4T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zOLzEHL5GHJ7">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and administration expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_zv5DkjtVHw6b" title="Sales and marketing expense">484,250</span> and $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20220301__20230228_zj2522yghbJ6" title="Sales and marketing expense">707,137</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zhxOkI2P3rRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zQm8MXm4rQE8">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no tax positions at February 29, 2024 and 2023 for which the ultimate deductibility is highly uncertain but for which there
is uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During
the years ended February 29, 2024 and February 28, 2023, the Company recognized no interest and penalties. All tax years starting with
2019 are open for examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNkTwcecrh59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zU9TY6EvEIne">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The FASB issued this ASU to address issues identified as a result of the complexity
associated with GAAP for certain financial instruments with characteristics of liabilities and equity. Complexity associated with the
accounting is a significant contributing factor to numerous financial statement restatements and results in complexity for users attempting
to understand the results of applying the current guidance. In addressing the complexity, the FASB focused on amending the guidance on
convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#8217;s own equity. For convertible
instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock.
Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared
with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features
that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for
a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums
are recorded as paid-in capital. The FASB concluded that eliminating certain accounting models simplifies the accounting for convertible
instruments, reduces complexity for preparers and practitioners, and improves the decision usefulness and relevance of the information
provided to financial statement users. In addition to eliminating certain accounting models, the FASB also decided to enhance information
transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance on
the basis of feedback from financial statement users. The FASB decided to amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. The FASB observed that the application
of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically
similar contracts as equity. The FASB also decided to improve and amend the related EPS guidance. The amendments in this ASU are effective
for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified
that an entity should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the
guidance through either a modified retrospective method of transition or a fully retrospective method of transition. The Company adopted
ASU 2020-06 on March 1, 2022 on a prospective basis. The adoption of this standard did not have an impact on the Company&#8217;s consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50),
Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU
2021-04 requires accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants)
that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The
recognition of the modification depends on the nature of the transaction in which the equity-classified written call option is modified.
If there is more than one element in a transaction (for example, if the modification involves both a debt modification and an equity
issuance), then the guidance requires allocating the effect of the option modification to each element. ASU 2021-04 is effective for
the Company beginning in the first quarter of 2022. ASU 2021-04 should be applied prospectively to modifications or exchanges occurring
on or after the effective date of the amendments. The Company adopted ASU 2021-04 on March 1, 2022 on a prospective basis. The adoption
of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, ASC Subtopic 326 &#8220;Credit Losses&#8221;: Troubled Debt Restructurings and Vintage Disclosures.
Since the issuance of Accounting Standards Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments, the Board has provided resources to monitor and assist stakeholders with the implementation of
Topic 326. Post-Implementation Review (PIR) activities have included forming a Credit Losses Transition Resource Group, conducting outreach
with stakeholders of all types, developing educational materials and staff question-and-answer guidance, conducting educational workshops,
and performing an archival review of financial reports. ASU No. 2022-02 is effective for annual and interim periods beginning after December
15, 2022. The adoption of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

<p id="xdx_85C_zunsJwzW3tH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294630056160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Discontinued Operations</a></td>
<td class="text"><p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zHCFg0lCGF38" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_825_ze8xQaKCsNPl">Discontinued Operations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year ended February 29, 2024, the Company completed the sale of certain assets of Sigma Additive Solutions, Inc., which has
been classified as discontinued operations in accordance with ASC 205-20, &#8220;Presentation of Financial Statements &#8211; Discontinued
Operations.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 6, 2023, the Company entered into a definitive asset purchase agreement (&#8220;APA&#8221;) with Divergent Technologies, Inc.,
(&#8220;Divergent&#8221;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from us, certain
assets consisting primarily of patents, software code and other intellectual property for a purchase price of $<span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zxJcJxQr6Uff" title="Purchase price">1,626,242</span>, including a
$<span id="xdx_90E_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zrFjlhjEZsGh" title="Earnest money deposit">37,000</span> earnest-money deposit previously paid to us by Divergent. The closing under the Asset Purchase Agreement occurred subsequent
to the closing of the reverse acquisition with NextTrip on January 12, 2024. The parties&#8217; respective obligations to close were
subject to the accuracy of the parties&#8217; respective representations and warranties and performance of their respective covenants
and satisfaction or waiver of other customary conditions specified in the Asset Purchase Agreement. In the interim, between the signing
date and closing date or termination of the Asset Purchase Agreement, Sigma granted Divergent a non-exclusive, nontransferable, non-sublicensable
(except to Divergent customers and affiliates), limited, irrevocable (except in connection with the termination of the Asset Purchase
Agreement), worldwide, royalty-free license to the &#8220;Licensed IP&#8221; (as defined) for testing, evaluation, and commercialization
purposes. A gain of $<span id="xdx_90E_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zk1mrDjw3uUd" title="Asset disposition">30,515</span> was recognized in the asset disposition transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended February 29, 2024, the Company recorded a loss of $<span id="xdx_904_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iN_di_c20230301__20240229_zeTfq5WMGYyf" title="Loss of discontinued operations">675,314</span> from discontinued operations as follows:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zspOW6uJbF67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zFJHwNhQ5ew8" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zLmFzUI83NA" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zQJi1B0w3Wbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,006</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zLmAEEUy63K5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zDE4WqxhGyXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross Profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_maDGIDOzcGq_zvoNuuDeMlIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,475</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_maDGIDOzcGq_zAzoLiABURl6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retention bonuses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,930</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationSeverance_maDGIDOzcGq_zsLZdk5FYSb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Severance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,500</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_maDGIDOzcGq_zR0TkxyWbB7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Organization costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,600</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zf4wrCCLOaoh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,185</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zcs3dGLy8rPi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">680,320</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zgDaX1rFDR5g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from Discontinued Operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(675,314</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<p id="xdx_8A7_zIBFAHsMzmJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205-20/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629970128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock', window );">Prepaid and Other Current Assets</a></td>
<td class="text"><p id="xdx_801_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zYfB9V0sTqj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 - <span id="xdx_823_zK7Bo5ikQCZf">Prepaid and Other Current Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zVCnlkJWw6vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 29, 2024 and as of February 28, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B5_zcDtWDvTfd0f" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_zqPJ57abXlch" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230228_znNv015iUfVc" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zBvMxNj4q7s9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid marketing expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zGnmmlyN62Xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">298,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,513</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_zD3GV9zMebki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,547</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_zgwEybw2ARma" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">340,921</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,613</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zY0TS1rL3iIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses and Other Current Assets [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629961344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureLeasesAbstract', window );"><strong>Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zCvjX1dqR5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_825_ze0gMf9lqdr7">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that the arrangement was an operating lease at inception and included it in operating lease ROU assets, operating lease liabilities
- current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023. The office facility was occupied
by NextTrip employees through March 16, 2023, when the landlord informed NextTrip that it would not recognize NextTrip as the tenant.
The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately unsuccessful, and as a result derecognized
the lease in the financial statements as of February 29, 2024. No restatement was made for fiscal year 2023 as the Company had use of
the offices at that time and was in negotiations to assume the lease from NextPlay Technologies, Inc. No payments have been made on the
lease and no expense has been recognized for the three and six months ended August 31, 2024. Rent expense for the three and six months
ended August 31, 2023 totaled $<span id="xdx_903_eus-gaap--PaymentsForRent_c20230601__20230831_zUDs8rrFXPq5" title="Rent expense">37,822</span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90E_eus-gaap--PaymentsForRent_c20230301__20230831_z3hIkLZPzzS7" title="Rent expense">74,847</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases approximately <span id="xdx_90B_eus-gaap--AreaOfLand_iI_usqft_c20230125__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zUtMjC0NwaG" title="Area of land">350
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">square feet of space for its principal
executive offices at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. The lease has a 6-month term which ends on December 31, 2024. The
landlord can terminate the lease upon 30 days written notice and NextTrip can terminate the lease upon 45 days written notice. Therefore,
the Company has elected the short-term lease recognition exemption, whereby leases are not recorded on the Company&#8217;s balance sheet
and lease payments are recognized as lease expense on a straight-line basis over the lease term. Rent expense related to this lease for
the three and six months ended August 31, 2024 was $<span id="xdx_901_eus-gaap--PaymentsForRent_c20240601__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z3nkNDFemIRb" title="Payments for rent">1,650
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_900_eus-gaap--PaymentsForRent_c20240301__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z2QdZaWDAlth" title="Payments for rent">3,300</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, and $<span id="xdx_90A_eus-gaap--PaymentsForRent_c20230301__20230831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zlWbTPJ1qB89" title="Payments for rent">0
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the same periods in 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<span></span>
</td>
<td class="text"><p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zOSHswfS6Zd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_82B_zYja0lqoGDzk">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determined that the arrangement was an operating lease at inception and included it in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023.
The office facility was occupied by NextTrip employees through March 16, 2023, when the landlord informed the NextTrip that would not
recognize NextTrip as the tenant. The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately
unsuccessful, and as a result derecognized the lease in the financial statements as of February 29, 2024. No restatement was made for
fiscal year 2023 as the Company had use of the offices at that time and was in negotiations to assume the lease from NextPlay Technologies,
Inc. No payments have been made on the lease and no expense has been recognized for the year ended February 29, 2024. Rent expense for the year ended February 28, 2023 was $<span id="xdx_90C_eus-gaap--OperatingLeasesRentExpenseNet_c20220301__20230228_zd83MwsvpiSl" title="Rent expense">40,554</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629892848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zljuX8EqEuQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 - <span id="xdx_82B_zfpt5DQVS2Z5">Property and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIh2ZEQDqJ0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zrxnKfDl0uy2" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_znd8yztfslTk" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zhsm8QhKGPEj" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRQ2QskFsU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Furniture and Fixtures</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">17,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">17,018</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zB0mQgDjUIpl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">82,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73,238</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zGz2ohFpxjeh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99,510</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">90,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zoHK50A27lB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(92,868</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(74,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zVBz1Kt5yYd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,642</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,226</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AF_z44mTML7o006" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_zyR0XnAW9mE6" title="Depreciation expense">18,838</span> and $<span id="xdx_90F_eus-gaap--Depreciation_c20220301__20230228_zBFlSoyJdpK2" title="Depreciation expense">30,386</span>, respectively, and is recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company acquired property and equipment of $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_z6fY6DCfUJF2" title="Property and equipment">9,253</span> and $<span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220301__20230228_zjwLTWO2FKJ1" title="Property and equipment">2,928</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294633290176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zWtrNzMvGv53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 &#8211; <span id="xdx_82A_zHPDyYR016y">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zr9WT6ZcWyUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of August 31, 2024, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B9_zZLh7VI8bnnl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20240831_zypz4PBWeJH9" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">August
                                            31,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240229_zmq5bCFnM775" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">February
                                            29,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zK34HO26Stbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7,122,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,602,028</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zgjptkxM7z95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zbrHfUCcbYyl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Trademark</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zzEbWzPCm2Jd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,918,455</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,397,887</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zqtA7BLv8aWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,607,528</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224,467</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_z0bG6nDEVe07" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,310,927</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,173,420</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AA_zvSE4RGIiv67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the six months ended August 31, 2024, and 2023 was $<span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20240831_zdUKXMaczsY5" title="Amortization">383,061
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20230831_zjYgpdH9JiTi" title="Amortization">657,389</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three and six months ended August 31, 2024, and 2023, the Company recorded <span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240601__20240831_z3B9tBdTvhAk" title="Impairment losses"><span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240301__20240831_z5UokqdZHCk7" title="Impairment losses"><span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230601__20230831_z0b4lIrlvFGd" title="Impairment losses"><span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230301__20230831_zCgPEc9tisM5" title="Impairment losses">no</span></span></span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">impairment losses associated with the
carrying value exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdOVf9nbV8e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BB_zu3DsFSttSQ7" style="display: none">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240831_zwls6gO7da3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zrxfoGgoe2Cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 80%">2025 (Remaining)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">200,232</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zyyape05oA41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,329</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zZeSfWHXjPrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">270,728</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zJ4mMxdyOqnj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zjQa3ZhpKh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_z0Or0MvqVMNg" style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">787,246</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<p id="xdx_8AE_zaWZBzr2vEkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVYFFpNKFXPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 - <span id="xdx_828_zYoY3M4ha6U6">Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zO1HTTvrUDY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zgo5YWMjDBfl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zrDVWbd38xfh" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zmKckj41Tnt5" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zxBbl1Pim1Y" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,602,028</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,908,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zD40Mz2DEGui" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">467,576</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zMJpTXH2eG1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zAy0at1JXwz3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,397,887</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,382,212</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zayVjVpyCGAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224,467</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,774,542</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zQUKwIYoULx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,173,420</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,607,670</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_zy9n6F23RI0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zknujk8DHPWh" title="Amortization">1,449,925</span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20220301__20230228_zo2bRN8czsGi" title="Amortization">676,853</span>, respectively, and recorded in operating
expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zU58TvfWVn3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The estimated aggregate amortization
expense for each of the succeeding years ending February 28 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zsOopBpmQzkj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20240229_zrlf0dRvuEok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zsH7hkik1xyc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025 (Remaining)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zAXCR42xSU57" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">660,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zxzDuRyyVaTi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,152</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zdfBL5UrbNAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,498</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zTfOo78Any02" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_zZD48rJHnVX" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">845,228</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p id="xdx_8A6_z1aPnAnQzyhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525640064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zkC1RJtuioTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 &#8211; <span id="xdx_827_zHoRWkQFrokf">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc. on December 29, 2023 was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#8220;IPO&#8221;) transaction. In the reverse acquisition, $<span id="xdx_90F_eus-gaap--Goodwill_iI_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zPbF6N17fze4" title="Goodwill">1,167,805
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of goodwill was allocated to the NextTrip
Reporting Unit under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zvcHrVcdP8Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 &#8211; <span id="xdx_823_zRfNrhMYhBJc">Goodwill</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
discussed in Note 1, the legal acquisition of NextTrip by Sigma Additive Solutions, Inc. was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents the allocation of the $<span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zc5R8nYrAQ5b" title="Consideration transferred">2,368,418</span> million consideration for the acquisition and summarizes the estimated fair
values of the Sigma (the accounting acquiree) assets acquired and liabilities assumed for NextTrip (the accounting acquirer). The estimated
consideration of approximately $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z7yjAcdaE3ah" title="Consideration transferred">2,368,418</span> million is based on Sigma&#8217;s closing share price of $<span id="xdx_90A_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zU7DMtPv8M15" title="Share price">3.0229</span> as reported on Nasdaq on December
29, 2023 multiplied by the <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_znCS7ZvRdSLb" title="Shares outstanding">780,423</span> shares outstanding as of that date and the fair value of Series E Preferred Stock into <span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zQv8pKIWaOL" title="Shares outstanding">3,069</span> common
shares.</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zU0HpIBWcCgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z0FBKE9xRo36" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_493_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zelEWS0SL4vi" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zRblBXCjObF3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">417,121</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_zTUEQnFulc8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts Receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,900</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zswCb8QG6JF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">257,873</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zzOi4JPFnZhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,802</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_zvXyQ7boHzP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,357</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_zXsuhXCfxOgf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,277,919</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zxzxBl7aRk0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(837,450</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zsfUNLIaEDFj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(61,001</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zw77aao7ReK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_zgrJKj8JaD1a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total identifiable net assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,148,303</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z26jriaUM0Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,220,115</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zmwtgIElz11i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,368,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zd0P6YPMG0Zj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,368,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zbckVppMMHZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#8217;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#8217;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#8217;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#8220;IPO&#8221;) transaction. In the reverse acquisition, $<span id="xdx_906_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzEb0MmaLE96" title="Goodwill">52,310</span> of goodwill was allocated
to the Sigma Reporting Unit and $<span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGsUMETXeva7" title="Goodwill">1,167,805</span> of goodwill was allocated to the NextTrip Reporting Unit under the acquisition method of accounting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined Company consists of two reporting units, Sigma and NextTrip. As the accounting acquirer in the reverse acquisition, NextTrip
is considered to be an existing reporting unit and Sigma is considered to be a new reporting unit in that it is not in the same business
as NextTrip. Accordingly, the reverse acquisition creates a new reporting unit which holds the Sigma business constituting an asset held
for sale as a result of the agreement for the sale of certain Sigma assets to Divergent 3D (&#8220;Divergent&#8221;) for a sales price
of $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zpSrraxdgqi7" title="Purchase price">1,626,242</span>. As such, the fair value of the Sigma Reporting Unit is determined to be $<span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zFpRVgsbDeg1" title="Purchase price">1,626,242</span> with the difference of $<span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwsfPzk1AYQ" title="Purchase consideration">742,176</span> from
the purchase consideration being allocated to the NextTrip Reporting Unit. The assets being sold to Divergent and the liabilities being
relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the net fair value of those
assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned to the NextTrip Reporting
Unit is determined by the difference between the purchase consideration assigned to the NextTrip Reporting Unit and the net acquired
Sigma assets and liabilities assumed that are assigned to the NextTrip Reporting Unit. A gain of $<span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zDq8bEsFkXnl" title="Gain on disposition transaction">37,592</span> was recognized in the disposition
transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zg3u7Jy9ySTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a reconciliation of goodwill as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zvUpXkpYVqPb" style="display: none">Schedule
of Reconciliation of Goodwill</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zKO6pqSRKh5k" style="border-bottom: Black 1pt solid; text-align: center">February 29,<br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_zJrrrh79dZXd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Reverse acquisition of Sigma Additive Solutions, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,220,115</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GoodwillPeriodIncreaseDecrease_zk91tNEAKvO" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Reduction from sale of assets to Divergent Technologies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(52,310</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--Goodwill_iE_zJxyuoFGa3Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,167,805</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zGdVHBz6bLO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629449152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zzAtnE9ulwBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_828_zFgUTuazIHNa">Accounts Payable and Accrued Liabilities</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, the Company had accounts payable of $<span id="xdx_900_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_zJ7LxLORrNQ2" title="Accounts payable">531,847</span> and accrued expenses of $<span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_zIqHsMwACo9" title="Accrued expenses">460,768</span>, compared to $<span id="xdx_90B_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20230228_zUWaYRq1bFv2" title="Accounts payable">519,136</span> of accounts
payable and $<span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20230228_z7omMexVLLii" title="Accrued expenses">329,922</span> of accrued expenses for the year ended February 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525647392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zt0ELRovIo6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 &#8211; <span id="xdx_82D_zf2xYgcTWgsg">Income Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting
methods and any available operating loss or tax credit carryforwards. Income tax returns open for examination by the Internal Revenue
Service consist of tax years ended December 31, 2020 through 2022.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had available at February 29, 2024 unused operating loss carryforwards of approximately $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_c20240229_z38HRGr7T7pa" title="Operating loss carryforwards">43,934,000</span> which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $<span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zHgrSdoo5Ltj" title="Operating loss carryforwards">9,820,000</span> expire in various years through 2038, and the remainder
of the losses, which total $<span id="xdx_902_ecustom--OperatingLossCarryforwardsRemainder_iI_c20240229_zdEMioKoGRW1" title="Operating loss carryforwards remainder">34,114,000</span> can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal
income tax reported purposes are subject to annual limitations. Due to the change in ownership as a result of the reverse acquisition,
the Company&#8217;s net operating loss carryforwards may be limited as to use in future years, and any such limitation will be determined
on a year-to-year basis. The
amount of and ultimate realization of the benefits from the operating loss carryforwards for income tax purposes is dependent, in part,
upon the tax laws in effect, the future earnings of the Company and other future events, the effects of which cannot be determined. Because
of the uncertainty surrounding the realization of the loss carryforwards, the Company has established a valuation allowance equal to
the tax effect of the loss carryforwards and other temporary differences of approximately $<span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zSvOYYN7sno5" title="Valuation allowance loss carryforwards">11,250,300</span> and $<span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20230228_z8PrZn3RIhDg" title="Valuation allowance loss carryforwards">8,575,900</span> at February 29, 2024, and February
28, 2023, respectively, and, therefore, no deferred tax asset has been recognized for the loss carryforwards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNd78jYTjuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zYyFUyW4r6ha" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_z1Oo3OS6nCDe" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230228_zzbE3PTwvBtj" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Deferred tax assets:</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z5v0R8PH3ck4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NOL carryover</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,226,100</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,636,900</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zxWcOEgFZtBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">173,900</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zDYqZkOxmHUi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,800</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0912">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_zv220t6LFyH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">1,772,500</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(61,000<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"></span></p>

</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_z2ASyRQwcpvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(11,250,300</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(8,575,900</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zXzFF6MQgqz6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_ziO8XR5YC6Ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (<span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230301__20240229_zgHGBAptIrAl" title="Federal statutory tax rate"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220301__20230228_znQlYJRtgStc" title="Federal statutory tax rate">21</span></span>%) to the Company&#8217;s effective
tax rate for the years ended February 29, 2024, and February 28, 2023 is as follows:</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zi0ZQcldxAfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zijvloCzLQ2e" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_z2YYUz1hkBFc" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220301__20230228_z1yWU06gOZti" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zGDEjhraeT47" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Book Loss</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,541,200</span></td><td style="text-align: left; width: 1%">)</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,837,400</span></td><td style="text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zofUGS1KiVQ3" style="vertical-align: bottom; background-color: White">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,100</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,700</span></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_z8XrZKhH0CU4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Meals &amp; Entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_zuvAhcfnaMjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,842</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zU40Yk60iqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">24,468</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(48,548</p></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zB1uWN5sMOtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on asset disposal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">67,274</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0945">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zYultU3MZX65" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">51,857</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0948">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zOREvUGNB4Nl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">114,928</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_zvyOGfbriJjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,431</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,906,648</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zUNGfoM9NiCk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A5_zy03wzJH66j5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294633083632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zRJTs7tgKSB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 &#8211; <span id="xdx_824_zDmSo9251hJ1">Notes Payable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 24, 2024, the Company issued an unsecured promissory note for $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_z6wxI60LEQqb" title="Proceeds from convertible debt">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to an investor upon receipt of proceeds.
The note bears an annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zUdxOsuTlXRa" title="Interest rate">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and will mature and be due and payable on the earlier date of the completion of a public financing or October 31, 2024, unless extended
by the written consent of the investor. The note can be prepaid at any time by the Company without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 11, 2024, the Company issued an unsecured promissory note for $<span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240711__20240711_zPvJWSx5YaWj" title="Proceeds from convertible debt">40,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to an investor upon receipt of proceeds.
The note bears an annual interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240711_zkSneW3Fkvpa" title="Interest rate">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and will mature and be due and payable on June 25, 2025, unless extended by the written consent of the investor. The note can be prepaid
at any time by the Company without penalty.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_zfGjwMdpqgB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 - <span>Convertible Notes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_82F_zcjiXNu7zabi" style="display: none">&#160;Notes
Payable</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
March 13, 2023 and June 9, 2023, the Company issued $<span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zT1NzGmoiSh" title="Convertible note issued">650,000</span> in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQ50vlyxTB0l" title="Interest rate">8</span>% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z4xCXSg7KHhg" title="Conversion price">3.00 </span>per common share, subject
to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zefV4QXnqyzb" title="Convertible note issued">3,012,000</span>
in convertible notes upon the receipt of proceeds from several investors. The notes had an interest at a rate of <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zlrkSrT4Jgid" title="Interest rate">8</span>%
per annum and were convertible into shares and warrants in a new public company upon the completion of a merger with a Special
Purpose Acquisition Corporation (&#8220;SPAC&#8221;) at a conversion price of $<span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zbKUUzCrPMte" title="Conversion price">3.00</span>
per common share, subject to certain adjustments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, in connection with, and contingent upon the acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc.
(the &#8220;Sigma Transaction&#8221;), each investor in a convertible note entered into a Debt Assignment and Conversion Agreement (the
Agreement&#8221;) with NextTrip Group, LLC (&#8220;Group&#8221;) and NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;) whereby the notes
and the debt represented thereon were assigned from NextTrip to Group and converted into common units of Group with the equivalent value
on the terms and conditions as set forth in the Agreements. In exchange for entering into the Agreements, each investor received the
right to receive a number of Restricted Sigma Shares, including both Closing Shares and Contingent Shares, to be distributed by the Company
to the investor following the consummation of the Sigma Transaction. The shares are issuable at a price of $<span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zGR8q3TDMzO4" title="Share price">3.00</span>, and include both principal
and accrued interest thereon.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sigma Transaction was closed on December 29, 2023, and as a result, the Company issued to investors <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqsUNYHhWPY8" title="Conversion of convertible notes, shares">52,818</span> Closing Shares, and the right
to receive <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_z6AGxmAKrwXc" title="Conversion of convertible notes, shares">1,978,598</span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the years ended February 29, 2024, and February 28, 2023, the Company recorded interest expense of $<span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230301__20240229_zEF6skVkqLwc" title="Interest expense">234,213</span> and $<span id="xdx_902_eus-gaap--InterestExpenseDebt_c20220301__20230228_zE38lbOK5SE6" title="Interest expense">72,347</span> respectively,
related to the notes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294630054912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Purchase Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureSharePurchaseAgreementsAbstract', window );"><strong>Share Purchase Agreements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharePurchaseAgreementsDisclosureTextBlock', window );">Share Purchase Agreements</a></td>
<td class="text"><p id="xdx_802_ecustom--SharePurchaseAgreementsDisclosureTextBlock_z6OzrSGhEMVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
12 &#8211; <span id="xdx_825_zi3AvZo6IKBf">Share Purchase Agreements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
August 10, 2023 and November 6, 2023, NextTrip entered into Share Purchase Agreements with several investors to purchase convertible
shares in NextTrip in exchange for total proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zkDGNfyAmjyd" title="Proceeds from convertible shares">1,755,970</span>. Pursuant to the Agreements, the shares were initially convertible into
the common shares of a public company at $<span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zlD2u3RIj5gj" title="Conversion share price">0.15</span> per share. The Agreements further provided that contingent upon the consummation of the
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc., the investors would receive the same number of Sigma
shares in lieu of NextTrip common shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, concurrent with the consummation of the acquisition, each investor entered into an Exchange Agreement with Group and
Holdings, whereby such investors exchanged their rights to NextTrip shares for rights to common units of Group of the same value, and
Group distributed to investors, that number of Closing Shares as set forth in the Exchange Agreements. Additionally, upon NextTrip&#8217;s
achievement of each of the milestones as set forth in the Share Exchange Agreement, if ever, Group will further distribute the number
of Contingent Shares in accordance with the Share Exchange Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third party consultant in which the Company received
a $<span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zLjiRDF7K6lf" title="Proceeds from downpayment for contract">150,000</span> down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty
in which the down payment became a noninterest bearing share issuance obligation in which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $<span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_za85LrKPJc26" title="Conversion share price">3.00</span> per common share, subject to adjustments. On December
29, 2023, upon the consummation of the reverse acquisition transaction with Sigma, the counterparty received <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zIDIl91RLXd4" title="Conversion of convertible notes, shares">1,996</span> Closing Shares and
the right to receive an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_z7tjzC67CDi3" title="Conversion of convertible notes, shares">74,786</span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of Closing Shares issued to investors, inclusive of the third party consultant, on December 29, 2023 was <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zOJnM37Cav2c" title="Conversion of convertible notes, shares">15,481</span>, and the
Contingent Shares issuable, if ever, totaled <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z9duZrUSNJ57" title="Conversion of convertible notes, shares">579,954</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant which provided for the
full settlement of $<span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zoHnFPGGnQe3" title="Consulting fees">180,000</span> in consulting fees by issuing common shares of Sigma contingent upon the closing of the reverse acquisition.
The reverse acquisition closed on December 29, 2023, pursuant to which Company issued <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zJ6aPH88sQ" title="Conversion of convertible notes, shares">4,337</span> Closing Shares to the consultant, and the
right to receive <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z6P1MdBd0Rsb" title="Conversion of convertible notes, shares">162,466</span> Contingent Shares, if issued.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureSharePurchaseAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureSharePurchaseAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharePurchaseAgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Purchase Agreements Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharePurchaseAgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294630017056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zWyRxbHZVW7k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 - <span id="xdx_827_zRWFXEx8pIc4">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 18, 2024, the Company&#8217;s wholly-owned subsidiary, NextTrip, entered into an unsecured promissory note for a line of credit
with Donald Monaco and William Kerby, the Company&#8217;s Chairman of the board of directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zXX8wLxbxl62" title="Principal amount">500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with an initial advance of $<span id="xdx_909_eus-gaap--LineOfCredit_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zv32yQuWcHp8" title="Line of credit">125,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
provided that the aggregate principal amount of the note does not exceed $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zR7gIUwNaJbl" title="Principal amount">500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at any time. Under the terms of the note,
advances under the line of credit may be made at the Company&#8217;s request until August 31, 2024. The note bears an annual interest
rate of <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_ziVau7vlg1id" title="Annual interest rate">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and matures on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20240318__20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zj8ZxDonO9fk" title="Maturity date">February
28, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, and may be prepaid by the Company
at any time prior to maturity without penalty. As of August 31, 2024, the full principal amount of the note had been advanced to the
Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2024, the Company&#8217;s board of directors approved the Company&#8217;s wholly-owned subsidiary, NextTrip, to enter into
a series of unsecured promissory notes with certain related parties, including investors, directors, officers and employees, who may
individually provide funds for the aggregate principal amount of $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zjmfVSNMXgx1" title="Principal amount">1,000,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The notes bear an annual interest rate of <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z4ITJ3vrEPsj" title="Annual interest rate">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
and shall mature one year from the date of each note&#8217;s execution, and may be prepaid by the Company at any time prior to maturity
without penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the board of directors, the directors unanimously
approved an increase in the principal amount of the related party line of credit to $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z1mX5NVwsI86" title="Principal amount">2,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on the same terms and conditions as previously
approved. As of August 31, 2024, $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zOaCBTT4pDah" title="Principal amount">1,411,414
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">had been advanced to the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 21, 2024, NextTrip issued an unsecured promissory note, in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240521__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zacbQbXqGnLg" title="Principal amount">455,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the &#8220;Promissory Note&#8221;), to
Mr. Monaco to memorialize the terms and conditions of certain working capital advances made by Mr. Monaco to NextTrip. As of August 31,
2024, the outstanding principal balance of the Line of Credit Promissory Note was $<span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zdCcsK6KsJkj" title="Outstanding principal amount">405,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
The Promissory Note accrues interest at a rate equal to <span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zIIP6DFhX3Fd" title="Annual interest rate">7.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
simple interest per annum, and will automatically mature and become due and payable in full on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240831__20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_z3oonYHhvxIc" title="Maturity date">February
28, 2025</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, subject to certain limited exceptions.
The Promissory Note, or any portion thereof, may be prepaid by NextTrip without any penalty. Mr. Monaco serves as Chairman of the Company&#8217;s
board of directors. The Promissory Note was approved by the Company&#8217;s Board of Directors, including the independent members thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total amounts due to related parties at August 31, 2024 and February 29, 2024 totaled $<span id="xdx_90A_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zjAVdZSeYa25" title="Notes payable - related parties">2,718,594
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_901_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNtwJ8WhjzWf" title="Notes payable - related parties">828,277</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4fwFlGmzgAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
13 - <span id="xdx_821_zEjXjSrIwhXd">Related Party Transactions</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC, (&#8220;TMT&#8221;), pursuant
to which it purchased the right, title and interest in the &#8220;Bookit&#8221; or &#8220;NextTrip 2.0&#8221; booking engine, including
customer lists, all current content associated with hotel and destination product in the booking engine (pictures, hotel descriptions,
restaurant descriptions, room descriptions, amenity descriptions, and destination information.) and source code related thereto. TMT
is a related entity owned by Don Monaco, the Company&#8217;s Chairman and William Kerby, the Company&#8217;s Chief Executive Officer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
due to related parties in 2024 and 2023 was $<span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties">828,277</span> and $<span id="xdx_904_eus-gaap--NotesPayableCurrent_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties">281,000</span>, respectively. The amounts due in both years are to William Kerby and
Donald Monaco.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded a loss of $<span id="xdx_906_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zDkGbGIz5Ivb" title="Loss on related party receivable">1,567,665</span> on the NextPlay related party receivable for the year ended February 29, 2024. The total amount
receivable from NextPlay was $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zIJzArv2G1Nk" title="Accounts receivable">2,567,665</span> at February 29, 2024. NextPlay is in default under the terms of its promissory note and as a
result the Company established an allowance for doubtful accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zpPYCuk8ayNg" title="Allowance for doubtful accounts">1,567,665</span> as collectability of the note is uncertain. As of February
28, 2023, <span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zsDbYr6wwLf8" title="Allowance for doubtful accounts">no</span> allowance for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629977520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Deferred Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredRevenueTextBlock', window );">Deferred Revenue</a></td>
<td class="text"><p id="xdx_805_ecustom--DeferredRevenueTextBlock_zYu3Z8tfW1rk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
14 - <span id="xdx_821_z5cIFTK9nBcc">Deferred Revenue</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue as of the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_z7ib0lWAXqcb" title="Deferred revenue">139,921</span> and $<span id="xdx_90A_eus-gaap--DeferredRevenueCurrent_iI_c20230228_zq2jYnylNuZg" title="Deferred revenue">22,750</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 29, 2024, and February 28, 2023 was driven by cash payments from customers in advance of satisfying our performance obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Revenue [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526556128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXbavLPv1cZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
15 - <span id="xdx_820_z9nVLyQGXowd">Commitments and Contingencies</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#8217;s evaluation of the possible liability or outcome of such litigation
or claims.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525819520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders&#8217; Equity</a></td>
<td class="text"><p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFEnqmQabPwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 - <span id="xdx_829_zeJLhLyM0iX4">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 8, 2024, at a special meeting of stockholders, the Company received approval to increase its authorized shares of common stock
from <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20240307_zgqrNH3Cp466" title="Common stock, shares authorized">1,200,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to
<span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20240308_z63XGH047bEf" title="Common stock, shares authorized">250,000,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
&#8220;Increase in Authorized&#8221;). On March 11, 2024, the Company filed a Certificate of Amendment to its amended and restated articles
of incorporation, as amended, with the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific
time on March 13, 2024, the Increase in Authorized was implemented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the first quarter of 2024, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zz25wajg3Ekd" title="Number of common stock issued">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zJdBKNDp3Hs8" title="Number of shares converted">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series G Convertible Preferred
Stock, <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8moQY9qjU9b" title="Number of common stock issued">117,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zOs2ScDReDxj" title="Number of shares converted">117,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series H Convertible Preferred
Stock, and <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zceM3EoWEXFi" title="Number of common stock issued">192,502
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock upon conversion
of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1XcgGetfQDd" title="Number of shares converted">192,502
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the second quarter of 2024, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240601__20240831__dei--LegalEntityAxis__custom--DooyaMediaGroupIncMember_zhssIOx2XrNe" title="Number of common stock issued">42,709
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock to a service provider
as partial compensation for development work related to Compass.TV, the Company&#8217;s Free-Ad Supported TV (&#8220;FAST&#8221;) channel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our amended and restated articles of incorporation, as amended (&#8220;Articles&#8221;), our board of directors has the authority, without
further action by stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion rights,
voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be preferential
to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20240831_zPBlx5We5Fej" title="Preferred stock, shares authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240229_ziS720W8L6j8" title="Preferred stock, shares authorized">10,000,000</span></span></span>
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock, $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229_zrisDs6fEKnb" title="Preferred stock, par value"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831_zIfYuIEv3nH1" title="Preferred stock, par value">0.001</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value. An aggregate of <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240831_z8do2g5cDy15" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831_zagDP9qu0ctg" title="Preferred stock, shares outstanding">93,295</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zwC5kZM3tOlg" title="Preferred stock, shares issued"><span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zfgTOPahMzei" title="Preferred stock, shares outstanding">472,996</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of preferred stock were issued
and outstanding at August 31, 2024 and February 29, 2024, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z6m2ooZr9fyd" title="Preferred stock, par value">1,500
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Stated Value&#8221;).
Dividends at the initial rate of <span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zLBREMrmDomk" title="Dividends percentage">9</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E Preferred
Stock by said amount. The holders of the Series E Preferred Shares have the right at any time to convert all or a portion of the Series
E Preferred Shares (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third anniversary
of the closing date) into shares of the Company&#8217;s common stock at an initial conversion rate determined by dividing the Conversion
Amount by the Conversion Price ($<span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z8pHYNUmYRD" title="Conversion price per share">0.13
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">above the consolidated closing bid price
for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the Stated Value
of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E Preferred Shares
being converted, plus the &#8220;Make Whole Amount&#8221; (the amount of any dividends that, but for the conversion, would have accrued
at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate is also subject
to adjustment for stock splits, dividends recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zYqkC5iZJpmj" title="Preferred stock, shares issued"><span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zkdeVtVujlla" title="Preferred stock, shares outstanding">316</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series E Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, including the make-whole dividends, would have resulted in
the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zbHuFHIiOY82" title="Common stock issuable upon conversion">3,259
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Series F Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIyUDMksYNGc" title="Preferred stock shares authorized">5,843,993
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series F Convertible Preferred Stock, par value $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zXoQxcel26V8" title="Preferred stock, par value">0.001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series F Preferred&#8221;).
The Series F Preferred was designated by the Company in connection with its acquisition of NextTrip, and, in the event that the Company
does not have sufficient shares of common stock available to fulfill its obligations pursuant to the Share Exchange Agreement governing
the terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares
of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series F Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series F Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series F Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series F Preferred or alter or amend the Series F Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series F Preferred, or
(iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Conversion
Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#8220;Liquidation&#8221;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIzKEFxJBZqc" title="Preferred stock, shares outstanding">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Series F Convertible Preferred
Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztJZ504a3rX8" title="Preferred stock shares authorized">100,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series G Preferred Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zQMolak1TwU7" title="Preferred stock, par value">0.001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series G Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_907_eus-gaap--PreferredStockRedemptionTerms_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z4pMlhkdfhPk" title="Preferred stock redemption right, description">The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with the
terms of the Perpetual License Agreement</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zEasTqb1MJ32" title="Preferred stock, shares outstanding">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series G Convertible
Preferred Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zn2EFnmpBy5d" title="Preferred stock, shares authorized">150,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series H Preferred Stock, par value $<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z2CWif6IqCle" title="Preferred stock, par value">0.001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series H Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zr03MBanu6Fc" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkILavaIEv64" title="Preferred stock, shares outstanding">33,000</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series H Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zepCDi8ghZGf" title="Common stock issuable upon conversion">33,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Series I Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zD5NoIQJCbW2" title="Preferred stock, shares authorized">331,124
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Company&#8217;s preferred
stock as Series I Convertible Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z3od5aJr6LId" title="Preferred stock, par value">0.001
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share (the &#8220;Series I Preferred&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or
(iii) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zM5pgFf0Dq11" title="Sale of stock, shares">4,967
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock, at $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKRUoIlMdNOl" title="Sale of stock, shares price">3.02
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, resulting in gross proceeds
to the Company of $<span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNwLkU9HEH1e" title="Sale of stock proceeds">15,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmeMEMVFPMC2" title="Sale of stock, shares">24,834
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock at $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzjQy2g38kog" title="Sale of stock, shares price">3.02
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, resulting in gross proceeds
to the Company of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsaGNggDVIR3" title="Sale of stock proceeds">75,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zrfLvlukg2Pi" title="Preferred stock, shares issued"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUwy5QtNMEl3" title="Preferred stock, shares outstanding">59,979</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the issued Series I Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of <span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zVSTCfiEE8ye" title="Converted issuance of shares of common stock">59,979
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan (the &#8220;2023 Plan&#8221;). <span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zMxq9VXF2Q2h" title="Common stock reserved for issuance">7,000,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock have been reserved
for issuance under the 2023 Plan., and as of August 31, 2024, all of such shares are available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&#8217;s 2013 Equity Incentive Plan expired on March 15, 2023. As such, no new grants may be made under the 2013 Plan. At August
31, 2024, there were <span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831_zkYBbGAlwL12" title="Common stock reserved for future issuance">78,877
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock reserved for issuance
upon exercise of outstanding stock options issued under the 2013 Plan prior to its expiration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfG1Bd8tLNck" title="Number of options issued"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8luLPE8lOAb" title="Number of options issued">no</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">issuances of stock options for the six
months ended August 31, 2024 or August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company&#8217;s
common stock on the grant date, but not less than 100% of the fair market value. Stock options are typically granted throughout the year
and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified.
The Company recognizes compensation expense for the fair value of the stock options over the vesting period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
stock-based compensation expense included in the statements of operations for the three and six months ended August 31, 2024 was $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20240601__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhcw6XOUVbDg" title="Stock based compensation">13,841
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC7UvZyFNVH8" title="Stock based compensation">30,235</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
respectively, all of which was related to stock options. There was <span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2mL3f0Bd4D2" title="Stock based compensation"><span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z1VdIpbt1Z0j" title="Stock based compensation">no</span>
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock-based compensation included in the
statements of operations for the three or six months ended August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKW0TltPBr2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B7_z6wRZwGPvSPb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Options outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zVPwjygNRui8" style="text-align: right" title="Number of Options Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z5MlF0ULIE13" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229_zM1eCMBvpwz9" style="text-align: right" title="Aggregate Intrinsic Value Outstanding">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zZJryDheMkse" style="width: 12%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">86,642</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_ztL0xiqu3Gbf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">61.43</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zX8uathfpHMf" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition">2.68</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229_zV3sY59loAyc" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229_zxuUZk3vXkMe" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zFVFTvBvicCk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2453">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_ztxqk2Xultm3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20230301__20240229_zjf9t1o51tZ2" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z4EScFQQHEN4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2459">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zB9EZyzFHrqc" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zUdaSndO13k7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(1,342</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z6ZP9fv9yAl4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">120.87</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zMgxWTWmT7A8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2467">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831_zqt32FAa0PV9" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_zVx7QiD91kd2" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z11gLOvNG9i3" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831_zKQSIjEOOO85" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831_z38Jy9bS1vq9" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zojvWxzLM2ej" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831_zhmGe9BizPr1" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20240301__20240831_z2bSGtIGzKig" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zXHfDQm7zppg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_z5FHicFbArmd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831_zrMMLLE2sR6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(6,423</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zUXxvWqBEVHd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">87.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_zl6TTOjgnMic" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831_z806xjANvI75" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance">78,877</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zrfE4T31Odd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">58.19</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831_zo18FHV6SF37" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.03</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831_zcNuu8x7ZMs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831_zd2OsdGTetib" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">1,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_z54MtrYKDiF4" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">32.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zfmcGnKHb1Dc" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">3.10</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zE35RunqK301" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831_zNfwjMbeqLA2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable">77,445</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zfGivz01ummg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">58.67</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zJnYi6P8Uar" title="Weighted Average Remaining Contractual Life Years, Exercisable">2.01</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831_zavGZEQo7pL5" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831_zgTgTrY381M6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">78,877</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20240831_z7zw842XH15c" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">58.19</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zd3tHOuZQX3c" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.03</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zzsR3sAGtJf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A3_zxqGBSRwDyK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no option
had an exercise price below the $<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831_z7RdAZlvv9Pj" title="Options exercise price">2.59
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">closing price of our common stock as reported
on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, there was $<span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCB5psPYGnac" title="Unrecognized stock-based compensation expense">16,139
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unrecognized stock-based compensation
expense related to unvested stock options with a weighted average remaining recognition period of <span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_za50Cy9in4Ce" title="Weighted average remaining recognition period">0.74
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan (the &#8220;SAR Plan&#8221;) are to: (i) enable the Company to attract and retain
the types of employees, consultants, and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the Company&#8217;s
long-range success; (ii) provide incentives that align the interests of Service Providers with those of the stockholders of the Company;
and (iii) promote the success of the Company&#8217;s business. The SAR Plan provides for incentive awards only in the form of stock appreciation
rights payable in cash (&#8220;SARs&#8221;) and no shares of common stock are reserved or will be issued pursuant to the SAR Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#8217;s
common stock (&#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a share of common stock on the date of grant of the SAR.
The administrator of the SAR Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including,
without limitation, the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company did not grant any SAR&#8217;s during the six months ended August 31, 2024 or August 31, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the vesting period for each
SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation,&#8221; and
any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zBcVO56mokq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B9_zMraIxzNLg1h" style="display: none">Schedule
of Stock Appreciation Rights Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">SARs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
                                            Life (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>SARs outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYkx0ZHYPWya" style="text-align: right" title="Options outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zS7uyrbPFhi6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4qR70CF3XKh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2539">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVjpZaEK5g25" style="width: 12%; text-align: right" title="Options, Assumed pursuant to reverse acquisition">40,390</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zX3ZSvxN0Vqc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">44.77</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFG7sAYamPr6" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition">2.99</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zvG4Xlkhks45" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zEMmUaNNo3Mb" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7HkD0YU49Ok" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zu6LQ7opMcU" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zofD6jbSpdW7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2555">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ2nUc70M7K8" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPeBdtZFr9ql" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zymMamZSGrmk" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Beginning Balance">40,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFjnfz7Fg6G5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">44.77</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeAAGWZvi1b2" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance">2.99</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYromUSLtAK8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRfhBr9C40X4" style="text-align: right" title="Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqeYMkayp6kb" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2571">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zxkk6a0l7HL" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2573">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPegzyktlkd7" style="text-align: right" title="Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMWjsximVtgk" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2577">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuXAJ4YstJha" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2579">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMsoQXUNk7c" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited or cancelled">(167</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znSNcasf1Sif" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">37.40</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zdAtLr9NkBjb" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3gqjAiT4wn" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending Balance">40,223</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zrEBS45lc8Z6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">44.80</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zCN3wrZTwhAl" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance">2.49</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zmsTvyPH9nf5" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl2593">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMotYWXHOC8" style="text-align: right" title="Options, Expected to vest">5,645</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zV1S0hNdgNUf" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">29.37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z1OFBeCyAIQ7" title="Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest">2.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuHLuAKzFJvk" style="text-align: right" title="Aggregate Intrinsic Value, Expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl2601">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z44NDFqKYff9" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Exercisable">34,578</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlD6VVfHUeFg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">47.31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zhMjmnXKBe8d" title="Weighted Average Remaining Contractual Life (Yrs.), Exercisable">2.43</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwrrLyJVoobh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and SARs expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ75WZfpdr1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest">40,223</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGDyBIu3c62g" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.80</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSvdfpAOI1s9" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.49</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z48Q5wRTqJj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Vested, Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zq2NCPWaM1xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no SAR
had an exercise price below the $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaaEsbHvLtS1" title="Options exercise price">2.59
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">closing price of our common stock as reported
on the Nasdaq Capital Market.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
August 31, 2024, there was $<span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJikAlhk7eF" title="Weighted average remaining recognition period">943
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of unrecognized stock-based compensation
expense related to unvested SARs with a weighted average remaining recognition period of <span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaRwDjEpAXB1" title="Weighted average remaining recognition period">0.64
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsMJkrYQxTV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_zkQxt8HKhodd" style="display: none">Schedule
of Warranty Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Warrants outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zzdUFYwYF1ye" style="text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2627">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z0I419FYMyw9" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2629">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_z9wrCuPcqxZg" style="width: 12%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition">217,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zjLCAK5GQZT" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">21.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_z0uKOTHVIUK4" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition">1.86</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zc6yCmU31tXd" style="text-align: right" title="Warrants, Granted">268,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zPc4aM2bHHid" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">3.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_ziCGPYjosccd" title="Weighted Average Remaining Contractual Life (Yrs.), Granted">2.17</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zOAcIfbmOxG5" style="text-align: right" title="Warrants,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2643">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zacem4gPZU6i" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2645">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zvH05pJxGWC7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2647">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zoqzvZ20UDE6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2649">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20240831_znYtPvJuDObh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Outstanding, Beginning Balance">486,165</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_z4nT0Ip458oh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">9.94</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zYZsstFAZGT" title="Weighted Average Remaining Contractual Life Years">1.96</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20240831_zw31jFWOnvZf" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zbFVB8r8IXP5" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2659">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20240831_zfFZ1vKAMVMj" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zlnZRkH0jAAj" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20240831_zRm1dGQc7Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled">(2,102</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20240831_zmIPPL4nLMp1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">322.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20240831_z5Q7qWwJNiv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">484,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zivlj0TsIhH9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">8.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20240831_z5XvcGsAF1P3" title="Weighted Average Remaining Contractual Life (Yrs.) Outstanding">1.46</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A1_zEgpYg2Y9qCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNEbszpW6zla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
16 &#8211; <span id="xdx_82D_zIYDn08hz347">Stockholders&#8217; Equity</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has <span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20240229_zdPXuaENxOBl" title="Common stock, shares authorized">1,200,000</span> shares of common stock authorized. For the years ended February 29, 2024 and February 28, 2023, the Company had
<span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20240229_z6O4gG20NB5j" title="Common stock, shares issued"><span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_z59S9wWhV7I4" title="Common stock, shares outstanding">936,430</span></span> and <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20230228_z077MhmHx3G" title="Common stock, shares issued"><span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20230228_zVG6L6TorTP9" title="Common stock, shares outstanding">83,371</span></span> shares of common stock, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_z6kfYgJVyEmk" title="Common stock, par value"><span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230228_zMaRPRRhT8vf" title="Common stock, par value">0.001</span></span> issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and have one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 22, 2023, we effected a <span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_zBMYljCigaF5" title="Reverse stock split">1-for-20 reverse stock split</span> of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zYuppuwALY54" title="Reverse stock split issued common shares">40,197</span> common
shares to round-up fractional shares to the nearest whole share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effects of the reverse stock split have been retroactively reflected in all periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Fiscal
Year Ended February 29, 2024</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September and October 2023, the Company sold <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWGZGVr39j98" title="Share issued and sold during period, shares">72,721</span> and <span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2ghHiETfBcl" title="Share issued and sold during period, shares">128,887</span> shares of common stock, respectively, through our ATM Agreement, resulting
in net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn3OsLTVbAh6" title="Net proceeds">364,555</span> and $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zURPciHU4IIj" title="Net proceeds">772,468</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 29, 2023, the Company acquired <span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwi7QEBlGU85" title="Equity interest acquired">100</span>% of the outstanding equity interests of NextTrip Holdings, Inc. pursuant to a share exchange
agreement by and among the Company, NextTrip and certain other parties (the &#8220;Acquisition&#8221;). As consideration for the Acquisition,
at closing the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zfLu2SyhkAEk" title="Restricted shares issued in acquisitions">156,007</span> restricted shares of its common stock, constituting <span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGnERLiFWTkg" title="Percentage of issued and outstanding common shares">19.99</span>% of its issued and outstanding shares
of common stock immediately prior to execution of the share exchange agreement, and agreed to issue up to an aggregate of <span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zdX4wd4V60I2" title="Shares issuable for consideration">5,843,993</span> shares
as further consideration upon NextTrip&#8217;s achievement of certain milestones set forth in the exchange agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Of
the <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zQykeyPefPC8" title="Restricted shares issued in acquisitions">156,007</span> restricted shares issued at closing, <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zXYNTfVXNad9" title="Shares issued in acquisitions">52,818</span> shares were issued pursuant to the Debt Assignment and Conversion agreements,
<span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zDAMv4JKQOpf" title="Purchase of shares issued">15,481</span> shares were issued pursuant to the Share Purchase and Exchange Agreements, and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zJeY2RmCbsNa" title="Shares issued during period services">4,337</span> shares were issued to a third-party consultant.
Pursuant to ASC 805-40-45-1,the remaining <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z3rNaVTKm6jl" title="Shares issued in acquisitions">83,371</span> Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#8217;s
legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal
parent.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Deferred
Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal years ended February 29, 2024 and February 28, 2023, the Company did not issue any shares of common stock to employees.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Preferred
Stock</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our articles of incorporation, our board of directors has the authority, without further action by stockholders, to designate one or
more series of preferred stock and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights
granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption,
liquidation preference and sinking fund terms, any or all of which may be preferential to or greater than the rights of the common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_z5brbXuhefm3" title="Preferred stock, shares authorized"><span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230228_ztskdZjb6CMd" title="Preferred stock, shares authorized">10,000,000</span></span> shares of preferred stock, $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_zMIhTuxIBrI" title="Preferred stock, par value"><span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230228_z7ls9C5dadnf" title="Preferred stock, par value">0.001</span></span> par value. <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zUu8VGlmUkI1" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zVWi8hP0ocs1" title="Preferred stock, shares outstanding">472,996</span></span> and <span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20230228_zPRS5vZzceB1" title="Preferred stock, shares issued"><span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20230228_zNGYECD7rzai" title="Preferred stock, shares outstanding">0</span></span> shares of preferred stock were
issued and outstanding at February 29, 2024 and February 28, 2023. respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
E Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $<span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zZDArrmFJj8k" title="Preferred stock, par value">1,500</span>
per share (the &#8220;Stated Value&#8221;). Dividends at the initial rate of <span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zke1y58qXVIe" title="Dividends percentage">9</span>% per annum will accrue and, on a monthly basis, shall
be payable in kind by the increase of the Stated Value of the Series E Preferred Stock by said amount. The holders of the Series E Preferred
Shares have the right at any time to convert all or a portion of the Preferred Shares (including, without limitation, accrued and unpaid
dividends and make-whole dividends through the third anniversary of the closing date) into shares of the Company&#8217;s Common Stock
at an initial conversion rate determined by dividing the Conversion Amount by the Conversion Price ($<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zV53xYW3Df13" title="Conversion price per share">0.13</span> above the consolidated closing
bid price for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the
Stated Value of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E
Preferred Shares being converted plus the &#8220;Make Whole Amount&#8221; (the amount of any dividends that, but for the conversion,
would have accrued at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate
is also subject to adjustment for stock splits, dividends recapitalizations and similar events.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z48xCbsCYbg2" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zqcyJYBE0U5e" title="Preferred stock, shares outstanding">316</span></span> shares of the issued Series E Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, including the make-whole dividends, would have resulted in the issuance of <span id="xdx_909_eus-gaap--CommonStockDividendsShares_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zHqKlJquvT74" title="Issuance of common stock dividends, shares">3,155</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
F Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;)
with the Secretary of State of the State of Nevada, designating <span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z8PQtH1UBGKe" title="Preferred stock shares authorized">5,843,993</span> shares of the Company&#8217;s preferred stock as Series F Convertible
Preferred Stock, par value $<span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z6sLeL4FDyG" title="Preferred stock, par value">0.001</span> per share (the &#8220;Series F Preferred&#8221;). The Series F Preferred was designated by the Company
in connection with its recent acquisition of NextTrip Holdings, Inc. (&#8220;NextTrip&#8221;), and, in the event that the Company does
not have sufficient shares of common stock available to fulfill its obligations pursuant to the share exchange agreement governing the
terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares of
Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ranking</i></b><i>.
</i>The Series F Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Dividends</i></b><i>.
</i>Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Voting</i></b>.
Except as provided by the Company&#8217;s amended and restated articles of incorporation, as amended (&#8220;Articles&#8221;) or as otherwise
required by the Nevada Revised Statutes, holders of Series F Preferred are entitled to vote with the holders of outstanding shares of
Company common stock, voting together as a single class, with respect to all matters presented to the Company&#8217;s stockholders for
their action or consideration. In any such vote, each holder is entitled to a number of votes equal to the number of shares of Common
Stock into which the Series F Preferred held by such holder is convertible. The Company may not, without the consent of holders of a
majority of the outstanding shares of Series F Preferred, (i) alter or change adversely the powers, preferences or rights given to the
Series F Preferred or alter or amend the Certificate of Designation, (ii) amend its Articles or other charter documents in any manner
that adversely effects any rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Conversion</i></b>.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Conversion
Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#8220;Liquidation&#8221;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zHCMb7Uyrswj" title="Preferred stock, shares outstanding">no</span> shares of the Series F Convertible Preferred Stock were outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
G Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#8220;Series G Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvwrZFxYRrfe" title="Preferred stock shares authorized">100,000</span> shares of the Company&#8217;s preferred
stock as Series G Preferred Stock, par value $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zlrEX0qVjs1c" title="Preferred stock, par value">0.001</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series G Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
G Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Redemption
Right</i>. <span id="xdx_904_eus-gaap--PreferredStockRedemptionTerms_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z92mrP7ixfGl" title="Preferred stock redemption right, description">The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, all <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvKCVyQ8I033" title="Preferred stock, shares issued"><span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztuD2BzyPIbd" title="Preferred stock, shares outstanding">100,000</span></span> shares of the issued Series G Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zxhWrseSBlxb" title="Converted issuance of shares of common stock">100,000</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
H Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#8220;Series H Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zUokPnKpbPlc" title="Preferred stock shares authorized">150,000</span> shares of the Company&#8217;s preferred
stock as Series H Preferred Stock, par value $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zHDSE5AH5XCf" title="Preferred stock, par value">0.001</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series H Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Company&#8217;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#8220;Series
H Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z12MNeQBJqAc" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkbIykyl0Sah" title="Preferred stock, shares outstanding">150,000</span></span> shares of the issued Series H Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_90C_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zBeba8KNeNg2" title="Converted issuance of shares of common stock">150,000</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Series
I Convertible Preferred Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#8220;Series I Certificate
of Designation&#8221;) with the Secretary of State of the State of Nevada, designating <span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1bmw1gvIbI8" title="Preferred stock shares authorized">331,124</span> shares of the Company&#8217;s preferred
stock as Series I Convertible Preferred Stock, par value $<span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zYpQFKtIHEd6" title="Preferred stock, par value">0.001</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ranking.
</i>The Series I Preferred rank pari passu to the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dividends.
</i>Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Voting</i>.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#8217;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Conversion</i>.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#8220;Series I Conversion Ratio&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Liquidation</i>.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#8217;s common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUt5kE0H2lHd" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zE1gCqn985zd" title="Preferred stock, shares outstanding">222,680</span></span> shares of the issued Series I Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of <span id="xdx_900_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zMWKmZWfJUZa" title="Converted issuance of shares of common stock">222,680</span> shares of common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 29, 2024, we had outstanding options under our 2013 Equity Incentive Plan to purchase an aggregate of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zRP7PwC4bESj" title="Common stock shares option outstanding">85,300</span> shares of our
common stock at a weighted-average exercise price of $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zkpdcyPeZOq7" title="Weighted average exercise price">60.50</span> per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, our stockholders approved our 2023 Equity Incentive Plan which has reserved for issuance <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zzIzNj75aTj6" title="Common stock shares reserved for issuance">7,000,000</span> shares of common
stock for equity awards of which <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20231228__20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPNmSrpCeLfl" title="Common stock shares equity award issued or granted">0</span> shares have been issued or granted thereunder to date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Options</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#8217;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan. <span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zpOTycNoRt7e" title="Common stock shares reserved for issuance">7,000,000</span> shares of common stock have been reserved for issuance under the Plan., and as of February
29, 2024, all such shares are available for issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
fiscal year 2024, the Company did not grant any options. In fiscal year 2024, <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230301__20240229_zvlmM07Srh2h" title="Share based compensation arrangement by award options vested">6,914</span> options vested and $<span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229_zK0Yhq1ApaXd" title="Alloacted share based compensation">116,512</span> of compensation cost
was recognized during the year. As of February 29, 2024, there were options to purchase <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zP10NLomDqaa" title="Share based compensation arrangement by award options vested outstanding">85,300</span>, shares issued and outstanding, <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenPlanMember_zNmPle8JY4wc" title="Share based compensation arrangement by award options vested outstanding">82,800</span>
of which have been issued under an Equity Incentive Plan. At February 29, 2024, there are vested options exercisable for <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229_z8NyHWp8vA93" title="Stock issued during Stock options exercised">81,849</span> shares
of common stock. <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20230301__20240229_zbhvWNXct6Ul" title="Share based compensation arrangement by award options grants">No</span> options to purchase shares of common stock were exercised during the fiscal year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#8217;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed options to purchase up to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__srt--RangeAxis__srt--MaximumMember_zGr1Oeir1278" title="Options to purchase of common stock">86,402</span> shares of common
stock. Between December 29, 2023 and February 29, 2024, <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zGEUxmzAgXj7" title="Options to forfeited or expired">1,342</span> options were forfeited or expired and no options were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
employee share-based compensation expense for the year ended February 29, 2024, was $<span id="xdx_901_eus-gaap--ShareBasedCompensation_pp0p0_c20230301__20240229_zV4g3sIm8nFe" title="Allocation share based compensation expense">116,512</span> all of which is related to stock options.
There was no capitalized share-based compensation cost as of February 29, 2024,and there were no recognized tax benefits during the fiscal
year ended February 29, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
estimate the value of an award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as expected
life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate compensation. These inputs
are subjective and generally require significant analysis and judgment to develop. While estimates of expected life, volatility and forfeiture
rate are derived primarily from the Company&#8217;s historical data, the risk-free rate is based on the yield available on U.S. Treasury
constant maturity rates with similar terms to the expected term of the stock option awards. The fair value of outstanding share-based
awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the outstanding options assumed
at February 29, 2024:</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zCSFN88TgWY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z4z3kIBvCuj8" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229_zlqBKDyoFgY8" title="Dividend yield">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230301__20240229_z24o0jAfRhXi" title="Risk-free interest rate, minimum">0.19</span>-<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230301__20240229_zXow7RiQAIG9" title="Risk-free interest rate, maximum">4.05</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229_zCWw7cqUHXWa" title="Expected volatility, minimum">100.2</span>
&#8211; <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229_zgJO7kFpKlt" title="Expected volatility, maximum">122.8</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229_zKwZJiTg4pi" title="Expected life">5</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A9_z6zJScHF9FIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zvt35IMaoIba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zv8wFumeSark" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zL5oyH2qQuw" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z8EFvLeepenc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zaB5PLhfK0Ph" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">86,642</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zz1jKHvhOtGl" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">61.43</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zWl06Az60yuj" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition">2.68</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_zvEB5RHJsxR" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20230301__20240229_zJfFwargF1u5" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zY9C4qfMfa8f" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zsYzXXft9K14" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zZ2EpPMLJcUk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(1,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zD2IrqUFHol7" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">120.87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zzjupgviHw64" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229_z7B8b01yMc1l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zCHV3vEAkOWb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_zZ6ysKBr6t61" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229_zgYMEo2TQSI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229_zl7BChXnnYmf" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">3,451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_z5BTVBA85kH3" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">33.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zSt28PDX2av4" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">3.54</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_zQoDu2MU2Eak" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Options exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229_zRnyakrA8o0k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable">81,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zjOzwRU1Mwb3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">61.64</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zbWURQG1Spfk" title="Weighted Average Remaining Contractual Life Years, Exercisable">2.48</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229_zztpefCeawxe" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20220301__20240229_zXolw9eI5SH5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">85,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230301__20240229_zWzXYpZ4o3sg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">60.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zrVYE3TZ1ugd" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.52</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_ztzN5ewEdRwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl1239">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AE_z6NsUfUTtzbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zub2aAN1mcEk" title="Options exercise price">2.99</span> closing price of our Common Stock on February 29, 2024.
All of the outstanding option grants have an exercise price above $<span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zEtxbW0EJI42" title="Options exercise price">2.99</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, there was $<span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240229_zKF4Hz2QOcBi" title="Unrecognized stock-based compensation expense, stock option">52,615</span> of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of <span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230301__20240229_ziIqWCowrmg6" title="Weighted average remaining recognition period">0.97</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
Appreciation Rights</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2020 Stock Appreciation Rights Plan are to: (i) enable the Company to attract and retain the types of employees, consultants,
and directors (collectively, &#8220;Service Providers&#8221;) who will contribute to the Company&#8217;s long-range success; (ii) provide
incentives that align the interests of Service Providers with those of the shareholders of the Company; and (iii) promote the success
of the Company&#8217;s business. The Plan provides for incentive awards that are only made in the form of stock appreciation rights payable
in cash (&#8220;SARs&#8221;). No shares of common stock were reserved in connection with the adoption of the Plan since no shares will
be issued pursuant to the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#8217;s
common stock (&#8220;Share&#8221;) upon the exercise of the SAR. The &#8220;Spread&#8221; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a Share on the date of grant of the SAR. The administrator
of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including, without limitation,
the exercise price and medium of payment and vesting provisions, and to specify the provisions of the SAR Agreement relating to such
grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zK4731N3g1H2" title="Reverse acquisition shares outstanding">40,390</span>
outstanding SARs. Between December 29, 2023 and February 29, 2024, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zg9YZD4oXUT2" title="Shares forfeited or expired::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1251">none </span></span>
were forfeited or expired and <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zM310cGJGHnj" title="Shares issued or exercised::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1253">no</span></span>
SARs were issued or exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#8217;s are revalued at each reporting date in accordance with ASC 718 &#8220;Compensation-Stock Compensation&#8221;,
and any changes in fair value are reflected in income as of the applicable reporting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ztgRBeF7azpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zxxYOHHfTTl" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zeMJPz4xb8c9" title="Dividend yield">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zVQRqsNLQFdk" title="Risk-free interest rate, minimum">0.22</span>-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z68qM2z7c3Ig" title="Risk-free interest rate, maximum">2.79</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zUj9ZmcPkHD8" title="Expected volatility, minimum">108.7</span>-<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zz7P4VAvaol8" title="Expected volatility, maximum">122.8</span>.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zBoe9PbkKj6g" title="Expected life">5</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A2_zbY86XLr6Pk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlXLys9C9ZSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zadJEwVq53t9" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">SARs</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zIMrjeHePj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BWnETrCiK9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3uHP9IIpJ87" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1275">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zTMm3uDNFvv7" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">40,390</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ziXzJa6obGb5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">44.77</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYJdEJuxiedl" title="Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition">2.99</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5b1ZtwhFD19" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsBzFm61Ph3b" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1285">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zZ0UbNEnJHid" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3Bd1iutlFWd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1289">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zylDxWQAfTI8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zU4OglGs21U6" title="Weighted Average Exercise Price, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1293">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zinJJy9TCc43" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1295">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9wmQesIStRd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance">40,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zyDj4FH9HK81" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.77</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVcT60xoQFz2" title="Weighted Average Remaining Contractual Life, Outstanding Balance">2.99</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BSIEor05T7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zLTUmsNO1Yt1" style="text-align: right" title="Number of Options, Expected to vest in the future, Balance">6,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zzRQbOq9DgRh" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">35.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeCcVa7Qq63a" title="Weighted Average Remaining Contractual Life, Expected to Vest">3.23</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmrqn5p3GF3" style="text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">SARs exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zG4hQA0mO2t1" style="margin-top: 0; margin-bottom: 0" title="Number of Options, Exercisable">33,504</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqob0xu8E512" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Exercisable">46.72</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlhYOyZZ3Ts1" title="Weighted Average Remaining Contractual Life, Exercisable">2.93</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znL79OeYO0Ah" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1319">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHitT1NzTBG" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance">40,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr7jfmrcrhlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.77</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zXmPLCf4Myf2" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest">2.99</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9EPt7KsGdW1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl1327">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AC_z8EcsBDOKQd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z6Nd0rKWCYO1" title="Options exercise price">2.99</span> closing price of our common stock on February 29, 2024.
All the SARs have an exercise price above $<span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zMkAecVhRf16" title="Options exercise price">2.99</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended February 29, 2024, $<span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zj9Eq7Xktc02" title="Share based compensation expense">10,107</span> of share-based compensation
expense was recognized, and at
February 29, 2024, there was $<span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zbrXhhMaIAOi" title="Unrecognized share based compensation cost">79,978</span> of unrecognized share-based compensation expense related to unvested SARs with a weighted average
remaining recognition period of <span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9SZl3WOrm2" title="Weighted average remaining recognition period">1.08</span> years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
February 29, 2024, the Company had outstanding warrants to purchase a total of <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1TolQeLPCJa" title="Purchase of outstanding warrants">486,165</span> shares of common stock. The warrants have exercise
prices that range from $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z9IQaBG5q4Uf" title="Warrants exercise price">3.02</span> to $<span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zmqGGQl9ICW3" title="Warrants exercise price">350.00</span>, which if not exercised, will <span id="xdx_90E_ecustom--DescriptionForWarrantExpiration_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztfAS2ujet98" title="Warrant description">expire between March 15, 2024 and January 25, 2028</span>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAn9vYBnJnsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zUiVstpbRCj6" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zR5hqo54MQY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_zrZt9l6sCFPa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zimhzZ6B6gu4" style="width: 14%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition">217,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zItCnLIOnlZk" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Assumed pursuant to reverse acquisition">21.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zZRTn3tQrpq3" title="Weighted Average Remaining Contractual Life Years, Assumed pursuant to reverse acquisition">1.86</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zhNYRpssB0ll" style="text-align: right" title="Warrants, Granted">268,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z1odbqFbJVnf" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">3.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zJqwOa61FR59" title="Weighted Average Remaining Contractual Life Years, Granted">2.17</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zC2dnuNAPTd1" style="text-align: right" title="Warrants,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zi59YJj7Maqj" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zVRAagQpbom3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1369">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zFBndNbq2Spk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230301__20240229_zx79BkwEf9Lh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">486,165</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zcqN1mm6SkP1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">9.94</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zQae4W9B7KIe" title="Weighted Average Remaining Contractual Life Years, Ending Balance">1.96</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526455536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zQks9xozp2hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
17 &#8211; <span id="xdx_827_zxwb1l59OIdg">Loss Per Share</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zushP6iSTtB3" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(6,656,837</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(5,033,496</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,663,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,033,496</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(675,314</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,339,276</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,033,496</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">228,274</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">71,581</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AD_zlQzZ3pJf9ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented as the Company&#8217;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 29, 2024, the Company had outstanding
warrants to purchase <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXqYqquStvY1" title="Class of warrant or right, outstanding">486,165</span> shares of common stock, and stock options exercisable for <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbXxvXGt6d9b" title="Share-based compensation arrangement by share-based payment award, options, exercisable, number">85,300</span> shares of common stock, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8tPW1RFQfZk" title="Conversion of stock, shares converted">316</span> shares of Series
E Preferred Stock, which could be converted into <span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zzNjMDxQbtok" title="Common stock issued conversion">3,155</span> shares of common stock, <span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zwtAF3a119s6" title="Conversion of stock, shares converted">100,000</span> shares of Series G Preferred Stock, convertible
into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zBD7Nr10xJCf" title="Common stock issued conversion">100,000</span> shares of common stock, <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z2OH8cgJ4ROh" title="Conversion of stock, shares converted">150,000</span> shares of Series H Preferred Stock, convertible into <span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z7Tpm96ol8J2" title="Common stock issued conversion">150,000</span> shares of common stock, and
<span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zmttEAvTtFjd" title="Conversion of stock, shares converted">222,680</span> shares of Series I Preferred Stock, convertible into <span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zsgYdnPTDTyh" title="Common stock issued conversion">222,680</span> shares of common stock, resulting in a potential total additional
<span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeOcBMTpquwk" title="Common stock, shares, outstanding">1,047,300</span> shares of common stock outstanding in the future. At February 28, 2023, the Company had <span id="xdx_90D_eus-gaap--DilutiveSecurities_do_c20220301__20230228_zSbJoHq6qtRk" title="Potentially dilutive securities">no</span> outstanding potentially dilutive
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629890192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentrations</a></td>
<td class="text"><p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_zQRr4cPefesf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
18 &#8211; <span id="xdx_826_z647dKS4EwH9">Concentrations</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenues
</b>&#8211; During the years ended February 29, 2024 and February 28, 2023, the Company did not have any significant customers who accounted
for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFyLlnfyYKah" title="Concentration of risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zkS3zcxl0UZ3" title="Concentration of risk percentage">10</span></span>% each of the Company&#8217;s revenue in at least one of the periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounts
Receivable</b> &#8211; The Company had no significant customers who accounted for more than <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFSyWAwvlpGl" title="Concentration of risk percentage"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVmX3RPcPRrf" title="Concentration of risk percentage">10</span></span>% each of the Company&#8217;s accounts
receivable balance at February 29, 2024 and February 28, 2023, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629892848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Defined Contribution Plans</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_z29jvcWYNCma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
19 - <span id="xdx_821_z8ASVaHXhRxl">Defined Contribution Plans</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The
Company has adopted two qualified 401(K) plans (&#8220;the Plans&#8221;), in which all employees over the age of 21 may participate.
Depending on the Plan, <span id="xdx_904_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230301__20240229_zoL9Bx6vk6pd" title="Contribution plan description">the
Company makes either a Safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</span>. The matching
contributions were $<span id="xdx_90C_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240229_z41hV0F4dkse" title="Cost of contribution">17,112</span>
in 2024 and $<span id="xdx_905_eus-gaap--DefinedContributionPlanCostRecognized_c20220301__20230228_zXQAogfHZkMg" title="Cost of contribution">6,997</span>
in 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526455120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zvgvmMIU2Om8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 - <span id="xdx_828_zKDN5G3RXJY9">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Related Party Advances</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between
September 1, 2024 and October 11, 2024, additional net related party advances totaled $<span id="xdx_902_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_c20240901__20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z70f9cDxZk99" title="Related party advances">84,060</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
and the aggregate outstanding principal balance of related party advances was $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zydsjIyvL4Dd" title="Related party advances">2,802,654</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 13, 2024, the Company&#8217;s board of directors approved the conversion of up to <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpH7f8ZZJUDh" title="Conversion percentage">100</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of the outstanding principal balance of the promissory notes held by Messrs. Kerby and Monaco into shares of a series of non-redeemable
convertible preferred stock preferred stock yet to be designated. Messrs. Kerby and Monaco have agreed to initially convert $<span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zrVjpegsVuJ7" title="Converted amount">1,500,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
or <span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_z05GQporSMui" title="Conversion percentage">56.3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%
of their total outstanding principal balance of $<span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zCZLS7gHqMQ3" title="Outstanding principal  amount">2,666,790
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into the new series of convertible preferred
stock, and, at their discretion, may convert up to the remaining principal balance, or any portion thereof, into additional shares of
such convertible preferred stock at a future date. The conversion remains subject to completion of final documentation for the transaction,
including the filing of the certificate of designation for the new series of convertible preferred stock with the Nevada Secretary of
State.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Nasdaq Listing Requirement Deficiency Notice </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2024, the Company received a notification letter (the &#8220;Notice&#8221;) from the Nasdaq Listing Qualifications Staff
(the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that its amount of stockholders&#8217;
equity has fallen below the $<span id="xdx_900_ecustom--MinimumRequiredStockholdersEquity_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh6ZX76RWGKe" title="Stockholders equity minimum required">2,500,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">required minimum for continued listing
set forth in Nasdaq Listing Rule 5550(b)(1). The Notice also noted that the Company does not meet the alternatives of market value of
listed securities or net income from continuing operations, and therefore, the Company no longer complies with Nasdaq&#8217;s Listing
Rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
Nasdaq Listing Rules, the Company has until November 4, 2024 to provide Nasdaq with a specific plan to achieve and sustain compliance.
If Nasdaq accepts the Company&#8217;s plan to regain compliance, Nasdaq may grant an extension of up to 180 calendar days from the date
of the Notice to evidence compliance. If Nasdaq does not accept the Company&#8217;s plan to regain compliance, the Company will have
the opportunity to appeal the decision to a Nasdaq Hearings Panel. A hearing request will stay the suspension and delisting of the Company&#8217;s
securities pending the Nasdaq Hearings Panel&#8217;s decision.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notice has no immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#8217;s
listing remains fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is evaluating various courses of action to achieve compliance with Nasdaq Listing Rule 5550(b)(1). There can be no assurance
that the Company will regain compliance with Nasdaq Listing Rule 5550(b)(1) or that the Company will be able meet the continued listing
requirements during any compliance period that may be granted by Nasdaq.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 18, 2024, the Company also received a letter from the Staff of Nasdaq indicating that the Staff has determined that the Company
has regained compliance with the periodic filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) because the Company filed its
Annual Report on Form 10-K for the fiscal year ended February 29, 2024 and the Quarterly Report on Form 10-Q for the quarter ended May
31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly,
the Company has regained full compliance with the periodic filing requirement deficiency, which the Company disclosed in those Current
Reports on Form 8-K filed with the Securities and Exchange Commission on June 21, 2024 and July 19, 2024, and Nasdaq has informed the
Company in writing that the matter is now closed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>September 2024 Alumni Capital Transactions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024 the Company entered into a securities purchase agreement (the &#8220;Note &amp; Warrant SPA&#8221;) with Alumni Capital
LP (Alumni Capital&#8221;) for the sale of a short-term promissory note (the &#8220;Alumni Note&#8221;) and warrants (the &#8220;Warrants&#8221;)
to Alumni Capital for total consideration of $<span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKZiBTGYZnf3" title="Total consideration">250,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
After deducting commissions, net proceeds to the Company were $<span id="xdx_909_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5ZZ2BU1OIRd" title="Net proceeds">230,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Alumni Note is in the principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zknXAbXIYace" title="Principal amount">300,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with an original issue discount of $<span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5P9Q1Y6laT6" title="Original issue discount">50,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and guaranteed interest on the principal
amount of ten percent (<span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOn32w44HPPa" title="Interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
per annum which shall be due and payable on <span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNPwmNUxeaW8" title="Maturity date">December
19, 2024</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. In the event of a failure to
re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase to the lesser of twenty-two percent (<span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zSWDZaP1ycbf" title="Interest rate">22</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
such an event of default, Alumni shall have the right to convert all or any part of the outstanding and unpaid principal, interest, penalties,
and all other amounts under the Alumni Note into fully paid and non-assessable shares of the <span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkdkhRbxlD4" title="Debt instrument description">Company&#8217;s
common stock at a conversion price of eighty percent (80%) of the lowest traded price of the common stock during the twenty (20) business
days prior to Alumni&#8217;s delivery of a notice of conversion (the &#8220;Conversion Price&#8217;), subject to adjustment in the event
the Company is no longer DWAC eligible, is subject to a DTC &#8220;chill&#8221; and/or the Company ceases to be a reporting issuer. Notwithstanding
the foregoing, conversions will be subject to limitation whereby such conversion would result in beneficial ownership by Alumni and its
affiliates of more than 9.99% of the outstanding shares of Company&#8217;s common stock (the &#8220;Beneficial Ownership Limitation&#8221;)
or would exceed 19.99% of the Company&#8217;s outstanding common stock</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
of September 19, 2024 (the &#8220;Exchange Cap&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued Warrants to purchase <span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJe9Oftka641" title="Warrants to purchase of common stock">96,774
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of common
stock at a price per share of $<span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCKyZnJ6fITe" title="Exercise price per share">3.10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Warrants are exercisable on or prior to the five
(<span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztAeVUu8jls6" title="Warrants exercise term">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">)
year anniversary of the date of issuance.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 19, 2024, the Company also entered into a Common Stock Securities Purchase Agreement (the &#8220;Common Stock SPA&#8221;) with
Alumni Capital. Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Alumni Capital to purchase
up to $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zVmxjK8NY4p6" title="Number of purchase of shares">10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock (the &#8220;Commitment
Amount&#8221;) at the Purchase Price (defined below) during the period beginning on the execution date of the Common Stock SPA and ending
on the earlier of (i) the date on which Alumni Capital has purchased $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxwKLMfSVCL1" title="Number of purchase of shares">10
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million shares of common stock pursuant
to the Common Stock SPA or (ii) December 31, 2025. <span id="xdx_90B_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GRZ4Rowijb" style="background-color: white" title="Sale of stock description">Pursuant
to the Common Stock SPA, the &#8220;Purchase Price&#8221; means the lowest traded price of Company common stock during the five (5) business
days prior a closing date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration
statement and no Purchase Notice will be in an amount greater than $500,000.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
consideration for Alumni Capital&#8217;s execution and delivery of, and performance under, the Common Stock SPA, the Company (i) issued
and delivered <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zz2mdgfPrNMg" title="Number of shares issued">32,786
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of Company
common stock to Alumni Capital on September 19, 2024, and (ii) within one (1) business day from the date off effectiveness of the S-1
Registration Statement registering shares issuable pursuant to the Common Stock SPA, the Company shall cause its transfer agent to issue
and deliver as DWAC or DRS shares to Alumni Capital that number of shares of common stock equal to two percent (2.00%) of the Commitment
Amount divided by the VWAP for the Company&#8217;s common stock for the business day prior to the notice of effectiveness.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>October
2024 Preferred Stock Sale</i></span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zH6sqARaCE8g" title="Sale of stock, shares">66,225
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Convertible Preferred
Stock at $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ze5wQJnyIt7b" title="Sale of stock, shares price">3.02
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share, for total consideration of
$<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6HTDv7wnkwk" title="Sale of stock proceeds">200,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p>




<span></span>
</td>
<td class="text"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zFiz1sHsZGB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
20 &#8211; <span id="xdx_82F_z1BjGDx7xlv4">Subsequent Events</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 8, 2024, the Company held a Special Meeting of Stockholders in a virtual format. The following proposals, constituting all of the
proposals, were voted on by stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 1: </b>The Company&#8217;s stockholders approved an amendment to the Current Articles of Incorporation to change the Company&#8217;s
    corporate name to &#8220;NextTrip, Inc.&#8221; </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 2:</b> The Company&#8217;s stockholders approved an amendment to the Current Articles to increase the number of shares of Company
    common stock authorized for issuance thereunder from <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20240307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB77jDUYEfY" title="Common stock, shares authorized">1,200,000</span> shares to <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240308__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7SuTkZwWo79" title="Common stock, shares authorized">250,000,000</span> shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal
    No. 3:</b> The Company&#8217;s stockholders approved the adjournment of the Special Meeting by the chairman thereof to a later date
    to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are
    not sufficient votes to approve either of the foregoing proposals.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
Proposal No. 3 was approved by the Company&#8217;s stockholders, the chairman of the Special Meeting did not elect to adjourn the meeting,
as both of the other two proposals were also approved.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 11, 2024, Sigma Additive Solutions, Inc. (the &#8220;Company&#8221;) filed a Certificate of Amendment to its Amended and Restated
Articles of Incorporation (the &#8220;Charter Amendment&#8221;), as amended to date (the &#8220;Current Articles&#8221;), with the Secretary
of State of the State of Nevada, pursuant to which (i) the Company&#8217;s corporate name was changed from Sigma Additive Solutions,
Inc. to &#8220;NextTrip, Inc.&#8221; (the &#8220;Name Change&#8221;), and (ii) the number of shares of Company common stock authorized
for issuance under the Current Articles was increased from <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20240310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztIWndeDhoC7" title="Common stock, shares authorized">1,200,000</span> shares to <span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20240311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTQ7uGmpz7Ul" title="Common stock, shares authorized">250,000,000</span> shares (the &#8220;Increase in Authorized).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Name Change, effective as of the open of the market on March 13, 2024, the Company&#8217;s common stock began trading
on the Nasdaq Capital Market under the new ticker symbol &#8220;NTRP&#8221; (the &#8220;Ticker Symbol Change&#8221;). The CUSIP of the
Company&#8217;s common stock remained unchanged.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 15, 2024, the Company&#8217;s Board of Directors approved the Company to enter into an unsecured promissory note for a line of
credit with Messrs. Monaco and Kerby, the Company&#8217;s Chairman of the Board of Directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zNQOLXIgAsfk" title="Principal amount">500,000</span>. Under the terms of the note, advances under the line of credit may be made at the Company&#8217;s
request until May 31, 2024. The note bears an annual interest rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zxrmgW74qKR3" title="Interest rate">7.5</span>% and matures on <span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20240315__20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zVbVfuKyUiB" title="Maturity date">February 28, 2025</span>, and may be prepaid by the
Company at any time prior to maturity without penalty. As of April 19, 2024, the full principal amount of the note had been advanced
to the Company and remains outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 25, 2024, the Company&#8217;s Board of Directors approved the Company to enter into a series of unsecured promissory notes
with certain related parties, including investors, directors, officers and employees, who shall individually provide funds for the
aggregate principal amount of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zg81RIUL8qU3" title="Principal amount">1,000,000</span>.
The notes bear an annual interest rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlLOyoRZ9K5" title="Interest rate">7.5</span>%
and shall mature <span id="xdx_909_eus-gaap--DebtInstrumentTerm_dc_c20240425__20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzuwFbgvkCFe" title="Debt instrument, term">one
year</span> from the date of each note&#8217;s execution, and may be prepaid by the Company at any time prior to maturity without
penalty. On August 14, 2024, the Board of Directors approved an increase in the aggregate principal amount of the unsecured
promissory notes to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3iq9JV8rSrh" title="Principal amount">2,000,000</span>.
As of August 31, 2024, $<span id="xdx_90A_eus-gaap--NotesPayable_iI_c20240831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxYGxDcGos9g" title="Outstanding payment">1,416,553</span>
had been advanced to the Company and remains outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 17, 2024, the Company received a notification letter (the &#8220;Initial Notice&#8221;) from the Listing Qualifications Department
of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) advising the Company that it was not in compliance with Nasdaq&#8217;s continued
listing requirements under Nasdaq Listing Rule 5250(c)(1) (the &#8220;Rule&#8221;) as a result of its failure to timely file its Annual
Report on Form 10-K for the fiscal year ended February 29, 2024 (the &#8220;Form 10-K&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 17, 2024, the Company received an additional notification letter (the &#8220;Additional Notice,&#8221; and together with the Initial
Notice, the &#8220;Notices&#8221;) from Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for
the quarter ended May 31, 2024 (the &#8220;Form 10-Q&#8221;), and because the Company remains delinquent in filing the Form 10-K, the
Company remains noncompliant with the Rule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
of the Notices have an immediate effect on the listing of the Company&#8217;s common stock on the Nasdaq Capital Market, and, therefore,
the Company&#8217;s listing remains fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notices require the Company to either file the delinquent Form 10-K and Form 10-Q with the Commission or submit a plan to regain compliance
with the Rule by August 16, 2024. If Nasdaq accepts the Company&#8217;s plan, then Nasdaq may grant an exception of up to 180 calendar
days from the Form 10-K&#8217;s due date, or until December 10, 2024, to regain compliance. If Nasdaq does not accept the Company&#8217;s
plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel under Nasdaq Listing Rule 5815.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 16, 2024, the Company submitted a plan to Nasdaq regain compliance with the Rule, including the steps the Company will take to
promptly file the Form 10-Q and regain compliance. The Company has requested an extension until September 30, 2024. There can be no assurance
that the Company will regain compliance with the Rule, secure an exception until September 30, 2024 to regain compliance, or maintain
compliance with other Nasdaq listing requirements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526576176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zifpSOSo4639" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_864_z4YEibwEO6hc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis
of Presentation</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The accompanying financial
statements have been prepared by the Company in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) in the
United States of America. The financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations
and cash flows at August 31, 2024 and 2023 and for the periods then ended have been made. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The Company suggests these
condensed financial statements be read in conjunction with the February 29, 2024 audited financial statements and notes thereto included
in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 4, 2024. The results
of operations for the period ended August 31, 2024 are not necessarily indicative of the operating results for the full year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zjJ4SkBSWIy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span><span>Basis
of Presentation and Principles of Consolidation</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zvT3CGhXthXf" style="display: none">Basis
of Presentation</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#8220;SEC&#8221;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) of the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
financial statements have been prepared on a consolidated basis with those of the Company&#8217;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Functional and presentation currency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYNgtlgrPaga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zvop3Yli0cV7">Functional
and presentation currency</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are presented in United States dollars (&#8220;USD&#8221;), which is the Company&#8217;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Accounting Estimates</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--UseOfEstimates_zgBfHCAwKx2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_867_zKlvO8tRqgS8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting
Estimates</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities,
the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates
that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents
granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<span></span>
</td>
<td class="text"><p id="xdx_844_eus-gaap--UseOfEstimates_zi8D4EThlaLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zECwVSN5l3dj">Use
of Estimates</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#8217;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#8217;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    assessment of the Company to continue as a going concern;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">The assessment of the allowance on the related party promissory note receivable;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of purchase price allocation;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    measurement and useful life of intangible assets and property and equipment</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Estimates of fair value of equity instruments;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recoverability
    of long lived assets</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Loss Per Share</a></td>
<td class="text"><p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zJwYcYLwKita" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_86B_zECKc0O4ONZ" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Loss
Per Share</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; The computation of loss
per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#8220;Earnings
Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options and preferred stock were excluded due to the anti-dilutive
effect they would have on the computation. At August 31, 2024 and 2023 the Company had the following common shares underlying these instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z0TGwOunwYed" style="display: none">Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">August 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">78,877</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">484,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">96,238</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">659,178</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2128">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A0_zl1be1T4GVai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B3_zJOeyE98NgVj" style="display: none">Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,533,519</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,160,763</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,521,145</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(2,256,134</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,688</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,376</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,544,207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,160,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,542,521</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,256,134</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,131</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,545,338</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,160,763</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,534,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,256,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8A8_zkRT0GjwF6Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 10, 2024, the Company determined that three of the four business milestones per the Share Exchange Agreement had been achieved.
As a result, <span id="xdx_900_ecustom--ContingentSharesIssuable_iI_c20240610_zO4JexHWcrO6" title="Contingent shares issuable">4,393,993</span> of the total contingent shares of <span id="xdx_90C_ecustom--ContingentShares_iI_c20240610_zv21vZEWMQOd" title="Contingent shares">5,843,993</span> became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable contingent shares:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zLOFrzikgY4j" style="display: none">Schedule
of Issuable Contingent Shares</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Business Milestones</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center">Contingent Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><p style="margin: 0"><i>Achieved</i></p>


</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Launch of leisure travel booking platform</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,450,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Launch of group travel booking platform</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of FlexPay technology</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,493,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,393,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><i>Not Achieved</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of travel agent platform</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total contingent shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,843,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AA_zoSl7kqh3My3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zm2k2w8JtlN5" style="display: none">Schedule
of Weighted Average Common Stock Shares Outstanding</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/>
    Number of Common Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj">1,388,641</span> common shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,359,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,319,146</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">4,393,993 issuable contingent shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,916,385</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,958,193</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<p id="xdx_8AE_z3vBGbGZscu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuable contingent shares are of the Company&#8217;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
loss per share was not presented, as the Company&#8217;s outstanding warrants, stock options and preferred stock common equivalent shares
for the periods presented would have had an anti-dilutive effect. At August 31, 2024, the Company had outstanding warrants to purchase
<span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMHCtVQDgIE8" title="Warrants outstanding to purchase common stock">484,063
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, stock options
exercisable for <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2MimFj4uJUa" title="Shares issuable upon exercisable of options">78,877
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8TCka5mm3qk" title="Number of shares converted">316
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series E Preferred Stock, which
could be converted into <span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zG35NXFRFZc9" title="Common stock issuable upon conversion">3,259
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, <span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zlIxo7WVjlSj" title="Number of shares converted">33,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series H Preferred Stock, convertible
into <span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpsaAcHrHdS2">33,000
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, and <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxcqulyETKN4" title="Number of shares converted">59,979
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Series I Preferred Stock, convertible
into <span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zFenO045MKba" title="Common stock issuable upon conversion">59,979
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock, resulting in a
potential total additional <span id="xdx_90E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbk2XzXNnf" title="Potentially dilutive securities">659,178
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of common stock outstanding in
the future. At August 31, 2023, the Company had <span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_do_c20230831__20230831_zA5fYSj15E4c" title="Potentially dilutive securities">no
</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding potentially dilutive securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znm0W8vScE4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zfCWQ5E57r05">Loss
Per Share</span> &#8211; </b>The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#8220;Earnings Per Share.&#8221; Shares underlying the Company&#8217;s outstanding warrants, options
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 29, 2024 and
February 28, 2023, the Company had the following common shares underlying these instruments:</span></p>

<p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_z8WLjXA0cLk5" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February 29 and 28,</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">486,165</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred Stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475,835</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,047,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p id="xdx_8AB_zFkqvzqgz067" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHcszlqY6qkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zrX1zFbuQVKb">Cash
and Cash Equivalents</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
consists of amounts denominated in US dollars. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were <span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_znz41uPYYRw1" title="Cash equivalents"><span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230228_zWUTqJt7Z4j" title="Cash equivalents">no</span></span> cash equivalents
as of February 29, 2024, or February 28, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidsPolicyTextBlock', window );">Prepaids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84E_ecustom--PrepaidsPolicyTextBlock_zP8hsNZqfpp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zNq5e7bygDi">Prepaids</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zcNsj0Pmudd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zpROZHUqB1aj">Accounts
Receivable</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#8217;s
best estimate of the amount of probable credit losses in its existing accounts receivable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade
accounts receivable balances as of February 29, 2024 and February 28, 2023, were $<span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_z7adHWduDhh4" title="Accounts receivable">34,092</span>, and $<span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_c20230228_zj00rlxIMbt7" title="Accounts receivable">0</span>, respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PromissoryNoteReceivablePolicyTextBlock', window );">Promissory Note Receivable</a></td>
<td class="text"><p id="xdx_841_ecustom--PromissoryNoteReceivablePolicyTextBlock_zmmDpMNdPObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_864_za2gVtlZF6M2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Promissory
Note Receivable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Promissory Note (the Note&#8221;) between NextTrip and NextPlay, the Note was due and payable in full on the earlier
of September 1, 2023 or the date the Company completed a financing of $<span id="xdx_909_eus-gaap--ConvertibleDebt_iI_pn6n6_c20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zZVrhW5ebi19" title="Convertible debt">10</span> million or more. No payments have been made by NextPlay, and
as such NextPlay is in default under the terms of the Note.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has entered into a non-binding Memorandum of Understanding (&#8220;MOU&#8221;) with NextPlay, whereby NextTrip has agreed to
forgive the entire amount due under the Note in exchange for NextTrip&#8217;s cancellation of the <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zixIQTEoeaWg" title="Number of shares issued">400,000</span>
Preferred Units of Group issued to them as described in Note 1. The Preferred Units are convertible into <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z8YGuYT6nNYa" title="Number of convertible shares issued">500,000</span>
NextTrip common shares, and NextTrip has a commitment from a third party to purchase such shares at a price of $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z39topvmdgid" title="Shares issue per shares">2.00</span>
per share. As a result, the since Company can realize a minimum of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zVMsH85qhCcc" title="Value of stock issued">1,000,000</span>
from the sale of the common shares, a valuation allowance of $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zgz5fuOcbhR4" title="Valuation allowance">1,567,665 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was
established as of February 29, 2024. The Company is in the process of negotiating a second offer to purchase the shares, and
therefore has not closed the transaction with NextPlay. The Company expects to close one of the transaction options before year-end.
During the three and six months ended August 31, 2024, and 2023, there was <span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_do_c20230301__20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zLiVFPSz3Dkg" title="Provision for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">bad
debt expense recorded related to the allowance account, and the allowance is unchanged as of August 31, 2024. As of August 31, 2023, <span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBkpsovmPgMi" title="Allowance for doubtful accounts">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allowance
for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_847_ecustom--PromissoryNoteReceivablePolicyTextBlock_zSMvO0PieUsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b><span id="xdx_864_zokZsbbIL4dd">Promissory Note Receivable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Receivables
from NextPlay under the promissory note as described in <b>NOTE 1 &#8211; Business Description and Going Concern</b> were $<span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBvEy3SmY4Dj" title="Accounts receivable">2,567,665</span>
and $<span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zbPdvDoogrB8" title="Accounts receivable">1,933,908</span> respectively. Management has determined that, since NextPlay is in default under the terms of the promissory note, collectability
of the entire related party receivable as of February 29, 2024 is uncertain, and has therefore established an allowance for doubtful
accounts of $<span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_ziXkWVEdo8g8" title="Allowance for doubtful accounts">1,567,665</span>. As of February 28, 2023, <span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z7sMx8ABAG27" title="Allowance for doubtful accounts">no</span> allowance for doubtful accounts was established.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWWo5BaTFOzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zpFrPVg4yYSa">Property
and Equipment</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition
and measurement</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items
of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Depreciation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#8217;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#8217;s property and equipment are as follows:</span></p>

<p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zmJtEukZpK03">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<p id="xdx_8A5_zniJYxbMVy04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1ThpQpoPZ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zZw8ET0O8Acd">Intangible
assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life">1</span>
    - <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life">0.5</span>
    - <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<p id="xdx_8A0_z9Q4puhFe4G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--InternalUseSoftwarePolicy_zwvkT5vMbYIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zl75EYJYMjS">Software
Development Costs</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#8220;<span style="text-decoration: underline">ASC 985-20-25</span>&#8221; Accounting for the Costs of Software to Be Sold, Leased,
or Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Impairment of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zvFWfDgI5X13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zZXLjEm7sf2a">Impairment
of Intangible Assets</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 350-30-65 &#8220;<span style="text-decoration: underline">Goodwill and Other Intangible Assets</span>&#8221;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
Significant underperformance compared to historical or projected future operating results.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Significant negative industry or economic trends.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zwKwrmEoAexe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zDAn9CatPkj2">Leases</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z64NtA2m0Nik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="xdx_860_z0TZFiK14hfe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassification</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zazYsWsiYD9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zi4sOZJnCCHi">Reclassification</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztnZGNMpNbla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zgQEEVdQUtyc">Fair
Value of Financial Instruments</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#8217;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of the Company&#8217;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketRiskBenefitPolicyTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--MarketRiskBenefitPolicyTextBlock_ztZNTINE94t6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zDSoyoXIgVT3">Concentration
of Credit Risk</span> -</b> The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zDu3emIxc3X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zPNXd2HD4tXl">Stock
Based Compensation</span></b> &#8211; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#8220;Compensation &#8211;
Stock Compensation.&#8221; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ze7a5NslSCBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_861_z1OgHMDoOhzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue
Recognition </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8211; </span></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (&#8220;ASU&#8221;) No. 2014-09, <i>Revenue from Contracts with Customers</i>. ASU 2014-09 is a comprehensive
revenue recognition standard that superseded nearly all existing revenue recognition guidance under prior U.S. GAAP and replaced it with
a principles-based approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon
the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to
be entitled in exchange for those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or
contracts, with our customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4)
allocating the transaction price to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance
obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<span></span>
</td>
<td class="text"><p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoUehf2CANRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zwZ4eZtFf9M">Revenue
Recognition</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes revenue in accordance with ASC Topic No. 606. In
May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, <i>Revenue from Contracts
with Customers</i>. ASU 2014-09 is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition
guidance under prior U.S. GAAP and replaced it with a principles-based approach for determining revenue recognition. The core principle
of the standard is the recognition of revenue upon the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. In general, we determine revenue
recognition by: (1) identifying the contract, or contracts, with our customer; (2) identifying the performance obligations in the contract;
(3) determining the transaction price; (4) allocating the transaction price to performance obligations in the contract; and (5) recognizing
revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company is primarily responsible for fulling the promise to provide such travel product.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company has discretion in establishing the price for the specified travel product.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#8217;s refund privileges lapse).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_z1eTiudxu4T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zOLzEHL5GHJ7">Sales
and Marketing</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and administration expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 29, 2024, and February 28, 2023 was $<span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_zv5DkjtVHw6b" title="Sales and marketing expense">484,250</span> and $<span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20220301__20230228_zj2522yghbJ6" title="Sales and marketing expense">707,137</span>,
respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zhxOkI2P3rRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zQm8MXm4rQE8">Income
Taxes</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#8220;Accounting for Income Taxes.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has no tax positions at February 29, 2024 and 2023 for which the ultimate deductibility is highly uncertain but for which there
is uncertainty about the timing of such deductibility.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During
the years ended February 29, 2024 and February 28, 2023, the Company recognized no interest and penalties. All tax years starting with
2019 are open for examination.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently adopted accounting pronouncements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNkTwcecrh59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zU9TY6EvEIne">Recently
adopted accounting pronouncements</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU 2020-06, Debt&#8212;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;
Contracts in Entity&#8217;s Own Equity (Subtopic 815-40). The FASB issued this ASU to address issues identified as a result of the complexity
associated with GAAP for certain financial instruments with characteristics of liabilities and equity. Complexity associated with the
accounting is a significant contributing factor to numerous financial statement restatements and results in complexity for users attempting
to understand the results of applying the current guidance. In addressing the complexity, the FASB focused on amending the guidance on
convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#8217;s own equity. For convertible
instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock.
Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared
with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features
that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for
a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums
are recorded as paid-in capital. The FASB concluded that eliminating certain accounting models simplifies the accounting for convertible
instruments, reduces complexity for preparers and practitioners, and improves the decision usefulness and relevance of the information
provided to financial statement users. In addition to eliminating certain accounting models, the FASB also decided to enhance information
transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance on
the basis of feedback from financial statement users. The FASB decided to amend the guidance for the derivatives scope exception for
contracts in an entity&#8217;s own equity to reduce form-over-substance-based accounting conclusions. The FASB observed that the application
of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically
similar contracts as equity. The FASB also decided to improve and amend the related EPS guidance. The amendments in this ASU are effective
for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified
that an entity should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the
guidance through either a modified retrospective method of transition or a fully retrospective method of transition. The Company adopted
ASU 2020-06 on March 1, 2022 on a prospective basis. The adoption of this standard did not have an impact on the Company&#8217;s consolidated
financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#8212;Modifications and Extinguishments (Subtopic 470-50),
Compensation&#8212;Stock Compensation (Topic 718), and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic
815-40): Issuer&#8217;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU
2021-04 requires accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants)
that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The
recognition of the modification depends on the nature of the transaction in which the equity-classified written call option is modified.
If there is more than one element in a transaction (for example, if the modification involves both a debt modification and an equity
issuance), then the guidance requires allocating the effect of the option modification to each element. ASU 2021-04 is effective for
the Company beginning in the first quarter of 2022. ASU 2021-04 should be applied prospectively to modifications or exchanges occurring
on or after the effective date of the amendments. The Company adopted ASU 2021-04 on March 1, 2022 on a prospective basis. The adoption
of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2022, the FASB issued ASU 2022-02, ASC Subtopic 326 &#8220;Credit Losses&#8221;: Troubled Debt Restructurings and Vintage Disclosures.
Since the issuance of Accounting Standards Update No. 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments, the Board has provided resources to monitor and assist stakeholders with the implementation of
Topic 326. Post-Implementation Review (PIR) activities have included forming a Credit Losses Transition Resource Group, conducting outreach
with stakeholders of all types, developing educational materials and staff question-and-answer guidance, conducting educational workshops,
and performing an archival review of financial reports. ASU No. 2022-02 is effective for annual and interim periods beginning after December
15, 2022. The adoption of this standard did not have an impact on the Company&#8217;s consolidated financial statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PromissoryNoteReceivablePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Promissory Note Receivable [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PromissoryNoteReceivablePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketRiskBenefitPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-7C<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-7C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketRiskBenefitPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525560592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_z0TGwOunwYed" style="display: none">Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center">2024</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center">2023</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">August 31,</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">78,877</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2119">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">484,063</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Preferred Stock</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">96,238</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2125">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">659,178</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2128">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B9_z8WLjXA0cLk5" style="display: none">Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February 29 and 28,</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Warrants</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">486,165</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Stock Options</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">85,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred Stock</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">475,835</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Underlying Common Shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,047,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0631">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock', window );">Schedule of Estimated Useful Lives for Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span style="display: none"><span id="xdx_8BF_zmJtEukZpK03">Schedule
of Estimated
Useful Lives for Property and Equipment</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture
    &amp; Fixtures</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life">5</span>
    years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computer
    &amp; Equipment</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life">3</span>
    years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock', window );">Schedule of Estimated Useful Lives for Finite Life Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated useful lives for the Company&#8217;s finite life intangible assets are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none">Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Category</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Method</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    useful life</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life">1</span>
    - <span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life">3</span> years</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software
    licenses</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight
    line</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life">0.5</span>
    - <span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life">4</span> years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B3_zJOeyE98NgVj" style="display: none">Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,533,519</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,160,763</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,521,145</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(2,256,134</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,688</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,376</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,544,207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,160,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,542,521</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,256,134</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,131</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,545,338</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,160,763</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,534,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,256,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zushP6iSTtB3" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(6,656,837</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(5,033,496</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,663,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,033,496</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(675,314</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,339,276</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,033,496</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">228,274</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">71,581</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ScheduleOfIssuableContingentSharesTableTextBlock', window );">Schedule of Issuable Contingent Shares</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zLOFrzikgY4j" style="display: none">Schedule
of Issuable Contingent Shares</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Business Milestones</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center">Contingent Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt"><p style="margin: 0"><i>Achieved</i></p>


</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White">
    <td style="width: 80%; text-align: left">Launch of leisure travel booking platform</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right">1,450,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Launch of group travel booking platform</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,450,000</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of FlexPay technology</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,493,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Total contingent shares issuable on June 10, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">4,393,993</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><i>Not Achieved</i></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Launch of travel agent platform</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Total contingent shares potentially issuable in future periods</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,450,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total contingent shares</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,843,993</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Common Stock Shares Outstanding</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zm2k2w8JtlN5" style="display: none">Schedule
of Weighted Average Common Stock Shares Outstanding</span>&#160;</span></p>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Weighted Average <br/>
    Number of Common Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended <br/>
    August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%"><span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj">1,388,641</span> common shares outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,359,126</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right">1,319,146</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">4,393,993 issuable contingent shares</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">3,916,385</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,958,193</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Weighted average common shares outstanding</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>



<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Estimated Useful Lives for Property and Equipment [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ScheduleOfIssuableContingentSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Issuable Contingent Shares [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ScheduleOfIssuableContingentSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629903040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Schedule of Discontinued Operations</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zspOW6uJbF67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B6_zFJHwNhQ5ew8" style="display: none">Schedule
of Discontinued Operations</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zLmFzUI83NA" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zQJi1B0w3Wbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,006</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zLmAEEUy63K5" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0717">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zDE4WqxhGyXl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Gross Profit</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">5,006</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_maDGIDOzcGq_zvoNuuDeMlIk" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Salaries and benefits</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28,475</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_maDGIDOzcGq_zAzoLiABURl6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Retention bonuses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">528,930</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationSeverance_maDGIDOzcGq_zsLZdk5FYSb8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Severance</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">62,500</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_maDGIDOzcGq_zR0TkxyWbB7a" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Organization costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">63,600</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zf4wrCCLOaoh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Other income</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,185</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zcs3dGLy8rPi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Total Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">680,320</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zgDaX1rFDR5g" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Loss from Discontinued Operations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(675,314</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-11<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5D<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3A<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294634899216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zVCnlkJWw6vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
and other current assets consisted of the following as of February 29, 2024 and as of February 28, 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span><span id="xdx_8B5_zcDtWDvTfd0f" style="display: none">Schedule
of Prepaid and Other Current Assets</span></span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49E_20240229_zqPJ57abXlch" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230228_znNv015iUfVc" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zBvMxNj4q7s9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Prepaid marketing expenses</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">100</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zGnmmlyN62Xb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid other expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">298,274</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">8,513</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_zD3GV9zMebki" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Prepaid cost of sales</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">42,547</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0746">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_zgwEybw2ARma" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">340,921</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">8,613</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629884608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIh2ZEQDqJ0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8B2_zrxnKfDl0uy2" style="display: none">Schedule
of Property and Equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_znd8yztfslTk" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zhsm8QhKGPEj" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRQ2QskFsU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Furniture and Fixtures</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">17,018</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">17,018</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zB0mQgDjUIpl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Computer and Equipment</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">82,492</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">73,238</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zGz2ohFpxjeh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">99,510</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">90,256</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zoHK50A27lB" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated depreciation</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(92,868</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(74,030</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zVBz1Kt5yYd3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Property and Equipment, net of depreciation</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,642</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">16,226</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525445120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zr9WT6ZcWyUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of August 31, 2024, and February 29, 2024 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B9_zZLh7VI8bnnl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_492_20240831_zypz4PBWeJH9" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">August
                                            31,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20240229_zmq5bCFnM775" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">February
                                            29,</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">2024</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zK34HO26Stbf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">7,122,596</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">6,602,028</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zgjptkxM7z95" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zbrHfUCcbYyl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Trademark</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zzEbWzPCm2Jd" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,918,455</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,397,887</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zqtA7BLv8aWf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,607,528</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224,467</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_z0bG6nDEVe07" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,310,927</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,173,420</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zO1HTTvrUDY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible
assets as of February 29, 2024, and February 28, 2023 consisted of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zgo5YWMjDBfl" style="display: none">Schedule
of Intangible Assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240229_zrDVWbd38xfh" style="border-bottom: Black 1pt solid; text-align: center">February 29, <br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_499_20230228_zmKckj41Tnt5" style="border-bottom: Black 1pt solid; text-align: center">February 28, <br/> 2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zxBbl1Pim1Y" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Software Development</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">6,602,028</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">5,908,353</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zD40Mz2DEGui" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Software Licenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">789,576</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">467,576</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zMJpTXH2eG1c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Trademark</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,283</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zAy0at1JXwz3" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">7,397,887</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">6,382,212</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zayVjVpyCGAb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accumulated amortization</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(5,224,467</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(3,774,542</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zQUKwIYoULx1" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Intangible assets, net of amortization</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,173,420</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,607,670</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Aggregate Amortization Expense</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdOVf9nbV8e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense for years ending February 28 is as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8BB_zu3DsFSttSQ7" style="display: none">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%">
  <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_49E_20240831_zwls6gO7da3" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zrxfoGgoe2Cg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 80%">2025 (Remaining)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">200,232</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zyyape05oA41" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">313,329</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zZeSfWHXjPrh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">270,728</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zJ4mMxdyOqnj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,957</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zjQa3ZhpKh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Thereafter</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2261">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_z0Or0MvqVMNg" style="vertical-align: bottom; background-color: White">
    <td style="display: none; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">787,246</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>




<span></span>
</td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zU58TvfWVn3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The estimated aggregate amortization
expense for each of the succeeding years ending February 28 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BD_zsOopBpmQzkj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Estimated Aggregate Amortization Expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%">
  <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_497_20240229_zrlf0dRvuEok" style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zsH7hkik1xyc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2025 (Remaining)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zAXCR42xSU57" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">2025</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">660,578</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zxzDuRyyVaTi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2026</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">172,152</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zdfBL5UrbNAh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2027</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12,498</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zTfOo78Any02" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0818">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_zZD48rJHnVX" style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">845,228</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525343936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Value of Assets Acquired</a></td>
<td class="text"><p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zU0HpIBWcCgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BB_z0FBKE9xRo36" style="display: none">Schedule
of Fair Value of Assets Acquired</span></span></p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td>
    <td colspan="2" id="xdx_493_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zelEWS0SL4vi" style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="5" style="font-weight: bold; text-align: center">Fair Value of Net Assets Acquired:</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zRblBXCjObF3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%">Cash</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">417,121</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_zTUEQnFulc8h" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts Receivable, net</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4,900</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zswCb8QG6JF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">257,873</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zzOi4JPFnZhb" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Prepaid expenses and other current assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">50,802</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_zvXyQ7boHzP1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Property and equipment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">52,357</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_zXsuhXCfxOgf" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Intangible assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,277,919</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zxzxBl7aRk0b" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(837,450</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zsfUNLIaEDFj" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accrued expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(61,001</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zw77aao7ReK5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Deferred revenue</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(14,218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_zgrJKj8JaD1a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Total identifiable net assets acquired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,148,303</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z26jriaUM0Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Goodwill</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1,220,115</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zmwtgIElz11i" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fair Value of Net Assets Acquired</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,368,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Purchase Consideration</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zd0P6YPMG0Zj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">2,368,418</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Reconciliation of Goodwill</a></td>
<td class="text"><p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zg3u7Jy9ySTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
is a reconciliation of goodwill as of February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<span id="xdx_8BF_zvUpXkpYVqPb" style="display: none">Schedule
of Reconciliation of Goodwill</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_493_20230301__20240229_zKO6pqSRKh5k" style="border-bottom: Black 1pt solid; text-align: center">February 29,<br/> 2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_zJrrrh79dZXd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Reverse acquisition of Sigma Additive Solutions, Inc.</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,220,115</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--GoodwillPeriodIncreaseDecrease_zk91tNEAKvO" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Reduction from sale of assets to Divergent Technologies</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(52,310</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_404_eus-gaap--Goodwill_iE_zJxyuoFGa3Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Balance, February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,167,805</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629894464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNd78jYTjuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
tax assets are comprised of the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zYyFUyW4r6ha" style="display: none">Schedule of Deferred Tax Assets</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_49C_20240229_z1Oo3OS6nCDe" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_491_20230228_zzbE3PTwvBtj" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Deferred tax assets:</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">&#160;</td><td style="text-align: right; width: 16%">&#160;</td><td style="text-align: left; width: 1%">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z5v0R8PH3ck4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">NOL carryover</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,226,100</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,636,900</span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zxWcOEgFZtBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">173,900</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0909">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zDYqZkOxmHUi" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Payroll accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">77,800</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0912">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Deferred tax liabilities:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_zv220t6LFyH4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">1,772,500</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(61,000<span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"></span></p>

</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_z2ASyRQwcpvb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt; text-align: left">Valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(11,250,300</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p style="margin: 0">(8,575,900</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zXzFF6MQgqz6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset (liability)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0920">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0921">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Provision for Income Taxes</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zi0ZQcldxAfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zijvloCzLQ2e" style="display: none">Schedule
of Reconciliation of Provision for Income Taxes</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_498_20230301__20240229_z2YYUz1hkBFc" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" id="xdx_494_20220301__20230228_z1yWU06gOZti" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zGDEjhraeT47" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 60%">Book Loss</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,541,200</span></td><td style="text-align: left; width: 1%">)</td><td style="width: 2%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,837,400</span></td><td style="text-align: left; width: 1%">)</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zofUGS1KiVQ3" style="vertical-align: bottom; background-color: White">
    <td>Depreciation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270,100</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,700</span></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_z8XrZKhH0CU4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Meals &amp; Entertainment</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">300</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0936">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_zuvAhcfnaMjh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Preferred dividends</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">422,842</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0939">-</span></span></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zU40Yk60iqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Stock compensation</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">24,468</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">(48,548</p></td><td style="text-align: left">)</td></tr>
  <tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zB1uWN5sMOtd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Loss on asset disposal</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">67,274</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0945">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zYultU3MZX65" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accrued payroll</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">51,857</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0948">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zOREvUGNB4Nl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Related party accruals</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0">114,928</p></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><p style="margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl0951">-</span></p></td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_zvyOGfbriJjh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589,431</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,906,648</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zUNGfoM9NiCk" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Provision for Income Taxes</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0957">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532708000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zCSFN88TgWY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_z4z3kIBvCuj8" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229_zlqBKDyoFgY8" title="Dividend yield">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230301__20240229_z24o0jAfRhXi" title="Risk-free interest rate, minimum">0.19</span>-<span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230301__20240229_zXow7RiQAIG9" title="Risk-free interest rate, maximum">4.05</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229_zCWw7cqUHXWa" title="Expected volatility, minimum">100.2</span>
&#8211; <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229_zgJO7kFpKlt" title="Expected volatility, maximum">122.8</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229_zKwZJiTg4pi" title="Expected life">5</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKW0TltPBr2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B7_z6wRZwGPvSPb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedule
of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Options</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Options outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zVPwjygNRui8" style="text-align: right" title="Number of Options Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl2437">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z5MlF0ULIE13" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl2439">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229_zM1eCMBvpwz9" style="text-align: right" title="Aggregate Intrinsic Value Outstanding">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2441">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zZJryDheMkse" style="width: 12%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">86,642</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_ztL0xiqu3Gbf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">61.43</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zX8uathfpHMf" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition">2.68</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229_zV3sY59loAyc" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl2449">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="display: none; vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229_zxuUZk3vXkMe" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2451">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zFVFTvBvicCk" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2453">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_ztxqk2Xultm3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2455">-</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20230301__20240229_zjf9t1o51tZ2" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z4EScFQQHEN4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2459">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zB9EZyzFHrqc" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2461">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zUdaSndO13k7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(1,342</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z6ZP9fv9yAl4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">120.87</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zMgxWTWmT7A8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2467">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831_zqt32FAa0PV9" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_zVx7QiD91kd2" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z11gLOvNG9i3" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831_zKQSIjEOOO85" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2475">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831_z38Jy9bS1vq9" style="text-align: right" title="Number of Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2477">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zojvWxzLM2ej" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2479">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831_zhmGe9BizPr1" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2481">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20240301__20240831_z2bSGtIGzKig" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zXHfDQm7zppg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2485">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_z5FHicFbArmd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2487">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831_zrMMLLE2sR6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(6,423</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zUXxvWqBEVHd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">87.06</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_zl6TTOjgnMic" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2493">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831_z806xjANvI75" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance">78,877</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zrfE4T31Odd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">58.19</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831_zo18FHV6SF37" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.03</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831_zcNuu8x7ZMs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831_zd2OsdGTetib" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">1,432</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_z54MtrYKDiF4" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">32.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zfmcGnKHb1Dc" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">3.10</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zE35RunqK301" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">Options exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831_zNfwjMbeqLA2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable">77,445</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zfGivz01ummg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">58.67</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zJnYi6P8Uar" title="Weighted Average Remaining Contractual Life Years, Exercisable">2.01</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831_zavGZEQo7pL5" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2517">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831_zgTgTrY381M6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">78,877</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20240831_z7zw842XH15c" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">58.19</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zd3tHOuZQX3c" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.03</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zzsR3sAGtJf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zvt35IMaoIba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BC_zv8wFumeSark" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Options</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zL5oyH2qQuw" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1185">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z8EFvLeepenc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">Options assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zaB5PLhfK0Ph" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">86,642</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zz1jKHvhOtGl" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">61.43</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zWl06Az60yuj" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition">2.68</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_zvEB5RHJsxR" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1195">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20230301__20240229_zJfFwargF1u5" style="text-align: right" title="Number of Options, Exercised">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zY9C4qfMfa8f" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1199">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zsYzXXft9K14" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1201">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zZ2EpPMLJcUk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled">(1,342</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zD2IrqUFHol7" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">120.87</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zzjupgviHw64" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1207">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Options outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229_z7B8b01yMc1l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance">85,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zCHV3vEAkOWb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance">60.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_zZ6ysKBr6t61" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance">2.52</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229_zgYMEo2TQSI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"><span style="-sec-ix-hidden: xdx2ixbrl1215">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229_zl7BChXnnYmf" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance">3,451</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_z5BTVBA85kH3" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">33.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zSt28PDX2av4" title="Weighted Average Remaining Contractual Life Years, Expected to Vest">3.54</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_zQoDu2MU2Eak" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"><span style="-sec-ix-hidden: xdx2ixbrl1223">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">Options exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229_zRnyakrA8o0k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable">81,849</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zjOzwRU1Mwb3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">61.64</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zbWURQG1Spfk" title="Weighted Average Remaining Contractual Life Years, Exercisable">2.48</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229_zztpefCeawxe" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Options vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20220301__20240229_zXolw9eI5SH5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance">85,300</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230301__20240229_zWzXYpZ4o3sg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">60.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zrVYE3TZ1ugd" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.52</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_ztzN5ewEdRwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl1239">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warranty Activity</a></td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsMJkrYQxTV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8B8_zkQxt8HKhodd" style="display: none">Schedule
of Warranty Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Warrants</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Life
                                            (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Warrants outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zzdUFYwYF1ye" style="text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2627">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z0I419FYMyw9" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2629">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 52%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_z9wrCuPcqxZg" style="width: 12%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition">217,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zjLCAK5GQZT" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">21.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_z0uKOTHVIUK4" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition">1.86</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zc6yCmU31tXd" style="text-align: right" title="Warrants, Granted">268,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zPc4aM2bHHid" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">3.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_ziCGPYjosccd" title="Weighted Average Remaining Contractual Life (Yrs.), Granted">2.17</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zOAcIfbmOxG5" style="text-align: right" title="Warrants,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2643">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zacem4gPZU6i" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2645">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zvH05pJxGWC7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2647">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zoqzvZ20UDE6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2649">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20240831_znYtPvJuDObh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Outstanding, Beginning Balance">486,165</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_z4nT0Ip458oh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">9.94</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zYZsstFAZGT" title="Weighted Average Remaining Contractual Life Years">1.96</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20240831_zw31jFWOnvZf" style="text-align: right" title="Warrants, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2657">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zbFVB8r8IXP5" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2659">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20240831_zfFZ1vKAMVMj" style="text-align: right" title="Warrants, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2661">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zlnZRkH0jAAj" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2663">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20240831_zRm1dGQc7Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled">(2,102</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20240831_zmIPPL4nLMp1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">322.00</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20240831_z5Q7qWwJNiv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">484,063</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zivlj0TsIhH9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">8.58</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20240831_z5XvcGsAF1P3" title="Weighted Average Remaining Contractual Life (Yrs.) Outstanding">1.46</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAn9vYBnJnsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B9_zUiVstpbRCj6" style="display: none">Schedule of Warranty Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p></td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zR5hqo54MQY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl1349">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_zrZt9l6sCFPa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl1351">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; text-align: left">Warrants assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zimhzZ6B6gu4" style="width: 14%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition">217,593</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zItCnLIOnlZk" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Assumed pursuant to reverse acquisition">21.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 14%; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zZRTn3tQrpq3" title="Weighted Average Remaining Contractual Life Years, Assumed pursuant to reverse acquisition">1.86</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zhNYRpssB0ll" style="text-align: right" title="Warrants, Granted">268,572</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z1odbqFbJVnf" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted">3.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zJqwOa61FR59" title="Weighted Average Remaining Contractual Life Years, Granted">2.17</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zC2dnuNAPTd1" style="text-align: right" title="Warrants,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1365">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zi59YJj7Maqj" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1367">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zVRAagQpbom3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1369">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zFBndNbq2Spk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1371">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Warrants outstanding at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230301__20240229_zx79BkwEf9Lh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance">486,165</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zcqN1mm6SkP1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">9.94</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zQae4W9B7KIe" title="Weighted Average Remaining Contractual Life Years, Ending Balance">1.96</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock', window );">Schedule of Stock Appreciation Rights Activity</a></td>
<td class="text"><p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zBcVO56mokq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"><span id="xdx_8B9_zMraIxzNLg1h" style="display: none">Schedule
of Stock Appreciation Rights Activity</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">SARs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
                                            Life (Yrs.)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Aggregate</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intrinsic</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Value
                                            ($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>SARs outstanding at February 28, 2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYkx0ZHYPWya" style="text-align: right" title="Options outstanding, Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2535">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zS7uyrbPFhi6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2537">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4qR70CF3XKh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl2539">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 36%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVjpZaEK5g25" style="width: 12%; text-align: right" title="Options, Assumed pursuant to reverse acquisition">40,390</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zX3ZSvxN0Vqc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">44.77</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFG7sAYamPr6" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition">2.99</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zvG4Xlkhks45" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl2547">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zEMmUaNNo3Mb" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2549">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7HkD0YU49Ok" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2551">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zu6LQ7opMcU" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2553">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zofD6jbSpdW7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2555">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ2nUc70M7K8" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2557">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPeBdtZFr9ql" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2559">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs outstanding at February 29, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zymMamZSGrmk" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Beginning Balance">40,390</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFjnfz7Fg6G5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance">44.77</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeAAGWZvi1b2" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance">2.99</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYromUSLtAK8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"><span style="-sec-ix-hidden: xdx2ixbrl2567">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>Granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRfhBr9C40X4" style="text-align: right" title="Options, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2569">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqeYMkayp6kb" style="text-align: right" title="Weighted Average Exercise Price, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2571">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zxkk6a0l7HL" style="text-align: right" title="Aggregate Intrinsic Value, Granted"><span style="-sec-ix-hidden: xdx2ixbrl2573">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPegzyktlkd7" style="text-align: right" title="Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2575">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMWjsximVtgk" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2577">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuXAJ4YstJha" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2579">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Forfeited or cancelled</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMsoQXUNk7c" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited or cancelled">(167</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znSNcasf1Sif" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled">37.40</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zdAtLr9NkBjb" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl2585">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3gqjAiT4wn" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending Balance">40,223</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zrEBS45lc8Z6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance">44.80</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zCN3wrZTwhAl" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance">2.49</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zmsTvyPH9nf5" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"><span style="-sec-ix-hidden: xdx2ixbrl2593">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of August 31, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMotYWXHOC8" style="text-align: right" title="Options, Expected to vest">5,645</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zV1S0hNdgNUf" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">29.37</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z1OFBeCyAIQ7" title="Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest">2.84</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuHLuAKzFJvk" style="text-align: right" title="Aggregate Intrinsic Value, Expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl2601">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt">SARs exercisable at August 31, 2024</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z44NDFqKYff9" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Exercisable">34,578</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlD6VVfHUeFg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable">47.31</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zhMjmnXKBe8d" title="Weighted Average Remaining Contractual Life (Yrs.), Exercisable">2.43</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwrrLyJVoobh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and SARs expected to vest at August 31, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ75WZfpdr1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest">40,223</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGDyBIu3c62g" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.80</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt; text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSvdfpAOI1s9" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest">2.49</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z48Q5wRTqJj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Vested, Exercisable and Options Expected to Vest"><span style="-sec-ix-hidden: xdx2ixbrl2617">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ztgRBeF7azpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assumptions:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B3_zxxYOHHfTTl" style="display: none">Schedule of Share Based Payments Award Stock Options Valuation Assumptions</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 80%; text-align: left">Dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zeMJPz4xb8c9" title="Dividend yield">0.00</span></td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zVQRqsNLQFdk" title="Risk-free interest rate, minimum">0.22</span>-<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z68qM2z7c3Ig" title="Risk-free interest rate, maximum">2.79</span></span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Expected volatility</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zUj9ZmcPkHD8" title="Expected volatility, minimum">108.7</span>-<span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zz7P4VAvaol8" title="Expected volatility, maximum">122.8</span>.0</span></td><td style="text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Expected life (in years)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zBoe9PbkKj6g" title="Expected life">5</span></td><td style="text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlXLys9C9ZSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SARs
activity for the year ended February 29, 2024 was as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8BE_zadJEwVq53t9" style="display: none">Schedule of Stock Option Activity</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Weighted Average</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Exercise</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Remaining</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Aggregate</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Price</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Contractual</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center">Intrinsic</td><td style="text-align: center; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">SARs</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Life (Yrs.)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Value ($)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding at February 28, 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zIMrjeHePj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"><span style="-sec-ix-hidden: xdx2ixbrl1271">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BWnETrCiK9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1273">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">-</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3uHP9IIpJ87" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance">&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="-sec-ix-hidden: xdx2ixbrl1275">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: left">SARs assumed pursuant to reverse acquisition</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zTMm3uDNFvv7" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition">40,390</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ziXzJa6obGb5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition">44.77</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYJdEJuxiedl" title="Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition">2.99</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5b1ZtwhFD19" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"><span style="-sec-ix-hidden: xdx2ixbrl1283">-</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsBzFm61Ph3b" style="text-align: right" title="Number of Options, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1285">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zZ0UbNEnJHid" style="text-align: right" title="Weighted Average Exercise Price, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1287">-</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3Bd1iutlFWd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1289">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Forfeited or cancelled</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zylDxWQAfTI8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1291">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zU4OglGs21U6" title="Weighted Average Exercise Price, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1293">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zinJJy9TCc43" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"><span style="-sec-ix-hidden: xdx2ixbrl1295">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt">SARs outstanding February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9wmQesIStRd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance">40,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zyDj4FH9HK81" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance">44.77</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVcT60xoQFz2" title="Weighted Average Remaining Contractual Life, Outstanding Balance">2.99</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BSIEor05T7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"><span style="-sec-ix-hidden: xdx2ixbrl1303">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">SARs expected to vest in the future as of February 29, 2024</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zLTUmsNO1Yt1" style="text-align: right" title="Number of Options, Expected to vest in the future, Balance">6,886</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zzRQbOq9DgRh" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest">35.25</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeCcVa7Qq63a" title="Weighted Average Remaining Contractual Life, Expected to Vest">3.23</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmrqn5p3GF3" style="text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1.5pt">SARs exercisable at February 29, 2024</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><p id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zG4hQA0mO2t1" style="margin-top: 0; margin-bottom: 0" title="Number of Options, Exercisable">33,504</p></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqob0xu8E512" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Exercisable">46.72</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlhYOyZZ3Ts1" title="Weighted Average Remaining Contractual Life, Exercisable">2.93</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znL79OeYO0Ah" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1319">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">SARs vested, exercisable, and options expected to vest at February 29, 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHitT1NzTBG" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance">40,390</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr7jfmrcrhlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest">44.77</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zXmPLCf4Myf2" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest">2.99</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9EPt7KsGdW1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"><span style="-sec-ix-hidden: xdx2ixbrl1327">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525517472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;<span id="xdx_8B3_zJOeyE98NgVj" style="display: none">Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Three Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Six Months
                                            Ended</p>
                                                                               <p style="margin-top: 0; margin-bottom: 0">August 31,</p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2023</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td><td>&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,533,519</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(1,160,763</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(3,521,145</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">(2,256,134</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Preferred dividends</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(10,688</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2138">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(21,376</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2140">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,544,207</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(1,160,763</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,542,521</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2,256,134</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Gain (loss) from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,131</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2148">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,778</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2150">-</span></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,545,338</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,160,763</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(3,534,743</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">(2,256,134</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,275,511</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">3,277,339</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">83,371</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text"><p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><span id="xdx_8B1_zushP6iSTtB3" style="display: none">Schedule of Earnings Per Share, Basic and Diluted</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <tr style="display: none; vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">Year Ended February</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: bottom; text-align: center">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2024</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">2023</td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom">&#160;</td></tr>
  <tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: left">Loss from continuing operations</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(6,656,837</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">(5,033,496</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Preferred dividends</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(7,125</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Loss from continuing operations applicable to common stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(6,663,962</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5,033,496</td><td style="text-align: left">)</td></tr>
  <tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1.5pt">Loss from discontinued operations applicable to common stockholders</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(675,314</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1393">-</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
  <tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Net loss applicable to common stockholders</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(7,339,276</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(5,033,496</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">228,274</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; text-align: right">71,581</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532429968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Description and Going Concern (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Jan. 25, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,295,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 24,151,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,811,863<span></span>
</td>
<td class="nump">$ 27,685,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_WorkingCapitalDeficit', window );">Working capital deficit</a></td>
<td class="nump">$ 262,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,310,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentSharesIssuable', window );">Contingent shares issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LaunchOfTravelAgentPlatformShares', window );">Contigent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember', window );">Next Innovation LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member] | Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Share price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member] | Share Exchange Agreement [Member] | Membership Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member] | Share Exchange Agreement [Member] | Preferred Units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,295,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Capital', window );">Contributed capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross', window );">Number of additional restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock', window );">Percentage for issued and outstanding capital stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Closing Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember', window );">NextTrip Holdings, Inc. [Member] | Share Exchange Agreement [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Restricted shares issuable in reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent shares issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LaunchOfTravelAgentPlatformShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Launch of travel agent platform shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LaunchOfTravelAgentPlatformShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PercentageForIssuedAndOutstandingCapitalStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage for issued and outstanding, capital stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PercentageForIssuedAndOutstandingCapitalStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Capital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of total capital as defined by regulatory framework.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477270/942-505-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Capital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=NTRP_NextInnovationLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ShareExchangeAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_MembershipUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_MembershipUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_PreferredUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_PreferredUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_ClosingSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_ClosingSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294527159936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">659,178<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">486,165<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">96,238<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">475,835<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525450336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Estimated Useful Lives for Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525471232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember', window );">Software [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember', window );">Software [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember', window );">Software Licenses [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember', window );">Software Licenses [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294533003088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 01, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,092<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,347<span></span>
</td>
<td class="nump">$ 49,758<span></span>
</td>
<td class="nump">$ 207,536<span></span>
</td>
<td class="nump">$ 90,539<span></span>
</td>
<td class="nump">$ 484,250<span></span>
</td>
<td class="nump">$ 707,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentSharesIssuable', window );">Contingent shares issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentShares', window );">Contingent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares issuable upon exercisable of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,275,511<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="nump">3,277,339<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember', window );">Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember', window );">Series I Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issuable upon conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares issuable upon exercisable of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants outstanding to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">484,063<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">659,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,567,665<span></span>
</td>
<td class="nump">$ 1,933,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Number of convertible shares issued</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issue per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Value of stock issued</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent shares issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629968624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Discontinued Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits', window );">Salaries and benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses', window );">Retention bonuses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">528,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance', window );">Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts', window );">Organization costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,185)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense', window );">Total Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">680,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from Discontinued Operations</a></td>
<td class="num">$ (1,131)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 7,778<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (675,314)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Retention bonuses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Salaries and benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal group including discontinued operations other income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294533714640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Discontinued Operations (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Oct. 06, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Asset disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,718)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss of discontinued operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,131<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (7,778)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 675,314<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember', window );">Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_EarnestMoneyDeposit', window );">Earnest money deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Asset disposition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_EarnestMoneyDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnest-money deposit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_EarnestMoneyDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477349/740-270-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532704864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract', window );"><strong>Prepaid And Other Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidAdvertising', window );">Prepaid marketing expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,274<span></span>
</td>
<td class="nump">8,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_PrepaidCostOfSales', window );">Prepaid cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,547<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 244,870<span></span>
</td>
<td class="nump">$ 340,921<span></span>
</td>
<td class="nump">$ 8,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_PrepaidCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid cost of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_PrepaidCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidAdvertising">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidAdvertising</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525325216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 25, 2023 </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_PrincipalExecutiveOfficesMember', window );">Principal Executive Offices [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for rent</a></td>
<td class="nump">$ 1,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_PrincipalExecutiveOfficesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_PrincipalExecutiveOfficesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526288512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,510<span></span>
</td>
<td class="nump">$ 90,256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92,868)<span></span>
</td>
<td class="num">(74,030)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, net of depreciation</a></td>
<td class="nump">$ 6,703<span></span>
</td>
<td class="nump">6,642<span></span>
</td>
<td class="nump">16,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Fixtures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,018<span></span>
</td>
<td class="nump">17,018<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,492<span></span>
</td>
<td class="nump">$ 73,238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532906272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 18,838<span></span>
</td>
<td class="nump">$ 30,386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">$ 9,253<span></span>
</td>
<td class="nump">$ 2,928<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526694848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">$ 7,918,455<span></span>
</td>
<td class="nump">$ 7,397,887<span></span>
</td>
<td class="nump">$ 6,382,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(5,607,528)<span></span>
</td>
<td class="num">(5,224,467)<span></span>
</td>
<td class="num">(3,774,542)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of amortization</a></td>
<td class="nump">2,310,927<span></span>
</td>
<td class="nump">2,173,420<span></span>
</td>
<td class="nump">2,607,670<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">7,122,596<span></span>
</td>
<td class="nump">6,602,028<span></span>
</td>
<td class="nump">5,908,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember', window );">Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">789,576<span></span>
</td>
<td class="nump">467,576<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">6,283<span></span>
</td>
<td class="nump">6,283<span></span>
</td>
<td class="nump">$ 6,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember', window );">Software Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Total</a></td>
<td class="nump">$ 789,576<span></span>
</td>
<td class="nump">$ 789,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=NTRP_SoftwareLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526901776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Estimated Aggregate Amortization Expense (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2025 (Remaining)</a></td>
<td class="nump">$ 200,232<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2026</a></td>
<td class="nump">313,329<span></span>
</td>
<td class="nump">$ 660,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2027</a></td>
<td class="nump">270,728<span></span>
</td>
<td class="nump">172,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2028</a></td>
<td class="nump">2,957<span></span>
</td>
<td class="nump">12,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 787,246<span></span>
</td>
<td class="nump">$ 845,228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite lived intangible assets amortization expense after year three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532662512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 383,061<span></span>
</td>
<td class="nump">$ 657,389<span></span>
</td>
<td class="nump">$ 1,449,925<span></span>
</td>
<td class="nump">$ 676,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526490848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Fair Value of Assets Acquired (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember', window );">Sigma Additive Solutions Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="nump">$ 417,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts Receivable, net</a></td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">257,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">50,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">52,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">1,277,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(837,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses', window );">Accrued expenses</a></td>
<td class="num">(61,001)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(14,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total identifiable net assets acquired</a></td>
<td class="nump">1,148,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,220,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total Fair Value of Net Assets Acquired</a></td>
<td class="nump">2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629450224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Goodwill (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Feb. 29, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Reverse acquisition of Sigma Additive Solutions, Inc.</a></td>
<td class="nump">$ 1,220,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Reduction from sale of assets to Divergent Technologies</a></td>
<td class="num">(52,310)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance, February 29, 2024</a></td>
<td class="nump">$ 1,167,805<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294528901520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 12, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">780,423<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (52,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Gain on disposition transaction</a></td>
<td class="nump">$ 37,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember', window );">Divergent Technologies, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase price</a></td>
<td class="nump">$ 1,626,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares outstanding</a></td>
<td class="nump">3,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember', window );">Sigma Additive Solutions Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="nump">$ 2,368,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Share price</a></td>
<td class="nump">$ 3.0229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="nump">$ 52,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">1,220,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase consideration</a></td>
<td class="nump">742,176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Goodwill</a></td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,167,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_DivergentTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_SigmaAdditiveSolutionsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526659856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="nump">$ 531,847<span></span>
</td>
<td class="nump">$ 519,136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued expenses</a></td>
<td class="nump">$ 460,768<span></span>
</td>
<td class="nump">$ 329,922<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294639905312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Deferred Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">NOL carryover</a></td>
<td class="nump">$ 9,226,100<span></span>
</td>
<td class="nump">$ 8,636,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxAssetDepreciation', window );">Related party accruals</a></td>
<td class="nump">173,900<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxAssetsPayrollAccruals', window );">Payroll accruals</a></td>
<td class="nump">77,800<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DeferredTaxLiabilitiesDepreciation', window );">Depreciation</a></td>
<td class="nump">1,772,500<span></span>
</td>
<td class="num">(61,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(11,250,300)<span></span>
</td>
<td class="num">(8,575,900)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax asset (liability)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxAssetDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax asset depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxAssetDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxAssetsPayrollAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets payroll accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxAssetsPayrollAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DeferredTaxLiabilitiesDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DeferredTaxLiabilitiesDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532630560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Reconciliation of Provision for Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_EffectiveIncomeTaxRateReconciliationBookLoss', window );">Book Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,541,200)<span></span>
</td>
<td class="num">$ (1,837,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation', window );">Depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,100<span></span>
</td>
<td class="num">(20,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Meals &amp; Entertainment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends', window );">Preferred dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">422,842<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,468<span></span>
</td>
<td class="num">(48,548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal', window );">Loss on asset disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,274<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll', window );">Accrued payroll</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,857<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals', window );">Related party accruals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,928<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">589,431<span></span>
</td>
<td class="nump">1,906,648<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_EffectiveIncomeTaxRateReconciliationBookLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation book loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_EffectiveIncomeTaxRateReconciliationBookLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense accrued payroll.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense loss on asset disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense preferred dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense related party accruals.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525547744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 43,934,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,820,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_OperatingLossCarryforwardsRemainder', window );">Operating loss carryforwards remainder</a></td>
<td class="nump">34,114,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance loss carryforwards</a></td>
<td class="nump">$ 11,250,300<span></span>
</td>
<td class="nump">$ 8,575,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal statutory tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_OperatingLossCarryforwardsRemainder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards remainder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_OperatingLossCarryforwardsRemainder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294533047760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Jun. 09, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 21, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,269,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 735,057<span></span>
</td>
<td class="nump">$ 3,233,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 234,213<span></span>
</td>
<td class="nump">$ 72,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,978,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember', window );">Debt Assignment and Conversion Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember', window );">Special Purpose Acquisition Corporation [Member] | Several Investors [Member] | Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,012,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_DebtAssignmentAndConversionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_SpecialPurposeAcquisitionCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_SeveralInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_SeveralInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294533626064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Purchase Agreements (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Dec. 28, 2023</div></th>
<th class="th"><div>Sep. 19, 2022</div></th>
<th class="th"><div>Nov. 06, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible shares</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,269,852<span></span>
</td>
<td class="nump">$ 735,057<span></span>
</td>
<td class="nump">$ 3,233,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember', window );">Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,978,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember', window );">Third Party Consultant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember', window );">Third Party Consultant [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">579,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember', window );">Share Purchase Agreements [Member] | Several Investors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,755,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Conversion share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ProceedsFromDownpaymentForContract', window );">Proceeds from downpayment for contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion share price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember', window );">Software as a Service Agreement [Member] | Third Party [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ConsultingFees', window );">Consulting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember', window );">Consulting Modification Agreement [Member] | Third Party Consultant [Member] | Contingent Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible notes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consulting fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ProceedsFromDownpaymentForContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from down-payment for contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ProceedsFromDownpaymentForContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=NTRP_ContingentSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_ThirdPartyConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SharePurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_SeveralInvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_SeveralInvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SoftwareAsAServiceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_ConsultingModificationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532327728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Mar. 18, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Aug. 14, 2024</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>May 21, 2024</div></th>
<th class="th"><div>Apr. 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on related party receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,092<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember', window );">Board Of Directors And Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_InvestorsDirectorsOfficersAndEmployeesMember', window );">Investors Directors Officers And Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 1,411,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=NTRP_DonaldMonacoMember', window );">Donald Monaco [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 455,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Annual interest rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">Feb. 28,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="nump">$ 405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LossOnRelatedPartyReceivable', window );">Loss on related party receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,567,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Notes payable - related parties</a></td>
<td class="nump">$ 2,718,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828,277<span></span>
</td>
<td class="nump">281,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember', window );">NextPlay Technologies Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,567,665<span></span>
</td>
<td class="nump">1,933,908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,567,665<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LossOnRelatedPartyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss on related party receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LossOnRelatedPartyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_InvestorsDirectorsOfficersAndEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_InvestorsDirectorsOfficersAndEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_DonaldMonacoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_DonaldMonacoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_NextPlayTechnologiesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294527868096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Deferred Revenue (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DisclosureDeferredRevenueAbstract', window );"><strong>Deferred Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 138,067<span></span>
</td>
<td class="nump">$ 139,921<span></span>
</td>
<td class="nump">$ 22,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DisclosureDeferredRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DisclosureDeferredRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526652144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Feb. 29, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.19%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">4.05%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">100.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">122.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">0.22%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">2.79%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">108.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">122.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532487152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition', window );">Number of Options, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition', window );">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Options, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="num">(6,423)<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87.06<span></span>
</td>
<td class="nump">$ 120.87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life Years, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 days<span></span>
</td>
<td class="text">2 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to Vest in the Future Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,451<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
<td class="nump">3,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.25<span></span>
</td>
<td class="nump">$ 32.25<span></span>
</td>
<td class="nump">$ 33.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life Years, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">3 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Expected of Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.64<span></span>
</td>
<td class="nump">$ 58.67<span></span>
</td>
<td class="nump">$ 61.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life Years, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 days<span></span>
</td>
<td class="text">2 years 5 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Outstanding, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 days<span></span>
</td>
<td class="text">2 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue', window );">Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition', window );">Number of Options, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition', window );">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Number of Options, Forfeited or cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.40<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life Years, Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to Vest in the Future Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,886<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
<td class="nump">6,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
<td class="nump">$ 29.37<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life Years, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 2 days<span></span>
</td>
<td class="text">3 years 2 months 23 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Expected of Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
<td class="nump">34,578<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
<td class="nump">$ 47.31<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life Years, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 4 days<span></span>
</td>
<td class="text">2 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Outstanding, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue', window );">Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition intrinsic value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share based payment award options granted in period intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, options, granted, weighted average remaining contractual term .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by share based payment award options weighted average exercise price assumed pursuant to reverse acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangements by share based payment award options exercises in period weighted average forfeited or cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options grant in period weighted average remaining contractual term2.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294533714800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Warranty Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Outstanding, Beginning Balance</a></td>
<td class="nump">486,165<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning Balance</a></td>
<td class="nump">$ 9.94<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition', window );">Warrants, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">217,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Warrants, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">268,572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Warrants, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Warrants, Forfeited or cancelled</a></td>
<td class="num">(2,102)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="nump">$ 322.00<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Warrants Outstanding, Ending Balance</a></td>
<td class="nump">484,063<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending Balance</a></td>
<td class="nump">$ 8.58<span></span>
</td>
<td class="nump">$ 9.94<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life Years, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life (Yrs.), Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life (Yrs.) Outstanding</a></td>
<td class="text">1 year 5 months 15 days<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award non option equity instruments assumed pursuant to reverse acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangements by share based payment award non options assumed pursuant to reverse acquisition in period weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants forfeited or cancelled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price, warrants grants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award non options equity instruments assumed pursuant to reverse acquisition weighted average remaining contractual term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award non options equity instruments granted in period weighted average remaining contractual term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life (years), warrants outstanding, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294508456672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders&#8217; Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 15, 2024</div></th>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Dec. 28, 2023</div></th>
<th class="th"><div>Sep. 22, 2023</div></th>
<th class="th"><div>Sep. 22, 2023</div></th>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Dec. 29, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Mar. 08, 2024</div></th>
<th class="th"><div>Mar. 07, 2024</div></th>
<th class="th"><div>Feb. 22, 2024</div></th>
<th class="th"><div>Jan. 26, 2024</div></th>
<th class="th"><div>Jan. 04, 2024</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1-for-20 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits', window );">Reverse stock split issued common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,905,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,996<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Share based compensation arrangement by award options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="nump">77,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued or exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares forfeited or expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Allocation share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 30,235<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 116,512<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Weighted average remaining recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=NTRP_DooyaMediaGroupIncMember', window );">Dooya Media Group Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="nump">40,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="nump">34,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
<td class="nump">34,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,578<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares issued or exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Shares forfeited or expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Weighted average remaining recognition period</a></td>
<td class="nump">$ 943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 months 20 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,235<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Stock issued during Stock options exercised</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Weighted average remaining recognition period</a></td>
<td class="nump">$ 16,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average remaining recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember', window );">2013 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember', window );">2023 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock reserved for future issuance</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Common stock shares equity award issued or granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenPlanMember', window );">2013 Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Reverse acquisition shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember', window );">2020 Stock Appreciation Rights Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized share based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod', window );">Weighted average remaining recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember', window );">Series E Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePercentage', window );">Dividends percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsShares', window );">Issuance of common stock dividends, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Converted issuance of shares of common stock</a></td>
<td class="nump">3,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember', window );">Series F Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember', window );">Series G Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockRedemptionTerms', window );">Preferred stock redemption right, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with the
terms of the Perpetual License Agreement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Converted issuance of shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember', window );">Series H Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Converted issuance of shares of common stock</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleSharesIssuable', window );">Converted issuance of shares of common stock</a></td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="nump">24,834<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, shares price</a></td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted shares issued in acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage of issued and outstanding common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issuable for consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued in acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Third Party Consultant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued during period services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Debt Assignment and Conversion Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Shares issued in acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember', window );">Next Trip Holdings Inc [Member] | Share Purchase And Exchange Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Purchase of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued during period services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Number of shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">409,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Purchase of outstanding warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_DescriptionForWarrantExpiration', window );">Warrant description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">expire between March 15, 2024 and January 25, 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=NTRP_AtTheMarketIssuanceSalesAgreementMember', window );">At-The-Market Issuance Sales Agreement [Member] | Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,887<span></span>
</td>
<td class="nump">72,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 772,468<span></span>
</td>
<td class="nump">$ 364,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_DescriptionForWarrantExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description for warrant expiration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_DescriptionForWarrantExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining recognition period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock issued as dividends during the period. Excludes stock splits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion of preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage rate used to calculate dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockRedemptionTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockRedemptionTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in the number of shares during the period as a result of a reverse stock split.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=NTRP_DooyaMediaGroupIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=NTRP_DooyaMediaGroupIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandThirteenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesEConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesFConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesGConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesHConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=NTRP_NextTripHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=NTRP_ThirdPartyConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=NTRP_ThirdPartyConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_DebtAssignmentAndConversionAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_DebtAssignmentAndConversionAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_SharePurchaseAndExchangeAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueArrangementTypeAxis=NTRP_SharePurchaseAndExchangeAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=NTRP_AtTheMarketIssuanceSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=NTRP_AtTheMarketIssuanceSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294506246960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Aug. 31, 2024</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2023</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2024</div></th>
<th class="th" colspan="2"><div>Aug. 31, 2023</div></th>
<th class="th" colspan="2"><div>Feb. 29, 2024</div></th>
<th class="th" colspan="2"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="num">$ (1,533,519)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,521,145)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (6,656,837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="num">(10,688)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(21,376)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,125)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Loss from continuing operations applicable to common stockholders</a></td>
<td class="num">(1,544,207)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,542,521)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,663,962)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Loss from discontinued operations applicable to common stockholders</a></td>
<td class="num">(1,131)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,778<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(675,314)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss applicable to common stockholders</a></td>
<td class="num">$ (1,545,338)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1,160,763)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (3,534,743)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (7,339,276)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (5,033,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)</a></td>
<td class="nump">5,275,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,277,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">83,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">228,274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">71,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zF2Iyi2frhtk" title="Number of shares acquired">83,371</span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <span id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zej8vkWWnJQ4" title="Percentage for issued and outstanding capital stock">100</span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</span>.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294532520672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Share (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Oct. 12, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based compensation arrangement by share-based payment award, options, exercisable, number</a></td>
<td class="nump">77,445<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="nump">1,388,641<span></span>
</td>
<td class="nump">936,430<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="nump">780,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Potentially dilutive securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="nump">3,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,069<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember', window );">Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="nump">33,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember', window );">Series I Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="nump">59,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Share-based compensation arrangement by share-based payment award, options, exercisable, number</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series E Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series G Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series H Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member] | Series I Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Common stock issued conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">222,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesGPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629781520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentrations (Details Narrative) - Customer Concentration Risk [Member] - Customer [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration of risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=NTRP_CustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=NTRP_CustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294629893616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Plans (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans', window );">Contribution plan description</a></td>
<td class="text">the
Company makes either a Safe Harbor contribution match of 100% of each participant&#8217;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Cost of contribution</a></td>
<td class="nump">$ 17,112<span></span>
</td>
<td class="nump">$ 6,997<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of defined contribution pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294508274032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">659,178<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,047,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">78,877<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">486,165<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Share-Based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">484,063<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total Underlying Common Shares</a></td>
<td class="nump">96,238<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">475,835<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526490096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Loss from continuing operations</a></td>
<td class="num">$ (1,533,519)<span></span>
</td>
<td class="num">$ (1,160,763)<span></span>
</td>
<td class="num">$ (3,521,145)<span></span>
</td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="num">$ (6,656,837)<span></span>
</td>
<td class="num">$ (5,033,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendsIncomeStatementImpact', window );">Preferred dividends</a></td>
<td class="num">(10,688)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(21,376)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(7,125)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Loss from continuing operations applicable to common stockholders</a></td>
<td class="num">(1,544,207)<span></span>
</td>
<td class="num">(1,160,763)<span></span>
</td>
<td class="num">(3,542,521)<span></span>
</td>
<td class="num">(2,256,134)<span></span>
</td>
<td class="num">(6,663,962)<span></span>
</td>
<td class="num">(5,033,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity', window );">Gain (loss) from discontinued operations applicable to common stockholders</a></td>
<td class="num">(1,131)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,778<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(675,314)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss Applicable to Common Stockholders</a></td>
<td class="num">$ (1,545,338)<span></span>
</td>
<td class="num">$ (1,160,763)<span></span>
</td>
<td class="num">$ (3,534,743)<span></span>
</td>
<td class="num">$ (2,256,134)<span></span>
</td>
<td class="num">$ (7,339,276)<span></span>
</td>
<td class="num">$ (5,033,496)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average number of common shares outstanding used in loss per share during the period (denominator)</a></td>
<td class="nump">5,275,511<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="nump">3,277,339<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-5C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483475/205-20-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendsIncomeStatementImpact">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendsIncomeStatementImpact</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294525263696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of Issuable Contingent Shares (Details) - shares<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Jun. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LaunchOfLeisureTravelBookingPlatform', window );">Launch of leisure travel booking platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LaunchOfGroupTravelBookingPlatform', window );">Launch of group travel booking platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LaunchOfFlexpayTechnology', window );">Launch of FlexPay technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,493,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentSharesIssuable', window );">Total contingent shares issuable on June 10, 2024</a></td>
<td class="nump">4,393,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
<td class="nump">4,393,993<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_LaunchOfTravelAgentPlatformShares', window );">Launch of travel agent platform</a></td>
<td class="nump">1,450,000<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentlyIssuableShares', window );">Total contingent shares potentially issuable in future periods</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ContingentShares', window );">Total contingent shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
<td class="nump">5,843,993<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentSharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent shares issuable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentSharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingently issuable shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LaunchOfFlexpayTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Launch of flexpay technology</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LaunchOfFlexpayTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LaunchOfGroupTravelBookingPlatform">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Launch of group travel booking platform</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LaunchOfGroupTravelBookingPlatform</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LaunchOfLeisureTravelBookingPlatform">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Launch of leisure travel booking platform</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LaunchOfLeisureTravelBookingPlatform</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_LaunchOfTravelAgentPlatformShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Launch of travel agent platform shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_LaunchOfTravelAgentPlatformShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294526867152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Weighted Average Common Stock Shares Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_CommonStockShareOutstanding', window );">1,388,641 common shares outstanding</a></td>
<td class="nump">1,359,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,319,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Shares, Outstanding</a></td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,388,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_WeightedAverageIssuableContingentShares', window );">4,393,993 issuable contingent shares</a></td>
<td class="nump">3,916,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,958,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Weighted average common shares outstanding</a></td>
<td class="nump">5,275,511<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
<td class="nump">3,277,339<span></span>
</td>
<td class="nump">83,371<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_CommonStockShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock share outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_CommonStockShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_WeightedAverageIssuableContingentShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average issuable contingent shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_WeightedAverageIssuableContingentShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294507885104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2024</div></th>
<th class="th"><div>Sep. 19, 2024</div></th>
<th class="th"><div>Sep. 13, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 15, 2024</div></th>
<th class="th"><div>Apr. 25, 2024</div></th>
<th class="th"><div>Mar. 15, 2024</div></th>
<th class="th"><div>Oct. 11, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Sep. 18, 2024</div></th>
<th class="th"><div>Aug. 14, 2024</div></th>
<th class="th"><div>Jul. 11, 2024</div></th>
<th class="th"><div>May 24, 2024</div></th>
<th class="th"><div>Mar. 11, 2024</div></th>
<th class="th"><div>Mar. 10, 2024</div></th>
<th class="th"><div>Mar. 08, 2024</div></th>
<th class="th"><div>Mar. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 281,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,295,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember', window );">Series I Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember', window );">Securities Purchase Agreement [Member] | Series I Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,834<span></span>
</td>
<td class="nump">4,967<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, shares price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,802,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Outstanding payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,416,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,416,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Related party advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Conversion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_MinimumRequiredStockholdersEquity', window );">Stockholders equity minimum required</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt instrument description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Company&#8217;s
common stock at a conversion price of eighty percent (80%) of the lowest traded price of the common stock during the twenty (20) business
days prior to Alumni&#8217;s delivery of a notice of conversion (the &#8220;Conversion Price&#8217;), subject to adjustment in the event
the Company is no longer DWAC eligible, is subject to a DTC &#8220;chill&#8221; and/or the Company ceases to be a reporting issuer. Notwithstanding
the foregoing, conversions will be subject to limitation whereby such conversion would result in beneficial ownership by Alumni and its
affiliates of more than 9.99% of the outstanding shares of Company&#8217;s common stock (the &#8220;Beneficial Ownership Limitation&#8221;)
or would exceed 19.99% of the Company&#8217;s outstanding common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants exercise term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 19,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayableCurrent', window );">Total consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Net proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Original issue discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Sale of stock description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Pursuant
to the Common Stock SPA, the &#8220;Purchase Price&#8221; means the lowest traded price of Company common stock during the five (5) business
days prior a closing date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration
statement and no Purchase Notice will be in an amount greater than $500,000.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Series I Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, shares</a></td>
<td class="nump">66,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, shares price</a></td>
<td class="nump">$ 3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock proceeds</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of purchase of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Messrs Kerby And Monaco [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentRate', window );">Conversion percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Converted amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,666,790<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Unsecured Promissory Note [Member] | Messrs Monaco and Kerby [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 28,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Unsecured Promissory Note [Member] | Related Party [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_MinimumRequiredStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum required stockholders equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_MinimumRequiredStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=NTRP_SeriesIConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=NTRP_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=NTRP_MessrsKerbyAndMonacoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=NTRP_MessrsKerbyAndMonacoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=NTRP_UnsecuredPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=NTRP_UnsecuredPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_MessrsMonacoAndKerbyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=NTRP_MessrsMonacoAndKerbyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46294503748976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of Stock Appreciation Rights Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 29, 2023</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition', window );">Options, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition', window );">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 8 months 4 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue', window );">Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="num">(6,423)<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87.06<span></span>
</td>
<td class="nump">$ 120.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 days<span></span>
</td>
<td class="text">2 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to Vest in the Future Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,451<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
<td class="nump">3,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.25<span></span>
</td>
<td class="nump">$ 32.25<span></span>
</td>
<td class="nump">$ 33.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 1 month 6 days<span></span>
</td>
<td class="text">3 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Expected of Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
<td class="nump">77,445<span></span>
</td>
<td class="nump">81,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61.64<span></span>
</td>
<td class="nump">$ 58.67<span></span>
</td>
<td class="nump">$ 61.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 days<span></span>
</td>
<td class="text">2 years 5 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Outstanding, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
<td class="nump">78,877<span></span>
</td>
<td class="nump">85,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
<td class="nump">$ 58.19<span></span>
</td>
<td class="nump">$ 60.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 days<span></span>
</td>
<td class="text">2 years 6 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember', window );">Stock Appreciation Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition', window );">Options, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition', window );">Weighted Average Exercise Price, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue', window );">Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options, Forfeited or cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(167)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37.40<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Forfeited or cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue', window );">Aggregate Intrinsic Value, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Balance</a></td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options, Expected to Vest in the Future Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,886<span></span>
</td>
<td class="nump">5,645<span></span>
</td>
<td class="nump">6,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
<td class="nump">$ 29.37<span></span>
</td>
<td class="nump">$ 35.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 2 days<span></span>
</td>
<td class="text">3 years 2 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding, Expected of Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
<td class="nump">34,578<span></span>
</td>
<td class="nump">33,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
<td class="nump">$ 47.31<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 4 days<span></span>
</td>
<td class="text">2 years 11 months 4 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Outstanding, Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of Options, Vested, Exercisable and Options Expected to Vest, Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
<td class="nump">40,223<span></span>
</td>
<td class="nump">40,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
<td class="nump">$ 44.80<span></span>
</td>
<td class="nump">$ 44.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">2 years 11 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition intrinsic value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share based payment award options granted in period intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by share based payment award options weighted average exercise price assumed pursuant to reverse acquisition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>NTRP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=NTRP_StockAppreciationRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M>5J4_X*76M89@7A;"+ZNE>4;K).L^I_^K!VQIP!)CP*J%="Q"KA6P%T%W*-
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MHJ[B?AUF8UOU:P"0^<RAJOL!F&/[!,/N=P_N=XWNOTV3+$.;-%E$.7JW$A]
M[[F:\0O?88KO=!#UB:^X3@=AFZC3,-%1#F-*$ 0ZR,6$6(K?=!1A/FYP&SNX
MC1GWA#)MB9_0I]>-3'*R(>0VUN5>T"79N$NR29=D09=DTX[(:AKQ#AKQC*'U
M$*["-.)9L6X]\IB+$,L@E7BZCHE8?Y7(&>DPZEJ^K43A6(=A$5\.5O<&'<=<
MSU$C,0#H7,NV/<7L5,<13&SBNW"@^0<G^F8GYLGL>U$_SY%(PV2L%6L_Y$=?
M/U7JV<IUCXSV8$D@*()T:U3DF^I"UI&U +@V[#I8W23^OKG:+&&KJO4L\SXB
M])V&J]T>/1?U9"139-DY :LY"U"+R]0-!8!AXOFJ1L< 3NR,5%4\1.=[EJ.D
M8 &$<PBVE.U]"EV%Y3MNP]Z"WQ3.^-C*42X;ZS#]SN4^ WH1Z[LDINJ", )@
MMD@P/-6).HQ8(@]1DQH YUL.]54G E8]L=.KVS. 8Q;#E#4XD51.)$8G?A4Y
M#<]D%U#(4FH]FG&TX!Q<@DNN6C0S43]JOM1Q8G7UM001P G=^I:E.E/'$=>B
MEJUZ$[!K$^Q8GNI.'>B*.J,I2\=5$8R-==/5-SY;QLDJ>?H!^H\"YX<M0E3_
MZ3B/,L]5W:?#*'%<K;Z!S&+?]2S5?0 ?QC;5Q*CCQ,YI8Z_!>U59B,UUX9?T
M*8S+LD7L8QF<")0D->]86L$P,MLZ8PL#[&'+QYZONKDC@P%@4*P(:E1,.[!7
MGZ>J&,7F:G1DJC?!*=/+,M\159XZ94#U1D5<JM41A/.HYJ$)@'-=YJDS%P X
M;+L><]7$ 0"*99C0)N57]24V%YA?\B5/$2^K)-"%0!U'F>^J+@0J1^$8K'H0
M@ DRK<($<4S-&0((YKB.NK!-H8L0CK8;W%?5F=A8HEQ]2W*Q?>GE)NA(!DXV
M59/2$02T?,M7U\,Q *0V=7S;4[VI T7Z3YCCJO[4@0ZS+4?-_:8 4&0M/G,;
M"@I<E6787)=5SI3M#M"1>C%S(3SI$U];BB&DY3% EP"2BBW<]:GJ2P!)1+;O
M>VH#!$(Z+O.IVIJ90DC;=[#W)B[J[JP*-.R;6R%%@)=-\G=[?<(W<5J4)\W]
MD$[9QIVR33IE"SIEFW;%5K^O556*Q%PI3F7#4>RN\RC;))E8W)(%"K.,PRF1
MF>Q<R73*-NZ4;=(I6T#TVE0L80RK]4(;JZ94BU1%+C$7N;=A%$L=\%>Y%F^C
M;%G<7!-J6$7A8[2*<K#2,+.>+8@NV<:=LDTZ90N(7F=CU_5\-?=N8]4HB*I@
M)^:"?;\P;-)D'659DOY <9)S)!)R'CV'CRNPE60F/5L/7;*-.V6;=,H6$+U1
M<"$R6Y%?.:HB6M@U*J+J.1!SS^$NSKF@S%%49A=E&?'S>Q3S'%2#7L!?N#;1
M^C@0CE&M+!I#.-_72O()A,/4QXY:3T! VW.UNU;@"6*/-?062=6)($<Z$;5T
M;>]0T)<MJG!#9'7)-NZ4;=(I6T#T)H>889=2=8IUW(7/F-4PPU4/@YA[&&7)
M"*7E\#SKI3\<,P .C!D !\8,@(-C!B)DS%;;?%,(Z&'7;@J:JHE!S$V,7WA>
M%(MH(?8F-$MBD;)L90695(^O/?)%DG*4AZ]P=4Z >^C8$<4Y5F_T@4BA-J8]
M!@(AJ2.*15MM=T!(0AP7JZWK $**3<'UJ%I40DC'HM1NNNE'JK8',;<]OJ;)
M<U0\P2N<NE_^FUW;XC8OU)\<=44T[HIHTA51T!71M .BNBBJQ@TQ-VY.B$)0
M'5"/!@X\" D''M3-@0,/ZN; @0<@&P(/ZOL8 Z_JYA#S_7;IXR=9F>V>!=JY
M6I3JI;?Y_(VSBRQ,%FS-@:G?MA8.59NL(_,YG1-VNCW&F-JL[,I< %V>RQRJ
MMO^G'5BL/[I:=5NHN=NRCQGP256H1^!0VU5OTHY )!@8$%)$&J6N(N()A(0#
M T(R2HF6*4PAI#$P:-6NH.9VQ=>4+WB:B@"81\_1G,=SV*=ZF7V!+==3'_,T
M6SM#\I!!@D5:IKJ[(X,!9)!A]:'2:0?VZC-5]1&HN8\@)5_T$JXWFU4TDXT#
ME"?H)EFO13Y1/%"T3%9SGL(3N"-WZD%AB_U"FT(("0<%@*0BT)BM]OXA9$-0
M $@1%#Y19WX*(<U!\>;)>'.!_C',HMEN3Q:[@GQ 2[HX6X8B$3YODRX-R4=J
MJK.T^NKCHS='3N@/##V3/P+9,>VK]W,^M:(?P_1]2UGR;ENQ3T!VPOKJ\TAW
MK>@#F-[O8X7^\S%Z M%/07IF]2GVW_RKF[H_UU1=OE4OA)I[(:-HM95?2>I$
MP#M3&!\3L/F4F@0,L8,";D,_AND! ;=AGX#LH(#;T <P/23@(_0- H;HCPKX
M3%-U 5>M'FIN]1Q=?QLR=U# >O/$4K5K/ILF[1I'G9YY?&IE?GS\NFY;$4^Z
MNJZ[5N:#<I0B^[[ZW,SG8^P-JN_HXN[/-5^/A*I#1\T=NA.6\G-B0>]L:;%@
M/I^F6#"..B<6VI@?'[^NVU;$DZZNZZZ5^: <=3P6CK WQ$)'%W=_KOEZ+%3-
M4VINGD[!&'B4>P4H=G9BYF*VVJ1XB!W,7-K0CV%Z('-IPSX!V<',I0U] -)3
MTE>_UO'Y&'V#;B'ZHYG+F:;J&JUZN=3<RX4U.M^MXJ!*O1,+1+/=)I5"[*!*
MV]"/87I I6W8)R [J-(V] %(#ZKT"'V#2B'ZHRH]TU1=I54WG)J[X;\7+V<1
MZ4+X+-*%)X[B[?I1B#99[ 2;H62;9WD8SV6!V+S"ZGUBAS#].WDW1TZG2;PZ
MO4<IPZITVY"/ 7)*&-/:8;>MZ">GG?M=*_( ("?$(\Q6A7N$O4&XP,T&['A8
ME>J9Y/7W#E2-?MO<Z#](-3Y%JH:%UM9[Z+!8CYQ0@U@!>DBLK<C' #DLUE;T
MD]/._:X5>0"0@V(]Q@Z+%6"'Q'HN>5VL\F9*_4C5M+?-37OAE"_Q3R,^XX5J
MR[>_T/?H(7I:A^AZ/H_DETG10R*$N[OY>!?/^BB<_;F-Y%V97_AK_BV--BB*
M45B\32+-^.[/621']"O(;9IL-^_1='J#7L(,15DF2D)Q;5]B]/8,?OH_GP'R
MZ'NA)H0M"WU;<GG'8A/&/]!2(%*^D"\D$Z!\&64H3\,X"W<O*$MYGB:[MY2M
M?DCC^5)4(6@1Q6$\B^27'P]O7((F;_#F#4]KGCX5KSK+1%ZVC?/R^Y:'PX?W
MJ5T7;Y52CG_$PT\8.#[&PSOH>("']]#QCV1X _&/R/ 3='Q,AK?0\0D9WD''
M S+\#!V?DN$]=/S:EB^0@\Y4J'K_:KE!Y;O=B^GNP_0IBC.TX@OA1ZO/G!Y*
M=^]ZVWW(DTWQ\JS'),^3=?'KDH=SGDJ ^/LB2?+]!VG@\,:]J_\!4$L#!!0
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MG2%M"%6^/LH&RJRXP!<2Z3E05"-ZL($R ^C_4DI\;9@W0?T$]'\!4$L#!!0
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MCT$/+[K<"^BB@T/IB\[U9PY>>-"! ^@+K3P6F7DL=*25V,QCMN&(!1%C46!
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M&$L>^K%)!NG6/RE:0H769;<5 "1>K0_:>,:QALP@J@X ::L%G(G0;#H#S$:
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MC+=R<PV5GK[A"V2LBR?;5+&.Q8)<HTPJ,&60B+1\\^?*AP:@V]L#<"N ^Z<
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M@LU%4Z[:I_+ORZ8IE^W+)YXL>"4-Q.</I4@VW85TL/WIB,M_ %!+ P04
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MH.L8=&YW+I "+K/>J*!Y]5.=+CD0(@'P:K(7I#*=@#^K/'/>![M %<G" K4
M^=3 P<SQ<0IUOX]NV&,%X@,9K5EWZIX7Y#04[QY$]LN\M4*'7>HMIO>D0C>
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ME050/)?2[#>V0/_O,/\-4$L#!!0    ( -.+;%ER[P<D1@8  )03   9
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M@^,L\4%U]_MN8.3*79%OI*$+MQ.7]$N$RFZ@];F49CNP!OJ?K,G?4$L#!!0
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M0E ;ERRG$XX,TC:IK0'W[#^QR(^G<W\<SGM/\3"(HF,VFP?^&%MR[ ?38_:
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MJCFY0"1RIM2&HK>F .C!+M+V@D)B++15%RZ^^,2HG9E[FN8;Y]ZM,*@$N?N
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M$L%S1N->%@]/:M%K(Y05W@@_'YW\&%('("=WN4Z6"C:K"Y#/'O3IG'%:4VF
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M($.&QT#TC4]D*;<(=$21JR6H6JL<L3"@-O ;I/%T/([GTP22?CJ&[[+W"?/
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M\=!5'<MSI0LF<SS6R*FX?5=G#UC;4&AI*+0L]DXWJJJ9?/Y7Q<"#VMC6P9%
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M4#L#6M\H90\#%Z![\*W^ 5!+ P04    " #3BVQ9CB"@1H '   D%   &0
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M91/H/)?2#!M;8/R?B'\!4$L#!!0    ( -.+;%DCE0WKQ0,  $((   9
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M/\S-UL\?ZF@A-?&&TQ#^Q8,8OS<96><7C";@%0)J.8(&^N-M-[C7_QY NO7
M$ZC[1T,^[4T'0,)TU/2_AR[[,/#\/I[1A4& T*5N$G9\U&3@]4<AG_2&$R!@
M,.)MM[[O>I?:'U%VXT/:<NB5:C?5PQN']:WF:3CR!F&?3T(O'/OZFM [&"?6
MI>YS!J;/>67N5!&0PS\&0SD.^E8-'&PX>FE_.E8%!PVQ25';TVZCL2SR2!\>
M-',N/)I7IDP8"ZFO"K].)'AW]B^TP5<=-GCF\H-6^VY6YL0;\>4>@T@0)A\'
MWC@ [05CF$S&/!Q!.!L.^1@^'XPFS2[PU&N9A2P">Y%0/G%_. )1C[D_Q63
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MKLU^I\FBK1^YK1_US?[BYZ1**R3 #SAW7B=XO[MVW#M--Y TMVK-K8?ZT]H
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M1/6=TR$R$!&T>FG@).WF%=^9'1J^R/,&YOAHMD59XUU N:\GX^&_PPH9K.-
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MY@1C OAVA1(Y7?#T"SK$Y]%V-B;!VTZ0(&:;RH )!@A>F4Z:$BT3J1R@(O(
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M P7YWVS^41VD[+D4C*_(@DBQH-@CWPC#-1CHMN1L,R,Y1)('T[W:2'$J@MC
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MRB;0>2&EV0>VP/!'D/X&4$L#!!0    ( -.+;%G5JC7>P (  #@&   9
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;(5546_:,!!^SZ\X9=742E$33(#
M(!+M6FT/E5#;;0_3'DQR$*M.G-I.:?_]; =2F"A[(;[+W7??Y\L=TXV03ZI
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MNT"0I.U#T0=:&MM")-$EJ3C;K^^0LA5[H[AIN^B+1%*<,S-G+AZ/-T(^J!6
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M 9DI!5J1DWN..W4Z]C3BFUM>OL6ZZ+#8*U@)^2P:O5+DNBF@&)"_/"X?L",
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M_;,4HR.[^;/;:+&V(]Q<:!P([7*%(SM(<P&_+X30NXU1T/\)F/X%4$L#!!0
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M+W=O<FMS:&5E=',O<VAE970S-RYX;6SE6FUOVS80_NY?<7"W(0$46>\O:6+
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MV1Q(E<%[5C2JLWI.][KH)G"=T]Z"%]BHT",H7=D@<[Z2H'(*I.1-I20TDF;
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MPM[0[43QVEQR9USAE=D,<_RHH4)OP.<+CHI83[2#]C-I_ -02P,$%     @
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M!XC]2T+X4T$:-&NJ9O\!4$L#!!0    ( -.+;%E6F-*<I0(  -D(   9
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M4D:%>:)=G1N%%DHW0K*B :L5%*2LW_BE\>$ X 9G %X#\"X%^ W OQ00-(#
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M@0*5 >+^@A"^G<B6I>QIW7]02P,$%     @ TXML64W_UI)] @  408  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULK55=;]HP%/TK5C9-K=0UP2$L
M[4*D JVVATZH5;>':0\FN1"KB9W:!MI_OVLG9$ IV\->B#_N.??<:_N0K*5Z
MU 6 (<]5*?30*XRI+WU?9P543)_+&@3NS*6JF,&I6OBZ5L!R!ZI*GP;!P*\8
M%UZ:N+6I2A.Y-"47,%5$+ZN*J9<1E'(]]'K>9N&.+PIC%_PTJ=D"[L$\U%.%
M,[]CR7D%0G,IB(+YT+OJ78XC&^\"OG-8ZZTQL97,I'RTDZ_YT NL("@A,Y:!
MX6<%8RA+2X0RGEI.KTMI@=OC#?N-JQUKF3$-8UG^X+DIAE[LD1SF;%F:.[G^
M FT]3F F2^U^R;J)C4*/9$MM9-6"44'%1?-ESVT?M@"]P1L V@+H/J#_!B!L
M :$KM%'FRIHPP])$R351-AK9[,#UQJ&Q&B[L*=X;A;L<<2:=*KP0RKP0)G)R
M_;3D-1Z1(2<3,(R7FGQC2C';Z5/RD3S<3\C)^]/$-YC9XOVLS3)JLM WLO0H
MN97"%)I<BQSR70(?)7>ZZ4;WB!YEO('9.:$79X0&M'] T/A?X+&#AT?DA%T;
M0\<7_J6-9V1:,NS?;C=_7LVT47AC?QUJ7</</\QL7_&EKED&0P^?J0:U B_]
M\*XW"#X?*OL_D>TTH=\UH7^,/9T DF:<N?<)SV@T&@X5W+!$CL6ZS"KMQ7$8
M)_YJNY+746$0QH,N:D=BU$F,CDK<N>ZP.:!#(J-7Z2]H%.YI?!U$+VB\)]'?
M>IT5J(4S+4TRN12FN?#=:N>+5\X.]M9'Z)>-O?VA:<SVEJD%%YJ4,$?*X/P3
M2E*-@343(VOG 3-IT%'<L$#/!V4#<'\NI=E,;(+N7R3]#5!+ P04    " #3
MBVQ9 UD8T? #  !@%0  &0   'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6RU
M6%V/VC@4_2M6MEJU4F<2.]^S$&F*576DJ30J_7BH]L& @:A)S-H&NOOK:X=,
M(!"\4'E>AC@YY^3>,[[VC0=;QG^():42_"R+2@R=I92K.]<5TR4MB;AE*UJI
M)W/&2R+5D"]<L>*4S&I26;C(\R*W)'GE9(/ZWA//!FPMB[RB3QR(=5D2_N\[
M6K#MT('.\XU/^6(I]0TW&ZS(@HZI_+)ZXFKDMBJSO*25R%D%.)T/G7MXAV&L
M"37B:TZWXN :Z%0FC/W0@X?9T/%T1+2@4ZDEB/K9T!$M"JVDXOBG$77:=VKB
MX?6S^OLZ>97,A @Z8L6W?":70R=QP(S.R;J0G]CV VT2"K7>E!6B_@NV.VSH
M.6"Z%I*5#5E%4.;5[I?\;(PX(,#@# $U!'0IP6\(_J6$H"$$M3.[5&H?,)$D
M&W"V!5RCE9J^J,VLV2K]O-+_]['DZFFN>#(;JXDT6Q<4L#EXJ"2I%OE$C>Z%
MH%* UYA*DA?B#;@!7\88O'[U9N!*]5I-=J?-*][M7H'.O.)^O;@%/GP+D(>"
M'OK(3']/)[< I6?I^!)Z4M/]+MU57K6&H=8P5.OYY_3R*I?TYE'-UEF/8]\?
M%1X\2%J*O_NLVHD'_>*ZR._$BDSIT%%5+"C?4"?[\P\8>7_U&6=3#%L2ZYCJ
MMZ;Z)O7L,Y.DZ+-K1PMKFE["-EF<PB0(PX&[.72B!^>G<9+$71P^Q45^@A!$
M+:X3?]#&'QCCOY].U^6Z(%+-"5(R+O/_B%[6^E+:*44'(=R$D1>'*#G*J0^(
M4!!$QTGU /TX#L+@3%9AFU5HS.I@=I-Z=K\%E=J)U$KQ?SF&)Q$A'WHI.HI\
MU(.#L1\@[RC#'IRR+(J]_@2C-L'(F."8S>66< HPW:@=<*7V,PF^?Z3EA/+>
MZC7*75N]-L6P);&.C7%K8_R22V)LTU2;8MB26,?4I#4U^;TE,3FIA1@B%*;1
M46V=XJ+(4YO@T3*#3W%AZB5^Z/?75MK&GUY66X_Y5+6)5!@+RZAU[1RP*88M
MB74\A-Z^._->LK0:=4N^6E7#MM2ZSA[TO?#WZLO,N]HS>%JN21K&1]6*>W!J
MHS_$=?/<MZO0V+AEGSF9J4]%]1EI+$"SRM596^U,;:EU'=SWIM!_T1HTMKY7
M.VM3#=M2ZSJ[[YJAN6T^7X.G+6V$$O]HA[L(A1M4> [5C7W?&T-S<WS=_F86
MNWH2V%3#MM2Z1NY[<!B]:'E9[<FMJF%;:EUG]VTY-#:HAO**3S^7>S:ET84X
M;([CVCS=@],L??;XD?!%7@E0T+F2]VYC%0_?'>?M!I*MZ@.N"9.2E?7EDJI=
MCVN >CYG3#X/])E9>ZB:_0)02P,$%     @ TXML6<19O5C7 @  ? @  !D
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M6%&[!NT.T/X*T>XGCJ#[ \A^ 5!+ P04    " #3BVQ9N1A0\>H$   W(@
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MGE?]'8*'WFDG!2W0@-("4%H(16M+=RC28'V51CND=A1HNNJ2<[V/WFJ!EFA
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MA9GA6OUD -<!ZOV2,7F8Z#[6_+8D?P!02P,$%     @ TXML6=>1W^V=!
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M&O+-DMK-CF"K<O'DE G!TG)S2:,YY44#>?Z)R>EPM5,8V"YL'O\'4$L#!!0
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M,*<LWX#_?)'P#)=W\@&J:XU/_@-02P,$%     @ TXML6?*KU[PS"   YF
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M6BAMC]?4-WDO.4'4$,H![\@L_H[4(X [_5B]LQVIN5#-ZWA)+*/C1)</'3:
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MSKC%I=Z$IM# TS(HDR&+HD&8<9$'\:3<6^AXHG96BAP6FIA=EG%]G(-4AVE
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M;O%? &AW .^OE;+/"Y>@^5\1_PU02P,$%     @ TXML676$;O!8"P  7G,
M !D   !X;"]W;W)K<VAE971S+W-H965T-C4N>&ULQ9UO;^,V$L:_"N$K#KO
MKFW]=_:2 $FH[17HML$NND51W O%9AQA;<N5Y&3S[8^R9=&4Z*%(S?7>M$F6
M_%&>QQKQ&9+VY4N6?RN>&"O)]_5J4UR-GLIR^V$R*>9/;)T4XVS+-OQ?'K-\
MG93\UWPY*;8Y2Q;[3NO5Q)U.P\DZ23>CZ\O]W^[SZ\ML5Z[2#;O/2;%;KY/\
M]9:MLI>KD3,Z_N%SNGPJJS],KB^WR9)]8>5OV_N<_S9I*(MTS39%FFU(SAZO
M1C?.ASCRJP[[%E]3]E*<_$RJE_*09=^J7WY:7(VFU16Q%9N7%2+A_WMF=VRU
MJDC\.OZJH:-FS*KCZ<]'^L?]B^<OYB$IV%VV^CU=E$]7H]F(+-ACLEN5G[.7
M?[/Z!045;YZMBOU_R4O==CHB\UU19NNZ,[^"=;HY_#_Y7@?BI(/CG^G@UAW<
M=H?@3 >O[N"U.KCG.OAU![_=(3S3(:@[[%_ZY/#:]X&C29E<7^;9"\FKUIQ6
M_;"/_KXWCU>ZJ=XH7\J<_VO*^Y777_@[;[%;,9(]DB]E-O]&?MWN%;RI%$S+
M5_*&LC))5\5;\I[\]H62-S^\O9R4?.@*,)G7P]P=AG'/#..23]FF?"I(O%FP
MA:(_A?N'NOXQW-^!+F#"8]8$SCT&[M8%B93-Q\2]>$?<J>NI @)W_\@>FNZ^
M*AYP]YO=<DP\YVSWV'IT*1A>\R[R]CSOW+OH*<G9^UM^PR[(7;;F6:Q(#N^B
M/$\V2\8S2TD>7LEIN_OD=?_GFY<D7Y _?^9(\E/)UL5_%*_G]C"^KQZ_RJ8?
MBFTR9U<CGBX+EC^ST?4__^&$TW^II,&$44Q8C 231/0;$7V(?OW+;OW \BH1
M'%) 07[=E469;!;I9OF.W":K9#-G*G% KJDXF#!Z@(5[6/7,?+Z>!=YT>CEY
M/HVZQ9 $"'C0!#P  _[[_BG&;X6;9Y;SIS*)O[-\GA:,W.?IG/4./SB*:?@Q
M8?0 <Z8G\0^GXZ 5?HLAH?"'3?A#L_?[.W)3\ D3%V2[RXM=PI-3F?'9$%>'
M:Y+,_]JE15JU5(D CF4J B:,8L+BL'M#A:'O-HI*2D2-$M&0&V&0+N#(IKI@
MPB@F+(X4=YHS]CVU,+-&F)F9,)]993YX0N*/^4V9\VG^+EF1G]-'1OY@2<YO
MH>KG08*!5V0J&":,8L)B./ N>:W"269D?9BV^F21O!9 UKMH)+T R3?+9<Z6
M2<DG6US E#N^.?F:K'9<M!_Y7*U4SJYO0::I*)@P:@$C*CV&<R0YG*DP8%/3
MQ] Q_2FE@'&F6J#2:$T[?3RTYUI@$SF$)Q[6&?;\@ ,*PHT#BDFC-C3EVQL!
M)(OC"G%<VX0#RP)BC67!I%$;FEJ6X2!9%N'8'=!+JM+.QRQ_9&EU'V4YF5=N
M8[4ZHPVJ':]IIRGAO>.=3"KKH"N:\:FGUTXP.IH<,.&.'=@>:Y.,0?A0#3,J
MC=8T:28YB\;3L!UF13O'G8YGT9E "U?LP+882!@&(48UQ:@T:D-39P]DY^P(
MZ^P8>N?>Q0H8;"R,PH]V"SQ4T2R:S:*H_9[6T>1H"7OK#/*W_6.':F8=E6?L
M5&>HJEDP&SL7[>#I<'+PA 5UT#WH23S!<*):350:U03EZ ^=J<(7UGKT(X1'
MAQGI'*8C+*9CZ3%/E5$J@NHS;6BJ/$NQ0#$"2%ZL$B[3M7"96S:O;JPR(U]9
M49)T0\HG1C[NREW.JH4RS?T##VFJEMLUAIX?.*ULI&CE^%YKJACK6'(0A<]T
M!_M,.:3*J*':S9HF95W/&[OM+*YLYW;:Q7J>'#MA UW8!EJD\5[11'6)J#2J
MB8AWS.&'#,PS\;E4WA/4I')'6RUTA4]T89\(S,:E:4LC%D\Q9\5"M8TV-&5Z
MQP+%""!9)6%.7<.UVZ:XDCRLU,D;U8.ZBH569^9?M+-0MUD4^7XG">EH<I2$
MLW0'+;CJ8X9J*EW5ZJ@S#OUVT!3M^ 0\;+L7/4\.FS![+FSVK%(W'$A4$XA*
MHYI@'.?-WOELW0\0'+.UJT+)4@FGZ<).LW^VAO5!-9HV-'6B1@+%""!9(.%F
M7=AV*1)U];1D"TD3PG5J*BOM:1!8(H"'-U9NUJN\HFBF*J]H:7),A=UT8;NI
M3>NF$58&%M6:UC1=[4753%5[T>+D77W"-7JP:S3)_&_^R(OQ6YQ@PY=EO-T/
M=8U3$[(>E9F>A/Z5&4\X6 ]VL#V?#X.T0_6W-C3ELP,+%". 9/&$A?8L5U)U
M9368:RP)JDFVH:EU05Y*]4XV/QLOI0);:6"8L1BX>YFQG# "2!9#.&%OX#(M
M) VJ)T:E41N:6IKA(%D:8;\]0_O]-^PFA"_)6%+4=6!46JP)OOF.0D\4"#S8
MT@*SBB'2H18)4&D4E1;;T,!;4M0+/+A>8+KY$,89:X*ZG[JF09L/P29R"(6C
M]V!'?S@U=[/EESA/#Z>>]L<M"_+G)U9%5WV>"=6GH](H*BW&HLGRB.* =_"^
M_\>C::B5 50:1:7%6#3Y>)JH1OB&:]C]#ZBAUA-0:=3OKE7[4^^B<T;-8E#H
M&>&+FH$_:-6[OPBHA0%4&O45R]Z^/^Z4,&U&!540YM^'S3_N:35X,&,M4"L"
MJ+2XIIV_O60]A.GW8=/_OSRS!@]MK YJB0"5%M<TX+Z3Y3DYRPR7 >R..<%0
MX\"C%@!L:,H"  )(%D44 'S8@YJZ#1C7_R7?V8  );#V;R. 9"6$8_<-E_2-
M3DS!<./;!-69V]#4XB";<E^8<M]Z$1^6!=6<H]*H#4TM"_+2O2^,OF^\=-__
M/ K,-DEEJ%;?[R[)OW<Z.XL0+EZ.N7#O_L"E?0,%4&TZ*HWZBO5[+QK[;1V0
MMX\'PGH'L/5&.9,%CV'\026H+MR&ILQ/""!9(^'3 ]BGVY=':K"F!''7KQE5
M-G,[YS2U-#D,PB@'AAO-;3]5!]4BUS1=@8&>:3=K!T^+DZ,G;&U@:&O13EO!
M QO'$]74:H+2W;)Y?J]^3Y3C@"Q9/>%Z TO7J]LA G.-Q4&RJA0+%". 9$E.
M/N/+PO,./'@%#VFL5M!)Q.%L%K834[=5$'9V[NM8<A"%70T&VU7]QC1X#..H
MA8HI6] ]>*5JYUZ,O?8<6\^38R?<9&!X^!CGX!4\JG$T4<VF)B(G6S2/.?A\
M.H=1QZ-7;O_-_($PG %L.#&/7L%#&<N%Y&8I%BA& ,DJ"8L:P!;5_.@5##36
MXJ*3<CTOF+9/$:F:^4'4F5CJ:/)'+0H#&1KN)#<\>@7C36-6T^3I<SB.VA\Y
MHVP7C;W6J>18SY/#)CQ=:+CV.OCH%3R@<2!15V$UP>A,PU5;V&I!^I'$+%R[
M&RX4!C2T_L KDS-8\"C&0B%MLZ98H!@!) LD/&YHO%\;]0P6/+RQ<MW/LU)5
M793-NE47+4V.J7">(>P\_Y8S6/ U& ?6[U>2.=.N_>34X^30"@<9XFV;QCR$
M!5^6<;11EV U(3,IV/1$F11LPI./H+;>.8UU'@N^ F,9D997*18H1@#)X@EG
M'5JNT^JJ;3#76!)4[VQ#4^N"O% ;"M\<&B_4 GM^8)BQ&*C+LS8TM1C==5[H
ML2_,;SAP?18*/*H-1J51&YHZ\(J576!6$ E#':$=S1[V^?FHQAN51E%IL2;@
M-A.!2!C]:.!'B_5?9H=',E8,U>&CTF(;&O2(B83'C] _S6SXG8A:$$"E451:
MK F^U9THJ@.1]0>>#1$/M2: 2J.HM-B&!MZ4H@81P34(T^W%,,Y@3YX-") #
M:]$; 7108G+R_8)KEB_W7^Q8D'FVVY2'KQIL_MI\>>3-_BL3)Z+YX9LG/R7Y
MDM]39,4>>=?I..+N.S]\F>/AES+;[K^M\"$KRVR]__&))0N65PWXOS]F67G\
MI1J@^4K-Z_\"4$L#!!0    ( -.+;%DK7>:&7P0  #45   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8V+GAM;*V8;8_:.!#'OXJ5.YU::4MB0P+L 1)LMW<G
MM>IJ5W=5=;H7)AD@:A)3VX'=;W]V$A*R!$,6WI GSXQ_X[']QZ,MXS_$"D"B
MYSA*Q-A:2;F^M6WAKR"FHL/6D*@O"\9C*M4C7]IBS8$&F5$<V<1Q/#NF86)-
M1MF[!SX9L51&80(/'(DTCBE_F4'$MF,+6[L7C^%R)?4+>S):TR4\@?Q[_<#5
MDUUZ"<(8$A&R!'%8C*TIOKTCCC;(6OP3PE;LW2.-,F?LAW[X*QA;CNX11.!+
M[8*JRP;N((JT)]6/GX53JXRI#??O=]X_9? *9DX%W+'H6QC(U=@:6"B !4TC
M^<BV?T(!Y&I_/HM$]HNV15O'0GXJ)(L+8]6#.$SR*WTN$K%G0'I'#$AA0%X;
MN$<,NH5!-P/->Y9A?:223D:<;1'7K94W?9/E)K-6-&&BA_%)<O4U5'9R\J3J
M(D@C0&R!OE'.:2)?T%3G-E0W[SZ"I&$DWJ,/Z%=D([&B',3(EBJRMK?](LHL
MCT*.1/'0%Y;(E4#W20!!@_V=V1X3@P-;(9?<9,<](T:/TW3905U\@XA#>DT=
M,IM_@GD'D6&3>:T[W7(8NIF_[A%_]S]3G>]_IW,AN2KM_YIRG+OH-;O0\_U6
MK*D/8TM-: %\ ];DMU^PY_S>Q'<E9S7:7DG;,WF?%(4FT-=4"DF3($R6-V@&
MRS!)U"V:T8@F/C3E('?L98[U$K69] 8>]MR1O=FG,\9OID,&,+<$<\U@V:H!
M 9IN@*M5$-T_ _=# >B!ASZ\@3>/AYT]X&%GV'N%:^Q5>UROQ/7.&L<;-!5J
M'U#<ZY2+5+U"DJE%7B5!H5-?%;<(]:K=1&@,T;:JO8/R(+CO#KMEOFJ<_9*S
M?\FP7H1OC-P6OW]8+01W'-R,/RCQ!^WP'T$+!%VY=VI5UNM52B/T.5P >O>=
MB\[[BS)B[$S;C)C),'H!RA%V4)QO+T,4T!=AF!K#,F?#,Z?&'_K:N.G-C"[.
MFK8YY/"PZKV!VR?-PXZ=2ALXE]6]@<WLN@5<X:A6U-V.<PQN3_C@JU7U=U4E
MYJ$T!VM;M2>Z3K*R%8CLRA;KLC54+2955LB9=;L;ZV9<HY<VHWNYHSIII;BP
M4>*<+FYS MZ@GYH3<+FC>@(J$8;/4V$W2/TA6D"H<\$X\K44B:(CV(?ZZP/!
M>Y.Q@+JR_L*5 ,,7*;!6K'DD=W_=(0>D5Y9>N-)>^#SQ51>5]]G5I"CQH4;J
M#7J.UWU-UM2N)K7K':_$%+Y(3;7F:1 ]@XX[>(W3T*RFI.LTE3;"UQ-'Q39R
M!M-5-= )@IT(PN5NXIY20;B20?B$#GJ#=C1MLV^03(;$F/O>>ILEE;(B+975
MR;3L3XNFS)P(6 RR:QSCXN3C+$]GE8N]=S 5 U]FYW4"^2Q-9'Y&5;XMSP2G
MV4F8737/#Q2_4*[^+@L4P4*9.IV^6GAY?D:7/TBVSHZYYDQ*%F>W*Z !<-U
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M)%I-A&H2JLFHIJ":BFH:JNFH9J":B6H6JMFHYESX'(@^Y_]VNWI\FBV_[OY
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MI_=PP(.+R]K-]JBGT?O<: ,W%OLURS401+:*#537"H/B7-FW9L[M&5%(N-7
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MK#DDC4#1=,U5&FZ;\_ JN%QU"RZ@J3@H+0"E$2B:[AV5N=O#HP@NH-D^*"T
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MZ/,0").@GV\Y5Z>)>4%UP@K_ E!+ P04    " #3BVQ9).HN(O4"  !R!P
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;,U836_;.!#]*X066+1
M&WU:LE/;0&RI:($&:]3;[:'H@9;&MA!)]))4G/S[)2E%L6Q9&[<\Y!*3%-^;
MX9O11)SQGM [M@7@Z"'/"C8QMISOKDV3Q5O(,;LB.RC$DS6A.>9B2C<FVU'
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MZAHJL-H2='2<L=WI$F3E[$ZY4*TG>L=)U(9)U(1R>MF)"J>H:H'"$N>(. =
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MW[!T>%&DN^HKA![2HD@WU8]/-%K1K"S _OZ8IL7Q1=E \SU7U_\#4$L#!!0
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ TXML62D^>-/S!0  IS(   \
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M(J_A/D."Z24AU@O$O+).5DUS\F3%M"Z[_6^"Z24AU@N*V1GT!--+0JP7O*:
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M4$L! A0#%     @ TXML66[L'=ON    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ TXML69E<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " #3BVQ9_X*XOE,$  #S$0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ TXML63<G]=T;"0  4B\
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M965T-BYX;6Q02P$"% ,4    " #3BVQ9'CN1W0,#   B"@  &
M    @(&".   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
MTXML6:%Z -P+"P  1D(  !@              ("!NSL  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( -.+;%DUY]L2V1$  'X]   8
M          " @?Q&  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " #3BVQ9EA9]KX4G  "&@0  &0              @($+60  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( -.+;%DF]?9X+P0  "L)
M   9              " @<>   !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ TXML63&PE.B, @  *08  !D              ("!+84
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " #3BVQ9<N\'
M)$8&  "4$P  &0              @('PAP  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( -.+;%E+;71I"@,  "<'   9
M  " @6V.  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
MTXML61J,6KRZ!   < T  !D              ("!KI$  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " #3BVQ9'<"_R%,'  !"%@  &0
M            @(&?E@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( -.+;%G6RP?*5P(  &4%   9              " @2F>  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ TXML61OAS&P$!0
MH H  !D              ("!MZ   'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " #3BVQ9G1E(W9P%  !S#@  &0              @('R
MI0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( -.+;%D_
M0Z>6-@0  /P)   9              " @<6K  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ TXML68X@H$: !P  )!0  !D
M     ("!,K   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
M" #3BVQ96150CIT"   S!@  &0              @('IMP  >&PO=V]R:W-H
M965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( -.+;%DCE0WKQ0,  $((   9
M              " @;VZ  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L!
M A0#%     @ TXML68J,]I+L&   WF\  !D              ("!N;X  'AL
M+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " #3BVQ9"&922P8$
M  !'"0  &0              @('<UP  >&PO=V]R:W-H965T<R]S:&5E=#(U
M+GAM;%!+ 0(4 Q0    ( -.+;%EP>- ,+ (  .0$   9              "
M@1G<  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ TXML
M6:#8A2;Q @  =08  !D              ("!?-X  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " #3BVQ9)6Q4S4D2  "=-@  &0
M        @(&DX0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( -.+;%G3DR2ND"D  (23   9              " @23T  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ TXML6=HV+.2+!P  01H
M !D              ("!ZQT! 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " #3BVQ9;?+*Y+P"   !!@  &0              @(&M)0$
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( -.+;%GOIF1M
MDP(  !0&   9              " @: H 0!X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ TXML6=6J-=[  @  . 8  !D
M ("!:BL! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #3
MBVQ9DPL0,1\$   0#   &0              @(%A+@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( -.+;%E N26)M@,  ) (   9
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M970S.2YX;6Q02P$"% ,4    " #3BVQ9>A]BS-\#  !^%@  &0
M    @(%Y4 $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M -.+;%DB[>CO6 (  /0&   9              " @8]4 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ TXML6>LY!8G% @  )@L  !D
M             ("!'E<! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " #3BVQ9FA7BR3@)  "<9   &0              @($:6@$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( -.+;%EY%R^(:00
M &D<   9              " @8EC 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ TXML6<-X#&W(!   7R4  !D              ("!
M*6@! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " #3BVQ9
M5IC2G*4"  #9"   &0              @($H;0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( -.+;%E0PWB93P,  !H0   9
M      " @01P 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ TXML6>A&/H]! P  WPX  !D              ("!BG,! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " #3BVQ93?_6DGT"  !1!@
M&0              @($"=P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( -.+;%D#61C1\ ,  & 5   9              " @;9Y 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ TXML6<19O5C7
M @  ? @  !D              ("!W7T! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " #3BVQ9CJ(3J H#  "R"P  &0
M@('K@ $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( -.+
M;%GPG:'5UP0  -H<   9              " @2R$ 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ TXML6>R>S:VK @  # 8  !D
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M=#4X+GAM;%!+ 0(4 Q0    ( -.+;%GZ$13O_@(  -H)   9
M  " @:V; 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
MTXML646PB>5G!@  Y#P  !D              ("!XIX! 'AL+W=O<FMS:&5E
M=',O<VAE970V,"YX;6Q02P$"% ,4    " #3BVQ9(N8QO,P'  !W7   &0
M            @(& I0$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4
M Q0    ( -.+;%GRJ]>\,P@  .9@   9              " @8.M 0!X;"]W
M;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ TXML6?+B4SDC @
MS 4  !D              ("![;4! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX
M;6Q02P$"% ,4    " #3BVQ939V?Y&\#  !C#   &0              @(%'
MN $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( -.+;%EU
MA&[P6 L  %YS   9              " @>V[ 0!X;"]W;W)K<VAE971S+W-H
M965T-C4N>&UL4$L! A0#%     @ TXML62M=YH9?!   -14  !D
M     ("!?,<! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -.+;%DDZBXB]0(  '('   9              "
M@0X2 @!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%     @ TXML
M60YF$D_U P  E18  !D              ("!.A4" 'AL+W=O<FMS:&5E=',O
M<VAE970W,BYX;6Q02P$"% ,4    " #3BVQ9T^#^-IP$  "'$@  &0
M        @(%F&0( >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0
M   ( -.+;%G[&?EQ(@,  +P,   9              " @3D> @!X;"]W;W)K
M<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ TXML61!,638Z P  U0L
M !D              ("!DB$" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q0
M2P$"% ,4    " #3BVQ9T#JN"BT8  !*H $ &0              @($#)0(
M>&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( -.+;%F9<RH!
MU0H  /-J   9              " @6<] @!X;"]W;W)K<VAE971S+W-H965T
M-S<N>&UL4$L! A0#%     @ TXML69**F6X[ P  \A,   T
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;72YX;6Q02P4&     %4 50!*%P  LU<"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>264</ContextCount>
  <ElementCount>405</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>79</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfOperationsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Business Description and Going Concern</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BusinessDescriptionAndGoingConcern</Role>
      <ShortName>Business Description and Going Concern</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperations</Role>
      <ShortName>Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Prepaid and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PrepaidAndOtherCurrentAssets</Role>
      <ShortName>Prepaid and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Share Purchase Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SharePurchaseAgreements</Role>
      <ShortName>Share Purchase Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Deferred Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DeferredRevenue</Role>
      <ShortName>Deferred Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Stockholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders??? Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShare</Role>
      <ShortName>Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Concentrations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/Concentrations</Role>
      <ShortName>Concentrations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Defined Contribution Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DefinedContributionPlans</Role>
      <ShortName>Defined Contribution Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperationsTables</Role>
      <ShortName>Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DiscontinuedOperations</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Prepaid and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PrepaidAndOtherCurrentAssets</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PropertyAndEquipment</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssetsTables</Role>
      <ShortName>Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/Goodwill</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IncomeTaxes</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Stockholders??? Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders??? Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/StockholdersEquity</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShareTables</Role>
      <ShortName>Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://nexttrip.com/role/LossPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Business Description and Going Concern (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative</Role>
      <ShortName>Business Description and Going Concern (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/BusinessDescriptionAndGoingConcern</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails</Role>
      <ShortName>Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Estimated Useful Lives for Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Schedule of Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails</Role>
      <ShortName>Schedule of Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Discontinued Operations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative</Role>
      <ShortName>Discontinued Operations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DiscontinuedOperationsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails</Role>
      <ShortName>Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/Leases</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails</Role>
      <ShortName>Schedule of Estimated Aggregate Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IntangibleAssetsDetailsNarrative</Role>
      <ShortName>Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IntangibleAssetsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails</Role>
      <ShortName>Schedule of Fair Value of Assets Acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails</Role>
      <ShortName>Schedule of Reconciliation of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Goodwill (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/GoodwillDetailsNarrative</Role>
      <ShortName>Goodwill (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/GoodwillTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails</Role>
      <ShortName>Schedule of Reconciliation of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/IncomeTaxesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://nexttrip.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/NotesPayable</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Share Purchase Agreements (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative</Role>
      <ShortName>Share Purchase Agreements (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SharePurchaseAgreements</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/RelatedPartyTransactions</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Deferred Revenue (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DeferredRevenueDetailsNarrative</Role>
      <ShortName>Deferred Revenue (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DeferredRevenue</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Schedule of Warranty Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails</Role>
      <ShortName>Schedule of Warranty Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Stockholders??? Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/StockholdersEquityDetailsNarrative</Role>
      <ShortName>Stockholders??? Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/StockholdersEquityTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Loss Per Share (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/LossPerShareDetailsNarrative</Role>
      <ShortName>Loss Per Share (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/LossPerShareTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Concentrations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ConcentrationsDetailsNarrative</Role>
      <ShortName>Concentrations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/Concentrations</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Defined Contribution Plans (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative</Role>
      <ShortName>Defined Contribution Plans (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/DefinedContributionPlans</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails</Role>
      <ShortName>Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails</Role>
      <ShortName>Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails</Role>
      <ShortName>Schedule of Issuable Contingent Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails</Role>
      <ShortName>Schedule of Weighted Average Common Stock Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://nexttrip.com/role/SubsequentEvents</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="forms-1a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails</Role>
      <ShortName>Schedule of Stock Appreciation Rights Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="S-1/A" isDefinitelyFs="true" isUsgaap="true" original="forms-1a.htm">forms-1a.htm</File>
    <File>ntrp-20240831.xsd</File>
    <File>ntrp-20240831_cal.xml</File>
    <File>ntrp-20240831_def.xml</File>
    <File>ntrp-20240831_lab.xml</File>
    <File>ntrp-20240831_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>aud_001.jpg</File>
    <File>aud_002.jpg</File>
    <File>forms-1a_001.jpg</File>
    <File>forms-1a_002.jpg</File>
    <File>forms-1a_003.jpg</File>
    <File>forms-1a_004.jpg</File>
    <File>forms-1a_005.jpg</File>
    <File>forms-1a_006.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1319">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>103
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "forms-1a.htm": {
   "nsprefix": "NTRP",
   "nsuri": "http://nexttrip.com/20240831",
   "dts": {
    "inline": {
     "local": [
      "forms-1a.htm"
     ]
    },
    "schema": {
     "local": [
      "ntrp-20240831.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ntrp-20240831_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ntrp-20240831_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ntrp-20240831_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ntrp-20240831_pre.xml"
     ]
    }
   },
   "keyStandard": 321,
   "keyCustom": 84,
   "axisStandard": 23,
   "axisCustom": 0,
   "memberStandard": 23,
   "memberCustom": 47,
   "hidden": {
    "total": 268,
    "http://fasb.org/us-gaap/2024": 207,
    "http://nexttrip.com/20240831": 58,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 264,
   "entityCount": 1,
   "segmentCount": 79,
   "elementCount": 635,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1319,
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://nexttrip.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "dei:AmendmentDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://nexttrip.com/role/BalanceSheets",
     "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://nexttrip.com/role/BalanceSheetsParenthetical",
     "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "USDPShares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R4": {
     "role": "http://nexttrip.com/role/StatementsOfOperations",
     "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
     "longName": "00000005 - Statement - Condensed Consolidated Statements of Operations (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Operations (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "From2024-02-292024-02-29",
      "name": "NTRP:PercentageForIssuedAndOutstandingCapitalStock",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R6": {
     "role": "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
     "longName": "00000006 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit)",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "AsOf2022-02-28_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2022-02-28_us-gaap_CommonStockMember",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
     "longName": "00000007 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "From2024-02-292024-02-29",
      "name": "NTRP:PercentageForIssuedAndOutstandingCapitalStock",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://nexttrip.com/role/StatementsOfCashFlows",
     "longName": "00000008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://nexttrip.com/role/BusinessDescriptionAndGoingConcern",
     "longName": "00000009 - Disclosure - Business Description and Going Concern",
     "shortName": "Business Description and Going Concern",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies",
     "longName": "00000010 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://nexttrip.com/role/DiscontinuedOperations",
     "longName": "00000011 - Disclosure - Discontinued Operations",
     "shortName": "Discontinued Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://nexttrip.com/role/PrepaidAndOtherCurrentAssets",
     "longName": "00000012 - Disclosure - Prepaid and Other Current Assets",
     "shortName": "Prepaid and Other Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://nexttrip.com/role/Leases",
     "longName": "00000013 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://nexttrip.com/role/PropertyAndEquipment",
     "longName": "00000014 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://nexttrip.com/role/IntangibleAssets",
     "longName": "00000015 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://nexttrip.com/role/Goodwill",
     "longName": "00000016 - Disclosure - Goodwill",
     "shortName": "Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities",
     "longName": "00000017 - Disclosure - Accounts Payable and Accrued Liabilities",
     "shortName": "Accounts Payable and Accrued Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://nexttrip.com/role/IncomeTaxes",
     "longName": "00000018 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://nexttrip.com/role/NotesPayable",
     "longName": "00000019 - Disclosure - Notes Payable",
     "shortName": "Notes Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://nexttrip.com/role/SharePurchaseAgreements",
     "longName": "00000020 - Disclosure - Share Purchase Agreements",
     "shortName": "Share Purchase Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://nexttrip.com/role/RelatedPartyTransactions",
     "longName": "00000021 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://nexttrip.com/role/DeferredRevenue",
     "longName": "00000022 - Disclosure - Deferred Revenue",
     "shortName": "Deferred Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:DeferredRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:DeferredRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://nexttrip.com/role/CommitmentsAndContingencies",
     "longName": "00000023 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://nexttrip.com/role/StockholdersEquity",
     "longName": "00000024 - Disclosure - Stockholders\u2019 Equity",
     "shortName": "Stockholders\u2019 Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://nexttrip.com/role/LossPerShare",
     "longName": "00000025 - Disclosure - Loss Per Share",
     "shortName": "Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://nexttrip.com/role/Concentrations",
     "longName": "00000026 - Disclosure - Concentrations",
     "shortName": "Concentrations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://nexttrip.com/role/DefinedContributionPlans",
     "longName": "00000027 - Disclosure - Defined Contribution Plans",
     "shortName": "Defined Contribution Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://nexttrip.com/role/SubsequentEvents",
     "longName": "00000028 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "longName": "00000029 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "29",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "longName": "00000030 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://nexttrip.com/role/DiscontinuedOperationsTables",
     "longName": "00000031 - Disclosure - Discontinued Operations (Tables)",
     "shortName": "Discontinued Operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables",
     "longName": "00000032 - Disclosure - Prepaid and Other Current Assets (Tables)",
     "shortName": "Prepaid and Other Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://nexttrip.com/role/PropertyAndEquipmentTables",
     "longName": "00000033 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://nexttrip.com/role/IntangibleAssetsTables",
     "longName": "00000034 - Disclosure - Intangible Assets (Tables)",
     "shortName": "Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://nexttrip.com/role/GoodwillTables",
     "longName": "00000035 - Disclosure - Goodwill (Tables)",
     "shortName": "Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://nexttrip.com/role/IncomeTaxesTables",
     "longName": "00000036 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://nexttrip.com/role/StockholdersEquityTables",
     "longName": "00000037 - Disclosure - Stockholders\u2019 Equity (Tables)",
     "shortName": "Stockholders\u2019 Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://nexttrip.com/role/LossPerShareTables",
     "longName": "00000038 - Disclosure - Loss Per Share (Tables)",
     "shortName": "Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R39": {
     "role": "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
     "longName": "00000039 - Disclosure - Business Description and Going Concern (Details Narrative)",
     "shortName": "Business Description and Going Concern (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "From2022-03-012023-02-28",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "NTRP:WorkingCapitalDeficit",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
     "longName": "00000040 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "shortName": "Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29_us-gaap_StockOptionMember",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
     "longName": "00000041 - Disclosure - Schedule of Estimated Useful Lives for Property and Equipment (Details)",
     "shortName": "Schedule of Estimated Useful Lives for Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
     "longName": "00000042 - Disclosure - Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)",
     "shortName": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsFiniteLivedPolicy",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "longName": "00000043 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)",
     "shortName": "Summary of Significant Accounting Policies (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails",
     "longName": "00000044 - Disclosure - Schedule of Discontinued Operations (Details)",
     "shortName": "Schedule of Discontinued Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
     "longName": "00000045 - Disclosure - Discontinued Operations (Details Narrative)",
     "shortName": "Discontinued Operations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:GainLossOnDispositionOfAssets1",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember",
      "name": "us-gaap:PaymentsToAcquireIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails",
     "longName": "00000046 - Disclosure - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:PrepaidAdvertising",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:PrepaidAdvertising",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://nexttrip.com/role/LeasesDetailsNarrative",
     "longName": "00000047 - Disclosure - Leases (Details Narrative)",
     "shortName": "Leases (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "From2022-03-012023-02-28",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-03-012023-02-28",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails",
     "longName": "00000048 - Disclosure - Schedule of Property and Equipment (Details)",
     "shortName": "Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative",
     "longName": "00000049 - Disclosure - Property and Equipment (Details Narrative)",
     "shortName": "Property and Equipment (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:Depreciation",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails",
     "longName": "00000050 - Disclosure - Schedule of Intangible Assets (Details)",
     "shortName": "Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails",
     "longName": "00000051 - Disclosure - Schedule of Estimated Aggregate Amortization Expense (Details)",
     "shortName": "Schedule of Estimated Aggregate Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://nexttrip.com/role/IntangibleAssetsDetailsNarrative",
     "longName": "00000052 - Disclosure - Intangible Assets (Details Narrative)",
     "shortName": "Intangible Assets (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
     "longName": "00000053 - Disclosure - Schedule of Fair Value of Assets Acquired (Details)",
     "shortName": "Schedule of Fair Value of Assets Acquired (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:Goodwill",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails",
     "longName": "00000054 - Disclosure - Schedule of Reconciliation of Goodwill (Details)",
     "shortName": "Schedule of Reconciliation of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://nexttrip.com/role/GoodwillDetailsNarrative",
     "longName": "00000055 - Disclosure - Goodwill (Details Narrative)",
     "shortName": "Goodwill (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "AsOf2023-10-12",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-10-122023-10-12",
      "name": "us-gaap:GainLossOnDispositionOfAssets",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:GoodwillDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative",
     "longName": "00000056 - Disclosure - Accounts Payable and Accrued Liabilities (Details Narrative)",
     "shortName": "Accounts Payable and Accrued Liabilities (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:AccountsPayableCurrentAndNoncurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails",
     "longName": "00000057 - Disclosure - Schedule of Deferred Tax Assets (Details)",
     "shortName": "Schedule of Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails",
     "longName": "00000058 - Disclosure - Schedule of Reconciliation of Provision for Income Taxes (Details)",
     "shortName": "Schedule of Reconciliation of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:EffectiveIncomeTaxRateReconciliationBookLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:EffectiveIncomeTaxRateReconciliationBookLoss",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://nexttrip.com/role/IncomeTaxesDetailsNarrative",
     "longName": "00000059 - Disclosure - Income Taxes (Details Narrative)",
     "shortName": "Income Taxes (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://nexttrip.com/role/NotesPayableDetailsNarrative",
     "longName": "00000060 - Disclosure - Notes Payable (Details Narrative)",
     "shortName": "Notes Payable (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "From2024-07-112024-07-11",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:InterestExpenseDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
     "longName": "00000061 - Disclosure - Share Purchase Agreements (Details Narrative)",
     "shortName": "Share Purchase Agreements (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "From2024-07-112024-07-11",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "NTRP:SharePurchaseAgreementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
     "longName": "00000062 - Disclosure - Related Party Transactions (Details Narrative)",
     "shortName": "Related Party Transactions (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:LossOnRelatedPartyReceivable",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://nexttrip.com/role/DeferredRevenueDetailsNarrative",
     "longName": "00000063 - Disclosure - Deferred Revenue (Details Narrative)",
     "shortName": "Deferred Revenue (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:DeferredRevenueCurrent",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R64": {
     "role": "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
     "longName": "00000064 - Disclosure - Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)",
     "shortName": "Schedule of Share Based Payments Award Stock Options Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
     "longName": "00000065 - Disclosure - Schedule of Stock Option Activity (Details)",
     "shortName": "Schedule of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails",
     "longName": "00000066 - Disclosure - Schedule of Warranty Activity (Details)",
     "shortName": "Schedule of Warranty Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
     "longName": "00000067 - Disclosure - Stockholders\u2019 Equity (Details Narrative)",
     "shortName": "Stockholders\u2019 Equity (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-09-212023-09-22",
      "name": "us-gaap:StockholdersEquityReverseStockSplit",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
     "longName": "00000068 - Disclosure - Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "shortName": "Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R69": {
     "role": "http://nexttrip.com/role/LossPerShareDetailsNarrative",
     "longName": "00000069 - Disclosure - Loss Per Share (Details Narrative)",
     "shortName": "Loss Per Share (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2022-03-012023-02-28",
      "name": "us-gaap:DilutiveSecurities",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://nexttrip.com/role/ConcentrationsDetailsNarrative",
     "longName": "00000070 - Disclosure - Concentrations (Details Narrative)",
     "shortName": "Concentrations (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "Pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:ConcentrationRiskDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative",
     "longName": "00000071 - Disclosure - Defined Contribution Plans (Details Narrative)",
     "shortName": "Defined Contribution Plans (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-03-012024-02-29",
      "name": "us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails",
     "longName": "00000072 - Disclosure - Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)",
     "shortName": "Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "From2024-03-01to2024-08-31",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember21742375",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
     "longName": "00000073 - Disclosure - Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)",
     "shortName": "Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R74": {
     "role": "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails",
     "longName": "00000074 - Disclosure - Schedule of Issuable Contingent Shares (Details)",
     "shortName": "Schedule of Issuable Contingent Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "NTRP:LaunchOfLeisureTravelBookingPlatform",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfIssuableContingentSharesTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-06-30",
      "name": "NTRP:LaunchOfLeisureTravelBookingPlatform",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "NTRP:ScheduleOfIssuableContingentSharesTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails",
     "longName": "00000075 - Disclosure - Schedule of Weighted Average Common Stock Shares Outstanding (Details)",
     "shortName": "Schedule of Weighted Average Common Stock Shares Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "NTRP:CommonStockShareOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-06-012024-08-31",
      "name": "NTRP:CommonStockShareOutstanding",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
     "longName": "00000076 - Disclosure - Subsequent Events (Details Narrative)",
     "shortName": "Subsequent Events (Details Narrative)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-31",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-03-11_us-gaap_SubsequentEventMember",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
     "longName": "00000077 - Disclosure - Schedule of Stock Appreciation Rights Activity (Details)",
     "shortName": "Schedule of Stock Appreciation Rights Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-29",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "Shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "forms-1a.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r91",
      "r95",
      "r834"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r692"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r864"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r595",
      "r654",
      "r699",
      "r868",
      "r869"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable, net",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued expenses",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued expenses",
        "label": "Accrued Liabilities",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r184",
      "r535"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r692",
      "r900"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r750",
      "r751",
      "r752",
      "r753",
      "r844",
      "r903"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Compensation",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r55",
      "r390"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r421",
      "r427"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r263",
      "r270",
      "r271",
      "r273",
      "r869"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r263",
      "r270"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r282",
      "r289",
      "r674"
     ]
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Underlying Common Shares",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r242"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AreaOfLand",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Area of land",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "NTRP_AssetPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "AssetPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asset Purchase Agreement [Member]",
        "documentation": "Asset Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r162",
      "r187",
      "r212",
      "r247",
      "r251",
      "r257",
      "r258",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r467",
      "r469",
      "r482",
      "r526",
      "r600",
      "r669",
      "r670",
      "r692",
      "r706",
      "r801",
      "r802",
      "r855"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ASSETS"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r193",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r467",
      "r469",
      "r482",
      "r692",
      "r801",
      "r802",
      "r855"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Non-Current Assets",
        "label": "Assets, Noncurrent",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r467",
      "r469",
      "r482",
      "r801",
      "r802",
      "r855"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_AtTheMarketIssuanceSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "AtTheMarketIssuanceSalesAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At-The-Market Issuance Sales Agreement [Member]",
        "documentation": "At-The-Market Issuance Sales Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_BoardOfDirectorsAndChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "BoardOfDirectorsAndChiefExecutiveOfficerMember",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Board Of Directors And Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r463",
      "r682",
      "r683"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r58",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r463",
      "r682",
      "r683"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted shares issuable in reverse acquisition",
        "verboseLabel": "Shares issuable for consideration",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Equity interest acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_BusinessAcquisitionSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionSharePrice",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price",
        "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Purchase consideration",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r12"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Prepaid expenses and other current assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, net",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "NTRP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accrued expenses",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities accrued expenses.",
        "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred revenue",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory",
        "documentation": "The amount of inventory recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total identifiable net assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and equipment",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Fair Value of Net Assets Acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r720",
      "r721"
     ]
    },
    "us-gaap_Capital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Capital",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributed capital",
        "documentation": "Amount of total capital as defined by regulatory framework."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r182",
      "r663"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "CASH AT BEGINNING OF PERIOD",
        "periodEndLabel": "CASH AT END OF PERIOD",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r118",
      "r208"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CHANGE IN CASH FOR PERIOD",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r118"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r734",
      "r867"
     ]
    },
    "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NET CASH PROVIDED IN OPERATING ACTIVITIES FROM DISCONTINUED OPERATIONS",
        "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r118"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r189",
      "r190",
      "r191",
      "r212",
      "r235",
      "r236",
      "r239",
      "r241",
      "r249",
      "r250",
      "r267",
      "r320",
      "r322",
      "r323",
      "r324",
      "r327",
      "r328",
      "r358",
      "r359",
      "r362",
      "r365",
      "r371",
      "r482",
      "r556",
      "r557",
      "r558",
      "r559",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r587",
      "r609",
      "r631",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r727",
      "r745",
      "r754"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise price",
        "verboseLabel": "Exercise price per share",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of outstanding warrants",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants outstanding to purchase common stock",
        "verboseLabel": "Warrants to purchase of common stock",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r372"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of warrant or right, outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ClosingSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ClosingSharesMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r154",
      "r528",
      "r586"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/CommitmentsAndContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r312",
      "r313",
      "r656",
      "r795",
      "r800"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock reserved for future issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_CommonStockDividendsShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsShares",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common stock dividends, shares",
        "documentation": "Number of shares of common stock issued as dividends during the period. Excludes stock splits."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r697",
      "r698",
      "r700",
      "r701",
      "r702",
      "r703",
      "r750",
      "r751",
      "r753",
      "r844",
      "r899",
      "r903"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, par shares",
        "verboseLabel": "Common stock, par value",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "NTRP_CommonStockShareOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "CommonStockShareOutstanding",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "1,388,641 common shares outstanding",
        "documentation": "Common stock share outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r587"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock, shares outstanding",
        "verboseLabel": "Shares outstanding",
        "terseLabel": "Common stock, shares, outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r99",
      "r587",
      "r606",
      "r903",
      "r904"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, $0.001 par value, 250,000,000 and 1,200,000 shares authorized, respectively; 1,388,641 and 936,430 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r530",
      "r692"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Contribution Plans",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r64",
      "r65",
      "r261",
      "r655"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r64",
      "r65",
      "r261",
      "r553",
      "r655"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r64",
      "r65",
      "r261",
      "r655",
      "r732"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Concentrations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentrations",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of risk percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r64",
      "r65",
      "r261"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r64",
      "r149",
      "r655"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r64",
      "r65",
      "r261",
      "r655"
     ]
    },
    "NTRP_ConsultingFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ConsultingFees",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees",
        "documentation": "Consulting fees."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConsultingModificationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ConsultingModificationAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting Modification Agreement [Member]",
        "documentation": "Consulting Modification Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ContingentShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ContingentShares",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent shares",
        "verboseLabel": "Total contingent shares",
        "documentation": "Contingent shares"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ContingentSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ContingentSharesIssuable",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent shares issuable",
        "verboseLabel": "Total contingent shares issuable on June 10, 2024",
        "documentation": "Contingent shares issuable"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ContingentSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ContingentSharesMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Shares [Member]",
        "documentation": "Contingent Shares [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ContingentlyIssuableShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ContingentlyIssuableShares",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total contingent shares potentially issuable in future periods",
        "documentation": "Contingently issuable shares"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ConversionOfConvertibleNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ConversionOfConvertibleNotes",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion of convertible notes",
        "documentation": "Conversion of convertible notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesConverted1",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares converted",
        "verboseLabel": "Conversion of stock, shares converted",
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConversionOfStockSharesIssued1",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock issuable upon conversion",
        "verboseLabel": "Common stock issued conversion",
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_ConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebt",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible debt",
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r153",
      "r865"
     ]
    },
    "us-gaap_ConvertibleDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes",
        "documentation": "The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "NTRP_ConvertibleNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ConvertibleNotesMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Convertible Notes [Member]",
        "documentation": "Convertible Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue (exclusive of depreciation and amortization, shown separately below)",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r482",
      "r669",
      "r801"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r261"
     ]
    },
    "NTRP_CustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "CustomerMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Member]",
        "documentation": "Customer [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DebtAssignmentAndConversionAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DebtAssignmentAndConversionAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Assignment and Conversion Agreements [Member]",
        "documentation": "Debt Assignment and Conversion Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Converted amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentRate",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion percentage",
        "documentation": "Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r210",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r318",
      "r319",
      "r329",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r345",
      "r352",
      "r353",
      "r354",
      "r491"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r90",
      "r91",
      "r151",
      "r153",
      "r216",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r691",
      "r746",
      "r796",
      "r797",
      "r798",
      "r850",
      "r851"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding principal amount",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r153",
      "r355"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Conversion price",
        "verboseLabel": "Conversion share price",
        "terseLabel": "Conversion price per share",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r332"
     ]
    },
    "us-gaap_DebtInstrumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentDescription",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument description",
        "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r47",
      "r68",
      "r90",
      "r151",
      "r153",
      "r491"
     ]
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r330",
      "r491",
      "r492",
      "r676",
      "r677",
      "r691"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest rate",
        "verboseLabel": "Annual interest rate",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r331"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r675",
      "r846",
      "r847"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r216",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r336",
      "r341",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r691",
      "r746",
      "r796",
      "r797",
      "r798",
      "r850",
      "r851"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt instrument, term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original issue discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r804",
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PrepaidAndOtherCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Prepaid and Other Current Assets",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueArrangementTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueArrangementTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue Arrangement Type [Axis]",
        "documentation": "Information by type of deferred revenue arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueArrangementTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueArrangementTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredRevenueCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredRevenueCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/DeferredRevenueDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred revenue",
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r736"
     ]
    },
    "NTRP_DeferredRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DeferredRevenueTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DeferredRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred Revenue",
        "documentation": "Deferred Revenue [Text Block]",
        "label": "Deferred Revenue [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DeferredTaxAssetDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DeferredTaxAssetDepreciation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party accruals",
        "documentation": "Deferred tax asset depreciation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax asset (liability)",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NOL carryover",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r839"
     ]
    },
    "NTRP_DeferredTaxAssetsPayrollAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DeferredTaxAssetsPayrollAccruals",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll accruals",
        "documentation": "Deferred tax assets payroll accruals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Valuation allowance",
        "label": "Valuation allowance loss carryforwards",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "NTRP_DeferredTaxLiabilitiesDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DeferredTaxLiabilitiesDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "documentation": "Deferred tax liabilities depreciation.",
        "label": "Deferred tax liabilities depreciation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of contribution",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r42"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r42"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation and amortization \u2013 property and equipment and intangibles",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r247",
      "r254",
      "r258",
      "r669",
      "r670"
     ]
    },
    "NTRP_DepreciationOfRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DepreciationOfRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation of right of use asset",
        "documentation": "Depreciation of right of use asset."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DescriptionForWarrantExpiration": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DescriptionForWarrantExpiration",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant description",
        "documentation": "Description for warrant expiration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans",
     "presentation": [
      "http://nexttrip.com/role/DefinedContributionPlansDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution plan description",
        "documentation": "Description of defined contribution pension and other postretirement plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DilutiveSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DilutiveSecurities",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Potentially dilutive securities",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "NTRP_DisclosureDeferredRevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisclosureDeferredRevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureLeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisclosureLeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureOfCashPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisclosureOfCashPaidAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of Cash Paid for:"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosurePrepaidAndOtherCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisclosurePrepaidAndOtherCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid And Other Current Assets",
        "verboseLabel": "Schedule Of Prepaid And Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisclosureSharePurchaseAgreementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisclosureSharePurchaseAgreementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of revenue",
        "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r179"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross Profit",
        "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)",
        "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r179"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Expenses",
        "label": "Disposal Group, Including Discontinued Operation, Operating Expense",
        "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationOrganizationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOrganizationCosts",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Organization costs",
        "documentation": "Organization costs.",
        "label": "DisposalGroupIncludingDiscontinuedOperationOrganizationCosts"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationRetentionBonuses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRetentionBonuses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retention bonuses",
        "documentation": "Retention bonuses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r179"
     ]
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Salaries and benefits",
        "documentation": "Salaries and benefits.",
        "label": "DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationSeverance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisposalGroupIncludingDiscontinuedOperationSeverance",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Severance",
        "documentation": "Severance."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DisposalGroupIncludingDiscontinuedOperationsOtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DisposalGroupIncludingDiscontinuedOperationsOtherIncome",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income",
        "documentation": "Disposal group including discontinued operations other income"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations",
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r125"
     ]
    },
    "NTRP_DivergentTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DivergentTechnologiesIncMember",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Divergent Technologies, Inc. [Member]",
        "documentation": "Divergent Technologies, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsPreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Preferred Stock Dividends",
        "label": "Dividends, Preferred Stock",
        "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r132"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r718",
      "r720",
      "r721"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "NTRP_DonaldMonacoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DonaldMonacoMember",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Donald Monaco [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_DooyaMediaGroupIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "DooyaMediaGroupIncMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dooya Media Group Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_EarnestMoneyDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "EarnestMoneyDeposit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnest money deposit",
        "documentation": "Earnest-money deposit"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r232",
      "r235",
      "r239",
      "r240",
      "r241",
      "r246",
      "r461",
      "r465",
      "r479",
      "r480",
      "r522",
      "r541",
      "r666"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r236",
      "r239"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss per common share diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r235",
      "r239",
      "r240",
      "r241",
      "r246",
      "r461",
      "r465",
      "r479",
      "r480",
      "r522",
      "r541",
      "r666"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Loss Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r243"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r242",
      "r244",
      "r245"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Federal statutory tax rate",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r433",
      "r450",
      "r685"
     ]
    },
    "NTRP_EffectiveIncomeTaxRateReconciliationBookLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "EffectiveIncomeTaxRateReconciliationBookLoss",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Book Loss",
        "documentation": "Effective income tax rate reconciliation book loss."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized share based compensation cost",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining recognition period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r422"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining recognition period",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r833"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r178",
      "r197",
      "r198",
      "r199",
      "r217",
      "r218",
      "r219",
      "r221",
      "r226",
      "r228",
      "r230",
      "r248",
      "r268",
      "r269",
      "r299",
      "r373",
      "r448",
      "r449",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r465",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r478",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r493",
      "r495",
      "r500",
      "r540",
      "r547",
      "r548",
      "r549",
      "r565",
      "r631"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r457",
      "r728",
      "r729",
      "r730",
      "r840",
      "r841",
      "r842",
      "r843"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r264"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value of Financial Instruments",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Estimated useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r274",
      "r288",
      "r674"
     ]
    },
    "NTRP_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Thereafter",
        "documentation": "Finite lived intangible assets amortization expense after year three."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r660",
      "r674"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2025 (Remaining)",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r660",
      "r674"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r660",
      "r674"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r291",
      "r292",
      "r519",
      "r520",
      "r660"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r288",
      "r520",
      "r674"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r288",
      "r291",
      "r292",
      "r295",
      "r519",
      "r660",
      "r674"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r291",
      "r292",
      "r660"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedAggregateAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r519",
      "r787"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Functional and presentation currency",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on disposition transaction",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r744",
      "r793",
      "r794"
     ]
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on disposal of assets",
        "verboseLabel": "Asset disposition",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on sale of intangible assets",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on extinguishment of liability",
        "negatedLabel": "Gain on extinguishment of liability",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r44",
      "r45"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and administrative",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r611"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "periodEndLabel": "Balance, February 29, 2024",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r276",
      "r521",
      "r670",
      "r673",
      "r686",
      "r692",
      "r769",
      "r776"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse acquisition of Sigma Additive Solutions, Inc.",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r673"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Intangible Assets",
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r294",
      "r297"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Goodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r277",
      "r279",
      "r673"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfReconciliationOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reduction from sale of assets to Divergent Technologies",
        "verboseLabel": "Goodwill",
        "documentation": "Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit (loss)",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r109",
      "r161",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r482",
      "r668",
      "r669",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r801"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment losses",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r282",
      "r744",
      "r792"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from continuing operations applicable to common stockholders",
        "totalLabel": "Loss from continuing operations applicable to common stockholders",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r107",
      "r120",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r237",
      "r241",
      "r465"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations before taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r156",
      "r161",
      "r523",
      "r537",
      "r668",
      "r669",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      },
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss from continuing operations",
        "label": "Net Loss \u2013 Continuing Operations",
        "verboseLabel": "Loss from continuing operations",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r161",
      "r212",
      "r220",
      "r226",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r461",
      "r465",
      "r480",
      "r482",
      "r537",
      "r668",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r801"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per common share from continuing operations",
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r157",
      "r200",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r235",
      "r239",
      "r240",
      "r461",
      "r465",
      "r480",
      "r522",
      "r870"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per common share from continuing operations",
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r200",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r235",
      "r239",
      "r240",
      "r241",
      "r465",
      "r480",
      "r522",
      "r870"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfDiscontinuedOperationsDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net gain (loss) from discontinued operations, net of taxes",
        "totalLabel": "Loss from Discontinued Operations",
        "negatedLabel": "Loss of discontinued operations",
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r85",
      "r179",
      "r454",
      "r538"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss from discontinued operations applicable to common stockholders",
        "verboseLabel": "Gain (loss) from discontinued operations applicable to common stockholders",
        "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72",
      "r73",
      "r74",
      "r75",
      "r81",
      "r85",
      "r146"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic loss per common share from discontinued operations",
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r200",
      "r236",
      "r239",
      "r240",
      "r863",
      "r870"
     ]
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted loss per common share from discontinued operations",
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r236",
      "r239",
      "r240"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r429",
      "r433",
      "r436",
      "r437",
      "r438",
      "r439",
      "r443",
      "r451",
      "r453",
      "r455",
      "r456",
      "r561",
      "r685"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for income taxes",
        "totalLabel": "Provision for Income Taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r175",
      "r229",
      "r230",
      "r247",
      "r255",
      "r258",
      "r432",
      "r433",
      "r452",
      "r542",
      "r685"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r430",
      "r431",
      "r439",
      "r440",
      "r442",
      "r447",
      "r555"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in valuation allowance",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r685",
      "r836"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued payroll",
        "documentation": "Income tax reconciliation nondeductible expense accrued payroll."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseDepreciation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible depreciation."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r837"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss on asset disposal",
        "documentation": "Income tax reconciliation nondeductible expense loss on asset disposal."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Meals &amp; Entertainment",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r837"
     ]
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpensePreferredDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncomeTaxReconciliationNondeductibleExpensePreferredDividends",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred dividends",
        "documentation": "Income tax reconciliation nondeductible expense preferred dividends."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Related party accruals",
        "documentation": "Income tax reconciliation nondeductible expense related party accruals.",
        "label": "IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfReconciliationOfProvisionForIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock compensation",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r685",
      "r836",
      "r837"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r207",
      "r444",
      "r445"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Assets and Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "NTRP_IncreaseDecreaseInPromissoryNoteReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncreaseDecreaseInPromissoryNoteReceivable",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Promissory note receivable",
        "documentation": "Increase decrease in promissory note receivable",
        "label": "Increase decrease in promissory note receivable"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IncreaseDecreaseInRightOfUseLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IncreaseDecreaseInRightOfUseLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of use lease liability",
        "documentation": "Increase decrease in right of use lease liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInSecurityDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInSecurityDeposits",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Security deposit",
        "label": "Increase (Decrease) in Security Deposits",
        "documentation": "The increase (decrease) during the reporting period in security deposits."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r293",
      "r296",
      "r659",
      "r660"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r515",
      "r516",
      "r517",
      "r519",
      "r665",
      "r779"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets, net",
        "totalLabel": "Intangible assets, net of amortization",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r787",
      "r789"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r349",
      "r356",
      "r678",
      "r679"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest income (expense), net",
        "documentation": "Amount of interest income (expense) classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r742",
      "r757"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r205",
      "r206"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development Costs",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r298"
     ]
    },
    "NTRP_InvestorsDirectorsOfficersAndEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "InvestorsDirectorsOfficersAndEmployeesMember",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors Directors Officers And Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfCommonSharesForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IssuanceOfCommonSharesForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of common shares for services",
        "documentation": "Issuance of common shares for services."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfPreferredSharesForPerpetualSoftwareLicense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IssuanceOfPreferredSharesForPerpetualSoftwareLicense",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of preferred shares for perpetual software license",
        "documentation": "Issuance of preferred shares for perpetual software license."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_IssuanceOfPreferredSharesForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "IssuanceOfPreferredSharesForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of preferred shares for services",
        "documentation": "Issuance of preferred shares for services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LaborAndRelatedExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LaborAndRelatedExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Salaries and benefits",
        "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit."
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "NTRP_LaunchOfFlexpayTechnology": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "LaunchOfFlexpayTechnology",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Launch of FlexPay technology",
        "documentation": "Launch of flexpay technology"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LaunchOfGroupTravelBookingPlatform": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "LaunchOfGroupTravelBookingPlatform",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Launch of group travel booking platform",
        "documentation": "Launch of group travel booking platform"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LaunchOfLeisureTravelBookingPlatform": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "LaunchOfLeisureTravelBookingPlatform",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Launch of leisure travel booking platform",
        "documentation": "Launch of leisure travel booking platform"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LaunchOfTravelAgentPlatformShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "LaunchOfTravelAgentPlatformShares",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfIssuableContingentSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contigent shares",
        "verboseLabel": "Launch of travel agent platform",
        "documentation": "Launch of travel agent platform shares"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://nexttrip.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r90",
      "r91",
      "r92",
      "r94",
      "r95",
      "r96",
      "r97",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r468",
      "r469",
      "r470",
      "r482",
      "r585",
      "r667",
      "r706",
      "r801",
      "r855",
      "r856"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LIABILITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r155",
      "r532",
      "r692",
      "r747",
      "r766",
      "r848"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Current Liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r181",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r468",
      "r469",
      "r470",
      "r482",
      "r692",
      "r801",
      "r855",
      "r856"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Non-Current Liabilities",
        "label": "Liabilities, Noncurrent",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r94",
      "r95",
      "r96",
      "r97",
      "r212",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r468",
      "r469",
      "r470",
      "r482",
      "r801",
      "r855",
      "r856"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non- Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r153",
      "r865"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_LossOnRelatedPartyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "LossOnRelatedPartyReceivable",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on promissory note receivable",
        "label": "Loss on promissory note receivable",
        "verboseLabel": "Loss on related party receivable",
        "documentation": "Loss on related party receivable."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r261",
      "r681",
      "r693",
      "r695",
      "r806",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898"
     ]
    },
    "us-gaap_MarketRiskBenefitPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketRiskBenefitPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration of Credit Risk",
        "documentation": "Disclosure of accounting policy for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Includes, but is not limited to, input, judgment, assumption and method used in measuring market risk benefit, and change in input, judgment, and assumption."
       }
      }
     },
     "auth_ref": [
      "r545",
      "r546"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r387",
      "r428",
      "r481",
      "r514",
      "r543",
      "r544",
      "r552",
      "r577",
      "r578",
      "r639",
      "r641",
      "r644",
      "r645",
      "r646",
      "r657",
      "r658",
      "r671",
      "r680",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r694",
      "r803",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "NTRP_MembershipUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "MembershipUnitsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Membership Units [Member]",
        "documentation": "Membership Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_MessrsKerbyAndMonacoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "MessrsKerbyAndMonacoMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messrs Kerby And Monaco [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_MessrsMonacoAndKerbyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "MessrsMonacoAndKerbyMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Messrs Monaco and Kerby [Member]",
        "documentation": "Messrs Monaco and Kerby [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r387",
      "r428",
      "r481",
      "r514",
      "r543",
      "r544",
      "r552",
      "r577",
      "r578",
      "r639",
      "r641",
      "r644",
      "r645",
      "r646",
      "r657",
      "r658",
      "r671",
      "r680",
      "r684",
      "r687",
      "r688",
      "r689",
      "r694",
      "r803",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "NTRP_MinimumRequiredStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "MinimumRequiredStockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders equity minimum required",
        "documentation": "Minimum required stockholders equity"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "auth_ref": [
      "r261",
      "r681",
      "r693",
      "r695",
      "r806",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FINANCING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "INVESTING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPERATING ACTIVITIES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN OPERATING ACTIVITIES FROM CONTINUING OPERATIONS",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations",
        "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r120"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "label": "Net Loss",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r120",
      "r158",
      "r179",
      "r194",
      "r195",
      "r199",
      "r212",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r229",
      "r230",
      "r237",
      "r267",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r461",
      "r465",
      "r480",
      "r482",
      "r539",
      "r608",
      "r629",
      "r630",
      "r704",
      "r801"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Loss Applicable to Common Stockholders",
        "label": "Net loss applicable to common stockholders",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r222",
      "r223",
      "r224",
      "r225",
      "r232",
      "r233",
      "r238",
      "r241",
      "r465"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Recently adopted accounting pronouncements",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextInnovationLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "NextInnovationLLCMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Innovation LLC [Member]",
        "documentation": "Next Innovation LLC [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextPlayTechnologiesIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "NextPlayTechnologiesIncMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NextPlay Technologies Inc. [Member]",
        "documentation": "NextPlay Technologies Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextTripGroupLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "NextTripGroupLLCMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NextTrip Holdings, Inc. [Member]",
        "documentation": "NextTrip Holdings, Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_NextTripHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "NextTripHoldingsIncMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Next Trip Holdings Inc [Member]",
        "documentation": "Next Trip Holdings Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Activities Disclosure:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Other Income (Expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income (Expenses)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r749"
     ]
    },
    "us-gaap_NotesAndLoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansPayableCurrent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total consideration",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of all long-term notes and loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91"
     ]
    },
    "us-gaap_NotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayable",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes payable",
        "label": "Outstanding payment",
        "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r153",
      "r865",
      "r866"
     ]
    },
    "us-gaap_NotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable - related parties",
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r91"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Operating Expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r668",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Liability \u2013 Short Term",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Liability \u2013 Long Term",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right of Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesRentExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rent expense",
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r446"
     ]
    },
    "NTRP_OperatingLossCarryforwardsRemainder": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "OperatingLossCarryforwardsRemainder",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating loss carryforwards remainder",
        "documentation": "Operating loss carryforwards remainder."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_OrganizationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "OrganizationCosts",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization costs",
        "documentation": "Organization costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OriginationOfNotesReceivableFromRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OriginationOfNotesReceivableFromRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Promissory note \u2013 related party",
        "label": "Origination of Notes Receivable from Related Parties",
        "documentation": "The cash outflow for a loan, supported by a promissory note, granted to related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_OtherExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenses",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other expenses",
        "documentation": "Amount of expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income (expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid other expenses",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r739",
      "r767"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PaymentsForSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForSoftware",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized software development costs",
        "label": "Payments for Software",
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase price",
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of equipment",
        "label": "Property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related party advances",
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r852"
     ]
    },
    "NTRP_PercentageForIssuedAndOutstandingCapitalStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PercentageForIssuedAndOutstandingCapitalStock",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage for issued and outstanding capital stock",
        "documentation": "Percentage for issued and outstanding, capital stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_PreferredStockConvertibleSharesIssuable": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockConvertibleSharesIssuable",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Converted issuance of shares of common stock",
        "documentation": "Number of common shares issuable upon conversion of preferred stock."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_PreferredStockDividendRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendRatePercentage",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends percentage",
        "documentation": "The percentage rate used to calculate dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r359",
      "r640",
      "r642",
      "r643",
      "r647"
     ]
    },
    "NTRP_PreferredStockDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PreferredStockDividends",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock dividends",
        "documentation": "Preferred stock dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockDividendsIncomeStatementImpact": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendsIncomeStatementImpact",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Preferred dividends",
        "label": "Preferred Stock Dividends, Income Statement Impact",
        "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock [Member]",
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r697",
      "r700",
      "r701",
      "r702",
      "r703",
      "r899",
      "r903"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, par value",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r358"
     ]
    },
    "us-gaap_PreferredStockRedemptionTerms": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockRedemptionTerms",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock redemption right, description",
        "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r47"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r587"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r358"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred stock, shares outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r587",
      "r606",
      "r903",
      "r904"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, $0.001 par value, 10,000,000 shares authorized; 93,295 and 472,996 shares issued and outstanding, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r529",
      "r692"
     ]
    },
    "NTRP_PreferredUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PreferredUnitsMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Units [Member]",
        "documentation": "Preferred Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidAdvertising": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidAdvertising",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid marketing expenses",
        "documentation": "Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r672",
      "r767"
     ]
    },
    "NTRP_PrepaidCostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PrepaidCostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid cost of sales",
        "documentation": "Prepaid cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid expenses and other current assets",
        "totalLabel": "Total",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "NTRP_PrepaidExpensesAndOtherCurrentAssetsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PrepaidAndOtherCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid and Other Current Assets",
        "documentation": "Prepaid Expenses and Other Current Assets [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PrepaidsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PrepaidsPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaids",
        "documentation": "Prepaids [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PrincipalExecutiveOfficesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PrincipalExecutiveOfficesMember",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Executive Offices [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassification",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "NTRP_ProceedsFromAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ProceedsFromAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reverse acquisition of Sigma Additive Solutions, Inc.",
        "documentation": "Proceeds from acquire businesses gross.",
        "label": "ProceedsFromAcquireBusinessesGross"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of convertible notes",
        "verboseLabel": "Proceeds from convertible debt",
        "terseLabel": "Proceeds from convertible shares",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "NTRP_ProceedsFromDownpaymentForContract": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ProceedsFromDownpaymentForContract",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from downpayment for contract",
        "documentation": "Proceeds from down-payment for contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuances of common shares",
        "verboseLabel": "Net proceeds",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuance of convertible preferred shares",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPreferredStockAndPreferenceStock",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuances of preferred shares",
        "documentation": "Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable",
        "verboseLabel": "Net proceeds",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advances from related parties",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Sigma Additive Solutions, Inc. assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Professional service fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r669",
      "r704",
      "r901",
      "r902"
     ]
    },
    "NTRP_PromissoryNoteReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PromissoryNoteReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory note receivable, net",
        "documentation": "Promissory note receivable net"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_PromissoryNoteReceivablePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "PromissoryNoteReceivablePolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Promissory Note Receivable",
        "documentation": "Promissory Note Receivable [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r499"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and Equipment",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r170",
      "r173",
      "r174"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r183",
      "r536"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property and equipment, net",
        "totalLabel": "Property and Equipment, net of depreciation",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r499",
      "r524",
      "r536",
      "r692"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r170",
      "r173",
      "r534"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://nexttrip.com/role/PropertyAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Property and Equipment",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r499"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated useful life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for doubtful accounts",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r272"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r384",
      "r387",
      "r417",
      "r418",
      "r419",
      "r428",
      "r481",
      "r512",
      "r513",
      "r514",
      "r543",
      "r544",
      "r552",
      "r577",
      "r578",
      "r639",
      "r641",
      "r644",
      "r645",
      "r646",
      "r657",
      "r658",
      "r671",
      "r680",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r694",
      "r698",
      "r799",
      "r803",
      "r846",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": [
      "r314",
      "r315",
      "r316",
      "r317",
      "r384",
      "r387",
      "r417",
      "r418",
      "r419",
      "r428",
      "r481",
      "r512",
      "r513",
      "r514",
      "r543",
      "r544",
      "r552",
      "r577",
      "r578",
      "r639",
      "r641",
      "r644",
      "r645",
      "r646",
      "r657",
      "r658",
      "r671",
      "r680",
      "r684",
      "r687",
      "r688",
      "r689",
      "r690",
      "r694",
      "r698",
      "r799",
      "r803",
      "r846",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r385",
      "r504",
      "r505",
      "r527",
      "r533",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r605",
      "r607",
      "r638"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r215",
      "r504",
      "r505",
      "r506",
      "r507",
      "r527",
      "r533",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r605",
      "r607",
      "r638"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r505",
      "r854"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r612",
      "r613",
      "r616"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r385",
      "r504",
      "r505",
      "r527",
      "r533",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r605",
      "r607",
      "r638",
      "r854"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r501",
      "r502",
      "r503",
      "r505",
      "r508",
      "r562",
      "r563",
      "r564",
      "r614",
      "r615",
      "r616",
      "r635",
      "r637"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r132",
      "r531",
      "r550",
      "r551",
      "r560",
      "r588",
      "r692"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r217",
      "r218",
      "r219",
      "r221",
      "r226",
      "r228",
      "r230",
      "r268",
      "r269",
      "r299",
      "r448",
      "r449",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r465",
      "r471",
      "r473",
      "r474",
      "r476",
      "r478",
      "r493",
      "r495",
      "r547",
      "r549",
      "r565",
      "r903"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r160",
      "r247",
      "r252",
      "r253",
      "r256",
      "r258",
      "r259",
      "r260",
      "r261",
      "r382",
      "r383",
      "r518"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r662"
     ]
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock proceeds",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockDescriptionOfTransaction",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock description",
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r63",
      "r147"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, shares",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of issued and outstanding common shares",
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of stock, shares price",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://nexttrip.com/role/ConcentrationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r731"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Underlying Common Shares Excluded from Computation of Loss Per Share",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Deferred Tax Assets",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r838"
     ]
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan [Table]",
        "documentation": "Disclosure of information about individual defined benefit pension plan or other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r48",
      "r49",
      "r50",
      "r51"
     ]
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://nexttrip.com/role/DiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Discontinued Operations",
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r19",
      "r21",
      "r70",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r84",
      "r86",
      "r87",
      "r127"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareTables",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares",
        "verboseLabel": "Schedule of Earnings Per Share, Basic and Diluted",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r34",
      "r235",
      "r236",
      "r239"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Provision for Income Taxes",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r685",
      "r836"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r264",
      "r265",
      "r266",
      "r457",
      "r728",
      "r729",
      "r730",
      "r840",
      "r841",
      "r842",
      "r843"
     ]
    },
    "NTRP_ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets",
        "documentation": "Schedule of Estimated Useful Lives for Finite Life Intangible Assets [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Useful Lives for Property and Equipment",
        "documentation": "Schedule of Estimated Useful Lives for Property and Equipment [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r288",
      "r291",
      "r292",
      "r295",
      "r519",
      "r660",
      "r674"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Intangible Assets",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r786"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://nexttrip.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Reconciliation of Goodwill",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r673",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778"
     ]
    },
    "NTRP_ScheduleOfIssuableContingentSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ScheduleOfIssuableContingentSharesTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Issuable Contingent Shares",
        "documentation": "Schedule of Issuable Contingent Shares [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentDetails",
      "http://nexttrip.com/role/ScheduleOfPropertyAndEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r499"
     ]
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/GoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Fair Value of Assets Acquired",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r612",
      "r613",
      "r616"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Option Activity",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r18",
      "r138"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock Appreciation Rights Activity",
        "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share Based Payments Award Stock Options Valuation Assumptions",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Warranty Activity",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Common Stock Shares Outstanding",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://nexttrip.com/role/IntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Estimated Aggregate Amortization Expense",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r788"
     ]
    },
    "NTRP_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Purchase Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "us-gaap_SecurityDeposit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecurityDeposit",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security deposit",
        "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease."
       }
      }
     },
     "auth_ref": [
      "r735"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and marketing",
        "verboseLabel": "Sales and marketing expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales and Marketing",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r835"
     ]
    },
    "NTRP_SeriesEConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesEConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Convertible Preferred Stock [Member]",
        "documentation": "Series E Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesEPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series E Preferred Stock [Member]",
        "documentation": "Series E preferred stock."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r805"
     ]
    },
    "NTRP_SeriesFConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesFConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series F Convertible Preferred Stock [Member]",
        "documentation": "Series F Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesGConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesGConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Convertible Preferred Stock [Member]",
        "documentation": "Series G Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesGPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesGPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series G Preferred Stock [Member]",
        "documentation": "Series G preferred stock."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r805"
     ]
    },
    "NTRP_SeriesHConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesHConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Convertible Preferred Stock [Member]",
        "documentation": "Series H Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesHPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesHPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series H Preferred Stock [Member]",
        "documentation": "Series H preferred stock."
       }
      }
     },
     "auth_ref": [
      "r737",
      "r738",
      "r805"
     ]
    },
    "NTRP_SeriesIConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesIConvertiblePreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series I Convertible Preferred Stock [Member]",
        "documentation": "Series I Convertible Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeriesIPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeriesIPreferredStockMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series I Preferred Stock [Member]",
        "documentation": "Series I Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SeveralInvestorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SeveralInvestorsMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Several Investors [Member]",
        "documentation": "Several Investors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      },
      "http://nexttrip.com/role/StatementsOfCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows",
      "http://nexttrip.com/role/StatementsOfOperations",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock based compensation",
        "verboseLabel": "Stock-based compensation",
        "terseLabel": "Allocation share based compensation expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend yield",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected volatility, minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangement by share based payment award non option equity instruments assumed pursuant to reverse acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrants, Exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised",
        "documentation": "Number of non-option equity instruments exercised by participants."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Warrants, Forfeited or cancelled",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Warrants Outstanding, Beginning Balance",
        "periodEndLabel": "Warrants Outstanding, Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r140"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance",
        "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance",
        "documentation": "Weighted average exercise price, warrants outstanding.",
        "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options, Assumed pursuant to reverse acquisition",
        "verboseLabel": "Options, Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition intrinsic value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares issuable upon exercisable of options",
        "periodEndLabel": "Number of Options, Exercisable",
        "verboseLabel": "Stock issued during Stock options exercised",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r398"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Forfeited or cancelled",
        "documentation": "Share based compensation arrangement by share based payment award options for feited or cancelled in period total intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Options, Forfeited or cancelled",
        "label": "Shares forfeited or expired",
        "negatedTerseLabel": "Options, Forfeited or cancelled",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Forfeited or cancelled",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r813"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Intrinsic Value, Granted",
        "documentation": "Share-based compensation arrangement by share based payment award options granted in period intrinsic value."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition",
        "documentation": "Share-based compensation arrangement by share-based payment award, options, granted, weighted average remaining contractual term ."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Options, Granted",
        "verboseLabel": "Number of options issued",
        "terseLabel": "Options, Granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Options exercise price",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r410"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value Outstanding",
        "periodStartLabel": "Aggregate Intrinsic Value Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Number of Options Outstanding, Balance",
        "periodEndLabel": "Number of Options Outstanding, Balance",
        "label": "Reverse acquisition shares outstanding",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted Average Exercise Price Outstanding, Balance",
        "periodEndLabel": "Weighted Average Exercise Price Outstanding, Balance",
        "label": "Weighted average exercise price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r397"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, Vested, Exercisable and Options Expected to Vest, Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding, Expected of Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Number of Options, Expected to Vest in the Future Ending Balance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Weighted Average Exercise Price, Expected to Vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Assumed pursuant to reverse acquisition",
        "documentation": "Sharebased compensation arrangement by share based payment award options weighted average exercise price assumed pursuant to reverse acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common stock shares equity award issued or granted",
        "documentation": "Number of shares issued under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangements by share based payment award non options assumed pursuant to reverse acquisition in period weighted average exercise price.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average exercise price, warrants exercised.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Forfeited or cancelled",
        "documentation": "Weighted average exercise price, warrants forfeited or cancelled.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Granted",
        "documentation": "Weighted average exercise price, warrants grants.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Exercised",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r401"
     ]
    },
    "NTRP_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Exercise Price, Forfeited or cancelled",
        "documentation": "Share based compensation arrangements by share based payment award options exercises in period weighted average forfeited or cancelled.",
        "label": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Exercise Price, Granted",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Based Compensation",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r388",
      "r395",
      "r414",
      "r415",
      "r416",
      "r417",
      "r420",
      "r423",
      "r424",
      "r425",
      "r426"
     ]
    },
    "NTRP_ShareExchangeAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ShareExchangeAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Exchange Agreement [Member]",
        "documentation": "Share Exchange Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share price",
        "label": "Conversion share price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAgreementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharePurchaseAgreementsDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share Purchase Agreements",
        "documentation": "Share Purchase Agreements Disclosure [Text Block]",
        "label": "Share Purchase Agreements Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharePurchaseAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase Agreements [Member]",
        "documentation": "Share Purchase Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharePurchaseAndExchangeAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharePurchaseAndExchangeAgreementsMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Purchase And Exchange Agreements [Member]",
        "documentation": "Share Purchase And Exchange Agreements [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expected life",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition",
        "documentation": "Sharebased compensation arrangement by sharebased payment award non options equity instruments assumed pursuant to reverse acquisition weighted average remaining contractual term"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (Yrs.), Granted",
        "documentation": "Sharebased compensation arrangement by sharebased payment award non options equity instruments granted in period weighted average remaining contractual term"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (Yrs.) Outstanding",
        "documentation": "Sharebased compensation arrangement by sharebased payment award non options equity instruments outstanding weighted average remaining contractual term"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition",
        "terseLabel": "Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term.",
        "label": "Share based compensation arrangement by share based payment award options assumed pursuant to reverse acquisition weighted average remaining contractual term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Aggregate Intrinsic Value, Outstanding, Exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Exercisable",
        "verboseLabel": "Weighted Average Remaining Contractual Life (Yrs.), Exercisable",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition",
        "documentation": "Share based compensation arrangement by share based payment award options grant in period weighted average remaining contractual term2."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Granted",
        "documentation": "Share based compensation arrangement by share based payment award options non grants weighted average remaining contractual term."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWarrantyActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Ending Balance",
        "documentation": "Weighted average remaining contractual life (years), warrants outstanding, beginning balance."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Outstanding Balance",
        "verboseLabel": "Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r413"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Remaining Contractual Life Years, Expected to Vest",
        "verboseLabel": "Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share based compensation arrangement by award options vested",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average remaining recognition period",
        "documentation": "Weighted average remaining recognition period.",
        "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price per share",
        "verboseLabel": "Shares issue per shares",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, shares",
        "periodEndLabel": "Balance, shares",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SigmaAdditiveSolutionsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SigmaAdditiveSolutionsIncMember",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfFairValueOfAssetsAcquiredDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sigma Additive Solutions Inc. [Member]",
        "documentation": "Sigma Additive Solutions Inc. [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r209"
     ]
    },
    "NTRP_SoftwareAsAServiceAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SoftwareAsAServiceAgreementMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software as a Service Agreement [Member]",
        "documentation": "Software as a Service Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareLicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SoftwareLicenseMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Software Licenses [Member]",
        "documentation": "Software Licenses [Member]",
        "label": "Software Licenses [Member] [Default Label]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SoftwareLicensesMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails",
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software Licenses [Member]",
        "documentation": "Software Licenses [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_SoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SoftwareMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software [Member]",
        "documentation": "Software [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "NTRP_SpecialPurposeAcquisitionCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "SpecialPurposeAcquisitionCorporationMember",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Special Purpose Acquisition Corporation [Member]",
        "documentation": "Special Purpose Acquisition Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r189",
      "r190",
      "r191",
      "r212",
      "r235",
      "r236",
      "r239",
      "r241",
      "r249",
      "r250",
      "r267",
      "r320",
      "r322",
      "r323",
      "r324",
      "r327",
      "r328",
      "r358",
      "r359",
      "r362",
      "r365",
      "r371",
      "r482",
      "r556",
      "r557",
      "r558",
      "r559",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r587",
      "r609",
      "r631",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r727",
      "r745",
      "r754"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r99",
      "r102",
      "r103",
      "r178",
      "r197",
      "r198",
      "r199",
      "r217",
      "r218",
      "r219",
      "r221",
      "r226",
      "r228",
      "r230",
      "r248",
      "r268",
      "r269",
      "r299",
      "r373",
      "r448",
      "r449",
      "r458",
      "r459",
      "r460",
      "r462",
      "r464",
      "r465",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r478",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r493",
      "r495",
      "r500",
      "r540",
      "r547",
      "r548",
      "r549",
      "r565",
      "r631"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LeasesDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r248",
      "r495",
      "r518",
      "r554",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r587",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r599",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r607",
      "r610",
      "r611",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631",
      "r699"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://nexttrip.com/role/GoodwillDetailsNarrative",
      "http://nexttrip.com/role/LeasesDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r217",
      "r218",
      "r219",
      "r248",
      "r262",
      "r495",
      "r518",
      "r554",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r587",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r596",
      "r597",
      "r598",
      "r599",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r607",
      "r610",
      "r611",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r631",
      "r699"
     ]
    },
    "NTRP_StockAppreciationRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockAppreciationRightsMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights [Member]",
        "documentation": "Stock Appreciation Rights [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodShareOfPreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodShareOfPreferredShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares, Shares",
        "documentation": "Stock issued during period share of preferred shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheetsParenthetical",
      "http://nexttrip.com/role/StatementsOfOperationsParenthetical",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficitParenthetical",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares acquired",
        "verboseLabel": "Shares issued in acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r99",
      "r132"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of additional restricted shares",
        "documentation": "Number of additional restricted shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Issued for Conversion of Preferred Stock, shares",
        "verboseLabel": "Conversion of convertible notes, shares",
        "terseLabel": "Number of shares converted",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r99",
      "r102",
      "r132",
      "r346"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of convertible shares issued",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r47",
      "r98",
      "r99",
      "r132"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Convertible Preferred Shares, shares",
        "documentation": "Stock issued during period shares issuance of convertible preferred shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Third Party Services, Shares",
        "verboseLabel": "Shares issued during period services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares, Shares",
        "verboseLabel": "Number of common stock issued",
        "terseLabel": "Number of shares issued",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r98",
      "r99",
      "r132",
      "r556",
      "r631",
      "r649"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesPurchasesOfCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodSharesPurchasesOfCommonShares",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of Common Shares, Sharers",
        "documentation": "Stock issued during period shares purchases of common shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of restricted shares",
        "verboseLabel": "Restricted shares issued in acquisitions",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r132"
     ]
    },
    "NTRP_StockIssuedDuringPeriodSharesReverseAcquisition": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodSharesReverseAcquisition",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Acquisition of Sigma Additive Solutions, Inc., Shares",
        "documentation": "Stock issued during period shares reverse acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesReverseStockSplits",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split issued common shares",
        "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfStockAppreciationRightsActivityDetails",
      "http://nexttrip.com/role/ScheduleOfStockOptionActivityDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Number of Options, Exercised",
        "label": "Number of Options, Exercised",
        "verboseLabel": "Shares issued or exercised",
        "terseLabel": "Options, Exercised",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r98",
      "r99",
      "r132",
      "r401"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of stock issued",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r99",
      "r102",
      "r103",
      "r132"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Shares Issued for Conversion of Preferred Stock",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r99",
      "r102",
      "r103",
      "r132"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeBenefitPlan",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Options Issued to Employees",
        "documentation": "Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Convertible Preferred Shares",
        "documentation": "Stock issued during period value issuance of convertible preferred shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares for Third Party Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Common Shares",
        "verboseLabel": "Number of common stock issued, value",
        "terseLabel": "Number of purchase of shares",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r98",
      "r99",
      "r132",
      "r565",
      "r631",
      "r649",
      "r705"
     ]
    },
    "NTRP_StockIssuedDuringPeriodValueOfPreferredShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodValueOfPreferredShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of Preferred Shares",
        "documentation": "Stock issued during period value of preferred shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValuePurchasesOfCommonShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodValuePurchasesOfCommonShares",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of Common Shares",
        "documentation": "Stock issued during period value purchases of common shares."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_StockIssuedDuringPeriodValueReverseAcquisition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "StockIssuedDuringPeriodValueReverseAcquisition",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse Acquisition of Sigma Additive Solutions, Inc.",
        "documentation": "Stock issued during period value reverse acquisition."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r698"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of shares issued",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r98",
      "r99",
      "r132",
      "r559",
      "r631",
      "r651"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://nexttrip.com/role/BalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets",
      "http://nexttrip.com/role/StatementsOfStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Stockholders\u2019 Equity",
        "periodStartLabel": "Balances",
        "periodEndLabel": "Balances",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r102",
      "r103",
      "r124",
      "r589",
      "r606",
      "r632",
      "r633",
      "r692",
      "r706",
      "r747",
      "r766",
      "r848",
      "r903"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://nexttrip.com/role/BalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholder\u2019s Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders\u2019 Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r211",
      "r357",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r373",
      "r477",
      "r634",
      "r636",
      "r653"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reverse stock split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r510"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r510"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r510"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r510"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r510"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r511"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubstantialDoubtAboutGoingConcernTextBlock",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcern"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Going Concern",
        "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern."
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Disclosures:"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_Technology": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "Technology",
     "crdr": "debit",
     "calculation": {
      "http://nexttrip.com/role/StatementsOfOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technology",
        "documentation": "Technology."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ThirdPartyConsultantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ThirdPartyConsultantMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party Consultant [Member]",
        "documentation": "Third Party Consultant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_ThirdPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "ThirdPartyMember",
     "presentation": [
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Third Party [Member]",
        "documentation": "Third Party [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r761",
      "r853"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://nexttrip.com/role/LeasesDetailsNarrative",
      "http://nexttrip.com/role/RelatedPartyTransactionsDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r763",
      "r764",
      "r765"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r674",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r787",
      "r789",
      "r790",
      "r791"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandAndTwentyStockAppreciationRightsPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "TwoThousandAndTwentyStockAppreciationRightsPlanMember",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfShareBasedPaymentsAwardStockOptionsValuationAssumptionsDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2020 Stock Appreciation Rights Plan [Member]",
        "documentation": "2020 Stock Appreciation Rights Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandThirteenEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "TwoThousandThirteenEquityIncentivePlanMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2013 Equity Incentive Plan [Member]",
        "documentation": "2013 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandThirteenPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "TwoThousandThirteenPlanMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2013 Plan [Member]",
        "documentation": "2013 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "NTRP_TwoThousandTwentyThreeEquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "TwoThousandTwentyThreeEquityIncentivePlanMember",
     "presentation": [
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "2023 Equity Incentive Plan [Member]",
        "documentation": "2023 Equity Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative",
      "http://nexttrip.com/role/DiscontinuedOperationsDetailsNarrative",
      "http://nexttrip.com/role/NotesPayableDetailsNarrative",
      "http://nexttrip.com/role/SharePurchaseAgreementsDetailsNarrative",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "NTRP_UnsecuredPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "UnsecuredPromissoryNoteMember",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unsecured Promissory Note [Member]",
        "documentation": "Unsecured Promissory Note [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r168",
      "r169",
      "r171",
      "r172"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://nexttrip.com/role/LossPerShareDetailsNarrative",
      "http://nexttrip.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails",
      "http://nexttrip.com/role/ScheduleOfUnderlyingCommonSharesExcludedFromComputationOfLossPerShareDetails",
      "http://nexttrip.com/role/StockholdersEquityDetailsNarrative",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r696",
      "r697",
      "r700",
      "r701",
      "r702",
      "r703"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://nexttrip.com/role/SubsequentEventsDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants exercise term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r845",
      "r846",
      "r847"
     ]
    },
    "NTRP_WeightedAverageIssuableContingentShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "WeightedAverageIssuableContingentShares",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "4,393,993 issuable contingent shares",
        "documentation": "Weighted average issuable contingent shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfAmountsUsedInComputingLossPerShareAndEffectOnNetLossAndWeightedAverageNumberOfSharesDetails",
      "http://nexttrip.com/role/ScheduleOfWeightedAverageCommonStockSharesOutstandingDetails",
      "http://nexttrip.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potentially dilutive securities",
        "verboseLabel": "Weighted average number of common shares outstanding used in loss per share during the period (denominator)",
        "terseLabel": "Weighted average common shares outstanding",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted nverage number of shares outstanding diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r241"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://nexttrip.com/role/ScheduleOfEarningsPerShareBasicAndDilutedDetails",
      "http://nexttrip.com/role/StatementsOfOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of shares outstanding basic",
        "verboseLabel": "Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r241"
     ]
    },
    "NTRP_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://nexttrip.com/20240831",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://nexttrip.com/role/BusinessDescriptionAndGoingConcernDetailsNarrative"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital deficit",
        "documentation": "Working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://nexttrip.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1B"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "205",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-20/tableOfContent"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3A"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-3B"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-4"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5C"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5D"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205-40/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3A"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 5.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479836/810-10-S99-5"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481501/840-20-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477349/740-270-45-3"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/830/tableOfContent"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477270/942-505-50-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7C"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7C"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>104
<FILENAME>0001493152-24-044881-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-044881-xbrl.zip
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M+MEK,&Y!DL:>7/)X6Y<1[3K=7V'R<NSHV>-2*WT/ R[^_6?][U4F0J!2SFL
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M;\^U()PO["2Z4?ANXW;7_GG0=JH6.H4U8-$^F(&[W%O$UGF2D4 +TB+PU&B
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M;6BF?,5K"PX.&C^-P[2OI3^D?C6^N0> B.7UJX7+U1\:ER5^I[;10"-TH@X
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M]RB>=\T]-[25O7Q:>A8A[E%#<I>/+D?M SI%3)'6"P:<\#&S-D2#05H90/A
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M[VW*_)Q^#@V=H6P7/)3\ PY :QWXP"W?^09:$D<!.U;,4&>$<5#3'!VZ!GB
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M+4+/1@G+&V&$2&_(M>_)[S)W1+P]#08UTS%"6N("]6XLVG%WN#>,)[T7&<*
MQ_Y47[_I=M>^EU%ZUTH"FU PUZ<L>TO4(WG7LWDT+?]0G. 8<@4IFB&]&=AK
M,QD1REZ:U>#-)UW/72M(;-ZP(2*P<"AEC613J:M0XR_BV0B3'.ZK=CHO<EF.
M/S^$%F5U8L=>LA5FZP4.K<"J2V 4+$AOY6I+J=A@I!S)+Z7M(9C;UHA1$8:7
M\[-Q:A*+S":;=\0HQP,1EJ\-"IKI)K^>5:.&IHT#]CZRD<P*4#,]8[C[6$'
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M\D:J(*3,F,'4W4Q:7(%.D"'*EV89PFF11[8H0("\[[B:C];!0:S1E6 ALI5
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M(S"HN_GW"M)>*]JNWE^]W!5_-3_A1=_::]([6A@W=,S5'#> .JX%W0R$E'_
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M753DH$9=%V8I)&'"#5=Q_L]$&2)UX/<(!40C)9K<2,K]?OUER1[P"D!-3%.
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M?"XGM@,&OOK]N7?9E/ZSGC)<NZ3 -WQC IJ$X??=B1.#QX=)V=4?^V8P!V_
MTUSHN[B"OJS+O(+KF AB^V '-$Q.S;"5.97&!BPO=C #%OOWG3=;E;Y,(77!
M]J#+/)3M&$W%5?XY$EO0I/9 JI9X>0+Y"].D[N9/2OC,?9^L7@/(*&]\#V''
MMR'-)")4$,29<0JQ<DL$/NYNM"PU8X53PC;EO-+">!3[%6J#B:0#[5%D<.@!
M=N>B\T'Y2S;1<QO.+5^P1]!#5Y-/^I:[!TQ'91EVM&02B@;U/DU'Q4BNL=O"
MWD+E3)P:WZ-]XD]=VW?V3[)V@[+_VA&1"W>.[2'( .2.*D6@T[#=OB+^G,EI
M[J>2EB!*"B:8[F6<I.Q\=O![Q6&;O>]G&FJB9E@(S#%..58%'=$I0:I'T6QP
M]2;E+X?"(ZD#F]B#H#OU \/S64BYNYGW-=W5@SPYZ2NO3SW]S,SUX 0N^-/4
M_=/>AV![N-],SH!KC $F$^1!X.X?H"UCJ ^HYW_(=J'+4A$T-0:..M05V1"D
M0]U(,C:DX$47/?F'3>3 73U&O?DU4($!DV*J4(V[P]C?=PIK5U)6]!%^]#ZQ
M;CIA)\:!D4$!:(V,/JZ -4.+602.,1+>SYWB9"70^.BR\Q/)C:O03M8EMLZH
M][@&5@YLZS+JZXXZ;3^<ZS >I(FG&2/))/&E0DD/GVGW,RZLLUSFG#D#!JKL
MCZ' 8CI4. D)M$K&VKP+<34E3Z^\9U"'B*,[(V/=7&),%'YM0_:WVVJQ+PQU
MP1,5A$;;X=1![3/\?6[&:KZ^FHW%5W_IC_[:BO$8$!U4-##@U9P JI%A23CZ
MI=5DH$FR$YX"2/*&52QN/\%'BLL'/F;6@9T5'DO-R :MO@P)-,F.H="L%8,B
M4.3IM=%<"3"43-LCOW.:U.5V'@NK-TIUF-8I2?Z^*Y730O"&)?'Z.B:<98P=
M(-7#V6+E7,%G\UK3$\PB1NP]1&P#018[QC3JBV;OHD=TO3&#]R#3 +&5!E)<
M9J"+C&5"NZ'X^,.R;^Z>Q8&>QXR.6/VHL<:/#*4";R9H]8P4:D87]($;G&;(
M*":C5N[3"63]A^'SJQF 4+L_I4:+6<9YV7&*&&:LH9GP"LR]/!H^=! 4(N9X
MPAK>,/3K:]Q^A<XL3_]^L7Q?L;;@%G\!ELA48YT#.AT!<BFLT?G=#](,&S*.
M@;+X,0JV3S-SS4?9LN5N[ M@]:W0CQY+1ES"B^SC0N*-F<]IWP*%N(*YO*JZ
MCQ)\MB$IGA!.LHD8Q@:TIB?,+_00A'NH/ O&!L#EJBE_Y#^GO)H0T5I67M0Y
M[X&T;I=B$+KOCY8&^+[O$'J>IK -<1BYV3:F=.76C8?O3R- 9=]N7'K';LX;
M>)#6I!95N0\G@1WC/>5_AR8$,/*,!2(J#2YJGQO."#T+$U4/!YK91T <55[(
M?C@,*8G.-9,)+\,KO-N3<1V(\*H^B_KZ]DHQ!PTFS2/Y,<;TB"230^BU;IF(
MN'8HN0;JSN!/8B,J/61E8?L7W2P*[H;;>;H/RZ:8CZR,+/Z(.%ER]\\WC]\]
M56K8T]SN/-^5QQ7<(9PDW)<$\B"-UD^!R6)'\U@S&!>PA76A/ZJ([0-FXMG6
M#%A26/@$5QEC.8*Z\FOC32#U\QKQGG+";VE= +JXE3?EYZ!=NHSHXHX2Z'9X
M4%6+)D[/18 .\UJ@"HZXFL05!Y+FA!@+23SCNXOIP^,,"E3V%Y;O?E2@.5TY
M19<4;Z),[^&U2LPJVXZO.9%MZJ]0$_QG%AUQSLJV[5/BCA_(.A2MG.7,Y=DY
MNC.*!I<C)'7(83\2Q $O^ &,(^=I!_]2:('R)Q H9;O$$#U%0 )#B*B4B^M!
M'O@QLEX0:M$B_-/?4V),UT/CRE,U66IN=X88)HK3! 2M[N". '2>%DW!T>U1
M@MR!":YH#/,6&$&?IUH^X K.L,_3[4O)]SEN0!I7>:P]J#0@B6%+W% X(LF$
MD@M43$/DFQ,T7V9Y-#?-8#:ZD/O_)7,QTF)+;$,H%MGSJ^F$-X4U\U&GF3+N
MA ,!W'V@$)4DC.;C\G4RAB[*Y#X(TY!9HP;];(1F:*(43J<(.ZXYC-.NC91$
MJ-U(EI@O' G/ )6Q,2P'H/,\#2#7Z^.@^(Y3'AB \6.B$PKZXX31^1YT,B<M
M6-<.SA572&/!/4C^1@GQU3?2E1BRMO[D^\/S2-I4PX-/&Z^G!2'K:JB9->80
M8X,M:LE4'*&Q;;A[.*\(0<AI=W-.#D:5\1,I0/*?J,<8-3+B6^1YW4*Q!-3G
M=O5*?&TWIR\0G67*'O$5,''A)LU':0TA+RXIMW:68K_ Z':D&7>F)AA1S9W$
M-6C1+K%.8:>-MB'I)H(@_BRGF&U.R9!&$RFD'H[R>P98WXG5IN]_5X;V(K:.
M9Q:AHW]/.(UJL36/C;T8N?9V)+I=ZXWK-L0@3 B>BCW B2;<1,T(]1I)]LRB
MR,B5$-Y@M1GOT& KCAI;OPAPXZDZ$J_9.T^'XT4)T5S8<FMY MN,,D]M>]JN
M^#)0HK7[XJR%\>6\,XV/)T^K/%*>)4D1_'$/D71'TLP$5Z"*OL8\S_B1T ?G
M_Q><O-V7Y8RYQY.*L6&K8B001NF+_HN#>**!]R8PAG+BZM]W!I8I/84&#+V9
M*QYHU"7_\,$='^QL3OL2'MCLN$1N?D (((''C^;2#%D.?H3F!)HDZR1XGPB3
MYVJS#W$><R4Q^[[^A>]CZX_H(F-EGIN(-C& GL'CJT2CWU6,4V!;MU%@H(N;
M^6SOH]:;%EPAO4(-"RL:8,_K5MFDAFU(*A!(FLR@2/8BDVZ[FC&<D:!M.Q_C
MXB+=U=7- V,&NL^C1#"G&<Z5>Y[Y.(4E-M(N$2^!2;K-S4T2P/0/Q=3#$*P]
MMYO4C%N9XOF/SV 4RPW;CVR<R  HCFQ74)R%P [/P>D1\>L<H2LQ5\$9^AIU
MHUL80<T@;D,DV"8G%/VQZNV,7>BN>8L@ SOO3$\-P]+#-YUA123Z^:'80AW0
MC/>[?\!+W@RH*8%>GLK3%<74H=Y!1->]Z@CGZ?)X]0YM-H+AT@W?_VLZ.VYB
MJ!1I3JD!K-K>CDP(^4P\M.)+/PMW57F9#/G?7='7A"Q"<F0_;D';LD)[^>6!
MG(#8CAO:4ME2!8-*):D[!2FFRF^5SX"]Z,&KK=Z"9O(MZ69MN&R+P<E>0T/(
MSI \4)GYA]-JLI_;A>2']L 2<R5E.NKNH&X9\Y&%M2DW&+#T=<9!"_6_#6MF
M;E.3@^'>QQIKV^_,^(V']F9EYSHTNSA5C79=#Z R9!R*I&U<[&J=I&TF[(+'
M,Y>KZM\@OO1K7YA)"OV&3W@+:!;>[XZL/58HJ=SO'^A,:*C<>QDO[LN6_5JI
MVF9Q,N;.$\<[)P%R$8Y^$18'>PWMDB7)H[O<S[CW&7V7= .(*,BT1XD;+HE]
M5D**.QQQS'JTW;#TV^QD080+NOMNR)SK>]*[CF9A;@2\(9<FSW!GO@(;J4 J
M(+6^&3XDM;Q1?_Y+I(D%[H7_:ZNAZQ3._LFL,(XD(OE.T[W @S<B"CE)05:/
M*UF._W)E2A)NP5):MR&]B%3/P_DNX^O^2LTCNOD1?A@#,D?P=%(>D:@@-BK7
MD"/CC!,ZE.<J7?*U43$2NS*HB?@<SM[L>>Z 3&1HQXL35J8OV63<7>PY5U):
MU<:LJ\@]W^#<!I_!%:.&)X[1=1(8KN/!E+R0II#XEVO!*N41B'B&^$@5)\$V
M3[5B.'61$M!?&]#HUV+WMO?)$0=S\3_I@XN-69LEC]G! ,)"3U&*=4'Y:[E*
M;W#&VO$D^U-X5D%JC@YW/D[,P>KZ_WN]P925!@+'7O[';-]9V-CJ_W]P3WG8
M?WJ<@2/$N^N/K3>PP6/E2C"&K;O%8Z&/9HP-SC1AZ\-WWS6G;0B_(=!?@A'C
M,=(2?%V0(0X<L!LC+)?@ML0!%($>FLO.L^Q$L#2+MR$7\2(NC-VS[MQ6:QYZ
MN_QH!WC%6T&"KPE;26>W(>>Y,<"?C$@#GE$.Y?T=^XA^LFIZ:>\(%M&^S*$]
M3Y\O0RS\SU-_M+9)5;B*BP]R-:@7KHX;Z1CE_,L%@$_A@4%&3QLL'KF_H6^T
M86_<NVU(!COB_BUW8J$@_<TW4?VB:H]#/@:Y2-\G?FXVT>%!YR:SSM8I::WH
ML(0QUSEM7*U)M@$86B9O0*1KE)*ZH?)S,W7TA6BVYEI=SC;$I0WY=,XC*N=Z
MD3\$Z)[FCB5U3=9#_Y[G/ )N9L20ZC*ZA$^329WO9(3<A<\<[F!H):YF*C$D
MT]B7C$6$MB$'P:J+>\NHW%\5Z!JAR+O.:7Y),B7)[BMHVUBU!;#B1ATJ5X,X
M:),/!(S8.'@VBCV..G.7:[5E'Z7\A\"O/76;!)THS0.SGY*7' :T6VHQN#@Z
M^.I2);=AX77KPB?5KBK7H&.C!2HCSUO\S3^Z %[(*37RZHHW/04!\@R=I:V[
MT$G_2"KJH,?Q?JJ6+)AG>PN)SNW>*!(O__J[?U:^Y>BMZNG=:0Y*$([_99J0
M^-'D$U,*\A:[8+B[_-YR?+3.OGLMR'>.169"]E(8X\M^(U<?)4?8YBRY305^
M*AAK""JOY&K\-&SR+9QG/.L-?7I#Y^KHR>[QGOEZN0O/7\V?U NP<5([-L/Y
M^KPFP68X[;_-[O6>-!=S<).[_G]AD>Z_^ +>?VR;JQ_J4$'_V^,F9BR)QY@P
M-A(:2.)HLYX\[Y]I^%]&[UIGKP2X!8T<_^9N+11=YEB,@6Z\R#IYI^4$>1LB
MC6N29(L,,*LXR5RU9MH_?F2-8T*I0WS^+ALRN 1:NWB%AQO;'KR855>@6_56
MW:D6<Y\2>/HZ@ JM[%U"W5I('G5NBC]]B@\(,C!]>OR!M.O-_5*4D#]RCVFI
MZ]6K1Z;&3SF>*W27UC_777?M3G=.+ZT8%G: ?_G[3^ECN_1C9VV@PBDQ*:ZI
MAY[G.0RW6=O82*0Z8BI=6?U*N$6L--C6TR'A%;)^Q_X6Z]BGHS:&$[L6#A;8
M'QA2J;#0S@F,M[-P*K*_Q S7_';K<>RH/Y"+Y#'4,C.#QTO*&9+<$85##'T\
M0X%XH?Y+T!'&_L=>E#YZ8TY>7F)S?0:Q:7)TY:! VOJW7&<8PX!02).9WWAM
MCEMIYNX5A ?:F3&#&-@BEL62B>%;NOGOYJ(9MO H]Y#20+4KB+ =Q9MSBZ]-
MO\HXJ!]3K??Y,><QIW;PUI$WF0TO%.^_!/ST5F.0 NU.U%/&""HJ08&?89E8
M<_5,67T-VMW\JYZ\R5FG]AGWV7,"FD'//AY^5E/@9B9FWNN5_DY_>FYN4$+J
M1O+X4:MYJQ>.F7OGORE:?9'/?)5^4@JF(BWEU/<XD]['O.N5^$DYK5 _W- P
M1"(D7.[P7LV;,W>8-@J#?J,A[\8:.5X]0R7.UE0XA'P*JD(G:5"6=)<MQ=4M
M]E^LC"=>#BW 6, T4U7[)K_$W6M4&;GS1.XV_>+M)R4CC;?RE9YGM'8=(M!%
M#IUB+CR<;B&)@UJ='=K<3QF]"F+TH63%4<VTW\^-K8L6C4;\-PX7>>DE?J5F
MUVC*4Q^F-GT4DE(\^%W]1FO#H;\+#X<05W?]E6>-+B]?Y13_],2!T+8MV$ -
M*=OMV^M8C9DLD6ADV 7ZHZ?G5:'9!\SC-,9WB%R9WSSXC?AP7TZ;4-EHDW@&
MY$Y$+30.(TV!\C=5&"M38,)H=Y;;#U2XO['ABU];1Y8F6+^E?VM]SLGLCPP7
M'=3T;M_WRR=$M&D3LEQ1HLC?[2:11#W--ZK'@5E/J)L,"T],AM<<D0_H&VJ\
M31]BNLYG*;V-RP\3S=80E;BY.\8M9UCIK+JM3'?=^4SU "NKKQ\D]'+C_![)
MF1^L^&.*HH3O'/NWW4%#R(RAF1O^$LPP'S4V*Y[K9LPM&GTN\'VU&'$QK31G
M:<#!6G?SW"-!3IG^^V\7H[8R+@PW#$K:-PS_/:/=9S%"TQB9&[ >7E'7718V
M^JR]*E(W2ONRR)#Z(1#;F.:U8]XG-CM1R\P<$FJD_[#(SZX:N/ZKU?[1]%Q-
M2/4R;')<?]KO:WC;L)R!6V&1W@M$0\"HJ3^*R7IFACAI99IE-A#J>9@'[/A>
MF>II4HJ)#,:8X5RC='&FJ90*W_/+:' C>P\],ZK->11_,U,TY*KE#]JTR ;M
M;&&N.>1?3DBL--N(?F:P9S6Z?1<9V.,QVW6HM8U.B/^+@+[[J'I,:A7^1I<%
M;4P<^'B-9?KXPYJRR"W1C[ F[^ES#P2?NNX[2[N6'**4>:@_V.W$[-[-D %(
MD,-9N1DPXNSCJTBQ--@%A:/NDJ/S$R3K2Z_ZRG+V,RO#?BD+NL.Z=R"?]'I]
ME%L]B-;JQ&KEVJ DT&9$!=7'EL^"&Y(PED6_MK[E.7U!YPGE:]&L/-V%GI7$
MBMT_4:-XKB.PREPF?3P9\CE+)4\RWF_#O5^T3\GQO4]:T37'^_Z'5,:7 QB[
M4S7O&J&^/[A*02,[L?OI82Y-'<+T\H1VY: HW8CF$##T_/#?0/?E\LAOLPB%
M[-U[?MZYF1O6;)JN9.*P63+D80X)*3Q$MXQNMWWE+].<9'R84G/_\K"/_]\S
M"/=AW0(>DEBWAN[0]INX]^2.7?F P11E;7IH(##C"&D0]>V\I:N$T$<+<M_U
M<'_7CTU[^W)<BQ.O[8N\8/8'H7CLWO]VU_._:Y>.XYS$,;L6X4;3XWC%9X=/
M=DDGB'SXN+L][C@$DZ[&YI$+N0;>L,%S0/ZDF=!YA<K:I:P!"C)!07V\0XJM
M_^7PZ88T:%>A\#L4].J<?U\[5Y5G":O!9/:&0=/D?#*OX 5GCP5-GXW7\SU:
M$GX^;4TZWBPS%W7*4N;EHT\W-TUO>8$\JHQNY$'E8< /N9?[!2:"->8.=?!-
MF)S ' 'KJ(%#,H.E:&4KQ $TL7/NV-CX(,;RI2?ZGKP+8CS<SB3HG&&XAGZ0
M!,E1/\3NKN9Y.Z4;B!C&+OYG7MKM\*_4'S9IUO97Z^Y@IANQ3IK)B,LMCAT3
MOLRA+XBDMT+QF,M#@2%8@X0_M8=Z;A<>S]@QO^;?FQ>O[[2IT^,8FGW*HOI/
MO[U89/EJSQW3ED8!X/17EV%^I@6GRO9#,?,6^%<IV2+>/(;"WRUPPTP!DC&8
M0=2XYVWVUDZ8-OCAX>NFWP9V;WE]WIQ3#?\U@X4#E$(P>QOR:19[_)?7DDE
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M6]>B;JPAE;7K17:AQL,!\7I;+FNDY+I$_@Y@4^T&H(VR"/X;L%$0[J[[Q*Z
M)>X*7VFN(RE@82?3B/8GSHN*:)H>?BXHH3T;=9?Z3.\PJ8>U<%P0)NZB5R >
MBO<(;<!.SEAH?S-,T<B; NB!-@TT8S"Z=+;3GYUMU::2\W%<'<A)?8<JQX:=
M!L:30]#W_U@ITM)DFHP>VG*\ZW@V?([H%6V;T!3<S0OB0!D1:*,&&*7P*7P7
M5IFM'+>_/\1NSC["!:Q"[Q%+)QE,E-?4E?>_GQ\8FW7)3(BG2&-P=8W0D7WQ
M].WTB;1PAP0"NCN^UD[<$R[+SV=C0&W6_ *'_DWC<G\(Z4^DS+\;%2HG4&W?
M@4Z<[G@*>"\KT0[Q>'P7X!!]!_+WK;H&R=\YY1K>K _AZQ!'JFK-YA)!K<($
MY%62DZ1B[C@942FS*5/X88ML-Z-;"9MX(8._;VAADML=>Q)$:N:<^E$4?UJT
M"A%3J%:"LS@#H*8-%H.HS"E^'R M^77=3ZA>7(P4>+_9FK>Y#FT4C9,/RAM&
M9?)SRT9'LV'GRFVKW!WF9Y;]O="VZ7]&-@O4QN'Z(BK"#Q;_[_C,  =0&_;8
M0I'[@*HU04XF41R2J0H\YZ[<#^@3#/&N?ORNV<Q?V:@'(?<$T1JNU=78EO)-
M%^;[O>2BP16QM#OO;3>_<DAL+$'/%;BQ;8'$\LX 66SD?/N$K'N;6UI,8B[6
MMUE]/3"4Q.DF9@IKOQ9KAJ.3:N)H)F"J<T6VT9;D!:$)6GWY\ <T$M3+:"9&
M2ZI)6E"46 L<^("[H&$/9@-9'(>%HSRY@%JO )A?+^XR.Y$5Y9:3BRZV>?!F
M-OU09\'G)"]MTH. VZB7VKZ:-]UN0#\0)DI(E()/P%&Q-$MP57@=E-#+N@>N
M@S5BC[62)[+#S@W\B1!9.0QR!_\,9.^C&')\!8<&-Y3<LM;1T;FK1FPA@+H9
M\Y,"77##Q"U\3PYB\">8Q'-IR%2J?PTJ-.3(\!P8A(2<H\/L.DL[#^8?<BQB
M>W VAE&3?NA[I>JG8)'AC$9$''>KU"MB.PS4FQ+NB!5+_P5.B*6K!!Y")_"R
MP!CKT$B0$VH -+1[L^?!_I!N%0\D&.9D[W2Z6B69N+F8$V^02U6Z&YEC3:E)
MR>Q#O='7?_?$4_2:[H?<U2) X91 68#%=9@O%VP :YOYV\!(;C$!C4BFRU"-
MN(MQ+#GA\>+9E= @W$Y0!\9("FK [XJU ?*:!(R52V,!F7/(KJ"[J@Y)96J&
M$(0C[M^MVJ^(XH3W@ U<Y04C-C)!9>@-\'MB6R@3L<MX&*Z&.]T'U\"N__IW
MX?1W;"[[(OVM/T*.@O(*NJ?QW1X>BUZ7T#IK%Z5IFD=\+384,Q$;\-+";0!K
M095+V'6]!2"W.N%,^X0:I7YPM2$+FS*0> EL*9T>@3V\([1D)ZE>H#-#4"*'
MRTP*7<?V,7,A=,CK<BTUP<F[@_YU#2+<@4= Q/V(ZEBA8G^#YSY17JZH6GB4
M=Y3MT.@ P7*YUJPHX>X)-2/.'1>:"H\>8S),/<R&0D9&L,B+0 QQ%V$[%C_E
M\/ARV(.\.<?LL^!H7CF ^*"VR""/Z'$+YV,E>.."12;NG5!0$\H@/X6?$+TU
M40M89U*3;$*,54DNG"!_&W]@M6>_;>Z<F:=A/W@B]LGMB87U#Q'>%NZ2TE5*
MJ!R./>K&ZXY9)B7@#P]03P'-;30M,(*G:@40&\E//8T&A9N*L:==V;S-9,XH
M=!MVAW@-TNRY/6$2DL@P%PQ?"W!1&EF@.EZL55P]-;,&448$D!_3]/L)-TGQ
MZE*B=T+K"?)&?"]A#_5H+NXH%8Q@1R!W@T'<'R/DV)"Y+$P,_N G.M!*I6T$
MNF9'X;D1G%S31_?>!IA;F+I%C=EC2U \!Z$\N4FL3I A-#HO^P?K20WB;"4G
MKR8JIB1A+J6O4_Q:E?L-2V@L*_@6<-QB=%36Y5),9U25YL?CL):_O@*+UFI"
M.4PH%S[$FG\V.D,"KB#BG/F7#'TJ^LO0N C>, /CM\4LM-J4PYZ,C:KGW+7U
MA"!R,2/NXJU!@KWX#G5$#8CD>7&4XS%PK6PEHYU(< .;T.R@+O3ED6(LS.ZJ
MJ'H0VN![_GU49.<L;4??^TU5R\M5/S]D6E*J90RF=XR45MAPUB#54D)%Y0;"
M=DD7A,:PU!'>@D49? _-1)2+U\1:3=C,]^?/N-4OT&-QIWBQ;3L\W8=/<2ZC
MLQV;6$WR(QZSZCK KT(4JNBP783MX_:/A5S,DPPNLMD!/* CW,EJ#J,#3JSU
MA,;C0@S7B"B'N]Q#83TE5&(:Z7$5.!_0*(+M >]OP.L Y!;B4[PD &:;IK)/
M*)<#?X&<)-$;PMM1?_B9GE/\;YIP.Z.&,JOF-4C%V11!@' =.,S%C)*;Z95A
M0D7'9CZ%M[SX!'%[;@TR+&@:UP&&LKQTHN!'9Y'K\*K3-$V>;&'\'30YOYIW
M 6[8H]+7[)(0&8!M8>C&0*##!F%\9PGDZK$N#4P)5/Y(3MZ0Q"6.*)P!A&+M
M-4CTIDB!I="T'W&;I12@$JXZMQ@;FJ$2C.8IG"5*VLZY7GWA+<-.28(VB.Y:
M+O6KBUTG\!,21!7PO:<D5'@)P&*%'CQE_G8P6R)7;CQH-.V$7Z9)QD.</X>X
MOCU?:#!4A5J#0%M@\91LIY/UKB8R2K3R'!_ES9V.%4?U4ULFF_G(!/H$>0T"
M.-C+\'%4T6L*:Z20;11'N28\85K)9DGY>1[L"X1K84G7_O%H*P -F]E4I9&:
M)'>W@9!\8O.O^-=C.P>Z>M$E&V*%[T0U5=!X4G79HE".>0EDLHE[Q)_QYB!7
M8"L\53^$0P!,SB8A; =^C]LL3$IH'9%W[1NVY#*0G?0SMF1694]X:&[Q=-^,
M:5*>O;[2@M8 [5;#NCE"M3&]IE"X8Y%-B)&8LG_+^1@<Y1<!83%X7:$!D,'H
M?@13$ROC5'K:DH3[N 25;V#@$C16O!?03LU#3I/DRG('G*?.QCK8QI3Y;GZ=
M&M=29&NI(]XZ++B$'^1GKD$:8,,N8NDU"*>1#1W1:"- :0?% SE'!LYF^1;9
MLR7?1]](E7]0,KVJ):I^>V'(CF?3EC)-A[[./-<VHF/&-MVEE10Y)8$/8(,8
MKF:VYFP!$WF5$OPOW!-<,6L:N]_?BM\.M"UX"*SF" JX#6R2PC1;F\*[D[.]
MIC\X&^HX0&DM?SQEGW7=_>.?E6J?ZJ4+*Z>17<AA4C.RAKE %-P0?Y-\^.7%
M83T.:9XY@8FE'>)E,^>S@ 3DR 8V\RDULA2)TP(WE+;X%'F"]A:JG.[M_B.*
ML40+_YLAY'&39=K[%:74IJ$YM$'ISQ\;5HSXMT05M%W"^Z($N*IX6*4[+IB\
M%0MS ]U]N 38[,@_O=]F<K8,_7'?8B#>-QW^M-IP:2-0DXBN$NU>>+Y[_"=*
M7J7XP?YK%E83$L574I"TM"F>7A-,QD*1AVIQ,XNC[1L?FV9M6X;!</O!$F"T
M<0TB;W)-+DL7)\5%J&)=3@.8>/N!4*9LWK?&R =AQ76MZ/7/G+D\(_[=?HG?
M]B')2GR*@\33$8!+!E>%ML#H9="' QT]T6@>._^739<;:2P5:H-M!'T)I>Z(
M9<!+>;7?HM@KC-WH$'O#D;Y(M^_M09R=@\&"SY?W&PO5).B[+DI?AGWK/ ?^
MVP0@H@R$)$M4DAB$1,06N!).5T2B^@+]#>;(!?>);EGP,0<*'45YRI$:G]L&
M^18)C0"AHT= $+9556;8,/@E-\JZ[T>L8\(-Z%S'+W&_0^7'@<#W.YHZ1J1_
M!1HN!FXJ2TJKH@9]'__N4=]^I<8=6Z9U%&.[GW+R?=9^_Y=B3Q IED%(V OP
M:EJ@4-S!7OBQ[U5M"4(7HT?"P]R(Q5B$ H4<)=;A/<N,T+6 L;L3P[NC@XGK
M4?A]'ZF43S7VJA<'38YX'\Z+T4R'F?4C,*,2:7I*^K"RP *($]!X"G$7#MU/
M]R4EJ"M]!&)C+*Q\B[#TBSR;.+AJ0$VXPQ.33JCLEY'W*64@W>Z(NW]H*H-8
MK%]CMQE$LWPG71X1[BR"6D]8@.WB,(9-9BP@FF J?SJ-I(72X#VT0!.T$BAX
M@+_+\#UB*+WG3[MQEP8[Z6OY6_"QD8+_N$5_%4;!<[8F,X?$C]"+Z*QZX&:3
MU("X0O?'@ >EYC&" \*31+9O"RS.4WL K].8WTA&20BGB#L"IO)R6\2[>@Q3
M:%WOP4(KT(--4!C'^MJFJSXHC*AK_5"=H!>1%>^&PHZ?[^/!)"V OQ<@-Y"B
M613:&]YH<Q!."B1S48B8'$4PL6!DSHT6#4TR,A[S<E9!2++$'4R5I=35"G%C
MSCB_T[FJDEY1^T(S7O/)7\)+T@=2&^8AJ8*U\.^>)&< Y((_E[19N F<XT'Y
M#RO =C8ZC$N,,V9M<>"2A^NN2%07354PC.(@E.;,<S(B\['N3M4\TZC(UZYS
M-?VC 4=*UYM$O-R%OVR7!R(YR1D1$G; 55_@VTF4#.$>'0!Z'91'A^5U%TSC
M]8!,JS7(EL4D"Q>VO>&\ 2-<)Q'G[H6VI+V.JU9Y_JU-*R%NX3L$.EW7S +<
M6*!.89P7;X[X5&4Q-@2YWO\N*HF-5)'4+EI"125LM_6@YJ$9M]AFV-993U6X
M+IB&*OFNV>45,>&AX>S1.AQB6F57;^Y.+"-XDT:]^"$BBA#!-9+#K>,E%W(V
M +\9]["(MAQUGMD3H=.$D0H6X1D15EM-X9E%X7P+_&C[^GP&]KMG4#Y2^Q:L
M <JGPXON7C6_L_A1 #W6A @:=@L5:((K/91BWQZ"%VLDZGI_P:<J>[Y*>G89
MZ'*Q3XD)>8><20$?7ZEJBKGR*>WM%M--]0+E4?<1"=UOT2?*9M 8Q=K."<(W
M?@2QDJ&1/ N""HR[UUE?;%CT6G>L_6BXYD9?XW6")Y"-*>/IN420/DX0J6K9
M_H\C$[;A<Z=9'6]31:Y"PI]]CO3+?S"3E\UCKO[0DYM5%;Q)F-K-_7!LD1A@
M[B T6H/8OGHAWDU@=A#^<>#0Q=LCUR#/?PN.$(8->&1Q?G6(D,Y<5EN#2,&_
ML8Q:,<-$9]?3KK 8\8G*H]M2]7NPE?;/K\)C3#[%E[?B>I?)D[U,%!IV]UVM
MI+7$PL>B">8\HO#%JPSP VLU-A8Q#GWK(LR=BB7P97/6('.7LY^22Q%>A&_,
M?UM&(R_1#D0 &>=^V\6%&.T&*\1[L+X-8J7DGR9U3 N;\.-R,4@PP_^@].#R
MKC>0VU]?"?:(VY#*=#3]J3FR"?IDQ.&EK]P8V-D2UB//IF\$D0M;#*OH<N,0
M5\8V&\&)<Y<NEA<U0X5_759U\ Q6N6_CXC??B87")LR3VF G)#4T4](UT$5Y
M][$9;>,'EFQ)UWE:P/7V2>E\E=!,[\,S_/L,Q7O'_<U!AR>H_QIH>'$X5/W\
ME=$Y?RW-^@"/!^K0/N3,\33LX1>$FS\49VZ/:_YT-:?<IQ:@LG39_\"U%3)6
M>W.L3;J2"[<F^?0$6OSA6E>_4=[?-F\DV(E3%<7@Y=R%!\#+MWRI'TW=2$0<
MBJ!"C[>(X!"U,2>N\S9-G.P[5_ @PZ'<T.EB>;IQTLE_J'2?,9M-#,?&NX]=
M?9+/^4;G[HA?F$0:8MTL2Q=52]!WHSY^==E;\:5\FVL)+D7,"S\A*Z@_YKD>
M.#&8<>OU1+ -NNW7X[J[I821[L"[A7N8BU?\+C7UQ<"VO?#KO?[,=LS0>:"J
M@OG*]$_MO],/#]P>'O)G/,@Y8?&U<NO?]ZA7G  .[V_ROD]76C@'[3\-V=<$
M'!F%*OYJ@ZI<3KB<8//Y@[A%HO0&59]#'.8E##5,Q'",>1ZDATZM\/TDMH@<
M=^:MWW(<[K %9V1\TOM[?]FGK2VI7TYKG#2E8@1:POV\-4A"%4(Y ,#FVE-Y
MV\Q]2$^-Z=O!&L\>W'&.P$/I9E!^&T=M<ZMK:=5E'S@O0-NCNCWHP>0.YHX,
M'FFTD#->#JR.L@,SWH),AE@]Z@I/O3"$6R_%IH0>X JZI6=6+3)6W+YFOYM]
MZ)_IF?3V9795*[7Q8_)JU]ON9PQ!QGP]9RRH!;;%XN@:1)J02#%2QO8Q+U13
MAQ:-NU .0[^\^I9?!8; MM7$Z_1]+D^\5@?,C9@PAWO.+EGK!=XG)[\L["A=
M@Y01R(PEG66\;W=@I-&*/Z@F3@7(C:LP!F:'T+$\846\@[ #1-D K:7J?VP+
M;7+]X-<J*JK[APY7G_/2RGM^.[+56G==2OFD2MA\$E!H^R'6NO(C+Z5/7ZSO
M3]JE'UQL86M1>SN#JV:X!G$=-!AOZNR0))U?!<Q !(7M419L4&HG]Z&8_ JO
MC;L!QDN$<A1SKM\A,427)C^S)+3H%5JQ:Y[9%-C<XWZS./76__=^WJ=1IW-Y
M%D^- ZY$/?;#?V&I_COYEVO6)AO!R"0E"*]-#.-@I>#O1KAL_]BRCH<BSC?R
MM5^*G]NA_7I=CDN=S8#-SJ44OL_VK.IQVZN^K +6&\1\#I+Y1:!Q390IWH/*
M40&+V1'3U',COJT(!9UXZNW>N?M6(>K%LM_-G[@H*=\X@_[SS1"MH8>J1IJ:
M^OA8[&SA$>:) +$U1[>6!R^@':RH&^+V*;?4NL0*+T?D^JD;$D]6Q\AJSS%4
MU-(U!K4K3>_I'_FXG1Y0=^.K;TK)2X"T$/9V;J20 86B2-N%J FD JC'YI?P
M5"2!^Q758B^M)[C=6]FQ/0AUHM.K]"S^JW<_^9A>R-(KS:3OB 9"]?9'7+(B
M[@3 Q<IPE*/OX/7\S3))CRSL.&C3ONZ+S/>44;]?F%)TNAZ(>[/1T8KOK_-[
M\]O G6\/-NZ]&>D[[V$3LH):%8V?$G?^"%F#R"%\,$_H.Z@V9@E5+W'7WLR.
MM$8KQU3ULXV4L+'-=\$HZX2QA3NE(0(9I629Z?D%CE^9[$  FL&\:6?23,WY
M-$&(I:D!RH\HL-C,+50DU$\%Y:]R?GQ<>G%OU?,312/?K\OYI$=@?;/#SN5_
M"/JX<,(">D;T[H_$)L6+8?]:R6BZG%#:Z*F)FI<]X$GFG"! K95R#>.>6S#O
MSRC5EHG&4S![;=U:?R[(L=ZDMB<@*^FIK;/(&D0,6G$9;<;&,"Q=&BJP'&CL
MB"]Q88'2 K06<FR7CU-*BFI$KSMWN(^=7H-0C_^.3_VUL%?VUE@J_2R9D-%]
M5^)ME\3TO$A[H(1-CJ'M '7. SI/DM_6JC]GUB@EEEQ7+6E17F$J5\;['&YU
M-,WQO[#;4\YT UH37(,0"=X.41(C377AD!3GVKEV$8MJTYVOP7>CIWF!E?E^
MJ\O_V-<.DN?_##L?R&RH;Z\VB^I((AM:/'MK:W4WQT!4(U8%75I7R3%3 "LA
M!+8=]&*8JLOS;(C&OU]GG[ :"MFMSTWN"N::HY0!_]]C31G],Y>^W-F68MFP
M&87FX]""VV!0HZ<VCQ^_!MG:S]&F^P#-SKU.;7"-GC\B\Y7F5>?$,G>3P60J
M!A,B:^X?Z#:^ 39<KAOU>8O6U@Y7.Z4L?^/Q18](*U%&9\\,SEJP1ZC-7$8?
M]<Q<:1MQ+G\#&ET "?FS;CK))K);5UG-*E?,0I_YMQ>Y$BDO#<LPOS3J$MAY
M"D].RI_^%-AL+<J"[\3>)\1TO9[)3'])DJ::<6 RX.EQ-;<EF7L%V,P1&?O
M2/M)9_3%5;;35[NFMCOD [<<KYX3"FQ%%1;2)FV)_2UX)=[4PS(<;.(<37>X
MBU-OV#K.98BE7HWHV5N=B[ /]YNL&PB\ZMAVX>-=S/G:O5X;D]00&\7#.=*\
M<+!B1-"$/P"T5DG2X<99F/R"L?UY!UF/+C+H>_%18#ZUTD[-<=7=X.(N0WU5
MQWXCAJ-K8N<1XM%.0Z9X> J,%1BEC'B*.V#2OX2;)F"Q#=BL"U6@A^4"\[&%
M32[X^+<M+_21R<( T^QLY]7*DPNH(*W.TO;]Z.%M 70&]R/@VTC8)#P!AD4
M]":9=_[FVKF^I08+ *TNPX,Z6/7'>W!YN*HS5[,B8&4_\L@!A1O7%%<,E>5!
MY!/$G2Z9UMKN1\8W@6:.=BJ:9]4<7OUIPM[.A=*7VR>T,TRYS33+/+-=K3M+
MKS[ZX7W35R;G[A=)APR+DN%'L:-<9'.2"X.& "9_)D;X<]"8B]5U'Q-:Q_MF
MATVR3W_W&^(-0\IT8CQ9 L-9V[O>_G*3\?<5WZ&Z\8$EJTM_-BTC-?K1^'6X
MXU6@F4[#9^.Y F =,)^CBNU;IM?HU*3EY7"=//S.5,@&1 Q[9__<FVH>J^HE
M&KSKJ2M*QLMCFUBGHYP(N[^-^8W+]0NE(HJFX?H#QO8.+>-;^G='U\10O8JN
ME:++9A;2W4?##M1[AS@^ODY2 G $)81_%X'K$E<J/H*ELR_& VN0MMJI9LP&
MT%>23'W[.5%. ..0;1#'04&U*J4*Y3Y%+3?E=SB;G*EW/$T-B&0Q)#&S"OJ(
MI@1&L)&JVF6\"*Y48GY='\5>I\%<BZI"3JR2U6ZUMW$<].E_F_*F5]_@SX?N
M=P&3&P]E)#WF.(R51<R)\%G$[P(8U(')T\>R^%= *VX8,,FHQN\#7N0H ;/@
MP8ZIAA$QF1T1+U3<<_H[ULG);[B+%=MW"-=TVOCMM>%)U<Y^G+U 5ZC#,WPU
M479DB-6BOKT.V!Q#4P18\3AI3C:R&:[W 9CO7:3VNC-28)393'L@62,$O;]<
M=FJ3SS45+0X&@7;8.),C]8GGLQ)%1?F4SB#E_SA$BW4!K86T?%+"']C.N:'X
ML!M]I^Y/UZ9G6Y:<-A:=7E\<KO%Q(_GYIR#Q,![:3T$FK+8E4*$\F285>N.P
M<1M/ZLFRAWIOR(E.A+RHWEC6LVEZ5JGVNO,*U[Y><*$VKU.MU'_/L\K4@T>1
MUP3*DS,E?Q=^&O$)-8&!]$*V5]D0PGLQ2J7P,55U F6IX]%C3%\W&Z:N"8P7
MLR/#KO0*K3?7/)!Q"W AC,S4VF4E>5,=9YUL?W=K'OHTO/MS(48 P^VKZJF"
M;3]).ZB"+^;!3H+YH02V%JUN0(OG&[NPM^KQ3[O12HUSVKK=#QY*,QX<>'1]
M,8J.ADJ!W6PB@QX?BI?C&:23@+[6OM^7JW,6K0;OA)PS[&._(=H/&5O:.59\
M_'1J#RFP>I_LJPAK[5,'I$=0+,KV#-,W;,1F_U7/*DPI[@)XF(R[W+/LIY5L
MTJL_3W&HSCMZ4SZ3,^)>XO&T5/':(]V)!2,1N=M]9?FFN/U'\/@^40Y-#9OA
M#.:^"P!F*Q$MB]NG:2J\QU;%8^ZZDDM8V>FEG16&B>TW?/O@1[JSDV!&H^;2
MU?UWQ5XE$L^^>=F[1V5IA:,P!@8U$8 867>Q0O9I>R<7X(5;[NPSOU515Z-7
M) JE\:4V8C^CFM<=6O;[6'?7N+PHCV;@'PZ;1^8:II5BES )0SG[Z;QH<==!
M#Y>6_N$ /9][!=]FP\?S;Q;Z\VL5LR>8)F<P1Y;$)U1UYY_<EHE"],T)G/W3
MD0K&L%B\#HCD09L^@'3&"GX[,)40 AI/ZU<E.9JZ4#[&6F<XU@XJV-8:[$DW
M?]J;Z)+LK_+E8HDIE%]5)7:9*9RY\6\C/+$HC>^B0RU4W^&.#/R)(ENPI(W5
M",WX'8+0]\S#;?E@\D+@>P/,NDN!VE7KE$9.*UY 4WX$3QG1O>G18>-RQ,8N
MH\32,@.:9@!2\4Y(!%1^S!5+LN/=+M[#<[A7$#!4I/GX@,I5ZYJ#G4?6;^<\
M9&8'P&J,HO_,D>1L0X!^SH5:Y2=P+7N@K@5^D/*A[WVPK(Y[LKBO]2M?E74<
M/Y3A>/WK[4>G1<1VZUOV32D9;\6#\ /]8D-Q[VK84ZK6>QM@E*V>Y%4ZC)RI
M=@MIZ:JBAO9=3.G&;'Z#B=!:@R2FSQ.\+XA#\LE\D^FZY^OT[^_X1D?,B6$\
M*-^SVE*/@2R?:NQ6 F.FK@]"D]X;F*"M[.@\G9@R:DAI,]M((2!3C:+$'V'&
M"<V?:[J,--GYWJFIG-1,^]Z^[[;OE=5WK8HU3\^DZ)\K/ZWH=33NJI?S8]VW
M"9CET[K[HEUU/1B_O*4VT9Q$.?2 [JWB'K/: N)KT(&1N7'5F;1I^N/ +PN#
M]]\H9J6_/EP? ^U<!LON8"8.O:G]0,4&RA<^L:5=$L"KXAY[:SQSE6,_.GMB
MIVF/],%U>Y(?:/YX?N_%I[\D"OBG7F0LU,=LOWBU'9C#U+-X6F\3#I[?JOOV
MX?^;:]__/N<CX,<:Y"Z!BDAYY\CM"&T]7^H-.>+PZ\6-< 4P7/W _S $Q.%_
M'@(BOP9Y'#JSDHEI,+@M,W>\5#N#F[$@&VKP\ZE-W"^\*?;7N1\GS?,28Z58
MEG._9KD-:Y#:OAE)5IL9B1W#/NWG_CKL7T ?VM/49=S/E*JT+URZ$X.DTF9,
M"5JE[;8IM]95FU,>'E]*@.S\Y_-S\Q.,3T?.[0U.G828/\T<O+]!U[(9BKOW
M#Y[@T/?&:O?V*W>/W27DX&FL[-"6B"I%$MT[\W=BE! V@3LS:*9\/C3DX)5H
M-^DUB*6.$GW);^['&'&RC=\O>FS3B$C*08"D(AO!>3"*KP;.AB2RXL<WB$BT
MO=B,<_6@#M<R4#6$IY.PC(D)]RX?!3O9R+AAWT$+^QLOS2TR=J11GLMD5^!/
M@TZM](KD?+0 CK5K(U29M=E6L:()E)S\-]C^5B62DL5MG$$8X,EL&M>K!\(8
MBU'AYC,CCX#"^& !2G9# S/]X%[TCMECURDT[!*=GE42\O*UZMC6SQ4V/].2
M!ILF-:.C-&?OGMT%B;)08[ATC1N(DA#>1'54$)C:2J_T;2#OQ"9,)H[-UDXU
MK4$V!YA'<RLW:_^Z9IP5C]F3\JS?9R#](#Z4_+P5Z')['O3FF(GVI.ZU8<\
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M9OJ:&L_6NPWJF:=-:J>Y:/ VAG[MS^16D2"@GCO/)5H84@+:-6=F/!4JU0[
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MAQRXX5W7OP9YP ]"!9;+4ZM"X!JB="^FQ"7GY2:V_&R!P\VB- _B$%.GV-[
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M&8F_0A<Q*Y&Q!+U'H['OP<3S_6 TG>*^8&@YUF$<!J-)/;[U<&LM%EE&"H7
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M-7.(DH>@T<;>JY.9E\3\/<P>A8D"A-8LEI8$7I"9*MU\4K4*@BRNK'4LG7_
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M2]%Y_H$],<MGD0R><!ITF1O ;)/D7/88Q/L)6/K5"_P%NU.=@0V=@44WI#H
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M.#PW#O^UXO -<WCJ#E0<GH'#XX'YBL'7SN#1K("*NU?G[JYJ,E=,G[]E7D*
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M/&TOZH&#)=(!66J)5&MKN27266.I)5)5\H66B%"TE:I2+P5(*]6B7Q:0=G9
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M3-?7AB)X[=#_NACM'JD3C'5:3(-;7'4FR!T4ZZ2)&(FH-S*723'-"!#N$/0
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M9FUJ=0!+@,0W"[NI10:;BN%:R,8+WRWPI<8<FC.+HAJ6 -"=D$7XS!LZ5EQ
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M3\@4O^3R86^.,:B)7%/C"_&. V-1PHLJL>H[_"Z.?6$#T/&/5$ 8KY3$IPG
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M->IWNI>=;Z)=^UQRQ:IH'>"L/7##_B@*6XP=A.*C;\46%3YS8=Z BGDMH(_
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MA)E>R3"JH 31\B+?,'4R8X253#1FE@5#AJ%:,+CN0H&S=ZSG,QZ5SH$[3>(
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MF;[VW\:)$\V!)KX\$WLZ:^C*@9L2DVI'O-!^2F#"$Z7%_E=+*KU9WUJ:O.$
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M&\ZL1]KTY=+D6ESCV/JR 9N=_51;UR9(L3[N#7S291D6I:A ,9J?8K62!;^
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M,Y0;+:HML'0 P01B-GHPO:A:.ZKY0":$F;M<DBIM!#[IG5F#H67- $HD$%>
MH/[;^Y6995*J]E=!9SJCI_2(LQ"PF:2D+Y5]BZ9#;P/>1EXZ-N9.'SHDD7LB
MSN+7I%N5(JGN$_^",29<!]"D.T ]/-_A/]6&C@%-)5]'0DM+;YMDHO(Q.Y5E
M5H\NK!2*<_Q36VT,D1G?:1U60N<^[]'*EC.3=WF\Q*OC.R<@C$)BU53\TD98
M;VK'Z/O:71I@O F&.;1D&8H*^0WX:W<@':9@NX(17QQ&F!UD-AUR&&X>8QKC
M@.I/M<*VF<6WSLP-*AA-Q'A;@GZHB]C5)*=)?MUE?P?KAIW\!X11C@ZH$(58
MC)$H+4"MVA4>KY(IBDCLN\]F&KO!AYOBG^6ZPW?8T0NS:_HM62.!%E@P\3N)
M9+K$$*;EHLB$_*A0D@^UYA)F5$.-JV.?NLIJM:)2R^\8\CI.VMG",,TB</%)
M%:1U.#2ZCNS+G=6'I-?T"BY#'B#"!:;@FR+JDOI]<+UQ2GB14V&! PV*C+3+
MZ4;'M4_9UG^,9V>$G;4JH:FQ<V0%3M_E8HXY/D7ZV>[C5#0=SK6E1I<F"J <
MM85@0,O,R[Q<\$\><:GL$1R6?N11B(5T%G\/D#NG<IE,/*V% 3W@=QK@FART
M%=)%"JN2N6)"R1NT%[Y(UD(EX(V5@-?;7EU=3KO2KA952G=99%DC$J_.88+1
M,6@KJ]I#L-DDN!2QNPOF9=-S^F\P?')YCN!<JQF(C J-XL_QH^SK>%;)R7?N
MBWM>I)C<'K3Q449?4 )8!XS;'0T)P)]H'/1)^JCEC<4DPX_)A1NPORDZ-W^0
M(<IU.?PMHLR<PJAA;Z60R)7<&=RM@0]IW1IKJI[L1;/!T^M%0K>PMT=>W3+F
M^DUA03A%-Y/E19))!D!N=+?9_F0*.WD#]AU[%<!NDFRQJVP-#D_!6JJO;#GK
M=+.7"JJ)YPQ(/6N2CMA/2H#2S6:1U)O- SVGE0\=,N*N>4)"PH9(W_X(B8KO
M.AKE"8U(U]8TEXJ3E%-9VV[%7$,;K?Y8;N1.LD??1334XL?MLVJ$%7<>$LBX
M402*@(EV/<L+S%X_>:4S]#H #Y,U4SN!MVY O? ](!? ]*J$Q88' 2NOR9@6
M#%]VIY!;_MY9CEWL<<%0?^DUZ1?1=%=5V2[4H:1;K2!+]0N]"\*WWXY*\')$
M)=@A*L'3$95@1"4X@MC/ZZ8Q2\9R">TAOL=,GETS20$L=K$7(V<@?<!>!+1J
M?LW_N.++D%R=?SN<UK#740*%6<UF4[X^B_\6D/,J73M_8HFX"VO]".%CW"EM
M3<:E>#RU,L4GY 844S$I;23:C4JO(6=".N9(]L/<4)EEMA/ [+DE$CJ/9&5T
M)4+SH@[)YN47H0?#B0/[6/Z#0:#</L$:.8%Y_H'ECC1T<_=ON-??E-4[&&3(
M5A3XGL3RKP6!EZZ#7MB-L_];WQ5M?5>GU!\FE%C/U@AA>V0MB1F5'7);&%&2
M%WU5,5 O20=M<YRQ:Z,KEZ@GVTG#1#8-$]@G;"9:_]@^>OTE1(*"HVTQ]&%\
MZY&R@,4F-, 0C:"-+&K3#=Y!3A8(>EI0>B&7BBPX/A]O-!IK^"VK9I(L,+7-
M7P5VJ L(A$-A=B8P:K,C9=LM;)2 4TL<GN&H"!U5Y8-NF*.IEVKPOH"-LO#K
MPI!&GR] 2<LE$"2!"GF>J9:T3'!V&T0S^&!@9$B"<>18_5N[U-']CF2B3LI2
MD:P[,5OQ3DEA+CG>S'^S'$[0:CZU9^-!CB=*N)_,[,$,X!.[,7>=8?O=1&EE
M^IFM';\$^>>R%@]Y6[MLU&V7'9-M!SZ=OYII2A90%.2L2(VQ+9)V E*,6>_Y
MLGVVI&UJSG"1WOFMR)"3>]ND''&;M(V"W7=4#4G+;V=OSZ(9W :-OLP1M&'Q
M0O254S[2^;?T"GUK3W;8#<BST==)70%'VEU47P<1N110#&58B:+FZT: ]46R
M>W9+(/2<=Z*W++/W6!),J,,>X(9*N^:2E2'##">X&&P#H2W)$%Z1!2LA=EA3
MW4FBT)*,OA_H^0#CX$"8#>C[*[#SG<XA3>R"),*C[BLODL@O#R9?U'I52'YB
M8^UXG>^P>+0K9&99KG6:OM[FEKG&+1'=YF5').BVXSNTX*@ /TWB_^9]BF!4
M N.-!0[++E^BTT!/6]!OBUHA<J]-R&>IK^/V3X21RN(Q?]W*R0WBLE%XZ\7V
MUMN8B1NQOIP$Y=NRT*_1UM"N3SDFJ5'#<)P?&)L,P]:W;!GJAX>CS@$[RO+W
M*S,3C*RJ@H2X0^4"L.J0;$BP/99RH"6U)BR8/MVB04(LF@$V>]$7/WM>-J3)
ML3Q7?(6IO=9'0.:WNADX#LZQ[N= IV.S1U%@T6J).,[U/)MI,C/@;W4Y.=<$
MB.#5],J(P4Q'OL,5WHV@"RXVR9ORL=I;8" W,-$K#S2R57:=3M>2\N]U'HHS
M@XIUN9V"+!/+J BN.PD]DC!-\Z@>&,V@ Y\.V<]*W.-8ABW%,*DTD=9YQBY<
M*+'E_!;^>OHDHCO>K^K;3I))M( #ZG-=MSFZ78/<=0L5?IU5;2V^WNIJ77,-
M 2Y$#+DJBVP:2Z27#E#LPQ8JT]&2[I).Q&9F<!3/XM?%NBRTWI2,#_?:K)JV
M2W9)P^?$[CDBW<NL)@>^*E<5IZDZ!UM"0"O0+Z6HY IXFB,QTE*MK*W:56A1
M>3<4C$I+1&EMW@LK(0<_K,BA9U6B(GR$(?@B6:!MD[J,E5O\R,;/-.?'IL^L
M8_,&12M>?6W54CPP6*ZS2HA-2EI-VEB>+5>JV4^>D1SJSO@ORV14&I)8*^*L
M=+"%%\1!H)PJ7+<PE7S!RQ3@%Z1BTXHC!8A6<&9/M=&V58G$L]-X&IJZ%W[%
MZ"]UQK2!CC*1:6FY]:>DKPPQA;-!!#T:I\NREVCO'9,N+^,M!-^66PL!QD%M
M^\Z8%59MJ3R)-:=^R\K&<#1 S1%?5+IM7@ZC07&@T_G5&8@<6(>(;!Y 3K*K
M: 0X+A+]LX=G[?XD7B.JO.1,=&P1/F'.#.=\^'K%YS1R@;^UJ_=L)=HINDN>
M%DB5/Y_+<H+"A##L><:KP+%^A*Q91OT+PFG0LQJ&P><@I8UPNV60A>$189V&
M0'&TVE\P'U&BUD)1J$;;J(T-U0T_5C5*J&6B#FOJQ#0WAGR3'TD2?JVR5>^D
M6^3)#YUNZR@N25%BX;J?PDE'3T-3YJ9 UJ)[#<U<TL5_5,CS1+>Y]@+O/\M%
M?(N*TKOY*JV6EK*5AN7,TRC(\L#C:TGM=5\K>:E0LY95P# 8,@ &QB7>9ZM@
M^M<8+?LL# =\8/13%F/6B'WIC-.\*1<&=^=)J[_;*Q=>C94+.ZQ<>#96+HR5
M"U^:@1()%_=<\MMU(^E%Z6+3=CA;]NG)">5FO?UF3"=EVVBI&MU8[&-Q1"UP
M_Y OY5)OA+8S1..X1C'(/3KGC3Z@EC*\ON ];$H8N0TM+R/<0JZBF%;K%><L
MZ6-%+37WH5?'T<$;$VD%W[NBO$&@4F+(02V[>[!M3G3D9S/U*R24C<7LF23R
M9TOPZ(+>PN6;S2..(K(?JW=SV+3!;G1H3M&%S8/D^D/NE)$5:0N=++*M=CLX
M'7V5PL0QA=H>B!")2:JMDE(NBB7AKDPXIK0$)?NC]/4;M C8;P8=*GS-W^:J
M<MXZ(#>&->KIW"-:[JQ''6P#SY)6!OM[WUQV=<BVI7*S^M@&D;F@HF_/%%Q+
MVZ9Y-,W3;,G5HRB4[7B.AI:.S<?).K1VTI8<^"KSE3OR"'Q*%KS690N%$ZM'
M1LXT1PKRI V58YX.))6T'6YB+6T2CFTMAUKB7 QJ1JZ>(GEA!\"5/XO[-F],
MH2('+P8BU!'VN02;&("$SLB0#HV\=Q%BX-./7H>F7%;UK3?%[6%#Z5J[-!6"
M';;08\M02/E(6RO)>I6ON_5*45O;Z+/X)Q)Q'-3Y&L&0.*+O[OXGG>%ZIBBB
M=$*YSOW&:.F5#1DB'8<BL2B8@6A)"TCE/]C7 [)?SD]*-*4:EL_0E^N6\W\V
M3;MJ)Z2-;*T<CJC37@E<1"R"AH@XA<4UX*BZ-SWUN8*^@8P$VBA=0DJ@Q99E
M8=C%JFF1ZGGJ"H!4@83W!]1Z1D*<5I%,77((]J6TTE,M]G>)-I_4]J4PD"T,
M*.?D(E\Z= +ZV5<)'^B21;U=2#H/3P8RJEUP "3@LZZSNYF3'#7@@4Y'4E_?
MKB?D:2BT9>0),UQ\'Y*2N<AE;M*9'*M:U9+KFVBUIY%-"#I9G,EG"":?T>_!
M(21!F,/>SJ1]PG!"V#FY*FL6MS%+M9?IV%3\>SKV8)(R48,637L5E=4B1:<+
M+J7\)D6>?74E="TVQ<BW9-RD[SC6TP%,E1H-B0K"S.,_N7 C8G/E4A[Z]O_\
M@^3DGP+2%3VZ85LY[01&4ZGCUI8TDD X)M#KN/BFY<Q()0%Z)FNZE/%<UR;#
MXBG]\W/XJ7QMX9,N1A_6&B#B:*EF(MM$SP?D:YES,!*;RG4/8MUK@Z'2\MH6
MF#"*;4B!/B[GC^WQT05A@U36BJ?*/D[D:K@W$UQ!P;:ONL845GSH^%MV'[H1
M9^T/M(]^\ZN_5FP:0J[)B*S9M&ZX!7A:,LZ!]8VTD1K?<2VW+O%D_1\;CW;C
M&-KU;B>\O>.1_'!5H1.#<;:%;WV2.X_FH.7<$-QR9N^^A(RA/"=A=X1 B58&
M2HN5$K9R#DJ\@,"'XG8O_73/I) W:IF9"L!8;WIHT_G%:-UU':F/J7+C07NT
MF4(Z"*UUI+DV)W4BDF);XE;CN$G0VN\.S769MQCBC$ZH=B:64RU.XB*.-)X&
ME^U0_L>=:HW1-]SYAPI 1/.\]Z]V:M]WEG-56%W"(P^PB+CB&D^JU1B=D+3'
MR(3'4]J1DAP'*5N'0UO7K9YN;J[O)&D43$DGBE/A 9]41Y(;,D$\91YSZ+Z.
M1(W?&)=ZTFHJP65$7<K<KSD^!K-=[Y5:TEJE9?L2=()_88"<L8:=S5-7_3(!
MYID,/&*T!;)!.$B /:Q+W%H(C7*E8Y B*VW]Q%HVRBE;NCI,VM3?Q%?EC9&:
M1OF$+C2V:E&R4=]H8@B*2=519$UQV0EA?(S[-LY&U$?J#T7>H)"P,UF]H2&]
M-1X$,5A12F/!+)JLE<%!PQHV!6Y#./15#$:N U+<;<4^)3#3I\[A9;V/34?1
M7&,QM7ROD*5G:P UEBTG;<59G&BN8 B8B0E+##:2HIQ"L_>7W<G;8C]A34:_
M;(^[-+AMV)58Z%J'KFNP^?3KBNZX"H6 N(X*LY#B1^<P)L-5"2*B>MER*2@<
M< 5D\6DL)]J!=I!))@*,-N_<@*)NW-.L==&!\-G$>=%;-+K1:!WN8C\3+=C5
M#I-.JS(GZ3CJP0U*]54J5936$51EN=F <=+.W:UYN,OS,0^WPSS<\S$/-^;A
MOBC[U%4>AT:@=G9.2</Z# I#4+(9(.UR81C21U^JX+JPWOAR6<YLB:*M,XF\
M?P]?JK#(A@AFU^%UJH].XCHGLZ?J6LN(\Q@7RU'KT8V&8\_NET$(-+'-UNG:
MF>7]'LD0-V.,]!SX=%XC9FA])F\P*!:38+AHJRGVV@$/]_E]278+8TO4;746
M&9HFG]M,AL@VFK*EU)5$Q3[.1NY]_=K?RW*1*RXGSH8"-O;QCJTM3-X<S-Y&
M\,?\0=)X)8T00&(HEX+[H[5Q-JH5U;0;W!*?">6;D4RDS#[6#B%^X/_\'R\O
M+UY\$Z"@=5;%QJCT#5.+^*C^0!;$;K[SA]5#_RK"#7; P%64AB<D$VBR-1FI
MJ6UY9Q2YF:VW#;JC^@'\;KYANR$8N0R/*Q% ]+>8P50/_9JKTH:R*EVOC$NZ
M7?6N+564H07::K@..^J:J0S8)ZT^M'IK/_3>5ZV;@_P0_)RB<1!L16VQC+K.
MBQ9 K,6MY[IL]8W4?2.S><:Q1FYH=LF3COV/EC)IA7(K0;K1!MG3"CE)%HJ;
MLLK%:]7YX%U1RF^K#+K'8-0/A.9R7B=$!>BGA2D754H>[Q0.H*Z: [:U'93=
M)92T5*<NU>TSEQ%T2_^M6U1UEY@=H*MVB6@9&+02E#_J"Z76F9Q:\KA*'AR[
M3W6ORQPQDV(=W$M!D"!*M<4K6#TM1;>I0UO^&'PB0#H5-TYO4@X*]X#2IRD,
M0CA^'5R,R,Z[I@N:GD[_FI!I_[A=N27+EDM@NG+E*J-Y- /)2V3IUCTG%B"#
M?#=:=]:CF*JP10@)%2ZY:_O].5!$+U]9E#9?#5R9H)2TF+E3.5WW2OEMZ$<>
M@WV6)DO&-T8A;P!0*M>/RLO6$#1_P7J[\TJ,>FYB(B_8=9JT14W^_ZS-L0_E
M30'SXJ3]RF.>CEBM_R"%R 7->F\ 'Y?#,F'W4-CB$>"NH96-;HJ%"ZUJG,(]
MRZ;J?;PBO(*BP3;IT4X\\.EPU:%&,^\C'$' C\O2EUDS',MGO'[["WV)A2"1
MM+93I;X67<HL;-^G *Z2:'&Z3CTJ6ST6EY-<2\8"9PHZ3_\@_I@+?D;A#*><
M/,(%-.=R^GDKZ2K)0*EEP>> J_88GZ56U'#F!*:'7)7YC /TG4I#7)329JTF
MMP!S:V%06%;3'__$I-J(YIOI0US%DI%K<SLQ7O0.>N*\2EMH;80]_5R["+Z<
M]NA@X4IYU?#BX"+IXHW6L&@9MB'L:DWK*SR?-M1PT'+=ZW_QG1[1W+#A9@#U
M@V0V/3<13,6UK!TVH]:X-4/8 'Y[2"#'*^E I],!HPX%B]PA '[5WBO\+[*6
MD_@'MIB_M6G?U^280<$ BK]B(UAN)&"YHW:%1'RC:U"[EU8HG4)&F$0<,$I7
M<"&CFZO2=2!I)(;$J7-(Q"SDTR8R^[,FHWE4;RRMP'<P2VT+)N!*!(S:-5W^
M_.V;^+NW;\_BWX)Z,AYP$JD^"(-%"K8O^'):=ZW$+;DM<B -K3AXTGZ(KC.8
M]QW26Q2R8:"2E_H=56:U8*Q4T72S+-&.4]<267/-C:$=F,ZWS2>]H[\6!@O'
MK;@A3)9+W_2&>Q9_[RH%(RUFP^&V-<"B1^:P'1*?(K/)'"V3Q!F/NV:RJ'>;
MU[' MKJM[-59/8$*TJX"_$^;)AS :A/)&5@DNW-2;FY?3/_F,D=X5TOAI[.=
MIUAL6\/@NF^5GN+*S,G)D@N7^\[T.WR9!$>$-_!D-,&)*;; 9O)MUB%]4]?H
M%D@U!F[3^E+GYY<3#LA\I$4>W6Z1.\">802C4;P.=#H.D&W/:&S:3\/X@OE:
MM'^]Q)4I12*1A0QXK%W/&S%:@ (!"BH$:KT5],O'%OG^+6Z+LP3D/MK-RV9D
MV%.LY%YDIF:5XA;R(-;]]_EFV Y\QNB<'O9TZ Q -'<N_ZZ??ZMDPQVT'1N.
ME2(.W=40[-[>]H$5XC\F(4S!T?*_O3&3H8B[K_*Q[\1(7!58U.W+YO$P$6X_
MT6?AAR5 :<^WG"'OUP51U[9P)S$@GI"PL_M4I+D.^U>0!TZG937S!A/4A^\L
MTYZ105-]O'\.=#I\\^SXQ#%<3X>9K'>Y!*<$<AGQO=(MVF;COS+=V+O-*8G7
M$6_ )6D-EQC?@Z\+TQ W)J*1VH![\ ?%;P@:&!U:4K*!L91L+2.'RYM.2C1D
M)$#^XK#;-;S'/*N70>;2IV1X,$(IQ\G+N^=X5EP=( T? WRSFHU!2U<F_R<O
M2_BPAE;HZE\MG+XDNB(C 5<Y(P.7Y.'-2MT+[8UR&2+0D#J+(DB-Q7=/C0F:
M1 $KH)02<W6?K):R*(&]9 GOIG6()8^J>KA'6]6M_>W*1ZW9K5KA%S.4S:)(
MD]/4'[*#N*M4<\';A(OT(]JP74VFMMU:W*E>U8>%?XHV4E1!\6G(9I-NK<+L
M9ZWNA@UR,@KMWB6$%V,)X0Y+"%^,)81C">$794%I\6 ',FSCT@@*:$(F$O&,
M*R&?LM>\O?\ZEK=6$.1!#!CU$ 69!TDD^,;N(K;-'9TLE%KL=[+6\7,B7ZB,
M=KN4SO%AVRR #)3*,74S_&"Z-( A%R0LP[2QT>U>%LNEXWJ@?<DM! 1HCPM:
M,+1!M?;9P;"TBC'--OJCNPF]3-MX;K<$N#/<MX3[\IRR$A!8N>E=\5-00F,R
M_A.ZULB0J;*<"S+H";2E;%3U$"KY<;41!$5-CEK7D0V'H+14F^U[7;Y!S2=M
M2Y/EG'3-N*4T(.&)D:FX3G-!@V$;#=LQV!\A!E_A:@40FYDV42\RV6M7#P9_
MTD;',4\GQ&-6G1+  %IH4YL)8E@*).<E,](H@D% GVPY5=UYE"@>PQ*,0;E#
MG@[ZG@?WV.9-I2O0<=G,>SH;Y8YP_[BJ##6I3*Y<=X@Y@\\PFG(1_ + *08-
M4?59Q.42>6:NC<<LWC*VFC5972NZ,!*C;G =O>0>%([.URMO:TV+O/.[@)<+
MI)=A>FG;\MD!CPT(/2VTR:W';'@+$M\UEO2=.OK U-! /,V0M)JY$RC@E$FW
M'3(MW,D<.+Y1<(>/JOM I_-K&=U!/]^8( W4"]1-R]6Z I!]XD]?$B-,H;8?
M_Q8F:$62+%9D"/#%]E%M[3*'N2VMK*[ENZD4E0AC4* N1I/[;:6_*&UNQW.9
MXQ!FRD;A<73\#*/.#.F'Y0I'E.MR%?T'1\V891PBD0=PW6QC8O(2X^(@7,"*
M$6*6 [HG751&2R/86F:J/[*XR[5Q0<P"!RPM7$;!O'.0:&4>]""P?=8A-W?U
M<T.XZ%&F>^>9PU95RVT>XA8(]YEEGKZB?=)*>2E>[DUZ6)%VBHIMB3YC,EA5
MD(BO@,:&K#&QY2<$;)56N0E+&A[AF@OF+@KF (-+EKNNT:L)<PNQW[UHHDZ\
MV(7;!"ONWZFPP"B82H>AS7<)>T9[#J&F4Q3I,,]W>!F(JM9;B"\,+K^W$=&F
M3)Q<"A,-D]0OLR*KKS:;?+NWH/4IY-GVN.C2!/NN(AD%5(2S4F'YX^NL#/PV
MCF;.Q.<J&+;JEOV5YR8ATK"NER\ :LHH?)#]BLWIZM_X2%IA \0U:A_XX+DK
M!R7ECZ4)A]%J@L)VEGLEV_;=+1#QD)&1-AB0 BAN#)')/BS&>E3JYG& CR)(
M#^A[0J&\G)F.8Q-]H!AZ\X8<;\4#G<[?[+9'P97F+KK-6\W" ^IYL/@*#O+&
M=?8((N':]_/P^87_37(E_1O^6[C1HK#5; -#W>(?UK;(4/F?A(E E4DVXWX8
M/7AAN5S-+:O,5./&3S\-'HI(#K*&:2Q*$#^E0>V;A9<?9?I I_.Y*H<VLZ$*
MGZ@M@I'</T(LMO6.X?L/]YK%Q]#>I@90F!P39,A[IC*=FV(6E']VB]$!^1BD
MOJ*PA%0Z$WJZ6:.A8ZCAP*?SK0TAVY;T3IMRQQ7GPFP'!VPMR:Z# AT?:[L&
M6]VJ1$DNYR0D;/%5Y5K!>@1?KE"="6LR6G K,N1668D1@KXIR.-!!X-4S?&?
MY<UU<*'426@R]F\7C8A*)QZ$/G P D,,\-PS!%-3KCY69VG><X*LM1@8@=LT
MOG-LF!W%&GJW'MHK ]-M'=F3ZZN@&)I*^IA-H751O S='<!*2*DUR@4[,*V<
M5W"M2"$]<F+-_$2B&ZCM+H/ S=*0D<\]+EI3N#E^55$6!*^54!3=J(R2!VQ8
MDL(FV6:<\B2<?0H3N#9-DW/Z7K?(!!I*D<$$D0O[HAWF-0/3%2XJ(UOE>*)L
MZ8D=+)Q-;;CJU,V'ZL[7Q\.)ZM3/]RH'0KP\,FA5_.NF7"DBDC]2 PL>#RPX
MO9+,>N#5LMQXF9/:B@ PT<T_\*6%'&\2-$-H!Q#:(;C+B#SCU%& <X^62"$W
MTPYX^58\>Q?+H,5V/Y;M>= T$'"26Y;MCUDYP07FLVQF^=H>8Q8V2;'UXI.N
MX]EYKU$02@]C<8ZAWJ\>(J!V[MU&N3Y\<H?!S.K#+A*DS21%74I.V["V@?P>
MOL)EEG)N&6'7"PREP?0_M)I1?S7[.)5B'H03$4<T.,5R6EEL89N7E2@/WQ&G
M><4>Q+Z;;'0 =?1GSQZX4N9RK)398:7,R[%29JR4^=P6_ITFP=NY^V0R#)*
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M.0J3$A@+;DR;*)RQ%SH&,-6>'2>  P]AGA6.PX2 HX"@8L#1)-(>GDJ .T5
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MYS/>:M_$DW3Z;E'!J@6$2%D!L)DND5VN:O13$;]N%^"'O7@AW>L2T/B6M1'
M#::&5"=PH7/3@)2+K7<5.M+Z@OG6^0X+-%T ).5Y62Q4M^49/84-</WR/_Y_
M]KZUN6TKR_8[?@4JX]RRJR V'Z(>24^J%-OIUDQL>2QY,CU?ID#R4$(;!!B
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M,E,,GSI@Q-H0[NJ2=1G8MQ)QIA :"4U+F)$1Y=IQ)[:?2X^C10,YJ;C/%)_
M+YZXM+EPWVO0)G>](G#?<+7Z!V X'K+0XKIDT9 ,.A/5B C(T@TRXDMGT:S
MJX &TCEN'1__J#\L3Z:0N+/^"^(DT01,E A,&0( 1[1J6%:!L^9P/*4G%ZPR
M6ZWT(V.QPY?I_7XQI?T!"^OR$F^+&9FK_>!HOQ<<'_=XPC(FN&BTT51>4#*
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MWN$2X]7#P"R^,4_W$+Y:T@)[H :'5]@W#;IWSSIEU(C*R1^-S(.15F,PIYE
M""U +$HK!CWZ<]=8]SC+/0[L&34I"BM&A6;L7_5-9</(A;B@0*->F\#M']'
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MEBI95A=-Q^*NR"=9M?!*O!<\RKPN]I,6,MHN&TUE)"W_RQW?]E:?"^AD%['
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MA4Q-PBC)#9OPTW2]<_^]K 6-8WF+>\L_CV -PXS[CFNE ;[9G^,!O6L5+>J
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M"@Q>[I4S8;_Z>CCZ\^([^K6+@G('@L4;KPX#9MY1F&T>RL=AX 0W9$F9W6(
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MYM%;C)^EVL^M[JM6_]T[7+;1DKX'\5^:,;5;W?YFUW5Q-F]K^2>Q2![')F#
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M%P/P<:,P(P<1CL]UA&Q=\F5G./8MI%_1\T1W.8))LSLKIP"+"^&(G*/"P(@
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M=N(.C@V-'[+-5M*404'>D@&.G5DLDKC'V@2PTA&.\/7Z;"[:G+G6@@6G"36
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M:.N0^4^<V79YF3Y<!Z!2C1F54A _H2):W0ZF/#L-7=U.7E"8IPG82+<F <"
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M(*%L!N++LDAQZ LI.%,89ZRBO)1G&0(X?IA"MNUWM<[UW*S>JS:K1TL:&QK
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M)Y/LVMUY8MQVGKC'SA.#MO/$X^X\L=EY_G%*X@?  9R[=*B>J/<KC4]Z8@"
M@QG\B[7GVG#(]:#CML8\TQE2L$V7A@#7Y8U$L(Y#*2DA(,W434:3IHHT><"F
M>DX/+61+I8J3S'5M<F" /T$3P7Z .EQE24A68)S.,#(O/9,5<G\GFH740N+L
MB#%DE*CK%(8(*MRC0%-OT!'#CSNTX4\6T0IC2[ETR$M71T4$7[7U_#JI'&%$
M1BTCJG=TN)ZB71R9.K)TJSC8(.R8N"?5$6@F6/_?L*H4:3,#>%5FZ0I#& G%
M-ER.=1C0D61H9XW[9I@FF8.>ON+-8Q@O,;X3^?Q&:&);6X0 OIT72N@T8;<C
M8KYRB'+1Z.9HF,DHX_\D>3AU>#N%$,%S_"%NS,#DL@0.TX7#'/5;ZD!@#DN6
MS_EI7XGTO)4CUCD&&?\NNPZ3Z/]"/G'>3Q&FQM8/TN:YW1>M>%^%6;S6"E>W
MZ&'/^2ULTT>X.%2KU*K@AV6B]R8*;H^F]EUET1*;Q!@])\TV+N-P[1N*$$H[
M<T<?5-4*=KJZJ?SI<[],BBCV_UDF"G5,)\!4;V*^&DY_+R-,"?R4T@N\5VA/
MPQ!RY;^)EJAD A]TS]PPX3/E,S:@D+XC9($7892@^$5^^BC-F P]@B'*BYSF
MFIG#7HS]I;4:YWE'W*F9<T0FR8$$UF',BN',4?=O6-W[[^7S9V=OWN?/C8F!
MXZT;-4@&;X@F\ NUIB>!71ML/A)+$DRND8Y*'4]3A*,1+(HL@FHV"O6EVU0$
M.?O#;+H@5?_/,"FIORSUEC5;FZ]*ZMQ2!<KJI0K@&469)=3?E(JN>#.(6H'V
M@S?&4+K'3#9=X\LXK MRT+<;!/ %,8)[<('/W_UR\9+#FY8S_PKO52M\'V;P
M'Q;*HUTYZHY]JEU81E.0 N !*$/F;G N 35F8ML?@PTJ!Z,Z-,X0,LMGT52Z
MD'%8Q)_&*?HOXK: _U$HM<(.#\2Q!PZ!X5[PJ-N9@:>:GL,+=&UFU+<"ZRI!
MLC#<$B^V/48.KTK@&,>N1\<=QG2JD;P+_16A_",7R;-(VR9Q!U-?J'CEP(2T
M7/.Y,P4A/G/D_&?A*2.#$2>P+QH.Y#9QJ_4ITUZ*D?RY]?X,?46C&PBG*!$7
MH)5V#R/MSM"6R,GI1)'W L]>@2?'/\MSU0JZ!QK\V1SL)2]7JU!"/126T6:'
M&P70MB!U'K+R)<3=(S/4V5(07]JF[%'GG )LM.L";4N4*HS.WS2^O!<4?V9#
M5X1NX#X7+4(0"NFJC$,CG"R!K4@GW5 291B&;+X_Z70TQ >'EF-3#&Y=,E64
MX\2P!@E6Y<\HB..Y0\ V'[I_$8*:[$DFX6M:V%V'U,D\),M/)9:CS*Z6:5L7
M^K.P""?P=EPZ%W^4KC!SQP&5P/NHP/8K0C#\J(5])=Y#OAJ5)=A2Y4]1R@9X
MIF!&"8_8=("D7DT,^&CEX ,,_@ITF_+X*N')L$?;N$!\G_!@R9]NE*][5F$]
M;Z638K6CDN[Y*-?+7HC;101:.$EO;0P6V1X]W?P''U&NIHPDAL/[FYIBBT)J
MW>B@"30=&VIV4-GF?F%(5!.3DI.#67>$_:HI1T1-JU*6+O2COC[TGI2/9**Z
M3<,TA\%4AU(YXMP+NG"A*P%4TY&H/=8/U*C4],E;I2P;,<Y/ >%PA9$ A+O!
M$4)Y5FVLAE(L2IJZF@9.+U.W0:XC3QF]R?TPQ4?WG!@V&[13M9)8]P:7)(VO
MX*YQRVAV1'#$\E.9K8^P(:<#[F\/UH.%C]\K=&Z\E]:3R=O8\=Z#/X">=+#7
M/Z?)$5QY=/^\-ZK JPDVT04'SN!RGK$9ZK^A2ZKA8.>"6GN-NN(*A(1_!KH%
M&5_NUZ_X%BN@S\9!C?M=XOT,:GTY@?T:!%(+0+WKDK2D7H^4UZ,6FS-?&IV&
M8)*8W?8W=OO9FW<7SW'/Q?7@A=G<8NJXS+Z Q[+;I>N9KB4.2I4*O4[G1"QI
M,(=P$!A8P&"I+E9%D(J:ZB:><WC;48YODR=S%; \(B=3RMH>]OQY>G :R0]K
M16E>#)'8D#!&2< XGY)%I/MIV]::QB@LTE5U $Y?V4JF-5,$ TUF.C[BTL"3
M$15HC.9'7 ":/KWK:!J#Z>EH2-:FQ_ZOTC'>4< 2UI'.]+2S9.LI:3\(EIE8
M;-1@9 $N";R4O)L!K:8GR\@5=/7" '*0P*"=87LD\FP:^](NHNO%D4(0++&
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M/D(0MF(^,YM<GZ1)29!B6/\I^.#&]K%/O\6\+'(RG'2ZSSX^9W@C%9;)2S"
M6%"7E<!?*,3L34/!HD=8]45&@1X@\L[#"J KOPJC&>6<T2QWMLT<-+!Q(JQ
MFBHS\$.0O%]<WF$5[JK,*#RN02QHNC+TBPZ7$K89H7V0E)4^APR"!D5%P=9<
M2;F<DVTC0SR&E16[EB'^:6;Y.QCZ@*3[8 TB9]ONX\'679@OY"O([HDU;+3S
M>,3D>X_"]_EF"B:.JX(7\X'(?1=IXO]RA>D9#4 P%LEY.J.@PJL"+"%>VQ?:
M63KG+%U@#6S,0F2XE]PK@(A2A=6-$M2,U^,^2HAFHE!ZZ!KLB[0@H)FPCU5K
M!4%1('4?<X=@>C@OB401=QDS6NM*^A$UB,)APR^-@V<2MXE)/XK[;[)/Q'QB
M#ZC.$@?V: :V6"'PG:J"-@/P>";R.#( ]UFL_P;A&DC'-U4*+VK^C:G[V_W:
M8SJ_*D^;MY9@./09'XQZ$J27Y@\6(,[*[JP(R'6 P!.L2@@,#C>#+Z#!/L64
M)(EF(]NHX@E#M8@;G<8(.4-R3:)L(KA%A$$6!ER8NG1Z"U<CH/F#5<[POX'4
M6]%#4,1A_E[&*1!?F@5(RTQ@R-+!QT:BFB'CDHAVX;K\$C;EN:R?Q2\Y$K!(
M!9'/GB5K"RF1WS#41L>E2HGLY03. ^N4PT_'_L6<Z,+ C6 C98$H70$.Z B4
MT2@8S&-#@I_.&6J[6<3U"$-0A*32JLT"'VP8$'6-A7P* (?,*+>8WNW38X?
M$T35JL@033,Z2_ 9ALC '0PJ.*,F'(P>TK<DV&IEQ+Y](J1 UKNP? ZM7+_O
MZ5Q%U\O0OPW1V=0<H2"H].)33N8M7)5H!O?L#1(_< S^9W43SL)*Z*_7#_SN
M^'0@D!?B0YE1% &1^2A=7A-V*D3O_2*9'G,?T$X7O-_$J=KJC3"$V.T$%."F
MW^+X] /A.3SH-^$$5H$>]([;A7;IE]A8=.,;$Q#021VN!T_E+[*H 6EVI9N
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M+YGI51C?().(XBL6%D64J#ANXR-?;A[VG^[:?;,[)H"B%B_T>*;S]\D_3 ;
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MYD!SPB;*XKCX"<YR#YY@.M]'<6PU C)X17O"_<L$B#EH8Y%;B$6:HU>Q@O4
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MV.)SG'8$_P>L"642"A9@6D !RT9Y"A.,X?/!*J(<J3A2Z%C6HLEK>4AL<C+
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M ]N/W2-#\!YT7E6S#/A7!K)JF'[%'=(MD.&C4QX9=Z($0X.LNL!/H\Q- ,"
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M+-%0@B6@W4EC7#_,<Y7GXCAD-0\,7)!O<[*;\/A36#OSIR&]\]B_+EK :P>
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MWQ3N6R3'0)UH$1YI$0WOK_7YVF.\CK(86(G_42V JR$9D?C-<[K;'"P[BL&
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M4&%,2=P"GFLQ%TJO;]!EMVG_>C*/$C1?0W>X?,>W\R06\*E"XQ'[L;#@E@]
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M#4-@LDSC:!YQ4A>K! YN76,S&H=NF'#%#Z#@;G!.@GZ8E$S;!MPIVY#T-/+
M>J"ASG!"AI_JYD)2=V1E,# 5.%6PP7:;2-],IZ![,'+*EA%-DR)+XV^-3ELL
M;<^UM($"&?VOK94M!CB6)0@ERC%&B3Y&Z?]>%MC D23)>Z>L?77)%SG-Q2OI
M1?.YFL#W"HC(-=/O:Z$*UYW>J*ABLM2KKQ'37 S[@S":C^(5 RGW@<NJ&#3)
M&'=!6P>.>P)6C;0OUW[_K/G9OY*HV D_PI/PKA9NPD,VCEF2'5J1H5F<J&CS
MWX_ /O>5?TO!,#!Y_J9BSKB Q1GN28U5.)YAHPCJU&^N$PT<X,KP>2S)?Z92
MJ[5.4 >.Y9US5>SM;;Y-=+-J.'H=).!K\2QOU6UTYPI;S&T!UMJV;4J*FX)2
M3U&I+C=\>+E*ALK*3);O'IA;7J2+[QI#GN75)\=#$ 4/W&S+C.A-?M[L&%3M
M G1U<7EEVP"U+/*$MUYC1S^EX[U81%R.D T6$05V0EN_CY'@(J^LO\$,^-:S
M?.SA=>:TL(M%'(%:-@FU&CH!)5/Z_GS;9W-M'6&&>=>\1.>#OU";^#0S[2)<
MI?6;/CY$K;D"N95)7Q#*F0QM"Q :B$[9'CH FBU2CHP=MYZ<GBW?:1FV6O5_
M3[N\GN!G<Q[ZK4VQ'4EE?VK)F:E11V>G&SW&UA,DJ<D9@TU@M-=7BM+ RBPP
M_(Q#]E3U0_YC$E%JW 0?&H<+,%KCZ'_$<'4]HVQ?8_9/- 6:HP=X:NXBB\B
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MD<INJZ]]EQ;*O]3,_4:R_MTW@UX'= _K!F3F.<YW6B<BNZ6E+,*KS+9K"O=
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M?$R3,O<6"$(U*_+L9' 0K@\[]JC5T>VL#E -GB- U5_>EPUN7;X(7EQ>;BG
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M35!WAX-RY(O :YN%$L:9"B=+/[UW--:&VXF\87HV5UX98I)3"BUW*)&(%K7
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M&=.&?"8=I$)#N _7-:#!;E9Y&];AC<K"G7 &NPEY;)@[Y$Q$=AV 'M\[NAW
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M7E&&5WB/>894O+]8Q-$8Z:L7)(_?#CK>GMWS\XH8N$<Z4._7Z>IN5O54Z,#
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M[%PF\.87BN9&:3J;!'2D1<-A3N<9F%08+0W !BFOP-BAP&"(KTX2A>Y(-*?
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MD9];QV&<2+5QN+FQPQ- KF)86$-"%AB"32%X2(.-;WRA9[)@"<A0VZJ+IOE
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M5RZ'Y]-1W=,B[G_M$ZSKF+=@8PR_7E*2%>4AR_\=04^E;IGFOP?%!&S5%^
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M/;["!3#C%#%BXI47VCHF?XU__6R^#JPGPJ@?HHIF/;?4SZ(ZWAMWC^0V$6^
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MG%/8V2RT0;> T)>\5J),[MVI22\.P 6SZ%@JA<U+27^YQFLJ2J-D7E"6EP*
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MP" 34TL%*1J.,^NN&'93&@O<,8Z=[T$40]BP*)2J/XJE\J)7K!+Z5+4Q;U!
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M :G;.X0[;$>2U+#J#H6A&^/]7KRZN@M>O1O+6\&K!W>%JJL*5'UU07$O)MY
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M36P8;?&K&;$:DR_ @/^2#9[^F'GX8P:W]Q4EK^[?PR$GE8K5\2GLN)A4%3O
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M@;Y+U(;"J.-O:'B-Z#@L$Y[-@]F459#M30/:9;$!TG%$M)>_P=;_2POPGG!
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M1X&LEC8#6=/,57=VZQ#,RI8$V#G<QXH-F[\0OG,$BV]9^YL]R7%^* G#")$
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M4+OPC]%(5;!'2_S$=1WWJWTQ3$\A>D(8Z))3"QRQ(BXO;/39I:(X/5,O!BG
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M0J1FPS"<48[.W$!Y1=71;FEH!*.LF^D )%8< )JREXH;QA80)R0130J0K-E
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M4FIC<LO'I>IO[X*^A'M@#6FD)RLQ7:_67#$ZQ<K>T93F$<8'.(Q/'BF@>-[
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MD=.6H?_S[X6!_,^A<'^!NY'AHUMH5VE!:PR0;+U,LI=LGLB["GQX$OX/E[E
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M:NNZ(K\LN:6Z"OT_4'TB':=U%!]JQ_*XQVN@CS0@D#4>?:@%"&Z X5(1[+6
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M.O(":).D/^EHUL>W1,)N^4'^.XD:!P6927/0I:Y,/E-)E,0U?F&F=IV_0R#
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M7)_QG,%O0Y^;.H4^61,*)Q@Z)G$87>;# E$@;%SR)_@42,A"AS;XH0/-R]N
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M6(]EWKD9%P2S)@$\FV8FQ9/P W35MXB8Z!Y=+N:DQ#XU-ED*3!;U+N+[6RR
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M$'LJ(9$,QBOYQH:]VC)MRWRD!ZLE;G=]BIR!NV7CH$V_&FN47"?\*O(D!7^
M8YILZ\T676B+3K Y7/6(UMP! P[6EBA;E+LS-$J0E8'!0:$I8'+N?$_:M1F>
M1L1_6#3[1\_MXJ_J2C<R^R5TP8&';^6VZ\M%/R2#_,Y/?QF%;WNEX)<-E*I$
M=RDX0ZH\15).';D$\OE_4AJ386TUORTDPS+[ ]L=F:9/<>%8R$)+6D[=;;6:
MKVF<HT!^+7^7@N.*C&B;TWS=I#T/B[R=$-W-JO_ :*;VM6B %ALN-$(#0=FB
MCH-\A1(IB(DX%EWRAV +D>*R<^(84B$.?:$?B)+KT"KQ W)G##O.<'G&T*-U
MBN#3BXE4XE_% >00"X#(YK:*XJY.?D6TK$>"39-1P#PS\+1&ORF<$)^VJNKW
M78=="<6:R,4%/[A#; (7$$W [I=J[MEDZD^Z9Y"_X//0%#*AGQ4,"@L(J"[F
M'\DN&PP]8F4#IAKV)>+H07]KT:7!%GM6%"& H0&&>\>/P3(8B""()8*.=,CQ
M(,]/GQU%6%%#?)/D6DU.?P9^QB/X*TY7H6LFS%"7]?3RV(31&7W-$V'E:F6M
M70AH(DN\ZHA/0+Q>NJ/(R;85*JY(PT!1D830_4[<>9WT)3&6);9K:S2IL;:5
M(X<7>FB)" V0;M/"8N7/^A=:NJ"K,6(+8@WU:8650*5HK+H!^BZ!*'YN?:$H
M%=TC-H_'1VMP*A7ELT4OD"<@\A[V(;S&3'1[A(=;[&9Y3F'N8(>8!@TUB#W*
M(W2T'R;S?J0[X]43M"J%*<:(_H5H!PN 1$ABR,?!E\MQ%Z8)0M0.T\8'C:L=
MF3;RBCS" 'U%#$M#0* WYMR\YEQ]HB3[DA(^PL.((T&\B'9P2P1ZEW$G3O>_
MY)J,Q1[4'+LW9J]3V&V<7AIK6Y'1:(Z??I?,W\%!IWX"!1DX!<HEW1Z;FHPW
M'WR*1<Q83M4$)MSH(5#)58!&0CDA%EDAER_14R $N2:I)G7')?]1/X/N^L+/
MKL0+;P:HX#\WKFZ^X.O@%5NYNJ;^U^+"1'&(?$?Y"@Z2;RJ?J(NOV[PL'6ZE
M]<6@_3V3'$8^&$+\:[U0+,&XQ4'0^*L_)/J;:&XR4 >.H)&J8W6=Y3.>I8D'
M*( :Q5FCW@,M>KG9OMI6#QN-<V9E8^;= /\=APV4)<2NM<C)Y'/K$T)O<!A
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M2 U@C68#+:NEG*@WDK"2\""ZV"HN-J\Q6M/)8G)+YP0K6-J<AP.^E$(I0T(
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MO]^S_"'?]_;NGXK#&T/H;[HH1O@=LX[SZ1__QF=Y/;-.SVGE?#E5IS_I26P
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MF+54>0TPZ_ZD;<H44S0((([!:[*; VDW=Y_V1ZVG0N.ROT1L0$I0&_-:ZQT
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M9*4A+_/SB*4DC$>]PN_]B[T_WR6$W7M?"/Y="*XT^4>E6='40I^T!=,!F!\
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M=:U>*"\&]&LL-H43X#ZWT+H\K;7'_J'U6E,X'<97RV5WYJH5K9:.E$S")V_
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M?%<"71W=-]J&OE_4>Q]'H#-'L.<7:&*74O.2_(R#0]^L^H^O@M,)LN/W@.&
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MT,+=W<TXWWO8.6BO.1BLU$PZ.?.CVYM<I7OV.[#>&!868:7D(?5YM,Z.ZSX
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M21!'%&^G$>"[;\^:J):V,4(/1[]T +>OE#<2YJB;QJL5+W9%S$//E@2)?;@
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M4^1MPC@S<Y7N5S*?I^) -[#,)E]'7QV@51+<9@'VQQG0*LS]!T95 )OB^A7
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M41P/=5<CM'4D7RXY]470NW0V 'Q66T6[JL7OLS]GO]1*Z[EEUS;<6G,)J,N
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MYO<KX<HQDG2K<2<)63,C[B1V%G*OHK<&=]+=XTYVS-NXEAWF53DS\"22 8*
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M.QGB2.TDFW?+[FHVV%>S5JS$ OHBIBNXHSTZPR%>A>@C\AR1GE<!&R"\"^H
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MD@1?N7^"O@HQ,RD)&"S/@>?+6S9:*BJ8P_Z4.]/>Y8^+P?U+E(8*)FOL/%,
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M^]^PU"FTIU/$D2*YT#? M=J__^M_V]%M[?29@)<X-=0I<L8TTV)&%[Y$K>N
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MU]A;]5/H!-S('$M#+V4K2="R4["4&>BOJE.';/6SD^H3*)0JK3A9T8VN$PP
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M3U;E^HW7WH:M7C'?CZ=EV$B^D0\4,M<J_X&&K/<V_(1:)C!_P>ZLJ#JB=Q0
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MD;,Z; );['B2RA=(G@^>IYJV_L6@IXM@2>S-*Q08$D]>29O_0C7_V9O]W,V
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M4LR&V T*4=9.0&(:&B=\C!@MN[T)2*O#CK;41KPR:V9/[<QAVR!SK'\;Y)Y
M/SH49@\.A:%!7S/X9T^@;SR,!&I(UK&&/9+)RFUNLE@R1[,DFP]N0EICI@X<
MNYKLMQ LM_EPG@00Z&F$LC8C5!;?1"@-?=49='?$>J<O=A8/=/NC_3*Y80OT
M5G)CJX"[*FH("\!4VSI5%G]P*NO84)A?,_I@7Z"O54L^PAI1_4<('O,1.L3]
M A>:9 O!L?QA6MED$![&WN9C=W#'1O"V;6QH,8SM>GM:-[X#S+X@GP8QW)R
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MWL\")KP^*6.L3R+0@ Y\!4G_6*D@4^'WZ^[V6%95H',%JN&54)T]8@(\&W"
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M^UYIY$>]DZ0X&1\<-7?<6@.Q')/4B.18XQ1;3\=>=2MID+$E#;!S@#L*K-)
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M![4G"%'(773(F%U_P7L+A?Y)>7]>,YK2 &W+2J8KJMWQ$ 1-URQTSWP.Q.[
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M\O"6CK])V)-1B]E(HI01KYKU"TB]6<S;194<%A364^3^@81YF6!L79:9  "
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M40&HC;&(T!"DM@&#QEP;<T?&@J %#= ?BW0/:0'R$98P*G-_>'=(I3%P42R
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MJ3R9;K%_EL679OA1[!PWY,MRN;BN4S/9;JPSP"QZ5\\MK-.X)9WGR.13@#5
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MX>*[ZX58=[W(1KSK-)!'XWCFC>:[G9O.T\>I?-%?VXTN'K#6C?;/R7-OE\Z
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MKV9WI8 $T$,TRH@3=*CZTGFV-.B@C0DF&3B'*?$D$9OZ2"#!^9&1LQ# C;*
MU@:_ \%F4GM,14HO&^"ML%0WTQE!WC,=$@X)JB%U0E(7?( FC\\ZX_<_T-!M
MD)RTO ]NQXGE;3DRQSJQ?1FV=QK>@$HX(ZC.2APD0 ^:N=Z]<;"A_")=T2W-
M0B,<BV0YN*(,("$]MGY(AWHR6A 6Q1G5!XK2KBE//!ZK^-H356HTRHUR3O:V
M$/QZ-'7^Q=,:T/DG*RI0>Q!>[M SS]KE7\EL+!9]X%W[(ED:L)A(O?#\T_/P
MOABFOR$S SQ*Y7PE6ZRNT0D06*\\'^_PW8D%B1U^2_\\KSP.WF;0;&GMA^_J
MG[?P\&/8CV&'7\%BD"T'55-)"\GV70NCIYPSP.5\95=!S8F7L1SRQNOL]KRM
ME?7^G[LC=K=R 4JAV<J%U]G)\$ZILL7\X#S_XS>]Q,8UW"<!;(6_L1" K(CB
M<B2@ Y\ <5(Z5DT![JK!73M69%*5 9\[7 #+M5@P;"/XUZST^=4LY2[J-Q\=
MA[.0#D*CB%U[&,Q;.PL]+'.F$%9 O7C %NQ_>>[_\FCE=0>,:#Z&B32AZ=!8
MV4?BB/B$1\;&V+B 4/QG*"[ R]6BNUI&HN!UMQ "N!>^KK1Q6WJZY>VB_^OU
MEP0<>M0XX59Y12S7A\O9X7-T&'%%?/22B%0K0@^_ZRK@5S'SX7DS7[<GRKS<
M)1%SE;G"UB,4*+ #BV-9@NQ<O+&DN4?&,$$_50BGRR3-'MDQ;Y,^'3#D+MX"
MAS7M#/9[< #>2/^.,N)=ER+G8VG*Y/,;%"/EO.EB@W_-KB?GCW=?Q6?^\6US
M8J1\D,_;__)PE*6#Q87O)T661Y<%2!%R_N]W,GKD&N^3T<:D2,"91S44=U2*
MG(]EQ+!%ZL_UB0%F13&0^4>*@<Q&Z^V5]_7V$JVWQ^[K[>WK[6W*<Y7W>:XN
M,']&Z&J$L$3$-'$!$%4MS('E#'K.?_%U=CQY>\H+'[?%F^)N^;'* 34MBJ\S
ME.M?]JK2AZ"6?_RFJ]V[KC9N=/ RC6=1C8/+$@ LKUHJA8;U!B!0J.'45Q$B
M=;NLDGC7$C]EVJ@[D!5)(?6@H.:>K[(8J2<'ET]5)&H$2P3)S:LJU.F",4GM
M")JZPP![)=B!AJ2HHL!_(U5D=R;?MG/V&%Y01J0KT]T]II)\Z2#',C_;R@BS
M5%*UL,#^Q= ;#6E6(BD$1\K#:>2H@<_1(&M7Z<N H+,( &H1$A78^(UFE2*<
M$HM6,=ECQOBS@V2@=AGB=9+0C1>MDRXAS,\\G@SMB[JGFPU,_A%EG)4UK1(/
M]KE1;(5LGZU)#%!KSL".T#*#!$M!:A("-_ ^?WMU;Q2SS/K^YBAHF3E@NC12
M28%,<Q[%@@MK"\;3ID_/Q%=J P2T2N"9CO9SE&]2B\O@7SVL'1(*AH5"B<*1
M2#UX%I[%2DN$?K[*N#]@C$)")9,-?PX0_3S^N(#9(.P&V+UX-ZQ1R.:*9H5#
M6M#0O&'>@J786N1EG3H8S&L-'%F4QQ2W+J.^HD.G2;-(Z'@X<A;QI)ME-J&T
MII5E.F-ZHE#W$,J#2E/P4HU)?<+>6**;#B=N%$?$-KHU32%C#VT@KPV_*"]A
M:@2T%+GHWEVOFE476L!5K ?)/ C %GA'C_2?HKE3I.JKL17F\@&^/R:5!\DL
MZ.$9!4WAOT2C0B$,BB=G;A!!^H)#A\@UQ]X0EUB@5#1*T>+)8DN?KFC 3Q!-
M'B#SI;26,2Z"#*=I548<\!I]TMXV*U,U>COH0^86=LC943%L@$S0 %PXU,6I
MU5X;"VPH*GPON"_R_8E64=7&T_6'C4IQSFZA']']D26ZX7+YI4-07#E;88/Z
MC#F=1YF4 2;UA5ONZ0/-#9KO%R_7L]E=.<TMG]/,E\LOG2A6+F0KA6\![-A!
MW6&MFJ:IY0'R\LL4)_.B&C6L E[U+O E 5?V6/OHF1<@CXW.2#!A*X_&4S;$
M2J>[UR_?CG.M3_[4!J'CSX)( C&XZ.K84PPIV9K+'^"Y&A#B!;/Q7*E896RL
M2P6[A!E9<8T1$.UC##6 >Z!#X7VC)AX((:BI;"5\9)!58M ACKEJ+L=<8\)0
M\(HDJ/".OX.U&1YK!%DRATOT)785IE(NYLI4%:.2=$#TCM(!D6LD9\>P3Q"4
M>W"6AG<5<LI82A>XSZDR:VI&=& 2P>%RC,!/-<L;CS4P4/^ 85OJU]P!"L6@
M <@45.*<S&;<"@N6[1+F2T8]#FV@8/(FJZ*#&@J"T3H9404N2^L_=^S+I2)+
M651!T!N*KJ\<B%/Q)2$,^A5+AX&!'#H)GAU]P"KIC-5X3#PJ#UV(#D@F-JWM
M#1W*'7L!*_"H)R8LD214BN; 4#X\GM83G.^47R ]"Y;"$B/;8"$;X>3WUDD#
M#9NW#EB.N9=P%0B:,@$Y7+!4'T]Z0CS>LG1*7SY;6B=K"520<@N/F$OAB-D;
MX85_/*E)^B#U(^96/V)VZ<0V+LNMM6:DJ\XL$WCBM9@J<3(G+CUVVM?G^8\C
MR(!-\\1]RO5R)[ZTV;/&"VW:IJ1*PP@_I C$ B>.EIU2;?W:>.J.O/6X"]<3
M;6-]Z7!WNM)]'RB2@%2M_C$6]2E@H1<CQYT2/_(8K[-&7?X8WO"=ZT^T6S&X
M2D ,KOHZ0^<7@XOI94Y\*OSX[=P'0^ECZ'[LXW(;/4&HFJ3(&7(^^S/8<&W_
MBJO6%6@AX)MV5+O2'-?('?DD"#]2O8HDDM)$>[N,%5A08QW;<,1ZT@:\2BLC
M=LGQTW$SQ*D\3]6AQ$)HY8X,4;/&=)2ZSI5?9_T/M77&'8\*);O$U+'C6UES
M#O:L%BDN<SX>7L$78)LN+K^<$X-^$*P--E(10"9).&=FGD,VXI%47F<E[NGT
M+%<H=^J]S1Y)Q7,DL5"6OB-AB[F(E1D3/!2HZY(QNT$Y:L79ZS?+NY!:=D;
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M5CNH>YJF=VCX^YF A(-B5/(ZMH:YZCGV\@X260CL8GUD=RX<_6F=C+@SK1)
M=L9>&%DM*]+<PE6O@19CU2':)EJDJV5.&<=Z&6O!U#+*^B@RMS&&=[:0\BI#
MY>:Y^O%V7^UL.\-;M!@/D<5*Z_036;Z\*PPOLCQ=&\-;3'97&GO7/;E%)U]O
M.\GP8M+BBI;DYFC18'AG\QD>V!E>JJQLC.DU%U)?%UUR=>6Q_M00MYWI+5J,
MA]!6LX_S539;S/DQ9%O(](ZWCNDM)KO\4[=_BO3>S4F0<;']3"\>+196M#@V
M1XL&TVO.8WI[U\/F7 \:@MK&2_D>EI9*'N"-@$3(E.OS4EW&-WGJ+?"I3/E+
M)(C\J:J,1XX&ZP--:UY]L4]J"VV#Y F&XX1-WW._5[/B"FRVG*MN7-0 8)Z4
MZ02$G-%U2<T8R68048$R*4C6:*H9(  $-$&2,J*X?D5]=V+""/5IVF'[(;B3
M54-%Z* F,'?C$909Q2^U'YB?AG.X4;MKFZY@ICO@91E)>S:S@3BGA]7O0YV;
MF3QIG9I1QNK\> 8S+YYA7:Z:\;1=2A\&#N@L-S"R<8S(EC[-FA4H,KVQ"D5R
M&8,1=Z;>&"O@@#6\'20\ N7N56:HJ,C176YDDI;!?DC[(87IB5_DHQ.%1&]'
MRB<9T!P-4GNRQKM05$#+9DA58_,OL">JV#4ZQ9!-PBP)@B\J0%PA(9&7#18%
MT.;A2-'P3T3-IETE7+-R5@LF\#,$0Y*1L@ZUW/Q5QIBU^83Q3;(TL^<M'MN"
M_4KBQU@4*$.UUV3 9F72G0#:WM&7LZ0N")1FEDB*+H5)VR69R=O J#-T;>[4
MRX&U W;1*XOW[WGK)O +8S6@UC4Y4"N63&O&:!!2I/TCO+>&Q"@-JL-G[B-)
MFBC7)>F'O !_@W0-GH0D'?<L0^X9C*"0>^TF%>-:!U(.@?+/F2%)-Y9,A8)0
MM(2^1".!6"3&K8S(A24-S?"-US1B9O!=?#DTT;[*=&HF>T,0:X7;2VXB7E\6
M*D;#-I#'] '^%OX3R>(CA=_HFF&O,4N ]A/ 56"JQMY!4RFX0'@W>*)T]$G,
M%9BCF1AO=FP+W$E,1>](ATR)+@K:*JO!FG%<]I("=SOCT<_V=W3#*?:B"PP$
M^ (P*.9V37"[!L*1)B3_[_I(^BH^HF(#.8NY>2Y3$-C$,P%VB0E >>N9>%=F
M<X^5B]);)=X$%E24FS>%>77)/4;6:E&,-"8)];,]DUS1O3T/E#,?R9]X4JMM
M)?HX^MS^C.ZMO.;5*Y76DB,EMK!-3A;K(3U5U$ZT4J_^1^Z$DQZV0YD)#.*G
M^>,5)D N7[/W/&[6)YQ\EH\V@1CD%#:%&&2UG#/[_N[D>AGZCSMA_V4M+N?Q
M=$XX=YC+Y2-?@]2<)=:9'S(UV=%V>@'<(HBA4-^4A_ J@L+VB]V3:;ZXD.E:
M?K!YF50!'W9T[O)\G>^?7%<_QKFNWE_X=4=OLV78*5U]#!):S:D6?X*.78HQ
MR]6D4I7+LM6@,I=KIO*@L.4BJO*2,V'DG\?%]Y=+3K^2%A-4&#GGER%G\O5>
MOWUUS0\N9TC<+#G[67AQ-<T@%7(.F.5J4=-"F<U6JZ7-TW.H\L)@,Q<9E$<2
MIIT=&Z.V%")NIN_85F2S95@K^S*LB99AY?9E6/=E6'<^!/6W^)NB$#+U8!0"
M8X2FQ'TVY$;#4R3*ZT['.7%$;:QZ9@:FI.X]P6SH7ZDP)YY<4J-?U*WB<P(U
MS@*;?X<KL-&< DL@G^H+D4^E(:LH+VJU-Q4V[FBH^'!-B^;OUA9+JUOY^6QQ
MG7!.Z)A+=$/&V6.<;AE5/JP,M,R)$>\SZ@TBB_#"^CN$VRWF4-!8P='9(:"M
M@Z?D21H4>'%T6[]4AR?*\-VB0'NM([OC0RS:"UYBO,HH2]%@0IV<_?B;]'I-
M6'V;C9;-I/DWF!I96I")E$N2IK04$S%8\5,=Y.S9_"[*5JL)*U_9F91HD+/U
M.Q];I8@.$KHGW8=(MU4:SO/$^Q:P9"NT[.I@!&V'Z3G2>+4*?96,?L*N<3,!
MX_ZTHNX6Y("QP_Q98\<H"F(LD^Y)@GU;29#N'1U\XG4@QQ_,0JZT/I6HPONR
M")$\Z-!L1NPD12/1?KR'?T%/%\61]QT$9'*'^'2GA')&8X%G.*KNXFTG$S/;
M$-LHU4R-G(3=^\,:XYI$%G_.;2'D;NCBN$GV.&28_!I$765T]MRZ'S[?GC@R
MIZW5T#BIQ9#C=:J9L[#4A-URGCZW2SO/K;'H5D<Q;B?TH $3F; %D\ [HD#/
M(&,5FE5Y"G3AI_ 7^*U"0^>T;)%]<RG.3S.(?C16NP-2%=<L/_\7Y2..TS:(
M6J2((@VSO@!FE5G(<'2HN=Q!,$L+'<Z,I+%&L3$DFFXP!+-]M,DT";C \-N8
M"PO]4,;SC2S]B$-GN,0<AGDD'(:NS5 <J&)!/TX*Z<M3%POB=5J/V=QTFT=D
MC2K15,^E'"YCJ!XV]HC7[<K M/#2?+YF-QZB/,F":A &YSLG$-\DTBUIBME"
M'O!$O !V T%ZPM?IP6LC2028D[T^%77Y$6;3DCCC;>"&AEFWA%5:@J_8UWS?
MQ.1K>L;CVO0G9Y:6B%^E(CB>/]Z/B^++^6BX& D1%D2H+QL32V5%[P)ZT!_&
M;Y+$;S[.MI(4W,(PQLIK6BWHP>6W*N!A(@9!EIGBS;$=&8_7A09$'#1G]@<1
M>PX12RN7^#B(#8ZE #B_TNT2:K2[ '2+H-DK3MB@]_X60N^O,XG+HG@0\6NX
MQYVS<>.L*5X]5]C :D!T2:!N>!+WXI%^Z!+3N@+EU3+4N"Q;W'@"RUZOV*AW
MOK'WSF_GY!T]Q HQ2FDY?/>.3-"YI^QVJEHOV.-FW.-:*5[+5-JR,D*P]$D"
M IO'(F<)F=%8*#.:T_N3RW?MN77:#=/]UH6JS1_@1;K$Q*+I>\3$:IBL8K92
MX++5ZAJ=(/-]=Q8X)&.X[[1(=.X(T/BC3N%6U.*H4VHT^*3<?'61Q)8>YD"[
MUQ1U6ID(DW#$!6%+UQUU,BG-6K(=>VK;SBG'WTG1/RNO3O"VAW8ETU">2DH@
MVGDTE'_2OA=9&G P>GH1UXS="\X8,B,H> ;0B8+H[]H8RI:+\&1(#C$_X46)
MZ+^0RC>6>A#?@$DH'2S?#)>0LT8B8>UD:^I?1LY-S6IBV8<N%#(DY-#^:$8&
M'7&PV8O*.B83L&=6],0PBHR/0K:/J(PU!I%ZRLZ8A]49!.^-)**Q79("Y)?=
MFFVO>FX\-X?2!/@8H0Z"D2L&#2LQ@P#REYUNWL8\%0=(4!L/\5)(>D\'2<KG
M?W=T9W;Z6+%%<<N3W-=#*%__.X05JO@9D%@B V4&QN:UGA>=V]_2S1RG!2Z@
M!WIF<]H@$2=2;@V9F+I$^;7#FT3ZCF(][<#V31E1<LS':?EN1R2XJ^/?25,&
M D)9\&AATLAF@!XLB;%GYULR>4PH#R0Q%FCD,(/5 30BS5R-4B26NF/6+\@2
M4(%&HWZ?(FE)15H:6T]24Y&YQ9)>([H[KX]U>'$PEP1!%)CD![&OB:([VJHZ
MWG5BQ^=35-9,^M65/J*5$Z#M&01B 3D+^GW6%Z$$O05KN3HD V-U14.R;NLO
M7D;GK+]@!@A%JT #30W7H*(+$7>'3%,FH4EMW"7YXPA?(![_DXX $4#G!>09
MF53F ?T''M;LVP9SD;V5NWP%?&2S'+9;'MM[/D 2.38R'WL27=LP,$.55#&%
M+&RLE]KP$#/.C6C8U7%*/-[$-U*_PE0>@\_-/ZLL\U/\"Q^#3E/C#?W42OXF
M6JE9H,)1D@*>-:M-B!-H$JR$+9M4<S"&)W4ZHNHK,#68&[R3 07;O!5V#C^>
M+BD*)2C=,6UV)-(S'T(]'94J^W8F.\V/IX'TN>G_0?NDJ!D\'SPA JVFYTW:
MDKL;TGO"[X J[RL@Z7>49^TZP[4#_Y3I7LGT @JT$Z+;&*3$IC$N:G.VRXC$
M"API]*2WI!D" I)%8P 29PG>0"<-!74#?Z(#"5GLW8LM\]_J(!HE_,UW]>=9
MC1D\6;R5)-5 (F56;*V#D#A4MK%&">+[S$\#0\&X,11DH4P7#\43(W,H$FB.
MJ.*K"O/#7.0OE[/ @0^[!09@N0IVE/AV_>9<V)5[Z-5I.OTH!N['4=X'0#*:
MIDAC4QQ_BI0(QR./<Q(3JDCX]P0_+5-?.'!4^\>?0,E9+-<,VG#,Q:KIE)FO
MX@1IV:3,&[2I V7 KV<?Z,J!B[1IHU!\-;IC0(/!S\Y.I6YZ-;0;QZP"KXLA
MH?!>Z:K8L3!G6#U"NM>+"W/VB*:]];=EDX\".UJ4-N]!Z@C*:D'^" &;V9]Z
MX^O\Z.4C-& 3#-:1E37%,>8'*3+!P([]!8C;/#%RYFIUG[F::.9J89^YNKN9
MJ]^((:0*F EIG;('S"PS^5]8_>R^]U4%6U9P0Q7UO^!PTE&2JW(@:=C2RE":
MN><?%"D^W024)KRTUQPH#5M*ISF4?OY2S!5X3GT*A3&L#TJ#%[E"YZ?RBOTI
M-M?Y*1Z0YC06>"8<N!4!/),6U=U<*A+_GF]_WI>W #RS&ME5TBK,MAGPS&D
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M4? XT:&93_5U]G#]^3;MMV['8B4 9&ANQY4S!?.(ERAN.F"=I#2UAPV 4_I
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M^R2UHOBGJJ)IJ>DSM[W!D5H]+N2>"GZ0F[%52;BO2]\LSC6WRG^PDR[IH_M
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MQ\V7:N7SX=$#AP"MD9[R;?FT1GIZ^%GE,5)Q!8&SS!.\/R*_OW&]<7-I[OS
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M4N-0\9Q7);V,RNXA-.FZ'$U=2H3L*1PM4YT/_VP=F+"0:^3()?R;_C3S\.I
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MVYBF?ZXS8R%!Q'L3,R'NOZX7;\_OH16N&PGNGF3>TJT]9/"\61$ Y>R>$@5
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MW/IA]'G( LRH9H;>T$O]5O%_U)Z12$*9Q9V8#".=0@)<)<0>3BJS0]\C,NR
M\-MA?71EAK M$)&E*>-DU) 4,5XR'G3 @8)HE\,.)F?4))61D>WT3+67I%SO
MVN' [#-M]$FC7)&C3PR>93 *?(R7*WM +>UIW/U3HN.V9[3&U^.0G%_/0RVM
M[I>:%8O[R2952V.2Q9<FYTSH3!C3-D*LG0!^KA)M% 2$WU;-*8.O\[%ISYMW
M9^8ED#F;& BE3%AB8I>"@<7V;,[K4 <7)Q \.K;;GOEQ[/((JH FX=+(HG$@
M+VS/"U15KY;V*OMSS,Y)$R\0Z*'OW]GF)VSE)MM44NASSLDY_HW3RQX#BTN.
M<X[5!L*P?/6'>=RZO#+1_>0QM[R6HU[C+9]YINQD6I4.@:P;;I8JNXVY;M6J
M)"<B'5^V<,H5!E!11<FX'1ZZI0GI% CN.-3LS^ CY[A6'PG-638*M6'37T$!
MCWCP/@@'%*Y%*1&J'L]=Y?_;>'S.R8<FQ=F3YD% G9=L%/%FG]9^%GVF-(/$
M:<T_,CCYM?-64DEHN>.AYZ@FY"?G"9>-'&X>>T528Q3-]--G1 =+9F?,\ULI
M%-N!D[+EZ*6NC:D/\G6Z2\?@+IV? 'M#;-?+#<7$:].[=7@Z:(O,T[CAIQ@_
M*$^+O"CF2YD)TF%@+[[2$X-%4+3#X(II@%4\C:K+7?CZ>/3T0?#T#=[:4WY1
M5!@([QO^BC]!I!7'^\=SBV=TZ7MW/"/QIG3P>F(9LN%6>IY+8PKKV!]%KZW*
MWL];#*VV-QG )6#IY$S%P_%5XFWUF(LC[E&#Y!Y)H  L"";/ 3D^2G/0?+)7
MK;K2&B@/S5WE@!19S_S>T>.G;#W?8RI:_A(#TC_K$[&3Q&U2(3*/ZN,'_OBS
M=:Y;O/$RY2]EHS2C9XM^LOC.24ZTW8)E-G>DZ[?>F*>^< 9);])3%SC<O:9=
MM3$E=/I@FQ2/5(STE9[O"9&C("%HTL"6@F)<Q< /HAW*!0.==PA0\@&.'C[T
MI?8&K8FS'B28$2!(OI,4^B2+ *OTIRJ/#,L&U5]!J4[JV<J-*/!(NTT!?7H@
M^L^L$<'[NZ6]/6T 8S)"H1G%L>+)S6.K(KF'2D4)*:%<C>[H^G(N([]Y>([7
M=4;8M8 S#VT72:^J@:])^:OAW!2[H#(;V8*)IJ^ A8&L,]023)-90RNT/C;9
M!L^:O/LH3B?@@ZW1R'4H1]4X^LZ&(S&(]Q%BU(6+<,&]'-&,; /4 $KXN,6
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MUFH5B]*->JQOU6T$XW^&7_^I6'MS)!Y-R770D-3R//;=/)P&HD/6=SP.V_/
M_WZ7;*E[V1VPWMAE8 :V8M/PD'7%Q+0"5E-@563S;:;^6<>?]Q<I&)[19E"(
M&04'4<NTD-7XI^.ZCCTT?V,!H"7_;KO2-UQ;: [F,X)JK<@ 7/?D6!"!B[3<
M/6?!B$48:SAQ0.@EFV>(,:#VT/>N=="48%??HZO &9D??!>3!704@N@;,O@T
M',O5'_SW,T,L63-"<T-JY<F,K,T7J$7BX+J!*D8\YUK@E<29&MQL-58&M*<X
M''H3B7HS5[4E4&LVK$6\I)]!# +(&!=E3ACZ0-^G?L32<[%G2<&$+CH%E]7I
M0[*7Q25/#K *3&9*OZ++VYHA:5F R@=!\L3Q& W#AG\ 3O)"*(\Z8D?MGOD)
M_J?KI^=-$)Z:*P;L$Y*BB+/:D@!;W2#J7*BXUK06$BP$PGMZZ*8(.-V<L.6.
MAYZCTE9.SB697K)1)!R)N4N5]!NJC46H=)+UZ.PDGLTL_L?>3%*N/QM2GBN$
M=0_?78)L<XY;/91JRQM+B8UG0XESM>QZ-'8ZFX_EUL]K:;+=7#Z:GQ):K96M
M__ZWT.*7U^+9]VI-:"]O#WQ0L[V(%@TZ[P?[SG.8^7_V</1&4O!&JYRYTE>U
M(*^'+S5%29<><UU!2&!V#8&MG9R<FR^!G;GC'M56*+;9*%L:%WNZ%%8O%S[X
M'/C7?T:^#>JH?\L"26VM*/(#C]UI] 4"-H2EV-$X8%0@+ 4SY6M0I4U6,XK-
MMK#S](E9Y?;I94&/#UYJVW,=C]'R_GIW<6+BD#:J6SGTNV,DI6? TI"*+@\^
M%%24&Q5=V=]]SQ_>@7",F!<Z(HML:#\WLCIHG11DM4JR.K#=[MCEXN_$\;YU
MT(Q^9D1V>'1<$-DJB4SFQSYC&CMIO2MH;)4T=F)WF/MLR>O\XJ@@KU62UWG
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MTW023CWX,\BR['BQ2N2ZW*$\6]";,.S,>@;\P8$W=]C =OLH3_$EH+JP@'^
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M\TN(9Q\^Z%3O_0_7Q:_,[Q0@LN^1!XYDDE=5L)W4D8V=;87=%WF)*D_,]26
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M;:9[UIRA0 &%@ F;C\> ID 4\*C?-EG.R4R2JH606PI2C B:UWGJ7#+G- J
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M/L<*%&Y;WKADG=(T:X,EWKYR>F,1M&5)@,M__/0Y]G+1;.JYRS%2NG4R:%S
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MWZ$](ASF\!XX1V=",!R,'H4<17.A9PC'T+Q &!S8,T@M7-"29!T%LJJ!(8@
M,L_]7?*5T5B$E&<(1YM15=*\YGK60_%YY=71FUL?-C>VE7TG6D;T7_V>G*<[
M:7U9HP51"+-X)H9=2CB0R)1]D$CK/NBNG#$C-:,Z[$189UM:>!6 Z//18?"D
M/MH']3]8,U<;#3?8%$*FFID,R4(N?=XV$YWE:#C$W?LU"E85 C0H.B2_$#L9
M,QN!E('(-^M_,EGPQ]3?JL4N:H8%%[<[);M/7>T;=[LQ>:+/7^6RB!IU-1J]
M^KK!8M*&@@672Q_S*+,[TY!%#C+JAJ1:IU*O+(N2])M1BK9R)Y%02YL49*FW
MBE]T!D7Z7ITD3=E/9>_B1O#EU%/VG-3Q[^C'JRQUP/" 2*4C4(L],508N])<
M$Z6S#[J?2,/T8,57$(+;FVERTMUOLRXS;F>CW$8O+DQO97WR,'U[T-;->G_]
M$OH9F3EO;]) 3A%/:_7L4!C/+BC(H9J(L\0\F:5 4"U+BC&U84,W77#)VX.Q
M0L=O:*PW<4Z@+K<P>$C#AT(26K1]/$+GU.BK2"*I\/B'\.??+C9XA4BU95'K
MZMX:W6QP6;2;] U7-C$_"N3XM(6GYMK?QV<,Q/#;.6^'SG0C+K>%%5%U9^/[
M48H61Y::2QX.JE$9#Y )10G.I](K[,I"_$(I_)D<<Z1O6D6>7U49;=4WIK2=
MKU3=F?^)3MUYI4&=XC*O@E2]]*5\PX>C\0W\EKQ1I#'29)4CV*?!0[MOM$!E
M'V2M+U2N1L<R<0>VI@(](L6S$;<X/V/%] $"Z)K[('? D^JM13(A-S$V*8-4
ME>Y3JU(%&4^!5!B8I=^61^H6?OEN_)<ZRK;:,T0*59+/K&R "U8FBISU2"I^
M!/^7_12V\ (BVGV(0R2 ,<$(:<Y'CWGB9JZ/.8,%X7U"32,E/ME0ZN/(,DY,
MKTG5SVEV3IS.%8 [T'WPSW^^]OEY53YD:DK81UIE^S#6YBWA2:J<$*/U4B2E
MN?=''BDJ]O?/[SL)P[H=2S[#AGU^43NWE*3OUCCDHQ3!PLF]M"B(1Q;%@4@N
M;"8GP84=4L7:*V"2P)'2CE?CE, '?70O/>.@^+SW,>X!H=6VV<2 G7)Q+FR5
M7:N,CR%?+MGWY;SSXTC1*-VZC4BX=$H50MR*&9W)JF-GP,+F9__0-DG?_*E3
M&Y)TOIX"CF@'?1&9UHMI@:TOTZ(.3-D]J?RO:H?_(#V=&:*$="@\0*XF*EQ_
MWK\SV>5NP9X=SJYCE#"ZOEEZ,//A03:?1SGO058A/)P3+%$@*(01PTP%UFJM
M@Q::^%:Q+PYLJ]N,8I7_,X^OWNXA>NZK'D,U36&=V5)V:56SJU(W+C9L2Z^Q
MSQV]0;OW9PB;Y@5WS:2SI%/P!?XQV2ZRBRI.O4'&MY14<WDE/("OEH9")>38
MEX"Z.9] "FF<PD[(Y1.ZQ]3-E>>QBWY>NYO',+W_DWY+*3<J+L;KB%4*25W4
M [F.U24&_J$X]5/I1C<$Q54B&S(H?E'3]3Y2!0@V#@%)I20BX0*Y-4?'\[4F
M+JOM,.C#+%$>YG?ZU$;(WEGT *RE<+V=_H4*R4"K VGGQEB.+_KK0W=G5]&R
M##%\?(@_#7;(:\5<96++$_&Z(6?NR8OI^5"TO'8H\]'.(X^Z+*,:JX-$/L=^
MQU% ?\:T0M:W]PPY Q@^M.K:/!<K@-:@=&E28:K5FW?>ADY(Z7*N S![-OTC
M_\G3C=9WMQ$VGLKZWDH7Q[<,$[?&;QXVO/5 7YO-17?,&?\13^^*?/4AF"'\
M2:%_1^H#X578LL-[E4 ^PYC=Y$HH65!%]2OG0VUI^4B7/CH N=TC6.J1)FXC
M#MTE\%-4L-Q17,.P]L@9$:/<-H_?SO ]2P-J@:UMNX4C<\!I9\)@NP9S/NY)
M[9J)94IH1.L[5]N1]0L9Q[HF(AIB]^S5BW_3#,6CB>!BQ<GI)W_-!3]'AM&7
M%S998F$'[?VZ)V/^@ :M]#:8(,J-C6.Y/D>93:%E@L7_%LP:9J$"%H]5M="]
M/ (F&]L3"M,TJKM;)QI8\) 7LBYK%Y*)NV4_6CJS;,."$ 4X^E7([!_F*KL"
MXR<@[\!^#@N "Z(, 36&%;G\"*.P;SC31VA<R^_"V0>ALP5YU4 A<;8I'7JQ
MKC^,5B85?Y-E6A<J5B[F.7)3L:VM._67*':,NOF/$46/=C1 <IAY&TQ5B=*0
MDR3[1[EWVV^L+2HE5Q6[[(-<7\8Q8B%"0ZF>&;V+/^"''*#3-ZX$""8\+)/8
M\;+=2EM X=,4RJYC]6A7 FZ*-O4CU07!"D/E$/#=5)-JU_/L #*5[I9"/$X*
M++H1Z"U5G*,2[4=_?7]'94CT!SNW%RI^]7Q,N+ZKV)2.E=D[THDS+[TL=(^=
M+I'T#\QUJ\K)7WQT]GKLM8'+#X)5+1:BOD@:T NR]-L(]"LYIQ/=\:T=R4R!
M5P6SM,D0C5\:U<E,= :M9 [IK=A>+NZ,K$X9=7ON'!L0<!@C57Z,$=33 0LP
M0U!,* =TOH+$,$?'4.=/TL%$!!A(Z_^-/+L'3W8:S;,:UXJC!DF,W50:>SZA
M^?U=&EG[ZZSW%\_XA!O/=_2ZN>@W45%R\OG0/Z+WW,&BOD@?H3[Z),RLQJ=1
MMS'<+M<_.Q612X2V:U2P"S]A^R>8XY&Q:XG6;RQU''U. <LV=R!\Y$:+^Y3!
M] Z8:/\8LEMEL -=+I?+FPKWZ':_5QYPAU0_IM?$;OA0N+"2R O,/C8K%5%0
M,<(\;;6&8(B[4PM6V82%9[ 6Q'KOGBF'1.!N!:<]1*'871P8DNOB.V]IE\E3
MG6.G7Q(F%,>@&@W(1W^)4_;X=)8UC4\O*#Q2O34'!@]CZY$\)AL:+;AKV>UC
MA( (0 5!,;-AXG!,$W8GFAN9N.#:O^'8U\[1IONT4@7L/.?Y5MND?+)J@))?
M8_:9WA$D9K<M^>ZSM<).-.$YLF#W4^.6V7G+[E?-!&>#/P#V: <YU[UH643E
MA]'ZD2/&DZKWB$%&X WH%\7W>B8[+OXD=TMKE^<Q5VY>M!%.R]O=4E$;72H-
M'L]1^<16E"8W\C0\"2B6.]T85;AD?/^UND*\WV\H94]):1B9I4I<V@GB7S9F
MJ\8,:,M8>/*EWW/CS<=M&ONJCN-=CF,WPJ^O[C)3GIX7);]M"#$Y(WYBYSB\
M;O5LP@T]VU>X#YDV'RJL%:;K.1YZYOV!Y$,&K'6O ^GVAH4W96<Q,+3-=<P>
M!'"EP%[_[;6U<4PFF>LP<O$U[5D&26J6+5)EG)J(('^:+7?#+\]SOUD6414_
M/<2SFE"P:N_9#[4V4>KWQ'::.+SO]EP *^;T05U(0 ] 9%@*S[\B46L0R'8.
M#ZE;E-"9NKO85ZXU A6BJ24%689?-FJ@$EI(!;,%Q2_2-3S^6(VK:^);FTNL
MPWUW99[TY*J3@EBF^4&CO3_<H,M&%8\"C>K?:@_\^8@16#+JJI0LI6H;_W).
MZ2<WNN>2J-JEXR^G!QZ^6[68<*XQ<=@I_;L"[NWPD::AEM-\<X9T9L2LTX=_
M?U0,*%B:.>+=;QP(-NZ]7O05 PZ2Z!)YL?0&+2Z9_;TAL]>Q4"W[S(N!''@8
M9,W"W?V\"G\]EYH*M_NE]R=SC\H_L#H<K4;IED)_AASFZ""3*>7B@"?#IM?<
MG"%.-',+1IN-L+0:9U;;Y\0FH'MO[<-KS]]<ORI=Q[=F$27^Y,;-]<:-"^3$
M^$KXQXB[,/K5B&Q,J])&>"(=QG0]R$AV(M,/L, C$RBT^0T^VHLN> RS[JTG
M1LVQA<Z[TMF67^7U+>SV@P_/ '.^::WR50$]%T;.=+B 1H,"4,B\P:[NTJ%K
MSG-XMQG^"\OK8_2P'CEM-J[+0VYNTY8 I"3Q8#]BA%'Q%>IR9UHGNISCCZ3@
MY4-&P]2> PI0TVI93X>N![/U0C/]$;W)=*PQ$O57H&BDQBI=^TW$T<77']O!
M1=\_7)L78RA*GQY<B7*6L7'[VMBM6*XED%YYCUC;L:ZN-D9:T@_VG7W.5H_(
M,3[1'\E44V^ZW"[HWVRG-]@,'1,N6+9==#T2V:V6KF?R51[!]^GN)SIPN0CJ
M(M<-._%S0<>QPE&@8)(TY3.!L6L9Z5E(^+O5PS4%14LT+=UV/J 5 =-KH3]\
M9XZ+7=](\(>D?N8,B1<6)&AEL'RU,EKCWC 4ZW>W)S.BDJB)"@S^SN'[7<9Q
M+WIB92$N4U 8+<PXKJ-XZ=TCOK>> ;MOF<T' 9N0=;U9>QI(+J85<#Z<<7LQ
M8L.3O@_JPXET09XBVVS>QVZ" 3CY@?5!Q[:1\@M7%2KE-,4Y2>ALG9A<69IJ
MR8%8O/H<T6I[[E>B>\5O>L,"#C)"N::M=NP132FW?[E(A?8299WG]YO5)$I$
M1C0N/X[YF'308[M^6"Z\YJ535+0(T5=V2J'5&5_%OP/+L0R;[GR,X<D9UOX\
M2(\_X@L_EDM%_>$N7@+,E?N3K$XV$7?"$_A$RXCZE)J%R->]EA,Z(JMGOHG*
M7(1_L;]+@0\3"/[#5Y9R<=@_S-W?872;A7:6R!J3- F["4N&O<)N".\9H,P!
M@R;@K>TX@A)M41<F-8?7\P3.D^541ED7%\K.$4D>V#2[N[563Z>GG\3C&8<+
M"A^$N6S6&I#"!'!%;IA>;\(-;!;N>+?JAST#SA"$NRMB 98".XZGWR#PQFVF
MBXOA6O Y^GO>+MZ:X?Y$'Q'X<3=XPIG@,QU=4DHIJ//@-$(B]\B$95FB-H9Q
M&-C\,I25)DC.UKUQ)(G]', KQD-?KT]IDW\4!UP*_!RG[5#@FS7(T"'.13ZM
M(8N^,OHJ:MQ^"+E-72.>ZPJ-4J\;-OMH%+.GQ7886CQ8E8'H=<&PDM&:O FG
MJ)%<[^2/D<TD]"]DAM/CGU1MB=4'?_=!E4.WHY%FYH1E_41V(H.3^*?T5J-5
MC\^93D;A/93"(M\\/Y#<>[M;D3Z7TSB'-.V_=8]"FA-[.Z&_%S:( X=-AGYL
MV^U^"'T=\I=1V>6W=(S_)B/??X)J%Y,/_8U<&_Z\((2SR]^Q]7"L<&F0JK&L
MDFI5'L\L554>KW*H4LVP>[PZ6N*(U\?;-5R.L;8KN_QX^=@P4]6@AJ8\0G+(
MRU?="G&M4N)]_+7&Y<#+&YO$A8S6V0Z4N1G:-:@Z7_N2XN&T>J[*Y.:'?= :
M]N^K]V9ZVQRG=>P?#I*Y_>+E@!'9[*[\(SB\VCR"KA_3*R%)47H0*9([0S:,
M^7UW?-<E\'YR#0N\I,-6"96S=(OKN6K]_4]I\I K?^2_B_AWEP7_7;_T$S-\
M^H[(':3^_6@P'E$-!L8B$W%/7JV4WJ:8XY/S-FWN61Z3J9$P@W/E;:Z-W_K[
ME.>Z(%[TQ.]XX\/"4\FX"+P?C#>$*\0'33\#P6_)LZ*#?[Y@]W*_BYSFP9*2
M]$I 3YXN!)47]Q]F4'Q@_+MLO3P+(\E>F 7NMZJY^VZX*OC35.._,MN4,UL;
M  AZYQ#/6#7<:'F-(U+Y='MSVPSCD;[0=I3+Z%RBT-3-A._9<;W#=JT&H%,2
M'^3*].XDL?4V=_:B"N8.TW\TD33\:;$ZW\"B:]T"].6[6LMA'SP^L&#4\(A^
M*<Y#$9?#.T+>5C5(HD?(K\_Q[4(V$7QE!8RIP*CW1M!H,RRDL&;C:GS\E^0[
M%=$FB[GO7AIM+WZ.;5"9K+OH[%1K5])DB4P8.!'E'.R4KS+T>(/A^/B%_>-G
M6S<?0V8LG8/M&W]VCE<X'[!4V&)(U2[W=*G:N;+0VV$%ST^E-TE\\'XQ^:)A
MTQ194+FG@QXVH:1Q# %'5\" _L>9/KRA4C,7!H/HR]H0/>*8^8P(EW$HK IP
MV71@].>,ZWY9*WP-))X?V6IJ^29O(]M6['?Z^J-9)80/G7/W&>!H\=_!CD]G
MAR_2-U.W<@S__1R;9*[0_G(TUEMN2-;49DS]*:* SX9/&JD1_@Q18.1W0>:0
MAT!IZ?8^R(AEIJ(RU!KZ\$>-1\.E/RJ_AZJL*66.*:*:[G8VQ?9XNT?Y;_)5
M(ZMQ9TX='0_ITV3</[V^B"2K_'YCW!HGLKZL8C?5KE_:<.O+%:S]3J8JK]KI
M01'[BR"18IX*'L;3[&RY;6%-<]QR \CVHNNS.^JN"ZX;FWMJZ!GTF0,93D&=
M9-<3@A!W.$> ">IP*HXW=A[<_7!Q4PK0.T]GXFGB.)I&/A-7&R*UG*Y?YA)\
M(W8?)#JS>JLP\MSDTL[)8VKZ)VHYS!&$:^]7;^Q"_930DP  ^A8"=;$O^5Y4
MJAAF(^K*XWFHU)>:0NZS[_6/9ET)4CW^/>6R6Z=#&G3V4:%Z):,KIM?XMMQW
MX 9.E[P4'P<5NYW'."(L^=BY=Y3\^>-KJ.T5GW^>^Y@>*O8-LA-=C1G'N_*X
M&!B?$A>7"QYF3/4GS!\TC23"J^%^+$\P['50'^$^ <(*HMVBNR;'#J?"A+H.
M!5#W00(LDRFHF3#03+.=X%329EI&:+@6=C,Q033_.8W#-UAGFQ"&:5ZY]I6U
MLB>$[D6TN;*$ZY@/Z=?GP2ULTT7X^B8CB_KWGCYA5MN"ACV&C-X']?A 6W-C
MWTWJF^EY3>AOG">=-3\RJ:75&!N6<U:ZKBRQ=[>["?]UMOKM$=PI3DJ(1>_A
M6R<YSELM4*>/]&)+S(-K'3'WZ<5*PA/DR6'=57>TKXO$0%&VG##?G4?]_GK9
M-_TMOHMJ9T$>F1C]NF'NF]%/TW$@D]]6@@M( .SQ8DRC#.T*1IB1:VA.577C
MA<**QS]&S^KV.!+]=8KJR3#'WNL=,NW'.S(+='[LK#;=^4$*F+ZA"#DF(_RT
M=AA@LQ^P+NY% FK,U@,:Y !U3!4ZC$C(+$G!]V^*A_C Z#RY36.VG1U9]D Q
M0Z/K%*V)WS:J 1G*5]<DZ#,;.OABI5UJG"\II,8*,OW+2YV)L0*D.4?G&7L'
M5I9GXX*Y0=B<Y"@L='A6F.:::JX=O.M44M:ZE/%\34Z P AL4LRC)86=^[-5
MEW2>4FANRKAA:&7M;7.9/E-XKCBH0WO^O/CZW_4/>WPL#79^MS(* S0MP$X
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MY!1NLF^8ZQ[U%_C#2[T^1KDD5;>T23:U$@WMH=*-.0JUQ=V*COWCNX3)R(D
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MYUSG?5_W=9USG_NH6>6&[-VS<:3GWZRP9KY?QO/5:70.B!_S<62[NMJ]FZU
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M0/%@D;\ADU-;OL#57>,^UI1%8P.[YG4-<LE[9(UKQ+%FN20$$1!Z.$,3I/8
M8(HR\@W%^,-5^SJ=KS&HH_&N^Z"KAKIL\BPVE7.U#' X\#(2:#%D/45_ZTFA
M\I"A+KT( CAX3D3@3_3R?5=(#,<I6XW=QT?(2N*FU3 -JF?ROKGK>V@]X743
M%$_@JJ/['O:QA6^RFBC06)T$<LN70&\Q@@!/%PV\<C2%(7MM51UL7HGZASBR
M>3&N'!?S#D:A;XQR3)6^3P?J5/V;DDMLU*E;>P54Y-V=#$(=-3A+MN^\EAYJ
MQ9/6^_,5/30D0=A_4@=1. #Q[!O%)7V]G3D 5ND^;G(H#9_:-4H9"RT4YD](
MT'&;777)O/L!U7VHR%?Y9L&]ES6W8[]6^'TCREJP\."Y9G.PN3I9R3('(I S
MUD]/BG=/P6=\&NRXI3C[KH(LF8I73^0>YEP&>G8O<3]!Q%%A=%J<KBZ$@.]"
MHD\?9'JN)"#_SS!.+=P[!2)2SAWXKXO+M-S <DM0^@M6U3_-K.FTS6>GSI=E
M21TE:-VJ_X#Y.LV[I;>'Y_)S>VF-D<NU^Z#ZK?IW\S2IML.<\^SM9S]8NJFY
MC)P7E:AP%B:1 Z$/)/=$5'LNS,CD6[!=.C\BKA.1*-TMY6FH=>.0?^/(YM1&
M^B5,S($NH,YM!;!67[.6/%L!)FMXCDP3-3Y'ZE _@LPT9\?'5@.1=D"L8$(U
M$+]TK66\6OOXQMYE*UD#DQ;W/\'8.!7\_884Z;1<6%>!;/?;!9H4ES]0[G(;
M$.'+QM"#MCMEU>TSS491Q_V9:_P>!V;"+9[*^!UT89T<&HBK-JF\"O>/C C%
M$K!3IQL)A?#B=+V"9WZ%2G.3GJ@Y4<,$Y2[' ;T,GLYOU%<MC]X7&-J8I'Q9
M^J'GH6V)3!G\].-R[YD$LEDU8BR<K3T6R*K2M:]YW?3TT=$@$_F.;FA_K<@'
M3-RZH,BGX?9>Q:V(2V^N/NNKY9BF4D:JX@@H,M2M@2U1F5664,;WP<.@^%KX
M;,70'V4&K1U,?7H3\&>SR_?>KJ'/('4ID+^,->?EQ/<*5+C'D<+FHX(EC.!X
M*6X&'<('0YG6CTIW1L5MO:CR=+MZ>/M2U\[H?*WW*^;K28Q2-72VD$0([@!/
M(CIHXL:R2U%MK]E%%,@)DG]&'$G$6 @E! 1A4?+L]"26KLE8,1O2B9"] ]AV
MZ9N1V.[,<)=,-WC47/(*RIP.$5TREJL;W\ IVS45'5B\F0+YK1< E $66J1Z
MQ3(SCBRUB;&V8S?Q,LA,!CJ-+4QO*SF0RN009+3C\,:*N^F$>A#*7:VN?%%'
MC$HH)\2\\YCOH>.@-^YXFGL21M5456IT:%OI>X5!1/ER@,MDDMH_8G@0^L09
MR##*3[=SX"B9'F/E1;#?CCJ?_O'"^[R@?OR=Y-\S"[7?"3_?V/6HCFJ82[__
M?<?K EL73)\!\^?\V+PTMNYQ]'8ZN?=<QU#)J\'VGYN7'']_]3QQ05#$3^9:
MFJ$GZAYK+"SJVQNY4SC+X3A)I>DW)G1Q_E Y15^V6P[&2CRA9_U$O7IGMW&W
M"S[')_1/EB;?ZQJP4%J7(Y[OU</%619PS"?@QT;(J^]^^DAD/]$33*'%>M<W
MK3QEK,F@N_.@%+ $=[Q-#C J62(UK"41KQK1D@C>AX!\,U9V80F+Z0)HL'89
M)45R').)X T!7]<ACHE<"A;H]1[CW#54CPBE[UG^[CCN6?Y["9*P#V+9&RAB
M$"OJGUJ@*PX*B413NO?)13'N%79WVAQK>N\'B?4QO&IJ'W0,I3.L3O1G%L7#
MBM+7C$^2$E704IRK@+GZ8ZT"81NK('G7P4SOPG$&=('7BPV-)ZH63R.+*')G
M!XFZ]"J)E5^M;#%2U<*.<9R_Z \6C&H54;4H+K830XR,=-$9'Q^V"DDQW#YI
M(O3H?)K[XSI@C67ER?)/:CL=4"1I++HX<X@50:%DI!"#RSE7667;SXCJT?=5
MOS:B3[,%&G%JF26>%XGU88(E$<'RYH_@9Y7/CPHH8"'B]18^&GI)+.P)1H S
M-K[$EM=![5>['<X\,=!_M8%NHEJB8HUR@H]T,,[ &N#C<7S:;36+BK>Q/VW;
M5<INU[X*1'E3/@1N*#&4QKKMO_ZH Y*=/MR7T7MG5H;J)X8T7!KU=1"/SY%+
MK1PLB!KU3;P92C%AE9 Q1S#WP.(9QP%?\CBI$4_&3Q8Y[36AA6SI0>H,]<[6
M![U;*:S@=BW @K$+3LMK2N;8^C%B;#OUU<FMWMVY^NX!+?<KJKVGW?J4 Z6"
M6ANZI"M_$#+B,$UJ"1<29M>DYDE-NJE<7B2X&T/HCN.*N*$@0&:H+_N^;(RA
MRZT#%L6D&I]#-NZ#.F%>]0Q\O"_Y%(TZWS*0J"V])&#\8]JB\EN/3T7Y#'<?
MY,&) 21OSUH+,ZQI71EQ8MZ"J*LQ<FG%G+^)0!S=(/@H0NJC55C07G89D!/C
MI)6R=\/#E49632.,YMZT\(NJ-Y&&#?QD&8L?6&5_DA *.LA51$"%.1#6=GN;
M/#NW$\J#]+\)9#(&^)#7(*>6H *H4#R2OU-S/E)\A^F*T/?LJJ)/M9I8M8ZL
MJ9U:^KMEA* X/JG6"<=!Q<,B[ ;V[#XKW4S%2C@@8=R90K52G&%XZ)(2LL=?
M^Z)]#D3TE?[E"J^"&W<J;UU:[W)Z<[EB-L=!R2,E%9E7>,$.NZ*LXJ204!6'
M/?[ [W>OW+W:FSUPEZK-Z@MN?$/8^"JKOXI?^=Q^4L97])C:M+RV&_:=H\&E
M0031.M,H[Y8#FWN/(P7X81A7@FO*V:T3%&N%K2^9E+:S+-PX*;2ZP'FN4XP&
MGHS 7;W;&A$,_@MG &J<FR!:LTA;E#:@;/<!,G,6'P\-@B1X*3<#& 9- -W?
M**?&[FK&HRZQM7>1^>8DX 7[5*\G6R%=O:'H.#!!R3L]WA#\F'MR,-Q*0),L
MEA3\KK?*=3'WDFKN&B2Q39\CP,I(6N&(,P9227Q$=:9TOK*LS8'5.W-PJ53%
M.QT6J&\84U9M*::C$8@8TQ5M@XSO\";^H)_>7VIRTC3-Z$C;9"BA>WF"E6("
MY.*1-*8N>=<4,,!2%XM.-5CK4J2,FQ@#O%2O1>K#A'O4[KCPWJ6T!WT_QPA!
M.ITFVJD/5"D_&^Y7KO^#KV=G7L$I>C][P/>^JE?*<08B[2"P[)<WNWXD+N=4
MN6#K"1L^>[+Y(2F!P6>77J6:RAAY&+)%96^(Q[IIB_<):C!@2FH.57H3[2.=
M2ON@2=?OS8QYIJ)O@,^E#]^J[]0-G,RYX*3QRN.\AZG*C4NC6=!C'"/6QRUZ
M+1!-_[8Y93N5X;&77[25-+A&?,1J(L/BFV=I5"?#,PC6XM8T09W'"\AD*J2W
M*?2P5FV3,LH6T>>&(FQEX&;14_!-63XJS>*-IVO,Q*X@M[_P8OU>K+$Z1Q6@
MLQ >06&=&&%,P(#8?-LA8* 4P%#0BJ,VK=6+,%(LH=7/GSLTM&DK/&U[OHR!
M>*Z[1JA3*_97,2UYCLZ$_R<.!1%<U6&.4#'' T!4 P.>0ZH<ZU*DE05[(#X"
M(AS(E?Y8+Y762"H+:(QZTY+&S0C#7AI5W92V@N/N'B@?ZW3SQJ\EQ6P:!1+O
MS;>\\7$MZ2">!%B+W;!18?.A8,,(1A]O1PZUK7+HM8OUB,)$\+(\J>VD_'<C
M7)65UD-V3\A\;==JF\TC1GEPP2V_'/*9WLNOQ_K??_^M_;LLK</'SUV9,B 9
M_R >PA^[!;SN&RU+ZA-AIG3>3--'?WE6NTH(]DW@0'I^JW1<2;,YW;?^BGSF
MZ^_CM^OCGG;1F28Z[=5RRB]=WWC=FJ??!ON[\V?M*L[6?DMP_A?OI9=Q.X&C
M #S:E4'=;?S?/30"X/(OX,+8_J0LB>.>)JV\J.2(C3K0(U-4R[U!YH)Q"A19
M!/FEB4[)@?E*^S= 9Z>Q3 Y?"9N:GBXOBO!]P/:@]%UE#6R-8:CY'>)>%UES
M*T7O@!SPU,R4.Y#"= <GBEOL*@9ZO[_4VI;2#D,_I>-T*3J-GQ;R#,>3JF$F
M;\]1'URH,30QZMLJ]CL,:=F96!'>A2+OTZY]9/-VVSZERN*3;S5^9/7UX]CJ
M[2TQI,0@=?55K2JKOE.(UKL7-ZT,"NS[UZSC5WO*FUYRQQE]=W1/]DBM0Z0Q
M@0.Q4)!*1#P0R^8APQE!TC>&-TM84U9L\?@:XPN+,.>ZZLGYA[H[T"?X"!S4
MF43(^;W\N?X<7*9Q//+W5$-7OZ-L. <V4.G2]84$]M.;_*45]@4Q-42Q:5">
M>]0?D^<3RB_N<B2)PO!-X,[$>Y\PEA=C+?&__*$XWFX%JAC[635;\W?%K9)X
MALS2(9FC"F>J[FE[:%VTB3?)#.$ZQ'=4RZK<%SX2EQWYW/92H;+ 4]<BW-R;
MOZ=EPL-XG7-_!,<:G]@'M5\K8;M0: DZ.PD4:UW+O2RT"'<LSWRYB:W0R=5K
MR^MFTC*X6H@)!X[8V.9NG[LCD<#6'NC '[8**UFH!UJD>ZUY.JW+/?]ZT2X_
MT4<3)/D/3(5URDFP'(V56+0510;D1 ")H+[LR53]GV?:F':>LQ]&N<SN@TYY
M+T+$V\XA _=!71!QXW-  5$7Z_9YG*M,:I3B?4JHJ@B?=NG(^T?(U*@:,K2=
M8JP,^+?+J8T8:C)>!VVHJJVW&RNSQTN8:8A.+\$A0T5ZGWI'U,"SABOT\:YZ
MA@'XI!DUCI:RG%9>X5OL!41]G;)"X);TG?:X"?!*X" 9XJ=LMV* F-E@0>2Z
M#1!+AR;!@E/:U) .L_[Q/D T,^-0X(M Z"FB&^9(@Y1 U\=W -:2U?6<JI-_
M;D9^(M]I''?A_6"0UZ^9F=^_EFSJ6R<$&%L1UCZB@B+T7 ?IO:*+XR6Y_5D+
M$^1;]?H2+1M+]N3U:XWPU*^:*HSWZ?+':E\MFRDLAK@JO>BP[Q:=C;?P<C5W
M2?E0/SF;XWO\9M6K#IS2-Y2S@7+GK9!-1:?.WY;I#D^^O/^>][00(J[BY1E/
M5@FR\(7W2KJO]V[5 9J5;N@)DCA:D>.^EX1RWXU J?SWS*'=6Y K &\3:V U
M)4[0;9/")0EU3*A 8$ZAXGAX3YNL.Y*Z:S<200'RWYIH_\K]\;EQ1/MKI(;I
M>C E8U)ZZT4"!4+0[?SO.V>"QD8<:7;N4\S=@6^_H9/,CB(^8Y6EG?+\".8^
MB&>J+#<1=2B"@20HPXTUU,DXE=[2ZS,7-!<R9";6IR@1OZ@>V+4B,BF-!D:?
M7X@JK_@7(;205HH@B31832MW1DJA7^"Z@UE/&2Y);2)(<B?6"O&G1KC#@C%P
M?/&%&Z+^&*ZT(=K\HYB+?>L;YU5C'8Y$ QO\#'4^@AU&SR8EHS!8> LI%G5%
M-YVC+M;,-%)P$Z3J8.F>JIM7H_'?$/PBN-+IA9O35RNJ-:7%WYB<\3*LIZ"V
M%4MR;R_< 2Q'>A]\%;1SEGCC%9GXB5%[)<+C?<C3STM.E!^NDCZU;HCV7X1:
M2932W7#VAZ_.2M6(@5>K?1SISYJ5?PKEA=[XONN^W!=VXE=6[0>53/Y7=(T_
M!3+CHDIJI\E#[>RCQGJ&]_TWOQ?FW'YM4^C@<.1I!UW1%FQMBN;[QC'<^W ?
M _^OR$O[(%:RHYGLW4=('HJQ/CLGCMF,P]QI)MUYUDHH,A^J1IV_S4B)U@PM
MGOH\!*18)9#[5%]2JO9!'>9A4=N#L,)(6X#_8&.7]C8!]J^$T%TW&LJ"W9T"
MO4\[PK%A->+9"A2I\:=E',U1C@);SCO613\R;A-\L@>+#&3L=F+)+FC!B?"<
M!.<$Y^;&'(.J@)(&J^!Y=3)$FLL/T#KS<I^BQ-G1](04HGN)F^>B/BG>4(-)
MXU^B<G-O8VFRZG:MI&&M5OM%[O"4S>CCD4U);.RI+C:S\6/ W1RM>WL*6W$
M+QZ)H!AK#G)U4?+CJ#.SCU3I;&QR REQYB2)M?:LC)C9\][V%$*GA=B"3IX8
M?B&;.'I?E4O]Z3S1IW)H&7WI;M4B.^$8ZZ=^> AP3S408H?3UTL6^?[35G#!
ML5<]OOU+?;&#P+-BG7>]_)9:H=F,7T4G4">_!*5$Z'4G(YPZ?4(E6B1>^U:0
MA>(Z'9\\8]M5V6I9B:8Y^B5B$[M\%+N7A#I'L^^)\DIHL@PHM/I]$$=$D[X=
M6S*,/H[,V"H;O\\]RR5#_^+8L?-L)5$6XX8N-534_1&N/-*'QNA^:BP[@R@\
MVU#4X2UT!KBW,Y96GD O</@GNN\"?S["R"]BO*[-<RVVZ!@) 1'@6.^]-+X(
M3'WR;G#IA!Q"G0'J=[T ,KE%(:-!QS:QD)\E5[5K?+4,&4WNY4UINWA 5I3&
M+<Q)PR!$*!8 WV#/I1:Y-H[67" T(XPN(RRFMM$33'R[]#Q16#NW2STN-Q1E
M]2%GA-X[A?J;5<KLW@X)/%[F 0-43"OKV*9]C17GHH+ZVI+5[S:2(AH*Y#\8
M>\(#B\31(@%HO6&TQ!)&N T"AYR* /XM,@$PE<A>\KB<]OCM#^)'J=::'=NP
M5-C8[VG5@B7J7MX7D_ <W0'0BWNK-QP<NF1F:OA%G^ ZB 9*KS[[%B=W.7P:
M[V N#5)F-=_@3V*]^1^31U/G;]7[/RE.+%,""SQKO]DQBH5IXC0<6 8*)1D=
MON_8&-&+M_P?5SS]--XU3/D)1 $RW6?[6/T2][R@0I:.5;Z_KS-#)0+K\#(V
MZK))E&N-<G8E-_Y M_!$@,3&;UFS#JC*6 (%8=]!*^^5JG'E /6NF:/LPF+?
MV15S^@ 9+-X HW6Y0Y*D^DJ-+S:Q1A/H,__'V'M&-96%_:.9L2 B(EU B T1
M$5!I2LNH(P@(D=[)*%)"!$1  H1$I4K+2!UID0Y2HD! ("224&9 1;H$*4E$
MFL Y N$((5Q\[WW_:]UUO]Q/64G6VGN?YSG[5]9Z]K-S.8'Q=>[H1N.3:7 9
M;*[)4];'>64?XLS$KD_O7D1!9U26?+;.-[77H*Z#V<RE4QPZ,W!LESGQ!T:_
M\^V%$O#2"[V!7,VG+4),DO2B?F!\M8XC(!9G:'$'R!F9=?ZT9H$11;&WR@J]
M>4%1M2OK(DAH!K!U'#%$L[?5N$*,;0L/*,BK<@%UI $#AV,=5NP!W?RBYB3G
M(1SJSOY7&Q['7O?/."394X<Y#4V#WHYQO)O*)E=GC=6WZPA>]/U8,4<HMQ+W
M"/*LP"HP!5J *7.;T&$L#Y+BJ4C/0HC,@2<T]!V"4+=&E/MU%(8'77YL.#11
M<S#,0PX1Q^3C6A_,EZ(WLF\+W(_=\-+TB>_=SM=)3;V4(O4FU,O<JK4JOGC)
M[X95B6?\;0:C].:YX?FKPP]#5;3QO?(7[3B+7".*?8R3WS"+V6^?Y]N5'[&<
M>69^(-/\"_3,ME3%/,5LZZRR59[8QRUX/$F">H-#DG+A7P2$EFR]@"M4RRWI
M1<'97>@[48T==!]=1Z1X2&R_$2A HQQX,E4$ \([=IEV*80LQE<>H/A?Y\15
ML?VOC;*SZD-]BBRG<]VO;=P:7D;-7A$H":96YZ9DJ,\(OBD&W-)9)IPU,,[Q
MIK"WB(G%3"7U87(#668,)Y7$GFSE3#W[@8._'O9?3[G>ODEOKR(]-MX_2%D1
M0>N[3Z9PDZ+$ W3:@[8&9;M(T4U*%^/97^ RQ@I([OQ:QJ@_7U(LU5!',W&V
M__1 5ZM,C5C\H*V_@[N^Y:$4/X,&BB_\YBE;1UV5/K(1"%\*W[J$Q;Q#B O.
M6()][%U?L@.+B5!N2J"=6% 2!\GQ.'>]..V:JR.*&MS;=8"@E! J/A+@Y#P'
M_L/T:VJM_O[GQME^C0SP<\9 ZGX=S>\9X?/VE6>^3!?VJ5P]5S!BG1R:+#4C
MCZNURK"U95K7!Q[A@A-=#Q(=DO.:;2I^NIT<[^_-O#*AK!?8!T^&[\<;X#1
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MZEPM$/G811X6(@$K[4(<F38.*<Y1H"CH'VAX(Q1#,\#".P5G(O/OW;Q_#WG
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M-,\P5*27CN4$F1M^F&C7L+I7></8J=9NW,)4[HJE\X,+ D;$)(E-W.^+A[=
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MY)@OCWQM7'EA=*PZ)SC1V ,B;IW 7<_E(IX)+O+UHMGJ[W)Y^9#LUA^^'@=
M'1Z%7:/E%O^.!#.T!>#=GS"L6B(;+F'Z$BH0]'6,1/!B7[GXYJRYU$&V9@.A
M+[1G7FAJ[\ ,H+ M<5PHT-BZI8ZUVH6P[5Q7]NCW<G"6@^Q4U^2L9W8GED!<
M\/JU71R+QFM!48<+"WNGWX:0]V-[5F]#N653."3=^ H86MZA;F&6Z]88M:]#
M/SB"%$>?+D8(30..<;BKW J<5_64'E/S$!\%$3F!,71A_%DLD1W/),9-:H (
MHJ%.,;35J3]97C2^T"(45_@6"N>8Z21H+IT971NW/+<#<\F^*7@7NWZ 1H;*
MMTQP.I !IR]V]ZEML05;'5-R9T )Z&0W@R8S3+7P/Y,[O?9) X?B&!'L!PNC
M3NW^#-#2.0:*@2Z@; )Y;>G<J'GJ\KWF+,[EFC*K6B]D5G)%V4^_:Z(#U#RT
M3:750QM[3[RY1E7;3?)#JP )\\/JUX4-ANS/-Q>KNJ#5/@9EV+H1.3E/&SSF
M35]$_B? 8.C K4#%*;X:Y#@M*M(!/T15U]R%%#A;J'WK;8ADS5P+,D&@NOLW
M")1S0U=8Y8.&E[,=!+^#WW=@AU<:_",[4'=;0/6VCW4Y0S3Y$:^G&(/$ K5=
MKL3CPD9W=S[\J.^F'J,&P?5)YF.XBG=7;X_BC?GVH/U&;,.*!%\9Z&8D8;;(
MQZ!HMM*;:?*S+%8G,;XPGM/$)$C@^R("8ZGA;!&$V!R!E;6Y$4]GGQPQ'AR@
M3[_<U>91O.Q:;+S3$#]\.E#X,]]HU%@=LNU20D ^W%V$#>:,,L4.6Q0QJ["#
M['TS@C0?<#W-C!,HHJ (O]6 E,+(3*H"WPJ+YQQ9 6^\(I4C">-;TQY]BBPL
MR1+Z &QTPL4,=8"-#M8*L^\83A:<? +NN=T$-7.-7-D;C!H5!EY)WG^I.]GP
M!BC4)7_C8S1[29(IL>!8?/M>T["M18':OTNA3GEC@28V022M-H6)H;S2LZWV
M5D&9YDGY'GX2UC$3:N:GM\Z+\?EFE\=<2FMZI:6&V<N4HS1'K_>Y&7;+)5BQ
MI4CV2E+!^=U@^O.= '@*7XBM$"@S#A6SLQ\;:K+SM9AZ^N0XOBD;>1 7#J'9
M47LZ!,>!_7$J[GK,@@L- QHX3\*TOX3S'6#J,<7"4L(U@_J&EJ5/T]I.$1CR
M34%"DK$N)D?O^_HT*4'70V?[!>57L9PTT/B&4Q/,ENVP$!LCN4#YKUR^\/\"
M\[N9*Z(+=.!OJ$D@$\O >FPRV5W-LDP4](< ;O:@0 ,C7-BP5@,7'-2</DHU
M Q%6H ^S+W%2EL@@2=)$^7) 6&P)A.&JT9.-5:!<T(>-KP+UIQ@1Y8_WYRD/
M>L??&O#2QS?[5WA@K;XQL.39T>E&YYGH3SBQK0C^ >@)AR",];2JA]X4(I)P
MZ$J^ZB[/=;,1R8:J;.1AOG__R>%:'<(3@?KHNNM9_Q#DL\8+<Q&_[NFY>>93
MP)FGZL9]J.8A<K6_AI?%A6++BCM2$I4.U/*CJ]U9%/U+>1*\C^=V32<OTZQ)
MU23_IKG>C=>4TWE5JY&ORXJFU-JNV%FG;T\LYVT/_;R;9F7MY\*?*A9TTQMD
MX_#*\_2&KOQ=)3G6[0$55O+MH59N2B0O:F@WEC)HU'X^O!3G"@4!V6SF D%,
M<.H&L&@_-,[)>A$()(ZZ@O%)&@*I^4;\KKJ,?0(*F38U?L(/[Z\D]/$UMN/H
MOO"G.9I/UMWW,*?JRCNFI)C ."\)NL&AQPDN9G<*Y" 5MJ4D%[FDP$6ENIBT
M C\8FGNP=.OF3W<&<>[^TU,)!%'R6KXXSKX82V V9GE<?$.\81V^KA2] ]MW
M8#M__8,GDW5?#;2]-8@++^:;@'"FF!QFZ@ 54XR%<\BQ-&GL=5NP.P7G"&QU
MC+)"'/1IL6CVTCG_Z^8%<^A!*&>2BQPRO.+_"JTWLAF]*=1.&A>;WNA&B?MZ
MR ,U31U1AU>Z:'N1B0B1%=I)OC88]E@[,(EP.,;ET*A  _*OQ!*1#?&H-_V#
MG1X*Z0ZO\YPP65D1O,Q7.[![_Q5/ME?HY^,^'DFOC#<_J(K,2;(8NVIF(EI]
MXR<Z<DJ$]V8&SRK^FI^'GIY1[G7XX?^#540WS'--L\IL+B\3<%MX#S:*"=$T
M-7P[7(DR)8+#0!;3$VH\IR&J--C$H;_;@26O\LW O\"P>,,[P*HMY$+?]WT=
M'C]Y!# F3??).)FQE\[TL>UZ 1_G0#AZ!P:0UU)<- ^C?%W>#GRLJ1R'2+ON
M@0]-@)+NV\4A^2=7INE/J;^!*DP2?!9(<\-XG -[%N!'C#6A%8; :(!Z _T2
MRGZWBHV?UEK0)\:OP+DQ^-\@$A=Q &<^$O@==[V$;P1\V0REY)</MB"6E@#>
MC\ D!Z43$ I,_W-8H(@CC"!\R$+81[WO6LB)NZA#[M(WC@_BF.6R4Y^7,,X,
MI=">E"UZG!H9F%]JF#H$H9!)'?*3]1C/*)D^Y[?;9-J!,3X,1"VI159CXWK9
M],<:H?XJW8U-'J*@-MX0\'E&->*<I2IS$/NQ\>RYP=S.1QZ:GZAF)]%AK(/H
M0?>>)>F1/,WO&M6UM:B18/, D<]5S8PC?FDD(Q>20Z9>:7B7;5KI-7&_B[$_
M7];8#U_]_OJAS3:W+KED,)=X_M22758#9\C1R,R@2<W%"KCMTTG3V2;1_8@B
M?*^6[2+#?4#W=+#?W<U!SJ-68/4/*)J#D$+3=*!<V7=O@&CS_B6^#I<>IYNE
M) %ZI%33,OWUEN2 Q4ZZ*$5A)5I?9R-VO2\FI[$R,DBG;V 'IFA\@.\R(M#%
MJ>^RUO@U2 N4=-KEF3XX_QBH]UB@M4 [ >S XD(F]#A*E.D/#U>[:?M'0@A"
MD"#2WV.$<- XA8,\[#%W@<#P8F-Z,>*<* G_LV=*/WH0VJ_3]HPMN'21.&)B
MN' @9?:I3M]A-%R:#>JU(Q70CZ;V5^/00?OHC_FNH,EZ]=<WGPSEN YO5QM0
M1YR^+ !7T>A7[HO]<XTL7;(ZT;T&/T'_/2003OS=K1/4__:!=A$;QHLD<HPS
M@=9.%HD124Q5.@4J$F.6!'(WN(L&PB'IM?,%QX=.#(2.CPJSVU0<GVY=;1XU
MH=\)+[V:5_#7C"7UY+=RDY!!NW';PK,E[#-OQ%Z<+3U[><C^F$U&^'Q1&J-4
MNPI][GGZQD!0I9QN27:=P\B"66>G[N!,NK$#)/?K1"\HRUR)=2S8!WXG[.6;
MO?IO2V@"_U_6*EI>HPAGY%6[8&P,=7.6K$.JU%%_IJV80>AP?R[]X+N<>P^_
M+!S8%''M\WK8XA\[T:?*G?I\BI<T@E?:A<2K12S\^TF5?H$V9JJ^K\.?P)GM
M4#?M&N"; ,0D@2B$FBZ/"R6)HG/LFYY0G/CV=UW9VIM-C"D%-ZB)J>=Q,+W#
MT6$S/D;'IWYU'5E&W;<+7X=^5:;^/F]\A@Y=![?,0%2B\4G<74 SAB8U3Q<-
M)4G_3RT":9^A9R76L0NO#0A>E-Z0"H9,K\NTV$+I]JU9/:-7P</-7M.%QN4<
MX?MWAAYP=XDVG7]Q4'":?[4?=X.-@KOR3P--,70?LKP3WZ.?I@1]VX'= #;B
MC0V<L,^7UNG)NALNBBE]3'6$Z?#:3>W>BE"+<)V4<U<"*9H2\SFZV6434S=:
MJG*W7-)#[,K*7FFS]S?/?WC8XG<Y-DP^,_ HPTHKW6\XSTTFX*C238U'19SI
MG(STF3SWH?'2HJ"X6K/+50:#EF;+@C%4G5@2 1THL0/S]1T5["->:][.IYW!
MR0YKDX^FF-L-:>+"P"I>$)1(1U,:^M<-7$F'S=A]T8(S ^N^Y9[:39ME*;^/
MN3GW1@5Y]\'QW?(K"7CC!9043G=*3)L@XD>2H=\C/W-L,1CW<%F0]0?$D-";
M8JAQ^=O'/I-LRW34< -!%M(R![;'WJH'E6,?C/DY/I+9?/1/VA:\2Y-5?A52
M!W/9) ;J",X82JIVXE^#0D$?SHV-#DU17\D%@0Q@\AS(00FEV&%3IFU/7@_"
M<(J#0\,57LT;FV0?^N36V';?G]]&F"XFP<X 'Y]Q%G?W%G9X+0K%[B#)!]+K
M:'OYUZG#.&7 RGXH]_JN MMUBVI;P4S\(3#"ES4T>6C+>Q>+A643SZ]9^E@/
MX!!!9?-AHP^"![*\OE>\LILYY]%C7<(]:G;9+MA%L![Y@6%NN*#EXASY:78$
M(]QG_1&-S+\RT3!45(R))$Z8F_-K:I:WQQY"7W[=V+"D,FWQX7H'2B1 < !+
M\@ )T83[\%C!J4%^)$=3'@HT P316W\(!@HN0ZO 5A?+H;00J]81-GF"!@QG
M)UE%<U&_3SCY'O'3NZ.AC9!W[?3^0/@Z^:LMOQ_?%=A>3F&/3Q 8QFH *BD$
M-0;#W:3#I6FGL:J&BM7X]R0QO"P6;E,/=#_FZTV/(HY4:P;0Y%42\0I^380C
M KDOD$6'O*!4@USJQWNNTUB\*5Z,9R%@N\+CL >4>PM4>J-34U8.B)G%6Q(.
M82YB6+N>O6$RGZV(G.[L>E9L=E]3QQW1^0#JZ5$94K>N"4G*5^C\>^''&(&A
M7J-3GHSM$QS4 XI&VPN.CU)_*\8V.0Q-70N4QIUM!;MC<!;3A-_YP4!M.A<A
M#-EVTDY#]IS%K?W1G?J.\7? @-QJ+>:^MH^5Q1.?H6C3QB&<CL&B^)(5S7<\
MQM>YL?"*_D&-A9YC \$./+<>ZR"/!>JKX&N7@C[: 2[F]AII#Q/MKV12'C;8
MH;HQ!O3P,9,/)7S\JD"XG9/O.4UJI\>F[5)I@=@H7UEEJ=Z+2U2"KGW\J5-8
M)A@ND(6&BS]/8>_>ZU]+RK>]W3!B? )KZPJ&%E09$P,K^EZZ60:&!X5CRMP4
M"A#;1(2O6-*D,+#!/VU\9/L?@01VE*WWS!BVB#]0!ZEQQ.3F;7%63=")8$X7
M00S;S4GGZP]0D/&3PJ<Z9ITA:[:_WJ[PZQ""T)Q6K1H/OX)3%B-U]9M37/*2
M[?3*V'CG: JH9E?_!B(4X^!#M%.+XG,">9#^3'#<:(@@15/":0W"30?XB)*I
M^9RL=-U*<,^MU[D636E(:62E.\NR?'Y4_K[L#^8,7OE7N0+.J/\;8));@CL+
ML6N@J@YX@V8<W8<NAS-N!78-_0XL 75H'26+W35QXH8&G D"4Q;\[TPANR:,
MR3KOR%)<S@Y3+RCW":YH03&CV!.>MY[><=6J*+21&OYS1O]U[M,9*_Q(J/2,
MBWA#4;F<JFK7Q0?)7L(]HLVV[<R<2[E)YA<RPO-9Q--_?:_\;T)/)L_-%?>A
M\H:9A@$O8#N!B@2ZN6$Q>#V(T_=.K,(5<N4])[D-_ 4Z)AFK8%S$.L12!,:0
M8LT\J_$)5U,>&_AGVN9WR)%M--.42KU1,H?_O6F8>OU5^&9@3);"MLLFMRJ=
M=Q]J+>+[0I61Q1"&AP-7&"LI=$7</G#0'5SI- %ERD$,FS(:356?UCS4%&>H
MS'9%'?SB2SM)_W0/D*ZM!X*[M/A_ '5\W2%*;F\2271QJ9B1L^$8^NMP\W9N
M",AQ-[4;HH:60EI_?J*=P[!D.WI7XO%GD]A]'?_BA7TW!6T@$@DY<D+KTL04
M%@12 S@U#F9M<&U.!B7I#!&<V@ T*)U%"@X^EA._M VHW(ST'FX@)[$<2.@R
M;*0[%%V]@!+&H;Q*^)*?#+TJ/= "X1&:SA<WYVY-9B]2NMT[=$O-WT%H6)MP
MT&T,*N]L(<1K&V2T5634JWZTS13^[V,&VGD ]^K"PRK+&^?Z_1YDU*9E_FQ&
M#Y6KOAW(5(Y)MK-W*I5KGK#T^&$NT?H5W67MTNHRFN%=E#?:.4!H-Z#I+Q(.
M&NH!UQW>0B+L;9%IPO?5+0N^'!0(JC&S"U2;07*WD2.7Q"!(X-0'0I')+G:"
M0X/3@%+"#FP<A+8XI:GI'+%$66-M*+-TON#DFRACM7UQW#&:CH"II NZ?VNN
MPETDL@^G7(!DMY2Q:B8 KT:I\N6<_&C*#LR+S+HVRHV-C4]0^ /H*FGQB5[W
M_WV L,^7-5.07>U'4[3T$]SDZP5[RGY>WNI3)+2;TJ2P@0PE(S L&J^(NP^1
MO*8),O.3$I168)2)$N]DDY7<KH.[5"/-?4;=QY6K]OH4FDN,%^B-RC =^I?+
M!RDI#MB[40<_[L!NMN@/*0U/B[&X[+ .4J(^D4$0G=N!21VFE/C)TA2&<3<(
M0%^G+FW/ )50@D59@@5TH-<93'3N*_'%&WS"Z;UB+<BR/"@:)*_0DQ-HEF[Y
MJX6L;!GK>?V?)?XN=LV>0C8/M[_8V0;D+?0$\98M"FQMT#]8MGGH:\=J\U7M
M@, -/]Q'<W&/K8#_S"]89]>;_:AHR*$]3\HKQ:/Y5X2^[P/]"(FLQM)J#\AJ
MXUW+[)(T1XQ5J/,&3.?8-Q:S20J+F^K?1VCB@W@YM))0?X._]PJ#=K(-)8*&
MB^L@$XZ@74B,7(,HN!/DK-RU9+B&_W6+7"2V;(,-9R+B\=+-D"4[Y3H##EA-
M)2#J9-J",64HUKQ\.7$=PA^8Q#HZ'D%O'I*5%?P^L+L5XI74Z#FNG=&N@R6@
MO)^\QW/U)4&%Y'>Q1((2[DX1WPW8> >/1AUN("1,2:TC8)-\>_ T[0)(W8&)
M&0I-(^)?8_S9*7";D?4)!(.F-QIJ%-RE=";Z]H"AULLYO&RKK4P2>8$U4E[B
M,L][[D<Q%L:/&!^!*)5CD*P+(*  &USU"HB"YB+B(J*[R>28==)3XU. 8QPU
MW(^F.7#77=)YT#N;H_*4LB*T$%23TOV,K\8Q$'7<TK1L2;(=U)[#5G<R\N\5
M]EI=K,CPW#]TS.Z42ZFRGK+P*V'5GG.70I;3'MKDVCUX95,>'FQN)>M?\I6D
M52[\8ZQ'HSA M3&CYE%F<<&N_"1NW<0)0XM [JX"9!*$<1K$SD>3)Z! =CZ"
M,7FB!8R-1I. >-_73.ZBHLT.["KP/4X-GI".T1.(A!OJE7CLP#SGY ^_B2P;
MFYHT\PD$KA':M067_38#$U7 >")>8@I*XHRV(Y*-ST$CVG.&UDKIG,#Q^NZ"
MO5 V0&;0)4-B2:9V#9 7>R6.+DM9$7[_ ]V/+3! _<XWR)HR+< 85)[</@+9
M;Z%^793'V8$=@K38KZ#5#L?),Y#E=&!*M",R7G"F#JA]LFMK..Y9;9'3:BM2
M4-%FSY1IOPY!BL#0JG5%%\@7S//_&)7'+1GG[GNU7?;ZSG8S_G?=5HZ!P3A9
MR5<@ DQ#*9(XOV&: K9K</I1?07_>--H %X%+2_6T5[:6SCE 5W!J7/^"2C[
M>QP=T;D2%_K!@"F?VDPH_W#_3*8;(^85(T7(?%G:R\SFV]>(:QKG0I5U/NA;
MF>MES%SN"4J:::EDBMA?LS^G.F9^,.#1MTFKY0O6CU+^S*U+3$IV=:P'3+:3
M\6<\L%VN_B[CT]\* 9#NBQQ#\6+D8T9;ODZJO*5#*D T>X.Q(H.]?AL8[HXN
MZ:_]BV@#!9=#X^U*)W9@,4FXT<WJQIRLE&(W]&V_ILGZ,D$?0H8O#L3S_@/"
MF/ C$)QIK NM@[:<OE2\^**X9=5G7Y)8(53,1AZ<4W$9/O&Z/P=#D/!E+9&>
MX3#*9<_183ZO,-DR U_\?H^RL&YYVH%JVGB'B=K3&3'U;&TE6>EW*E!:SOQP
M%RF$G9V>35T3@T-)C!V8C&%X&?\2%,Z9$L)>7*M<[Y.<\S@)CI#OL)O<+['<
M??X86O9?HMJ6^#Z<<"GY&09OZG[B-6(L[:LORT 1Y;N:N2NI\O1WA*.0!R&N
MI2N)BXBFJ0[B)?UV8$?OU^+"V#57]T[]-4I5QI1@6M0G<\."R_R4)(8H2"G6
M0CJ3G6_5GAN>_+WT^D12M)_=],L)V6/7'GZK9I_>3@Q&_[#4]/Z:]_-T&L-D
MR6[$W'S!YJ%Y44B.0_G[FB7X.?R:ZVR]]3>4(18A$!X#D>SL9U2],LB'(WC"
M1<6VA*40/(F*EEZ<_(-][3F\Z%?XGIPT*.!>?P-Y[YS*'R/*()%A@3HTE[Z0
M4SW24H7QV-_OV=:2CFQ&5^-W8)_HWO2GDT>A^BI<4+^AG ZI4_21NXN_;0<=
MR(0&?JB]"/WW3K3='?;BBK@;]N[4TL6K$K&4_CL6_JTU#D+>GM.RO\[\(L>B
M;W[BW^!,!%I#SXH@N#F0G4P-91,4_1 B?$]XK+$ZA&3/S.034T*)T2TQ+B&#
M6(&1\,J2IL3@+8JE*:K?^]>+PAB)6'Z<YH?.Y)*ALTW,/F&T0SUZ2ABOC\%K
M-$$S0/0T/5%P%,77'Z&J@Z<8O!V8?&WH3;XT>  *=&A$ZY .8K(V-6IV8 ?X
M.2$SE"@4D@I,=+0X-/E$H?WLG6M/U$:$VF9X65E=3)&VMAI(>S7$EL-8!D\H
MRRG+YZ7CJJ/;;9!9#] ZVKFA5XZ%6,DFE]!4>KW'+=\&WW#'QZJ=6+BY T,@
M%_S<%V#M*C]W8.8_X.*X,$B-+784&\F>3<:?@_;L&BY#AYP_"XX!FL]PSD6^
M-,T11!/Y]&!#R"#5*"KJ<'FX1G$%TYCDG068!V@69HTHKIKT&+L#=+Z4"'NY
MF=VWI(ADJW0OR7:V$#L125,B?%F ,<K.>D.&-CB2?#F0],Q0G;,B#9F:O3Z0
M;2SW::E!(7)%9B$G9O-1+MO(T[$.B/JPO=P65'ZC$F"*)E0T%YH4$UM6 NR&
M\@8RPK]<*8X(IG)F#OQHNM+N%])#.=MJ7F([:C'Y\9QZ>4^ISXI)_Z.,V@Q/
ME<*-GT&4^N>Q=R.!WU3@\0-%,&U,6M@V,''%\^V:RIMVI;Q0<DX(@K4#XWF#
M^[.!+>MH+H$Y(8]*='CCCH5?!>/HZ.DI68R&X$0;D/+Q']H14&L>K]PPJKT#
MDT7GD&,H1O(KEM$V@SADF9^\X@Q5/[;DDTK_I:3BH*/NO4?.N09<;.^-7WYX
M&39[[/E_U;-6I7I^&;.6K:5]PB;\FBZ';XG(++/RGJ_I#O<K/DHZ)A<KES.5
MU=S=/3ZPYLMJ,T<:M:\_?1G6OC="O'L'YA9I$P_[K0\604CYX^;'R"?_SC^'
M4MMV8*4Z9U*1Z_?)T7&LX*;%^2DERCX9N?K!)WP!10Z6+/YWI$W_'U*X!'KK
M#<L;, MJ!'R0CTZ^^M4'48KX:QU1#EF_CB -\L_^]FQC='M&<)?>.<I=Y]O@
M/Q$:+GWW)!*G%$;19Z]V=R)DR&47'ORQMZ#8Z"&"=>7V?ML^Z_G%-3)H#6W^
MW"ZD^\:T!T+_(E+=_T7\L,>Y""FNKOUWYFW0\,(=KM7M(+>/9F7I;6F4VM%'
M=SP:YL^^-3/AC_JC[N6L#6?AS$ 41RR%^&0'QCX%.C176 *C[2V!CW&B#S2]
M&EIWF2>F(3HD!Y_I$WJ/M['O96.K?B3*[!3J"]JAY=&+X&"=U%ROO8;_4(?V
M5>LFA5>H9P@_:N1=X\TYC]?\3)XJT<7[C+%=>7$R0S)G,P-O7=3Y]$]';-!W
M)ZU#E0Y[8'G^T\G[C6?)QX(7W?W;6EI$*YM?7Z(U+U]L7RR@'BZBSGW36:IZ
M:K:6Z**1Q3<(N3*IT6165E/U-;%INF&5;^[ BB/C%T\M1)3G?QO_4MTD7\JO
M2\K]G</X>C- "=G@],)+5S).8BQ\8#N3<^F_UHI80U1$W;\X^YIZB[O:E;@)
M@GM8KD5*\K.2'LOQ\!R7F[<JRYHQRG]G.^V-R2DLFP^LF_([]-CV^5/\HW^Y
MH_WTPW%MLK<&OVA,G9]^[1;%@<WN30W*^QW_M&6>6VJ _Y';UF#MCG?=@;FF
MK_?\I_<A,I2'1O6[Y_T-!"9HRA@\TPG2$O9ZKH2IN>9\-VOANOK[?Y?=!S#/
M-BR#SUWZS_"]]XN":TYS8_S3(RO+=]ZX+FF;/02ORA\-^&+PY>;?U^6+&)WO
MDQ<2"ZT>2NW)<ZQ#.RAD*7OMV?,W;.ZWKX?NO+ZY&/?N:VBW4]9['77EOWP.
MKWXNT@\PDS#)EY93/.#U5Z?YI?P%INI3RL";PXLYUO5HG*J1B^N8<EO+XB<+
MA82 _\KIG\VF4'K]]RE1SV<*+FYG\.],DW^#LCG*DZ7L#Z:F0/3]D<)!]4#Y
MY<EO1C:6,C_Z7[P\<B.HW.^"A3^VKJ=0Z=*++[#:5I[^=C+UQM;=22M#=>[*
M'KY./4H*+1![/8(++,4^Y?39CZR[&RM>8['&^$8^H2<#+R5)2^Z3F'S%T/K6
M94F"5.!=_FJ=^G3B#NS>#NR99'L8&Y42MED>FV/IMWQS]#JH/C'\,R&7@?LW
M9)=+3KHB]5NH\GF-&WZ]EUKU%F6_?YBV0#R>_)T&^#P.J;FF*,:4'Z)==G6=
MS[4>9K'718UG5E2&2IXI9W%&_]/-^O&JJW%I[QW;X)M]RUY_MX]4SW,J[4DK
M4O*QIL*V?I:]3@VSLJ99U=YIWUJM6Y('9KL\W_SC.Y28X6['X4P<_?%6#VWL
M.J&]HF#TZ-&7!3KGJ";K:6AB\):5X,.EZD_%W6H0@9/E(6=W,R;ND][9O]H3
M7^^5_'>O?+/_#FQ_JV HA@-G!?-\4S[_]?V3L:KJ7T&/S2%LVF$AH2=//@=M
M8_AB8-14*DT&BW1YV_*4:QMO-L 9/MU@P$ZSR#<6&3?(^%JG/IS/N"G%]=Q/
M?#7:BK[T^G3>LPLOCUP*^F@2/%C9A2^C-9:+SH#)I4>' G@H>@5_$#UNX;Q1
MOVZ86< =^AD^/[;..S)N0AM=6_DDN#@H$,5L5TT\U5RRWM*J(H1MB7 :_Y@G
M_I0%+D:_^_!0GLA7< :G3$?\URQ1O$_;&6N]+R@8@EAO<&0ISC;:XC6X;ZEU
MUU3M+Z_H+51NBVNJ'._R?CU8[O6V0"@N*FE?A\1_VP-HWC>3O<?WR)T^E!:9
M]WQH<ZW/[P<BD5!':D<\ [#I'1Y:4* GQ_VZ[=M/E&UOU= :E%F2RQ!5':WQ
MHF1RHK1T32;8X_.\HZ-,(_CQN>LD_IO:?]*F>33+6U7[9 :H]SC#5ZQJ',5\
MUXB7B%1NY(1*T7";W%"]6]>CKYDR&WYV^!ZKI8>T_(BQ"3_"8;@D?7I*<]?2
M'CK]+)#@-S76UQ&DT_3L=',;L/P,U%]%#JR+B9J5"Z^EN"P82=AZ!D7Y5)I6
MC7VA6OJ&.'65W8M$+XT)(@ D7WR4*Y0:VIJ_OYN[\L[RW(])17^N^Z.5#MXE
M=W=?U8B [_X<2UW?B?)(.<_7+5O(,8WW([?J7K8DP^?'>?60]$NL*P>1@+M2
M#FF:0X'%"_*FS\L@(C,86V"!W">2M#B.<:)>+4\(J+F_ADFZ$K+H[C+Y+BIQ
MPRMI;.'UN)OA<^A1RK3F7C_YFH(:,D9&5DE\2QXZ?)02A9\<MVH=/E^:.FY.
M??KYAG%ED;/[8J-L!+X\]!"/V4L?U"R.Q#Q[7@C=ZI5$B?YC*GJMS-W2-F_"
M'-NS6GPNXR6G_+)^6LQ/B3RO@Z\\>H(ST)IH74Z>EAON5<^E2G.9;_[F,3;6
M\4[-'R\%.."H(\,Z:"/9564QOF1Q=T3M&YEH-B*QX#!85AE48UGHXHP-8Q3H
MYJS>;HMSB"U@B"1=]LQA7;$S#7JX<80UWGJ.PJPJ22Y0_Y\6%_< QR0=HM B
M_@)@X3&7,],5&UZ)YM%.M/3+8]30RSHB%125^J?[&M_DC'"M_GG_J:$EYJX(
M@J+]>EGP F</;#&FA$P[Y POLGLCMTW-@!S=V&J^]M!ID*K;0GL3&9#NALV^
MW1P^,ZAX*M5(W^!,:**<NH/"V8[10.59!@&^CJX)G3!F;%IBS(?XUO[  FOJ
MUO"9K3V?M>F'_QK6/(&!:WY?JE)G?MQ(?\54KBT.\;*_KH'LFJ5>);$O0-6Z
M#J_MWZR59Y[7/?>JW-#(_AG9=E^R+?-V/AHY=M=11UH^(Q/EJ;O (%*>3ZU_
MO\>UT0Y7L5$[-#US5(/@KY\Q@V782]FDQ26B>Y;-NE1+(2^][T'<CD'JC:JK
MG!4AC\]8[SX+ZI!WDSQM6/"9'FWY)N:%O_7=L+<M3^1*SSU^$92NY"K93JAK
M2L:%<80-M0JA<@:)93TQWZC.>_/*Q36JV'8X9$D1,1"PY%^8>C:08F%]ONG2
M.Z+L"VV?WH.N/,SUP:]OH5.<FR%&PD>B"]W12B='JHOJ/E&B+C$]W!$=,CGO
M\FL#5KS<K02NKDF]C\]7+Y__*Q*S)_2<^PTP.]:='Z;7Q1L(?:O=)P8%_R'S
MHZ?EUN:^'%KVKO\6&D=]F<",RF3U!1\;&._S*=$RQ9QNLC5\J-6]Q>*\"_+&
M)%1E,6K^+$UXQ[DH/=<G9!7#*49=*#:IN3<_7!D]6Q6=>2XD8[&GVO.\R=_V
MXN/Q-8D=V_977>P][>VRE8M#/4+NV'>:!.3M8C,G+Z-8SO+MCT;<^BM!>X'!
MH.%%S21/Z 4P[CQ0!.Z+C^-O[\4FV3Z>FO(=<7G_\DMW^;F*08>E:IVS[RV5
M&PN](I5&;EYO<O_5=GMAN\C5-&W5O?[3><[KX8 UTB'3H.DI26SC+"K.(+AR
MW$_>B!=?[&'JS]Z^91&J^YQ0V;>O.M;;=_+L; )B;BI:FR")LP0(T7PY-E',
MC7\IW14<J0E6>E%QGM>2L:N?GMW9=2#B"V$RMZ-2!9-;MXZ8EDW4_!NWO+!\
M5B;R>>@>TN<:CT7;)F!BY3%>:>Z1QY'70]KD[UM1-IO+/ YOW8/%4IM (-O:
MJ!:0AJQYS'7OOR?E&M8?E]:[L$Z>U\L':T]I=GC]C))CU.HI9/3!A>(+Y8'9
MO#<!.B6E\JD%AW?51,ZK3!^7T,KV'U:WD]L6GC-N=UKW1J6JR"951I<G9+I<
MK+0R'K 0EU7M<AN:&[0IE3U*QUC7FORT:UN94=V!_45,XE56N6$<26)K%D9'
MI5^0#4^0^RHFOC0P%"PPHF=&K;+0,ZW*\L>]4XI2F.^?3^^A UR!\# 8QKFG
M=PGM<0)R+[;P'E"HTA2';)U>#ZG7''GE.CGA5$,=S7HJ,+WJB3$4#KT$1_0Z
M[5_=XH+PJR,XS:)<I+RSTYR+"N_ZO. (P".2>ZNQ/>ALJZ>7C]</:QQEEF,V
M>(#AZ.2IH?7+GIY!YSZ;!25XD_/H/JT?;&W!-?D4,E/]%+L\3N?M;/\:7!:3
MTY5>#25UT$Z-:[R0B0ZJ<?&8G&_Q+UJ0')O0H2JP<PY\:/M>M,S^FOT5&T9\
M.WJQ^\Y9[Z,14A>&+](=:US*%(2N7LOA/>=E*LP$/4R;C;FC8_\*5RMI&V X
M%G7HQLWNQ7]<_IZI<LDH/9AH8QVG9)MB_G>Y607]/EO)U$$BB*YSN2]';974
MC@+, Q-I"*5CZ4R"M+&092#';N1;P]LV )G\?:],A/*N2PH?\E!+4?8B60TM
MVW@/U-8,<YOCA+W/:/_A2LL6'.@&<T1]S#XM&VL+/F9EYU ^,(0U^.J<.?7S
M#:T&]UIIH.A,^Z#'Z0%U_B)6)![S0F/YY!-_I@1S(\9I+F+_FPHWEI^:6(RA
M-%N$(*I!OYQYWU^;(-JMG;.2J"2;>,6:DN]AZ?VCQR3'B9_]YH3+T:>C&3@U
MJ"T<M%K"GX"GB$.GIK.9X52ST.!R* Q)H0U3[;(DF&&[%M9'IDGJ69@H]8)S
M^$6-YR>=T(O^/O[G)L,'-9?L@Q9%XI_F.XU6R8>4V]19Q_B=?KE@-Q/+W:=W
MIJB(I*EM9Y=C!/^^V)]BIFKSS>W9%?<MY[+Y3A/'AVD;MBXW&K]45Q/?]TGO
MP-KW"BY@#6X1K=NVJQ#W1+C&4^>8YKO>);64ZMEPLS/+\N1O1YSJCTOL2[M&
ML[.NOQ3 _PK&?S<")6\.4US#^9'3O6V:S*8]IB0/^3.M;))8YTRQFTMIC$M^
M3?7J^(3VPJU^UV;7*O):V:K<O]LK_;03OYI=*/$]V7*X2"Y<!"<R2!G_<'AA
M4@W-/U4&<1T8J.OA>Y^5LQ9<C/.#_,I<_POQ=YMT<XVM:TIS\"UV1RKB/Y*$
M= *E+6NQ&,: V[R\27I88!C;/WSTCX&2M_W5A9>^N*!9R=F/_MNK95)7GK!<
M,+"\\.?V^EJZ])YO6K?")(8S@OXY_TA$M5?U[.I@UN^7^=ZG<APR?0PM_4+F
MVCTNE!X,2O?_&/QHXT[-H9RT6:?J]CLS!RJM@DLMK<O[;-/RSGWHG4C?<J/V
MJ(^-AVYN[$+==<"X!M@0")<#6HR<K?G!A4?XXU!3^/D6]R%'WJ6KKW"FH^2:
M0WH/OJD^:\H\E"MR[HKJV\SCA!N"_<TJ[7CY<,62C/G;3]];7#SPP^3QFZ]+
M-^R.Y>W;\[(3?Y[0;MA5ZK-U$J=3-[S4H"#RX=(.K"O"SPGKO<S:,JVKJP=O
M;#JYC+NQV@,#3__-.IHV?3RO>CQS>3E/^\.6VBYD[ Y_&MS.2NF[,WL+R14$
MHZH=*VV:#CW8]AN,-:=<^'QEJ/) !2.XX*"538S]T"D][Z)<"PQ%JN_]PPI]
MG!G)]EM,AA^G^(.5E=UL;ZJY5DQ.4H:73.G^ 5S]? U??I#G,]2@F>AQ%LQ^
M(KC,OP' F2L)",FUJ>0=F(2QN*\^,OKT(-46_+W7'. ]?[5-ZI;/2@KG:HI!
M>EV?L$CF(':6H>\_KE%C1"O*<:A\R<*T4"A]3W[=!7%96_.[J-J[G.ZE/:"M
M,X29)CR=4C+^#7<2^),EQ.R]"&RPI[K;)&\"O(ILC^,-P";&6!L4BP[)ET0.
MXN#5BS]B+?5EDES>#&LNKU ,2)[UVZ7&I[#9',<.1;UW\+WG=_6.Z_1LIR_M
M$-\62@D"=;N9 OT!ONVOALB'L<1.#Q6@B6FP Q-M?,%!_@;M'^W4MV]LTYDB
M:J..+@:+6J&$L$BWU*Z/1JB.,[OB*QHJ9Q+$M/N2\;K;!2<'\,?X-I HB.).
M?5_42 <]^CS L!1M8AS\L#)4CV$C$^7E@+C\4KX.""<:[@O43# T"GV)(1U9
M4U<<<!?JV$S-KZZI#N,/C?@4E9]=U3%75;T35:YW6E%[18EPO^*MV2K"[S7O
M(:G>2FTJG>'WM?3>MW%*@$6PF1DY,GNL)=',^:%^4T-XCD\ESGL[?HK3-MJ5
M0-4"-SB$]EW5CA] '-:>BD<H4J^P%>'O6GJQ+8J2[:,%OPWPD>PV3&>$3$T%
M5J&CR?AP2SS3XS3)3/:1_B2Q=-Y"NN!%):NQ4F.D:DL*0MF"612. CEA\O_B
MZ-SCF6[_/ZZ[@R16.97*[HJ$6.54S':7$&(AAYQV=ZN8Q1*R,MM=SL?=(>Z(
M)23'E88P%IOM6Y*<)A,[13GE\ZGPB9F?^_?7]L?GK^NZWJ_W\_GX7-?U.9[#
MOO.%P[J+UJ*3M@HP":/.*"MHCTBH2K*N+[8)7C&([BN!V!W%NSZ8"7=\]0C$
M;"[_;-E2G(RBV<C^A\SIHC4*Y[1$.+FA#S%_T16X8KFFL)D,^XIEL*A;\E?L
MV,\^]@*' E&FV'JBTR0FL=';BLZMU<8DCQ^CN@&W:B\_)F[[C//:-451,QG&
MOG0.@VN1/Z'5&:MX7@OU+OI:.@)..@+ N-@$VL9KH!_IZ@ )(26H070I+:E]
M5^CX!OY/^,;0<94<9P;P]&$=*0AXFBHMK(WD6FB_+[QL_*U5/*?&<7GJ/Q4^
M:&J^FVOZ5/(DUS]4?'0@(\AUX6CAHY+=W)S<1[\.A+SB'MWW/#^,Z]T:=M*K
M/;/9U[+?T*7Y65T@+K1,L-=2IM9]=HBY"[4'$DJ_=*'WD)  M8.:(MP@WQ*B
MG7=?9(R:$</B47J0'0H^[?M(,/GP\6D*".?JZ #J.Z#U9/F2;GNZXNO-T%W"
MJ8*GS94!>,2"_"X0_\=Z5G-[*-(H[?<O;TOV4T3S;'J\6LC-VG2<YK(^FZI.
M_-'E&_Y"F?>;T(1>&4A<EH^Z.X:/<_P^^C0T,$WW)A=*8/LH'7^8KRDD6Q!$
M]!3*MO763:7FK2GL;2#<R[?:W-L%VSF-WE0[,8!2_<K:G\.SE6"3Y6HS.N@<
M=@OU;YEMF<_HUS[9 <).GE0IG%$]ZN>BV2<[^S$/"WAT%[;I7P+M:+,S-1TB
MEH)L]TNH%$1<: ?'V@OKIN2Z?+*1[!*T5XQ6("JREYL2?G+!<GH&>3WQ7K1^
M(!^8\2[>]L'[-4H_N4N[J#QS[DF(Y95GUQZ4WC8)<7$U'&!SU3SWHX)U/+>^
M\2J,=\]J"+4TUITX_.#\?LNK9:7=QI[>1UX9C%@WF\]*RFI^)KC[EJO'LNZM
MPY=P X00HSG"A#N4+%D$*A5T7B2LC^/L0'5H4Q\Q=L7[/-";'(XZ_FD4RG%Q
M#K.P/@QJ=)-PPP=?.5?'9AYS*,.I:&1KMJ\XM!-?BF#Q,IQD/HF\_LRW:@H!
M$(J;NN!)2N(1U/]:,&DD:Q#O"'BE2P[4YJ9@=?M\B >'KG,+(W [PIPOX/AG
MC-^AC\J\5QGRH[(M?23K,E((M%-$V"P[#]V5ME(4299YW=+ :@DAWFHB9[TL
MY39\F2V=..H N5ARA*IK"IU[GT)>*V?Y47<!O%LSOV&E=A\4N.3>9[+@XGWF
MZ\\UA=';#6L*(^Q.^!Z2-9#CQ83BI<*,8_+>XIU00.7, #'&?DANZ"+MP;Q^
M,5[!L8ED>UFB@:IP-8=!$JX"FF)JFX=A.UZ,=E\6_2(YQL&2WSD5!Z%\W_M/
MUSJ>,0_RRB@U>/^H\JU31+W;C03)M)$]ZGW,Y]SP*6>EO0-N$S?NY<0GGAT,
MTM,MB"&]=4]W&VH/&7EC;1)%Z;!"FDK@RCY$F"29!TMC[23M%R$2EILZ:'_G
MF8X0M3H+6!TLE5 /XNE9ID.8!*8"A?/G>=A=I%,P]OQFGZ\ZAN!U+:\+OE^;
MW+%$LGQ-(9"_H#RU@/YHL5X/@0=!*K5=7SX 5V=&@!X<U#X(44[TXWFUJT-7
MQ<Z4).WYV150GT/3(&M#+SOD:OW,XR;)$<\0:4@'TOBQ ::+3G,9L>)\\;R+
MA2 Z\]VMQH\QPB;+KC8$Q[>W<\QC\5H_7&J1N6(G,UY]) $6'X(M;RD;IEMX
M'-I=JS4%GA$E)2_0H@78GT?'B3*-G#]<>\$<:(!MZ9(Z/O'K3D&B]013R^0R
MV&B^I$>8B=0 '!Q6"Z.4Z0(M#ER-?$QV "3'/Y/AJ:[0)1%KI\Q@_0>=<4M^
MM!%<;6*/.7#(^@ \G:0!'NIL:E3" <O=7%_74K( 52%.*7\^:%+;T(BO_I)4
MY=%2K/JV^(&AIU=FB7TIH^J]@7W-YT'I*<<*K8ZP;N/!L&[L)?SNCID:25V)
M5HRK(1CA:/ZU>.]JBH@!OI5=!)>X_^VAV87Z_1,I# H"ASV'"#_1FXB1YPH#
MH$M ?A=%\2=:.40.!^2I8802Z,2,+1@V28^YDF\IZ!CN=Y[D/]5:NH\.1U_!
M;'&L2%<B>4A2YVB+SX?0^-O9(0PO1YEGU;1VXFKOO0G;B@>$K6J5+H1'E.N[
MW2Q#-W<?_[5,@8Z$5^.#@BC/9%L+G>N!Y+L4G!!.[OOA+SLW\(W:N1<]<DBR
MI0B8EY ?B+>N+W45?\NN6N= /J% *O[\3U/"T07KW5(:9X 8*)YXD?2M=>66
MS D*793O@=I6+ 0A:#4214Q3@')$^O_=D95^'B3G2%M9*4(-I!) < 0<LIB7
MGT%HMJ90%>DF%NXAG0?.MAL/SIG1]Q#1*QO=!AO@RGBY;GO?Y_[PR_WO/@\)
M)NO=TBJ3J*VJP=_.6#BI2\;LAW)#&KQ%N-R*>,>I\F^CF5YT(Y)[3+A[]@7^
MW* K7*.OJ);\VNI;IABAZNM#BH%*0'V[59I<4W8=P,Z*@?3  10<=P=%JR"=
M@<PEV$1?Q4095A*K G,=1@9'B..4/1G_O6B0G:X.O7.%[WM=%X\5Q.3'+->,
MTU9.R-_J'('(PHVRJV"L9(F*TH4*1?.O>ZS%^6RJ(K'4%;!)I+&O@EK))(T@
MZ4B#2V2GKTWFF@('J^6$A)=!-V'J>.],C<;,,/*?+UL&%VHQODS1\.($]**"
MV,U#;T:ZK9Q:-Q9HY3'I-'0 :.IH.9P)ED=3$L=/@?I<Z@:9'92-=$!G?9/K
MX'1T ?H])EP,3](YRAK*G&>OS&N&>K?@<;[HI+JRMOXZ0C6Q:?'^ZO,H5CIY
M.U!\'U#N<)'H0AO!;I[<"O*@DZ[UFPFWF=0"; F!O1]F!Q(2VH_B C> FFTU
MEZ#1SG&]03$0'E]'1'?TAD54U0AWS,J.6^3L=;YY*4,T=;%H4\6>08\'YX_Z
M3[7$/"HYTN6K$=<:6:VA9?5 3SO;O\<@O9/K%)'I_5:JJ*'=8V#@:^C8=-MV
MI'RW]7>N4H?UX55+_]44XTF0DD:*$\UGR,T![_0ZU$DL^0--)?H<TU(4%T?>
M3?H#Q+)GZ$E8M=D_FX9^>ND@  <.16GL#:$2(G"RG6-*QGEASR"\?_^WZW,Z
MJO=9012E[A4D<4U!9%(K[=4.7<)JDL*>D9RA?!#US68+0HM(DZ@V20,.\;3Y
MK9H/@\O](+^S]7GS9P=^VB!.]S-BXTSM@*&BHL26-]'APS\F(-YBGC:/O:;P
M<53RY6X8,GHU?>4/8KX3?Y:T_PE,B5<'I=OS*=?FT^%:#.$F_ <H_OS0P=OS
M)C)$!>Y%EW@LB!TC!'(/YZXI #DF"05%>>7O9#M7FP9XPDWDD[)PJ%JT'R$>
MHKZF;L-"\UP==: I\YLL3+H?9CM VEM)%'H#K SF'@E!D60&LNZVZT&A \[,
MONBXC8$ ![6?;W[$;BD>Z2TQ/E!G,ON=(C!Y%/Q.4.'[Z.@#/7=SG/>B>DEX
MX.UGPTEIWPHJYU&AV6'"%<.<S.R;">6W)D5B*W+_36&>Y=.%.XYLNY!RPFF(
MMG*0Z"#)A3?L\\U/EUTJ1\QYB.')*!CHAP._OB<97P4$;*_G R:RHR8UA[U;
M!G.\"ES.AZXIA/^-C(C+.^)]AZ58*>_\:XGSH:X0_"$)O N0A8L/@/FY( +@
MY]K'5#')@7>%Z4O"J%USP1C";F&(%LJ$DDS6A^X28B6%PJWI@\W/^='XQH'H
MKV;_7F?@"0I@\IP8'!8[9(4A \ 9L>9]0"JVRY_%@?&+J3I;  QGOYHDG"YI
M"UZ?XQ4TY/'ZCF:Y9"]5$;*?[R2;?,B1>')S)'X!YLS3(J51SHM0WYC4Z!>/
MT?DE<)GZ2^XN8G 7^AJD)9ZSY<AW@-B[/VMCN%;>660#+/D]2@>@9?U$[\=K
MZAB #IS%U>):&:6T/;,*VH7]#<KF(^(+LJA/B%2.7&6H ;WK$A'C5^@]T)"Y
MO7\G]66NWI;'.9GGD6*M;L/CC'(MG3LW*M[T;)E0C7HR<:I>SWO+YU\Y&3EY
M6>9!A^NJK,L&)G++>[J-#$XVSCZA1C-64Z*QR@%3VL-LM$"+1]X"HN-).'#4
M'XJIL4Q ;I0X4[9#^HM4,)K&0:>AMT>'';K8US_ M=(=1P\PA!H0-H"_'XD1
MS[3INSRW*BXMH^ ^AMYIJ9@U%P?$=% 8\(1U.DVCJ3'M(E<<2$<A+,#BH8X-
M?P&&EM*1]"1MU8:24:C.^E64LHW5#*=85WMB:+$EW*QW-O=5UM:H6E-,?88?
M[/<^]/7U=F;%RT0PC8"ECAVRLU J&+3>XE09]"3Y-M"AB[K1AW0(,'D0N6)"
M-)52LQ9\R$:DDP Z/;R!M0WW#WY;7E.!2Q.GQY:K<YA_^14PP;TO6GS(L";K
MK+;(34FG!V4&(DRR\.66!-118C(/W1!S=P&KN@[\M76I8O@V?_E;E & 26P8
M76'MAF+%P^DF"RG(Z-M2(P)D?[F?>6( MU(+#]2,*')D#(H?CCD7*W79AX?[
MA-Y,RRCU= IW\UB\46W78!"H6G-X$&O])=3'H>)HT;R&AG:]"T,TZ!Z._)YX
MML K7_=)8=_-U=/@Z"*Q'NJ64'Z#*N1JM%T0P@V@KX>F[!0KV;9?9EWM2RQ]
MC=WSDPJ;&C_V83XG<&!>KW\^J 7(3UIP.130]Y3!JL][._W>+2:HTO\U,I*#
M??X\#O66+:[@]:92E%PK5ZP@T\7+$"WV\=?BC</SJ(,D)!1;2HRW!ZXU9DJH
MJM,7B&B)SEU8.M/'&(EY/+J:Y1,]];C]0YT0TU<QT!XUO)Y[M;Z;+ JV5(H1
M"=EXS47A%M1>$@Y*%1=%=A6,%TI7_#"IRA**T;J5=]9J=0I5F1&/9;;@<')^
MI]50UU=0*VV=["*]";-%IK;\;_/FULG]+?3=9(%P']/#LH.ZFV0*!95!WB(8
M!SWJ_)KU<BR9T^/,+0BOE/:J0107B":!)U-VS#?0$P05\:+T3IT]H$6;N C+
M#MS->@$VEDKG4'ZQ<7@O@)M\]<YD%QM6X)YYLMWW O7$O6K#?97E7J2L$QF?
M/J]F?'%5N4B>?K3/_;3AJU/-;<'Z;R?^5Q78TXE\4Z&QFX[;W3-NY+U'/W+\
M)_:C@[@X72H<8?$BH%*N]Z'%:,A!C$T B;ZWS;"0G?PP-1FEQ4<: "^YQ>AZ
MER/^_D2ZN)::03[D#P7&'9QQ>9&T#IAW'O1TE<T]_<JZ#%*4*1W&9$W(PYX)
M9-*IYF>!6X6B7TPE8)'M#.$ RA\@.I%DB4Y#'I>H_[?11Z+Z0/0_$A94\^F?
M1>I5$!T<ADBGG[%?LO.MTO&W6N2L*/./+80L2J,E9_YO(0/#M5'V!6"))&=
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M*DGT=@EV33]M-ZE8C?/731G9<WN@I5H\M=&'M 7S,.B&T?'WI0MI_72OA(A
M[LD[)[UFWK<=W:*UT]W+'QHQS'%?/IJCG+*<Z#3DI:^4Q#X3=>.5TY"!5VU:
MD2-&&'T(%NQ:I.1$YI\DQWC5%'@2*+A?E#6%S1I]Z!"_-IT5\5(G^K?I@J;.
M;NO]J'DIG$/;!MWK7/$9-.DW.F<LVWCY\5??Q,G:I[A ^'--EV=/*RL$=G2A
M?V?-J#N.&@/D+-H!+#8F2=OA;^;MF^T[AU!'II?A:4P[\=@)R2Q>YRB0G&0<
MM>HN/=,V=)3T9BZLX:$7WR;8Z67&Z<MXFW=W./6$-*>5._/BID[*5AEE@*S_
ME:7(8/TVW4C6/RR/.SB--T ZQF@ENT4'8+F!>P?#1YV8P]'ZS5:,$^:UW/KH
ML]KI94SF6&\&ZN"4HA21B;BZPT7BC$@8%@3>#:K"55?Z3;GAK9AJ;Y]C,=N?
M-XV&_YG%GPMJ&I!HWC'[1U=+MQG^4O)R<T:EH5.FO\F)+*L+CR=GV"I>F=KN
M.;4HQP^93BK<1^JZTQ4FX;Z1_&LY/F]S,LVJW#,,SM1J#[A5VKM7AMP<O%%Y
M\HQ[=+!%\R-IMX[/0$XR @VP.^3JH/%2ZBQ*J>[NDS>:=,WR*N4']<EV+X>C
MQDR,L+ 0ZJ*RHX3&%IRQ**5W5_AT&_]<JKRL\3]JI,8/H1I1?_%O(&X^A>0@
MI:L1+3DTE2O9/M%CD6P=C<$&H8;?)\PA7@P\+:K-S_V#N3&B\WOWS1=%?FQ'
MB;4+:FRC<^FH84^43:2X[ Y,9M15;\5+E@S5SM,3BH\TMM8_KT_F>M]WJ.K=
M) AK&W^HP?PM*"BZ<G1&ZWE/]'5Q^!E[CIU4D#_W ,2RBW]_#KE(VJS%K"[8
M?BB[<SE@(X_V6]=D@QBNXFA<SIF!<S"PD>F6Q5IQ]TC0/<>C[H)E%X2G-:E9
MM/.M=V-=D"'1$.M;ZV2:M-^)\;4_"AA.>V"WU;U23V]OH%5W@7NXNYN+H-*-
M<YJ?,*']W2<U=NB0JT:!?YU[9KD[LNE>J&%TJ$?"H=[Y%6#UYFKZG%D/>C$:
M"&NDHO(CRRQJ)2MM5O-VKYS;+";[YSDQ+QTB")%J9I$/+>''G^AMO/>XJ(PV
M/)_\?!ZP3#I/_<Q;S4T@''"&603>/OEY6?X;2Y,B*KZ#2#&CCMB*Y;2ZCU."
M\'+-9O"W2\8_QT[];-WZ5PM83(\.#XOZ58?0^70N9X__[7Z#;(=H08TZF2^S
M>I[)U!"GZL<4K2F\/(0^97WZQ[7IYE,+7[+N>$\[:SCO[=QGFE%:OL]+<4-@
MM@MZ;.BUTP6^<=?7)I>Z=[)2HZJ9B,.QGO->=29WS)9X2YG\-X$]U6.'YV(F
M"IIFNP'8)2A;J$E@PJ)CI0Z@?I(L[%D#*Y5Y.4BL$L,C;W\1[PQ0J4@70,X+
M; !@J<@P<::5H+_W+.C:)&Y=#7UOO5^/#U;T1=VN.16@OWA@]5_& _"\!6W[
M8Q?++AU5D,ZN+OKM1U?[R2&2C9BV@>3\:B68RMP+?&$+Z*DF#'1BNPZ8^/J2
M>9NE>(R:)&[.,L*;[?AX2>![&J!S>P7Y$FJBW$0^I.V=C,8YMZE)M#IHF>BM
M,KT5*_);+YHR"5%YB13! /,[UQ3NR0\.(?<_"[5$[66"+"HLC>DH$:KC6*-P
MF,Q9/$J//S<EH>SNC2[I"MN1[ ;-K=CJIR!/5\KL5DN1#D"UB)Y."4=061NB
ML2F # V%/<4)7\ZS$0GUQ$\DR^?]3#L);$OH<EA6)1C#:6S!),W+#4FN3?_=
M;BX0X I4,Z]6X)?GZAJB')2S/L?[-.UNB6H.ZDUUZ>*:7]YVXT);H,](A7.!
MR8W%8[E5=AZ!,[5)D]F+2@VGQK[WX\PFE)QNWF28S$=;F^^)==33_$RNF!%N
M:M<@/I'RO -_!Q*?5D:#EN*PB@[T_FZ;\:=4"2*Q4;_K\'"G%C:X+36L1HRR
M !VU;AGAJRP7.2OS_W;@/WLV0!H $2<83P\6K9JNF : \W=1NG@^,&WUZ,4G
MXHKXNLYF!G"XU3K3[G/R!6 0O5VFK-*60= H^\+F]SP;^528+HW^=0&-IPCR
MV?(-0&!K6(V0=+II]7&^5&MV;%W)OV&3O.ZHL-)0EE_77:(NBC8R+)U/8<2&
M'188Z[/AZN2=H2A=D)JZZQN7]UJ0@%7\?5AF63[EZTVMG=L6PMI-PHJH\&F=
M#2"!=W8UOWUW*!J.OAZ[&BEUI0(#8F[A;=!20F53U$CF#( 0C[2M@O([?'OO
M76^@[/UJE9_1_OO,T19U'2.HPN3O<3A0_/):@6LI(2IOHV:IWD)BR CW6-&E
M'X:N%XHJNZRR+I8],-_:,>AQDVIXX9ED_' \;L5XZ6;&H7#R)?L?.9^=<#^:
M3]U\5?;M4REED*(E[Q%N(H55SK04OQ#CTS$:^/83_2A]+)'.1AT'8^*1D9>E
M+O".6T*5**$6D<*1JPW_I.R$_OHAWQ& 0BL%M-^->^HS8W5B;*JEK>VG=TRU
MN8WEHL=JT<],10Y*DP%=>OPI1.<H=/FI; ]HGU_M4H//:S\$A0750"Q.GD"U
M4< O?^8?.L!*05*DB!U8*/E" 44MM*4WA=ZP'W.IM?7[M61@>/$.E Q6G(%V
M GAWP(2EGXCZ'7HIYLWFB%9HZ5IPI:/A,ARAE!2\7AE9LK\  N=PSCF0^_"9
M<.22BVAE9,'&M*-=-V]R^/52/DN (.SKCM!=4_"!FJ1T'N8WTNE6:"<(6Z2"
MEG^W[R3Z+3X$X6RA&GEXF1>/TKY$'.=U_I"_IVQ''9<= Q13%@J%OS5U"%4#
MB17<=G,P.+&7TSV_P7<]L"GW&$+%KLWYF<@S!;E+'AO3$\:.!.W+U;-V*&XR
MS=QS\U2G^J]"1N7 Q2E[UYJ"] 2US#=9!S.R'SU?O.G6.E&![XD\\M:]WMNC
M\)'@@I.L'_=QI7]TT72UJ(:!;SN!4(+R_%98ZD0*-YAGR5)O-\#*?%Z Z 2&
M,TN9B/'J1QF/0^^E$E3&^#[@?<DSB.)4WR]SQE?8EDP+^ ^-'RT*OM7GK[J6
MKYR2[1ILWZ'_VGI=HT[' /7CW\?EQJI27U"WA6FU6I&BF#&'#"!(K_'1XI/I
MO M0JXY1.L]1LE,R"!ZQ&E[DC7:["K="AQ:+(;"*TF%%1LAB/C #488R5X#&
MF<\:UUPWM5S(Y_I53))\^^J3!GJRA5!-*-:AXH)0U3$B;()F#'PG+#&[)Q@T
M:]?9T?"2_6RUN)7^<4FJG\*\O7*.% <%/R7WMU#G,$#D:\H6U :HJ4,'-4@R
M%H59^<CPTMI8R2S*HA\M1D*WQ1@ER)FGVD))8NJ;6CQX6@6Y(7).#WHV./LU
MP[5SCU=I3&/4]!><ZB>79BPJG#_JGVP_6]F]^H3V,M/!R;T!&ZP\4!EWR%MU
MPNEX67[3O:96%Q/'%8>WPZ:1V)9\T[0"[V2SMJ]%F"R*B,;:W% BLH9O#5$N
MP3TG][5KK3XF'YNVXF60=?&HDU!.'1$MQF22]X5H?P47>E._D8*"P8U.A?Y
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M=0:&DJJE<#A^7 \TY]\7MUDYUIJI[%G SK8=,*%/U#.2OK@/ZK?(7@(.7+2
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M%F1-NQS HI/>P;@[WGI]E2$]?&M,H3#&>)P!7K$_.]1Z?=JV7ZC4L\(3)5:
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M?W>HQT] 5>3KE-*Y#_M'A_+3#UF;\_FK]0IQS3:GZ5/0,IZCGDL?ISVQG?A
M-VX>45!7.N*6Y*W(U'_'HOE3RE\O,W-M1>S='3RA7B3=6%_^;KY$HO7@?O%,
MGA+'H_@I=# 5L;Y$+I-VA9IAYM4":):.0I^<%6N\ TM<C6OPA3JH<A'?H']J
MOW5N2%>I9*_\>%LVU4T;=WB4L!]@F.903<\U=54N]7.6V$Y74G 9VN=R'4K
ME?\NG!'O(CH+>BR848*&N[3P=QZE\IM.?[-$:OET#92_R&+JYBPQR((XBB09
M?Q VTFDLS$\Z@G=C^.E,9);,*7T!&YI,Q1=#\EJ_DGY=;=-0)I$4NUWV\90
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M<^803 ?_>%7>=&9/V;N%'5G_>RWV -ZZ;@FY'2TJTA;;47 B''")O75R0+5
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M(<LDK^2QD%,_6>'M-:FS^SA.\0GSYZ(Z"G:.%(%^[+7D;8@\B?%'7QNUR[\
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M1/!)N&3T'5NIIYR>5-K\4V@]JALE19+D^VX5PB5[_9BT3Q?9"2LZ\U9P5<'
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M(?33ZI\"6/X)J61AN<<(=@D^YC J2S6*O0SBLUA[UKYRUI)61FZ,_&H.$SK
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M[RJ;'+L^.JL>_!2=]RI%OK:D BJWIO?6R&%.@</50:5$-G/8Y=K3UGBN%OJ
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MI*SH--1=2;)I@79))9 -(6PWU'TO8,KV& L4W6BB3N&8@EX119Y>!+F$]RA
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M"'O7 N6.+::#?&(MA2SK(RETQ#O[1!S=ASC>H0T#OTDJN[(9#@@[6N4 PWC
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M4CC/_;]Q^.ND30T/CY_52Q ;/;W$(G6#EJP+WY^B8LSB=W692YU>TX,4.<4
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M8]*!R(AA3#7@WI8D-%^?,D#:5?M29(C4RY 4QUYI7KVN QZ99<^"2Q%_"1(
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MHX.RW=:L+%(Z;3?^S C2;%[[8".4=[.&V(D-XBU:\<*K33/$EKR4)OKBU(:
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MZG Q^!Y6A]0M2'[HS],#5?:%[-H_>:(W8GNT_[][M[ZY>C/W^C:EGVBA<3.
MZ"9!QBV+3&+-MU&DS<"7U52:3$_YY-Q>R[:&M@;0/9D;VVXM-#?NS5PM.W&J
MA5I/;6Y=]_N! P,^$^NQ6MY(5\ ]%%M&P4D4/^>T[E$@1%L1I*>'A>F->OH5
M'I[XZF+C OFN_##?UWSS/6%@K]['DFOVEBL(J9H^(LU14W[2;"QRQ?&FV3ZC
MM4M]XZ:=JM/:[8VIC9F.SL.+ML3R$,&=Z/+0YN"O+H9AE+"@06SMR\',%LT'
MEK@[[;;([=R9^-ZY+C47LW+U@-9RGRV]6YT?"Y*?8CPR;5XW5GS-<>IB1YS[
M\GM&YHO2VZ"/U  C>?T\WJ$S-[SURG2]9'U-E7+?Z5H_UG&K>>I9HUPRG(/$
MC9?U+<"]QFA[Q89O6EX!UP1I>'=.5>1R%K]KVK+UZEAC]8OC^3S-L(!3AT)'
M_QH]?;MIQ6[J.4.O2/C5,"$=D%T4<'[30XQ0R?F"I$:T5HBV7G_"RG5*,7LV
MSRLD&ISS3H\+L7O<O.SE]XGMN.N0!499YLZO4=$)PI<MJ%-LL1<8W'Y]R(*=
MJM&XK.KSTJFJ1;S'Z$MZV[E7N,477X'57[7[FF\+1Y=W[!NX4\^ZJWJFR1YT
M=%ZM:'*_&V %HN-M43Q7K^[#!%5Z.T!*O!&&MZJ&V!?IUD%"SX!9I-8@5<^D
MCM"%C;SR>JK:;VH2COP^06S>K_'K5=:^'IR-6B*/6'MMY*=M\\[6]\W;KU?S
M[[Q\7?4A\8;N@>9VN26C*2_AXV]7YMZ'6VK,>$:(\$.FG3?UY+4>ONCHVY):
M"0])NG##U6D@4V,XM#L2XZ \-RB\E3AL5WMA=F'PZ54>?;NEX&,?OW<L>>D"
M58>#W4'L/#::9&SB%-F3'B6ZT2'GJA$P:5QC<=#9=&_:YY2KQXH"-ST\>5N5
MWC!%C]?DBE$[Q-%<-BP4>6@XS (+KVM0>=_S N.TJ6SL]M#.L,'WTU\V]NAV
MSZ2[-V_=FF?FJ/N&F$4,A4.&=+$R@I/3V&J2Q^O;8<^CRT%=QX:H49Q>\\ZQ
MB:\M%?,3=KD%EJ3$J+CCME8FY27'JU9S75RO2T$__RXMU<+&INV?L+-,JR_8
M;@1DL)Q.##;6Z"2FQ>0Q/C?V1V$UH7S_O<M<5II%K4X7\NB0VNDT=^6Y0Y"/
M(\ES>-_@]:'P2 6LVVAXGNM0>'?VB_EFZY+.E6O-%RAE+3N^>E(8MC:)-3YJ
M!YJ^6+S*_;GER^.9DV87_G,XW S72NYPV%GE=;XJ-LK;,NA$Y+>!\@#G7 VB
ME6.GB5;2)L_,T-?,K>@F879Q6FE:M;[3E9&=PQX).3N=1XY>YVMCAL,/N=(+
M;,U*_4)0P'FZ>G")L.\BR05J!W_KT(:N)V%BO]6:4+T?!/@YA1DF\B(9'+^^
M?1=L5!W5]7H3Z9F+ML8<I\B'VN5EA\07VP<M-*,B;DOT719WC'E0=7JN118X
MM3?>'QU_TM.'W7/NW"?6".IRL_7W8K"MFSR^XEU[YPXE-*:0G*H[R&EO:_;W
M_/ =+']%VWX@]^!TE]EMO]N)9=[[ \_I.O837V6@Y 1(;4B;S;>L*([E!H&R
MZ?HO7=48UNQ$++W9O/C!2W8P;1=H-_SCTG%+AJ'RRM^-)U_=^2[[N-Y)_//I
M]:B&K:.TO>W[/2@!;A5[=WR-/(^_6G]AXD/!T\ C)RSK<PR9[_=7-J2%Z7T*
M7'7I^NW;^1EW6N3\,*/:H=S2*>"%3E+EO<YN[5^U'DW)KH8_NEWU!-?9180N
MR<[5/(*^.!;,0#>RDFR)6PG;H##0AK>+L*Y_@2)H' ]O-#0>% H8!V?SFGW+
M:YOCOUZ:MFCXYT5E6BS1^L?T59=8^G_P"5M_O,YJ*3Q-L@L7R*#)#M0N:5DQ
MK!%)31]-7^AKH"8NCRQ>?MU,S;^X+;MJ<K_RCJE+3 .LM6'J6_=YQTZP1X22
M])N"FDR)'%0@);]8)DK>$KL.Y]US+)O12DFA=8&J%H./7(R(<*E\A_,TH9E4
MVUT31>5UX_^&71VJJVM<;KGCZ>+.)$*&L@Q2 @W1!I5R_\RHKQ/4T2S(6_QQ
M\F? Z28,CZ0\[WN[IB(8F BYQ<85H*'>*)5"4M*!!,^/<QIJR8*-!6%2-\>$
M!#4@D[1:;W5Y9J=E^IKL?SQY[M/UK^57![]ZYQ1[>M^^N?PXH.BVL>&5FU&E
M;AZ%NS"/&-V*Y\\]JS;X>63RH97JE\U''<E/_$Y]^=F7]B6>![_/ 25/C!FY
M$I,F4"WU6=)%U$@<-?5ZRU_J]+B0VT%) <_^:6"I".EO^R9LG$']M^1QNO :
M=![ ,-$:>$PQWJ2="G5PZ1L_X:85_!@Q]*0Z\9WGODWU_8%D4: S4'2/\C$T
MICVS*#.JTA$K4_QW:U/.YS%/JQG$?9K>M\-T&;'ALP <L3M?]]_!)N.=A5X=
MR+VO^HV;W!5KF=TYBF-7AZX,GAXI>613(X.Y.[;]=93WI8??R*]J*[L%B2]Q
M*'Y0EWNJ&=YVA O,I-12]]3AHGDMR7@$KQWI[VE3:'VAD/"IE99Y??D@TZ3J
M_K3-_.1.)M6@?RJW;I>,@LCVMG9CZ!6N!B!T\ZA4/])M6:Q:Z-+IX?Q^;GEV
M>+[7#/3JJ;?0=U'QQ,6.GBUT,O@0T%U[NF?\R(=#M])N9[N9UDDU)/&")9D!
M3T(IBIWSSU>^303&,B-)&T.U=S_%U?5QRW,;5I_$C"$18^5#>*V;L:68Y?J0
MUM7908HE:[C2_Y#/T.7\?M<P[!+K+F&7^#@07L@5K)^=MONS>%U JDDJ_S1M
M%[0''Q;%MP"(J6*[FW47,1[?D/H \HE>0OXI5=7!*6C0/WSZ0I--&W;;9'!+
MR\^.C>1_<@F'5Y\UNB?0E<7K4(Q:^;/]U#N\3!1/NY0S3TRY'5.9O(16MX\-
MBWX.U9P%!H/59!D$B_;['Z;974.LZH_ORNPW34PV5E==.FX:$2ARE(QI4-+#
M);N#:190+8^481WPI RR\H/(7(,H4U6&1#9MIX!JSFD:",,;Z15B3;*K Z;F
M?*)7$C.GJY%-497L\7];VQ^,[+I#T$C+N!2(8U:A0F3U/I?*/0IQK;14?31S
MTSW?S<S5P27W8H6YDOK/]YX9GPM/BXXZJ%9\\7SL]=G[?G98E7W3^^R"$229
MC\ULPJ 3\Z,S\"9(DX!O2#W0<CF9>KP.NF]HB8"A<;/?376R3P*T^HC 3<R6
M-,[]?O_I;ZJ9!VHQU78C4X6M/;!L;E]F3!_#%<&E=).3M0\-1F&WA :HO^ZW
M0"E!+@QA] 0QY5<<UADT;IFP\'?H_N7WZ>*<]ZNC!6>;7J=.*]0W=-;N_B=&
M-M/V;*MJ(7?* 9$F,1G*<P47*22+N/48HAJN#D<,UJPO&W?AM\L>;P:6A"66
M+E,HQ_X7EP)8D<[?FN?KAVVWXY875< 2]W0L&.1'A?+XI)VA=,6Q8V-+-J2T
M5@3)6!Q2-S>M(GD[$.5_\BQ(:."VR[J EDLENK4O7K%KT.\"51ZW5+@ZF)LO
M=\'=+)3*W<QK%H%7U=8/G0RZSXV$>V>[W;Q_DW2XSMWI<([XVS!-5Q237>ET
MEKG?HUQ?W_"#2N'F7ALWB[ES(7TYR NWIO<+\E8WX3VN\.UDN>WE3[V.KY;R
M40F2=>V ZLO\VY3HB$KQ"2B*NZC/"E#%59"6;^?F?Y$4FB1<;4\RCXB.#E*I
MSS_Q[0X\\\_6Y-V4B=B.%?>T2=Y6M$(D(A4UCC0;M3U@\A>FW1JMW$Y*&;=4
M,#_17TGK7RA^!);GN>3YMM%QE6D37S<75N303%<+B<&D"5DA!;K'92?19!N
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M8)">Y,.[7D $<G\,<?-# C8 R\F_X,KXDX/TE[^\7X+QN*&+\8Y ;7=+Z71
M!R5$T<EBO<UI6>'YA:&%'?LEM9T$7=O.7]FYJKFR:D^X@=Z9MO8QGW*T#'A_
M#Y6K[&_I.E>M/I*C$4IJR/%M_%SU/H,\]/?H%1+7-EWK?N_?'[=Z>]:,U*)M
M[GR5G3MR:3#3V<LC=X=GI6>[W.LEDQBSI^71M@=T4&$J\'MT3EG1]@%3PE:Q
M*@A/*'VD$,L@F([:FO(*-]K$59X",[1EADR7[(Q6+R%Q:7.S^8/"L:A:AI^&
M_@<.2HMJ!O:PT/*"T;'.:6,HGM,;[9A3>WT4K\^SBW48-OE^(\ A>?&AW]R
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MX5INU!=7OQ>U=_))W9\W7R+-.);=ZWG:</H\XP.,EFAY&,8"K/0FI"1IJ1_
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M .\>T-ATRQAK@J.X*" ]QW$N!>@ZV3?5ZD(6V<DP.?1(^EKX-ZA.%0B?@I+
MI1(%;$AO642P(Z=+GH_S3,DTTVZP3^[=>0<7U6WC!]7(</I1=<$K\L 1 7;G
M:^BRRCTJ7K-D*):\%KHTB<PR.V6J,4M3R$BY;U4YTN>+B#.5D5*[-MY22I:4
M/OT-J&D5HR[-"JTHELIK4+&4?C-\73WHE.V8FLF_3 3>B10G@+K;'O$1]M&#
M->'0F2;O>*N6UVGBX_<S[$6:;2.T;@MO(=\S4L[AM>1L_<$?V\RN@?:\@,/2
MI3,Y[]/EA^Z-;B-AUQ$HW1OR#H,>=X=%E26\U/,I)\]QZDX?S3B[:@E8QZ!'
MX4=R#Z@KZ1>8:6/FZOS9L C)_!VL.;QOR".1U042]O_L&%Y44_(1UBE2G.YW
MGEI$I%N,E4D*Q.ENZ5E-I+*HL34HNYVPSR%'Q^Z!9PEK/EZA1XL--;U9JFOP
M3H QK0()K72D@/ J?@8'6H;T<C=3 MN9!A[Z%5/8M=!;U>X@*!ALTI'R,G#(
M#1:O\H)Y/0IJR.47HS'!Z#27L N=WJ\3FX-*ZU264L+,&2VJF&4UG0=^M(H-
MFMRP-A0;F9F ER82\@O)03VS9/0HD: ;-]SD*?<,/ "<'RS1EI<I2^KG>4!7
MO^PVB?VUKVJF=G3;;:,*5+Y81IX&JZ"R]@ 1[ 5M>:E=0TWZ$OIZH4Y6DVXY
MI:+E%-=NR%GEI4444S_4$]=**5$[L_?XOAPL:M"BPXH05M,G<<VS2&U^_5A'
MUD=O#=1@H$8IAH&+<D*&T=Z+]6;I*>@:UO0#L(T^_$.FS\B84]PFL+E/5 >H
MFP%ANS]A+W12-D*PHIR (@XW-X%:E%C!71D33+_!W10*-<J4J2]%E.1>2\J!
M6TROGPW1;<#3 TUHJ?TP#3E,40D(P"FT&:UMB+:BOK&I#CQ?UZ:_X5MGPITL
MV6D88Y>YIHJYUHFZ[C$E4= [229ATK['5A[C%'BNC0Y\N,MIW/&)!#E\-BFQ
MM<AZ@&JD\O27T9/S"_-NT%#$?$::QN(MBVHS>+9W)J[0O35\=7_5Q3M/)%;'
M/4V)#L%=_(2-(G]1])410NLYA_ ]?AYV4OHP7C:4@9,^@?6DO&&QC)[I_<F5
M#C1[;"J&7<!2;IW&,$,T(F+>%KEP2YYG\5:WVH3P=0<%"\['G0\ZW,W\'[+#
MP4NSRE]UGH*7,*;%8*,,EX4[AUL313"CK0C1]-)<\_B:52 A(P**E^9$"NC(
MGUW(R.U87?J=AXN(=2'2A.C@K_5Q<J3(3%K&5V3V0>2.^/Q3.?' TZ&]O5(N
M&#^*XS!F@L# %APJ#I^L04"%JMW4I7W4=:JM1"9'"VX"G A_8!#>^Q3V;NJ#
M"950,"Y]#)UR!$H%.L1\S3K@HMNJ*9Z91^2*<ED2W>L56'<CUP_XQS[Q<OS5
MV76#N#.$VPMVJ7&W^G'GF!D:"\@1C*'I#A0W0BXRM8YT8_ZEDK)HTX6\-"=X
MU L/+#U-W![M%FJ6']J '^:<9H\LN^MDVKMU$'Q?KS*'(Z'X"#!$%EZM<H1/
M0_[ O. X88)IV'3].6P+?N.SEE(:>K\/'7[X;V='^*\%IX"A-*H/D>Y05+A1
MN?#@89G)IX>#+[MV"6XME? @.U8[[K:839B)5QVAQH+?Z^-+HA(ZIWFJI3%%
MJR [6M'F0UB]$)@(>2:"*0*-Q=ZKLC>P"_8Q]5B25KC(4U?A/;W4D"KSV)#$
MRF"^_P?KGI+_OG42@!-T$6$?&)GA03HO(P^;M2TBULSRH"W"6S@)TW0144//
MF16:\V8LQBP;H<['U.V#M,U,@R"J[ZN^@HXQZUX72T8FUA@(@JXN(E;.$O3(
ML\V7PNC'W]1%QY$'<C#*5^K\Q]!)U7%:G\9J@Z*5AW"B)I7!%T%6FL<64OQ+
M2K'&.##% 0YX,3JNG6@5(R/_0J$TZ90SD#IM5N<Z'WW9X>']'IN==46P#V@&
M&SV==#+2#/X$K$5$)"X+Y0"D9V@,*4L["(9-=A)>&MT8:P]%"K3XHXU^32:
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MU[H5,YNVF8)2'0/R,F(5RXF'L.72*:)58%L^.AWV*RG+8$QP614:8;@I:,L
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M*_RB[7?Z;,:9>/S>]/J7\9;_M>;J/T#<V_UR,O8_3;JW_I=QGFL@M/R,W"%
MCK[I_+,+EXEV^,4=\<$Y_XZC3%1QM7\VM/\3[%AV];)1C!G#JC)_Y&-K'.7\
MF[LVN$B#-/&&I0NWBZ$R92\85YJ2*!4.$T]!J:78FU+%M(/?SYV4<2J],+.
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M"QC8V$O.$N"RZ BNT21-OQ=K032C<WQ:"Y$=W(V "4\P0Y36"7"WQ,8T4\V
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MEO&PE660D?*R%GAN4&W)*R"\/U- 1U+M*[7/7;L*)@/?;P*+B(-@^JV9SW7
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MO&T%=NL_(Z69O K0=R[A4NR&\XQ]QN"N3U\,\#KJKH-2WH%]&';):V7$-Y?
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M/9-MVJM[V= :BN%SU2<ECA\9>M^)!U\-GG]U$^56*MD*!E<*J>DW=._D?;,
M\)9=K<.5M/#.;9K.28F6)P:<CH5D@'YSU\3[(*Y 2N-0-A,0P+=Z\.2X/T#*
M_ *N^>T_YW^C6L DW]F"6B6$:T"V([XI'6A3L.#V4RT0PG1-[@)^5 LP:KN*
M2G+UO.ME71^)7;P5&()TF3:&Y/O-D\4VQ/=$9<@ R.Z6;926+H@R$YAD0A)-
M$@'ZI1)<GYR5;.XG& G@&4O+S2G51'6(XE:\%'6XRT&V41@IX-;-^&DYF5T*
MVGSIE]&7!01D&C976_,Y<N3],T)L'\.@(HUAA6_FD[HIZA+CP5AF*JG!KF!.
MS&>JXUF"<BIPN$O)LW"6K3N<RR>MQS_"]LOW>].TH1KZ4+^5F5\@L)=AU/_2
M7,27+(A_S5<K+25!9OQ$+/E&,$*^H!-[1OC(7$D<:,1O./#?Y[2_)W5V&>>5
M@*+,AI2=/767B28>F<5V05ZN[Z:W@B<KOSJKW\68&_@MQ4$&-01CL+>]#<LO
M2%M$I&(U1*C$YY"HW<:WWNT)E.\I%[VY =V,PX.X9Y$I5PMDV\ ;+2^@NX*?
MPX+);R-G6VV6"0_R60I=/VU8&&A/P5RML)S^J#L;]%B*[O\&1981P@&;3&8$
ME_P;LXY@"8;Q9%4OPPT1V(P5V ;K7&=/9C/CH]4\KJM88Z"Q#<XV8A%M^GJS
MZ(>27N!]1XX/7T%^X_Q-LSB,+A[I('U(2!3OQKOQC.<M@==+]R$^'S<J/ :6
M37'L$CNUQOS82&U70=< [0).C6 .D<MG9-JUI/7!GV:]:TI"JT8O:VYW+OL<
MT/T+!G\VOK1%FC\%D?G4K *,XL)AK@'^N+!=-_WA2^QL\%Y&<]L(<?.T>CA&
MC8X55"O_9FM"B9Q@-' @/RHT@D_*"#[PD6XOC$*(+5V*>[%Y4RX#NQI!VJBE
M;'TC8+-TK0&@9<5QE?&1'(P^R@Q4$5:PW1"9+HP=C0-7Z/9@A<"90O>^*8C2
M:U\NR+!&K/\^B?98"WW *$0&8VK[GX"7:BOL*^UWU13>J(ZY)-G0M@)3C(56
M\3'J!%= JP)@+>6 <#8F':&]0!WM%ME#2< +(7LLC$T=.R ZDM*5P.R$IQAN
M9PPUF,)U9B;U@)P"PP,C<6TA,G4/M7 &O"G)+7"HX?7OH+W+VIUP: ]RC@F2
MN_KPNA/H/01KT%BRDZ0O0\P,8[?(]"]3-Y#39%ME'QCK@3 V)0NM!%H55K-R
M3=FZ8;?H%PG84B6-Z>)MP%0:*K3Z^UCNMX(25ES"J@5.+C.T]Q9"77(S#CPL
M%]>JL9B-D,@3&$DE;'L166 YL_3^)13?;GB0+/"[W3 ??[)NL#HV]RIDP[&
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M6DPZE%U*\.J3>)PGW10<YJH6881II0\06\99DVJOA[\!E.1&3-:!>.U_\.)
MP#>3+\5UN3V?J7XYHXU[,>,>QPN1*5<"AL+.UAW+'IV]8V%!T$ UP1OL[2@1
M[XS K#]7L%38+XD'>CO'$!14$JX&.CK;I56L-D"WX]-6X:LZ9%:/NLF<GQ#&
MIQ\5QC\HP=1<7F9F6$V8$R@ZI(YSI(LXQ8EPMYL18(7G1V=6KX+$%VH6J"#3
M;)N*PL26>!7!YJ62"GS,6>G3!NRF27Q\-U&U55O7O 7]FO\>WBDS!9W3&J(,
M?[%E._IC:2IMQ?6QJY;BV=C1R"4"U(S,C$8;$?8 O5DUDB >25%R<(1&N[ML
MX#35P=V "JJ$Q/REAQ&59R;'N!':Z'4@H_8YU-Q9^(UR[3SMN^&VHK@HY.FF
MMN:F0L3!5NDMTD4]VKII0V4YS?6X(X^!VGFHLZ%5TV@3\%NF<)KN"!X8.XS,
M6*ZA@<[.H#N%S=P8B%_NGNQD=4?2H'HO,GO8UBDM]&77S<@GW_O/2*IH<J#*
M76KHO)'/L)6=,9\YCQ%&^8X+F6S$**=3:W(C=-C@/;.+F858C^AR!SV.0\Y5
ML\&[^Q8\])QYB0AEM\I YXA*^Q?0"[40Q_^@Q#(\*RC)PW4 W0+UB"\1D) E
MT,M'L*MZX007\#\(%"3!.YCKZ>OY2+4S$888$)MES5T/D3GJX3:Z6+8TGO\A
MEV\0S&*A-X&;)Y^6X6>Q0'=I:_&_DUH-#70P[MNC)Y.PZ"!9-[/N*S>5[LWS
M!#PZ$N+34!=68"J[AA=R5X_]9GE6C[1+35G+QAVS4N59UDAKZ._414QZ C8-
M=2B25^W1V6QK_I3/+SGC7A'(NK:ZQW^ ^)94W];;CE&7]30SE0DVE80U8/HC
M01*RBZNVZ%UY>0R;Q0.;ZI,$R"U!^$>G!G$_&N=)9T"/C#@[YV!0*<,ZRE\4
M-+18-5[MM0+S+%X.>RPI)?%*BC=^I)\7!JV=[5B!:1+B:BX'[X.L>;W)S%7T
M]4!(ER%"^LPZ-T9@,R<. W^S=6UR8G&9Q;L )GFA1[XHQV:"=X GGPI<&7KA
M<C**G=W'IVX*_ R]2$+;N9J1>)5<1>MQ[#I_2)LW->\.:G**#X C\^K E#/D
MRJ>D'FA":$01?,2F7"CL!#00)C"P["[>"SP@\[-Q&R:A*O?F =KB"DP]8JEX
MYROO"/Z?.+T>J0;7%[;<21KU6(IY)<>6Q'\%ID3?5&P$%<4 1T6<L4;&X^%F
MM,DKZ2/K[*1$WK%6ZNBE]%VXM.7&HB)N&GM?9U/YAP\Z75UM971/9@>W;F1N
M!?:W?%>3X +$LPS@#F IPQS*%_YOL2JQZ$+(>8$HQ^M,+^CAW]\PVW9<Z-I7
M 4J_/8JHQ)<;Z'9W#O@./8@*_C:Q>/CUZQ;&<5!;LCE_R;N_ ;D!:G:F",AY
M$NV; *Z#U*#-1FA!F(X'E'*)"F0GG%Z<)<$AIN#'0X$[B55L4OO*%Z#F& _3
M]7@T.)[+D1D.2(QIEY>GTJY8/0K'U1Q:@65R_Q8UJ4X7FT*1?%$J5AF]"QKO
M+#XHK65H$M]0 <8B=6WP66+OV#>F@)0!0'!!7,5M0D3%3/UL87DMSZ1Z47J
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M--EA;'^WH%M)H0!WR5SZ@*&._^4)/01F><PT@HW05(S;<J:#I%K8_;0<BO>
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M6D<(;6REN+0.$TTDV_H(&+ZXS:B]>--0(U95<G1 #D!R?0USYU1.K)W3E&L
M2?G[Y.&^T$&K]5U?..Q?_HVON[:V-DA5P +)9J9L_2*-8"-]0C#@449GL*F%
MO]D]U"P,D#F+1D!8?EO"YG[)>2%7#Y_M5C](:T1H!UQF: _B8LWB[>N'S*S*
MA^C:_*J)W0%0?.= Q(/6V&ND?9HA[]IEFW*=[-9$2GYZT.S<]ZW;D+JPH10L
M5EB-_ZWO-U2SYU[H>HY)N].IV!U_]NGD'CQ]?]W'G)U>]R)M8UK+#.-V[A"9
M!CRD;G_EE)7#^W6"4')P)'?*>=6ASH.9I^\-V=XMF=\6YGO<?'^VJ]/O6FF
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MFRG.UV=V4B7:*4O)$%+L*1]$_@NGYE+KN6P[)0&MDZ0=O@);RP-68'ET*UR
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MM\;_DF-)RE!)Y]6S>*]+>S6/TA^,>&4M_=S!0(?QN-!.I4[J&HDE PHI)WA
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M<NC6??\@38PE' $H&3]B>[,81@ Q.X3O3N*,H2G +Y;W!((<X@X@R8T&WC[
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MK2+A.'(C/M]IN)H.A[,-8MR +FX7 C'+W8#:)J!IS:+U@.AF@7/QY-NEWJ-
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MFT&9<@23^E0J"+*#"^R] S"6&SWSB%Z5<F)F::RKBA9O3EMTZZ.C%?]J0OB
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M\7ZM%TT]M^ 722;)LUU?&)S]#/74[P!V82O$;:T ]YW/!BY_L3>*CH]OJ _
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M'GP\QG>GJ0/AT5,5TPJ).M[)ZE[EJ,W4U+U"RS!J*QSZ\KUM4_^^Z\B&*T*
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M1P96B1'$B15%:RH;M\'?F@(91D&+.V")B5ZOQXX][JD:K D8C^,/YQXQ 7>
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MSE>'"O)+2K?HE^CD:6T(QB\K;DC2[)A;?7U[)&2<W9-+D3[C9#"X\5V9UEP
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M\+2#]Q]"B37_LPC/R:+D)S.@L+;">+6T5.'/TW^W@ +)C_^M,=;]7\/_UV/
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M+3%A7S P,RYJ<&>DNW=0D]_W-1I$0&JD=Z)2E2H=#.2C" @(2.\@(%T("$B
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MU%07/QXU*P "H% DWB<"_I]HACX)+92Z%M%D]&GGC;&<;8WOFY>\Z.8"%)T
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M-)^,+15Y4"& ?2M@D=B@458W<4*Z\9;H?K<[S#<@SO0.YV-=$XM>#!B\N&;
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MGD[JL#=(::@;W4;,<G*25\@1I./34/B%MXRJ@0T1]<YRD9[Y3K%";/.1O*1
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M3S3F0\WC9K C.ZO1!SP/V 25AA.ZCJH=#(V5O=+L2(OK92E+*S)DB@2*XUA
MFP_<<L(6GEZ4(NAM3J]-N18%+XMWE':;KZ/RM6(*0,M,,$HP)NV'&X>)4R;H
M(XUIW@"]]?"GC8[] +]!-3TZX4CY#!E$[),W 62EYXF $05'6]?]F\1*VL
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M;HA;+U&G@T28 RJXA%6>57([N^TJSO"AI'P-.KGUEB <[%6J":G]2H=]<3V
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M4[_=;>'!!6LY&WN31Q)XUEM<I$<60U;NU!/_1HU#FY2,DNA!9?RTY[71;6K
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M@B%%0;0PI\B&?GGLB&J;W%BQI(CN[C+]==9V4/EN_- \HQN4(;;QURXJ9J1
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MF,^-W/'1X;D4@M;?6OBIC(FT%S:,O+]*[6>CIR<,H0-H ^;.H@8-G\Z1NX*
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MV8$-D%[^L]1_ +[R&PG(^M>P>TJRXK7[^1^ N/HF%7L*X0:>3]]P0R9KL#-
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MN5NAIN#_NL7/>\M_A8]+TG </0O#3Y#3C@*7RQ]?-LPKW3MZ&I7SOZ!MK*V
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M6>IE_%#OS@LS#T__ _YR-#'WPFJDEQ.4$UL_/+D*_Z66I>6M$5!_=/C1\Q=
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M'$FUL-Q]=>T+QZ/A1Z7SV?;KN+E#<6N>^2\-1,\N%[F=; [9EO?8=W[F5Z&
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MM1WF]00%WY#CI(9RLEKQM1NB@_UB8Z_&@AB5=+LHF7:UZQ<"SI!M%R9[!65
MM0/.P?E\VGCI:0C=A3? )$>;IMY@*4K?KZ#T]U;+/J),U8"Q;",Y.(J'1U'P
M/!!:3"ZLH'1-_@76S$]C1QP(?%6BYQB3(TG9EE(ORS:K)>4.86(30!4.J4+V
M@)VL5.9F(!C^ >:)8L&D$6$BX@VI' .IQ=#!Y9,%RUV-+#6&2D0IW,,W?Z2=
M\CQTQADT3;$.^Z-/ =N;/M1%C>W-,'O< N/DAU909/KDT!D(W]X?UV"T458@
M^I]I1%$ON+SPJQ2)ACO%^P!_V.<IG,OS3OLS(YO)J;,IY6?0QEO.PI5*V0PK
MR)OWY2WXUF&_9=9+Y, ;D)"UU.O-GMXT%.FXL\>/F7 ()?XAR$,TA(?A6LB8
MG]=!7DW]P,+0@D)D<5.!$L&;6;1X"N@/(_)J>1"=': Q^).@]M7[^Q0\TQJP
M=U1J0)$.M=N]'8NG\_'MO9[M1CO>@!7ZAS.7R30>1VTNVH.6SN(68&J_54*%
M(@+\_E(@'Z]PEMIMI)C22E25ZL$DKV1,$A4+-B96A.^EW;8C=&09GZ@?KK>(
M)L3I9TG+^;3$J/6AO\/ZDO@$V6OV,YOB&7,KA/SLS]!;@TZFPWFN\*/0XPTL
MQ^N?B/"4U-""A>,I'<2ZT\NW&4$T,)JPFMI'EP>4Q<YG86$[79[(MZ"G5C%W
M4 1M- V&&4^,3]%AZ11]J OS/@"G"=;\7 QD-QL^R+G62XD0_9;4,)P%6 UJ
MKTXCK::S=%&A\L_34)W%:)@@T*(G.]QZ@:P'.?%476FWD8&L$]P@C;,P=06U
M_CRD_1:*Z= F5U&"V!AE#?ZVK-(0ZBZ&_VY9H7U+'G/G)Q>ORL__/ZJN/9ZI
M__^O%$4LR3V6A HMY1+6UDV2M*3<69(TE_81LIBMB.6ZRC<^$2M"<JO<2FO#
M-ON4)/>:F&V?<L\YGYA3F_FM/W__[7'V>)R=O=_/U_-RWK=1%?GZ!F"^ Z&'
M$=H#"=SZ+$4J#28[1[ :H^=GQ8\"9-;]).T8D. );I$? -%E!% 3;83(?4&R
M'Y9O#6;E-M6G2E9@FTT!=*4HLGK2O)\EU!Y HO8NSZ>MP$((:6/:T!&I'<FX
M7^8%KEYB_WE#P?O,NCRO%)&0D+@*5*X4=Q_A(K08;LI4,=+T:/K[F8YW2&[M
M5?WHA:P#%I[VK>3_F0X,7:XKF?^YK, C8F2?"T0%4R7^PU<H86]QXBM%4@*Y
MA_("TT'++J2DHQ*>D"P_6:-MR%T.*[ F9"9S)^DXE)0@ELY=7>K\!"6Q?[.H
M)#L@R1V49U2.RHX.,.R$+,B]LO>'V4#E=[F9PAVYL2)78#?&G):?RI45<'>'
M3$&DJ("-R$4\]VFCI2HLMH)LK*''22$')N:R'I%<ANS@MS$Z9.4IX_T@+OL'
MRD48I-(^7;(%LA-B] )Z1+B-.&(P'Z$?@)?;I7ML5EK 20J74\E:Y/Y@"^BF
MF+*%6,WCZY2!:I++K<L%A.&.!*9Q2]\%*"D2#%?D*5U6<TW9P,*!$TD47:SH
MK<ZPNX.#@ZX!5K)E^*_FNY*AS%]VB@;]C!7JSKG4DKP'R&818\Z-16+X+#=6
MN@,J<P683163H"_1W1]<H&^&9Z&0R;OO)U_'BZ-U<2&Q(0=F^>GI0Q)OR5*A
M];2MB/!Q!#Y"ETP/Q6.591L;@(0;MG $Q))\@CRESI<%6\A[Y#V(S6@-*)1+
M62>C*#HW$EH4(77H7XIP4*%\/S#/$:2CMT&^<3L;JWMN*[73-6U'?=C\NH*G
ME_/YS$>VUTDN4CRE_2!3GX1:?D:VA);.+/]/YBZD?=:5T#ZAU60^0$\ZTX#D
MWKLXS_=JE^_*$JIDVB%O!VL.VR$S_>_7S_X4=:L)>9W=&B/'@+C?A$YK0Q]0
MD(XZS*?=KD'9U4YAOIQ'>!'%\O5E0L$6(@VG^-N-/3P6'&*+*"DR4R&6'\ M
MT56PV'*HJ(=F+U!O')E7@P(Z?5J+!>TS[YCJ,O<5V*W@[UCE(.+\N*K,:8!
MLJN8W+&M8=A672N@?YD>I.@_%:A(2)MS!RB<I6#[ 9*AU)=TN ]%$8UD(3<5
MF_H!KMF-")C,#""D+^*HQMO[:\N&; ]XM=& ?6TEML#'IAKWVNDAIF,3W8OU
M:B!J-,KK)RM 82_RY(-.!9V(+ ,6FW;K/X@J1+1C1DSE^H?GA<GULR-@4L"
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MXE*2 :OWASB+(S?*#%*%IJX=1.PBF2[3,/@N03;B!;6]$XJ5!I/L( >IOGQ
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MJ;SL?QQTE>T):I0GA3W[==<-%3 ??<7D5<B&ET?O-1S+/K?/:V?CDC?!_9B
MG%&R)?G;M=KPTH1EK-<>C[\VOZ/L$=_W>&98\B;]^$353(_*IR#TCH<?^IBB
MJ]VV M-0I2MZ-]:)*Q_7/_P^A#H28^*[#33\L7_4O!P?:5!RXXZYODK=-6/9
M59NCOL12\8[HOL 7SDT>B:*PKYS_>OT[V&L>:DX@*VRRV<_ZHIV_V#>.O9MJ
MN>L4&^0<*6N-^.TG)[OV:V%+V:8>L=7^%N^??3KP >VO>6^[ZI,]=^CW,ZZN
M<S$\I&_[#42D9;]X-NWF7";KY0=TQWU\HY]9O6-=-MPL@U+PK3/ ="(RVK3S
MQ3]GOL]T7--A[=AT2)W]S^. &^JC'4<#;NC^-0YF;_$)P)>G91=UD]TGQJ-S
M=VS-<429-)W_ %,DN-M&W;&[%LWYDFMXBP0S(V18:Z*LN] CH 3O%S?WC3*P
M8.3%(R-:TCW7,BO,/K?[3V]NRI[ [-G4BE9V>FKQ,/?&L*AG;A[H%[EV8C+(
M&T'$#9E)-50XA%1KSGCJ5G'L7FWM8%U5;,RZ5^%W86XFK=Y^CKB[!5MS*;XC
M)YNZCM-#\;H_&B45/E%_:5P<.P4_[/NO!N="=7>D9LZ]"T6G]IK\C#Z[0:QZ
M?NO$IT<J*-5ZPCFW$Z?[4".U@R7=^"?W!N.&_S'3>[5_IS.K<;"^GX7E54%X
M@">QAWHDAC,YA+82LWZD_V\E@J;\XW\6#;E6KZ_E2TRWI!\^BWAP3</'L=Z+
MN7R'<2[YF5U/)M.@J^;A2Y/7H+SX"7KP\^&TIOO_>BNE&)^"J6X^[S-]K"59
M:.3H*JF=\5]E&%:\V*E:'L,BY7Y*P"3O2RVQO*GP<$M"]/_Z/'2:0HF'MKFH
M6V5S0G=U;ZL;:OOWZOZO^Y\26SY6"/$*I1GC)R*[ZL_NBILS=&KQ85F>&JU;
M''X_*VO_Q JA93B@K:17&G2I"_#U_K@#W^XS#&2)0T^L2E_[M/2?<-%Z$:IQ
M(3(C[.NU'UOOP:1=0FQ[._"^3WP*>/LP8'[W$T:^Z&#Z;,;M;?:O-OY((GX.
MT\S5S' ^A/K]C<K%:41NBOHDZGN2<WW?*"Z VW0$_M#5M'.=$=9BZW)LSC/2
MF>?[W"O]9X;4S;_GGNLO&3MZ\Y2#)1;Q]_'#CJI??\Q\WBDVV\ZH&ZPW=!;X
M)"S-?0O97UT[VCRU%)$8EOY I+UN:=@[_YFNQK,?/QWVZPD/3E2I5*Z*?/[2
M?(WUCNOO[SLSFE$7Q\5,RJY?I\3B^/R;3GA@VJ&@H/N#-S^8NO9#BRIG-[K?
MF1GX,*S0KJU'3WO&'\%Y,_-/*/V<],"M4_1)B8\N!K2_#ZB9^AU1[HQZN,MT
MD^\X3-FCOV;"4'!VMM]'2C\720Y:Q3R7 !FSS9_TTFQ"CL)(E>_-3\:O4>99
ME#P[=N!U3;0KIU1OS#5W\LXZ[XMA&1H_T*?/3CS:<L,9[#[;U_0K_D:?$>)L
MBMG6H\/>EQ"-CHA]1Q_@5RM_W;?C9.C^=NVOOHJXK?MT>]"N+Y^>7\R43)W?
M:Q+V<3'3<9W)U3;QW<[DA.PB++;KYZ1K8^;8S(\5V+Z/XWF=S!WIQQM]ZU!9
M]_\3O_H[N7!'ZFX'4^;1ORU,#6E*L,(V[!<"I["Y5J>LFEBWQ__<=5&D_9N'
MQY[LJ]%RVW58;6%5Z?YW,O*[WKBIV<<MN;Y10E_1:>\OHRG/<6_2CSJJMV^/
M3>42WAOO+SF:_6;7OEVK/MR"MZ[[<6J7J B_,/PC$1-<H?7L6^E+P;E!N] >
MT@% WG.D?ZXF1)5U*==VW[K0G&\7/^K5A)[_>%U<9R,POAE2J>8K3P@G<QZ.
M7]1\N+9'26\JM3_S&^J R!IWAO56D3Z.1SI')JA%HK+?_RSF[/W[;TOU1Q<=
MCBT<B'QM?/&FNSI5O\W1J/4>'%-9'E6:_\_'']TX5\&9FLES#=GQ"X:ML?/]
MBP=<[?)L-H6N25?++GFM/U&7>#?@#.S0AJMCW'3'?_]*BI7'G,XZ^V_::/N[
M=_M[O-[-G PB?"/<[9E6*[:7I=Z5.#]^]P[SFLR: /[U^6U!VKP"NV<'Y,G?
M%=Q@+6KW5<O^BW<^;3L"E-%>?!W_B_(MZ^$$T/-HH7[! ;*R 6*%>Q:@\'&;
M7\2 $]KE!P3_]-%Q!=.)89L]_0VT_]_,M=.!]YJ'-SC5;+J[J/FB:KII7G9]
M= 4VW+@"^[US4NDCTT*V%0H#>X2=E4"+0LE2&I&WC5>!ZLU_VQ$V0)G]<_9>
M@7B?:X5U=Y^.',_1'GM0<[GP;4Y^_>/(Q#!N27UIA,0[L2(O*?RI?\!7UV\(
M#=8%RA<?H4O+K?. ;CMFW62+L3+T^!DI$OC1M'_03K"9"R;X \>:@'XO**^:
MR.(XY5>+Z%K$CQ/"B=OQE#64CD.BZ%"?@1"@MF_2^R>WTI\?T+ZXX8CFL0.F
MAW[MT#:#D:/DGU=@SYMH7#IUV(#2CDAG->0(;MM1^*H(_CZ10ZK<=A)MU1\'
MSRQ!$=8<&7>F:T^Q=)B&7WD@=CR!6V1MX0;42RRX=-C(= O;#9CCI<;3X=-D
M8W!WQ?G_D%^2Y.MO M5MN-7H/223Y5+T%IDA6"E#$OB[1R39H 4;22T,SXBK
M3T>L1^'"A?5K(/?VOV0(\%AM4BBX4Q8DQ,%EF/ZFN5"Q5<O8%E"0R;A>1ZSG
M'%;?)/ RB)"W#SLFXVV5 _):16L<EBKUM=C.;<]'>,I;OIVUK;QOF?].[>9!
MQ-]T \KX0T62^7>Y6$8!JB4XZ(C4$=JVQ!MS!E2X<$,\3H>A+<+J0OM$S'I
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M97%MW%S=/UX28.*05]R>ST]X39KWMSPN]2Z:GD_P/^YBUDEBUDW4<X,+EQS
MV=YUV(Y%)+H.\G(#M<DI2TK=5+T1TQ5_O^,-@TCTYF)AR8$Y)J9B<FY,+2.N
MRC0GFXRC_G1ZH%EQKWC^*3XBQ[M=?VN OEW*)2WP8.:G<*UE!0^E6VN/HZIT
MPG]L_^:9?79[=A%T2:#EM".P5*/CDJWR/+-6PSQLC&+0D'UWLNYM68S[_FPO
MT\\="Q/_\7[Q#Y*ZK- 7,;?0]9B,=5CD.BP#OJ.6N$?$1"FV@'4IOVEI63$Z
M9%Q$9&!9N)6O?D=3<5FX2=[<F8D?]Y6;6U/68255 ?WH\<!<0SN%H(^DOZ6Q
MO1C5V/$VSCIL\0]G.=L**XG2%5P:)LKC5WM$%J^+G4&'7KJO5.;R[N$&S84I
M#;%U=BKM\0:$[5;2MK4KM<(4IG.$?OO+/#'AB>,5<)+V"=.%K:]<_,6F08:8
M12<.=@(EYI^5DN4;*$VHOUM#6'I'N[;:+^SQEG&%=(%10GGX6GEJ87GOU6!M
M1EE8C%GNZD?G2[*=;;2MXH\ULUX)YOBV>#7>56&!X#2 FTGKQF;X4A@#BGBG
M / BF<094#U+2T-B*L*: I3:6D96(E'3\PNGQBJ'ZQZ/KK":YHW$LU%YY-(A
M2CQ5;19ZL%FUR>GV5?D#2H[J.9=&RQ[=J"T0^J;NCWZ!KY&\9+D?WW^F<O'[
M2%EN]\DJ$U>JQFFC-S^M"=A[)_,+ O\-'C8<+9'Q/M;+*3 :*]'PI)^LD[FK
MZ]P:=??;5Y=KC391/N,HG$C&7ZR</-!@D5F#-_@[L1UFY2"9YSN"V@.1V)3>
MN$@+;X$#%W<+M2N_MY64O+("6ORXCVMUD\95MC3F^Q1TJPL,JO^]9 %Y3"1H
MSM&.6;"@/;.+-D SG=48LTI?8.6\ 9IYUX'*;JQ2N2B?,V>!52Q&J'\O6OG1
M_K,KY*$%HW[W=!C/-7B3*OAF4^0_FB,WX?>Q]62!RN6^;G3#.HS!RB;)&20Q
MUF$2*%N!':B63=0E;!I=L;7F?%T4'$DP_\CR[;,J*9^CV@SM#&YL>>V-=1N=
M29^+?Q&=^?9'_[)8FR%CKT60,Z!"_#@D<!06B_3PS6Q6'TU>< #X5C[SIW%9
MUN^=6.8WAEE_H)!PS]Y'UHS?42VW+,=95#&7-U5KM]^ZF)%N#ZB78HHNO&[]
M5VL2P0A^/7$FYI_7BQ:73$/W%+LQZ]P?/- (JW)PL3U$?M(=!'C/NS3)=Y@X
M'+(LLX[*?CSAU=QF$,G\>KUP-;(J"YCD_3T'<HXX:LH=2"/5J^6LPT)SX)QO
M&< ZS ]LNO,4_VW@)+GGME.9<^1E&JYQY+?L,<1, 8_W8?K;J&Q;Q&"D>;/J
MT(^4NR)5QQ_:0W82]"&GG1[7_[RT<=IIA]FK[ETU?W@3AQ8>C8 ,5Q=# %0_
M@[A;6$ *%.+8K-XZ1;S5&>!B,:<DMI>7']IT/9YV]R>J:E.\J",V)BPR%A=&
M&#USYL5 HFG-&<;:Z"&]VT1#1SW/EC=YCF8_#VW8FN?<\B2Q[&;+>''H3(A$
M>=Q;4]X95D7A*Q:QM18>5?[6R@7$O!+8W)G/)]&I_+!#EK'(I-+;5/L$Q4GD
MV)KFWQYW>8> 8M$;RHUUV(KJ4+4 6.9<9RZ_H/V<NW:(6[,_?FQ-Y_]=57G3
M6FRG[OBY5&<ZM]FTZ;HD$K%5<]$G'7P>!60:/I15/ND ^_M2\5B'B9 X],($
M2:@Z<OD9:^NX/WGM.F4=YF !\\:\IOVH^ZD\?X'P&'X*^\7H-^RT7W]PVXWN
M#]^I%SQ4CU\6#F?MU )3C5-Y!EHCSVKC=J8.??-P29^YU[\AK^UD\17MM]SK
MMD\E\D,NYCRW?W;?M.Y;)EMMV[&U'([?X4+%N^AVQ6<;7<#4@^?*GP6E?SWW
M\EE*6]')RW_&]>+],_N4?)L^.]W/#KZ"#SYH>JNA2NE)P=N9HP:)&E/ZBIM3
M?QS<G?<C\.NV,[8#;;<WPR]?B7OV@_S56>*H?>/="M=#6[Q\8FR/5>US9\5D
MA_><>[/3<%=+YR93G;D&:)_N)E<_1V16]<7"-]37T[VH"[)??TA(R'0N[OS6
M?^SXQ2\J9_+D[#@VR1X["USY=QL:<SEHA(W@!64?O+LW">9;]OJ.P^<#N,\O
M/D<4;G0X46]G4N,QNG,08#YK$B@QKF?GWL(SE>P5#6M^SEG>'%%AM_@EQ"'V
MG$DWVO;RHMZ7$!MYY:\W).Y=/W[":?5RO^P9^3?FO@Z9Z>^K/EW/MW&\6OKL
ML.FM<K<'W=,?&Z[MF,UD3%NJJUUG?%M>LLK9-2FJ/9QQ[-)6(_:A 2=<B.2K
M&UFO:PJWZ_ZG\L0^:E?!B;H;=O5:YX+V/MN1MS_RQ&:)L.;C^>YZQY:12W;>
M=/S/D%_<?_PT;WAMZMM>0?20UOKR,V(@O(D<N?V5"N6_N$N?X8;V%8=_='_^
MU9C-,%#7/:CM>&0N [;]&&RCLP%LPQN]4IA$'L:E<X035SC@J<7[.2',.YAD
M>.=)1ZE>V+G\31<F"SH]"-TP0R?S#69W"W[<+I ?*WBI1C*WNH\3EHEN!^JE
MR-VP^_W?E@TR[GN7"M?ZUV%K(I+0H.GQAY&EZ;DGP23K<^=W!A9LX1[CYMK?
M;,F/./?SG\\ZQR0?3IJNK?(#+W>43HRGK:Q%*V^(_[\M3C<^PZ[#^NZQ.AHZ
MA5LO20ML$ZY_JQWQ&RRV>;D0B=:.XE=PP8>RN@_79'PO1'8HTMHS6:L?I=:8
MWV&/,PW_]U7A;'*ES-FXYNK#?IO;S\I&,F;DG0QRPU8&PF/E3/(F=]?T;SR6
M[V.C;)V<[U?# P^?4MOS3\W/2,,KZ/0+)S9.36=5)V0Y-KY;_%&-,PKVJ2UK
MRU3Z)W_?N8/GP!N=39NG/H>8V>UQWA)W,:/W/Z\Y$DY_^FD3E&/_4K5+=Z?5
MU+DG<FF[*<FQY^S].\TR7PFJXK2X'AGW=?6<C;TG9F=U%5\$7/_GO>)+1*1Q
M_^MCO"S51ZHSEV7.!IPU/Z#;^N?*TVSCEL/TJ#3US@W&MX?>U61^:'TR=^6^
M:GX#63NE(59O1OH&+.ICZH]8CW^9^&:9?HVIB4ES'_IMO[D361D74AZ\Q&L$
MZ; '6 ;JY[I>FA&>!&[+"V8&X<%6QM?C^2R7R']JD.^",^1R6-%5G,?Z1:I&
MWZ14R8W%<:T-K:,(F9Q.%04-AS=]#AXHN^$-^X^=<KBZ4Z[)9NJ:@U3XNY_[
M;KTI^^]/B#=/P>2&U;X/V(W_ROI6+$VRW)FKV^61[UT]<"L]AV2M-_:.K-J8
MW)<YX-%PWB?@'ZG"&-)6S1-/G5X-[?;*\]["L=PO>'[CP6+PR=MA=_9_&!TZ
M?LRON+CDVG4)^/?1I/[Z<U*[;F\Y^M+0A+7OO/1#R>@(["'=$W[N+[(PR1M[
MWM&&+=M[MPBYTA*ZCGZA7A]@ZD_N("D->F@;[_')4%Z9I,^/93O-^VIO._<K
M[W7_]O9MSH/MSM$&Q0<.3DBWCBV?)@8V?[,<O!= OV-B\_F7NMN37'79':.C
MSN.D*)7I-KRL:O: #>FQT;$_CI)#ISPP3C+RTC"%>]>+G]SD-82%/9P\N$'F
MC:ZQ_[&@LX7J%VXW79- [7OS),:G*/119^:/T.C^*\EYK8EY::VOFZ_K;:LY
M[;__U-U#TYV!-QI?Z>7"WS$7G]#^-<3NM[4_=?%8:_XWO? ?[7FG@S2SM$R-
M'0=_W+RF,[$C^OM;K;L=M-VN_0O7_CGF<*]]9-.V;5\>_X:= -]-1\@-3A]?
M2\XLV^A_X+A;D\C[/V.Q4S.\*^F:8M-TRP'?W)>XOR< V#FX4BWKYN4V8K'#
M8#1::#>D^=[J=/-P;5V>9D*_S;]?FEIR(I7^:VDJ,KCE0+ ^)FTP\5].<\49
M0[V\@U:/3GN;F"]/-PJ.GMMB=E%:Z_6?0_S%3RI?Q*XZP)/M1Z K#SR?G/)_
M'M=8LG19MSDE_ORAVMOO6OIC)8],^A]$K]:@A8GDKXBY/V>_]%7/@$;KL('*
M/]VL'/*7!9',W[.1NF)U[VML@M+X6M#$&(\ E;"?EG(= +FA_VB;&UWOM?,C
M4)3(2%Q,W(QI6-9^GWE?@D9J_J4GW:W^>39G^P1M@K 1="1B''%R#"4K&FT=
MZ(5+/R^N"<L*>PR5!8RMP%.)^K>F$R8G;4.ZFPT\7P/+F:862F$[^6<*;;],
M$/(?619\^+5['5:>O__I[$_AON]26KP5%0ZZ06IQ##C *X/BGA%,(#[0UTU2
M:E>J[MW]IAQ?['KK9R0J[N[.X6@WI]#A:.TS2&.'JCDKR]C!VS+NUCJ? YR2
MZ.@PEWM[5?*O>>08OO[E<G8HS\U*VGE^RDJE>O7R).IR[M[R@ZTQ6L\\\AKR
M'I19UCW^UE'D&OK6]'KH.FR?/YS;G$8U%+A!<>70&$=_->MW;1"]8%J9[$X=
MY+X8;-=/Y$KZ;^0'8-0&))_8F<KASH^X5UUM^J"H[.FLZ:!\JZV$Q&9EMMM\
M(T5(=@S5QOB[.N?3964L.MZ->ED9\X+M9KJ;R5K-^\W/]<5$;G?>NHS;?4AT
MAVJU#NMZK;,5BN0NR3(H]5^%ZS"ZPK@(OCULHI).N6']^TXEO9HLYV.O>S9T
M>A/8?G62^JKP@(DB1K76MB[=@_Y>IZ3*_VS-+AH<'4D9]^1@._\>3?.Q/E,=
M"!APO.A;S(AJ>.(\9V6%),?Z_/U:>%_G1&4:XAMIVYS7M!KS8KY#JE<F9]*S
M^>6MHR5?@G.H8[=>91KK<3(NQNQRK-B<HN7N46 F4QN>&YZZY^[3GWPK]Q-/
MR]4QPK)24\^B@$&=BS;[2Y!CACWG O6=U#VBP1,ELLRO5W$3=G5[KU3I>*D[
MCN:MUKW+1QV$I/EV[X$@SO'XK2<'$F8H2F864WOC/&0U(ZHN>PSUT541C9Q7
MK8T/E*G[CIYL& (_J#^Z.;:&@CKXYB(&:I<U*Y>@#I)/0L77$ ),)23%KD@!
MR>S9U$CD5?D[;%N7/B<HF(/5?%^Q#@N>F]X_BC+$N_9Z:6"R+NM'[D/*5N%Q
MF/IZ#5K&XBSN2Y&HZU)[=&![<^B7QH9!T^>/Q;$)_&I+7_5<VJ<WI& I=4UG
M2\7=>Y]W%YSVQOR69+_'BJ1M9RC;\4P/B,2IDYO U_42Y5\T0X$S<FJG(3*'
MEMJ*()->$<TPN$00<W9XV7?R]-"/\B&B9KA5ZP\RNT26;DW*2$NI(?BS<U2[
MN;T>\H)\!4\5/\733N983SK#A>ISL\#27:;<V*/VT*&]BA7LO0V?=S]X.-_
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MF&E7QCNT5*WCRK=>MU*_A<_FM%<'57_U/EWHT7O>,/#*;V)]@,M\U!H5_FM
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MJ#K0G*^S0SP=N:(^T7ZPA)4DL )C$-]$'Z <$GOJ&DZ"X#@DD 85B?)[RJ+
M,)0BP7VDW2 86.!*CO5,V1P;L4 HAM&V"EPY.7::<HC3M,;F]GJFA70M49TB
MDOX*MG'[EN0 ,A>^%/=8U*<1T )$,(K4Z.AMXE14)$"#Z./"AV*-'U D& -+
MTW]_OG5T;!D9+%=0#/BQ7TV=G9LV!BFW!&AQ/#JPL#JM-4B !W,T$;+4VMBJ
M/Y@N&J0WQL#"(!Q;K0NG!%6R21DB5>)[HB*4PJY+)FV+(6>SFM1R!%<Y<E$G
MH"/<Y62*),$A"A GPFWK,/9A@=28&+$X>#@9E#@-Q%#H_@CZ/LNJ,KQQMV@+
MD^!P5?7?#6L10()(YA ?3B!1170H LQ[*^)Z0SX<> YQVXC 9X:5CMW:#N>R
MDD3:^9@D.EI1I /U<[Q2"/IL4KJ.(O"@B%$(SVZLVQ)AW=B<XB9L:!U_V51J
MG/;U-P4RPBTZ/8."&*C]<(TG0P1M8)D=38*O=(B)4QYE"FU_NSJ#RD!:NZTR
M2&E2C%*ICQ50+2"&92LSLJX]!)A64/Y>4/OL^\^I*3V-;V3;Y4QH3"1=_5S@
M#:GSM01*H $=+A=F+=6%_H3A#BQ>!='^P'1Q'*JZJHZQ/"YVI?7"ODRJIOU3
MW[X(E8+\.';;$M$&OBW+\VKXQ*GMG1<S+Y"_+HMGJFN/>#]G4J2HN@);Z#X'
M<3,^-FNG\ XRD6]), #_@P;Y(8)KI;/B^,WJ7(O-:D^X6B:X!H[6L2FWB%*C
MR ,S<GOZ/:'3?ZO[KXGX)U^_0@,OEW[3I,,*XI]*S9VI^MLC2$AN2#1F5W1<
M%0]:K0F[ VG#P>T@H#[^1B11-)'V8I+H+-TR5@ZL9J,,YVD*#=BTYNF#8M+U
MUSSA?8^X!ZKN*3*X%>,:D>4WI71V> EA>K$X#V )5!1X_B"%@1FGL?MZ_+&]
M)*5V([Z8,Z%RT)5=R2!+X)7Z?%>[!Y\(#,'E9)'JO&+X].Y70/MH:TS..BQ]
M)2>P$D0]LBU,)5A4?M\V'Z __'O*JI>HU#&R) 9A"2V,IB :BX4WTA;KJ@E;
M1BU(Z=CZY11:""Y+1U+X< _X[4Y@11A+GA#+)>D(#D$IP"I=M'$(Z?RT<:ID
ME<[2F*-:0;%/PXHL"[F:IX .864V\E!5:![U$4CK&H#VA"Q) &7=Z%?P'CXK
MG2:%#&7)$N6($Q08.K0_*Q+=*]K8.";2%DV@-:+1&?$#N2(IW["UZ[2@,CRS
MZSI5O9FYA%3D3&(AQSV)V/^2Z"_LGTR>G88EKLZLPR CS*(;-W;TR2#UX%R3
MK^4=,?HX\-XL] ZHOCL #1CT+&L($)"+-G6/P [R A48T\KB2VX1S? VG1\9
MJ]3=H%2/:4)O463NO:\+D3:AS,GY[7RI3O1$]4SLTGYDL$(W7'E^K;06X"WT
MC(HL@.:L=@E0EAV;0[!2RS8/!N%),?Z8+K@RP7AF6;6'O0Y3#]T:0Y*&LD/?
M/\*G#FD.+';8?8NT.9$Z]E-VABS87LVEI+;; ,N=<,45^#BK#Z4L+*6%K,.R
M2)NIVZ%"#B*7= DQL;VGCZH/6G7;VO-( "Y#X,^W)GA"U8\%.I#M3 M1=;Z5
MEP,&L6DW+A-"%#*7&B>7Y2!=+""55MLP/O:##!G,+K[G'R5^.$DXW03U<Q$R
ME3<%]@H]V@?8?VL!2!).0#U@7S=-*K)=G?T><QPLF4T5&1$2ZQNA1PIIA,1G
MK+ Q7X/NK(P8N+3@GY? [S!VA_O\++WU4[9$S2!ZIH+TTB"#H,)%I!.UH8\Q
M UL@.&=/#I!T8L2<EH95>4ZAHU57EJ*PP#0%:&8W%95N%HU C>"6B%*UL88E
MIVZX[&*[__/0H;DQA9KQ3X>ID?'H[H')(-YYZ'T=9-6-51 9^H7K_ -^68>I
M- @ENB8&4@5!XM56<Z@3R%.Z;XN5."U=L(^KH!#JRTI"7IT);8]BF[IZ 4Y9
MB]%H%=>'"TT!>LR&K&6%^S$'::@8!+1'C?X=?0$]CF:[9X&RW?6$4.$=,6>S
M,FAP@JU^939Q'\%4K$,RDYRT#)2M+SZIJ[4R5Z0T7PJ'7LX8SQ'AA)CAG+1<
MI)5J;6PYU.^8@S-7V 8%G1DUY[^K#1%)5_'MZCHC8^E864$,@)L96!JB- A9
M2\; +\Y1C=6^Y>Q2.6#D6RU0"A_/]P9FZ0KI+'6D'X>4Q5)9T62-OYWU''S>
M[JI=>*.AC:P4-KVYN1$(*"S'VTWS (DERE_V<A&[OF7Y[Q-[VEEJXDL#.7)H
MSD5:$+R'E4I1)>Z9+Q!MA6RX.5YL&KTN0X,AQFCG])XQ<X64TAT@-:T&3\1D
MK$V75$(*8MY]_E6,@72+".^<WA-0EGA#V A3B1KA&@5D#CFWH!D^#I='2H$D
M>NM 4KLL:,5!) MT@2C.O=K>L9LH!-3#H,* D R"+AN;4KJSL:F4HY"NP6NN
MA,Z,3A\R:Y0[,S1J=)',I:3# 5=R.EQ.$"R^XW78*\L6=MQOK(RH#RZS#@OB
MUTD*CD(K_).B@=$UM^;.]UA&45\/-G,;GLP["VZ^3P(W)SHN<##9>Z!\\7 9
MUHG)J%W##KFTAQ"W)[Y#? ,71A)MV&2!4@0=+B."$\<H<@(;#B:UR5>JC_0)
MQR,)\ZC:/M_CU3*C2S2[?2E= TGH'2*->8VFRO((W[YLBP2,9+A&'[W?S;-G
M31W$9:W4(HXU#9N(\[!'Q[ZIJ1N)@U'\4X0-@^;8W+6*:O" 0V8/SQ=PS^<.
MD&-YO%;&H^ 9A2WA- 4]J*P"NL69Q3 O/QXS0;1OP"$REB9[%&K[]6\K;A%]
MFKLT'0E*B&2TQ?J+ $\":=DBQ!X**?B) #U&\*G^A#?@(-()2D"?$U1S?AV6
M$OE4$"P6?Y9T.%42VA?)/3;;W/:1Q:&D$W:',"]'-H8=M3Y-MWI%#(/$_N0E
M_R(4Q79:,@#\9G!TTGC="6!UZ2I?5: JO$\UQB=QAN%*EU;J4N';B,JB]TSB
M!_&=$[7#J$I#,9H8.-Z)053.=Q^)%EKUQA<F_66NU(D%CU*LRMQJTN'F0>B1
M.'M40(,U^ %>2@. RR1JX/\VIHP+ DJ(IGX$>VB 'P"9]746$K4@?6"9AX?*
M*WP%BM N4*J+)(<.Q6R!QOZ*EMF"_9!H9P1)OM'M@.](HYLN=I3@P#[8\-Z:
M+O&[FD<1-E!UB&^I*&$A09)+EA4X@G*L)6<PQ \ZR>YPZB1N DDYM>V(A,<$
M*_'&-&HL(;*ZXS>W7.?5K\.Z$;@R^TK?HQ-5Y%-M(&(<DTHPYM1B7("!\2R1
M3#$?24AH \0\@:EV!L8X8K-PB! /23W&AR\?AE*>0@J>4!K@Q<'0<3*],Y$V
M7/^QF]&D%"N64KO3#'F# =T"BL!Q"L'3Y07EJ)+(H*?O*P:,URA+)_D'!:Z@
MZ!%?&]\\L^<1\,L-E%J\#_*8G,BZ%**A/]0TUCV]%_!?%3-N%G:CQ7M)Y!%V
ML7]4P-"*T-@.JA#M E:61N_7^(AQEZ)36)->&V/4*$N2%/,KA;+-O&Z\C1<'
M&8HL 9.BY:XZR/ XK4FGMM8IL*:B\!G>&C<IP<$NJ2-2&_X5O47L! G3JN (
M+:VRK>4H4W_L_/"%A )FB(\>;-746"3CS]^^0)6&4D!-1VA<M7*&E8K=UD!+
M#M@]>DD@ =HYC*!,(U!ZH^V[ H$V]DH&X#&/547MMLH@V%:'KJ+D(/\0KL(V
M;W]?2O,G/P>3_>@X,1YY;&$ARL ;OW^U&ZW\L'2VCZ3>B!MG.0*\1C964YR:
MXTE]IK)=Q%U05C7!%"3?%)QFUVKVLA0$V) 9G&Q$@+$U+K<!*R^LM$OM]Z@O
MX#"]!\N'409,]$PI6ET@R[?\>Q0?2N324KS0#0:+L?S3A(O"BG89I$\EOEBD
M7$?? &8QX T7_I8X( 1,1#Z@&@-?/[.VDD)++IO:]/FB<FKG==2AC"<^$2=#
MB3L'GU"9RRT=&-Y&875,3D* L.JY ,='38K&Q&N9#Q3RGKZ"KH9(D0MYN&:@
MKQL]SNP54U;N/2!OM4_J&";#:X)7#_1PI#(%?E4"+$DB;A"_B,<Y)K$7\ =Z
M/OJ>A27.BE/UG+"0J!9*-!]%8D"[J1# BM&/&&_V 'YDL#%:4#TCOJYO"=,E
MT@%%)4!A%W4S4)?:2-Z!%].;%5$6=,_B!+\ 4%F<+0\'#=J'?_PPK?D=&1Z)
M_K*<20'.H,=)QX#F)-1. A+TI]%)F_V)8T28\#;*U%];BH-(16( 3X;(%HKA
MX#3>XT@SKLL;T+F-RW#OWC!VSF9TZFC1QHB?"U1]LN.=R)@V]89QE!E4#\"Y
M3HL9EEG\,,%5J(5O#6&YIUC R8%T+!R)NMQN ^8M\]R!Y612*'K<N(M6+U\K
MSDUJ]"5$CP8EAZA88N4,D4Q9:;0P.<_NOJX"T?Z6C]%P)2C"95"0&%,11IA=
MC +L.7U+85QL-K;A^B,N/#FVZ._W,UB4O&AX#4='IZW!LVM%"H33 +H+\8G6
M1=LL\ P$[,^,+>X<%<26AZ(0"31)7T' B$G#E 1'*AVIR>E(<')ULW0S^[!-
MX3/V)K8!W0V?P/3XTK)1V_!-W( 70%_6"CF-:MHX3#C 84G@!SI1^X$OK4<G
M^FZB=@E0(#6#3=' 6_6>[*WRQCI70(7VS.>7HQ,Q;J.FDM/D*I^ @1G4WT1Y
ME]BK8PS.)J/@^ 3N634=78@,;E]F&_1$_(9((&K@;W^-= WS-5%)-=Z5+47O
M_SM0)'3'+"FQ(GP;E'4:P&;&E*BY)C@_:1D^?W-KXV?!'F'I"D5"X"M\38CA
M^(<X=WQ<AT4@,J8W@=-IY=_AD:]&&FHE[(7%*'7!IM=#*]7C'#_/.FPX"M8V
MVL#O5VVY96JYX.*7FOM3^A'Y%[,3_4)AJ>0QWHNW05@B< 8E>'ZM0LK?T[.L
M!H4>A#:$[EW3R0'E$=DL=:H600T@Y:*T\?O[ X#:;V2%FU05_*0[4)A3^P4D
MEK-K20P-4H[@2%"4:4Y?4K2MX^RQ5M@J-I,&G*:-5W:7[H8B9W I&C\)9T$L
M63QJ7 KZ5;2BTV-H'=93"FL%K3*IN^;@LBA]<@II1PQ\TV?!/U Y9R#I%98U
M'V  X&X)/)^QI 97BHT72I!S\24C9"9%CA19-Q[+8?4ZBW> #?0$Z<#U$WL&
M^Z/7@=C<WSA9:)BP;:2PBZ12*]+ZV^71M%* @NJL>C [!M9A6]9A9%-Q4*70
MO734AR?\$H_LMEQ%.7U[GB(6+5#XLJ$N60QAS&+M.DP6S@LDC9-X^X7/1)($
M/!!"-_R-@8NE0QPADH"RF<+>=.HN"-M)-  >Q&\E;@#4Z*_-;3)^E^ X9U(X
MI&U.H,0I9EE'OCWP@&@PYML_30M!?^KCY4#[^)[A),4+8&P7-HVTX>((.K0V
MA,Y20&U9H*G#NUA:[0Y@&N-Z?/--Y.D:T0!EVT50JGM@O(]CE32R8NO)"<DF
MRN)+ET3[H+8SPXUR?HZ#OX4!/_HQL#5=;HA 68UW1/A X,I9ATD(L%"76JK%
M.BR5NGE($ AZ1"(Z*4J$$#8I60<.7HB-7;-L!H/$\1K I0OT@>>X[>.^G\_B
M0]Q!1OW#>5]AM>]4V.B0]_3X -H&5!+)!/$5!1;#,26ZO23U'Y%FT6+COE5D
MB"_B'H4"05RO]=_FX+<H2N;KL"7,9H$?)+:0V,[6IGS@%_M;XZ7FS<N]J'W4
MC[_]M?S<+29ST(MCCO 2$9+(0#=^93SZ^\T\@%M<XB+&6]$I%.!$AQH]?C:[
M$9?K&TOW$>T2*(.\1CX*2N"%@@Y]:>:D+7.K$U*]RQ(1I8J 58K%@-SW:?TQ
M@AKBIN!([/,G=_ ]]@FF^O&T#<1.JBV N;D.NX3>BH58G<VKV :U10.^A:B?
M"&]MKA^[D'14O!;KL!LD9:K"_/0NT/BS=Y_%;&I,I!]'LJ"J?&)";RTY_C3U
M,<[D44?!CB\P7MV$C4AF%]^$.(  ->U ##W"S;Y/1Q[RIBFO1"H= 59S"9YL
M\A;\WD3$F0[ K KTXQC<$AL,[":")L"B^SLY%;!Z_CX9]0^Q;QYN^//AY;GF
MHDL8:Z$2'RTX0>$V=Z)OLC01YN9 S3I,2Z0L,(.JXM@I-!&3W,TKW?>7[OED
M^3=/$POZ^([:>Q//<%W]CX_[R-)3;=(:F_<GEJ"-S#&?)'C]D/$,.1<K0Y44
M. @+&P=DB</P^H$N="I)%>D )CE#=^(X"BFT'6(GW(^2%]YM/\(AITV8Y92'
M:SCUUJ65&@*X&X)]M:&B#>#SVADC H(3]'S*?WI! YT>,K1$\T1?9*44-7>)
MA6]&H4L;Z\E<R8D59RZQ>TDF;:I;*3&][.4\THA+*Y7XB#S D>7KMV=JTIF-
MTM'.EZ-G6YM3OQ\QB3 YZ?;:4*HAXW03QE"QL,C-=U;7=*,]O\3:TC9@>N;6
M7!^H_<C+Q/?QJ9]@H]EY1*/W%Z?GX0DE2Y1G#9NEK72#[TCW'#O6*\DY=^&$
M[V:GUUO.FPR4A97]%R$E=2A_2>^-^INW/X>B?:_Z2"LVY :;[8Q+]F'%/:V\
M'QCW9JM<\H[T9OG7LIKG;VBH[KIW./63(WBT9@=EL=H1NX3WRV$XOM[4[3Q]
M>+/5D<R?E.Q@&ELU;;^9EV]]1(W9U)QM+3>,<.?6N7JOG,[)--WKOWYY5?^Y
MZ?5ATK(W>RJ=;K_'%'42EX ;4Q_^LN>,Q-Z9BPY![^,,&.\-&!-U*34U[=+L
M8MR.B'_PN<J4X\,$YTBV9E"0:<G4)YI&^33EF9.NMU3J6^-=EX)ON[Q7?OG$
M 4XP*=OJH/[^*<-"Z6[I&U_?#OYS<A1%3?I4CU>RFOE7MZ>U%K&Y17.#/PB?
MV2ZW4;R#ES_?COJL0[%_?_C)K=CM/33W,F;NH;G300!I:>?NJ768C&M/]M8K
MK63(7V/'+H/\MV?SV<<WG]%K,0B_<0CQ\R-2D^]L=$Y,BTC+_RJX=\#JHUN)
M[ZY]D6!O<Y]Q'%Q-O<96*UI3>,XFS0K0/W&BPW]HBX(0 50HDL2LP_+,@@SM
M+H20B=,KOYI[:>-),WV,$EQ/J1Z4-H.0@YJ]@(J'$P6%"AGFU8E8^[86RZ6(
MKPM%1]O.#Y_[Z;TE^*)?L7I9ZOQX^Z?3F(_&,P,3AU\< 9QZ;A1F2 D"2I1V
MOE>\Y]R7_.$K+&BG=E_ZZ&'I;:[B?3?A-J8[$Y+F\B<"@=:,5M8S9VR31^K?
M.-*E9SGXL?G^3XW<0#N9\(//3WMLK[20,FRQ"W]OM<C*]W(?RHPX55=RO$[%
M\YZK/,OD[N,_9>J.+KR[!NI1=BYK+J:VJQCLK)]('$'%TY$QBHX(A"\= HB3
MQ_^>S,&FH;<N(K6M.I?32J5?D)V@NHKO$XR75Q]K&_OFGV)ZN8_^?H\^V?QJ
M*-"R?M*APB_ ]W.;O^;!&=&1):KB ## 42&G$4W$@4XJ>45;R3L"K8*/#0"^
M/6)CE'PF#Q6ZT)JR,",UW =OY.AYCA,I95.Z?86-4_]#U7F%-=%%>S\(2F\B
MO43I'440A) @*$4$% 24%@61)AT$(28JO4900*DJ3:3W%@@= 0'I4D."2I>,
M2!@EA)/WN_B><R[F*IF]]ZR]RN__S,J.9!'F8^Y_1U6\M37)7M&*F<,\34-?
M7C?#UOJ\DJ+)DXEU]0/)Y6UFVLEHK[]EE+BC%U3O0]NY]4:DZ#'$+9\IK'+V
M:I9HNY*-9;*]'C[I4<;2A+>/SG#?A3 +]@7S<[F56;^Z'C0WY?[ZWGS;[,W]
MK([#GE'$<+,68\)034#%F_L!&2%U;&_B;49D!@UNGRV>$4F1J+UNX;=4(*<T
MG'[='/&6)'%ZM Y;>OM]2N]DU7/_9/F9[^DB\;,V7J.%[U9E;#^86J!R:DV5
MU)[@5S*O'F71H*#7YIK])$Z)I")%;*_5""^)HYJ6$IS!LM[&UJ+2IM;(KG"9
MBO2&Z?8&[*]Y%==;3=YM?^6"ZYO.7:EZ.DD3<*9J3E ?W"<GSV)A*B3DJ9(8
M9665G=U?#>WLEO7UDZ0)F&[IQGQ"1?>F4,ZR5Y"!!,L7N],&P_(/D!O9O1BR
M(3;>MK4XOA)UCJQ%,?28[R\)E8OMD*$^^0JS*Y2V&O0-;M/3V3,@<R9]+8E=
MUHT47'A4TCIE;Y)!<_-V"UV?I;%J'?K6<,H^)R>=E]X#+#9:1H.:PZ3Y<EX&
MJJN;;"&+?DBH^,\@XPN2*5,7?',U+7(YK/N()48YWE;E%59GEN[8_2SBW_&<
M3O^PQB(C@$T;!1D17_RG_8/SI-C'G'.]&M:MB^[>?BVEW=RE;"YJG>/VI*O"
M3:A^TAXCC)8'-4M1%T"#^?RX^B#B5EG9VY!$4062MW%+\_0NYTAQMA][=SGI
MJJS">.-.C# 24B:PAXG&G]B'\O8@L"C/#PO+FR)'N*I"!^3&9&[&^**;IFB
MM+<(G]#OG64-?Y_4VSX,IC0<6@'3Q8WP&TM GR?7@2_4GO%0]<:K)#.07-QQ
MK7T_BS"ZK#*XYK0G5'[.PL#%\H YHR$9#Y4;??Q%KV?=2=R@-)1ZQC8D9;+K
M*VTD3VQB9T?%I9H/[/C]:Y.%2^5=O!2]:,#FKXB)&I0'J':)5-YI^;WU)^Q(
M,O#1F&CF],!JH,=$ETU%XONHBKB!B<[[-7QIE!#"I;OQN>%3GB5LM_QQ;@KF
M6K)HO[=A=@.7'SN]G1P"A'^J"6>M*MJ5)KY/OR^37!29JR/8.>&GUVU=P)8N
MK^9M95-T^5H_Y]TAPJ!F9;HW<0%?YW7)T\]58+=^C.69L;=O7++R[\XRF2ZV
M9_U8C5O=]B&\@FZ=(&$ #\"GU=32^K:)GO8$\V?]/ YWF=V:K!8N)69"S& E
MND4/UYOYCYZAZ-GS!2-=N-R"RWQSV'A\#.%%/#S2Z:J4;I^Y.K__W9K0\6;P
MN[TP'9B8>O?L61,7E8-J<W_ .OG]E\6?'$-.#6&Z3%5M/3#$>[01BST=?1B!
M;ZO_C"04]C*1*'&J\QM*@/#\Q3N1?>U7 S2^T6F8=',L@QDGBW5Z&+'LY[2\
M2P!ORJOK=Q\*?YRPRM7NF[AEY6OV=MX,SDNN2PI<?C0FG/ZP^HMBUWBR#N&V
M593"[9SW]D7:/]\D!&^21"T^)=MGE @-F%M^M[,#/5ZUXU)-%9U?AYYP/)OQ
M0U]^_,96@_0WKFT>48^YAI3Y#8T=CHL;\VY?6)I8A?0?F#>_73)S-#D%"3I=
M&Z]_/[=B0//HAAG]@6KIQC!6NQ$Z"[]\]+;DYO.IDB2JM9]DMZ#V,215<^4N
MR^'$*;&DMC69IXRFQY#(!\<0/S,EC>:.UJ,\IO$%!DJB6MS\@I/0,R9>O8$7
M"0]>6'[N"C0HJYZW7*L#N'OF0\I(\NYWM$>KY'0H88.?<G 5C7F"=B/BXI,(
M?<?+ \V?_'M<:K<-H@7^*EH$N_H&SRH[7N"<5[+(B- HQUR BX/&)"<#WB#7
MHB<S>T]>^N2Q)T8\CN^ZPC<<<N;1^/9E=X9(W=/<!GHZLY0 X&JI6*,.-J;<
MZ9) ?5O>YH.D'Z%2H@Z/%UVO_$Y*2M.ZESQ]='X.T]6(;^RU$JK45(L*[&<W
MJ,%TKP#,KZ7OH,;/Q<.D(QE8YW*V T/E'2]L:G"#6L:4R7%5VPU-3+3@W4L[
M_+AC"']#9N,S1S'CN/SNBI]:)Y&/ UGD*^'W/H55=5<GWD$=0UA%KQ@@MK7?
MPIW*<SZ6RB[]JK?=FVIU9,@;*JGO=?LVV*([929L=#[[^F"S8L;XHX6?XTYU
M?S]$4GR!\Z'-]2*&U\??U-R;=+@:+\7\^H.9R$6-I'>YVX4\1MON\!'R%@4]
M(0(4@-'W2:)E4J<+H7.AY^U[UL[W-"S6^+8%WV2(NY82Z*#HCREH0X)GFW;P
MKD+>063KDP_2H_)/[\N%\ ZYZ(:"-XM-SU9.?+Q]K^;5]PIZF#/)'[49W;8D
MF_WPO,D-WA7)>N&29'($D^L\N_* LY!&ELR9S;7N>Y02_,-"^"=;0M9,L =)
M?FK2?81#;W=S;IJ;JT:Q4'%Z"+#YP41Z;U^A0TYR.B*@V[/J=HJ'#8')GF51
M<G[/+J?3.H*[_ =YS_E'I>:]XCV;-,/.#'.##9%0CP]_SUV)<X%NDKA;L--0
M!BH[AKQ[?:IA=CKD&H!,_"YHWU@F\?[CO)>ZY]_3=[XMU3H1W[+K#5XSF9!2
M[_Y8)L3XA[D'2C:H6O =OC.YK^>UL-+X_K[7\&-E%9KTYO59OF*))3GUL/-]
MWPM(IC9F\9>B?MS)^L>*7WF%;,R)8%S'L,Q^2775)YQQ[PI=]&^C2D3'01K[
MAGES/_E[_[S@Z-.3WD+:&[(Y*K NLZH/X)?1:G6</O_[L;GSH R9HK>HQ?XP
M6.JDF7*I@<;D;:+9-^LD:UOO#'Z?BE=XN\K* ^H<()>XKW?1I'5J'\H7EGYV
M\H.:4")R1B T]1@2*EY1<^A.P#VMOL0 =[AX^D36[]T8*/GUIOH6_,),0SYO
MV596-M)^P8RD%^@AW9Q4V_#'WQ%Y/D&[CA*AWW9;L6Z@QB#A2 \(I?*N439G
M-3DO2;F3K3A/?-4;F:[//ZTIK.;K#!.>1X"%+L^=[LLJZ2],"Q>F&11 0K_2
M Y^^]8_:(L)<&L;AO-<X;DG[&\!EEEA6XQ@:U/.X[G>OIB\*??]U>? '5I \
M4;RR!Q//K?*R]H55;LYT5QXMYS8*_JO(&BVRKQO>'+*.K<N$O?M+;,BB[&CZ
M*,]6&>[Y1@R_-FYNG=%,?LGJGN:=&W1;4D,X[:[88/B5VTZ]?+F?6(1N1?Z-
M/+R*N@7DE9(V-$4K_/H?BUSUM[Q/;!-U"KK#>PQQOZL3[\O_:)]#K^_[1/P/
M%X:_J_%A<0Q'_. DC85P&!969=PTKG(,(9IY/IZU,S_"2Z*N3DN856A:&8JG
M1V*Z1?KE,OSJLN.+A]ZL!O-6WU-*G,3_=]Y>P_6E#>]/ZP3F7\%M9NNJ#YL0
MO WL TD]&H$JB[<LB:)N^-8XN>PS@K,7%D2?Q?*>O4Q@[:<J19?NN*7TD,1\
MTR];924F)H8'W1>QS+Z:?D"P5MLWO%"<U>.&L7F=A=LPBG+[X.E\_4-&)LW]
M7_[0J1I Q+OX?DAYV#@!3929C8-=\S);^TY?-Y]\CEL<K(RW'E*2]6^2XG@4
M=0SQ02Y(KH^0W8EK?6U0]NZO*@>]?F+@0!^: ?1\@%67&G8CF:/_">&,UJ%?
M(BPYYKT.G.UK/.+IN.T*/74,64E;9@#U/LHERAZ]1/$"KB18D,P2/K%#D6I!
M1C?=+US^$&.6S-S5N,P4V?/82'C*U$?FJ+'L":O/2(14)?(/7T_'"7"Z8-/.
M_@?=0Q [3VU_*6D+L%=APX/ 4.,7W3-*)BK4"\0W5"F?#V'A$U<$\X-\[KO$
MJPP+FRXRP.:JDMX(60?7*A<G?/I W,\)5AC%PC]I*A!=8VUDTWQH_\K/C7?;
M>?ZY#]/MGRD=RR)]*-U3^*0='EKJHS<XFVXLVIY=(JS12J'Y'4,>8D!)P4@5
MG*EK$<H2,.ZUG-<Q\2F0T)AY#\Q4$,?F0DVF_RS=-"P'S0M;VJ=A$0![+UDQ
MJ2@FGS@B^:67(S/5\3JL:CV3;I?M-2+V10=++8A9,<%IKG"S>OYNVZ )@I9$
M<;FN5I4H]:7A4)7JMM00)V_;-&)A:/MTB-E&"'OV6[EFNQ?&CN%ZZ?G]2Y<4
MZG?4*$^_EM_S3JRXMA*["H^I4>DO") ^.#W !EKRLE8RI=5[BODS/Y1G%.#W
ML5XE;Y&EC.12,,0@CX)BS.8M!!&)_;EH^F8M)!<U(&R%JPKK,LC5.;,3<EBN
M*<-V)LTR8S/[XX3CM)R;'V[X-X>JD]DWXOF: G;I?=_"\@7<IOFHE<]@FX+\
M\DS"8EL)>.-:Z1O2Q(J.PJ2J=+Y]V[2O:H/[-.<7DZS ;X[7I$05?$*7%C<1
MCZY>+'Q<]M#TXNS,8\73_2."OXHJ6JO&[^OK!'RU&["+/[SB=$6:DZQV_?<"
MDS&T?T3V1)^_@; K.:MC8%Y 'VUK<(7I-/<WG7O-(KYY:BHS$]MWYMG+;')]
M;>=7KD#S?9L44RNZ>U37>[=$E-]??7[F_*T5VX\EPYZ7TO]XS8Q[M[6/>;/&
M!HL=+=O(B"H1;B\\Y0U/D"_GFF@_<TM?0/Y# N2_2X';\(^>#NU,_4WF3F33
M[HX>X$JY#C*N[,8C3G4(;$ %8=85Z ED76A7]B[G5H?4).J"NP_Q&)*$%Z>*
MDYONM+\XM)H.CK-H@#G+8@W)WZM"9%*P)$[7&X!@G(HJ]6*!M^UO%![@H[%;
MDA'$6"S5C[A[!A3?1G&2K0<ZA$&S0X.PS;55NTYSW5XH%UQF2V"9%W-F@R8$
M:I:A]*O!&L"UB\#FA_,L\LSG1070'8I3]%:0*TF++/!V]3-.LURSBD!/*=S;
M"^_1T_G,N"OD" < DT"3L(1BX2+4Z^3,%"J/A@+*=(40AV&AG:5#S4$/GN_N
MG; 28X Y)N2-!EXTS,RH;>J/"N;:E$:%G[G9B.HO?K,"#>0Y1WH0*E#YY/K$
MD:23L?W'$ D/'42O99S$&7 0&.C.DNL9>T;V0O+!+W@(2/ T FJ)?S#Q!W@.
M-9H\57Z\0WD)E+HZ!5<(DR+.)M0_9;S]!'>%.5JPJP8LZ)6[!?DSQH!>_N]G
M9MS0>>Y80BV6/H$0;60^MG^,GS;6B*@GQ*K!V,L\ L&U3IKJ+%H"+.M71ZDW
M *+4:XDK%JD >X_.;J0J7#59W>S.;OU?E*%6+)',:+PJ]Q=+D:.S=CKU+K#V
M N-F?6B&8@'ZXPO0$\<0'IHL]0S9>.>"^Q/R_$*7A"+81^3F0=W#?0T6-R3&
M/">958F%J77350VFNR)PH;-#>THCHQ[@:BIVN%:V@99H B2>EWKA+<,$*4S-
MH"? M;S;F=\ W6$D(N9( ZON"1@/;^XY[Y[,9?9Q&+<?(-7?H31#?4IZRDF-
M* 9M%T@- UWF#B3N>$V"N!.*/[-OH#MH:_[UO-OP8IBX"SG0-\R.P@0^(5I&
M(6O]NK80HN#RVK6CU Y=0V"WJ[5BC,)-J4J &7(@!22=^/I.B,OJ(K8-X"I;
M3,FR"Y8=HYE%I&U,T=$[QE&X+GII61=D/_3&1CK+@W9%F!XUT)6B")8>WJ7:
M@BO+LI/G9G'<A51E(":Z&,RWEQ#6R=[,:HI!Z;XCF(G3DHO#T'N]6?U599Y-
M]LH5)1OV]6J35)ZC#DVUN'R^#E[4);#E4)WJ<)0-I620[>+A9]%?6G=[.4.)
M _$5'=(;$CQ?@ZL$P=CN/.7)#FA826\XMAN3\-B9=<:'ZB[X F8M1LG,XLHG
M:5? S-7B8)KE'K;M SL,A]R@%"42'*"'6*+S6: J\4^$:0<3ROXH$ZU&O53;
M0.XO6D&F(.O6^CV#RXXA B!CGV?Y>F:>%'EZ,7PTO@2YD:="YL(3JWBN^,ZG
MI <$A;BBK;C45MRW(7AVFAQ*%<P$="FOP(7#ZXOHT0XV -J#GWME"%;XD!?,
M:L K1#S_^C^[&,T=OULX,&0%P^R%.=,ANPGG&%=&":OU(N,$=2H+N&,K-7_4
M53=,HRQ)XG96D"(@B/)]-M@O(9^?)DJ5.$KOT*9-Z+AO#S]=08(>50(HQ2D8
M@V?(RHA?/UID$O:T)$R+>! )LR&I*/7B17!//E#U9C6XQ<"2;@G>%Z/>/H*]
M:(F)/SYFC@#Z8YYPXAA<[K_^#93>BI[AJF7B'\0<@;26C'$CS.63F!"L"(^Q
M>0>#*2J#)Y$0ZZPT[HO3#0!.[>J##N5A,9,DOUXU%I3HJ[Y+-U%.@%'DA^YY
M_N5<4@22PQ.MEMD=OFH?'MN'^2:PUH\Y@U9!707O'MZD8HZR_XS-(V@\:T>%
M]#2'WNJ<*0/D;I'58O[0B=U30IZ,34*9$L5#^_$G42&?0&:3<1PKJ4H(I3%3
MGVML2_X92=S*/C..L_LP'Y;C[_Q?.[A+F"')J!1 7FL$#X&2+F2=VH[<ZF>X
M$GJ<4%L28_R,^WF'//AK$\%U#.E^> ^@5:WL6))VG^-D )?5[M;;QQ!!ZCFB
MFL@&Q5F].;^WSMX11".%PM[NG^>&@>G'D)/7&\#04&"U]R)Z$%K/'$]CI(U"
MZZ^M;0\"0:M:,2&$J-E9"H$7=>TI>=68O'/00XB>19^O!=92J')/2-@$-"MY
MM.730E_A(NBU9^<=6;QE[_NVDN!!H2+I@QM7@\;O4$]?K69N-P!UG5!!C/M3
M=XI+QRR-+<S5$?0!S'J7M<E:.SZ I.4+_"F<$_D8@B1GQLWVZ.POTK1K@%.1
M) SKIMV\<\F'31HT5Z5RWPEJ-:&9./:>>HUNT;]@ ,F2CE_U^=VZ>+&PGYQ2
ME#=')7\(\YE](CCH-^@\30RPS5Y%1DEH87LDQ#R#8QLDA+(.5Y:CW=4W;0]:
MW]9-[>LU=0>XJS2-0,FWCB'?3NRN7DH%>DB9/1%5\3H#O01L*()L@8]VEOR*
M$JY87Q9M(X?V$.:R*5]C290J0*XK_'NU@Y>(7^(?;J[_WB;#S[;B6O#X&'D4
MM"!9S;BE34L@/(Y9]-#D/\T.5Z%> NT.]<.,ME:J$HXA;ICY.B(^LH,!=9,L
M&[LZ8DW$]^TR@WLK UB\IQHC50@03$!I5H6QWYF!7;[41#RLXG$.0PY(G)F>
MM)B&*7T*B^V>[T]5;2OPRGI<>[2;B%^I@S+ S@&O^M"GVLF#KXCN/83Y$\.4
M>\!!WR!:%<4S"3,LH#K@@.5X<NO/I]P4U!0J@KG_/Q_1),_VYO-\"U/KZ[@\
MCE.<#7^Z7]Q6N2$A.(OC?^?5(=^X",C12YH!^-X=B+@%'M)K@R>X"AB2=F/0
M/%35:K"%Q"E*](OV0TN@SM'SNY\Q2/P ,G?"V<&G*U@.4'4(*1"VUO,/70)
M^T4Z$C$D;GY3OR)CL5:GV%@-)_AL,8)LEA\K@!<+P2>@N<&F5>PI*@+('%!
M>$)%J9)?<>+DARM;>($JE+$[Z1AR.E=MU:*$_/,8LAH;#1<'M_K^!<.E 4+/
M$N- QHQ]?\$3$J>NY52])3N8Z4#>66%^$69&8_M!(G!0U6=Q5PX-J0P3,#Y
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M(6_^@U*JCU*W\5YF5<_FMQ&"'7(H/J!JFP@\/%RU[+$4H2IC6'/M"?VOJ.K
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M7HA12$@L17%TX@Y#&K?U_KKQH\?_:+?W^+C\>\.CQXA=6[<_%M=/(O-7RL6
M75 ]-2['/2?P8OV!."T7PX;NIY1YLY\?Y8+G . ^S4D!]0XB+9;7>UXOC((X
M\OIHG6!I%['UE%JY$UH\^\UQRZ%=Q]>:I7<E9$UX-^D!UM>#MV;E'@U#M#NQ
MLJ+P?67U);RD07>X<QT""QV#ETB[5MVP3<BW>:J)UO]94=S1I*#A%K [4+4Z
MX,7$])(JMB^\T[F*K;)2/)1GI O_6$SID6>WWF";]N6N$A&_O[X+XPO4.=AN
M[>';'"F9:FV)DG7+JJH&Q&>I#G0.1J?5)2!/6_P8<@)3K,#D&XHJ>9ZWN+>_
M"O0A7.4W280*_!>+HH:#<+1NR-.$AV+AJ[-2U(OFW_0L-VC\Q2H+0C"MDK_"
MQQ Y /Z%AG]?]@^WXZT$GT>72^EI-%3-8KZ.\0"?J6/:_[A_S*1_6#\C%K(J
M/,HMIU=C-[.4$@XL"%''8.' )"SIP0D)$]VZ%+;?E[?RN,6>S\YDO9>I18:W
M<7N[N_O@11>^#&5)2K[>Z_5](E6;AKE^# FNFE/"SEE3W"3RZ]:ZL$=V$J)5
MY+[F*!:YS0"FPJ>/+^GITOAI:_FU[M2LINVQ8\C#([+[,<1F+&9K;U0G,K+3
M21/C4V5>\ 'M9(%3?MVR;V?NI!K[5>/6-30JY'\= O[?A9H$(BF?CS+@D+",
MV2Z",$T/I0D&D-I&U%4><G.!V;T9&?9=$Y4R&>P1?Y49TDC+\S_O/'3P5#U]
M+N"'R=?=VP\E!LF').@+N!)X\0H82R;T_K-,HO*2$HT[R ?Q?Y32<1.:B=J_
MW.O22$,_].]^,"OSCA-^)I0FZ/RA_8:%<>[*;ZJJ3^)@W2-9FY2 %&:-/K>W
M,5#5_J%;I=H#K-BJ%P61?9<-TN_VW0<T<]Y?+RP8$;*XM>?_=]0R<8 4B%/U
M22?5P4Z_KGGK*WJADW210S+I/2O,EBU&M5*)HT"Q?E4.R6V68:/0[UB;XZJ:
M:,7D\&13W4<F8>M5TX^8:YY/('GW]T[IKHG]K$K17T?G(MC^EE%*CJKP#RV_
MM1$IV<!%2CG81T2\P'"C#$D1EB<\G>6!I$Q@HS4VH<%<Z<[T]A]MKES7CQ9^
MJL$5['?:];^6&W#"B7G7SAD&X6OM=H8/96@+'2* 91S&32V%Q@JN?:#"IH+'
MN,%)6_*#K#+[=9V. E<52KYG^'SCVV+3G\YS"Y9!?'UBJ6>21\E&2L-Z4EL)
M"JQLK"YGN I?0G8&82$D'+?]44D'2U@$!4MVWTXO Z=5X BJ/NA*0B;E\9'/
MC:.N*'EAN%!2Y0[K\+, GS?9,S#LX:!RB,,;'W07IMS!*_1D4D9CT-7R%4:"
M1Z$TQ/0LA%4Z!\(LG18&X2I^H=]O(GR6XZ6ZI?[%J;R>TG<GR[> 'YH5RP&4
MB"A35FT)\[%_NM^#_SJ;?%][_F-M!G=]EO(.%']R:.&57S/2E+SZBI(TWL%Q
MA_8U/+-G;!O)H]QX#&'95Q,<7-%%"!Q#NO7_68'.MS/[;L$S@C^&E&HV+_A,
MM0;>K5V$AN9)M[ZX8X:J+4R]J+!N\N 1;_Y;49B_H2H7RSO6]4^-@;C&K[A>
M5I,Y6;:5$>$+@]6EBD.C29]OYY0*R56H_/A1G.^MMW\TW9"<7NZC.;+T'7"P
M7^B.5%,^X%._QN%UV3UU^G:@R3MVYF<6^IVPO,C%0[:?E0_2O'O$DM=8=D6$
MQEEX^_PBBJNM_0U\0E3+C5B[ C*_LZU_OR+M&ZL=_$ ;1GP=&3FI#1-9'7_
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M>09+,,&F[LMOQ2H)$;-&P3ZV"03;0*"VA?P,#&PEVG/DV_"!)\7$^L@22G(
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M.[XY37D2WUWE 6X,93RF'5UCP42O!LL=ZO&0OX"2M@33>&U:79_;?<B4Q4A
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MP31"%PS6)>;)],"_[6?^(VZ=P*RUGDU"5.&:>$8AZ-7FVP:(6S&@K9 1UW"
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M1AT=[+\7(:2VT-1"##*^!FSJ"<<A707J 0@5D.:2M:C5#V$%1FK-'(9F-<,
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M>E*A&78U7"O%VI?-?"\CT? 87V#@HW@%+SG28V9]^#-Z'J:_PZ7$8]'EAC2
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M&)M23O:CS&0O?O6Q?H<N7)T:GS-MH]1$-?F;'5$8QB!@7!C5XI'&T"4%X91
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M\I7%RTF/%WC L248UZ2)5S$+:>&.@($"&:998<Y)Y\-6+F+2,2IR&,CA4^]
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M !Z'QGIP#3'@,_YLHJ1 5?844BDE+ ?94@MPA F )SE"2H*B GZ@M0A["HP
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MGO\$FW;LU%6)T7>D*="C:8BU19K535"+BH2AP-B%S>Y^# ?#9X2ILPIK^-5
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MN .:*(TN)A$1B4$0[=>M6*0:B!$PU)O'%%SPQ6QZ1_$4[*%KJMC"H4#H3N[
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M0V=Y>X83_:'4Q%<[N+8 831U(5**((D8^R'-%IRG"@R'-"WT5W_YI'5+M;0
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MSUT]*F/2N\&#<(N2\I>@2'M6262JABX3CGU63JBZJ-/[-HLUGYY;/Z6%0WO
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M#Z@)ON)L<DUI21]!M5Z)Z?1-EFE40G7;N!P_K=V<M]SK,<2'PYS6L7N=>?>
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M\$).4?B%LBUWKN0/T2#_^0I:?C^WTNZ_$50H#PSSX;0V:,L0-==)TNS,VX:
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MN.N[T*500$<M_&(@I@29W+= #0+U'V=0*V;9-4-@L.5!R4SL%+!U1!-ZJMR
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MG&#FWFEP,.!'M0[5M?@@5BW?MX9BU](6,2G?_C Y9>_LUTD8Q/L-1C;=-)S
M;N25$\F5K62Z"/!NV>M:PT%&# Q #VE2N;CS0:"T<8)I9I81VM<O\E9%F2._
M.-[^O/K,\[1M MZJ*=;7MJ7I96NW@>L3859A/,+?U0H"GN$0S#'_\B-\A]!9
M#K:!S^>5.T%]EL$98'';Q7KO6]*:W<Y4%N[G"BSIFJG*M-;+=L5YW0P$B^:.
M"^00IPRXX;*<?P;1"@R4NDFZF-IFX=EG[?L:&[ EY&:$U"AVNIE;K6Z)KBEQ
MHB#^G#!/$2W#W59 <DPI2E#@1ZBK_5J!USLP"4'8/X[5&Q@=[R(P[D5>7[+L
MI&^0,4*/K?V2!F,MKVU3X<^?VH0],EH9FF":ES:91D C?1EAW2Q65)ETT]G?
M-'Z,+?7K=X7,<&SB(_-G=WPU#K\=182U>7+<BJ1C,-IT^)]5?>M3G"&0+XO@
MK_F1H"\95C\8R30KA L"-6,^O(K>E!%RWYC6UFEU/5UE=''+1A>PP)L^N:!H
M>U6&.%*.GC1JFCE?D3>-5VMJB/8+9]9J:OZSHT(SI&>JXDT;>'(P;M:)_+-1
M)>RH__<<R/VCQJVT(6[O."W_C16ESNYO?C9I,W?E$F@P%?PB-R?$(M6)V]:?
MJ^^WU!_+;'UY;/2$"'2/@@M=JKU7I<BC]>J<31>"OZL# <<UU;S0.Q-!V*>
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M?F1LF['?&[.*\WO/V?4FAN&AUPQW9FM[F"1K8[4DAN;B=0X5PS*?M!! (/R
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M4M4$A;:HB?<Q /S9S\V *-6^&/Q!N+J]$6IW$^H2"<#7/[:>(/"UFT44/D*
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M(07W$+.H;T8$$YP11\P^1WFG?!/P%I,20V/@K1+.*.ZAO5CM[%$5;B$8BE
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M>]78(=QY9/[PJQ9_M 7-[)I\46D:4LVJ+;S6DDFK$06T<IDPEX_E9AF'ED!
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M9,@'(.",U[[\1/'FB_"OP7J_BOQ%/):Z)I47G74T,32NJE@N0J\GEATKNQ6
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M9@K)1;SRSFAU,97X:XB>0L1; P\A)?Q*4]Z(*83''?6?)-.W"&-?K<UTUD=
MM[=)?:M 8?[:6K\?<=K?J.CGBOE$0L^Y;[197_7;_H617L?#@9$2S#;^Z/"3
M?+QO)U LK-3-8AL];J -WO=-4R;6Y>"T':<@X5%O%TTWVS=?-+^:%B'Z-]:/
MF[<A86NO$:3E?]K()JZ46D0+UPXINE1]*%4^5CI.&:WT[ )3S.592]#9&@/D
M?"JC_:F.;N=APO#QOJ3O/0\T$Y?1AE.WFX4Z<8QI\O18M+ICT_$BGUN=)$X=
M^I)J$Y645G]DY93%ADA0/O1)B$_ZO^:>04825:?J-0;WU7OG??;I:U8BQNJJ
MQOCY "<A5-0FN@$)=DK62/: 62^ZX@;AIUUM5")X(=#5ET>Z4U?:7M#(R$A9
M*E+"H(" ,9\DRY5%H0Y:_UCS4<DC/=@>L#;\S",0\OG'5(LJ/,;$K*.-QH]!
M!1XREKYE'1XAEZEN:<:1[G2W1=;&*+R\3$9VV;XH"#S+[(Y%0YAMQH:WB(#;
M-VG@M^,^Y1R325QU@V[O8N88&NP"/ZOO!OO^UNGGO^276><B'R^$?B@9LBG&
MD58PWS;!NG9#E)N?L9F$R8<!$5Z;JDINKC-?)J]^V_/!9&$$-<O#.%]_@0RZ
MJSQ</V*@48<XMI'>ATF\-O;$ZA71GA.@(9J-#4V0J6]LF,V-QS%)LHQKZ0DE
M8J.TD^3+SWO1(4Q>.<%OTD]=XB@0A9EOJO+)1RCS1>S"W_[D3+RKH[C-=(%^
MS<;YRW(-)*E+V?MKPS(2GX9^!EELQQXS")E6>K";C\-Q*CRL9QW;;3R"(J9]
M,YJIBR2#<19\6@=CD&\Q^L:1B__"XH6.4^@X/##>D=M,=E)9)Y]Q^@^_*I-C
M3@0;JC1%BHO:OW,>S=:0^1G6,*6?\IB142-],S31?1#[@)K*FUB,P$SL87J]
MMA:I60]WC]PT80).SOP!OLTMZK2+*V]M_!8T6O>LGQ'0.D@M,C]9IV?_BE3O
MA8YNSO'\C?Y6[\:AN8V(CF[4-M)RT^!4@A"T1CXM.<59,&'/-VPF'.05 UYB
M7/'&CN?QQIX?N'4X!FVIJBC,;9_1AM2I*A\C.>O@)TGS@MP?/LWFZHYU*0P&
M-Q!&W$GV/O6>P"[OO?H)RA]3QU9M[]C /.BY5LL9B\M1=_/4>'W1 F.BKTL6
M5Q78)SI=^.;P53C*Z[34)GJFQ,(IL9N^RX^)7.Y51RN50F<.'&,BJR\X\^]>
M>]Z>;_>H=Q985QDC<C>O,W-5M[CJF9NFW41]W)1F-CT4&UZXBT6LNV+OYSNM
ML=VGN:T_0[XZJVC>\E%EZ.0>]LJ^21$_*8L_7/KAGA#*O4)I32BD^^'FTP 3
MMD?&U;6/KQO\=A1,NL#?^G> <3KLVNL1$![TBX3_'=5%>F>HTSERE15K/#J#
MI&7ZBU$TKUYS#=ON>O?;)!-P8B'(L0'=^V4<E3E:"..9(2N45-KY/2*R4Q*#
MTU_<S%>[!GX:TB)LF0?<.L5:73M,(<F)/W0RZFP]V8K8U-%4(*C7EP<,;^@Y
MG75?"Y^!KTO/>('PY$ Q[BT.IIXD799L$.EMT+(QPHMC@FOQ=?0/9.'S8EV=
MG9-QY5L%6<0F?+O[EF.U+=CJFEJ@3VX1E*_?2Z1&HT7[L^0K*^?FL,1Z2V%C
MQ;H6(J3PL/;0$8M#[7I;'7KGW&EE;1&/Y9O%H\Q['F",[>PIA/8RS-!63T9[
M:ZYP"(+?;M%.?K2TW]O(YT<K4U=_EA12$*D*@BE1S?W5'<K9FIQX"TM^[CO%
MTKG0' @;YSH.WA[T97,KP<.T4?%Y!&!PII>.;QB-?B&MF<VJCWC/PB"+*4WY
MBN[3.;XO=-5,?_!LO'MH[@\'?SC%N09-!F'/(Z"GPRN''NXR%&HY*+0Y<\FW
MCC S)5T:&2S.*4B7*.3Z]46[ETK"ZF?>J_B-GC\R02@=C!::UU"T0=2!!TS_
M,?_7TP]42$?X_+>Z:,%.?,\_#ULJ6.*X!\:=EMAS-B2D*)YZ:&P!>$(  EVQ
M%QOKT<FFE!,M+RH](9T/I!-UU"0FS)XY8V>5]B=41C_I,L;H2L"I)\TDC'"G
M0]/6+:ZH);30*\HCC'*H47,J68K/CYH:'B\-=A9>86&JYW' "F<T_E_%_I.F
M!).?(0W1\D.[&.963G8,J4,$>1F.V!U$R_2N;VH6^FR%]]D.?QM7FP 3Q;CN
M:)'RT$G.LD? )@%\/(1IJH6@&&&]8B/R,PZIX^;8&./UH+%;4K7^2_ =QV&
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M"D:7L3RINZ'8'J:3I1-OT]*5K*;F-/0\<1_R3L^ ,NC_*ZE[$$Q KT_X;)
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M4"YQP13S'Y# R:@ZWS?/,>6)9V7##/BX0$/OC;V:[<2ES]453G-E?@TVG3?
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M"#P]R:$ A27+^?,(*D<Z_:&&JM*D@8U/E=,F*>ZGF]"S(BA<'%<2T^$GU8Z
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M<M9I[OQ8@?@Z[C8G#K6F AZZ"K6O#J&U[)Z:10M?M,^\4:7L%D$RJ7KL6MP
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MQ1>LP]:2J2K')VGV5-DP%@=@JW,Q^!?Q4=ZA(,C7 7#)&47:J%^D9G?'MC2
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M=5HF>.D=_RKIJ.6]JMD/P($_%IF@2]5<5ZHG]^$U!QNRUG'@;Z[2I^I/I&\
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M=-IOGV&^-_*KCF[J!&K//FT)3#>C9Z4<YVX=7J/3:;L:F1U=WDS8\DYPF__
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M?WK1-%:EM?,*VMJ8*[V=/$49^=_9MTWGFCCTOP>G]P#\VZY0Z39P7[SS^CW
M1X/M9J"]8S*8$EHNM:X!7(WUOP<HJ78C<++AF%K>F]T;G+>D,:0,A9K\[/H-
M;QD:.W]R=^F_ SGYH(N#19*H],A3OK0TGN?@?&OD;DSX ZHG5>X:/>R^*,)<
M-.VR\.ZS3T)+=#%[CX*?VEK'OW 1M_P[I1ZTK<":)D7FEQ8/3I(U[T=.60X-
MAHIQ"?2K1 ",OIEM)@;51K2XI7;N%TY^TPC[?HXX%V2L-;OP$'Q R24QF*DL
M\*@GPH],_&/ZVZ[=+2?U&WI9BVJ:Y0(R?*8PAZGZ8!4K=-G07UQW:(E;3ZC&
MF>.^?-T;R7:#4Q4'4;:B_ 3W#TJ)3^7_-LBHZ3#(9 @Z23FKW/Q]<.8D??8W
M2.75M5?"/8#K; "#H&7;&A\1D\OSUL7!SRO*P173BBZ[!^22G^2?]S]#"JS-
M3Z([7!AS;TO%@4H0F\R51L^+*TI X'' R?'YS;15Q2+^6&>]373*^.K-Y AP
MV!&&L_ZD/Y>YP\!5U,'JT>W:7?+4;#!CJR4.+G,6)EM&,2[ZC67AK60_7$73
MQ?OQ<EP_Y@N&<GT5?3'>87DN"'CW0I'63)GWO6&QJ8&/J,0]@'Q@36V&T3$1
M_WF8I*3  )I][=A-"BZ55Y6#'[H0XI>[&/1CI47_N^4/L7X'=2GGMK4MYPI[
MJI@4?CF">?DV@&3832]3'URA\:Q["ST<8T^Y.<SV.S,T3>VOF_S1DN@1'H!E
MY'><5>722U%,^PRGF6#..6>:5;:?[ !#J!PTD9-/RC"Z--_]+:X;(2A$]I_/
M[M[[ 6;E[V':6Y@7Z<Q!(S*/]<G<WGB.*MX#N--QW3IVK_\^:)'2"@(6<,2D
MR:*A2E'0S66KTZ@[^__(AB]FI([C3<XA? [*GHP[88E_J2_#R^*)9O?:H=/]
MFP%]P_Q6Z;69.- A J PYUCU5IERDZU,+(-:CKD1_2_FSA('_5;HM<WA$2'P
M)91$';?D=*3[MEN(P7(@CC8N6O0 H0@"\N/KJ&?VNZ?Q6WJQ_GCXYI(VATS
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M/R?0HTWIU,C)BT%AZ.I&5W)]\O(>8,]52%+TQR_:MSQ-V7.?+,ATJ,D47\X
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M*:W;T[9EYI\X&'7L:V'5:$IF5U:TW):^3U,FV7]C6_\Y1W:APT$_?( 5( :
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M4?Y?E''7/I?A+P5X-\2:EI*0Z?H=ZLUY%;ZV5N+G[)"?LV]UT^0?>^<.6R>
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M(Q/[/=@,JM6Y--DDC60*"V.?ZUI+;GJV#[5:A;R\C'R_RK.55]!^S,6WTZ3
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MQ_SV_>?7VXJ'6KVLFAJ-*][&=XP^$(T?P7_;>GZ[9ZDR6$E_<6JJ\<GD)<M
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MK;EX(R0>"*S['X+W.HV<&H6_B716T:ZDBM[34\S".YFDF> 1!/+W*1)&P)8
M $-G%7_B)XF^(^C>)+Y_$#:IH$[WEP@A\I(DCE$J2R1J\:A7D1Q%N;)?*KN/
M:N<OOB!XDUB1'N-8F=XY(I52-(XHU:)V>-E1%"J59W;@#)8DYJ8.LTFFK!+V
M:T:9T]C^SKXON;>QXMHKJZ$;-9R.X:"-]Y60MC:_$;$JA+#CCFEC^ ]_:7=N
M;_4[(VUP^RVCA=TGN@;5[@%59/W>U4.X2 $=.I!KGF^)GBCR[2-=>N0MI*)H
M6PF\."Q&7V[F4;WPC$J-QXQ4-Q\0O$-Q=1SRZU.98W,D918T6-C$82555"K^
M[)3  &">,\T?[0]VB6Z71,Z&7X,WUG'<S/K6D?9=.0OJUPIEVZ:! LXWC9E\
MHPQY>[Y@155_AQ<VNN:AI]QJ^F06]AI*ZW/J6Z1H/LK*C!E 7<6PZ_+C.>*I
M^'?BAJNC:U)>W5S=:A#<,6N85E6,RMY)A#DE&4E8SM 964CJIK2NOC-J]QXN
MUS7[>".&[U'2QI,6_;+Y$2JBJQ#+MD.V/D%=IW'   %*U<=Z=KEM_@WJD%Q'
M;W&K:3;W%U#<76G1-)(3J-O#!YSRQ$+@ KP ^"6!&.*N2?!EX\6P\3Z6^JC4
M9-/DMUCF,4?EVGVJ5S+MP=B9! '4<$UR\?Q.\8QB\V^(KH&[:5ICMC)/F1B.
M0*2F8PR *53:" !C@547QUXCMS=-'K-SNO)VN9VVH2\IC,3/DKE28V9#MQD'
MGM2Y*W=!S4^B.LM?@IKNH:>U_97MA=:?)$LMA=H9 E\I@\_@E?W7R8_UFWYB
M%J-O@[J,;ZAOUK3)#ITD$=U#:F1Y$:14<K]S PLB_,V$+97=D5S=GXV\2Z?I
M2V,&LSQV9@6U6 JC!(E0HJH64E,*S+N4@D'!)J:U\>>)K3[>8M:N(VU AKEP
ML9>4A57.XKE?E10=I&0H!S1:KW07I]CL/^%'WDVK:E9Z9J]GJUNMZVGVUT':
M)$G6\CMV28,F<@2HV4X^;() Q6=8_!VYUBQ>_L=;TN\TUK9YX;J$RGSF1V21
M!'LWC:R'+%=H!4YP:H>&?B9KWAW6;:^%_-=PQWYU&:TD8*D\QD25F8@9!+QH
MW'=121_%#Q7'=M<KK<L<S1>3F.&%55,L<(H0*AR[G<H#'<>>:AJLGHT.]*VJ
M.7CAB:,'?P>1S4B^3",#)X[58U;49M8U2ZOYUC2:XD,C+"@1%S_"JCH , #T
M%5,5MZF.G0>T^_CH/2F^8G<YHW>U+D4[= N)YB'O3D\MV +[!W8CI2<?2F-,
M%S@9-5'<3NU8UVL;&2QGF@D>0QCDG@9^E.\&Z&GB[QEH&@B?[+_:M_!8FXV;
MO*\R14W[<C.,YQ[5B_;)%MWA#;8Y&W,!W_\ K4NG:G=:+J5IJ-A<26=]9S)<
M6]Q%]^*1"&5QGN" ?PKMQ=2G64?9147;6VUSBPE.I1<E5FY*^E^QZ5I?[/\
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MQAI?],DM$9KE8SLQ\A4H-V-S @=,USX^*7BZ.&_A&OW12^:1KG<L;,_F*JR
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M(_.E,@'?C'%0,DW'&,T9_"HO,7KN%'F+W8&E8+DA/IS33D\5'YJ8^\*%DW8
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M(;=))-I7BK;1I#E$4*!SQUHHJ&W=(L@P-V, =:@< EN.]%%6B1NT>E.7&X#
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M9:['X5O,Y;[ABXT/:*'Z*R\B2'<*'S;8:2OO@@]^?=^SLVPQ4"'O]KWB":P
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M?YV=_3XKC5\79AD ZDPQ$IYQ"P.<&NW$R[ UF1 <!2;OVQ2%>]H20(,)NKD
M/EV/1XW24T)=M(7])5DS'L-WFF*_Z[75UZ0[SKX8A_S(OWM#!TJ)PQR$J*)D
M $GFX$4@E['8Q04=)M3")ZPZ96:C\Y ]I"V.;$,;8ZE-@E&;5E?TT6GAZ*=!
MWX"3K^HJ?EZ,G:JMOI*,:A&.8?(I4DZWF."^/7*^]6B)"SK^N44YV_QIWUKC
M[_!)FHT"RVGHU*\&OZ 2\S.]0<BK"7UG7_$BY=7KWJ?K64F'Q>?;.?'4GJ-
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MC!#RS[J+0RIU#0M-IV@0+28LWOC4%V0J=MY;#MKY=S5>6E,N:X^I6K?'6<=
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MQE8BAI*-J=F?M2.+T@7J*=!Q4H\1/)&MOF/#R^+7F(BE'AJ/U4$9M<9P&NQ
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M/WZ'^84\]-:!(L"6__=>A6?JZ"%EX;]9&)_D.4["#&F5TPK"I(5EKT!5"&:
ME\INX%\D_;KGOT+M1[@@JKOU+)Y5N<G![T9LS,1H-[L/"1C[7@\WY((RFH,
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M;&F?&!]\0LV1\KCI-1PDVWLCYNJ6^=J@<$E31"U7O/4C5@4#A%%FUI+.3B1
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MWXEJYOO\:7I/^(7&4-\;OQ2D$GM<7 X$/NF9(9_G/K]R3>)=9-:!Q>YSH(N
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M:=(JX0G\>V05LB2+M7BG8QJJK?+;#G SSC(-((H"2<46P.H!;#7PL5K'Z#\
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ME_1@,N!0:>3A6$G31%XOW^W*U?5WJ,?V30'>/L&Y%[B"Q3F8G;?H'AN^!QK
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M9X]6HIOV(.-;?JX-(1 >2YWG4<JDK/'7U&O0V[0(B*>3*'TS^9&(D8.P]%1
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M3\-X^)"1ZD)>&'W$L#YA_8.:SL6)^OQ0RO TEB*O<\1&$@QLU+F1:,90*-F
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MUUF+,65)T)):GT(N843&_4(0TL#SE2M(+T7J#T[/J[<UA#<UKTJ1,C4QH25
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M!MBO%CDMRQ4I+UV1Y&WUD/[!-Q*3("=7(()Y+@"%*[G2BSO>KN&:KV$*],Z
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M7!QJFT:9=0VCP7N@X]C;06^_]>L408C"L0N42A7V3&/3AP(6:V3^1JN&=U
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MA6/?#@POX!<>5\=5M/_JPP''- B#NQ#"1F8UD3DW:3_7_UP(.,8[2UA,KL#
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M(S%AKQJ;K#69\[0*MQW4_+\XWUGH0A>)<Q'WRW?]H)%JZ>=)0A TLMVK:Z6
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M'4)1F=Z%.Z#CWKC$A?'"POM[>)VFH@C[3S$>(8:O.FXG]*A4D/.EU8">;^@
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M*X3D*PV02@?A:+.\C&<WX_/%<9L3"4D5FIGZ@_G+/ZDKP:1T6NDZ#;V+/J@
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M1Y\_8-WM5 *TNNUJB"?>)$50LIV VLXN"_N1BT T=:=<<Z6Q$84BU+1Q&R%
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M@IYJ1 !E%H!Z$.Q5IM2P1[,2*-7IEY21W3E3!MY^F1])#ZG-P^9#0S$S:>@
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M8W/@2\S+<=ZP;T/M@W,Y01V/OCEYMD_/(ARO&(G,"T?\3LV)HK#+@!D.=P4
M[QSK_<"^YCI-DT2+K47CS$H7_(1[_WG);+2G/Q^8![-FH"%X[NI),[OZK#L-
MM:$,(NV#G4GUKLC' M>I,T&FU?'M6ADQF64%EG.A!P0L/A HZT8[H;KV/NLP
M1PIL58G""W NXBY4#,'L?3Z#(EV49ACH!; :G1A&VJ:3'M5[QO92K:GU$R"Z
MH[XI(ZK023*($6W56HYM(NW=[+3>[+XQ35X1ST=#3Q'Z&A5VM5Q39P=M$T=:
M-3:TO5IW N;J3D141WN8?ZT#[#/3B-]P"%Y:F(_'Z:F%=5=@R35OV6HL-Q.*
M%I]/$\H&4"L7@3F$ @+8#F[F&G73.082Z-I6AL#\/^1*-817"UEDHTM<)71*
M?!@9RM8L0/K3:6?&K=L)6#N3P3),2=N2$@:GK]3V^>I"VYR.B.9083(0*RQ7
MKV;!K<$>4ROO)UYYD9!M6JVH6$Y-U+)PBA^*UK+^=*>7_]- H6;1X#,^G(S9
MC*BTO$WR.2"JL*-:UJ'9+LXX1!F+-?_A9IYWO_1ZDO*98LL$KZ+KQ5:\<@4C
M76[4#_9B/0X\C@>3E1R1 DT(V-YVVA&/#0\1\"_>9=PC1 Q.V7/WB!A3(K!O
M&"UIH6+95JR[C%4*O7H^E"WE2+1.^]H3M9.WFD.?G8K[Y;9M6<.[A#^$G_X,
MY]>Y 99]@_+E <YM]OQMF6I?A]@7'6<BRW@7D^#<; ,6LH7&M^$1+JD&A(8H
MC[3;=D8H(<@AF_K#),((*4PIM_+=BLR0])"4RWC_QN2M+<6O?4K3UISCBUK.
M']A2,TJVZY2QX29Z@+@)(!J,=WGF_)9U"INEUS0<M]Y:LP\1*/59UL 9IE;>
MD<PI6+IJFYOO'Z;[%]5:]GX?4N&[0F8A.0)-<&O0HPCW'.QGB?C3@K>39FXW
MLV)#V&JLUYW&5-PU.O]QUS$U)G/" 8)0:2U[EH_M73'1\\P))RJK21%DDPS!
M-=YK;]VQ.91S<_:I'$[-@_)?/P:^+%MBBS3\+(0-/WT::'7ZBGU2\:G(I_BI
M5%1Z1;5<[_@01?]4^5_G2&L8+30=++O8??U#^<:-OT\K=ZZ6%#C.!+4]+3;;
M,B^O(D9W7[OQ\RI6BW3%,?-XPBNAI<ZE#4^+:SCUV'W(-"%0 +"*);OM0T)W
M/"AMK%.T*M^@3973+K:5V!E$%2I";/N]#^KH EF8K229+)+A7X@U1AYV<X#W
M$>F#'I?(")S=<IRM+K>KNIZV/J.3&<DH"R*+L5VGX8)LV;Y5SEF0YP"=19FZ
M9;C; SH7)B>PK<B03-$,58QEES%PK#,(0QJ/%<T2@O\J(7UO=,;D([^4;96D
MMHE^<+68FF)#]L*JB5860/0\!3^Z_(@E'5)(E U3O=HLY"':7H*SKFML&B8V
M&@B)=C'0D;T2DX_M>U[Z=&9L&I!G>@[WW9-BPCSR.3\EI4;>@<$^ -J$!6^+
M#;7-:CW[C"4;CKLA6343&R)6%B; :_7-+X#80^3M::!WK0F?75GUWM,YQ^[V
MCI2@O3Q^J M&I7P=:E&$<\W?^%RYZ%@%)3[3K!#V-.+]U\0FZ;CYM7\)=_,,
M/SE<[/QJ3C"-YA[-Y$MPM:+0Q6(?7_<0<C*29)UWBC-K@_5HE%1,_]D^KZ8H
MV,Z2N63CH',V_9CAIPCSQ6<:SLH6KN9YJ#/Z5SJ&$W$Z4N)O<>V>!PMU%7QV
M;.(-&KBQE?PVIM"9CBZ[]8TC6*GEVR:^#PD>(W3XPT-&AK<=M(R&6-$T"D:+
M_XR=W;CMI*N7A"T%(?9YT')UC';#?!_ROC3PYTW1,8OFC#R<%>M%5O&4G71F
M'9V?RW5G+D4G$AJJ P6#VJ9D2*>7N_"%KLU<R0Q42*,FPXA7_L<^I.U(F^>R
MI=^+CP6Z.?:/H5Y9+=!R$OF,,N=F+_\*(_ R6TWKLABA304T@DG6D]^[P[3/
M3QWK@]HU(=YB2-%&QF%=TUVWFFRO;!Y_8$7IAI&=8@:4G=NA_.3I#!H?3HG.
MO-6>JK)"HR.Y<.>'O<GG0'\CC!%EJQPKMLNHC<3!)3.(S5GY2TA_3#9VN7TG
M-GA58O.*+#!<[.V-WOV4.3;0PY!8? 93C,]F8I%1$QEGBS86G,N-E@7SPKU^
M)[Y4,JR^:%@[:,%UI<_'982HM9%CQF^HL>(V.W5-.LP<2WG'9/X&-J^=5S<U
MW6F4IUNHFZI>\RXTRW#CEY 'W,F5Q+L?KF[F(85-K:%R8/#_$H0$VN_*@RI;
M(<,<2=>Q[7"</\N*$?J/-RJTWBK*L<\QBX+G8C]CR?>V.ZB$/F8=^S@QYOQ/
MX/E),-/^DI'+_*#:Y%T*Q9)/605CM .-.EC%+UE'8>*,+ GL$]".00L7;X'S
MP[19\N/60&^P:M>D2L>.:/@*[&*1*Q[XH.?)$$<\LZU!P#O%A'L(#+V!'"#S
M7ZEA,[-AIIW^5]IB/3X(_VP?(J('K-UK #Q:ZI0?[D.$9T'4M(>8#?8Q6@ >
M ;,J0K!0ID!LD-IX0\I:#DL_C)2A;S&DAKC9P2R=X7\KU*>G6*3A$GCJ '!@
MS_LW4<*V"ZBJ>\W0 55>6?J+8H8US)$>KHKB7Y09>1!Y#Z"@#1B6%<!4L4Q6
MCLOIQ5J1$2W?, )U R-S1>4RB4I,.DN(!7H.-(VF!UZ)MHCJ1I,+7PA=H2:)
MB\9\,Y)OR9VW-8FQ>]_ZK+SGRUR2?,TSVYQ$PT^/Y0D^UWM%%K\'(",U#+V;
M<^(/D&;\3R/"KZ+]R1]VQ[EF+5/S@KNONSW!QN/RJJE1KQ)>_U#-$?-F83OA
M9ZD'@RV \SFR1"J4J^G0<PZ@K,50\VG7S./Q%(?S5.EAU3,L_A912=EAY689
M,&F]$SDM%#*P=<;Y<UEHM7FRV24CGJ/#:R$;>;D'0[#$'>)_YP,7Q?9.PSNZ
M9;9UXV=T:LL6 @5) "&">@=$ UX,+;;*H,[E9;$\6C@,?LK6/8_Q]RGP.U4O
M772L-(LXMBS^I+'OY<61LJ;Q3G+5]@H_,*,'V,>V>7S8AQR'2=,]3H/Q>GTP
M-5^B*[#H<"[-%B@+@NF5+@SO#->I,9M3^%)$@V'PTAOD,!7C>.*/CW:H:'V3
M9I+ $CJK"KER;H;H@03FZ@#*%I8%#8?=YUP&\_*P&'>8IG)%F1W(Q'@TFLUH
MW]*M&'I6/P2#,YRIBIN1RUUV!HVW?'P=)>O$>+Z*;?@J]K;*:;D33GKB*Q(-
M'0:(BL/!\IF4DY.:18:)5G?5/%5MDV[FUHVUM6:@J:9M=VM3_^#%Z=R97=$:
M2L/FR_7FR\]_I0XV5T0Y#"L7%]^Q2CPEX?3]?6Z=Z)"39731:WJ1"0 -VX<
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MW.0L(@T%W ;SSH[!!DSCDR\U:>2=LT)X665C[ P4_GRM/IYUW;9;G1AOH-"
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M#YI9Q? &0@]G#E/!YT_I^KXMMKV?+,>;Q<L9A?+@])UF>,)5R\1=1,E\C7K
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M=;?[T9N6Z$9TPM86D97*BIU_;I-K412, VN#'++C7LT@FE(ZDR7/-1MUWU3
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M$O(S&+:+#AF1M@+#V!2JTEOBIBU8RUJCD(>>K_[YP-D^F!&"DC5[-4.NAL3
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M<-[(/;QN@KP!*@Y^ .QB1(E1R:I\X([UCI%VD[P2)C3EWPL$6^;#6G-SDOB
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MY5?S!D^!B'[&.8K_ZVXUA?^;$WN?!E*";9LF/U.P53(3%ATI"G<@[UQ>9NT
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M%274&\G&WHO4BL&.HQI_\ TEU2>/SA$)KD(\%Y2@(\P%H)V5$6E9SI<=Q8X
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M">-/\#1%/N5IC"*RP (U)E"CJ@EN2([3L$-F3$[5I;WC:\T)17IV;A'DM_0
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M@IA9#N(Z/:*M"S4K'L[BYTD!,Y@7'<[:+$MO7]"#=ITU,1U-)C+Q:4ZD<>D
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MA\XW?3HW8.,K]W.:1H\HYM\8<?BV3]JF^6@4&=7G=:A]UZ>V005J7%3Q-3;
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M-_Y&@QF!LT4!,YF2"<[M4+HNQS%3\_;\^K?#(4C2R%-/;YCS:>(,S=19I[,
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M1W^S908A60?JZ>$M>X\;?3*Z00<V^";FJCT[WF0!CF=#@E:3+>9&BAH=H/A
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M'T!2$B4B 9 " 5"E^3#ML@$P,Y\$D$@D,O_ZGZ_S:/",2!+B^&]O3G[Z^<T
MQ3X.PGCZMS>_/KP=/IQ?7[\9)*D7!UZ$8_2W-S%^\Y__^W_^CP']WU__[>W;
MP56(HN"7P07VWU['$_R7P:TW1[\,OJ$8$2_%Y"^#W[PH8[_!5V&$R. <SQ<1
M2A']0_'A7P8??SK]\#1X^U9AW-]0'&#RZ_WU>MQ9FBZ27]Z]>WEY^2G&S]X+
M)G\D/_EXKC;@0^JE6;(>[>?7G\O_%=W_&H7Q'[^P_WOR$C2@\HJ37UZ3\&]O
MV'?+S[Z\_PF3Z;O3GW\^>?=_O]\\^#,T]]Z&,9.;C]ZL>K%1>/U.OG[]^B[_
MZZIIK>7K$XE6WWC_;D7.>F3ZUR!==Z@V_OBN^&.U:2@8ND)T$OZ2Y)S<8-]+
M<PV14C0 6[!_O5TU>\M^]?;D].W[DY]>D^#-"J=<V 1'Z!Y-!NR_%.CU5V/T
MFJ8D7#!LW[$_OCO'5'<II7FW&4$3JIXI6=#13S_\_*48^]^W&J7+!=7A)&0J
M^&;PKN5WS[R(R>AAAE":R+[/;=P!'7<>07$Z0VGH>U$CHK@]]5#(9A>:T]&3
MT62T8"L"U2.IR,2]NJ2LD1 ;#*&?YH<4^W_,<!301?3RGUF8+B_0)/3#M G5
MTD$,TMU:],U&U,_1N9?,KB+\TDBM:YTTK0A9$L8H22Y0XM,_,(4<QL$W3#?T
M<TPG/(FE*X/R")HDF<WG'EE2&,-I'%+<O#@=^C[.XI1^\@Y'%$DD%VVC4?10
M?A$F/F;C9RA07]O$O?10=D?0P@L#BMN(JC\YSPB;",,D4=BN5/KJH?(&44M
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MVBO)5VD6.9A-"OXJ3'PO*NB[HK\#W,A@\YX P*?;%4=.0=U_(X\H0[!NW"L
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M#H\8N$G,67JB6WS KKQ0G.1O$^]1P1LJ%X^"_7ODXVF!CR1)?-=?=E=[3 H
MU#AKR14NPN<P0'&0; =XP(H"=' >7Q'=("QMG50M]ECV:Y9 >>O@O+\?6&58
M=['3QAV(L.8$"E(#3R_$ZN/V$N.&[($@6RO2(M+=R_DBPDN$SE!,84CO(D\0
M]-EP('?1WH,?,"BAPJMSCTH4DE)\[NB%R3%;Q3%;Q3%;Q3%;Q3%;Q3%;Q3%;
MQ3%;Q3%;Q3%;Q3%;Q3%;Q3%;Q3%;Q3%;14^R59Q[R>PJPB] BLXO;7P';,Q!
M.6A7*3I7:%R@Q*=_R)4F#K[A'-;81R3F,_25,G$1)NQ4EQ%$_[$::% 9:4 G
M\R ?:[ >K+-<H]E\[I'E:/(03N-P$OI>G Y]'V=Y<?4[*N)J3?DM9DY^WF6F
M'"QWX&R&&VS&&VP&[(HA1E!>&9XNCI(,L"<GNPQ4.QM)]7I'T,(+\U4\G2%R
MGA'FTAHF"4H!FD]W:2Z'R)4F'V10CC)8#=,5\3>(16+QR7R_2^:J<7>2Q!2O
M=$E%R3R%B^J98YNT#W4)%EUS$58Z=T4J7:6]>,K<_"*@/^Z2N>G6.;+?, Y>
MPHCOT3WYM$O9IGE7!)5+2'+G+9F/AH),?T/H+*W4J.43^WF7V-50@W*L'/5R
MM,'6<-WASY[D/'JO$,U?ZM"S'H.R2U=TW>(4K23,)ZRV?>5=!NL^G>U2[%RR
MBOT<3NDA-=_MN42>UK<EUGNPZCZH]N^*X-*K>.?19>61>''B^? ^=%K;A\KN
M@[S_8'N SC;.\L:111/%&5\!3FN[SZK78-VM*_I8O&]81+#0Z7^>;]-3%(/F
MR6EM"ZJ,D$_ZG3&Z2^<.O7/?IK>V+VU=@OW[E].3SZM;L [W=)PDN^69MLFL
M[4NLRX#V&92=NE. F!UW1!;=:6UKVNW4X>QAB1>82I'P*<N/9Y$'D5G;E,KN
M@VK_03E =Z;_4X+^F;',1<_P:EK;BS;=!JM^=@\GPD/*:6W+4C^D#/ZT^NG/
MMGG,;Z;X'+[?XQ@V^%,Q<(?\\<]C(GY43V4&B!<=ST0L-#ZD&>&E?D 2\5#;
M/OG') .4[YZ71%37-M':J<D P:OSD(C0VC:ZZF1$H.L#B(C$VF9:/888(+-N
M.(FHK>VIL/FTH=U>QIVSW3CK(:%F_C0_F)PM-TWHV8K]:OCB$7K8E6>UU3"V
M[7@C*0\)Q(1R--+>GW F5DF?,H&13)KP<#[.J2"9?D <W;33S(&8)ET 81&?
MSETEMN=ZPUD<L$/6K3>7QMAT\S4[T51\9#F9TSJ2KDMA5_W7(I>#NVQIFM$H
ML-S0'"X6!/EA\60NG,Y2.,WH^DD(U,=6(MA.Y_SN>Q@A\^ Z86^WX>RV50GD
M/(WR^_N$O?,H1)<DV7RQ\7@\TKES%@D?(.K]SOB#HYJDTRK=4SR0KMG;DB2&
M797'H9^&SZN3<4OU:C;V#Z%2+43BGGV\X:OF2&'WMK][3'9I,B+%\MM,>YH-
M><A*TT(2X/;F@*[(YT < !MX80ITN2*U^?0AZUZ'$@.M9SM1H]6+:9$;N'9?
MN7T];<!M+8\-O6!I^J/DEJT15/[\B_;W+6-%V0O9?/C!>GQ+?NYS'-'IC@L:
MJJ<(*HY;2BSPYVJXBX+'6^]7;"^_&KA1=H+K^Y8SWO N5 Y<?75CY;R#_* >
M FM'[_A>F-?U^%ZXA["Y[%+N^WOAN\A;/B)_%N,(3T.47,>^]-DPV*=OKX>%
MC.A>&3M\M&WI_:#.5]MN%@5C=PBC266_%1L80//#-R^$<G+(L53GW.,S*ZV<
MV'0@.X:'&!>\'TON&2&VX'790.E0!<Q>:S-_V>6K/V/TK!]-B6^U!5TLF2IM
M)QE6Y\JY1??0ZM6;VE1;UKRW5G;P6//>T;/YL>:](GA&-[1BQ4YFX>)7*D-Q
M?!:WK<N%[(5$ZUZYH 1.JZS%<OGRFCI=GUY(-.BYT"S@]8OEM,C4)10QO[&M
MW,G*0A:0#8GYDUYW14+2RB)/_[59X.D_*I=U!4_?43K#P77\C(H""_7?(L3B
M(0'CBPZYWX@';)?M+1M(8_26&98H#$0B:!;03K(^AHTV74!@908-&77&H7/2
MK#,-K_%+E^LXQL]Y\).*PY_3VG@0F?H4P6K$@TNAQ1RMY2GB//*2594!11=%
MO<L!;X-RYB%PK97ZJI(H._[RVEIV2H 2QE+*W?-&[(>%DQN6-KR,[D3G$4[H
MT4;E[%9O.3ZQ=#P6*#E6H!@\&[MX.#ZQ]/).4<8"HD$QG^IU3TL,YOO\C@0\
MZ5;^?,#[]3:CH-?"."[@C%@1;.GNG"LOS"?-C7-A$W$ZN8&JB[R;';*5U+][
MK^$\FXODOM5D?&(Z3@O05BRB#W8>6[M8%):'N$4O^9_:ELY8]Q^?6/)%FW@E
MT$ "D +8S8E1%FR_(T7-WZV,H$!B"UZ7@P99S#0XL1V;UGE9RO:S>KO[0>.M
M+@#03+&%/2^Y=QWB:JM#1K+.)VCAV(TAV77#CU[BXH9_4_Q%%E>B,,0A0]U0
M"&9N#'798GE!H=!/RW+O^9ON;P0G;6TS<+Q#UI!])*+;\=ZF\/HP"'(,O*B)
M.D@+DRL,>Y!:H4\PNCT_SM3-.U386T@!POBSK?WBGF5_B%%PZ9&84IP,?3^;
M9WD]D;)T.KPWR/L>)/0-N8<@_Z)W6O^.R1\;E8.Q8XVY;0\2*PFW$#9?K5V^
M%D0*;ER+!@<)%H]%T"OBTDOZXM"P+J=9; 6C?$M@1\;;C(FTS+]4_A5&6,_X
MAZP@.B4$WS=W>]V\HDSQPGG5_"!AE3,,7U?K1>G&RV)_-II0LI]1-&3DW-$=
M?8+)O" +@$O:[V!Q4^0<OK6RDQ]N<ZL_I'KW-@BCC$G@ ?GT_,;J.5Z^^E%&
MQ[NB F7/$+(T#Y(<35;FWLIY7Z9/6[-83<KVH5YLJ?PNJ[:T]>7!YM.#U;<'
M#,U!Y>NLU^K[U21U)0V6$K<Q/O808$V].,^]M7W!=L*V/3E13M:FYSO.)&K3
MK6)@DC:=^#B?H&U/9L^6_ $D]5"Z_*@#46):-0B;$YUSU\]\8E7*9LA[6BJD
M8@ _%8UQN\1*=[@[&5KGK&Z8C.1KH!YEJG19AJ"M9K:2R:C./BPFW;FEN9(R
M7(9#K:FM:C4MP>#3#ZZ:UB!9)QO("9:APFMM*_%]2V! %L"0#,<L&>6U?3AG
MA9@[LZB+X<=?74)?V\E.GVP@M?K9M@/K,DG#.;MU_#5!DRRZH9PF5YCP"C@+
M?56U0MI57]7Z(X/B*X/\,X,))F"A9[M.J155K+Q86I6!@KM)I:]M1Q)(H[*+
M2#:",\X?=2A!MXZ:M)QWV(!LG"WS:GI"QXM29P<<*(I8[5H#RI)QR(Z&6:4?
ME9UVE3K;<70T04,1Q[I$7/)9= VDRYZ+3L%VU EQE5$[,:5F$J7Z*GQE/TES
M%L-]++DGFLPUW( 5YY;9PL1'9,V@#"J@@ZV,@^V!$C&B/?*ENU5T=;*9" Q;
MA<ZVZC"T-F!5>>K;V?2*?0@Q\J_CU(NG(37LADF"TD1X0CUM>4(M/C=@WQML
M/C@HOG@\J!X/JL>#JF[[J)S@SRC8G>%GR^_>/S#)4]B(#ZR-!NGKP;6%I!RR
MK 34;VA7N;IM/)"=@VT;M)3Q%DG,I<.N+=!=/@0;5PRSM5WP)'WQ")S"*'\$
MN=7(TIFV[?3"(CYT+[L2*=^$/M5*248Z?F-;E^L:Q<YAR-!M^R'EJFMFBZAE
MH-.;C.28@<Y5<3JYS_8S QT5F2P#7;6)Z4U3GG]NESHGUH;FB?V<DVN-/-#&
ML)8""M[35=RQ*KW''WOFCU5FRC6';#:?>V0YFCR$TSB<A#[CV_=9;!-+5H*C
MT _1RO=ZR\)/6;P4WPG[ON:$+09G/MC*\(/-^(/5!]:NUL'Z&Y:<KNM,X I.
M5EY;RQ409*[3G7;..$AAL4.U"_KE]KQ'>?J/.X\N+M47M&?+ZE_$7L\F8]@[
M:/#QV4V0TE0:#GDVJR3*_%B\MG;\DRU$#F/FK@=R/W"</-]T!Z#QZDG4K%H^
M(G\6XPA/Z;9_'?O2&DI@'UL>+<%$P$U(-^2[:F-%'$BY9Y6MJ&6I9FMGKV.I
M9D=WGF.I9D7P' W<;/5ZU%8I):4BN##%H$UM+\*/\C+'L=(3Q5I3:RF4FL
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MY?=-E^=XOL!Q+A&UAX?\;GW:3I4DX%"8SPZ9LB,!T-SRHT2AK+$* ^YMB#J
M<7ESTP:>HP\5*X'/,I.EUM3X:Q>ER0$&=G?YX 4^.*=AS![?%%'ELH,SI_'X
MD\-"EI -B?F3M9W_CF ?H2"YHNQ6SOMLNX057]#)6F'H1G$Z4@8@H!SQ E[3
M-9MJ5GI/U^)\00[NJ'%$_^!-!1%7ZF/T \6F_$"@6IM\VPQ4%'%S@,A?10E>
M]"D/T4=(I>PX=ZFE\GRO\MJM%YCLTNN<\S<W9JZ3)$/!19YBM'@+5>R^&\49
M32KZ](!\VI2%T8N.M_N,VQ-P-?#HG,]YM164Y0W$Q@RG<3^@ PE7<%88S8";
MKQ\9\6=>@C8.,;4(_I/:XPHVVF UW& SGD/1_,<\LL<\LL<[SC89X1K>:EJS
MW(^WFL=;S>.M9B]O-0%S1!P)*NIC*9)'P\6EE"W=ZRX$"9ZD+Y2483)\0.29
MGC37Q(AAD?4;\Y:0GF"CQ!NX=.KWVR=T\:#GP^\X"">AGS]\44-)J>_X2V^1
M4N</0NN+7CLF(6EEDZ/_VFQP]!_C1W; &DVNXR!\#H/,BP [DK8%FCIJ0\($
MF_$3-I7[[V$ZR\/ZF7[-PL4CECQFY#$H&\2PO2C%0("5FCPZMQ,=A-%)N[ [
MJ(]/@L1[UQZ3Q\I;(4#RC[.0% ^:A#+?;6;<J-,C;BX;H*0[$W5IK7@2HPWN
M8#S^0K?XN0Q!0'RR=Y5X8#&9C0I"-(O"M';S>(S"/$9A'J,P78O"M'1YNU\4
MIO B7;,UH",*T^505PG9D)CM97?7'X5IR?&IG@571CP$DKT*-@U#NUQ'8)=6
M0[[^*O 7^"5>%.F0KS!A,Y9X/D_C64]Y1X=EWH0!,\Y*9\-4G<6P'2O.G5E<
MC99T'7<=_($&7E>W=5>("]GVM15KY+#\(6)!,\Y.F".4&DLMSO%T-\ZQ'&Z0
MCS>H#NA.H"/ <@U)Y9R"-]:#("N9P54RG2GG.&XTG#,AE:H @VF06TC1^3C,
M'S"G9AL8]2?;="*+ZC'9IF.NWF.R3>O)-K5B*//WUMLZFY%32+$A?\LMU;B[
MR%LVJ>DI[&.K\K): E0YZ:#V6Z_M6<DN+K8>P X'82I(Q.&08XQ':5'339JC
M4Z&K':M!)GTY5EP)N&0Q= F;R_:$9FB-1NGIW\8L^;O49XSRKM;)0X ?+K1<
MQP[6/ )=[S6 @Z'+QPCT@X#1R7WM0"+0S[!'@M'D@NX!/@O$9AE$9R&:7+XB
M/V/N_=%D$OJ("#>[9H,8#]_1$\3;@DGPEDCS.7L=1K\FKJ2%$7DY7T1XB221
M5DV&&'_N)8"-683@^ZP9O@L<>U'PG?Z_C\4IC6L-Z5K12RP@3N!K&&L>DFKE
MU_.,D,IN4#^C<1J/3RR%*[:\0 -9@+#1O",5-<^KQ-\C'X7/P&TGZR/JTAOQ
MJS'BW/W4JF+XAM!;))@@W.:]P4C.A'-^PF$4X1<O]M$5)A<X>THG652G7P"8
M4O_>(=B *S/'Y]8QD5>>CX9S1KEJ".2F1]]@$_,! 64M%R!C9S0Y)R@(!>!4
M6_4-D#KMX)G'C=G2??;B?@'8E#,(WD]NP/O=2UG0Z_*"TJX*9[5/O^&K<P(>
M8=V Z]PC9!G&TV;[UW:O?D/&XP4"[8N=X.(+-$'T&!C<HV<49T@MIOC];DSQ
M:I1!.0PWDGC#GV8>JE5Y/(+.O(0!MRQ2+[UX),@C[$>+W(/QFQ=E11ZE),GF
MBVHD-9_9#[5$L>7G!GA2)HW-OSA8?7*0?W.0?W10?G6P_NR@\MVUF&SEDUV+
MB[U[1%3)BSFUSE-UMJQ)-&>N-@V %VM[CFT[5%O*0P(QH1R^O?<GG GIUJ=,
M8-"W)CR<#P2_B[R855 5!VMMMW+@?EL7/%C IG,NLA5YL@"?W79V@K"XPN3+
MV]TPJW8B=_*BN2TL1J^1'U_PXPQGB1<'PSAX?*&<+'/K9KA8$.2'^32_#Z>S
M-&%4BM,_M1FK ^B4#@' 5, ZV $7,GNU.MMNX%=>2)A]BRJF+:L=X=,#U 6[
M1:3&_+WPS-[YIVW%EG=G%!F1F.Y;0;=T]#Y,_K@B"%4=8]^I1LRSN2%5%5!P
MU-A]!.><F=@]]]ZK;<4M*#@J[CZ"<^Z*N9.-YC?,XHFB,%V:7W.%-!R5=S_1
M.7>=;H)_HRNOD(:C^NXG.N>"#'+FGN3\/S7AG]4!%*34ZNZ;AZF>W8E*(=S"
M:+W%C:=W<Z$V]%-Z:DR7PCNTC\([M,I%V6 UW/%J['@U=KP:.UZ-U2)><Y+I
M!\1W8SO-#O9RC"N./KD]0*XWG,6!ZH5/-U^S<U/'1[:A=;R'=%VZ\.N_%KE\
M^6A+T\P68^)?RHEK,HGZ.'N6V6?.XR;,@]"YN]M HBFC]$99FJ1>'(3Q]#83
M)PO3_JGQ5T?UR;CK1BBAP[F1K+/Y.V)3# 5#5CYMBBY?J9D9)DJE ;HGX*B?
M>\A-MUTNJD"]!TNY,XK^)2-)YL7I(V;AW"1!E91"T%;9_9</1P%-"DSW?6)'
MFB>:0?:T<D^JCAJK6YBZKQ<[TN9OM"'E=(?C>\3 H]O%JBI+YD7,U]^1\C8C
MXJBK>\I.]]5AMZIY'1=%1J[I9\(X"?W\,JI;3>1_\ZAXS42E<"?H4-F?ZLN[
MU8H?",XRC<<Z'/793P206EA[NMW>3[7#7[*:#!T=C[72<7CJ:%Y\D"I;>]:^
M[Z)>$\$C3KU(NO5J\E.H?/W'4UM=0H.4]4M?E?4*DPD*TXSN-BQSXNLB)$7J
MOY4DNM-4Z:>/:MI*8I".?CU8';7C2=^+K*-N:Y>F**3)I3-YR2D*,#EG:>NB
M:',"5#,5=!P]&U)Q./IJ2WB@>MJ]/V\3SBR]$H-<9Z<=A*&W)^9P=-JR#$'5
MMON00L]MKZF#&_C)PU33SB0%*J,]E^F>_/Z&$C83<ZNH>#*"V:\,AB^I4G!4
MU7T$!VJNNU[=O=FW<W3;CZZCENL7)ZC[=MW >QA3C84"V5A=O-W43N-AS@EW
M1 O.C]YZGN4"&DZG!$V]%)DRP5N3=)C:;TV2H++WUH5=;GAY>9&.;?7:IX[*
MJ20A,'2VMV\-*GS:,;,5"3@JZ!YR ]6VMVYEF'L+%G(+8@Y3G2W($%1MN]G1
M]$ABV^PQH\$[WSPJ:C-1@?K8OW1G8C/=H+6J2L%AZJHIP8&:V]L+.CG[3GF6
MCY:P-7&"NF_W/E"_:]$INUD?C8<Y)]P1+3@_#NW6L2(@5SS+<I(.4_NM21)4
M]MZ^-LF?$*Z#9+\1G'21BA+^V%%!%64$JIZ[EQJRQU[;K%IZL*=.Q(^GJIIE
M!ZFP]NQM>UI(.5L 5TU"D]>AXJ9I.1Q-M2M"4&%-9V+:]]GL^L'!://@H.W#
MD"YH.4"%M2)"4&&[2."TQY14R."C(1V.$P0>H&J[(U=0WQU+\:3 MI%7>XWI
M.$#M-2X^4$DKMR=V"G/\[C'6TZ5258Y/HJH<JY%X%3DV3.IFA.6WF>&(2C.Y
MI BL&;AEU% Z$)^3SS5.*@/]Q[]_.3WY_)=!,>":C<%Z3%LE1K*G) Q"CRP?
MO'51E9JV<P[(DGZ6? =KJD:DD/1WE,Y8"JMGYJ!#%5KIG*PU7C6350?1^A5W
M"H0HJ<+N8;\#B3M?_X,K*7$M$$$7>W5!NL .4@] 4BZ5"=E0R++2CR:/=.])
MJ&E(92@MUZ#0UTX)#SD"N#$G#@8E=XJ=RX4S].-KM"3&,'V<H>\>^0.E+-\@
M<SLP"I/AE*!< L+B&(J]QQ\L'3?4YQ)NQQ0$TP=[JVCJI3F5Q2;!3D0X9LXI
MR?XH[G;0>Z2*Q!PJQKQ#IFQY!9I;V@V59(U5&'!O$]0!C--;G2[PNMGA]L:/
M4CG'<;Z6@+M>V;;6U-86)YX<6(%H< NSML"57B<9!EO-QN\_N0\ AV)P%GRR
M9D&<94D8HR2IN#_%M@/8X9"M!HF4])6GZ 1/]B.U9F5;E$)7.W:$3/IRK+@2
M<,F:Z!(VEZT,S= :/4W?4D8?2;CX.XY8-H/D.O:%YV>P_=C2;J8^4[ J%Y#L
M[6UP%VB""$$!N^:+,U2Y*)37E%;I>\C;GKKL]%7!Z1APV6JJUMO./M@ CB8X
MNKLK=@^ERWMCIW ;W2DOT%,Z3))P&N?1&'%PCF,6=,$DO/*SB@LS-QC!5KA+
MHTF&V[,&@?:UB_C NXSX,R]!^6,;^A/E2!$QU>Y4$?N%5S/&X$MV:QZ7>Q1Y
M*8N-(NFR<D<B-H6$G0[9!E*0ED.EV0!J95NEI)L=<T=%\DI8N6O@= &7RR:-
M9DB-&C&/LY 4=- -.J%2$'FM60^XP_A$/T9*>Y[:!,'J/(#;VXF]!$VKBZOS
MR$L2M7@QN,LA;VU223E47+)*HFQYY+6U? ,.2AA+*7=OU]H/"Y?WI_WQ,KHE
M/2 2HN2R.#"F(9WI=Z0\U8@OMO-SC%+G\0E/SPQL58*I@-LQ >Y5K?-D"F&Y
MV@<66>?QB:40A":PJ#$!PM(ZK$X(R[=]8)%U'I]8NLII HL:$R LK:]RA+#\
M?1]89)W')Y9\@DU@46,"A.5K)[!<[P.+K//XU-(QJ DL:DR 1IJ]TGYWD1>S
M0&CQT6>[U2&?=GCR<*CD^(H\F4&]V\[.P88K3+Z\W3W'M!.YR^>7QK"8]:"]
MX,<9SA(O#IA?B<[7>#5]?<I5^(P8<6*?6H,AQJ<\!@QL+X#FXWW8 &>/[CPV
M5=)>*"W+1]H<[8.3PBCC4TO'F690*7,"HJ7[3,-1I#9SJ$J_)5.YU:39I1N4
MNV[KN$++<*48A;-HL2#(#_.D%/<L"4K2! _UL<;O^S!CFO(#[D3VGMCEN4/D
MH8([S0[9D.9*I(Z9NU7IP-1=&\[B0-4X[.9K=JQZ/K*Z$D[*I>O2X:#_6N3R
M0<66ICGZ&#%?CXL$5;*'<+6FX],OCN;WVF<EV+VIYC(-KAI?=#M#^>:+V <J
MZC-^;^E:S01HBMR#T]!>W;K+^2+"2VHEJ<]'L,OXHZMY]_3-2PGS$,(?6Q_'
M^ @G)*V@2_^U09;^8WR?A^?RS7?Z]\J?#])LWV81PD1O"GH51,"9M2)XU<"P
M,<R5%^:39LANU2A.)ZU"=9&;-. D4O_NO8;S;"Z2^U:3\7O3+QT ;<4B^F#9
M&EVSOU.AR(1;;3)^_]DYX=;I X7[64NX;(+\GZ;X^5V PD*V](>-6.D_QC=H
MZD67<4KW#&!#I*UJC0YR6^0Q"N'#6S.[@*>@!706T";;+0SOC *188#";C=(
MW1)U<G-L+'6S;SLQ7GK?$9UWWPC.%K(D"%#S\8>/AM=O2%6Q*K&0A#]\M'9^
M96>WT:1RU!-?6@#-#W*Y%[,,+OSV[ITJYW5Z'+_%L5=YH;IYNP,[H5:NUJ8#
MV;E[$ .#]V/)O>L%6_ ZN<-UKP*&GV7X&:'B1,GZF;A2@EUIO_%'2Q%-;2<<
M;LP<Z#)L7?Y(9Z;(W&V:##.Z*9'P7]SZ6ZL08[C3^).M"YLV-0>DC$"(N9#9
MLZ"8)79NA%71H><X59D S1MG,!IE:9)Z,4LIU@"H2J^>HU7C!#19'(#LSB,C
MDK^5#/(227>(Y%PH(0=U[BV 8H9 H\-JK,%6Q:6R E:AC8LH3&$<%3KW"T=E
MAL#3OE4<BT7^@EI6\;0H,UDL)S4FA-D/&@W40WR;,@<:H2Y47,F8D.@_*IO\
M=5RQP05 -QBE9R@WY@R"V%J"BSN"?82"Y(H*9%6)9#2I;#,PKM*N_0)3D1T(
M06LO^#CI=.EBPUZ(>%/*P&\XI<O/=9PBJI=I4F;:%1Q+VHW7+ZSWX1%2 'N!
MY^*])DE)Z*?EX^$\U.H;P4G[C1D8KU\*L ^/D +H#65JMTU7M7CT$E,S8Q8N
MAA.JR$VW:J61>@9Z*^ZZO9S7M.*O;J+*%:O0[!')][&G"/&LDT8[0(OQ^Z4;
M.GEV[U9/N-Q56&Z[*U2'Z!?N#=D"H;68=Y R<(\6Y>T&APL)IL*^/013@1\0
M1;O>,4@-B]]?8?* R'/H2Q%5'J>'Z#;D#43:FO]L.YF/^LV>N%^_D%3A!43.
MFC=LF^KFEQ%J_?N,9+LKB1.+SJ^Z'LJ,8[A/GY%K8,3:2U7%H5CI_E;2L?^X
M*=_BGEAS4FV3?1$^AP&*@WNZ5&R.XJH(\GOW&4811R"6UOQ-K'3,=9RD),MS
M%F\2%6Y*R-P1:H.=P( J#]$O5!NR!09;N!#$M-+)1':*A/OT"SP9'R!:]G)M
M;BTB]RA \_PQ]",B<P%@PF[]PDR!%1 V:RZ;;:(KJ\3&"JL^)9 !" [09R@E
M3(&@VO/@R-(?0-D/BOP%51NN\"P+G#RZ/]4O1>F(?5"E[(5:Z6/T=\3RH*!@
M2"<5M2PO7ZF1&28H-T:,*)J(@!]6_>1" 972FA>L8B6=>XLP]:+UI3DBS[D+
M]BI+,X)6,31*AJ/:4/U2E);L@9!;<Y.UUOCM8+C"7=_!:L/[3+]4I0/6036R
MYK_+:7V2,_D$+)R_L5>VP?:UNT2;-'^MATK5B01 W;+F7AQ&^;@HX,^DRU?V
MHV K4NO?+_R;\ 0B:B^H;4\SJS2F-I$ZW9FYM4_U2T\Z8A]2*<OI3J$ @DHN
MP15'HFO YF/U3"E:\@>B;B_V;4_U_D8;ILG*N)+%3NO_6,_TIBL!@(IE+_)N
M3U;I^6^"0G8 9,D-Z'8<DGR$I,.CDNJG?RRE4Q0'J(*..9V;ZLTA@"U!J+<^
MW.WU<,=AF/_Q@IKX5UY(\H@K4SN3E)!#T*F.A0,JJS7?[CJO=A%#RY?*+2[R
MG15INY-'G'I1]>_G.$EO<?K?*+U'/I[&+*2S:C#"*FKD\_U23(,B =71FM^Y
M,^:+:4IW_?)7K)T@6,DL'4<%E<D&U%1KKNW.I&!!*8_Z%\M?(;QOZ^F&<O>U
M]=7OV!KWB$DZC*>560,>)O/\>)U_N"?Z9%(8H%99\[:7I<E_S_,KIB.2E\U9
M7_VL<RB>>U&$@K/EI>?/MML*;OGW';HG"J2774A%>.4W+:K(5LC*^H])^==$
M8%2U&NX 5$&-11!^S17&+E#BDS _!E!3JR1FXP #-@U)KYZ@I,P)"(;=1]_0
M[<PM>LG_U/:9\+I_3W!LP1.(J)L/P#>O1UA"JDU@]'HW:8FT=-P#T@!%7D'-
ML.=!KF2M87N&_*$QU*-G: JY '%R(5DBU2_*+RKV$'H&0.$S"D:-LR7*A^DM
MHJJL@3!7G))_?;?#-:7CC]7?.'_:&A2]IB@.-HZ6+2'%]*\I-0]^\O'\72Z=
M!W^&@HRQ<>D1=L)+5FIYYB6A/XR#BS#*Z$GP J5>&&TD$:9LW)_S_WWZ,G@[
MN @3/\))1A#]QVK8 9X,5@,/Z,B#?.C_-<@''WAQ,"B''_RI_,"?*W+0S.L-
M3M;<E5^[90922K'B\_5UER\VQ(:/-=&#]3A_?F/'7\<#KZ:^'*>;I)^EE4>L
ME&?+(A(]/XX\BE^6M1A*Z^I#3\5OVM;Q4 -U=TUJ*SM^0K@5Z70&H.!O;U*2
M<21DRJ+TTEQR11XSYM'"<5Y)0UB<2=+-7I&FUD#M&HD*8G&H9,$.F6!)N=4D
MX#>W4UQ)3=98A0$(%WM/Y74 XW)9)&W@F:R=VP"_TMDC*W2UU6QLQ]H6SPDL
MIM>Y%6W[H;=,_KS68]ZL=PP'D&YP);-7\X]=8;$J:&++8*=9[RT!+ML.5;Z1
M!J4E4%3:AK,XN(N\^-:;(]G^U,W7[-@=?&0;AOSM(5V7S)3^:Y'+1I(M37/4
MIEI'XVRB"V7[.]BE ]C57)M=+@Q \!*7=]!PLYA&O#P2E#?;17D$-7="O4OO
M#0BI.!PJOU8E4;:(\]I:=B" $N9&7'"X=&E+W@\+E[?#_?%R=&-[0"1$R66S
MHZN@DZT3K&""X$:T@[/*WG$II_A;&XBXG<:6BEXWA BF'9Q%EB'Z>QN(N)W&
MO&A(]R"":0>OM]M"!):&9W1<*PJ^J)L.]AA_=%7J*H1#(O]H;59PPT35"E-+
M>HXM18>TNHE58@9"SUWWBLMI:OJD'MUP[]SE2#5,L9+AOXQ81($HHE[6M5=X
MJW'CG-,>(+N(2FT.7MGO$)"KLN*>>V23J[.@5FW_%?3J&6021D!#U5H-"A8'
M&3XKQ<#7V_8*'(!\T)"U$QE+9STK6U(FSE&*%_W\\VZ\Z/8@[L2+;M%U'R;U
M4&?NB@[VL;8W;5,D"0:%VCL3\2F'I;XU"23@?$AGC?RSY1F*_=G<(Y)K&'E/
M:[<Q$DPD  (2<,NBWR%Y1;#4]R_M:>=61AD$&79\03AU5=,9>"Y?XW0$L*MW
M.U[$DO(_HSA#MT@:$,IM;BDP5'E*U1]B<5EP;O$<^C[.XC0IGHBQC4$&#]3#
MVHU;.XB$;(#KI$.;W%(>4"KLU%M[Q.&(TCIK]&.--[)J)V<,$$D,G@+G3IL=
M>P+5,V.C/9B.FACG69+B.2(URF6[F:2C*V8'9S;AIGR862T3DE8 H__:@$7_
M,?[N_0.3%;'02TG:D-?.\1T+H-J,*UXB=A8I.YILD0>N=K2]H+GA#4DL5*Q"
ML:'=QQ "3NXT>Z/4S;8"!.NL/BV,S]EN9'H?4-)H+*+6P1O G45T4X==?&T+
M]K(6)[6W5WR7"0BLG^U<-5VPD5@<"*4Y?,KR[)J1IWKI=+)[Z50.-ZB.-\@'
MY%Y =99O9?,LX5?:BT3+,)Z6%[/YG>SEJQ]E=+@K"CB+@<G2'+#1A).HA<_Z
MJ2COS.:C@^*K1=*69+#Z[H!IVJ#R9=8+R/!BZ9YN&*=A4+LN!06W>QU;FR@<
M]Y*V+]C.%;,G)\J)9/1\QYD[1]TJ!N:CT8F/\S>;>S)[MN0/('G0WN5''7C=
MIE6#L#G1N7<+P256Y3VTO*>E%_(&\%/1&+??SG>'NY/'9&=UPU&O;H\R""G/
MOKXE$]*:<<#2%7%+<,1\N'='K"'ODZ7W?BT!:O[LSS$+1WG-'\Y9L$)GEG8Q
M_/BK2^AK._'IDXUC;KK*022G,?F5'C.OXX(;RD+5;<7*KDXFR$]'\2U*V5_H
M;W:JZJR+J.1N*:&CZ[W(T552,V#D#*[CP9J@76<6R[=<4#48Q0-*5]& _7I%
MVJ"D;5 0-QA-5EXS PF:-P)F;VO8:8VY,"DCU+I3$-('D9!6(PXV0UKA;$<'
M1 ]5A,Q^%#%;0W/E &7?6;%=^9(1$61/"?IGQO)O/K.D0VK.[4\U-M?##(IQ
MW'E4L<.A@O,5[F')F;I-C\PERFWMC&-3!L>NHU+ N_/NQEWBI:&*8 =[;CZ1
M_,5020,4[248JU,JS3@(=[&4LTHB;2DV[OK#=,+CL@=,$X2.NJUVZ)6^=^ U
MM^3&DL\6(30.^[$NT%-Z'2=T4\P35P@W(U[;/NQ#,(\.Q<AO$ZGBZX=[V-F
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MA>9'ZS1N/=@;7/$LRTDZ3.VW)DE0V2O7C%#"[O+W[/_8U*2_^?]02P,$%
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M3O/'SV3R6::1S"J9D"]"J &V;! E0%!!"4LH2-@)HE;2,PEN2DQ)B,F'8(<
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M %5GN)N:'[O8F&L%.F)9XS**Z_0%GT9UU&!3VJL2]WVH4@=Z?)I2)@N(0EJ
MRO.3G0XM%1.UG I6,J8\(:'68Z')$A])^2\<(T 4:\=T(H#H(<.EJ2!3HE8V
M"!?NGJ,L.]Y6:8XK]4 TDO++!2G$(1<&(H"X(,.EX (31:UL$"Z</>/RD0QO
MG\KB2_W4U&=5VJ:0]LL-+>0A1Z2B@+BBPZ?@3*N"N$Y;4C<,>;[N"HKS*HMJ
M2R6BGFFC!#OBC" 'B3 J< );,AS3]9:KHD;W!?JQPJA^PHBELR;D[[U*\+R=
M4#>-\&O&>52>)U$IHY!.V/NM(TK PMTC@B0((AGAJ>\AZ310J^*9-=>$PV5_
M'L= T+OTE*<=S"J^&&0+ON6121X$FRQ!CCG%U(:3:Z;([D4,6<VH7]Q>'>(-
MA#Q'QA* H\"X)P&"(TI8JK"X?U= F-IYVX<LC<^S(E*OL@QD/%?,$^&-BN7M
M!  Q0$2E*I''!!&3#/+]CZ/\EW*[J>/7F[*(,:995E7GK4SK;Y;:?CGC9-*0
M35:J@'CF@E?!P%T3J-?&46_$"KF81Y/&:36W(O[E[BDB+_!Z6U=T!"7 U*O@
M6B7/VPL6!HPV&30:@*AG 5.UX< T$5,]0EP9];0#S<^J715 G!R_WN(U+NFY
M@WO\M3XF#_I%,\.PT/4]>[,V9SR9,RJ"(*$K6M54KT+]!M #S1%KFD _TT80
M:\7W_>4G15Y',;TQIBKR'&>*E&.YF+^:%6J0N](5H@P( FF B84LF"CJ9.=/
M.5Y'U0,#OJW>/4;1AM,"9W75_F7'C^8/?[N+GW"RS?#U^A2OTYS0'^?D'_4-
M 5^=IE6<%=66O++[Z$'(4)[8A@]F[64>I=VD!H)S<A_4@G/CFJA11527>#.J
M,:\CFT);T:R=59?D%[HN,MZK<]3U25,G<_KTM%($0TL7M%9TW*FCGVD#;#VL
M"D_/557ANEH]T-LNXO',5R7DDW!R@'UF#27 4$@*2\B>O;L[N[\+SH*3J'I:
MY0G]/V=_WZ8O449CQ55]$I7E*YFC_!1E6]68:JGKDS-.YO2I9*4(AF$N:(4@
MCR@A,@%%,?T'WJGOR\6\+CG!OO_#Q_>,9%?WMS=_NR$?**VJHGR]*FI\BV-,
M'D@&Z"L\=CIF<1]4L@5-V6.2#4X82X!B.8)6 ^5$!96=SA'*\;PK9)/&+KYM
M60ULD:_AVJEX'=<LP ]&.8U\<((Y@!1&P$8%'+MN2KR)TN3LZP;G%29^EFUM
M\E%=3S(K39]<<S"E3SD+-3#,L\<J*;I"-1'FJA4;%0NVC1TWN>(1:R8X(VVX
M%Y!E1CZ%8TY=U%%V:0S6]42YIXUTYP=6D#AQ1;X.QV4UDY.)^V>*&K1(&E$6
MC.<Q !0KN>3O3F#Y%1+G;7!9O]*%BIJX3CJ9V-#= C$XMU/Q.[:9P0\'-;4\
M&$Y9@)0$ZTR%#5^XE8<12EWD-8&:DM"NZ2RX/OL:9UNZ_?FI*)(O::9Z$W:J
M/@GG8DR?>#9Z8 CH '9,Q)UJX]]@<+ MBG&*-T65JOR:(.5U"T@.<;#),Q0!
MPQ<Y+F5ADH2+!2>%P?F$<3 Z)P+.41B<0?MS\"]]30;'B.9W7>*HPK?IXU-]
MO?ZQXNY-89M!QR<GK.#WB:)5 ,,>&Y1C2C$I6A.+'GUA@L')-9X"6,X4PDZZ
M;"9;$"?I CKY/+T_SP(U5]<:%X(2:B) _/S:CP[D0U^FT4.:I76*33OK4DF?
M%-! [?-!(@9F$%%C$ZYRN5@=7UQ>W%^<A=]R[Z$^L5JZTRD$8HP"N((X)T 7
M\(P0A;WS9ECI*0:G4[N-=A.]TBTTNUW0L7"(_4\Y8-G.YU 2#'VT\)2[G1LN
M#8$WY18G8A]06ZN2]\P>/>P1@>3"D#BD12BA$97O]BR#T^BDR%]P6=-5OU/\
M8$C"4 E[31'3 A[DA$DEP5!'"T^2VM\*TP(2 (AS2H^?E#BYQ2\XWQK&+96P
MYP1H#>!1QK-$$@QQM/ D.<U,&)5<.CAO&'NM@AVII$_&:*#VZ2(1 \,5-39Q
M>YM(MM$->D?XDK&39INH!!$G#U<<VP'W54\ADU*XE6"5 >JEX+$&&(Y9P13*
MC;1*B&EU4[)7],__](</[]__"=T]%26]G6WF"N?S3/FM9Z2AI_AV4WM8ZX76
MT?0PL0O2K+Z'Q3K%RZ 3B$=VR5Y:!3">R@:E+.T+),44;M>XF66A!V!8U&]W
M&97 4,X6J?OX>%F0'Z$-CT;V*62#.S=KIP9VJ)RPO0K)G?6PF&T-1A@#3<"2
M0TL)2#2@17?2FE4\H2<D"U;<$N>QFA9:#;\KDT;HP^5)I3B8T<N,45RH[#18
M0O- )SB[6"VGIR)+<%G1U.SZU1"3ZQ2\9I@:@0^239728)AEA"BDH.X46 3T
MKW^J$%<,SJJ;LEED91AU1^ZEDIX/%*J@C@X0CL7 ,$>-37) L%G\;FJX_3_?
M?_O]]^_IDB9ZH7I'Z/WW1]]_S_X_JGB!MVA;/Q5E^@^<_ G]\/'HPP__POS8
M[_[UP]$//_R^E4KIK58)/W&XJPAWA,AO&\PN&,G"\[)7^DY;!T(0\SUJRD".
MA\J^#!@N*H#)!L5=)4&1A1_^94=#2JGW1Q]4I!Q2[$]$].,?_G#T^]^]9XH_
M?/S]T>\^?G]0+%TE":MZ'V4W49I<Y"?1)B51J6K#727M-8E!#WF0PB 7!<-@
M/3XA?:&31E0<I3EJ%(+3Z!;7$:W>=!:5.:T,NXKC[?.6[6'1NDZQ\N20C:)/
M<MD;TN>960L,Y:RA2I)G6D&4<,G@M!/C6.N -_0,PF[F &M)0XE/OK+1%V]F
M#5 F#?WDYSRQII%9+502NLX(54:Z3 <6X2S1&A?66! &F(Z[<IZWF,S#MW&]
M+8ES)C;?\D20DZ*J+4NT6K00ID"KM6GR\JQ&=3!#K#MFX;!>7P]1<3"%60?0
M*#)F5H7+%V-=5CM5O]&>O3'#>,^L!X:.#F M>$@]::,-JR3K<&7J)BJO2WI%
M,4[8VL -+MD= E;+6FKE<*N%)H/4"X@J33 $=8*K7F:L^ )/M[(#C)'\"HM5
MMY9D]3)$I7 ,5!F@9MY8 RCC%#"-3!.6!T$R[H(M0SJ\B%8A--.&P$TLX]*@
M&3: :,LNOHH,DEGJ6Y:LM4)S3''/DJ4*:+:9;UI24:Y8Z):E/7?1'$,Z*\U
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M5-)@J&6$*!G_FL'ON54(3B<Z:\!5Q4ZHGF-ER1A1S//%EU*0H\LN!S)@:*(
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M4YYT:(Y^#QLG^'A@_?$TK1J8.-F]$F+']5I]*->MB7!]Q\XX=8_0ZP,;*IQ
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MD_&L9R*4+&C[*=G><SJHD^W])MD'L62DQFU<,@(YU5:8>4[BE3R>8<E(VQ
M%EL8:L%F32M@W/!DZ&-BGU]<K:Y.@/&X/\BP$+M)N[ 8DX;BH89^&6C5@-^7
M!<,O T"QB (1:1-<0-&G5X*V?TY28ZZ@$8I$"N@J'HW$05))CE$R.V8:B+X;
ME/8*"L>]@L)TXAP^4.Q;9ZB:K+F'P+F54)QT,%'%4XLF0'+7'O<T/F^Z ME
M2JRJC&>W6$X@<T\/ GT%,VP(VRF!I^@8J1TI*\Y*=M,=:!H..]XJ3_@?,/G1
MG9OFQL(3UM9@,XM-+0&GMB5\![Z#]KS]DC*6$:RH$HJ^*O JDH[E05)1 5*L
M'OG"&<8(U]_920%0S'X!8>\5"*A+0_LM"1W$ J<:MSG5\_BO".3B$+63_G^:
M9?(299C5#*CJ,HU)_Z(_D"%A^(>>)+_]0SP_T51N/OL:LYH7MZ2OGJW76+E
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M5MB\)[J(*=.1N5-'/?W@K/P<E;_@FN;^MZFJ5D.T6<TG%VV-Z-/0I .&@99
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ME'#9A1S37XKR%P*NJ7 R^@)]KBH$O;D0+=#.+TBE8'1V';3Q]V]D4<R%Y^+
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M\F*[]"FO3X?2?8-9+NF[5 I.X=YE7\HI7F/RMT1_O;UG#&]GM%:\7G^C]0@
ME.X>TGBQ'@R7 G/'^9PO19W0.?M3#K77*E)&9WX$K!S398R3WV66]IICQVWY
M-!A%3:.'VM_:>;^??F=^V@'T/]M7-D,_-#WJ3?1'2R/E_?(\2DOT4Y1M,3T
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MK5(J(\L0]?)8;\=0/+[$+AW8PS.#1[V>#34.RD>H:0QMFM907:"2MX>B78-
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ML(/!22(7W*E8@!.&ITX4,5DPN9 C&RX-F9!J\8#L$4!K&'0)+@?2 -#,I$M
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M!PI?\G7UG0%S<=+Y,S(2;-B,5I>%4#3R;1)SO_:1QNX6P]GH5HS.QE>E0R_
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M1ET^Y%64ZG^'S"2?\NK?M&I#C0@K9R8K?X)R5L?>PR) 9%B!*C[90!L(:LT
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M,";>136?]CF+-HS?SB-/J/XE':'(8)]N%;B @D])1/D_C))W(E1ZFX-ONJS
M0D"Q)0B\5T/@/1P![%.OE&)+$/A6#8%OX0A@GWRE%&,B<$Y_7,6/T2?.13NW
M,93[V"=?";68O,]WI56<O[<M"E'( .CT@*)@QX%83#?J,BAL \@:J%I"66_'
MX;B?3DR6WT5)Z@3_G[^3F:7][:'LM^.8+*)Y:M=G(0+,6\*+KFHU@;(:^V3<
M2]G4W&63C8G#%^IF"RAOL8^[?71-S-J;B%W;/$>AT&G<;05E,?:YE4??U$J:
MO6Y*N+JA]F=PJ!^V"FY3-#%'?XO]E,Z /0O,PM)/Q+GFXS2%<AK[L"FD=&*N
M/^1)'-D3TX_4W(S]0V&D)LO[VD'YC7VTY-,X,;/OXOS5*Z'F?![EQMY'QJOU
MFJ>E1>VAS,<^6<IIQ@6!/;0FL2H4/;V@@& ?,J'T3ZV(B@S);^_>/SVRU[\<
M-=1I!64[]@&31]_$;+Z-'F.'/;%_>-L^10'_?4YO0RBSL8^3 BHGYG=C'OV<
M;C6!\AC['-E+&9+2N'QUGYUP0_BA&_TMH;S&/E>*Z$33TQN0GMXHZFGL\R6/
M/B0V%['W=)VMG@)_X_#?^@D[@-\\6<)\ =53/[;,GU^QJM_Q-I_'%?VA'P%.
M4RCOL4^E0DJGYGKF^2Q34#ZE*S]T0I>>V@[U<CD 2'M!L< ^L4+I1[F9^(T$
MP7^'T:?P@3A)%!*O.$*(+B>X7:" 8)]B092CH/%K%&2487$>1QL+DZ-TFD*Y
MCWUD%5**$[I:1(KO]RFV-'F/$L0]H!A@GU\A=",%\J6$)9+R7\B%DSKE#$50
M\'I H< ^W4+H1GNJ$)_336H3B:,$6@VAC,<^\@JH1.'WP]8)@BJACHC?K890
M?F,?>P54HO#[<DOB#=5Z'^+H4_I<OLD5\9W3 <I_[+,P@&H<'%X/"0**%XI"
M$'I:@Y-1V($ EUZLW"O[(G /+&.K$W, $+6'0H!]+I;3/#$(>>FTN@663X9-
M7Q3Q(>\%!03[< RE'V=+KF5K$.[(C790UMMQ#.ZC$><I6_84^.Y5$#E">[_1
M#,IJ.\Z\/12B</K,"?^(LUWJOMW%D4L(N_E)]FL0<.8"#@!%QX[3L!)7</P4
M@B3K0F^%L!\4)3L.RA >(-E1R>']'?'.WNY9D2,6F/%(7M,S^J$_Q&85H#L4
M*NRCM3)')H\'S]/54NL[B<*0!/R;YOZ64!RPC]PB.GM8_O>O.]30T?^H_MK[
MQ\9HBE4"SIS H=) +1!2NP5I5 MXO_ARL;\IR<L%T/'#A'CLIR0*?(^)UJ(<
M:5$.-5J$UD[RE$.3)5]N'&=7R!$)TJ3ZS4&@RE_\OI_F:KV_Y+F+BG.>H.Y
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M>?*#_M=+_<N!/P!Z-@'=*U_&*XL-N#OGC>DHYHMVW3BC@EA.7IC7;.AXZ,D
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MWO>3/]CN_PM[+)@Z?@BKTR'IAF4*UOC)9JAH $)Z8WLK('!US#PX6RQ82O3
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ML2M-5G&A:=5$1W5([!=24TC,,#;;)"ARF0\]SD9=;/DF==&P3UMO/TVBJL;
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M^DG$7U)V540U9FO#E]HTA4U3$F.7-1416HAKDB>,^B7TTZ$2T#,.=A$K/9+
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M&SKG/($1R=-WP@,_ 8/8$4VD-_(30#9^Z&=CDFQJ^403$K^0SKU%%V-8;SO
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MK- [CT+VHI1QKCJL)T(%JC0">KRQBCC6U>H /IF\8;[+8O?924A> 8'^1&D
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M,3 W+FAT;5!+ 0(4 Q0    ( -.+;%FE=?"N<0,  +02   *
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M-0( $               @ ''[@@ 9F]R;7,M,6%?,# S+FIP9U!+ 0(4 Q0
M   ( -.+;%D!8Y\3\K@  *VZ   0              "  9T;"P!F;W)M<RTQ
M85\P,#0N:G!G4$L! A0#%     @ TXML67)!#1 BTP  B=0  !
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M,#(T,#@S,5]D968N>&UL4$L! A0#%     @ TXML62.TPF\ CP  0K,( !4
M             ( !LT4/ &YT<G M,C R-# X,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( -2+;%F<>/)8\FP  ,J-!P 5              "  >;4#P!N=')P+3(P
D,C0P.#,Q7W!R92YX;6Q02P4&     !  $ #: P  "T(0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>forms-1a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:NTRP="http://nexttrip.com/20240831"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ntrp-20240831.xsd" xlink:type="simple"/>
    <context id="From2024-03-01to2024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_NonrelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2022-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2023-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:MembershipUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-25</endDate>
        </period>
    </context>
    <context id="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:PreferredUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-25</startDate>
            <endDate>2023-01-25</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="AsOf2023-01-25_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_NextInnovationLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2024-02-292024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-02-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_NextInnovationLLCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">NTRP:NextInnovationLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ClosingSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ShareExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember21725562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_PreferredStockMember21725578">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-09-01_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-01</instant>
        </period>
    </context>
    <context id="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-06-10</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-06</startDate>
            <endDate>2023-10-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:AssetPurchaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-06</instant>
        </period>
    </context>
    <context id="AsOf2023-01-25_custom_PrincipalExecutiveOfficesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-25</instant>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_custom_PrincipalExecutiveOfficesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_custom_PrincipalExecutiveOfficesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_custom_PrincipalExecutiveOfficesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:PrincipalExecutiveOfficesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_ComputerEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_SoftwareLicenseMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-02-28_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_SoftwareDevelopmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SoftwareLicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SoftwareLicensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">NTRP:SoftwareLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_TrademarksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:SigmaAdditiveSolutionsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="AsOf2023-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-12</instant>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DivergentTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="From2023-10-122023-10-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-10-12</startDate>
            <endDate>2023-10-12</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="AsOf2017-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-13</startDate>
            <endDate>2023-06-09</endDate>
        </period>
    </context>
    <context id="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-09</instant>
        </period>
    </context>
    <context id="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-27</startDate>
            <endDate>2023-02-21</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:ConvertibleNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:SpecialPurposeAcquisitionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-21</instant>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-10</startDate>
            <endDate>2023-11-06</endDate>
        </period>
    </context>
    <context id="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:SeveralInvestorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SharePurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-06</instant>
        </period>
    </context>
    <context id="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-19</startDate>
            <endDate>2022-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-19</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SoftwareAsAServiceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NTRP:ContingentSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:ConsultingModificationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_custom_NextPlayTechnologiesIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextPlayTechnologiesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-18</instant>
        </period>
    </context>
    <context id="From2024-03-182024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:BoardOfDirectorsAndChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-18</startDate>
            <endDate>2024-03-18</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-23</instant>
        </period>
    </context>
    <context id="AsOf2024-08-14_custom_InvestorsDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-14</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_InvestorsDirectorsOfficersAndEmployeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:InvestorsDirectorsOfficersAndEmployeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-05-21_custom_DonaldMonacoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-21</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_DonaldMonacoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-08-312024-08-31_custom_DonaldMonacoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:DonaldMonacoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-09-212023-09-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-09-21</startDate>
            <endDate>2023-09-22</endDate>
        </period>
    </context>
    <context id="From2023-09-222023-09-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-09-22</startDate>
            <endDate>2023-09-22</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">NTRP:AtTheMarketIssuanceSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2024-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:DebtAssignmentAndConversionAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DeferredRevenueArrangementTypeAxis">NTRP:SharePurchaseAndExchangeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NTRP:NextTripHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">NTRP:ThirdPartyConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-04</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SeriesFConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesFConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-26</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-26</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-22</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-28</instant>
        </period>
    </context>
    <context id="From2023-12-282023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-28</startDate>
            <endDate>2023-12-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_TwoThousandThirteenPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandThirteenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-12-292024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-12-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-29</instant>
        </period>
    </context>
    <context id="From2023-12-292023-12-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-29</startDate>
            <endDate>2023-12-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandAndTwentyStockAppreciationRightsPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_WarrantMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_WarrantMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_WarrantMember21736515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-03-07</instant>
        </period>
    </context>
    <context id="AsOf2024-03-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-03-08</instant>
        </period>
    </context>
    <context id="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_custom_DooyaMediaGroupIncMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NTRP:DooyaMediaGroupIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_custom_SeriesEConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_custom_SeriesGConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesGConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesHConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-15</startDate>
            <endDate>2024-08-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-15</instant>
        </period>
    </context>
    <context id="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">NTRP:TwoThousandTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-31_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="AsOf2023-02-28_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_custom_StockAppreciationRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NTRP:StockAppreciationRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesGPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesHPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2022-03-012023-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NTRP:CustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-07_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-07</instant>
        </period>
    </context>
    <context id="AsOf2024-03-08_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-08</instant>
        </period>
    </context>
    <context id="AsOf2024-03-10_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-10</instant>
        </period>
    </context>
    <context id="AsOf2024-03-11_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-11</instant>
        </period>
    </context>
    <context id="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:MessrsMonacoAndKerbyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-15</instant>
        </period>
    </context>
    <context id="From2024-03-152024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NTRP:MessrsMonacoAndKerbyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-15</startDate>
            <endDate>2024-03-15</endDate>
        </period>
    </context>
    <context id="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-25</instant>
        </period>
    </context>
    <context id="From2024-04-252024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">NTRP:UnsecuredPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-25</startDate>
            <endDate>2024-04-25</endDate>
        </period>
    </context>
    <context id="AsOf2024-08-14_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-14</instant>
        </period>
    </context>
    <context id="AsOf2024-08-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="From2024-09-012024-10-11_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-10-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-11_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-11</instant>
        </period>
    </context>
    <context id="From2024-09-132024-09-13_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-13</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-13</startDate>
            <endDate>2024-09-13</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">NTRP:MessrsKerbyAndMonacoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-13</instant>
        </period>
    </context>
    <context id="AsOf2024-09-18_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-18</instant>
        </period>
    </context>
    <context id="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="AsOf2024-09-19_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-19</instant>
        </period>
    </context>
    <context id="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-19</startDate>
            <endDate>2024-09-19</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">NTRP:SeriesIConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">NTRP:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-01</instant>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_WarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember21742375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember21742390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-08-31_us-gaap_PreferredStockMember21742406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-08-31_us-gaap_PreferredStockMember21742421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="From2024-05-242024-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-05-24</startDate>
            <endDate>2024-05-24</endDate>
        </period>
    </context>
    <context id="AsOf2024-05-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-05-24</instant>
        </period>
    </context>
    <context id="From2024-07-112024-07-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <startDate>2024-07-11</startDate>
            <endDate>2024-07-11</endDate>
        </period>
    </context>
    <context id="AsOf2024-07-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000788611</identifier>
        </entity>
        <period>
            <instant>2024-07-11</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-03-01to2024-08-31" id="Fact000003">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-03-01to2024-08-31" id="Fact000004">0000788611</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-03-01to2024-08-31" id="xdx2ixbrl0012">S-1/A</dei:DocumentType>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0043"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Goodwill
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0066"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0087"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0096"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0105"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0108"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0114"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0115"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0121"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:OrganizationCosts
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0224"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0227"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0230"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0244"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0245"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0257"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0274"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0276"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0305"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0309"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0312"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0315"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0320"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0325"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0331"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0341"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0346"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0348"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodShareOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0353"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0355"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0363"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0366"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0371"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0374"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0392"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0396"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0399"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:DepreciationOfRightOfUseAsset
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0447"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0475"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncreaseDecreaseInRightOfUseLeaseLiability
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0477"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0490"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OriginationOfNotesReceivableFromRelatedParties
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0504"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ProceedsFromAcquireBusinessesGross
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0508"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0511"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0529"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0532"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0558"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0559"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfPreferredSharesForServices
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ConversionOfConvertibleNotes
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0571"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:PreferredStockDividends
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0574"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0577"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-03-012023-02-28_us-gaap_WarrantMember"
      id="xdx2ixbrl0622"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-03-012023-02-28_us-gaap_StockOptionMember"
      id="xdx2ixbrl0625"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-03-012023-02-28_us-gaap_PreferredStockMember21725578"
      id="xdx2ixbrl0628"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0631"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0717"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:PrepaidCostOfSales
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0746"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0818"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:DeferredTaxAssetDepreciation
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0909"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:DeferredTaxAssetsPayrollAccruals
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0912"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl0920"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl0921"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0936"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0939"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0945"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0948"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl0956"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl0957"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl1185"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl1187"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1195"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1199"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1201"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1207"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1223"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1231"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1239"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-12-292023-12-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1251"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-12-292023-12-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1253"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1271"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1273"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1275"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1283"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1285"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1287"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1289"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1291"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1293"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1295"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1303"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1319"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl1327"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl1349"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl1351"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1365"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1367"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1369"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl1371"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl1387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2022-03-012023-02-28"
      id="xdx2ixbrl1393"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_NonrelatedPartyMember"
      id="xdx2ixbrl1524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl1535"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl1536"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1596"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:OrganizationCosts
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1619"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:OrganizationCosts
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1621"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-06-012024-08-31"
      id="xdx2ixbrl1663"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1664"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl1665"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1666"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1674"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1676"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1684"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1686"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1713"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl1715"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1721"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1723"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1770"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1771"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1772"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1776"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1777"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-06-012024-08-31"
      id="xdx2ixbrl1780"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1783"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1785"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1790"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1793"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1798"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1799"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1801"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1814"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-05-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1820"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1824"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1825"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1826"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1830"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1836"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1853"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1854"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1855"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1859"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1860"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl1863"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1866"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1868"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1875"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1876"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl1877"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1883"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1886"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1891"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1892"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl1894"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1907"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1913"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1917"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1923"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1927"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl1928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl1929"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1939"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1943"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl1949"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:DepreciationOfRightOfUseAsset
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl1971"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1975"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IncreaseDecreaseInPromissoryNoteReceivable
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl1986"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl1996"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2002"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2019"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2023"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2026"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2050"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:PreferredStockDividends
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2053"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2061"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012023-08-31_us-gaap_WarrantMember"
      id="xdx2ixbrl2119"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember21742390"
      id="xdx2ixbrl2122"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012023-08-31_us-gaap_PreferredStockMember21742421"
      id="xdx2ixbrl2125"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2128"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl2138"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-06-012023-08-31"
      id="xdx2ixbrl2148"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-03-012023-08-31"
      id="xdx2ixbrl2150"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl2261"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl2437"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl2439"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl2441"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2449"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2451"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2453"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2459"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2461"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29"
      id="xdx2ixbrl2475"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2477"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2479"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2481"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2485"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2487"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2493"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl2501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl2509"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl2517"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-08-31"
      id="xdx2ixbrl2525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2535"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2537"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2023-02-28_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2539"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2547"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2549"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2551"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2553"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2555"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2557"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2559"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2567"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2569"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2571"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2573"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2575"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2577"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2579"
      unitRef="USD"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2585"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2593"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2601"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2609"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      id="xdx2ixbrl2617"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl2627"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2023-02-28"
      id="xdx2ixbrl2629"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2643"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2645"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2647"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
      contextRef="From2023-03-012024-02-29"
      id="xdx2ixbrl2649"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2657"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2659"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2661"
      unitRef="Shares"
      xsi:nil="true"/>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2024-08-31"
      id="xdx2ixbrl2663"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <dei:AmendmentDescription contextRef="From2024-03-01to2024-08-31" id="Fact000011">Amendment
No. 2</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="From2024-03-01to2024-08-31" id="Fact000013">NEXTTRIP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-03-01to2024-08-31" id="Fact000014">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-03-01to2024-08-31" id="Fact000015">27-1865814</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-03-01to2024-08-31" id="Fact000016">3900 Paseo del Sol</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-03-01to2024-08-31" id="Fact000017">Santa Fe</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-03-01to2024-08-31" id="Fact000018">NM</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2024-03-01to2024-08-31" id="Fact000019">87507</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-03-01to2024-08-31" id="Fact000020">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-03-01to2024-08-31" id="Fact000021">526-9688</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="From2024-03-012024-08-31_dei_BusinessContactMember"
      id="Fact000022">William Kerby</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="From2024-03-012024-08-31_dei_BusinessContactMember"
      id="Fact000023">3900 Paseo del Sol</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="From2024-03-012024-08-31_dei_BusinessContactMember"
      id="Fact000024">Santa Fe</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="From2024-03-012024-08-31_dei_BusinessContactMember"
      id="Fact000025">NM</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="From2024-03-012024-08-31_dei_BusinessContactMember"
      id="Fact000026">87507</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-03-01to2024-08-31" id="Fact000027">(954)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-03-01to2024-08-31" id="Fact000028">526-9688</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2024-03-01to2024-08-31" id="Fact000029">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2024-03-01to2024-08-31" id="Fact000030">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-03-01to2024-08-31" id="Fact000031">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000036"
      unitRef="USD">323805</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000037"
      unitRef="USD">282475</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000039"
      unitRef="USD">1000000</NTRP:PromissoryNoteReceivableNet>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000040"
      unitRef="USD">1933908</NTRP:PromissoryNoteReceivableNet>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000042"
      unitRef="USD">34082</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000045"
      unitRef="USD">340921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000046"
      unitRef="USD">8613</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000048"
      unitRef="USD">1698808</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000049"
      unitRef="USD">2224996</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000054"
      unitRef="USD">6642</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000055"
      unitRef="USD">16226</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000057"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000058"
      unitRef="USD">2607670</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000060"
      unitRef="USD">42167</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000061"
      unitRef="USD">15000</us-gaap:SecurityDeposit>
    <us-gaap:Goodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000063"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000067"
      unitRef="USD">1020443</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000069"
      unitRef="USD">3390034</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000070"
      unitRef="USD">3659339</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000072"
      unitRef="USD">5088842</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000073"
      unitRef="USD">5884335</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000081"
      unitRef="USD">531847</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000082"
      unitRef="USD">519136</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000084"
      unitRef="USD">460768</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000085"
      unitRef="USD">329922</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleDebtCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000088"
      unitRef="USD">3233503</us-gaap:ConvertibleDebtCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000090"
      unitRef="USD">139921</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000091"
      unitRef="USD">22750</us-gaap:DeferredRevenueCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-02-28_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">281000</us-gaap:NotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000097"
      unitRef="USD">149339</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000099"
      unitRef="USD">1960813</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000100"
      unitRef="USD">4535650</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000106"
      unitRef="USD">864575</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000109"
      unitRef="USD">864575</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000111"
      unitRef="USD">1960813</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000112"
      unitRef="USD">5400225</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000123"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000125"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000127"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000129"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000131"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000133"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000135"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000137"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000120"
      unitRef="USD">474</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000142"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000144"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000146"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000148"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000150"
      unitRef="Shares">936430</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact000152"
      unitRef="Shares">936430</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">83371</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">83371</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000139"
      unitRef="USD">936</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000140"
      unitRef="USD">83</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000158"
      unitRef="USD">27277758</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000159"
      unitRef="USD">17295890</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000161"
      unitRef="USD">-24151139</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000162"
      unitRef="USD">-16811863</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000164"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000165"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000167"
      unitRef="USD">5088842</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000168"
      unitRef="USD">5884335</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000171"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000173"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000175"
      unitRef="USD">458752</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000176"
      unitRef="USD">382832</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000178"
      unitRef="USD">397532</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000179"
      unitRef="USD">354921</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000181"
      unitRef="USD">61220</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000182"
      unitRef="USD">27911</us-gaap:GrossProfit>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000187"
      unitRef="USD">1604487</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000188"
      unitRef="USD">2124296</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000190"
      unitRef="USD">116512</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000193"
      unitRef="USD">152106</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000194"
      unitRef="USD">209561</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000196"
      unitRef="USD">484250</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000197"
      unitRef="USD">707137</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000199"
      unitRef="USD">1421508</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000200"
      unitRef="USD">615432</us-gaap:ProfessionalFees>
    <NTRP:Technology
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000202"
      unitRef="USD">311430</NTRP:Technology>
    <NTRP:Technology
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000203"
      unitRef="USD">551418</NTRP:Technology>
    <NTRP:OrganizationCosts
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000205"
      unitRef="USD">25000</NTRP:OrganizationCosts>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000208"
      unitRef="USD">1468762</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000209"
      unitRef="USD">707238</us-gaap:DepreciationAndAmortization>
    <us-gaap:OtherExpenses
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000211"
      unitRef="USD">156522</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000212"
      unitRef="USD">64684</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000214"
      unitRef="USD">5740577</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000215"
      unitRef="USD">4979766</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000217"
      unitRef="USD">-5679357</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000218"
      unitRef="USD">-4951855</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000223"
      unitRef="USD">-14718</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000226"
      unitRef="USD">166890</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000229"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000232"
      unitRef="USD">-48620</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000233"
      unitRef="USD">-71871</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000235"
      unitRef="USD">486633</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000236"
      unitRef="USD">-9770</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000238"
      unitRef="USD">-977480</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000239"
      unitRef="USD">-81641</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000241"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000242"
      unitRef="USD">-5033496</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000247"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000248"
      unitRef="USD">-5033496</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000250"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000253"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000254"
      unitRef="USD">-5033496</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000256"
      unitRef="USD">7125</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000259"
      unitRef="USD">-7339276</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000260"
      unitRef="USD">-5033496</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000262"
      unitRef="USDPShares">-29.16</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000264"
      unitRef="USDPShares">-29.16</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000266"
      unitRef="USDPShares">-70.32</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000268"
      unitRef="USDPShares">-70.32</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000270"
      unitRef="USDPShares">-2.96</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000272"
      unitRef="USDPShares">-2.96</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000278"
      unitRef="USDPShares">-32.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000280"
      unitRef="USDPShares">-32.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000282"
      unitRef="USDPShares">-70.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000284"
      unitRef="USDPShares">-70.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000286"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000288"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000290"
      unitRef="Shares">71581</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000292"
      unitRef="Shares">71581</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000295"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000297"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2022-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000307"
      unitRef="Shares">70370</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000300"
      unitRef="USD">70</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000301"
      unitRef="USD">30</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000302"
      unitRef="USD">-11778367</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2022-02-28"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-11778267</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000317"
      unitRef="Shares">13001</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000310"
      unitRef="USD">13</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-03-012023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000311"
      unitRef="USD">17295860</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000313"
      unitRef="USD">17295873</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000322"
      unitRef="USD">-5033496</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000323"
      unitRef="USD">-5033496</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000333"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000326"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000327"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000328"
      unitRef="USD">-16811863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000329"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000343"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000337"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000338"
      unitRef="USD">-16811863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000339"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <NTRP:StockIssuedDuringPeriodShareOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000351"
      unitRef="USD">472680</NTRP:StockIssuedDuringPeriodShareOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000345"
      unitRef="USD">473</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000347"
      unitRef="USD">1603027</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <NTRP:StockIssuedDuringPeriodValueOfPreferredShares
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000349"
      unitRef="USD">1603500</NTRP:StockIssuedDuringPeriodValueOfPreferredShares>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000361"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000356"
      unitRef="USD">53</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000357"
      unitRef="USD">3968507</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000359"
      unitRef="USD">3968560</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000369"
      unitRef="Shares">15481</NTRP:StockIssuedDuringPeriodSharesPurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000364"
      unitRef="USD">16</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000365"
      unitRef="USD">1905954</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000367"
      unitRef="USD">1905970</NTRP:StockIssuedDuringPeriodValuePurchasesOfCommonShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000377"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000372"
      unitRef="USD">4</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000373"
      unitRef="USD">13106</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000375"
      unitRef="USD">13110</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <NTRP:StockIssuedDuringPeriodSharesReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000385"
      unitRef="Shares">316</NTRP:StockIssuedDuringPeriodSharesReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000379"
      unitRef="USD">1</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodSharesReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000387"
      unitRef="Shares">780423</NTRP:StockIssuedDuringPeriodSharesReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000380"
      unitRef="USD">780</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000381"
      unitRef="USD">2367637</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <NTRP:StockIssuedDuringPeriodValueReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000383"
      unitRef="USD">2368418</NTRP:StockIssuedDuringPeriodValueReverseAcquisition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000391"
      unitRef="USD">116512</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000393"
      unitRef="USD">116512</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000397"
      unitRef="USD">-7125</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000398"
      unitRef="USD">7125</us-gaap:DividendsPreferredStock>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000405"
      unitRef="USD">-7332151</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000413"
      unitRef="Shares">472996</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000407"
      unitRef="USD">474</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000415"
      unitRef="Shares">936430</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000408"
      unitRef="USD">936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000409"
      unitRef="USD">27277758</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000410"
      unitRef="USD">-24151139</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000411"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000423"
      unitRef="Shares">472996</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000417"
      unitRef="USD">474</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000425"
      unitRef="Shares">936430</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000418"
      unitRef="USD">936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000419"
      unitRef="USD">27277758</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000420"
      unitRef="USD">-24151139</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000421"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000428"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000430"
      unitRef="Pure">1</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000435"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000436"
      unitRef="USD">-5033496</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000444"
      unitRef="USD">1468762</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000445"
      unitRef="USD">707238</us-gaap:DepreciationDepletionAndAmortization>
    <NTRP:DepreciationOfRightOfUseAsset
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000448"
      unitRef="USD">12168</NTRP:DepreciationOfRightOfUseAsset>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000450"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000453"
      unitRef="USD">116512</us-gaap:ShareBasedCompensation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000456"
      unitRef="USD">166890</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000459"
      unitRef="USD">-14718</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000465"
      unitRef="USD">662939</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000466"
      unitRef="USD">-5053</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000468"
      unitRef="USD">281506</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000469"
      unitRef="USD">-48796</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000474"
      unitRef="USD">-27167</us-gaap:IncreaseDecreaseInSecurityDeposits>
    <NTRP:IncreaseDecreaseInRightOfUseLeaseLiability
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000478"
      unitRef="USD">-18697</NTRP:IncreaseDecreaseInRightOfUseLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000480"
      unitRef="USD">-531367</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000481"
      unitRef="USD">533193</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000483"
      unitRef="USD">102954</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000484"
      unitRef="USD">-46855</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000486"
      unitRef="USD">-5056095</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000487"
      unitRef="USD">-3792600</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000489"
      unitRef="USD">-675314</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000492"
      unitRef="USD">-5731409</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000493"
      unitRef="USD">-3792600</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000498"
      unitRef="USD">9253</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000499"
      unitRef="USD">2928</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForSoftware
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000501"
      unitRef="USD">1016175</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000502"
      unitRef="USD">2354094</us-gaap:PaymentsForSoftware>
    <us-gaap:OriginationOfNotesReceivableFromRelatedParties
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000505"
      unitRef="USD">1933908</us-gaap:OriginationOfNotesReceivableFromRelatedParties>
    <NTRP:ProceedsFromAcquireBusinessesGross
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000507"
      unitRef="USD">-417122</NTRP:ProceedsFromAcquireBusinessesGross>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000510"
      unitRef="USD">1589241</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000513"
      unitRef="USD">980935</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000514"
      unitRef="USD">-4290930</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000520"
      unitRef="USD">281000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000522"
      unitRef="USD">735057</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000523"
      unitRef="USD">3233503</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000528"
      unitRef="USD">1905970</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000531"
      unitRef="USD">1603500</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000534"
      unitRef="USD">547277</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000535"
      unitRef="USD">4620452</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000537"
      unitRef="USD">4791804</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000538"
      unitRef="USD">8134955</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000540"
      unitRef="USD">41330</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000541"
      unitRef="USD">51425</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000543"
      unitRef="USD">282475</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2022-02-28"
      decimals="0"
      id="Fact000544"
      unitRef="USD">231050</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000546"
      unitRef="USD">323805</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000547"
      unitRef="USD">282475</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000555"
      unitRef="USD">4381</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000556"
      unitRef="USD">1769</us-gaap:InterestPaidNet>
    <NTRP:IssuanceOfPreferredSharesForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000564"
      unitRef="USD">569000</NTRP:IssuanceOfPreferredSharesForServices>
    <NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000567"
      unitRef="USD">362000</NTRP:IssuanceOfPreferredSharesForPerpetualSoftwareLicense>
    <NTRP:ConversionOfConvertibleNotes
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000570"
      unitRef="USD">3968507</NTRP:ConversionOfConvertibleNotes>
    <NTRP:PreferredStockDividends
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000573"
      unitRef="USD">7125</NTRP:PreferredStockDividends>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000576"
      unitRef="USD">13106</NTRP:IssuanceOfCommonSharesForServices>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2023-03-012024-02-29" id="Fact000579">&lt;p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zqXYvRElwtUa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 - &lt;span id="xdx_825_zkGPBstIeW96"&gt;Business Description and Going Concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sigma
Additive Solutions, Inc. (&#x201c;Sigma&#x201d;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended to date, with
the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other
things, Sigma&#x2019;s corporate name was changed from Sigma Additive Solutions, Inc. to &#x201c;NextTrip, Inc.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s corporate office is located at 3900 Paseo del Sol, Santa Fe NM 87507 The consolidated financial statements include the
accounts of the Company&#x2019;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc., incorporated on June 24, 2002.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;Prior
to the Share Exchange Agreement as described below, NextTrip Holdings, Inc. (&#x201c;NextTrip&#x201d;) was a wholly owned subsidiary
of NextTrip Group, LLC (&#x201c;Group&#x201d;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc.
(&#x201c;NextPlay&#x201d;). All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023,
NextPlay and Group entered into an Amended and Restated Separation Agreement (&#x201c;Separation Agreement&#x201d;), Amended and
Restated Operating Agreement (&#x201c;Operating Agreement&#x201d;), and Exchange Agreement (&#x201c;Exchange Agreement&#x201d;),
together the Agreements (&#x201c;Agreements&#x201d;), whereby NextPlay transferred their interest in the travel business to Group.
Pursuant to the Exchange Agreement, NextPlay exchanged &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zC1bjJuh2PSg" title="Number of common stock issued"&gt;1,000,000&lt;/span&gt;
Membership Units of Group for &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_ztVenDw12gh4" title="Number of common stock issued"&gt;400,000&lt;/span&gt;
Preferred Units of Group, with a value of $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_z5RjezcFwEtl" title="Share price per shares"&gt;10&lt;/span&gt;
per unit. Prior to the exchange for Preferred Units, Group had a payable due to NextPlay of $&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zqx3olpfVV8f" title="Number of common stock issued, value"&gt;17,295,873&lt;/span&gt;,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#x2019;s
ongoing support obligations except for a $&lt;span id="xdx_907_eus-gaap--NotesPayable_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zK8euId603zb" title="Notes payable"&gt;1.5&lt;/span&gt; million advance remaining under a promissory note and as such NextTrip recorded the
payable as contributed capital. &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and all-inclusive travel packages. Our proprietary booking engine, branded
as NextTrip 2.0, provides travel distributors access to a sizeable inventory.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company owns &lt;span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20240229__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_zh7s8zm6l2d4" title="Ownership percentage"&gt;50&lt;/span&gt;% of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor
operations occurred in 2023 or 2024 and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reverse
Acquisition&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#x201c;Exchange Agreement&#x201d;) with NextTrip, Group,
and William Kerby (the &#x201c;NextTrip Representative&#x201d;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zjZzxRkOfoe" title="Number of restricted shares"&gt;156,007&lt;/span&gt; restricted shares of Sigma
common stock (the &#x201c;Closing Shares&#x201d;), issuable at closing, and the right to receive up to an additional &lt;span id="xdx_90C_ecustom--StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z73AcNf6WlV9" title="Number of additional restricted shares"&gt;5,843,993&lt;/span&gt; restricted
shares of Sigma common stock upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#x201c;Contingent Shares,&#x201d;
and together with the Closing Shares, the &#x201c;Restricted Shares&#x201d;), which Restricted Shares are issuable to the members of Group,
on a pro rata basis, under the terms of the Exchange Agreement, subject to certain closing conditions (the &#x201c;Acquisition&#x201d;).
Upon the closing of the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contingent Shares, together with the Closing Shares, will not exceed &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_zM7Xcb3ip1Ok" title="Shares issued"&gt;6,000,000&lt;/span&gt; shares of Sigma common stock, or approximately &lt;span id="xdx_90F_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20240229__20240229_z5PfBXCLVr8c" title="Percentage for issued and outstanding capital stock"&gt;90.2&lt;/span&gt;% of
the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a change
of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the legacy
shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma is
treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information presented
is that of NextTrip.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;1,&lt;/i&gt; the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with &lt;i&gt;one&lt;/i&gt; adjustment, which
is to retroactively adjust the accounting acquirer&#x2019;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;2,&lt;/i&gt; the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    retained earnings and other equity balances of the legal subsidiary before the business combination;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value under ASC 805 as described in &lt;b&gt;NOTE 8 &#x2013;
Goodwill&lt;/b&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going
Concern&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 29, 2024, and February 28, 2023, the Company had an accumulated deficit of $&lt;span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20240229_zdrVeNWcMHQ3" title="Accumulated deficit"&gt;24,151,139&lt;/span&gt; and $&lt;span id="xdx_906_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20230228_z3cV7l4trhdk" title="Accumulated deficit"&gt;16,811,863&lt;/span&gt; respectively, and
working capital deficit of $&lt;span id="xdx_90F_ecustom--WorkingCapitalDeficit_iI_c20240229_zRjT0YloBUtk" title="Working capital deficit"&gt;262,005&lt;/span&gt; and $&lt;span id="xdx_901_ecustom--WorkingCapitalDeficit_iI_c20230228_zT4KhWTtX9Sg" title="Working capital deficit"&gt;2,310,654&lt;/span&gt;, respectively, and has incurred losses since incorporation. The Company will need
to raise additional funds through equity or debt financings to support the on-going operations, increase market penetration of our products,
expand the marketing and development of our travel and technology driven products, provide capital expenditures for additional equipment
and development costs, payment obligations, and systems for managing the business including covering other operating costs until the
planned revenue streams are fully implemented and begin to offset our operating costs. In the event the Company is unable to raise adequate funding in the future
for its operations and to pay its outstanding debt obligations, the Company may be forced to scale back its business plan and/or liquidate
some or all of its assets or may be forced to seek bankruptcy protection.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;In light of the foregoing, there is substantial doubt about our ability
to continue as a going concern for 12 months from the date of the filing of this prospectus.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Recent
Issues Surrounding the COVID-19 Pandemic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse
public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
duration and severity of the COVID-19 pandemic impeded global economic activity for an extended period of time, even as restrictions
have been lifted in many jurisdictions (including the United States) and vaccines are being made available, leading to decreased per
capita income and disposable income, increased and sustained unemployment or a decline in consumer confidence, all of which significantly
reduced discretionary spending by individuals and businesses on travel and may create a recession in the United States or globally. In
turn, that could have a negative impact on demand for our services. We also cannot predict the long-term effects of the COVID-19 pandemic
on our partners and their business and operations or the ways that the pandemic may fundamentally alter the travel industry. The aforementioned
circumstances could result in a material adverse impact on our business, financial condition, results of operations and cash flows, potentially
for a prolonged period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
we currently cannot predict the full impact of the COVID-19 pandemic on our fiscal 2025 financial results relating to our operations,
we anticipate an increase in year-over-year revenue as compared to fiscal year 2023. However, the ultimate extent of the COVID-19 pandemic
and its impact on global travel and overall economic activity is constantly changing and impossible to predict currently. However, the
Company is seeing the return to normal operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember"
      decimals="INF"
      id="Fact000581"
      unitRef="Shares">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="INF"
      id="Fact000583"
      unitRef="Shares">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact000585"
      unitRef="USDPShares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="0"
      id="Fact000587"
      unitRef="USD">17295873</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NotesPayable
      contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember"
      decimals="-5"
      id="Fact000589"
      unitRef="USD">1500000</us-gaap:NotesPayable>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-02-29_custom_NextInnovationLLCMember"
      decimals="INF"
      id="Fact000591"
      unitRef="Pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000593"
      unitRef="Shares">156007</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <NTRP:StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact000595"
      unitRef="Shares">5843993</NTRP:StockIssuedDuringPeriodSharesAdditionalRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact000597"
      unitRef="Shares">6000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2024-02-292024-02-29"
      decimals="INF"
      id="Fact000599"
      unitRef="Pure">0.902</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000601"
      unitRef="USD">-24151139</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000603"
      unitRef="USD">-16811863</us-gaap:RetainedEarningsAccumulatedDeficit>
    <NTRP:WorkingCapitalDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000605"
      unitRef="USD">262005</NTRP:WorkingCapitalDeficit>
    <NTRP:WorkingCapitalDeficit
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000607"
      unitRef="USD">2310654</NTRP:WorkingCapitalDeficit>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2023-03-012024-02-29" id="Fact000609">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zGEHqlcFYsC3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_826_zn2PsYiDS8Uf"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zjJ4SkBSWIy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&lt;span&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zvT3CGhXthXf" style="display: none"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#x201c;SEC&#x201d;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) of the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYNgtlgrPaga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zvop3Yli0cV7"&gt;Functional
and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in United States dollars (&#x201c;USD&#x201d;), which is the Company&#x2019;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zi8D4EThlaLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zECwVSN5l3dj"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#x2019;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#x2019;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the Company to continue as a going concern;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;The assessment of the allowance on the related party promissory note receivable;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Estimates of purchase price allocation;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    measurement and useful life of intangible assets and property and equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Estimates of fair value of equity instruments;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverability
    of long lived assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znm0W8vScE4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zfCWQ5E57r05"&gt;Loss
Per Share&lt;/span&gt; &#x2013; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#x201c;Earnings Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 29, 2024 and
February 28, 2023, the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_z8WLjXA0cLk5" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;Year Ended February 29 and 28,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zFkqvzqgz067" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHcszlqY6qkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zrX1zFbuQVKb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
consists of amounts denominated in US dollars. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_znz41uPYYRw1" title="Cash equivalents"&gt;&lt;span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230228_zWUTqJt7Z4j" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents
as of February 29, 2024, or February 28, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--PrepaidsPolicyTextBlock_zP8hsNZqfpp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNq5e7bygDi"&gt;Prepaids&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zcNsj0Pmudd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zpROZHUqB1aj"&gt;Accounts
Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#x2019;s
best estimate of the amount of probable credit losses in its existing accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable balances as of February 29, 2024 and February 28, 2023, were $&lt;span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_z7adHWduDhh4" title="Accounts receivable"&gt;34,092&lt;/span&gt;, and $&lt;span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_c20230228_zj00rlxIMbt7" title="Accounts receivable"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_ecustom--PromissoryNoteReceivablePolicyTextBlock_zSMvO0PieUsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&lt;span id="xdx_864_zokZsbbIL4dd"&gt;Promissory Note Receivable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
from NextPlay under the promissory note as described in &lt;b&gt;NOTE 1 &#x2013; Business Description and Going Concern&lt;/b&gt; were $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBvEy3SmY4Dj" title="Accounts receivable"&gt;2,567,665&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zbPdvDoogrB8" title="Accounts receivable"&gt;1,933,908&lt;/span&gt; respectively. Management has determined that, since NextPlay is in default under the terms of the promissory note, collectability
of the entire related party receivable as of February 29, 2024 is uncertain, and has therefore established an allowance for doubtful
accounts of $&lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_ziXkWVEdo8g8" title="Allowance for doubtful accounts"&gt;1,567,665&lt;/span&gt;. As of February 28, 2023, &lt;span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z7sMx8ABAG27" title="Allowance for doubtful accounts"&gt;no&lt;/span&gt; allowance for doubtful accounts was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWWo5BaTFOzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zpFrPVg4yYSa"&gt;Property
and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recognition
and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Depreciation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#x2019;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#x2019;s property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BF_zmJtEukZpK03"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zniJYxbMVy04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1ThpQpoPZ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zZw8ET0O8Acd"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_z9Q4puhFe4G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--InternalUseSoftwarePolicy_zwvkT5vMbYIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zl75EYJYMjS"&gt;Software
Development Costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#x201c;&lt;span style="text-decoration: underline"&gt;ASC 985-20-25&lt;/span&gt;&#x201d; Accounting for the Costs of Software to Be Sold, Leased,
or Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zvFWfDgI5X13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zZXLjEm7sf2a"&gt;Impairment
of Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 350-30-65 &#x201c;&lt;span style="text-decoration: underline"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&#x201d;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
Significant underperformance compared to historical or projected future operating results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
Significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zwKwrmEoAexe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zDAn9CatPkj2"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zazYsWsiYD9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zi4sOZJnCCHi"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztnZGNMpNbla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zgQEEVdQUtyc"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--MarketRiskBenefitPolicyTextBlock_ztZNTINE94t6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zDSoyoXIgVT3"&gt;Concentration
of Credit Risk&lt;/span&gt; -&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zDu3emIxc3X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zPNXd2HD4tXl"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/b&gt; &#x2013; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#x201c;Compensation &#x2013;
Stock Compensation.&#x201d; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoUehf2CANRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zwZ4eZtFf9M"&gt;Revenue
Recognition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company recognizes revenue in accordance with ASC Topic No. 606. In
May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &lt;i&gt;Revenue from Contracts
with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition
guidance under prior U.S. GAAP and replaced it with a principles-based approach for determining revenue recognition. The core principle
of the standard is the recognition of revenue upon the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. In general, we determine revenue
recognition by: (1) identifying the contract, or contracts, with our customer; (2) identifying the performance obligations in the contract;
(3) determining the transaction price; (4) allocating the transaction price to performance obligations in the contract; and (5) recognizing
revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_z1eTiudxu4T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zOLzEHL5GHJ7"&gt;Sales
and Marketing&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and administration expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 29, 2024, and February 28, 2023 was $&lt;span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_zv5DkjtVHw6b" title="Sales and marketing expense"&gt;484,250&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20220301__20230228_zj2522yghbJ6" title="Sales and marketing expense"&gt;707,137&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zhxOkI2P3rRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zQm8MXm4rQE8"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#x201c;Accounting for Income Taxes.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no tax positions at February 29, 2024 and 2023 for which the ultimate deductibility is highly uncertain but for which there
is uncertainty about the timing of such deductibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During
the years ended February 29, 2024 and February 28, 2023, the Company recognized no interest and penalties. All tax years starting with
2019 are open for examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNkTwcecrh59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zU9TY6EvEIne"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;
Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). The FASB issued this ASU to address issues identified as a result of the complexity
associated with GAAP for certain financial instruments with characteristics of liabilities and equity. Complexity associated with the
accounting is a significant contributing factor to numerous financial statement restatements and results in complexity for users attempting
to understand the results of applying the current guidance. In addressing the complexity, the FASB focused on amending the guidance on
convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#x2019;s own equity. For convertible
instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock.
Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared
with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features
that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for
a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums
are recorded as paid-in capital. The FASB concluded that eliminating certain accounting models simplifies the accounting for convertible
instruments, reduces complexity for preparers and practitioners, and improves the decision usefulness and relevance of the information
provided to financial statement users. In addition to eliminating certain accounting models, the FASB also decided to enhance information
transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance on
the basis of feedback from financial statement users. The FASB decided to amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. The FASB observed that the application
of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically
similar contracts as equity. The FASB also decided to improve and amend the related EPS guidance. The amendments in this ASU are effective
for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified
that an entity should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the
guidance through either a modified retrospective method of transition or a fully retrospective method of transition. The Company adopted
ASU 2020-06 on March 1, 2022 on a prospective basis. The adoption of this standard did not have an impact on the Company&#x2019;s consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50),
Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic
815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU
2021-04 requires accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants)
that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The
recognition of the modification depends on the nature of the transaction in which the equity-classified written call option is modified.
If there is more than one element in a transaction (for example, if the modification involves both a debt modification and an equity
issuance), then the guidance requires allocating the effect of the option modification to each element. ASU 2021-04 is effective for
the Company beginning in the first quarter of 2022. ASU 2021-04 should be applied prospectively to modifications or exchanges occurring
on or after the effective date of the amendments. The Company adopted ASU 2021-04 on March 1, 2022 on a prospective basis. The adoption
of this standard did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, ASC Subtopic 326 &#x201c;Credit Losses&#x201d;: Troubled Debt Restructurings and Vintage Disclosures.
Since the issuance of Accounting Standards Update No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments, the Board has provided resources to monitor and assist stakeholders with the implementation of
Topic 326. Post-Implementation Review (PIR) activities have included forming a Credit Losses Transition Resource Group, conducting outreach
with stakeholders of all types, developing educational materials and staff question-and-answer guidance, conducting educational workshops,
and performing an archival review of financial reports. ASU No. 2022-02 is effective for annual and interim periods beginning after December
15, 2022. The adoption of this standard did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_zunsJwzW3tH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000611">&lt;p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zjJ4SkBSWIy3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span&gt;&lt;span&gt;Basis
of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_86B_zvT3CGhXthXf" style="display: none"&gt;Basis
of Presentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying consolidated financial statements and related disclosures have been prepared pursuant to the rules and regulations of the
Securities and Exchange Commission (&#x201c;SEC&#x201d;). The Financial Statements have been prepared using the accrual basis of accounting
in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) of the United States.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly owned subsidiaries. All intercompany
transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000613">&lt;p id="xdx_84F_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zYNgtlgrPaga" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zvop3Yli0cV7"&gt;Functional
and presentation currency&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;These
financial statements are presented in United States dollars (&#x201c;USD&#x201d;), which is the Company&#x2019;s functional and reporting
currency. All financial information has been rounded to the nearest dollar except where otherwise indicated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2023-03-012024-02-29" id="Fact000615">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_zi8D4EThlaLl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zECwVSN5l3dj"&gt;Use
of Estimates&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated
financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates. These differences could have a material effect on the Company&#x2019;s future results of operations and financial position.
Significant items subject to estimates and assumptions include the carrying amounts of intangible assets, depreciation and amortization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Information
about key assumptions and estimation uncertainty that has a significant risk of resulting in a material adjustment to the carrying amounts
of the Company&#x2019;s assets and liabilities within the next financial year are referenced in the notes to the financial statements
as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assessment of the Company to continue as a going concern;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;The assessment of the allowance on the related party promissory note receivable;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Estimates of purchase price allocation;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    measurement and useful life of intangible assets and property and equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;Estimates of fair value of equity instruments;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Recoverability
    of long lived assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000617">&lt;p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znm0W8vScE4k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zfCWQ5E57r05"&gt;Loss
Per Share&lt;/span&gt; &#x2013; &lt;/b&gt;The computation of loss per share is based on the weighted average number of shares outstanding during the period
in accordance with ASC Topic No. 260, &#x201c;Earnings Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options
or note conversion features were excluded due to the anti-dilutive effect they would have on the computation. At February 29, 2024 and
February 28, 2023, the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_z8WLjXA0cLk5" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;Year Ended February 29 and 28,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AB_zFkqvzqgz067" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2023-03-012024-02-29" id="Fact000619">&lt;p id="xdx_89A_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zLcOymGTnQU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_z8WLjXA0cLk5" style="display: none"&gt;Schedule of Anti-dilutive Securities Excluded
from Computation of Earnings Per Share&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20230301__20240229_zH5EHFQ7DIRb" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20220301__20230228_zgqnmzmHcpyl" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;Year Ended February 29 and 28,&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_z8Mh4dX5lnnd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;486,165&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zG99JYq3Q5Mg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;85,300&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zEqZSQZfQGuh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;475,835&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0628"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zceH1tdecvjb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,047,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0631"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact000621"
      unitRef="Shares">486165</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact000624"
      unitRef="Shares">85300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember21725562"
      decimals="INF"
      id="Fact000627"
      unitRef="Shares">475835</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000630"
      unitRef="Shares">1047300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000633">&lt;p id="xdx_848_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zHcszlqY6qkl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86C_zrX1zFbuQVKb"&gt;Cash
and Cash Equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
consists of amounts denominated in US dollars. The Company has not experienced any losses on such accounts. The Company considers all
highly liquid investments with a maturity of three months or less when purchased to be cash equivalents. There were &lt;span id="xdx_90B_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20240229_znz41uPYYRw1" title="Cash equivalents"&gt;&lt;span id="xdx_90F_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20230228_zWUTqJt7Z4j" title="Cash equivalents"&gt;no&lt;/span&gt;&lt;/span&gt; cash equivalents
as of February 29, 2024, or February 28, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000635"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000637"
      unitRef="USD">0</us-gaap:CashEquivalentsAtCarryingValue>
    <NTRP:PrepaidsPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000639">&lt;p id="xdx_84E_ecustom--PrepaidsPolicyTextBlock_zP8hsNZqfpp" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86E_zNq5e7bygDi"&gt;Prepaids&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company records cash paid in advance for goods and/or services to be received in the future as prepaid expenses. Prepaid expenses are
expensed over time according to the terms of the purchase. Other current assets are recognized when it is probable that the future economic
benefits will flow to the Company and the asset has a cost or value that can be measured reliably. It is then charged to expense over
the expected number of periods during which economic benefits will be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:PrepaidsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2023-03-012024-02-29" id="Fact000641">&lt;p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zcNsj0Pmudd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zpROZHUqB1aj"&gt;Accounts
Receivable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company&#x2019;s
best estimate of the amount of probable credit losses in its existing accounts receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers accounts receivable to be fully collectible; accordingly, no allowance for doubtful accounts is required. If amounts
become uncollectible, they will be charged to operations when that determination is made.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
accounts receivable balances as of February 29, 2024 and February 28, 2023, were $&lt;span id="xdx_900_eus-gaap--AccountsReceivableNet_iI_c20240229_z7adHWduDhh4" title="Accounts receivable"&gt;34,092&lt;/span&gt;, and $&lt;span id="xdx_90A_eus-gaap--AccountsReceivableNet_iI_c20230228_zj00rlxIMbt7" title="Accounts receivable"&gt;0&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000643"
      unitRef="USD">34092</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000645"
      unitRef="USD">0</us-gaap:AccountsReceivableNet>
    <NTRP:PromissoryNoteReceivablePolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000647">&lt;p id="xdx_847_ecustom--PromissoryNoteReceivablePolicyTextBlock_zSMvO0PieUsi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;b&gt;&lt;span id="xdx_864_zokZsbbIL4dd"&gt;Promissory Note Receivable&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Receivables
from NextPlay under the promissory note as described in &lt;b&gt;NOTE 1 &#x2013; Business Description and Going Concern&lt;/b&gt; were $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBvEy3SmY4Dj" title="Accounts receivable"&gt;2,567,665&lt;/span&gt;
and $&lt;span id="xdx_909_eus-gaap--AccountsReceivableNet_iI_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zbPdvDoogrB8" title="Accounts receivable"&gt;1,933,908&lt;/span&gt; respectively. Management has determined that, since NextPlay is in default under the terms of the promissory note, collectability
of the entire related party receivable as of February 29, 2024 is uncertain, and has therefore established an allowance for doubtful
accounts of $&lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_ziXkWVEdo8g8" title="Allowance for doubtful accounts"&gt;1,567,665&lt;/span&gt;. As of February 28, 2023, &lt;span id="xdx_902_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z7sMx8ABAG27" title="Allowance for doubtful accounts"&gt;no&lt;/span&gt; allowance for doubtful accounts was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:PromissoryNoteReceivablePolicyTextBlock>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000649"
      unitRef="USD">2567665</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000651"
      unitRef="USD">1933908</us-gaap:AccountsReceivableNet>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000653"
      unitRef="USD">1567665</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact000655"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000657">&lt;p id="xdx_848_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zWWo5BaTFOzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_866_zpFrPVg4yYSa"&gt;Property
and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Recognition
and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Items
of property and equipment are measured at cost less accumulated depreciation and accumulated impairment losses. When parts of an item
of property and equipment have different estimated useful lives, they are accounted for as separate items within property and equipment.
The costs of the ongoing regular repairs and maintenance of property and equipment are recognized in the period in which they are incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Depreciation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
is recognized in profit or loss over the estimated useful lives of each part of an item of property and equipment in a manner that most
closely reflects management&#x2019;s estimated future consumption of the future economic benefits embodied in the asset. The estimated
useful lives for the Company&#x2019;s property and equipment are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BF_zmJtEukZpK03"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zniJYxbMVy04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000659">&lt;p id="xdx_894_ecustom--ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock_zSMRh27w5Ai2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span style="display: none"&gt;&lt;span id="xdx_8BF_zmJtEukZpK03"&gt;Schedule
of Estimated
Useful Lives for Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furniture
    &amp;amp; Fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_ztqTWAP3dTdj" title="Estimated useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Computer
    &amp;amp; Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20240229__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zvzWOHXoQLU6" title="Estimated useful life"&gt;3&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</NTRP:ScheduleOfEstimatedUsefulLivesForPropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember"
      id="Fact000661">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember"
      id="Fact000663">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="From2023-03-012024-02-29" id="Fact000665">&lt;p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_z1ThpQpoPZ04" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zZw8ET0O8Acd"&gt;Intangible
assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company measures separately acquired intangible assets at cost less accumulated amortization and impairment losses. The Company recognizes
internally developed intangible assets when it has determined that the completion of such is technically feasible, and the Company has
sufficient resources to complete the development. Subsequent expenditures are capitalized when they increase the future economic benefits
of the associated asset. All other expenditures are recorded in profit or loss as incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company assesses whether the life of intangible asset is finite or indefinite. The Company reviews the amortization method and period
of use of its intangible assets at least annually. Changes in the expected useful life or period of consumption of future economic benefits
associated with the asset are accounted for prospectively by changing the amortization method or period as a change in accounting estimates
in profit or loss. The Company has assessed the useful life of its trademarks as indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_z9Q4puhFe4G4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000667">&lt;p id="xdx_891_ecustom--ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock_z8mWlk6QYPL3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated useful lives for the Company&#x2019;s finite life intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BA_z3yAQ8BJA8Vb" style="display: none"&gt;Schedule
of Estimated
Useful Lives for Finite Life Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Category&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Method&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Estimated
    useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MinimumMember_zzvKjMs8W8Mi" title="Estimated useful life"&gt;1&lt;/span&gt;
    - &lt;span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember__srt--RangeAxis__srt--MaximumMember_zCSmFcoJVX7c" title="Estimated useful life"&gt;3&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Software
    licenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Straight
    line&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MinimumMember_zaWfj77leiyj" title="Estimated useful life"&gt;0.5&lt;/span&gt;
    - &lt;span id="xdx_90F_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20240229__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember__srt--RangeAxis__srt--MaximumMember_zaHR23opW0cf" title="Estimated useful life"&gt;4&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</NTRP:ScheduleOfEstimatedUsefulLivesForFiniteLifeIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-02-29_custom_SoftwareMember_srt_MinimumMember"
      id="Fact000669">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-02-29_custom_SoftwareMember_srt_MaximumMember"
      id="Fact000671">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MinimumMember"
      id="Fact000673">P0Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember_srt_MaximumMember"
      id="Fact000675">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy contextRef="From2023-03-012024-02-29" id="Fact000677">&lt;p id="xdx_849_eus-gaap--InternalUseSoftwarePolicy_zwvkT5vMbYIk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_864_zl75EYJYMjS"&gt;Software
Development Costs&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company capitalizes internal software development costs subsequent to establishing technological feasibility of a software application
in accordance with guidelines established by &#x201c;&lt;span style="text-decoration: underline"&gt;ASC 985-20-25&lt;/span&gt;&#x201d; Accounting for the Costs of Software to Be Sold, Leased,
or Otherwise Marketed, requiring certain software development costs to be capitalized upon the establishment of technological feasibility.
The establishment of technological feasibility and the ongoing assessment of the recoverability of these costs require considerable judgment
by management with respect to certain external factors such as anticipated future revenue, estimated economic life, and changes in software
and hardware technologies. Amortization of the capitalized software development costs begins when the product is available for general
release to customers. Capitalized costs are amortized based on the straight-line method over the remaining estimated economic life of
the product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy contextRef="From2023-03-012024-02-29" id="Fact000679">&lt;p id="xdx_84F_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zvFWfDgI5X13" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_861_zZXLjEm7sf2a"&gt;Impairment
of Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC 350-30-65 &#x201c;&lt;span style="text-decoration: underline"&gt;Goodwill and Other Intangible Assets&lt;/span&gt;&#x201d;, the Company assesses the impairment of identifiable
intangible assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors the Company
considers important, which could trigger an impairment review include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1.
Significant underperformance compared to historical or projected future operating results.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;2.
Significant changes in the manner or use of the acquired assets or the strategy for the overall business, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;3.
Significant negative industry or economic trends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the Company determines that the carrying value of an intangible asset may not be recoverable based upon the existence of one or more
of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows,
the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using
a discount rate determined by management to be commensurate with the risk inherent to the current business model. Significant management
judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. Intangible assets that have
finite useful lives are amortized over their useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000681">&lt;p id="xdx_84C_eus-gaap--LesseeLeasesPolicyTextBlock_zwKwrmEoAexe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zDAn9CatPkj2"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheets. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ROU
assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease
payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present
value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we generally use our incremental
borrowing rate based on the estimated rate of interest for collateralized borrowing over a similar term of the lease payments at commencement
date. The operating lease ROU asset also includes any lease payments made and excludes lease incentives. Our lease terms may include
options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments
is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2023-03-012024-02-29" id="Fact000683">&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zazYsWsiYD9a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zi4sOZJnCCHi"&gt;Reclassification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2023-03-012024-02-29" id="Fact000685">&lt;p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_ztnZGNMpNbla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86B_zgQEEVdQUtyc"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company follows accounting guidelines on fair value measurements for financial instruments measured on a recurring basis, as well as
for certain assets and liabilities that are initially recorded at their estimated fair values. Fair Value is defined as the exit price,
or the amount that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
as the measurement date. The Company uses the following three-level hierarchy that maximizes the use of observable inputs and minimizes
the use of unobservable inputs to value its financial instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    1: Observable inputs such as unadjusted quoted prices in active markets for identical instruments.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    2: Quoted prices for similar instruments that are directly or indirectly observable in the marketplace.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
    3: Significant unobservable inputs which are supported by little or no market activity and that are financial instruments whose values
    are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which
    the determination of fair value requires a significant judgment or estimation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial
instruments measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair
value measurement. The Company&#x2019;s assessment of the significance of a particular input to the fair value measurement in its entirety
requires it to make judgments and consider factors specific to the asset or liability. The use of different assumptions and/or estimation
methodologies may have a material effect on estimated fair values. Accordingly, the fair value estimates disclosed, or initial amounts
recorded may not be indicative of the amount that the Company or holders of the instruments could realize in a current market exchange.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying amounts of the Company&#x2019;s financial instruments including cash, accounts receivable, accounts payable, accrued expenses,
convertible notes and notes payable are of approximately fair value due to the short-term maturities of these instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:MarketRiskBenefitPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000687">&lt;p id="xdx_84C_eus-gaap--MarketRiskBenefitPolicyTextBlock_ztZNTINE94t6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_868_zDSoyoXIgVT3"&gt;Concentration
of Credit Risk&lt;/span&gt; -&lt;/b&gt; The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The
Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on its cash and
cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:MarketRiskBenefitPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2023-03-012024-02-29" id="Fact000689">&lt;p id="xdx_84D_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zDu3emIxc3X7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_865_zPNXd2HD4tXl"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/b&gt; &#x2013; The Company recognizes compensation costs to employees under ASC Topic No. 718, &#x201c;Compensation &#x2013;
Stock Compensation.&#x201d; Under ASC Topic No. 718, companies are required to measure the compensation costs of share-based compensation
arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees
are required to provide services. Share based compensation arrangements may include stock options, grants of shares of common stock with
and without restrictions, performance-based awards, share appreciation rights and employee share purchase plans. As such, compensation
cost is measured on the date of grant at its fair value. Such compensation amounts, if any, are amortized over the respective vesting
periods of the option or stock grants.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: -0.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Equity
instruments issued to non-employees are recorded on the basis of the fair value of the instruments, as required by ASC Topic No. 718.
In general, the measurement date is either (a) when a performance commitment, as defined, is reached or (b) the earlier of the date that
(i) the non-employee performance requirement is complete or (ii) the instruments are vested. The measured value related to the instruments
is recognized over a period based on the facts and circumstances of each particular grant as defined in the FASB Accounting Standards
Codification.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000691">&lt;p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zoUehf2CANRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86A_zwZ4eZtFf9M"&gt;Revenue
Recognition&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company recognizes revenue in accordance with ASC Topic No. 606. In
May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2014-09, &lt;i&gt;Revenue from Contracts
with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition
guidance under prior U.S. GAAP and replaced it with a principles-based approach for determining revenue recognition. The core principle
of the standard is the recognition of revenue upon the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the company expects to be entitled in exchange for those goods or services. In general, we determine revenue
recognition by: (1) identifying the contract, or contracts, with our customer; (2) identifying the performance obligations in the contract;
(3) determining the transaction price; (4) allocating the transaction price to performance obligations in the contract; and (5) recognizing
revenue when, or as, we satisfy performance obligations by transferring the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company are recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000693">&lt;p id="xdx_84C_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_z1eTiudxu4T1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_867_zOLzEHL5GHJ7"&gt;Sales
and Marketing&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling
and administration expenses consist primarily of marketing and promotional expenses, expenses related to our participation in industry
conferences, and public relations expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sales
and marketing expenses are charged to expense as incurred and are included in selling and promotions expenses in the accompanying consolidated
financial statements. Sales and marketing expense for the years ended February 29, 2024, and February 28, 2023 was $&lt;span id="xdx_905_eus-gaap--SellingAndMarketingExpense_c20230301__20240229_zv5DkjtVHw6b" title="Sales and marketing expense"&gt;484,250&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--SellingAndMarketingExpense_c20220301__20230228_zj2522yghbJ6" title="Sales and marketing expense"&gt;707,137&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000695"
      unitRef="USD">484250</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000697"
      unitRef="USD">707137</us-gaap:SellingAndMarketingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000699">&lt;p id="xdx_847_eus-gaap--IncomeTaxPolicyTextBlock_zhxOkI2P3rRd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_86D_zQm8MXm4rQE8"&gt;Income
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740, &#x201c;Accounting for Income Taxes.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred
tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation
allowance on deferred tax assets is established when management considers it is more likely than not that some portion or all of the
deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Tax
benefits from an uncertain tax position are only recognized if it is more likely than not that the tax position will be sustained on
examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated
financial statements from such a position are measured based on the largest benefit that has a greater than fifty percent likelihood
of being realized upon ultimate resolution. Interest and penalties related to unrecognized tax benefits are recorded as incurred as a
component of income tax expense. The Company has not recognized any tax benefits from uncertain tax positions for any of the reporting
periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has no tax positions at February 29, 2024 and 2023 for which the ultimate deductibility is highly uncertain but for which there
is uncertainty about the timing of such deductibility.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During
the years ended February 29, 2024 and February 28, 2023, the Company recognized no interest and penalties. All tax years starting with
2019 are open for examination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2023-03-012024-02-29" id="Fact000701">&lt;p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zNkTwcecrh59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_862_zU9TY6EvEIne"&gt;Recently
adopted accounting pronouncements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
August 2020, the FASB issued ASU 2020-06, Debt&#x2014;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;
Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40). The FASB issued this ASU to address issues identified as a result of the complexity
associated with GAAP for certain financial instruments with characteristics of liabilities and equity. Complexity associated with the
accounting is a significant contributing factor to numerous financial statement restatements and results in complexity for users attempting
to understand the results of applying the current guidance. In addressing the complexity, the FASB focused on amending the guidance on
convertible instruments and the guidance on the derivatives scope exception for contracts in an entity&#x2019;s own equity. For convertible
instruments, the FASB decided to reduce the number of accounting models for convertible debt instruments and convertible preferred stock.
Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared
with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features
that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for
a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums
are recorded as paid-in capital. The FASB concluded that eliminating certain accounting models simplifies the accounting for convertible
instruments, reduces complexity for preparers and practitioners, and improves the decision usefulness and relevance of the information
provided to financial statement users. In addition to eliminating certain accounting models, the FASB also decided to enhance information
transparency by making targeted improvements to the disclosures for convertible instruments and earnings-per-share (EPS) guidance on
the basis of feedback from financial statement users. The FASB decided to amend the guidance for the derivatives scope exception for
contracts in an entity&#x2019;s own equity to reduce form-over-substance-based accounting conclusions. The FASB observed that the application
of the derivatives scope exception guidance results in accounting for some contracts as derivatives while accounting for economically
similar contracts as equity. The FASB also decided to improve and amend the related EPS guidance. The amendments in this ASU are effective
for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted,
but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The FASB specified
that an entity should adopt the guidance as of the beginning of its annual fiscal year. The FASB decided to allow entities to adopt the
guidance through either a modified retrospective method of transition or a fully retrospective method of transition. The Company adopted
ASU 2020-06 on March 1, 2022 on a prospective basis. The adoption of this standard did not have an impact on the Company&#x2019;s consolidated
financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt&#x2014;Modifications and Extinguishments (Subtopic 470-50),
Compensation&#x2014;Stock Compensation (Topic 718), and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic
815-40): Issuer&#x2019;s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. ASU
2021-04 requires accounting for modifications or exchanges of freestanding equity-classified written call options (for example, warrants)
that remain equity classified after the modification or exchange based on the economic substance of the modification or exchange. The
recognition of the modification depends on the nature of the transaction in which the equity-classified written call option is modified.
If there is more than one element in a transaction (for example, if the modification involves both a debt modification and an equity
issuance), then the guidance requires allocating the effect of the option modification to each element. ASU 2021-04 is effective for
the Company beginning in the first quarter of 2022. ASU 2021-04 should be applied prospectively to modifications or exchanges occurring
on or after the effective date of the amendments. The Company adopted ASU 2021-04 on March 1, 2022 on a prospective basis. The adoption
of this standard did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
March 2022, the FASB issued ASU 2022-02, ASC Subtopic 326 &#x201c;Credit Losses&#x201d;: Troubled Debt Restructurings and Vintage Disclosures.
Since the issuance of Accounting Standards Update No. 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of
Credit Losses on Financial Instruments, the Board has provided resources to monitor and assist stakeholders with the implementation of
Topic 326. Post-Implementation Review (PIR) activities have included forming a Credit Losses Transition Resource Group, conducting outreach
with stakeholders of all types, developing educational materials and staff question-and-answer guidance, conducting educational workshops,
and performing an archival review of financial reports. ASU No. 2022-02 is effective for annual and interim periods beginning after December
15, 2022. The adoption of this standard did not have an impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will
have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000703">&lt;p id="xdx_803_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_zHCFg0lCGF38" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_825_ze8xQaKCsNPl"&gt;Discontinued Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal year ended February 29, 2024, the Company completed the sale of certain assets of Sigma Additive Solutions, Inc., which has
been classified as discontinued operations in accordance with ASC 205-20, &#x201c;Presentation of Financial Statements &#x2013; Discontinued
Operations.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 6, 2023, the Company entered into a definitive asset purchase agreement (&#x201c;APA&#x201d;) with Divergent Technologies, Inc.,
(&#x201c;Divergent&#x201d;), pursuant to which the Company agreed to sell to Divergent, and Divergent agreed to purchase from us, certain
assets consisting primarily of patents, software code and other intellectual property for a purchase price of $&lt;span id="xdx_907_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zxJcJxQr6Uff" title="Purchase price"&gt;1,626,242&lt;/span&gt;, including a
$&lt;span id="xdx_90E_ecustom--EarnestMoneyDeposit_iI_c20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zrFjlhjEZsGh" title="Earnest money deposit"&gt;37,000&lt;/span&gt; earnest-money deposit previously paid to us by Divergent. The closing under the Asset Purchase Agreement occurred subsequent
to the closing of the reverse acquisition with NextTrip on January 12, 2024. The parties&#x2019; respective obligations to close were
subject to the accuracy of the parties&#x2019; respective representations and warranties and performance of their respective covenants
and satisfaction or waiver of other customary conditions specified in the Asset Purchase Agreement. In the interim, between the signing
date and closing date or termination of the Asset Purchase Agreement, Sigma granted Divergent a non-exclusive, nontransferable, non-sublicensable
(except to Divergent customers and affiliates), limited, irrevocable (except in connection with the termination of the Asset Purchase
Agreement), worldwide, royalty-free license to the &#x201c;Licensed IP&#x201d; (as defined) for testing, evaluation, and commercialization
purposes. A gain of $&lt;span id="xdx_90E_eus-gaap--GainLossOnDispositionOfAssets1_c20231006__20231006__us-gaap--TypeOfArrangementAxis__custom--AssetPurchaseAgreementMember__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zk1mrDjw3uUd" title="Asset disposition"&gt;30,515&lt;/span&gt; was recognized in the asset disposition transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended February 29, 2024, the Company recorded a loss of $&lt;span id="xdx_904_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iN_di_c20230301__20240229_zeTfq5WMGYyf" title="Loss of discontinued operations"&gt;675,314&lt;/span&gt; from discontinued operations as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zspOW6uJbF67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zFJHwNhQ5ew8" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230301__20240229_zLmFzUI83NA" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zQJi1B0w3Wbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,006&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zLmAEEUy63K5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zDE4WqxhGyXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Gross Profit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,006&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_maDGIDOzcGq_zvoNuuDeMlIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Salaries and benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_maDGIDOzcGq_zAzoLiABURl6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retention bonuses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationSeverance_maDGIDOzcGq_zsLZdk5FYSb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Severance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_maDGIDOzcGq_zR0TkxyWbB7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Organization costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zf4wrCCLOaoh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zcs3dGLy8rPi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total Expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;680,320&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zgDaX1rFDR5g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from Discontinued Operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zIBFAHsMzmJ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000705"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <NTRP:EarnestMoneyDeposit
      contextRef="AsOf2023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000707"
      unitRef="USD">37000</NTRP:EarnestMoneyDeposit>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="From2023-10-062023-10-06_custom_AssetPurchaseAgreementMember_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000709"
      unitRef="USD">30515</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000711"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="From2023-03-012024-02-29" id="Fact000713">&lt;p id="xdx_89A_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zspOW6uJbF67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zFJHwNhQ5ew8" style="display: none"&gt;Schedule
of Discontinued Operations&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230301__20240229_zLmFzUI83NA" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzv4w_zQJi1B0w3Wbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,006&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzv4w_zLmAEEUy63K5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Cost of revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0717"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzv4w_maDGIDOzv2d_zDE4WqxhGyXl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Gross Profit&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;5,006&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits_maDGIDOzcGq_zvoNuuDeMlIk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Salaries and benefits&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;28,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DisposalGroupIncludingDiscontinuedOperationRetentionBonuses_maDGIDOzcGq_zAzoLiABURl6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Retention bonuses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;528,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationSeverance_maDGIDOzcGq_zsLZdk5FYSb8" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Severance&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;62,500&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--DisposalGroupIncludingDiscontinuedOperationOrganizationCosts_maDGIDOzcGq_zR0TkxyWbB7a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Organization costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;63,600&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationsOtherIncome_maDGIDOzcGq_zf4wrCCLOaoh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Other income&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,185&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzcGq_msDGIDOzv2d_zcs3dGLy8rPi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Total Expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;680,320&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTax_iT_mtDGIDOzv2d_zgDaX1rFDR5g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Loss from Discontinued Operations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000715"
      unitRef="USD">5006</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000719"
      unitRef="USD">5006</us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000721"
      unitRef="USD">28475</NTRP:DisposalGroupIncludingDiscontinuedOperationSalariesAndBenefits>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationRetentionBonuses
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000723"
      unitRef="USD">528930</NTRP:DisposalGroupIncludingDiscontinuedOperationRetentionBonuses>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationSeverance
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000725"
      unitRef="USD">62500</NTRP:DisposalGroupIncludingDiscontinuedOperationSeverance>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationOrganizationCosts
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000727"
      unitRef="USD">63600</NTRP:DisposalGroupIncludingDiscontinuedOperationOrganizationCosts>
    <NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000729"
      unitRef="USD">-3185</NTRP:DisposalGroupIncludingDiscontinuedOperationsOtherIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000731"
      unitRef="USD">680320</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000733"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock contextRef="From2023-03-012024-02-29" id="Fact000735">&lt;p id="xdx_801_ecustom--PrepaidExpensesAndOtherCurrentAssetsTextBlock_zYfB9V0sTqj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 - &lt;span id="xdx_823_zK7Bo5ikQCZf"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zVCnlkJWw6vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
and other current assets consisted of the following as of February 29, 2024 and as of February 28, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B5_zcDtWDvTfd0f" style="display: none"&gt;Schedule
of Prepaid and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240229_zqPJ57abXlch" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230228_znNv015iUfVc" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zBvMxNj4q7s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Prepaid marketing expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zGnmmlyN62Xb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid other expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;298,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_zD3GV9zMebki" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;42,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_zgwEybw2ARma" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;340,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,613&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zY0TS1rL3iIj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000737">&lt;p id="xdx_895_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zVCnlkJWw6vd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prepaid
and other current assets consisted of the following as of February 29, 2024 and as of February 28, 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span&gt;&lt;span id="xdx_8B5_zcDtWDvTfd0f" style="display: none"&gt;Schedule
of Prepaid and Other Current Assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49E_20240229_zqPJ57abXlch" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230228_znNv015iUfVc" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--PrepaidAdvertising_iI_maPEAOAzw6s_zBvMxNj4q7s9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Prepaid marketing expenses&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherPrepaidExpenseCurrent_iI_maPEAOAzw6s_zGnmmlyN62Xb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid other expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;298,274&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;8,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PrepaidCostOfSales_iI_maPEAOAzw6s_zD3GV9zMebki" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Prepaid cost of sales&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;42,547&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_mtPEAOAzw6s_zgwEybw2ARma" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;340,921&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;8,613&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000739"
      unitRef="USD">100</us-gaap:PrepaidAdvertising>
    <us-gaap:PrepaidAdvertising
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000740"
      unitRef="USD">100</us-gaap:PrepaidAdvertising>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000742"
      unitRef="USD">298274</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000743"
      unitRef="USD">8513</us-gaap:OtherPrepaidExpenseCurrent>
    <NTRP:PrepaidCostOfSales
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000745"
      unitRef="USD">42547</NTRP:PrepaidCostOfSales>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000748"
      unitRef="USD">340921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000749"
      unitRef="USD">8613</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2023-03-012024-02-29" id="Fact000751">&lt;p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zOSHswfS6Zd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_82B_zYja0lqoGDzk"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determined that the arrangement was an operating lease at inception and included it in operating lease right-of-use (&#x201c;ROU&#x201d;)
assets, operating lease liabilities - current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023.
The office facility was occupied by NextTrip employees through March 16, 2023, when the landlord informed the NextTrip that would not
recognize NextTrip as the tenant. The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately
unsuccessful, and as a result derecognized the lease in the financial statements as of February 29, 2024. No restatement was made for
fiscal year 2023 as the Company had use of the offices at that time and was in negotiations to assume the lease from NextPlay Technologies,
Inc. No payments have been made on the lease and no expense has been recognized for the year ended February 29, 2024. Rent expense for the year ended February 28, 2023 was $&lt;span id="xdx_90C_eus-gaap--OperatingLeasesRentExpenseNet_c20220301__20230228_zd83MwsvpiSl" title="Rent expense"&gt;40,554&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000753"
      unitRef="USD">40554</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000755">&lt;p id="xdx_807_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zljuX8EqEuQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 - &lt;span id="xdx_82B_zfpt5DQVS2Z5"&gt;Property and Equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIh2ZEQDqJ0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment as of February 29, 2024, and February 28, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zrxnKfDl0uy2" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_znd8yztfslTk" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230228_zhsm8QhKGPEj" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRQ2QskFsU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zB0mQgDjUIpl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,492&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zGz2ohFpxjeh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99,510&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;90,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zoHK50A27lB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(92,868&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(74,030&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zVBz1Kt5yYd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and Equipment, net of depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,642&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;16,226&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z44mTML7o006" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Depreciation
expense for the years ended February 29, 2024, and February 28, 2023 was $&lt;span id="xdx_906_eus-gaap--Depreciation_c20230301__20240229_zyR0XnAW9mE6" title="Depreciation expense"&gt;18,838&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--Depreciation_c20220301__20230228_zBFlSoyJdpK2" title="Depreciation expense"&gt;30,386&lt;/span&gt;, respectively, and is recorded in operating
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 29, 2024, and February 28, 2023, the Company acquired property and equipment of $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20230301__20240229_z6fY6DCfUJF2" title="Property and equipment"&gt;9,253&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_c20220301__20230228_zjwLTWO2FKJ1" title="Property and equipment"&gt;2,928&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2023-03-012024-02-29" id="Fact000757">&lt;p id="xdx_891_eus-gaap--PropertyPlantAndEquipmentTextBlock_zIh2ZEQDqJ0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment as of February 29, 2024, and February 28, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B2_zrxnKfDl0uy2" style="display: none"&gt;Schedule
of Property and Equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_znd8yztfslTk" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230228_zhsm8QhKGPEj" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zRQ2QskFsU9f" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Furniture and Fixtures&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;17,018&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zB0mQgDjUIpl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Computer and Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;82,492&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,238&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--PropertyPlantAndEquipmentGross_iI_maPPAENzyNw_zGz2ohFpxjeh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;99,510&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;90,256&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_msPPAENzyNw_zoHK50A27lB" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(92,868&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(74,030&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--PropertyPlantAndEquipmentNet_iTI_mtPPAENzyNw_zVBz1Kt5yYd3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Property and Equipment, net of depreciation&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;6,642&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;16,226&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000759"
      unitRef="USD">17018</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_FurnitureAndFixturesMember"
      decimals="0"
      id="Fact000760"
      unitRef="USD">17018</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000762"
      unitRef="USD">82492</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28_us-gaap_ComputerEquipmentMember"
      decimals="0"
      id="Fact000763"
      unitRef="USD">73238</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000765"
      unitRef="USD">99510</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000766"
      unitRef="USD">90256</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000768"
      unitRef="USD">92868</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000769"
      unitRef="USD">74030</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000771"
      unitRef="USD">6642</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000772"
      unitRef="USD">16226</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000774"
      unitRef="USD">18838</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000776"
      unitRef="USD">30386</us-gaap:Depreciation>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000778"
      unitRef="USD">9253</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000780"
      unitRef="USD">2928</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000782">&lt;p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zVYFFpNKFXPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - &lt;span id="xdx_828_zYoY3M4ha6U6"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zO1HTTvrUDY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of February 29, 2024, and February 28, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zgo5YWMjDBfl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zrDVWbd38xfh" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230228_zmKckj41Tnt5" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zxBbl1Pim1Y" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,908,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zD40Mz2DEGui" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;467,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zMJpTXH2eG1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zAy0at1JXwz3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,382,212&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zayVjVpyCGAb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,774,542&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zQUKwIYoULx1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,607,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_zy9n6F23RI0e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the years ended February 29, 2024, and February 28, 2023 was $&lt;span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20240229_zknujk8DHPWh" title="Amortization"&gt;1,449,925&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20220301__20230228_zo2bRN8czsGi" title="Amortization"&gt;676,853&lt;/span&gt;, respectively, and recorded in operating
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 29, 2024, and February 28, 2023, the Company recorded no impairment losses associated with the carrying value
exceeding its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zU58TvfWVn3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The estimated aggregate amortization
expense for each of the succeeding years ending February 28 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zsOopBpmQzkj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Estimated Aggregate Amortization Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20240229_zrlf0dRvuEok" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zsH7hkik1xyc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025 (Remaining)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zAXCR42xSU57" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;660,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zxzDuRyyVaTi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zdfBL5UrbNAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,498&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zTfOo78Any02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_zZD48rJHnVX" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;845,228&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A6_z1aPnAnQzyhj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000784">&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zO1HTTvrUDY8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of February 29, 2024, and February 28, 2023 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zgo5YWMjDBfl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240229_zrDVWbd38xfh" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29, &lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230228_zmKckj41Tnt5" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 28, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zxBbl1Pim1Y" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;5,908,353&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicenseMember_zD40Mz2DEGui" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;467,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zMJpTXH2eG1c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zAy0at1JXwz3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,382,212&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zayVjVpyCGAb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(3,774,542&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_zQUKwIYoULx1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,607,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact000786"
      unitRef="USD">6602028</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-02-28_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact000787"
      unitRef="USD">5908353</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact000789"
      unitRef="USD">789576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-02-28_custom_SoftwareLicenseMember"
      decimals="0"
      id="Fact000790"
      unitRef="USD">467576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact000792"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-02-28_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact000793"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000795"
      unitRef="USD">7397887</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000796"
      unitRef="USD">6382212</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000798"
      unitRef="USD">5224467</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000799"
      unitRef="USD">3774542</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000801"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000802"
      unitRef="USD">2607670</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000804"
      unitRef="USD">1449925</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000806"
      unitRef="USD">676853</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000808">&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zU58TvfWVn3k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The estimated aggregate amortization
expense for each of the succeeding years ending February 28 is as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BD_zsOopBpmQzkj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Estimated Aggregate Amortization Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20240229_zrlf0dRvuEok" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zsH7hkik1xyc" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2025 (Remaining)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zAXCR42xSU57" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;660,578&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zxzDuRyyVaTi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;172,152&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zdfBL5UrbNAh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;12,498&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zTfOo78Any02" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0818"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_zZD48rJHnVX" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;845,228&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000812"
      unitRef="USD">660578</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000814"
      unitRef="USD">172152</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000816"
      unitRef="USD">12498</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000820"
      unitRef="USD">845228</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000822">&lt;p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zvcHrVcdP8Vc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 &#x2013; &lt;span id="xdx_823_zRfNrhMYhBJc"&gt;Goodwill&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
discussed in Note 1, the legal acquisition of NextTrip by Sigma Additive Solutions, Inc. was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table presents the allocation of the $&lt;span id="xdx_903_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zc5R8nYrAQ5b" title="Consideration transferred"&gt;2,368,418&lt;/span&gt; million consideration for the acquisition and summarizes the estimated fair
values of the Sigma (the accounting acquiree) assets acquired and liabilities assumed for NextTrip (the accounting acquirer). The estimated
consideration of approximately $&lt;span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_z7yjAcdaE3ah" title="Consideration transferred"&gt;2,368,418&lt;/span&gt; million is based on Sigma&#x2019;s closing share price of $&lt;span id="xdx_90A_eus-gaap--BusinessAcquisitionSharePrice_iI_pid_c20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zU7DMtPv8M15" title="Share price"&gt;3.0229&lt;/span&gt; as reported on Nasdaq on December
29, 2023 multiplied by the &lt;span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20231012_znCS7ZvRdSLb" title="Shares outstanding"&gt;780,423&lt;/span&gt; shares outstanding as of that date and the fair value of Series E Preferred Stock into &lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20231012__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zQv8pKIWaOL" title="Shares outstanding"&gt;3,069&lt;/span&gt; common
shares.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zU0HpIBWcCgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z0FBKE9xRo36" style="display: none"&gt;Schedule
of Fair Value of Assets Acquired&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zelEWS0SL4vi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;Fair Value of Net Assets Acquired:&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zRblBXCjObF3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;417,121&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_zTUEQnFulc8h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts Receivable, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zswCb8QG6JF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;257,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zzOi4JPFnZhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_zvXyQ7boHzP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_zXsuhXCfxOgf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,277,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zxzxBl7aRk0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(837,450&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zsfUNLIaEDFj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,001&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zw77aao7ReK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,218&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_zgrJKj8JaD1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total identifiable net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,148,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z26jriaUM0Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zmwtgIElz11i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Fair Value of Net Assets Acquired&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Purchase Consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zd0P6YPMG0Zj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zbckVppMMHZ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#x2019;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#x2019;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#x2019;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#x201c;IPO&#x201d;) transaction. In the reverse acquisition, $&lt;span id="xdx_906_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zzEb0MmaLE96" title="Goodwill"&gt;52,310&lt;/span&gt; of goodwill was allocated
to the Sigma Reporting Unit and $&lt;span id="xdx_90B_eus-gaap--GoodwillPeriodIncreaseDecrease_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGsUMETXeva7" title="Goodwill"&gt;1,167,805&lt;/span&gt; of goodwill was allocated to the NextTrip Reporting Unit under the acquisition method of accounting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
combined Company consists of two reporting units, Sigma and NextTrip. As the accounting acquirer in the reverse acquisition, NextTrip
is considered to be an existing reporting unit and Sigma is considered to be a new reporting unit in that it is not in the same business
as NextTrip. Accordingly, the reverse acquisition creates a new reporting unit which holds the Sigma business constituting an asset held
for sale as a result of the agreement for the sale of certain Sigma assets to Divergent 3D (&#x201c;Divergent&#x201d;) for a sales price
of $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zpSrraxdgqi7" title="Purchase price"&gt;1,626,242&lt;/span&gt;. As such, the fair value of the Sigma Reporting Unit is determined to be $&lt;span id="xdx_900_eus-gaap--PaymentsToAcquireIntangibleAssets_c20231012__20231012__dei--LegalEntityAxis__custom--DivergentTechnologiesIncMember_zFpRVgsbDeg1" title="Purchase price"&gt;1,626,242&lt;/span&gt; with the difference of $&lt;span id="xdx_90C_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwsfPzk1AYQ" title="Purchase consideration"&gt;742,176&lt;/span&gt; from
the purchase consideration being allocated to the NextTrip Reporting Unit. The assets being sold to Divergent and the liabilities being
relieved from the Divergent transaction are assigned to the Sigma Reporting unit with the difference between the net fair value of those
assets and liabilities and the Sigma Reporting Unit being assigned to goodwill. The goodwill being assigned to the NextTrip Reporting
Unit is determined by the difference between the purchase consideration assigned to the NextTrip Reporting Unit and the net acquired
Sigma assets and liabilities assumed that are assigned to the NextTrip Reporting Unit. A gain of $&lt;span id="xdx_906_eus-gaap--GainLossOnDispositionOfAssets_c20231012__20231012_zDq8bEsFkXnl" title="Gain on disposition transaction"&gt;37,592&lt;/span&gt; was recognized in the disposition
transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zg3u7Jy9ySTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
is a reconciliation of goodwill as of February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zvUpXkpYVqPb" style="display: none"&gt;Schedule
of Reconciliation of Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230301__20240229_zKO6pqSRKh5k" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_zJrrrh79dZXd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Reverse acquisition of Sigma Additive Solutions, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GoodwillPeriodIncreaseDecrease_zk91tNEAKvO" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Reduction from sale of assets to Divergent Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52,310&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Goodwill_iE_zJxyuoFGa3Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,167,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zGdVHBz6bLO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000824"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000826"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessAcquisitionSharePrice
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="INF"
      id="Fact000828"
      unitRef="USDPShares">3.0229</us-gaap:BusinessAcquisitionSharePrice>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-10-12"
      decimals="INF"
      id="Fact000830"
      unitRef="Shares">780423</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-10-12_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact000832"
      unitRef="Shares">3069</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000834">&lt;p id="xdx_89A_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zU0HpIBWcCgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BB_z0FBKE9xRo36" style="display: none"&gt;Schedule
of Fair Value of Assets Acquired&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zelEWS0SL4vi" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="5" style="font-weight: bold; text-align: center"&gt;Fair Value of Net Assets Acquired:&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_maBCRIAzMVe_zRblBXCjObF3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%"&gt;Cash&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;417,121&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_maBCRIAzMVe_zTUEQnFulc8h" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accounts Receivable, net&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4,900&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_maBCRIAzMVe_zswCb8QG6JF7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;257,873&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_maBCRIAzMVe_zzOi4JPFnZhb" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Prepaid expenses and other current assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;50,802&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_maBCRIAzMVe_zvXyQ7boHzP1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Property and equipment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;52,357&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_maBCRIAzMVe_zXsuhXCfxOgf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Intangible assets&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,277,919&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_msBCRIAzMVe_zxzxBl7aRk0b" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accounts payable&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(837,450&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses_iNI_di_msBCRIAzMVe_zsfUNLIaEDFj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Accrued expenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,001&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_di_msBCRIAzMVe_zw77aao7ReK5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Deferred revenue&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(14,218&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtBCRIAzMVe_maBCRIAzevg_zgrJKj8JaD1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Total identifiable net assets acquired&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,148,303&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--Goodwill_iI_maBCRIAzevg_z26jriaUM0Bi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_mtBCRIAzevg_zmwtgIElz11i" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Fair Value of Net Assets Acquired&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Total Purchase Consideration&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--BusinessCombinationConsiderationTransferred1_c20231012__20231012__us-gaap--BusinessAcquisitionAxis__custom--SigmaAdditiveSolutionsIncMember_zd0P6YPMG0Zj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,368,418&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000836"
      unitRef="USD">417121</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000838"
      unitRef="USD">4900</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000840"
      unitRef="USD">257873</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000842"
      unitRef="USD">50802</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000844"
      unitRef="USD">52357</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">1277919</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000848"
      unitRef="USD">837450</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000850"
      unitRef="USD">61001</NTRP:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">14218</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000854"
      unitRef="USD">1148303</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000856"
      unitRef="USD">1220115</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="AsOf2023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000858"
      unitRef="USD">2368418</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000859"
      unitRef="USD">2368418</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2023-10-122023-10-12_custom_SigmaAdditiveSolutionsIncMember"
      decimals="0"
      id="Fact000861"
      unitRef="USD">52310</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember"
      decimals="0"
      id="Fact000863"
      unitRef="USD">1167805</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000865"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2023-10-122023-10-12_custom_DivergentTechnologiesIncMember"
      decimals="0"
      id="Fact000867"
      unitRef="USD">1626242</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2023-10-122023-10-12_custom_NextTripHoldingsIncMember"
      decimals="0"
      id="Fact000869"
      unitRef="USD">742176</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="From2023-10-122023-10-12"
      decimals="0"
      id="Fact000871"
      unitRef="USD">37592</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="From2023-03-012024-02-29" id="Fact000873">&lt;p id="xdx_890_eus-gaap--ScheduleOfGoodwillTextBlock_zg3u7Jy9ySTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
is a reconciliation of goodwill as of February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_zvUpXkpYVqPb" style="display: none"&gt;Schedule
of Reconciliation of Goodwill&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20230301__20240229_zKO6pqSRKh5k" style="border-bottom: Black 1pt solid; text-align: center"&gt;February 29,&lt;br/&gt; 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GoodwillAcquiredDuringPeriod_zJrrrh79dZXd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Reverse acquisition of Sigma Additive Solutions, Inc.&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,220,115&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--GoodwillPeriodIncreaseDecrease_zk91tNEAKvO" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Reduction from sale of assets to Divergent Technologies&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(52,310&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--Goodwill_iE_zJxyuoFGa3Ik" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Balance, February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;1,167,805&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000875"
      unitRef="USD">1220115</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000877"
      unitRef="USD">-52310</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000879"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000881">&lt;p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zzAtnE9ulwBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 - &lt;span id="xdx_828_zFgUTuazIHNa"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 29, 2024, the Company had accounts payable of $&lt;span id="xdx_900_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20240229_zJ7LxLORrNQ2" title="Accounts payable"&gt;531,847&lt;/span&gt; and accrued expenses of $&lt;span id="xdx_90B_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20240229_zIqHsMwACo9" title="Accrued expenses"&gt;460,768&lt;/span&gt;, compared to $&lt;span id="xdx_90B_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_c20230228_zUWaYRq1bFv2" title="Accounts payable"&gt;519,136&lt;/span&gt; of accounts
payable and $&lt;span id="xdx_90A_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iI_c20230228_z7omMexVLLii" title="Accrued expenses"&gt;329,922&lt;/span&gt; of accrued expenses for the year ended February 28, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000883"
      unitRef="USD">531847</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000885"
      unitRef="USD">460768</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000887"
      unitRef="USD">519136</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrentAndNoncurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000889"
      unitRef="USD">329922</us-gaap:AccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000891">&lt;p id="xdx_803_eus-gaap--IncomeTaxDisclosureTextBlock_zt0ELRovIo6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
10 &#x2013; &lt;span id="xdx_82D_zf2xYgcTWgsg"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC Topic No. 740. This standard requires the Company to provide a net deferred
tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting
methods and any available operating loss or tax credit carryforwards. Income tax returns open for examination by the Internal Revenue
Service consist of tax years ended December 31, 2020 through 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company had available at February 29, 2024 unused operating loss carryforwards of approximately $&lt;span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_c20240229_z38HRGr7T7pa" title="Operating loss carryforwards"&gt;43,934,000&lt;/span&gt; which may be applied against
future taxable income. Losses incurred between 2010 and 2017, which total $&lt;span id="xdx_905_eus-gaap--OperatingLossCarryforwards_iI_c20171231_zHgrSdoo5Ltj" title="Operating loss carryforwards"&gt;9,820,000&lt;/span&gt; expire in various years through 2038, and the remainder
of the losses, which total $&lt;span id="xdx_902_ecustom--OperatingLossCarryforwardsRemainder_iI_c20240229_zdEMioKoGRW1" title="Operating loss carryforwards remainder"&gt;34,114,000&lt;/span&gt; can be carried forward indefinitely. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carryforwards for Federal
income tax reported purposes are subject to annual limitations. Due to the change in ownership as a result of the reverse acquisition,
the Company&#x2019;s net operating loss carryforwards may be limited as to use in future years, and any such limitation will be determined
on a year-to-year basis. The
amount of and ultimate realization of the benefits from the operating loss carryforwards for income tax purposes is dependent, in part,
upon the tax laws in effect, the future earnings of the Company and other future events, the effects of which cannot be determined. Because
of the uncertainty surrounding the realization of the loss carryforwards, the Company has established a valuation allowance equal to
the tax effect of the loss carryforwards and other temporary differences of approximately $&lt;span id="xdx_900_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20240229_zSvOYYN7sno5" title="Valuation allowance loss carryforwards"&gt;11,250,300&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_c20230228_z8PrZn3RIhDg" title="Valuation allowance loss carryforwards"&gt;8,575,900&lt;/span&gt; at February 29, 2024, and February
28, 2023, respectively, and, therefore, no deferred tax asset has been recognized for the loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNd78jYTjuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zYyFUyW4r6ha" style="display: none"&gt;Schedule of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240229_z1Oo3OS6nCDe" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230228_zzbE3PTwvBtj" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 60%"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z5v0R8PH3ck4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;NOL carryover&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,226,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,636,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zxWcOEgFZtBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Related party accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;173,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zDYqZkOxmHUi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payroll accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_zv220t6LFyH4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;1,772,500&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(61,000&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_z2ASyRQwcpvb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;(11,250,300&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;(8,575,900&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zXzFF6MQgqz6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset (liability)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_ziO8XR5YC6Ei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
reconciliation of the provision for income taxes computed at the U.S. federal statutory tax rate (&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20230301__20240229_zgHGBAptIrAl" title="Federal statutory tax rate"&gt;&lt;span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_c20220301__20230228_znQlYJRtgStc" title="Federal statutory tax rate"&gt;21&lt;/span&gt;&lt;/span&gt;%) to the Company&#x2019;s effective
tax rate for the years ended February 29, 2024, and February 28, 2023 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zi0ZQcldxAfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zijvloCzLQ2e" style="display: none"&gt;Schedule
of Reconciliation of Provision for Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230301__20240229_z2YYUz1hkBFc" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220301__20230228_z1yWU06gOZti" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zGDEjhraeT47" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 60%"&gt;Book Loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,541,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,837,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zofUGS1KiVQ3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(20,700&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_z8XrZKhH0CU4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Meals &amp;amp; Entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_zuvAhcfnaMjh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Preferred dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;422,842&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zU40Yk60iqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;24,468&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(48,548&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zB1uWN5sMOtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on asset disposal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;67,274&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0945"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zYultU3MZX65" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;51,857&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zOREvUGNB4Nl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;114,928&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_zvyOGfbriJjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;589,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,906,648&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zUNGfoM9NiCk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Provision for Income Taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0956"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zy03wzJH66j5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000893"
      unitRef="USD">43934000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2017-12-31"
      decimals="0"
      id="Fact000895"
      unitRef="USD">9820000</us-gaap:OperatingLossCarryforwards>
    <NTRP:OperatingLossCarryforwardsRemainder
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000897"
      unitRef="USD">34114000</NTRP:OperatingLossCarryforwardsRemainder>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000899"
      unitRef="USD">11250300</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000901"
      unitRef="USD">8575900</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000903">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zNd78jYTjuPg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
tax assets are comprised of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zYyFUyW4r6ha" style="display: none"&gt;Schedule of Deferred Tax Assets&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49C_20240229_z1Oo3OS6nCDe" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230228_zzbE3PTwvBtj" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 60%"&gt;Deferred tax assets:&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTANzaXy_z5v0R8PH3ck4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;NOL carryover&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;9,226,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;8,636,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--DeferredTaxAssetDepreciation_iI_pp0p0_maDTANzaXy_zxWcOEgFZtBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Related party accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;173,900&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeferredTaxAssetsPayrollAccruals_iI_pp0p0_maDTANzaXy_zDYqZkOxmHUi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Payroll accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;77,800&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0912"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Deferred tax liabilities:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--DeferredTaxLiabilitiesDepreciation_iNI_di_msDTANzaXy_zv220t6LFyH4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;1,772,500&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(61,000&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_msDTANzaXy_z2ASyRQwcpvb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;Valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;(11,250,300&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p style="margin: 0"&gt;(8,575,900&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzaXy_zXzFF6MQgqz6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net deferred tax asset (liability)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0921"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000905"
      unitRef="USD">9226100</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000906"
      unitRef="USD">8636900</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <NTRP:DeferredTaxAssetDepreciation
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000908"
      unitRef="USD">173900</NTRP:DeferredTaxAssetDepreciation>
    <NTRP:DeferredTaxAssetsPayrollAccruals
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000911"
      unitRef="USD">77800</NTRP:DeferredTaxAssetsPayrollAccruals>
    <NTRP:DeferredTaxLiabilitiesDepreciation
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000914"
      unitRef="USD">-1772500</NTRP:DeferredTaxLiabilitiesDepreciation>
    <NTRP:DeferredTaxLiabilitiesDepreciation
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000915"
      unitRef="USD">61000</NTRP:DeferredTaxLiabilitiesDepreciation>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact000917"
      unitRef="USD">11250300</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact000918"
      unitRef="USD">8575900</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact000923"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact000925"
      unitRef="Pure">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact000927">&lt;p id="xdx_895_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zi0ZQcldxAfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8B7_zijvloCzLQ2e" style="display: none"&gt;Schedule
of Reconciliation of Provision for Income Taxes&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20230301__20240229_z2YYUz1hkBFc" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20220301__20230228_z1yWU06gOZti" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--EffectiveIncomeTaxRateReconciliationBookLoss_maITEBzMQv_zGDEjhraeT47" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 60%"&gt;Book Loss&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,541,200&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;&lt;td style="text-align: right; width: 16%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,837,400&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseDepreciation_maITEBzMQv_zofUGS1KiVQ3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Depreciation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;270,100&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(20,700&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment_maITEBzMQv_z8XrZKhH0CU4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Meals &amp;amp; Entertainment&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;300&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--IncomeTaxReconciliationNondeductibleExpensePreferredDividends_maITEBzMQv_zuvAhcfnaMjh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Preferred dividends&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;422,842&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_maITEBzMQv_zU40Yk60iqgb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Stock compensation&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;24,468&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;(48,548&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal_maITEBzMQv_zB1uWN5sMOtd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Loss on asset disposal&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;67,274&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0945"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll_maITEBzMQv_zYultU3MZX65" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Accrued payroll&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;51,857&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0948"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals_maITEBzMQv_zOREvUGNB4Nl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Related party accruals&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;114,928&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;p style="margin: 0"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0951"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzMQv_zvyOGfbriJjh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Change in valuation allowance&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;589,431&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;1,906,648&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzMQv_zUNGfoM9NiCk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Provision for Income Taxes&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0956"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <NTRP:EffectiveIncomeTaxRateReconciliationBookLoss
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000929"
      unitRef="USD">-1541200</NTRP:EffectiveIncomeTaxRateReconciliationBookLoss>
    <NTRP:EffectiveIncomeTaxRateReconciliationBookLoss
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000930"
      unitRef="USD">-1837400</NTRP:EffectiveIncomeTaxRateReconciliationBookLoss>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000932"
      unitRef="USD">270100</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000933"
      unitRef="USD">-20700</us-gaap:IncomeTaxReconciliationNondeductibleExpenseDepreciation>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000935"
      unitRef="USD">300</us-gaap:IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment>
    <NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000938"
      unitRef="USD">422842</NTRP:IncomeTaxReconciliationNondeductibleExpensePreferredDividends>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000941"
      unitRef="USD">24468</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000942"
      unitRef="USD">-48548</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000944"
      unitRef="USD">67274</NTRP:IncomeTaxReconciliationNondeductibleExpenseLossOnAssetDisposal>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000947"
      unitRef="USD">51857</NTRP:IncomeTaxReconciliationNondeductibleExpenseAccruedPayroll>
    <NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000950"
      unitRef="USD">114928</NTRP:IncomeTaxReconciliationNondeductibleExpenseRelatedPartyAccruals>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000953"
      unitRef="USD">589431</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000954"
      unitRef="USD">1906648</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000959">&lt;p id="xdx_809_eus-gaap--DebtDisclosureTextBlock_zfGjwMdpqgB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
11 - &lt;span&gt;Convertible Notes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"&gt;&lt;span id="xdx_82F_zcjiXNu7zabi" style="display: none"&gt;&#160;Notes
Payable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
March 13, 2023 and June 9, 2023, the Company issued $&lt;span id="xdx_90C_eus-gaap--ProceedsFromConvertibleDebt_c20230313__20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zT1NzGmoiSh" title="Convertible note issued"&gt;650,000&lt;/span&gt; in convertible notes upon the receipt of proceeds from several investors.
The notes had an interest at a rate of &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zQ50vlyxTB0l" title="Interest rate"&gt;8&lt;/span&gt;% per annum and were convertible into shares and warrants in a new public company upon the completion
of a merger with a Special Purpose Acquisition Corporation (&#x201c;SPAC&#x201d;) at a conversion price of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230609__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_z4xCXSg7KHhg" title="Conversion price"&gt;3.00 &lt;/span&gt;per common share, subject
to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
July 27, 2022 and February 21, 2023, the Company issued a total principal amount of $&lt;span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_c20220727__20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zefV4QXnqyzb" title="Convertible note issued"&gt;3,012,000&lt;/span&gt;
in convertible notes upon the receipt of proceeds from several investors. The notes had an interest at a rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zlrkSrT4Jgid" title="Interest rate"&gt;8&lt;/span&gt;%
per annum and were convertible into shares and warrants in a new public company upon the completion of a merger with a Special
Purpose Acquisition Corporation (&#x201c;SPAC&#x201d;) at a conversion price of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_pid_c20230221__dei--LegalEntityAxis__custom--SpecialPurposeAcquisitionCorporationMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeveralInvestorsMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNotesMember_zbKUUzCrPMte" title="Conversion price"&gt;3.00&lt;/span&gt;
per common share, subject to certain adjustments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, in connection with, and contingent upon the acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc.
(the &#x201c;Sigma Transaction&#x201d;), each investor in a convertible note entered into a Debt Assignment and Conversion Agreement (the
Agreement&#x201d;) with NextTrip Group, LLC (&#x201c;Group&#x201d;) and NextTrip Holdings, Inc. (&#x201c;NextTrip&#x201d;) whereby the notes
and the debt represented thereon were assigned from NextTrip to Group and converted into common units of Group with the equivalent value
on the terms and conditions as set forth in the Agreements. In exchange for entering into the Agreements, each investor received the
right to receive a number of Restricted Sigma Shares, including both Closing Shares and Contingent Shares, to be distributed by the Company
to the investor following the consummation of the Sigma Transaction. The shares are issuable at a price of $&lt;span id="xdx_902_eus-gaap--SharePrice_iI_pid_c20231229__us-gaap--TypeOfArrangementAxis__custom--DebtAssignmentAndConversionAgreementsMember_zGR8q3TDMzO4" title="Share price"&gt;3.00&lt;/span&gt;, and include both principal
and accrued interest thereon.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sigma Transaction was closed on December 29, 2023, and as a result, the Company issued to investors &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqsUNYHhWPY8" title="Conversion of convertible notes, shares"&gt;52,818&lt;/span&gt; Closing Shares, and the right
to receive &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember_z6AGxmAKrwXc" title="Conversion of convertible notes, shares"&gt;1,978,598&lt;/span&gt; Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended February 29, 2024, and February 28, 2023, the Company recorded interest expense of $&lt;span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20230301__20240229_zEF6skVkqLwc" title="Interest expense"&gt;234,213&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--InterestExpenseDebt_c20220301__20230228_zE38lbOK5SE6" title="Interest expense"&gt;72,347&lt;/span&gt; respectively,
related to the notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-03-132023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000961"
      unitRef="USD">650000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000963"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-06-09_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000965"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2022-07-272023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="0"
      id="Fact000967"
      unitRef="USD">3012000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000969"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2023-02-21_custom_SpecialPurposeAcquisitionCorporationMember_custom_SeveralInvestorsMember_custom_ConvertibleNotesMember"
      decimals="INF"
      id="Fact000971"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:SharePrice
      contextRef="AsOf2023-12-29_custom_DebtAssignmentAndConversionAgreementsMember"
      decimals="INF"
      id="Fact000973"
      unitRef="USDPShares">3.00</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000975"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact000977"
      unitRef="Shares">1978598</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:InterestExpenseDebt
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact000979"
      unitRef="USD">234213</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact000981"
      unitRef="USD">72347</us-gaap:InterestExpenseDebt>
    <NTRP:SharePurchaseAgreementsDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact000983">&lt;p id="xdx_802_ecustom--SharePurchaseAgreementsDisclosureTextBlock_z6OzrSGhEMVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
12 &#x2013; &lt;span id="xdx_825_zi3AvZo6IKBf"&gt;Share Purchase Agreements&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
August 10, 2023 and November 6, 2023, NextTrip entered into Share Purchase Agreements with several investors to purchase convertible
shares in NextTrip in exchange for total proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromConvertibleDebt_c20230810__20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zkDGNfyAmjyd" title="Proceeds from convertible shares"&gt;1,755,970&lt;/span&gt;. Pursuant to the Agreements, the shares were initially convertible into
the common shares of a public company at $&lt;span id="xdx_909_eus-gaap--SharePrice_iI_c20231106__us-gaap--TypeOfArrangementAxis__custom--SharePurchaseAgreementsMember__srt--TitleOfIndividualAxis__custom--SeveralInvestorsMember_zlD2u3RIj5gj" title="Conversion share price"&gt;0.15&lt;/span&gt; per share. The Agreements further provided that contingent upon the consummation of the
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc., the investors would receive the same number of Sigma
shares in lieu of NextTrip common shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, concurrent with the consummation of the acquisition, each investor entered into an Exchange Agreement with Group and
Holdings, whereby such investors exchanged their rights to NextTrip shares for rights to common units of Group of the same value, and
Group distributed to investors, that number of Closing Shares as set forth in the Exchange Agreements. Additionally, upon NextTrip&#x2019;s
achievement of each of the milestones as set forth in the Share Exchange Agreement, if ever, Group will further distribute the number
of Contingent Shares in accordance with the Share Exchange Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2022, the Company entered into a Software as a Service Agreement with a third party consultant in which the Company received
a $&lt;span id="xdx_90A_ecustom--ProceedsFromDownpaymentForContract_c20220919__20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zLjiRDF7K6lf" title="Proceeds from downpayment for contract"&gt;150,000&lt;/span&gt; down payment upon signing of the contract. On December 31, 2022, the Company entered into an amended agreement with the counterparty
in which the down payment became a noninterest bearing share issuance obligation in which such amount will be converted to shares in
a new public company upon the completion of a merger at a conversion price of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220919__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_za85LrKPJc26" title="Conversion share price"&gt;3.00&lt;/span&gt; per common share, subject to adjustments. On December
29, 2023, upon the consummation of the reverse acquisition transaction with Sigma, the counterparty received &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_zIDIl91RLXd4" title="Conversion of convertible notes, shares"&gt;1,996&lt;/span&gt; Closing Shares and
the right to receive an additional &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__us-gaap--TypeOfArrangementAxis__custom--SoftwareAsAServiceAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyMember_z7tjzC67CDi3" title="Conversion of convertible notes, shares"&gt;74,786&lt;/span&gt; Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total number of Closing Shares issued to investors, inclusive of the third party consultant, on December 29, 2023 was &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zOJnM37Cav2c" title="Conversion of convertible notes, shares"&gt;15,481&lt;/span&gt;, and the
Contingent Shares issuable, if ever, totaled &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z9duZrUSNJ57" title="Conversion of convertible notes, shares"&gt;579,954&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, the Company entered into a Consulting Modification Agreement with a third-party consultant which provided for the
full settlement of $&lt;span id="xdx_90F_ecustom--ConsultingFees_c20231228__20231228__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zoHnFPGGnQe3" title="Consulting fees"&gt;180,000&lt;/span&gt; in consulting fees by issuing common shares of Sigma contingent upon the closing of the reverse acquisition.
The reverse acquisition closed on December 29, 2023, pursuant to which Company issued &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_zJ6aPH88sQ" title="Conversion of convertible notes, shares"&gt;4,337&lt;/span&gt; Closing Shares to the consultant, and the
right to receive &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20231229__20231229__us-gaap--TypeOfArrangementAxis__custom--ConsultingModificationAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--ContingentSharesMember__srt--TitleOfIndividualAxis__custom--ThirdPartyConsultantMember_z6P1MdBd0Rsb" title="Conversion of convertible notes, shares"&gt;162,466&lt;/span&gt; Contingent Shares, if issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:SharePurchaseAgreementsDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-08-102023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="0"
      id="Fact000985"
      unitRef="USD">1755970</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:SharePrice
      contextRef="AsOf2023-11-06_custom_SharePurchaseAgreementsMember_custom_SeveralInvestorsMember"
      decimals="INF"
      id="Fact000987"
      unitRef="USDPShares">0.15</us-gaap:SharePrice>
    <NTRP:ProceedsFromDownpaymentForContract
      contextRef="From2022-09-192022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="0"
      id="Fact000989"
      unitRef="USD">150000</NTRP:ProceedsFromDownpaymentForContract>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2022-09-19_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact000991"
      unitRef="USDPShares">3.00</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_SoftwareAsAServiceAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact000993"
      unitRef="Shares">1996</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_SoftwareAsAServiceAgreementMember_custom_ThirdPartyMember"
      decimals="INF"
      id="Fact000995"
      unitRef="Shares">74786</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact000997"
      unitRef="Shares">15481</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact000999"
      unitRef="Shares">579954</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <NTRP:ConsultingFees
      contextRef="From2023-12-282023-12-28_custom_ConsultingModificationAgreementMember_custom_ThirdPartyConsultantMember"
      decimals="0"
      id="Fact001001"
      unitRef="USD">180000</NTRP:ConsultingFees>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_us-gaap_CommonStockMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001003"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2023-12-292023-12-29_custom_ConsultingModificationAgreementMember_custom_ContingentSharesMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001005"
      unitRef="Shares">162466</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact001007">&lt;p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_z4fwFlGmzgAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
13 - &lt;span id="xdx_821_zEjXjSrIwhXd"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 28, 2023, the Company entered into an Asset Purchase Agreement with Travel and Media Tech, LLC, (&#x201c;TMT&#x201d;), pursuant
to which it purchased the right, title and interest in the &#x201c;Bookit&#x201d; or &#x201c;NextTrip 2.0&#x201d; booking engine, including
customer lists, all current content associated with hotel and destination product in the booking engine (pictures, hotel descriptions,
restaurant descriptions, room descriptions, amenity descriptions, and destination information.) and source code related thereto. TMT
is a related entity owned by Don Monaco, the Company&#x2019;s Chairman and William Kerby, the Company&#x2019;s Chief Executive Officer.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amounts
due to related parties in 2024 and 2023 was $&lt;span id="xdx_906_eus-gaap--NotesPayableCurrent_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"&gt;828,277&lt;/span&gt; and $&lt;span id="xdx_904_eus-gaap--NotesPayableCurrent_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_pp0p0" title="Notes payable - related parties"&gt;281,000&lt;/span&gt;, respectively. The amounts due in both years are to William Kerby and
Donald Monaco.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recorded a loss of $&lt;span id="xdx_906_ecustom--LossOnRelatedPartyReceivable_c20230301__20240229__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember_zDkGbGIz5Ivb" title="Loss on related party receivable"&gt;1,567,665&lt;/span&gt; on the NextPlay related party receivable for the year ended February 29, 2024. The total amount
receivable from NextPlay was $&lt;span id="xdx_903_eus-gaap--AccountsReceivableNet_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zIJzArv2G1Nk" title="Accounts receivable"&gt;2,567,665&lt;/span&gt; at February 29, 2024. NextPlay is in default under the terms of its promissory note and as a
result the Company established an allowance for doubtful accounts of $&lt;span id="xdx_90E_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zpPYCuk8ayNg" title="Allowance for doubtful accounts"&gt;1,567,665&lt;/span&gt; as collectability of the note is uncertain. As of February
28, 2023, &lt;span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20230228__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zsDbYr6wwLf8" title="Allowance for doubtful accounts"&gt;no&lt;/span&gt; allowance for doubtful accounts was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001009"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2023-02-28_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001011"
      unitRef="USD">281000</us-gaap:NotesPayableCurrent>
    <NTRP:LossOnRelatedPartyReceivable
      contextRef="From2023-03-012024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001013"
      unitRef="USD">1567665</NTRP:LossOnRelatedPartyReceivable>
    <us-gaap:AccountsReceivableNet
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001015"
      unitRef="USD">2567665</us-gaap:AccountsReceivableNet>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001017"
      unitRef="USD">1567665</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="AsOf2023-02-28_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact001019"
      unitRef="USD">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <NTRP:DeferredRevenueTextBlock contextRef="From2023-03-012024-02-29" id="Fact001021">&lt;p id="xdx_805_ecustom--DeferredRevenueTextBlock_zYu3Z8tfW1rk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
14 - &lt;span id="xdx_821_z5cIFTK9nBcc"&gt;Deferred Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue as of the years ended February 29, 2024, and February 28, 2023 was $&lt;span id="xdx_90B_eus-gaap--DeferredRevenueCurrent_iI_c20240229_z7ib0lWAXqcb" title="Deferred revenue"&gt;139,921&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--DeferredRevenueCurrent_iI_c20230228_zq2jYnylNuZg" title="Deferred revenue"&gt;22,750&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
revenue consists of travel deposits received from users in advance of revenue recognition. The deferred revenue balance for the years
ended February 29, 2024, and February 28, 2023 was driven by cash payments from customers in advance of satisfying our performance obligations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:DeferredRevenueTextBlock>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001023"
      unitRef="USD">139921</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact001025"
      unitRef="USD">22750</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact001027">&lt;p id="xdx_80C_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zXbavLPv1cZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
15 - &lt;span id="xdx_820_z9nVLyQGXowd"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is involved, from time to time, in litigation, other legal claims and proceedings involving matters associated with or incidental
to our business, including, among other things, matters involving breach of contract claims, intellectual property, employment issues,
and other related claims and vendor matters. The Company believes that the resolution of currently pending matters could, individually
or in the aggregate, have a material adverse effect on our financial condition or results of operations. However, assessment of the current
litigation or other legal claims could change considering the discovery of facts not presently known to the Company or by judges, juries
or other finders of fact, which are not in accord with management&#x2019;s evaluation of the possible liability or outcome of such litigation
or claims.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact001029">&lt;p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zNEbszpW6zla" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
16 &#x2013; &lt;span id="xdx_82D_zIYDn08hz347"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has &lt;span id="xdx_903_eus-gaap--CommonStockSharesAuthorized_iI_c20240229_zdPXuaENxOBl" title="Common stock, shares authorized"&gt;1,200,000&lt;/span&gt; shares of common stock authorized. For the years ended February 29, 2024 and February 28, 2023, the Company had
&lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20240229_z6O4gG20NB5j" title="Common stock, shares issued"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockSharesOutstanding_iI_c20240229_z59S9wWhV7I4" title="Common stock, shares outstanding"&gt;936,430&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_c20230228_z077MhmHx3G" title="Common stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20230228_zVG6L6TorTP9" title="Common stock, shares outstanding"&gt;83,371&lt;/span&gt;&lt;/span&gt; shares of common stock, par value $&lt;span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240229_z6kfYgJVyEmk" title="Common stock, par value"&gt;&lt;span id="xdx_908_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230228_zMaRPRRhT8vf" title="Common stock, par value"&gt;0.001&lt;/span&gt;&lt;/span&gt; issued and outstanding, respectively. All shares have equal voting rights,
are fully-paid and non-assessable, and have one vote per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 22, 2023, we effected a &lt;span id="xdx_905_eus-gaap--StockholdersEquityReverseStockSplit_c20230921__20230922_zBMYljCigaF5" title="Reverse stock split"&gt;1-for-20 reverse stock split&lt;/span&gt; of the outstanding shares of our common stock and a corresponding decrease
in the number of shares of our common stock that we are authorized to issue. In connection with the reverse split, we issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesReverseStockSplits_c20230922__20230922_zYuppuwALY54" title="Reverse stock split issued common shares"&gt;40,197&lt;/span&gt; common
shares to round-up fractional shares to the nearest whole share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
effects of the reverse stock split have been retroactively reflected in all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;Fiscal
Year Ended February 29, 2024&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
September and October 2023, the Company sold &lt;span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zWGZGVr39j98" title="Share issued and sold during period, shares"&gt;72,721&lt;/span&gt; and &lt;span id="xdx_905_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2ghHiETfBcl" title="Share issued and sold during period, shares"&gt;128,887&lt;/span&gt; shares of common stock, respectively, through our ATM Agreement, resulting
in net proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20230901__20230930__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn3OsLTVbAh6" title="Net proceeds"&gt;364,555&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20231001__20231031__us-gaap--SubsidiarySaleOfStockAxis__custom--AtTheMarketIssuanceSalesAgreementMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zURPciHU4IIj" title="Net proceeds"&gt;772,468&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 29, 2023, the Company acquired &lt;span id="xdx_903_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zwi7QEBlGU85" title="Equity interest acquired"&gt;100&lt;/span&gt;% of the outstanding equity interests of NextTrip Holdings, Inc. pursuant to a share exchange
agreement by and among the Company, NextTrip and certain other parties (the &#x201c;Acquisition&#x201d;). As consideration for the Acquisition,
at closing the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zfLu2SyhkAEk" title="Restricted shares issued in acquisitions"&gt;156,007&lt;/span&gt; restricted shares of its common stock, constituting &lt;span id="xdx_908_eus-gaap--SaleOfStockPercentageOfOwnershipAfterTransaction_pid_dp_uPure_c20231229__20241229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zGnERLiFWTkg" title="Percentage of issued and outstanding common shares"&gt;19.99&lt;/span&gt;% of its issued and outstanding shares
of common stock immediately prior to execution of the share exchange agreement, and agreed to issue up to an aggregate of &lt;span id="xdx_90F_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zdX4wd4V60I2" title="Shares issuable for consideration"&gt;5,843,993&lt;/span&gt; shares
as further consideration upon NextTrip&#x2019;s achievement of certain milestones set forth in the exchange agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Of
the &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zQykeyPefPC8" title="Restricted shares issued in acquisitions"&gt;156,007&lt;/span&gt; restricted shares issued at closing, &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--DebtAssignmentAndConversionAgreementsMember_zXYNTfVXNad9" title="Shares issued in acquisitions"&gt;52,818&lt;/span&gt; shares were issued pursuant to the Debt Assignment and Conversion agreements,
&lt;span id="xdx_908_eus-gaap--StockRepurchasedDuringPeriodShares_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--DeferredRevenueArrangementTypeAxis__custom--SharePurchaseAndExchangeAgreementsMember_zDAMv4JKQOpf" title="Purchase of shares issued"&gt;15,481&lt;/span&gt; shares were issued pursuant to the Share Purchase and Exchange Agreements, and &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember__us-gaap--RelatedPartyTransactionAxis__custom--ThirdPartyConsultantMember_zJeY2RmCbsNa" title="Shares issued during period services"&gt;4,337&lt;/span&gt; shares were issued to a third-party consultant.
Pursuant to ASC 805-40-45-1,the remaining &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_z3rNaVTKm6jl" title="Shares issued in acquisitions"&gt;83,371&lt;/span&gt; Closing Shares are reflected as a retroactive adjustment to adjust the accounting acquirer&#x2019;s
legal capital to reflect the legal capital of the accounting acquiree. That adjustment is required to reflect the capital of the legal
parent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred
Compensation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the fiscal years ended February 29, 2024 and February 28, 2023, the Company did not issue any shares of common stock to employees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Preferred
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
our articles of incorporation, our board of directors has the authority, without further action by stockholders, to designate one or
more series of preferred stock and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights
granted to or imposed upon the preferred stock, including dividend rights, conversion rights, voting rights, rights and terms of redemption,
liquidation preference and sinking fund terms, any or all of which may be preferential to or greater than the rights of the common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20240229_z5brbXuhefm3" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20230228_ztskdZjb6CMd" title="Preferred stock, shares authorized"&gt;10,000,000&lt;/span&gt;&lt;/span&gt; shares of preferred stock, $&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20240229_zMIhTuxIBrI" title="Preferred stock, par value"&gt;&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20230228_z7ls9C5dadnf" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;&lt;/span&gt; par value. &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zUu8VGlmUkI1" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zVWi8hP0ocs1" title="Preferred stock, shares outstanding"&gt;472,996&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90F_eus-gaap--PreferredStockSharesIssued_iI_c20230228_zPRS5vZzceB1" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20230228_zNGYECD7rzai" title="Preferred stock, shares outstanding"&gt;0&lt;/span&gt;&lt;/span&gt; shares of preferred stock were
issued and outstanding at February 29, 2024 and February 28, 2023. respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
E Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $&lt;span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zZDArrmFJj8k" title="Preferred stock, par value"&gt;1,500&lt;/span&gt;
per share (the &#x201c;Stated Value&#x201d;). Dividends at the initial rate of &lt;span id="xdx_900_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zke1y58qXVIe" title="Dividends percentage"&gt;9&lt;/span&gt;% per annum will accrue and, on a monthly basis, shall
be payable in kind by the increase of the Stated Value of the Series E Preferred Stock by said amount. The holders of the Series E Preferred
Shares have the right at any time to convert all or a portion of the Preferred Shares (including, without limitation, accrued and unpaid
dividends and make-whole dividends through the third anniversary of the closing date) into shares of the Company&#x2019;s Common Stock
at an initial conversion rate determined by dividing the Conversion Amount by the Conversion Price ($&lt;span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zV53xYW3Df13" title="Conversion price per share"&gt;0.13&lt;/span&gt; above the consolidated closing
bid price for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the
Stated Value of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E
Preferred Shares being converted plus the &#x201c;Make Whole Amount&#x201d; (the amount of any dividends that, but for the conversion,
would have accrued at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate
is also subject to adjustment for stock splits, dividends recapitalizations and similar events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, &lt;span id="xdx_904_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z48xCbsCYbg2" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zqcyJYBE0U5e" title="Preferred stock, shares outstanding"&gt;316&lt;/span&gt;&lt;/span&gt; shares of the issued Series E Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, including the make-whole dividends, would have resulted in the issuance of &lt;span id="xdx_909_eus-gaap--CommonStockDividendsShares_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zHqKlJquvT74" title="Issuance of common stock dividends, shares"&gt;3,155&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
F Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#x201c;Certificate of Designation&#x201d;)
with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z8PQtH1UBGKe" title="Preferred stock shares authorized"&gt;5,843,993&lt;/span&gt; shares of the Company&#x2019;s preferred stock as Series F Convertible
Preferred Stock, par value $&lt;span id="xdx_909_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_z6sLeL4FDyG" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; per share (the &#x201c;Series F Preferred&#x201d;). The Series F Preferred was designated by the Company
in connection with its recent acquisition of NextTrip Holdings, Inc. (&#x201c;NextTrip&#x201d;), and, in the event that the Company does
not have sufficient shares of common stock available to fulfill its obligations pursuant to the share exchange agreement governing the
terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares of
Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ranking&lt;/i&gt;&lt;/b&gt;&lt;i&gt;.
&lt;/i&gt;The Series F Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Dividends&lt;/i&gt;&lt;/b&gt;&lt;i&gt;.
&lt;/i&gt;Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Voting&lt;/i&gt;&lt;/b&gt;.
Except as provided by the Company&#x2019;s amended and restated articles of incorporation, as amended (&#x201c;Articles&#x201d;) or as otherwise
required by the Nevada Revised Statutes, holders of Series F Preferred are entitled to vote with the holders of outstanding shares of
Company common stock, voting together as a single class, with respect to all matters presented to the Company&#x2019;s stockholders for
their action or consideration. In any such vote, each holder is entitled to a number of votes equal to the number of shares of Common
Stock into which the Series F Preferred held by such holder is convertible. The Company may not, without the consent of holders of a
majority of the outstanding shares of Series F Preferred, (i) alter or change adversely the powers, preferences or rights given to the
Series F Preferred or alter or amend the Certificate of Designation, (ii) amend its Articles or other charter documents in any manner
that adversely effects any rights of the holders of the Series F Preferred, or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Conversion&lt;/i&gt;&lt;/b&gt;.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Conversion
Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Liquidation&lt;/i&gt;&lt;/b&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#x201c;Liquidation&#x201d;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zHCMb7Uyrswj" title="Preferred stock, shares outstanding"&gt;no&lt;/span&gt; shares of the Series F Convertible Preferred Stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#x201c;Series G Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvwrZFxYRrfe" title="Preferred stock shares authorized"&gt;100,000&lt;/span&gt; shares of the Company&#x2019;s preferred
stock as Series G Preferred Stock, par value $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zlrEX0qVjs1c" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series G Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
G Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
Right&lt;/i&gt;. &lt;span id="xdx_904_eus-gaap--PreferredStockRedemptionTerms_c20230301__20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z92mrP7ixfGl" title="Preferred stock redemption right, description"&gt;The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, all &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zvKCVyQ8I033" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztuD2BzyPIbd" title="Preferred stock, shares outstanding"&gt;100,000&lt;/span&gt;&lt;/span&gt; shares of the issued Series G Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of &lt;span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zxhWrseSBlxb" title="Converted issuance of shares of common stock"&gt;100,000&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
H Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#x201c;Series H Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zUokPnKpbPlc" title="Preferred stock shares authorized"&gt;150,000&lt;/span&gt; shares of the Company&#x2019;s preferred
stock as Series H Preferred Stock, par value $&lt;span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zHDSE5AH5XCf" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series H Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Charter or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (c) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
H Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z12MNeQBJqAc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkbIykyl0Sah" title="Preferred stock, shares outstanding"&gt;150,000&lt;/span&gt;&lt;/span&gt; shares of the issued Series H Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of &lt;span id="xdx_90C_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zBeba8KNeNg2" title="Converted issuance of shares of common stock"&gt;150,000&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
I Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#x201c;Series I Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1bmw1gvIbI8" title="Preferred stock shares authorized"&gt;331,124&lt;/span&gt; shares of the Company&#x2019;s preferred
stock as Series I Convertible Preferred Stock, par value $&lt;span id="xdx_903_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zYpQFKtIHEd6" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series I Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Charter or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or (c)
enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Charter to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#x201c;Series I Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, &lt;span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUt5kE0H2lHd" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zE1gCqn985zd" title="Preferred stock, shares outstanding"&gt;222,680&lt;/span&gt;&lt;/span&gt; shares of the issued Series I Convertible Preferred Stock were outstanding, which if converted as of February
29, 2024, would have resulted in the issuance of &lt;span id="xdx_900_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240229__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zMWKmZWfJUZa" title="Converted issuance of shares of common stock"&gt;222,680&lt;/span&gt; shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Outstanding
Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of February 29, 2024, we had outstanding options under our 2013 Equity Incentive Plan to purchase an aggregate of &lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zRP7PwC4bESj" title="Common stock shares option outstanding"&gt;85,300&lt;/span&gt; shares of our
common stock at a weighted-average exercise price of $&lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenEquityIncentivePlanMember_zkpdcyPeZOq7" title="Weighted average exercise price"&gt;60.50&lt;/span&gt; per share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, our stockholders approved our 2023 Equity Incentive Plan which has reserved for issuance &lt;span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zzIzNj75aTj6" title="Common stock shares reserved for issuance"&gt;7,000,000&lt;/span&gt; shares of common
stock for equity awards of which &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c20231228__20231228__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zPNmSrpCeLfl" title="Common stock shares equity award issued or granted"&gt;0&lt;/span&gt; shares have been issued or granted thereunder to date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#x2019;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan. &lt;span id="xdx_906_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zpOTycNoRt7e" title="Common stock shares reserved for issuance"&gt;7,000,000&lt;/span&gt; shares of common stock have been reserved for issuance under the Plan., and as of February
29, 2024, all such shares are available for issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
fiscal year 2024, the Company did not grant any options. In fiscal year 2024, &lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20230301__20240229_zvlmM07Srh2h" title="Share based compensation arrangement by award options vested"&gt;6,914&lt;/span&gt; options vested and $&lt;span id="xdx_90B_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229_zK0Yhq1ApaXd" title="Alloacted share based compensation"&gt;116,512&lt;/span&gt; of compensation cost
was recognized during the year. As of February 29, 2024, there were options to purchase &lt;span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zP10NLomDqaa" title="Share based compensation arrangement by award options vested outstanding"&gt;85,300&lt;/span&gt;, shares issued and outstanding, &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandThirteenPlanMember_zNmPle8JY4wc" title="Share based compensation arrangement by award options vested outstanding"&gt;82,800&lt;/span&gt;
of which have been issued under an Equity Incentive Plan. At February 29, 2024, there are vested options exercisable for &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229_z8NyHWp8vA93" title="Stock issued during Stock options exercised"&gt;81,849&lt;/span&gt; shares
of common stock. &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_do_c20230301__20240229_zbhvWNXct6Ul" title="Share based compensation arrangement by award options grants"&gt;No&lt;/span&gt; options to purchase shares of common stock were exercised during the fiscal year ended February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generally grants stock options to employees, consultants and directors at exercise prices equal to the fair market value of the
Company&#x2019;s stock on the dates of grant. Stock options are typically granted throughout the year and generally vest over three years
of service and expire five years from the date of the award, unless otherwise specified. The Company recognizes compensation expense
for the fair value of the stock options over the requisite service period for each stock option award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed options to purchase up to &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__srt--RangeAxis__srt--MaximumMember_zGr1Oeir1278" title="Options to purchase of common stock"&gt;86,402&lt;/span&gt; shares of common
stock. Between December 29, 2023 and February 29, 2024, &lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_pid_c20231229__20240229_zGEUxmzAgXj7" title="Options to forfeited or expired"&gt;1,342&lt;/span&gt; options were forfeited or expired and no options were issued or exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
employee share-based compensation expense for the year ended February 29, 2024, was $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensation_pp0p0_c20230301__20240229_zV4g3sIm8nFe" title="Allocation share based compensation expense"&gt;116,512&lt;/span&gt; all of which is related to stock options.
There was no capitalized share-based compensation cost as of February 29, 2024,and there were no recognized tax benefits during the fiscal
year ended February 29, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;To
estimate the value of an award, the Company uses the Black-Scholes option-pricing model. This model requires inputs such as expected
life, expected volatility and risk-free interest rate. The forfeiture rate also impacts the amount of aggregate compensation. These inputs
are subjective and generally require significant analysis and judgment to develop. While estimates of expected life, volatility and forfeiture
rate are derived primarily from the Company&#x2019;s historical data, the risk-free rate is based on the yield available on U.S. Treasury
constant maturity rates with similar terms to the expected term of the stock option awards. The fair value of outstanding share-based
awards was estimated using the Black-Scholes model with the following weighted-average assumptions for the outstanding options assumed
at February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zCSFN88TgWY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z4z3kIBvCuj8" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229_zlqBKDyoFgY8" title="Dividend yield"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230301__20240229_z24o0jAfRhXi" title="Risk-free interest rate, minimum"&gt;0.19&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230301__20240229_zXow7RiQAIG9" title="Risk-free interest rate, maximum"&gt;4.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229_zCWw7cqUHXWa" title="Expected volatility, minimum"&gt;100.2&lt;/span&gt;
&#x2013; &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229_zgJO7kFpKlt" title="Expected volatility, maximum"&gt;122.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229_zKwZJiTg4pi" title="Expected life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A9_z6zJScHF9FIg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zvt35IMaoIba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zv8wFumeSark" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zL5oyH2qQuw" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z8EFvLeepenc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Options assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zaB5PLhfK0Ph" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;86,642&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zz1jKHvhOtGl" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;61.43&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zWl06Az60yuj" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_zvEB5RHJsxR" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20230301__20240229_zJfFwargF1u5" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zY9C4qfMfa8f" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zsYzXXft9K14" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zZ2EpPMLJcUk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(1,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zD2IrqUFHol7" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;120.87&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zzjupgviHw64" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229_z7B8b01yMc1l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zCHV3vEAkOWb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_zZ6ysKBr6t61" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229_zgYMEo2TQSI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options expected to vest in the future as of February 29, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229_zl7BChXnnYmf" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;3,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_z5BTVBA85kH3" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;33.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zSt28PDX2av4" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;3.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_zQoDu2MU2Eak" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Options exercisable at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229_zRnyakrA8o0k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable"&gt;81,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zjOzwRU1Mwb3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;61.64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zbWURQG1Spfk" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;2.48&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229_zztpefCeawxe" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20220301__20240229_zXolw9eI5SH5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230301__20240229_zWzXYpZ4o3sg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zrVYE3TZ1ugd" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_ztzN5ewEdRwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_z6NsUfUTtzbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zub2aAN1mcEk" title="Options exercise price"&gt;2.99&lt;/span&gt; closing price of our Common Stock on February 29, 2024.
All of the outstanding option grants have an exercise price above $&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229_zEtxbW0EJI42" title="Options exercise price"&gt;2.99&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, there was $&lt;span id="xdx_908_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240229_zKF4Hz2QOcBi" title="Unrecognized stock-based compensation expense, stock option"&gt;52,615&lt;/span&gt; of unrecognized share-based compensation expense related to unvested stock options with a weighted
average remaining recognition period of &lt;span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20230301__20240229_ziIqWCowrmg6" title="Weighted average remaining recognition period"&gt;0.97&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Appreciation Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purposes of the 2020 Stock Appreciation Rights Plan are to: (i) enable the Company to attract and retain the types of employees, consultants,
and directors (collectively, &#x201c;Service Providers&#x201d;) who will contribute to the Company&#x2019;s long-range success; (ii) provide
incentives that align the interests of Service Providers with those of the shareholders of the Company; and (iii) promote the success
of the Company&#x2019;s business. The Plan provides for incentive awards that are only made in the form of stock appreciation rights payable
in cash (&#x201c;SARs&#x201d;). No shares of common stock were reserved in connection with the adoption of the Plan since no shares will
be issued pursuant to the Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#x2019;s
common stock (&#x201c;Share&#x201d;) upon the exercise of the SAR. The &#x201c;Spread&#x201d; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a Share on the date of grant of the SAR. The administrator
of the Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including, without limitation,
the exercise price and medium of payment and vesting provisions, and to specify the provisions of the SAR Agreement relating to such
grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
closing of the reverse acquisition of Sigma on December 29, 2023, the Company assumed &lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zK4731N3g1H2" title="Reverse acquisition shares outstanding"&gt;40,390&lt;/span&gt;
outstanding SARs. Between December 29, 2023 and February 29, 2024, &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zg9YZD4oXUT2" title="Shares forfeited or expired::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1251"&gt;none &lt;/span&gt;&lt;/span&gt;
were forfeited or expired and &lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_dxL_c20231229__20231229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zM310cGJGHnj" title="Shares issued or exercised::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1253"&gt;no&lt;/span&gt;&lt;/span&gt;
SARs were issued or exercised.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the requisite service period
for each SAR award. The SAR&#x2019;s are revalued at each reporting date in accordance with ASC 718 &#x201c;Compensation-Stock Compensation&#x201d;,
and any changes in fair value are reflected in income as of the applicable reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ztgRBeF7azpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zxxYOHHfTTl" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zeMJPz4xb8c9" title="Dividend yield"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zVQRqsNLQFdk" title="Risk-free interest rate, minimum"&gt;0.22&lt;/span&gt;-&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z68qM2z7c3Ig" title="Risk-free interest rate, maximum"&gt;2.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zUj9ZmcPkHD8" title="Expected volatility, minimum"&gt;108.7&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zz7P4VAvaol8" title="Expected volatility, maximum"&gt;122.8&lt;/span&gt;.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zBoe9PbkKj6g" title="Expected life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A2_zbY86XLr6Pk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlXLys9C9ZSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zadJEwVq53t9" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zIMrjeHePj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BWnETrCiK9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1273"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3uHP9IIpJ87" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;SARs assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zTMm3uDNFvv7" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;40,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ziXzJa6obGb5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;44.77&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYJdEJuxiedl" title="Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5b1ZtwhFD19" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsBzFm61Ph3b" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zZ0UbNEnJHid" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3Bd1iutlFWd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zylDxWQAfTI8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zU4OglGs21U6" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1293"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zinJJy9TCc43" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9wmQesIStRd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zyDj4FH9HK81" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVcT60xoQFz2" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BSIEor05T7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SARs expected to vest in the future as of February 29, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zLTUmsNO1Yt1" style="text-align: right" title="Number of Options, Expected to vest in the future, Balance"&gt;6,886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zzRQbOq9DgRh" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;35.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeCcVa7Qq63a" title="Weighted Average Remaining Contractual Life, Expected to Vest"&gt;3.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmrqn5p3GF3" style="text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;SARs exercisable at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zG4hQA0mO2t1" style="margin-top: 0; margin-bottom: 0" title="Number of Options, Exercisable"&gt;33,504&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqob0xu8E512" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;46.72&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlhYOyZZ3Ts1" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znL79OeYO0Ah" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and options expected to vest at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHitT1NzTBG" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr7jfmrcrhlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zXmPLCf4Myf2" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9EPt7KsGdW1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_z8EcsBDOKQd9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of
our common stock for those awards that have an exercise price below the $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z6Nd0rKWCYO1" title="Options exercise price"&gt;2.99&lt;/span&gt; closing price of our common stock on February 29, 2024.
All the SARs have an exercise price above $&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zMkAecVhRf16" title="Options exercise price"&gt;2.99&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For the year ended February 29, 2024, $&lt;span id="xdx_90E_eus-gaap--AllocatedShareBasedCompensationExpense_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zj9Eq7Xktc02" title="Share based compensation expense"&gt;10,107&lt;/span&gt; of share-based compensation
expense was recognized, and at
February 29, 2024, there was $&lt;span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_iI_c20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zbrXhhMaIAOi" title="Unrecognized share based compensation cost"&gt;79,978&lt;/span&gt; of unrecognized share-based compensation expense related to unvested SARs with a weighted average
remaining recognition period of &lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zX9SZl3WOrm2" title="Weighted average remaining recognition period"&gt;1.08&lt;/span&gt; years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
February 29, 2024, the Company had outstanding warrants to purchase a total of &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z1TolQeLPCJa" title="Purchase of outstanding warrants"&gt;486,165&lt;/span&gt; shares of common stock. The warrants have exercise
prices that range from $&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MinimumMember_z9IQaBG5q4Uf" title="Warrants exercise price"&gt;3.02&lt;/span&gt; to $&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zmqGGQl9ICW3" title="Warrants exercise price"&gt;350.00&lt;/span&gt;, which if not exercised, will &lt;span id="xdx_90E_ecustom--DescriptionForWarrantExpiration_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_ztfAS2ujet98" title="Warrant description"&gt;expire between March 15, 2024 and January 25, 2028&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAn9vYBnJnsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zUiVstpbRCj6" style="display: none"&gt;Schedule of Warranty Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zR5hqo54MQY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_zrZt9l6sCFPa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Warrants assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zimhzZ6B6gu4" style="width: 14%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition"&gt;217,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zItCnLIOnlZk" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Assumed pursuant to reverse acquisition"&gt;21.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zZRTn3tQrpq3" title="Weighted Average Remaining Contractual Life Years, Assumed pursuant to reverse acquisition"&gt;1.86&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zhNYRpssB0ll" style="text-align: right" title="Warrants, Granted"&gt;268,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z1odbqFbJVnf" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;3.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zJqwOa61FR59" title="Weighted Average Remaining Contractual Life Years, Granted"&gt;2.17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zC2dnuNAPTd1" style="text-align: right" title="Warrants,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zi59YJj7Maqj" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zVRAagQpbom3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zFBndNbq2Spk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230301__20240229_zx79BkwEf9Lh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;486,165&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zcqN1mm6SkP1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;9.94&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zQae4W9B7KIe" title="Weighted Average Remaining Contractual Life Years, Ending Balance"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001031"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001033"
      unitRef="Shares">936430</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001035"
      unitRef="Shares">936430</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001037"
      unitRef="Shares">83371</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001039"
      unitRef="Shares">83371</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001041"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001043"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2023-09-212023-09-22" id="Fact001045">1-for-20 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits
      contextRef="From2023-09-222023-09-22"
      decimals="INF"
      id="Fact001047"
      unitRef="Shares">40197</us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001049"
      unitRef="Shares">72721</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001051"
      unitRef="Shares">128887</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-09-012023-09-30_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001053"
      unitRef="USD">364555</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2023-10-012023-10-31_custom_AtTheMarketIssuanceSalesAgreementMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001055"
      unitRef="USD">772468</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001057"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001059"
      unitRef="Shares">156007</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="From2023-12-292024-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001061"
      unitRef="Pure">0.1999</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001063"
      unitRef="Shares">5843993</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001065"
      unitRef="Shares">156007</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_DebtAssignmentAndConversionAgreementsMember"
      decimals="INF"
      id="Fact001067"
      unitRef="Shares">52818</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_SharePurchaseAndExchangeAgreementsMember"
      decimals="INF"
      id="Fact001069"
      unitRef="Shares">15481</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember_custom_ThirdPartyConsultantMember"
      decimals="INF"
      id="Fact001071"
      unitRef="Shares">4337</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripHoldingsIncMember"
      decimals="INF"
      id="Fact001073"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001075"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001077"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001079"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001081"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001083"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001085"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001087"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2023-02-28"
      decimals="INF"
      id="Fact001089"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001091"
      unitRef="USDPShares">1500</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001093"
      unitRef="Pure">0.09</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001095"
      unitRef="USDPShares">0.13</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001097"
      unitRef="Shares">316</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001099"
      unitRef="Shares">316</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockDividendsShares
      contextRef="From2023-03-012024-02-29_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001101"
      unitRef="Shares">3155</us-gaap:CommonStockDividendsShares>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001103"
      unitRef="Shares">5843993</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001105"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001107"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001109"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001111"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockRedemptionTerms
      contextRef="From2023-03-012024-02-29_custom_SeriesGConvertiblePreferredStockMember"
      id="Fact001113">The Company shall have the right to redeem up to 50% of the Preferred Stock for an aggregate price of $1.00 in accordance
with the terms of the Perpetual License Agreement</us-gaap:PreferredStockRedemptionTerms>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001115"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001117"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-02-29_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001119"
      unitRef="Shares">100000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001121"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001123"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001125"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001127"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-02-29_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001129"
      unitRef="Shares">150000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001131"
      unitRef="Shares">331124</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001133"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001135"
      unitRef="Shares">222680</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001137"
      unitRef="Shares">222680</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-02-29_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact001139"
      unitRef="Shares">222680</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001141"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_TwoThousandThirteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001143"
      unitRef="USDPShares">60.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001145"
      unitRef="Shares">7000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="From2023-12-282023-12-28_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001147"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-02-29_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001149"
      unitRef="Shares">7000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001151"
      unitRef="Shares">6914</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001153"
      unitRef="USD">116512</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001155"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_custom_TwoThousandThirteenPlanMember"
      decimals="INF"
      id="Fact001157"
      unitRef="Shares">82800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001159"
      unitRef="Shares">81849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001161"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-03-012024-02-29_srt_MaximumMember"
      decimals="INF"
      id="Fact001163"
      unitRef="Shares">86402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-12-292024-02-29"
      decimals="INF"
      id="Fact001165"
      unitRef="Shares">1342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensation
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001167"
      unitRef="USD">116512</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact001169">&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zCSFN88TgWY4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_z4z3kIBvCuj8" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229_zlqBKDyoFgY8" title="Dividend yield"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20230301__20240229_z24o0jAfRhXi" title="Risk-free interest rate, minimum"&gt;0.19&lt;/span&gt;-&lt;span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_pid_dp_uPure_c20230301__20240229_zXow7RiQAIG9" title="Risk-free interest rate, maximum"&gt;4.05&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229_zCWw7cqUHXWa" title="Expected volatility, minimum"&gt;100.2&lt;/span&gt;
&#x2013; &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229_zgJO7kFpKlt" title="Expected volatility, maximum"&gt;122.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229_zKwZJiTg4pi" title="Expected life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001171"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001173"
      unitRef="Pure">0.0019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001175"
      unitRef="Pure">0.0405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001177"
      unitRef="Pure">1.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001179"
      unitRef="Pure">1.228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2023-03-012024-02-29" id="Fact001181">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact001183">&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zvt35IMaoIba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zv8wFumeSark" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1.5pt; vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zL5oyH2qQuw" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1185"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z8EFvLeepenc" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;Options assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zaB5PLhfK0Ph" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;86,642&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zz1jKHvhOtGl" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;61.43&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zWl06Az60yuj" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_zvEB5RHJsxR" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1195"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di0_c20230301__20240229_zJfFwargF1u5" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zY9C4qfMfa8f" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zsYzXXft9K14" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1201"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zZ2EpPMLJcUk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(1,342&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zD2IrqUFHol7" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;120.87&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zzjupgviHw64" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1207"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229_z7B8b01yMc1l" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zCHV3vEAkOWb" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_zZ6ysKBr6t61" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229_zgYMEo2TQSI4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options expected to vest in the future as of February 29, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229_zl7BChXnnYmf" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;3,451&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_z5BTVBA85kH3" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;33.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zSt28PDX2av4" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;3.54&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_zQoDu2MU2Eak" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1223"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;Options exercisable at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229_zRnyakrA8o0k" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable"&gt;81,849&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zjOzwRU1Mwb3" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;61.64&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&lt;span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zbWURQG1Spfk" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;2.48&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229_zztpefCeawxe" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1231"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20220301__20240229_zXolw9eI5SH5" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20230301__20240229_zWzXYpZ4o3sg" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229_zrVYE3TZ1ugd" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229_ztzN5ewEdRwe" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001189"
      unitRef="Shares">86642</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001191"
      unitRef="USDPShares">61.43</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact001193">P2Y8M4D</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001197"
      unitRef="Shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001203"
      unitRef="Shares">1342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001205"
      unitRef="USDPShares">120.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001209"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001211"
      unitRef="USDPShares">60.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-03-012024-02-29" id="Fact001213">P2Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001217"
      unitRef="Shares">3451</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001219"
      unitRef="USDPShares">33.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="From2023-03-012024-02-29" id="Fact001221">P3Y6M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001225"
      unitRef="Shares">81849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001227"
      unitRef="USDPShares">61.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2023-03-012024-02-29" id="Fact001229">P2Y5M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001233"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001235"
      unitRef="USDPShares">60.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2023-03-012024-02-29" id="Fact001237">P2Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001241"
      unitRef="USDPShares">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001243"
      unitRef="USDPShares">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001245"
      unitRef="USD">52615</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="From2023-03-012024-02-29" id="Fact001247">P0Y11M19D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2023-12-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001249"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001255">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ztgRBeF7azpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of outstanding SAR awards was estimated using the Black-Scholes model with the following weighted-average assumptions for
the twelve months ended February 29, 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Assumptions:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zxxYOHHfTTl" style="display: none"&gt;Schedule of Share Based Payments Award Stock Options Valuation Assumptions&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 75%; margin-right: auto"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zeMJPz4xb8c9" title="Dividend yield"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Risk-free interest rate&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zVQRqsNLQFdk" title="Risk-free interest rate, minimum"&gt;0.22&lt;/span&gt;-&lt;span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_z68qM2z7c3Ig" title="Risk-free interest rate, maximum"&gt;2.79&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Expected volatility&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zUj9ZmcPkHD8" title="Expected volatility, minimum"&gt;108.7&lt;/span&gt;-&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_dp_uPure_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zz7P4VAvaol8" title="Expected volatility, maximum"&gt;122.8&lt;/span&gt;.0&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Expected life (in years)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20230301__20240229__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyStockAppreciationRightsPlanMember_zBoe9PbkKj6g" title="Expected life"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001257"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001259"
      unitRef="Pure">0.0022</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001261"
      unitRef="Pure">0.0279</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001263"
      unitRef="Pure">1.087</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001265"
      unitRef="Pure">1.228</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      id="Fact001267">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001269">&lt;p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_hus-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlXLys9C9ZSc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zadJEwVq53t9" style="display: none"&gt;Schedule of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Aggregate&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Intrinsic&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Value ($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zIMrjeHePj35" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1271"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BWnETrCiK9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1273"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3uHP9IIpJ87" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl1275"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 40%; text-align: left"&gt;SARs assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zTMm3uDNFvv7" style="width: 11%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;40,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_ziXzJa6obGb5" style="width: 11%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;44.77&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;&lt;span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYJdEJuxiedl" title="Weighted Average Remaining Contractual Life, Assumed pursuant to reverse acquisition"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z5b1ZtwhFD19" style="width: 11%; text-align: right" title="Aggregate Intrinsic Value, Life, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1283"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zsBzFm61Ph3b" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1285"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zZ0UbNEnJHid" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1287"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3Bd1iutlFWd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1289"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zylDxWQAfTI8" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1291"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_903_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageForfeitedOrCancelled_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zU4OglGs21U6" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1293"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zinJJy9TCc43" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1295"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9wmQesIStRd" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Outstanding, Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zyDj4FH9HK81" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Outstanding Balance"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVcT60xoQFz2" title="Weighted Average Remaining Contractual Life, Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7BSIEor05T7" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1303"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SARs expected to vest in the future as of February 29, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zLTUmsNO1Yt1" style="text-align: right" title="Number of Options, Expected to vest in the future, Balance"&gt;6,886&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zzRQbOq9DgRh" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;35.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeCcVa7Qq63a" title="Weighted Average Remaining Contractual Life, Expected to Vest"&gt;3.23&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zKmrqn5p3GF3" style="text-align: right" title="Aggregate Intrinsic Value, Options expected to vest in the future"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1.5pt"&gt;SARs exercisable at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;p id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zG4hQA0mO2t1" style="margin-top: 0; margin-bottom: 0" title="Number of Options, Exercisable"&gt;33,504&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqob0xu8E512" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;46.72&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlhYOyZZ3Ts1" title="Weighted Average Remaining Contractual Life, Exercisable"&gt;2.93&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znL79OeYO0Ah" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Options exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and options expected to vest at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zHitT1NzTBG" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zr7jfmrcrhlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zXmPLCf4Myf2" title="Weighted Average Remaining Contractual Life, Vested, Exercisable and Options Expected to Vest"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z9EPt7KsGdW1" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Options vested, exercisable and options expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001277"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001279"
      unitRef="USDPShares">44.77</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001281">P2Y11M26D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantInPeriodWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001297"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001299"
      unitRef="USDPShares">44.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001301">P2Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001305"
      unitRef="Shares">6886</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001307"
      unitRef="USDPShares">35.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001309">P3Y2M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001313"
      unitRef="Shares">33504</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001315"
      unitRef="USDPShares">46.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001317">P2Y11M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001321"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact001323"
      unitRef="USDPShares">44.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact001325">P2Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001329"
      unitRef="USDPShares">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="INF"
      id="Fact001331"
      unitRef="USDPShares">2.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="0"
      id="Fact001333"
      unitRef="USD">10107</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="AsOf2024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      decimals="0"
      id="Fact001335"
      unitRef="USD">79978</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod
      contextRef="From2023-03-012024-02-29_custom_TwoThousandAndTwentyStockAppreciationRightsPlanMember"
      id="Fact001337">P1Y29D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardWeightedAverageRemainingRecognitionPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2024-02-29_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001339"
      unitRef="Shares">486165</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-02-29_us-gaap_WarrantMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001341"
      unitRef="USDPShares">3.02</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-02-29_us-gaap_WarrantMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001343"
      unitRef="USDPShares">350.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <NTRP:DescriptionForWarrantExpiration
      contextRef="From2023-03-012024-02-29_us-gaap_WarrantMember21736515"
      id="Fact001345">expire between March 15, 2024 and January 25, 2028</NTRP:DescriptionForWarrantExpiration>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2023-03-012024-02-29" id="Fact001347">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zAn9vYBnJnsc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B9_zUiVstpbRCj6" style="display: none"&gt;Schedule of Warranty Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Weighted Average&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Exercise&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Remaining&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Price&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-weight: bold; text-align: center"&gt;Contractual&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;($)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; font-weight: bold; text-align: center"&gt;Life (Yrs.)&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at February 28, 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zR5hqo54MQY2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_zrZt9l6sCFPa" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1351"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 46%; text-align: left"&gt;Warrants assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zimhzZ6B6gu4" style="width: 14%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition"&gt;217,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zItCnLIOnlZk" style="width: 14%; text-align: right" title="Weighted Average Exercise Price Outstanding, Assumed pursuant to reverse acquisition"&gt;21.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zZRTn3tQrpq3" title="Weighted Average Remaining Contractual Life Years, Assumed pursuant to reverse acquisition"&gt;1.86&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zhNYRpssB0ll" style="text-align: right" title="Warrants, Granted"&gt;268,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z1odbqFbJVnf" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;3.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zJqwOa61FR59" title="Weighted Average Remaining Contractual Life Years, Granted"&gt;2.17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zC2dnuNAPTd1" style="text-align: right" title="Warrants,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1365"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zi59YJj7Maqj" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1367"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zVRAagQpbom3" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zFBndNbq2Spk" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20230301__20240229_zx79BkwEf9Lh" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;486,165&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20230301__20240229_zcqN1mm6SkP1" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;9.94&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zQae4W9B7KIe" title="Weighted Average Remaining Contractual Life Years, Ending Balance"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001353"
      unitRef="Shares">217593</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001355"
      unitRef="USDPShares">21.01</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact001357">P1Y10M9D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001359"
      unitRef="Shares">268572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001361"
      unitRef="USDPShares">3.02</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact001363">P2Y2M1D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001373"
      unitRef="Shares">486165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001375"
      unitRef="USDPShares">9.94</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact001377">P1Y11M15D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2023-03-012024-02-29" id="Fact001379">&lt;p id="xdx_80B_eus-gaap--EarningsPerShareTextBlock_zQks9xozp2hl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
17 &#x2013; &lt;span id="xdx_827_zxwb1l59OIdg"&gt;Loss Per Share&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zushP6iSTtB3" style="display: none"&gt;Schedule of Earnings Per Share, Basic and Diluted&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;Year Ended February&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(6,656,837&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,125&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,663,962&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(7,339,276&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;228,274&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;71,581&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zlQzZ3pJf9ge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dilutive
loss per share was not presented as the Company&#x2019;s outstanding common and preferred warrants, stock options and preferred stock
common equivalent shares for the periods presented would have had an anti-dilutive effect. At February 29, 2024, the Company had outstanding
warrants to purchase &lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zXqYqquStvY1" title="Class of warrant or right, outstanding"&gt;486,165&lt;/span&gt; shares of common stock, and stock options exercisable for &lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zbXxvXGt6d9b" title="Share-based compensation arrangement by share-based payment award, options, exercisable, number"&gt;85,300&lt;/span&gt; shares of common stock, &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8tPW1RFQfZk" title="Conversion of stock, shares converted"&gt;316&lt;/span&gt; shares of Series
E Preferred Stock, which could be converted into &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zzNjMDxQbtok" title="Common stock issued conversion"&gt;3,155&lt;/span&gt; shares of common stock, &lt;span id="xdx_90A_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zwtAF3a119s6" title="Conversion of stock, shares converted"&gt;100,000&lt;/span&gt; shares of Series G Preferred Stock, convertible
into &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesGPreferredStockMember_zBD7Nr10xJCf" title="Common stock issued conversion"&gt;100,000&lt;/span&gt; shares of common stock, &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z2OH8cgJ4ROh" title="Conversion of stock, shares converted"&gt;150,000&lt;/span&gt; shares of Series H Preferred Stock, convertible into &lt;span id="xdx_909_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_z7Tpm96ol8J2" title="Common stock issued conversion"&gt;150,000&lt;/span&gt; shares of common stock, and
&lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesConverted1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zmttEAvTtFjd" title="Conversion of stock, shares converted"&gt;222,680&lt;/span&gt; shares of Series I Preferred Stock, convertible into &lt;span id="xdx_90C_eus-gaap--ConversionOfStockSharesIssued1_c20230301__20240229__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zsgYdnPTDTyh" title="Common stock issued conversion"&gt;222,680&lt;/span&gt; shares of common stock, resulting in a potential total additional
&lt;span id="xdx_901_eus-gaap--CommonStockSharesOutstanding_iI_c20240229__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zeOcBMTpquwk" title="Common stock, shares, outstanding"&gt;1,047,300&lt;/span&gt; shares of common stock outstanding in the future. At February 28, 2023, the Company had &lt;span id="xdx_90D_eus-gaap--DilutiveSecurities_do_c20220301__20230228_zSbJoHq6qtRk" title="Potentially dilutive securities"&gt;no&lt;/span&gt; outstanding potentially dilutive
securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2023-03-012024-02-29" id="Fact001381">&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zMND0AEV6U3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following data show the amounts used in computing loss per share and the effect on income and the weighted average number of shares of
dilutive potential common stock for the periods ended February 29, 2024 and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zushP6iSTtB3" style="display: none"&gt;Schedule of Earnings Per Share, Basic and Diluted&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230301__20240229_zRQWxBxhPHkc" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20220301__20230228_z4cRa5xHQFa3" style="border-bottom: Black 1pt solid; display: none; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;Year Ended February&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="vertical-align: bottom; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1.5pt; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_zQOqpc3vdAKi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(6,656,837&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_zHxptnbtWpT4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(7,125&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1387"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--IncomeLossFromContinuingOperations_zIhLcoyrPznb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6,663,962&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_zpllrU9yyV3c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Loss from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(675,314&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1393"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_zjvICMTh7sF" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(7,339,276&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(5,033,496&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_z9ndD6RIg4Gg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares Outstanding used in loss per share during the Period (denominator)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;228,274&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;71,581&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001383"
      unitRef="USD">-6656837</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact001384"
      unitRef="USD">-5033496</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001386"
      unitRef="USD">7125</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001389"
      unitRef="USD">-6663962</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact001390"
      unitRef="USD">-5033496</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001392"
      unitRef="USD">-675314</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001395"
      unitRef="USD">-7339276</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact001396"
      unitRef="USD">-5033496</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact001398"
      unitRef="Shares">228274</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-03-012023-02-28"
      decimals="INF"
      id="Fact001399"
      unitRef="Shares">71581</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-02-29_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact001401"
      unitRef="Shares">486165</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001403"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001405"
      unitRef="Shares">316</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact001407"
      unitRef="Shares">3155</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact001409"
      unitRef="Shares">100000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesGPreferredStockMember"
      decimals="INF"
      id="Fact001411"
      unitRef="Shares">100000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact001413"
      unitRef="Shares">150000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact001415"
      unitRef="Shares">150000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact001417"
      unitRef="Shares">222680</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2023-03-012024-02-29_us-gaap_PreferredStockMember_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact001419"
      unitRef="Shares">222680</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact001421"
      unitRef="Shares">1047300</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:DilutiveSecurities
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact001423"
      unitRef="USD">0</us-gaap:DilutiveSecurities>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2023-03-012024-02-29" id="Fact001425">&lt;p id="xdx_806_eus-gaap--ConcentrationRiskDisclosureTextBlock_zQRr4cPefesf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
18 &#x2013; &lt;span id="xdx_826_z647dKS4EwH9"&gt;Concentrations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenues
&lt;/b&gt;&#x2013; During the years ended February 29, 2024 and February 28, 2023, the Company did not have any significant customers who accounted
for more than &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFyLlnfyYKah" title="Concentration of risk percentage"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zkS3zcxl0UZ3" title="Concentration of risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;% each of the Company&#x2019;s revenue in at least one of the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounts
Receivable&lt;/b&gt; &#x2013; The Company had no significant customers who accounted for more than &lt;span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230301__20240229__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zFSyWAwvlpGl" title="Concentration of risk percentage"&gt;&lt;span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220301__20230228__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerMember_zVmX3RPcPRrf" title="Concentration of risk percentage"&gt;10&lt;/span&gt;&lt;/span&gt;% each of the Company&#x2019;s accounts
receivable balance at February 29, 2024 and February 28, 2023, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-03-012024-02-29_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001427"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-03-012023-02-28_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001429"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2023-03-012024-02-29_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001431"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2022-03-012023-02-28_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerMember"
      decimals="INF"
      id="Fact001433"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="From2023-03-012024-02-29" id="Fact001435">&lt;p id="xdx_80C_eus-gaap--CompensationAndEmployeeBenefitPlansTextBlock_z29jvcWYNCma" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
19 - &lt;span id="xdx_821_z8ASVaHXhRxl"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The
Company has adopted two qualified 401(K) plans (&#x201c;the Plans&#x201d;), in which all employees over the age of 21 may participate.
Depending on the Plan, &lt;span id="xdx_904_eus-gaap--DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans_c20230301__20240229_zoL9Bx6vk6pd" title="Contribution plan description"&gt;the
Company makes either a Safe Harbor contribution match of 100% of each participant&#x2019;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants&lt;/span&gt;. The matching
contributions were $&lt;span id="xdx_90C_eus-gaap--DefinedContributionPlanCostRecognized_c20230301__20240229_z41hV0F4dkse" title="Cost of contribution"&gt;17,112&lt;/span&gt;
in 2024 and $&lt;span id="xdx_905_eus-gaap--DefinedContributionPlanCostRecognized_c20220301__20230228_zXQAogfHZkMg" title="Cost of contribution"&gt;6,997&lt;/span&gt;
in 2023.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans contextRef="From2023-03-012024-02-29" id="Fact001437">the
Company makes either a Safe Harbor contribution match of 100% of each participant&#x2019;s contribution up to 3% of salary, and 50%
of the next 2% of salary contributed, or a 3% non-elective contribution for all eligible participants</us-gaap:DescriptionOfDefinedContributionPensionAndOtherPostretirementPlans>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="From2023-03-012024-02-29"
      decimals="0"
      id="Fact001439"
      unitRef="USD">17112</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="From2022-03-012023-02-28"
      decimals="0"
      id="Fact001441"
      unitRef="USD">6997</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2023-03-012024-02-29" id="Fact001443">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zFiz1sHsZGB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
20 &#x2013; &lt;span id="xdx_82F_z1BjGDx7xlv4"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 8, 2024, the Company held a Special Meeting of Stockholders in a virtual format. The following proposals, constituting all of the
proposals, were voted on by stockholders:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Proposal
    No. 1: &lt;/b&gt;The Company&#x2019;s stockholders approved an amendment to the Current Articles of Incorporation to change the Company&#x2019;s
    corporate name to &#x201c;NextTrip, Inc.&#x201d; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Proposal
    No. 2:&lt;/b&gt; The Company&#x2019;s stockholders approved an amendment to the Current Articles to increase the number of shares of Company
    common stock authorized for issuance thereunder from &lt;span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20240307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zB77jDUYEfY" title="Common stock, shares authorized"&gt;1,200,000&lt;/span&gt; shares to &lt;span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20240308__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z7SuTkZwWo79" title="Common stock, shares authorized"&gt;250,000,000&lt;/span&gt; shares.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Proposal
    No. 3:&lt;/b&gt; The Company&#x2019;s stockholders approved the adjournment of the Special Meeting by the chairman thereof to a later date
    to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Special Meeting, there are
    not sufficient votes to approve either of the foregoing proposals.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Although
Proposal No. 3 was approved by the Company&#x2019;s stockholders, the chairman of the Special Meeting did not elect to adjourn the meeting,
as both of the other two proposals were also approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 11, 2024, Sigma Additive Solutions, Inc. (the &#x201c;Company&#x201d;) filed a Certificate of Amendment to its Amended and Restated
Articles of Incorporation (the &#x201c;Charter Amendment&#x201d;), as amended to date (the &#x201c;Current Articles&#x201d;), with the Secretary
of State of the State of Nevada, pursuant to which (i) the Company&#x2019;s corporate name was changed from Sigma Additive Solutions,
Inc. to &#x201c;NextTrip, Inc.&#x201d; (the &#x201c;Name Change&#x201d;), and (ii) the number of shares of Company common stock authorized
for issuance under the Current Articles was increased from &lt;span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20240310__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztIWndeDhoC7" title="Common stock, shares authorized"&gt;1,200,000&lt;/span&gt; shares to &lt;span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_c20240311__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zTQ7uGmpz7Ul" title="Common stock, shares authorized"&gt;250,000,000&lt;/span&gt; shares (the &#x201c;Increase in Authorized).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the Name Change, effective as of the open of the market on March 13, 2024, the Company&#x2019;s common stock began trading
on the Nasdaq Capital Market under the new ticker symbol &#x201c;NTRP&#x201d; (the &#x201c;Ticker Symbol Change&#x201d;). The CUSIP of the
Company&#x2019;s common stock remained unchanged.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 15, 2024, the Company&#x2019;s Board of Directors approved the Company to enter into an unsecured promissory note for a line of
credit with Messrs. Monaco and Kerby, the Company&#x2019;s Chairman of the Board of Directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zNQOLXIgAsfk" title="Principal amount"&gt;500,000&lt;/span&gt;. Under the terms of the note, advances under the line of credit may be made at the Company&#x2019;s
request until May 31, 2024. The note bears an annual interest rate of &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zxrmgW74qKR3" title="Interest rate"&gt;7.5&lt;/span&gt;% and matures on &lt;span id="xdx_906_eus-gaap--DebtInstrumentMaturityDate_c20240315__20240315__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MessrsMonacoAndKerbyMember_zVbVfuKyUiB" title="Maturity date"&gt;February 28, 2025&lt;/span&gt;, and may be prepaid by the
Company at any time prior to maturity without penalty. As of April 19, 2024, the full principal amount of the note had been advanced
to the Company and remains outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 25, 2024, the Company&#x2019;s Board of Directors approved the Company to enter into a series of unsecured promissory notes
with certain related parties, including investors, directors, officers and employees, who shall individually provide funds for the
aggregate principal amount of $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_iI_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zg81RIUL8qU3" title="Principal amount"&gt;1,000,000&lt;/span&gt;.
The notes bear an annual interest rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQlLOyoRZ9K5" title="Interest rate"&gt;7.5&lt;/span&gt;%
and shall mature &lt;span id="xdx_909_eus-gaap--DebtInstrumentTerm_dc_c20240425__20240425__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zzuwFbgvkCFe" title="Debt instrument, term"&gt;one
year&lt;/span&gt; from the date of each note&#x2019;s execution, and may be prepaid by the Company at any time prior to maturity without
penalty. On August 14, 2024, the Board of Directors approved an increase in the aggregate principal amount of the unsecured
promissory notes to $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3iq9JV8rSrh" title="Principal amount"&gt;2,000,000&lt;/span&gt;.
As of August 31, 2024, $&lt;span id="xdx_90A_eus-gaap--NotesPayable_iI_c20240831__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxYGxDcGos9g" title="Outstanding payment"&gt;1,416,553&lt;/span&gt;
had been advanced to the Company and remains outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 17, 2024, the Company received a notification letter (the &#x201c;Initial Notice&#x201d;) from the Listing Qualifications Department
of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) advising the Company that it was not in compliance with Nasdaq&#x2019;s continued
listing requirements under Nasdaq Listing Rule 5250(c)(1) (the &#x201c;Rule&#x201d;) as a result of its failure to timely file its Annual
Report on Form 10-K for the fiscal year ended February 29, 2024 (the &#x201c;Form 10-K&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 17, 2024, the Company received an additional notification letter (the &#x201c;Additional Notice,&#x201d; and together with the Initial
Notice, the &#x201c;Notices&#x201d;) from Nasdaq stating that, because the Company has not filed its Quarterly Report on Form 10-Q for
the quarter ended May 31, 2024 (the &#x201c;Form 10-Q&#x201d;), and because the Company remains delinquent in filing the Form 10-K, the
Company remains noncompliant with the Rule.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Neither
of the Notices have an immediate effect on the listing of the Company&#x2019;s common stock on the Nasdaq Capital Market, and, therefore,
the Company&#x2019;s listing remains fully effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Notices require the Company to either file the delinquent Form 10-K and Form 10-Q with the Commission or submit a plan to regain compliance
with the Rule by August 16, 2024. If Nasdaq accepts the Company&#x2019;s plan, then Nasdaq may grant an exception of up to 180 calendar
days from the Form 10-K&#x2019;s due date, or until December 10, 2024, to regain compliance. If Nasdaq does not accept the Company&#x2019;s
plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel under Nasdaq Listing Rule 5815.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 16, 2024, the Company submitted a plan to Nasdaq regain compliance with the Rule, including the steps the Company will take to
promptly file the Form 10-Q and regain compliance. The Company has requested an extension until September 30, 2024. There can be no assurance
that the Company will regain compliance with the Rule, secure an exception until September 30, 2024 to regain compliance, or maintain
compliance with other Nasdaq listing requirements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-07_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001445"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-08_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001447"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-10_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001449"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-11_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact001451"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember"
      decimals="0"
      id="Fact001453"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember"
      decimals="INF"
      id="Fact001455"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-03-152024-03-15_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_custom_MessrsMonacoAndKerbyMember"
      id="Fact001457">2025-02-28</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001459"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember"
      decimals="INF"
      id="Fact001461"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2024-04-252024-04-25_us-gaap_SubsequentEventMember_custom_UnsecuredPromissoryNoteMember_us-gaap_RelatedPartyMember"
      id="Fact001463">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-08-14_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001465"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NotesPayable
      contextRef="AsOf2024-08-31_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact001467"
      unitRef="USD">1416553</us-gaap:NotesPayable>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001472"
      unitRef="USD">102006</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001473"
      unitRef="USD">323805</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001475"
      unitRef="USD">1000000</NTRP:PromissoryNoteReceivableNet>
    <NTRP:PromissoryNoteReceivableNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001476"
      unitRef="USD">1000000</NTRP:PromissoryNoteReceivableNet>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001478"
      unitRef="USD">11201</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001479"
      unitRef="USD">34082</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001481"
      unitRef="USD">244870</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001482"
      unitRef="USD">340921</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001484"
      unitRef="USD">1358077</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001485"
      unitRef="USD">1698808</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001490"
      unitRef="USD">6703</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001491"
      unitRef="USD">6642</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001493"
      unitRef="USD">2310927</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001494"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001496"
      unitRef="USD">45167</us-gaap:SecurityDeposit>
    <us-gaap:SecurityDeposit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001497"
      unitRef="USD">42167</us-gaap:SecurityDeposit>
    <us-gaap:Goodwill
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001499"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001500"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001502"
      unitRef="USD">3530602</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001503"
      unitRef="USD">3390034</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001505"
      unitRef="USD">4888679</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001506"
      unitRef="USD">5088842</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001514"
      unitRef="USD">1145536</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001515"
      unitRef="USD">531847</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001517"
      unitRef="USD">880585</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001518"
      unitRef="USD">460768</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001520"
      unitRef="USD">138067</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001521"
      unitRef="USD">139921</us-gaap:DeferredRevenueCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-08-31_us-gaap_NonrelatedPartyMember"
      decimals="0"
      id="Fact001523"
      unitRef="USD">140000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-08-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001526"
      unitRef="USD">2718594</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact001527"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001529"
      unitRef="USD">5022782</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001530"
      unitRef="USD">1960813</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001532"
      unitRef="USD">5022782</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001533"
      unitRef="USD">1960813</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001543"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001544"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact001545"
      unitRef="Shares">93295</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001546"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001541"
      unitRef="USD">94</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001542"
      unitRef="USD">474</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001550"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact001551"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001552"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact001553"
      unitRef="Shares">1388641</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact001554"
      unitRef="Shares">936430</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001548"
      unitRef="USD">1389</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001549"
      unitRef="USD">936</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001556"
      unitRef="USD">27550296</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001557"
      unitRef="USD">27277758</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001559"
      unitRef="USD">-27685882</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001560"
      unitRef="USD">-24151139</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001562"
      unitRef="USD">-134103</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001563"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001565"
      unitRef="USD">4888679</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001566"
      unitRef="USD">5088842</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001568"
      unitRef="USD">154498</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001569"
      unitRef="USD">27663</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001570"
      unitRef="USD">343291</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001571"
      unitRef="USD">47225</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001573"
      unitRef="USD">155455</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001574"
      unitRef="USD">23734</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001575"
      unitRef="USD">329036</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001576"
      unitRef="USD">41452</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001578"
      unitRef="USD">-957</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001579"
      unitRef="USD">3929</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001580"
      unitRef="USD">14255</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001581"
      unitRef="USD">5773</us-gaap:GrossProfit>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001588"
      unitRef="USD">628759</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001589"
      unitRef="USD">360947</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001590"
      unitRef="USD">1255511</us-gaap:LaborAndRelatedExpense>
    <us-gaap:LaborAndRelatedExpense
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001591"
      unitRef="USD">768555</us-gaap:LaborAndRelatedExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001593"
      unitRef="USD">13841</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001595"
      unitRef="USD">30235</us-gaap:ShareBasedCompensation>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001598"
      unitRef="USD">21677</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001599"
      unitRef="USD">128955</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001600"
      unitRef="USD">49231</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001601"
      unitRef="USD">198058</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001603"
      unitRef="USD">51347</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001604"
      unitRef="USD">49758</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001605"
      unitRef="USD">207536</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001606"
      unitRef="USD">90539</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ProfessionalFees
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001608"
      unitRef="USD">372027</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001609"
      unitRef="USD">125934</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001610"
      unitRef="USD">895900</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001611"
      unitRef="USD">260304</us-gaap:ProfessionalFees>
    <NTRP:Technology
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001613"
      unitRef="USD">141022</NTRP:Technology>
    <NTRP:Technology
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001614"
      unitRef="USD">83786</NTRP:Technology>
    <NTRP:Technology
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001615"
      unitRef="USD">325691</NTRP:Technology>
    <NTRP:Technology
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001616"
      unitRef="USD">119680</NTRP:Technology>
    <NTRP:OrganizationCosts
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001618"
      unitRef="USD">80452</NTRP:OrganizationCosts>
    <NTRP:OrganizationCosts
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001620"
      unitRef="USD">109189</NTRP:OrganizationCosts>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001623"
      unitRef="USD">95414</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001624"
      unitRef="USD">331549</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001625"
      unitRef="USD">383000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001626"
      unitRef="USD">667889</us-gaap:DepreciationAndAmortization>
    <us-gaap:OtherExpenses
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001628"
      unitRef="USD">63796</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001629"
      unitRef="USD">10001</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001630"
      unitRef="USD">179655</us-gaap:OtherExpenses>
    <us-gaap:OtherExpenses
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001631"
      unitRef="USD">17731</us-gaap:OtherExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001633"
      unitRef="USD">1468335</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001634"
      unitRef="USD">1090930</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001635"
      unitRef="USD">3435948</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001636"
      unitRef="USD">2122756</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001638"
      unitRef="USD">-1469292</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001639"
      unitRef="USD">-1087001</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001640"
      unitRef="USD">-3421693</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001641"
      unitRef="USD">-2116983</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001648"
      unitRef="USD">-64227</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001649"
      unitRef="USD">-73762</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001650"
      unitRef="USD">-99452</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001651"
      unitRef="USD">-139151</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001653"
      unitRef="USD">-64227</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001654"
      unitRef="USD">-73762</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001655"
      unitRef="USD">-99452</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001656"
      unitRef="USD">-139151</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001658"
      unitRef="USD">-1533519</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001659"
      unitRef="USD">-1160763</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001660"
      unitRef="USD">-3521145</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001661"
      unitRef="USD">-2256134</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001668"
      unitRef="USD">-1533519</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001669"
      unitRef="USD">-1160763</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001670"
      unitRef="USD">-3521145</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001671"
      unitRef="USD">-2256134</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001673"
      unitRef="USD">-1131</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001675"
      unitRef="USD">7778</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001678"
      unitRef="USD">-1534650</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001679"
      unitRef="USD">-1160763</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001680"
      unitRef="USD">-3513367</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001681"
      unitRef="USD">-2256134</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001683"
      unitRef="USD">10688</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001685"
      unitRef="USD">21376</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001688"
      unitRef="USD">-1545338</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001689"
      unitRef="USD">-1160763</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001690"
      unitRef="USD">-3534743</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001691"
      unitRef="USD">-2256134</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001693"
      unitRef="USDPShares">-0.29</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001695"
      unitRef="USDPShares">-0.29</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001697"
      unitRef="USDPShares">-13.92</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001699"
      unitRef="USDPShares">-13.92</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001701"
      unitRef="USDPShares">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001703"
      unitRef="USDPShares">-1.07</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001705"
      unitRef="USDPShares">-27.06</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001707"
      unitRef="USDPShares">-27.06</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001709"
      unitRef="USDPShares">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001711"
      unitRef="USDPShares">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001717"
      unitRef="USDPShares">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001719"
      unitRef="USDPShares">-0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001725"
      unitRef="USDPShares">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001727"
      unitRef="USDPShares">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001729"
      unitRef="USDPShares">-13.92</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001731"
      unitRef="USDPShares">-13.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001733"
      unitRef="USDPShares">-1.07</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001735"
      unitRef="USDPShares">-1.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001737"
      unitRef="USDPShares">-27.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001739"
      unitRef="USDPShares">-27.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001741"
      unitRef="Shares">5275511</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact001743"
      unitRef="Shares">5275511</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001745"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact001747"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001749"
      unitRef="Shares">3277338</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact001751"
      unitRef="Shares">3277338</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001753"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact001755"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001757"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001758"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001766"
      unitRef="Shares">63494</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001760"
      unitRef="USD">64</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001768"
      unitRef="Shares">1345932</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001761"
      unitRef="USD">1346</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001762"
      unitRef="USD">27304840</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001763"
      unitRef="USD">-26140544</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-05-31"
      decimals="0"
      id="Fact001764"
      unitRef="USD">1165706</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001773"
      unitRef="USD">-1534650</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001774"
      unitRef="USD">-1534650</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001778"
      unitRef="USD">-10688</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-06-012024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001779"
      unitRef="USD">10688</us-gaap:DividendsPreferredStock>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001788"
      unitRef="Shares">29801</NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001782"
      unitRef="USD">30</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001784"
      unitRef="USD">89970</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001786"
      unitRef="USD">90000</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001796"
      unitRef="Shares">42709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001791"
      unitRef="USD">43</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001792"
      unitRef="USD">130957</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001794"
      unitRef="USD">131000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-06-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001800"
      unitRef="USD">13841</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact001802"
      unitRef="USD">13841</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001810"
      unitRef="Shares">93295</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001804"
      unitRef="USD">94</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001812"
      unitRef="Shares">1388641</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001805"
      unitRef="USD">1389</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001806"
      unitRef="USD">27550296</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001807"
      unitRef="USD">-27685882</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001808"
      unitRef="USD">-134103</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001822"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001815"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001816"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001817"
      unitRef="USD">-17907234</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-05-31"
      decimals="0"
      id="Fact001818"
      unitRef="USD">-611261</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001827"
      unitRef="USD">-1160763</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact001828"
      unitRef="USD">-1160763</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001838"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001831"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001832"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001833"
      unitRef="USD">-19067997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31"
      decimals="0"
      id="Fact001834"
      unitRef="USD">-1772024</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001840"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001841"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001849"
      unitRef="Shares">472996</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001843"
      unitRef="USD">474</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001851"
      unitRef="Shares">936430</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001844"
      unitRef="USD">936</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001845"
      unitRef="USD">27277758</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001846"
      unitRef="USD">-24151139</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact001847"
      unitRef="USD">3128029</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001856"
      unitRef="USD">-3513367</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001857"
      unitRef="USD">-3513367</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001861"
      unitRef="USD">-21376</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2024-03-012024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001862"
      unitRef="USD">21376</us-gaap:DividendsPreferredStock>
    <NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001871"
      unitRef="Shares">29801</NTRP:StockIssuedDuringPeriodSharesIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001865"
      unitRef="USD">30</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001867"
      unitRef="USD">89970</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001869"
      unitRef="USD">90000</NTRP:StockIssuedDuringPeriodValueIssuanceOfConvertiblePreferredShares>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001879"
      unitRef="Shares">-409502</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001873"
      unitRef="USD">-410</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001881"
      unitRef="Shares">409502</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001874"
      unitRef="USD">410</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001889"
      unitRef="Shares">42709</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001884"
      unitRef="USD">43</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001885"
      unitRef="USD">130957</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001887"
      unitRef="USD">131000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-03-012024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001893"
      unitRef="USD">30235</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001895"
      unitRef="USD">30235</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001903"
      unitRef="Shares">93295</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact001897"
      unitRef="USD">94</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001905"
      unitRef="Shares">1388641</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001898"
      unitRef="USD">1389</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001899"
      unitRef="USD">27550296</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001900"
      unitRef="USD">-27685882</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact001901"
      unitRef="USD">-134103</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001915"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001908"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001909"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001910"
      unitRef="USD">-16811863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact001911"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001925"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001918"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001919"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001920"
      unitRef="USD">-16811863</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact001921"
      unitRef="USD">484110</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001930"
      unitRef="USD">-2256134</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001931"
      unitRef="USD">-2256134</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001941"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001934"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001935"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001936"
      unitRef="USD">-19067997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31"
      decimals="0"
      id="Fact001937"
      unitRef="USD">-1772024</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001951"
      unitRef="Shares">83371</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001944"
      unitRef="USD">83</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact001945"
      unitRef="USD">17295890</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact001946"
      unitRef="USD">-19067997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2023-08-31"
      decimals="0"
      id="Fact001947"
      unitRef="USD">-1772024</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="From2023-12-292023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001953"
      unitRef="Shares">83371</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="AsOf2023-12-29_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact001954"
      unitRef="Pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001959"
      unitRef="USD">-3521145</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001960"
      unitRef="USD">-2256134</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001968"
      unitRef="USD">383000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001969"
      unitRef="USD">667889</us-gaap:DepreciationDepletionAndAmortization>
    <NTRP:DepreciationOfRightOfUseAsset
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001972"
      unitRef="USD">74848</NTRP:DepreciationOfRightOfUseAsset>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001974"
      unitRef="USD">30235</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001980"
      unitRef="USD">-22881</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001981"
      unitRef="USD">5000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001983"
      unitRef="USD">-96051</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001984"
      unitRef="USD">34114</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <NTRP:IncreaseDecreaseInPromissoryNoteReceivable
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001987"
      unitRef="USD">8722</NTRP:IncreaseDecreaseInPromissoryNoteReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001989"
      unitRef="USD">1033506</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001990"
      unitRef="USD">110959</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001992"
      unitRef="USD">-1854</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001993"
      unitRef="USD">57156</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInSecurityDeposits
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001995"
      unitRef="USD">-3000</us-gaap:IncreaseDecreaseInSecurityDeposits>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact001998"
      unitRef="USD">-1960326</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact001999"
      unitRef="USD">-1393118</us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations>
    <us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002001"
      unitRef="USD">7778</us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002004"
      unitRef="USD">-1952548</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002005"
      unitRef="USD">-1393118</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsForSoftware
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002010"
      unitRef="USD">389568</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002011"
      unitRef="USD">345807</us-gaap:PaymentsForSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002013"
      unitRef="USD">-389568</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002014"
      unitRef="USD">-345807</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002020"
      unitRef="USD">1269852</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002022"
      unitRef="USD">90000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002025"
      unitRef="USD">140000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002028"
      unitRef="USD">1890317</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002029"
      unitRef="USD">292500</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002031"
      unitRef="USD">2120317</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002032"
      unitRef="USD">1562352</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002034"
      unitRef="USD">-221799</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002035"
      unitRef="USD">-176573</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact002037"
      unitRef="USD">323805</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-02-28"
      decimals="0"
      id="Fact002038"
      unitRef="USD">282475</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002040"
      unitRef="USD">102006</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2023-08-31"
      decimals="0"
      id="Fact002041"
      unitRef="USD">105902</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <NTRP:IssuanceOfCommonSharesForServices
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002049"
      unitRef="USD">131000</NTRP:IssuanceOfCommonSharesForServices>
    <NTRP:PreferredStockDividends
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002052"
      unitRef="USD">21736</NTRP:PreferredStockDividends>
    <us-gaap:InterestPaidNet
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002058"
      unitRef="USD">8620</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002059"
      unitRef="USD">410</us-gaap:InterestPaidNet>
    <us-gaap:SubstantialDoubtAboutGoingConcernTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002064">&lt;p id="xdx_800_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zyGhn9QLvXGg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
1 - &lt;span id="xdx_820_zbjEvc9jZZRi"&gt;Business Description and Going Concern&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Sigma
Additive Solutions, Inc. (&#x201c;Sigma&#x201d;), the legal acquiror of NextTrip, was initially incorporated as Messidor Limited in Nevada
on December 23, 1985, and changed its name to Framewaves Inc. in 2001. On September 27, 2010, the name was changed to Sigma Labs, Inc.
On May 17, 2022, Sigma Labs, Inc. began doing business as Sigma Additive Solutions, and on August 9, 2022, changed its name to Sigma
Additive Solutions, Inc.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 11, 2024, Sigma filed a Certificate of Amendment to its Amended and Restated Articles of Incorporation, as amended, with the Secretary
of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific time on March 13, 2024, among other things, Sigma&#x2019;s
corporate name was changed from Sigma Additive Solutions, Inc. to &#x201c;NextTrip, Inc.&#x201d;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s corporate office is located at 3900 Paseo del Sol, Santa Fe, NM 87507 The consolidated financial statements include the
accounts of the Company&#x2019;s wholly owned subsidiaries, NextTrip Holdings Inc. incorporated October 22, 2015, and Extraordinary Vacations
USA, Inc. incorporated on June 24, 2002.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Prior
to the Exchange Agreement as described below, NextTrip Holdings, Inc. (&#x201c;NextTrip&#x201d;) was a wholly owned subsidiary of NextTrip
Group, LLC (&#x201c;Group&#x201d;), which in turn, was a wholly owned subsidiary of NextPlay Technologies, Inc. (&#x201c;NextPlay&#x201d;).
All of the business operations of Group were conducted through its subsidiaries. On January 25, 2023, NextPlay and Group entered into
an Amended and Restated Separation Agreement (&#x201c;Separation Agreement&#x201d;), Amended and Restated Operating Agreement (&#x201c;Operating
Agreement&#x201d;), and Exchange Agreement (&#x201c;Exchange Agreement&#x201d;, and together, the &#x201c;Agreements&#x201d;), whereby NextPlay
transferred their interest in the travel business to Group. Pursuant to the Exchange Agreement, NextPlay exchanged &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--MembershipUnitsMember_zru9sXqXfHDd" title="Number of common stock issued"&gt;1,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Membership Units of Group for &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_z7nlvlVz3ujb" title="Number of common stock issued"&gt;400,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Preferred Units of Group, with a value
of $&lt;span id="xdx_90E_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zP70YTOmZl9k" title="Share price per share"&gt;10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per unit. Prior to the exchange for Preferred
Units, Group had a payable due to NextPlay of $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20230125__20230125__us-gaap--BusinessAcquisitionAxis__custom--NextPlayTechnologiesIncMember__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--StatementEquityComponentsAxis__custom--PreferredUnitsMember_zbgKB0pjyuB2" title="Number of common stock issued, value"&gt;17,295,873&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
representing cash advances and payment of expenses by NextPlay on behalf of Group, while NextPlay had obligations to provide ongoing
support to NextTrip. Such liability was settled by the issuance of the Preferred Units and the waiver of all of NextPlay&#x2019;s ongoing
support obligations except for a $&lt;span id="xdx_90A_eus-gaap--Capital_iI_pn5n6_c20230125__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zPFIR2iYhn0a" title="Contributed capital"&gt;1.5
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million advance remaining under a promissory
note and as such NextTrip recorded the payable as contributed capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company provides travel technology solutions with sales originating in the United States, with a primary emphasis on hotels, air, and
all-inclusive travel packages. Our proprietary booking engine, branded as NextTrip 2.0, provides travel distributors access to a sizeable
inventory.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company owns &lt;span id="xdx_904_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pid_dp_uPure_c20240831__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--NextInnovationLLCMember_z0Ep2sDSfEGb" title="Ownership percentage"&gt;50&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of Next Innovation LLC (Joint Venture) and this entity is in the process of a first structure plan. No activities nor operations occurred
in 2023 or 2024 for this entity, and NextTrip, Inc. does not have control of the company and therefore no minority interest was recorded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reverse
Acquisition&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 12, 2023, Sigma entered into a Share Exchange Agreement (as amended, the &#x201c;Exchange Agreement&#x201d;) with NextTrip, Group,
and William Kerby (the &#x201c;NextTrip Representative&#x201d;). Under the terms of the Exchange Agreement, the parties agreed that Group
would sell and transfer to Sigma all of the issued and outstanding shares of NextTrip in exchange for &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ClosingSharesMember_zI93RNZrJNVh" title="Restricted shares issuable in reverse acquisition"&gt;156,007
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;restricted shares of Sigma common stock
(the &#x201c;Closing Shares&#x201d;), issuable at closing, and the right to receive up to an additional &lt;span id="xdx_901_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__us-gaap--StatementClassOfStockAxis__custom--ContingentSharesMember_zB9TW4QL8e87" title="Restricted shares issuable in reverse acquisition"&gt;5,843,993
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;restricted shares of Sigma common stock
upon satisfaction of certain milestones set forth in the Exchange Agreement (the &#x201c;Contingent Shares,&#x201d; and together with the
Closing Shares, the &#x201c;Restricted Shares&#x201d;), which Restricted Shares are issuable to the members of Group, on a pro rata basis,
under the terms of the Exchange Agreement, subject to certain closing conditions (the &#x201c;Acquisition&#x201d;). Upon the closing of
the Acquisition on December 29, 2023, NextTrip became a wholly owned subsidiary of Sigma.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Contingent Shares, together with the Closing Shares, will not exceed &lt;span id="xdx_900_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_pid_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember__srt--RangeAxis__srt--MaximumMember_zNyAfJDKGSqd" title="Restricted shares issuable in reverse acquisition"&gt;6,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Sigma common stock, or approximately
&lt;span id="xdx_901_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_uPure_c20231012__20231012__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zik42pZ7S4N1" title="Percentage for issued and outstanding capital stock"&gt;90.2&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the issued and outstanding shares of Sigma common stock immediately prior to the closing. The Acquisition will likely result in a
change of control, with the members of Group receiving an aggregate number of shares that exceeds the number of shares that held by the
legacy shareholders of Sigma. As a result, the Acquisition is accounted for as a reverse acquisition of NextTrip by Sigma, whereby Sigma
is treated as the legal acquirer and NextTrip is treated as the accounting acquirer. As a result, the historical financial information
presented is that of NextTrip.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;As of August 31, 2024, three of the
four business milestones had been achieved as further described in Note 2 under &#x201c;Loss Per Share&#x201d; below. As a result, &lt;span id="xdx_902_ecustom--ContingentSharesIssuable_iI_c20240831_zxPZe6MGvHmc" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt;
of the contingent shares were eligible to be issued. The remaining &lt;span id="xdx_90A_ecustom--LaunchOfTravelAgentPlatformShares_iI_c20240831_zervhS9n3lo1" title="Contigent shares"&gt;1,450,000&lt;/span&gt; contingent shares will be eligible for issue upon the launch
of the Company&#x2019;s Travel Agent platform, currently scheduled for the first quarter of calendar year 2025.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Despite having achieved three of the
four business milestones, the Company cannot issue the contingent shares until Nasdaq approves the Company&#x2019;s initial listing application,
which is pending with Nasdaq. 2024. The Company has been advised by Nasdaq that issuing the contingent shares prior to
approval of the application will result in the immediate delisting of the Company, as such issuance will trigger a change in control.
The Company does anticipate such issuances will occur shortly after the closing of this offering and the Company intends to issue said
securities as soon as Nasdaq has cleared its application.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
accordance with ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;1,&lt;/i&gt; the consolidated financial statements prepared following a reverse acquisition
are issued under the name of the legal parent (NextTrip, Inc., f/k/a Sigma Additive Solutions, Inc.) but described in the notes to the
financial statements as a continuation of the financial statements of the legal subsidiary (NextTrip), with &lt;i&gt;one&lt;/i&gt; adjustment, which
is to retroactively adjust the accounting acquirer&#x2019;s legal capital to reflect the legal capital of the accounting acquiree. That
adjustment is required to reflect the capital of the legal parent. Comparative information presented in the consolidated financial statements
also is retroactively adjusted to reflect the legal capital of the legal parent.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
ASC &lt;i&gt;805&lt;/i&gt;-&lt;i&gt;40&lt;/i&gt;-&lt;i&gt;45&lt;/i&gt;-&lt;i&gt;2,&lt;/i&gt; the consolidated financial statements represent the continuation of the legal subsidiary
except for the capital structure, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal subsidiary recognized and measured at their pre-combination carrying amounts;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    assets and liabilities of the legal parent recognized and measured in accordance with the guidance in this topic applicable to business
    combinations (ASC 805);&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(c)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    retained earnings and other equity balances of the legal subsidiary before the business combination;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(d)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    amount required to be recognized as issued equity interests in the consolidated financial statements determined by adding the issued
    equity interest of the legal subsidiary outstanding immediately before the business combination to the fair value of the legal parent
    determined in accordance with the guidance in ASC 805 applicable to business combinations. However, the equity structure reflects
    the equity structure of the legal parent, including the equity interests the legal parent issued to affect the combination. Accordingly,
    the equity structure of the legal subsidiary is restated using the exchange ratio established in the acquisition agreement to reflect
    the number of shares of the legal parent issued in the reverse acquisition.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
assets and liabilities of Sigma Additive Solutions, Inc. were recognized at fair value pursuant to ASC 805.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going
Concern &lt;/b&gt;&#x2013; The Company has sustained losses and had negative cash flows from operating activities since its inception.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company currently does not have sufficient cash and working capital to fund its operations and will require additional funding in the
public or private markets in the near-term to be able to continue operations. The Company currently has no understanding or agreement
to obtain such funding, and there is no assurance that we will be successful in obtaining additional funding. If we fail to obtain sufficient
funding when needed, we will be forced to delay, scale back or eliminate all or a portion of our commercialization efforts and operations.
As a result, there is substantial doubt about our ability to continue as a going concern.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubstantialDoubtAboutGoingConcernTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_MembershipUnitsMember"
      decimals="INF"
      id="Fact002066"
      unitRef="Shares">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="INF"
      id="Fact002068"
      unitRef="Shares">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember"
      decimals="INF"
      id="Fact002070"
      unitRef="USDPShares">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2023-01-252023-01-25_custom_NextPlayTechnologiesIncMember_custom_ShareExchangeAgreementMember_custom_PreferredUnitsMember"
      decimals="INF"
      id="Fact002072"
      unitRef="USD">17295873</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:Capital
      contextRef="AsOf2023-01-25_custom_NextTripGroupLLCMember"
      decimals="-5"
      id="Fact002074"
      unitRef="USD">1500000</us-gaap:Capital>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2024-08-31_custom_NextInnovationLLCMember"
      decimals="INF"
      id="Fact002076"
      unitRef="Pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ClosingSharesMember"
      decimals="INF"
      id="Fact002078"
      unitRef="Shares">156007</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_custom_ContingentSharesMember"
      decimals="INF"
      id="Fact002080"
      unitRef="Shares">5843993</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002082"
      unitRef="Shares">6000000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <NTRP:PercentageForIssuedAndOutstandingCapitalStock
      contextRef="From2023-10-122023-10-12_custom_ShareExchangeAgreementMember_custom_NextTripGroupLLCMember"
      decimals="INF"
      id="Fact002084"
      unitRef="Pure">0.902</NTRP:PercentageForIssuedAndOutstandingCapitalStock>
    <NTRP:ContingentSharesIssuable
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002086"
      unitRef="Shares">4393993</NTRP:ContingentSharesIssuable>
    <NTRP:LaunchOfTravelAgentPlatformShares
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002088"
      unitRef="Shares">1450000</NTRP:LaunchOfTravelAgentPlatformShares>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002090">&lt;p id="xdx_806_eus-gaap--SignificantAccountingPoliciesTextBlock_zkLlHzbaT2m4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
2 &#x2013; &lt;span id="xdx_825_zqSGuePCW51"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zifpSOSo4639" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_864_z4YEibwEO6hc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- The accompanying financial
statements have been prepared by the Company in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) in the
United States of America. The financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations
and cash flows at August 31, 2024 and 2023 and for the periods then ended have been made. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The Company suggests these
condensed financial statements be read in conjunction with the February 29, 2024 audited financial statements and notes thereto included
in the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 4, 2024. The results
of operations for the period ended August 31, 2024 are not necessarily indicative of the operating results for the full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z64NtA2m0Nik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span id="xdx_860_z0TZFiK14hfe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reclassification&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_ecustom--PromissoryNoteReceivablePolicyTextBlock_zmmDpMNdPObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span id="xdx_864_za2gVtlZF6M2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note Receivable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Promissory Note (the Note&#x201d;) between NextTrip and NextPlay, the Note was due and payable in full on the earlier
of September 1, 2023 or the date the Company completed a financing of $&lt;span id="xdx_909_eus-gaap--ConvertibleDebt_iI_pn6n6_c20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zZVrhW5ebi19" title="Convertible debt"&gt;10&lt;/span&gt; million or more. No payments have been made by NextPlay, and
as such NextPlay is in default under the terms of the Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has entered into a non-binding Memorandum of Understanding (&#x201c;MOU&#x201d;) with NextPlay, whereby NextTrip has agreed to
forgive the entire amount due under the Note in exchange for NextTrip&#x2019;s cancellation of the &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zixIQTEoeaWg" title="Number of shares issued"&gt;400,000&lt;/span&gt;
Preferred Units of Group issued to them as described in Note 1. The Preferred Units are convertible into &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z8YGuYT6nNYa" title="Number of convertible shares issued"&gt;500,000&lt;/span&gt;
NextTrip common shares, and NextTrip has a commitment from a third party to purchase such shares at a price of $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z39topvmdgid" title="Shares issue per shares"&gt;2.00&lt;/span&gt;
per share. As a result, the since Company can realize a minimum of $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zVMsH85qhCcc" title="Value of stock issued"&gt;1,000,000&lt;/span&gt;
from the sale of the common shares, a valuation allowance of $&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zgz5fuOcbhR4" title="Valuation allowance"&gt;1,567,665 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was
established as of February 29, 2024. The Company is in the process of negotiating a second offer to purchase the shares, and
therefore has not closed the transaction with NextPlay. The Company expects to close one of the transaction options before year-end.
During the three and six months ended August 31, 2024, and 2023, there was &lt;span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_do_c20230301__20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zLiVFPSz3Dkg" title="Provision for doubtful accounts"&gt;no &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;bad
debt expense recorded related to the allowance account, and the allowance is unchanged as of August 31, 2024. As of August 31, 2023, &lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBkpsovmPgMi" title="Allowance for doubtful accounts"&gt;no &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;allowance
for doubtful accounts was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zJwYcYLwKita" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_86B_zECKc0O4ONZ" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
Per Share&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; The computation of loss
per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#x201c;Earnings
Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options and preferred stock were excluded due to the anti-dilutive
effect they would have on the computation. At August 31, 2024 and 2023 the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z0TGwOunwYed" style="display: none"&gt;Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;August 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;78,877&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;484,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;96,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2125"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;659,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2128"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zl1be1T4GVai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B3_zJOeyE98NgVj" style="display: none"&gt;Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,533,519&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,521,145&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,688&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2138"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(21,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,544,207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,542,521&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Gain (loss) from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,778&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,545,338&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,534,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zkRT0GjwF6Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 10, 2024, the Company determined that three of the four business milestones per the Share Exchange Agreement had been achieved.
As a result, &lt;span id="xdx_900_ecustom--ContingentSharesIssuable_iI_c20240610_zO4JexHWcrO6" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt; of the total contingent shares of &lt;span id="xdx_90C_ecustom--ContingentShares_iI_c20240610_zv21vZEWMQOd" title="Contingent shares"&gt;5,843,993&lt;/span&gt; became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable contingent shares:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zLOFrzikgY4j" style="display: none"&gt;Schedule
of Issuable Contingent Shares&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Business Milestones&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center"&gt;Contingent Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;p style="margin: 0"&gt;&lt;i&gt;Achieved&lt;/i&gt;&lt;/p&gt;


&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Launch of leisure travel booking platform&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Launch of group travel booking platform&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of FlexPay technology&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,493,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total contingent shares issuable on June 10, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,393,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;i&gt;Not Achieved&lt;/i&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of travel agent platform&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total contingent shares potentially issuable in future periods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,843,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AA_zoSl7kqh3My3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zm2k2w8JtlN5" style="display: none"&gt;Schedule
of Weighted Average Common Stock Shares Outstanding&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average &lt;br/&gt;
    Number of Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj"&gt;1,388,641&lt;/span&gt; common shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,359,126&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,319,146&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;4,393,993 issuable contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,916,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,958,193&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AE_z3vBGbGZscu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issuable contingent shares are of the Company&#x2019;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dilutive
loss per share was not presented, as the Company&#x2019;s outstanding warrants, stock options and preferred stock common equivalent shares
for the periods presented would have had an anti-dilutive effect. At August 31, 2024, the Company had outstanding warrants to purchase
&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMHCtVQDgIE8" title="Warrants outstanding to purchase common stock"&gt;484,063
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, stock options
exercisable for &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2MimFj4uJUa" title="Shares issuable upon exercisable of options"&gt;78,877
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8TCka5mm3qk" title="Number of shares converted"&gt;316
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series E Preferred Stock, which
could be converted into &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zG35NXFRFZc9" title="Common stock issuable upon conversion"&gt;3,259
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zlIxo7WVjlSj" title="Number of shares converted"&gt;33,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series H Preferred Stock, convertible
into &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpsaAcHrHdS2"&gt;33,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, and &lt;span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxcqulyETKN4" title="Number of shares converted"&gt;59,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Preferred Stock, convertible
into &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zFenO045MKba" title="Common stock issuable upon conversion"&gt;59,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, resulting in a
potential total additional &lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbk2XzXNnf" title="Potentially dilutive securities"&gt;659,178
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock outstanding in
the future. At August 31, 2023, the Company had &lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_do_c20230831__20230831_zA5fYSj15E4c" title="Potentially dilutive securities"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;outstanding potentially dilutive securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_zgBfHCAwKx2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_867_zKlvO8tRqgS8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounting
Estimates&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities,
the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates
that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents
granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ze7a5NslSCBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_861_z1OgHMDoOhzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue
Recognition &lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;/span&gt;&lt;/b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive
revenue recognition standard that superseded nearly all existing revenue recognition guidance under prior U.S. GAAP and replaced it with
a principles-based approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon
the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to
be entitled in exchange for those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or
contracts, with our customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4)
allocating the transaction price to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance
obligations by transferring the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_zw8ENaStwBEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002092">&lt;p id="xdx_84A_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zifpSOSo4639" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_864_z4YEibwEO6hc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- The accompanying financial
statements have been prepared by the Company in accordance with Generally Accepted Accounting Principles (&#x201c;GAAP&#x201d;) in the
United States of America. The financial statements have been prepared on a consolidated basis with those of the Company&#x2019;s wholly
owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. In the opinion of management, all
adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position, results of operations
and cash flows at August 31, 2024 and 2023 and for the periods then ended have been made. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. The Company suggests these
condensed financial statements be read in conjunction with the February 29, 2024 audited financial statements and notes thereto included
in the Company&#x2019;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on September 4, 2024. The results
of operations for the period ended August 31, 2024 are not necessarily indicative of the operating results for the full year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2024-03-01to2024-08-31" id="Fact002094">&lt;p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z64NtA2m0Nik" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span id="xdx_860_z0TZFiK14hfe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Reclassification&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
prior year amounts have been reclassified to conform to the current period presentation. These reclassifications had no impact on the
net earnings (loss) or financial position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <NTRP:PromissoryNoteReceivablePolicyTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002096">&lt;p id="xdx_841_ecustom--PromissoryNoteReceivablePolicyTextBlock_zmmDpMNdPObf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span id="xdx_864_za2gVtlZF6M2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note Receivable&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to the terms of the Promissory Note (the Note&#x201d;) between NextTrip and NextPlay, the Note was due and payable in full on the earlier
of September 1, 2023 or the date the Company completed a financing of $&lt;span id="xdx_909_eus-gaap--ConvertibleDebt_iI_pn6n6_c20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zZVrhW5ebi19" title="Convertible debt"&gt;10&lt;/span&gt; million or more. No payments have been made by NextPlay, and
as such NextPlay is in default under the terms of the Note.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has entered into a non-binding Memorandum of Understanding (&#x201c;MOU&#x201d;) with NextPlay, whereby NextTrip has agreed to
forgive the entire amount due under the Note in exchange for NextTrip&#x2019;s cancellation of the &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zixIQTEoeaWg" title="Number of shares issued"&gt;400,000&lt;/span&gt;
Preferred Units of Group issued to them as described in Note 1. The Preferred Units are convertible into &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z8YGuYT6nNYa" title="Number of convertible shares issued"&gt;500,000&lt;/span&gt;
NextTrip common shares, and NextTrip has a commitment from a third party to purchase such shares at a price of $&lt;span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_z39topvmdgid" title="Shares issue per shares"&gt;2.00&lt;/span&gt;
per share. As a result, the since Company can realize a minimum of $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20230901__20230901__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zVMsH85qhCcc" title="Value of stock issued"&gt;1,000,000&lt;/span&gt;
from the sale of the common shares, a valuation allowance of $&lt;span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zgz5fuOcbhR4" title="Valuation allowance"&gt;1,567,665 &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was
established as of February 29, 2024. The Company is in the process of negotiating a second offer to purchase the shares, and
therefore has not closed the transaction with NextPlay. The Company expects to close one of the transaction options before year-end.
During the three and six months ended August 31, 2024, and 2023, there was &lt;span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_do_c20230301__20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zLiVFPSz3Dkg" title="Provision for doubtful accounts"&gt;no &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;bad
debt expense recorded related to the allowance account, and the allowance is unchanged as of August 31, 2024. As of August 31, 2023, &lt;span id="xdx_90C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NextPlayTechnologiesIncMember_zBkpsovmPgMi" title="Allowance for doubtful accounts"&gt;no &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;allowance
for doubtful accounts was established.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</NTRP:PromissoryNoteReceivablePolicyTextBlock>
    <us-gaap:ConvertibleDebt
      contextRef="AsOf2023-09-01_custom_NextPlayTechnologiesIncMember"
      decimals="-6"
      id="Fact002098"
      unitRef="USD">10000000</us-gaap:ConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember"
      decimals="INF"
      id="Fact002100"
      unitRef="Shares">400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember"
      decimals="INF"
      id="Fact002102"
      unitRef="Shares">500000</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="INF"
      id="Fact002104"
      unitRef="USDPShares">2.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="From2023-09-012023-09-01_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact002106"
      unitRef="USD">1000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2024-02-29_custom_NextPlayTechnologiesIncMember"
      decimals="0"
      id="Fact002108"
      unitRef="USD">1567665</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002114">&lt;p id="xdx_84F_eus-gaap--EarningsPerSharePolicyTextBlock_zJwYcYLwKita" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_86B_zECKc0O4ONZ" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Loss
Per Share&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; The computation of loss
per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, &#x201c;Earnings
Per Share.&#x201d; Shares underlying the Company&#x2019;s outstanding warrants, options and preferred stock were excluded due to the anti-dilutive
effect they would have on the computation. At August 31, 2024 and 2023 the Company had the following common shares underlying these instruments:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z0TGwOunwYed" style="display: none"&gt;Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;August 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;78,877&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;484,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;96,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2125"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;659,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2128"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zl1be1T4GVai" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B3_zJOeyE98NgVj" style="display: none"&gt;Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,533,519&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,521,145&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,688&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2138"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(21,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,544,207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,542,521&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Gain (loss) from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,778&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,545,338&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,534,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zkRT0GjwF6Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
June 10, 2024, the Company determined that three of the four business milestones per the Share Exchange Agreement had been achieved.
As a result, &lt;span id="xdx_900_ecustom--ContingentSharesIssuable_iI_c20240610_zO4JexHWcrO6" title="Contingent shares issuable"&gt;4,393,993&lt;/span&gt; of the total contingent shares of &lt;span id="xdx_90C_ecustom--ContingentShares_iI_c20240610_zv21vZEWMQOd" title="Contingent shares"&gt;5,843,993&lt;/span&gt; became eligible for issuance. Pursuant to ASC 260, as there are no
circumstances under which the shares will not be issued, such eligible contingent shares are included in the computation of basic earnings
per share. The following table shows the business milestones and the issuable contingent shares:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zLOFrzikgY4j" style="display: none"&gt;Schedule
of Issuable Contingent Shares&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Business Milestones&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center"&gt;Contingent Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;p style="margin: 0"&gt;&lt;i&gt;Achieved&lt;/i&gt;&lt;/p&gt;


&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Launch of leisure travel booking platform&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Launch of group travel booking platform&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of FlexPay technology&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,493,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total contingent shares issuable on June 10, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,393,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;i&gt;Not Achieved&lt;/i&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of travel agent platform&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total contingent shares potentially issuable in future periods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,843,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AA_zoSl7kqh3My3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zm2k2w8JtlN5" style="display: none"&gt;Schedule
of Weighted Average Common Stock Shares Outstanding&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average &lt;br/&gt;
    Number of Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj"&gt;1,388,641&lt;/span&gt; common shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,359,126&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,319,146&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;4,393,993 issuable contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,916,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,958,193&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;p id="xdx_8AE_z3vBGbGZscu7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
issuable contingent shares are of the Company&#x2019;s sole class of common stock, and as such have the same rights and privileges as
existing common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dilutive
loss per share was not presented, as the Company&#x2019;s outstanding warrants, stock options and preferred stock common equivalent shares
for the periods presented would have had an anti-dilutive effect. At August 31, 2024, the Company had outstanding warrants to purchase
&lt;span id="xdx_909_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zMHCtVQDgIE8" title="Warrants outstanding to purchase common stock"&gt;484,063
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, stock options
exercisable for &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2MimFj4uJUa" title="Shares issuable upon exercisable of options"&gt;78,877
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_z8TCka5mm3qk" title="Number of shares converted"&gt;316
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series E Preferred Stock, which
could be converted into &lt;span id="xdx_90E_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zG35NXFRFZc9" title="Common stock issuable upon conversion"&gt;3,259
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, &lt;span id="xdx_90B_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zlIxo7WVjlSj" title="Number of shares converted"&gt;33,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series H Preferred Stock, convertible
into &lt;span id="xdx_900_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesHPreferredStockMember_zpsaAcHrHdS2"&gt;33,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, and &lt;span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zxcqulyETKN4" title="Number of shares converted"&gt;59,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Preferred Stock, convertible
into &lt;span id="xdx_908_eus-gaap--ConversionOfStockSharesIssued1_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIPreferredStockMember_zFenO045MKba" title="Common stock issuable upon conversion"&gt;59,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock, resulting in a
potential total additional &lt;span id="xdx_90E_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_c20240301__20240831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zKbk2XzXNnf" title="Potentially dilutive securities"&gt;659,178
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock outstanding in
the future. At August 31, 2023, the Company had &lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_do_c20230831__20230831_zA5fYSj15E4c" title="Potentially dilutive securities"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;outstanding potentially dilutive securities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002116">&lt;p id="xdx_896_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zhOaTBTuYF03" style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z0TGwOunwYed" style="display: none"&gt;Schedule
of Underlying Common Shares Excluded from Computation of Loss Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20240301__20240831_z4dkDUQ2Bpq" style="text-align: center"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20230301__20230831_zH59QI3Czysh" style="text-align: center"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;August 31,&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zZ0HbyiQSdr5" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;Warrants&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;78,877&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2119"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--EmployeeStockOptionMember_zdaobIbhGojd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Stock Options&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;484,063&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_zY0MebQFQFXg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Preferred Stock&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;96,238&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2125"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z2kxh9Rnnbwi" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Total Underlying Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;659,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2128"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012024-08-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002118"
      unitRef="Shares">78877</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember21742375"
      decimals="INF"
      id="Fact002121"
      unitRef="Shares">484063</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-012024-08-31_us-gaap_PreferredStockMember21742406"
      decimals="INF"
      id="Fact002124"
      unitRef="Shares">96238</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002127"
      unitRef="Shares">659178</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002130">&lt;p id="xdx_89C_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_z6YoFBIM3sFh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the amounts used in computing loss per share and the effect on net loss and the weighted average number of shares
of dilutive potential common stock for the periods three and six months ended August 31, 2024, and 2023:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B3_zJOeyE98NgVj" style="display: none"&gt;Schedule
of Amounts Used In Computing Loss Per Share and Effect On Net Loss and Weighted Average Number Of Shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20240601__20240831_zkqQ7ZAxgz66" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20230601__20230831_zrGgtdHYHi4b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240301__20240831_zNkJ3nnB331b" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20230301__20230831_z6TVb9OxAsN7" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Three Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;Six Months
                                            Ended&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;August 31,&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_maILFCOzJ8f_zmTOkeKHrLIg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Loss from continuing operations&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,533,519&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(3,521,145&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PreferredStockDividendsIncomeStatementImpact_iN_di_msILFCOzJ8f_zepbTXs4usQh" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Preferred dividends&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(10,688&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2138"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(21,376&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2140"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eus-gaap--IncomeLossFromContinuingOperations_iT_mtILFCOzJ8f_maNILATzAGW_zJy5ZkQLJYp6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Loss from continuing operations applicable to common stockholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,544,207&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,542,521&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity_maNILATzAGW_zf00IkSZrtTg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Gain (loss) from discontinued operations applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,131&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;7,778&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2150"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iT_mtNILATzAGW_zN0fgMQluiB" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Net loss applicable to common stockholders&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,545,338&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,160,763&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(3,534,743&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;(2,256,134&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zsThfSXzrqDc" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Weighted average number of common shares outstanding used in loss per share
    during the period (denominator)&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;83,371&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002132"
      unitRef="USD">-1533519</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact002133"
      unitRef="USD">-1160763</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002134"
      unitRef="USD">-3521145</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002135"
      unitRef="USD">-2256134</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002137"
      unitRef="USD">10688</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002139"
      unitRef="USD">21376</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002142"
      unitRef="USD">-1544207</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact002143"
      unitRef="USD">-1160763</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002144"
      unitRef="USD">-3542521</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002145"
      unitRef="USD">-2256134</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002147"
      unitRef="USD">-1131</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002149"
      unitRef="USD">7778</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002152"
      unitRef="USD">-1545338</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact002153"
      unitRef="USD">-1160763</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002154"
      unitRef="USD">-3534743</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002155"
      unitRef="USD">-2256134</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact002157"
      unitRef="Shares">5275511</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact002158"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002159"
      unitRef="Shares">3277339</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2023-03-012023-08-31"
      decimals="INF"
      id="Fact002160"
      unitRef="Shares">83371</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <NTRP:ContingentSharesIssuable
      contextRef="AsOf2024-06-10"
      decimals="INF"
      id="Fact002162"
      unitRef="Shares">4393993</NTRP:ContingentSharesIssuable>
    <NTRP:ContingentShares
      contextRef="AsOf2024-06-10"
      decimals="INF"
      id="Fact002164"
      unitRef="Shares">5843993</NTRP:ContingentShares>
    <NTRP:ScheduleOfIssuableContingentSharesTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002166">&lt;p id="xdx_890_ecustom--ScheduleOfIssuableContingentSharesTableTextBlock_zG8b0AfqnN47" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zLOFrzikgY4j" style="display: none"&gt;Schedule
of Issuable Contingent Shares&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid"&gt;Business Milestones&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240630_zt8eNIJpGer9" style="border-bottom: Black 1pt solid; text-align: center"&gt;Contingent Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;p style="margin: 0"&gt;&lt;i&gt;Achieved&lt;/i&gt;&lt;/p&gt;


&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="padding-bottom: 1pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--LaunchOfLeisureTravelBookingPlatform_iI_zUUmCL8k3QQl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;Launch of leisure travel booking platform&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--LaunchOfGroupTravelBookingPlatform_iI_zG5yWcTOKgdb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;Launch of group travel booking platform&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LaunchOfFlexpayTechnology_iI_zBVuNc6g37i6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of FlexPay technology&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,493,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ContingentSharesIssuable_iI_z8iW0Egm5PJd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total contingent shares issuable on June 10, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;4,393,993&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;i&gt;Not Achieved&lt;/i&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LaunchOfTravelAgentPlatformShares_iI_zpcBMbEeqK1e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Launch of travel agent platform&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentlyIssuableShares_iI_znyowkRtGGPa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Total contingent shares potentially issuable in future periods&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--ContingentShares_iI_zipN08SJIIi6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,843,993&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</NTRP:ScheduleOfIssuableContingentSharesTableTextBlock>
    <NTRP:LaunchOfLeisureTravelBookingPlatform
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002168"
      unitRef="Shares">1450000</NTRP:LaunchOfLeisureTravelBookingPlatform>
    <NTRP:LaunchOfGroupTravelBookingPlatform
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002170"
      unitRef="Shares">1450000</NTRP:LaunchOfGroupTravelBookingPlatform>
    <NTRP:LaunchOfFlexpayTechnology
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002172"
      unitRef="Shares">1493993</NTRP:LaunchOfFlexpayTechnology>
    <NTRP:ContingentSharesIssuable
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002174"
      unitRef="Shares">4393993</NTRP:ContingentSharesIssuable>
    <NTRP:LaunchOfTravelAgentPlatformShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002176"
      unitRef="Shares">1450000</NTRP:LaunchOfTravelAgentPlatformShares>
    <NTRP:ContingentlyIssuableShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002178"
      unitRef="Shares">1450000</NTRP:ContingentlyIssuableShares>
    <NTRP:ContingentShares
      contextRef="AsOf2024-06-30"
      decimals="INF"
      id="Fact002180"
      unitRef="Shares">5843993</NTRP:ContingentShares>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002182">&lt;p id="xdx_89C_eus-gaap--ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_zyHFyosDQkdf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table shows the reconciliation of the weighted average common shares outstanding for the three and six months ended August
31, 2024 to the weighted average common shares used in the computation of basic earnings per share:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_8BA_zm2k2w8JtlN5" style="display: none"&gt;Schedule
of Weighted Average Common Stock Shares Outstanding&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240601__20240831_zeull9dqhCth" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240301__20240831_zBIxHcRXXNfj" style="border-bottom: Black 1pt solid; display: none; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;Weighted Average &lt;br/&gt;
    Number of Common Shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Three Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;Six Months Ended &lt;br/&gt;
    August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--CommonStockShareOutstanding_zmkxezcWGJRh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%"&gt;&lt;span id="xdx_90D_eus-gaap--SharesOutstanding_iI_c20240831_zG1EJraQD3pj"&gt;1,388,641&lt;/span&gt; common shares outstanding&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,359,126&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;1,319,146&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--WeightedAverageIssuableContingentShares_iI_z9GASTPR5X49" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;4,393,993 issuable contingent shares&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;3,916,385&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,958,193&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--WeightedAverageNumberDilutedSharesOutstandingAdjustment_zPV1vgOsXHwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Weighted average common shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;5,275,511&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;3,277,339&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002186"
      unitRef="Shares">1388641</us-gaap:SharesOutstanding>
    <NTRP:CommonStockShareOutstanding
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact002184"
      unitRef="Shares">1359126</NTRP:CommonStockShareOutstanding>
    <NTRP:CommonStockShareOutstanding
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002185"
      unitRef="Shares">1319146</NTRP:CommonStockShareOutstanding>
    <NTRP:WeightedAverageIssuableContingentShares
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact002188"
      unitRef="Shares">3916385</NTRP:WeightedAverageIssuableContingentShares>
    <NTRP:WeightedAverageIssuableContingentShares
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002189"
      unitRef="Shares">1958193</NTRP:WeightedAverageIssuableContingentShares>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact002191"
      unitRef="Shares">5275511</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002192"
      unitRef="Shares">3277339</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-08-31_us-gaap_WarrantMember"
      decimals="INF"
      id="Fact002194"
      unitRef="Shares">484063</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact002196"
      unitRef="Shares">78877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact002198"
      unitRef="Shares">316</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012024-08-31_us-gaap_SeriesEPreferredStockMember"
      decimals="INF"
      id="Fact002200"
      unitRef="Shares">3259</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact002202"
      unitRef="Shares">33000</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012024-08-31_us-gaap_SeriesHPreferredStockMember"
      decimals="INF"
      id="Fact002203"
      unitRef="Shares">33000</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact002205"
      unitRef="Shares">59979</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="From2024-03-012024-08-31_custom_SeriesIPreferredStockMember"
      decimals="INF"
      id="Fact002207"
      unitRef="Shares">59979</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="From2024-03-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002209"
      unitRef="Shares">659178</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:UseOfEstimates contextRef="From2024-03-01to2024-08-31" id="Fact002213">&lt;p id="xdx_84A_eus-gaap--UseOfEstimates_zgBfHCAwKx2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_867_zKlvO8tRqgS8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounting
Estimates&lt;/b&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;- The preparation of financial statements
in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities,
the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates
that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents
granted as offering costs, and allowance for bad debts and inventory obsolescence.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002215">&lt;p id="xdx_849_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_ze7a5NslSCBg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_861_z1OgHMDoOhzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Revenue
Recognition &lt;/b&gt;&lt;/span&gt;&lt;b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;/span&gt;&lt;/b&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue in accordance with ASC Topic No. 606. In May 2014, the Financial Accounting Standards Board (FASB) issued
Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2014-09, &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt;. ASU 2014-09 is a comprehensive
revenue recognition standard that superseded nearly all existing revenue recognition guidance under prior U.S. GAAP and replaced it with
a principles-based approach for determining revenue recognition. The core principle of the standard is the recognition of revenue upon
the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to
be entitled in exchange for those goods or services. In general, we determine revenue recognition by: (1) identifying the contract, or
contracts, with our customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4)
allocating the transaction price to performance obligations in the contract; and (5) recognizing revenue when, or as, we satisfy performance
obligations by transferring the promised goods or services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes revenue when the customer has purchased the product, the occurrence of the earlier of date of travel or the date of
cancellation has expired, as satisfaction of the performance obligation, the sales price is fixed or determinable and collectability
is reasonably assured. Revenue for customer travel packages purchased directly from the Company is recorded gross (the amount paid to
the Company by the customer is shown as revenue and the cost of providing the respective travel package is recorded to cost of revenues).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generates revenues from sales directly to customers as well as through other distribution channels of tours and activities at
destinations throughout the world.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company controls the specified travel product before it is transferred to the customer and is therefore a principal, based on but not
limited to, the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company is primarily responsible for fulling the promise to provide such travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has inventory risk before the specified travel product has been transferred to a customer or after transfer of control to
    a customer.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company has discretion in establishing the price for the specified travel product.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Payments
for tours or activities received in advance of services being rendered are recorded as deferred revenue and recognized as revenue at
the earlier of the date of travel or the last date of cancellation (i.e., the customer&#x2019;s refund privileges lapse).&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002217">&lt;p id="xdx_804_eus-gaap--IntangibleAssetsDisclosureTextBlock_zWtrNzMvGv53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
3 &#x2013; &lt;span id="xdx_82A_zHPDyYR016y"&gt;Intangible Assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zr9WT6ZcWyUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of August 31, 2024, and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B9_zZLh7VI8bnnl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240831_zypz4PBWeJH9" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;August
                                            31,&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240229_zmq5bCFnM775" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;February
                                            29,&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zK34HO26Stbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;7,122,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zgjptkxM7z95" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zbrHfUCcbYyl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zzEbWzPCm2Jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,918,455&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zqtA7BLv8aWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,607,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_z0bG6nDEVe07" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,310,927&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zvSE4RGIiv67" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Amortization
expense for the six months ended August 31, 2024, and 2023 was $&lt;span id="xdx_909_eus-gaap--AmortizationOfIntangibleAssets_c20240301__20240831_zdUKXMaczsY5" title="Amortization"&gt;383,061
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_c20230301__20230831_zjYgpdH9JiTi" title="Amortization"&gt;657,389&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three and six months ended August 31, 2024, and 2023, the Company recorded &lt;span id="xdx_90C_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240601__20240831_z3B9tBdTvhAk" title="Impairment losses"&gt;&lt;span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20240301__20240831_z5UokqdZHCk7" title="Impairment losses"&gt;&lt;span id="xdx_90A_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230601__20230831_z0b4lIrlvFGd" title="Impairment losses"&gt;&lt;span id="xdx_90E_eus-gaap--ImpairmentOfIntangibleAssetsFinitelived_do_c20230301__20230831_zCgPEc9tisM5" title="Impairment losses"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;impairment losses associated with the
carrying value exceeding its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdOVf9nbV8e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated aggregate amortization expense for years ending February 28 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BB_zu3DsFSttSQ7" style="display: none"&gt;Schedule
of Estimated Aggregate Amortization Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240831_zwls6gO7da3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zrxfoGgoe2Cg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 80%"&gt;2025 (Remaining)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;200,232&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zyyape05oA41" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zZeSfWHXjPrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zJ4mMxdyOqnj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zjQa3ZhpKh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_z0Or0MvqVMNg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;787,246&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




&lt;p id="xdx_8AE_zaWZBzr2vEkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002219">&lt;p id="xdx_897_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zr9WT6ZcWyUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Intangible
assets as of August 31, 2024, and February 29, 2024 consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8B9_zZLh7VI8bnnl" style="display: none"&gt;Schedule
of Intangible Assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20240831_zypz4PBWeJH9" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;August
                                            31,&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240229_zmq5bCFnM775" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;February
                                            29,&lt;/p&gt;
                                                                               &lt;p style="margin-top: 0; margin-bottom: 0"&gt;2024&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareDevelopmentMember_zK34HO26Stbf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 64%; text-align: left"&gt;Software Development&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;7,122,596&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 14%; text-align: right"&gt;6,602,028&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareLicensesMember_zgjptkxM7z95" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Software Licenses&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;789,576&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zbrHfUCcbYyl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Trademark&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;6,283&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzjZg_zzEbWzPCm2Jd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,918,455&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;7,397,887&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzjZg_zqtA7BLv8aWf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Accumulated amortization&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,607,528&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(5,224,467&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzjZg_z0bG6nDEVe07" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Intangible assets, net of amortization&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,310,927&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;2,173,420&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-08-31_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact002221"
      unitRef="USD">7122596</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_SoftwareDevelopmentMember"
      decimals="0"
      id="Fact002222"
      unitRef="USD">6602028</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-08-31_custom_SoftwareLicensesMember"
      decimals="0"
      id="Fact002224"
      unitRef="USD">789576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_custom_SoftwareLicensesMember"
      decimals="0"
      id="Fact002225"
      unitRef="USD">789576</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-08-31_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact002227"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29_us-gaap_TrademarksMember"
      decimals="0"
      id="Fact002228"
      unitRef="USD">6283</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002230"
      unitRef="USD">7918455</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact002231"
      unitRef="USD">7397887</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002233"
      unitRef="USD">5607528</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact002234"
      unitRef="USD">5224467</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002236"
      unitRef="USD">2310927</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="AsOf2024-02-29"
      decimals="0"
      id="Fact002237"
      unitRef="USD">2173420</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002239"
      unitRef="USD">383061</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002241"
      unitRef="USD">657389</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2024-06-012024-08-31"
      decimals="0"
      id="Fact002243"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2024-03-01to2024-08-31"
      decimals="0"
      id="Fact002245"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact002247"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002249"
      unitRef="USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002251">&lt;p id="xdx_890_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdOVf9nbV8e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimated aggregate amortization expense for years ending February 28 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;span id="xdx_8BB_zu3DsFSttSQ7" style="display: none"&gt;Schedule
of Estimated Aggregate Amortization Expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20240831_zwls6gO7da3" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_iI_maFLIANzgGq_zrxfoGgoe2Cg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; width: 80%"&gt;2025 (Remaining)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;200,232&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_maFLIANzgGq_zyyape05oA41" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2026&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;313,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_maFLIANzgGq_zZeSfWHXjPrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2027&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;270,728&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_maFLIANzgGq_zJ4mMxdyOqnj" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2028&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,957&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearThree_iI_maFLIANzgGq_zjQa3ZhpKh9e" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2261"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_mtFLIANzgGq_z0Or0MvqVMNg" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="display: none; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;787,246&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;




</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002253"
      unitRef="USD">200232</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002255"
      unitRef="USD">313329</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002257"
      unitRef="USD">270728</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002259"
      unitRef="USD">2957</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="AsOf2024-08-31"
      decimals="0"
      id="Fact002263"
      unitRef="USD">787246</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002265">&lt;p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zkC1RJtuioTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
4 &#x2013; &lt;span id="xdx_827_zHoRWkQFrokf"&gt;Goodwill&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
legal acquisition of NextTrip Holdings, Inc. by Sigma Additive Solutions, Inc. on December 29, 2023 was determined to be a reverse acquisition,
with NextTrip as the accounting acquirer, using the acquisition method of accounting in accordance with ASC 805, Business Combinations.
Under this method of accounting, the purchase price is allocated to the assets acquired and liabilities assumed based upon their estimated
fair values at the date of consummation of the transaction.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to ASC 350-20, the Company assigned its goodwill to reporting units and is required to test each reporting unit&#x2019;s goodwill for
impairment at least on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than
not reduce the fair value of a reporting unit below its carrying amount. The goodwill resulting from the reverse acquisition is primarily
attributable to NextTrip&#x2019;s objective to obtain access to public markets to provide funding wherewithal to fund business growth.
NextTrip&#x2019;s benefit in paying for these synergies in the reverse acquisition transaction are to avoid the time and expense of organizing
and executing an Initial Public Offering (&#x201c;IPO&#x201d;) transaction. In the reverse acquisition, $&lt;span id="xdx_90F_eus-gaap--Goodwill_iI_c20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripHoldingsIncMember_zPbF6N17fze4" title="Goodwill"&gt;1,167,805
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of goodwill was allocated to the NextTrip
Reporting Unit under the acquisition method of accounting.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="AsOf2023-12-29_custom_NextTripHoldingsIncMember"
      decimals="0"
      id="Fact002267"
      unitRef="USD">1167805</us-gaap:Goodwill>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002269">&lt;p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zWyRxbHZVW7k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
5 - &lt;span id="xdx_827_zRWFXEx8pIc4"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 18, 2024, the Company&#x2019;s wholly-owned subsidiary, NextTrip, entered into an unsecured promissory note for a line of credit
with Donald Monaco and William Kerby, the Company&#x2019;s Chairman of the board of directors and Chief Executive Officer, respectively,
for the aggregate principal amount of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zXX8wLxbxl62" title="Principal amount"&gt;500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;with an initial advance of $&lt;span id="xdx_909_eus-gaap--LineOfCredit_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zv32yQuWcHp8" title="Line of credit"&gt;125,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
provided that the aggregate principal amount of the note does not exceed $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zR7gIUwNaJbl" title="Principal amount"&gt;500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at any time. Under the terms of the note,
advances under the line of credit may be made at the Company&#x2019;s request until August 31, 2024. The note bears an annual interest
rate of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_ziVau7vlg1id" title="Annual interest rate"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and matures on &lt;span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_dd_c20240318__20240318__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsAndChiefExecutiveOfficerMember_zj8ZxDonO9fk" title="Maturity date"&gt;February
28, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, and may be prepaid by the Company
at any time prior to maturity without penalty. As of August 31, 2024, the full principal amount of the note had been advanced to the
Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 23, 2024, the Company&#x2019;s board of directors approved the Company&#x2019;s wholly-owned subsidiary, NextTrip, to enter into
a series of unsecured promissory notes with certain related parties, including investors, directors, officers and employees, who may
individually provide funds for the aggregate principal amount of $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zjmfVSNMXgx1" title="Principal amount"&gt;1,000,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The notes bear an annual interest rate of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240423__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z4ITJ3vrEPsj" title="Annual interest rate"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and shall mature one year from the date of each note&#x2019;s execution, and may be prepaid by the Company at any time prior to maturity
without penalty. On August 14, 2024, at a joint meeting of the Audit Committee and the board of directors, the directors unanimously
approved an increase in the principal amount of the related party line of credit to $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20240814__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_z1mX5NVwsI86" title="Principal amount"&gt;2,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;on the same terms and conditions as previously
approved. As of August 31, 2024, $&lt;span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--InvestorsDirectorsOfficersAndEmployeesMember_zOaCBTT4pDah" title="Principal amount"&gt;1,411,414
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;had been advanced to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 21, 2024, NextTrip issued an unsecured promissory note, in the principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240521__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zacbQbXqGnLg" title="Principal amount"&gt;455,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(the &#x201c;Promissory Note&#x201d;), to
Mr. Monaco to memorialize the terms and conditions of certain working capital advances made by Mr. Monaco to NextTrip. As of August 31,
2024, the outstanding principal balance of the Line of Credit Promissory Note was $&lt;span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zdCcsK6KsJkj" title="Outstanding principal amount"&gt;405,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
The Promissory Note accrues interest at a rate equal to &lt;span id="xdx_906_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_zIIP6DFhX3Fd" title="Annual interest rate"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
simple interest per annum, and will automatically mature and become due and payable in full on &lt;span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_dd_c20240831__20240831__srt--TitleOfIndividualAxis__custom--DonaldMonacoMember_z3oonYHhvxIc" title="Maturity date"&gt;February
28, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;, subject to certain limited exceptions.
The Promissory Note, or any portion thereof, may be prepaid by NextTrip without any penalty. Mr. Monaco serves as Chairman of the Company&#x2019;s
board of directors. The Promissory Note was approved by the Company&#x2019;s Board of Directors, including the independent members thereof.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
total amounts due to related parties at August 31, 2024 and February 29, 2024 totaled $&lt;span id="xdx_90A_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zjAVdZSeYa25" title="Notes payable - related parties"&gt;2,718,594
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_901_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20240229__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zNtwJ8WhjzWf" title="Notes payable - related parties"&gt;828,277&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact002271"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCredit
      contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact002273"
      unitRef="USD">125000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact002275"
      unitRef="USD">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember"
      decimals="INF"
      id="Fact002277"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-03-182024-03-18_custom_BoardOfDirectorsAndChiefExecutiveOfficerMember"
      id="Fact002279">2025-02-28</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fact002281"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-04-23_custom_InvestorsDirectorsOfficersAndEmployeesMember"
      decimals="INF"
      id="Fact002283"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-08-14_custom_InvestorsDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fact002285"
      unitRef="USD">2000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-08-31_custom_InvestorsDirectorsOfficersAndEmployeesMember"
      decimals="0"
      id="Fact002287"
      unitRef="USD">1411414</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-05-21_custom_DonaldMonacoMember"
      decimals="0"
      id="Fact002289"
      unitRef="USD">455000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-08-31_custom_DonaldMonacoMember"
      decimals="0"
      id="Fact002291"
      unitRef="USD">405000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-08-31_custom_DonaldMonacoMember"
      decimals="INF"
      id="Fact002293"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-08-312024-08-31_custom_DonaldMonacoMember"
      id="Fact002295">2025-02-28</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-08-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002297"
      unitRef="USD">2718594</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="AsOf2024-02-29_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact002299"
      unitRef="USD">828277</us-gaap:NotesPayableCurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002301">&lt;p id="xdx_80B_eus-gaap--DebtDisclosureTextBlock_zRJTs7tgKSB2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
6 &#x2013; &lt;span id="xdx_824_zDmSo9251hJ1"&gt;Notes Payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
May 24, 2024, the Company issued an unsecured promissory note for $&lt;span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240524__20240524_z6wxI60LEQqb" title="Proceeds from convertible debt"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to an investor upon receipt of proceeds.
The note bears an annual interest rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240524_zUdxOsuTlXRa" title="Interest rate"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and will mature and be due and payable on the earlier date of the completion of a public financing or October 31, 2024, unless extended
by the written consent of the investor. The note can be prepaid at any time by the Company without penalty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
July 11, 2024, the Company issued an unsecured promissory note for $&lt;span id="xdx_90B_eus-gaap--ProceedsFromConvertibleDebt_c20240711__20240711_zPvJWSx5YaWj" title="Proceeds from convertible debt"&gt;40,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to an investor upon receipt of proceeds.
The note bears an annual interest rate of &lt;span id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240711_zkSneW3Fkvpa" title="Interest rate"&gt;7.5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
and will mature and be due and payable on June 25, 2025, unless extended by the written consent of the investor. The note can be prepaid
at any time by the Company without penalty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-05-242024-05-24"
      decimals="0"
      id="Fact002303"
      unitRef="USD">100000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-05-24"
      decimals="INF"
      id="Fact002305"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="From2024-07-112024-07-11"
      decimals="0"
      id="Fact002307"
      unitRef="USD">40000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-07-11"
      decimals="INF"
      id="Fact002309"
      unitRef="Pure">0.075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002311">&lt;p id="xdx_803_eus-gaap--LesseeOperatingLeasesTextBlock_zCvjX1dqR5Q5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
7 - &lt;span id="xdx_825_ze0gMf9lqdr7"&gt;Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 25, 2023, as part of the separation agreement with NextPlay Technologies Inc., the Company assumed control of a lease arrangement
for office space in Florida.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted ASU 2016-02 (Topic ASC 842) Leases, which requires a lessee to recognize a lease asset and a leases liability for operating
leases arrangements greater than twelve (12) months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
determined that the arrangement was an operating lease at inception and included it in operating lease ROU assets, operating lease liabilities
- current, and operating lease liabilities - noncurrent on the balance sheet as of February 28, 2023. The office facility was occupied
by NextTrip employees through March 16, 2023, when the landlord informed NextTrip that it would not recognize NextTrip as the tenant.
The Company continued to negotiate the assumption of the lease with the landlord, but was ultimately unsuccessful, and as a result derecognized
the lease in the financial statements as of February 29, 2024. No restatement was made for fiscal year 2023 as the Company had use of
the offices at that time and was in negotiations to assume the lease from NextPlay Technologies, Inc. No payments have been made on the
lease and no expense has been recognized for the three and six months ended August 31, 2024. Rent expense for the three and six months
ended August 31, 2023 totaled $&lt;span id="xdx_903_eus-gaap--PaymentsForRent_c20230601__20230831_zUDs8rrFXPq5" title="Rent expense"&gt;37,822&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_90E_eus-gaap--PaymentsForRent_c20230301__20230831_z3hIkLZPzzS7" title="Rent expense"&gt;74,847&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company leases approximately &lt;span id="xdx_90B_eus-gaap--AreaOfLand_iI_usqft_c20230125__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zUtMjC0NwaG" title="Area of land"&gt;350
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;square feet of space for its principal
executive offices at 3900 Paseo del Sol, Santa Fe, New Mexico 87507. The lease has a 6-month term which ends on December 31, 2024. The
landlord can terminate the lease upon 30 days written notice and NextTrip can terminate the lease upon 45 days written notice. Therefore,
the Company has elected the short-term lease recognition exemption, whereby leases are not recorded on the Company&#x2019;s balance sheet
and lease payments are recognized as lease expense on a straight-line basis over the lease term. Rent expense related to this lease for
the three and six months ended August 31, 2024 was $&lt;span id="xdx_901_eus-gaap--PaymentsForRent_c20240601__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z3nkNDFemIRb" title="Payments for rent"&gt;1,650
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_900_eus-gaap--PaymentsForRent_c20240301__20240831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_z2QdZaWDAlth" title="Payments for rent"&gt;3,300&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, and $&lt;span id="xdx_90A_eus-gaap--PaymentsForRent_c20230301__20230831__srt--TitleOfIndividualAxis__custom--PrincipalExecutiveOfficesMember_zlWbTPJ1qB89" title="Payments for rent"&gt;0
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;for the same periods in 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:PaymentsForRent
      contextRef="From2023-06-012023-08-31"
      decimals="0"
      id="Fact002313"
      unitRef="USD">37822</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-03-012023-08-31"
      decimals="0"
      id="Fact002315"
      unitRef="USD">74847</us-gaap:PaymentsForRent>
    <us-gaap:AreaOfLand
      contextRef="AsOf2023-01-25_custom_PrincipalExecutiveOfficesMember"
      decimals="INF"
      id="Fact002317"
      unitRef="sqft">350</us-gaap:AreaOfLand>
    <us-gaap:PaymentsForRent
      contextRef="From2024-06-012024-08-31_custom_PrincipalExecutiveOfficesMember"
      decimals="0"
      id="Fact002319"
      unitRef="USD">1650</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2024-03-012024-08-31_custom_PrincipalExecutiveOfficesMember"
      decimals="0"
      id="Fact002321"
      unitRef="USD">3300</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent
      contextRef="From2023-03-012023-08-31_custom_PrincipalExecutiveOfficesMember"
      decimals="0"
      id="Fact002323"
      unitRef="USD">0</us-gaap:PaymentsForRent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002325">&lt;p id="xdx_801_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zFEnqmQabPwe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
8 - &lt;span id="xdx_829_zeJLhLyM0iX4"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Common
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 8, 2024, at a special meeting of stockholders, the Company received approval to increase its authorized shares of common stock
from &lt;span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20240307_zgqrNH3Cp466" title="Common stock, shares authorized"&gt;1,200,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;to
&lt;span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_c20240308_z63XGH047bEf" title="Common stock, shares authorized"&gt;250,000,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(the
&#x201c;Increase in Authorized&#x201d;). On March 11, 2024, the Company filed a Certificate of Amendment to its amended and restated articles
of incorporation, as amended, with the Secretary of State of the State of Nevada, pursuant to which, effective as of 12:01 a.m. Pacific
time on March 13, 2024, the Increase in Authorized was implemented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the first quarter of 2024, the Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zz25wajg3Ekd" title="Number of common stock issued"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock upon conversion
of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zJdBKNDp3Hs8" title="Number of shares converted"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series G Convertible Preferred
Stock, &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z8moQY9qjU9b" title="Number of common stock issued"&gt;117,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock upon conversion
of &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zOs2ScDReDxj" title="Number of shares converted"&gt;117,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series H Convertible Preferred
Stock, and &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zceM3EoWEXFi" title="Number of common stock issued"&gt;192,502
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock upon conversion
of &lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20240301__20240531__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z1XcgGetfQDd" title="Number of shares converted"&gt;192,502
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Convertible Preferred
Stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
the second quarter of 2024, the Company issued &lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240601__20240831__dei--LegalEntityAxis__custom--DooyaMediaGroupIncMember_zhssIOx2XrNe" title="Number of common stock issued"&gt;42,709
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock to a service provider
as partial compensation for development work related to Compass.TV, the Company&#x2019;s Free-Ad Supported TV (&#x201c;FAST&#x201d;) channel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Preferred
Stock&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
our amended and restated articles of incorporation, as amended (&#x201c;Articles&#x201d;), our board of directors has the authority, without
further action by stockholders, to designate one or more series of preferred stock and to fix the voting powers, designations, preferences,
limitations, restrictions and relative rights granted to or imposed upon the preferred stock, including dividend rights, conversion rights,
voting rights, rights and terms of redemption, liquidation preference and sinking fund terms, any or all of which may be preferential
to or greater than the rights of the common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection
with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing
a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders
of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is authorized to issue &lt;span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20240831_zPBlx5We5Fej" title="Preferred stock, shares authorized"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240229_ziS720W8L6j8" title="Preferred stock, shares authorized"&gt;10,000,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of preferred stock, $&lt;span id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240229_zrisDs6fEKnb" title="Preferred stock, par value"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831_zIfYuIEv3nH1" title="Preferred stock, par value"&gt;0.001&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;par value. An aggregate of &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20240831_z8do2g5cDy15" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831_zagDP9qu0ctg" title="Preferred stock, shares outstanding"&gt;93,295&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20240229_zwC5kZM3tOlg" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20240229_zfgTOPahMzei" title="Preferred stock, shares outstanding"&gt;472,996&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of preferred stock were issued
and outstanding at August 31, 2024 and February 29, 2024, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
E Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
the Certificate of Designations for the Series E Preferred Stock, the Series E Preferred Shares have an initial stated value of $&lt;span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z6m2ooZr9fyd" title="Preferred stock, par value"&gt;1,500
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Stated Value&#x201d;).
Dividends at the initial rate of &lt;span id="xdx_901_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zLBREMrmDomk" title="Dividends percentage"&gt;9&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
per annum will accrue and, on a monthly basis, shall be payable in kind by the increase of the Stated Value of the Series E Preferred
Stock by said amount. The holders of the Series E Preferred Shares have the right at any time to convert all or a portion of the Series
E Preferred Shares (including, without limitation, accrued and unpaid dividends and make-whole dividends through the third anniversary
of the closing date) into shares of the Company&#x2019;s common stock at an initial conversion rate determined by dividing the Conversion
Amount by the Conversion Price ($&lt;span id="xdx_90B_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z8pHYNUmYRD" title="Conversion price per share"&gt;0.13
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;above the consolidated closing bid price
for the trading day prior to the execution of the relates stock purchase agreement). The Conversion Amount is the sum of the Stated Value
of the Series E Preferred Shares then being converted plus any other unpaid amounts payable with respect to the Series E Preferred Shares
being converted, plus the &#x201c;Make Whole Amount&#x201d; (the amount of any dividends that, but for the conversion, would have accrued
at the dividend rate for the period through the third anniversary of the initial issuance date). The Conversion Rate is also subject
to adjustment for stock splits, dividends recapitalizations and similar events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, &lt;span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zYqkC5iZJpmj" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90E_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zkdeVtVujlla" title="Preferred stock, shares outstanding"&gt;316&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the issued Series E Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, including the make-whole dividends, would have resulted in
the issuance of &lt;span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zbHuFHIiOY82" title="Common stock issuable upon conversion"&gt;3,259
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
F Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 4, 2024, the Company filed a Certificate of Designation of Series F Convertible Preferred Stock (the &#x201c;Series F Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIyUDMksYNGc" title="Preferred stock shares authorized"&gt;5,843,993
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s preferred
stock as Series F Convertible Preferred Stock, par value $&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240104__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zXoQxcel26V8" title="Preferred stock, par value"&gt;0.001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Series F Preferred&#x201d;).
The Series F Preferred was designated by the Company in connection with its acquisition of NextTrip, and, in the event that the Company
does not have sufficient shares of common stock available to fulfill its obligations pursuant to the Share Exchange Agreement governing
the terms of the acquisition, shares of Series F Preferred shall be issued to the previous equity holders of NextTrip in lieu of shares
of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series F Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series F Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series F Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series F Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series F Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series F Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series F Preferred or alter or amend the Series F Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series F Preferred, or
(iii) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series F Preferred, each outstanding share of Series F Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Conversion
Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary (each, a &#x201c;Liquidation&#x201d;),
holders of Series F Preferred will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Conversion
Ratio, with holders of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, &lt;span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesFConvertiblePreferredStockMember_zIzKEFxJBZqc" title="Preferred stock, shares outstanding"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Series F Convertible Preferred
Stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
G Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series G Convertible Preferred Stock (the &#x201c;Series G Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_ztJZ504a3rX8" title="Preferred stock shares authorized"&gt;100,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s preferred
stock as Series G Preferred Stock, par value $&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zQMolak1TwU7" title="Preferred stock, par value"&gt;0.001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Series G Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series G Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series G Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series G Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series G Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series G Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series G Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series G Preferred or alter or amend the Series G Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series G Preferred,
or (iii) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series G Preferred, each outstanding share of Series G Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
G Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series G Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series G Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Redemption
Right&lt;/i&gt;. &lt;span id="xdx_907_eus-gaap--PreferredStockRedemptionTerms_c20240301__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_z4pMlhkdfhPk" title="Preferred stock redemption right, description"&gt;The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with the
terms of the Perpetual License Agreement&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, &lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesGConvertiblePreferredStockMember_zEasTqb1MJ32" title="Preferred stock, shares outstanding"&gt;no
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the issued Series G Convertible
Preferred Stock were outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
H Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
January 26, 2024, the Company filed a Certificate of Designation of Series H Convertible Preferred Stock (the &#x201c;Series H Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_909_eus-gaap--PreferredStockSharesAuthorized_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zn2EFnmpBy5d" title="Preferred stock, shares authorized"&gt;150,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s preferred
stock as Series H Preferred Stock, par value $&lt;span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240126__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_z2CWif6IqCle" title="Preferred stock, par value"&gt;0.001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Series H Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series H Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series H Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series H Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Company&#x2019;s Articles or as otherwise required by the Nevada Revised Statutes, holders of Series H Preferred
are entitled to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect
to all matters presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled
to a number of votes equal to the number of shares of common stock into which the Series H Preferred held by such holder is convertible.
The Company may not, without the consent of holders of a majority of the outstanding shares of Series H Preferred, (i) alter or change
adversely the powers, preferences or rights given to the Series H Preferred or alter or amend the Series H Certificate of Designation,
(ii) amend its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series H Preferred,
or (iii) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding Series H Preferred, each outstanding share of Series H Preferred shall
automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the &#x201c;Series
H Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series H Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculate based on the Series H Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, &lt;span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zr03MBanu6Fc" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zkILavaIEv64" title="Preferred stock, shares outstanding"&gt;33,000&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the issued Series H Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of &lt;span id="xdx_904_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesHConvertiblePreferredStockMember_zepCDi8ghZGf" title="Common stock issuable upon conversion"&gt;33,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
I Convertible Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 22, 2024, the Company filed a Certificate of Designation of Series I Convertible Preferred Stock (the &#x201c;Series I Certificate
of Designation&#x201d;) with the Secretary of State of the State of Nevada, designating &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesAuthorized_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zD5NoIQJCbW2" title="Preferred stock, shares authorized"&gt;331,124
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the Company&#x2019;s preferred
stock as Series I Convertible Preferred Stock, par value $&lt;span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20240222__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_z3od5aJr6LId" title="Preferred stock, par value"&gt;0.001
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share (the &#x201c;Series I Preferred&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
terms and conditions set forth in the Series I Certificate of Designation are summarized below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Ranking.
&lt;/i&gt;The Series I Preferred rank pari passu to the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Dividends.
&lt;/i&gt;Holders of Series I Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Voting&lt;/i&gt;.
Except as provided by the Articles, or as otherwise required by the Nevada Revised Statutes, holders of Series I Preferred are entitled
to vote with the holders of outstanding shares of Company common stock, voting together as a single class, with respect to all matters
presented to the Company&#x2019;s stockholders for their action or consideration. In any such vote, each holder is entitled to a number
of votes equal to the number of shares of common stock into which the Series I Preferred held by such holder is convertible. The Company
may not, without the consent of holders of a majority of the outstanding shares of Series I Preferred, (i) alter or change adversely
the powers, preferences or rights given to the Series I Preferred or alter or amend the Series I Certificate of Designation, (ii) amend
its Articles or other charter documents in any manner that adversely effects any rights of the holders of the Series I Preferred, or
(iii) enter into any agreement with respect to the foregoing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;.
On such date that the Company amends its Articles to increase the number of shares of common stock authorized for issuance thereunder,
to at least the extent required to convert all of the outstanding shares of Series I Preferred, each outstanding share of Series I Preferred
shall automatically be converted into one share of Company common stock (subject to adjustment under certain limited circumstances) (the
&#x201c;Series I Conversion Ratio&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Liquidation&lt;/i&gt;.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series I Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series I Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 15, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zM5pgFf0Dq11" title="Sale of stock, shares"&gt;4,967
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Convertible Preferred
Stock, at $&lt;span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_c20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKRUoIlMdNOl" title="Sale of stock, shares price"&gt;3.02
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, resulting in gross proceeds
to the Company of $&lt;span id="xdx_907_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240815__20240815__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNwLkU9HEH1e" title="Sale of stock proceeds"&gt;15,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zmeMEMVFPMC2" title="Sale of stock, shares"&gt;24,834
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Convertible Preferred
Stock at $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zzjQy2g38kog" title="Sale of stock, shares price"&gt;3.02
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, resulting in gross proceeds
to the Company of $&lt;span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240831__20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zsaGNggDVIR3" title="Sale of stock proceeds"&gt;75,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, &lt;span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zrfLvlukg2Pi" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zUwy5QtNMEl3" title="Preferred stock, shares outstanding"&gt;59,979&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of the issued Series I Convertible
Preferred Stock were outstanding, which if converted as of August 31, 2024, would have resulted in the issuance of &lt;span id="xdx_907_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20240831__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember_zVSTCfiEE8ye" title="Converted issuance of shares of common stock"&gt;59,979
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 29.7pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 28, 2023, at the Annual Meeting of Stockholders of the Company, the Company&#x2019;s stockholders approved the adoption of the
NextTrip 2023 Equity Incentive Plan (the &#x201c;2023 Plan&#x201d;). &lt;span id="xdx_901_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831__us-gaap--PlanNameAxis__custom--TwoThousandTwentyThreeEquityIncentivePlanMember_zMxq9VXF2Q2h" title="Common stock reserved for issuance"&gt;7,000,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock have been reserved
for issuance under the 2023 Plan., and as of August 31, 2024, all of such shares are available for issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s 2013 Equity Incentive Plan expired on March 15, 2023. As such, no new grants may be made under the 2013 Plan. At August
31, 2024, there were &lt;span id="xdx_908_eus-gaap--CommonStockCapitalSharesReservedForFutureIssuance_iI_c20240831_zkYBbGAlwL12" title="Common stock reserved for future issuance"&gt;78,877
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of common stock reserved for issuance
upon exercise of outstanding stock options issued under the 2013 Plan prior to its expiration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were &lt;span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zfG1Bd8tLNck" title="Number of options issued"&gt;&lt;span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z8luLPE8lOAb" title="Number of options issued"&gt;no&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;issuances of stock options for the six
months ended August 31, 2024 or August 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company generally grants stock options to employees and directors at exercise prices equal to the fair market value of the Company&#x2019;s
common stock on the grant date, but not less than 100% of the fair market value. Stock options are typically granted throughout the year
and generally vest over a period from one to three years of service and expire five years from the grant date, unless otherwise specified.
The Company recognizes compensation expense for the fair value of the stock options over the vesting period for each stock option award.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Total
stock-based compensation expense included in the statements of operations for the three and six months ended August 31, 2024 was $&lt;span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_c20240601__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zhcw6XOUVbDg" title="Stock based compensation"&gt;13,841
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and $&lt;span id="xdx_909_eus-gaap--AllocatedShareBasedCompensationExpense_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zC7UvZyFNVH8" title="Stock based compensation"&gt;30,235&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
respectively, all of which was related to stock options. There was &lt;span id="xdx_905_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230601__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z2mL3f0Bd4D2" title="Stock based compensation"&gt;&lt;span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_do_c20230301__20230831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_z1VdIpbt1Z0j" title="Stock based compensation"&gt;no&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;stock-based compensation included in the
statements of operations for the three or six months ended August 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKW0TltPBr2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span id="xdx_8B7_z6wRZwGPvSPb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Life
                                            (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Options outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zVPwjygNRui8" style="text-align: right" title="Number of Options Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z5MlF0ULIE13" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229_zM1eCMBvpwz9" style="text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Options assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zZJryDheMkse" style="width: 12%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;86,642&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_ztL0xiqu3Gbf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;61.43&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zX8uathfpHMf" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229_zV3sY59loAyc" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229_zxuUZk3vXkMe" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2451"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zFVFTvBvicCk" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_ztxqk2Xultm3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20230301__20240229_zjf9t1o51tZ2" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z4EScFQQHEN4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2459"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zB9EZyzFHrqc" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zUdaSndO13k7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(1,342&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z6ZP9fv9yAl4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;120.87&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zMgxWTWmT7A8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831_zqt32FAa0PV9" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_zVx7QiD91kd2" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z11gLOvNG9i3" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831_zKQSIjEOOO85" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2475"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831_z38Jy9bS1vq9" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2477"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zojvWxzLM2ej" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831_zhmGe9BizPr1" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20240301__20240831_z2bSGtIGzKig" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zXHfDQm7zppg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_z5FHicFbArmd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2487"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831_zrMMLLE2sR6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(6,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zUXxvWqBEVHd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;87.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_zl6TTOjgnMic" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831_z806xjANvI75" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;78,877&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zrfE4T31Odd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;58.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831_zo18FHV6SF37" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831_zcNuu8x7ZMs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options expected to vest in the future as of August 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831_zd2OsdGTetib" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;1,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_z54MtrYKDiF4" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;32.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zfmcGnKHb1Dc" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;3.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zE35RunqK301" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Options exercisable at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831_zNfwjMbeqLA2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable"&gt;77,445&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zfGivz01ummg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;58.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zJnYi6P8Uar" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;2.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831_zavGZEQo7pL5" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831_zgTgTrY381M6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;78,877&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20240831_z7zw842XH15c" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;58.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zd3tHOuZQX3c" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zzsR3sAGtJf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A3_zxqGBSRwDyK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no option
had an exercise price below the $&lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831_z7RdAZlvv9Pj" title="Options exercise price"&gt;2.59
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;closing price of our common stock as reported
on the Nasdaq Capital Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, there was $&lt;span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_zCB5psPYGnac" title="Unrecognized stock-based compensation expense"&gt;16,139
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of unrecognized stock-based compensation
expense related to unvested stock options with a weighted average remaining recognition period of &lt;span id="xdx_90F_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__us-gaap--EmployeeStockOptionMember_za50Cy9in4Ce" title="Weighted average remaining recognition period"&gt;0.74
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Stock
Appreciation Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 31.9pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
purposes of the 2020 Stock Appreciation Rights Plan (the &#x201c;SAR Plan&#x201d;) are to: (i) enable the Company to attract and retain
the types of employees, consultants, and directors (collectively, &#x201c;Service Providers&#x201d;) who will contribute to the Company&#x2019;s
long-range success; (ii) provide incentives that align the interests of Service Providers with those of the stockholders of the Company;
and (iii) promote the success of the Company&#x2019;s business. The SAR Plan provides for incentive awards only in the form of stock appreciation
rights payable in cash (&#x201c;SARs&#x201d;) and no shares of common stock are reserved or will be issued pursuant to the SAR Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
may be granted to any Service Provider. A SAR is the right to receive an amount equal to the Spread with respect to a share of the Company&#x2019;s
common stock (&#x201c;Share&#x201d;) upon the exercise of the SAR. The &#x201c;Spread&#x201d; is the difference between the exercise price
per share specified in a SAR agreement on the date of grant and the fair market value per share on the date of exercise of the SAR. The
exercise price per share will not be less than 100% of the fair market value of a share of common stock on the date of grant of the SAR.
The administrator of the SAR Plan will have the authority to, among other things, prescribe the terms and conditions of each SAR, including,
without limitation, the exercise price and vesting provisions, and to specify the provisions of the SAR Agreement relating to such grant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company did not grant any SAR&#x2019;s during the six months ended August 31, 2024 or August 31, 2023.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes compensation expense and a corresponding liability for the fair value of the SARs over the vesting period for each
SAR award. The SARs are revalued at each reporting date in accordance with ASC 718 &#x201c;Compensation-Stock Compensation,&#x201d; and
any changes in fair value are reflected in the Statement of Operations as of the applicable reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zBcVO56mokq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span id="xdx_8B9_zMraIxzNLg1h" style="display: none"&gt;Schedule
of Stock Appreciation Rights Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual
                                            Life (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;SARs outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYkx0ZHYPWya" style="text-align: right" title="Options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zS7uyrbPFhi6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2537"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4qR70CF3XKh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;SARs assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVjpZaEK5g25" style="width: 12%; text-align: right" title="Options, Assumed pursuant to reverse acquisition"&gt;40,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zX3ZSvxN0Vqc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;44.77&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFG7sAYamPr6" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zvG4Xlkhks45" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zEMmUaNNo3Mb" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7HkD0YU49Ok" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2551"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zu6LQ7opMcU" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zofD6jbSpdW7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2555"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ2nUc70M7K8" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPeBdtZFr9ql" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;SARs outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zymMamZSGrmk" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Beginning Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFjnfz7Fg6G5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeAAGWZvi1b2" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYromUSLtAK8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRfhBr9C40X4" style="text-align: right" title="Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqeYMkayp6kb" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2571"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zxkk6a0l7HL" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2573"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPegzyktlkd7" style="text-align: right" title="Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2575"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMWjsximVtgk" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2577"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuXAJ4YstJha" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2579"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMsoQXUNk7c" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited or cancelled"&gt;(167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znSNcasf1Sif" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;37.40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zdAtLr9NkBjb" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3gqjAiT4wn" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending Balance"&gt;40,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zrEBS45lc8Z6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;44.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zCN3wrZTwhAl" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"&gt;2.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zmsTvyPH9nf5" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2593"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SARs expected to vest in the future as of August 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMotYWXHOC8" style="text-align: right" title="Options, Expected to vest"&gt;5,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zV1S0hNdgNUf" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;29.37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z1OFBeCyAIQ7" title="Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest"&gt;2.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuHLuAKzFJvk" style="text-align: right" title="Aggregate Intrinsic Value, Expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2601"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;SARs exercisable at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z44NDFqKYff9" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Exercisable"&gt;34,578&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlD6VVfHUeFg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;47.31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zhMjmnXKBe8d" title="Weighted Average Remaining Contractual Life (Yrs.), Exercisable"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwrrLyJVoobh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and SARs expected to vest at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ75WZfpdr1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest"&gt;40,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGDyBIu3c62g" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSvdfpAOI1s9" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z48Q5wRTqJj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Vested, Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2617"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_zq2NCPWaM1xi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the market price of
our common stock for those awards that have an exercise price below the market price of our common stock. At August 31, 2024, no SAR
had an exercise price below the $&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaaEsbHvLtS1" title="Options exercise price"&gt;2.59
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;closing price of our common stock as reported
on the Nasdaq Capital Market.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2024, there was $&lt;span id="xdx_909_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_iI_c20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJikAlhk7eF" title="Weighted average remaining recognition period"&gt;943
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of unrecognized stock-based compensation
expense related to unvested SARs with a weighted average remaining recognition period of &lt;span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zaRwDjEpAXB1" title="Weighted average remaining recognition period"&gt;0.64
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsMJkrYQxTV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B8_zkQxt8HKhodd" style="display: none"&gt;Schedule
of Warranty Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Life
                                            (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Warrants outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zzdUFYwYF1ye" style="text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2627"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z0I419FYMyw9" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2629"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Warrants assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_z9wrCuPcqxZg" style="width: 12%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition"&gt;217,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zjLCAK5GQZT" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;21.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_z0uKOTHVIUK4" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"&gt;1.86&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zc6yCmU31tXd" style="text-align: right" title="Warrants, Granted"&gt;268,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zPc4aM2bHHid" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;3.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_ziCGPYjosccd" title="Weighted Average Remaining Contractual Life (Yrs.), Granted"&gt;2.17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zOAcIfbmOxG5" style="text-align: right" title="Warrants,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2643"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zacem4gPZU6i" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2645"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zvH05pJxGWC7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zoqzvZ20UDE6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2649"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20240831_znYtPvJuDObh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;486,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_z4nT0Ip458oh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;9.94&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zYZsstFAZGT" title="Weighted Average Remaining Contractual Life Years"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20240831_zw31jFWOnvZf" style="text-align: right" title="Warrants, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zbFVB8r8IXP5" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2659"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20240831_zfFZ1vKAMVMj" style="text-align: right" title="Warrants, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zlnZRkH0jAAj" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2663"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20240831_zRm1dGQc7Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;(2,102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20240831_zmIPPL4nLMp1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;322.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20240831_z5Q7qWwJNiv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;484,063&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zivlj0TsIhH9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;8.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20240831_z5XvcGsAF1P3" title="Weighted Average Remaining Contractual Life (Yrs.) Outstanding"&gt;1.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zEgpYg2Y9qCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-07"
      decimals="INF"
      id="Fact002327"
      unitRef="Shares">1200000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2024-03-08"
      decimals="INF"
      id="Fact002329"
      unitRef="Shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002331"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-05-31_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002333"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002335"
      unitRef="Shares">117000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-05-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002337"
      unitRef="Shares">117000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002339"
      unitRef="Shares">192502</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-03-012024-05-31_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002341"
      unitRef="Shares">192502</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-06-012024-08-31_custom_DooyaMediaGroupIncMember"
      decimals="INF"
      id="Fact002343"
      unitRef="Shares">42709</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002345"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002347"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002349"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002351"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002353"
      unitRef="Shares">93295</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002355"
      unitRef="Shares">93295</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002357"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002359"
      unitRef="Shares">472996</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002361"
      unitRef="USDPShares">1500</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2024-03-012024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002363"
      unitRef="Pure">0.09</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002365"
      unitRef="USDPShares">0.13</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002367"
      unitRef="Shares">316</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002369"
      unitRef="Shares">316</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-08-31_custom_SeriesEConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002371"
      unitRef="Shares">3259</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002373"
      unitRef="Shares">5843993</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-04_custom_SeriesFConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002375"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002379"
      unitRef="Shares">100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesGConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002381"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockRedemptionTerms
      contextRef="From2024-03-012024-08-31_custom_SeriesGConvertiblePreferredStockMember"
      id="Fact002383">The
Company shall have the right to redeem up to 50% of the Series G Preferred Stock for an aggregate price of $1.00 in accordance with the
terms of the Perpetual License Agreement</us-gaap:PreferredStockRedemptionTerms>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002387"
      unitRef="Shares">150000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-01-26_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002389"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002391"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002393"
      unitRef="Shares">33000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-08-31_custom_SeriesHConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002395"
      unitRef="Shares">33000</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002397"
      unitRef="Shares">331124</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2024-02-22_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002399"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002401"
      unitRef="Shares">4967</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002403"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-08-152024-08-15_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002405"
      unitRef="USD">15000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002407"
      unitRef="Shares">24834</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002409"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-08-312024-08-31_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002411"
      unitRef="USD">75000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002413"
      unitRef="Shares">59979</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002415"
      unitRef="Shares">59979</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-08-31_custom_SeriesIConvertiblePreferredStockMember"
      decimals="INF"
      id="Fact002417"
      unitRef="Shares">59979</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-08-31_custom_TwoThousandTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact002419"
      unitRef="Shares">7000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002421"
      unitRef="Shares">78877</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="INF"
      id="Fact002425"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-06-012024-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact002427"
      unitRef="USD">13841</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact002429"
      unitRef="USD">30235</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2023-03-012023-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact002433"
      unitRef="USD">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002435">&lt;p id="xdx_895_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKW0TltPBr2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Option
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span id="xdx_8B7_z6wRZwGPvSPb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Schedule
of Stock Option Activity&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Options&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Life
                                            (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Options outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229_zVPwjygNRui8" style="text-align: right" title="Number of Options Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2437"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z5MlF0ULIE13" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229_zM1eCMBvpwz9" style="text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;Options assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_zZJryDheMkse" style="width: 12%; text-align: right" title="Number of Options, Assumed pursuant to reverse acquisition"&gt;86,642&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_ztL0xiqu3Gbf" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;61.43&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zX8uathfpHMf" title="Weighted Average Remaining Contractual Life Years, Life, Assumed pursuant to reverse acquisition"&gt;2.68&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229_zV3sY59loAyc" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2449"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20230301__20240229_zxuUZk3vXkMe" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2451"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zFVFTvBvicCk" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20230301__20240229_ztxqk2Xultm3" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20230301__20240229_zjf9t1o51tZ2" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z4EScFQQHEN4" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2459"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zB9EZyzFHrqc" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2461"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229_zUdaSndO13k7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(1,342&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_z6ZP9fv9yAl4" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;120.87&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229_zMgxWTWmT7A8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Options outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831_zqt32FAa0PV9" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options Outstanding, Balance"&gt;85,300&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_zVx7QiD91kd2" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;60.50&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229_z11gLOvNG9i3" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.52&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831_zKQSIjEOOO85" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2475"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831_z38Jy9bS1vq9" style="text-align: right" title="Number of Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2477"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zojvWxzLM2ej" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2479"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831_zhmGe9BizPr1" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_d0_c20240301__20240831_z2bSGtIGzKig" style="text-align: right" title="Number of Options, Exercised"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zXHfDQm7zppg" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2485"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_z5FHicFbArmd" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2487"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831_zrMMLLE2sR6b" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;(6,423&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zUXxvWqBEVHd" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;87.06&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831_zl6TTOjgnMic" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2493"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Options outstanding August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831_z806xjANvI75" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options Outstanding, Balance"&gt;78,877&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zrfE4T31Odd" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Balance"&gt;58.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831_zo18FHV6SF37" title="Weighted Average Remaining Contractual Life Years, Outstanding Balance"&gt;2.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831_zcNuu8x7ZMs2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value Outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2501"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Options expected to vest in the future as of August 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831_zd2OsdGTetib" style="text-align: right" title="Number of Options, Expected to Vest in the Future Ending Balance"&gt;1,432&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_z54MtrYKDiF4" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;32.25&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zfmcGnKHb1Dc" title="Weighted Average Remaining Contractual Life Years, Expected to Vest"&gt;3.10&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zE35RunqK301" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding, Expected of  Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Options exercisable at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831_zNfwjMbeqLA2" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Exercisable"&gt;77,445&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zfGivz01ummg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;58.67&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zJnYi6P8Uar" title="Weighted Average Remaining Contractual Life Years, Exercisable"&gt;2.01&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831_zavGZEQo7pL5" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Outstanding, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2517"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Options vested, exercisable, and options expected to vest at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831_zgTgTrY381M6" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest, Balance"&gt;78,877&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_c20240301__20240831_z7zw842XH15c" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;58.19&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831_zd3tHOuZQX3c" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.03&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831_zzsR3sAGtJf4" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Outstanding,Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002443"
      unitRef="Shares">86642</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002445"
      unitRef="USDPShares">61.43</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact002447">P2Y8M4D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002457"
      unitRef="Shares">-0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002463"
      unitRef="Shares">1342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002465"
      unitRef="USDPShares">120.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002469"
      unitRef="Shares">85300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002471"
      unitRef="USDPShares">60.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2023-03-012024-02-29" id="Fact002473">P2Y6M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002483"
      unitRef="Shares">-0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002489"
      unitRef="Shares">6423</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002491"
      unitRef="USDPShares">87.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002495"
      unitRef="Shares">78877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002497"
      unitRef="USDPShares">58.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2024-03-01to2024-08-31" id="Fact002499">P2Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002503"
      unitRef="Shares">1432</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002505"
      unitRef="USDPShares">32.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2024-08-31" id="Fact002507">P3Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002511"
      unitRef="Shares">77445</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002513"
      unitRef="USDPShares">58.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2024-08-31" id="Fact002515">P2Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002519"
      unitRef="Shares">78877</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002521"
      unitRef="USDPShares">58.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2024-03-01to2024-08-31" id="Fact002523">P2Y10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002527"
      unitRef="USDPShares">2.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-08-31_us-gaap_EmployeeStockOptionMember"
      decimals="0"
      id="Fact002529"
      unitRef="USD">16139</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2024-03-012024-08-31_us-gaap_EmployeeStockOptionMember"
      id="Fact002531">P0Y8M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002533">&lt;p id="xdx_893_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock_zBcVO56mokq5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;SARs
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; display: none; text-align: justify"&gt;&lt;span id="xdx_8B9_zMraIxzNLg1h" style="display: none"&gt;Schedule
of Stock Appreciation Rights Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;SARs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual
                                            Life (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;SARs outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYkx0ZHYPWya" style="text-align: right" title="Options outstanding, Beginning balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zS7uyrbPFhi6" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2537"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z4qR70CF3XKh" style="text-align: right" title="Aggregate Intrinsic Value, Outstanding Balance"&gt;&#160;&#160;&#160;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 36%; text-align: left"&gt;SARs assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zVjpZaEK5g25" style="width: 12%; text-align: right" title="Options, Assumed pursuant to reverse acquisition"&gt;40,390&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zX3ZSvxN0Vqc" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;44.77&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFG7sAYamPr6" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zvG4Xlkhks45" style="width: 12%; text-align: right" title="Aggregate Intrinsic Value, Assumed pursuant to reverse acquisition"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2547"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zEMmUaNNo3Mb" style="text-align: right" title="Number of Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z7HkD0YU49Ok" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2551"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zu6LQ7opMcU" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zofD6jbSpdW7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of Options, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2555"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ2nUc70M7K8" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2557"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPeBdtZFr9ql" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2559"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;SARs outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zymMamZSGrmk" style="border-bottom: Black 1pt solid; text-align: right" title="Options Outstanding, Beginning Balance"&gt;40,390&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zFjnfz7Fg6G5" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;44.77&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230301__20240229__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zeAAGWZvi1b2" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"&gt;2.99&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zYromUSLtAK8" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zRfhBr9C40X4" style="text-align: right" title="Options, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zqeYMkayp6kb" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2571"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zxkk6a0l7HL" style="text-align: right" title="Aggregate Intrinsic Value, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2573"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zPegzyktlkd7" style="text-align: right" title="Options, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2575"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMWjsximVtgk" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2577"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuXAJ4YstJha" style="text-align: right" title="Aggregate Intrinsic Value, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2579"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zMsoQXUNk7c" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Forfeited or cancelled"&gt;(167&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_znSNcasf1Sif" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;37.40&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zdAtLr9NkBjb" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2585"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;SARs outstanding August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z3gqjAiT4wn" style="border-bottom: Black 2.5pt double; text-align: right" title="Options Outstanding, Ending Balance"&gt;40,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zrEBS45lc8Z6" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;44.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zCN3wrZTwhAl" title="Weighted Average Remaining Contractual Life (Yrs.), Outstanding Balance"&gt;2.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zmsTvyPH9nf5" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Ending Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2593"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;SARs expected to vest in the future as of August 31, 2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zAMotYWXHOC8" style="text-align: right" title="Options, Expected to vest"&gt;5,645&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zV1S0hNdgNUf" style="text-align: right" title="Weighted Average Exercise Price, Expected to Vest"&gt;29.37&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z1OFBeCyAIQ7" title="Weighted Average Remaining Contractual Life (Yrs.), Expected to Vest"&gt;2.84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zuHLuAKzFJvk" style="text-align: right" title="Aggregate Intrinsic Value, Expected to vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2601"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;SARs exercisable at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z44NDFqKYff9" style="border-bottom: Black 1pt solid; text-align: right" title="Options, Exercisable"&gt;34,578&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zlD6VVfHUeFg" style="padding-bottom: 1pt; text-align: right" title="Weighted Average Exercise Price, Exercisable"&gt;47.31&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&lt;span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zhMjmnXKBe8d" title="Weighted Average Remaining Contractual Life (Yrs.), Exercisable"&gt;2.43&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zwrrLyJVoobh" style="border-bottom: Black 1pt solid; text-align: right" title="Aggregate Intrinsic Value, Exercisable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;SARs vested, exercisable, and SARs expected to vest at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zJ75WZfpdr1b" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of Options, Vested, Exercisable and Options Expected to Vest"&gt;40,223&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_iE_pid_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zGDyBIu3c62g" style="padding-bottom: 2.5pt; text-align: right" title="Weighted Average Exercise Price, Vested, Exercisable and Options Expected to Vest"&gt;44.80&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_zSvdfpAOI1s9" title="Weighted Average Remaining Contractual Life (Yrs.), Vested, Exercisable and Options Expected to Vest"&gt;2.49&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iE_pp0p0_c20240301__20240831__us-gaap--AwardTypeAxis__custom--StockAppreciationRightsMember_z48Q5wRTqJj2" style="border-bottom: Black 2.5pt double; text-align: right" title="Aggregate Intrinsic Value, Vested, Exercisable and Options Expected to Vest"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2617"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002541"
      unitRef="Shares">40390</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002543"
      unitRef="USDPShares">44.77</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAssumedPursuantToReverseAcquisition>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact002545">P2Y11M26D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002561"
      unitRef="Shares">40390</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002563"
      unitRef="USDPShares">44.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-03-012024-02-29_custom_StockAppreciationRightsMember"
      id="Fact002565">P2Y11M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002581"
      unitRef="Shares">167</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002583"
      unitRef="USDPShares">37.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002587"
      unitRef="Shares">40223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002589"
      unitRef="USDPShares">44.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="Fact002591">P2Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002595"
      unitRef="Shares">5645</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002597"
      unitRef="USDPShares">29.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="Fact002599">P2Y10M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002603"
      unitRef="Shares">34578</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002605"
      unitRef="USDPShares">47.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="Fact002607">P2Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002611"
      unitRef="Shares">40223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002613"
      unitRef="USDPShares">44.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="Fact002615">P2Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      decimals="INF"
      id="Fact002619"
      unitRef="USDPShares">2.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="AsOf2024-08-31_custom_StockAppreciationRightsMember"
      decimals="0"
      id="Fact002621"
      unitRef="USD">943</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="From2024-03-012024-08-31_custom_StockAppreciationRightsMember"
      id="Fact002623">P0Y7M20D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002625">&lt;p id="xdx_896_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zsMJkrYQxTV" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
activity for the six months ended August 31, 2024 and the year ended February 29, 2024 was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; display: none; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8B8_zkQxt8HKhodd" style="display: none"&gt;Schedule
of Warranty Activity&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Warrants&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price
                                            ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Life
                                            (Yrs.)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Warrants outstanding at February 28, 2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20230301__20240229_zzdUFYwYF1ye" style="text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2627"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20230301__20240229_z0I419FYMyw9" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2629"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 52%; text-align: left"&gt;Warrants assumed pursuant to reverse acquisition&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition_pid_c20230301__20240229_z9wrCuPcqxZg" style="width: 12%; text-align: right" title="Warrants, Assumed pursuant to reverse acquisition"&gt;217,593&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zjLCAK5GQZT" style="width: 12%; text-align: right" title="Weighted Average Exercise Price, Assumed pursuant to reverse acquisition"&gt;21.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_z0uKOTHVIUK4" title="Weighted Average Remaining Contractual Life (Yrs.), Assumed pursuant to reverse acquisition"&gt;1.86&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20230301__20240229_zc6yCmU31tXd" style="text-align: right" title="Warrants, Granted"&gt;268,572&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zPc4aM2bHHid" style="text-align: right" title="Weighted Average Exercise Price Outstanding, Granted"&gt;3.02&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_ziCGPYjosccd" title="Weighted Average Remaining Contractual Life (Yrs.), Granted"&gt;2.17&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20230301__20240229_zOAcIfbmOxG5" style="text-align: right" title="Warrants,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2643"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20230301__20240229_zacem4gPZU6i" style="text-align: right" title="Weighted Average Exercise Price Outstanding,Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2645"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20230301__20240229_zvH05pJxGWC7" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2647"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20230301__20240229_zoqzvZ20UDE6" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Forfeited or cancelled"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2649"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;Warrants outstanding at February 29, 2024&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20240301__20240831_znYtPvJuDObh" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants Outstanding, Beginning Balance"&gt;486,165&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240301__20240831_z4nT0Ip458oh" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price Outstanding, Beginning Balance"&gt;9.94&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20230301__20240229_zYZsstFAZGT" title="Weighted Average Remaining Contractual Life Years"&gt;1.96&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Granted&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20240301__20240831_zw31jFWOnvZf" style="text-align: right" title="Warrants, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2657"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zbFVB8r8IXP5" style="text-align: right" title="Weighted Average Exercise Price, Granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2659"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;Exercised&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20240301__20240831_zfFZ1vKAMVMj" style="text-align: right" title="Warrants, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2661"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice_pid_c20240301__20240831_zlnZRkH0jAAj" style="text-align: right" title="Weighted Average Exercise Price, Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2663"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Forfeited or cancelled&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20240301__20240831_zRm1dGQc7Kb" style="border-bottom: Black 1pt solid; text-align: right" title="Warrants, Forfeited or cancelled"&gt;(2,102&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled_pid_c20240301__20240831_zmIPPL4nLMp1" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted Average Exercise Price, Forfeited or cancelled"&gt;322.00&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;-&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Warrants outstanding at August 31, 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20240301__20240831_z5Q7qWwJNiv2" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrants Outstanding, Ending Balance"&gt;484,063&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240301__20240831_zivlj0TsIhH9" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted Average Exercise Price Outstanding, Ending Balance"&gt;8.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20240301__20240831_z5XvcGsAF1P3" title="Weighted Average Remaining Contractual Life (Yrs.) Outstanding"&gt;1.46&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002631"
      unitRef="Shares">217593</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAssumedPursuantToReverseAcquisition>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002633"
      unitRef="USDPShares">21.01</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsAssumedPursuantToReverseAcquisitionInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact002635">P1Y10M9D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsAssumedPursuantToReverseAcquisitionWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002637"
      unitRef="Shares">268572</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2023-03-012024-02-29"
      decimals="INF"
      id="Fact002639"
      unitRef="USDPShares">3.02</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact002641">P2Y2M1D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsGrantedInPeriodWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002651"
      unitRef="Shares">486165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-02-29"
      decimals="INF"
      id="Fact002653"
      unitRef="USDPShares">9.94</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2023-03-012024-02-29" id="Fact002655">P1Y11M15D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002665"
      unitRef="Shares">2102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
      contextRef="From2024-03-01to2024-08-31"
      decimals="INF"
      id="Fact002667"
      unitRef="USDPShares">322.00</NTRP:ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002669"
      unitRef="Shares">484063</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-08-31"
      decimals="INF"
      id="Fact002671"
      unitRef="USDPShares">8.58</NTRP:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice>
    <NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2024-03-01to2024-08-31" id="Fact002673">P1Y5M15D</NTRP:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2024-03-01to2024-08-31" id="Fact002675">&lt;p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_zvgvmMIU2Om8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;NOTE
9 - &lt;span id="xdx_828_zKDN5G3RXJY9"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"&gt;&lt;i&gt;Related Party Advances&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Between
September 1, 2024 and October 11, 2024, additional net related party advances totaled $&lt;span id="xdx_902_eus-gaap--PaymentsToFundLongtermLoansToRelatedParties_c20240901__20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z70f9cDxZk99" title="Related party advances"&gt;84,060&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
and the aggregate outstanding principal balance of related party advances was $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20241011__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zydsjIyvL4Dd" title="Related party advances"&gt;2,802,654&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 13, 2024, the Company&#x2019;s board of directors approved the conversion of up to &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_pid_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpH7f8ZZJUDh" title="Conversion percentage"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of the outstanding principal balance of the promissory notes held by Messrs. Kerby and Monaco into shares of a series of non-redeemable
convertible preferred stock preferred stock yet to be designated. Messrs. Kerby and Monaco have agreed to initially convert $&lt;span id="xdx_90B_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zrVjpegsVuJ7" title="Converted amount"&gt;1,500,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
or &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentRate_dp_uPure_c20240913__20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_z05GQporSMui" title="Conversion percentage"&gt;56.3&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%
of their total outstanding principal balance of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentCarryingAmount_iI_c20240913__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--MessrsKerbyAndMonacoMember_zCZLS7gHqMQ3" title="Outstanding principal  amount"&gt;2,666,790
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;into the new series of convertible preferred
stock, and, at their discretion, may convert up to the remaining principal balance, or any portion thereof, into additional shares of
such convertible preferred stock at a future date. The conversion remains subject to completion of final documentation for the transaction,
including the filing of the certificate of designation for the new series of convertible preferred stock with the Nevada Secretary of
State.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;i&gt;Nasdaq Listing Requirement Deficiency Notice &lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 18, 2024, the Company received a notification letter (the &#x201c;Notice&#x201d;) from the Nasdaq Listing Qualifications Staff
(the &#x201c;Staff&#x201d;) of The Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) notifying the Company that its amount of stockholders&#x2019;
equity has fallen below the $&lt;span id="xdx_900_ecustom--MinimumRequiredStockholdersEquity_iI_c20240918__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh6ZX76RWGKe" title="Stockholders equity minimum required"&gt;2,500,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;required minimum for continued listing
set forth in Nasdaq Listing Rule 5550(b)(1). The Notice also noted that the Company does not meet the alternatives of market value of
listed securities or net income from continuing operations, and therefore, the Company no longer complies with Nasdaq&#x2019;s Listing
Rules.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Under
Nasdaq Listing Rules, the Company has until November 4, 2024 to provide Nasdaq with a specific plan to achieve and sustain compliance.
If Nasdaq accepts the Company&#x2019;s plan to regain compliance, Nasdaq may grant an extension of up to 180 calendar days from the date
of the Notice to evidence compliance. If Nasdaq does not accept the Company&#x2019;s plan to regain compliance, the Company will have
the opportunity to appeal the decision to a Nasdaq Hearings Panel. A hearing request will stay the suspension and delisting of the Company&#x2019;s
securities pending the Nasdaq Hearings Panel&#x2019;s decision.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Notice has no immediate effect on the listing of the Company&#x2019;s common stock on the Nasdaq Capital Market, and, therefore, the Company&#x2019;s
listing remains fully effective.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is evaluating various courses of action to achieve compliance with Nasdaq Listing Rule 5550(b)(1). There can be no assurance
that the Company will regain compliance with Nasdaq Listing Rule 5550(b)(1) or that the Company will be able meet the continued listing
requirements during any compliance period that may be granted by Nasdaq.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 18, 2024, the Company also received a letter from the Staff of Nasdaq indicating that the Staff has determined that the Company
has regained compliance with the periodic filing requirements set forth in Nasdaq Listing Rule 5250(c)(1) because the Company filed its
Annual Report on Form 10-K for the fiscal year ended February 29, 2024 and the Quarterly Report on Form 10-Q for the quarter ended May
31, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accordingly,
the Company has regained full compliance with the periodic filing requirement deficiency, which the Company disclosed in those Current
Reports on Form 8-K filed with the Securities and Exchange Commission on June 21, 2024 and July 19, 2024, and Nasdaq has informed the
Company in writing that the matter is now closed.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;i&gt;September 2024 Alumni Capital Transactions&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2024 the Company entered into a securities purchase agreement (the &#x201c;Note &amp;amp; Warrant SPA&#x201d;) with Alumni Capital
LP (Alumni Capital&#x201d;) for the sale of a short-term promissory note (the &#x201c;Alumni Note&#x201d;) and warrants (the &#x201c;Warrants&#x201d;)
to Alumni Capital for total consideration of $&lt;span id="xdx_90C_eus-gaap--NotesAndLoansPayableCurrent_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zKZiBTGYZnf3" title="Total consideration"&gt;250,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
After deducting commissions, net proceeds to the Company were $&lt;span id="xdx_909_eus-gaap--ProceedsFromNotesPayable_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5ZZ2BU1OIRd" title="Net proceeds"&gt;230,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Alumni Note is in the principal amount of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zknXAbXIYace" title="Principal amount"&gt;300,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;with an original issue discount of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z5P9Q1Y6laT6" title="Original issue discount"&gt;50,000
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and guaranteed interest on the principal
amount of ten percent (&lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zOn32w44HPPa" title="Interest rate"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%)
per annum which shall be due and payable on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zNPwmNUxeaW8" title="Maturity date"&gt;December
19, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;. In the event of a failure to
re-pay the Alumni Note on or before December 19, 2024, the interest rate will increase to the lesser of twenty-two percent (&lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_uPure_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zSWDZaP1ycbf" title="Interest rate"&gt;22&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;%)
per annum or the maximum amount permitted under law from the due date thereof until the same is paid. The Alumni Note is convertible
into common stock of the Company only upon an event of default.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Upon
such an event of default, Alumni shall have the right to convert all or any part of the outstanding and unpaid principal, interest, penalties,
and all other amounts under the Alumni Note into fully paid and non-assessable shares of the &lt;span id="xdx_90A_eus-gaap--DebtInstrumentDescription_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zfkdkhRbxlD4" title="Debt instrument description"&gt;Company&#x2019;s
common stock at a conversion price of eighty percent (80%) of the lowest traded price of the common stock during the twenty (20) business
days prior to Alumni&#x2019;s delivery of a notice of conversion (the &#x201c;Conversion Price&#x2019;), subject to adjustment in the event
the Company is no longer DWAC eligible, is subject to a DTC &#x201c;chill&#x201d; and/or the Company ceases to be a reporting issuer. Notwithstanding
the foregoing, conversions will be subject to limitation whereby such conversion would result in beneficial ownership by Alumni and its
affiliates of more than 9.99% of the outstanding shares of Company&#x2019;s common stock (the &#x201c;Beneficial Ownership Limitation&#x201d;)
or would exceed 19.99% of the Company&#x2019;s outstanding common stock&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;as
of September 19, 2024 (the &#x201c;Exchange Cap&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;In
conjunction with the issuance of the Alumni Note to Alumni, the Company also issued Warrants to purchase &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zJe9Oftka641" title="Warrants to purchase of common stock"&gt;96,774
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;shares of common
stock at a price per share of $&lt;span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCKyZnJ6fITe" title="Exercise price per share"&gt;3.10&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;,
which represents 100% warrant coverage on the principal amount of the Alumni Note. The Warrants are exercisable on or prior to the five
(&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ztAeVUu8jls6" title="Warrants exercise term"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;)
year anniversary of the date of issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2024, the Company also entered into a Common Stock Securities Purchase Agreement (the &#x201c;Common Stock SPA&#x201d;) with
Alumni Capital. Pursuant to the Common Stock SPA, the Company has the right, but not the obligation to cause Alumni Capital to purchase
up to $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--RangeAxis__srt--MaximumMember_zVmxjK8NY4p6" title="Number of purchase of shares"&gt;10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million shares of common stock (the &#x201c;Commitment
Amount&#x201d;) at the Purchase Price (defined below) during the period beginning on the execution date of the Common Stock SPA and ending
on the earlier of (i) the date on which Alumni Capital has purchased $&lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn6n6_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zxwKLMfSVCL1" title="Number of purchase of shares"&gt;10
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million shares of common stock pursuant
to the Common Stock SPA or (ii) December 31, 2025. &lt;span id="xdx_90B_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z8GRZ4Rowijb" style="background-color: white" title="Sale of stock description"&gt;Pursuant
to the Common Stock SPA, the &#x201c;Purchase Price&#x201d; means the lowest traded price of Company common stock during the five (5) business
days prior a closing date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration
statement and no Purchase Notice will be in an amount greater than $500,000.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;In
consideration for Alumni Capital&#x2019;s execution and delivery of, and performance under, the Common Stock SPA, the Company (i) issued
and delivered &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240919__20240919__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zz2mdgfPrNMg" title="Number of shares issued"&gt;32,786
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"&gt;shares of Company
common stock to Alumni Capital on September 19, 2024, and (ii) within one (1) business day from the date off effectiveness of the S-1
Registration Statement registering shares issuable pursuant to the Common Stock SPA, the Company shall cause its transfer agent to issue
and deliver as DWAC or DRS shares to Alumni Capital that number of shares of common stock equal to two percent (2.00%) of the Commitment
Amount divided by the VWAP for the Company&#x2019;s common stock for the business day prior to the notice of effectiveness.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;October
2024 Preferred Stock Sale&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 1, 2024, the Company entered into a securities purchase agreement with an investor for the sale of &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zH6sqARaCE8g" title="Sale of stock, shares"&gt;66,225
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;shares of Series I Convertible Preferred
Stock at $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_ze5wQJnyIt7b" title="Sale of stock, shares price"&gt;3.02
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share, for total consideration of
$&lt;span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20241001__20241001__us-gaap--StatementClassOfStockAxis__custom--SeriesIConvertiblePreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6HTDv7wnkwk" title="Sale of stock proceeds"&gt;200,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.&lt;/span&gt;&lt;/p&gt;




</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="From2024-09-012024-10-11_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002677"
      unitRef="USD">84060</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-10-11_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002679"
      unitRef="USD">2802654</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002681"
      unitRef="Pure">1</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember"
      decimals="0"
      id="Fact002683"
      unitRef="USD">1500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentRate
      contextRef="From2024-09-132024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember"
      decimals="INF"
      id="Fact002685"
      unitRef="Pure">0.563</us-gaap:DebtConversionConvertedInstrumentRate>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2024-09-13_us-gaap_SubsequentEventMember_custom_MessrsKerbyAndMonacoMember"
      decimals="0"
      id="Fact002687"
      unitRef="USD">2666790</us-gaap:DebtInstrumentCarryingAmount>
    <NTRP:MinimumRequiredStockholdersEquity
      contextRef="AsOf2024-09-18_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002689"
      unitRef="USD">2500000</NTRP:MinimumRequiredStockholdersEquity>
    <us-gaap:NotesAndLoansPayableCurrent
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002691"
      unitRef="USD">250000</us-gaap:NotesAndLoansPayableCurrent>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002693"
      unitRef="USD">230000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002695"
      unitRef="USD">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="0"
      id="Fact002697"
      unitRef="USD">50000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002699"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002701">2024-12-19</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember"
      decimals="INF"
      id="Fact002703"
      unitRef="Pure">0.22</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember"
      id="Fact002705">Company&#x2019;s
common stock at a conversion price of eighty percent (80%) of the lowest traded price of the common stock during the twenty (20) business
days prior to Alumni&#x2019;s delivery of a notice of conversion (the &#x201c;Conversion Price&#x2019;), subject to adjustment in the event
the Company is no longer DWAC eligible, is subject to a DTC &#x201c;chill&#x201d; and/or the Company ceases to be a reporting issuer. Notwithstanding
the foregoing, conversions will be subject to limitation whereby such conversion would result in beneficial ownership by Alumni and its
affiliates of more than 9.99% of the outstanding shares of Company&#x2019;s common stock (the &#x201c;Beneficial Ownership Limitation&#x201d;)
or would exceed 19.99% of the Company&#x2019;s outstanding common stock</us-gaap:DebtInstrumentDescription>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002707"
      unitRef="Shares">96774</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002709"
      unitRef="USDPShares">3.10</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2024-09-19_us-gaap_SubsequentEventMember"
      id="Fact002711">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_srt_MaximumMember"
      decimals="-6"
      id="Fact002713"
      unitRef="USD">10000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="-6"
      id="Fact002715"
      unitRef="USD">10000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      id="Fact002717">Pursuant
to the Common Stock SPA, the &#x201c;Purchase Price&#x201d; means the lowest traded price of Company common stock during the five (5) business
days prior a closing date multiplied by eighty nine percent (89%). No Purchase Notice will be made without an effective registration
statement and no Purchase Notice will be in an amount greater than $500,000.</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-09-192024-09-19_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember"
      decimals="INF"
      id="Fact002719"
      unitRef="Shares">32786</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002721"
      unitRef="Shares">66225</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002723"
      unitRef="USDPShares">3.02</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2024-10-012024-10-01_custom_SeriesIConvertiblePreferredStockMember_custom_SecuritiesPurchaseAgreementMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002725"
      unitRef="USD">200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000139"
          xlink:label="Fact000139"
          xlink:type="locator"/>
        <link:footnote id="Footnote000169" xlink:label="Footnote000169" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_z6Ekva3JH2xg"
  title="Number of shares acquired">83,371</xhtml:span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <xhtml:span
  id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zZ1iSAPMmFo3"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <xhtml:span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000139"
          xlink:to="Footnote000169"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000140"
          xlink:label="Fact000140"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000140"
          xlink:to="Footnote000169"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000158"
          xlink:label="Fact000158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000158"
          xlink:to="Footnote000169"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000159"
          xlink:label="Fact000159"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000159"
          xlink:to="Footnote000169"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000262"
          xlink:label="Fact000262"
          xlink:type="locator"/>
        <link:footnote id="Footnote000293" xlink:label="Footnote000293" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zF2Iyi2frhtk"
  title="Number of shares acquired">83,371</xhtml:span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <xhtml:span
  id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zej8vkWWnJQ4"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <xhtml:span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000262"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000264"
          xlink:label="Fact000264"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000264"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000266"
          xlink:label="Fact000266"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000266"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000268"
          xlink:label="Fact000268"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000268"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000270"
          xlink:label="Fact000270"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000270"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000272"
          xlink:label="Fact000272"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000272"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0274"
          xlink:label="xdx2ixbrl0274"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0274"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0276"
          xlink:label="xdx2ixbrl0276"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0276"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000278"
          xlink:label="Fact000278"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000278"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000280"
          xlink:label="Fact000280"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000280"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000282"
          xlink:label="Fact000282"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000282"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000284"
          xlink:label="Fact000284"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000284"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000286"
          xlink:label="Fact000286"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000286"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000288"
          xlink:label="Fact000288"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000288"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000290"
          xlink:label="Fact000290"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000290"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000292"
          xlink:label="Fact000292"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000292"
          xlink:to="Footnote000293"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0299"
          xlink:label="xdx2ixbrl0299"
          xlink:type="locator"/>
        <link:footnote id="Footnote000426" xlink:label="Footnote000426" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On December 29,
2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pid_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zwrW1FaxviGd"
  title="Number of shares acquired">83,371</xhtml:span> shares of Sigma
Additive Solutions, Inc. common stock in exchange for <xhtml:span
  id="xdx_90E_ecustom--PercentageForIssuedAndOutstandingCapitalStock_pid_dp_c20231229__20231229__us-gaap--BusinessAcquisitionAxis__custom--NextTripGroupLLCMember_zekArRvcggKb"
  title="Percentage for issued and outstanding capital stock">100</xhtml:span>% of the issued and outstanding capital stock of NextTrip at the time of the
reverse acquisition. <xhtml:span style="text-decoration: underline">The Company has reflected this transaction retroactively in these financial statements</xhtml:span>.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0299"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000300"
          xlink:label="Fact000300"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000300"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000301"
          xlink:label="Fact000301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000301"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000302"
          xlink:label="Fact000302"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000302"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000303"
          xlink:label="Fact000303"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000303"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0305"
          xlink:label="xdx2ixbrl0305"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0305"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000307"
          xlink:label="Fact000307"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000307"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0325"
          xlink:label="xdx2ixbrl0325"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0325"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000326"
          xlink:label="Fact000326"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000326"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000327"
          xlink:label="Fact000327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000327"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000328"
          xlink:label="Fact000328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000328"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000329"
          xlink:label="Fact000329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000329"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0331"
          xlink:label="xdx2ixbrl0331"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0331"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000333"
          xlink:label="Fact000333"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000333"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0341"
          xlink:label="xdx2ixbrl0341"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0341"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000343"
          xlink:label="Fact000343"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000343"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000407"
          xlink:label="Fact000407"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000407"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000408"
          xlink:label="Fact000408"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000408"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000409"
          xlink:label="Fact000409"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000409"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000410"
          xlink:label="Fact000410"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000410"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000411"
          xlink:label="Fact000411"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000411"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000413"
          xlink:label="Fact000413"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000413"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000415"
          xlink:label="Fact000415"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000415"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000423"
          xlink:label="Fact000423"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000423"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000425"
          xlink:label="Fact000425"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000425"
          xlink:to="Footnote000426"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001693"
          xlink:label="Fact001693"
          xlink:type="locator"/>
        <link:footnote id="Footnote001756" xlink:label="Footnote001756" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001693"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001695"
          xlink:label="Fact001695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001695"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001697"
          xlink:label="Fact001697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001697"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001699"
          xlink:label="Fact001699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001699"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001701"
          xlink:label="Fact001701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001701"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001703"
          xlink:label="Fact001703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001703"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001705"
          xlink:label="Fact001705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001705"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001707"
          xlink:label="Fact001707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001707"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001709"
          xlink:label="Fact001709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001709"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001711"
          xlink:label="Fact001711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001711"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1713"
          xlink:label="xdx2ixbrl1713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1713"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1715"
          xlink:label="xdx2ixbrl1715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1715"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001717"
          xlink:label="Fact001717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001717"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001719"
          xlink:label="Fact001719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001719"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1721"
          xlink:label="xdx2ixbrl1721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1721"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1723"
          xlink:label="xdx2ixbrl1723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1723"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001725"
          xlink:label="Fact001725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001725"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001727"
          xlink:label="Fact001727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001727"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001729"
          xlink:label="Fact001729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001729"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001731"
          xlink:label="Fact001731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001731"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001733"
          xlink:label="Fact001733"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001733"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001735"
          xlink:label="Fact001735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001735"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001737"
          xlink:label="Fact001737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001737"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001739"
          xlink:label="Fact001739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001739"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001741"
          xlink:label="Fact001741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001741"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001743"
          xlink:label="Fact001743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001743"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001745"
          xlink:label="Fact001745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001745"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001747"
          xlink:label="Fact001747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001747"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001749"
          xlink:label="Fact001749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001749"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001751"
          xlink:label="Fact001751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001751"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001753"
          xlink:label="Fact001753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001753"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001755"
          xlink:label="Fact001755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001755"
          xlink:to="Footnote001756"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1814"
          xlink:label="xdx2ixbrl1814"
          xlink:type="locator"/>
        <link:footnote id="Footnote001839" xlink:label="Footnote001839" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1814"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001815"
          xlink:label="Fact001815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001815"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001816"
          xlink:label="Fact001816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001816"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001817"
          xlink:label="Fact001817"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001817"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001818"
          xlink:label="Fact001818"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001818"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1820"
          xlink:label="xdx2ixbrl1820"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1820"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001822"
          xlink:label="Fact001822"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001822"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1830"
          xlink:label="xdx2ixbrl1830"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1830"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001831"
          xlink:label="Fact001831"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001831"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001832"
          xlink:label="Fact001832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001832"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001833"
          xlink:label="Fact001833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001833"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001834"
          xlink:label="Fact001834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001834"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1836"
          xlink:label="xdx2ixbrl1836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1836"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001838"
          xlink:label="Fact001838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001838"
          xlink:to="Footnote001839"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1907"
          xlink:label="xdx2ixbrl1907"
          xlink:type="locator"/>
        <link:footnote id="Footnote001952" xlink:label="Footnote001952" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
    December 29, 2023, Sigma Additive Solutions, Inc. acquired NextTrip in a reverse acquisition. NextTrip Group, LLC was issued </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1907"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001908"
          xlink:label="Fact001908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001908"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001909"
          xlink:label="Fact001909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001909"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001910"
          xlink:label="Fact001910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001910"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001911"
          xlink:label="Fact001911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001911"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1913"
          xlink:label="xdx2ixbrl1913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1913"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001915"
          xlink:label="Fact001915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001915"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1923"
          xlink:label="xdx2ixbrl1923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1923"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001925"
          xlink:label="Fact001925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001925"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1933"
          xlink:label="xdx2ixbrl1933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1933"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001934"
          xlink:label="Fact001934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001934"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001935"
          xlink:label="Fact001935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001935"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001936"
          xlink:label="Fact001936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001936"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001937"
          xlink:label="Fact001937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001937"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1939"
          xlink:label="xdx2ixbrl1939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1939"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001941"
          xlink:label="Fact001941"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001941"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1949"
          xlink:label="xdx2ixbrl1949"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1949"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001951"
          xlink:label="Fact001951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001951"
          xlink:to="Footnote001952"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
